Citrus Sinensis ID: 008031

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580
Protein Sequence
MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSGSTPCPSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDAGPSTSE
Secondary Structure (PSIPRED)
cEEEEcccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccEEEEcccccccHHHHHHHcccEEccccccEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHcccccccccccccEEEcccccEEEEEcccccccHHHHHHcccccccccHHHHHHHHHHHHHHHHccccccccccccccccccccccccccEEccccHHHccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEcccccEEccccHHHHHcccccEEEEEEEcccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHccccccHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHcHccccccccccccccccccccccccccEEEEccccccccHHHHHHHHccccccccccEEEEEEcccccEEEEEEccccccccccHHHHHHHHHHHcccccHHHEHEEEccccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcHHHcEEEcccccEEccccccEEccccccccHHHccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHcccccHEccHHHccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccccccc
Coil and Loop (DISEMBL)
MFLALQYNnlsgripaslgklselqeislshnkisgvmpsdlgrlsrlrildfsynaingslpasfSNLSSLVSLTlesnnlddQILDSLdklhnlsvlnlkrnqisghipstigniSTLTILDlsqnklsgeipasfsnlksLSSFNVsynnlsgpvptslalkfnassfvgniqlcgysgstpcpsppaekpksrgrklstkDIILIGAGALLIVLLIIVCILMCCLIRkrtaskaedgqatasgtaargekgapsaageveaggenggklvhfdgplmftADDLLCATAEimgkstygTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLlgkirhpnlLALRAYylgpkgekllvfdymphgslatflhargpetpidwptRMKIIKGMTRGllhlhsneniihgnltssnvllddstnakisdfgLSRLMTAAANVNVIATAGalgyrapelsklkkantktdvYSLGVTILELltgkspgeplngaelpQWVASIVKEewtnevfdlelmrdaptiGDELLNTLKLALhcvdpspsarpEVLQVVQQLEEIRpeaataatssgdagpstse
Flexible Loop (DISEMBL)
MFLALQYNNLSGRIPASLGKLSELQEISLshnkisgvmpsdLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSGSTPCPSppaekpksrgrklSTKDIILIGAGALLIVLLIIVCILMCCLIRKRtaskaedgqatasgtaargekgaPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYkatledgsqvAVKRLREKItkgqrefesevsllgkirhpnLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALgyrapelsklkkantktdvYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPeaataatssgdagpstse
Low Complexity Region (SEG)
MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAsfsnlkslssfnvsYNNLSGPVPTSLALKFNASSFVGNIQLCGYSGSTPCPSPPAEKPKSRGRKLSTKDiiligagallivlliivcilmccliRKRTASKAEDGQATASGTAARGEKgapsaageveaggenggKLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMtaaanvnviatagaLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEaataatssgdagpstsE
Disordered region (IsUnstruct)
*********************************ISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYS**********************KDIILIGAGALLIVLLIIVCILMCCLIRK***************************************KLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVD***************************************
Disordered Region (DISOPRED)
MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGY**************************ILIGAGALLIVLLIIVCILMCCLIRK***************************************KLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREK*****REFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ************************
Disordered Region (DISEMBL)
MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSGS****************KLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRT*******************************GGENGGKLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP******************
Disordered Region (DISPRO)
MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSGSTPCP**************STKDIILIGAGALLIVLLIIVCILMCCLIRKRTA*********************************NGGKLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR*******************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSGSTPCPSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDAGPSTSE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	580	2.2.26 [Sep-21-2011]
C0LGP9	784	Probable leucine-rich rep	yes	no	0.968	0.716	0.675	0.0
Q9SCT4	836	Probably inactive leucine	yes	no	0.955	0.662	0.689	0.0
O48788	658	Probable inactive recepto	no	no	0.9	0.793	0.401	4e-99
Q9C9Y8	640	Probable inactive recepto	no	no	0.887	0.804	0.386	2e-94
Q9LVM0	654	Probable inactive recepto	no	no	0.886	0.785	0.407	6e-94
P33543	674	Putative kinase-like prot	no	no	0.931	0.801	0.387	7e-90
Q9M9C5	670	Probable leucine-rich rep	no	no	0.868	0.752	0.376	1e-89
Q9SH71	587	Putative inactive recepto	no	no	0.843	0.833	0.360	3e-87
Q9SUQ3	638	Probable inactive recepto	no	no	0.875	0.796	0.379	1e-86
Q9LP77	655	Probable inactive recepto	no	no	0.908	0.804	0.365	4e-86

>sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1

 Score =  767 bits (1980), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/574 (67%), Positives = 454/574 (79%), Gaps = 12/574 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLS-RLRILDFSYNAINGS 61
           L L +N+LSG+IP SL + S LQ ++L HN +SG +    G  S  LR+L   +N+++G 
Sbjct: 202 LNLSFNSLSGQIPVSLSRSSSLQFLALDHNNLSGPILDTWGSKSLNLRVLSLDHNSLSGP 261

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
            P S  NL+ L   +   N +   +   L KL  L  +++  N +SGHIP T+GNIS+L 
Sbjct: 262 FPFSLCNLTQLQDFSFSHNRIRGTLPSELSKLTKLRKMDISGNSVSGHIPETLGNISSLI 321

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYS 181
            LDLSQNKL+GEIP S S+L+SL+ FNVSYNNLSGPVPT L+ KFN+SSFVGN  LCGYS
Sbjct: 322 HLDLSQNKLTGEIPISISDLESLNFFNVSYNNLSGPVPTLLSQKFNSSSFVGNSLLCGYS 381

Query: 182 GSTPCPSPPAEKP----KSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRT-AS 236
            STPCP+ P+  P    K   R LSTKDIILI +GALLIV+LI+VC+L CCL+RK+   +
Sbjct: 382 VSTPCPTLPSPSPEKERKPSHRNLSTKDIILIASGALLIVMLILVCVL-CCLLRKKANET 440

Query: 237 KAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATAEIMG 296
           KA+ G+A     AA+ EKG     GE EAGGE GGKLVHFDGP+ FTADDLLCATAEIMG
Sbjct: 441 KAKGGEAGPGAVAAKTEKG-----GEAEAGGETGGKLVHFDGPMAFTADDLLCATAEIMG 495

Query: 297 KSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPK 356
           KSTYGTVYKATLEDGSQVAVKRLREKITK Q+EFE+E+++LG+IRHPNLLALRAYYLGPK
Sbjct: 496 KSTYGTVYKATLEDGSQVAVKRLREKITKSQKEFENEINVLGRIRHPNLLALRAYYLGPK 555

Query: 357 GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTS 416
           GEKL+VFDYM  GSLATFLHARGP+  I+WPTRM +IKGM RGL +LH++ NIIHGNLTS
Sbjct: 556 GEKLVVFDYMSRGSLATFLHARGPDVHINWPTRMSLIKGMARGLFYLHTHANIIHGNLTS 615

Query: 417 SNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLG 476
           SNVLLD++  AKISD+GLSRLMTAAA  +VIATAGALGYRAPELSKLKKANTKTDVYSLG
Sbjct: 616 SNVLLDENITAKISDYGLSRLMTAAAGSSVIATAGALGYRAPELSKLKKANTKTDVYSLG 675

Query: 477 VTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLA 536
           V ILELLTGKSP E LNG +LPQWVA+ VKEEWTNEVFDLEL+ D  T+GDE+LNTLKLA
Sbjct: 676 VIILELLTGKSPSEALNGVDLPQWVATAVKEEWTNEVFDLELLNDVNTMGDEILNTLKLA 735

Query: 537 LHCVDPSPSARPEVLQVVQQLEEIRPEAATAATS 570
           LHCVD +PS RPE  QV+ QL EIRPE  TA TS
Sbjct: 736 LHCVDATPSTRPEAQQVMTQLGEIRPEETTATTS 769

Can phosphorylate AGL24.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SCT4|IMK2_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase IMK2 OS=Arabidopsis thaliana GN=IMK2 PE=1 SV=1

 Score =  746 bits (1927), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/573 (68%), Positives = 456/573 (79%), Gaps = 19/573 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N  SG +P SL K S L+E+S+SHN++SG +P + G L  L+ LDFSYN+ING++
Sbjct: 244 LNLDHNRFSGAVPVSLCKHSLLEEVSISHNQLSGSIPRECGGLPHLQSLDFSYNSINGTI 303

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P SFSNLSSLVSL LESN+L   I D++D+LHNL+ LNLKRN+I+G IP TIGNIS +  
Sbjct: 304 PDSFSNLSSLVSLNLESNHLKGPIPDAIDRLHNLTELNLKRNKINGPIPETIGNISGIKK 363

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LDLS+N  +G IP S  +L  LSSFNVSYN LSGPVP  L+ KFN+SSF+GNIQLCGYS 
Sbjct: 364 LDLSENNFTGPIPLSLVHLAKLSSFNVSYNTLSGPVPPVLSKKFNSSSFLGNIQLCGYSS 423

Query: 183 STPCPSPPAEKP------------KSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLI 230
           S PCP+P    P            K   RKLS KD+ILI  GALL +LL++ CIL+CCLI
Sbjct: 424 SNPCPAPDHHHPLTLSPTSSQEPRKHHHRKLSVKDVILIAIGALLAILLLLCCILLCCLI 483

Query: 231 RKRTASKAEDGQ-ATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLC 289
           +KR A K +DG+  T+  T + G       AG   AGGE GGKLVHFDGP +FTADDLLC
Sbjct: 484 KKRAALKQKDGKDKTSEKTVSAG------VAGTASAGGEMGGKLVHFDGPFVFTADDLLC 537

Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           ATAEIMGKSTYGT YKATLEDG++VAVKRLREK TKG +EFE EV+ LGKIRH NLLALR
Sbjct: 538 ATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKGVKEFEGEVTALGKIRHQNLLALR 597

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           AYYLGPKGEKLLVFDYM  GSL+ FLHARGPET I W TRMKI KG++RGL HLHSNEN+
Sbjct: 598 AYYLGPKGEKLLVFDYMSKGSLSAFLHARGPETLIPWETRMKIAKGISRGLAHLHSNENM 657

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           IH NLT+SN+LLD+ TNA I+D+GLSRLMTAAA  NVIATAG LGYRAPE SK+K A+ K
Sbjct: 658 IHENLTASNILLDEQTNAHIADYGLSRLMTAAAATNVIATAGTLGYRAPEFSKIKNASAK 717

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           TDVYSLG+ ILELLTGKSPGEP NG +LPQWVASIVKEEWTNEVFDLELMR+  ++GDEL
Sbjct: 718 TDVYSLGIIILELLTGKSPGEPTNGMDLPQWVASIVKEEWTNEVFDLELMRETQSVGDEL 777

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP 562
           LNTLKLALHCVDPSP+ARPE  QVV+QLEEIRP
Sbjct: 778 LNTLKLALHCVDPSPAARPEANQVVEQLEEIRP 810

Arabidopsis thaliana (taxid: 3702)

>sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1

 Score =  362 bits (930), Expect = 4e-99,   Method: Compositional matrix adjust.
 Identities = 235/585 (40%), Positives = 347/585 (59%), Gaps = 63/585 (10%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L    L G+IP+ SLG+L+EL+ +SL  N++SG +PSD   L+ LR L   +N  +G 
Sbjct: 71  LRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGE 130

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
            P SF+ L++L+ L + SNN                         +G IP ++ N++ LT
Sbjct: 131 FPTSFTQLNNLIRLDISSNNF------------------------TGSIPFSVNNLTHLT 166

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCG-- 179
            L L  N  SG +P   S    L  FNVS NNL+G +P+SL+ +F+A SF GN+ LCG  
Sbjct: 167 GLFLGNNGFSGNLP---SISLGLVDFNVSNNNLNGSIPSSLS-RFSAESFTGNVDLCGGP 222

Query: 180 -----YSGSTPCPSPPAEKPKSRGRKLSTKD----IILIGAGALLIVLLIIVCILMCCLI 230
                    +P PSP    P +R     +K     I+ I   + L+ LL++  +L  CL 
Sbjct: 223 LKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLR 282

Query: 231 RKRTASKAEDGQATASGTAARG---EKGAPSAAGEVEA-----GGE-NGGKLVHFDGPLM 281
           ++R +++A   Q   +G A R      GA S+  EV       GGE    KLV  +G + 
Sbjct: 283 KRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVY 342

Query: 282 -FTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKI 340
            F  +DLL A+AE++GK + GT YKA LE+G+ V VKRL++ +   ++EFE+++ ++GKI
Sbjct: 343 SFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKD-VMASKKEFETQMEVVGKI 401

Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLH-ARGP-ETPIDWPTRMKIIKGMTR 398
           +HPN++ LRAYY   K EKLLVFD+MP GSL+  LH +RG   TP+DW  RM+I     R
Sbjct: 402 KHPNVIPLRAYYYS-KDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAAR 460

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAP 458
           GL HLH +  ++HGN+ +SN+LL  + +  +SD+GL++L + ++  N +A     GY AP
Sbjct: 461 GLAHLHVSAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLA-----GYHAP 515

Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE---LPQWVASIVKEEWTNEVFD 515
           E+ + +K   K+DVYS GV +LELLTGKSP +   G E   LP+WV S+V+EEWT EVFD
Sbjct: 516 EVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFD 575

Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +ELMR    I +E++  L++A+ CV   P  RP + +V++ +E++
Sbjct: 576 VELMR-YHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  346 bits (888), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 216/559 (38%), Positives = 316/559 (56%), Gaps = 44/559 (7%)

Query: 44  RLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKR 103
           +L  LRI+    N + G++P+   +L  + SL    NN    I   L   H L  L+L  
Sbjct: 90  KLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFHENNFSGTIPPVLS--HRLVNLDLSA 147

Query: 104 NQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           N +SG+IP+++ N++ LT L L  N LSG IP     LK L   N+S+NNL+G VP+S+ 
Sbjct: 148 NSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLPPRLKYL---NLSFNNLNGSVPSSVK 204

Query: 164 LKFNASSFVGNIQLCGYSGSTPCP-SPPAEKPKS-------------RG---RKLSTKDI 206
             F ASSF GN  LCG +  TPCP +  A  P               RG   + LST  I
Sbjct: 205 -SFPASSFQGNSLLCG-APLTPCPENTTAPSPSPTTPTEGPGTTNIGRGTAKKVLSTGAI 262

Query: 207 ILIGAGALLIVLLIIVCILMCCLIRKRTASKAEDGQATASGTAARGEKGAPSAAGEVEAG 266
           + I  G  +++ +I+  I +CC  +KR     +D  A       R +  A      V+  
Sbjct: 263 VGIAVGGSVLLFIILAIITLCC-AKKRDG--GQDSTAVPKAKPGRSDNKAEEFGSGVQEA 319

Query: 267 GENGGKLVHFDGP-LMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK 325
            +N  KLV F+G    F  +DLL A+AE++GK +YGT YKA LE+G+ V VKRL+E +  
Sbjct: 320 EKN--KLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKE-VAA 376

Query: 326 GQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHA--RGPET 382
           G+REFE ++  +G+I  H N+  LRAYY   K EKLLV+DY   G+ +  LH    G   
Sbjct: 377 GKREFEQQMEAVGRISPHVNVAPLRAYYFS-KDEKLLVYDYYQGGNFSMLLHGNNEGGRA 435

Query: 383 PIDWPTRMKIIKGMTRGLLHLHS--NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA 440
            +DW TR++I     RG+ H+HS     ++HGN+ S NVLL    +  +SDFG++ LM+ 
Sbjct: 436 ALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSH 495

Query: 441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE---L 497
               + +  + +LGYRAPE  + +K   K+DVYS GV +LE+LTGK+ G+     E   L
Sbjct: 496 ----HTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDL 551

Query: 498 PQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           P+WV S+V+EEWT EVFD+EL++    + +E++  L++A+ CV   P +RP + +VV  +
Sbjct: 552 PKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMM 611

Query: 558 EEIRPEAATAATSSGDAGP 576
           EEIRP  +   + +  + P
Sbjct: 612 EEIRPSGSGPGSGNRASSP 630

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  345 bits (885), Expect = 6e-94,   Method: Compositional matrix adjust.
 Identities = 230/564 (40%), Positives = 327/564 (57%), Gaps = 50/564 (8%)

Query: 37  VMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNL 96
           + P+ LG+L  LRIL    N ++G+LP    +L SL  + L+ NN   ++   + +   L
Sbjct: 103 IPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVSR--QL 160

Query: 97  SVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLK--SLSSFNVSYNNL 154
           ++L+L  N  +G IP+T  N+  LT L L  NKLSG +P    NL   SL   N+S N+L
Sbjct: 161 NILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVP----NLDTVSLRRLNLSNNHL 216

Query: 155 SGPVPTSLALKFNASSFVGNIQLCGY-----SGSTPCPS----------PPAEKPKSRGR 199
           +G +P++L   F +SSF GN  LCG      + S+P PS          PP    +   R
Sbjct: 217 NGSIPSALG-GFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHKEGSKR 275

Query: 200 KLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTASKAEDGQATASGTAARGEKGAPSA 259
           KL    II I AG   ++LLI V IL CC+ +K    K ED          + ++   S 
Sbjct: 276 KLHVSTIIPIAAGGAALLLLITVIILCCCIKKK---DKREDSIVKVKTLTEKAKQEFGSG 332

Query: 260 AGEVEAGGENGGKLVHFDG-PLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKR 318
             E E       KLV F+G    F  +DLL A+AE++GK +YGT YKA LE+ + V VKR
Sbjct: 333 VQEPEKN-----KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKR 387

Query: 319 LREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHA 377
           L+E +  G+REFE ++ ++ ++  HP+++ LRAYY   K EKL+V DY P G+L++ LH 
Sbjct: 388 LKE-VAAGKREFEQQMEIISRVGNHPSVVPLRAYYYS-KDEKLMVCDYYPAGNLSSLLHG 445

Query: 378 -RGPE-TPIDWPTRMKIIKGMTRGLLHLHS--NENIIHGNLTSSNVLLDDSTNAKISDFG 433
            RG E TP+DW +R+KI     +G+ HLH+       HGN+ SSNV++   ++A ISDFG
Sbjct: 446 NRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFG 505

Query: 434 LSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPL- 492
           L+ LM        IA     GYRAPE+ + +K   K+DVYS GV ILE+LTGKSP +   
Sbjct: 506 LTPLMAVP-----IAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPS 560

Query: 493 --NGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEV 550
             +  +LP+WV S+V+EEWT+EVFD+ELMR    I +E++  L++A+ CV   P  RP +
Sbjct: 561 RDDMVDLPRWVQSVVREEWTSEVFDIELMRFQ-NIEEEMVQMLQIAMACVAQVPEVRPTM 619

Query: 551 LQVVQQLEEIR-PEAATAATSSGD 573
             VV+ +EEIR  ++ T   SS D
Sbjct: 620 DDVVRMIEEIRVSDSETTRPSSDD 643

Arabidopsis thaliana (taxid: 3702)

>sp|P33543|TMKL1_ARATH Putative kinase-like protein TMKL1 OS=Arabidopsis thaliana GN=TMKL1 PE=1 SV=1

 Score =  332 bits (850), Expect = 7e-90,   Method: Compositional matrix adjust.
 Identities = 223/575 (38%), Positives = 313/575 (54%), Gaps = 35/575 (6%)

Query: 9   NLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSN 68
           NL+G +P  +G+ S LQ + L+ N +SG +P +LG  S L  +D S NA+ G LP S  N
Sbjct: 110 NLTGSLPREIGEFSMLQSVFLNINSLSGSIPLELGYTSSLSDVDLSGNALAGVLPPSIWN 169

Query: 69  LSS-LVSLTLESNNLDDQILDSL---DKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
           L   LVS  +  NNL   + +         NL VL+L  N+ SG  P  I     +  LD
Sbjct: 170 LCDKLVSFKIHGNNLSGVLPEPALPNSTCGNLQVLDLGGNKFSGEFPEFITRFKGVKSLD 229

Query: 125 LSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNI-QLCGYSGS 183
           LS N   G +P     L+ L S N+S+NN SG +P     KF A SF GN   LCG    
Sbjct: 230 LSSNVFEGLVPEGLGVLE-LESLNLSHNNFSGMLPDFGESKFGAESFEGNSPSLCGLP-L 287

Query: 184 TPCPSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTASKAEDGQA 243
            PC       P               GA A L++ L+   +++  L+     +K      
Sbjct: 288 KPCLGSSRLSP---------------GAVAGLVIGLMSGAVVVASLLIGYLQNKKRK--- 329

Query: 244 TASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATAEIMGKSTYGTV 303
             S   +  +        E+       GKLV F G    T DD+L AT ++M K++YGTV
Sbjct: 330 --SSIESEDDLEEGDEEDEIGEKEGGEGKLVVFQGGENLTLDDVLNATGQVMEKTSYGTV 387

Query: 304 YKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF 363
           YKA L DG  +A++ LRE   K +      +  LG+IRH NL+ LRA+Y G +GEKLL++
Sbjct: 388 YKAKLSDGGNIALRLLREGTCKDRSSCLPVIRQLGRIRHENLVPLRAFYQGKRGEKLLIY 447

Query: 364 DYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVL 420
           DY+P+ SL   LH   P  P ++W  R KI  G+ RGL +LH+ +   IIHGN+ S NVL
Sbjct: 448 DYLPNISLHDLLHESKPRKPALNWARRHKIALGIARGLAYLHTGQEVPIIHGNIRSKNVL 507

Query: 421 LDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTIL 480
           +DD   A++++FGL ++M  A    +++ A + GY+APEL K+KK N ++DVY+ G+ +L
Sbjct: 508 VDDFFFARLTEFGLDKIMVQAVADEIVSQAKSDGYKAPELHKMKKCNPRSDVYAFGILLL 567

Query: 481 ELLTGKSPGEP-LNGAE---LPQWVASIVKEEWTNEVFDLELMRDAPTIGDE-LLNTLKL 535
           E+L GK PG+   NG E   LP  V + V EE T EVFDLE M+   +  +E L++ LKL
Sbjct: 568 EILMGKKPGKSGRNGNEFVDLPSLVKAAVLEETTMEVFDLEAMKGIRSPMEEGLVHALKL 627

Query: 536 ALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATS 570
           A+ C  P  + RP + +VV+QLEE RP   +A  S
Sbjct: 628 AMGCCAPVTTVRPSMEEVVKQLEENRPRNRSALYS 662

Does not seem to have conserved a kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1

 Score =  331 bits (848), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 221/587 (37%), Positives = 318/587 (54%), Gaps = 83/587 (14%)

Query: 27  ISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQI 86
           +SL HN +SG +P +L  L+ L++L  S N  +G+ P S ++L+ L  L L  NN     
Sbjct: 96  LSLKHNNLSGPIP-NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNF---- 150

Query: 87  LDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSS 146
                               SG IP  + +++ L  L L  N+ SG+IP    NL  L  
Sbjct: 151 --------------------SGQIPPDLTDLTHLLTLRLESNRFSGQIPN--INLSDLQD 188

Query: 147 FNVSYNNLSGPVPTSLALKFNASSFVGNIQLCG--------YSGSTPCPSPPAE------ 192
           FNVS NN +G +P SL+ +F  S F  N  LCG         S     P  P E      
Sbjct: 189 FNVSGNNFNGQIPNSLS-QFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPL 247

Query: 193 -KPKS---------------RGRKLSTKDIILIGAGALLIV----LLIIVCILMCCLIRK 232
            KP++                  ++ST  +I I  G  +I+    LL+  C      + K
Sbjct: 248 NKPETVPSSPTSIHGGDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNK 307

Query: 233 RTASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATA 292
           +  SK  +G+     +         +     + G +  GK+V F+G   F  +DLL A+A
Sbjct: 308 KKHSKILEGEKIVYSSNPYPTSTQNNNNQNQQVGDK--GKMVFFEGTRRFELEDLLRASA 365

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAY 351
           E++GK  +GT YKA LEDG++VAVKRL++ +T  G++EFE ++ +LG++RH NL++L+AY
Sbjct: 366 EMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAY 425

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGP-ETPIDWPTRMKIIKGMTRGLLHLHSNE-- 407
           Y   + EKLLV+DYMP+GSL   LH  RGP  TP+DW TR+KI  G  RGL  +H +   
Sbjct: 426 YFA-REEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKT 484

Query: 408 -NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
             + HG++ S+NVLLD S NA++SDFGLS    +         A + GYRAPEL   +K 
Sbjct: 485 LKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQ------TVAKSNGYRAPELIDGRKH 538

Query: 467 NTKTDVYSLGVTILELLTGKSP-----GEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
             K+DVYS GV +LE+LTGK P     G      +LP+WV S+V+EEWT EVFDLELMR 
Sbjct: 539 TQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMR- 597

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAA 568
              I +E++  L++A+ C   +   RP++  VV+ +E+IR   + A+
Sbjct: 598 YKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIRGGGSEAS 644

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1

 Score =  323 bits (827), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 193/536 (36%), Positives = 287/536 (53%), Gaps = 47/536 (8%)

Query: 39  PSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSV 98
           P  + RLS L+ L    N   G  P+ F+NL SL  L L+ N+L   +L    +L NL V
Sbjct: 81  PFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQHNHLSGPLLAIFSELKNLKV 140

Query: 99  LNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV 158
           L+L  N  +G IP+++  +++L +L+L+ N  SGEIP    +L  LS  N+S N L G +
Sbjct: 141 LDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPN--LHLPKLSQINLSNNKLIGTI 198

Query: 159 PTSLALKFNASSFVGNIQLCGYSGSTPCPSPPAEKPKSRGR--KLSTKDIILIGAGALLI 216
           P SL  +F +S+F GN                 E+ K R     LS    +LI + A ++
Sbjct: 199 PKSLQ-RFQSSAFSGN--------------NLTERKKQRKTPFGLSQLAFLLILSAACVL 243

Query: 217 VLLIIVCILMCCLIRKRTASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHF 276
            +  +  I++ C  + R + K             R     P      +   E GGK++ F
Sbjct: 244 CVSGLSFIMITCFGKTRISGKLR----------KRDSSSPPGNWTSRDDNTEEGGKIIFF 293

Query: 277 DGP-LMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVS 335
            G   +F  DDLL ++AE++GK  +GT YK T+ED S V VKRL+E +  G+REFE ++ 
Sbjct: 294 GGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKRLKE-VVVGRREFEQQME 352

Query: 336 LLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLH---ARGPETPIDWPTRMKI 392
           ++G IRH N+  L+AYY   K +KL V+ Y  HGSL   LH    R    P+DW  R++I
Sbjct: 353 IIGMIRHENVAELKAYYY-SKDDKLAVYSYYNHGSLFEILHGNRGRYHRVPLDWDARLRI 411

Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA 452
             G  RGL  +H  +  IHGN+ SSN+ LD      I D GL+ +M +      + +   
Sbjct: 412 ATGAARGLAKIHEGK-FIHGNIKSSNIFLDSQCYGCIGDVGLTTIMRSLPQTTCLTS--- 467

Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGE-----PLNG--AELPQWVASIV 505
            GY APE++  +++   +DVYS GV +LELLTGKSP       P  G   +L  W+ S+V
Sbjct: 468 -GYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGGENMDLASWIRSVV 526

Query: 506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
            +EWT EVFD+E++  +    +E++  L++ L CV      RP + QV++ +E+IR
Sbjct: 527 AKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQQERPHIAQVLKLIEDIR 582

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1

 Score =  321 bits (822), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 204/537 (37%), Positives = 308/537 (57%), Gaps = 29/537 (5%)

Query: 39  PSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSV 98
           P+ + RLS LR+L    N I+G  P  F  L  L  L L+ NNL   +        NL+ 
Sbjct: 86  PNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKNLTS 145

Query: 99  LNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN-NLSGP 157
           +NL  N  +G IPS++  +  +  L+L+ N LSG+IP   S L SL   ++S N +L+GP
Sbjct: 146 VNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIP-DLSVLSSLQHIDLSNNYDLAGP 204

Query: 158 VPTSLALKFNASSFVG-NIQLCGYSGSTPCPSPPAE----KP-KSRGRKLSTKDIILIGA 211
           +P  L  +F  SS+ G +I   G + +   P PP+E    KP K+R   LS    +LI  
Sbjct: 205 IPDWLR-RFPFSSYTGIDIIPPGGNYTLVTPPPPSEQTHQKPSKARFLGLSETVFLLIVI 263

Query: 212 GALLIVLLIIVCILMCCLIRKRTASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGG 271
              ++V+  +  +L  C +R+    K   G    S    + +KG  S    V    +   
Sbjct: 264 AVSIVVITALAFVLTVCYVRR----KLRRGDGVISDNKLQ-KKGGMSPEKFVSRMEDVNN 318

Query: 272 KLVHFDG-PLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF 330
           +L  F+G    F  +DLL A+AE++GK T+GT YKA LED + VAVKRL++ +  G+R+F
Sbjct: 319 RLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKD-VAAGKRDF 377

Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPET--PIDWPT 388
           E ++ ++G I+H N++ L+AYY   K EKL+V+DY   GS+A+ LH    E   P+DW T
Sbjct: 378 EQQMEIIGGIKHENVVELKAYYYS-KDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWET 436

Query: 389 RMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV 446
           RMKI  G  +G+  +H   N  ++HGN+ SSN+ L+  +N  +SD GL+ +M+  A    
Sbjct: 437 RMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAP--- 493

Query: 447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE---LPQWVAS 503
              +   GYRAPE++  +K++  +DVYS GV +LELLTGKSP     G E   L +WV S
Sbjct: 494 -PISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHS 552

Query: 504 IVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +V+EEWT EVFD+EL+R    I +E++  L++A+ CV  +   RP++  +V+ +E +
Sbjct: 553 VVREEWTAEVFDIELLR-YTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENV 608

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1

 Score =  319 bits (817), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 214/585 (36%), Positives = 321/585 (54%), Gaps = 58/585 (9%)

Query: 34  ISGVMPSDL-GRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDK 92
           +SG +P  + G L++LR L    NA++GSLP   S  S+L  L L+ N    +I + L  
Sbjct: 84  LSGDIPEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFS 143

Query: 93  LHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLK-SLSSFNVSY 151
           L +L  LNL  N  +G I S   N++ L  L L  N+LSG IP    +L   L  FNVS 
Sbjct: 144 LSHLVRLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIP----DLDLPLVQFNVSN 199

Query: 152 NNLSGPVPTSLALKFNASSFVGNIQLCGY-----------------SGSTPCPSPPAEKP 194
           N+L+G +P +L  +F + SF+    LCG                   G+   PS    + 
Sbjct: 200 NSLNGSIPKNLQ-RFESDSFL-QTSLCGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEE 257

Query: 195 KSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTASKA--------------ED 240
           K +  KLS   I  I  G ++   LI++ +++ C  +    S+A               D
Sbjct: 258 KKKKNKLSGGAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGD 317

Query: 241 GQATASG---TAARGEKGAPSAAGEV-EAGGENGGKLVHF-DGPLMFTADDLLCATAEIM 295
            +A  +G   + +     A +  G+  E  G    KLV F +   +F  +DLL A+AE++
Sbjct: 318 KEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVL 377

Query: 296 GKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP 355
           GK T+GT YKA L+  + VAVKRL++ +    +EF+ ++ L+G + H NL+ LRAYY   
Sbjct: 378 GKGTFGTAYKAVLDAVTVVAVKRLKD-VMMADKEFKEKIELVGAMDHENLVPLRAYYFS- 435

Query: 356 KGEKLLVFDYMPHGSLATFLHA-RGP-ETPIDWPTRMKIIKGMTRGLLHLHSN-ENIIHG 412
           + EKLLV+D+MP GSL+  LH  RG   +P++W  R +I  G  RGL +LHS   +  HG
Sbjct: 436 RDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTSTSHG 495

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLM-TAAANVNVIATAGALGYRAPELSKLKKANTKTD 471
           N+ SSN+LL  S +AK+SDFGL++L+ ++A N N      A GYRAPE++  K+ + K D
Sbjct: 496 NIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNR-----ATGYRAPEVTDPKRVSQKGD 550

Query: 472 VYSLGVTILELLTGKSPGEPL---NGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           VYS GV +LEL+TGK+P   +    G +LP+WV S+ ++EW  EVFD EL+  A    + 
Sbjct: 551 VYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEM 610

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGD 573
           +   ++L L C    P  RPE+ +VV+++E +RP + +   +  D
Sbjct: 611 MAEMVQLGLECTSQHPDQRPEMSEVVRKMENLRPYSGSDQVNEAD 655

Arabidopsis thaliana (taxid: 3702)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	580
224109228	827	predicted protein [Populus trichocarpa]	0.996	0.698	0.767	0.0
356553753	797	PREDICTED: probably inactive leucine-ric	0.996	0.725	0.752	0.0
356499179	833	PREDICTED: probably inactive leucine-ric	0.996	0.693	0.755	0.0
224140493	826	predicted protein [Populus trichocarpa]	0.998	0.700	0.725	0.0
225448572	869	PREDICTED: probable leucine-rich repeat	0.996	0.665	0.758	0.0
239500655	849	receptor-like kinase [Glycine max] gi|23	0.984	0.672	0.727	0.0
239500659	849	receptor-like kinase [Glycine max] gi|23	0.984	0.672	0.727	0.0
255571471	811	Systemin receptor SR160 precursor, putat	0.979	0.700	0.722	0.0
226693201	854	receptor-like kinase [Glycine max] gi|22	0.984	0.668	0.730	0.0
356538008	852	PREDICTED: probable leucine-rich repeat	0.984	0.670	0.723	0.0

>gi|224109228|ref|XP_002315129.1| predicted protein [Populus trichocarpa] gi|222864169|gb|EEF01300.1| predicted protein [Populus trichocarpa]

 Score =  869 bits (2246), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 453/590 (76%), Positives = 506/590 (85%), Gaps = 12/590 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L+L +N  SG IPASLGKL ELQ+I +SHN+I+G +P ++G LSRLR LD S NAINGSL
Sbjct: 238 LSLSHNFFSGSIPASLGKLRELQDIYVSHNQINGAIPVEIGGLSRLRTLDLSNNAINGSL 297

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
             S SN+SSLV L LE+N+LD+QI +++ +LHNLSVLNLK NQ SGHIP+TIGNISTLT 
Sbjct: 298 SDSLSNVSSLVLLNLENNDLDNQIPEAIGRLHNLSVLNLKGNQFSGHIPATIGNISTLTQ 357

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LD+S+NKLSGEIP S ++L +L SFNVSYNNLSGPVP  L+ KFN+SSFVGNIQLCGYSG
Sbjct: 358 LDVSENKLSGEIPDSLADLNNLISFNVSYNNLSGPVPIPLSQKFNSSSFVGNIQLCGYSG 417

Query: 183 STPCPSPPAEKPKS---------RGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKR 233
           + PCPS                   RKLSTKDIILI AGALL+V+LII CIL+CCLIRKR
Sbjct: 418 TAPCPSHAPSPSVPVPPPEKPKKHHRKLSTKDIILIAAGALLVVMLIICCILLCCLIRKR 477

Query: 234 TASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATAE 293
            ASK+ +GQAT    AARGEKG P AAGEVE+GGE GGKLVHFDGP++FTADDLLCATAE
Sbjct: 478 AASKSNNGQATTRAAAARGEKGVPPAAGEVESGGEAGGKLVHFDGPMVFTADDLLCATAE 537

Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           IMGKSTYGTVY+ATLEDG+QVAVKRLREKITKGQREFESEV++LGKIRHPNLLALRAYYL
Sbjct: 538 IMGKSTYGTVYRATLEDGNQVAVKRLREKITKGQREFESEVNVLGKIRHPNLLALRAYYL 597

Query: 354 GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
           GPKGEKLLVFDY+P GSLATFLHARGP+T IDWPTRMKI +GMTRGL +LH+NENIIHGN
Sbjct: 598 GPKGEKLLVFDYIPKGSLATFLHARGPDTLIDWPTRMKIAQGMTRGLFYLHNNENIIHGN 657

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVY 473
           LTSSNVLLD+ TNAKI+D+GLSRLMTAAA+ NVIATA  LGYRAPELSKLKKANTKTDVY
Sbjct: 658 LTSSNVLLDERTNAKIADYGLSRLMTAAASTNVIATASVLGYRAPELSKLKKANTKTDVY 717

Query: 474 SLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
           SLGV ILELLTGKSPGE +NG +LPQWVASIVKEEWTNEVFDLELM+DA  IGDELLNTL
Sbjct: 718 SLGVIILELLTGKSPGEAMNGVDLPQWVASIVKEEWTNEVFDLELMKDASIIGDELLNTL 777

Query: 534 KLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDAG---PSTSE 580
           KLALHCVDPSPSARPEV  V+QQLEEIRPE A +   SGD G   PSTS+
Sbjct: 778 KLALHCVDPSPSARPEVQLVLQQLEEIRPETAASPGPSGDDGAGVPSTSD 827

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553753|ref|XP_003545217.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase IMK2-like [Glycine max]

 Score =  859 bits (2220), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/587 (75%), Positives = 491/587 (83%), Gaps = 9/587 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L + +N LSG IPASLG LSEL EISLSHN+ SG +P+++G LSRL+ LDFS NA+NGSL
Sbjct: 211 LIIDHNLLSGSIPASLGGLSELTEISLSHNQFSGAIPNEIGNLSRLKTLDFSNNALNGSL 270

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           PA+ SN+SSL  L +E+N+L +QI ++L +LHNLSVL L RNQ SGHIP  IGNIS L  
Sbjct: 271 PAALSNVSSLTLLNVENNHLGNQIPEALGRLHNLSVLVLSRNQFSGHIPQNIGNISKLRQ 330

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LDLS N LSGEIP +F NL+SLS FNVS+NNLSGPVPT LA KFN+SSFVGNIQLCGYS 
Sbjct: 331 LDLSLNNLSGEIPVAFDNLRSLSFFNVSHNNLSGPVPTLLAQKFNSSSFVGNIQLCGYSP 390

Query: 183 STPCPS------PPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTAS 236
           ST CPS      PP        +KL TKDIILI AG LL+VL+ I CIL+ CLI+KR +S
Sbjct: 391 STTCPSLAPSGSPPEISEHRHHKKLGTKDIILIVAGVLLVVLVTICCILLFCLIKKRASS 450

Query: 237 KAEDGQATASGTAARG---EKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATAE 293
            AE GQAT   +AA     EKG P   GE EAGGE GGKLVHFDGPL FTADDLLCATAE
Sbjct: 451 NAEGGQATGRASAAAAGRTEKGVPPVTGEAEAGGEVGGKLVHFDGPLTFTADDLLCATAE 510

Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           IMGKSTYGTVYKATLEDGSQ AVKRLREKITKGQREFESEVS++G+IRHPNLLALRAYYL
Sbjct: 511 IMGKSTYGTVYKATLEDGSQAAVKRLREKITKGQREFESEVSIIGRIRHPNLLALRAYYL 570

Query: 354 GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
           GPKGEKLLVFDYMP+GSLA+FLH+RGPET IDWPTRMKI +GM  GLL+LHS ENIIHGN
Sbjct: 571 GPKGEKLLVFDYMPNGSLASFLHSRGPETAIDWPTRMKIAQGMAHGLLYLHSRENIIHGN 630

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVY 473
           LTSSNVLLD++ NAKI+DFGLSRLMT AAN NVIATAGALGYRAPELSKLKKANTKTDVY
Sbjct: 631 LTSSNVLLDENVNAKIADFGLSRLMTTAANSNVIATAGALGYRAPELSKLKKANTKTDVY 690

Query: 474 SLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
           SLGV +LELLTGK PGE +NG +LPQWVASIVKEEWTNEVFD+ELMRDA T GDE+LNTL
Sbjct: 691 SLGVILLELLTGKPPGEAMNGVDLPQWVASIVKEEWTNEVFDVELMRDASTYGDEMLNTL 750

Query: 534 KLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDAGPSTSE 580
           KLALHCVDPSPSARPEV QV+QQLEEIRPE + A++    A PSTSE
Sbjct: 751 KLALHCVDPSPSARPEVQQVLQQLEEIRPEISAASSGDDGAIPSTSE 797

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356499179|ref|XP_003518420.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase IMK2-like [Glycine max]

 Score =  831 bits (2146), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 444/588 (75%), Positives = 491/588 (83%), Gaps = 10/588 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N LSG IPASLG LSEL EISLSHN+ SG +P ++G LSRL+ +DFS N +NGSL
Sbjct: 246 LILDHNLLSGSIPASLGSLSELTEISLSHNQFSGAIPDEIGSLSRLKTVDFSNNDLNGSL 305

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           PA+ SN+SSL  L +E+N+L + I ++L +LHNLSVL L RNQ  GHIP ++GNIS LT 
Sbjct: 306 PATLSNVSSLTLLNVENNHLGNPIPEALGRLHNLSVLILSRNQFIGHIPQSVGNISKLTQ 365

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LDLS N LSGEIP SF NL+SLS FNVS+NNLSGPVPT LA KFN SSFVGNIQLCGYS 
Sbjct: 366 LDLSLNNLSGEIPVSFDNLRSLSFFNVSHNNLSGPVPTLLAQKFNPSSFVGNIQLCGYSP 425

Query: 183 STPCPSP-----PAEKPKSRG-RKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTAS 236
           STPCPS      P E  + R  +KL TKDIILI AG LL+VL+ I CIL+ CLIRKR  S
Sbjct: 426 STPCPSQAPSGSPHEISEHRHHKKLGTKDIILIVAGVLLVVLVTICCILLFCLIRKRATS 485

Query: 237 KAEDGQATASGTAARG----EKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATA 292
            AE GQAT   +A+      EKG P  AGE EAGGE GGKLVHFDGPL FTADDLLCATA
Sbjct: 486 NAEAGQATGRASASAAAARTEKGVPPVAGEAEAGGEAGGKLVHFDGPLAFTADDLLCATA 545

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           EIMGKSTYGTVYKATLEDGSQ AVKRLREKITKGQREFESEVS++G+IRHPNLLALRAYY
Sbjct: 546 EIMGKSTYGTVYKATLEDGSQAAVKRLREKITKGQREFESEVSVIGRIRHPNLLALRAYY 605

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           LGPKGEKLLVFDYMP+GSLA+FLHARGPET IDW TRMKI +GM RGLL+LHSNENIIHG
Sbjct: 606 LGPKGEKLLVFDYMPNGSLASFLHARGPETAIDWATRMKIAQGMARGLLYLHSNENIIHG 665

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           NLTSSNVLLD++TNAKI+DFGLSRLMT AAN NVIATAGALGYRAPELSKL KANTKTDV
Sbjct: 666 NLTSSNVLLDENTNAKIADFGLSRLMTTAANSNVIATAGALGYRAPELSKLNKANTKTDV 725

Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           YSLGV +LELLTGK PGE +NG +LPQWVASIVKEEWTNEVFD+ELMRDA T GDE+LNT
Sbjct: 726 YSLGVILLELLTGKPPGEAMNGVDLPQWVASIVKEEWTNEVFDVELMRDASTYGDEMLNT 785

Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDAGPSTSE 580
           LKLALHCVDPSPSAR EV QV+QQLEEIRPE + A++    A PSTSE
Sbjct: 786 LKLALHCVDPSPSARLEVQQVLQQLEEIRPEISAASSGDDGAIPSTSE 833

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224140493|ref|XP_002323617.1| predicted protein [Populus trichocarpa] gi|222868247|gb|EEF05378.1| predicted protein [Populus trichocarpa]

 Score =  826 bits (2134), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 429/591 (72%), Positives = 489/591 (82%), Gaps = 12/591 (2%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           FL L +N +SG IP SL KL+ LQEISLSHN++SG +P ++G LSRL+ LD S NA +GS
Sbjct: 236 FLTLDHNRISGTIPVSLSKLALLQEISLSHNQLSGAIPYEMGSLSRLQKLDISNNAFSGS 295

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P SFSNL+SLVSL LE N LD+QI +  D+LHNLS+LNLK NQ  G IP++IGNIS++ 
Sbjct: 296 IPFSFSNLTSLVSLNLEGNRLDNQIPEGFDRLHNLSMLNLKNNQFKGPIPASIGNISSIN 355

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYS 181
            LDL+QN  SGEIPAS + L +L+ FNVSYNNLSG VP+S+A KFN+SSFVGN+QLCGYS
Sbjct: 356 QLDLAQNNFSGEIPASLARLANLTYFNVSYNNLSGSVPSSIAKKFNSSSFVGNLQLCGYS 415

Query: 182 GSTPCPSPPAE--------KPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKR 233
            STPCPSPP E         PK   RKLSTKDIILI AG LL+VLL++  IL+CCL++KR
Sbjct: 416 ISTPCPSPPPEILPAPTKGSPKHHHRKLSTKDIILIAAGILLVVLLLLCSILLCCLMKKR 475

Query: 234 TASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATAE 293
           +ASK + G+ T  G   +GEK    A  EVE+GGE GGKLVHFDGP +FTADDLLCATAE
Sbjct: 476 SASKEKSGKTTTRGLPGKGEKTGAVAGPEVESGGEMGGKLVHFDGPFLFTADDLLCATAE 535

Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           IMGKSTYGT YKATLEDG+QVAVKRLREK TKGQREFE+E + LGKIRHPNLLALRAYYL
Sbjct: 536 IMGKSTYGTAYKATLEDGNQVAVKRLREKTTKGQREFETEAAALGKIRHPNLLALRAYYL 595

Query: 354 GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
           GPKGEKLLVFDYM  GSLA++LHARGPET ++WPTRM I  G+ RGL HLHS ENIIHGN
Sbjct: 596 GPKGEKLLVFDYMHKGSLASYLHARGPETTVNWPTRMNIAIGVARGLNHLHSQENIIHGN 655

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVY 473
           LTSSNVLLD+ TNA I+DFGLSRLMTAAAN NVIATAG LGYRAPELSKLK A+TKTDVY
Sbjct: 656 LTSSNVLLDEQTNAHIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNASTKTDVY 715

Query: 474 SLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG-DELLNT 532
           SLGV ILELLTGKSPGEP+NG +LPQWVASIVKEEWTNEVFDLE+MRDA TIG DELLNT
Sbjct: 716 SLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLEIMRDAQTIGDDELLNT 775

Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDAG---PSTSE 580
           LKLALHCVDP+P+ARPE  QVVQQLEEI+PE A AA ++ D G   P T+E
Sbjct: 776 LKLALHCVDPTPAARPEAEQVVQQLEEIKPELAAAAAAAADEGAEVPPTTE 826

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225448572|ref|XP_002277929.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase IMK3-like isoform 1 [Vitis vinifera]

 Score =  825 bits (2131), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 446/588 (75%), Positives = 503/588 (85%), Gaps = 10/588 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           LAL +N  SG +P SLGKLSELQ++SLSHN+I+G +P ++GRLSRL+ +DFS NAINGSL
Sbjct: 282 LALDHNFFSGSMPTSLGKLSELQKVSLSHNQITGAIPDEIGRLSRLKTVDFSSNAINGSL 341

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P S SNLSSL+ L LE+N LD QI D+ +KL NLSVLNL+RN+ +G IP +IGN S LT 
Sbjct: 342 PISLSNLSSLLVLNLENNGLDSQIPDAFEKLQNLSVLNLRRNRFNGPIPGSIGNASALTQ 401

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LDLSQN L+G+IP+S ++L +L+SFNVSYNNLSG VP  L+ KFN+S FVGN+QLCGY  
Sbjct: 402 LDLSQNNLTGDIPSSIADLPNLNSFNVSYNNLSGSVPALLSQKFNSSCFVGNLQLCGYDA 461

Query: 183 STPCPS---------PPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKR 233
           STPCPS         P   KP+S GRKLSTKDIILI AGALLI+LL++ CIL+CCLIRKR
Sbjct: 462 STPCPSEVPSQVVPAPSRGKPRSHGRKLSTKDIILIAAGALLIILLLVCCILLCCLIRKR 521

Query: 234 TASKAEDGQATASGT-AARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATA 292
            ASKA+DGQAT     AAR EKGAPSA  EVEAGGE GGKLVHFDGP++FTADDLLCATA
Sbjct: 522 AASKAKDGQATGRRPGAARAEKGAPSAGVEVEAGGEAGGKLVHFDGPMVFTADDLLCATA 581

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           EIMGKSTYGTVYKATLEDG++VAVKRLREKITK QREFE+EV++LGKIRHPNLLALRAYY
Sbjct: 582 EIMGKSTYGTVYKATLEDGNEVAVKRLREKITKSQREFETEVNVLGKIRHPNLLALRAYY 641

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           LGPKGEKLLVFDYMP GSLA FLHARGP+  IDWPTRM+I +G TRGL HLH+NENIIHG
Sbjct: 642 LGPKGEKLLVFDYMPKGSLAAFLHARGPDISIDWPTRMRIAQGTTRGLFHLHNNENIIHG 701

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           NLTSSN+LLD++  AKI+DFGLSRLMT AAN NVIATAGALGYRAPELSKLKKA+TKTDV
Sbjct: 702 NLTSSNLLLDENITAKIADFGLSRLMTTAANSNVIATAGALGYRAPELSKLKKASTKTDV 761

Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           YSLGV ILELLTGKSPGE  NG +LPQWVASIVKEEWTNEVFDLELM+DA TIGDELLNT
Sbjct: 762 YSLGVIILELLTGKSPGEATNGVDLPQWVASIVKEEWTNEVFDLELMKDASTIGDELLNT 821

Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDAGPSTSE 580
           LKLALHCVDPSPSARPEV QV+QQLEEIRPEAA ++   G   PS S+
Sbjct: 822 LKLALHCVDPSPSARPEVHQVLQQLEEIRPEAAASSGEDGAGVPSASD 869

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|239500655|dbj|BAH70326.1| receptor-like kinase [Glycine max] gi|239500657|dbj|BAH70327.1| receptor-like kinase [Glycine max]

 Score =  821 bits (2120), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/583 (72%), Positives = 471/583 (80%), Gaps = 12/583 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N  +G +PASLG L EL EISLSHNK SG +P+++G LSRL+ LD S NA NGSL
Sbjct: 265 LILDHNFFTGNVPASLGSLRELSEISLSHNKFSGAIPNEIGTLSRLKTLDISNNAFNGSL 324

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P + SNLSSL  L  E+N L++QI +SL  L NLSVL L RNQ SGHIPS+I NIS L  
Sbjct: 325 PVTLSNLSSLTLLNAENNLLENQIPESLGTLRNLSVLILSRNQFSGHIPSSIANISMLRQ 384

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LDLS N LSGEIP SF + +SL  FNVSYN+LSG VP  LA KFN+SSFVGNIQLCGYS 
Sbjct: 385 LDLSLNNLSGEIPVSFESQRSLDFFNVSYNSLSGSVPPLLAKKFNSSSFVGNIQLCGYSP 444

Query: 183 STPC-----------PSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIR 231
           STPC           P+P     +   R LSTKDIILI AG LL+VL+I+ CIL+ CLIR
Sbjct: 445 STPCLSQAPSQGVIAPTPEVLSEQHHRRNLSTKDIILIVAGVLLVVLIILCCILLFCLIR 504

Query: 232 KRTASKAEDGQATASGTAARGEKGAPS-AAGEVEAGGENGGKLVHFDGPLMFTADDLLCA 290
           KR+ SKAE+GQAT      R EKG P  +AG+VEAGGE GGKLVHFDGPL FTADDLLCA
Sbjct: 505 KRSTSKAENGQATGRAATGRTEKGVPPVSAGDVEAGGEAGGKLVHFDGPLAFTADDLLCA 564

Query: 291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRA 350
           TAEIMGKSTYGTVYKA LEDGSQVAVKRLREKITKG REFESEVS+LGK+RHPN+LALRA
Sbjct: 565 TAEIMGKSTYGTVYKAILEDGSQVAVKRLREKITKGHREFESEVSVLGKVRHPNVLALRA 624

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           YYLGPKGEKLLVFDYMP G LA+FLH  G ET IDWPTRMKI + MTRGL  LHS ENII
Sbjct: 625 YYLGPKGEKLLVFDYMPKGGLASFLHGGGTETFIDWPTRMKIAQDMTRGLFCLHSLENII 684

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           HGNLTSSNVLLD++TNAKI+DFGLSRLM+ AAN NVIATAGALGYRAPELSKLKKANTKT
Sbjct: 685 HGNLTSSNVLLDENTNAKIADFGLSRLMSTAANSNVIATAGALGYRAPELSKLKKANTKT 744

Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D+YSLGV +LELLT KSPG  +NG +LPQWVASIVKEEWTNEVFD ++MRDA T+GDELL
Sbjct: 745 DIYSLGVILLELLTRKSPGVSMNGLDLPQWVASIVKEEWTNEVFDADMMRDASTVGDELL 804

Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGD 573
           NTLKLALHCVDPSPS RPEV QV+QQLEEIRPE +  A+   D
Sbjct: 805 NTLKLALHCVDPSPSVRPEVHQVLQQLEEIRPERSVTASPGDD 847

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|239500659|dbj|BAH70328.1| receptor-like kinase [Glycine max] gi|239500661|dbj|BAH70329.1| receptor-like kinase [Glycine max]

 Score =  820 bits (2119), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/583 (72%), Positives = 471/583 (80%), Gaps = 12/583 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N  +G +PASLG L EL EISLSHNK SG +P+++G LSRL+ LD S NA NGSL
Sbjct: 265 LILDHNFFTGNVPASLGSLRELSEISLSHNKFSGAIPNEIGTLSRLKTLDISNNAFNGSL 324

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P + SNLSSL  L  E+N L++QI +SL  L NLSVL L RNQ SGHIPS+I NIS L  
Sbjct: 325 PVTLSNLSSLTLLNAENNLLENQIPESLGTLRNLSVLILSRNQFSGHIPSSIANISMLRQ 384

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LDLS N LSGEIP SF + +SL  FNVSYN+LSG VP  LA KFN+SSFVGNIQLCGYS 
Sbjct: 385 LDLSLNNLSGEIPVSFESQRSLDFFNVSYNSLSGSVPPLLAKKFNSSSFVGNIQLCGYSP 444

Query: 183 STPC-----------PSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIR 231
           STPC           P+P     +   R LSTKDIILI AG LL+VL+I+ CIL+ CLIR
Sbjct: 445 STPCLSQAPSQGVIAPTPEVLSEQHHRRNLSTKDIILIVAGVLLVVLIILCCILLFCLIR 504

Query: 232 KRTASKAEDGQATASGTAARGEKGAPS-AAGEVEAGGENGGKLVHFDGPLMFTADDLLCA 290
           KR+ SKAE+GQAT    A R EKG P  +AG+VEAGGE GGKLVHFDGPL FTADDLLCA
Sbjct: 505 KRSTSKAENGQATGRAAAGRTEKGVPPVSAGDVEAGGEAGGKLVHFDGPLAFTADDLLCA 564

Query: 291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRA 350
           TAEIMGKSTYGTVYKA LEDGSQVAVKRLREKITKG REFESEVS+LGK+RHPN+LALRA
Sbjct: 565 TAEIMGKSTYGTVYKAILEDGSQVAVKRLREKITKGHREFESEVSVLGKVRHPNVLALRA 624

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           YYLGPKGEKLLVFDYMP G LA+FLH  G ET IDWPTRMKI + M RGL  LHS ENII
Sbjct: 625 YYLGPKGEKLLVFDYMPKGGLASFLHGGGTETFIDWPTRMKIAQDMARGLFCLHSLENII 684

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           HGNLTSSNVLLD++TNAKI+DFGLSRLM+ AAN NVIATAGALGYRAPELSKLKKANTKT
Sbjct: 685 HGNLTSSNVLLDENTNAKIADFGLSRLMSTAANSNVIATAGALGYRAPELSKLKKANTKT 744

Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D+YSLGV +LELLT KSPG  +NG +LPQWVASIVKEEWTNEVFD ++MRDA T+GDELL
Sbjct: 745 DIYSLGVILLELLTRKSPGVSMNGLDLPQWVASIVKEEWTNEVFDADMMRDASTVGDELL 804

Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGD 573
           NTLKLALHCVDPSPS RPEV QV+QQLEEIRPE +  A+   D
Sbjct: 805 NTLKLALHCVDPSPSVRPEVHQVLQQLEEIRPERSVTASPGDD 847

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255571471|ref|XP_002526683.1| Systemin receptor SR160 precursor, putative [Ricinus communis] gi|223533983|gb|EEF35705.1| Systemin receptor SR160 precursor, putative [Ricinus communis]

 Score =  818 bits (2112), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/580 (72%), Positives = 484/580 (83%), Gaps = 12/580 (2%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           FL L +N ++G IP S  KLS LQEISLSHN+ISG +P++LG+LS L+ LDFS N INGS
Sbjct: 229 FLTLDHNLITGNIPVSFSKLSLLQEISLSHNQISGSIPTELGKLSSLQKLDFSNNIINGS 288

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P SFSNLSSLVSL LESN L++QI ++ +KLHNLSVLNLK NQ  G IP++IGNIS+++
Sbjct: 289 MPPSFSNLSSLVSLNLESNGLENQIPEAFEKLHNLSVLNLKNNQFKGLIPASIGNISSIS 348

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYS 181
            LDL+QN  +GEIPAS + L +L+SFNVSYNNLSG VP  L+  FN+SSFVGN+QLCGYS
Sbjct: 349 QLDLAQNNFTGEIPASLAGLTNLASFNVSYNNLSGAVPALLSKNFNSSSFVGNLQLCGYS 408

Query: 182 GSTPCPSPP---------AEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRK 232
            STPCPSPP         +  PK   +KLST+DIILI  GALL +LL++ CIL+CCL+R+
Sbjct: 409 ISTPCPSPPPVIQPSPTISGPPKHHHKKLSTRDIILIAVGALLGILLLLCCILICCLMRR 468

Query: 233 RTASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCATA 292
           R AS  ++G+  A     + EK   +AA  VE+GGE GGKLVHFDGP +FTADDLLCATA
Sbjct: 469 RAASH-QNGKTVARQAVEKTEKSGGAAA--VESGGEMGGKLVHFDGPFVFTADDLLCATA 525

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           EIMGKSTYGT YKATLEDG+QVAVKRLREK TKGQ+EFESE + LGKIRHPNLLALRAYY
Sbjct: 526 EIMGKSTYGTAYKATLEDGNQVAVKRLREKTTKGQKEFESEAASLGKIRHPNLLALRAYY 585

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           LGPKGEKLLVFDYMP GSLA+FLHARGPET I+WPTRM I  G+ RGL +LH+ ENIIHG
Sbjct: 586 LGPKGEKLLVFDYMPKGSLASFLHARGPETAINWPTRMNIAIGIGRGLTYLHTEENIIHG 645

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           NLTSSN+LLD+ TNA I+D+GLS+LMTAAAN N+IATAGALGYRAPEL+KLK ANTKTDV
Sbjct: 646 NLTSSNILLDEQTNAHIADYGLSKLMTAAANTNIIATAGALGYRAPELAKLKNANTKTDV 705

Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           YSLGV ILELLTGK+PGEP NG +LPQWVASIVKEEWTNEVFDLELMRDAP IGDELLNT
Sbjct: 706 YSLGVIILELLTGKAPGEPTNGMDLPQWVASIVKEEWTNEVFDLELMRDAPAIGDELLNT 765

Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSG 572
           LKLALHCVDPSPSARPEV QVVQQLEEI+P+ A ++   G
Sbjct: 766 LKLALHCVDPSPSARPEVQQVVQQLEEIKPDLAASSADEG 805

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|226693201|dbj|BAH56600.1| receptor-like kinase [Glycine max] gi|226693205|dbj|BAH56602.1| receptor-like kinase [Glycine max]

 Score =  817 bits (2110), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/583 (73%), Positives = 474/583 (81%), Gaps = 12/583 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N  +G +PASLG L EL EISLSHNK SG +P+++G LSRL+ LD S NA+NG+L
Sbjct: 270 LILDNNFFTGDVPASLGSLRELNEISLSHNKFSGAIPNEIGTLSRLKTLDISNNALNGNL 329

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           PA+ SNLSSL  L  E+N LD+QI  SL +L NLSVL L RNQ SGHIPS+I NIS+L  
Sbjct: 330 PATLSNLSSLTLLNAENNLLDNQIPQSLGRLRNLSVLILSRNQFSGHIPSSIANISSLRQ 389

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LDLS N  SGEIP SF + +SL+ FNVSYN+LSG VP  LA KFN+SSFVGNIQLCGYS 
Sbjct: 390 LDLSLNNFSGEIPVSFDSQRSLNLFNVSYNSLSGSVPPLLAKKFNSSSFVGNIQLCGYSP 449

Query: 183 STPCPS----------PPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRK 232
           STPC S          PP        RKLSTKDIILI AG LL+VL+I+ C+L+ CLIRK
Sbjct: 450 STPCLSQAPSQGVIAPPPEVSKHHHHRKLSTKDIILIVAGVLLVVLIILCCVLLFCLIRK 509

Query: 233 RTASKAEDGQATASGTAA-RGEKGAPS-AAGEVEAGGENGGKLVHFDGPLMFTADDLLCA 290
           R+ SKA +GQAT    A  R EKG P  AAG+VEAGGE GGKLVHFDGP+ FTADDLLCA
Sbjct: 510 RSTSKAGNGQATEGRAATMRTEKGVPPVAAGDVEAGGEAGGKLVHFDGPMAFTADDLLCA 569

Query: 291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRA 350
           TAEIMGKSTYGTVYKA LEDGSQVAVKRLREKITKG REFESEVS+LGKIRHPN+LALRA
Sbjct: 570 TAEIMGKSTYGTVYKAILEDGSQVAVKRLREKITKGHREFESEVSVLGKIRHPNVLALRA 629

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           YYLGPKGEKLLVFDYM  GSLA+FLH  G ET IDWPTRMKI + + RGL  LHS ENII
Sbjct: 630 YYLGPKGEKLLVFDYMSKGSLASFLHGGGTETFIDWPTRMKIAQDLARGLFCLHSQENII 689

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           HGNLTSSNVLLD++TNAKI+DFGLSRLM+ AAN NVIATAGALGYRAPELSKLKKANTKT
Sbjct: 690 HGNLTSSNVLLDENTNAKIADFGLSRLMSTAANSNVIATAGALGYRAPELSKLKKANTKT 749

Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D+YSLGV +LELLT KSPG P+NG +LPQWVAS+VKEEWTNEVFD +LMRDA T+GDELL
Sbjct: 750 DIYSLGVILLELLTRKSPGVPMNGLDLPQWVASVVKEEWTNEVFDADLMRDASTVGDELL 809

Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGD 573
           NTLKLALHCVDPSPSARPEV QV+QQLEEIRPE +  A+   D
Sbjct: 810 NTLKLALHCVDPSPSARPEVHQVLQQLEEIRPERSVTASPGDD 852

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356538008|ref|XP_003537497.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase IMK3-like [Glycine max]

 Score =  817 bits (2110), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/586 (72%), Positives = 472/586 (80%), Gaps = 15/586 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N  +G +PASLG L EL EISLSHNK SG +P+++G LSRL+ LD S NA NGSL
Sbjct: 265 LILDHNFFTGNVPASLGSLRELSEISLSHNKFSGAIPNEIGTLSRLKTLDISNNAFNGSL 324

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P + SNLSSL  L  E+N L++QI +SL  L NLSVL L RNQ SGHIPS+I NIS L  
Sbjct: 325 PVTLSNLSSLTLLNAENNLLENQIPESLGTLRNLSVLILSRNQFSGHIPSSIANISMLRQ 384

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           LDLS N LSGEIP SF + +SL  FNVSYN+LSG VP  LA KFN+SSFVGNIQLCGYS 
Sbjct: 385 LDLSLNNLSGEIPVSFESQRSLDFFNVSYNSLSGSVPPLLAKKFNSSSFVGNIQLCGYSP 444

Query: 183 STPC-----------PSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIR 231
           STPC           P+P     +   R LSTKDIILI AG LL+VL+I+ CIL+ CLIR
Sbjct: 445 STPCLSQAPSQGVIAPTPEVLSEQHHRRNLSTKDIILIVAGVLLVVLIILCCILLFCLIR 504

Query: 232 KRTASKAEDGQATASGTAARGEKGAPS-AAGEVEAGGENGGKLVHFDGPLMFTADDLLCA 290
           KR+ SKAE+GQAT    A R EKG P  +AG+VEAGGE GGKLVHFDGPL FTADDLLCA
Sbjct: 505 KRSTSKAENGQATGRAAAGRTEKGVPPVSAGDVEAGGEAGGKLVHFDGPLAFTADDLLCA 564

Query: 291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRA 350
           TAEIMGKSTYGTVYKA LEDGSQVAVKRLREKITKG REFESEVS+LGK+RHPN+LALRA
Sbjct: 565 TAEIMGKSTYGTVYKAILEDGSQVAVKRLREKITKGHREFESEVSVLGKVRHPNVLALRA 624

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHAR---GPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           YYLGPKGEKLLVFDYMP G LA+FLH +   G ET IDWPTRMKI + M RGL  LHS E
Sbjct: 625 YYLGPKGEKLLVFDYMPKGGLASFLHGKFGGGTETFIDWPTRMKIAQDMARGLFCLHSLE 684

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
           NIIHGNLTSSNVLLD++TNAKI+DFGLSRLM+ AAN NVIATAGALGYRAPELSKLKKAN
Sbjct: 685 NIIHGNLTSSNVLLDENTNAKIADFGLSRLMSTAANSNVIATAGALGYRAPELSKLKKAN 744

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
           TKTD+YSLGV +LELLT KSPG  +NG +LPQWVASIVKEEWTNEVFD ++MRDA T+GD
Sbjct: 745 TKTDIYSLGVILLELLTRKSPGVSMNGLDLPQWVASIVKEEWTNEVFDADMMRDASTVGD 804

Query: 528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGD 573
           ELLNTLKLALHCVDPSPS RPEV QV+QQLEEIRPE +  A+   D
Sbjct: 805 ELLNTLKLALHCVDPSPSVRPEVHQVLQQLEEIRPERSVTASPGDD 850

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	580
TAIR|locus:2098267	836	IMK2 "inflorescence meristem r	0.956	0.663	0.614	5.7e-178
TAIR|locus:2202359	670	AT1G68400 [Arabidopsis thalian	0.486	0.420	0.478	2.7e-86
TAIR|locus:2093121	674	TMKL1 "transmembrane kinase-li	0.501	0.431	0.454	3.1e-85
TAIR|locus:2161308	654	AT5G58300 [Arabidopsis thalian	0.486	0.431	0.464	1.3e-84
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.910	0.802	0.366	2.7e-84
TAIR|locus:2077898	640	AT3G08680 [Arabidopsis thalian	0.9	0.815	0.370	1.2e-81
TAIR|locus:2044913	672	AT2G36570 [Arabidopsis thalian	0.410	0.354	0.462	4e-81
TAIR|locus:2128414	638	AT4G23740 [Arabidopsis thalian	0.486	0.442	0.430	5.8e-80
TAIR|locus:2088500	647	RLK902 "receptor-like kinase 9	0.489	0.438	0.428	1.1e-78
TAIR|locus:2198090	655	RKL1 "receptor-like kinase 1"	0.491	0.435	0.432	3.6e-78

TAIR|locus:2098267 IMK2 "inflorescence meristem receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1728 (613.3 bits), Expect = 5.7e-178, P = 5.7e-178
 Identities = 353/574 (61%), Positives = 411/574 (71%)

Query:     3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             L L +N  SG +P SL K S L+E+S+SHN++SG +P + G L  L+ LDFSYN+ING++
Sbjct:   244 LNLDHNRFSGAVPVSLCKHSLLEEVSISHNQLSGSIPRECGGLPHLQSLDFSYNSINGTI 303

Query:    63 PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
             P SFSNLSSLVSL LESN+L   I D++D+LHNL+ LNLKRN+I+G IP TIGNIS +  
Sbjct:   304 PDSFSNLSSLVSLNLESNHLKGPIPDAIDRLHNLTELNLKRNKINGPIPETIGNISGIKK 363

Query:   123 LDLSQNKLSGEIPAXXXXXXXXXXXXXXYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
             LDLS+N  +G IP               YN LSGPVP  L+ KFN+SSF+GNIQLCGYS 
Sbjct:   364 LDLSENNFTGPIPLSLVHLAKLSSFNVSYNTLSGPVPPVLSKKFNSSSFLGNIQLCGYSS 423

Query:   183 STPCPSP----P-------AEKP-KSRGRKLSTKDXXXXXXXXXXXXXXXXXXXXXXXXX 230
             S PCP+P    P       +++P K   RKLS KD                         
Sbjct:   424 SNPCPAPDHHHPLTLSPTSSQEPRKHHHRKLSVKDVILIAIGALLAILLLLCCILLCCLI 483

Query:   231 RKRTASKAEDGQ-ATASGTAARGEKXXXXXXXXXXXXXXXXXKLVHFDGPLMFTADDLLC 289
             +KR A K +DG+  T+  T + G                   KLVHFDGP +FTADDLLC
Sbjct:   484 KKRAALKQKDGKDKTSEKTVSAG------VAGTASAGGEMGGKLVHFDGPFVFTADDLLC 537

Query:   290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
             ATAEIMGKSTYGT YKATLEDG++VAVKRLREK TKG +EFE EV+ LGKIRH NLLALR
Sbjct:   538 ATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKGVKEFEGEVTALGKIRHQNLLALR 597

Query:   350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
             AYYLGPKGEKLLVFDYM  GSL+ FLHARGPET I W TRMKI KG++RGL HLHSNEN+
Sbjct:   598 AYYLGPKGEKLLVFDYMSKGSLSAFLHARGPETLIPWETRMKIAKGISRGLAHLHSNENM 657

Query:   410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
             IH NLT+SN+LLD+ TNA I+D+GLSRLM              LGYRAPE SK+K A+ K
Sbjct:   658 IHENLTASNILLDEQTNAHIADYGLSRLMTAAAATNVIATAGTLGYRAPEFSKIKNASAK 717

Query:   470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
             TDVYSLG+ ILELLTGKSPGEP NG +LPQWVASIVKEEWTNEVFDLELMR+  ++GDEL
Sbjct:   718 TDVYSLGIIILELLTGKSPGEPTNGMDLPQWVASIVKEEWTNEVFDLELMRETQSVGDEL 777

Query:   530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
             LNTLKLALHCVDPSP+ARPE  QVV+QLEEIRPE
Sbjct:   778 LNTLKLALHCVDPSPAARPEANQVVEQLEEIRPE 811

GO:0004672 "protein kinase activity" evidence=IEA;NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016020 "membrane" evidence=NAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005618 "cell wall" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0008283 "cell proliferation" evidence=RCA

TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)]

 Score = 673 (242.0 bits), Expect = 2.7e-86, Sum P(2) = 2.7e-86
 Identities = 144/301 (47%), Positives = 199/301 (66%)

Query:   272 KLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT-KGQREF 330
             K+V F+G   F  +DLL A+AE++GK  +GT YKA LEDG++VAVKRL++ +T  G++EF
Sbjct:   345 KMVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEF 404

Query:   331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHA-RGP-ETPIDWPT 388
             E ++ +LG++RH NL++L+AYY   + EKLLV+DYMP+GSL   LH  RGP  TP+DW T
Sbjct:   405 EQQMEVLGRLRHTNLVSLKAYYFA-REEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTT 463

Query:   389 RMKIIKGMTRGLLHLHSN---ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXX 445
             R+KI  G  RGL  +H +     + HG++ S+NVLLD S NA++SDFGLS          
Sbjct:   464 RLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAK 523

Query:   446 XXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP-----GEPLNGAELPQW 500
                     GYRAPEL   +K   K+DVYS GV +LE+LTGK P     G      +LP+W
Sbjct:   524 SN------GYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRW 577

Query:   501 VASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             V S+V+EEWT EVFDLELMR    I +E++  L++A+ C   +   RP++  VV+ +E+I
Sbjct:   578 VQSVVREEWTAEVFDLELMR-YKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDI 636

Query:   561 R 561
             R
Sbjct:   637 R 637

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2093121 TMKL1 "transmembrane kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 629 (226.5 bits), Expect = 3.1e-85, Sum P(2) = 3.1e-85
 Identities = 136/299 (45%), Positives = 188/299 (62%)

Query:   272 KLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFE 331
             KLV F G    T DD+L AT ++M K++YGTVYKA L DG  +A++ LRE   K +    
Sbjct:   356 KLVVFQGGENLTLDDVLNATGQVMEKTSYGTVYKAKLSDGGNIALRLLREGTCKDRSSCL 415

Query:   332 SEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-IDWPTRM 390
               +  LG+IRH NL+ LRA+Y G +GEKLL++DY+P+ SL   LH   P  P ++W  R 
Sbjct:   416 PVIRQLGRIRHENLVPLRAFYQGKRGEKLLIYDYLPNISLHDLLHESKPRKPALNWARRH 475

Query:   391 KIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXX 448
             KI  G+ RGL +LH+ +   IIHGN+ S NVL+DD   A++++FGL ++M          
Sbjct:   476 KIALGIARGLAYLHTGQEVPIIHGNIRSKNVLVDDFFFARLTEFGLDKIMVQAVADEIVS 535

Query:   449 XXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP-LNGAE---LPQWVASI 504
                  GY+APEL K+KK N ++DVY+ G+ +LE+L GK PG+   NG E   LP  V + 
Sbjct:   536 QAKSDGYKAPELHKMKKCNPRSDVYAFGILLLEILMGKKPGKSGRNGNEFVDLPSLVKAA 595

Query:   505 VKEEWTNEVFDLELMRDAPTIGDE-LLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP 562
             V EE T EVFDLE M+   +  +E L++ LKLA+ C  P  + RP + +VV+QLEE RP
Sbjct:   596 VLEETTMEVFDLEAMKGIRSPMEEGLVHALKLAMGCCAPVTTVRPSMEEVVKQLEENRP 654

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)]

 Score = 643 (231.4 bits), Expect = 1.3e-84, Sum P(2) = 1.3e-84
 Identities = 139/299 (46%), Positives = 196/299 (65%)

Query:   272 KLVHFDG-PLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF 330
             KLV F+G    F  +DLL A+AE++GK +YGT YKA LE+ + V VKRL+E +  G+REF
Sbjct:   340 KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKE-VAAGKREF 398

Query:   331 ESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHA-RGPE-TPIDWP 387
             E ++ ++ ++  HP+++ LRAYY   K EKL+V DY P G+L++ LH  RG E TP+DW 
Sbjct:   399 EQQMEIISRVGNHPSVVPLRAYYYS-KDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWD 457

Query:   388 TRMKIIKGMTRGLLHLHS--NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXX 445
             +R+KI     +G+ HLH+       HGN+ SSNV++   ++A ISDFGL+ LM       
Sbjct:   458 SRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPM 517

Query:   446 XXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGE-PLNG--AELPQWVA 502
                     GYRAPE+ + +K   K+DVYS GV ILE+LTGKSP + P      +LP+WV 
Sbjct:   518 RGA-----GYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLPRWVQ 572

Query:   503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
             S+V+EEWT+EVFD+ELMR    I +E++  L++A+ CV   P  RP +  VV+ +EEIR
Sbjct:   573 SVVREEWTSEVFDIELMR-FQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIR 630

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
 Identities = 212/579 (36%), Positives = 314/579 (54%)

Query:     3 LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
             L L    L G+IP+ SLG+L+EL+ +SL  N++SG +PSD   L+ LR L   +N  +G 
Sbjct:    71 LRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGE 130

Query:    62 LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTL 120
              P SF+ L++L+ L + SNN    I  S++ L +L+ L L  N  SG++PS ++G    L
Sbjct:   131 FPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLG----L 186

Query:   121 TILDLSQNKLSGEIPAXXXXXXXXXXXXXXYNNLSGPVPTSLALKFNASSFVGNIQLCGY 180
                ++S N L+G IP+               +   GP      LK   S FV        
Sbjct:   187 VDFNVSNNNLNGSIPSSLSRFSAESFTGNV-DLCGGP------LKPCKSFFV-------- 231

Query:   181 SGSTPCPSP----PAEKPKSRGRKLSTKDXXXXXXXXXXXXXXXXXXXXXXXXXRKRTAS 236
                +P PSP    P+ +  S+  KLS                            ++R ++
Sbjct:   232 ---SPSPSPSLINPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSN 288

Query:   237 KAEDGQATASGTAARG---------EKXXXXXXXXXXXXXXXXXKLVHFDGPLM-FTADD 286
             +A   Q   +G A R           K                 KLV  +G +  F  +D
Sbjct:   289 EARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLED 348

Query:   287 LLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL 346
             LL A+AE++GK + GT YKA LE+G+ V VKRL++ +   ++EFE+++ ++GKI+HPN++
Sbjct:   349 LLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKD-VMASKKEFETQMEVVGKIKHPNVI 407

Query:   347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLH-ARGP-ETPIDWPTRMKIIKGMTRGLLHLH 404
              LRAYY   K EKLLVFD+MP GSL+  LH +RG   TP+DW  RM+I     RGL HLH
Sbjct:   408 PLRAYYYS-KDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLH 466

Query:   405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLK 464
              +  ++HGN+ +SN+LL  + +  +SD+GL++L                GY APE+ + +
Sbjct:   467 VSAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLA-----GYHAPEVLETR 521

Query:   465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAE---LPQWVASIVKEEWTNEVFDLELMRD 521
             K   K+DVYS GV +LELLTGKSP +   G E   LP+WV S+V+EEWT EVFD+ELMR 
Sbjct:   522 KVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMR- 580

Query:   522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                I +E++  L++A+ CV   P  RP + +V++ +E++
Sbjct:   581 YHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)]

 Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
 Identities = 207/559 (37%), Positives = 291/559 (52%)

Query:    27 ISLSHNKISGVMPSD-LGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQ 85
             + L  + + G +P     +L  LRI+    N + G++P+   +L  + SL    NN    
Sbjct:    72 LRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFHENNFSGT 131

Query:    86 ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAXXXXXXXXX 145
             I   L   H L  L+L  N +SG+IP+++ N++ LT L L  N LSG IP          
Sbjct:   132 IPPVLS--HRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIP---NLPPRLK 186

Query:   146 XXXXXYNNLSGPVPTSLALKFNASSFVGNIQLCGYSGSTPCP--------SP--PAEKPK 195
                  +NNL+G VP+S+   F ASSF GN  LCG +  TPCP        SP  P E P 
Sbjct:   187 YLNLSFNNLNGSVPSSVK-SFPASSFQGNSLLCG-APLTPCPENTTAPSPSPTTPTEGPG 244

Query:   196 SR--GRKLSTKDXXXXXXXXXXXXXXXXXXXXXXXXXRKRTASKAEDGQ-ATASGTAARG 252
             +   GR  + K                              A K + GQ +TA   A  G
Sbjct:   245 TTNIGRG-TAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKPG 303

Query:   253 EKXXXXXXXXXXXXXXXXXKLVHFDGPLM-FTADDLLCATAEIMGKSTYGTVYKATLEDG 311
                                KLV F+G    F  +DLL A+AE++GK +YGT YKA LE+G
Sbjct:   304 RSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEG 363

Query:   312 SQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHGS 370
             + V VKRL+E +  G+REFE ++  +G+I  H N+  LRAYY   K EKLLV+DY   G+
Sbjct:   364 TTVVVKRLKE-VAAGKREFEQQMEAVGRISPHVNVAPLRAYYFS-KDEKLLVYDYYQGGN 421

Query:   371 LATFLHAR--GPETPIDWPTRMKIIKGMTRGLLHLHS--NENIIHGNLTSSNVLLDDSTN 426
              +  LH    G    +DW TR++I     RG+ H+HS     ++HGN+ S NVLL    +
Sbjct:   422 FSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELH 481

Query:   427 AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
               +SDFG++ LM              LGYRAPE  + +K   K+DVYS GV +LE+LTGK
Sbjct:   482 VCVSDFGIAPLMSHHTLIPSRS----LGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGK 537

Query:   487 SPGEPLNGAE---LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPS 543
             + G+     E   LP+WV S+V+EEWT EVFD+EL++    + +E++  L++A+ CV   
Sbjct:   538 AAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKH 597

Query:   544 PSARPEVLQVVQQLEEIRP 562
             P +RP + +VV  +EEIRP
Sbjct:   598 PDSRPSMEEVVNMMEEIRP 616

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)]

 Score = 506 (183.2 bits), Expect = 4.0e-81, Sum P(3) = 4.0e-81
 Identities = 116/251 (46%), Positives = 158/251 (62%)

Query:   272 KLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQREF 330
             +LV F+    F  DDLL A+AE++GK + GTVYKA L+DGS  VAVKRL++     ++EF
Sbjct:   340 RLVFFERRKQFELDDLLKASAEMLGKGSLGTVYKAVLDDGSTTVAVKRLKDANPCPRKEF 399

Query:   331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHA-RGP-ETPIDWPT 388
             E  + ++G+++H N++ LRAYY   K EKLLV++Y+P+GSL + LH  RGP   P+DW T
Sbjct:   400 EQYMEIIGRLKHQNVVKLRAYYYA-KEEKLLVYEYLPNGSLHSLLHGNRGPGRIPLDWTT 458

Query:   389 RMKIIKGMTRGLLHLH---SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXX 445
             R+ ++ G  RGL  +H   S   I HGN+ SSNVLLD +  A I+DFGLS L+       
Sbjct:   459 RISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDRNGVALIADFGLSLLLNPVHAIA 518

Query:   446 XXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV 505
                     GYRAPE S++K+ + K DVYS GV +LE+LTGK+P         P+  AS+ 
Sbjct:   519 RLG-----GYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGKAPSI-FPSPSRPRSAASVA 572

Query:   506 KEEWTNEVFDL 516
              EE    V DL
Sbjct:   573 VEEEEEAVVDL 583

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)]

 Score = 616 (221.9 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
 Identities = 128/297 (43%), Positives = 191/297 (64%)

Query:   272 KLVHFDG-PLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF 330
             +L  F+G    F  +DLL A+AE++GK T+GT YKA LED + VAVKRL++ +  G+R+F
Sbjct:   319 RLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKD-VAAGKRDF 377

Query:   331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHA-RGPET-PIDWPT 388
             E ++ ++G I+H N++ L+AYY   K EKL+V+DY   GS+A+ LH  RG    P+DW T
Sbjct:   378 EQQMEIIGGIKHENVVELKAYYYS-KDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWET 436

Query:   389 RMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXX 446
             RMKI  G  +G+  +H   N  ++HGN+ SSN+ L+  +N  +SD GL+ +M        
Sbjct:   437 RMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPIS 496

Query:   447 XXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE---LPQWVAS 503
                    GYRAPE++  +K++  +DVYS GV +LELLTGKSP     G E   L +WV S
Sbjct:   497 RQA----GYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHS 552

Query:   504 IVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             +V+EEWT EVFD+EL+R    I +E++  L++A+ CV  +   RP++  +V+ +E +
Sbjct:   553 VVREEWTAEVFDIELLRYT-NIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENV 608

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)]

 Score = 608 (219.1 bits), Expect = 1.1e-78, Sum P(2) = 1.1e-78
 Identities = 128/299 (42%), Positives = 192/299 (64%)

Query:   272 KLVHF-DGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF 330
             KLV F +   +F  +DLL A+AE++GK T+GT YKA L+  + VAVKRL++ +T   REF
Sbjct:   347 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKD-VTMADREF 405

Query:   331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHA-RGP-ETPIDWPT 388
             + ++ ++G + H NL+ LRAYY     EKLLV+D+MP GSL+  LH  +G    P++W  
Sbjct:   406 KEKIEVVGAMDHENLVPLRAYYYSGD-EKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEV 464

Query:   389 RMKIIKGMTRGLLHLHSNENII-HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXX 447
             R  I  G  RGL +LHS + +  HGN+ SSN+LL +S +A++SDFGL++L+         
Sbjct:   465 RSGIALGAARGLDYLHSQDPLSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNR 524

Query:   448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPL---NGAELPQWVASI 504
                   GYRAPE++  ++ + K DVYS GV +LELLTGK+P   +    G +L +WV S+
Sbjct:   525 AT----GYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSV 580

Query:   505 VKEEWTNEVFDLELM--RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
              +EEW NEVFD ELM      ++ +E+   L+L + C +  P  RP +++VV++++E+R
Sbjct:   581 AREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELR 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 613 (220.8 bits), Expect = 3.6e-78, Sum P(2) = 3.6e-78
 Identities = 129/298 (43%), Positives = 189/298 (63%)

Query:   272 KLVHF-DGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF 330
             KLV F +   +F  +DLL A+AE++GK T+GT YKA L+  + VAVKRL++ +    +EF
Sbjct:   353 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKD-VMMADKEF 411

Query:   331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHA-RGP-ETPIDWPT 388
             + ++ L+G + H NL+ LRAYY   + EKLLV+D+MP GSL+  LH  RG   +P++W  
Sbjct:   412 KEKIELVGAMDHENLVPLRAYYFS-RDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDV 470

Query:   389 RMKIIKGMTRGLLHLHSN-ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXX 447
             R +I  G  RGL +LHS   +  HGN+ SSN+LL  S +AK+SDFGL++L+         
Sbjct:   471 RSRIAIGAARGLDYLHSQGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNR 530

Query:   448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPL---NGAELPQWVASI 504
                   GYRAPE++  K+ + K DVYS GV +LEL+TGK+P   +    G +LP+WV S+
Sbjct:   531 AT----GYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSV 586

Query:   505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP 562
              ++EW  EVFD EL+  A    + +   ++L L C    P  RPE+ +VV+++E +RP
Sbjct:   587 ARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLRP 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005774 "vacuolar membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP9	IMK3_ARATH	2, ., 7, ., 1, 1, ., 1	0.6759	0.9689	0.7168	yes	no
Q9SCT4	IMK2_ARATH	No assigned EC number	0.6893	0.9551	0.6626	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	580
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-60
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-35
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-32
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-29
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-29
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-22
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-20
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-16
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-16
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-15
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-09
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	2e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	6e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	7e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.003
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.003
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  215 bits (548), Expect = 4e-60
 Identities = 177/591 (29%), Positives = 271/591 (45%), Gaps = 86/591 (14%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           FL +  NNL GRI +    +  LQ +SL+ NK  G +P D     RL  LD S N  +G+
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGA 490

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P    +LS L+ L L  N L  +I D L     L  L+L  NQ+SG IP++   +  L+
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA-LKFNASSFVGNIQLCG- 179
            LDLSQN+LSGEIP +  N++SL   N+S+N+L G +P++ A L  NAS+  GNI LCG 
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610

Query: 180 --YSGSTPCPSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTASK 237
              SG  PC            R   T          L   L++ +       IR R   +
Sbjct: 611 DTTSGLPPCK-----------RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE 659

Query: 238 AEDGQATASGTAARGEKGAPSAAGEVEAGGENGG-KLVHFDGPLM--FTADDLLCATAE- 293
            +                       VE   E+G  +L  FD  +    T +D+L +  E 
Sbjct: 660 LK----------------------RVE--NEDGTWELQFFDSKVSKSITINDILSSLKEE 695

Query: 294 -IMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            ++ +   G  YK  ++++G Q  VK    +I        SE++ +GK++HPN++ L   
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVK----EINDVNSIPSSEIADMGKLQHPNIVKLIGL 751

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL--LHLHSNENI 409
               KG   L+ +Y+   +L+  L        + W  R KI  G+ + L  LH   +  +
Sbjct: 752 CRSEKG-AYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV 804

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           + GNL+   +++D      +    L   +        I++A    Y APE  + K    K
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLP-GLLCTDTKCFISSA----YVAPETRETKDITEK 858

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF---------DLELMR 520
           +D+Y  G+ ++ELLTGKSP +   G        SIV  EW    +         D  +  
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVH-----GSIV--EWARYCYSDCHLDMWIDPSIRG 911

Query: 521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSS 571
           D     +E++  + LALHC    P+ARP    V++ L     E+A+ ++SS
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL-----ESASRSSSS 957

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (423), Expect = 1e-47
 Identities = 76/265 (28%), Positives = 122/265 (46%), Gaps = 24/265 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           E +G+ ++G VY A   + G  VA+K ++ +KI K +     E+ +L K++HPN++ L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            +      KL LV +Y   G L   L  RG  +  +   R   ++ +   L +LHS   I
Sbjct: 65  VFEDED--KLYLVMEYCEGGDLFDLLKKRGRLSEDE--AR-FYLRQILSALEYLHSK-GI 118

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           +H +L   N+LLD+  + K++DFGL+R +     +      G   Y APE+   K     
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
            D++SLGV + ELLTGK    P  G +    +   + +                 I  E 
Sbjct: 177 VDIWSLGVILYELLTGKP---PFPGDDQLLELFKKIGKP------KPPFPPPEWDISPEA 227

Query: 530 LNTLKLALHCVDPS--PSARPEVLQ 552
            + ++  L   DP    +A  E LQ
Sbjct: 228 KDLIRKLL-VKDPEKRLTAE-EALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (406), Expect = 1e-45
 Identities = 63/191 (32%), Positives = 97/191 (50%), Gaps = 9/191 (4%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           G+  +GTVY A   + G +VA+K ++ E  +    E   E+ +L K+ HPN++ L   + 
Sbjct: 2   GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61

Query: 354 GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
                  LV +Y   GSL   L        +     ++I+  +  GL +LHSN  IIH +
Sbjct: 62  DEN-HLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHSN-GIIHRD 117

Query: 414 LTSSNVLLDDST-NAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKLKKANTKTD 471
           L   N+LLD      K++DFGLS+L+T+     +    G   Y APE L      + K+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 472 VYSLGVTILEL 482
           ++SLGV + EL
Sbjct: 177 IWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (401), Expect = 2e-44
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 32/280 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           + +G+  +G VYK  L+       +VAVK L+E  ++ +R +F  E  ++ K+ HPN++ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM------KIIKGMTRGLL 401
           L       +    LV +YM  G L  +L    P  P    + +           + +G+ 
Sbjct: 61  LLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APE 459
           +L S    +H +L + N L+ +    KISDFGLSR +    +     T G L  R  APE
Sbjct: 120 YLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAPE 177

Query: 460 LSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
             K     +K+DV+S GV + E+ T G +P   L+  E+ +++          + + L  
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---------RKGYRLPK 228

Query: 519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
               P   DEL     L L C    P  RP   ++V++LE
Sbjct: 229 PEYCP---DELYE---LMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (400), Expect = 3e-44
 Identities = 88/271 (32%), Positives = 126/271 (46%), Gaps = 27/271 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL--REKITKGQREFESEVSLLGKIRHPNLLALR 349
             +G  ++GTVYKA     G  VAVK L  R + +K  +    E+ +L ++ HPN++ L 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
             +   K    LV +Y   G L  +L   GP   +      KI   + RGL +LHSN  I
Sbjct: 65  DAF-EDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN-GI 119

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAPELSKLKKAN 467
           IH +L   N+LLD++   KI+DFGL++ +      +   T   G   Y APE+  L   N
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLL---KSSSSLTTFVGTPWYMAPEV--LLGGN 174

Query: 468 ---TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
               K DV+SLGV + ELLTGK P    N  +  Q +  I+            L  D P 
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGP---------PLEFDEPK 225

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
                     L   C++  PS RP   +++Q
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  153 bits (388), Expect = 1e-42
 Identities = 78/278 (28%), Positives = 130/278 (46%), Gaps = 37/278 (13%)

Query: 293 EIMGKSTYGTVYKATLEDGS-----QVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLL 346
           + +G+  +G VYK TL+        +VAVK L+E  ++ +R EF  E S++ K+ HPN++
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L            +V +YMP G L  FL   G    +     +++   + +G+ +L S 
Sbjct: 65  RLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIAKGMEYLESK 121

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLK 464
            N +H +L + N L+ ++   KISDFGLSR +            G L  +  APE  K  
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK-RGGGKLPIKWMAPESLKDG 179

Query: 465 KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK----EEWTNEVFDLELM 519
           K  +K+DV+S GV + E+ T G+ P   ++  E+ + +    +    E   +E+++  LM
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYE--LM 237

Query: 520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
                            L C    P  RP   ++V+ L
Sbjct: 238 -----------------LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  146 bits (371), Expect = 3e-40
 Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 30/274 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGS-----QVAVKRLRE-KITKGQREFESEVSLLGKIRHPNLL 346
           + +G+  +G VYK  L+        +VAVK L+E    +   EF  E  ++ K+ HPN++
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L            +V +YM  G L ++L    P+  +     +     + RG+ +L S 
Sbjct: 65  KLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLESK 121

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLK 464
            N IH +L + N L+ ++   KISDFGLSR +            G L  R  APE  K  
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK--RGGKLPIRWMAPESLKEG 178

Query: 465 KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           K  +K+DV+S GV + E+ T G+ P   ++  E+ +++ +          + L    + P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---------YRLPQPPNCP 229

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
               EL +   L L C    P  RP   ++V+ L
Sbjct: 230 ---PELYD---LMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  146 bits (371), Expect = 3e-40
 Identities = 82/274 (29%), Positives = 127/274 (46%), Gaps = 29/274 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGS-----QVAVKRLRE-KITKGQREFESEVSLLGKIRHPNLL 346
           + +G+  +G VYK TL+        +VAVK L+E    +   EF  E  ++ K+ HPN++
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L           ++V +YMP G L  +L    P   +     +     + RG+ +L S 
Sbjct: 65  KLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK 122

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLK 464
            N IH +L + N L+ ++   KISDFGLSR +       V    G L  R  APE  K  
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV--KGGKLPIRWMAPESLKEG 179

Query: 465 KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           K  +K+DV+S GV + E+ T G+ P   ++ AE+ +++            + L    + P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---------YRLPKPPNCP 230

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
               EL    KL L C    P  RP   ++V+ L
Sbjct: 231 ---PEL---YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  134 bits (340), Expect = 7e-36
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 21/207 (10%)

Query: 293 EIMGKSTYGTVYKATLED-GSQVAVK--RLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           E++G+ ++G+VY A  +D G  +AVK   L     +     E E+ +L  ++HPN++   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63

Query: 350 AYYLG----PKGEKLLVF-DYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLH 402
             Y G     +   L +F +Y+  GSL++ L   G  PE  I   TR      +  GL +
Sbjct: 64  --YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ-----ILEGLAY 116

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELS 461
           LHSN  I+H ++  +N+L+D     K++DFG ++ +          +  G   + APE+ 
Sbjct: 117 LHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           + ++     D++SLG T++E+ TGK P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (335), Expect = 3e-35
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA-LRAYYL 353
           GK  +G VYKA     G +VA+K ++ +  + + +  +E+ +L K +HPN++    +Y  
Sbjct: 9   GKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL- 67

Query: 354 GPKGEKLLVFDYMPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             K E  +V ++   GSL   L +      E+ I       + K + +GL +LHSN  II
Sbjct: 68  -KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI-----AYVCKELLKGLEYLHSN-GII 120

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           H ++ ++N+LL      K+ DFGLS  ++     N +   G   + APE+   K  + K 
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKA 178

Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+T +EL  GK P
Sbjct: 179 DIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  131 bits (330), Expect = 7e-32
 Identities = 72/181 (39%), Positives = 105/181 (58%), Gaps = 9/181 (4%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           +L L  NN +G IP   G +  L+ + LS+N +SG +P+D+G  S L++LD   N + G 
Sbjct: 122 YLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P S +NL+SL  LTL SN L  QI   L ++ +L  + L  N +SG IP  IG +++L 
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTS-------LALKFNASSFVGN 174
            LDL  N L+G IP+S  NLK+L    +  N LSGP+P S       ++L  + +S  G 
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Query: 175 I 175
           I
Sbjct: 300 I 300

Length = 968

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 2e-29
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 29/209 (13%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES-------EVSLLGKIRHPN 344
             +G+ TYG VYKA   + G  VA+K++R      + E E        E+ LL K+RHPN
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRM-----ENEKEGFPITAIREIKLLQKLRHPN 59

Query: 345 LLALRAYYLGP-KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           ++ L+       KG   +VF+YM H  L   L +  PE           +K +  GL +L
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYL 116

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV---NVIATAGALGYRAPEL 460
           HSN  I+H ++  SN+L+++    K++DFGL+R  T   +    N + T   L YR PEL
Sbjct: 117 HSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT---LWYRPPEL 172

Query: 461 SKL---KKANTKTDVYSLGVTILELLTGK 486
             L    +   + D++S+G  + EL  GK
Sbjct: 173 --LLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 6e-29
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 24/205 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES----EVSLLGKIRHPNLLA 347
           E +G+ TYG VYKA   + G  VA+K++R  +   +    S    E+SLL +++HPN++ 
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVK 62

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L       +  KL LVF+Y     L  +L  R    P+       I+  + RGL + HS+
Sbjct: 63  LLDVIHTER--KLYLVFEYCDM-DLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSH 117

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA--ANVNVIATAGALGYRAPELSKL- 463
             I+H +L   N+L++     K++DFGL+R          + + T   L YRAPE+  L 
Sbjct: 118 -RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT---LWYRAPEI--LL 171

Query: 464 --KKANTKTDVYSLGVTILELLTGK 486
             K  +T  D++S+G    E++TGK
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (295), Expect = 7e-29
 Identities = 76/277 (27%), Positives = 120/277 (43%), Gaps = 20/277 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALR 349
             +G+ ++G VY A   D   VA+K L +K+    K    F  E+ +L  + HP  +  +
Sbjct: 6   RKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV-K 62

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            Y        L LV +Y+  GSL   L   G + P+     + I+  +   L +LHS   
Sbjct: 63  LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK-G 121

Query: 409 IIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANVNVIATA-----GALGYRAPEL-- 460
           IIH ++   N+LLD D    K+ DFGL++L+    + + I        G  GY APE+  
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 461 -SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM 519
              L  A++ +D++SLG+T+ ELLTG  P E    +        I+ E  T  +      
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
            +   I     + LK     +   P  R      +  
Sbjct: 242 SNPELISKAASDLLK---KLLAKDPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  114 bits (289), Expect = 8e-29
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 30/269 (11%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREF-ESEVSLLGKIRHPNLLALRAYY 352
           GK ++G VY      DG    +K +    +++ +RE   +EV +L K+ HPN++     +
Sbjct: 9   GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF 68

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPE-TPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              KG+  +V +Y   G L+  +  +  E  P      +     +   L +LHS   I+H
Sbjct: 69  EE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILH 126

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN--VIATAGALGYRAPELSKLKKANTK 469
            ++   N+ L  +   K+ DFG+S+++++  ++   V+ T     Y +PEL + K  N K
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP---YYLSPELCQNKPYNYK 183

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT--NEVFDLELMRDAPTIGD 527
           +D++SLG  + EL T K    P  G  L +    I+K ++      +  EL      +  
Sbjct: 184 SDIWSLGCVLYELCTLKH---PFEGENLLELALKILKGQYPPIPSQYSSELRN----LVS 236

Query: 528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
            LL             P  RP + Q++Q 
Sbjct: 237 SLLQ----------KDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  121 bits (304), Expect = 1e-28
 Identities = 61/158 (38%), Positives = 93/158 (58%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
           L YNNLSG IP  +G L+ L  + L +N ++G +PS LG L  L+ L    N ++G +P 
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
           S  +L  L+SL L  N+L  +I + + +L NL +L+L  N  +G IP  + ++  L +L 
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338

Query: 125 LSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           L  NK SGEIP +     +L+  ++S NNL+G +P  L
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  120 bits (302), Expect = 2e-28
 Identities = 60/161 (37%), Positives = 87/161 (54%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           FL L  N L G+IP  LG++  L+ I L +N +SG +P ++G L+ L  LD  YN + G 
Sbjct: 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P+S  NL +L  L L  N L   I  S+  L  L  L+L  N +SG IP  +  +  L 
Sbjct: 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           IL L  N  +G+IP + ++L  L    +  N  SG +P +L
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  119 bits (301), Expect = 3e-28
 Identities = 63/162 (38%), Positives = 94/162 (58%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L  N L G+IP SL  L+ L+ ++L+ N++ G +P +LG++  L+ +   YN ++G 
Sbjct: 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P     L+SL  L L  NNL   I  SL  L NL  L L +N++SG IP +I ++  L 
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
            LDLS N LSGEIP     L++L   ++  NN +G +P +L 
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  118 bits (298), Expect = 6e-28
 Identities = 68/161 (42%), Positives = 92/161 (57%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L YNNL+G IP+SLG L  LQ + L  NK+SG +P  +  L +L  LD S N+++G +
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P     L +L  L L SNN   +I  +L  L  L VL L  N+ SG IP  +G  + LT+
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           LDLS N L+GEIP    +  +L    +  N+L G +P SL 
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401

Length = 968

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 3e-27
 Identities = 57/202 (28%), Positives = 108/202 (53%), Gaps = 15/202 (7%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLR-EKITKGQ-REFESEVSLLGKIRHPNLLALR 349
           +++G+  +G VYK   LE G  VA+K++  EKI +   +    E+ LL  ++HPN++   
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 350 AYYLGPKGEKLLVF-DYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSN 406
                   + L +  +Y  +GSL   +   G  PE+ +        +  + +GL +LH  
Sbjct: 66  GSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAYLH-E 117

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           + +IH ++ ++N+L       K++DFG++  +   +  +  +  G   + APE+ ++  A
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVIEMSGA 176

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +T +D++SLG T++ELLTG  P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (273), Expect = 1e-26
 Identities = 71/284 (25%), Positives = 131/284 (46%), Gaps = 28/284 (9%)

Query: 295 MGKSTYGTVYKATLE-----DGSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V     +      G QVAVK L      + + +FE E+ +L  + H N++  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           +     P G  L L+ +Y+P GSL  +L  +     I+    +     + +G+ +L  ++
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG-SQ 128

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKK 465
             IH +L + N+L++     KISDFGL++++    +   +   G       APE  +  K
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188

Query: 466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDL-ELMRDAP 523
            ++ +DV+S GVT+ EL T G     P       +++  I   +    V  L EL+++  
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSP-----PAEFLRMIGIAQGQMIVTRLLELLKEGE 243

Query: 524 TIG------DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
            +       DE+ + +KL   C +  P  RP    ++  ++ +R
Sbjct: 244 RLPRPPSCPDEVYDLMKL---CWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 43/278 (15%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
             +GK  +G V       G +VAVK L++  T  Q  F +E S++  +RHPNL+ L    
Sbjct: 12  ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVV 69

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           L       +V +YM  GSL  +L +RG    I    ++     +  G+ +L    N +H 
Sbjct: 70  LQGNP-LYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK-NFVHR 126

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           +L + NVL+ +   AK+SDFGL++     A+    +    + + APE  + KK +TK+DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 473 YSLGVTILELLT-GKS--PGEPLNGAELPQWVASIVK-------EEWTNEVFDLELMRDA 522
           +S G+ + E+ + G+   P  PL   ++   V  + K       E    EV+  ++M+D 
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPL--KDV---VPHVEKGYRMEAPEGCPPEVY--KVMKD- 234

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                           C +  P+ RP   Q+ +QL  I
Sbjct: 235 ----------------CWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  104 bits (261), Expect = 5e-25
 Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 30/268 (11%)

Query: 296 GKSTYGTVYKATL-EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AYY 352
           G+ + G VYK      G   A+K++     +  R +   E+  L     P ++    A+Y
Sbjct: 10  GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
              +GE  +V +YM  GSLA  L   G  PE  +       I + + +GL +LH+  +II
Sbjct: 70  --KEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHTKRHII 122

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAA---ANVNVIATAGALGYRAPELSKLKKAN 467
           H ++  SN+L++     KI+DFG+S+++       N  V    G + Y +PE  + +  +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTYMSPERIQGESYS 178

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
              D++SLG+T+LE   GK P  P       + + +I             L  +      
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP------PPSLPAEE--FSP 230

Query: 528 ELLNTLKLALHCVDPSPSARPEVLQVVQ 555
           E  + +     C+   P  RP   +++Q
Sbjct: 231 EFRDFIS---ACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  108 bits (270), Expect = 2e-24
 Identities = 57/161 (35%), Positives = 96/161 (59%), Gaps = 3/161 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLS-RLRILDFSYNAINGS 61
           + L   N+SG+I +++ +L  +Q I+LS+N++SG +P D+   S  LR L+ S N   GS
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P     + +L +L L +N L  +I + +    +L VL+L  N + G IP+++ N+++L 
Sbjct: 134 IPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLE 191

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
            L L+ N+L G+IP     +KSL    + YNNLSG +P  +
Sbjct: 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232

Length = 968

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 2e-24
 Identities = 84/276 (30%), Positives = 141/276 (51%), Gaps = 40/276 (14%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKR--LREKITKGQ---REFESEVSLLGKIRHPNLL 346
           E++G  ++G+VY+   L+DG   AVK   L +    GQ   ++ E E++LL K++HPN++
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 347 ALRAYYLGPK--GEKLLVF-DYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLL 401
                YLG +   + L +F + +P GSLA  L   G  PE  I   TR +I+ G    L 
Sbjct: 66  Q----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLG----LE 116

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
           +LH   N +H ++  +N+L+D +   K++DFG+++ +         +  G+  + APE+ 
Sbjct: 117 YLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVI 173

Query: 462 KLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
             +       D++SLG T+LE+ TGK P   L G      VA++         F +   +
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAV---------FKIGRSK 218

Query: 521 DAPTIGDELLNTLKL-ALHCVDPSPSARPEVLQVVQ 555
           + P I D L +  K   L C+   PS RP   ++++
Sbjct: 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  102 bits (255), Expect = 3e-24
 Identities = 65/234 (27%), Positives = 110/234 (47%), Gaps = 19/234 (8%)

Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRLREKITKG-QREFESEVSLLGKIRHPNLLAL-RAY 351
           +G    G V K       ++ AVK +R +I +  Q++   E+ +L K   P ++    A+
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           Y    G+  +  +YM  GSL   L  +  +  I      KI   + +GL +LH    IIH
Sbjct: 69  YN--NGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAPELSKLKKANTK 469
            ++  SN+L++     K+ DFG+S  +     VN +A    G   Y APE  +    + K
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQL-----VNSLAKTFVGTSSYMAPERIQGNDYSVK 179

Query: 470 TDVYSLGVTILELLTGKSPGEPLN-GAELP-QWVASIVKEE---WTNEVFDLEL 518
           +D++SLG++++EL TG+ P  P N   +   + +  IV E      +  F  + 
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 6e-24
 Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 23/221 (10%)

Query: 294 IMGKSTYGTVYKAT-LEDGSQ----VAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLA 347
           ++G   +GTVYK   + +G +    VA+K LRE+ + K  +E   E  ++  + HP+++ 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLH----ARGPETPIDWPTRMKIIKGMTRGLLHL 403
           L    L  +    L+   MP G L  ++       G +  ++W    +I KGM+    +L
Sbjct: 74  LLGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIAKGMS----YL 125

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELS 461
              + ++H +L + NVL+    + KI+DFGL++L+         A  G +  +  A E  
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE-YHAEGGKVPIKWMALESI 183

Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWV 501
             +    K+DV+S GVT+ EL+T G  P E +   E+P  +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 53/282 (18%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFE----------SEVSLLGKIR 341
           E++GK TYG VY A  +  G  +AVK++    T   R             SE+  L  + 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 342 HPNLLALRAYYLG--PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR 398
           H N++     YLG     E L +F +Y+P GS+ + L   G           ++++  T 
Sbjct: 67  HLNIVQ----YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTE 115

Query: 399 ----GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA-ANVNVIATAGAL 453
               GL +LHS + I+H +L + N+L+D     KISDFG+S+       N   ++  G++
Sbjct: 116 QVLEGLAYLHS-KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174

Query: 454 GYRAPEL--SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN 511
            + APE+  S  +  + K D++SLG  +LE+  G+ P           W      EE   
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-----------W----SDEEAIA 219

Query: 512 EVFDLELMRDAPTIGDELLNTL-KLALH----CVDPSPSARP 548
            +F L   R AP I  ++   L  +AL     C   +P  RP
Sbjct: 220 AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 22/204 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G+ +YG+VYKA   E G  VA+K +   + +  +E   E+S+L +   P ++     
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           Y   K   L +V +Y   GS++  +        E  I       I+    +GL +LHSN 
Sbjct: 67  YF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEI-----AAILYQTLKGLEYLHSN- 118

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT---AAANVNVIATAGALGYRAPELSKLK 464
             IH ++ + N+LL++   AK++DFG+S  +T   A  N  VI T     + APE+ +  
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPF---WMAPEVIQEI 174

Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
             N K D++SLG+T +E+  GK P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (260), Expect = 3e-23
 Identities = 55/159 (34%), Positives = 85/159 (53%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  NN +G+IP +L  L  LQ + L  NK SG +P +LG+ + L +LD S N + G +
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P    +  +L  L L SN+L+ +I  SL    +L  + L+ N  SG +PS    +  +  
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTS 161
           LD+S N L G I +   ++ SL   +++ N   G +P S
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471

Length = 968

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 4e-23
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 39/276 (14%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAY 351
           E +GK  +G VYK  L+  ++VAVK  R  +    +  F  E  +L +  HPN++ L   
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL--- 57

Query: 352 YLGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +G   +K    +V + +P GSL TFL  R  +  +     +++      G+ +L S +N
Sbjct: 58  -IGVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLES-KN 113

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG-----YRAPELSKL 463
            IH +L + N L+ ++   KISDFG+SR         +   +  L      + APE    
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNY 169

Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
            +  +++DV+S G+ + E  + G +P   ++  +             T E  +      A
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------------TRERIESGYRMPA 216

Query: 523 PTIGDELLNTLKLALHCVDPSPSARP---EVLQVVQ 555
           P +  E +   +L L C    P  RP   E+   +Q
Sbjct: 217 PQLCPEEIY--RLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 20/202 (9%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREK--ITKGQREF-ESEVSLLGKIRHPNLLALRAY 351
           GK ++G V     +D  ++ A+K L++K  I + + E   +E ++L +I HP ++ L   
Sbjct: 2   GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSNE 407
           +     EKL LV +Y P G L + L   G   E       R +     +   L +LHS  
Sbjct: 62  FQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEE------RARFYAAEIVLALEYLHSL- 112

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMTAAANVNVIATAGALGYRAPELSKLKKA 466
            II+ +L   N+LLD   + K++DFGL++ L +  +  N     G   Y APE+   K  
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF--CGTPEYLAPEVLLGKGY 170

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D +SLGV + E+LTGK P
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.3 bits (245), Expect = 4e-23
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 15/212 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQV-AVKR--LREKITKGQREFESEVSLLGKIRHPNLLALR 349
             +GK ++G V+K   +   +V A+K+  L +   + + E   E  +L K+    ++   
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPID--WPTRMKIIKGMTRGLLHLHSN 406
             +L  KG+  +V +Y  +G L   L   RG   P D  W    +    +  GL HLHS 
Sbjct: 66  ESFL-DKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLHSK 120

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-VNVIATAGALGYRAPELSKLKK 465
           + I+H ++ S N+ LD   N KI D G+++L++   N  N I   G   Y +PEL + K 
Sbjct: 121 K-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--GTPYYLSPELCEDKP 177

Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
            N K+DV++LGV + E  TGK P +  N   L
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.5 bits (245), Expect = 5e-23
 Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 21/264 (7%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     +  +VA+K +RE     + +F  E  ++ K+ HP L+ L      
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCT- 69

Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    LVF++M HG L+ +L  R         T + +   +  G+ +L S+ N+IH +L
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDL 126

Query: 415 TSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYS 474
            + N L+ ++   K+SDFG++R +      +   T   + + +PE+    K ++K+DV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 475 LGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
            GV + E+ + GK+P E  + +E        V E   N  F L   R A     EL+   
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSE--------VVET-INAGFRLYKPRLASQSVYELMQ-- 235

Query: 534 KLALHCVDPSPSARPEVLQVVQQL 557
               HC    P  RP    ++ QL
Sbjct: 236 ----HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 97.6 bits (243), Expect = 8e-23
 Identities = 76/269 (28%), Positives = 133/269 (49%), Gaps = 28/269 (10%)

Query: 294 IMGKSTYGTVYKATLEDGSQ-VAVKRLR-EKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           ++G+  +G V+    +   + V +K++  E++TK +R   ++E  +L  + HPN++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +L  K   ++V +Y P G+LA ++  R     +D  T +     +   L H+H  + I+
Sbjct: 67  NFLEDK-ALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVH-TKLIL 123

Query: 411 HGNLTSSNVLLDDSTNA-KISDFGLSR-LMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           H +L + N+LLD      KI DFG+S+ L + +    V+ T     Y +PEL + K  N 
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPC---YISPELCEGKPYNQ 180

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           K+D+++LG  + EL + K   E    A LP  V  I+   +            AP I D 
Sbjct: 181 KSDIWALGCVLYELASLKRAFE---AANLPALVLKIMSGTF------------AP-ISDR 224

Query: 529 LLNTLK-LALHCVDPSPSARPEVLQVVQQ 556
               L+ L L  ++  PS RP++ Q++ Q
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 35/281 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR--EFESEVSLLGKIRHPNLL 346
            ++GK  +G VY  TL D        AVK L  +IT  +   +F  E  ++    HPN+L
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTRGLLHL 403
           +L    L  +G  L+V  YM HG L  F+  R        PT   +I     + +G+ +L
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHN---PTVKDLIGFGLQVAKGMEYL 114

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPEL 460
            +++  +H +L + N +LD+S   K++DFGL+R +      +V    GA   + + A E 
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 461 SKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM 519
            + +K  TK+DV+S GV + EL+T G  P   ++  ++            T  +     +
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI------------TVYLLQGRRL 221

Query: 520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                  D L     + L C  P P  RP   ++V ++E+I
Sbjct: 222 LQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 79/276 (28%), Positives = 126/276 (45%), Gaps = 40/276 (14%)

Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           ++GK TYG VY A  L    ++A+K + E+ ++  +    E++L   ++H N++     Y
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----Y 70

Query: 353 LGPKGEKLLVFDYM---PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           LG   E      +M   P GSL+  L ++      +  T +   K +  GL +LH N+ I
Sbjct: 71  LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ-I 129

Query: 410 IHGNLTSSNVLLDD-STNAKISDFGLSRLMTAAANVNVIATA--GALGYRAPEL--SKLK 464
           +H ++   NVL++  S   KISDFG S+ +   A +N       G L Y APE+     +
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRL---AGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 465 KANTKTDVYSLGVTILELLTGKSP----GEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
                 D++SLG TI+E+ TGK P    GEP                     +F + + +
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEP------------------QAAMFKVGMFK 228

Query: 521 DAPTIGDELLNTLK-LALHCVDPSPSARPEVLQVVQ 555
             P I + L    K   L C +P P  R     ++Q
Sbjct: 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 75/295 (25%), Positives = 126/295 (42%), Gaps = 56/295 (18%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES---------EVSLLGKIRHPN 344
           +G+ TYG VYKA     G  VA+K+++ +       FES         E+ LL ++ HPN
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLR-------FESEGIPKTALREIKLLKELNHPN 59

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L   +   KG+  LVF++M    L   +  +  +  +        +  + +GL   H
Sbjct: 60  IIKLLDVF-RHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA--AANVNVIATAGALGYRAPE-LS 461
           S+  I+H +L   N+L++     K++DFGL+R   +      + + T     YRAPE L 
Sbjct: 116 SH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT---RWYRAPELLL 171

Query: 462 KLKKANTKTDVYSLGVTILELLTGKS--PGEPLNGAELPQW------VASIVKEEWT--- 510
             K  +T  D++S+G    ELL+ +   PG+    +E+ Q       + +   E W    
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGK----SEIDQLFKIFRTLGTPDPEVWPKFT 227

Query: 511 ------NEVF----DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
                    F     + L +  P    + L+ L   LH     P  R    Q + 
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHY---DPHKRITAEQALA 279

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (253), Expect = 3e-22
 Identities = 61/181 (33%), Positives = 90/181 (49%), Gaps = 7/181 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           +L L  N LSG IP S+  L +L  + LS N +SG +P  + +L  L IL    N   G 
Sbjct: 264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P + ++L  L  L L SN    +I  +L K +NL+VL+L  N ++G IP  + +   L 
Sbjct: 324 IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF 383

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA-------LKFNASSFVGN 174
            L L  N L GEIP S    +SL    +  N+ SG +P+          L  + ++  G 
Sbjct: 384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGR 443

Query: 175 I 175
           I
Sbjct: 444 I 444

Length = 968

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score =  100 bits (251), Expect = 3e-22
 Identities = 57/168 (33%), Positives = 85/168 (50%), Gaps = 15/168 (8%)

Query: 75  LTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEI 134
           L L++  L   I + + KL +L  +NL  N I G+IP ++G+I++L +LDLS N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 135 PASFSNLKSLSSFNVSYNNLSGPVPTSLA---LKFNASSFVGNIQLCGYSGSTPCPSPPA 191
           P S   L SL   N++ N+LSG VP +L    L   + +F  N  LCG  G   C     
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC----- 537

Query: 192 EKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTASKAE 239
                 G  LS    I I  G  +  L +++C  MC   R++   +A+
Sbjct: 538 ------GPHLSVGAKIGIAFGVSVAFLFLVICA-MCWWKRRQNILRAQ 578

Length = 623

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 96.2 bits (239), Expect = 4e-22
 Identities = 69/277 (24%), Positives = 138/277 (49%), Gaps = 29/277 (10%)

Query: 293 EIMGKSTYGTVYKATLE----DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V++  L+        VA+K L+   T+ QR +F SE S++G+  H N++ 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L       K   +++ +YM +G+L  +L    G  +       + +++G+  G+ +L S+
Sbjct: 71  LEGVVTKFK-PAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGMKYL-SD 125

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLK 464
            N +H +L + N+L++ +   K+SDFGLSR++          + G +  R  APE    +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 465 KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           K  + +DV+S G+ + E+++ G+ P   ++  E+ + +         N+ F L    D P
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---------NDGFRLPAPMDCP 236

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +   +L+      L C     + RP  + +V  L+++
Sbjct: 237 SAVYQLM------LQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 44/282 (15%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V +  L+   +    VA+K L+   +  QR +F +E S++G+  HPN++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 348 LRAYYLGPKGEKLL-VFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           L       K   ++ + +YM +GSL  FL    G  T       + +++G+  G+ +L S
Sbjct: 70  LEGVVT--KSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMKYL-S 123

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMTAAANVNVIATAGALGYRAPELSKLK 464
             N +H +L + N+L++ +   K+SDFGLSR L  + A          + + APE    +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN-EV-------FDL 516
           K  + +DV+S G+ + E+++           E P W       + +N +V       + L
Sbjct: 184 KFTSASDVWSFGIVMWEVMS---------YGERPYW-------DMSNQDVIKAVEDGYRL 227

Query: 517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
               D P+   +L+      L C     + RP   Q+V  L+
Sbjct: 228 PPPMDCPSALYQLM------LDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           E +GK ++GTV K     DG  +  K +    +T+ +++   SEV++L +++HPN++   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63

Query: 350 AYY---LGPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLH 404
            YY   +    + L +V +Y   G LA  +   +     I+     +I+  +   L   H
Sbjct: 64  -YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 405 ----SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAP 458
                   ++H +L  +N+ LD + N K+ DFGL++++      +  A    G   Y +P
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAKTYVGTPYYMSP 179

Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
           E       + K+D++SLG  I EL     P    N  +L    AS +KE           
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL----ASKIKE---------GK 226

Query: 519 MRDAPTI-GDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
            R  P     EL   +K     ++  P  RP   +++Q
Sbjct: 227 FRRIPYRYSSELNEVIK---SMLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 7e-22
 Identities = 74/273 (27%), Positives = 133/273 (48%), Gaps = 34/273 (12%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V++    + + VAVK L+   T   ++F +E  ++ K+RHP L+ L  Y + 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQL--YAVC 70

Query: 355 PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
              E + +V + M +GSL  +L        +  P  + +   +  G+ +L + +N IH +
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEA-QNYIHRD 128

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI-ATAGA---LGYRAPELSKLKKANTK 469
           L + NVL+ ++   K++DFGL+R++      ++  A  GA   + + APE +   + + K
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE----DIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 470 TDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           +DV+S G+ + E++T G+ P   +  AE+ Q V    +            M   P    E
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------MPCPPGCPKE 232

Query: 529 LLNTLKLALHCVDPSPSARP--EVLQVVQQLEE 559
           L +   + L C    P  RP  E LQ   +LE+
Sbjct: 233 LYD---IMLDCWKEDPDDRPTFETLQ--WKLED 260

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 26/206 (12%)

Query: 292 AEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ------REFESEVSLLGKIR--- 341
           AEI G+  YGTVYKA  L  G  VA+K++R  +++        RE    ++LL ++    
Sbjct: 5   AEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE----IALLKQLESFE 59

Query: 342 HPNLLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
           HPN++ L     GP+ ++     LVF+++    LAT+L ++ P+  +   T   +++ + 
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLL 117

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT-AAANVNVIATAGALGYR 456
           RG+  LHS+  I+H +L   N+L+      KI+DFGL+R+ +   A  +V+ T   L YR
Sbjct: 118 RGVDFLHSHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT---LWYR 173

Query: 457 APELSKLKKANTKTDVYSLGVTILEL 482
           APE+       T  D++S+G    EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 70/212 (33%), Positives = 102/212 (48%), Gaps = 31/212 (14%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES---------EVSLLGKIRHPNL 345
           G+ TY  VYKA   E G  VA+K    KI  G+R+            E+ LL +++HPN+
Sbjct: 9   GEGTYAVVYKARDKETGRIVAIK----KIKLGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMT-RGLLHL 403
           + L   + G K    LVF++M    L   +  +    TP D    +K    MT RGL +L
Sbjct: 65  IGLLDVF-GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPAD----IKSYMLMTLRGLEYL 118

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
           HSN  I+H +L  +N+L+      K++DFGL+R    + N  +        YRAPEL  L
Sbjct: 119 HSN-WILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPEL--L 174

Query: 464 ---KKANTKTDVYSLGVTILELLTGKS--PGE 490
              +      D++S+G    ELL      PG+
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKR--LREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  +G V+KA   E G  VA+K+  LR        +   E+  L   +HP ++ L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +  P G    LV +YMP   L+  L     E P+        ++ + +G+ ++H+N  I+
Sbjct: 68  F--PHGSGFVLVMEYMPS-DLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHAN-GIM 121

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL---KKAN 467
           H +L  +N+L+      KI+DFGL+RL +               YRAPEL  L   +K +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL--LYGARKYD 179

Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
              D++++G    ELL G    PGE
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGE 204

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 70/213 (32%), Positives = 111/213 (52%), Gaps = 20/213 (9%)

Query: 295 MGKSTYGTVYKAT--LEDGSQ--VAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALR 349
           +G   +G+V K    ++ G +  VAVK L+ E I  G++EF  E S++ ++ HP ++ L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT---RGLLHLHSN 406
               G     +LV +  P G L  +L  R  E P+       + +       G+ +L S 
Sbjct: 63  GVCKGEP--LMLVMELAPLGPLLKYLKKR-REIPV-----SDLKELAHQVAMGMAYLES- 113

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG--ALGYRAPELSKLK 464
           ++ +H +L + NVLL +   AKISDFG+SR + A ++     TAG   L + APE     
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 465 KANTKTDVYSLGVTILELLT-GKSPGEPLNGAE 496
           K ++K+DV+S GVT+ E  + G  P   + GAE
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 48/259 (18%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNL 345
           E +G+  +G VYK  L         + VA+K L+E    K Q+EF  E  L+  ++HPN+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 346 LALRAYYLG--PKGEKL-LVFDYMPHGSLATFLHARGP-------------ETPIDWPTR 389
           + L    LG   K +   ++F+Y+ HG L  FL    P             ++ +D    
Sbjct: 71  VCL----LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT 449
           + I   +  G+ +L S+ + +H +L + N L+ +    KISDFGLSR + +A    V + 
Sbjct: 127 LHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 450 AGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL--------- 497
           +  L  R   PE     K  T++D++S GV + E+ + G  P    +  E+         
Sbjct: 186 S-LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244

Query: 498 -------PQWVASIVKEEW 509
                  P  V +++ E W
Sbjct: 245 LPCPEDCPARVYALMIECW 263

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 59/218 (27%), Positives = 112/218 (51%), Gaps = 21/218 (9%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V++   ++  +VA+K L+      Q++F+ EV  L ++RH +L++L A  + 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA--VC 71

Query: 355 PKGEKL-LVFDYMPHGSLATFLHARGPE-TPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             GE + ++ + M  GSL  FL  R PE   +   + + +   +  G+ +L    N IH 
Sbjct: 72  SVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHR 128

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLM------TAAANVNVIATAGALGYRAPELSKLKKA 466
           +L + N+L+ +    K++DFGL+RL+      ++   +    T       APE +     
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT-------APEAASHGTF 181

Query: 467 NTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVAS 503
           +TK+DV+S G+ + E+ T G+ P   +N  E+   + +
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 296 GKSTYGTVYKA-TLEDGSQVAVK--RLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           G  T+G VY A  L+ G  +AVK  R+++   K  +E   E+ +L  ++HPNL+  + Y 
Sbjct: 9   GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV--KYYG 66

Query: 353 LGPKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +    EK+ +F +Y   G+L   L         D          +  GL +LHS+  I+H
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHGRIL---DEHVIRVYTLQLLEGLAYLHSH-GIVH 122

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV---NVIATAGALGYRAPELSKLKKANT 468
            ++  +N+ LD +   K+ DFG +  +          V + AG   Y APE+    K   
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 469 K---TDVYSLGVTILELLTGKSP 488
                D++SLG  +LE+ TGK P
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 26/226 (11%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNL 345
             +G+  +G V+           D   VAVK L+E  +   R+ FE E  LL   +H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 346 LALRAYYLGPKGEKLL-VFDYMPHGSLATFLHARGP-----------ETPIDWPTRMKII 393
           +    Y +  +G+  + VF+YM HG L  FL + GP              +     ++I 
Sbjct: 71  VKF--YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGAL 453
             +  G+++L S ++ +H +L + N L+      KI DFG+SR +       V      L
Sbjct: 129 VQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT-ML 186

Query: 454 GYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAE 496
             R   PE    +K  T++DV+S GV + E+ T GK P   L+  E
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 74/270 (27%), Positives = 133/270 (49%), Gaps = 27/270 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  +G V       G++VAVK ++   T   + F +E S++ ++RH NL+ L    
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  KG   +V +YM  GSL  +L +RG  + +     +K    +   + +L +N N +H 
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHR 126

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           +L + NVL+ +   AK+SDFGL++  ++  +   +     + + APE  + KK +TK+DV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEALREKKFSTKSDV 182

Query: 473 YSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL- 530
           +S G+ + E+ + G+ P   +   ++   V    K              DAP     ++ 
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------MDAPDGCPPVVY 229

Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           + +K    C     + RP  LQ+ +QLE I
Sbjct: 230 DVMK---QCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 71/266 (26%), Positives = 120/266 (45%), Gaps = 26/266 (9%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKR--LREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +GK +YG+VYK   L D    A+K   L     K + +  +E+ +L  + HPN+++ +  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGP-ETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           +L   G KL +V +Y P G L+  +  R      I      +I   + RGL  LH    I
Sbjct: 68  FL--DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KI 124

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           +H +L S+N+LL  +   KI D G+S+++        I T     Y APE+ K +  + K
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP---HYMAPEVWKGRPYSYK 181

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           +D++SLG  + E+ T   P E  +  +L              +V   +     P    +L
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEARSMQDL------------RYKVQRGKYPPIPPIYSQDL 229

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQ 555
            N ++     +   P  RP   +++ 
Sbjct: 230 QNFIR---SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 54/295 (18%)

Query: 294 IMGKSTYGTVYKATL--EDGS--QVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLA 347
           ++GK  +G+V +A L  EDGS  +VAVK L+  I       EF  E + + +  HPN++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 348 LRAYYLG--PKGE---KLLVFDYMPHGSLATFL-HARGPETPIDWP--TRMKIIKGMTRG 399
           L    L    KG     +++  +M HG L TFL  +R  E P   P  T ++ +  +  G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE 459
           + +L S++N IH +L + N +L+++    ++DFGLS+ + +              YR   
Sbjct: 126 MEYL-SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-----------YRQGC 173

Query: 460 LSKLKKA------------NTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK 506
            SKL                T +DV++ GVT+ E++T G++P             A +  
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP------------YAGVEN 221

Query: 507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
            E  N +     ++  P   +++     L   C  P P  RP    +  QLE I 
Sbjct: 222 SEIYNYLIKGNRLKQPPDCLEDVYE---LMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 33/272 (12%)

Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +     VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 68

Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L    N I
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKK-NFI 126

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKAN 467
           H +L + N L+ ++   K++DFGLSRLMT        A AGA   + + APE     K +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 468 TKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG 526
            K+DV++ GV + E+ T G S   P  G +L Q    + K       + +E     P   
Sbjct: 184 IKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKG------YRMERPEGCPP-- 232

Query: 527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
                  +L   C   +PS RP   ++ Q  E
Sbjct: 233 ----KVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 74/295 (25%), Positives = 131/295 (44%), Gaps = 54/295 (18%)

Query: 293 EIMGKSTYGTVYKATL--EDGSQ--VAVKRLREKITKGQ--REFESEVSLLGKIRHPNLL 346
           +I+G+  +G+V +  L  +DGSQ  VAVK ++  I       EF SE + +    HPN++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 347 AL-----RAYYLGPKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRM--KIIKGMTR 398
            L      A  L    + +++  +M HG L +FL ++R    P   P +   K +  +  
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAP 458
           G+ +L SN N IH +L + N +L +     ++DFGLS+ + +              YR  
Sbjct: 125 GMEYL-SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY-----------YRQG 172

Query: 459 ELSKL------------KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIV 505
            ++K+            +   +K+DV++ GVT+ E+ T G++P   +   E+  +     
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----- 227

Query: 506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                  +     ++      DEL +   L   C    P  RP   ++ + LE I
Sbjct: 228 -------LRHGNRLKQPEDCLDELYD---LMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 64/222 (28%), Positives = 114/222 (51%), Gaps = 22/222 (9%)

Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V+ A        +D   VAVK L++     +++F  E  LL  ++H +++  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV-- 70

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPE----------TPIDWPTRMKIIKGMT 397
           + Y +  +G+ L +VF+YM HG L  FL A GP+            +     + I + + 
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA-TAGALGYR 456
            G+++L S ++ +H +L + N L+ ++   KI DFG+SR + +     V   T   + + 
Sbjct: 131 AGMVYLAS-QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 457 APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
            PE    +K  T++DV+SLGV + E+ T GK P   L+  E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 76/265 (28%), Positives = 127/265 (47%), Gaps = 30/265 (11%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+  T    ++VAVK L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQL--YAVC 70

Query: 355 PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            + E + +V +YM  GSL  FL + G    +  P  + +   +  G+ +L S  N IH +
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRD 128

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKANTKT 470
           L + N+L+ ++   KI+DFGL+RL+    +    A  GA   + + APE +   +   K+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185

Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV+S G+ + E++T G+ P   +   E+ + V            + +    + P   +EL
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE---------RGYRMPRPPNCP---EEL 233

Query: 530 LNTLKLALHCVDPSPSARP--EVLQ 552
            +   L L C D  P  RP  E LQ
Sbjct: 234 YD---LMLQCWDKDPEERPTFEYLQ 255

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 28/221 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLA 347
           + +G  ++G V +            VAVK L+ +K++    +F  E +++  + H NL+ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARG-PETPID--WPTRMKIIKGMTRGLLHLH 404
           L    L      ++V +  P GSL   L         I       ++I  GM     +L 
Sbjct: 61  LYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR----YLE 114

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM-------TAAANVNVIATAGALGYRA 457
           S +  IH +L + N+LL      KI DFGL R +           ++ V        + A
Sbjct: 115 S-KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-----PFAWCA 168

Query: 458 PELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           PE  + +  +  +DV+  GVT+ E+ T G+ P   L+G+++
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI 209

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 91.1 bits (227), Expect = 5e-20
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           G   YG V  A     G +VA+K++    + +   +R    E+ LL  +RH N++ L   
Sbjct: 9   GSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDI 67

Query: 352 YLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMK-IIKGMTRGLLHLHSN 406
              P  E      +V + M    L   + +  P T       ++  +  + RGL +LHS 
Sbjct: 68  LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTD----DHIQYFLYQILRGLKYLHS- 121

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG--YRAPEL---- 460
            N+IH +L  SN+L++ + + KI DFGL+R +    +     T   +   YRAPEL    
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181

Query: 461 SKLKKANTKTDVYSLGVTILELLTGK 486
           S+  KA    D++S+G    ELLT K
Sbjct: 182 SRYTKAI---DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 75/283 (26%), Positives = 140/283 (49%), Gaps = 39/283 (13%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           E++G   +G V +  L+   +    VA+K L+   T+ QR +F SE S++G+  HPN++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L    +      +++ ++M +G+L +FL    G  T I     + +++G+  G+ +L S 
Sbjct: 70  LEGV-VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL-SE 124

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG------YRAPEL 460
            N +H +L + N+L++ +   K+SDFGLSR +    + +      +LG      + APE 
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE--DDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV---FDLE 517
              +K  + +DV+S G+ + E+++           E P W  S   ++  N +   + L 
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS---------YGERPYWDMS--NQDVINAIEQDYRLP 231

Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              D PT   +L+      L C     +ARP+  Q+V  L+++
Sbjct: 232 PPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.2 bits (221), Expect = 9e-20
 Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 33/278 (11%)

Query: 294 IMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLAL 348
           ++G   +G V    L+   +    VA+K L+   T+ QR +F SE S++G+  HPN++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
                  K   ++V +YM +GSL  FL    G  T I     + +++G+  G+ +L S+ 
Sbjct: 71  EGVVTKSK-PVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYL-SDM 125

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++            G +  R  APE    +K
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K     E + L    D 
Sbjct: 186 FTSASDVWSYGIVMWEVMS---------YGERPYWEMSNQDVIKA--IEEGYRLPAPMDC 234

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P    +L+      L C     + RP+  Q+V  L+++
Sbjct: 235 PAALHQLM------LDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 31/209 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLA-LR 349
           E +G+   G VYKAT    G +VA+K++R  + K  +E   +E+ ++   +HPN++    
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDW-PTRMK------IIKGMTRGLLH 402
           +Y +G   E  +V +YM  GSL            I     RM       + + + +GL +
Sbjct: 83  SYLVG--DELWVVMEYMDGGSLTDI---------ITQNFVRMNEPQIAYVCREVLQGLEY 131

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN--VNVIATAGALGY-RAPE 459
           LHS  N+IH ++ S N+LL    + K++DFG +  +T   +   +V+ T     Y  APE
Sbjct: 132 LHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP----YWMAPE 186

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           + K K    K D++SLG+  +E+  G+ P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 24/223 (10%)

Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V+ A        +D   VAVK L+E     +++F+ E  LL  ++H +++  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV-- 70

Query: 349 RAYYLGPKGEKLL-VFDYMPHGSLATFLHARGPET------------PIDWPTRMKIIKG 395
           R Y +  +G  LL VF+YM HG L  FL + GP+              +     + I   
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA-TAGALG 454
           +  G+++L S  + +H +L + N L+      KI DFG+SR + +     V   T   + 
Sbjct: 131 IASGMVYLAS-LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAE 496
           +  PE    +K  T++D++S GV + E+ T GK P   L+  E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 92.6 bits (230), Expect = 2e-19
 Identities = 57/163 (34%), Positives = 87/163 (53%), Gaps = 7/163 (4%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDL---GRLSRLRILDFSYNAIN 59
           L L  N  SG IP +LGK + L  + LS N ++G +P  L   G L +L IL FS N++ 
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL-IL-FS-NSLE 393

Query: 60  GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
           G +P S     SL  + L+ N+   ++     KL  +  L++  N + G I S   ++ +
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           L +L L++NK  G +P SF + K L + ++S N  SG VP  L
Sbjct: 454 LQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495

Length = 968

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 19/207 (9%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLR-----EKITKGQREFESEVSLLGKIRHPNLL 346
           +++G+  +G VY    ++ G ++AVK++       +  K     E E+ LL  ++H  ++
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 347 ALRAYYLG--PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
                Y G     E L +F +YMP GS+   L A G  T  +  TR K  + +  G+ +L
Sbjct: 68  Q----YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALT--ETVTR-KYTRQILEGVEYL 120

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIAT-AGALGYRAPELS 461
           HSN  I+H ++  +N+L D + N K+ DFG S RL T  ++   + +  G   + +PE+ 
Sbjct: 121 HSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +    K DV+S+G T++E+LT K P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 21/218 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQV----AVKRLREKI-TKGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G  V    A+K L E    K   EF  E  ++  + HP+L+
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L P  +  LV   MPHG L  ++H      G +  ++W  ++       +G+++
Sbjct: 73  RLLGVCLSPTIQ--LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMY 124

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA-AANVNVIATAGALGYRAPELS 461
           L     ++H +L + NVL+    + KI+DFGL+RL+       N       + + A E  
Sbjct: 125 LEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
             +K   ++DV+S GVTI EL+T G  P + +   E+P
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP 221

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 35/223 (15%)

Query: 293 EIMGKSTYGTVYKATL-EDGSQVAVKRL-REKITKGQRE----FESEVSLLGKI-RHPNL 345
           +I+G+ ++ TV  A   E   + A+K L + ++ K ++      E EV  L ++  HP +
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV--LTRLNGHPGI 64

Query: 346 LALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           + L  YY     E L  V +Y P+G L  ++   G    +D          +   L +LH
Sbjct: 65  IKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH 119

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA-------AANVNVIATAGALGYR- 456
           S   IIH +L   N+LLD   + KI+DFG ++++           +   I +      R 
Sbjct: 120 SK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 457 -----------APELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                      +PEL   K A   +D+++LG  I ++LTGK P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 70/278 (25%), Positives = 125/278 (44%), Gaps = 44/278 (15%)

Query: 294 IMGKSTYG--TVYKATLEDGSQVAVKR--LREKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++GK  +G  T+Y+ T ED S V  K   L     K +R+  +E+ +L  ++HPN++A  
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 350 AYYLGPKGEKLLV-FDYMPHGSLA-TFLHARG---PETPIDWPTRMKIIKGMTRGLLHLH 404
            +++      LL+  +Y   G+L    +  +G    E  + W      +  +   + ++H
Sbjct: 66  NHFM--DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIH 118

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM---TAAANVNVIATAGALGYRAPELS 461
               I+H ++ + N+ L  +   K+ DFG+S+++    + A   V    G   Y +PEL 
Sbjct: 119 KA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV----GTPYYMSPELC 173

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV--FDLELM 519
           +  K N K+D+++LG  + ELLT K   +  N       V  IV+  +T  V  +  EL+
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPVVSVYSSELI 230

Query: 520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
                          L    +   P  RP   +V+ Q 
Sbjct: 231 --------------SLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 30/215 (13%)

Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLR-----EKITKGQRE----FESEVSLLGKIRHP 343
           ++G  ++G+VY       G  +AVK++            +R        E++LL +++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 344 NLLALRAYYLGPK--GEKLLVF-DYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTR 398
           N++     YLG     + L +F +Y+P GS+A  L+  G   ET +        ++ + +
Sbjct: 67  NIVQ----YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILK 117

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-----LMTAAANVNVIATAGAL 453
           GL +LH N  IIH ++  +N+L+D+    KISDFG+S+      ++   N    +  G++
Sbjct: 118 GLNYLH-NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
            + APE+ K      K D++SLG  ++E+LTGK P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 10/198 (5%)

Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES--EVSLLGKIRHPNLLALRA 350
            +G+ TYG VY+A     G  VA+K++R    +      S  E++LL  +RHPN++ L+ 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
             +G   + + LV +Y     LA+ L      TP        ++  + RGL +LH N  I
Sbjct: 74  VVVGKHLDSIFLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN-FI 129

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKLKKANT 468
           IH +L  SN+LL D    KI+DFGL+R     A   +      L YRAPE L       T
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTT 188

Query: 469 KTDVYSLGVTILELLTGK 486
             D++++G  + ELL  K
Sbjct: 189 AIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.1 bits (213), Expect = 9e-19
 Identities = 69/284 (24%), Positives = 131/284 (46%), Gaps = 47/284 (16%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLRE-KITKGQRE-----FESEVSLLGKIRHPNL 345
           + +G   + + Y+A  ++ G+ +AVK++   + T  ++E        E+ L+ ++ HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 346 LALRAYYLGPKGEKL---LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
           + +    LG   E     L  ++M  GS++  L   G          +   + + RGL +
Sbjct: 66  IRM----LGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSY 118

Query: 403 LHSNENIIHGNLTSSNVLLDDS-TNAKISDFGLSRLMTAAANVNVIATA---------GA 452
           LH N+ IIH ++  +N+L+D +    +I+DFG      AAA +    T          G 
Sbjct: 119 LHENQ-IIHRDVKGANLLIDSTGQRLRIADFG------AAARLAAKGTGAGEFQGQLLGT 171

Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE 512
           + + APE+ + ++     DV+S+G  I+E+ T K    P N  +    +A I K      
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP---PWNAEKHSNHLALIFKIASATT 228

Query: 513 VFDLELMRDAPTIGDELLNTLK-LALHCVDPSPSARPEVLQVVQ 555
                    AP+I + L   L+ + L C++  P  RP   ++++
Sbjct: 229 ---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 41/223 (18%)

Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLA 347
           +G+  +G V++A        E  + VAVK L+E+     Q +F+ E +L+ +  HPN++ 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 348 LRAYYLG--PKGEKL-LVFDYMPHGSLATFLHARGPET-------------------PID 385
           L    LG    G+ + L+F+YM +G L  FL  R P                     P+ 
Sbjct: 73  L----LGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 386 WPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA---- 441
              ++ I K +  G+ +L S    +H +L + N L+ ++   KI+DFGLSR + +A    
Sbjct: 129 CTEQLCIAKQVAAGMAYL-SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           A+ N    A  + +  PE     +  T++DV++ GV + E+ +
Sbjct: 188 ASEN---DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRL-REKITKGQ--REFESEVSLLGKIRHPNLLALR 349
           ++GK  +G V      D  ++ A+K + ++K  +    R   +E  +L ++ HP L+ L 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL- 65

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHSNE 407
            +Y     E + LV D +  G L   L  +   +      ++K  I  +   L +LHS  
Sbjct: 66  -WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE----EQVKFWICEIVLALEYLHSK- 119

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
            IIH ++   N+LLD+  +  I+DF ++  +T   +    +T+G  GY APE+   +  +
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTSTSGTPGYMAPEVLCRQGYS 177

Query: 468 TKTDVYSLGVTILELLTGKSP 488
              D +SLGVT  E L GK P
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 13/206 (6%)

Query: 292 AEIMGKSTYGTVYKATLED-GSQVAVKRL-----REKITKGQREFESEVSLLGKIRHPNL 345
            +++G+  +G VY     D G ++AVK++      ++ +K     E E+ LL  +RH  +
Sbjct: 7   GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66

Query: 346 LALRAYYLGPKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           +        P+ +KL +F +YMP GS+   L A G  T  +  TR +  + + +G+ +LH
Sbjct: 67  VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT--ENVTR-RYTRQILQGVSYLH 123

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMT-AAANVNVIATAGALGYRAPELSK 462
           SN  I+H ++  +N+L D + N K+ DFG S R+ T   +   + +  G   + +PE+  
Sbjct: 124 SNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +    K DV+S+  T++E+LT K P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.1 bits (221), Expect = 2e-18
 Identities = 53/158 (33%), Positives = 83/158 (52%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N+LSG IP  + +L  L+ + L  N  +G +P  L  L RL++L    N  +G +
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P +    ++L  L L +NNL  +I + L    NL  L L  N + G IP ++G   +L  
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT 160
           + L  N  SGE+P+ F+ L  +   ++S NNL G + +
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446

Length = 968

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+         VA+K +RE     + +F  E  ++ K+ HPNL+ L  Y + 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQL--YGVC 68

Query: 355 PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLHSNENIIH 411
            K   + +V +YM +G L  +L  R  +   +W   M   + + M     +L SN   IH
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME----YLESN-GFIH 123

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTD 471
            +L + N L+ +    K+SDFGL+R +      +   T   + +  PE+    + ++K+D
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 472 VYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           V+S GV + E+ + GK P E  + +E+ + V+           + L   + APT    ++
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESVS---------AGYRLYRPKLAPTEVYTIM 234

Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQL 557
                   C    P  RP   +++ QL
Sbjct: 235 Y------SCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 16/207 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-VAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           E++G      VY A     ++ VA+KR+  EK      E   EV  + +  HPN++  + 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV--KY 64

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y     G++L LV  Y+  GSL   + +  P   +D      ++K + +GL +LHSN  I
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLS------RLMTAAANVNVIATAGALGYRAPE-LSK 462
            H ++ + N+LL +  + KI+DFG+S         T       + T     + APE + +
Sbjct: 125 -HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC---WMAPEVMEQ 180

Query: 463 LKKANTKTDVYSLGVTILELLTGKSPG 489
           +   + K D++S G+T +EL TG +P 
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 28/210 (13%)

Query: 296 GKSTYGTVYKATLEDGSQ---VAVKRLREKITKGQREFES-----EVSLLGKIRHPNLLA 347
           G+ TYG VYKA  ++G      A+K+   K  K Q    S     E++LL +++H N+++
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLH 404
           L   +L    + + L+FDY  H         R  +  +  P  M   ++  +  G+ +LH
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKR-VSIPPSMVKSLLWQILNGVHYLH 125

Query: 405 SNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAA----ANVN-VIATAGALGY 455
           SN  ++H +L  +N+L+     +    KI D GL+RL  A     A+++ V+ T   + Y
Sbjct: 126 SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT---IWY 181

Query: 456 RAPELSKLKKANTKT-DVYSLGVTILELLT 484
           RAPEL    +  TK  D++++G    ELLT
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 36/279 (12%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLR--EKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           +GK  +  VYKA  L DG  VA+K+++  E +    R+    E+ LL ++ HPN++   A
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++    E  +V +    G L+  + H +  +  I   T  K    +   L H+HS + I
Sbjct: 70  SFI-ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRI 127

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLM---TAAANVNVIATAGALGYRAPELSKLKKA 466
           +H ++  +NV +  +   K+ D GL R     T AA+  V    G   Y +PE       
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSPERIHENGY 183

Query: 467 NTKTDVYSLGVTILELLTGKSP--GEPLNGAELPQWVASIVKEEWT---NEVFDLELMRD 521
           N K+D++SLG  + E+   +SP  G+ +N   L +    I K ++     + +  EL RD
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---KIEKCDYPPLPADHYSEEL-RD 239

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                        L   C++P P  RP++  V+Q  +E+
Sbjct: 240 -------------LVSRCINPDPEKRPDISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 66/225 (29%), Positives = 115/225 (51%), Gaps = 25/225 (11%)

Query: 295 MGKSTYGTVYKAT------LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V+ A        +D   VAVK L++     +++F+ E  LL  ++H +++  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV-- 70

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPI---DWPTRMKIIKGMTRGLLHLH 404
           + Y +   G+ L +VF+YM HG L  FL A GP+  I     P + K   G+++ +LH+ 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ-MLHIA 129

Query: 405 S----------NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA-TAGAL 453
           S          +++ +H +L + N L+  +   KI DFG+SR + +     V   T   +
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
            +  PE    +K  T++DV+S GV + E+ T GK P   L+  E+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRL------REKITKGQREFESEVSLLGKIRHPNLL 346
           E++GK  YGTVY      G  +AVK++           K   + + EV LL  ++H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 347 ALRAYYLGPKGEKLLV---FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
                YLG   +   +    +++P GS+++ L+  GP   +  P   K  K +  G+ +L
Sbjct: 66  Q----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYL 118

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMTAAANVN----VIATAGALGYRAP 458
           H+N  ++H ++  +NV+L  +   K+ DFG +R L     +      + +  G   + AP
Sbjct: 119 HNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           E+        K+D++S+G T+ E+ TGK P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.0 bits (218), Expect = 4e-18
 Identities = 54/142 (38%), Positives = 78/142 (54%), Gaps = 3/142 (2%)

Query: 22  SELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS-FSNLSSLVSLTLESN 80
           S +  I LS   ISG + S + RL  ++ ++ S N ++G +P   F+  SSL  L L +N
Sbjct: 69  SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNN 128

Query: 81  NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSN 140
           N    I      + NL  L+L  N +SG IP+ IG+ S+L +LDL  N L G+IP S +N
Sbjct: 129 NFTGSI--PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186

Query: 141 LKSLSSFNVSYNNLSGPVPTSL 162
           L SL    ++ N L G +P  L
Sbjct: 187 LTSLEFLTLASNQLVGQIPREL 208

Length = 968

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 34/205 (16%)

Query: 299 TYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE----SEVSLLGKIRHPNLLALRAYYL 353
           TYG VY+A   + G  VA+K+L  K+ K +  F      E+++L K++HPN++ ++   +
Sbjct: 17  TYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           G   +K+ +V +Y+ H  L + +   + P           ++  +  G+ HLH N  I+H
Sbjct: 75  GSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQ---SEVKCLMLQLLSGVAHLHDNW-ILH 129

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRL-------MTAAANVNVIATAGALGYRAPELSKL- 463
            +L +SN+LL++    KI DFGL+R         T      V+     L YRAPEL  L 
Sbjct: 130 RDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ----LVV----TLWYRAPEL--LL 179

Query: 464 --KKANTKTDVYSLGVTILELLTGK 486
             K+ +T  D++S+G    ELLT K
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 44/292 (15%)

Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 350 A--YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM----KIIKGMTRGLLHL 403
              Y  G +  +L V +Y+P+GSL  +L        +D    +    +I KGM     +L
Sbjct: 72  GVCYSAGRRNLRL-VMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGME----YL 124

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG--ALGYRAPELS 461
            S +  +H +L + N+L++     KI DFGL++++        +   G   + + APE  
Sbjct: 125 GS-KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 462 KLKKANTKTDVYSLGVTILELLT----GKSP--------GEPLNGAELPQWVASIVKEEW 509
              K +  +DV+S GV + EL T      SP        G    G  +   +  ++K   
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243

Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
                 L      P    E+   +K    C +  PS RP   ++  Q+E IR
Sbjct: 244 R-----LPAPPGCP---AEIYAIMKE---CWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 27/206 (13%)

Query: 296 GKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRAY 351
           G  TYG VYKA  +  G  VA+K +  K+  G  +FE    E+S+L + RHPN++A    
Sbjct: 12  GSGTYGDVYKARDIATGELVAIKVI--KLEPGD-DFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHA-RGP--ETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           YL  + +KL +V +Y   GSL       RGP  E  I +  R  +     +GL +LH   
Sbjct: 69  YL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHET- 120

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA--AANVNVIATAGALGYRAPELSKLKK 465
             IH ++  +N+LL +  + K++DFG+S  +TA  A   + I T     + APE++ +++
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP---YWMAPEVAAVER 177

Query: 466 A---NTKTDVYSLGVTILELLTGKSP 488
               + K D+++LG+T +EL   + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 13/215 (6%)

Query: 295 MGKSTYGTVYKATLED-GSQVAVKRL---REKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G V    ++  G   A K+L   R K  KG++   +E  +L K+    +++L A
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y    K +  LV   M  G L   ++  G E        +     +  GL HLH    I+
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLH-QRRIV 117

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           + +L   NVLLDD  N +ISD GL+  +     +     AG  GY APE+ + +  +   
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK--GRAGTPGYMAPEVLQGEVYDFSV 175

Query: 471 DVYSLGVTILELLTGKSP----GEPLNGAELPQWV 501
           D ++LG T+ E++ G+SP     E +   EL +  
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 76/264 (28%), Positives = 122/264 (46%), Gaps = 29/264 (10%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+  T    ++VAVK L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQL--YAVV 70

Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL   G    +  P  + +   +  G+ ++    N IH +L
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIE-RMNYIHRDL 128

Query: 415 TSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKANTKTD 471
            S+N+L+ D    KI+DFGL+RL+    +    A  GA   + + APE +   +   K+D
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 472 VYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           V+S G+ + EL+T G+ P   +N  E+ + V            + +   +D P    EL+
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQV---------ERGYRMPCPQDCPISLHELM 236

Query: 531 NTLKLALHCVDPSPSARP--EVLQ 552
                 L C    P  RP  E LQ
Sbjct: 237 ------LQCWKKDPEERPTFEYLQ 254

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 41/229 (17%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLG--------------- 338
           +G+ TYG V KA     G  VA+K++  KI +   +   +  L+G               
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV--KIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 339 -KIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
            +I+H N++ L   Y+       LV D M    L   +  +     +       I+  + 
Sbjct: 75  NEIKHENIMGLVDVYV-EGDFINLVMDIM-ASDLKKVVDRK---IRLTESQVKCILLQIL 129

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-------------LMTAAANV 444
            GL  LH     +H +L+ +N+ ++     KI+DFGL+R               T     
Sbjct: 130 NGLNVLH-KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 445 NVIATAGALGYRAPE-LSKLKKANTKTDVYSLGVTILELLTGKS--PGE 490
            + +    L YRAPE L   +K +   D++S+G    ELLTGK   PGE
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237

Length = 335

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 57/197 (28%), Positives = 106/197 (53%), Gaps = 12/197 (6%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           EI+G+  +G V +     G +VAVK ++  +T   + F  E +++ K+ H NL+ L    
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           L       +V + M  G+L  FL  RG    +     ++    +  G+ +L S + ++H 
Sbjct: 69  L--HNGLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK-LVHR 124

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           +L + N+L+ +   AK+SDFGL+R+ +   + + +     + + APE  K KK ++K+DV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL----PVKWTAPEALKHKKFSSKSDV 180

Query: 473 YSLGVTILELLT-GKSP 488
           +S GV + E+ + G++P
Sbjct: 181 WSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 33/215 (15%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLR-EKITKGQ-----REFESEVSLLGKIRHPNL 345
           E +G+ TYG VYKA     G  VA+K++R E   +G      RE    +SLL ++ HPN+
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELNHPNI 60

Query: 346 LALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           + L    +     KL LVF+++    L  ++ +  P T +D P     +  + +G+ + H
Sbjct: 61  VRL--LDVVHSENKLYLVFEFLDL-DLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV------IATAGALGYRAP 458
           S+  ++H +L   N+L+D     K++DFGL+R    A  V V      + T   L YRAP
Sbjct: 117 SHR-VLHRDLKPQNLLIDREGALKLADFGLAR----AFGVPVRTYTHEVVT---LWYRAP 168

Query: 459 E-LSKLKKANTKTDVYSLGVTILELLTGKS--PGE 490
           E L   ++ +T  D++S+G    E++  +   PG+
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 83.4 bits (206), Expect = 7e-18
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 12/213 (5%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V          VA+K ++E  +  + EF  E  ++ K+ H  L+ L  Y + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQL--YGVC 68

Query: 355 PKGEKL-LVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
            K   + +V +YM +G L  +L  H +  +        +++ K +  G+ +L S +  IH
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGMAYLESKQ-FIH 123

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTD 471
            +L + N L+DD    K+SDFGLSR +      + + +   + +  PE+    K ++K+D
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 472 VYSLGVTILELLT-GKSPGEPLNGAELPQWVAS 503
           V++ GV + E+ + GK P E  N +E  + V+ 
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 83.2 bits (205), Expect = 8e-18
 Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 19/209 (9%)

Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLR-----EKITKGQREFESEVSLLGKIRHPNL 345
            +++G+  +G VY    ++ G ++A K+++      + +K     E E+ LL  ++H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 346 LALRAYY--LGPKGEKLLV--FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
           +    YY  L  + EK L    +YMP GS+   L A G  T  +  TR K  + +  G+ 
Sbjct: 67  VQ---YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALT--ESVTR-KYTRQILEGMS 120

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMT-AAANVNVIATAGALGYRAPE 459
           +LHSN  I+H ++  +N+L D + N K+ DFG S RL T   +   + +  G   + +PE
Sbjct: 121 YLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    K DV+SLG T++E+LT K P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 62/207 (29%), Positives = 110/207 (53%), Gaps = 23/207 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-----EKITKGQREFESEVSLLGKIRH---P 343
           E++G+  YG VY+   +  G  VA+K +      + ++  QRE    V+LL ++R    P
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQRE----VALLSQLRQSQPP 62

Query: 344 NLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
           N+      YL  KG +L ++ +Y   GS+ T + A     PI       II+ +   L +
Sbjct: 63  NITKYYGSYL--KGPRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKY 116

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LS 461
           +H    +IH ++ ++N+L+ ++ N K+ DFG++ L+   ++       G   + APE ++
Sbjct: 117 IHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVIT 174

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           + K  +TK D++SLG+TI E+ TG  P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 29/216 (13%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNL 345
           E +G+  +G VYK  L      E    VA+K L++K     RE F+ E  +  +++HPN+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 346 LALRAYYLG--PKGEKL-LVFDYMPHGSLATFLHARGP-------------ETPIDWPTR 389
           + L    LG   K + L ++F Y  H  L  FL  R P             ++ ++    
Sbjct: 71  VCL----LGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126

Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT 449
           + I+  +  G+  L S+ +++H +L + NVL+ D  N KISD GL R + AA    ++  
Sbjct: 127 VHIVTQIAAGMEFL-SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 450 AG-ALGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           +   + + +PE     K +  +D++S GV + E+ +
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 19/210 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRA 350
           E +GK TYG VYK T  +DGS  AVK L + I+    E E+E ++L  +  HPN++    
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 351 -YYLGPK---GEKLLVFDYMPHGSLATFLHA---RGPETPIDWPTRMKIIKGMTRGLLHL 403
            +Y   K   G+  LV +    GS+   +      G    +D      I+ G   GL HL
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILYGALLGLQHL 144

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
           H+N  IIH ++  +N+LL      K+ DFG+S  +T +  +    + G   + APE+   
Sbjct: 145 HNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTPFWMAPEVIAC 202

Query: 464 KKA-----NTKTDVYSLGVTILELLTGKSP 488
           ++      + + DV+SLG+T +EL  G  P
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 296 GKSTYGTVYKA-TLEDGSQVAVKRLRE----KITKGQREFESEVSLLGKIRHPNLLALRA 350
           G+  YG V K      G  VA+K+ +E    +  K  +    EV +L ++RH N++ L+ 
Sbjct: 10  GEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK--KTALREVKVLRQLRHENIVNLKE 67

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   KG   LVF+Y+   +L   L A     P D       I  + + + + HS+ NII
Sbjct: 68  AFRR-KGRLYLVFEYVER-TLLELLEASPGGLPPD--AVRSYIWQLLQAIAYCHSH-NII 122

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL----SKLKKA 466
           H ++   N+L+ +S   K+ DFG +R + A     +        YRAPEL    +   K 
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 467 NTKTDVYSLGVTILELLTGKS--PGE 490
               DV+++G  + ELL G+   PG+
Sbjct: 183 ---VDVWAIGCIMAELLDGEPLFPGD 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 41/221 (18%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRL---REK----ITKGQREFESEVSLLGKIRHPNLL 346
           +G+ T+G VYKA  ++ G  VA+K++    EK    IT   RE    + +L K++HPN++
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT-ALRE----IKILKKLKHPNVV 70

Query: 347 AL--RAYYLGP-----KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
            L   A          +G   +V  YM H  L+  L    P   +        +  +  G
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE--NPSVKLTESQIKCYMLQLLEG 127

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL-------------MTAAANVNV 446
           + +LH N +I+H ++ ++N+L+D+    KI+DFGL+R                     N+
Sbjct: 128 INYLHEN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186

Query: 447 IATAGALGYRAPEL-SKLKKANTKTDVYSLGVTILELLTGK 486
           + T     YR PEL    ++  T  D++ +G    E+ T +
Sbjct: 187 VVTR---WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 18/217 (8%)

Query: 295 MGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLA 347
           +GK  +G V     +AT   G   A K+L +K  K ++ +E    E  +L K+ H   + 
Sbjct: 1   LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIV 56

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSN 406
             AY    K +  LV   M  G L   ++    E P    P        +  GL HLH  
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
             II+ +L   NVLLD+  N +ISD GL+  +    +      AG  G+ APEL + ++ 
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEY 174

Query: 467 NTKTDVYSLGVTILELLTGKSP----GEPLNGAELPQ 499
           +   D ++LGVT+ E++  + P    GE +   EL Q
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 43/286 (15%)

Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    +++ 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 348 LRAYYLGPKGEK-LLVFDYMPHGSLATFLHARGPE----TPIDWPTRMKII-------KG 395
           L    +   G+  L+V + M  G L ++L +R PE      +  PT  K I        G
Sbjct: 74  L--LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGY 455
           M     +L + +  +H +L + N ++ +    KI DFG++R +    +       G L  
Sbjct: 132 MA----YLAAKK-FVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-ETDYYRKGGKGLLPV 185

Query: 456 R--APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV 513
           R  APE  K     TK+DV+S GV + E+ T          AE P    S   EE    V
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQPYQGLS--NEEVLKFV 234

Query: 514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            D   + D P    + L  L+L   C   +P  RP  L++V  L++
Sbjct: 235 IDGGHL-DLPENCPDKL--LELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 26/214 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRA 350
           E++G+ TYG VYKA   + G  VA+K + + I   + E + E ++L K   HPN+     
Sbjct: 12  EVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 351 YYL-----GPKGEKLLVFDYMPHGS---LATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
            ++     G   +  LV +    GS   L   L  +G     +W     I++   RGL +
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAY 128

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA---NVNVIATAGALGYRAPE 459
           LH N  +IH ++   N+LL  +   K+ DFG+S  + +     N  +    G   + APE
Sbjct: 129 LHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----GTPYWMAPE 183

Query: 460 --LSKLKKANT---KTDVYSLGVTILELLTGKSP 488
                 +   +   ++DV+SLG+T +EL  GK P
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 55/200 (27%), Positives = 105/200 (52%), Gaps = 19/200 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRAY 351
           E++GK  +G V+K TL+D + VAVK  +E + +  + +F SE  +L +  HPN++ L   
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 352 YLGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +G   ++    +V + +P G   +FL  +  E       +  +      G+ +L S +N
Sbjct: 58  -IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES-KN 113

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG----ALGYRAPELSKLK 464
            IH +L + N L+ ++   KISDFG+SR      +  + +++G     + + APE     
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYG 169

Query: 465 KANTKTDVYSLGVTILELLT 484
           + ++++DV+S G+ + E  +
Sbjct: 170 RYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 19/203 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-----REKITKGQREFESEVSLLGKIRHPNLL 346
           E +GK ++G VYKA        VA+K +      ++I   Q+E    +  L + R P + 
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQE----IQFLSQCRSPYIT 62

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
                +L  KG KL ++ +Y   GS    L        +D      I++ +  GL +LH 
Sbjct: 63  KYYGSFL--KGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE 116

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK 465
            E  IH ++ ++N+LL +  + K++DFG+S  +T+  +       G   + APE+ K   
Sbjct: 117 -EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQSG 174

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
            + K D++SLG+T +EL  G+ P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 13/206 (6%)

Query: 292 AEIMGKSTYGTVYKATLED-GSQVAVKRLR-----EKITKGQREFESEVSLLGKIRHPNL 345
            +++G+  +G VY     D G ++AVK+++      + +K     E E+ LL  + H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66

Query: 346 LALRAYYLGPKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           +        P    L +F ++MP GS+   L + G  T  +  TR K  + +  G+ +LH
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALT--ENVTR-KYTRQILEGVSYLH 123

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAA-ANVNVIATAGALGYRAPELSK 462
           SN  I+H ++  +N+L D   N K+ DFG S RL T   +   + +  G   + +PE+  
Sbjct: 124 SNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +    K D++S+G T++E+LT K P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 30/220 (13%)

Query: 309 EDGSQVAVKRLREKITKGQRE---FESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY 365
             G +VA+K LR    + + +   F  E +L  ++ HPN++AL      P G    VF+Y
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 366 MPHGSLATFLHARGPETPIDWPTRM-KIIKGMTRGLLHLHSNENIIHGNLTSSNVLL--- 421
           +P  +L   L A G     +    M +++  +       H N+ I+H +L   N+++   
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALA----CAH-NQGIVHRDLKPQNIMVSQT 115

Query: 422 DDSTNAKISDFGLSRLMT---AAANVNVIATAGALG---YRAPELSKLKKANTKTDVYSL 475
               +AK+ DFG+  L+     A    +  T   LG   Y APE  + +     +D+Y+ 
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 476 GVTILELLTGKSPGEPLNGAE------------LPQWVAS 503
           G+  LE LTG+   +  + AE            LP W+A 
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAG 215

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 81/293 (27%), Positives = 134/293 (45%), Gaps = 56/293 (19%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQV--AVKRLREKITKG-QREFESEVSLLGKI-RHPNLLA 347
           +++G+  +G V +A ++ DG ++  A+K L+E  ++   R+F  E+ +L K+  HPN++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 348 LRAYYLGP---KGEKLLVFDYMPHGSLATFLHA-------------RGPETPIDWPTRMK 391
           L    LG    +G   +  +Y P+G+L  FL                G  + +     ++
Sbjct: 68  L----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG 451
               +  G+ +L S +  IH +L + NVL+ ++  +KI+DFGLSR       V V  T G
Sbjct: 124 FASDVATGMQYL-SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMG 178

Query: 452 ALGYRAPELSKLKKA--NTKTDVYSLGVTILELLT-GKSPGEPLNGAE----LPQWVASI 504
            L  R   +  L  +   TK+DV+S GV + E+++ G +P   +  AE    LPQ     
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238

Query: 505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
                 +EV+  ELMR                  C    P  RP   Q+  QL
Sbjct: 239 KPRNCDDEVY--ELMR-----------------QCWRDRPYERPPFAQISVQL 272

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 17/200 (8%)

Query: 296 GKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAY 351
           G   +G V    ++      A+K ++++    T  Q    SE  +L +  HP ++ L   
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT 61

Query: 352 YLGPKGEKLLVF--DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           +   K +K +    +Y   G L T L  RG     ++  R   I  +     +LH+   I
Sbjct: 62  F---KDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARF-YIACVVLAFEYLHNR-GI 114

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELSKLKKANT 468
           I+ +L   N+LLD +   K+ DFG ++ +    +     T  G   Y APE+   K  + 
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGYDF 171

Query: 469 KTDVYSLGVTILELLTGKSP 488
             D +SLG+ + ELLTG+ P
Sbjct: 172 SVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 12/198 (6%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 70

Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL        +  P  + +   +  G+ ++    N +H +L
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDL 128

Query: 415 TSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKANTKTD 471
            ++N+L+ ++   K++DFGL+RL+    +    A  GA   + + APE +   +   K+D
Sbjct: 129 RAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 472 VYSLGVTILELLT-GKSP 488
           V+S G+ + EL T G+ P
Sbjct: 186 VWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 72/269 (26%), Positives = 132/269 (49%), Gaps = 30/269 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ--VAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK ++G V+K  +++ +Q  VA+K +  E+      + + E+++L +   P +    
Sbjct: 10  ERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             YL  KG KL ++ +Y+  GS    L A     P D      ++K + +GL +LHS E 
Sbjct: 69  GSYL--KGTKLWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS-EK 121

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
            IH ++ ++NVLL +  + K++DFG++  +T    +      G   + APE+ +    ++
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           K D++SLG+T +EL    + GEP N    P  V  ++ +             + PT+  E
Sbjct: 181 KADIWSLGITAIEL----AKGEPPNSDMHPMRVLFLIPKN------------NPPTLTGE 224

Query: 529 LLNTLK-LALHCVDPSPSARPEVLQVVQQ 556
                K     C++  PS RP   ++++ 
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 85/307 (27%), Positives = 141/307 (45%), Gaps = 56/307 (18%)

Query: 293 EIMGKSTYGTVYKATL-EDGSQV--AVKRLREKITKG-QREFESEVSLLGKI-RHPNLLA 347
           +++G+  +G V KA + +DG ++  A+KR++E  +K   R+F  E+ +L K+  HPN++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 348 LRAYYLGP---KGEKLLVFDYMPHGSLATFLH-------------ARGPETPIDWPTRMK 391
           L    LG    +G   L  +Y PHG+L  FL              A    + +     + 
Sbjct: 73  L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG 451
               + RG+ +L S +  IH +L + N+L+ ++  AKI+DFGLSR       V V  T G
Sbjct: 129 FAADVARGMDYL-SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 183

Query: 452 ALGYRAPELSKLKKA--NTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEE 508
            L  R   +  L  +   T +DV+S GV + E+++ G +P   +  AEL + +    + E
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243

Query: 509 ----WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA 564
                 +EV+D  LMR                  C    P  RP   Q++  L  +  E 
Sbjct: 244 KPLNCDDEVYD--LMR-----------------QCWREKPYERPSFAQILVSLNRMLEER 284

Query: 565 ATAATSS 571
            T   ++
Sbjct: 285 KTYVNTT 291

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 73/274 (26%), Positives = 130/274 (47%), Gaps = 37/274 (13%)

Query: 294 IMGKSTYGTVYKAT-LEDGSQVAVKRL--REKITKGQREFESEVSLLGKIRHPNLLALRA 350
           ++GK +YG V       DG Q  +K+L  R    + ++  E E  LL +++HPN++A R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARG----PETPI-DWPTRMKIIKGMTRGLLHLHS 405
            + G  G   +V  +   G L   L  +     PE  + +W  ++ +       L +LH 
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM------ALQYLHE 120

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA--GALGYRAPELSKL 463
            ++I+H +L + NV L  +   K+ D G++R++    N   +A+   G   Y +PEL   
Sbjct: 121 -KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE---NQCDMASTLIGTPYYMSPELFSN 176

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD-A 522
           K  N K+DV++LG  + E+ T K      N  ++   V  I++ +         + +D +
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLK---HAFNAKDMNSLVYRIIEGKLP------PMPKDYS 227

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
           P +G EL+ T+      +   P  RP V  +++Q
Sbjct: 228 PELG-ELIATM------LSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 36/215 (16%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-VAVKRLRE--------KITKGQREFESEVSLLGKIRHP 343
            ++G+ +YG V K   ++  Q VA+K+  E        KI         E+ +L ++RH 
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM------REIRMLKQLRHE 60

Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           NL+ L   +   K    LVF+++ H  L            +D     K +  + RG+   
Sbjct: 61  NLVNLIEVFRRKK-RLYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFC 116

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPEL- 460
           HS+ NIIH ++   N+L+  S   K+ DFG +R + A   V  + +AT     YRAPEL 
Sbjct: 117 HSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---WYRAPELL 172

Query: 461 ---SKLKKANTKTDVYSLGVTILELLTGKSPGEPL 492
              +K  +A    D++++G  + E+LT    GEPL
Sbjct: 173 VGDTKYGRA---VDIWAVGCLVTEMLT----GEPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 57/210 (27%), Positives = 107/210 (50%), Gaps = 12/210 (5%)

Query: 295 MGKSTYGTVYKATLEDGSQ---VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRA 350
           +G   +G V K   +   +   VA+K L+ +  K  R E   E  ++ ++ +P ++  R 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV--RM 60

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             +      +LV +    G L  FL  +  E  +     ++++  ++ G+ +L   +N +
Sbjct: 61  IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLEG-KNFV 117

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA--LGYRAPELSKLKKANT 468
           H +L + NVLL +   AKISDFGLS+ + A  +     +AG   L + APE    +K ++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 469 KTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           ++DV+S G+T+ E  + G+ P + + G E+
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEV 207

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 20/212 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           E++GK +YG V  A     G +VA+K++    E ++   R    E+ LL  +RHP+++ +
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEI 64

Query: 349 RAYYLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           +   L P   +     +VF+ M    L   + A    TP         +  + R L ++H
Sbjct: 65  KHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQF---FLYQLLRALKYIH 120

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAPEL-- 460
           +  N+ H +L   N+L +     KI DFGL+R+        +  T       YRAPEL  
Sbjct: 121 TA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKS--PGE 490
           S   K     D++S+G    E+LTGK   PG+
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 84/293 (28%), Positives = 135/293 (46%), Gaps = 56/293 (19%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQV--AVKRLREKITKG-QREFESEVSLLGKI-RHPNLLA 347
           +++G+  +G V KA ++ DG ++  A+KR++E  +K   R+F  E+ +L K+  HPN++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 348 LRAYYLGP---KGEKLLVFDYMPHGSLATFLH-----------ARGPETPIDWPTR--MK 391
           L    LG    +G   L  +Y PHG+L  FL            A    T     ++  + 
Sbjct: 61  L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG 451
               + RG+ +L S +  IH +L + N+L+ ++  AKI+DFGLSR       V V  T G
Sbjct: 117 FAADVARGMDYL-SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 171

Query: 452 ALGYRAPELSKLKKA--NTKTDVYSLGVTILELLT-GKSPGEPLNGAE----LPQWVASI 504
            L  R   +  L  +   T +DV+S GV + E+++ G +P   +  AE    LPQ     
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231

Query: 505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
                 +EV+  +LMR                  C    P  RP   Q++  L
Sbjct: 232 KPLNCDDEVY--DLMR-----------------QCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 43/219 (19%)

Query: 294 IMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQRE-FE----SEVSLLGKIRHPNLLA 347
            +G+ TYG VYKA  +D G  VA+K++R      ++E F      E+ +L ++ H N++ 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 348 LRAY---------YLGPKGEKLLVFDYMPH-------GSLATFLHARGPETPIDWPTRMK 391
           L+           +   KG   LVF+YM H         L  F                 
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH----------IKS 120

Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN---VNVIA 448
            +K +  GL + H  +N +H ++  SN+LL++    K++DFGL+RL  +  +    N + 
Sbjct: 121 FMKQLLEGLNYCH-KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 449 TAGALGYRAPELSKLKKANTKT-DVYSLGVTILELLTGK 486
           T   L YR PEL   ++      DV+S G  + EL T K
Sbjct: 180 T---LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 35/228 (15%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES-------EVSLLGKIRHPN 344
           E +G+ TYG VYKA     G  VA+K+     T+ + + E        E+SLL  +    
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKK-----TRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 345 LLA--LRAYYLGPKGEKL---LVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMT 397
            +   L   ++  K  K    LVF+Y+    L  F+  + RGP  P+   T    +  + 
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNA-KISDFGLSRLMT--AAANVNVIATAGALG 454
           +G+ H H +  ++H +L   N+L+D      KI+D GL R  +    +  + I T   L 
Sbjct: 121 KGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVT---LW 176

Query: 455 YRAPE-LSKLKKANTKTDVYSLGVTILELLTGKS--PGEPLNGAELPQ 499
           YRAPE L      +T  D++S+G    E+   +   PG+    +EL Q
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD----SELQQ 220

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 65/238 (27%), Positives = 120/238 (50%), Gaps = 46/238 (19%)

Query: 290 ATAEIMGKSTYGTVYKATL-EDGS--QVAVKRLREKI-TKGQRE-FESEVSLLGKIRHPN 344
           A  + +G+  +G+V +  L +D S  +VAVK ++  I T+ + E F SE   + +  HPN
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 345 LLAL---------RAYYLGPKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRM--KI 392
           ++ L            Y  P    +++  +M HG L +FL ++R  + P   PT+M  K 
Sbjct: 62  VMRLIGVCLQTVESEGYPSP----VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117

Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA 452
           +  +  G+ +L S+++ IH +L + N +L+++ N  ++DFGLS+ +              
Sbjct: 118 MTDIASGMEYL-SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY--------- 167

Query: 453 LGYRAPELSKL------------KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             YR   ++K+            +   TK+DV+S GVT+ E+ T G++P   +  +E+
Sbjct: 168 --YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 18/201 (8%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+       ++VA+K L++  +     F +E +L+ +++HP L+  R Y + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLV--RLYAVV 70

Query: 355 PKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRM--KIIKGMTRGLLHLHSNENIIH 411
            +    ++ +YM +GSL  FL    G +  I+    M  +I +GM          +N IH
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA-----FIERKNYIH 125

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKANT 468
            +L ++N+L+ ++   KI+DFGL+RL+    +    A  GA   + + APE         
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 469 KTDVYSLGVTILELLT-GKSP 488
           K+DV+S G+ + E++T G+ P
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL-RAYY 352
           +G   +G VYKA   E G   A K ++ +  +   +F  E+ +L + +HPN++ L  AY+
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
              K   L+  ++   G+L + +     E  +  P    + + M   L  LHS+  +IH 
Sbjct: 73  YENKLWILI--EFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH-KVIHR 127

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT----AGALGYRAPEL-----SKL 463
           +L + N+LL    + K++DFG+S     A N + +       G   + APE+      K 
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS-----AKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLN 493
              + K D++SLG+T++EL   + P   LN
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 9/198 (4%)

Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G V    +++ G   A K+L +K  K   G++    E  +L K+  P ++ L A
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y    K    LV   M  G L   ++  G E  ++    +     +T G+LHLHS  +I+
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS-MDIV 117

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           + ++   NVLLDD  N ++SD GL+  +     +     AG  GY APE+ K +  +   
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT--QRAGTNGYMAPEILKEEPYSYPV 175

Query: 471 DVYSLGVTILELLTGKSP 488
           D +++G +I E++ G++P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 57/203 (28%), Positives = 109/203 (53%), Gaps = 20/203 (9%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G  TYG VYKA  +  G   A+K ++ +  +     + E+ ++   +H N++A    YL
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 354 GPKGEKLLV-FDYMPHGSLATFLHARGP--ETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             + +KL +  ++   GSL    H  GP  E+ I + +R  +     +GL +LH ++  +
Sbjct: 77  --RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH-SKGKM 128

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTA--AANVNVIATAGALGYRAPELSKLKKA-- 466
           H ++  +N+LL D+ + K++DFG+S  +TA  A   + I T     + APE++ +++   
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP---YWMAPEVAAVERKGG 185

Query: 467 -NTKTDVYSLGVTILELLTGKSP 488
            N   D++++G+T +EL   + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFE-SEVSLLGKIRHPNLLALRA 350
           E +G+ TY TVYK      G  VA+K +     +G       E+SL+ +++H N++ L  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             +  + + +LVF+YM    L  ++   G    +D  T       + +G+   H N  ++
Sbjct: 66  V-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-VL 122

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE-LSKLKKAN 467
           H +L   N+L++     K++DFGL+R      N   N + T   L YRAP+ L   +  +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVT---LWYRAPDVLLGSRTYS 179

Query: 468 TKTDVYSLGVTILELLTGK 486
           T  D++S+G  + E++TG+
Sbjct: 180 TSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 12/198 (6%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPL--YAVV 70

Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V ++M  GSL  FL   G    +  P  + +   +  G+ ++    N IH +L
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIE-RMNYIHRDL 128

Query: 415 TSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKANTKTD 471
            ++N+L+ D+   KI+DFGL+RL+    +    A  GA   + + APE +   +   K+D
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 472 VYSLGVTILELLT-GKSP 488
           V+S G+ + EL+T G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLALR 349
           E +G+ TYGTV+KA   E    VA+KR+R +   +G       E+ LL +++H N++ L 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                 K +  LVF+Y     L  +  +   +  ID       +  + +GL   HS  N+
Sbjct: 66  DVLHSDK-KLTLVFEYCDQ-DLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHS-HNV 120

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV---IATAGALGYRAPE-LSKLKK 465
           +H +L   N+L++ +   K++DFGL+R    A  + V    A    L YR P+ L   K 
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
            +T  D++S G    EL     P
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 19/208 (9%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ TYG VYKA  +DG       L++    G       E++LL +++HPN++AL+  +L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 354 GPKGEKL-LVFDYMPHG--SLATFLHA-RGPETPIDWPTRM--KIIKGMTRGLLHLHSNE 407
                K+ L+FDY  H    +  F  A +  + P+  P  M   ++  +  G+ +LH+N 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 408 NIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAA----ANVNVIATAGALGYRAPE 459
            ++H +L  +N+L+     +    KI+D G +RL  +     A+++ +       YRAPE
Sbjct: 129 -VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 185

Query: 460 LSKLKKANTKT-DVYSLGVTILELLTGK 486
           L    +  TK  D++++G    ELLT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 14/201 (6%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+        +VA+K + E     + +F  E  ++ K+ HP L+ L  Y + 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQL--YGVC 68

Query: 355 PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            + + L +V ++M +G L  +L  R  +   D    + + + +  G+ +L  N + IH +
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERN-SFIHRD 125

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKANTKT 470
           L + N L+  +   K+SDFG++R +    +    +++GA   + +  PE+    K ++K+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVL---DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 471 DVYSLGVTILELLT-GKSPGE 490
           DV+S GV + E+ T GK P E
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 73/284 (25%), Positives = 121/284 (42%), Gaps = 38/284 (13%)

Query: 294 IMGKSTYGTVYKATL-----EDGSQ-VAVKRLRE-KITKGQREFESEVSLLGKIRHPNLL 346
            +G+  +G V+ A       E G   V VK L++ K    Q EF  E+ +  K+ H N++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 347 ALRAYYLGPKGEK---LLVFDYMPHGSLATFLHARGPET------PIDWPTRMKIIKGMT 397
            L    LG   E     ++ +Y   G L  FL A   +       P+    ++ +   + 
Sbjct: 72  RL----LGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRA 457
            G+ HL SN   +H +L + N L+      K+S   LS+ +  +    +      L + A
Sbjct: 128 LGMDHL-SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186

Query: 458 PELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDL 516
           PE  +    +TK+DV+S GV + E+ T G+ P   L+  E    V + ++         L
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAG------KL 236

Query: 517 ELMRDAPTIGDELLNTL-KLALHCVDPSPSARPEVLQVVQQLEE 559
           EL      + +   + L KL   C   +P  RP   ++V  L E
Sbjct: 237 EL-----PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     + ++VAVK L+   T   + F  E +L+  ++H  L+  R Y + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLV--RLYAVV 70

Query: 355 PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K E + ++ +YM  GSL  FL +      +  P  +     +  G+ ++   +N IH +
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE-RKNYIHRD 128

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKANTKT 470
           L ++NVL+ +S   KI+DFGL+R++    +    A  GA   + + APE         K+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 471 DVYSLGVTILELLT-GKSP 488
           DV+S G+ + E++T GK P
Sbjct: 186 DVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 18/208 (8%)

Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQ-REFESEVSLLGKIRHPNLLALR-AY 351
           +GK  YG+VYK      G  +A+K +R ++ + +  +   E+ +L K   P ++    A+
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNENII 410
           ++  +G   +  +YM  GSL   L+A G  T  I      +I   + +GL  L    NII
Sbjct: 69  FI--EGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIATAGALGYRAPELSKLKKAN-- 467
           H ++  +NVL++ +   K+ DFG+S  L+ + A  N+    G   Y APE  K    N  
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQN 181

Query: 468 ----TKTDVYSLGVTILELLTGKSPGEP 491
                ++DV+SLG++ILE+  G+ P  P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 70/269 (26%), Positives = 130/269 (48%), Gaps = 30/269 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ--VAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK ++G V+K  +++ +Q  VA+K +  E+      + + E+++L +   P +    
Sbjct: 10  EKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             YL  K  KL ++ +Y+  GS    L       P+D      I++ + +GL +LHS E 
Sbjct: 69  GSYL--KDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS-EK 121

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
            IH ++ ++NVLL +    K++DFG++  +T    +      G   + APE+ K    ++
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           K D++SLG+T +EL  G+ P   L+    P  V  ++ +             + PT+   
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELH----PMKVLFLIPKN------------NPPTLEGN 224

Query: 529 LLNTLK-LALHCVDPSPSARPEVLQVVQQ 556
               LK     C++  PS RP   ++++ 
Sbjct: 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 64/225 (28%), Positives = 110/225 (48%), Gaps = 25/225 (11%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREF-ESEVSLLGKIRHPNLLALR 349
           + +G+ ++G +Y A  + D     +K +   K+   ++E  + EV LL K++HPN++   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLH-ARG----PETPIDWPTRMKIIKGMTRGLLHLH 404
           A      G   +V +Y   G L   ++  RG     +  + W  ++ +      GL H+H
Sbjct: 66  AS-FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH 118

Query: 405 SNENIIHGNLTSSNVLLDDSTN---AKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
            +  I+H ++ S N+ L  S N   AK+ DFG++R +  +  +      G   Y +PE+ 
Sbjct: 119 -DRKILHRDIKSQNIFL--SKNGMVAKLGDFGIARQLNDSMEL-AYTCVGTPYYLSPEIC 174

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK 506
           + +  N KTD++SLG  + EL T K P E   G  L Q V  I +
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE---GNNLHQLVLKICQ 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 22/227 (9%)

Query: 297 KSTYGTVYKATLE-DGSQVAVKRLREK--ITKGQ-REFESEVSLLGKIRHPNLLALRAYY 352
           K  +G+VY A     G   A+K L++   I K Q    ++E +++        +A + YY
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA-KLYY 64

Query: 353 LGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
                + L LV +Y+  G  A+ +   G   P DW    + I  +  G+  LH    IIH
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAK--QYIAEVVLGVEDLHQR-GIIH 120

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTD 471
            ++   N+L+D + + K++DFGLSR      N   + T     Y APE       +  +D
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN--GLENKKFVGTP---DYLAPETILGVGDDKMSD 175

Query: 472 VYSLGVTILELLTGKSPGEPLNGAELPQWV-ASIVKEE--WTNEVFD 515
            +SLG  I E L G  P      AE P  V  +I+     W  EV +
Sbjct: 176 WWSLGCVIFEFLFGYPPFH----AETPDAVFDNILSRRINWPEEVKE 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 293 EIMGKSTYGTV----YKATLED-GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLL 346
            ++G+  +G V    Y    +  G  VAVK L+ +  +     ++ E+++L  + H N++
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 347 ALRAYYLG---PKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
                Y G    +G K   L+ +Y+P GSL  +L    P+  ++    +   + +  G+ 
Sbjct: 70  K----YKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMA 121

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG--ALGYRAPE 459
           +LHS ++ IH +L + NVLLD+    KI DFGL++ +        +   G   + + A E
Sbjct: 122 YLHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 460 LSKLKKANTKTDVYSLGVTILELLT 484
             K  K +  +DV+S GVT+ ELLT
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 59/205 (28%), Positives = 109/205 (53%), Gaps = 13/205 (6%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ--VAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK ++G VYK  +++ ++  VA+K +  E+      + + E+++L +   P +    
Sbjct: 10  ERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             YL  KG KL ++ +Y+  GS    L       P++      I++ + +GL +LHS E 
Sbjct: 69  GSYL--KGTKLWIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS-ER 121

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
            IH ++ ++NVLL +  + K++DFG++  +T    +      G   + APE+ K    + 
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           K D++SLG+T +EL  G+ P   L+
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLH 205

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 75.9 bits (186), Expect = 5e-15
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 19/208 (9%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ TYG VYKA  +DG       L++    G       E++LL +++HPN+++L+  +L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 354 GPKGEKL-LVFDYMPHG--SLATFLHA-RGPETPIDWPTRM--KIIKGMTRGLLHLHSNE 407
                K+ L+FDY  H    +  F  A +  + P+  P  M   ++  +  G+ +LH+N 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 408 NIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAA----ANVNVIATAGALGYRAPE 459
            ++H +L  +N+L+     +    KI+D G +RL  +     A+++ +       YRAPE
Sbjct: 129 -VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 185

Query: 460 LSKLKKANTKT-DVYSLGVTILELLTGK 486
           L    +  TK  D++++G    ELLT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 71/249 (28%), Positives = 113/249 (45%), Gaps = 46/249 (18%)

Query: 282 FTADDLLCATAEIMGKSTYGTVYKATLED-GSQVAVKRLR-EKITKGQREFESEVSLLGK 339
           FTA+DL     EI G+  +GTV K   +  G+ +AVKR+R     K Q+    ++ ++ +
Sbjct: 1   FTAEDLK-DLGEI-GRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR 58

Query: 340 IRH-PNLLALRAYY--LGPKGEKLLVFDYMPHG--SLATFLHARGPETPIDWPTRM--KI 392
               P ++    +Y  L  +G+  +  + M         +++          P  +  KI
Sbjct: 59  SSDCPYIVK---FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV---IPEEILGKI 112

Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--- 449
                + L +L     IIH ++  SN+LLD + N K+ DFG+S  +     V+ IA    
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-----VDSIAKTRD 167

Query: 450 AGALGYRAPEL---SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK 506
           AG   Y APE    S     + ++DV+SLG+T+ E+ TGK P         P+W      
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP--------YPKW------ 213

Query: 507 EEWTNEVFD 515
               N VFD
Sbjct: 214 ----NSVFD 218

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 294 IMGKSTYGTV----YKATLEDGSQVAVKRLREKITKGQREFES----EVSLLGKIRHPNL 345
           ++GK  +G V     +AT   G   A K+L +K  K +R+ E+    E  +L K+    +
Sbjct: 7   VLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFV 62

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           ++L AY    K    LV   M  G L   ++  G     D    +     +T GL  LH 
Sbjct: 63  VSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLHR 120

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK 465
            E I++ +L   N+LLDD  + +ISD GL+  +       +    G +GY APE+ K ++
Sbjct: 121 -ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNER 177

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LG  I E++ GKSP
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 34/240 (14%)

Query: 328 REFESEVSLLGKIRHPNLLALRAYYLG-----PKGEKLLVFDYMPHGSLATFLHARGPET 382
              E+E+  L +I   N+L +  + +      P+    L+ +Y   G L   L     E 
Sbjct: 63  DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL--SLILEYCTRGYLREVLDK---EK 117

Query: 383 PIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA 442
            + + T++ +     +GL +L+   N  + NLTS + L+ ++   KI   GL +++++  
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177

Query: 443 --NVNVIATAGALGYRAPELSK--LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP 498
             NVN +       Y + ++      +   K D+YSLGV + E+ TGK P E L   E+ 
Sbjct: 178 FKNVNFMV------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI- 230

Query: 499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
                I+ +   N    L L  D P    E+   ++    C       RP + +++  L 
Sbjct: 231 --YDLIINK---NNSLKLPL--DCPL---EIKCIVE---ACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 85/308 (27%), Positives = 132/308 (42%), Gaps = 70/308 (22%)

Query: 291 TAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RH 342
             + +G+  +G V KA         + S VAVK L++  T K   +  SE+ ++  I +H
Sbjct: 16  LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 343 PNLLALRAYYLG---PKGEKLLVFDYMPHGSLATFLHAR----------GPETPIDWPTR 389
            N++ L    LG    +G   +V +Y  HG+L  FL AR           P  P +  T+
Sbjct: 76  KNIINL----LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 390 MKIIK---GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV 446
             ++     + RG+  L S +  IH +L + NVL+ +    KI+DFGL+R      +++ 
Sbjct: 132 KDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVLVTEDHVMKIADFGLAR------DIHH 184

Query: 447 I-----ATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKS--PGEPLNGAE 496
           I      T G L  +  APE    +    ++DV+S GV + E+ T G S  PG P+    
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 240

Query: 497 LPQWVASIVKEEWTNEVFDL----ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQ 552
                          E+F L      M        EL     L   C    PS RP   Q
Sbjct: 241 --------------EELFKLLKEGYRMEKPQNCTQEL---YHLMRDCWHEVPSQRPTFKQ 283

Query: 553 VVQQLEEI 560
           +V+ L+ +
Sbjct: 284 LVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 31/217 (14%)

Query: 293 EIMGKSTYGTVYKATL-----EDGSQVAVKRLREKITKGQR--EFESEVSLLGKIRHPNL 345
           E +G+  +G +YK  L     +    VA+K L++ I   Q+  EF+ E SL+ ++ HPN+
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD-INNPQQWGEFQQEASLMAELHHPNI 69

Query: 346 LALRAYYLGPKGEK---LLVFDYMPHGSLATFLHARGP--------------ETPIDWPT 388
           + L    LG   ++    ++F+Y+  G L  FL  R P              ++ +D   
Sbjct: 70  VCL----LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125

Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA 448
            + I   +  G+ +L S+   +H +L + N+L+ +  + KISD GLSR + +A    V  
Sbjct: 126 FLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 449 -TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
            +   + +  PE     K ++ +D++S GV + E+ +
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 43/284 (15%)

Query: 290 ATAEIMGKSTYGTVYKATLEDGSQ--VAVKRL---REKITKGQREFE-------SEVSLL 337
           A  E +G   +G VYK   ++  Q  +A+K +        K +RE +       SEV+++
Sbjct: 3   AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 338 GK-IRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFL------HARGPETPIDWPTR 389
            + +RHPN++     +L  + ++L +V D +    L            R  E  I W   
Sbjct: 63  KEQLRHPNIVRYYKTFL--ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-W--- 116

Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT 449
             I   M   L +LH  + I+H +LT +N++L +     I+DFGL++         + + 
Sbjct: 117 -NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSV 173

Query: 450 AGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW 509
            G + Y  PE+ K +    K DV++ G  + ++ T + P    N   L   +   V E  
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233

Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQV 553
              ++  E + D   I             C+ P   ARP+++QV
Sbjct: 234 PEGMYS-EDVTD--VIT-----------SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 32/270 (11%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G+  +  VY+AT L DG  VA+K+++       K + +   E+ LL ++ HPN++   A
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++    E  +V +    G L+  + H +  +  I   T  K    +   L H+HS   +
Sbjct: 70  SFI-EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-V 127

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLM---TAAANVNVIATAGALGYRAPELSKLKKA 466
           +H ++  +NV +  +   K+ D GL R     T AA+    +  G   Y +PE       
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHENGY 183

Query: 467 NTKTDVYSLGVTILELLTGKSP--GEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
           N K+D++SLG  + E+   +SP  G+ +N       + S+ K+        +E     P 
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMN-------LYSLCKK--------IEQCDYPPL 228

Query: 525 IGDELLNTL-KLALHCVDPSPSARPEVLQV 553
             D     L +L   C++P P  RP++  V
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 71/211 (33%), Positives = 110/211 (52%), Gaps = 25/211 (11%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLALR 349
           E +G+ TYG VYKA     G  VA+K++R +  T+G       E+SLL ++ HPN++ L 
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
                    KL LVF+++ H  L  F+ A  P + I  P     +  + +GL   HS+  
Sbjct: 66  DVIHTEN--KLYLVFEFL-HQDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHSHR- 120

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV------IATAGALGYRAPE-LS 461
           ++H +L   N+L++     K++DFGL+R    A  V V      + T   L YRAPE L 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR----AFGVPVRTYTHEVVT---LWYRAPEILL 173

Query: 462 KLKKANTKTDVYSLGVTILELLTGKS--PGE 490
             K  +T  D++SLG    E++T ++  PG+
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 24/206 (11%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLRE--KITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G   +G V  A     G  VA+K++ +        +    E+ LL  +RH N+++L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           ++ P  +   V + +    L   L +R  E         +I+    RGL ++HS   ++H
Sbjct: 78  FISPLEDIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQIL----RGLKYVHS-AGVVH 131

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRL----MTAAANVNVIATAGALGYRAPELS-KLKKA 466
            +L  SN+L++++ + KI DFGL+R+    MT   +           YRAPE+    +K 
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--------YRAPEIMLTWQKY 183

Query: 467 NTKTDVYSLGVTILELLTGKS--PGE 490
           + + D++S G    E+L GK   PG+
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGK 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G  TYG VYKA  L  G   AVK ++ +        + E+ ++ + +H N++A    YL
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 354 GPKGEKLLV-FDYMPHGSLATFLHARGP--ETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
               EKL +  +Y   GSL    H  GP  E  I +  R  +     +GL +LHS   + 
Sbjct: 77  SR--EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM- 128

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTA--AANVNVIATAGALGYRAPELSKLKKA-- 466
           H ++  +N+LL D+ + K++DFG++  +TA  A   + I T     + APE++ ++K   
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTP---YWMAPEVAAVEKNGG 185

Query: 467 -NTKTDVYSLGVTILELLTGKSP 488
            N   D++++G+T +EL   + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.7 bits (182), Expect = 2e-14
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 36/208 (17%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES--------EVSLLGKI-RHPNL 345
           G  T+G+VY A   E G  VA+K++++K       F S        EV  L K+  HPN+
Sbjct: 8   GDGTFGSVYLARNKETGELVAIKKMKKK-------FYSWEECMNLREVKSLRKLNEHPNI 60

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L+  +     E   VF+YM  G+L   +  R    P        II  + +GL H+H 
Sbjct: 61  VKLKEVFR-ENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHK 117

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM------TAAANVNVIATAGALGYRAPE 459
           +    H +L   N+L+      KI+DFGL+R +      T       ++T     YRAPE
Sbjct: 118 H-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-----YVSTR---WYRAPE 168

Query: 460 -LSKLKKANTKTDVYSLGVTILELLTGK 486
            L +    ++  D+++LG  + EL T +
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 19/217 (8%)

Query: 281 MFTADD--LLCATAEIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFE---SEV 334
           +F  DD   L +    +G  ++G VY A  + +   VA+K++     +   +++    EV
Sbjct: 7   LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66

Query: 335 SLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK 394
             L K+RHPN +  R  YL  +    LV +Y   GS +  L     + P+       +  
Sbjct: 67  RFLQKLRHPNTIQYRGCYL-REHTAWLVMEYC-LGSASDLLEVH--KKPLQEVEIAAVTH 122

Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG 454
           G  +GL +LH + N+IH ++ + N+LL +    K+ DFG + +M  A         G   
Sbjct: 123 GALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPY 176

Query: 455 YRAPEL---SKLKKANTKTDVYSLGVTILELLTGKSP 488
           + APE+       + + K DV+SLG+T +EL   K P
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 53/198 (26%), Positives = 103/198 (52%), Gaps = 10/198 (5%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA-LRA 350
           E +G+   GTV+ A  +  G +VA+K++  +    +    +E+ ++ ++++PN++  L +
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           + +G   E  +V +Y+  GSL   +     ET +D      + +   + L  LH+N+ +I
Sbjct: 85  FLVG--DELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHANQ-VI 137

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           H ++ S NVLL    + K++DFG    +T   +       G   + APE+   K    K 
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 196

Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 23/219 (10%)

Query: 294 IMGKSTYGTVYKAT-LEDGSQ----VAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLA 347
           ++G   +GTVYK   + DG      VA+K LRE  + K  +E   E  ++  +  P +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLHL 403
           L    L    +  LV   MP+G L  ++       G +  ++W   ++I KGM+      
Sbjct: 74  LLGICLTSTVQ--LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGMS-----Y 124

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
                ++H +L + NVL+    + KI+DFGL+RL+         A  G +  +   L  +
Sbjct: 125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIKWMALESI 183

Query: 464 --KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
             ++   ++DV+S GVT+ EL+T G  P + +   E+P 
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 28/206 (13%)

Query: 300 YGTVY----KATLEDGSQVAVKRL--REKITKGQRE-FESEVSLLGKIRHPNLLALRAYY 352
           YG V+    K+T   G   A+K +   + I K Q +   +E  +L + + P ++  + YY
Sbjct: 6   YGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV--KLYY 60

Query: 353 LGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                + L LV +Y+P G LA+ L   G   E           I  +   L +LHSN  I
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIAEIVLALEYLHSN-GI 114

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSR--LMTAAANVNVIATA-----GALGYRAPELSK 462
           IH +L   N+L+D + + K++DFGLS+  L+    N+N          G   Y APE+  
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +  +   D +SLG  + E L G  P
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 38/105 (36%), Positives = 60/105 (57%), Gaps = 12/105 (11%)

Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT- 449
           KI   + + L +LHS  ++IH ++  SNVL++ +   K+ DFG+S  +     V+ +A  
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-----VDSVAKT 161

Query: 450 --AGALGYRAPEL----SKLKKANTKTDVYSLGVTILELLTGKSP 488
             AG   Y APE        K  + K+DV+SLG+T++EL TG+ P
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 10/198 (5%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G+   GTVY A  +  G +VA+K++  +    +    +E+ ++ + +HPN++     
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           YL   G++L +V +Y+  GSL   +     ET +D      + +   + L  LHSN+ +I
Sbjct: 85  YL--VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 137

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           H ++ S N+LL    + K++DFG    +T   +       G   + APE+   K    K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 196

Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 56/226 (24%)

Query: 295 MGKSTYGTVYKATLED---GSQVAVKRLREKI-------TKGQREFESEVSLLGKIR-HP 343
           +GK  YG V+KA   D      VA+K    KI       T  QR F  E+  L ++  HP
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALK----KIFDAFRNATDAQRTFR-EIMFLQELGDHP 67

Query: 344 NLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGM------ 396
           N++ L         + + LVF+YM      T LHA           R  I++ +      
Sbjct: 68  NIVKLLNVIKAENDKDIYLVFEYM-----ETDLHA---------VIRANILEDVHKRYIM 113

Query: 397 ---TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV------- 446
               + L ++HS  N+IH +L  SN+LL+     K++DFGL+R ++              
Sbjct: 114 YQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 447 IATAGALGYRAPE-LSKLKKANTKTDVYSLGVTILELLTGKS--PG 489
           +AT     YRAPE L    +     D++S+G  + E+L GK   PG
Sbjct: 173 VATR---WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 25/211 (11%)

Query: 295 MGKSTYGTVYKATL----EDGSQVAVKRLR-EKITKGQR-EFESEVSLLGKIRHPNLLAL 348
           +G+ ++G   KA L    EDG Q  +K +   K++  +R E   EV++L  ++HPN++  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHA-RG---PETPI-DWPTRMKIIKGMTRGLLHL 403
           +  +    G   +V DY   G L   ++A RG   PE  I DW  ++ +       L H+
Sbjct: 65  QESF-EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHV 117

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPELSK 462
           H +  I+H ++ S N+ L      K+ DFG++R++ +   V +  T  G   Y +PE+ +
Sbjct: 118 H-DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VELARTCIGTPYYLSPEICE 174

Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLN 493
            +  N K+D+++LG  + E+ T K   E  N
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRA 350
           E +G+  +G V+   L  D + VAVK  RE +    + +F  E  +L +  HPN++ L  
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL-- 58

Query: 351 YYLGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
             +G   +K    +V + +  G   TFL   GP   +     +++++    G+ +L S +
Sbjct: 59  --IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK--ELIQMVENAAAGMEYLES-K 113

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGAL-----GYRAPELSK 462
           + IH +L + N L+ +    KISDFG+SR         V A+ G +      + APE   
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 463 LKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
             + ++++DV+S G+ + E  + G  P   L+  +  + +   V+         L     
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------LPCPEL 220

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
            P   D +    +L   C +  P  RP    V Q+L
Sbjct: 221 CP---DAV---YRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 56/208 (26%), Positives = 106/208 (50%), Gaps = 14/208 (6%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+ AT    ++VAVK ++   +     F +E +++  ++H  L+ L A  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA--VV 70

Query: 355 PKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K    ++ ++M  GSL  FL +  G + P+  P  +     +  G+  +    N IH +
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE-QRNYIHRD 127

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LGYRAPELSKLKKANTKT 470
           L ++N+L+  S   KI+DFGL+R++    +    A  GA   + + APE         K+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAEL 497
           DV+S G+ ++E++T G+ P   ++  E+
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEV 212

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 61/204 (29%), Positives = 88/204 (43%), Gaps = 23/204 (11%)

Query: 296 GKSTYGTVYKATLEDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           GK   G  +       ++V VK LR   T   Q  F  EV    ++ HPN+L      LG
Sbjct: 9   GKVLLGEAH--RGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC----LG 62

Query: 355 PKGEK---LLVFDYMPHGSLATFLHA-RGPETPIDWP-TRMKIIKGMTRGLLHLHSNENI 409
              E    LLV ++ P G L  +L + RG    +       ++   +  GLL LH   + 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DF 121

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELS------ 461
           IH +L   N  L    + KI D+GL+ L     +  +     A+  R  APEL       
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180

Query: 462 -KLKKANTKTDVYSLGVTILELLT 484
              K    K++++SLGVT+ EL T
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 56/266 (21%), Positives = 105/266 (39%), Gaps = 52/266 (19%)

Query: 311 GSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP 367
           G    V  + + +    R+  +     SL+ ++ H +L+  + Y +  + E ++V +Y+ 
Sbjct: 26  GPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLV--KLYGVCVRDENIMVEEYVK 83

Query: 368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDS 424
            G L  FLH       + W  ++ + K +   L +L     ++HGN+   N+L+     +
Sbjct: 84  FGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLN 140

Query: 425 TN----AKISDFGLSRLMTAAANVNVIATAGALGYR-------APELSKLKKANTKT--D 471
                  K+SD G+              T  +   R       APE  +  +A+     D
Sbjct: 141 EGYVPFIKLSDPGIPI------------TVLSREERVERIPWIAPECIRNGQASLTIAAD 188

Query: 472 VYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLN 531
            +S G T+LE+ +     EPL+     +      KE +  +   L  M D   +   L+N
Sbjct: 189 KWSFGTTLLEICSNGE--EPLSTLSSSE------KERFYQDQHRLP-MPDCAELA-NLIN 238

Query: 532 TLKLALHCVDPSPSARPEVLQVVQQL 557
                  C    P+ RP    +++ L
Sbjct: 239 ------QCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 32/210 (15%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES-----------EVSLLGKI 340
           E +G+ TYG VYK    + G  VA+K++R          ES           E+SLL ++
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIR---------LESEEEGVPSTAIREISLLKEL 56

Query: 341 RHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           +HPN++ L+   +     +L L+F+++    L  +L +      +D       +  + +G
Sbjct: 57  QHPNIVCLQDVLMQES--RLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRA 457
           +L  HS   ++H +L   N+L+D+    K++DFGL+R       V  + + T   L YRA
Sbjct: 114 ILFCHSRR-VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVT---LWYRA 169

Query: 458 PE-LSKLKKANTKTDVYSLGVTILELLTGK 486
           PE L    + +T  D++S+G    E+ T K
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 294 IMGKSTYGTVY---KATLED-GSQVAVKRLREKIT-----KGQREFESEVSLLGKIRH-P 343
           ++G   YG V+   K    D G   A+K L+ K T     K      +E  +L  +R  P
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLK-KATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 344 NLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLL 401
            L+ L  +Y      KL L+ DY+  G L T L+ R   T     + +++    +   L 
Sbjct: 66  FLVTL--HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE----SEVRVYIAEIVLALD 119

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
           HLH    II+ ++   N+LLD   +  ++DFGLS+   A       +  G + Y APE+ 
Sbjct: 120 HLH-QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 462 KLKKA--NTKTDVYSLGVTILELLTGKSP 488
           +      +   D +SLGV   ELLTG SP
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 32/192 (16%)

Query: 313 QVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRAYYLG--PKGEKL-LVFDYMPH 368
            VAVK LR   +   R +F  EV +L ++  PN+  L    LG       L ++ +YM +
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVDPPLCMIMEYMEN 103

Query: 369 GSLATFLHARGPET--------PIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL 420
           G L  FL     ET         + + T + +   +  G+ +L  + N +H +L + N L
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLNFVHRDLATRNCL 162

Query: 421 LDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAP--------ELSKLKKANTKTDV 472
           +  +   KI+DFG+SR + ++    V         RAP        E   L K  TK+DV
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYYRV-------QGRAPLPIRWMAWESVLLGKFTTKSDV 215

Query: 473 YSLGVTILELLT 484
           ++ GVT+ E+LT
Sbjct: 216 WAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.1 bits (177), Expect = 7e-14
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 9/163 (5%)

Query: 327 QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDW 386
           +++   E+ ++ + R P +++    +L  +    +  ++M  GSL       GP      
Sbjct: 47  RKQILRELQIMHECRSPYIVSFYGAFLN-ENNICMCMEFMDCGSLDRIYKKGGPIPV--- 102

Query: 387 PTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVN 445
               KI   +  GL +L++   I+H ++  SN+L++     K+ DFG+S  L+ + A+  
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162

Query: 446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           V    G   Y +PE  +  K   K+DV+SLG++I+EL  GK P
Sbjct: 163 V----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 66/230 (28%), Positives = 110/230 (47%), Gaps = 33/230 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQ----VAVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +    VA+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 73  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 123

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL-S 461
                 ++H +L + NVL+    + KI+DFGL++L+ A       A  G +  +   L S
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK-EYHAEGGKVPIKWMALES 182

Query: 462 KLKKANT-KTDVYSLGVTILELLT-GKSP--GEPL--------NGAELPQ 499
            L +  T ++DV+S GVT+ EL+T G  P  G P          G  LPQ
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E++G  TYG VYK       Q+A  ++ +     + E + E+++L K  H   +A   YY
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIA--TYY 79

Query: 353 -----LGPKGEK---LLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHL 403
                  P G      LV ++   GS+   + + +G     DW     I + + RGL HL
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHL 137

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIATAGALGYRAPELSK 462
           H+++ +IH ++   NVLL ++   K+ DFG+S +L       N     G   + APE+  
Sbjct: 138 HAHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIA 194

Query: 463 LKKA-----NTKTDVYSLGVTILELLTGKSP 488
             +      + ++D++SLG+T +E+  G  P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 10/198 (5%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA-LRA 350
           E +G+   GTVY A  +  G +VA+K++  +    +    +E+ ++ + ++PN++  L +
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y +G   E  +V +Y+  GSL   +     ET +D      + +   + L  LHSN+ +I
Sbjct: 85  YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQ-VI 137

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           H ++ S N+LL    + K++DFG    +T   +       G   + APE+   K    K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 196

Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 22/202 (10%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE--FESEVSLLGKIRHPNLLALRAY 351
           +G+ + G V  AT    G QVAVK++   + K QR     +EV ++   +HPN++ + + 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           YL   G++L +V +++  G+L   + H R     ++      +   + + L  LH+ + +
Sbjct: 85  YL--VGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFLHA-QGV 136

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPELSKLKKA 466
           IH ++ S ++LL      K+SDFG      A  +  V      +G   + APE+      
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGF----CAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
            T+ D++SLG+ ++E++ G+ P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRA 350
           E +GK TYG V+K    ++GS+ AVK L + I     E E+E ++L  +  HPN++    
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82

Query: 351 YYLGP---KGEKL-LVFDYMPHGS---LATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
            Y       G++L LV +    GS   L      RG    ++ P    I+     GL HL
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER--MEEPIIAYILHEALMGLQHL 140

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
           H N+  IH ++  +N+LL      K+ DFG+S  +T +  +    + G   + APE+   
Sbjct: 141 HVNKT-IHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTPFWMAPEVIAC 198

Query: 464 KKA-----NTKTDVYSLGVTILELLTGKSP 488
           ++      + + DV+SLG+T +EL  G  P
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 69/256 (26%), Positives = 113/256 (44%), Gaps = 45/256 (17%)

Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLR---EK----ITKGQREFESEVSLLGKIRHPNL 345
            +G+ T+G V+KA   +    VA+K++    EK    IT  +     E+ +L  ++H N+
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-----EIKILQLLKHENV 73

Query: 346 LAL-------RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR 398
           + L          Y   KG   LVF++  H  LA  L               K++K +  
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS--NKNVKFTLSEIKKVMKMLLN 130

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN------VNVIATAGA 452
           GL ++H N  I+H ++ ++N+L+      K++DFGL+R  + + N       N + T   
Sbjct: 131 GLYYIHRN-KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT--- 186

Query: 453 LGYRAPELSKLKKAN--TKTDVYSLGVTILELLT------GKSPGEPLNGAELPQWVASI 504
           L YR PEL  L + +     D++  G  + E+ T      G +    L    + Q   SI
Sbjct: 187 LWYRPPEL-LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT--LISQLCGSI 243

Query: 505 VKEEWTNEVFDLELMR 520
             E W   V  LEL +
Sbjct: 244 TPEVWPG-VDKLELFK 258

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 67/282 (23%), Positives = 127/282 (45%), Gaps = 43/282 (15%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLR--EKI-TKGQREFESEVSLLGKIRHPNLLALRA 350
           +G+  +  VY+AT L D   VA+K+++  E +  K +++   E+ LL ++ HPN++    
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++    E  +V +    G L+  + + +  +  I   T  K    +   + H+HS   +
Sbjct: 70  SFI-EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-V 127

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLM---TAAANVNVIATAGALGYRAPELSKLKKA 466
           +H ++  +NV +  +   K+ D GL R     T AA+    +  G   Y +PE       
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHENGY 183

Query: 467 NTKTDVYSLGVTILELLTGKSP--GEPLNGAELPQWVAS-----IVKEEWTNEVFDLELM 519
           N K+D++SLG  + E+   +SP  G+ +N   L Q +       +  E ++ ++ +L  M
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243

Query: 520 RDAPTIGDELLNTLKLALHCVDPSPSARPE---VLQVVQQLE 558
                              C+ P P  RP+   V Q+ +Q+ 
Sbjct: 244 -------------------CIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 33/243 (13%)

Query: 292 AEIMGKSTYGTVYKA-TLEDGSQ-VAVKRLREKITKGQREFES--EVSLLGKIR---HPN 344
           AEI G+  YG V+KA  L++G + VA+KR+R +  +      +  EV++L  +    HPN
Sbjct: 7   AEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 345 LLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
           ++ L       + ++     LVF+++    L T+L  + PE  +   T   ++  + RGL
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIKDMMFQLLRGL 123

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL 460
             LHS+  ++H +L   N+L+  S   K++DFGL+R+ +    +  +     L YRAPE+
Sbjct: 124 DFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEV 180

Query: 461 SKLKKANTKTDVYSLGVTILE------LLTGKSP----GEPLNGAELPQWVASIVKEEWT 510
                  T  D++S+G    E      L  G S     G+ L+   LP       +E+W 
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG------EEDWP 234

Query: 511 NEV 513
            +V
Sbjct: 235 RDV 237

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 56/284 (19%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLAL-RA 350
           +G   +G VYKA  ++   +A  ++ E  TK + E E    E+ +L    HP ++ L  A
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 351 YYLGPKGEKLLVFDYMPHGSL-ATFLHA-RGPETPIDWPTRMKII-KGMTRGLLHLHSNE 407
           +Y    G+  ++ ++ P G++ A  L   RG   P     ++++I + M   L +LHS +
Sbjct: 78  FYW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEP-----QIQVICRQMLEALQYLHSMK 130

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI----ATAGALGYRAPEL--- 460
            IIH +L + NVLL    + K++DFG+S     A NV  +    +  G   + APE+   
Sbjct: 131 -IIHRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 461 SKLKKA--NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
             +K    + K D++SLG+T++E+   + P   LN   +   +  I K            
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAKS----------- 230

Query: 519 MRDAPTIGD------ELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
             + PT+        E  + LK AL   D  P  RP   Q+++ 
Sbjct: 231 --EPPTLSQPSKWSMEFRDFLKTAL---DKHPETRPSAAQLLEH 269

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E++G  TYG VYK       Q+A  ++ +     + E + E+++L K  H   +A   YY
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA--TYY 69

Query: 353 -----LGPKG---EKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHL 403
                  P G   +  LV ++   GS+   + + +G     +W     I + + RGL HL
Sbjct: 70  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHL 127

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIATAGALGYRAPELSK 462
           H ++ +IH ++   NVLL ++   K+ DFG+S +L       N     G   + APE+  
Sbjct: 128 HQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIA 184

Query: 463 LKKA-----NTKTDVYSLGVTILELLTGKSP 488
             +      + K+D++SLG+T +E+  G  P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 10/198 (5%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA-LRA 350
           E +G+   GTVY A  +  G +VA++++  +    +    +E+ ++ + ++PN++  L +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y +G   E  +V +Y+  GSL   +     ET +D      + +   + L  LHSN+ +I
Sbjct: 86  YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 138

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           H ++ S N+LL    + K++DFG    +T   +       G   + APE+   K    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 197

Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 38/283 (13%)

Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLA 347
             +G+  +G VY+            VAVK  +   +   RE F  E  ++ +  HP+++ 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 348 LRAYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           L    +G   E    +V +  P G L ++L        +   + +     ++  L +L S
Sbjct: 72  L----IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLA--SLILYSYQLSTALAYLES 125

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK 465
            +  +H ++ + NVL+      K+ DFGLSR +   +          + + APE    ++
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRD 521
             + +DV+  GV + E+L  G  P          Q V +   I + E       L +  +
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPF---------QGVKNNDVIGRIENGER---LPMPPN 232

Query: 522 APTIGDELLNTL-KLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
            P        TL  L   C    PS RP   ++  QL +I  E
Sbjct: 233 CPP-------TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 293 EIMGKSTYGTVY---KATLED-GSQVAVKRLRE----KITKGQREFESEVSLLGKIRHPN 344
           +++G   YG V+   K T  D G   A+K L++    +  K      +E ++L  +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHL 403
            L    Y    + +  L+ DY+  G + T L+ R   +       ++   G +   L HL
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILALEHL 121

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
           H    I++ ++   N+LLD   +  ++DFGLS+   +       +  G + Y APE+ + 
Sbjct: 122 H-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 464 KKANTK-TDVYSLGVTILELLTGKSP 488
           K  + K  D +SLG+ I ELLTG SP
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 39/267 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLAL-R 349
           EI+G    GTVYKA  L     +AVK +   IT + Q++  SE+ +L K   P ++    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           A+++  +    +  ++M  GSL   ++ + PE         +I   + +GL +L S + I
Sbjct: 67  AFFV--ENRISICTEFMDGGSLD--VYRKIPE-----HVLGRIAVAVVKGLTYLWSLK-I 116

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA--GALGYRAPELSKLKKAN 467
           +H ++  SN+L++     K+ DFG+S  +     VN IA    G   Y APE    ++  
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQL-----VNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 468 TKTDVYSLGVTILELLTGKSPGEPL---NGAELP-QWVASIVKEEWTNEVFDLELMRDAP 523
             +DV+SLG++ +EL  G+ P   +    G+ +P Q +  IV E             D P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------------DPP 218

Query: 524 TIGDELLNT--LKLALHCVDPSPSARP 548
            +     +   +     C+   P  RP
Sbjct: 219 VLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 16/202 (7%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           ++G+ ++G        +  Q  A+K +R  K +    +   E  LL K++HPN++A +  
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLH-ARG---PE-TPIDWPTRMKIIKGMTRGLLHLHSN 406
           +    G   +V +Y   G L   +   RG   PE T + W  +M +      G+ H+H  
Sbjct: 67  FEA-DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH-E 118

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           + ++H ++ S N+ L  +   K+ DFG +RL+T+          G   Y  PE+ +    
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-ACTYVGTPYYVPPEIWENMPY 177

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           N K+D++SLG  + EL T K P
Sbjct: 178 NNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 38/214 (17%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLRE--------KITKGQREFESEVSLLGKIRHPNL 345
           +G+ +YG V+K    E G  VA+K+  E        KI         E+ +L +++HPNL
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL------REIRMLKQLKHPNL 62

Query: 346 LALRAYYLGPKGEKL-LVFDYMPHGSLATF-LHARG-PETPIDWPTRMKIIKGMTRGLLH 402
           + L   +   +  KL LVF+Y  H  L     + RG PE  I      KII    + +  
Sbjct: 63  VNLIEVF--RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQAVNF 115

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA--AANVNVIATAGALGYRAPEL 460
            H + N IH ++   N+L+      K+ DFG +R++T       + +AT     YRAPEL
Sbjct: 116 CHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---WYRAPEL 171

Query: 461 SKL---KKANTKTDVYSLGVTILELLTGKS--PG 489
             L    +     DV+++G    ELLTG+   PG
Sbjct: 172 --LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 8/103 (7%)

Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIAT 449
           K+   + + L +L     +IH ++  SN+LLD S N K+ DFG+S RL+ + A      +
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR---S 174

Query: 450 AGALGYRAPELSKLKKANTK----TDVYSLGVTILELLTGKSP 488
           AG   Y APE       N K     DV+SLG++++EL TG+ P
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 75/286 (26%), Positives = 126/286 (44%), Gaps = 38/286 (13%)

Query: 294 IMGKSTYGTVYKATLED-------GSQVAVKRLRE-KITKGQREFESEVSLLGKIRHPNL 345
            +G   +G VY+ T  D         +VAVK LR+    + ++EF  E  L+    HPN+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLH-ARGPETPIDWPTRMKIIK---GMTRGLL 401
           + L    L  +  + ++ + M  G L ++L  AR         T  +++     + +G +
Sbjct: 62  VKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNA-----KISDFGLSRLMTAAANVNVIATAGALGYR 456
           +L    + IH +L + N L+ +         KI DFGL+R +  +         G L  R
Sbjct: 121 YLE-QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK-EGEGLLPVR 178

Query: 457 --APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV 513
             APE     K  T++DV+S GV + E+LT G+ P   LN  E+ Q V +  +       
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR------- 231

Query: 514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
             L+   + P   D++     L  +C    PS RP   ++ + L+ 
Sbjct: 232 --LQKPENCP---DKIYQ---LMTNCWAQDPSERPTFDRIQEILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 47/283 (16%)

Query: 299 TYGTVYKATLEDGS-----QVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAYY 352
           T+G ++   L D       +V VK +++  ++ Q      E  LL  + H N+L +    
Sbjct: 18  TFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC 77

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK------GMTRGLLHLHSN 406
           +       +++ YM  G+L  FL  +      + P  +   +       +  G+ +LH  
Sbjct: 78  IEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMTAAANVNVIATAGALG---YR-----A 457
             +IH ++ + N ++D+    KI+D  LSR L     +         LG    R     A
Sbjct: 137 G-VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH--------CLGDNENRPVKWMA 187

Query: 458 PELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDL 516
            E    K+ ++ +DV+S GV + EL+T G++P               I   E    + D 
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTP------------YVEIDPFEMAAYLKDG 235

Query: 517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
             +       DEL   +          P  RP   Q+VQ L +
Sbjct: 236 YRLAQPINCPDELFAVMACCWAL---DPEERPSFSQLVQCLTD 275

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)

Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES--EVSLLGKIR---HPNL 345
           AEI G   YGTVYKA     G  VA+K +R +  +      +  EV+LL ++    HPN+
Sbjct: 6   AEI-GVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64

Query: 346 LALRAYYLGPKGEK----LLVFDYMPHGSLATFLH-ARGPETPIDWPTRMKIIKGMTRGL 400
           + L       + ++     LVF+++    L T+L     P  P +  T   +++   RGL
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE--TIKDLMRQFLRGL 121

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPE 459
             LH+N  I+H +L   N+L+      K++DFGL+R+ +    +  V+ T   L YRAPE
Sbjct: 122 DFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT---LWYRAPE 177

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGK 486
           +       T  D++S+G    E+   K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 29/254 (11%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G  ++G VY A  +     VA+K++    ++  +  ++   EV  L +I+HPN +  + 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            YL  +    LV +Y   GS +  L     + P+       I  G  +GL +LHS+ N+I
Sbjct: 93  CYL-REHTAWLVMEYC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH-NMI 147

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL---SKLKKAN 467
           H ++ + N+LL +    K++DFG S  + + AN  V    G   + APE+       + +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG-SASIASPANSFV----GTPYWMAPEVILAMDEGQYD 202

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVA-----SIVKEEWTNEVFDL------ 516
            K DV+SLG+T +EL   K P   +N       +A     ++   EW++   +       
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262

Query: 517 ELMRDAPTIGDELL 530
           ++ +D PT  +ELL
Sbjct: 263 KIPQDRPT-SEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 68/225 (30%), Positives = 97/225 (43%), Gaps = 59/225 (26%)

Query: 296 GKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFES---------EVSLLGKIRHPNL 345
           G   YG V  A   + G +VA+K+L        R F+S         E+ LL  + H N+
Sbjct: 24  GSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATF------LHARGPETPIDWPTRMK-------- 391
           + L           L VF   P  SL  F       H  G     D    +K        
Sbjct: 77  IGL-----------LDVF--TPASSLEDFQDVYLVTHLMGA----DLNNIVKCQKLSDDH 119

Query: 392 ---IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA 448
              ++  + RGL ++HS   IIH +L  SN+ +++    KI DFGL+R  T       +A
Sbjct: 120 IQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTGYVA 177

Query: 449 TAGALGYRAPELSKLKKANTKT-DVYSLGVTILELLTGKS--PGE 490
           T     YRAPE+        +T D++S+G  + ELLTGK+  PG 
Sbjct: 178 TR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 71/271 (26%), Positives = 127/271 (46%), Gaps = 35/271 (12%)

Query: 295 MGKSTYGTVYKATLEDGSQ-VAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G  ++G VY AT    ++ VAVK++    ++  +  ++   EV  L +++HPN +  + 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            YL  +    LV +Y   GS +  L     + P+       I  G  +GL +LHS+ N+I
Sbjct: 89  CYL-KEHTAWLVMEYC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH-NMI 143

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL---SKLKKAN 467
           H ++ + N+LL +    K++DFG S   ++ AN  V    G   + APE+       + +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFG-SASKSSPANSFV----GTPYWMAPEVILAMDEGQYD 198

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI-G 526
            K DV+SLG+T +EL   K P   +N       +A                  D+PT+  
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------------NDSPTLQS 242

Query: 527 DELLNTLK-LALHCVDPSPSARPEVLQVVQQ 556
           +E  ++ +    +C+   P  RP   ++++ 
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 69/254 (27%), Positives = 112/254 (44%), Gaps = 19/254 (7%)

Query: 294 IMGKSTYGTVYKATLE-DGSQVAVKRL---REKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++GK  +G V    +   G   A K+L   R K  KG+    +E  +L K+    +++L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL- 65

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           AY    K    LV   M  G L   ++  G E   +    +     +  GL  LH  E I
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH-QERI 123

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           ++ +L   N+LLDD  + +ISD GL+  +     +      G +GY APE+ K ++    
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRVGTVGYMAPEVVKNERYTFS 181

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
            D ++LG  + E++ G+SP +        + V  +VKE    E +  +   DA ++   L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VQEEYSEKFSPDARSLCKML 239

Query: 530 LNTLKLALHCVDPS 543
           L        C DP 
Sbjct: 240 L--------CKDPK 245

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 24/211 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-VAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLALR 349
           E +G+ TYG VYKA     ++ +A+K++R E+  +G       E+SLL +++H N++ L+
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG----MTRGLLHLHS 405
                 K    LVF+Y     L   L      +P D+    ++IK     + RG+ + HS
Sbjct: 68  DVVHSEK-RLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 406 NENIIHGNLTSSNVLLDDSTNA-KISDFGLSRL--MTAAANVNVIATAGALGYRAPE-LS 461
           +  ++H +L   N+L+D  TNA K++DFGL+R   +      + + T   L YRAPE L 
Sbjct: 121 HR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT---LWYRAPEILL 176

Query: 462 KLKKANTKTDVYSLGVTILELLTGKS--PGE 490
             +  +T  D++S+G    E++  K   PG+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207

Length = 294

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.4 bits (172), Expect = 7e-13
 Identities = 60/164 (36%), Positives = 86/164 (52%), Gaps = 7/164 (4%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N+LS  +P  L  LS L  + LS NKIS  +P ++  LS L  LD S N+I   L
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-EL 224

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
            +S SNL +L  L L +N L+D + +S+  L NL  L+L  NQIS    S++G+++ L  
Sbjct: 225 LSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRE 281

Query: 123 LDLSQNKLSGEIPASFS-NLKSLSSFNVSYNNLSGPVPTSLALK 165
           LDLS N LS  +P      L      N+     +  +  +  L 
Sbjct: 282 LDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILL 325

Length = 394

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)

Query: 293 EIMGKSTYGTVYKATLE--DGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLA 347
           E +G   YG V  A ++   G +VA+K++    +  T  +R    E+ +L   +H N++A
Sbjct: 11  ENIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIA 68

Query: 348 LRAYYLGPKGEK---LLVFDYMPHGSLATFLHARGP--ETPIDWPTRMKIIKGMTRGLLH 402
           +R     P  +     +V D M    L   +H+  P  E  I +      +  + RGL +
Sbjct: 69  IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-----FLYQLLRGLKY 122

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN------VIATAGALGYR 456
           +HS  N+IH +L  SN+L+++    +I DFG++R ++++   +       +AT     YR
Sbjct: 123 IHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT---RWYR 178

Query: 457 APELS-KLKKANTKTDVYSLGVTILELL 483
           APEL   L +  T  D++S+G    E+L
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 70/243 (28%), Positives = 107/243 (44%), Gaps = 15/243 (6%)

Query: 294 IMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFES----EVSLLGKIRHPNLLAL 348
           ++GK  +G V    +   G   A KRL +K  K +R+ ES    E  +L K+    ++ L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNL 65

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHLHSNE 407
            AY    K    LV   M  G L   ++  G   P     R       +  GL  LH  E
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLH-RE 121

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
           N ++ +L   N+LLDD  + +ISD GL+  +    ++      G +GY APE+   ++  
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR--GRVGTVGYMAPEVLNNQRYT 179

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
              D + LG  I E++ G+SP          + V   V E  T EV+  +   +A +I  
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE--TEEVYSAKFSEEAKSICK 237

Query: 528 ELL 530
            LL
Sbjct: 238 MLL 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 45/296 (15%)

Query: 294 IMGKSTYGTVYKAT------LEDGSQVAVKRLREKITKGQ-REFESEVSLLGKIRHPNLL 346
            +G+  +G V KAT          + VAVK L+E  +  + R+  SE +LL ++ HP+++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---GP----------ETPIDWPTRMKII 393
            L        G  LL+ +Y  +GSL +FL      GP           + +D P    + 
Sbjct: 67  KLYGA-CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 394 KGM--------TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMTAAANV 444
            G         +RG+ +L +   ++H +L + NVL+ +    KISDFGLSR +    + V
Sbjct: 126 MGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASI 504
                   + + A E        T++DV+S GV + E++T    G P  G   P+ + ++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--LGGNPYPGIA-PERLFNL 241

Query: 505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +K  +         M       +E+ N   L L C    P  RP    + ++LE++
Sbjct: 242 LKTGYR--------MERPENCSEEMYN---LMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLAL-RA 350
           +G   +G VYKA  ++   +A  ++ +  TK + E E    E+ +L    HPN++ L  A
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 351 YYLGPKGEKLLVFDYMPHGSL-ATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           +Y   +    ++ ++   G++ A  L     E P+  P    + K     L +LH N+ I
Sbjct: 71  FYY--ENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK-I 124

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI----ATAGALGYRAPEL----- 460
           IH +L + N+L     + K++DFG+S     A N   I    +  G   + APE+     
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLN 493
           SK +  + K DV+SLG+T++E+   + P   LN
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 33/208 (15%)

Query: 295 MGKSTYGTVYKATLEDGSQ-VAVKRL--REKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           +G  T+G V+           A+K +   E I   Q +   +E  +L ++ HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 351 YYLGPKGEKLL--VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR--------GL 400
            +     ++ L  + +Y+P G L ++L   G           +                L
Sbjct: 67  -FWTEHDQRFLYMLMEYVPGGELFSYLRNSG-----------RFSNSTGLFYASEIVCAL 114

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL 460
            +LHS E I++ +L   N+LLD   + K++DFG ++ +            G   Y APE+
Sbjct: 115 EYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----RTWTLCGTPEYLAPEV 169

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
            + K  N   D ++LG+ I E+L G  P
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVS----LLGKIRHPNLLA 347
           +++GK ++G V  A  + DG   AVK L++KI   ++E +  ++    LL  ++HP L+ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  +Y     EKL  V D++  G L  F H +  E     P        +   L +LHS 
Sbjct: 61  L--HYSFQTTEKLYFVLDFVNGGEL--FFHLQ-RERSFPEPRARFYAAEIASALGYLHS- 114

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
            NI++ +L   N+LLD   +  ++DFGL +   A ++       G   Y APE+ + +  
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT-TFCGTPEYLAPEVIRKQPY 173

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D + LG  + E+L G  P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G+  YG V  A   E   +VA+K++    +     +R    E+ LL  + H N++A++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71

Query: 351 YYLGPKGEKL----LVFDYMPHGSLATFLHA--RGPETPIDWPTRMKIIKGMTRGLLHLH 404
               P  E      +V++ M      T LH   R  +T  D   +  + + + RGL ++H
Sbjct: 72  IMPPPHREAFNDVYIVYELMD-----TDLHQIIRSSQTLSDDHCQYFLYQ-LLRGLKYIH 125

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN--VNVIATAGALGYRAPE-LS 461
           S  N++H +L  SN+LL+ + + KI DFGL+R  +   +     + T     YRAPE L 
Sbjct: 126 S-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---WYRAPELLL 181

Query: 462 KLKKANTKTDVYSLGVTILELLTGKS--PG 489
              +  T  DV+S+G    ELL  K   PG
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRLREKI---------TKGQREFESEVSLLGKIRHPN 344
           +GK T+G VY+   +D  ++ A+K L +K          T G+R       L      P 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL---DESPF 57

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKI-IKGMTRGLL 401
           ++ L+  +     +  LV DYM  G L   L   G   E       R K  I  +   L 
Sbjct: 58  IVGLKFSFQTDS-DLYLVTDYMSGGELFWHLQKEGRFSED------RAKFYIAELVLALE 110

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRAPEL 460
           HLH   +I++ +L   N+LLD + +  + DFGLS+  +T     N     G   Y APE+
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTEYLAPEV 167

Query: 461 SKLKKANTK-TDVYSLGVTILELLTGKSP 488
              +K  TK  D +SLGV + E+  G SP
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 53/226 (23%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALR 349
             +G+  YG V  AT    G +VA+K++   E  T  QR    E+ +L + +H N++ + 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGIL 69

Query: 350 AYYLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG---------- 395
                P  E      +V + M      T L+              K+IK           
Sbjct: 70  DIIRPPSFESFNDVYIVQELME-----TDLY--------------KLIKTQHLSNDHIQY 110

Query: 396 ----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-----VNV 446
               + RGL ++HS  N++H +L  SN+LL+ + + KI DFGL+R+     +        
Sbjct: 111 FLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Query: 447 IATAGALGYRAPELSKLKKANTKT-DVYSLGVTILELLTGKS--PG 489
           +AT     YRAPE+    K  TK  D++S+G  + E+L+ +   PG
Sbjct: 170 VATR---WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 19/185 (10%)

Query: 314 VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSL 371
           VAVK LR  +TK  R +F  E+ ++ ++++PN++ L    +    + L ++ +YM +G L
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV--SDDPLCMITEYMENGDL 104

Query: 372 ATFLHARGPETPIDWPTRMKIIKGMTRG-LLHLH----------SNENIIHGNLTSSNVL 420
             FL  R  E+     T    I  ++   LL++           ++ N +H +L + N L
Sbjct: 105 NQFLSQREIESTF---THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161

Query: 421 LDDSTNAKISDFGLSRLMTAAANVNVIATAG-ALGYRAPELSKLKKANTKTDVYSLGVTI 479
           + +    KI+DFG+SR + +     +   A   + + A E   L K  T +DV++ GVT+
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221

Query: 480 LELLT 484
            E+ T
Sbjct: 222 WEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 51/220 (23%), Positives = 102/220 (46%), Gaps = 25/220 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQ----VAVKRLREKITKGQREFES---EVSLLGKIRHPN 344
           +++G   +GTV+K   + +G      VA+K ++++   G++ F+     +  +G + H  
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAY 70

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGL 400
           ++ L     G   +  LV    P GSL   +        P+  ++W   ++I KGM    
Sbjct: 71  IVRLLGICPGASLQ--LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGM---- 122

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA-LGYRAPE 459
            +      ++H NL + N+LL   +  +I+DFG++ L+         +     + + A E
Sbjct: 123 -YYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 460 LSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
                +   ++DV+S GVT+ E+++ G  P   +   E+P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP 221

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 14/203 (6%)

Query: 293 EIMGKSTYGTVY---KATLEDGSQV-AVKRLREKITKGQREFES--EVSLLGKIRHPNLL 346
           +++G+ ++G V+   K T  D  Q+ A+K L++   K +    +  E  +L ++ HP ++
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHS 405
            L  Y    +G+  L+ D++  G L T L      T  D    +K  +  +   L HLHS
Sbjct: 62  KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALALDHLHS 116

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK 465
              II+ +L   N+LLD+  + K++DFGLS+           +  G + Y APE+   + 
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRG 174

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D +S GV + E+LTG  P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 20/188 (10%)

Query: 314 VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLA 372
           VAVK LR    K  R +F  EV +L +++ PN++ L    +  +    ++ +YM +G L 
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-EDPLCMITEYMENGDLN 107

Query: 373 TFLHAR----------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTS 416
            FL +                      I + + + +   +  G+ +L S+ N +H +L +
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL-SSLNFVHRDLAT 166

Query: 417 SNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG-ALGYRAPELSKLKKANTKTDVYSL 475
            N L+ ++   KI+DFG+SR + A     +   A   + + A E   + K  T +DV++ 
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226

Query: 476 GVTILELL 483
           GVT+ E+L
Sbjct: 227 GVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 64/267 (23%), Positives = 114/267 (42%), Gaps = 26/267 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKR--LREKITKGQREFESEVSLLGKIRHPNLLALRA 350
             +G+   G+V K  L++   +   +    +     Q++   E+ +    + P ++    
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLH------ARGPETPIDWPTRMKIIKGMTRGLLHL 403
            +L      + +  +Y   GSL +          R  E  +      KI + + +GL +L
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYL 121

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIATAGALGYRAPELSK 462
           HS   IIH ++  SN+LL      K+ DFG+S  L+ + A        G   Y APE  +
Sbjct: 122 HS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQ 176

Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
            K  +  +DV+SLG+T+LE+   + P  P    E    +  I    +   + + EL +D 
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPP----EGEPPLGPIELLSYIVNMPNPEL-KDE 231

Query: 523 PTIGDELLNTLKLAL-HCVDPSPSARP 548
           P  G +     K  +  C++  P+ RP
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 50/272 (18%)

Query: 314 VAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYMPH 368
           VAVK L++  T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y   
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYASK 105

Query: 369 GSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLT 415
           G+L  +L AR P             +  + +   +     + RG+ +L S +  IH +L 
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLA 164

Query: 416 SSNVLLDDSTNAKISDFGLSRLMTAAANVNVI-----ATAGAL--GYRAPELSKLKKANT 468
           + NVL+ ++   KI+DFGL+R      +VN I      T G L   + APE    +    
Sbjct: 165 ARNVLVTENNVMKIADFGLAR------DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           ++DV+S GV + E+ T       L G+  P     I  EE    + +   M       +E
Sbjct: 219 QSDVWSFGVLMWEIFT-------LGGSPYP----GIPVEELFKLLKEGHRMDKPANCTNE 267

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           L   ++   H +   PS RP   Q+V+ L+ I
Sbjct: 268 LYMMMRDCWHAI---PSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 11/153 (7%)

Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS--LATFLHARGPETPIDWPTRM 390
           E  LL  + HP+++ ++   L       +V   +PH S  L T+L  R    P+     +
Sbjct: 107 EAMLLQNVNHPSVIRMKDT-LVSGAITCMV---LPHYSSDLYTYLTKR--SRPLPIDQAL 160

Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA 450
            I K +  GL +LH+ + IIH ++ + N+ ++D     I D G ++    A     +  A
Sbjct: 161 IIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF--LGLA 217

Query: 451 GALGYRAPELSKLKKANTKTDVYSLGVTILELL 483
           G +   APE+    K N+K D++S G+ + E+L
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 60/168 (35%), Positives = 88/168 (52%), Gaps = 7/168 (4%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N +   +P+ L  L  L+ + LS N +S  +P  L  LS L  LD S N I+  L
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DL 201

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P     LS+L  L L +N++  ++L SL  L NLS L L  N++   +P +IGN+S L  
Sbjct: 202 PPEIELLSALEELDLSNNSI-IELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLET 259

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASS 170
           LDLS N++S    +S  +L +L   ++S N+LS  +P    L      
Sbjct: 260 LDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL 305

Length = 394

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 73/216 (33%), Positives = 96/216 (44%), Gaps = 31/216 (14%)

Query: 295 MGKSTYGTVYKATLEDG---SQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRA 350
           +G   +G V    +  G   +QV VK LR   + + Q +F  E      ++H NLL    
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC-- 60

Query: 351 YYLGPKGEK---LLVFDYMPHGSLATFLHA-RGPE--TPIDWPTRMKIIKGMTRGLLHLH 404
             LG   E    LLV ++ P G L  +L + R  E  TP D  T  ++   +  GLLHLH
Sbjct: 61  --LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLH 117

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG----ALGYRAPEL 460
            N N IH +L   N LL      KI D+GLS         +   T       L + APEL
Sbjct: 118 KN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE---DYYVTPDQLWVPLRWIAPEL 173

Query: 461 SKLKKAN------TK-TDVYSLGVTILELLT-GKSP 488
                 N      TK ++V+SLGVTI EL   G  P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 78/299 (26%), Positives = 128/299 (42%), Gaps = 58/299 (19%)

Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V +A          +    VAVK L++  T K   +  SE+ L+  I +H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 345 LLALRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG------ 395
           ++ L    LG    +G   ++ +Y   G+L  FL AR P  P       K+ +       
Sbjct: 80  IINL----LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 396 -------MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI- 447
                  + RG+ +L S    IH +L + NVL+ +    KI+DFGL+R       V+ I 
Sbjct: 136 LVSCAYQVARGMEYLES-RRCIHRDLAARNVLVTEDNVMKIADFGLAR------GVHDID 188

Query: 448 ----ATAGAL--GYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
                + G L   + APE    +    ++DV+S G+ + E+ T       L G+  P   
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT-------LGGSPYP--- 238

Query: 502 ASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             I  EE    + +   M        EL   ++   H V   P+ RP   Q+V+ L+++
Sbjct: 239 -GIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAV---PTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G VY A  +     VA+K++     +   +++    EV  L ++RHPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            YL  +    LV +Y   GS +  L     + P+       I  G  +GL +LHS+E I 
Sbjct: 83  CYL-REHTAWLVMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHERI- 137

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL---SKLKKAN 467
           H ++ + N+LL +    K++DFG S  + + AN  V    G   + APE+       + +
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFV----GTPYWMAPEVILAMDEGQYD 192

Query: 468 TKTDVYSLGVTILELLTGKSP 488
            K DV+SLG+T +EL   K P
Sbjct: 193 GKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 26/271 (9%)

Query: 296 GKSTYGTVYKATLEDGS-QVAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLLALRAYY 352
           GK    T Y  +  D   +VAVK L+      +RE   SE+ ++  +  H N++ L    
Sbjct: 49  GKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNL---- 104

Query: 353 LGP---KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           LG     G  L++ +Y  +G L  FL  R  E+ +     +     + +G+  L S +N 
Sbjct: 105 LGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAFLAS-KNC 162

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG-ALGYRAPELSKLKKANT 468
           IH +L + NVLL      KI DFGL+R +   +N  V   A   + + APE         
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF 222

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           ++DV+S G+ + E+ +       L     P      V  ++   + +   M        E
Sbjct: 223 ESDVWSYGILLWEIFS-------LGSNPYP---GMPVDSKFYKLIKEGYRMAQPEHAPAE 272

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
           + + +K    C D  P  RP   Q+VQ + +
Sbjct: 273 IYDIMK---TCWDADPLKRPTFKQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 16/207 (7%)

Query: 293 EIMGKSTYGTVY---KATLEDGSQVAVKRLREKIT-----KGQREFESEVSLLGKIRHPN 344
           +++G   YG V+   K +  D  ++   ++ +K T     K      +E  +L  IR   
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHL 403
            L    Y      +  L+ DY+  G L T L  R           ++I  G +   L HL
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
           H    II+ ++   N+LLD + +  ++DFGLS+           +  G + Y AP++ + 
Sbjct: 122 H-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 464 KKA--NTKTDVYSLGVTILELLTGKSP 488
                +   D +S+GV + ELLTG SP
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 16/183 (8%)

Query: 314 VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSL 371
           VAVK LRE   K  R +F  E+ ++ +++ PN++ L A  +    + L ++ +YM +G L
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI--TSDPLCMITEYMENGDL 106

Query: 372 ATFLHARGPETP--------IDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD 423
             FL    P+          I + T + +   +  G+ +L S+ N +H +L + N L+  
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL-SSLNFVHRDLATRNCLVGK 165

Query: 424 STNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKANTKTDVYSLGVTILE 481
           +   KI+DFG+SR + +     +   A  L  R  + E   L K  T +DV++ GVT+ E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRA-VLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 482 LLT 484
           +LT
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVS-LLGKIRHPNLLA 347
           +++GK ++G V  A  + DGS  AVK L++K     K Q    +E + LL  ++HP L+ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L   +     EKL  V DY+  G L  F H +     ++   R    + +   + +LHS 
Sbjct: 61  LHYSFQTA--EKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS- 114

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELSKLKK 465
            NII+ +L   N+LLD   +  ++DFGL +           +T  G   Y APE+ + + 
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
            +   D + LG  + E+L G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 18/200 (9%)

Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT +  G QVAVK++  +  + +    +EV ++    H N++ +   YL
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + R L +LH N+ +IH
Sbjct: 90  --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH-NQGVIH 141

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPELSKLKKANT 468
            ++ S ++LL      K+SDFG      A  +  V      +G   + APE+       T
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF----CAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 469 KTDVYSLGVTILELLTGKSP 488
           + D++SLG+ ++E++ G+ P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 26/222 (11%)

Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G+  YG V+ A  +D G  VA+KR+++ +     E     +E  +L   +   L+ L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-- 66

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            Y     E L L  +Y+P G   T L+  G     +   R  + + M   +  LH     
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAE-MFEAVDALH-ELGY 122

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           IH +L   N L+D S + K++DFGLS+ +   AN  V    G+  Y APE+ + K  +  
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRGKGYDFT 178

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN 511
            D +SLG  + E L G            P +  S   E W N
Sbjct: 179 VDYWSLGCMLYEFLCG-----------FPPFSGSTPNETWEN 209

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 18/219 (8%)

Query: 295 MGKSTYGTVYKA---TLEDGSQVAVKRLREKITKG--QREFESEVSLLGKIRHPNLLALR 349
           +G   +GTV K      +    VAVK L+        + E   E +++ ++ +P ++ + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61

Query: 350 AYYLGP-KGEK-LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G  + E  +LV +    G L  FL      T  +     +++  ++ G+ +L    
Sbjct: 62  ---IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNI---TELVHQVSMGMKYLEET- 114

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA--LGYRAPELSKLKK 465
           N +H +L + NVLL     AKISDFGLS+ + A  N     T G   + + APE     K
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVAS 503
            ++K+DV+S GV + E  + G+ P + + G E+ Q + S
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 13/213 (6%)

Query: 293 EIMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLG-KIRHPNLLA 347
           +++GK ++G V+ A L+  +Q  A+K L++ +     + E    E  +L     HP L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L   +   K     V +Y+  G L    H +      D P        +  GL  LHS +
Sbjct: 61  LYCTF-QTKENLFFVMEYLNGGDL--MFHIQSCHK-FDLPRATFYAAEIICGLQFLHS-K 115

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRAPELSKLKKA 466
            I++ +L   N+LLD   + KI+DFG+ +  M   A        G   Y APE+   +K 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--GTPDYIAPEILLGQKY 173

Query: 467 NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
           NT  D +S GV + E+L G+SP    +  EL Q
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.6 bits (152), Expect = 8e-11
 Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 7/178 (3%)

Query: 311 GSQVAVKRLREKITKGQ-REFESEVSLLGKIRHPNLLALRAYYLGPKGEKL-LVFDYMPH 368
           G QVAVK L+ +       + + E+ +L  + H N++  +       G  + L+ +++P 
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAK 428
           GSL  +L     +  I+   ++K    + +G+ +L S    +H +L + NVL++     K
Sbjct: 93  GSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVK 149

Query: 429 ISDFGLSRLMTAAANVNVIAT--AGALGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           I DFGL++ +        +       + + APE     K    +DV+S GVT+ ELLT
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 10/94 (10%)

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALG 454
           GL  LH    II+ +L   NVLLD   + KI+DFG+ +      N+N    A    G   
Sbjct: 108 GLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-----NMNGEGKASTFCGTPD 161

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           Y APE+ K +K N   D +S GV + E+L G+SP
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 21/202 (10%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFES--EVSLLGKIRHPNLLALR 349
           E +G+ +Y TVYK   + +G  VA+K +R +  +G   F +  E SLL  ++H N++ L 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLH 69

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKI-IKGMTRGLLHLHSN 406
              +  K    LVF+Y+ H  L  ++  H  G       P  +K+ +  + RGL ++H  
Sbjct: 70  DI-IHTKETLTLVFEYV-HTDLCQYMDKHPGGLH-----PENVKLFLFQLLRGLSYIH-Q 121

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE-LSKL 463
             I+H +L   N+L+ D+   K++DFGL+R  +  ++   N + T   L YR P+ L   
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVT---LWYRPPDVLLGS 178

Query: 464 KKANTKTDVYSLGVTILELLTG 485
            + +T  D++ +G   +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 34/209 (16%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEV---------SLLGKIRHPN 344
           +G   YG+V  A     G +VA+K+L        R F+SE+         +LL  ++H N
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 345 LLALRAYYL-GPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           ++ L   +     G++     LV  YM    L   +     E  + +     ++  M  G
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQY-----LVYQMLCG 129

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE 459
           L ++HS   IIH +L   N+ +++    KI DFGL+R   A     V+       YRAPE
Sbjct: 130 LKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----WYRAPE 184

Query: 460 -LSKLKKANTKTDVYSLGVTILELLTGKS 487
            +      N   D++S+G  + E+LTGK+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 15/202 (7%)

Query: 294 IMGKSTYGTV----YKATLEDGSQVAVKRL---REKITKGQREFESEVSLLGKIRHPNLL 346
           ++GK  +G V     +AT   G   A K+L   R K  KG+    +E  +L K+    ++
Sbjct: 7   VLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVV 63

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           +L AY    K    LV   M  G L   ++  G     D    +     +  GL  L   
Sbjct: 64  SL-AYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ-R 120

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           E I++ +L   N+LLDD  + +ISD GL+  +     V      G +GY APE+   +K 
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR--GRVGTVGYMAPEVINNEKY 178

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D + LG  I E++ G+SP
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 47/219 (21%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL-- 81

Query: 351 YYLGPKGEKLLVFDYMPHGSLATF------LHARGPETPIDWPTRMK-----------II 393
                    L VF   P  SL  F       H  G     D    +K           +I
Sbjct: 82  ---------LDVFT--PARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLI 126

Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGAL 453
             + RGL ++HS  +IIH +L  SN+ +++    KI DFGL+R  T       +AT    
Sbjct: 127 YQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATR--- 181

Query: 454 GYRAPELS-KLKKANTKTDVYSLGVTILELLTGKS--PG 489
            YRAPE+       N   D++S+G  + ELLTG++  PG
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 12/144 (8%)

Query: 357 GEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
           GE  +  ++M  GSL   L   G  PE         KI   + RGL +L     I+H ++
Sbjct: 72  GEISICMEHMDGGSLDQVLKKAGRIPE-----NILGKISIAVLRGLTYLREKHKIMHRDV 126

Query: 415 TSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVY 473
             SN+L++     K+ DFG+S +L+ + AN  V    G   Y +PE  +      ++D++
Sbjct: 127 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYTVQSDIW 182

Query: 474 SLGVTILELLTGKSPGEPLNGAEL 497
           SLG++++E+  G+ P  P +  EL
Sbjct: 183 SLGLSLVEMAIGRYPIPPPDAKEL 206

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 22/204 (10%)

Query: 299 TYGTVYKATLEDGSQVAVKR--LREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPK 356
               + K      + VAVK+  L     +  +  + E+    +++HPN+L     ++   
Sbjct: 14  MIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-D 71

Query: 357 GEKLLVFDYMPHGS----LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
            E  +V   M +GS    L T      PE  I +     I+K +   L ++HS    IH 
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIHSK-GFIHR 125

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV------IATAGALGYRAPEL--SKLK 464
           ++ +S++LL       +S    S  M               ++   L + +PE+    L+
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ 185

Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
             N K+D+YS+G+T  EL  G  P
Sbjct: 186 GYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 18/204 (8%)

Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KA+   G   A+K L++++   + E     +E  +L   RHP L
Sbjct: 1   KLLGKGTFGKVILVREKAS---GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            +L+ Y    K     V +Y+  G L  F H        +  TR    + +   L +LHS
Sbjct: 58  TSLK-YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAE-IVSALDYLHS 113

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRAPELSKLK 464
            + I++ +L   N++LD   + KI+DFGL +  +T AA +      G   Y APE+ +  
Sbjct: 114 GK-IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--CGTPEYLAPEVLEDN 170

Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
                 D + LGV + E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 15/169 (8%)

Query: 333 EVSLLGKIRHPNLLALR-AYYLGPKGEKLLVFDYMPHGSLATFLHA--RGPETPIDWPTR 389
           E+ +L +   P ++    A+Y    GE  +  ++M  GSL   L    R PE  +     
Sbjct: 53  ELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---- 106

Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIA 448
            K+   + RGL +L     I+H ++  SN+L++     K+ DFG+S +L+ + AN  V  
Sbjct: 107 -KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-- 163

Query: 449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
             G   Y +PE  +    + ++D++S+G++++EL  G+ P  P +  EL
Sbjct: 164 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 27/267 (10%)

Query: 294 IMGKSTYGTVYKATLEDGSQ----VAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLAL 348
           I+G   +G + +  L+  S+    VA+  LR   + K +R F +E   LG+  H N++ L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 349 RAYYLGPKGEKLL-VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
                  +G  ++ V +YM +G+L +FL  R  E  +     M ++ G+  G+ +L S  
Sbjct: 72  EGVI--TRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL-SEM 126

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
             +H  L +  VL++     KIS F   +   + A    ++    + + APE  +    +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 468 TKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG 526
           + +DV+S G+ + E+++ G+ P   ++G ++ + V          + F L   R+ P   
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV---------EDGFRLPAPRNCP--- 234

Query: 527 DELLNTLKLALHCVDPSPSARPEVLQV 553
             LL+  +L L C       RP   Q+
Sbjct: 235 -NLLH--QLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 294 IMGKSTYGTVYKATLEDGSQ----VAVKRLRE-KITKGQREF---ESEVSLLGKIRHPNL 345
           ++GK  YG V++     G+      A+K L++  I + Q++    ++E ++L  ++HP +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L  Y     G+  L+ +Y+  G L   L   G        T    +  ++  L HLH 
Sbjct: 63  VDL-IYAFQTGGKLYLILEYLSGGELFMHLEREGIFME---DTACFYLSEISLALEHLHQ 118

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK 465
            + II+ +L   N+LLD   + K++DFGL +       V      G + Y APE+     
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH-TFCGTIEYMAPEILMRSG 176

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D +SLG  + ++LTG  P
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 35/209 (16%)

Query: 295 MGKSTYGTV-YKATLEDGSQVAVKRLREKITKGQREFES---------EVSLLGKIRHPN 344
           +G   YGTV        G++VA+K+L        R F+S         E+ LL  ++H N
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMKHEN 75

Query: 345 LLALRAYY-----LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           ++ L   +     L    +  LV  +M         H +  E  I +     ++  M +G
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-----LVYQMLKG 130

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE 459
           L ++H+   IIH +L   N+ +++    KI DFGL+R   +     V+       YRAPE
Sbjct: 131 LKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----WYRAPE 185

Query: 460 --LSKLKKANTKTDVYSLGVTILELLTGK 486
             L+ +    T  D++S+G  + E+LTGK
Sbjct: 186 VILNWMHYTQT-VDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 294 IMGKSTYGTVYKATLED-GSQVAVKRL---REKITKGQREFESE---VSLLGKIRHPNLL 346
           I+G+  +G VY     D G   A+K L   R K+ +G+    +E   +SL+     P ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHLH 404
            +   +  P  +KL  + D M  G L   L   G  +  +    M+     +  GL H+H
Sbjct: 61  CMTYAFHTP--DKLCFILDLMNGGDLHYHLSQHGVFSEKE----MRFYATEIILGLEHMH 114

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKL 463
            N  +++ +L  +N+LLD+  + +ISD GL+      +     A+ G  GY APE L K 
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKG 170

Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
              ++  D +SLG  + +LL G SP
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 60.3 bits (147), Expect = 6e-10
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 293 EIMGKSTYGTVYKATLEDGSQV-AVKRL-REKITKGQREFE---SEVSLLGKIRHPNLLA 347
           + +G  ++G V     +   +  A+K L + KI K  ++ E   +E  +L  IRHP L+ 
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRHPFLVN 65

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLH 404
           L   +       L LV +Y+P G L + L   G  PE     P        +   L +LH
Sbjct: 66  LYGSFQDDS--NLYLVMEYVPGGELFSHLRKSGRFPE-----PVARFYAAQVVLALEYLH 118

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLS-----RLMTAAANVNVIATAGALGYRAPE 459
           S  +I++ +L   N+LLD     KI+DFG +     R  T           G   Y APE
Sbjct: 119 SL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT---------LCGTPEYLAPE 168

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   K      D ++LG+ I E+L G  P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 75/274 (27%), Positives = 120/274 (43%), Gaps = 50/274 (18%)

Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 106

Query: 367 PHGSLATFLHARGPE------TPIDWPTRMKIIKGM-------TRGLLHLHSNENIIHGN 413
             G+L  +L AR P        P   P      K +        RG+ +L S +  IH +
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-CIHRD 165

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI-----ATAGAL--GYRAPELSKLKKA 466
           L + NVL+ +    KI+DFGL+R      +++ I      T G L   + APE    +  
Sbjct: 166 LAARNVLVTEDNVMKIADFGLAR------DIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219

Query: 467 NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG 526
             ++DV+S GV + E+ T       L G+  P     +  EE    + +   M       
Sbjct: 220 THQSDVWSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCT 268

Query: 527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 269 NELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 68/284 (23%), Positives = 131/284 (46%), Gaps = 39/284 (13%)

Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    +++ 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 348 LRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPET---PIDWPTRMKIIKGMT---- 397
           L    LG   +G+  L++ + M  G L ++L +  PE    P+  P  +K +  M     
Sbjct: 74  L----LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR- 456
            G+ +L++N+  +H +L + N ++ +    KI DFG++R +    +       G L  R 
Sbjct: 130 DGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRW 187

Query: 457 -APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
            +PE  K     T +DV+S GV + E+ T     +P  G         +  E+    V +
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQG---------MSNEQVLRFVME 236

Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
             L+       D L   +++   C   +P  RP  L+++  ++E
Sbjct: 237 GGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 41/169 (24%), Positives = 69/169 (40%), Gaps = 9/169 (5%)

Query: 322 KITKGQREFESEVSLLGKIRHPNLL-ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGP 380
           K   G +    E+ +L  I H  ++  + AY          V   MP      F +    
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHAYRWKS-----TVCMVMPKYKCDLFTYVDRS 179

Query: 381 ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA 440
             P+     + I + +   L +LH    IIH ++ + N+ LD+  NA + DFG +  + A
Sbjct: 180 G-PLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237

Query: 441 AANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
             +       +G L   +PEL  L     KTD++S G+ + E+      
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 17/211 (8%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKG--QREFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +    +  ++L     K   + +   E+ +L +   P ++    A+
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  +      K+   + +GL +L     I
Sbjct: 73  Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHKI 125

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           +H ++  SN+L++     K+ DFG+S +L+ + AN  V    G   Y +PE  +    + 
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSV 181

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
           ++D++S+G++++E+  G+ P  P +  EL  
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 9e-10
 Identities = 35/88 (39%), Positives = 55/88 (62%), Gaps = 2/88 (2%)

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPEL 460
           H+HS +++IH ++ S+N+LL  +   K+ DFG S++  A  + +V  T  G   Y APE+
Sbjct: 158 HVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
            + K  + K D++SLGV + ELLT K P
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 39/213 (18%)

Query: 294 IMGKSTYGTVYKATLE-DGSQVAVKRL--------REKITKGQREFESEVSLLGKIRHPN 344
            +G    GTVYK      G   A+K +        R +I +       E+ +L  + HPN
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR-------EIEILRDVNHPN 133

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPI-DWPTRMKIIKGMTRGLLHL 403
           ++     +    GE  ++ ++M  GSL          T I D      + + +  G+ +L
Sbjct: 134 VVKCHDMF-DHNGEIQVLLEFMDGGSLEG--------THIADEQFLADVARQILSGIAYL 184

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA---ANVNVIATAGALGYRAPE- 459
           H   +I+H ++  SN+L++ + N KI+DFG+SR++       N +V    G + Y +PE 
Sbjct: 185 HR-RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----GTIAYMSPER 239

Query: 460 ----LSKLKKANTKTDVYSLGVTILELLTGKSP 488
               L+         D++SLGV+ILE   G+ P
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K LR+++   + E     +E  +L   RHP L
Sbjct: 1   KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 58  TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 113

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRAPELSKLK 464
             ++++ ++   N++LD   + KI+DFGL +  ++  A +      G   Y APE+ +  
Sbjct: 114 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLEDN 170

Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
                 D + LGV + E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 23/206 (11%)

Query: 294 IMGKSTYGTVYKAT-LEDGSQVAVKRLREKIT---KGQREFESEVS-LLGKIRHPNLLAL 348
           ++GK ++G V  A    DG   AVK L++K     K Q+   +E + LL  ++HP L+ L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLH----ARGPETPIDWPTRMKIIKG-MTRGLLH 402
              +     +KL  V DY+  G L  F H       PE       R +     +   L +
Sbjct: 62  HYSFQTA--DKLYFVLDYVNGGEL--FFHLQRERSFPEP------RARFYAAEIASALGY 111

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSK 462
           LHS  NII+ +L   N+LLD   +  ++DFGL +      +       G   Y APE+ +
Sbjct: 112 LHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +  +   D + LG  + E+L G  P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 50/205 (24%), Positives = 99/205 (48%), Gaps = 16/205 (7%)

Query: 294 IMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQREFES----EVSLLGKIRHPNLLAL 348
           ++G+  YG V K   ++  + VA+K+ ++  ++   E +     E+ +L  ++  N++ L
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK-IIKGMTRGLLHLHSNE 407
           +  +   +G+  LVF+Y+    L   L       P   P +++  I  + + +   H N+
Sbjct: 66  KEAFR-RRGKLYLVFEYVEKNMLE-LLEEMPNGVP---PEKVRSYIYQLIKAIHWCHKND 120

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
            I+H ++   N+L+  +   K+ DFG +R ++  +N N         YR+PEL       
Sbjct: 121 -IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
              D++S+G  + EL  G+   PGE
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGE 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 294 IMGKSTYGTVYKATLED-GSQVAVKRL---REKITKGQREFESE---VSLLGKIRHPNLL 346
           I+G+  +G VY     D G   A+K L   R K+ +G+    +E   +SL+     P ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHLH 404
            +   +  P  +KL  + D M  G L   L   G  +  +    M+     +  GL H+H
Sbjct: 61  CMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAE----MRFYAAEIILGLEHMH 114

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKL 463
            N  +++ +L  +N+LLD+  + +ISD GL+      +     A+ G  GY APE L K 
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKG 170

Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
              ++  D +SLG  + +LL G SP
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 15/182 (8%)

Query: 311 GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF-DYMPHG 369
           G QVAVK +  +  + +    +EV ++   +H N++ +   YL   GE+L V  +++  G
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQGG 103

Query: 370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKI 429
           +L   +     +T ++      + + + + L +LHS + +IH ++ S ++LL      K+
Sbjct: 104 ALTDIV----SQTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDGRVKL 158

Query: 430 SDFGLSRLMTAAANVNVIATAGALG---YRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
           SDFG      A  + +V      +G   + APE+       T+ D++SLG+ ++E++ G+
Sbjct: 159 SDFGF----CAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Query: 487 SP 488
            P
Sbjct: 215 PP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 18/183 (9%)

Query: 311 GSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-----EKLLV 362
           G  VAVK+L    +  T  +R +  E+ LL  + H N+++L   +   K      +  LV
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104

Query: 363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD 422
            + M   +L   +H       +D      ++  M  G+ HLHS   IIH +L  SN+++ 
Sbjct: 105 MELM-DANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK 157

Query: 423 DSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILEL 482
                KI DFGL+R  TA  N  +        YRAPE+          D++S+G  + EL
Sbjct: 158 SDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Query: 483 LTG 485
           + G
Sbjct: 216 VKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)

Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K L++++   + E     +E  +L   RHP L
Sbjct: 1   KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 58  TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLHS 113

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRAPELSKLK 464
            +N+++ +L   N++LD   + KI+DFGL +  +   A +      G   Y APE+ +  
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYLAPEVLEDN 171

Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
                 D + LGV + E++ G+ P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 26/220 (11%)

Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRAYY 352
           +G+ TY TV+K   +   + VA+K +R +  +G       EVSLL  ++H N++ L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK-GMTRGLLHLHSNENIIH 411
           +  +    LVF+Y+    L  +L   G    +     +KI    + RGL + H  + I+H
Sbjct: 72  IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCHKRK-ILH 126

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE-LSKLKKANT 468
            +L   N+L+++    K++DFGL+R  +       N + T   L YR P+ L    + +T
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT---LWYRPPDVLLGSTEYST 183

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE 508
             D++ +G  + E+ TG+           P +  S VKEE
Sbjct: 184 PIDMWGVGCILYEMATGR-----------PMFPGSTVKEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 11/210 (5%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVS----LLGKIRHPNLLA 347
           +++GK ++G V  A  + +    AVK L++K    ++E +  +S    LL  ++HP L+ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L  +      +   V DY+  G L  F H +     ++   R    + +   L +LHS  
Sbjct: 61  LH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS-L 115

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
           NI++ +L   N+LLD   +  ++DFGL +      N       G   Y APE+   +  +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
              D + LG  + E+L G  P    N AE+
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 17/203 (8%)

Query: 295 MGKSTYGTVYK--ATLEDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRAY 351
           +G+ TY TVYK  + L D + VA+K +R +  +G       EVSLL  ++H N++ L   
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
            +  +    LVF+Y+    L  +L   G    I+       +  + RGL + H    ++H
Sbjct: 73  -IHTEKSLTLVFEYLDK-DLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH-RRKVLH 127

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE-LSKLKKANT 468
            +L   N+L+++    K++DFGL+R  +       N + T   L YR P+ L      +T
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT---LWYRPPDILLGSTDYST 184

Query: 469 KTDVYSLGVTILELLTGKS--PG 489
           + D++ +G    E+ TG+   PG
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 18/200 (9%)

Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT++  G  VAVK++  +  + +    +EV ++   +H N++ +   YL
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + + L  LH+ + +IH
Sbjct: 88  --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHA-QGVIH 139

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPELSKLKKANT 468
            ++ S ++LL      K+SDFG      A  +  V      +G   + APEL        
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195

Query: 469 KTDVYSLGVTILELLTGKSP 488
           + D++SLG+ ++E++ G+ P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 73/269 (27%), Positives = 118/269 (43%), Gaps = 44/269 (16%)

Query: 314 VAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYMPH 368
           VAVK L++  T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y   
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL----LGACTQDGPLYVLVEYASK 102

Query: 369 GSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLT 415
           G+L  +L AR P             E  + +   +     + RG+ +L S +  IH +L 
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLA 161

Query: 416 SSNVLLDDSTNAKISDFGLSRLMTAAANVNVI--ATAGAL--GYRAPELSKLKKANTKTD 471
           + NVL+ +    KI+DFGL+R      N++     T G L   + APE    +    ++D
Sbjct: 162 ARNVLVTEDNVMKIADFGLAR---DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218

Query: 472 VYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLN 531
           V+S GV + E+ T       L G+  P     I  EE    + +   M        EL  
Sbjct: 219 VWSFGVLLWEIFT-------LGGSPYP----GIPVEELFKLLKEGHRMDKPANCTHELYM 267

Query: 532 TLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            ++   H V   PS RP   Q+V+ L+ +
Sbjct: 268 IMRECWHAV---PSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 52.2 bits (126), Expect = 5e-09
 Identities = 22/59 (37%), Positives = 33/59 (55%)

Query: 24 LQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL 82
          L+ + LS+N+++ +       L  L++LD S N +    P +FS L SL SL L  NNL
Sbjct: 2  LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 295 MGKSTYGTVYKATLEDGS--QVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALR 349
           +G  ++G V  AT ++     VA+KR  +     Q++ +   SE  +L  I HP  + L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 350 AYYLGPKGEKLL--VFDYMPHGSLATFLHARGPETPID----WPTRMKIIKGMTRGLLHL 403
             +   K E  L  V +++  G   TFL  R    P D    +  ++ +I    + L   
Sbjct: 98  GSF---KDESYLYLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQSL--- 150

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
               NI++ +L   N+LLD     K++DFG ++++    +       G   Y APE+   
Sbjct: 151 ----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV----DTRTYTLCGTPEYIAPEILLN 202

Query: 464 KKANTKTDVYSLGVTILELLTGKSP---GEPL 492
                  D ++LG+ I E+L G  P    EPL
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 31/209 (14%)

Query: 294 IMGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           I+G  ++G VY+A   D S +VA+K++ +      R    E+ ++  + H N++ L+ YY
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYY 128

Query: 353 LGP---KGEKLL----VFDYMPHGSLATFLH-ARGPETPIDWPTRMKIIK----GMTRGL 400
                 K EK +    V +++P        H AR           + ++K     + R L
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA-----LPLFLVKLYSYQLCRAL 183

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNA-KISDFGLSR-LMTAAANVNVIATAGALGYRAP 458
            ++HS + I H +L   N+L+D +T+  K+ DFG ++ L+    +V+ I +     YRAP
Sbjct: 184 AYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAP 239

Query: 459 ELSKLKKAN--TKTDVYSLGVTILELLTG 485
           EL  L   N  T  D++SLG  I E++ G
Sbjct: 240 EL-MLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 5/164 (3%)

Query: 8   NNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFS 67
           +N    +P+SL +L  L  +S S         + L  L  L  LD + N +  ++     
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLP-LPSLDLNLNRLRSNISELL- 113

Query: 68  NLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ 127
            L++L SL L++NN+ D          NL  L+L  N+I   +PS + N+  L  LDLS 
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172

Query: 128 NKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSF 171
           N LS ++P   SNL +L++ ++S N +S  +P  + L       
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214

Length = 394

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 19/214 (8%)

Query: 293 EIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFE---SEVSLLGKIR-HPNLLA 347
            ++GK ++G V  A L E G   AVK L++ +     + E   +E  +L   R HP L  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 348 LRAYYLGPKGEKLL-VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y      ++L  V +++  G L    H +      D          +T  L+ LH  
Sbjct: 61  L--YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRR-FDEARARFYAAEITSALMFLHD- 114

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA---GALGYRAPELSKL 463
           + II+ +L   NVLLD   + K++DFG    M      N   T+   G   Y APE+ + 
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
                  D +++GV + E+L G +P E  N  +L
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)

Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +GK ++G V +    D  ++ A+K +R+     + E     +E ++L ++  P ++ L+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHSNEN 408
            +  P  EKL LV  ++  G L   L   G        +R +     +   L +LH   N
Sbjct: 61  SFQSP--EKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTAELLCALENLHK-FN 113

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRAPELSKLKKAN 467
           +I+ +L   N+LLD   +  + DFGL +L M      N     G   Y APEL  L    
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEYLAPEL-LLGHGY 170

Query: 468 TK-TDVYSLGVTILELLTGKSP 488
           TK  D ++LGV + E+LTG  P
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 293 EIMGKSTYGTVYKATLED--------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPN 344
           E +G+ T+  ++K    +         ++V +K L +        F    S++ ++ H +
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           L+      +    E ++V +Y+  GSL T+L        I W  ++++ K +   L  L 
Sbjct: 61  LVLNYGVCVCG-DESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117

Query: 405 SNENIIHGNLTSSNVLL----DDSTNA----KISDFGLSRLMTAAANVNVIATAGALG-- 454
               + HGN+ + NVLL    D  T      K+SD G+S        + V+     L   
Sbjct: 118 DK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--------ITVLPKEILLERI 168

Query: 455 -YRAPE-LSKLKKANTKTDVYSLGVTILELLTG 485
            +  PE +   +  +   D +S G T+ E+ +G
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 17/202 (8%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLA--- 347
           +G   +G V+  T   DG +VA+K++    + +   +R F  E+ +L   +H N+L+   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66

Query: 348 -LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHS 405
            L+  ++ P  E  +V + M    L   + +  P +       +K+ +  + RGL +LHS
Sbjct: 67  ILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSS----DHVKVFLYQILRGLKYLHS 121

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKLK 464
              I+H ++   N+L++ +   KI DFGL+R+     + ++        YRAPE L   +
Sbjct: 122 -AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR 180

Query: 465 KANTKTDVYSLGVTILELLTGK 486
              +  D++S+G    ELL  +
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 69/288 (23%), Positives = 132/288 (45%), Gaps = 40/288 (13%)

Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 348 LRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPID----WPTRMKIIK---GMT 397
           L    LG   KG+  L+V + M HG L ++L +  PE   +     PT  ++I+    + 
Sbjct: 74  L----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR- 456
            G+ +L++ +  +H +L + N ++      KI DFG++R +    +       G L  R 
Sbjct: 130 DGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRW 187

Query: 457 -APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
            APE  K     T +D++S GV + E+ +     +P  G         +  E+    V D
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQG---------LSNEQVLKFVMD 236

Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL-EEIRP 562
              +       + + + +++   C   +P  RP  L++V  L +++ P
Sbjct: 237 GGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHP 281

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 11/198 (5%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFES--EVSLLGKIRHPNLLALR 349
           E +G+ +Y TVYK     +G  VA+K +  K  +G   F +  E SLL  ++H N++ L 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  K     VF+YM H  LA ++  + P     +  R+ + + + RGL ++H  ++I
Sbjct: 70  DI-IHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRLFMFQ-LLRGLAYIH-GQHI 124

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKLKKANT 468
           +H +L   N+L+      K++DFGL+R  +  +     +    L YR P+ L      ++
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSS 183

Query: 469 KTDVYSLGVTILELLTGK 486
             D++  G   +E+L G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREK---ITKGQREFESEVSLLGKIRHPNLLAL 348
           E +G  ++G V  A  +  G   A+K L+++     K  +    E S+L ++ HP ++ +
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL----HLH 404
              +   +     + +++  G L T L   G   P D      + K     L+    +LH
Sbjct: 84  MCSFQD-ENRVYFLLEFVVGGELFTHLRKAG-RFPND------VAKFYHAELVLAFEYLH 135

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK 464
            +++II+ +L   N+LLD+  + K++DFG ++ +            G   Y APE+ + K
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----RTFTLCGTPEYLAPEVIQSK 190

Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
                 D +++GV + E + G  P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K L++++   + E     +E  +L   RHP L
Sbjct: 1   KLLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM---KIIKGMTRGLLH 402
            AL+ Y          V +Y   G L  F H        +   R    +I+  +     +
Sbjct: 58  TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALG----Y 110

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRAPELS 461
           LHS  ++++ +L   N++LD   + KI+DFGL +  ++  A +      G   Y APE+ 
Sbjct: 111 LHS-CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVL 167

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           +        D + LGV + E++ G+ P
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 5e-08
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 3/102 (2%)

Query: 67  SNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS-TLTILDL 125
           +N S +VS+ L   N+  +I  ++ +L  +  +NL  NQ+SG IP  I   S +L  L+L
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 126 SQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFN 167
           S N  +G IP     + +L + ++S N LSG +P  +    +
Sbjct: 126 SNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSS 165

Length = 968

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 20/216 (9%)

Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQRE---FESEVSLLGKIRHPNLL 346
           ++G+  +G V     KAT   G   A+K +++ +   Q     FE E  +L     P + 
Sbjct: 8   LVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L+ Y    K    LV +Y P G L + L+    E   D       +  +   +  +H  
Sbjct: 65  QLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ- 120

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
              +H ++   NVL+D + + K++DFG +  +TA   VN     G   Y APE+      
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 467 NTKT------DVYSLGVTILELLTGKSPGEPLNGAE 496
           + K       D +SLGV   E++ G+SP      A+
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 59/227 (25%), Positives = 90/227 (39%), Gaps = 52/227 (22%)

Query: 295 MGKSTYGTVYKATL--EDGS----QVAVKRLREKITKGQRE--FESEVSLLGKIRHPNLL 346
           +G   +G VY+      DG     QVAVK L E     Q E  F  E  ++ K  H N++
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-SCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK----IIKGMTRGLLH 402
            L       +  + ++ + M  G L +FL    P         MK      + + +G  +
Sbjct: 73  RLIGVSF-ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 403 LHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE 459
           L  N + IH ++ + N LL        AKI+DFG++R +                YRA  
Sbjct: 132 LEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI----------------YRASY 174

Query: 460 LSKLKKA-----------------NTKTDVYSLGVTILELLT-GKSP 488
             K  +A                  +KTDV+S GV + E+ + G  P
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 19/206 (9%)

Query: 293 EIMGKSTYGTVYK--ATLEDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR 349
           E +G+ TY TV+K  + L + + VA+K +R +  +G       EVSLL  ++H N++ L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHSNEN 408
                 K   L VF+Y+    L  ++   G    +     +KI +  + RGL + H  + 
Sbjct: 71  DIVHTDKSLTL-VFEYLDK-DLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRK- 124

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE-LSKLKK 465
           ++H +L   N+L+++    K++DFGL+R  +       N + T   L YR P+ L    +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVT---LWYRPPDVLLGSSE 181

Query: 466 ANTKTDVYSLGVTILELLTGKS--PG 489
            +T+ D++ +G    E+ +G+   PG
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 293 EIMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFE---SEVSLLGKIR-HPNLLA 347
           +++GK ++G V  A L+   +V A+K L++ +     + +   +E  +L     HP L A
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 348 LRAYYLGPKGEKLL-VFDYMPHGSLATFLH-ARGPETPIDWPTRMKIIKG-MTRGLLHLH 404
           L   +     ++L  V +Y+  G L   +  +R  + P     R +     +T  L+ LH
Sbjct: 61  LHCCFQTK--DRLFFVMEYVNGGDLMFQIQRSRKFDEP-----RSRFYAAEVTLALMFLH 113

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELSKL 463
            +  +I+ +L   N+LLD   + K++DFG+ +      N     T  G   Y APE+ + 
Sbjct: 114 RH-GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
            +     D ++LGV + E++ G+ P E  N  +L
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 53.7 bits (130), Expect = 7e-08
 Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 25/164 (15%)

Query: 342 HPNLLALRAYY-LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
           +PN + L  YY +      +L+ DY+  G L   L     E  +      KII+ +   L
Sbjct: 68  NPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEAL 122

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTN-AKISDFGLSRLMTAAANVNVIATA----GALGY 455
             LH + NIIH ++   NVL D + +   + D+GL +         +I T     G L Y
Sbjct: 123 NDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------IIGTPSCYDGTLDY 172

Query: 456 RAPELSKLKKANTKT--DVYSLGVTILELLTGKSPGEPLNGAEL 497
            +PE  K+K  N     D +++GV   ELLTGK P +     EL
Sbjct: 173 FSPE--KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214

Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 59/214 (27%), Positives = 85/214 (39%), Gaps = 38/214 (17%)

Query: 294 IMGKSTYGTV----YKATLEDGSQVAVKRLREKITKGQREFESEVS------LLGKIRHP 343
           ++G+  +G V    YK T   G   A+K L++     + E ES +            RHP
Sbjct: 6   VLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLH 402
            L+ L A +   +     V +Y   G L   +H      P     R       +  GL +
Sbjct: 63  FLVNLFACF-QTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLGLQY 116

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGL--------SRLMTAAANVNVIATAGALG 454
           LH N  I++ +L   N+LLD     KI+DFGL         R  T           G   
Sbjct: 117 LHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST---------FCGTPE 166

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           + APE+          D + LGV I E+L G+SP
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 23/208 (11%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL-- 348
           +G   YG+V  A       +VAVK+L    + +   +R +  E+ LL  ++H N++ L  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81

Query: 349 ---RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
               A  +    E  LV + M           +  +  + +     +I  + RGL ++HS
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKYIHS 136

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS-KLK 464
              IIH +L  SNV +++    +I DFGL+R     A+  +        YRAPE+     
Sbjct: 137 -AGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWM 191

Query: 465 KANTKTDVYSLGVTILELLTGKS--PGE 490
             N   D++S+G  + ELL GK+  PG 
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGN 219

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 35/103 (33%), Positives = 61/103 (59%), Gaps = 2/103 (1%)

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAP 458
           L  +HS + ++H +L S+N+ L  +   K+ DFG S+  + + +++V ++  G   Y AP
Sbjct: 182 LDEVHSRK-MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240

Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
           EL + K+ + K D++SLGV + ELLT   P +  +  E+ Q V
Sbjct: 241 ELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283

Length = 478

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 23/208 (11%)

Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES--EVSLLGKIRHPNLLALR 349
           + +G+ +Y TVYK  +   G  VA+K +R +  +G   F +  E SLL  ++H N++ L 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLH 69

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKI-IKGMTRGLLHLHSN 406
              +  K    LVF+Y+    L  ++     G          +++ +  + RGL + H  
Sbjct: 70  DI-IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLS-----MHNVRLFLFQLLRGLAYCHQ- 121

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE-LSKL 463
             ++H +L   N+L+ +    K++DFGL+R  +  +    N + T   L YR P+ L   
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVT---LWYRPPDVLLGS 178

Query: 464 KKANTKTDVYSLGVTILELLTGKS--PG 489
            + +T  D++ +G    E+ TG+   PG
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPG 206

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 23/207 (11%)

Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVS----LLGKIRHPNLLA 347
           +++GK ++G V  A L+  G   AVK L++ +     + E  +     L     +P L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG------MTRGLL 401
           L   +   K     V +++  G L   +  +G         R  + +       +  GL 
Sbjct: 61  LYCTF-QTKEHLFFVMEFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQ 110

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
            LHS   II+ +L   NV+LD   + KI+DFG+ +      N       G   Y APE+ 
Sbjct: 111 FLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYIAPEIL 168

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           +  K     D +S GV + E+L G+SP
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 9/132 (6%)

Query: 361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL 420
           +V +YMP G L   +     + P  W  R    + +   L  +HS    IH ++   N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNY--DIPEKW-ARFYTAE-VVLALDAIHS-MGFIHRDVKPDNML 174

Query: 421 LDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT----KTDVYSLG 476
           LD S + K++DFG    M A   V      G   Y +PE+ K +  +     + D +S+G
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234

Query: 477 VTILELLTGKSP 488
           V + E+L G +P
Sbjct: 235 VFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 21/164 (12%)

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA---LG 454
           RG+  L S +  IH +L + N+LL ++   KI DFGL+R +    + + +    A   L 
Sbjct: 184 RGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDARLPLK 240

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV 513
           + APE    K   T++DV+S GV + E+ + G SP   +            + EE+   +
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-----------IDEEFCRRL 289

Query: 514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
            +   MR       E+ + +   L C   +P  RP   ++V+ L
Sbjct: 290 KEGTRMRAPEYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 10/105 (9%)

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALG 454
           GL  LHS + II+ +L   NV+LD   + KI+DFG+ +      N+    T     G   
Sbjct: 113 GLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFCGTPD 166

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
           Y APE+   +      D ++ GV + E+L G+ P +  +  EL Q
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 211

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 19/191 (9%)

Query: 311 GSQVAVK--RLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD-YMP 367
           G+ V V+   L     +  +  ++EV L    RHPN++     +    G  L V   +M 
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF--TTGSWLWVISPFMA 82

Query: 368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA 427
           +GS  + L    PE   +      I+ G  RGL +LH N   IH N+ +S++L+  S + 
Sbjct: 83  YGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN-GYIHRNIKASHILI--SGDG 138

Query: 428 KISDFGLSRLMTAAANVNVIATA--------GALGYRAPELSK--LKKANTKTDVYSLGV 477
            +S  GLS L +   N                 L + +PEL +  L   N K+D+YS+G+
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198

Query: 478 TILELLTGKSP 488
           T  EL TG+ P
Sbjct: 199 TACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 30/213 (14%)

Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY- 352
           +G  + G V+ A   D   +VAVK++     +  +    E+ ++ ++ H N++  + Y  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV--KVYEV 70

Query: 353 LGPKGEKL--------------LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMT 397
           LGP G  L              +V +YM    LA  L      E              + 
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQ-----LL 124

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANVNVIATAGALG-- 454
           RGL ++HS  N++H +L  +NV ++ +    KI DFGL+R++    +     + G +   
Sbjct: 125 RGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 455 YRAPELSKLKKANTKT-DVYSLGVTILELLTGK 486
           YR+P L       TK  D+++ G    E+LTGK
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 51/197 (25%), Positives = 97/197 (49%), Gaps = 15/197 (7%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLR--EKITKGQR------EFESEVSLLGKIRHPNLL 346
           +GK ++GTVY   ++D   VA +RL+  ++I  G+       +   E  LL K+ HP ++
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHS 405
              A +L  +    ++ +Y     L   L   +     +      +    +  G+ ++H 
Sbjct: 66  KFHASFL-ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK 465
              I+H +L + N+ L ++   KI DFG+SRL+  + ++    T G   Y +PE  K + 
Sbjct: 125 RR-ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALKHQG 181

Query: 466 ANTKTDVYSLGVTILEL 482
            ++K+D++SLG  + E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.8 bits (112), Expect = 4e-07
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 95  NLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL 154
           NL  L+L  N+++         +  L +LDLS N L+   P +FS L SL S ++S NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 42/217 (19%)

Query: 295 MGKSTYGTVYKAT---LEDGSQVAVKRLREKITK---GQREFESEVSLLGKIR-HPNLLA 347
           +G+  YG V  A      +   VA+K++    +K    +R    E+ LL   R H N+  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66

Query: 348 L-----------RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGM 396
           L              YL    E+L+  D      L   + +  P T   + +    I  +
Sbjct: 67  LYDMDIVFPGNFNELYLY---EELMEAD------LHQIIRSGQPLTDAHFQS---FIYQI 114

Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN------VIATA 450
             GL ++HS  N++H +L   N+L++     KI DFGL+R  +     N       +AT 
Sbjct: 115 LCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT- 172

Query: 451 GALGYRAPELSKLKKANTKT-DVYSLGVTILELLTGK 486
               YRAPE+    ++ TK  DV+S+G  + ELL  K
Sbjct: 173 --RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.4 bits (111), Expect = 5e-07
 Identities = 18/60 (30%), Positives = 27/60 (45%)

Query: 47  RLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQI 106
            L+ LD S N +      +F  L +L  L L  NNL     ++   L +L  L+L  N +
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 14/204 (6%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLLAL 348
           +++G+  +G V     +   +V   +L  K    +R     F  E  ++     P ++ L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              +   K    +V +YMP G L   +     + P  W         +   L  +HS   
Sbjct: 109 FCAFQDDK-YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYT--AEVVLALDAIHS-MG 162

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN- 467
           +IH ++   N+LLD   + K++DFG    M     V      G   Y +PE+ K +  + 
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 468 ---TKTDVYSLGVTILELLTGKSP 488
               + D +S+GV + E+L G +P
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 21/202 (10%)

Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L    +  T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 349 RAYYLGPKG----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
              +   K     + + +   +   +L   +     +  +D      ++  M  G+ HLH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK 464
           S   IIH +L  SN+++      KI DFGL+R  TA  +  +        YRAPE+    
Sbjct: 144 S-AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200

Query: 465 KANTKTDVYSLGVTILELLTGK 486
                 D++S+G  + E++ G 
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 38/111 (34%), Positives = 57/111 (51%), Gaps = 7/111 (6%)

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRA 457
           GL  LH    II+ +L   NVLLD   + KI+DFG+ +  +      +     G   Y A
Sbjct: 108 GLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF--CGTPDYIA 164

Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE 508
           PE+   +      D ++LGV + E+L G+SP E  +  EL Q   SI+++E
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ---SILEDE 212

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.0 bits (110), Expect = 7e-07
 Identities = 17/58 (29%), Positives = 25/58 (43%)

Query: 1  MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAI 58
            L L  N L+     +   L  L+ + LS N ++ + P     L  LR LD S N +
Sbjct: 3  KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 2/101 (1%)

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAP 458
           GL  LHS + II+ +L   NV+LD   + KI+DFG+ +       V      G   Y AP
Sbjct: 113 GLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAP 170

Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
           E+   +      D ++ GV + E+L G++P E  +  EL Q
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 16/205 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLLAL 348
           +++G+  +G V     +   +V   +L  K    +R     F  E  ++     P ++ L
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
             +Y       L +V +YMP G L   +     + P  W  R    + +   L  +HS  
Sbjct: 109 --FYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKW-ARFYTAE-VVLALDAIHS-M 161

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
             IH ++   N+LLD S + K++DFG    M     V      G   Y +PE+ K +  +
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 468 ----TKTDVYSLGVTILELLTGKSP 488
                + D +S+GV + E+L G +P
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 26/188 (13%)

Query: 311 GSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-----EKLLV 362
           G  VA+K+L    + +T  +R +  E+ L+  + H N++ L   +   K      +  LV
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99

Query: 363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD 422
            + M   +L   +        +D      ++  M  G+ HLHS   IIH +L  SN+++ 
Sbjct: 100 MELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK 152

Query: 423 DSTNAKISDFGLSRLMTAAANVNVIATAGALG--YRAPE--LSKLKKANTKTDVYSLGVT 478
                KI DFGL+R     A  + + T   +   YRAPE  L    K N   D++S+G  
Sbjct: 153 SDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN--VDIWSVGCI 206

Query: 479 ILELLTGK 486
           + E++ G 
Sbjct: 207 MGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 59/236 (25%), Positives = 90/236 (38%), Gaps = 55/236 (23%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREK--ITKGQ-REFESEVSLLGKIRHPNLLAL- 348
           ++G+  +G V+    +D  QV A+K LR+   I + Q     +E  +L     P ++ L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67

Query: 349 ------RAYYLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGL 400
                    YL        V +YMP G L   L  +   PE    +      I  +   L
Sbjct: 68  YSFQDEEHLYL--------VMEYMPGGDLMNLLIRKDVFPEETARF-----YIAELVLAL 114

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS------------------RLMTAAA 442
             +H     IH ++   N+L+D   + K++DFGL                    L     
Sbjct: 115 DSVHK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 443 NV--------NVIA--TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
            V         V A  T G   Y APE+ +      + D +SLGV + E+L G  P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)

Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L    +  T  +R +  E+ L+  + H N+++L
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 135

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R  TA  +  +        YRAPE+   
Sbjct: 136 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 27/174 (15%)

Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA 450
           ++ KGM+       +++N IH +L + N+LL      KI DFGL+R +   +N  V   A
Sbjct: 222 QVAKGMS-----FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 451 G-ALGYRAPELSKLKKANT-KTDVYSLGVTILELLT-GKS--PGEPLNGAELPQWVASIV 505
              + + APE S      T ++DV+S G+ + E+ + G S  PG P++          ++
Sbjct: 277 RLPVKWMAPE-SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMI 330

Query: 506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
           KE      + +     AP+   E+ + +K    C D  P  RP   Q+VQ +E+
Sbjct: 331 KEG-----YRMLSPECAPS---EMYDIMK---SCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 8/133 (6%)

Query: 361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL 420
           LV DY   G L T L       P D   R  I + M   +  +H   + +H ++   NVL
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYIAE-MVLAIHSIH-QLHYVHRDIKPDNVL 134

Query: 421 LDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSK-----LKKANTKTDVYSL 475
           LD + + +++DFG    M     V      G   Y +PE+ +     + K   + D +SL
Sbjct: 135 LDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 194

Query: 476 GVTILELLTGKSP 488
           GV + E+L G++P
Sbjct: 195 GVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 17/164 (10%)

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG-ALG 454
           + +G+  L S +  IH +L + N+LL ++   KI DFGL+R +    +      A   L 
Sbjct: 188 VAKGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV 513
           + APE    +    ++DV+S GV + E+ + G SP   +            + EE+   +
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-----------IDEEFCRRL 295

Query: 514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
            +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 296 KEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 36/222 (16%)

Query: 361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL 420
           LV +Y+  G + + LH  G     D    +K I  +   L +LH +  IIH +L   N+L
Sbjct: 81  LVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNML 136

Query: 421 LDDSTNAKISDFGLSRL-MTAAANVNVIATAGALGYRAPELSKLKKANTKT--DVYSLGV 477
           + +  + K++DFGLS++ +    N+  I T        P ++K K   ++T   V SL +
Sbjct: 137 ISNEGHIKLTDFGLSKVTLNRELNMMDILT-------TPSMAKPKNDYSRTPGQVLSL-I 188

Query: 478 TILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLAL 537
           + L   T     +  +         +              LM +     + L  +LKL+ 
Sbjct: 189 SSLGFNTPVGEKDQGSVNSG----QNNGTSSVRTGTSHPLLMINK----ESLPMSLKLSK 240

Query: 538 HCVDPSPSA--------RPEVLQVVQQLEEIRPEAATAATSS 571
            C++ S S+         P +L+        RPEA+T++T S
Sbjct: 241 SCLETSESSPSLPVRSLTPNLLK-----SRKRPEASTSSTHS 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 42/212 (19%)

Query: 296 GKSTYGTVYKATLEDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           GK     +Y  T    ++V VK L+   + K Q EF  +      ++HPN+L      LG
Sbjct: 9   GKVLLSEIYTDT--GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC----LG 62

Query: 355 PKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR-------GLLHLH 404
              E    LLVF+Y   G L ++L          W  R   +  + R       G+ H+H
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHMH 116

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGL--SRLMTAAANVNVIAT----AGALGYRAP 458
            + N +H +L   N  L      K+ D+G+  SR        + I T       L + AP
Sbjct: 117 KH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-----DYIETEDDKCVPLRWLAP 170

Query: 459 EL------SKLKKANTK-TDVYSLGVTILELL 483
           EL        +    TK ++V++LGVT+ EL 
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 45/210 (21%), Positives = 94/210 (44%), Gaps = 11/210 (5%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREF---ESEVSLLGKI-RHPNLLAL 348
           ++G+ +Y  V    L+   ++ A+K +++++     +    ++E  +  +   HP L+ L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            + +   +     V +Y+  G L  F   R  + P +          +    LH      
Sbjct: 62  HSCF-QTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH---ERG 116

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           II+ +L   NVLLD   + K++D+G+ +      +       G   Y APE+ + +    
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGF 175

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELP 498
             D ++LGV + E++ G+SP + +  ++ P
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 9/210 (4%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKIRHPNLLALR 349
           ++GK ++G V  A  +   ++ A+K L++ +     + E    E  +L     P  L   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                       V +Y+  G L   +   G       P  +     ++ GL  LH    I
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLH-RRGI 122

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           I+ +L   NV+LD   + KI+DFG+ +       V      G   Y APE+   +     
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
            D ++ GV + E+L G+ P +  +  EL Q
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 39/115 (33%), Positives = 61/115 (53%), Gaps = 9/115 (7%)

Query: 381 ETPIDWPTRM----KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR 436
           +T   WP  +    +    + +G+  L S +N IH ++ + NVLL D   AKI DFGL+R
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Query: 437 LMTAAANVNVIATAG-ALGYRAPELSKLKKANT-KTDVYSLGVTILELLT-GKSP 488
            +   +N  V   A   + + APE S      T ++DV+S G+ + E+ + GKSP
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPE-SIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 17/170 (10%)

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG-ALG 454
           + RG+  L S +  IH +L + N+LL ++   KI DFGL+R +    +     +A   L 
Sbjct: 183 VARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV 513
           + APE    K   T++DV+S GV + E+ + G SP           +    + EE+   +
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-----------YPGVQINEEFCQRL 290

Query: 514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
            D   MR AP      +   ++ L C    P  RP    +V+ L ++  E
Sbjct: 291 KDGTRMR-APENATPEI--YRIMLACWQGDPKERPTFSALVEILGDLLQE 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 25/212 (11%)

Query: 288 LCATAEIMGKSTYGTVYKATLEDGSQ-----VAVKRLREK--ITKGQRE-FESEVSLLGK 339
           LCA A   G    G     T   G++         +  E   I  GQR    +E  +L  
Sbjct: 81  LCAEARA-GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRA 139

Query: 340 IRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           I HP+++ L+  +   K   L++  Y     L  +L A+      D    + I + + R 
Sbjct: 140 INHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICDI---LAIERSVLRA 194

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-----AGALG 454
           + +LH N  IIH ++ + N+ ++   +  + DFG      A   V++ A      AG + 
Sbjct: 195 IQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFG-----AACFPVDINANKYYGWAGTIA 248

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
             APEL          D++S G+ + E+ T  
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 45/200 (22%), Positives = 90/200 (45%), Gaps = 11/200 (5%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREF---ESEVSLLGKIR-HPNLLAL 348
           ++G+ +Y  V    L+   Q+ A+K +++++     +    ++E  +  +   +P L+ L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            + +        LV +Y+  G L  F   R  + P +          +    LH      
Sbjct: 62  HSCF-QTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARFYAAEICIALNFLH---ERG 116

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           II+ +L   NVLLD   + K++D+G+ +      +       G   Y APE+ + ++   
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS-TFCGTPNYIAPEILRGEEYGF 175

Query: 469 KTDVYSLGVTILELLTGKSP 488
             D ++LGV + E++ G+SP
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 26/177 (14%)

Query: 330 FESEVSLLGKIRHPNLLALRAYYL-GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPT 388
           F    SL+ ++ H +L  +    + G   E ++V +++ HG L   L       P+ W  
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAW-- 118

Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL-----LDDSTNA--KISDFGLSRLMTAA 441
           ++ + + +   L +L  ++N++HGN+ + N+L     L + T+   K+SD G+S   TA 
Sbjct: 119 KITVAQQLASALSYLE-DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175

Query: 442 ANVNVIATAGALGYRAPE-LSKLKKANTKTDVYSLGVTILEL-------LTGKSPGE 490
           +    +     + + APE +      +T  D +S G T+LE+       L  ++P E
Sbjct: 176 SREERVER---IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 49/237 (20%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLLAL 348
           +++G+  +G V     +D   V   ++  K    ++E      +E  +L  +   +L  +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL--VEADSLWVV 64

Query: 349 RAYY-LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           + +Y    K    L+ +++P G + T L  +  +T  +  T+  I       +L + S  
Sbjct: 65  KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYI----AETVLAIDSIH 118

Query: 408 NI--IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA-------------------ANVN- 445
            +  IH ++   N+LLD   + K+SDFGL   +  A                    N+N 
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 446 --------------VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                           +T G   Y APE+      N   D +SLGV + E+L G  P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 9e-05
 Identities = 21/60 (35%), Positives = 29/60 (48%)

Query: 71  SLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKL 130
           +L SL L +N L      +   L NL VL+L  N ++   P     + +L  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 13/205 (6%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLLAL 348
           +++G+  +G V    L++  +V   ++  K    +R     F  E  +L    +  +  L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             Y    +    LV DY   G L T L       P D   R  + + M   +  +H   +
Sbjct: 67  H-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYLAE-MVIAIDSVH-QLH 122

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK---- 464
            +H ++   N+L+D + + +++DFG    +     V      G   Y +PE+ +      
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 465 -KANTKTDVYSLGVTILELLTGKSP 488
            K   + D +SLGV + E+L G++P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 15/168 (8%)

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMTAAANVNVIATAGALG 454
           + RG+  L S +N +H +L + NVLL      KI DFGL+R +M  +  V+  +T   + 
Sbjct: 246 VARGMEFLAS-KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF 514
           + APE        T +DV+S G+ + E+ +       L G   P     IV   + N++ 
Sbjct: 305 WMAPESIFDNLYTTLSDVWSYGILLWEIFS-------LGGTPYP---GMIVDSTFYNKIK 354

Query: 515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP 562
               M        E+ + +   + C +  P  RP  L +   +E + P
Sbjct: 355 SGYRMAKPDHATQEVYDIM---VKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 38/148 (25%), Positives = 64/148 (43%), Gaps = 15/148 (10%)

Query: 343 PNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPID-WPTRMKIIKGMTRG 399
           PN++ L  Y +  +    LV  +   G L + +      PE  +  W   M         
Sbjct: 45  PNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEM------VVA 97

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE 459
           L  LH  E I+  +L  +N+LLDD  + +++ F     +  + +   +       Y APE
Sbjct: 98  LDALH-REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKS 487
           +  + +     D +SLG  + ELLTGK+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKT 180

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 18/142 (12%)

Query: 361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL 420
           +V +Y+  G  AT L   G   P+D   RM   + +   L +LH N  I+H +L   N+L
Sbjct: 78  MVMEYVEGGDCATLLKNIGA-LPVDM-ARMYFAETVL-ALEYLH-NYGIVHRDLKPDNLL 133

Query: 421 LDDSTNAKISDFGLSR--LMTAAANV---NVIATA---------GALGYRAPELSKLKKA 466
           +    + K++DFGLS+  LM+   N+   ++             G   Y APE+   +  
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D +++G+ + E L G  P
Sbjct: 194 GKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 27/100 (27%), Positives = 51/100 (51%), Gaps = 3/100 (3%)

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPE 459
           L+      II+ +L   NVLLD   + K++D+G+ +        +  +T  G   Y APE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
           + + +      D ++LGV + E++ G+SP + +  ++ P 
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 16/158 (10%)

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMTAAANVNVIATAGALGYRAPELSKL 463
           +++N +H +L + NVL+ +    KI DFGL+R +M  +  ++  +T   L + APE    
Sbjct: 256 ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315

Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
               T +DV+S G+ + E+ T G +P       ELP      + E++ N +     M   
Sbjct: 316 NLYTTLSDVWSFGILLWEIFTLGGTP-----YPELP------MNEQFYNAIKRGYRMAKP 364

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
               DE+   ++    C +     RP+  Q+V  + ++
Sbjct: 365 AHASDEIYEIMQ---KCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 38/177 (21%)

Query: 22  SELQEISLSHNKISGVMPSDL-GRLSRLRILDFSYNAINGSLPASFSNL----SSLVSL- 75
           S LQ + L HNKIS  +P +L   L  L + D S   +   LP+  ++L    +SL +L 
Sbjct: 262 SALQSLDLFHNKIS-CLPENLPEELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLTALP 320

Query: 76  -----TLESNNLDDQILDSLDKL--HNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQN 128
                 L++    +  L SL       L VL++ +NQI+  +P T+    T+T LD+S+N
Sbjct: 321 ETLPPGLKTLEAGENALTSLPASLPPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRN 377

Query: 129 KLSG---EIPASFSNLKSLSSFNVSYNNLS------------GPVPTSLALKFNASS 170
            L+     +PA+   +++      S NNL             GP PT + +++N  S
Sbjct: 378 ALTNLPENLPAALQIMQA------SRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428

Length = 754

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 27/80 (33%), Positives = 42/80 (52%), Gaps = 5/80 (6%)

Query: 113 TIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFV 172
           T  N S +  +DLS   +SG+I ++   L  + + N+S N LSGP+P  +   F  SS +
Sbjct: 64  TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDI---FTTSSSL 120

Query: 173 GNIQLC--GYSGSTPCPSPP 190
             + L    ++GS P  S P
Sbjct: 121 RYLNLSNNNFTGSIPRGSIP 140

Length = 968

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 43/172 (25%), Positives = 66/172 (38%), Gaps = 29/172 (16%)

Query: 3   LALQYNNLSGR----IPASLGKLSELQEISLSHN------KISGVMPSDLGRLSRLRILD 52
           L L+ N L       + ++L     L+E+ LS N      +    +   L +   L+ LD
Sbjct: 28  LRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELD 87

Query: 53  FSYNAINGSLPASFSNL---SSLVSLTLESNNLDDQILDSL-----DKLHNLSVLNLKRN 104
            S NA+         +L   SSL  L L +N L D+ L  L     D    L  L L RN
Sbjct: 88  LSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRN 147

Query: 105 QISGH----IPSTIGNISTLTILDLSQNKLSG-------EIPASFSNLKSLS 145
           ++ G     +   +     L  L+L+ N +         E   +  NL+ L 
Sbjct: 148 RLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 61/288 (21%), Positives = 109/288 (37%), Gaps = 48/288 (16%)

Query: 236 SKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLM-FTADDLLCATAEI 294
           S AED  A+        ++  P AAG V        KL H D  L  F   D L A A  
Sbjct: 110 SGAEDSDASHLDF----DEAPPDAAGPVPLAQ---AKLKHDDEFLAHFRVIDDLPAGA-- 160

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQR--------------EFESEVSLLGKI 340
            GK     +  +T E  ++  V    +   K +R              + E+E+  LG++
Sbjct: 161 FGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220

Query: 341 RHPNLLALRAYYLGPKGEKLL-------VFDYMPHGSLATFLHARGPETPIDWPTRMKII 393
            H N+L +           ++       ++ +M   +          + P+   TR  I+
Sbjct: 221 NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPLLKQTR-AIM 273

Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGAL 453
           K +   + ++H  + +IH ++   N+ L+      + DFG +               G +
Sbjct: 274 KQLLCAVEYIHD-KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT---------GKSPGEPL 492
              +PE+         TD++S G+ +L++L+         G  PG+ L
Sbjct: 333 ATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380

Length = 501

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 58/278 (20%), Positives = 119/278 (42%), Gaps = 48/278 (17%)

Query: 293 EIMGKSTYGTVYKATLED---------GSQVAVKRLREKITKGQRE----FESEVSLLGK 339
           E +G+ T   +Y   L             +  +K + + +    R+    F    S++ +
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 340 IRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           + H +++ L    +    E ++V +++  G L  F+H +     +  P + K+ K +   
Sbjct: 61  VSHKHIVLLYGVCVRDV-ENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASA 117

Query: 400 LLHLHSNENIIHGNLTSSNVLL-------DDSTNAKISDFGLS-RLMTAAANVNVIATAG 451
           L +L  +++++HGN+ + N+LL       +     K+SD G+   +++    V  I    
Sbjct: 118 LSYLE-DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP--- 173

Query: 452 ALGYRAPELSK-LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT 510
              + APE  +  K  +   D +S G T+ E+          NG E+P    ++ ++E  
Sbjct: 174 ---WIAPECVEDSKNLSIAADKWSFGTTLWEIC--------YNG-EIPLKDKTLAEKE-- 219

Query: 511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARP 548
              ++ + M   P+   EL     L  HC++  P+ RP
Sbjct: 220 -RFYEGQCMLVTPSC-KEL---ADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 41.0 bits (97), Expect = 6e-04
 Identities = 16/50 (32%), Positives = 29/50 (58%), Gaps = 2/50 (4%)

Query: 387 PTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR 436
               ++++ + R +  LH    I+HG+LT+SN+++ D     I DFGL +
Sbjct: 90  EGNDELLREIGRLVGKLHKA-GIVHGDLTTSNIIVRDDKLYLI-DFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 62/242 (25%), Positives = 99/242 (40%), Gaps = 52/242 (21%)

Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLR--EKITKGQRE-FESEVSLLGKIRHPNLL 346
           + +++G+  +G V     +D G   A+K+LR  E + K Q     +E  +L +  +P ++
Sbjct: 5   SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVV 64

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            L  YY       L L+ +Y+P G + T L  +  +T  +  TR  I       +L + S
Sbjct: 65  KL--YYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYI----AETILAIDS 116

Query: 406 --NENIIHGNLTSSNVLLDDSTNAKISDFGLS---------------------------- 435
                 IH ++   N+LLD   + K+SDFGL                             
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 436 -------RLMTAAANVNVIA--TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
                  +  T   N   +A  T G   Y APE+      N + D +SLGV + E+L G 
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236

Query: 487 SP 488
            P
Sbjct: 237 PP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 6e-04
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 53/195 (27%)

Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM-- 390
           EV+++ +++H N++     +L    +KL +        L  F  A      I    +M  
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYI--------LMEFCDAGDLSRNIQKCYKMFG 113

Query: 391 KI----IKGMTRGLLHL----------HSNENIIHGNLTSSNVLLDDSTN---------- 426
           KI    I  +TR LLH            + E ++H +L   N+ L               
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173

Query: 427 -------AKISDFGLSRLMTAAANVNVIATA----GALGYRAPEL--SKLKKANTKTDVY 473
                  AKI DFGLS+      N+ + + A    G   Y +PEL   + K  + K+D++
Sbjct: 174 NLNGRPIAKIGDFGLSK------NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227

Query: 474 SLGVTILELLTGKSP 488
           +LG  I EL +GK+P
Sbjct: 228 ALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 38/124 (30%), Positives = 55/124 (44%), Gaps = 6/124 (4%)

Query: 8   NNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFS 67
           NN    +P S+G LS L+ + LS+N+IS    S LG L+ LR LD S N+++ +LP    
Sbjct: 241 NNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIAL 298

Query: 68  NLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ 127
            L  L  L      L    L     L N ++L+          P  +  + +L  L    
Sbjct: 299 LLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE----TSSPEALSILESLNNLWTLD 354

Query: 128 NKLS 131
           N L 
Sbjct: 355 NALD 358

Length = 394

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 17/34 (50%), Positives = 22/34 (64%), Gaps = 2/34 (5%)

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR 436
           LHS   IIHG+LT+SN++L       I DFGL+ 
Sbjct: 111 LHSA-GIIHGDLTTSNMILSGGKIYLI-DFGLAE 142

Length = 211

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 37/135 (27%), Positives = 60/135 (44%), Gaps = 12/135 (8%)

Query: 361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI--IHGNLTSSN 418
           LV DY   G L T L       P D   R  +       +L + S   +  +H ++   N
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYL----AEMVLAIDSVHQLGYVHRDIKPDN 132

Query: 419 VLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSK-----LKKANTKTDVY 473
           VLLD + + +++DFG    + A   V      G   Y +PE+ +       +   + D +
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192

Query: 474 SLGVTILELLTGKSP 488
           SLGV + E+L G++P
Sbjct: 193 SLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 28/201 (13%)

Query: 304 YKATLEDGSQVAVKRLR-EKITKGQREF-ESEVSLLGKIRHPNLLALRAYYLGPKGEKLL 361
           YK T   G  V V+R+  E  T     F + E+ +     HPN++  RA ++    E  +
Sbjct: 21  YKPT---GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWV 76

Query: 362 VFDYMPHGS----LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSS 417
           V  +M +GS    + T       E  I +     I++G+ + L ++H +   +H ++ +S
Sbjct: 77  VTSFMAYGSAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIH-HMGYVHRSVKAS 130

Query: 418 NVLLDDSTNAKISDFGLSR---LMTAAANVNVIA-----TAGALGYRAPEL--SKLKKAN 467
           ++L+  S + K+   GL     ++     + V+      +   L + +PE+    L+  +
Sbjct: 131 HILI--SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 188

Query: 468 TKTDVYSLGVTILELLTGKSP 488
            K+D+YS+G+T  EL  G  P
Sbjct: 189 AKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.002
 Identities = 15/44 (34%), Positives = 24/44 (54%)

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           L  LDLS N+L+     +F  L +L   ++S NNL+   P + +
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFS 45

Length = 60

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.0 bits (94), Expect = 0.003
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 22/161 (13%)

Query: 16  ASLGKLSELQEISLSHNKISG-----VMPSDLGRLSRLRILDFSYNAING----SLPASF 66
            SL + S LQE+ L++N +       +          L  L    N + G    +L  + 
Sbjct: 102 ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161

Query: 67  SNLSSLVSLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQI----SGHIPSTIGNIS 118
                L  L L +N + D     + + L    NL VL+L  N +    +  +  T+ ++ 
Sbjct: 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221

Query: 119 TLTILDLSQNKLSGEI-----PASFSNLKSLSSFNVSYNNL 154
           +L +L+L  N L+         A  S   SL + ++S N++
Sbjct: 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 42/174 (24%), Positives = 67/174 (38%), Gaps = 42/174 (24%)

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI- 409
           Y    K    L+ +++P G + T L  +  +T  +  T+  I       +L + +   + 
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYI----AETVLAIDAIHQLG 121

Query: 410 -IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA-------------------ANVN---- 445
            IH ++   N+LLD   + K+SDFGL   +  A                    N+N    
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 446 -----------VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                        +T G   Y APE+      N   D +SLGV + E+L G  P
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 23/136 (16%), Positives = 45/136 (33%), Gaps = 12/136 (8%)

Query: 303 VYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEK-LL 361
           VY    +D     +K    +     RE E  +  L  +    L   +    G       L
Sbjct: 14  VYLLGTKDED-YVLKINPSREKGADREREVAILQL--LARKGLPVPKVLASGESDGWSYL 70

Query: 362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL 421
           + +++   +L          +  +     + +  +    LH      + HG+L   N+L+
Sbjct: 71  LMEWIEGETL-------DEVSEEEKEDIAEQLAELLA-KLHQLPLLVLCHGDLHPGNILV 122

Query: 422 DDSTNAKISDFGLSRL 437
           DD     I D+  +  
Sbjct: 123 DDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 49/233 (21%)

Query: 294 IMGKSTYGTVYKATLED---GSQVAVKRLREKITKG---QREFESEVSLLGKIRHPNLLA 347
           ++GK   G VY A   D     +VA+K++RE +++    ++ F  E  +   + HP ++ 
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 348 LRAYYLGPKGEKLLVFDYMPH---GSLATFL------------HARGPETPIDWPTRMKI 392
           +  Y +   G+   V+  MP+    +L + L             A    T +     + I
Sbjct: 67  V--YSICSDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK--TSV--GAFLSI 118

Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR--------LMTAAANV 444
              +   + ++HS + ++H +L   N+LL       I D+G +         L+    + 
Sbjct: 119 FHKICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 445 NVIATA---------GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
             I  +         G   Y APE      A+  TD+Y+LGV + ++LT   P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 6/150 (4%)

Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           E  LL ++ HP +LAL    +      L++  Y     L T+L AR    P+       +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGAR--LRPLGLAQVTAV 265

Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV-IATAG 451
            + +   + ++H  E IIH ++ + NVL++   +  + DFG +     + +       AG
Sbjct: 266 ARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAG 324

Query: 452 ALGYRAPELSKLKKANTKTDVYSLGVTILE 481
            +   APE+          D++S G+ I E
Sbjct: 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	580
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.81
PRK10345	210	hypothetical protein; Provisional	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
smart00090	237	RIO RIO-like kinase.	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.71
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.61
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.58
PLN03150	623	hypothetical protein; Provisional	99.56
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.51
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.5
KOG1243	690	consensus Protein kinase [General function predict	99.44
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.33
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.33
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.31
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.31
PLN03150	623	hypothetical protein; Provisional	99.31
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.3
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.3
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.27
COG4248	637	Uncharacterized protein with protein kinase and he	99.26
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.26
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.25
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.24
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.22
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.21
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.19
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.14
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.14
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
KOG3087	229	consensus Serine/threonine protein kinase [General	99.13
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.08
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.07
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.01
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.98
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.96
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.94
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.92
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.88
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.77
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.75
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.72
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.7
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.65
PRK09902	216	hypothetical protein; Provisional	98.65
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.63
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.62
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.61
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.58
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.58
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.52
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.52
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.5
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.47

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-63  Score=572.82  Aligned_cols=515  Identities=30%  Similarity=0.507  Sum_probs=352.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|.+++.++..+..+++|+.|+|++|.+.+.+|..+ ..++|+.|+|++|++++..|..|.++++|+.|+|++|.
T Consensus       432 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~  510 (968)
T PLN00113        432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK  510 (968)
T ss_pred             EEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCc
Confidence            34444454444444444445555555555555554444433 24567777777777777777777788888888888888


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChh
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTS  161 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~  161 (580)
                      +++..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..
T Consensus       511 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  590 (968)
T PLN00113        511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST  590 (968)
T ss_pred             ceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc
Confidence            88778888888888888888888888888888888888888888888888888888888888888888888888877754


Q ss_pred             hh-hhcCCCcccccccccCCCC---CCCCCCCCCCCCCCcCCCCCCcceeeehhHHHHHHHHHHHHHHhhhhhhcccccc
Q 008031          162 LA-LKFNASSFVGNIQLCGYSG---STPCPSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLIIVCILMCCLIRKRTASK  237 (580)
Q Consensus       162 ~~-~~~~~~~~~~~~~~~~~~~---~~~C~s~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~r~r~~~~  237 (580)
                      -. ..+....+.||+.+|+...   ...|..        . .+ ....+++++++++++++++++++++++++|+++...
T Consensus       591 ~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~--------~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  660 (968)
T PLN00113        591 GAFLAINASAVAGNIDLCGGDTTSGLPPCKR--------V-RK-TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL  660 (968)
T ss_pred             chhcccChhhhcCCccccCCccccCCCCCcc--------c-cc-cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccc
Confidence            22 3456667889988998542   122311        0 01 112222332222222222222222233222222111


Q ss_pred             cccCcccccccccCCCCCCCCCCCcccCCCCCCCeeeeeCC--CcccCHHHH--HHhhhccccccCceEEEEEEeC-CCC
Q 008031          238 AEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDG--PLMFTADDL--LCATAEIMGKSTYGTVYKATLE-DGS  312 (580)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~ig~G~~g~Vy~~~~~-~~~  312 (580)
                      +.....          .+.    .+.          ..+..  ...++.++.  .+...+.||+|+||.||+|... +|.
T Consensus       661 ~~~~~~----------~~~----~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~  716 (968)
T PLN00113        661 KRVENE----------DGT----WEL----------QFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGM  716 (968)
T ss_pred             cccccc----------ccc----ccc----------cccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCc
Confidence            100000          000    000          00000  001222222  2334568999999999999974 789


Q ss_pred             EEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHH
Q 008031          313 QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI  392 (580)
Q Consensus       313 ~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i  392 (580)
                      .||||.++.....    ..+|++.+++++||||++++++|.+ ++..++||||+++|+|.++++.      ++|.++.++
T Consensus       717 ~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i  785 (968)
T PLN00113        717 QFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHEYIEGKNLSEVLRN------LSWERRRKI  785 (968)
T ss_pred             EEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHH
Confidence            9999998643221    2346889999999999999999987 5678999999999999999963      789999999


Q ss_pred             HHHHHHHHHHhhcC--CCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeecCccccCCccccccCCCCCcc
Q 008031          393 IKGMTRGLLHLHSN--ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT  470 (580)
Q Consensus       393 ~~~i~~~l~~LH~~--~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~  470 (580)
                      +.|+|+|++|||..  ++|+||||||+||+++.++..++. ||........     ....++..|||||++.+..++.++
T Consensus       786 ~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~s  859 (968)
T PLN00113        786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKS  859 (968)
T ss_pred             HHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCccc
Confidence            99999999999931  599999999999999998888775 6655432211     123578899999999999999999


Q ss_pred             cchhHHHHHHHHHcCCCCCCCCC--CCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 008031          471 DVYSLGVTILELLTGKSPGEPLN--GAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARP  548 (580)
Q Consensus       471 Dv~s~G~~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  548 (580)
                      |||||||++|||+||+.||....  ......|............+.|+......+...++..++.+++.+||+.||++||
T Consensus       860 Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP  939 (968)
T PLN00113        860 DIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP  939 (968)
T ss_pred             chhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc
Confidence            99999999999999999996432  2345555544433333444555555444444556777889999999999999999


Q ss_pred             CHHHHHHHHhhhcccccccc
Q 008031          549 EVLQVVQQLEEIRPEAATAA  568 (580)
Q Consensus       549 s~~ev~~~L~~~~~~~~~~~  568 (580)
                      ||.|+++.|+++.......+
T Consensus       940 t~~evl~~L~~~~~~~~~~~  959 (968)
T PLN00113        940 CANDVLKTLESASRSSSSCV  959 (968)
T ss_pred             CHHHHHHHHHHhhccccccc
Confidence            99999999999876555444

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=403.29  Aligned_cols=283  Identities=42%  Similarity=0.706  Sum_probs=240.0

Q ss_pred             CcccCHHHHHHhh-----hccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 008031          279 PLMFTADDLLCAT-----AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL  353 (580)
Q Consensus       279 ~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  353 (580)
                      ...|+++++.-++     .+.||+|+||.||+|..++|+.||||++........++|..|+.++.+++|||+|+++|||.
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            4467888888777     36899999999999999999999999887654331556999999999999999999999999


Q ss_pred             CCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCcccCCCCCCCeeeCCCCCeEEee
Q 008031          354 GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN--ENIIHGNLTSSNVLLDDSTNAKISD  431 (580)
Q Consensus       354 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--~~i~H~Dlk~~Nil~~~~~~~kl~D  431 (580)
                      +...+.++|||||++|+|.++|+..... +++|..+++||.++|+||+|||..  +.|+|||||++|||+|++.++||+|
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            7433599999999999999999986433 889999999999999999999985  3599999999999999999999999


Q ss_pred             cccccccccccccceeee-cCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCC---CCCChhHHHHHHhhh
Q 008031          432 FGLSRLMTAAANVNVIAT-AGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPL---NGAELPQWVASIVKE  507 (580)
Q Consensus       432 fg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~---~~~~~~~~~~~~~~~  507 (580)
                      ||+|+..... ....... .||.+|+|||++..+..+.|+||||||+++.|++||+.|.+..   ....+..|+......
T Consensus       221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            9999765441 1111222 7999999999999999999999999999999999999988753   344578888888888


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ....+++|+.+.........++.++.+++.+|++.+|++||+|.||++.|+.+...
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            88899999998742222226888899999999999999999999999999776554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-50  Score=396.23  Aligned_cols=258  Identities=34%  Similarity=0.542  Sum_probs=211.9

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccccc--HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKG--QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      ..+.+.||+|+||+||+|.+.....||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.....++|||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            34566799999999999999944449999997654332  4589999999999999999999999987444789999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-cccCCCCCCCeeeCCCC-CeEEeeccccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN-IIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ++|+|.++++.. ....+++..+++++.|||+||.|||++ + |||||||++|||++.++ ++||+|||+++...... .
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            999999999884 345799999999999999999999995 8 99999999999999997 99999999998665432 2


Q ss_pred             ceeeecCccccCCccccc--cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          445 NVIATAGALGYRAPELSK--LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      ......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+....   +.+........+..         .
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~~~~Rp~---------~  267 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVVGGLRPP---------I  267 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcCCCCC---------C
Confidence            333467999999999999  669999999999999999999999999987753   33333322222111         0


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      +.  .....+..+|.+||+.||+.||++.+++..|+.+...
T Consensus       268 p~--~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  268 PK--ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             Cc--cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            11  1333666788899999999999999999999988653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-49  Score=391.39  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=221.4

Q ss_pred             HHHHHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          285 DDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       285 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      ....+...+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|++||+++|+|.. ++..+||||
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~~piyIVtE  281 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-QEPIYIVTE  281 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-CCceEEEEE
Confidence            33345678999999999999999997779999999875 3456789999999999999999999999986 447999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ||+.|+|.+||+... ...+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...++...
T Consensus       282 ~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~  359 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT  359 (468)
T ss_pred             ecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence            999999999999732 45688999999999999999999994 9999999999999999999999999999966555554


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ......-++.|.|||.+..+.|+.|||||||||+||||+| |+.||..++..+..+.+.+..+            +..+.
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR------------lp~P~  427 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR------------LPRPE  427 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc------------CCCCC
Confidence            4444456678999999999999999999999999999999 9999999887776666654221            22344


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      .++++   +.++|..||+.+|++||||..+...|+++...
T Consensus       428 ~CP~~---vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  428 GCPDE---VYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCHH---HHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            44444   44678899999999999999999999998654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-49  Score=371.71  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=214.0

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +..+.||+|..|+||++.++ +++.+|+|.+..... ...+++.+|+++++..+||+||.+||.|.......+|+||||+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            46789999999999999997 788999999965443 3457899999999999999999999999873325999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   +.+++....+++.++++||.|||+.++|+||||||+|||++..|.|||||||.+......   ...
T Consensus       162 gGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~  235 (364)
T KOG0581|consen  162 GGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN  235 (364)
T ss_pred             CCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence            99999999875   469999999999999999999996469999999999999999999999999999877554   334


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCC--CCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPL--NGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      +++||..|||||.+.+..|+.++||||||+.++|+.+|+.||.+.  +.....+.+..+..+..+.      +    |..
T Consensus       236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~------l----P~~  305 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR------L----PEG  305 (364)
T ss_pred             cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC------C----Ccc
Confidence            678999999999999999999999999999999999999999874  3455666666665543321      1    110


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                       ....++..++..||++||.+|||++|+++|=.
T Consensus       306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf  337 (364)
T KOG0581|consen  306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF  337 (364)
T ss_pred             -cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence             23457788899999999999999999998743

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.3e-48  Score=400.29  Aligned_cols=260  Identities=29%  Similarity=0.482  Sum_probs=221.6

Q ss_pred             hhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          290 ATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ...+.||+|+||.||+|+..      +...||||.+++.... .+++|++|+++++.++|||||+++|.|.+ ++..|+|
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-~~P~~Mv  567 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-GDPLCMV  567 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-CCeeEEE
Confidence            34678999999999999853      3557999999987766 67889999999999999999999999987 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCC-----------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEee
Q 008031          363 FDYMPHGSLATFLHARGPE-----------TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISD  431 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~D  431 (580)
                      +|||..|+|.+||+.+++.           .+++..+.+.||.|||.|++||-++ .+|||||.++|+||.++..|||+|
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIsD  646 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKISD  646 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEecc
Confidence            9999999999999875322           2388899999999999999999984 899999999999999999999999


Q ss_pred             ccccccccccccccee-eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhc
Q 008031          432 FGLSRLMTAAANVNVI-ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       432 fg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      ||+++.....+.++.. ...-+++|||||.|..++|+++||||||||+|||+++ |+-||.+....+..+.+...     
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g-----  721 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG-----  721 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC-----
Confidence            9999987766666554 3456789999999999999999999999999999999 99999999988877776642     


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                             +++..+..++   .+++.||..||+.+|++||+|+||-..|+........
T Consensus       722 -------~lL~~Pe~CP---~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~  768 (774)
T KOG1026|consen  722 -------QLLSCPENCP---TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK  768 (774)
T ss_pred             -------CcccCCCCCC---HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence                   1222233333   3566788899999999999999999999987655443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=362.45  Aligned_cols=206  Identities=29%  Similarity=0.489  Sum_probs=180.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREK--ITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||+||+|++. ++.+||||.+...  ..+..+-+..|+.+|+.++|||||++++++.. ++..|+||||
T Consensus        12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lVMEy   90 (429)
T KOG0595|consen   12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLVMEY   90 (429)
T ss_pred             ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEEEEe
Confidence            445567999999999999986 7899999999765  34455678999999999999999999999987 6699999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC------CCeEEeecccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS------TNAKISDFGLSRLMT  439 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~------~~~kl~Dfg~~~~~~  439 (580)
                      |+||+|.+|++.++   .+++..+..++.|+|.||++||++ +|+||||||+|||++.+      -.+||+|||+|+...
T Consensus        91 C~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   91 CNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999864   799999999999999999999995 99999999999999864      458999999999876


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHH
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWV  501 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~  501 (580)
                      ...-  ..+..|++-|||||++....|+.|+|+||+|+++|+|++|+.||...+..++..++
T Consensus       167 ~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~  226 (429)
T KOG0595|consen  167 PGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI  226 (429)
T ss_pred             chhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            4332  23467999999999999999999999999999999999999999877666555533

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-47  Score=379.84  Aligned_cols=249  Identities=26%  Similarity=0.436  Sum_probs=210.8

Q ss_pred             HHHhhhccccccCceEEEEEEe-CCCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATL-EDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ..|...++||+|||+.||.+++ .+|..||+|++.+..   ....+.+.+||++.++|+|||||+++++|.+ .+..|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEE
Confidence            4567789999999999999998 789999999997643   2334568899999999999999999999987 6699999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      .|+|+.++|..+++.+   .++++.+++.++.||+.||.|||++ +|+|||||..|++++++.+|||+|||+|.....+.
T Consensus        97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999999854   4799999999999999999999995 99999999999999999999999999999876543


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      . ...+..||+.|+|||++....++..+||||+||++|-|+.|++||+..+-.+....+.   ..++.            
T Consensus       173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik---~~~Y~------------  236 (592)
T KOG0575|consen  173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK---LNEYS------------  236 (592)
T ss_pred             c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH---hcCcc------------
Confidence            3 3445789999999999999999999999999999999999999998755443333332   11111            


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                       ....-..+..+||.++|+.||.+|||+++|+.+=
T Consensus       237 -~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  237 -MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             -cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence             1112233566888899999999999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-47  Score=362.99  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=202.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      |-+.+.+|+|+||.|-+|... +|+.||||+++.....       ......+|+++|++|+|||||++++++.. .+..|
T Consensus       174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-~ds~Y  252 (475)
T KOG0615|consen  174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-PDSSY  252 (475)
T ss_pred             eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-CCceE
Confidence            456799999999999999875 8999999999754321       22346799999999999999999999987 56889


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC---CCeEEeecccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS---TNAKISDFGLSRL  437 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~---~~~kl~Dfg~~~~  437 (580)
                      |||||++||+|.+++-.++   .+.+.....+++|++.|+.|||+ +||+||||||+|||++.+   ..+||+|||+|+.
T Consensus       253 mVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             EEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999999997753   57788889999999999999999 599999999999999865   6799999999998


Q ss_pred             cccccccceeeecCccccCCccccccCCCC---CcccchhHHHHHHHHHcCCCCCCCCCCCC-hhHHHHHHhhhhccccc
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLKKAN---TKTDVYSLGVTILELLTGKSPGEPLNGAE-LPQWVASIVKEEWTNEV  513 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  513 (580)
                      ....  ..+.+.+||+.|.|||++.+..+.   .++|+||+||+||-+++|.+||.+..... +.+.+.   ++.+.   
T Consensus       329 ~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~---~G~y~---  400 (475)
T KOG0615|consen  329 SGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL---KGRYA---  400 (475)
T ss_pred             cccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh---cCccc---
Confidence            7633  334457899999999998765433   37799999999999999999998754432 333333   22221   


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      +.+      +...+-..+..++|.+||..||++|||+.|+++|=+
T Consensus       401 f~p------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  401 FGP------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             ccC------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence            111      222233456778999999999999999999998754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-47  Score=342.03  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=205.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCc-EEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGE-KLLVF  363 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~lv~  363 (580)
                      .|.+.++||+|.||+||++..- +|..||.|.++-..-  +..++...|+.+|++|+|||||+++++-...+.+ .+|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            3678899999999999999864 899999999874332  3345688999999999999999999944333444 89999


Q ss_pred             eeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcC-CC--cccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          364 DYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSN-EN--IIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       364 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~--i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ||++.|+|.+.++.. .....+++..+++++.|++.||.++|+. +.  |+||||||.||+++.+|.||++|||+++++.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            999999999998653 3345699999999999999999999983 24  9999999999999999999999999999887


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ...... ...+||+.||+||.+.+..|+.|+||||+||++|||..-++||.+.+   ..+.-.++.+++.          
T Consensus       180 s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~KI~qgd~----------  245 (375)
T KOG0591|consen  180 SKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCKKIEQGDY----------  245 (375)
T ss_pred             chhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHHHHHcCCC----------
Confidence            654433 34689999999999999999999999999999999999999998863   4444444444322          


Q ss_pred             ccCCCcH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          520 RDAPTIG--DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       520 ~~~~~~~--~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                         +.++  ....++..+|..|+..||+.||+...+++.+
T Consensus       246 ---~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  246 ---PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ---CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence               2122  2345677888899999999999854444443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.4e-45  Score=334.77  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .|+...++|+|+||.||+++++ +|+.||||++.+...+  ..+-..+|+++|++++|+|+|.++++|.. ....++|+|
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVFE   81 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVFE   81 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEee
Confidence            4677789999999999999987 7999999999765432  23457899999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ||+. ++.+-|....  ..++...+.+++.|++.|+.|+|++ +++||||||+|||++.++.+|+||||+|+..... ..
T Consensus        82 ~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD  156 (396)
T ss_pred             ecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence            9977 5555555542  3478889999999999999999996 9999999999999999999999999999988642 33


Q ss_pred             ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc------------c
Q 008031          445 NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT------------N  511 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------~  511 (580)
                      ..+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+-|.+.++-+....+...+..-.+            .
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            3445678999999998876 78999999999999999999999999887766655544433321100            0


Q ss_pred             -----cccchhh-hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          512 -----EVFDLEL-MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       512 -----~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                           +.-+++- .+..+   ....-+++++..|++.||.+|++-+|++.|
T Consensus       237 Gv~lP~~~~~epLe~k~p---~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYP---KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeecCCCCCccchhhhcc---cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                 0000000 01111   122356789999999999999999999865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-46  Score=357.61  Aligned_cols=266  Identities=21%  Similarity=0.301  Sum_probs=217.2

Q ss_pred             HHHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc-HHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEE
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG-QREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ..+|.+.+.||.|+||.||+|+.. +|..||||+++..-... +..-.+|+..|++|+ ||||+++.+.+.+.+..+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            346888999999999999999865 79999999998654432 333579999999998 999999999999866689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      ||||+ .+|+++++.+  ...+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+......
T Consensus        89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCC
Confidence            99995 5999999887  56799999999999999999999996 99999999999999988899999999999776543


Q ss_pred             ccceeeecCccccCCcccc-ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc------
Q 008031          443 NVNVIATAGALGYRAPELS-KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD------  515 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  515 (580)
                      .  .+..+.|.+|+|||++ ..+.|+.+.|+||+||+++|+.+-++-|.+.++.+-...+..++.......+..      
T Consensus       165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            3  3345689999999975 567889999999999999999999999998887776666666654332222221      


Q ss_pred             ---hhhhccC-----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          516 ---LELMRDA-----PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       516 ---~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                         ..+....     ...+....+++++|.+|+++||.+|||+.|++++-
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence               1111111     12223557888999999999999999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=355.61  Aligned_cols=262  Identities=26%  Similarity=0.395  Sum_probs=222.0

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccH-HHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      ...+.++||+|.||+|..+....+..||||+++....+.. .+|.+|+++|.+++||||++++|.|.. ++..++|+|||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchHHHHHHH
Confidence            3456889999999999999999889999999998766554 789999999999999999999999987 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++|+|.+|+.++.... ..-....+|+.|||.|++||.+- ++|||||.++|+|++.++++||+|||+++-+...+.+..
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            9999999998874332 45567788999999999999994 999999999999999999999999999996655544443


Q ss_pred             e-eecCccccCCccccccCCCCCcccchhHHHHHHHHHc--CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          447 I-ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT--GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       447 ~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      . ..+-+++|||||.+..+++++++|||+||+++||+++  .+.||+...+++..+....+...........     .++
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~-----~P~  770 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS-----RPP  770 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc-----CCC
Confidence            3 2346789999999999999999999999999999887  8889999988888887777766655443321     222


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      .++   .+++++|.+||..+.++||||+++...|.+.
T Consensus       771 ~cp---~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  771 ACP---QGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCc---HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            222   3566899999999999999999999998764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=345.26  Aligned_cols=246  Identities=25%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      ++..++||+|+||.||.++.. +++.+|+|++++...   .+.+....|..+|.+++||+||+++..|++ .+.+|+|+|
T Consensus        27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLylVld  105 (357)
T KOG0598|consen   27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYLVLD  105 (357)
T ss_pred             eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEEEEe
Confidence            567899999999999999876 789999999976542   345678999999999999999999999987 679999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+.||.|..+|.+.   ..+++..+.-++.+|+.||.|||+ .||+||||||+|||+|++|+++|+|||+++..-... .
T Consensus       106 ~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~  180 (357)
T KOG0598|consen  106 YLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-D  180 (357)
T ss_pred             ccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-C
Confidence            99999999999875   479999999999999999999999 599999999999999999999999999998543332 2


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ...+++||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+..   .+..++..+..+         .....
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~---~~~~~I~~~k~~---------~~p~~  248 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK---KMYDKILKGKLP---------LPPGY  248 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH---HHHHHHhcCcCC---------CCCcc
Confidence            334578999999999999999999999999999999999999999876543   344444433311         01111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP----EVLQVVQ  555 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp----s~~ev~~  555 (580)
                      ..   .+..+++.+.++.||++|.    ++.++.+
T Consensus       249 ls---~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  249 LS---EEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             CC---HHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            22   2455677799999999996    4555443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-46  Score=375.69  Aligned_cols=256  Identities=25%  Similarity=0.473  Sum_probs=215.0

Q ss_pred             hhhccccccCceEEEEEEeC-C---CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          290 ATAEIMGKSTYGTVYKATLE-D---GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .+.++||.|.||.||+|.++ .   ...||||.++.... +...+|..|+.+|.+++||||+++.|+... ....+||+|
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-s~PvMIiTE  710 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-SKPVMIITE  710 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-CceeEEEhh
Confidence            35778999999999999986 2   34699999987654 455689999999999999999999999976 457899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ||++|+|..||+.++  ..+++-+...++.+||.|+.||-.. ++|||||.++||||+.+-.+||+|||+++...++...
T Consensus       711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            999999999999875  5699999999999999999999985 9999999999999999999999999999977655433


Q ss_pred             ceeeecC--ccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          445 NVIATAG--ALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       445 ~~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      .....-|  +.+|.|||.+..++++.++||||||+++||.++ |..||.++...+....+.+..           +    
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy-----------R----  852 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY-----------R----  852 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc-----------C----
Confidence            3322222  468999999999999999999999999999999 999999988766554443311           1    


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .|...++...+.+||+.||++|-.+||.|.+++..|..+-.++
T Consensus       853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            1222244457889999999999999999999999999975443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-44  Score=351.69  Aligned_cols=270  Identities=26%  Similarity=0.346  Sum_probs=215.9

Q ss_pred             CHHHHHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCc
Q 008031          283 TADDLLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGE  358 (580)
Q Consensus       283 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~  358 (580)
                      ......|+..++||+|+||.||+|++. +|+.||+|+++....  ....-..+||.+|++|+||||+++.+...+. .+.
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            344556788899999999999999874 899999999976543  3445678999999999999999999999885 468


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      +|+|+|||++ +|.-++...  .-.|+..++..+++|++.||+|||+ +||+|||||.+|||||++|.+||+|||+|+++
T Consensus       193 iYlVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999999987 888887653  3569999999999999999999999 59999999999999999999999999999998


Q ss_pred             ccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccccc--c
Q 008031          439 TAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF--D  515 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~  515 (580)
                      ........+..+-|.+|+|||++.+ ..|+.+.|+||.||||.||++|++.|.+.++.+-...+-++........|-  +
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            8877777777888999999998775 579999999999999999999999998877655555554443321111111  1


Q ss_pred             hhh---hccCCCcHH---H-----HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 LEL---MRDAPTIGD---E-----LLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ~~~---~~~~~~~~~---~-----~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...   .+....-..   +     ....++|+..+|..||.+|.|+.++++.
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            110   000000001   1     1346688889999999999999998875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=346.52  Aligned_cols=260  Identities=25%  Similarity=0.454  Sum_probs=205.2

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-cEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-EKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e~  365 (580)
                      .+...+.||+|+||.||.+... +|...|||.+........+.+.+|+.+|.+++|||||+++|......+ .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            3567899999999999999986 589999998865533335668999999999999999999998655344 68899999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-CCCeEEeeccccccccc--cc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-STNAKISDFGLSRLMTA--AA  442 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~--~~  442 (580)
                      +++|+|.+++.+.+.  .+++..+.+++.||++||+|||+ +||+||||||+|||++. ++.+||+|||++.....  ..
T Consensus        98 ~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            999999999998652  69999999999999999999999 59999999999999999 79999999999987663  22


Q ss_pred             ccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          443 NVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ........||+.|||||++..+ ....++||||+||++.||+||+.||...  .+...++..+......     +.+   
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~-----P~i---  244 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSL-----PEI---  244 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCC-----CCC---
Confidence            2233456899999999999853 3345999999999999999999999764  2222322222221111     111   


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      +...+   .+..+++.+|++.||++|||+.++++|--.....
T Consensus       245 p~~ls---~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  245 PDSLS---DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             CcccC---HHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            11122   3455788899999999999999999997655433

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=384.21  Aligned_cols=257  Identities=27%  Similarity=0.439  Sum_probs=212.6

Q ss_pred             HhhhccccccCceEEEEEEeC--CCC----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE--DGS----QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      .+..+.||+|+||.||.|.+.  .|.    .||||.++.... ....+|.+|+.+|+.++|||||+++|+|.+ .+..+|
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~~i  772 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPPLI  772 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCcEE
Confidence            455789999999999999875  343    499999976654 345689999999999999999999999998 778999


Q ss_pred             EEeeCCCCChhhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          362 VFDYMPHGSLATFLHARG----PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ++|||++|+|..||++..    ....++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...|||+|||+|+.
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchhHh
Confidence            999999999999998762    234689999999999999999999995 999999999999999999999999999995


Q ss_pred             cccccccceeee-cCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          438 MTAAANVNVIAT-AGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       438 ~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      +........... .-..+|||||.+..+.|+.|+|||||||++||++| |..||...+..++...+.   .++       
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~---~gg-------  921 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL---EGG-------  921 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH---hCC-------
Confidence            554444333333 34578999999999999999999999999999999 999998877665544332   222       


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                        .+..++.+++   .++++|..||+.+|++||+|..+++.+..+..
T Consensus       922 --RL~~P~~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 --RLDPPSYCPE---KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             --ccCCCCCCCh---HHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence              1223334444   55588889999999999999999998887753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.5e-44  Score=319.06  Aligned_cols=265  Identities=24%  Similarity=0.339  Sum_probs=209.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc--HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG--QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +|...+.+|+|.||.||+|++. +|+.||||+++.....+  .....+|++.|+.++|+||+.++++|.. .+...+|+|
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVfE   81 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVFE   81 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEEE
Confidence            4677899999999999999975 89999999997653322  3567899999999999999999999986 678999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ||+ .+|+..++.+  ...++..++..++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+++.+......
T Consensus        82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            995 4999999765  45789999999999999999999995 9999999999999999999999999999988765544


Q ss_pred             ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh----
Q 008031          445 NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM----  519 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  519 (580)
                      ... .+-|.+|+|||++.+ +.|+...|+||.||++.||+-|.+-|.+.++-+-...+-+.........|-+..-+    
T Consensus       158 ~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  158 QTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            332 367899999997765 57999999999999999999999888877665444443333322111111111110    


Q ss_pred             --ccCC------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          520 --RDAP------TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       520 --~~~~------~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                        ...|      ..+....+.++++.++|..||.+|+|+.|++++=-
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y  283 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY  283 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence              1011      12233456689999999999999999999988643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=350.86  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=210.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+++.||+|+|++|++|+.. +++++|||++.+...   ...+.+.+|-.+|.+| .||.|++++..|++ +..+|+|+
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~~sLYFvL  153 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-EESLYFVL  153 (604)
T ss_pred             cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-ccceEEEE
Confidence            456899999999999999875 799999999865432   2234577899999999 89999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++++.+   .+++...+.++.+|+.||+|||++ |||||||||+|||+|.++++||+|||.|+.+.....
T Consensus       154 e~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  154 EYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            9999999999999864   799999999999999999999995 999999999999999999999999999987754221


Q ss_pred             c----------c--eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          444 V----------N--VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       444 ~----------~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      .          .  ...++||..|.+||++..+..+..+|+|+|||++|+|+.|++||.+.++.-+.+.+-+.       
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-------  302 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-------  302 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-------
Confidence            1          1  14578999999999999999999999999999999999999999998876666655442       


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                         +..+...++      ..+.+|+.+.|-.||.+|+|..+|.+|.
T Consensus       303 ---~y~fp~~fp------~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  303 ---DYEFPEGFP------EDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ---cccCCCCCC------HHHHHHHHHHHccCccccccHHHHhhCc
Confidence               122222222      2556778899999999999999999885

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=353.71  Aligned_cols=245  Identities=28%  Similarity=0.463  Sum_probs=205.2

Q ss_pred             hhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ..+-+|.|+.|.||+|+++ ++.||||+++.-.       ..+|+-|++|+|+||+.|.|+|.. ...+|||||||..|.
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq-sPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ-SPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC-CceeEEeeecccccc
Confidence            4578999999999999998 7899999875432       357889999999999999999987 558999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeec
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA  450 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  450 (580)
                      |+..|+..   .+++-.....|.++||.|+.|||.+ .|||||||.-||||+.+..|||+|||-++...+.  ...+.+.
T Consensus       199 L~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA  272 (904)
T ss_pred             HHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence            99999874   4788889999999999999999997 8999999999999999999999999999876554  4455789


Q ss_pred             CccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHH
Q 008031          451 GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL  530 (580)
Q Consensus       451 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  530 (580)
                      ||..|||||++.+...+.|+||||||||||||+||..||.+.+...+.--+..    .    .+.      .+....+..
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs----N----sL~------LpvPstcP~  338 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS----N----SLH------LPVPSTCPD  338 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC----C----ccc------ccCcccCch
Confidence            99999999999999999999999999999999999999987765543332221    1    111      111122233


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          531 NTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       531 ~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .+.-|+.+||+-.|..||||.+++.||+-..++-
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            5556888999999999999999999998776543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=351.12  Aligned_cols=248  Identities=22%  Similarity=0.338  Sum_probs=209.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |+..+.||+|+.|.||.|... +++.||||.+........+-+..|+.+|+..+|+|||.+++.+.. +++.|.|||||+
T Consensus       275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVVMEym~  353 (550)
T KOG0578|consen  275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-GDELWVVMEYME  353 (550)
T ss_pred             hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-cceeEEEEeecC
Confidence            555688999999999999864 788999999976655556678899999999999999999999987 578999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      ||+|.|.+...    .+++.++..|+.++++||+|||. +||+|||||.+|||++.+|.+||+|||++..+..... +..
T Consensus       354 ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~  427 (550)
T KOG0578|consen  354 GGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRS  427 (550)
T ss_pred             CCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccc
Confidence            99999999864    59999999999999999999999 5999999999999999999999999999987766544 444


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..+||+.|||||++....|++|.||||||++++||+.|++||-..+   ..+.+..+...+.+.          ......
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---PlrAlyLIa~ng~P~----------lk~~~k  494 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATNGTPK----------LKNPEK  494 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHHHHHHHhhcCCCC----------cCCccc
Confidence            5689999999999999999999999999999999999999996533   334344333333221          111222


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....+.+++.+||..|+++||++.|+++|
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            33466788889999999999999999986

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=348.74  Aligned_cols=258  Identities=29%  Similarity=0.420  Sum_probs=204.5

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .....+.||+|.||+||+|.+.+  .||||++......  ..+.|+.|+.++++=+|.||+-+.|+|.. + ...||+.|
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-p-~~AIiTqw  468 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-P-PLAIITQW  468 (678)
T ss_pred             Hhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-C-ceeeeehh
Confidence            34568899999999999999973  5999999755433  34679999999999999999999999986 3 45999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc-ccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA-ANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  444 (580)
                      |+|-+|+.+++-..  ..|+..+.+.||.|||+|+.|||. ++|+|||||+.||++.+++.|||+|||++...... ...
T Consensus       469 CeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            99999999998763  568999999999999999999999 59999999999999999999999999998754332 111


Q ss_pred             ceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          445 NVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ......|...|||||++.   ...|++.+||||||+|+|||++|..||...+...+.-.+.+    ++.    -+.....
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr----G~l----~pd~s~~  617 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR----GYL----MPDLSKI  617 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc----ccc----Cccchhh
Confidence            222335778899999875   45788999999999999999999999985444333322222    111    0111111


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ..   +..+++.+|+..||.+++++||.+.+|+..|+.+.+.
T Consensus       618 ~s---~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  618 RS---NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             hc---cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            12   2334666788899999999999999999999998764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=346.42  Aligned_cols=262  Identities=23%  Similarity=0.397  Sum_probs=219.1

Q ss_pred             ccCHHHHHHhhhccccccCceEEEEEEeC---CCC--EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEEC
Q 008031          281 MFTADDLLCATAEIMGKSTYGTVYKATLE---DGS--QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLG  354 (580)
Q Consensus       281 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  354 (580)
                      -|..+....+..++||+|.||.||+|.+.   .|.  .||||.-+.... ++.+.|..|+.+|+.++||||++++|+|.+
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            45555556677899999999999999874   233  489998887544 445679999999999999999999999975


Q ss_pred             CCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccc
Q 008031          355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL  434 (580)
Q Consensus       355 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~  434 (580)
                        ...|||||.++.|.|..||+..  ...++......++.||+.||+|||+. .+|||||.++|||+....-||++|||+
T Consensus       463 --~P~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  463 --QPMWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             --cceeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccch
Confidence              5799999999999999999876  35688899999999999999999995 999999999999999999999999999


Q ss_pred             ccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          435 SRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       435 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      ++.+.+...++.....-++.|||||.++..+++.++|||.|||++||+++ |..||.+....+..-.+.   +++     
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE---nGe-----  609 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE---NGE-----  609 (974)
T ss_pred             hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec---CCC-----
Confidence            99888777666655566778999999999999999999999999999999 999998876655433222   111     


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                          ..+.++.   +...++.++.+||.++|.+||.+.++...|+++.+
T Consensus       610 ----RlP~P~n---CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  610 ----RLPCPPN---CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ----CCCCCCC---CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                1222333   34456678889999999999999999999998876

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-42  Score=351.69  Aligned_cols=263  Identities=26%  Similarity=0.407  Sum_probs=204.9

Q ss_pred             HHHHhhhccccccCceEEEEEEe------CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCC
Q 008031          286 DLLCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKG  357 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  357 (580)
                      ...|.+.+.||+|+||.||+|.+      .+++.||||+++.... .....+.+|+.++.++ +||||++++++|....+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            34567789999999999999974      2356899999875433 2345688999999999 89999999999987566


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCC---------------------------------------------------------
Q 008031          358 EKLLVFDYMPHGSLATFLHARGP---------------------------------------------------------  380 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  380 (580)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            78999999999999999975321                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-ceeeecCccccCC
Q 008031          381 --ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-NVIATAGALGYRA  457 (580)
Q Consensus       381 --~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~a  457 (580)
                        ...+++.++..++.||++||+|||+ +||+||||||+||+++.++.+||+|||+++........ ......++..|+|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence              1347888999999999999999999 59999999999999999999999999999765332221 1112345678999


Q ss_pred             ccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHH
Q 008031          458 PELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLA  536 (580)
Q Consensus       458 PE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  536 (580)
                      ||++.+..++.++|||||||++|||++ |..||......+.  .......+..         .....   .....+.+++
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~~~~~~---------~~~~~---~~~~~l~~li  310 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQRLKDGTR---------MRAPE---NATPEIYRIM  310 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHHHhcCCC---------CCCCC---CCCHHHHHHH
Confidence            999998999999999999999999997 9999976543221  1111111110         00011   1123567899


Q ss_pred             hhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          537 LHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       537 ~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      .+||+.||++|||+.|+++.|+.+..+
T Consensus       311 ~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         311 LACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=332.30  Aligned_cols=257  Identities=22%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|+..+.||.|..++||+|+.. .+..||||++.-... .+-+.+.+|+..|..++||||++++..|.. +...|+||.|
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvVmpf  105 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVVMPF  105 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEeehh
Confidence            4677899999999999999864 789999999964433 335789999999999999999999999987 6699999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  444 (580)
                      |.+|++.+.+....+.. +++..+..|++++++||.|||.+ |.+|||||+.|||++.+|.|||+|||.+..+...+.. 
T Consensus       106 Ma~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence            99999999998865443 89999999999999999999995 9999999999999999999999999987655443321 


Q ss_pred             --ceeeecCccccCCccccc--cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc---ccchh
Q 008031          445 --NVIATAGALGYRAPELSK--LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE---VFDLE  517 (580)
Q Consensus       445 --~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  517 (580)
                        ....++||++|||||++.  ...|+.|+||||||+...||.+|..||..+.+..+.-   ..+++..+.-   ..+..
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl---~tLqn~pp~~~t~~~~~d  260 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL---LTLQNDPPTLLTSGLDKD  260 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH---HHhcCCCCCcccccCChH
Confidence              113458999999999844  4578999999999999999999999998877543222   2222221100   00111


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...      .....+.+++..|++.||.+|||+++++++
T Consensus       261 ~~k------~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  261 EDK------KFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             Hhh------hhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            100      112367788889999999999999999876

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=352.34  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=207.8

Q ss_pred             hhccccccCceEEEEEEeCC--C--CE-EEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          291 TAEIMGKSTYGTVYKATLED--G--SQ-VAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ..+.||+|+||.||+|.+..  +  .. ||||..+...   .....+|.+|+++|+.++|||||+++|++.. ....++|
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~-~~Pl~iv  239 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL-EEPLMLV  239 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCccEEE
Confidence            34899999999999998752  2  23 8999988522   3455789999999999999999999999987 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      ||+|+||+|.++|++.+  ..++..++++++.+.|.||+|||++ +++||||.++|+|++.++.+||+|||+++.-....
T Consensus       240 mEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV  316 (474)
T ss_pred             EEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence            99999999999999864  2689999999999999999999995 99999999999999999989999999987543111


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ... ....-+.+|+|||.+....|+.++|||||||++||+++ |..||.+....++..++.   ..+++..        .
T Consensus       317 ~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~---~~~~r~~--------~  384 (474)
T KOG0194|consen  317 MKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV---KNGYRMP--------I  384 (474)
T ss_pred             ecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH---hcCccCC--------C
Confidence            111 01235678999999999999999999999999999999 899999887665555442   2222211        1


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                      ....+.   .+..++.+||..+|+.||||.++.+.|+.+......
T Consensus       385 ~~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  385 PSKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             CCCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            122223   445677799999999999999999999998766543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.1e-42  Score=338.33  Aligned_cols=258  Identities=21%  Similarity=0.340  Sum_probs=205.8

Q ss_pred             cCHHHHHHhhhccccccCceEEEEEEeCCCCEEEEEEcccccccc---HHHHHHHHHHHhcCCCCcceeeeeEEEC--C-
Q 008031          282 FTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKG---QREFESEVSLLGKIRHPNLLALRAYYLG--P-  355 (580)
Q Consensus       282 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~--~-  355 (580)
                      .+.+++.......||+|++|.||+|.+. |+.||||.++......   .+.+.+|+.++++++||||+++++++.+  . 
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   93 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD   93 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence            3455554455578999999999999984 8999999997553333   3567899999999999999999999875  2 


Q ss_pred             CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          356 KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       356 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      ....++||||+++|+|.+++++.   ..+++....+++.|++.|+.|||+..+++||||||+||++++++.+||+|||++
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence            23678999999999999999864   368899999999999999999997448999999999999999999999999998


Q ss_pred             cccccccccceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      +......    ....++..|+|||++.+  ..++.++|||||||++|||++|+.||...+..+...   .+.......  
T Consensus       171 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~---~i~~~~~~~--  241 (283)
T PHA02988        171 KILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD---LIINKNNSL--  241 (283)
T ss_pred             hhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhcCCCC--
Confidence            7654322    12457889999999876  689999999999999999999999998765333222   222211110  


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                         .    .+  ......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       242 ---~----~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        242 ---K----LP--LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ---C----CC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence               0    11  012235678888999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=345.01  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=203.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccc----cc-ccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREK----IT-KGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~l  361 (580)
                      |...+.||+|.||.|+.|.+. +|..||+|++...    .. ...+.+.+|+.++++++ ||||++++.++.. ....++
T Consensus        19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-~~~~~i   97 (370)
T KOG0583|consen   19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-PTKIYI   97 (370)
T ss_pred             eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-CCeEEE
Confidence            556789999999999999875 7899999977553    11 23456778999999998 9999999999987 557999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-CCeEEeeccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-TNAKISDFGLSRLMTA  440 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~  440 (580)
                      ||||+.||+|.+++...   .++.+..+..++.|+++|++|||+ +||+||||||+|||++.+ +++||+|||++.... 
T Consensus        98 vmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-  172 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-  172 (370)
T ss_pred             EEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence            99999999999999884   368889999999999999999999 499999999999999998 999999999998774 


Q ss_pred             ccccceeeecCccccCCccccccCC-CC-CcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          441 AANVNVIATAGALGYRAPELSKLKK-AN-TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ..........||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||++.+..   .....+..+...        
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~ki~~~~~~--------  241 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYRKIRKGEFK--------  241 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHHHHhcCCcc--------
Confidence            2233344578999999999999877 76 6899999999999999999999874433   333333322211        


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                         .+.... ..++..++.+|+..||.+|+|+.+++++=+
T Consensus       242 ---~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w  277 (370)
T KOG0583|consen  242 ---IPSYLL-SPEARSLIEKMLVPDPSTRITLLEILEHPW  277 (370)
T ss_pred             ---CCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence               111100 346778899999999999999999995443

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-44  Score=340.51  Aligned_cols=248  Identities=26%  Similarity=0.421  Sum_probs=207.3

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|+..+.||+|.||.||+|.+. +++.||+|++.-... +..+++++|+.++.+++++||.++|+.+.. +..++++|||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMey   92 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIMEY   92 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHHH
Confidence            3555689999999999999986 789999999975443 445789999999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      |.||++.+.++...   .+++..+.-++.+++.|+.|||+ ++.+|||||+.||++..+|.+|++|||.+-.+.......
T Consensus        93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            99999999998642   44777888899999999999999 599999999999999999999999999998776655544


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                       ..++||+.|||||++....|+.|+||||+|++.+||.+|.+|+.+..+......+.+         ...|.+.+     
T Consensus       169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---------~~PP~L~~-----  233 (467)
T KOG0201|consen  169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---------SAPPRLDG-----  233 (467)
T ss_pred             -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---------CCCCcccc-----
Confidence             568899999999999999999999999999999999999999988766432222211         11111111     


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       .....+.+++..||++||+.|||++++++|
T Consensus       234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence             233457788999999999999999999876

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.7e-43  Score=342.74  Aligned_cols=246  Identities=24%  Similarity=0.372  Sum_probs=209.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|.||.||||+-+ +.+.||+|.+.+...  ++.+.+.+|++++++++||||+.++++|.. ..++|+|+||
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVte~   82 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVTEY   82 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEehh
Confidence            566788999999999999876 788999999865433  345678999999999999999999999986 6799999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +.| +|..++...   ..++++.+..++.+++.||.|||++ +|+|||+||+|||++.++++|+||||+|+-+... ...
T Consensus        83 a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v  156 (808)
T KOG0597|consen   83 AVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV  156 (808)
T ss_pred             hhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence            976 999999875   4689999999999999999999996 9999999999999999999999999999977653 334


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+-|||||+..+..|+..+|+||+||++||+++|++||-..   .+.+.++.+..+...             ..
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~d~v~-------------~p  220 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILKDPVK-------------PP  220 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhcCCCC-------------Cc
Confidence            45678999999999999999999999999999999999999999643   355566555443211             11


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ......+..++...+.+||..|.|+.+++.|=
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence            13445777888899999999999999998763

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=312.27  Aligned_cols=234  Identities=25%  Similarity=0.368  Sum_probs=197.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +++.+.||.|+||.|-.++.+ +|..+|+|++....-   +..+....|..+|+.+.||+++++++.+.+ .+..++|||
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~lymvme  124 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNLYMVME  124 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeEEEEEe
Confidence            567899999999999999986 788999999976532   334567889999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |++||.|.+++++.+   ++++..++.+|.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.....   
T Consensus       125 yv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             ccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            999999999999864   799999999999999999999995 9999999999999999999999999999876433   


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       ..+.+||+.|+|||++....|+.++|.|||||++|||+.|.+||...+...+.+   ++..++..          -++.
T Consensus       198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~---KI~~~~v~----------fP~~  263 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE---KILEGKVK----------FPSY  263 (355)
T ss_pred             -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH---HHHhCccc----------CCcc
Confidence             556789999999999999999999999999999999999999998877644333   33333211          1112


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCC
Q 008031          525 IGDELLNTLKLALHCVDPSPSAR  547 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~R  547 (580)
                      ...   ++.+|+.+.++.|-.+|
T Consensus       264 fs~---~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  264 FSS---DAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cCH---HHHHHHHHHHhhhhHhh
Confidence            222   44567778888888888

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-42  Score=345.30  Aligned_cols=248  Identities=26%  Similarity=0.399  Sum_probs=207.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |..++.||+|+.|.|-.|++. +|+.+|||++.+...   .....+.+|+-+|+.+.||||+++++.+.+ +.++|+|.|
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylvlE   92 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLVLE   92 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEEEE
Confidence            456799999999999999975 899999999976532   234568999999999999999999999987 679999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|.|.+++-+++   ++++.++++++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|......  .
T Consensus        93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--k  166 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--K  166 (786)
T ss_pred             ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCC--c
Confidence            999999999998864   788999999999999999999995 9999999999999999888999999999865432  2


Q ss_pred             ceeeecCccccCCccccccCCCC-CcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKAN-TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      -..+.+|+++|.|||++.+..|+ .++||||.||+||.|+||+.||++.+   +...+.+..++.+-             
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~G~f~-------------  230 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQRGVFE-------------  230 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCccc-------------
Confidence            23346799999999999999886 58999999999999999999998544   55555444443321             


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ....-..++.+|+.+|+..||++|.|+.||.+|-.-
T Consensus       231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence            111222356678889999999999999999998643

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-42  Score=324.78  Aligned_cols=252  Identities=24%  Similarity=0.411  Sum_probs=212.6

Q ss_pred             HHHhhhccccccCceEEEEEEe-CCCCEEEEEEccccccccHH---HHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQR---EFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      -+|++.+.+|+|.||.|-+|.. ..|+.||||.+++...++++   .+.+|+++|..|+||||+.++.+|.. .+...||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIviv  131 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVIV  131 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEEE
Confidence            4588899999999999999986 58999999999876655554   46899999999999999999999976 6789999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||..+|.|+||+.+++   .+++.+...++.||.+|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+....
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999998864   799999999999999999999997 99999999999999999999999999998876544


Q ss_pred             ccceeeecCccccCCccccccCCCC-CcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          443 NVNVIATAGALGYRAPELSKLKKAN-TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ..  .+++|++-|.+||++++..|. +.+|-||+|++||-|..|..||++.+...+   +.++-.+.+++          
T Consensus       208 fL--qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l---vrQIs~GaYrE----------  272 (668)
T KOG0611|consen  208 FL--QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL---VRQISRGAYRE----------  272 (668)
T ss_pred             HH--HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH---HHHhhcccccC----------
Confidence            33  357899999999999998885 679999999999999999999988765443   33443443321          


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                       |..+.   ...-||.+||..+|++|.|+.+|..|-+-=..
T Consensus       273 -P~~PS---dA~gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  273 -PETPS---DASGLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             -CCCCc---hHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence             11122   23357779999999999999999999765433

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.3e-41  Score=331.85  Aligned_cols=262  Identities=26%  Similarity=0.334  Sum_probs=204.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|... +|+.||+|.+.....   .....+.+|++++++++|++|+++++++.+ ++..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEEE
Confidence            345688999999999999875 799999999864322   223457889999999999999999999876 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......  
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            999999998886543 2358899999999999999999999 599999999999999999999999999997653322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......|+..|+|||++.+..++.++||||+||++|||++|+.||...........+.........      ..   ...
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~---~~~  227 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE------EY---SEK  227 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc------cC---Ccc
Confidence            122346899999999999999999999999999999999999999876543332222221111100      00   011


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH--Hhhhccccccc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQ--LEEIRPEAATA  567 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~--L~~~~~~~~~~  567 (580)
                         ....+.+++.+||+.||++||+     +++++++  ++.+..+..+.
T Consensus       228 ---~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~  274 (285)
T cd05631         228 ---FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEA  274 (285)
T ss_pred             ---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHh
Confidence               1235667888999999999997     8888886  44544443333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.6e-41  Score=330.80  Aligned_cols=250  Identities=22%  Similarity=0.285  Sum_probs=203.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +.+...||+|+||.||.|+-+ +|..+|+|++++..-   ...+.+..|-.+|...++|.||+++..|++ .+++|+|||
T Consensus       143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~LYLiME  221 (550)
T KOG0605|consen  143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYLYLIME  221 (550)
T ss_pred             chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCeeEEEEE
Confidence            567889999999999999876 799999999986543   344668899999999999999999999987 679999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc----
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA----  440 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~----  440 (580)
                      |++||++..+|...   ..+++..+..++.+++-|++.+|+. |++||||||+|+|||..|++||+|||+|.-...    
T Consensus       222 ylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  222 YLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             ecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            99999999999885   4799999999999999999999995 999999999999999999999999999843211    


Q ss_pred             ------------------cccc------------------------ceeeecCccccCCccccccCCCCCcccchhHHHH
Q 008031          441 ------------------AANV------------------------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVT  478 (580)
Q Consensus       441 ------------------~~~~------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~  478 (580)
                                        ....                        ....++||+-|||||++.+..|+..+|+||+||+
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                              0000                        0013579999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 008031          479 ILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPE---VLQVVQ  555 (580)
Q Consensus       479 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ev~~  555 (580)
                      +|||+.|.+||...+..+....+......-            .+|...+...+..+||.+|+. ||++|.-   +.||.+
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l------------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETL------------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhc------------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            999999999998776555444433322111            112222223567788999998 9999975   666666


Q ss_pred             H
Q 008031          556 Q  556 (580)
Q Consensus       556 ~  556 (580)
                      |
T Consensus       445 H  445 (550)
T KOG0605|consen  445 H  445 (550)
T ss_pred             C
Confidence            5

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.1e-41  Score=310.57  Aligned_cols=266  Identities=26%  Similarity=0.316  Sum_probs=208.9

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc--HHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG--QREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLV  362 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv  362 (580)
                      ..|+..+.|++|+||.||+|++. +++.||+|+++......  .-...+||.+|.+++|||||.+..+.... -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            35778899999999999999986 78899999998654332  23457999999999999999999988763 3468999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      ||||++ +|.+.++..+  +++...++.-+..|+++|++|||.+ .|+|||||++|+|+++.|.+||+|||+|+.++...
T Consensus       156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999987 9999998864  6799999999999999999999996 99999999999999999999999999999887653


Q ss_pred             ccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---ccccchh-
Q 008031          443 NVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEVFDLE-  517 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-  517 (580)
                       ...+..+-|.+|+|||++.+ ..|+++.|+||+||++.||+++++-|.+..+.+-.+.+-..+....-   ....... 
T Consensus       232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence             33445677999999998765 57999999999999999999999999887665544444433321100   0000111 


Q ss_pred             -------------hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          518 -------------LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       518 -------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                                   +.+.++... -...-.+|+..++.+||.+|.|+.|.+++=.
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h~~  363 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKHEY  363 (419)
T ss_pred             hhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcccc
Confidence                         011111111 1134567888999999999999999998743

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-40  Score=333.11  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=201.9

Q ss_pred             HHhhhccccccCceEEEEEEeCC-----------------CCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeee
Q 008031          288 LCATAEIMGKSTYGTVYKATLED-----------------GSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALR  349 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~  349 (580)
                      .|.+.+.||+|+||.||+|.+++                 +..||+|.+...... ...++.+|++++++++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            35567899999999999998532                 336999998764333 345789999999999999999999


Q ss_pred             eEEECCCCcEEEEEeeCCCCChhhhhhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCC
Q 008031          350 AYYLGPKGEKLLVFDYMPHGSLATFLHARG----------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN  413 (580)
Q Consensus       350 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~D  413 (580)
                      +++.+ .+..++||||+++|+|.+++....                ....+++..+.+++.||+.||+|||+. ||+|||
T Consensus        86 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~ivH~d  163 (304)
T cd05096          86 GVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-NFVHRD  163 (304)
T ss_pred             EEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-CccccC
Confidence            99987 568999999999999999986531                113478889999999999999999995 999999


Q ss_pred             CCCCCeeeCCCCCeEEeecccccccccccccce-eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc--CCCCCC
Q 008031          414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV-IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT--GKSPGE  490 (580)
Q Consensus       414 lk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~  490 (580)
                      |||+||+++.++.+||+|||+++.......... ....++..|+|||.+.++.++.++||||||+++|||++  +..||.
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            999999999999999999999976543322211 12235778999999988899999999999999999987  667887


Q ss_pred             CCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          491 PLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      .....+....+............     ....+.   ....+.+++.+||+.||++|||+.++.+.|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         244 ELTDEQVIENAGEFFRDQGRQVY-----LFRPPP---CPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCHHHHHHHHHHHhhhcccccc-----ccCCCC---CCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            76555444443332221111000     001111   12356789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=318.02  Aligned_cols=262  Identities=26%  Similarity=0.420  Sum_probs=195.5

Q ss_pred             hhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhc--CCCCcceeeeeEEECCC---CcEEEEEe
Q 008031          290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGK--IRHPNLLALRAYYLGPK---GEKLLVFD  364 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---~~~~lv~e  364 (580)
                      ...+.||+|+||.||+|++. ++.||||++...   +.+.|..|-++.+.  ++|+||+++++.-....   -++++|+|
T Consensus       213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            45688999999999999998 699999998654   34556666666655  58999999998865421   26899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN--------ENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      |.+.|+|.+||..+    .++|....+++..+++||+|||+.        ++|+|||||++||||.+|++..|+|||+|.
T Consensus       289 fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  289 FHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999875    699999999999999999999974        689999999999999999999999999998


Q ss_pred             cccccccc-ceeeecCccccCCccccccCCCC------CcccchhHHHHHHHHHcCCCCCCC--CCCCCh----------
Q 008031          437 LMTAAANV-NVIATAGALGYRAPELSKLKKAN------TKTDVYSLGVTILELLTGKSPGEP--LNGAEL----------  497 (580)
Q Consensus       437 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~------~~~Dv~s~G~~l~el~tg~~p~~~--~~~~~~----------  497 (580)
                      .+...... .....+||.+|||||++.+...-      .+.||||+|.|+|||++...-+.+  .++..+          
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            87644332 23347899999999998764322      258999999999999997655421  111111          


Q ss_pred             -hHHHHHH-hhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          498 -PQWVASI-VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       498 -~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                       ...+... ++.+.+..+  +..++..    ..+..+.+.++.||++||+.|.|+.=+-+.+.++..-..
T Consensus       445 t~e~mq~~VV~kK~RP~~--p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKI--PDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CHHHHHHHHHhhccCCCC--hhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence             0111111 111111111  1111111    234567788999999999999999988888888764443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-41  Score=320.78  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=200.2

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhc--CCCCcceeeeeEEECCCC---cEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGK--IRHPNLLALRAYYLGPKG---EKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~---~~~lv~  363 (580)
                      ....+.||+|.||.||+|.++ |..||||++...   +++.+.+|.++...  |+|+||+.+++.-..+.+   ++|+|+
T Consensus       213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT  288 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT  288 (513)
T ss_pred             eEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence            345789999999999999999 899999998654   44556677777665  599999999987655333   579999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-------ENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      +|.+.|+|+|||...    +++....++++..+|.||++||-.       +.|.|||||+.||||..++.+.|+|+|+|-
T Consensus       289 dYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             ecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            999999999999874    799999999999999999999942       789999999999999999999999999998


Q ss_pred             ccccccc---cceeeecCccccCCccccccCC----C--CCcccchhHHHHHHHHHcC----------CCCCCCCCCCCh
Q 008031          437 LMTAAAN---VNVIATAGALGYRAPELSKLKK----A--NTKTDVYSLGVTILELLTG----------KSPGEPLNGAEL  497 (580)
Q Consensus       437 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~----~--~~~~Dv~s~G~~l~el~tg----------~~p~~~~~~~~~  497 (580)
                      .+.....   ......+||.+|||||++...-    +  ...+||||||.++||+...          +.||.+..+.+.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            7755432   2333468999999999876432    1  1258999999999998863          357766543332


Q ss_pred             h-HHHHHHhhhhccccccchhhhccCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          498 P-QWVASIVKEEWTNEVFDLELMRDAP---TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       498 ~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      . +.+.+        -+...++.+..|   ...+.+..+.++|..||..+|..|.|+-.+.+.|.++..
T Consensus       445 s~eeMrk--------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  445 SFEEMRK--------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CHHHHhc--------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            1 11111        111222211111   234678889999999999999999999999999988764

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.1e-41  Score=328.12  Aligned_cols=254  Identities=22%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             HHhhhccccccCceEEEEEEeC----CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+.    .+..||+|.++..... ....+.+|+..+++++||||+++++++.. .+..++|
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   84 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMMIV   84 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcEEE
Confidence            4567889999999999999763    3568999998765432 34568999999999999999999999986 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++....  ..+++.+++.++.|++.||+|||+ +|++||||||+||+++.++.+|++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            99999999999997642  468999999999999999999999 599999999999999999999999999876543222


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+....+.    ....     ..   .
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~----~~~~-----~~---~  229 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE----DGFR-----LP---A  229 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH----CCCC-----CC---C
Confidence            121222335678999999999999999999999999999876 999998765443333221    1110     00   0


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ...   ....+.+++.+||+.+|++|||+.++.+.|+++
T Consensus       230 ~~~---~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         230 PRN---CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCC---CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            111   223566788899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=326.07  Aligned_cols=258  Identities=26%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--------------cHHHHHHHHHHHhcCCCCcceeeeeEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--------------GQREFESEVSLLGKIRHPNLLALRAYY  352 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~~~~~~  352 (580)
                      +|++.+.||+|.||.|-+|+.. +++.||||++.+....              ..+...+|+.+|++++|||||+++++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            4778899999999999999986 7999999999643211              124678999999999999999999999


Q ss_pred             ECC-CCcEEEEEeeCCCCChhhhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          353 LGP-KGEKLLVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       353 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                      .+. .+.+|||+|||..|.+...-.    ..+ +++.++++++.++..||+|||. +||+||||||+|+|++++|+|||+
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcCCCcEEee
Confidence            764 346899999999887754322    234 8999999999999999999999 699999999999999999999999


Q ss_pred             ecccccccccc----cccceeeecCccccCCccccccCC----CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHH
Q 008031          431 DFGLSRLMTAA----ANVNVIATAGALGYRAPELSKLKK----ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       431 Dfg~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~  502 (580)
                      |||.+..+...    ........+||+.|+|||.+.++.    .+.+.||||+||+||+|+.|+.||-+....   ....
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---~l~~  329 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---ELFD  329 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---HHHH
Confidence            99998866322    112233478999999999877632    345789999999999999999999764433   3333


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      +++....           .+|..++....+.+||.++|.+||+.|.+..+|..|.+..+...
T Consensus       330 KIvn~pL-----------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  330 KIVNDPL-----------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             HHhcCcc-----------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            3332211           13333344456778999999999999999999999998877633

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-40  Score=314.09  Aligned_cols=271  Identities=23%  Similarity=0.341  Sum_probs=207.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCc-ceeeeeEEECCCC-----c
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPN-LLALRAYYLGPKG-----E  358 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~-----~  358 (580)
                      .|+..++||+|+||+||+|+.. +|+.||+|+++-...  .......+|+.+++.++|+| |+.+++++.....     .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            3566788999999999999976 899999999875433  24456789999999999999 9999999987442     7


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPE-TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      .++|+||++ -+|.+++...... ..++...+..++.||++||+|||++ +|+||||||+|||++++|.+||+|||+|+.
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchHHH
Confidence            889999995 4999999876432 3466788999999999999999996 999999999999999999999999999986


Q ss_pred             cccccccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh----hcccc
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE----EWTNE  512 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~  512 (580)
                      ..-.... ....++|.+|+|||++.+. .|+...||||+||+++||++++.-|.+..+.+....+-..+..    .|+..
T Consensus       170 ~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  170 FSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             hcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            6533222 3345789999999988776 7999999999999999999999999887764433333333221    12211


Q ss_pred             ccchhhh---cc---CCCcHH----HHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhc
Q 008031          513 VFDLELM---RD---APTIGD----ELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIR  561 (580)
Q Consensus       513 ~~~~~~~---~~---~~~~~~----~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~  561 (580)
                      ..-+..-   ..   ......    ......+++.+|++++|.+|.|++.+++|  +..+.
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            1100000   00   001111    11356789999999999999999999998  55553

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.9e-41  Score=336.50  Aligned_cols=242  Identities=23%  Similarity=0.319  Sum_probs=195.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.||+|+||.||++... +|+.||+|+++....   .....+.+|+.++++++||||+++++++.. .+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence            46899999999999875 789999999875432   223457889999999999999999999987 6689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++...... .....
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~  154 (323)
T cd05571          80 GELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT  154 (323)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence            9999998764   3689999999999999999999995 99999999999999999999999999987532221 12234


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...+......   .+.....       ..   ...   .
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~-------~~---p~~---~  218 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEI-------RF---PRT---L  218 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH---HHHcCCC-------CC---CCC---C
Confidence            568999999999999999999999999999999999999997644322222   1111110       01   111   1


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          529 LLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ..++.+++.+||+.||++||     ++.++++|
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            23566788899999999999     79998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=315.24  Aligned_cols=268  Identities=23%  Similarity=0.319  Sum_probs=204.5

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCcceeeeeEEEC----CCCcEEEEEe
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREK--ITKGQREFESEVSLLGKIRHPNLLALRAYYLG----PKGEKLLVFD  364 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~~lv~e  364 (580)
                      .+.||+|+||.|.++.+. +|+.||||++...  .....++..+|+++|+.++|+||+.+.+.+..    .-...|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            588999999999999986 8999999998733  23345677899999999999999999999875    2346899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc-c
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA-N  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  443 (580)
                      +| +.+|...++..   +.++...+..+++|+++||.|+|+ .+|+||||||.|++++.+..+||+|||+|+...... .
T Consensus       107 lM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  107 LM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             HH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            99 66999999874   359999999999999999999999 599999999999999999999999999999775432 2


Q ss_pred             cceeeecCccccCCcccc-ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh---ccc--------
Q 008031          444 VNVIATAGALGYRAPELS-KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE---WTN--------  511 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~--------  511 (580)
                      ..++..+.|.+|+|||++ ....|+.+.||||.||++.||++|++-|.+.+.-+-.+.+-......   ...        
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence            223456789999999975 46789999999999999999999999998765433322222211100   000        


Q ss_pred             cccc-------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhccccccc
Q 008031          512 EVFD-------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPEAATA  567 (580)
Q Consensus       512 ~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~~~~~  567 (580)
                      ..+.       ..+...++.   .-...++|+.+||..||.+|+|++|+++|  |+.+.....++
T Consensus       262 ~yi~slp~~p~~~f~~~fp~---a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPN---ANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCC---CCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            0000       000001111   22456788899999999999999999987  45555444443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-41  Score=298.36  Aligned_cols=248  Identities=25%  Similarity=0.356  Sum_probs=209.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +++++.+|+|.||.||.|+.+ ++-.||+|++.+..   ...+.++.+|+++-..|+||||.++|+++.+ ....|+++|
T Consensus        24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-~~riyLilE  102 (281)
T KOG0580|consen   24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-SKRIYLILE  102 (281)
T ss_pred             ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-cceeEEEEE
Confidence            467899999999999999976 67789999986543   2345789999999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |..+|++...|.... ...+++.....++.|+|.|+.|+|. ++|+||||||+|+|++..+.+|++|||.+...+   ..
T Consensus       103 ya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~  177 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN  177 (281)
T ss_pred             ecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence            999999999998543 3468888999999999999999999 599999999999999999999999999886543   23


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      +.....||.-|.+||+..+..++..+|+|++|++.||++.|.+||+.....+..+.+.+.       ...++        
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------~~~~p--------  242 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------DLKFP--------  242 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------cccCC--------
Confidence            344567999999999999999999999999999999999999999987766666655542       11111        


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                       ........++|.+|+.++|.+|.+..|++++=.
T Consensus       243 -~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  243 -STISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             -cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence             112235668999999999999999999998754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.6e-40  Score=320.86  Aligned_cols=250  Identities=22%  Similarity=0.393  Sum_probs=201.6

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +++.+.||+|+||.||++.+.++..+|+|.+... ......+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~~   83 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFMEN   83 (256)
T ss_pred             cEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcCCC
Confidence            4567889999999999999988889999988643 2345678899999999999999999999976 6689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.++++...  ..+++..+..++.|++.||+|||+. |++||||+|+||++++++.+|++|||.++............
T Consensus        84 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          84 GCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence            99999987642  3588999999999999999999995 99999999999999999999999999987654332222223


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+   ..+...   ..+      ..   
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i---~~~~~~---~~~------~~---  225 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---SRGFRL---YRP------KL---  225 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HCCCCC---CCC------CC---
Confidence            345668999999988889999999999999999999 99999765543333322   221111   000      01   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ...++.+++.+||+.+|.+|||+.++++.|.
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1235678999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=341.62  Aligned_cols=260  Identities=24%  Similarity=0.407  Sum_probs=216.1

Q ss_pred             HHHHHhhhccccccCceEEEEEEeC-CCC----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCc
Q 008031          285 DDLLCATAEIMGKSTYGTVYKATLE-DGS----QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       285 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  358 (580)
                      ++.+....++||+|+||+||+|.+- .|.    +||+|++..... +...++.+|+.+|.+++|||+++++|+|..+  .
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~  771 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--T  771 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--h
Confidence            4555566789999999999999873 444    689998866543 3467899999999999999999999999863  4


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      ..||++||+.|+|.||++..  +..+-.+..+.|..|||+||.|||. +++|||||.++||||.+...+||.|||+++..
T Consensus       772 ~qlvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            88999999999999999875  4568889999999999999999998 69999999999999999999999999999988


Q ss_pred             cccccccee-eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          439 TAAANVNVI-ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       439 ~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      ..+...... ...-.+.|||-|.+....|+.++|||||||.+||++| |..||.+....++...+...            
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g------------  916 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG------------  916 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc------------
Confidence            665443221 2233567999999999999999999999999999999 99999998887777665531            


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      +.   .+..+-...+++.++.+||..|+..||+|+++...+.++..+.
T Consensus       917 eR---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  917 ER---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             cc---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            11   1222334456778899999999999999999999998875443

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=333.85  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=212.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +...++||-|.||.||.|.|+ -.-.||||.+++.. -...+|.+|+.+|+.++|||+|+++|+|.. ...+|||+|||.
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~-EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EPPFYIITEFMC  346 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CCCeEEEEeccc
Confidence            456789999999999999997 45679999998653 346789999999999999999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+||++.. ...++.--.++++.||++|++||.. +++|||||.++|+|+.++..|||+|||+++++..+....+.
T Consensus       347 yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA  424 (1157)
T KOG4278|consen  347 YGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA  424 (1157)
T ss_pred             CccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence            999999999875 3446666788999999999999998 59999999999999999999999999999999877665555


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      +..-.+.|.|||.+....++.|+|||+|||+|||+.| |-.||.+.+-.+    +...+..+++.        ..+..++
T Consensus       425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----VY~LLEkgyRM--------~~PeGCP  492 (1157)
T KOG4278|consen  425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYGLLEKGYRM--------DGPEGCP  492 (1157)
T ss_pred             CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----HHHHHhccccc--------cCCCCCC
Confidence            5556778999999999999999999999999999999 888987765333    23333333321        1222222


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                         .++++||+.||+++|..||+|.|+-+.+|.+-.
T Consensus       493 ---pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  493 ---PKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ---HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence               356678889999999999999999999987643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-41  Score=331.49  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=198.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+.++++++||||+++++++.+ ++..++|||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e   81 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYMLME   81 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEEEe
Confidence            456789999999999999986 789999999864321   234568899999999999999999998876 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--  155 (291)
T cd05612          82 YVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--  155 (291)
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence            99999999999764   368899999999999999999999 499999999999999999999999999987654321  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                        ....|++.|+|||++.+..++.++||||+||++|+|++|+.||...+..+..+.   +.....       ..   ...
T Consensus       156 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~-------~~---~~~  220 (291)
T cd05612         156 --WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK---ILAGKL-------EF---PRH  220 (291)
T ss_pred             --ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCc-------CC---Ccc
Confidence              234689999999999988999999999999999999999999976543332222   221110       00   011


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQL  557 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~L  557 (580)
                      .   ...+.+++.+||+.||.+||+     +.++++|-
T Consensus       221 ~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         221 L---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             C---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence            1   225668888999999999995     99998885

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.2e-40  Score=321.34  Aligned_cols=255  Identities=22%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             HHHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          287 LLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      ..|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.. .+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEecC
Confidence            3466789999999999999998888899999886532 235678999999999999999999999876 66789999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.++++... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++++|||++...........
T Consensus        84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence            9999999997642 3458889999999999999999999 4999999999999999999999999999986644322222


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+....+.    .....     ..   ..  
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~----~~~~~-----~~---~~--  227 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ----RGYRM-----PR---ME--  227 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH----cCCCC-----CC---CC--
Confidence            22345678999999988889999999999999999998 999997654333222221    11110     00   01  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                       ....++.+++.+||+.+|++|||++++.+.|+++
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         228 -NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             1123567888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.6e-40  Score=320.45  Aligned_cols=257  Identities=24%  Similarity=0.395  Sum_probs=210.1

Q ss_pred             HHHHHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          285 DDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       285 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      ....|+..+.||+|+||.||+|.+.++..+|+|.+..........+.+|+.+++.++|+||+++++++.. ....++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEEEe
Confidence            3445788999999999999999998899999999976655556778999999999999999999999986 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++.... ...+++..+..++.|++.|++|||+ .|++|+||+|+||++++++.+|++|||.+.........
T Consensus        83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            999999999998643 3458999999999999999999999 59999999999999999999999999999766433222


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      . ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.   .. ...        ....
T Consensus       161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~-~~~--------~~~~  227 (261)
T cd05148         161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AG-YRM--------PCPA  227 (261)
T ss_pred             c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hC-CcC--------CCCC
Confidence            1 13345678999999988899999999999999999998 899997665433333222   11 100        0011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                         .....+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       228 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         228 ---KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               1223567888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-41  Score=329.71  Aligned_cols=250  Identities=20%  Similarity=0.351  Sum_probs=211.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.+|+|+||.++.++++ +++.+++|.+.-..  ....+...+|+.++++++|||||.+.+.+.+++...+|||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            567899999999999999876 78899999986443  233456889999999999999999999999855449999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ++||++.+.+.+.. ...++++.+..|+.|++.|+.|||++ .|+|||||+.||+++.++.||++|||+|+.+...... 
T Consensus        86 ~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~-  162 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL-  162 (426)
T ss_pred             cCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchhh-
Confidence            99999999998764 46799999999999999999999985 9999999999999999999999999999988766522 


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+.||.||++.+..|+.|+||||+||++|||++-+++|...+   ....+.++.....            .|..
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~~~~~------------~Plp  227 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKINRGLY------------SPLP  227 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHhhccC------------CCCC
Confidence            234679999999999999999999999999999999999999998655   4444444443321            1222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .....++..++..|++.+|+.||++.+++.+
T Consensus       228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            3345577788899999999999999999986

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=335.69  Aligned_cols=251  Identities=21%  Similarity=0.263  Sum_probs=201.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|+++....   .....+.+|+.++..++||||+++++++.. .+..++|||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e   81 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLAME   81 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEEEe
Confidence            456789999999999999986 689999999875432   234568899999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....    
T Consensus        82 ~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          82 YVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            99999999999764   3688999999999999999999994 999999999999999999999999999876543    


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+......     ...+......  
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~--  226 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-----LQRPVYDDPR--  226 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----ccCCCCCccc--
Confidence            222356899999999999999999999999999999999999999865543333322211100     0000000000  


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       .....++.+++.+||+.+|.+|||+.+++++
T Consensus       227 -~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 -FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             1122356678889999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=336.37  Aligned_cols=239  Identities=23%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +...++||+|.||.|+.+..+ +++.+|||++++...   ++.+..+.|.+++... +||.++.++.++++ .++.|+||
T Consensus       370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~~l~fvm  448 (694)
T KOG0694|consen  370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KEHLFFVM  448 (694)
T ss_pred             eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CCeEEEEE
Confidence            456789999999999999987 788999999987643   3455678888888887 59999999999987 77999999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+.||++..+.+.    ..+++..+..++..|+.||.|||++ ||+|||||.+|||+|.+|++||+|||+++.--.. .
T Consensus       449 ey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g  522 (694)
T KOG0694|consen  449 EYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-G  522 (694)
T ss_pred             EecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCC-C
Confidence            99999996666554    3699999999999999999999996 9999999999999999999999999999854322 2


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ....++.||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+.+++++..-+..   .+             ..
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~---d~-------------~~  586 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN---DE-------------VR  586 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---CC-------------CC
Confidence            245568999999999999999999999999999999999999999998887765554432   11             11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEV  550 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~  550 (580)
                      ...-...+.+.++.+++..+|++|.-+
T Consensus       587 yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCcccHHHHHHHHHHhccCcccccCC
Confidence            111233467788889999999999865

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-40  Score=335.07  Aligned_cols=243  Identities=21%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|.++....   ...+.+.+|+.++++++||||+++++++.. ++..++|||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e   98 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYFLLE   98 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEEEc
Confidence            567789999999999999986 689999999865321   234568899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++.......  
T Consensus        99 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         99 FVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             CCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            99999999999864   3578889999999999999999994 99999999999999999999999999998654322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                        ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+   ....+......       .   ...
T Consensus       173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~~~~~~-------~---p~~  237 (329)
T PTZ00263        173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEKILAGRLK-------F---PNW  237 (329)
T ss_pred             --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHHHhcCCcC-------C---CCC
Confidence              23468999999999999999999999999999999999999997644322   22222211100       0   001


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~  556 (580)
                      .   ...+.+++.+||+.||.+||+     +.++++|
T Consensus       238 ~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        238 F---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             C---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1   124568888999999999997     6888876

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.3e-40  Score=331.65  Aligned_cols=264  Identities=21%  Similarity=0.323  Sum_probs=202.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|+..+.||+|+||.||++.+. +|..||+|.+..... .....+.+|++++++++||||+++++++.. ++..++||||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   84 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEH   84 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEeec
Confidence            3566789999999999999986 788999999875432 234568999999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++|+|.+++...   ..+++..+..++.|++.||.|||+..+|+||||||+||+++.++.+||+|||++.......   
T Consensus        85 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  158 (331)
T cd06649          85 MDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (331)
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence            9999999999764   3588999999999999999999984369999999999999999999999999987553322   


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh---ccc-----------
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE---WTN-----------  511 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~-----------  511 (580)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...+..++...+.......   ...           
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            123468899999999999999999999999999999999999997544332222111100000   000           


Q ss_pred             ----------------cccchhhhccCCC--cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          512 ----------------EVFDLELMRDAPT--IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       512 ----------------~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                                      ...+.......+.  ......++.+++.+||+.||++|||+.|++++-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                            0000000000000  0012346778999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=333.63  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=211.3

Q ss_pred             HHHhhhccccccCceEEEEEEeC--CCC--EEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE--DGS--QVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      ..+...++||+|.||.|++|.|.  +|+  .||||.++..... ...+|.+|+.+|.+|+|+|++++||+..+  ...++
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mM  187 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMM  187 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhH
Confidence            34567899999999999999986  455  4899999866544 55789999999999999999999999985  47889


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      |||.++.|+|.+.|++ .....+-......++.|||.|+.||.+ +++|||||.++|+++-....|||+|||+.+-+...
T Consensus       188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            9999999999999998 446678889999999999999999999 59999999999999999999999999999987655


Q ss_pred             cccceeee--cCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          442 ANVNVIAT--AGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       442 ~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .....+..  .-.+.|+|||.+....|+.++|||+|||++|||+| |+.||-+.....+.+.+.+   +         +.
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~---~---------er  333 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA---G---------ER  333 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc---c---------cc
Confidence            44332221  23457999999999999999999999999999999 9999988877666555542   1         11


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      .....   .+.+++++++..||.++|++||||..+.+.+-..+
T Consensus       334 LpRPk---~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  334 LPRPK---YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             CCCCC---CChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            22233   34456778888999999999999999986554433

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.1e-40  Score=336.87  Aligned_cols=257  Identities=26%  Similarity=0.365  Sum_probs=200.3

Q ss_pred             HHhhhccccccCceEEEEEEe------CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      .|.+.+.||+|+||.||+|.+      .++..||||+++.... ...+.+.+|+++++.+ +||||++++++|.. .+..
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-~~~~  114 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-GGPT  114 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-CCcc
Confidence            467789999999999999974      2466899999875432 3345688999999999 89999999999977 6689


Q ss_pred             EEEEeeCCCCChhhhhhhcCC-----------------------------------------------------------
Q 008031          360 LLVFDYMPHGSLATFLHARGP-----------------------------------------------------------  380 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------------  380 (580)
                      ++||||+++|+|.++++....                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999865321                                                           


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          381 -------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       381 -------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                                   ...+++..+.+++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++...........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence                         1247888999999999999999999 59999999999999999999999999999765433222111


Q ss_pred             -eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          448 -ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       448 -~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                       ...++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+.........        .....
T Consensus       274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~--------~~~~~  342 (375)
T cd05104         274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIKEGYRML--------SPECA  342 (375)
T ss_pred             CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHHhCccCC--------CCCCC
Confidence             1234567999999999999999999999999999998 889987654321   1111112111100        00111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                         ..++.+++.+||+.||++|||+.|+++.|++.
T Consensus       343 ---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         343 ---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               13567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=303.60  Aligned_cols=254  Identities=23%  Similarity=0.300  Sum_probs=206.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREK--ITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .|.+.+.||+|.|+.||++... +|+.+|+|++...  ...+.+++.+|+++-+.|+||||+++...+.. .+..|+|+|
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~~ylvFe   90 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFD   90 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-cceeEEEEe
Confidence            4677899999999999999875 8999999987533  23356789999999999999999999999876 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC---CCCCeEEeecccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD---DSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +|+|++|..-+-.+   ..+++..+-..+.||+.||.|+|.+ +|||||+||+|+++-   ....+|++|||++....  
T Consensus        91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--  164 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--  164 (355)
T ss_pred             cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence            99999998665443   2577888889999999999999996 999999999999995   34569999999998877  


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ......+.+||++|||||++...+|+..+|||+.||+||-|+.|.+||.+.+...+.+.+.+   +.+   .++++.   
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~---g~y---d~~~~~---  235 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA---GAY---DYPSPE---  235 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc---ccc---CCCCcc---
Confidence            44556678999999999999999999999999999999999999999988665555444432   211   122222   


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ++..   .++..+|+.+||..||.+|.|+.|.++|=+-.
T Consensus       236 w~~i---s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~  271 (355)
T KOG0033|consen  236 WDTV---TPEAKSLIRRMLTVNPKKRITADEALKHPWIC  271 (355)
T ss_pred             cCcC---CHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence            2222   33555788899999999999999998875543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.5e-39  Score=327.89  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=194.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      +...+.||+|+||.||+|.+. +|+.||||++...... ....+.+|+++++.++|+||+++++++.. .+..++||||+
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~  154 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFM  154 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEecC
Confidence            456789999999999999976 7899999998654332 34568899999999999999999999976 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++|+|.+..       ..++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++....... ..
T Consensus       155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  225 (353)
T PLN00034        155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC  225 (353)
T ss_pred             CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence            999986532       345677889999999999999994 999999999999999999999999999986543221 12


Q ss_pred             eeecCccccCCcccccc-----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          447 IATAGALGYRAPELSKL-----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ....|+..|+|||.+..     ...+.++|||||||++|||++|+.||......+.......+......           
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  294 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP-----------  294 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC-----------
Confidence            23468999999998743     23456899999999999999999999854433332222222111100           


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                       ........++.+++.+||+.||++|||+.|++++-.-..
T Consensus       295 -~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        295 -EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             -CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence             001112236778899999999999999999999854333

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=318.59  Aligned_cols=253  Identities=25%  Similarity=0.432  Sum_probs=203.7

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.+.+.||+|+||.||+|.+.+++.||+|.++... ...+++.+|+.++++++|+||+++++++.. .+..+++|||+++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~   85 (261)
T cd05068           8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTELMKY   85 (261)
T ss_pred             eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeecccC
Confidence            56679999999999999998878899999987543 345678999999999999999999999876 6689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      ++|.+++.... ...+++..+..++.|++.|+.|||+. |++||||||+||++++++.+||+|||++.............
T Consensus        86 ~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (261)
T cd05068          86 GSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG  163 (261)
T ss_pred             CcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence            99999997643 34689999999999999999999994 99999999999999999999999999998765332222222


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |+.||...........+.    .....           +....
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~-----------~~~~~  228 (261)
T cd05068         164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD----QGYRM-----------PCPPG  228 (261)
T ss_pred             CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----cCCCC-----------CCCCc
Confidence            223457999999998899999999999999999999 999997654322222111    11100           00111


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ....+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            223677889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.8e-40  Score=328.98  Aligned_cols=258  Identities=23%  Similarity=0.418  Sum_probs=203.5

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCC----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGS----QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      ..|...+.||+|+||.||+|.+. +|.    .||+|.++.... ...+++.+|+.+++.++||||++++++|..  +..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCce
Confidence            34667899999999999999864 333    489999875432 345678899999999999999999999975  3678


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +++||+++|+|.+++....  ..+++..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            9999999999999998642  358889999999999999999999 5999999999999999999999999999987653


Q ss_pred             ccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          441 AANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       441 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....++.+    +......       .
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~----~~~~~~~-------~  230 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGER-------L  230 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHhCCCC-------C
Confidence            32211 112234567999999999999999999999999999998 999997654333222    1111110       0


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                       ...+.   ....+.+++.+||+.+|.+|||+.+++..+.++..+.
T Consensus       231 -~~~~~---~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         231 -PQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             -CCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence             00111   1235678899999999999999999999999886554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.3e-40  Score=325.25  Aligned_cols=262  Identities=20%  Similarity=0.283  Sum_probs=197.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++.. .+..++||||+
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~   85 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFEYL   85 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEeCC
Confidence            566789999999999999876 789999999864432 234567899999999999999999999876 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++ +|.+++...+  ..+++..+..++.||+.||+|||+ +||+||||||+||++++++.+||+|||+++....... ..
T Consensus        86 ~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~  160 (288)
T cd07871          86 DS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TY  160 (288)
T ss_pred             Cc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cc
Confidence            74 9999887643  357889999999999999999999 5999999999999999999999999999875432221 12


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---ccc---------
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEV---------  513 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~---------  513 (580)
                      ....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+.........   ...         
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            23457889999998765 56889999999999999999999999765544333332222111000   000         


Q ss_pred             cchhhhccC--CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 FDLELMRDA--PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..+......  ........++.+++.+|++.||.+|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000000  0000112356789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-39  Score=318.74  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=202.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +...+.||+|+||.||+|.+. +++.||+|.+... ......+.+|++++++++|+||+++++++.. ++..+++|||++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   85 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMT   85 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEeCC
Confidence            456688999999999999976 6889999998643 2334678899999999999999999999976 668899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++.... ...+++..+..++.|++.||+|||+. |++||||||+||++++++.+||+|||++............
T Consensus        86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence            999999997643 34589999999999999999999994 9999999999999999999999999998766443222222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+..+   .+ .....     ...   ...  
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~---~~-~~~~~-----~~~---~~~--  229 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---LL-EKGYR-----MER---PEG--  229 (263)
T ss_pred             CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HH-HCCCC-----CCC---CCC--
Confidence            2234567999999998999999999999999999998 999987644322222   11 11110     000   111  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                       ...++.+++.+||+.+|++|||+.++++.|+++
T Consensus       230 -~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         230 -CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             123567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-39  Score=317.57  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=201.5

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |.+.+.||+|+||.||.|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++.. .+..+++|||+.+
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~   83 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYMSN   83 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcCCC
Confidence            45678899999999999998877789999987442 345678999999999999999999999976 5578999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.+++....  ..+++..+..++.||+.||+|||+. |++|+||+|+||+++.++.+|++|||.++............
T Consensus        84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence            99999997643  2689999999999999999999994 99999999999999999999999999987654433222223


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+   .......          .+.  .
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~~~~~~----------~~~--~  225 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV---SQGLRLY----------RPH--L  225 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH---hcCCCCC----------CCC--C
Confidence            345678999999988889999999999999999999 99999765543322222   1111100          000  1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ....+.+++.+||+.+|.+|||+.++++.|+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1246778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.3e-40  Score=331.03  Aligned_cols=242  Identities=23%  Similarity=0.333  Sum_probs=194.6

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.||+|+||.||++... +|+.||+|.++....   .....+.+|+++++.++||||+++++++.. .+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence            46899999999999975 789999999875432   233457789999999999999999999986 5689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|||++....... .....
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  154 (323)
T cd05595          80 GELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT  154 (323)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence            9999988764   3689999999999999999999995 99999999999999999999999999987532221 12223


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+   .....       ..   ....   
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~---~~~~~-------~~---p~~~---  218 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---LMEEI-------RF---PRTL---  218 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---hcCCC-------CC---CCCC---
Confidence            56899999999999999999999999999999999999999765433222221   11110       00   1111   


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          529 LLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ..++.+++.+||+.||++||     ++.+++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            23556788899999999998     88888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.8e-40  Score=325.66  Aligned_cols=263  Identities=18%  Similarity=0.271  Sum_probs=198.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|+++....  ...+.+.+|+.+++.++||||+++++++.. ++..++||||
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   81 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVFEY   81 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEEec
Confidence            556789999999999999986 688999999865432  234567899999999999999999999976 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ++++.+..+...   ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus        82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          82 VEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            998766554432   2358899999999999999999999 499999999999999999999999999998764433333


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc----cccccchhh---
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW----TNEVFDLEL---  518 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---  518 (580)
                      .....|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+........    .....++..   
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            3345688999999999988999999999999999999999999987554332222221111000    000000000   


Q ss_pred             ----hccCCC-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          519 ----MRDAPT-----IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       519 ----~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          ......     .......+.+++.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                000000     00112357789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-40  Score=324.17  Aligned_cols=248  Identities=33%  Similarity=0.572  Sum_probs=191.4

Q ss_pred             hccccccCceEEEEEEeC-----CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          292 AEIMGKSTYGTVYKATLE-----DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .+.||.|.||.||+|.+.     .+..|+||.++..... ..+.+.+|++.+++++||||++++|++.. .+..++||||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-cccccccccc
Confidence            578999999999999976     3567999999654333 36789999999999999999999999995 5579999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  444 (580)
                      +++|+|.++++... ...+++..+..|+.||++||+|||+. +++|+||+++||++++++.+||+|||++......... 
T Consensus        83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccc-cccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence            99999999998862 34689999999999999999999995 9999999999999999999999999999876322221 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ..........|+|||.+....++.++||||||+++||+++ |+.||...+..+.   ...+.......         ...
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~---~~~~~~~~~~~---------~~~  228 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI---IEKLKQGQRLP---------IPD  228 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH---HHHHHTTEETT---------SBT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccce---------ecc
Confidence            1122346678999999998889999999999999999999 7899876643332   22222211110         011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ..   ...+.+++.+||+.+|++|||+.++++.|
T Consensus       229 ~~---~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 NC---PKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TS---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ch---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11   22566788899999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-41  Score=316.65  Aligned_cols=267  Identities=23%  Similarity=0.333  Sum_probs=199.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC----cEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG----EKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~~lv~  363 (580)
                      |...+++|.|+||.||+|... ++..||||+.-...    +.-.+|+++|+.++|||||++..++....+    +..+||
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            445689999999999999976 67899999864332    233579999999999999999998876433    245999


Q ss_pred             eeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-CCCeEEeecccccccccc
Q 008031          364 DYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-STNAKISDFGLSRLMTAA  441 (580)
Q Consensus       364 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~  441 (580)
                      |||+. +|.++++.. ...+.++.-.+.-+..||++||+|||+ .||+||||||+|+|+|. .|.+||||||.|+.....
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            99976 999998742 123467788889999999999999999 59999999999999995 589999999999987654


Q ss_pred             cccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc--------
Q 008031          442 ANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE--------  512 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  512 (580)
                      ....  ....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+..+....+-+++.....++        
T Consensus       180 epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  180 EPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             CCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            4432  3446788999998765 5799999999999999999999999988665544444443332111110        


Q ss_pred             --ccchhhhccC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhccc
Q 008031          513 --VFDLELMRDA---PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPE  563 (580)
Q Consensus       513 --~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~  563 (580)
                        ...+.+....   -.......+.++++.++++++|.+|.++.|++++  ..+++..
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence              0001111000   0111223567789999999999999999999976  4555544

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.4e-40  Score=334.56  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=201.5

Q ss_pred             HHHHhhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCC
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRAYYLGPKG  357 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  357 (580)
                      ...|.+.+.||+|+||.||+|...      ++..||+|+++..... ....+.+|+++++.+ +|+||++++++|.. .+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-GG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-CC
Confidence            345678899999999999999742      3457999999754332 345688999999999 89999999999987 56


Q ss_pred             cEEEEEeeCCCCChhhhhhhcC----------------------------------------------------------
Q 008031          358 EKLLVFDYMPHGSLATFLHARG----------------------------------------------------------  379 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  379 (580)
                      ..++||||+++|+|.++++...                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            8999999999999999986431                                                          


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee-ee
Q 008031          380 ---------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI-AT  449 (580)
Q Consensus       380 ---------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~  449 (580)
                               ....+++..+.+++.||+.||+|||+ +|++||||||+||++++++.+||+|||+++........... ..
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     01247888999999999999999999 59999999999999999999999999998765433221111 12


Q ss_pred             cCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          450 AGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      .++..|||||++.+..++.++|||||||++|||++ |+.||........   ...........     ..   ....   
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~~~~~~~~-----~~---~~~~---  340 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKMVKRGYQM-----SR---PDFA---  340 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHHHHcccCc-----cC---CCCC---
Confidence            34567999999998999999999999999999997 9999976543221   11111111100     00   0111   


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      ..++.+++.+||+.||++|||+.++++.|+++.
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            235678888999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-40  Score=329.17  Aligned_cols=240  Identities=22%  Similarity=0.307  Sum_probs=191.8

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ||+|+||.||+|... +++.||+|.++...   ......+.+|+.++++++||||+++++++.. .+..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence            699999999999986 68899999986532   2233567889999999999999999999876 668999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeec
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA  450 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  450 (580)
                      |.+++...   ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....... ......
T Consensus        80 L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~  154 (312)
T cd05585          80 LFHHLQRE---GRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFC  154 (312)
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccccc
Confidence            99999764   358999999999999999999999 5999999999999999999999999999875432221 222346


Q ss_pred             CccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHH
Q 008031          451 GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL  530 (580)
Q Consensus       451 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  530 (580)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||...+..   +....+.....       ..   ...   ...
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~~~~~~~~-------~~---~~~---~~~  218 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYRKILQEPL-------RF---PDG---FDR  218 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCC-------CC---CCc---CCH
Confidence            899999999999999999999999999999999999999764432   22222222110       00   011   123


Q ss_pred             HHHHHHhhccCCCCCCCCC---HHHHHHH
Q 008031          531 NTLKLALHCVDPSPSARPE---VLQVVQQ  556 (580)
Q Consensus       531 ~l~~li~~cl~~~P~~Rps---~~ev~~~  556 (580)
                      ++.+++.+||+.||++||+   +.|++.|
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            5667888999999999986   4565554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.7e-40  Score=330.72  Aligned_cols=242  Identities=24%  Similarity=0.335  Sum_probs=194.9

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.||+|+||.||++... +|+.||+|++.....   .....+.+|+++++.++||||+++++++.. ++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence            46899999999999976 789999999875432   234567889999999999999999999886 6689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... .....
T Consensus        80 g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~  154 (328)
T cd05593          80 GELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT  154 (328)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence            9999988764   3689999999999999999999995 99999999999999999999999999987532221 12233


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      ..||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+...   .+.....       ..   ....   
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~---~~~~~~~-------~~---p~~~---  218 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEDI-------KF---PRTL---  218 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH---HhccCCc-------cC---CCCC---
Confidence            568999999999998999999999999999999999999997654322222   1111110       01   1111   


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          529 LLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ..++.+++.+||+.||++||     ++.+++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            23566788899999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-39  Score=334.42  Aligned_cols=258  Identities=18%  Similarity=0.262  Sum_probs=194.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|...      ...+.+|++++++++||||+++++++.. +...++|+|++.
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILPRYK  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEecCC
Confidence            667899999999999999975 78999999643      2346789999999999999999999976 568899999994


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                       ++|.+++...   ..+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++...........
T Consensus       167 -~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        167 -TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             -CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence             6898888664   3588999999999999999999995 9999999999999999999999999999754333333334


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC----ChhHHHHHHhhh-hc-ccc-cc------
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA----ELPQWVASIVKE-EW-TNE-VF------  514 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~----~~~~~~~~~~~~-~~-~~~-~~------  514 (580)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||-.....    +....+..+... +. ... ..      
T Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            467999999999999999999999999999999999999876432211    011111111110 00 000 00      


Q ss_pred             ch----------hhhccCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          515 DL----------ELMRDAP---TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       515 ~~----------~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      +.          ......+   .......++.+++.+||+.||++|||++|++++=.
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence            00          0000000   01112346778999999999999999999997543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-39  Score=328.33  Aligned_cols=264  Identities=20%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      ..|++.+.||+|+||.||++.+. ++..+|+|.++.... .....+.+|++++++++|+||+++++++.. ++..++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   83 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICME   83 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEEe
Confidence            34677899999999999999987 788899998865432 234568899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.|++.||.|||+..+++|+||||+||++++++.+||+|||++........ 
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-  159 (333)
T cd06650          84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  159 (333)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc-
Confidence            99999999999764   35788999999999999999999743799999999999999999999999999875533211 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc-----------
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV-----------  513 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------  513 (580)
                        ....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+............           
T Consensus       160 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         160 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             --ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence              2245889999999999889999999999999999999999999764432222111100000000000           


Q ss_pred             -----------------cchhhhccCCCc--HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          514 -----------------FDLELMRDAPTI--GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       514 -----------------~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                                       .+.......+..  .....++.+++.+||+.||++|||+.|++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence                             000000000000  00123567899999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.6e-39  Score=328.45  Aligned_cols=261  Identities=25%  Similarity=0.371  Sum_probs=204.3

Q ss_pred             HHHhhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCc
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  358 (580)
                      -.|.+.+.||+|+||.||+|...      +++.||+|+++..... ....+.+|+.++.++ +|+||++++++|...+..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            35778899999999999999642      3578999998754322 235678899999999 899999999999876677


Q ss_pred             EEEEEeeCCCCChhhhhhhcCC----------------------------------------------------------
Q 008031          359 KLLVFDYMPHGSLATFLHARGP----------------------------------------------------------  380 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  380 (580)
                      .+++|||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            8999999999999999864321                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-ceeeecCccccCCcc
Q 008031          381 ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPE  459 (580)
Q Consensus       381 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE  459 (580)
                      ...+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||++......... ......++..|+|||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence            12688999999999999999999994 9999999999999999999999999999865432221 112234567899999


Q ss_pred             ccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhh
Q 008031          460 LSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALH  538 (580)
Q Consensus       460 ~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  538 (580)
                      .+.+..++.++|||||||++|||++ |..||......+.   ............        ..   .....++.+++.+
T Consensus       246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~--------~~---~~~~~~~~~l~~~  311 (337)
T cd05054         246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCRRLKEGTRMR--------AP---EYATPEIYSIMLD  311 (337)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HHHHHhccCCCC--------CC---ccCCHHHHHHHHH
Confidence            9999999999999999999999998 9999976433221   111111111000        00   1122467789999


Q ss_pred             ccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          539 CVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       539 cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ||+.+|++|||+.|++++|+++.+
T Consensus       312 cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.1e-39  Score=315.01  Aligned_cols=253  Identities=27%  Similarity=0.436  Sum_probs=203.8

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|.+.+.||+|+||.||+|...++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++.  ....+++|||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~   83 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVTEYMS   83 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEEEecC
Confidence            4677899999999999999988888999999875433 3567899999999999999999999884  456899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.++++... ...+++.++..++.|++.||+|||+. +++||||+|+||++++++.++++|||++............
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence            999999997643 33589999999999999999999995 9999999999999999999999999999765443322222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.   .....            +...
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~------------~~~~  226 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE---RGYRM------------PCPQ  226 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCCCC------------CCCC
Confidence            2345668999999988899999999999999999999 899997655433222221   11000            0011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      .....+.+++.+||+.+|.+|||+.++.+.|+++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  260 (260)
T cd05070         227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY  260 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            1223677899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.3e-39  Score=320.04  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=202.3

Q ss_pred             HhhhccccccCceEEEEEEeCC------CCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLED------GSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      +.+.+.||+|+||.||+|....      ...||+|.++..... ....+.+|++++++++||||+++++++.. .+..++
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~~   85 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQPTCM   85 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CCceEE
Confidence            4567899999999999998652      257999998754332 34568999999999999999999999976 567899


Q ss_pred             EEeeCCCCChhhhhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeE
Q 008031          362 VFDYMPHGSLATFLHARGPE-------------TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAK  428 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~k  428 (580)
                      +|||+++|+|.+++......             ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+|
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCcEE
Confidence            99999999999999764211             3578899999999999999999995 999999999999999999999


Q ss_pred             Eeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhh
Q 008031          429 ISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK  506 (580)
Q Consensus       429 l~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  506 (580)
                      |+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..   
T Consensus       165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~---  241 (283)
T cd05048         165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS---  241 (283)
T ss_pred             ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---
Confidence            9999998765332221 1222346788999999988899999999999999999998 9999987654443332221   


Q ss_pred             hhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ....            +.......++.+++.+||+.||++|||+.|++++|+.+
T Consensus       242 ~~~~------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         242 RQLL------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             CCcC------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1100            00111224677888999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=313.88  Aligned_cols=250  Identities=24%  Similarity=0.402  Sum_probs=200.3

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .+++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++||||+++++++.. .+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecCC
Confidence            356789999999999999998877889999986432 234578889999999999999999999876 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++....  ..+++..+..++.|++.|++|||+ .|++||||||+||++++++.+|++|||+++...........
T Consensus        83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            999999997643  368999999999999999999999 49999999999999999999999999998765432222212


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+..    ..     ....   ...  
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~-----~~~~---~~~--  225 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA----GY-----RLYR---PKL--  225 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc----CC-----cCCC---CCC--
Confidence            2234457999999998899999999999999999999 8999976554333222211    10     0000   111  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                       ...++.+++.+||+.+|++|||+.|+++.|
T Consensus       226 -~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         226 -APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             223677899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=294.82  Aligned_cols=264  Identities=22%  Similarity=0.290  Sum_probs=207.1

Q ss_pred             HHHHHhhhccccccCceEEEEEEe-CCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC----CCcE
Q 008031          285 DDLLCATAEIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP----KGEK  359 (580)
Q Consensus       285 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~  359 (580)
                      .+.+|++.+.+|+|||+-||.++. .++..+|+|++.-...++.+..++|++..++++||||+++++++...    ....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            344578889999999999999984 57899999999766666777899999999999999999998887642    2248


Q ss_pred             EEEEeeCCCCChhhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcC-CCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPE-TPIDWPTRMKIIKGMTRGLLHLHSN-ENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~-~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      |++++|...|+|.+.+....-+ ..+++.++++|+.+|++||.+||+. +.++||||||.||++++++.+++.|||.++.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999999875433 4799999999999999999999995 2399999999999999999999999999875


Q ss_pred             ccccc--------ccceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh
Q 008031          438 MTAAA--------NVNVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK  506 (580)
Q Consensus       438 ~~~~~--------~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  506 (580)
                      ..-.-        -..+.....|..|+|||.+.   +...++++|||||||++|+|+.|..||+....           +
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----------~  247 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----------Q  247 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------c
Confidence            53110        01112235788899999875   45678899999999999999999999975321           1


Q ss_pred             hhccccc-cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          507 EEWTNEV-FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       507 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      ++...-. .....  ..|........+.+++.+|++.||.+||++.+++.++..+.
T Consensus       248 GgSlaLAv~n~q~--s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 GGSLALAVQNAQI--SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CCeEEEeeecccc--ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1111110 01111  12333335567888999999999999999999999998753

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.5e-39  Score=327.18  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=197.1

Q ss_pred             HhhhccccccCceEEEEEEe----CCCCEEEEEEccccc----cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          289 CATAEIMGKSTYGTVYKATL----EDGSQVAVKRLREKI----TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      |.+.+.||+|+||.||++..    .+++.||+|++....    ....+.+.+|+.+++++ +|++|+++++++.. ++..
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~   80 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAKL   80 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCEE
Confidence            45678999999999999975    368899999986432    12234578899999999 59999999998876 6689


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            9999999999999999764   358899999999999999999999 499999999999999999999999999998654


Q ss_pred             cccccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          440 AAANVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ...........||..|+|||++.+. .++.++|||||||++|||++|+.||...........+.......      ++..
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------~~~~  230 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC------DPPF  230 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC------CCCC
Confidence            4333333345789999999998765 47889999999999999999999997654433332222211110      1111


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                         ....   ...+.+++.+||+.||++||     ++.+++++
T Consensus       231 ---~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         231 ---PSFI---GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ---CCCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence               0111   23456788899999999999     77788876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.2e-40  Score=330.17  Aligned_cols=243  Identities=22%  Similarity=0.262  Sum_probs=197.0

Q ss_pred             HhhhccccccCceEEEEEEeC-C-CCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-D-GSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|.+. + +..||+|.+....   ......+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv~  110 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLYLVL  110 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEEEEEE
Confidence            567789999999999999865 2 3689999986432   2234568899999999999999999999987 56899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++......  
T Consensus       111 Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        111 EFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            999999999999764   368899999999999999999999 49999999999999999999999999999765432  


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.....   ..+.....       .   ...
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~~i~~~~~-------~---~p~  249 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY---QKILEGII-------Y---FPK  249 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH---HHHhcCCC-------C---CCC
Confidence              22456899999999999888999999999999999999999999765432222   22221110       0   011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ...   ..+.+++.+||+.||++|+     |+++++++
T Consensus       250 ~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        250 FLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            112   2456788899999999995     89999887

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=342.36  Aligned_cols=264  Identities=22%  Similarity=0.331  Sum_probs=211.5

Q ss_pred             HHHHHhhhccccccCceEEEEEEeCCC-CEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeee-EEECC--C---
Q 008031          285 DDLLCATAEIMGKSTYGTVYKATLEDG-SQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRA-YYLGP--K---  356 (580)
Q Consensus       285 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~~~--~---  356 (580)
                      ....+++.+.|.+|||+.||.|.+..+ ..||+|++-.......+.+.+|+++|++|. |+|||.+++ .....  +   
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            334456779999999999999998755 999999987776667788999999999995 999999999 33221  1   


Q ss_pred             CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          357 GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-ENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       357 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      -++++.||||.||.|.|++..+... .|++.++++|+.++++|+++||.. +.|+|||||.+|||++.++..||||||.+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            2567999999999999999876533 499999999999999999999984 46999999999999999999999999998


Q ss_pred             ccccccc-cc-------ceeeecCccccCCcccc---ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHH
Q 008031          436 RLMTAAA-NV-------NVIATAGALGYRAPELS---KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASI  504 (580)
Q Consensus       436 ~~~~~~~-~~-------~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~  504 (580)
                      +-.-... ..       .......|+.|+|||++   .+...++|+||||+||+||-|+....||+......       |
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------I  266 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------I  266 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------E
Confidence            6332211 11       11123578899999975   57789999999999999999999999998753322       1


Q ss_pred             hhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccc
Q 008031          505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATA  567 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~  567 (580)
                      +.+.         .  .+|..+.....+.+||..||++||.+||++.+|+..+-++.......
T Consensus       267 lng~---------Y--~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~  318 (738)
T KOG1989|consen  267 LNGN---------Y--SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI  318 (738)
T ss_pred             Eecc---------c--cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence            2221         1  13333556677888999999999999999999999998887655443

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.6e-39  Score=318.15  Aligned_cols=255  Identities=25%  Similarity=0.434  Sum_probs=203.2

Q ss_pred             HHhhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .|.+.+.||+|+||.||+|...      ++..||+|.++..... ....+.+|+++++.++|+||+++++++.. ....+
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   84 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDPPI   84 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCCeE
Confidence            4677899999999999999864      3478999998765443 35679999999999999999999999987 56899


Q ss_pred             EEEeeCCCCChhhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEE
Q 008031          361 LVFDYMPHGSLATFLHARGP-----------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKI  429 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl  429 (580)
                      +||||+++++|.++++..+.           ...+++.++..++.|++.|++|||+. |++||||||+||+++.++.+|+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl  163 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKI  163 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEE
Confidence            99999999999999976431           23578899999999999999999995 9999999999999999999999


Q ss_pred             eeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhh
Q 008031          430 SDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE  507 (580)
Q Consensus       430 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  507 (580)
                      +|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+.   .+
T Consensus       164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~---~~  240 (280)
T cd05049         164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT---QG  240 (280)
T ss_pred             CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cC
Confidence            999998754322211 1112345678999999999999999999999999999998 999997655443333222   11


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ...         ....   .....+.+++.+||+.||++|||+.|+++.|++
T Consensus       241 ~~~---------~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 RLL---------QRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CcC---------CCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            110         0001   112356788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5e-39  Score=313.85  Aligned_cols=253  Identities=24%  Similarity=0.394  Sum_probs=203.0

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|.+.+.||+|+||.||+|.+.++..||+|.++... .....+.+|++++++++|+||+++++++.  ....++||||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~   83 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMS   83 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEEEEEcCC
Confidence            467789999999999999998877789999987532 23467899999999999999999999874  356899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.++...........
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence            999999997642 23578999999999999999999994 9999999999999999999999999999766443322222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...++..|+|||...+..++.++||||||+++|||++ |+.||......+...   .+.. ...           .+...
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~---~~~~-~~~-----------~~~~~  226 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---QVER-GYR-----------MPCPP  226 (262)
T ss_pred             CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH---HHhc-CCC-----------CCCcc
Confidence            3346678999999988899999999999999999999 888987654332221   1111 100           01111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      .....+.+++.+||+.+|++|||+.++++.|+++
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            2234677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.2e-40  Score=331.55  Aligned_cols=260  Identities=23%  Similarity=0.375  Sum_probs=195.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC----CcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK----GEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~l  361 (580)
                      |++.+.||+|+||.||+|... +|..||||+++....  .....+.+|++++++++||||+++++++....    ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            556789999999999999976 789999999864322  23456889999999999999999999886422    24799


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+. ++|.+++...   ..+++..+..++.||++||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus        82 v~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          82 VFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            999995 6899988764   3589999999999999999999994 9999999999999999999999999999754322


Q ss_pred             cc--cceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc--------
Q 008031          442 AN--VNVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW--------  509 (580)
Q Consensus       442 ~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  509 (580)
                      ..  .......|+..|+|||++.+  ..++.++|||||||++|||++|+.||...+.......+........        
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            21  11223468999999999865  6789999999999999999999999976543322222211110000        


Q ss_pred             -------cccc---cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          510 -------TNEV---FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       510 -------~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                             ....   .........+..   ...+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNA---DPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCC---ChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                   0000   000000001111   2346688999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.4e-40  Score=329.86  Aligned_cols=243  Identities=23%  Similarity=0.329  Sum_probs=194.5

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.||+|+||.||++... +|+.||+|+++....   .....+..|++++..++||||+++++++.. ++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence            46899999999999875 789999999875432   233457789999999999999999999876 6689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.+++...   ..+++..+..++.||+.||+|||+..||+||||||+|||++.++.+||+|||+++....... ....
T Consensus        80 ~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (325)
T cd05594          80 GELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT  155 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence            9999988764   36899999999999999999999734999999999999999999999999999875332211 2223


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+   .....       ..   ....   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---~~~~~-------~~---p~~~---  219 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LMEEI-------RF---PRTL---  219 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---hcCCC-------CC---CCCC---
Confidence            46899999999999999999999999999999999999999765433222211   11110       00   0111   


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          529 LLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ..++.+++.+||+.||++|+     ++.++++|
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            23566788899999999997     89999877

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-39  Score=313.86  Aligned_cols=253  Identities=24%  Similarity=0.449  Sum_probs=202.2

Q ss_pred             HhhhccccccCceEEEEEEeC----CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...+.||+|+||.||+|.+.    +...||+|.++..... ....+.+|+.++++++||||+++++++.. .+..+++|
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~   84 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVMIIT   84 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceEEEE
Confidence            556789999999999999875    2457999998754332 34578899999999999999999999876 56899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||+ .+|+|+||+|+||++++++.++++|||++........
T Consensus        85 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          85 EYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            9999999999997643  368999999999999999999999 4999999999999999999999999999987642211


Q ss_pred             -cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          444 -VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       444 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                       .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.   .....           
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~-----------  227 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE---DGYRL-----------  227 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH---cCCCC-----------
Confidence             11112234578999999998999999999999999999998 999997654333222221   11000           


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                       +........+.+++.+||+.+|++||++.+++++|+++
T Consensus       228 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             00011223567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.1e-39  Score=313.51  Aligned_cols=254  Identities=23%  Similarity=0.391  Sum_probs=204.6

Q ss_pred             HHHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          287 LLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      ..|.+.+.||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++.  .+..+++|||+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~   82 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYM   82 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEcC
Confidence            3466789999999999999998889999999987543 23567899999999999999999999874  45789999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++.... ...+++.++..++.|++.||+|||+. |++||||+|+||++++++.++++|||++...........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence            9999999987643 34689999999999999999999994 999999999999999999999999999876553222222


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      ....++..|+|||.+....++.++||||||+++||+++ |+.||...+..+....+..    ....     ..   ... 
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~-----~~---~~~-  227 (260)
T cd05067         161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER----GYRM-----PR---PDN-  227 (260)
T ss_pred             cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc----CCCC-----CC---CCC-
Confidence            23345678999999998899999999999999999999 9999976554333322211    1100     00   011 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                        ...++.+++.+||+.+|++|||+++++..|+.+
T Consensus       228 --~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         228 --CPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             --CCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence              123577888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.4e-39  Score=316.15  Aligned_cols=247  Identities=23%  Similarity=0.303  Sum_probs=193.2

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ||+|+||+||++.+. +|+.||+|.+......   ..+.+..|+++++.++|+||+++.+++.. +...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence            699999999999876 7899999998654322   22456789999999999999999998876 568999999999999


Q ss_pred             hhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeee
Q 008031          371 LATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT  449 (580)
Q Consensus       371 L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  449 (580)
                      |.+++... .....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........ .....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~  157 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY  157 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence            99887543 2234689999999999999999999994 999999999999999999999999999876543322 22234


Q ss_pred             cCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHH
Q 008031          450 AGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL  529 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  529 (580)
                      .|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+........            ........
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~  225 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS------------VTYPDKFS  225 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC------------CCCcccCC
Confidence            688999999999999999999999999999999999999976543221111111110000            00001122


Q ss_pred             HHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          530 LNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       530 ~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ..+.+++.+||+.||++||     ++++++++
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            3566888899999999999     67788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-39  Score=325.98  Aligned_cols=242  Identities=25%  Similarity=0.410  Sum_probs=193.6

Q ss_pred             ccccccCceEEEEEEe----CCCCEEEEEEcccccc----ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          293 EIMGKSTYGTVYKATL----EDGSQVAVKRLREKIT----KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +.||+|+||.||++..    .+++.||+|+++....    .....+.+|+.+++.++||||+++++++.. ++..++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEe
Confidence            6799999999999985    3578999999875321    223457789999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+.+..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          81 YLSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            99999999999764   3578888999999999999999995 999999999999999999999999999875432221 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||...+...   ....+.....       ..   .+.
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~~~~~~~~-------~~---~~~  222 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TIDKILKGKL-------NL---PPY  222 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCC-------CC---CCC
Confidence            1223468999999999998889999999999999999999999997654322   2222222110       00   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      .   ..++.+++.+||+.||++||     ++.+++++
T Consensus       223 ~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         223 L---TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             C---CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            1   23566888899999999999     78888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-39  Score=342.40  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=200.0

Q ss_pred             HhhhccccccCceEEEEEEeC-C-CCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-D-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~~  147 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEECC
Confidence            556789999999999999865 4 67889987754444444567889999999999999999999986 67899999999


Q ss_pred             CCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-
Q 008031          367 PHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-  444 (580)
Q Consensus       367 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  444 (580)
                      ++|+|.+++... ....++++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ 
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            999999988643 223468899999999999999999999 59999999999999999999999999999866443221 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+   .+..+..+....      .   .. 
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~------~---~~-  293 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVLYGKYDP------F---PC-  293 (478)
T ss_pred             cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCC------C---Cc-
Confidence            2233468999999999999999999999999999999999999997644322   222222211100      0   01 


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ....++.+++.+||+.||++|||+.+++.+
T Consensus       294 --~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        294 --PVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             --cCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence              112356788889999999999999998754

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.6e-39  Score=320.85  Aligned_cols=263  Identities=25%  Similarity=0.363  Sum_probs=195.5

Q ss_pred             HhhhccccccCceEEEEEEeC--CCCEEEEEEccccccc--cHHHHHHHHHHHhcC---CCCcceeeeeEEEC----CCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE--DGSQVAVKRLREKITK--GQREFESEVSLLGKI---RHPNLLALRAYYLG----PKG  357 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----~~~  357 (580)
                      |.+.+.||+|+||.||+|.+.  +++.||+|.++.....  ....+.+|+.+++.+   +||||+++++++..    ...
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            566789999999999999873  4688999998644322  234566777777765   69999999999863    234


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            6899999996 69999987643 3358899999999999999999999 5999999999999999999999999999976


Q ss_pred             cccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh----hhccccc
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK----EEWTNEV  513 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~  513 (580)
                      ....  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+.....    ..+....
T Consensus       160 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (290)
T cd07862         160 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  237 (290)
T ss_pred             ccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence            5433  122334688999999999888999999999999999999999999987665443333322111    0000000


Q ss_pred             -cchh-hhccCCCcH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 -FDLE-LMRDAPTIG-----DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 -~~~~-~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       .... .........     .....+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence             0000 000000000     112345688999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-39  Score=324.71  Aligned_cols=241  Identities=27%  Similarity=0.355  Sum_probs=189.3

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +++.||+|.++....   ...+.+..|..++... +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46899999999999976 688999999875432   2234456677777654 89999999999876 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        80 gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          80 GGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            99999998764   358899999999999999999999 499999999999999999999999999987543222 2223


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...   .+.....       ..   ....  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~---~i~~~~~-------~~---~~~~--  219 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD---SILNDRP-------HF---PRWI--  219 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHcCCC-------CC---CCCC--
Confidence            3568999999999999899999999999999999999999998655432222   2111100       00   0111  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVL-QVVQ  555 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~-ev~~  555 (580)
                       ..++.+++.+||+.||.+||++. ++++
T Consensus       220 -~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         220 -SKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence             22456788899999999999876 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.9e-39  Score=332.56  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=194.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|... +++.||+|++.....   .....+.+|++++++++|+||+++++++.+ .+..++|||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~E   81 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVMD   81 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEEe
Confidence            456789999999999999875 788999999865422   233568899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  443 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++++||+|||+++....... 
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            99999999999764   358889999999999999999999 5999999999999999999999999999754311000 


Q ss_pred             ---------------------------------------------cceeeecCccccCCccccccCCCCCcccchhHHHH
Q 008031          444 ---------------------------------------------VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVT  478 (580)
Q Consensus       444 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~  478 (580)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00112468999999999998899999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHHH
Q 008031          479 ILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALH--CVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       479 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~Rps~~ev~~~  556 (580)
                      +|||++|+.||...+..+....   +......     ... .......   .++.+++.+  |+..+|..||++.++++|
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~---i~~~~~~-----~~~-~~~~~~s---~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLK---VINWENT-----LHI-PPQVKLS---PEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHH---HHccccc-----cCC-CCCCCCC---HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999999999976543322211   1110000     000 0011122   245566656  666777789999999987


Q ss_pred             H
Q 008031          557 L  557 (580)
Q Consensus       557 L  557 (580)
                      -
T Consensus       306 p  306 (381)
T cd05626         306 P  306 (381)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.6e-39  Score=331.38  Aligned_cols=262  Identities=23%  Similarity=0.337  Sum_probs=202.8

Q ss_pred             HHHHHhhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcCC-CCcceeeeeEEECCC
Q 008031          285 DDLLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKIR-HPNLLALRAYYLGPK  356 (580)
Q Consensus       285 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  356 (580)
                      ..-.+.+.+.||+|+||.||+|.+.      .+..||||+++..... ..+.+.+|+++++++. ||||+++++++.. .
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-~  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-S  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-C
Confidence            3445677899999999999999863      2346999999754332 3456899999999995 9999999999976 6


Q ss_pred             CcEEEEEeeCCCCChhhhhhhcCC--------------------------------------------------------
Q 008031          357 GEKLLVFDYMPHGSLATFLHARGP--------------------------------------------------------  380 (580)
Q Consensus       357 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  380 (580)
                      +..++||||+++|+|.++++....                                                        
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            689999999999999999865310                                                        


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC
Q 008031          381 -------------------------------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD  423 (580)
Q Consensus       381 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~  423 (580)
                                                           ...+++..++.++.|++.||+|||+. +++||||||+||++++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~  272 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeC
Confidence                                                 12477888999999999999999994 9999999999999999


Q ss_pred             CCCeEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHH
Q 008031          424 STNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWV  501 (580)
Q Consensus       424 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~  501 (580)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.   .
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---~  349 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---F  349 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---H
Confidence            999999999998765432221 1122346678999999998999999999999999999997 9999876432211   1


Q ss_pred             HHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          502 ASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ..........           +........+.+++.+||+.+|++|||+.++++.|+++.+
T Consensus       350 ~~~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         350 YNKIKSGYRM-----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHhcCCCC-----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            1111111100           0011122366789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.1e-39  Score=315.98  Aligned_cols=256  Identities=20%  Similarity=0.368  Sum_probs=199.2

Q ss_pred             HHHhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  359 (580)
                      -.|+..+.||+|+||.||+|.+.      ++..||+|++..... ....++.+|+.+++.++||||+++++++.. ....
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~   84 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPT   84 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCe
Confidence            34677899999999999999753      356799999864322 234568899999999999999999999876 5689


Q ss_pred             EEEEeeCCCCChhhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeec
Q 008031          360 LLVFDYMPHGSLATFLHARGP-------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDF  432 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Df  432 (580)
                      ++||||+++|+|.++++....       ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.++++||
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCCCEEECCC
Confidence            999999999999999975321       2346788999999999999999999 59999999999999999999999999


Q ss_pred             ccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhcc
Q 008031          433 GLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWT  510 (580)
Q Consensus       433 g~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  510 (580)
                      |+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....   .......
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~---~~~~~~~  240 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF---VMEGGLL  240 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHcCCcC
Confidence            9987553322211 111235678999999998899999999999999999999 7889876543322221   1111110


Q ss_pred             ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      .         ....   ....+.+++.+||+.+|++|||+.|+++.|++
T Consensus       241 ~---------~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         241 D---------KPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             C---------CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            0         0111   12356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-39  Score=330.86  Aligned_cols=252  Identities=20%  Similarity=0.233  Sum_probs=198.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      .|.+.+.||+|+||.||++... +++.||+|.+....   ......+.+|+.+++.++||||+++++++.+ +...++||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~lv~  122 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLYMVM  122 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEEEEE
Confidence            4667889999999999999986 78899999986432   1233457889999999999999999999876 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...    .++...+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||++........
T Consensus       123 Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         123 EYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999998753    478888999999999999999994 999999999999999999999999999976644332


Q ss_pred             cceeeecCccccCCccccccC----CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          444 VNVIATAGALGYRAPELSKLK----KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+...   ....+.......        
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~~~~~--------  266 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIMDHKNSL--------  266 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---HHHHHHcCCCcC--------
Confidence            222345689999999987643    47889999999999999999999998654322   222222211100        


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSA--RPEVLQVVQQL  557 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ev~~~L  557 (580)
                       ..+.......++.+++.+|++.+|.+  |||+.|+++|-
T Consensus       267 -~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         267 -TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             -CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence             01111112235667888999999988  99999998874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=317.76  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=199.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |+..+.||+|+||.||++... +++.||+|.+.....   .....+.+|+.++++++||||+++++++.. ++..++|||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   80 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEEe
Confidence            456788999999999999975 789999999865322   123457789999999999999999999876 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-  157 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence            999999999887543 34589999999999999999999995 999999999999999999999999999876543222 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....|+..|+|||.+.+..++.++||||+||++|||++|+.||.+.+.......+...+.....            ..
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------~~  224 (285)
T cd05605         158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE------------EY  224 (285)
T ss_pred             -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc------------cc
Confidence             12346889999999999889999999999999999999999999875543322222222111100            00


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      .......+.+++.+||+.||++||     ++.+++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            011223566888999999999999     88899877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.9e-40  Score=330.59  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=199.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||++... +|+.||+|+++....   .....+.+|+.+++.++|+||+++++++.+ .+..++|||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv~e   81 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLVME   81 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEEEC
Confidence            456789999999999999976 789999999875432   234568899999999999999999999876 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...  ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999765  2468999999999999999999999 49999999999999999999999999999876544333


Q ss_pred             ceeeecCccccCCccccc------cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          445 NVIATAGALGYRAPELSK------LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........   ...+.......       
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i~~~~~~~-------  228 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---YNNIMNFQRFL-------  228 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---HHHHHcCCCcc-------
Confidence            333456899999999876      45678899999999999999999999976543222   22222111000       


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ..+........+.+++.+|++ +|.+|||+.++++|
T Consensus       229 --~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         229 --KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence              011111122356678889998 99999999999976

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.6e-39  Score=324.96  Aligned_cols=242  Identities=23%  Similarity=0.361  Sum_probs=192.9

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|... +++.||+|+++...   ......+..|..++..+ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence            46899999999999986 68899999987542   22345677888888876 79999999999976 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...... ....
T Consensus        80 ~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (320)
T cd05590          80 GGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS  154 (320)
T ss_pred             CchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence            99999998764   358899999999999999999999 499999999999999999999999999987542221 1223


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+...   .+.....    ..      ....  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---~i~~~~~----~~------~~~~--  219 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---AILNDEV----VY------PTWL--  219 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH---HHhcCCC----CC------CCCC--
Confidence            3568999999999999999999999999999999999999998655333222   2221111    00      0111  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEV------LQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~------~ev~~~  556 (580)
                       ..++.+++.+||+.||++||++      +++++|
T Consensus       220 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         220 -SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             -CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence             2356678889999999999998      666655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.5e-39  Score=316.88  Aligned_cols=261  Identities=21%  Similarity=0.329  Sum_probs=207.1

Q ss_pred             HHHhhhccccccCceEEEEEEeCC-----CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLED-----GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      ..|.+.+.||+|+||.||+|.+.+     +..|++|.+..... .....+.+|+.++++++|+||+++++++...+...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            345667899999999999999865     68899999875433 234568899999999999999999999887667889


Q ss_pred             EEEeeCCCCChhhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          361 LVFDYMPHGSLATFLHARGPE-----TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      +++||+++++|.+++......     ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+|++|||++
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~  164 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALS  164 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCc
Confidence            999999999999999764322     4689999999999999999999995 9999999999999999999999999999


Q ss_pred             cccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          436 RLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       436 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      +.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...+..+...++.    ....   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----~~~~---  237 (280)
T cd05043         165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK----DGYR---  237 (280)
T ss_pred             ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH----cCCC---
Confidence            8654332211 112345677999999988899999999999999999999 999997654433222221    1110   


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                        ...   ...   ....+.+++.+||+.+|++|||+.++++.|+.+..+
T Consensus       238 --~~~---~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         238 --LAQ---PIN---CPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             --CCC---CCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence              000   011   113567889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-39  Score=324.81  Aligned_cols=242  Identities=24%  Similarity=0.362  Sum_probs=193.8

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|... +++.||+|+++....   .....+..|.+++..+ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence            46899999999999986 688999999875432   2334567888888876 89999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++........ ...
T Consensus        80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05591          80 GGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT  154 (321)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence            99999988764   3588999999999999999999995 999999999999999999999999999875432221 222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||...+..+..+   .+......    .      ....  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~---~i~~~~~~----~------p~~~--  219 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE---SILHDDVL----Y------PVWL--  219 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH---HHHcCCCC----C------CCCC--
Confidence            3468999999999999999999999999999999999999998665433222   22221110    0      0111  


Q ss_pred             HHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARP-------EVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rp-------s~~ev~~~  556 (580)
                       ..++.+++.+||+.||++||       ++.+++++
T Consensus       220 -~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         220 -SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence             23567888899999999999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-38  Score=310.63  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=195.3

Q ss_pred             cccccCceEEEEEEeC---CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          294 IMGKSTYGTVYKATLE---DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      .||+|+||.||+|.+.   ++..||+|.+...... ..+.+.+|+.++++++|+||+++++++.  ....++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCC
Confidence            3899999999999764   3557999998755332 3456899999999999999999999985  34789999999999


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce--e
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV--I  447 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~--~  447 (580)
                      +|.+++...  ...+++..+.+++.|++.||+|||+. |++||||||+||+++.++.+|++|||++...........  .
T Consensus        80 ~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          80 PLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999998753  24689999999999999999999994 999999999999999999999999999876543322211  1


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...++..|+|||.+.+..++.++|||||||++||+++ |+.||......+....+.   .....      .   ..+   
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~------~---~~~---  221 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE---QGKRL------D---CPA---  221 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---CCCCC------C---CCC---
Confidence            1223568999999988889999999999999999997 999998765433222221   11110      0   011   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ....++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            1223666889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=331.53  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=200.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +|+.||+|+++....   .....+.+|++++..++|+||+++++++.+ ++..++|||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   81 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLVME   81 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEEEc
Confidence            456789999999999999986 789999999875432   334568899999999999999999999876 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc--
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA--  442 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~--  442 (580)
                      |+++++|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          82 YMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            99999999999875   468899999999999999999999 599999999999999999999999999987654432  


Q ss_pred             --------------------------ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC
Q 008031          443 --------------------------NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE  496 (580)
Q Consensus       443 --------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~  496 (580)
                                                ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                      112223468999999999999999999999999999999999999998755322


Q ss_pred             hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHH
Q 008031          497 LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPE-VLQVVQQL  557 (580)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ev~~~L  557 (580)
                      ..   ..+....  ...   .    .+.......++.+++.+|+. ||.+||+ +.+++++-
T Consensus       238 ~~---~~i~~~~--~~~---~----~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         238 TY---NKIINWK--ESL---R----FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             HH---HHHhccC--Ccc---c----CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            22   2221100  000   0    01000112356678889997 9999999 99999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.9e-39  Score=310.87  Aligned_cols=246  Identities=26%  Similarity=0.372  Sum_probs=196.1

Q ss_pred             cccccCceEEEEEEeC---CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          294 IMGKSTYGTVYKATLE---DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      .||+|+||.||+|.++   ++..+|+|+++.....  ..+++.+|+.+++.++|+||+++++++.  .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence            5899999999999753   5788999998644322  3457889999999999999999999985  3478999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc--e
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN--V  446 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~  446 (580)
                      |+|.+++...   ..+++..+..++.|++.|++|||+ +|++||||||.||++++++.+||+|||++..........  .
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          80 GPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999999764   358899999999999999999999 599999999999999999999999999997664332211  1


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      ....++..|+|||.+....++.++|+|||||++|||++ |+.||......+..+.+.   .+...      ..   ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~---~~~~~------~~---~~~~  223 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE---SGERM------EC---PQRC  223 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---CCCCC------CC---CCCC
Confidence            12234578999999988889999999999999999998 999998655433333222   11110      00   1111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                         ..++.+++.+||+.||++||++.+|++.|+++
T Consensus       224 ---~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         224 ---PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence               23566889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.5e-39  Score=324.84  Aligned_cols=244  Identities=25%  Similarity=0.348  Sum_probs=192.3

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHH---hcCCCCcceeeeeEEECCCCcEEEE
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLL---GKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .+.+.||+|+||.||+|.+. +|+.||||+++...   ....+.+.+|++++   +.++||||+++++++.. .+..|+|
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv   80 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCFV   80 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEEE
Confidence            45688999999999999876 78999999987542   12234566676655   56789999999999986 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|..+++.    ..+++..+..++.||+.||+|||+ .|++||||||+||++++++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999999999988864    358999999999999999999999 499999999999999999999999999987532222


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                       .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+..+..   ..+......       .   .
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~---~~i~~~~~~-------~---p  221 (324)
T cd05589         156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF---DSIVNDEVR-------Y---P  221 (324)
T ss_pred             -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhCCCC-------C---C
Confidence             1223456899999999999999999999999999999999999999765433222   222221110       0   1


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ...   ...+.+++.+||+.||.+||     ++.+++++
T Consensus       222 ~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         222 RFL---SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCC---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            111   23566788899999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-38  Score=314.07  Aligned_cols=257  Identities=19%  Similarity=0.347  Sum_probs=200.1

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCC----EEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGS----QVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      .+...+.||+|+||.||+|.+. +++    .+++|.+...... ...++..|+..+++++||||+++++++.  ....++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~~~   85 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQL   85 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCccEE
Confidence            3456789999999999999874 444    4778877543222 2356778888999999999999999985  346789


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ++||+++|+|.+++....  ..+++..+..++.||+.||+|||+ ++++||||||+||++++++.+|++|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            999999999999997642  468999999999999999999999 59999999999999999999999999999865433


Q ss_pred             ccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 ANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.+.......+.+    .......       
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~-------  231 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL----EKGERLA-------  231 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCcCC-------
Confidence            221 1223346778999999988899999999999999999998 99999765433322222    1111000       


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                       .....   ...+.+++.+||+.+|++|||+.|+++.|+.+..+.
T Consensus       232 -~~~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         232 -QPQIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             -CCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence             00111   124567888999999999999999999999976544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.6e-39  Score=317.61  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=205.1

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      +...+.||+|+||.||+|...      ++..+++|.++.......+.+.+|++++++++|+||+++++++.. .+..++|
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   85 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLIMV   85 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceEEE
Confidence            445688999999999999752      355689999876555555678999999999999999999999986 5689999


Q ss_pred             EeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEE
Q 008031          363 FDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKI  429 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl  429 (580)
                      |||+++++|.+++.....             ...+++..++.++.||+.|++|||++ |++||||||+||+++.++.++|
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEE
Confidence            999999999999976431             23488999999999999999999994 9999999999999999999999


Q ss_pred             eeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhh
Q 008031          430 SDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE  507 (580)
Q Consensus       430 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  507 (580)
                      +|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..+.   +..+
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---~~~~  241 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---ITQG  241 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HhCC
Confidence            999998765432221 1122346778999999998999999999999999999999 9999876554332222   1111


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ... .        ....   ....+.+++.+||+.+|++|||+.++++.|+++...
T Consensus       242 ~~~-~--------~~~~---~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         242 RVL-E--------RPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCC-C--------CCcc---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111 0        0011   123567899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.3e-39  Score=321.91  Aligned_cols=241  Identities=26%  Similarity=0.358  Sum_probs=191.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +++.||+|.++...   ......+..|..++... +||||+++++++.+ .+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence            46899999999999986 68899999987543   22334566788888764 99999999999987 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++....... ....
T Consensus        80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05619          80 GGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC  154 (316)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence            99999999764   3588999999999999999999994 99999999999999999999999999987432211 1223


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||..|+|||++.+..++.++||||+||++|||++|+.||...+..+..+.+.   ....       ..   ...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~---~~~~-------~~---~~~---  218 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR---MDNP-------CY---PRW---  218 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCC-------CC---Ccc---
Confidence            4568999999999999999999999999999999999999997655333222221   1100       00   001   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVL-QVVQ  555 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~-ev~~  555 (580)
                      ...++.+++.+||+.||++||++. ++.+
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            123566888899999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.8e-39  Score=316.33  Aligned_cols=259  Identities=26%  Similarity=0.433  Sum_probs=204.7

Q ss_pred             HHhhhccccccCceEEEEEEeC------CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      .+.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|++++++++||||+++++++.. .+..++
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   84 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLIM   84 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEE
Confidence            3556789999999999999752      345689999876544445678999999999999999999999986 668999


Q ss_pred             EEeeCCCCChhhhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEee
Q 008031          362 VFDYMPHGSLATFLHARGP----------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISD  431 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~D  431 (580)
                      ||||+++++|.+++...+.          ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+|++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCCcEEecc
Confidence            9999999999999975431          2348999999999999999999999 4999999999999999999999999


Q ss_pred             ccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhc
Q 008031          432 FGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       432 fg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      ||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...   .+..+..
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~---~i~~~~~  240 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE---CITQGRV  240 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCCc
Confidence            9998755332211 1112235678999999998899999999999999999999 999987654332222   2222111


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ..      .   ...   ...++.+++.+||+.||.+|||+.++++.|+++...
T Consensus       241 ~~------~---~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         241 LQ------R---PRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CC------C---CCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            00      0   011   123577899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.8e-39  Score=328.83  Aligned_cols=251  Identities=22%  Similarity=0.295  Sum_probs=192.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |+..+.||+|+||.||+|... +++.||+|+++....   .....+.+|+.++.+++|+||+++++.+.+ ....++|||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv~E   81 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLIME   81 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEEEc
Confidence            456789999999999999876 689999999865422   223467889999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  443 (580)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          82 FLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            99999999999764   3689999999999999999999995 999999999999999999999999999875432110 


Q ss_pred             ---------------------------------cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCC
Q 008031          444 ---------------------------------VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGE  490 (580)
Q Consensus       444 ---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~  490 (580)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00123469999999999999999999999999999999999999997


Q ss_pred             CCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHHH
Q 008031          491 PLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALH--CVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~Rps~~ev~~~  556 (580)
                      ..+..+....+   .....  ..   .... .....++   +.+++.+  |...++..||++.|+++|
T Consensus       238 ~~~~~~~~~~i---~~~~~--~~---~~p~-~~~~s~~---~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         238 SETPQETYKKV---MNWKE--TL---IFPP-EVPISEK---AKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCHHHHHHHH---HcCcC--cc---cCCC-cCCCCHH---HHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            65533322222   11100  00   0000 1112233   3444444  333344567999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=331.59  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=195.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|... +|+.||||++....   ......+.+|+.++..++||||+++++++.+ ++..++|||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E   81 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLIME   81 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEEEC
Confidence            456789999999999999986 78999999986532   1223457889999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          82 YLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            99999999999764   3589999999999999999999995 9999999999999999999999999998654321100


Q ss_pred             -------------------------------------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCC
Q 008031          445 -------------------------------------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKS  487 (580)
Q Consensus       445 -------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~  487 (580)
                                                           ......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 0112358999999999999999999999999999999999999


Q ss_pred             CCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 008031          488 PGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPE---VLQVVQQ  556 (580)
Q Consensus       488 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ev~~~  556 (580)
                      ||...+..+.   ...+.....  ..   ... .....   ...+.+++.+|+. +|.+|++   +.|++++
T Consensus       238 Pf~~~~~~~~---~~~i~~~~~--~~---~~~-~~~~~---s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         238 PFCSDNPQET---YRKIINWKE--TL---QFP-DEVPL---SPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCHHHH---HHHHHcCCC--cc---CCC-CCCCC---CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9976543222   222211110  00   000 00011   2245577778886 9999998   8888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.8e-39  Score=319.41  Aligned_cols=260  Identities=22%  Similarity=0.347  Sum_probs=194.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.+++.++||||+++++++.. +...++||||+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~   85 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLVFEYV   85 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEEEECC
Confidence            566789999999999999986 789999999865432 233467889999999999999999999986 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      . ++|.+++...  ...++...+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||++....... ...
T Consensus        86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  160 (303)
T cd07869          86 H-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY  160 (303)
T ss_pred             C-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence            5 6888888654  24588899999999999999999994 99999999999999999999999999987543221 122


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh---hh----ccc----ccc
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK---EE----WTN----EVF  514 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---~~----~~~----~~~  514 (580)
                      ....+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+..+  ....+..+..   ..    +..    ...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            23457889999998765 4578899999999999999999999986533  2222221111   00    000    000


Q ss_pred             chhhhc--cCCCcH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          515 DLELMR--DAPTIG------DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       515 ~~~~~~--~~~~~~------~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ++....  ......      .....+.+++.+||+.||++|||+.|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            000000  000000      011356688999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-38  Score=309.33  Aligned_cols=248  Identities=25%  Similarity=0.407  Sum_probs=195.0

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      +.||+|+||.||+|.+. +++.||+|.+..... .....+.+|++++++++||||+++++++.. ....++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence            46899999999999985 789999998765432 234568999999999999999999999976 568999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce-eee
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV-IAT  449 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~  449 (580)
                      |.+++...+  ..+++..+..++.|++.||+|||+. |++||||+|+||+++.++.+|++|||++........... ...
T Consensus        80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            999997642  3588999999999999999999994 999999999999999999999999999875432211110 011


Q ss_pred             cCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          450 AGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      ..+..|+|||.+.+..++.++||||||+++|||++ |..||......+....+.    .....           +.....
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~----~~~~~-----------~~~~~~  221 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE----QGVRL-----------PCPELC  221 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH----cCCCC-----------CCcccC
Confidence            23456999999998899999999999999999998 888987554322211111    11000           000111


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ..++.+++.+||+.+|++|||+.++.+.|++
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            2367788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=302.45  Aligned_cols=257  Identities=21%  Similarity=0.360  Sum_probs=214.2

Q ss_pred             ccCHHHHHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcE
Q 008031          281 MFTADDLLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       281 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  359 (580)
                      .-...+..+.+.+++|+|+||.||+|.++ +|+.+|||.+.  ...+.+++.+|+.+|.+++.|+||++||.+.. ...+
T Consensus        27 L~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDL  103 (502)
T KOG0574|consen   27 LNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDL  103 (502)
T ss_pred             hcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCce
Confidence            34455666889999999999999999986 79999999874  34567889999999999999999999999987 6689


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      |+|||||.-|+..|.++.+  ..++++.++..++...++||+|||.. .-+|||||+.|||++.+|.+|++|||.+..+.
T Consensus       104 WIVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             EeehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence            9999999999999999876  46799999999999999999999985 78999999999999999999999999997665


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      +... +.....||+.|||||++..-.|+.++||||+|+...||..|++||.+..+....-    ++....+..       
T Consensus       181 DTMA-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----MIPT~PPPT-------  248 (502)
T KOG0574|consen  181 DTMA-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----MIPTKPPPT-------  248 (502)
T ss_pred             hhHH-hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----eccCCCCCC-------
Confidence            4432 2335679999999999999999999999999999999999999998765432111    111111111       


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        +.....+..++-+++.+||-.+|++|-|+.++++|-
T Consensus       249 --F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  249 --FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             --CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence              223334556788999999999999999999998863

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-38  Score=321.75  Aligned_cols=246  Identities=18%  Similarity=0.335  Sum_probs=192.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|... +++.||+|+++....   .....+.+|+.++.++ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence            46899999999999976 688999999875432   2234577899888877 89999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        80 ~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (329)
T cd05618          80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS  154 (329)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence            99999888764   3689999999999999999999995 999999999999999999999999999875322211 222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCC-----CChhHHHHHHhhhhccccccchhhhccC
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNG-----AELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.....     .....++.........      ..   +
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~---p  225 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI---P  225 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC---C
Confidence            35689999999999999999999999999999999999999963221     1112222222111110      00   1


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPE------VLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps------~~ev~~~  556 (580)
                      .   ....++.+++.+||+.||++||+      +.++++|
T Consensus       226 ~---~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         226 R---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             C---CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            1   11235668889999999999998      5677666

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-39  Score=322.25  Aligned_cols=241  Identities=24%  Similarity=0.331  Sum_probs=190.6

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +|+.||+|.++...   ......+..|..++... +||||+++++++.. ++..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence            46899999999999986 68899999987543   22334567788888764 89999999999987 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++...... ....
T Consensus        80 ~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05620          80 GGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS  154 (316)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence            99999998764   3588999999999999999999994 99999999999999999999999999987432211 1223


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.   ...       +..   ...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~---~~~-------~~~---~~~---  218 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR---VDT-------PHY---PRW---  218 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCC-------CCC---CCC---
Confidence            4568999999999999999999999999999999999999997654332222211   110       000   011   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVL-QVVQ  555 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~-ev~~  555 (580)
                      ...++.+++.+||+.||++||++. ++.+
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            123566788899999999999985 5553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-38  Score=310.35  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=201.1

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|+|++++++++.  .+..+++|||+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~   84 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTEFMGK   84 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEEcCCC
Confidence            56678899999999999998877789999876432 23467889999999999999999999875  4568999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      ++|.++++... ...+++..+..++.|++.||+|||+ .|++|+||+|+||++++++.++|+|||++.............
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05069          85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG  162 (260)
T ss_pred             CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence            99999997643 3357899999999999999999999 599999999999999999999999999997654332222222


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||...+..++.++||||||+++|||++ |+.||......+....+..    ....           +....
T Consensus       163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~-----------~~~~~  227 (260)
T cd05069         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER----GYRM-----------PCPQG  227 (260)
T ss_pred             CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCC-----------CCCcc
Confidence            345678999999988899999999999999999999 9999976544332222211    1100           00011


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ....+.+++.+||+.+|++||++.++++.|+++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            223567888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.8e-38  Score=307.78  Aligned_cols=247  Identities=26%  Similarity=0.421  Sum_probs=196.6

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCCh
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSL  371 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L  371 (580)
                      ++||+|+||.||+|...+++.+|+|.++..... ....+.+|++++++++||||+++++++.. .+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCcH
Confidence            468999999999999888999999998755432 23468899999999999999999999986 5689999999999999


Q ss_pred             hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeecC
Q 008031          372 ATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG  451 (580)
Q Consensus       372 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  451 (580)
                      .+++....  ..+++..+..++.|++.||.|+|+ .|++||||+|+||+++.++.+|++|||++...............+
T Consensus        80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            99987542  357899999999999999999999 499999999999999999999999999987543322211112234


Q ss_pred             ccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHH
Q 008031          452 ALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL  530 (580)
Q Consensus       452 ~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  530 (580)
                      +..|+|||++.+..++.++||||||+++|++++ |..||...........+.    .....     .   ...   ....
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~----~~~~~-----~---~~~---~~~~  221 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE----KGYRM-----S---CPQ---KCPD  221 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH----cCCCC-----C---CCC---CCCH
Confidence            567999999998899999999999999999999 999997654322222111    11110     0   011   1123


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          531 NTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       531 ~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .+.+++.+||+.+|++|||+.|+++.|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            6778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=310.28  Aligned_cols=255  Identities=26%  Similarity=0.435  Sum_probs=204.9

Q ss_pred             HHHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          287 LLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      ..|.+.+.||+|+||.||+|..++++.||||.+.... ....++.+|+.++++++|+||+++++++.. ....+++|||+
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~   83 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEYM   83 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEecc
Confidence            3466788999999999999998888899999987543 345678999999999999999999999876 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++.... ...+++.++..++.|++.|++|||++ +++|+||+|+||++++++.+|++|||.+...........
T Consensus        84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence            9999999997643 34589999999999999999999995 999999999999999999999999999876654322222


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....+..|+|||.+.+..++.++|+||+|+++|++++ |+.||.........+.+.   .. ...        ......
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---~~-~~~--------~~~~~~  229 (261)
T cd05034         162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE---RG-YRM--------PRPPNC  229 (261)
T ss_pred             hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC-CCC--------CCCCCC
Confidence            23335568999999998899999999999999999999 999997654332222221   11 000        000111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                         ...+.+++.+||+.+|++||+++++.+.|+.+
T Consensus       230 ---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         230 ---PEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             ---CHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence               23567888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9e-39  Score=321.84  Aligned_cols=246  Identities=21%  Similarity=0.310  Sum_probs=194.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCC-cceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHP-NLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|... +++.||+|+++...   ....+.+..|++++..+.|+ +|+++++++.. .+..++||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~   80 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVM   80 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEEE
Confidence            456789999999999999876 67899999987542   22345678899999999764 58888888876 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++....... 
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            999999999998764   358899999999999999999999 599999999999999999999999999986432211 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.   ....       ..   ..
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~---~~~~-------~~---~~  222 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM---EHNV-------SY---PK  222 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---cCCC-------CC---CC
Confidence            12234568999999999999999999999999999999999999998655433322221   1110       00   01


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEV-----LQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ev~~~  556 (580)
                      .   ...++.+++.+||+.||.+|++.     .++.++
T Consensus       223 ~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         223 S---LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             C---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1   12356688889999999999986     666655

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-38  Score=312.21  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=196.7

Q ss_pred             hhhccccccCceEEEEEEeCC-CC--EEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----CCcE
Q 008031          290 ATAEIMGKSTYGTVYKATLED-GS--QVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGP-----KGEK  359 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  359 (580)
                      ++.+.||+|+||.||+|.+.+ +.  .||+|.++...  ....+.+.+|+.+++.++|+||+++++++...     ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            356889999999999999763 33  58999886543  22345688999999999999999999987542     1246


Q ss_pred             EEEEeeCCCCChhhhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          360 LLVFDYMPHGSLATFLHAR---GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      +++|||+++|+|.+++...   .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCCccc
Confidence            8999999999999987432   123458899999999999999999999 499999999999999999999999999998


Q ss_pred             ccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhcccccc
Q 008031          437 LMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVF  514 (580)
Q Consensus       437 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ......... .....++..|+|||...+..++.++||||||+++|||++ |+.||......+....+   ..+...    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~~~~~~----  233 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL---RQGNRL----  233 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HcCCCC----
Confidence            664332211 112235678999999999999999999999999999999 88999764433222221   111110    


Q ss_pred             chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       515 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                           ...+.   ....+.+++.+||+.||++|||+.++++.|+++
T Consensus       234 -----~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         234 -----KQPPD---CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -----CCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 00111   123567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-38  Score=314.75  Aligned_cols=254  Identities=25%  Similarity=0.425  Sum_probs=198.5

Q ss_pred             HhhhccccccCceEEEEEEe-----CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATL-----EDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      +++.+.||+|+||.||+|..     .++..||+|.+..... .....+.+|+.++++++||||+++++++.. +...+++
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv   85 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPVCML   85 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCceEEE
Confidence            44568899999999999985     2567899999875332 233578899999999999999999999876 5689999


Q ss_pred             EeeCCCCChhhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeE
Q 008031          363 FDYMPHGSLATFLHARGP--------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAK  428 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~k  428 (580)
                      |||+++++|.+++.....              ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~~k  164 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLHVK  164 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCcEE
Confidence            999999999999864321              23478889999999999999999994 999999999999999999999


Q ss_pred             Eeecccccccccccc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhh
Q 008031          429 ISDFGLSRLMTAAAN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK  506 (580)
Q Consensus       429 l~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  506 (580)
                      ++|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......++.+.+..   
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---  241 (283)
T cd05090         165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK---  241 (283)
T ss_pred             eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---
Confidence            999999976533221 11122345677999999988889999999999999999999 9999876543332222221   


Q ss_pred             hhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                       ....     .   .....   ..++.+++.+||+.||++||++.++.++|..
T Consensus       242 -~~~~-----~---~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 -RQLL-----P---CSEDC---PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -CCcC-----C---CCCCC---CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             1100     0   01111   2356678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-38  Score=320.84  Aligned_cols=246  Identities=18%  Similarity=0.331  Sum_probs=193.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +++.||+|+++....   .....+.+|..++..+ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence            46899999999999976 788999999975432   2234578899999998 79999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||+++...... ....
T Consensus        80 ~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (329)
T cd05588          80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS  154 (329)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence            99999988754   368999999999999999999999 499999999999999999999999999987432211 1222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-----ChhHHHHHHhhhhccccccchhhhccC
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA-----ELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      ...||..|+|||++.+..++.++|+||+||++|+|++|+.||......     ....+..........      ..   +
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---p  225 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI---P  225 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC---C
Confidence            356899999999999999999999999999999999999999643211     111222222111110      00   1


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPE------VLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps------~~ev~~~  556 (580)
                      ...   ..++.+++.+||+.||.+|||      +.++++|
T Consensus       226 ~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         226 RSL---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCC---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            111   235668888999999999997      6777765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=330.57  Aligned_cols=251  Identities=21%  Similarity=0.276  Sum_probs=193.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||++... +++.||||++....   ......+.+|++++++++||||+++++++.+ ++..|+|||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~E   81 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLIME   81 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEEEe
Confidence            456789999999999999875 78999999986432   1223567889999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+|++|||+++.+......
T Consensus        82 ~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          82 FLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            99999999999764   368899999999999999999999 59999999999999999999999999998643211000


Q ss_pred             ----------------------------------------------ceeeecCccccCCccccccCCCCCcccchhHHHH
Q 008031          445 ----------------------------------------------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVT  478 (580)
Q Consensus       445 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~  478 (580)
                                                                    ......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0012458999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 008031          479 ILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSAR---PEVLQVVQ  555 (580)
Q Consensus       479 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---ps~~ev~~  555 (580)
                      +|||++|+.||...+..+...   .+....  ...       ..+.......++.+++.+|+. +|.+|   +|+.|+++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~---~i~~~~--~~~-------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYR---KIINWR--ETL-------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHH---HHHccC--Ccc-------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            999999999997654322222   221110  000       001100112355678888997 66665   59999988


Q ss_pred             HH
Q 008031          556 QL  557 (580)
Q Consensus       556 ~L  557 (580)
                      +-
T Consensus       305 hp  306 (377)
T cd05629         305 HP  306 (377)
T ss_pred             CC
Confidence            74

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.2e-39  Score=322.88  Aligned_cols=246  Identities=22%  Similarity=0.311  Sum_probs=194.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|... +++.||+|+++....   .....+..|..++..+ +|++|+++++++.. .+..++||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~   80 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFVM   80 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEEE
Confidence            345788999999999999876 678999999875432   2234567788888877 68999999998876 56899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+ .||+||||||+|||+++++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            999999999998764   358899999999999999999999 5999999999999999999999999999875432211


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.+   .....       ..   ..
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i---~~~~~-------~~---p~  222 (323)
T cd05616         157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---MEHNV-------AY---PK  222 (323)
T ss_pred             -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCC-------CC---CC
Confidence             222356899999999999999999999999999999999999999875543333222   21110       00   01


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEV-----LQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ev~~~  556 (580)
                         ....++.+++.+|++.||.+|++.     .++.++
T Consensus       223 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         223 ---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ---cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence               112356788889999999999984     666554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.1e-38  Score=308.46  Aligned_cols=249  Identities=27%  Similarity=0.452  Sum_probs=199.4

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .+.+.+.||+|+||.||++... |..||+|.++..  ...+.+.+|+.++++++|+|++++++++...++..+++|||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            4566789999999999999876 788999988643  2345788999999999999999999987765667899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.++++... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+|++|||++........    
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~----  157 (256)
T cd05082          84 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----  157 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCCcEEecCCccceeccccCC----
Confidence            999999997653 3358899999999999999999999 5999999999999999999999999999875433221    


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+.   . .....     .   .+.  
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---~-~~~~~-----~---~~~--  223 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---K-GYKMD-----A---PDG--  223 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---c-CCCCC-----C---CCC--
Confidence            1234567999999998899999999999999999998 999987544322222211   1 11110     0   111  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                       ....+.+++.+||+.+|++|||+.++++.|+++
T Consensus       224 -~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         224 -CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence             123566788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-38  Score=325.46  Aligned_cols=264  Identities=23%  Similarity=0.344  Sum_probs=203.6

Q ss_pred             cCHHHHHHhhhccccccCceEEEEEEeC------CCCEEEEEEcccccccc-HHHHHHHHHHHhcCC-CCcceeeeeEEE
Q 008031          282 FTADDLLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITKG-QREFESEVSLLGKIR-HPNLLALRAYYL  353 (580)
Q Consensus       282 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~  353 (580)
                      +....-.+.+.+.||+|+||.||+|.+.      .+..||+|+++...... .+.+.+|++++.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344445667899999999999999864      34689999997543322 346889999999997 999999999998


Q ss_pred             CCCCcEEEEEeeCCCCChhhhhhhcCC-----------------------------------------------------
Q 008031          354 GPKGEKLLVFDYMPHGSLATFLHARGP-----------------------------------------------------  380 (580)
Q Consensus       354 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  380 (580)
                      . .+..++||||+++|+|.++++....                                                     
T Consensus       112 ~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 K-GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             c-CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            7 5689999999999999999975321                                                     


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCC
Q 008031          381 ------------------------------------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSN  418 (580)
Q Consensus       381 ------------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~N  418 (580)
                                                                ...+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~N  269 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARN  269 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcce
Confidence                                                      1236778889999999999999999 599999999999


Q ss_pred             eeeCCCCCeEEeecccccccccccc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCC
Q 008031          419 VLLDDSTNAKISDFGLSRLMTAAAN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAE  496 (580)
Q Consensus       419 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  496 (580)
                      |++++++.+|++|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999976533221 11122346788999999998889999999999999999998 899987554322


Q ss_pred             hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          497 LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      .   ...........        .....   ...++.+++.+||+.+|++||+++|+++.|+++.
T Consensus       350 ~---~~~~~~~~~~~--------~~p~~---~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 Q---FYNAIKRGYRM--------AKPAH---ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             H---HHHHHHcCCCC--------CCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1   11111111100        00111   1235677888999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=311.46  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=199.3

Q ss_pred             hhhccccccCceEEEEEEeC-C---CCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-----c
Q 008031          290 ATAEIMGKSTYGTVYKATLE-D---GSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-----E  358 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~  358 (580)
                      .+.+.||+|+||.||+|... +   +..||+|.++....  .....+.+|+..++.++||||+++++++.....     .
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45688999999999999864 2   36799999875332  223568899999999999999999998875332     3


Q ss_pred             EEEEEeeCCCCChhhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          359 KLLVFDYMPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      .++++||+++|+|.+++....   ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCCeEEECCccce
Confidence            789999999999999985431   22468999999999999999999999 49999999999999999999999999999


Q ss_pred             cccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          436 RLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       436 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      +......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+..+.+.   .....   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~~---  234 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR---HGNRL---  234 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCC---
Confidence            8664332211 111234567999999988899999999999999999999 899997655433322221   11110   


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                         .      .......++.+++.+||+.||.+|||+.|+++.|+++
T Consensus       235 ---~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         235 ---K------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---C------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               0      0111233677888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.4e-39  Score=327.20  Aligned_cols=252  Identities=20%  Similarity=0.247  Sum_probs=196.0

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      .|.+.+.||+|+||.||++... +++.||+|.+....   ......+.+|+.+++.++||||+++++++.. +...++||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~  122 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYLYMVM  122 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEE
Confidence            4667789999999999999986 68899999986422   1234457899999999999999999999986 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...    .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++........
T Consensus       123 Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         123 EYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999999999753    47888999999999999999999 5999999999999999999999999999987654333


Q ss_pred             cceeeecCccccCCccccccC----CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          444 VNVIATAGALGYRAPELSKLK----KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||...+..   .....+.......        
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~--------  266 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTYSKIMDHKNSL--------  266 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCccc--------
Confidence            233345699999999998654    3788999999999999999999999765432   2222222211100        


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSA--RPEVLQVVQQL  557 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ev~~~L  557 (580)
                       ..+........+.+++.+|+..++.+  |+|+.|+++|-
T Consensus       267 -~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         267 -NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             -CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence             01111111234556777888755543  89999999983

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2e-38  Score=313.31  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=199.2

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      +.+.+.||+|+||.||+|.+.      ++..||+|.++..... ..+.+.+|+.++..++||||+++++++.. .+..++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~~   85 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQPLSM   85 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CCceEE
Confidence            567899999999999999864      2578999998754332 23568899999999999999999999976 567899


Q ss_pred             EEeeCCCCChhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeE
Q 008031          362 VFDYMPHGSLATFLHARG-------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAK  428 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~k  428 (580)
                      ++||+.+++|.+++....             ....+++..+.+++.|++.||+|||+ .|++||||||.||++++++.+|
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~k  164 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFDKLNVK  164 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecCCCceE
Confidence            999999999999985321             12357888999999999999999999 4999999999999999999999


Q ss_pred             Eeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhh
Q 008031          429 ISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK  506 (580)
Q Consensus       429 l~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  506 (580)
                      |+|||+++......... .....+++.|+|||.+.+..++.++||||+||++|||++ |..||.+....+..   ..+..
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~i~~  241 (283)
T cd05091         165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---EMIRN  241 (283)
T ss_pred             ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHc
Confidence            99999987654332221 112345678999999988889999999999999999998 88888765433222   22222


Q ss_pred             hhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ....         ......   ...+.+++.+||+.+|++||++.++++.|+.
T Consensus       242 ~~~~---------~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 RQVL---------PCPDDC---PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCcC---------CCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1110         001112   2346678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-38  Score=309.14  Aligned_cols=240  Identities=22%  Similarity=0.363  Sum_probs=188.2

Q ss_pred             ccccccCceEEEEEEeCC-------------CCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcE
Q 008031          293 EIMGKSTYGTVYKATLED-------------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  359 (580)
                      +.||+|+||.||+|...+             ...|++|.+..........+.+|+.+++.++||||+++++++.. +...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCCC
Confidence            468999999999998542             22589998876555555678899999999999999999999986 5678


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC-------eEEeec
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN-------AKISDF  432 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~-------~kl~Df  432 (580)
                      +++|||+++|+|..++...  ...+++..+.+++.||+.||+|||+ ++|+||||||+||+++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999988754  2458999999999999999999999 59999999999999986654       899999


Q ss_pred             ccccccccccccceeeecCccccCCccccc-cCCCCCcccchhHHHHHHHHH-cCCCCCCCCCCCChhHHHHHHhhhhcc
Q 008031          433 GLSRLMTAAANVNVIATAGALGYRAPELSK-LKKANTKTDVYSLGVTILELL-TGKSPGEPLNGAELPQWVASIVKEEWT  510 (580)
Q Consensus       433 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~  510 (580)
                      |++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+...    ...... 
T Consensus       157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~~~~~~-  226 (262)
T cd05077         157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----FYEGQC-  226 (262)
T ss_pred             CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----HHhcCc-
Confidence            998654322     1234778899999876 567889999999999999998 5888886543322111    111110 


Q ss_pred             ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                                  ....+...++.+++.+||+.||++||++.++++++.
T Consensus       227 ------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         227 ------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                        000111235678899999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5e-39  Score=330.03  Aligned_cols=263  Identities=20%  Similarity=0.277  Sum_probs=197.8

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC----CcEEEE
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK----GEKLLV  362 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv  362 (580)
                      ...+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|+.+++.++|+||+++++++....    ...++|
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            45789999999999999975 799999999864322  23456889999999999999999999997633    268999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+. ++|.+++...   ..+++..+..++.||+.||+|||+ .|++||||||+||+++.++.+||+|||+++......
T Consensus        83 ~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          83 TELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             eeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            99996 5888877653   468999999999999999999999 499999999999999999999999999997654333


Q ss_pred             ccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc---------
Q 008031          443 NVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE---------  512 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  512 (580)
                      ........++..|+|||.+.+. .++.++||||+||++|||++|+.||...+..+....+...........         
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence            3333334678899999988764 578999999999999999999999987654433332222111000000         


Q ss_pred             --c-----cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          513 --V-----FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       513 --~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        .     ..+..............++.+++.+||+.||++|||+.|++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence              0     00000000000011134677899999999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.1e-39  Score=321.58  Aligned_cols=242  Identities=26%  Similarity=0.364  Sum_probs=193.5

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +++.||+|+++...   ......+..|..+++.+ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46899999999999986 68899999987543   22334567889999888 79999999999876 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........ ...
T Consensus        80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (318)
T cd05570          80 GGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS  154 (318)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence            99999988764   368999999999999999999999 4999999999999999999999999999864322211 122


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...|+..|+|||++.+..++.++||||+||++|+|++|+.||...+..+..   ..+.....       ..   ...   
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~---~~i~~~~~-------~~---~~~---  218 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF---QSILEDEV-------RY---PRW---  218 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH---HHHHcCCC-------CC---CCc---
Confidence            345889999999999999999999999999999999999999765433222   22211110       00   011   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEV-----LQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~-----~ev~~~  556 (580)
                      ....+.+++.+||+.||.+|||+     .+++++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            12356788889999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-38  Score=315.48  Aligned_cols=259  Identities=28%  Similarity=0.406  Sum_probs=203.2

Q ss_pred             HHHHhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCC
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKG  357 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  357 (580)
                      ...|+..+.||+|+||.||++...      ....+|+|.+..... .....+.+|+.++.++ +|+||+++++++.. ++
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-EG   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-CC
Confidence            344667889999999999999864      235799999875432 2335688999999999 89999999999976 66


Q ss_pred             cEEEEEeeCCCCChhhhhhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          358 EKLLVFDYMPHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      ..+++|||+++|+|.++++..             .....+++..+++++.|++.||+|||+. +|+||||||+||+++++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTED  168 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCC
Confidence            899999999999999999753             1234688999999999999999999995 99999999999999999


Q ss_pred             CCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHH
Q 008031          425 TNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~  502 (580)
                      +.+|++|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+..+.+.
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  248 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  248 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence            999999999998664432211 112234567999999988899999999999999999998 999987654333222221


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                         ......         ...   .....+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus       249 ---~~~~~~---------~~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         249 ---EGYRME---------KPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---cCCcCC---------CCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               111000         001   11235678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-38  Score=321.77  Aligned_cols=261  Identities=25%  Similarity=0.361  Sum_probs=202.0

Q ss_pred             HHHhhhccccccCceEEEEEEe------CCCCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCc
Q 008031          287 LLCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  358 (580)
                      -.|.+.+.||+|+||.||+|.+      .+++.||||.++..... ....+.+|+.++.++ +|+||+++++++...+..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            3578899999999999999974      25788999999754332 345688999999999 789999999998776667


Q ss_pred             EEEEEeeCCCCChhhhhhhcCC----------------------------------------------------------
Q 008031          359 KLLVFDYMPHGSLATFLHARGP----------------------------------------------------------  380 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  380 (580)
                      .+++|||+++|+|.++++....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            8999999999999999865310                                                          


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-ceeeecCcc
Q 008031          381 ------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-NVIATAGAL  453 (580)
Q Consensus       381 ------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~  453 (580)
                            ...+++.++..++.||+.||+|||+. +|+||||||+||++++++.+|++|||++......... ......++.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence                  12367888999999999999999994 9999999999999999999999999998765332211 111223566


Q ss_pred             ccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHH
Q 008031          454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT  532 (580)
Q Consensus       454 ~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  532 (580)
                      .|+|||.+.+..++.++||||||+++|+|++ |..||.......  . ............        ....   ...++
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~-~~~~~~~~~~~~--------~~~~---~~~~~  311 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E-FCRRLKEGTRMR--------APDY---TTPEM  311 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H-HHHHHhccCCCC--------CCCC---CCHHH
Confidence            7999999988899999999999999999997 999986543221  1 111111111100        0001   11356


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          533 LKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       533 ~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      .+++.+||+.+|++|||+.|++++|+.+.+
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-38  Score=312.92  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=202.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCC----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGS----QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      .+...+.||+|+||.||+|.+. +|+    .||+|.++.... .....+.+|+.+++.++|+||+++++++..  ...++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~l   85 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQL   85 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcEE
Confidence            3556789999999999999864 444    489999865433 234678899999999999999999999974  46789


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ++||+++|+|.++++..  ...+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.....
T Consensus        86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            99999999999999764  2458999999999999999999999 59999999999999999999999999999866432


Q ss_pred             cccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 ANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .... .....++..|+|||...+..++.++|||||||++|||++ |..||...........+..   ....         
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~---------  230 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK---GERL---------  230 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCcC---------
Confidence            2211 112234568999999998899999999999999999998 9999876544333332221   1100         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                         +.......++.+++.+||+.||++||++.++++.|+++....
T Consensus       231 ---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 ---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence               000112235678899999999999999999999999886654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-38  Score=308.30  Aligned_cols=258  Identities=22%  Similarity=0.358  Sum_probs=203.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||+|... +++.||||.++...   ......+.+|+++++.++||||+++++++.. .+..++++|
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   82 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIVLE   82 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEEEE
Confidence            456788999999999999975 78999999875422   2233568899999999999999999999886 568899999


Q ss_pred             eCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          365 YMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      |+++|+|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            999999999886432 234578899999999999999999995 999999999999999999999999999876543322


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      . .....++..|+|||.+.+..++.++|+||+|+++|||++|+.||..... +.......+......      ..     
T Consensus       162 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~------~~-----  228 (267)
T cd08228         162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYP------PL-----  228 (267)
T ss_pred             H-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCC------CC-----
Confidence            1 1224578889999999888899999999999999999999999865322 222222221111110      00     


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      ........+.+++.+||+.+|++|||+.++++.|++++
T Consensus       229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            01112245778899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.4e-39  Score=331.02  Aligned_cols=250  Identities=20%  Similarity=0.257  Sum_probs=193.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||+|... +++.||+|++.....   .....+.+|++++++++|+||+++++.+.+ ++..++|||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E   81 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVMD   81 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEEEe
Confidence            456789999999999999976 689999999864321   234567899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc--
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA--  442 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~--  442 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++..+....  
T Consensus        82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            99999999999764   3578888999999999999999995 99999999999999999999999999975321000  


Q ss_pred             ----------------------------------------ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHH
Q 008031          443 ----------------------------------------NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILEL  482 (580)
Q Consensus       443 ----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el  482 (580)
                                                              ........||+.|||||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0001124689999999999999999999999999999999


Q ss_pred             HcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 008031          483 LTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARP---EVLQVVQQ  556 (580)
Q Consensus       483 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp---s~~ev~~~  556 (580)
                      ++|+.||...+..+....+.   ....  .. .  . ......   ..++.+++.+|+ .+|.+|+   |+.+++++
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~---~~~~--~~-~--~-~~~~~~---s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVI---NWET--TL-H--I-PSQAKL---SREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHh---ccCc--cc-c--C-CCCCCC---CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999998755433222111   1000  00 0  0 001111   224456666765 4999999   89999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-38  Score=306.89  Aligned_cols=248  Identities=28%  Similarity=0.433  Sum_probs=197.7

Q ss_pred             ccccccCceEEEEEEeC-C---CCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-D---GSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. .   +..+|+|.+...... ..+.+.+|+++++++.|+||+++++++.  ....++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence            46899999999999864 2   268999998755432 4567899999999999999999999885  346899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++....   .+++..+..++.|++.|++|||. .+++|+||||+||+++.++.+|++|||+++...........
T Consensus        79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            999999998653   68999999999999999999999 59999999999999999999999999998866433322111


Q ss_pred             --eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          448 --ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       448 --~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                        ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+..   ....         .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~---~~~~---------~~~~~  222 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES---GERL---------PRPEE  222 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc---CCcC---------CCCCC
Confidence              1123467999999998899999999999999999998 9999976654333332221   1110         00111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                         ....+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       223 ---~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         223 ---CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence               1236678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.4e-39  Score=329.56  Aligned_cols=250  Identities=20%  Similarity=0.281  Sum_probs=191.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|... +++.||+|++.....   .....+.+|+.++++++|+||+++++.+.+ ++..++|||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~E   81 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVMD   81 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEEe
Confidence            456789999999999999875 788999999865422   233568899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc--
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA--  442 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~--  442 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++..+....  
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999999999764   357888999999999999999999 599999999999999999999999999975321000  


Q ss_pred             --------------------------------------------ccceeeecCccccCCccccccCCCCCcccchhHHHH
Q 008031          443 --------------------------------------------NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVT  478 (580)
Q Consensus       443 --------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~  478 (580)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 008031          479 ILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPE---VLQVVQ  555 (580)
Q Consensus       479 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ev~~  555 (580)
                      +|||++|+.||...+..+...   .+......     ... .......   .++.+++.+|+ .+|++|++   +.++++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~---~i~~~~~~-----~~~-p~~~~~s---~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQM---KVINWQTS-----LHI-PPQAKLS---PEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHH---HHHccCCC-----cCC-CCcccCC---HHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999997654322221   11110000     000 0011122   24455665654 49999997   888776


Q ss_pred             H
Q 008031          556 Q  556 (580)
Q Consensus       556 ~  556 (580)
                      |
T Consensus       305 h  305 (382)
T cd05625         305 H  305 (382)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.9e-39  Score=324.01  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=204.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-C-----CcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-H-----PNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~  360 (580)
                      +|.+.++||+|+||.|.+|.+. +++.||||+++..... ..+...|+.+|..|+ |     -|+|++++++.. .++.|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-cccee
Confidence            5778999999999999999876 7999999999865432 345567999999996 4     389999999986 77999


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC--CCeEEeeccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS--TNAKISDFGLSRLM  438 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~--~~~kl~Dfg~~~~~  438 (580)
                      ||+|.+ .-+|+++++... ...++...++.++.||+.||..||+. +|||+||||+|||+.+.  ..+||+|||.|+..
T Consensus       265 iVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999999 459999998865 44599999999999999999999996 99999999999999743  46999999999876


Q ss_pred             ccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh--------h-hc
Q 008031          439 TAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK--------E-EW  509 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------~-~~  509 (580)
                      ...-.    ...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.++.+....+...+.        . ..
T Consensus       342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            44322    44567889999999999999999999999999999999998987776554444433221        0 00


Q ss_pred             cccccch-----------h------------------hhccCC----Cc----H-HHHHHHHHHHhhccCCCCCCCCCHH
Q 008031          510 TNEVFDL-----------E------------------LMRDAP----TI----G-DELLNTLKLALHCVDPSPSARPEVL  551 (580)
Q Consensus       510 ~~~~~~~-----------~------------------~~~~~~----~~----~-~~~~~l~~li~~cl~~~P~~Rps~~  551 (580)
                      ....++.           .                  .....|    ..    . .+-..+++++.+|+..||.+|+|..
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence            0111111           0                  000001    00    0 1235678999999999999999999


Q ss_pred             HHHHHHh
Q 008031          552 QVVQQLE  558 (580)
Q Consensus       552 ev~~~L~  558 (580)
                      ++++|=.
T Consensus       498 qal~Hpf  504 (586)
T KOG0667|consen  498 QALNHPF  504 (586)
T ss_pred             HHhcCcc
Confidence            9998853

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-38  Score=310.83  Aligned_cols=257  Identities=22%  Similarity=0.371  Sum_probs=203.6

Q ss_pred             HHhhhccccccCceEEEEEEeCC----CCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLED----GSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .+...+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.++++++||||+++++++..  ...++|
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv   84 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWIV   84 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEEE
Confidence            45677899999999999998653    2468999886554 3344678999999999999999999999864  467899


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            99999999999997642  358999999999999999999999 599999999999999999999999999987654432


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ........++..|+|||.+....++.++||||||+++||+++ |..||......+....+.   .+...         ..
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~~~---------~~  229 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE---NGERL---------PM  229 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cCCcC---------CC
Confidence            222222234567999999988889999999999999999996 999997665443322221   11111         01


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .+..   ...+.+++.+||..+|.+|||+.++++.|+.++.+.
T Consensus       230 ~~~~---~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         230 PPNC---PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            1111   235667888999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-38  Score=310.34  Aligned_cols=244  Identities=24%  Similarity=0.378  Sum_probs=190.8

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ||+|+||.||++... +|+.||+|.+.....   .....+..|++++++++||||+++.+++.. +...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence            699999999999876 689999999864322   123445679999999999999999999876 668999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeec
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA  450 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  450 (580)
                      |.+++.... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.++|+|||++.......  ......
T Consensus        80 L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          80 LKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            999886543 3358899999999999999999999 599999999999999999999999999987654322  222346


Q ss_pred             CccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh-hHHHHHHhhhhccccccchhhhccCCCcHHHH
Q 008031          451 GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL-PQWVASIVKEEWTNEVFDLELMRDAPTIGDEL  529 (580)
Q Consensus       451 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  529 (580)
                      |+..|+|||++.+..++.++||||+||++|||++|+.||........ ............     ..    ....   ..
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~----~~~~---~~  223 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-----KF----EHQN---FT  223 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-----cc----cccc---CC
Confidence            88999999999988899999999999999999999999976433211 111111111110     00    0011   12


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHH
Q 008031          530 LNTLKLALHCVDPSPSARPEVLQVVQ  555 (580)
Q Consensus       530 ~~l~~li~~cl~~~P~~Rps~~ev~~  555 (580)
                      .++.+++.+||+.||++||++.|+++
T Consensus       224 ~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         224 EESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHHHHHHhccCHhhCCCCccchh
Confidence            35678888999999999999966553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-39  Score=324.10  Aligned_cols=238  Identities=24%  Similarity=0.375  Sum_probs=190.8

Q ss_pred             ccccccCceEEEEEEe----CCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          293 EIMGKSTYGTVYKATL----EDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      +.||+|+||.||++..    .+|+.||+|+++....  .....+..|++++++++||||+++++++.. .+..++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence            6799999999999875    3688999999875432  233457789999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++|+|.+++.+.   ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++....... ...
T Consensus        81 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~  155 (318)
T cd05582          81 RGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA  155 (318)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence            999999999764   368999999999999999999999 499999999999999999999999999987654332 223


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+..+.   ...+......          ..... 
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i~~~~~~----------~p~~~-  221 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMILKAKLG----------MPQFL-  221 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHHHcCCCC----------CCCCC-
Confidence            345689999999999988899999999999999999999999976543222   2222211110          01111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHH
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQ  552 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~e  552 (580)
                        ...+.+++.+||+.||++|||+.+
T Consensus       222 --~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 --SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CHHHHHHHHHHhhcCHhHcCCCCC
Confidence              125567888999999999999444

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-38  Score=312.41  Aligned_cols=264  Identities=23%  Similarity=0.357  Sum_probs=198.3

Q ss_pred             hhhccccccCceEEEEEEe-----CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEEE
Q 008031          290 ATAEIMGKSTYGTVYKATL-----EDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLLV  362 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv  362 (580)
                      ...+.||+|+||.||.+.+     .++..||+|.++.... .....+.+|++++++++||||+++++++.... ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            5678999999999988653     3578899999875533 23456889999999999999999999987543 357899


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++++|.+++...    .+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus        87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            9999999999999763    489999999999999999999995 99999999999999999999999999988664332


Q ss_pred             ccc--eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHh---hhhccccccchh
Q 008031          443 NVN--VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV---KEEWTNEVFDLE  517 (580)
Q Consensus       443 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  517 (580)
                      ...  .....++..|+|||.+.+..++.++||||||+++|||++|..||...... .........   .........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhhcC
Confidence            211  11123456799999998889999999999999999999999998653321 000000000   000000000000


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      ..  .+.......++.+++.+||+.+|++|||++++++.|+++.
T Consensus       241 ~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 MR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00  0001112246778899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.9e-38  Score=308.15  Aligned_cols=252  Identities=22%  Similarity=0.409  Sum_probs=202.2

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +...+.||+|+||.||+|.+.++..+|+|.++... .....+.+|++++++++|+||+++.+++..  ...+++|||+++
T Consensus         8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~   84 (260)
T cd05073           8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAK   84 (260)
T ss_pred             eeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCC
Confidence            55678999999999999998878889999886532 234678899999999999999999999875  578999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      ++|.+++.+.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+|++|||.+.............
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  162 (260)
T cd05073          85 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  162 (260)
T ss_pred             CcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence            99999997643 3457889999999999999999999 499999999999999999999999999987654332222222


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||.+....++.++|+|||||++|++++ |+.||...+..+....+..    ....           +....
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~----~~~~-----------~~~~~  227 (260)
T cd05073         163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER----GYRM-----------PRPEN  227 (260)
T ss_pred             CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC----CCCC-----------CCccc
Confidence            345677999999998889999999999999999999 9999976544333322211    1100           00111


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ...++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            223577888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-38  Score=316.23  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=200.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCC--EEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGS--QVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +.+.+.||+|+||.||+|.+. ++.  .+|+|.++.... .....+.+|+.++.++ +|+||+++++++.. ++..++||
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~   87 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAI   87 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCceEEE
Confidence            456788999999999999975 454  457777764332 2345788999999999 89999999999976 66899999


Q ss_pred             eeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          364 DYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                      ||+++++|.++++....             ...+++.+++.++.|++.|++|||+ .|++||||||+||+++.++.+||+
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCCCcEEeC
Confidence            99999999999975421             2357899999999999999999999 599999999999999999999999


Q ss_pred             ecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhc
Q 008031          431 DFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       431 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      |||++.......  ......++..|+|||.+.+..++.++|||||||++|||+| |..||...+..+....+.    ...
T Consensus       167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----~~~  240 (303)
T cd05088         167 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP----QGY  240 (303)
T ss_pred             ccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh----cCC
Confidence            999986432111  1111234567999999988889999999999999999998 999997654433222211    110


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                      ..     ..   ...   ....+.+++.+||+.+|++|||+.++++.|+++.....
T Consensus       241 ~~-----~~---~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         241 RL-----EK---PLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             cC-----CC---CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            00     00   001   12256788999999999999999999999998765554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=317.24  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=209.9

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|.||.||+++.. +|+.+|+|.+.+....   +...+.+|+++|+++. |||||.+.+.+.+ ....++|
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~~~lv  114 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PDSVYLV  114 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CCeEEEE
Confidence            3666799999999999999987 5999999999765443   3357899999999998 9999999999987 5689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC----CCCeEEeeccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD----STNAKISDFGLSRLM  438 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~----~~~~kl~Dfg~~~~~  438 (580)
                      ||++.||.|.+.+...    .+++..+..++.|++.++.|||+ .||+||||||+|+|+..    ++.+|++|||++...
T Consensus       115 mEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            9999999999999875    38999999999999999999999 59999999999999963    247999999999987


Q ss_pred             ccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          439 TAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ..  .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.........   +...++   .++.  
T Consensus       190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~---i~~~~~---~f~~--  259 (382)
T KOG0032|consen  190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA---ILRGDF---DFTS--  259 (382)
T ss_pred             cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH---HHcCCC---CCCC--
Confidence            66  4455678899999999999999999999999999999999999999998776554442   222222   1111  


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                          +........+.+++..|+..||.+|+|+.++++|-+
T Consensus       260 ----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  260 ----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             ----CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                112223345667888999999999999999999744

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=336.25  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=199.3

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-------
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-------  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------  357 (580)
                      .|.+.+.||+|+||.||+|... +|+.||||.+....  ......+.+|+.++..++|+|++++.+.+...+.       
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            3567799999999999999875 79999999986442  2234567899999999999999999887754221       


Q ss_pred             cEEEEEeeCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      ..++||||+++|+|.+++..+. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence            2679999999999999997542 23468999999999999999999999 599999999999999999999999999998


Q ss_pred             ccccccc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          437 LMTAAAN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       437 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ...+.........     
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~~~~~~~~~~-----  263 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHKTLAGRYD-----  263 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCC-----
Confidence            6543221 122235689999999999999999999999999999999999999976442   2222222221110     


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      +    ..+..   ..++.+++.+||+.||.+|||+.+++++
T Consensus       264 ~----~~~~~---~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        264 P----LPPSI---SPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C----CCCCC---CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            0    01111   2356688889999999999999999875

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-38  Score=315.42  Aligned_cols=264  Identities=26%  Similarity=0.390  Sum_probs=206.2

Q ss_pred             cCHHHHHHhhhccccccCceEEEEEEeC--------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeE
Q 008031          282 FTADDLLCATAEIMGKSTYGTVYKATLE--------DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAY  351 (580)
Q Consensus       282 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~  351 (580)
                      +......|.+.+.||+|+||.||+|++.        ++..||+|.+..... ...+.+.+|+.+++.+ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3445556778899999999999999741        345799999875432 3346789999999999 89999999999


Q ss_pred             EECCCCcEEEEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCC
Q 008031          352 YLGPKGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSN  418 (580)
Q Consensus       352 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~N  418 (580)
                      +.. ....+++|||+++|+|.+++.....             ...+++.++..++.||+.||+|||++ |++||||||+|
T Consensus        90 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~N  167 (304)
T cd05101          90 CTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARN  167 (304)
T ss_pred             Eec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-Ceeecccccce
Confidence            986 5688999999999999999976421             23578889999999999999999995 99999999999


Q ss_pred             eeeCCCCCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCC
Q 008031          419 VLLDDSTNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAE  496 (580)
Q Consensus       419 il~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  496 (580)
                      |++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            999999999999999998664432221 112235678999999988899999999999999999998 888886554322


Q ss_pred             hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          497 LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ....+    .......        ...   .....+.+++.+||+.+|.+|||+.|+++.|+++..
T Consensus       248 ~~~~~----~~~~~~~--------~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         248 LFKLL----KEGHRMD--------KPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HHHHH----HcCCcCC--------CCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            22221    1111100        011   122356778889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-38  Score=311.76  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=200.3

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      +...+.||+|+||.||++...      ++..+|+|.+..........+.+|++++++++|+||+++++++.. .+..+++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   85 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLLMV   85 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCceEEE
Confidence            445789999999999999642      466899999876655556789999999999999999999999986 5678999


Q ss_pred             EeeCCCCChhhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          363 FDYMPHGSLATFLHARGP------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                      |||+++++|.++++..+.            ...+++..+..++.|++.|++|||+ .|++||||||+||++++++.+||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCCCCEEEC
Confidence            999999999999976432            1357899999999999999999999 599999999999999999999999


Q ss_pred             ecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhh
Q 008031          431 DFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEE  508 (580)
Q Consensus       431 Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  508 (580)
                      |||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+....+   ....
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~~~~  241 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI---TQGR  241 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH---HcCc
Confidence            999987553322111 112234678999999998999999999999999999998 99998765443322221   1111


Q ss_pred             ccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ..      .   .....+   ..+.+++.+||+.||++||++.++++.|+.
T Consensus       242 ~~------~---~~~~~~---~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         242 EL------E---RPRTCP---PEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             cC------C---CCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            10      0   011111   246688889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-38  Score=321.12  Aligned_cols=242  Identities=26%  Similarity=0.382  Sum_probs=189.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHH-HHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVS-LLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +|+.||+|++.....   .....+..|.. +++.++||||+++++++.. .+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence            46899999999999986 789999999864322   12234455544 5678999999999999876 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++........ ...
T Consensus        80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (323)
T cd05575          80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTS  154 (323)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-ccc
Confidence            99999998764   3688999999999999999999995 999999999999999999999999999875322211 222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+..   +....+.....       ..   .+..  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~-------~~---~~~~--  219 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILNKPL-------RL---KPNI--  219 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHHHHHcCCC-------CC---CCCC--
Confidence            346899999999999999999999999999999999999999765432   22222222110       00   1111  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH----HHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVL----QVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~----ev~~~  556 (580)
                       ...+.+++.+||+.||.+||++.    +++++
T Consensus       220 -~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         220 -SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             -CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence             23566888899999999999884    55543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.6e-38  Score=307.08  Aligned_cols=251  Identities=26%  Similarity=0.418  Sum_probs=193.9

Q ss_pred             ccccccCceEEEEEEeC----CCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE----DGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+.    ++..||+|.+.... ......+.+|+.+++.++||||+++++++...++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    24579999885432 22345788999999999999999999988765667899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc--
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN--  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--  445 (580)
                      +|+|.+++....  ...++..+..++.|++.||+|||+ .+++||||||+||++++++.+|++|||+++.........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            999999997642  346778889999999999999999 499999999999999999999999999987553322111  


Q ss_pred             -eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcC-CCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          446 -VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTG-KSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       446 -~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                       .....++..|+|||.+.+..++.++|||||||++|||++| ..||...+..+.   ...........         ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~  225 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI---TVYLLQGRRLL---------QPE  225 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHhcCCCCC---------CCC
Confidence             1123456789999999888999999999999999999995 566655433222   22221111100         000


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      .   ....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       226 ~---~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         226 Y---CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             c---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            1   1135678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.3e-38  Score=312.92  Aligned_cols=257  Identities=27%  Similarity=0.400  Sum_probs=201.1

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      +.+.+.||+|+||.||+|...      ....+|+|.+..... .....+.+|+.+++.++||||+++++.+.. ++..++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l   80 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLLL   80 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcEE
Confidence            345688999999999999863      235789998865433 234568899999999999999999999976 567899


Q ss_pred             EEeeCCCCChhhhhhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCee
Q 008031          362 VFDYMPHGSLATFLHARG---------------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL  420 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil  420 (580)
                      ++||+.+++|.+++....                     ....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dikp~nil  159 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNVL  159 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-CeehhhhhhheEE
Confidence            999999999999986421                     123578999999999999999999994 9999999999999


Q ss_pred             eCCCCCeEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChh
Q 008031          421 LDDSTNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP  498 (580)
Q Consensus       421 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~  498 (580)
                      +++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....++.
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            999999999999998755332221 1122345678999999988899999999999999999999 99999765433333


Q ss_pred             HHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      +.+.    .....     .    .+  .....++.+++.+||+.+|++||++.++++.|+++-.
T Consensus       240 ~~~~----~~~~~-----~----~~--~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         240 NLLK----TGYRM-----E----RP--ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHh----CCCCC-----C----CC--CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            2222    11100     0    00  1122367788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-38  Score=314.18  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=199.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCC--EEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGS--QVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|... ++.  .+++|.++.... ...+.+.+|+.++.++ +||||+++++++.. .+..++++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~   82 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYIAI   82 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceEEE
Confidence            456788999999999999875 333  478888874322 2345788999999999 79999999999876 56799999


Q ss_pred             eeCCCCChhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          364 DYMPHGSLATFLHARG-------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                      ||+++++|.++++...             ....+++..++.++.|++.||+|||+ .|++||||||+||++++++.+||+
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCCeEEEC
Confidence            9999999999997532             11358899999999999999999999 599999999999999999999999


Q ss_pred             ecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhc
Q 008031          431 DFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       431 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      |||++........  ......+..|+|||.+.+..++.++|||||||++|||++ |..||......+....   ...+ .
T Consensus       162 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~---~~~~-~  235 (297)
T cd05089         162 DFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK---LPQG-Y  235 (297)
T ss_pred             CcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HhcC-C
Confidence            9999864322111  111123457999999998899999999999999999998 9999976543332221   1111 0


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ..     ..   ...   ....+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus       236 ~~-----~~---~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         236 RM-----EK---PRN---CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CC-----CC---CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            00     00   011   1235678899999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-38  Score=313.14  Aligned_cols=268  Identities=24%  Similarity=0.398  Sum_probs=199.2

Q ss_pred             HHhhhccccccCceEEEEEEe-----CCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATL-----EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~l  361 (580)
                      .+.+.+.||+|+||.||++..     .++..||+|.++.......+.+.+|++++++++||||+++++++... ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            356678999999999999974     25889999998766555556789999999999999999999987643 346889


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||+|||+. |++||||||+||++++++.+||+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          85 VMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            999999999999997542  3588999999999999999999994 9999999999999999999999999999866433


Q ss_pred             ccccee--eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh-c---cccccc
Q 008031          442 ANVNVI--ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE-W---TNEVFD  515 (580)
Q Consensus       442 ~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~---~~~~~~  515 (580)
                      ......  ...++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...+.+....... .   ......
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHHHh
Confidence            221111  11234469999999888999999999999999999998877543221 1100000000000 0   000000


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      ..  ...+.......++.+++.+||+.+|++|||+.|+++.|+.++
T Consensus       241 ~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         241 NN--GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             cC--CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            00  000111112235778899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-38  Score=310.53  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=198.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++.. ++..++||||+
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e~~   88 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWICMEYC   88 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEeCC
Confidence            4677899999999999999975 788999999875544445668899999999999999999999986 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.++++..   ..+++..+..++.|++.|+.|||+ .+|+||||+|+||+++.++.++|+|||++........ ..
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~  163 (267)
T cd06646          89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR  163 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence            999999998754   358899999999999999999999 5999999999999999999999999999986543221 12


Q ss_pred             eeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          447 IATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ....++..|+|||.+.   ...++.++||||+||++|||++|+.||......+...   .+.....     .+..   ..
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~~~~~~-----~~~~---~~  232 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNF-----QPPK---LK  232 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---eeecCCC-----CCCC---Cc
Confidence            2345788999999874   4557889999999999999999999986543221111   0000000     0000   00


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ........+.+++.+||+.+|++|||+.+++++|
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1111224677889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-38  Score=310.49  Aligned_cols=257  Identities=23%  Similarity=0.383  Sum_probs=202.1

Q ss_pred             HHHHhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCc
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  358 (580)
                      ...+.+.+.||+|+||.||+|...      ++..||+|.+..... .....+.+|+.+++.++|+||+++++++.. ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-GQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-CCC
Confidence            345667899999999999999874      246899999865432 234568899999999999999999999986 568


Q ss_pred             EEEEEeeCCCCChhhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEee
Q 008031          359 KLLVFDYMPHGSLATFLHARGP-------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISD  431 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~D  431 (580)
                      .++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECC
Confidence            9999999999999999975421       22478889999999999999999994 999999999999999999999999


Q ss_pred             ccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhc
Q 008031          432 FGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       432 fg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      ||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |..||...+..+....+.   ....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~~~  239 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI---DGGH  239 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh---cCCC
Confidence            9998765433221 1122345778999999988889999999999999999998 999997655433333222   1111


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      .      ..   ...   ...++.+++.+||+.+|++|||+.++++.|++
T Consensus       240 ~------~~---~~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         240 L------DL---PEN---CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             C------CC---CCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            0      00   111   12366789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.6e-38  Score=307.60  Aligned_cols=253  Identities=24%  Similarity=0.468  Sum_probs=200.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCC---EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGS---QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      ++..+.||+|+||.||+|... ++.   .+|+|.++.... ...+.+..|++++++++|+|++++.+++.. .+..++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   85 (268)
T cd05063           7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPAMIIT   85 (268)
T ss_pred             ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCcEEEE
Confidence            456789999999999999875 333   799999865432 234568899999999999999999999976 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++++|.+++...  ...+++.++..++.|++.|++|||+ .|++|+||||+||++++++.+|++|||++........
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          86 EYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            999999999999764  2468999999999999999999999 5999999999999999999999999999876543322


Q ss_pred             cceee--ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          444 VNVIA--TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       444 ~~~~~--~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .....  ...+..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+   .....           
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---~~~~~-----------  228 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---NDGFR-----------  228 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---hcCCC-----------
Confidence            22111  123457999999988899999999999999999998 99999765433222222   11110           


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                       .+...+...++.+++.+||+.+|++||++.++++.|+++
T Consensus       229 -~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 -LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             011111223667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.9e-38  Score=310.22  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=197.9

Q ss_pred             HHhhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .+.+.+.||+|+||.||+|.+.      ++..||+|.+...... ....+.+|+.++++++|+||+++++++.+ .+..+
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   85 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RLPRF   85 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCcE
Confidence            3566789999999999999875      3567899988644332 34568999999999999999999999876 55789


Q ss_pred             EEEeeCCCCChhhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC---CeEEeecc
Q 008031          361 LVFDYMPHGSLATFLHARGP----ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---NAKISDFG  433 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~---~~kl~Dfg  433 (580)
                      +||||+++++|.++++....    ...+++..+++++.||+.|++|||+. +++||||||+||+++.++   .+|++|||
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCc
Confidence            99999999999999976532    23589999999999999999999994 999999999999998654   59999999


Q ss_pred             cccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          434 LSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       434 ~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      +++......... ......+..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+   ...... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~---~~~~~~-  240 (277)
T cd05036         165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV---TGGGRL-  240 (277)
T ss_pred             cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HcCCcC-
Confidence            998653322111 111223567999999998899999999999999999997 99999765443322221   111110 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                           .   .....   ...+.+++.+||+.+|++|||+.+++++|.+
T Consensus       241 -----~---~~~~~---~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         241 -----D---PPKGC---PGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             -----C---CCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                 0   01111   2356788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.4e-38  Score=315.35  Aligned_cols=260  Identities=26%  Similarity=0.377  Sum_probs=202.5

Q ss_pred             HHHhhhccccccCceEEEEEEeC--------CCCEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCC
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE--------DGSQVAVKRLREKI-TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPK  356 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  356 (580)
                      ..|.+.+.||+|+||.||++.+.        ++..+|+|.++... ......+.+|+.+++.+ +|+||+++++++.. .
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~   96 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-D   96 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-C
Confidence            35678899999999999999753        23569999987543 23345688899999999 79999999999987 5


Q ss_pred             CcEEEEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC
Q 008031          357 GEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD  423 (580)
Q Consensus       357 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~  423 (580)
                      +..++||||+++|+|.+++.....             ...+++.++++++.|++.||+|||+. |++||||||+||+++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~  175 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTE  175 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHheEEcC
Confidence            689999999999999999976431             23588999999999999999999995 9999999999999999


Q ss_pred             CCCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHH
Q 008031          424 STNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWV  501 (580)
Q Consensus       424 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~  501 (580)
                      ++.+|++|||.++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~  255 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  255 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            9999999999987654322111 111224467999999988889999999999999999998 88898654432222211


Q ss_pred             HHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          502 ASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                          ......        ....   ....++.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus       256 ----~~~~~~--------~~~~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         256 ----KEGHRM--------DKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ----HcCCCC--------CCCC---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                111110        0011   1123666788899999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=313.03  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=200.8

Q ss_pred             HHHhhhccccccCceEEEEEEeCC---------------CCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeee
Q 008031          287 LLCATAEIMGKSTYGTVYKATLED---------------GSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRA  350 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~  350 (580)
                      -.|.+.+.||+|+||.||++...+               ...||+|.++..... ....+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            346678899999999999987642               224899998754332 3456899999999999999999999


Q ss_pred             EEECCCCcEEEEEeeCCCCChhhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee
Q 008031          351 YYLGPKGEKLLVFDYMPHGSLATFLHARGP---------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL  421 (580)
Q Consensus       351 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~  421 (580)
                      ++.. .+..++||||+++++|.+++.....         ...+++..+..++.|++.|++|||+. +++|+||||+||++
T Consensus        85 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill  162 (295)
T cd05097          85 VCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRNCLV  162 (295)
T ss_pred             EEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChhhEEE
Confidence            9976 6689999999999999999865321         12468889999999999999999995 99999999999999


Q ss_pred             CCCCCeEEeecccccccccccccce-eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc--CCCCCCCCCCCChh
Q 008031          422 DDSTNAKISDFGLSRLMTAAANVNV-IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT--GKSPGEPLNGAELP  498 (580)
Q Consensus       422 ~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~~~~~~~~~  498 (580)
                      ++++.+|++|||++........... ....++..|+|||.+.+..++.++|||||||++|+|++  +..||......+..
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~  242 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI  242 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence            9999999999999876533222111 11234678999999988899999999999999999998  66788766554444


Q ss_pred             HHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ..+............     ....+..   ...+.+++.+||+.||++|||+.+|++.|++
T Consensus       243 ~~~~~~~~~~~~~~~-----~~~~~~~---~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         243 ENTGEFFRNQGRQIY-----LSQTPLC---PSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHhhhhcccccc-----CCCCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            333322211111000     0001111   1367789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.6e-38  Score=317.63  Aligned_cols=246  Identities=18%  Similarity=0.330  Sum_probs=192.8

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|... +++.||+|+++....   .....+.+|+.++.++ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence            46899999999999976 678999999975432   2234578899999888 69999999999876 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||+++...... ....
T Consensus        80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (327)
T cd05617          80 GGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS  154 (327)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence            99999988754   368999999999999999999999 499999999999999999999999999987532221 1223


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC---ChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA---ELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......   .....+.........      ..   ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~---p~~  225 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI---PRF  225 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC---CCC
Confidence            456899999999999999999999999999999999999999653221   222222222211110      00   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPE------VLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps------~~ev~~~  556 (580)
                      .   ..++.+++.+||+.||++|++      +.++++|
T Consensus       226 ~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         226 L---SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             C---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            1   135668888999999999998      4577665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.8e-38  Score=305.82  Aligned_cols=249  Identities=27%  Similarity=0.442  Sum_probs=200.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|++|.||+|... +++.|++|.+....  ......+.+|++++++++|||++++++++.. ++..++||||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   80 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVMEY   80 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEEe
Confidence            345688999999999999986 78999999886432  2345678899999999999999999999986 5689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.++++... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++++|||++..........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence            99999999998642 3468899999999999999999999 599999999999999999999999999987665432221


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                       ....++..|+|||+..+..++.++|+||||+++|+|++|+.||...+..+.   ......+...          ..+  
T Consensus       159 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~----------~~~--  222 (256)
T cd08529         159 -NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---ILKIIRGVFP----------PVS--  222 (256)
T ss_pred             -hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHcCCCC----------CCc--
Confidence             234578899999999988999999999999999999999999976553221   2221111110          000  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......+.+++.+||+.+|++||++.+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            0122367789999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.7e-38  Score=308.86  Aligned_cols=239  Identities=22%  Similarity=0.346  Sum_probs=186.6

Q ss_pred             cccccCceEEEEEEeCC-------------------------CCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceee
Q 008031          294 IMGKSTYGTVYKATLED-------------------------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL  348 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  348 (580)
                      .||+|+||.||+|....                         ...||+|.+..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997521                         23589999876544445678899999999999999999


Q ss_pred             eeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC---
Q 008031          349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---  425 (580)
Q Consensus       349 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~---  425 (580)
                      ++++.. +...++||||+++|+|.+++...  ...+++..+..++.||++||+|||+ ++|+||||||+||+++..+   
T Consensus        82 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVR-GSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEe-CCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEeccCccc
Confidence            999987 56889999999999999998753  2458899999999999999999999 5999999999999997543   


Q ss_pred             ----CeEEeecccccccccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHH-cCCCCCCCCCCCChhH
Q 008031          426 ----NAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELL-TGKSPGEPLNGAELPQ  499 (580)
Q Consensus       426 ----~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~-tg~~p~~~~~~~~~~~  499 (580)
                          .+|++|||.+.......     ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+...
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             CccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence                38999999875432211     2346778999998865 56889999999999999995 6999997654433222


Q ss_pred             HHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          500 WVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ...    ...       ..   ..   .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       233 ~~~----~~~-------~~---~~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 FYE----KKH-------RL---PE---PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH----hcc-------CC---CC---CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111    100       00   00   01125678899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6e-38  Score=311.99  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=200.2

Q ss_pred             HhhhccccccCceEEEEEEeC-----------------CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-----------------DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRA  350 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~  350 (580)
                      |++.+.||+|+||.||++...                 ++..||+|.++..... ...++.+|+.+++.++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            567789999999999998543                 2346899998754332 3457899999999999999999999


Q ss_pred             EEECCCCcEEEEEeeCCCCChhhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC
Q 008031          351 YYLGPKGEKLLVFDYMPHGSLATFLHARGP--------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD  422 (580)
Q Consensus       351 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~  422 (580)
                      ++.. ++..+++|||+++++|.+++.....        ...+++.++..++.|++.|++|||+. |++|+||||+||+++
T Consensus        87 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~  164 (296)
T cd05095          87 VCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVG  164 (296)
T ss_pred             EEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCChheEEEc
Confidence            9987 5679999999999999999976421        12477889999999999999999995 999999999999999


Q ss_pred             CCCCeEEeeccccccccccccccee-eecCccccCCccccccCCCCCcccchhHHHHHHHHHc--CCCCCCCCCCCChhH
Q 008031          423 DSTNAKISDFGLSRLMTAAANVNVI-ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT--GKSPGEPLNGAELPQ  499 (580)
Q Consensus       423 ~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~~~~~~~~~~  499 (580)
                      .++.++++|||+++.+......... ...++..|+|||...++.++.++|||||||++|||++  |..||...+..+...
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~  244 (296)
T cd05095         165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE  244 (296)
T ss_pred             CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence            9999999999998765433221111 1234568999998888889999999999999999998  778887655444333


Q ss_pred             HHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          500 WVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ...............     ....   .....+.+++.+||+.||++|||+.++++.|++
T Consensus       245 ~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         245 NTGEFFRDQGRQVYL-----PKPA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHhhccccccC-----CCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            222222111110000     0011   122467789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.4e-38  Score=331.47  Aligned_cols=261  Identities=21%  Similarity=0.257  Sum_probs=193.2

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC------CCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR------HPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~~~  360 (580)
                      .|.+.+.||+|+||.||+|.+. +++.||||+++... .....+..|+.+++.++      |.+++++++++....+..|
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            4677889999999999999875 68889999986432 22334556777766664      4568999999987666789


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC---------------
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---------------  425 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~---------------  425 (580)
                      +|||++ +++|.+++.+.   ..+++..+..++.||+.||+|||++.||+||||||+|||++.++               
T Consensus       209 iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             EEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            999998 77899988764   36899999999999999999999734999999999999998655               


Q ss_pred             -CeEEeecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHH
Q 008031          426 -NAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASI  504 (580)
Q Consensus       426 -~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~  504 (580)
                       .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...
T Consensus       285 ~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~  360 (467)
T PTZ00284        285 CRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT  360 (467)
T ss_pred             ceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence             499999998764322    222457899999999999999999999999999999999999999876554433333222


Q ss_pred             hhh---hccc------------------cccchhhhcc---CCCcH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          505 VKE---EWTN------------------EVFDLELMRD---APTIG--DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       505 ~~~---~~~~------------------~~~~~~~~~~---~~~~~--~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ...   .+..                  ...++.....   .....  .....+.+|+.+||+.||++|||++|+++|=
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence            110   0000                  0000000000   00000  0123567899999999999999999999863

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.3e-38  Score=308.21  Aligned_cols=254  Identities=25%  Similarity=0.462  Sum_probs=201.2

Q ss_pred             HHhhhccccccCceEEEEEEeC-C---CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-D---GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+. +   +..+|+|.++.... ...+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   83 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMIV   83 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEEE
Confidence            3556789999999999999864 2   33799999875432 234578999999999999999999999976 5689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++++|.+++....  ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999997653  358999999999999999999999 599999999999999999999999999998765433


Q ss_pred             ccceee--ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NVNVIA--TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~~~~~--~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ......  ..++..|+|||.+.+..++.++|+||||+++||+++ |+.||......+....+.   .. ..         
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~~-~~---------  227 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE---EG-YR---------  227 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh---CC-Cc---------
Confidence            222111  123467999999998899999999999999999887 999997655433322222   11 10         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                        .+........+.+++.+||+.+|.+|||+.++++.|+++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 --LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              000111123567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.3e-38  Score=314.42  Aligned_cols=263  Identities=26%  Similarity=0.384  Sum_probs=204.0

Q ss_pred             HHHHHHhhhccccccCceEEEEEEeC--------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 008031          284 ADDLLCATAEIMGKSTYGTVYKATLE--------DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYL  353 (580)
Q Consensus       284 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  353 (580)
                      .....+.+.+.||+|+||.||+|...        .+..+|+|.++.... .....+.+|+++++++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            33445678899999999999999752        245689999875432 2345688999999999 6999999999997


Q ss_pred             CCCCcEEEEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCee
Q 008031          354 GPKGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL  420 (580)
Q Consensus       354 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil  420 (580)
                      . .+..+++|||+++|+|.+++.....             ...+++.++.+++.|++.||.|||++ |++||||||+||+
T Consensus        89 ~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nil  166 (314)
T cd05099          89 Q-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAARNVL  166 (314)
T ss_pred             c-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeeccccceeEE
Confidence            6 5679999999999999999976421             24588999999999999999999995 9999999999999


Q ss_pred             eCCCCCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChh
Q 008031          421 LDDSTNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP  498 (580)
Q Consensus       421 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~  498 (580)
                      +++++.+|++|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+..
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999997654322211 111224467999999988899999999999999999999 89998765433322


Q ss_pred             HHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ..+.    .....     .   ....   ...++.+++.+||+.+|++|||+.++++.|+++...
T Consensus       247 ~~~~----~~~~~-----~---~~~~---~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         247 KLLR----EGHRM-----D---KPSN---CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHH----cCCCC-----C---CCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            2221    11100     0   0111   122566788899999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-38  Score=304.50  Aligned_cols=249  Identities=29%  Similarity=0.465  Sum_probs=202.3

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .+.+.+.||.|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.. ....++||||++
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~   83 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMA   83 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEecC
Confidence            3556789999999999999876 88999999876544 45678999999999999999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.++++... ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||.++.......    
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----  157 (256)
T cd05039          84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----  157 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence            999999997653 23589999999999999999999994 999999999999999999999999999986632221    


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ....+..|+|||.+....++.++||||||+++|||++ |..||...+..++...+.    ......     .   ...  
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----~~~~~~-----~---~~~--  223 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE----KGYRME-----A---PEG--  223 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh----cCCCCC-----C---ccC--
Confidence            2234567999999988889999999999999999997 999997654333222221    111100     0   011  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                       ...++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       224 -~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         224 -CPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -CCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence             123667889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-38  Score=320.11  Aligned_cols=238  Identities=26%  Similarity=0.350  Sum_probs=186.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHH-HHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVS-LLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +++.||+|++.....   .....+..|.. +++.++||||+++++++.. .+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence            46899999999999986 678899999865321   22234444444 5678899999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++....... ...
T Consensus        80 ~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~  154 (325)
T cd05602          80 GGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS  154 (325)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence            99999999764   3577888899999999999999995 999999999999999999999999999875432211 223


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+...   .+.....       .   ..+..  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~-------~---~~~~~--  219 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD---NILNKPL-------Q---LKPNI--  219 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH---HHHhCCc-------C---CCCCC--
Confidence            4568999999999999999999999999999999999999997654333222   2211110       0   01111  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQ  552 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~e  552 (580)
                       ...+.+++.+||+.||.+||++.+
T Consensus       220 -~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         220 -TNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             -CHHHHHHHHHHcccCHHHCCCCCC
Confidence             225667888999999999998774

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=317.63  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=208.2

Q ss_pred             HHHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      +..|...+.||.|+||.||-|++. +...||||++.-...   ..+.++.+|+++|++++|||++.+.|||.. +...|+
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWL  103 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWL  103 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHH
Confidence            334666789999999999999976 778899999864433   235678999999999999999999999986 557899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||| -|+-.|.+.-.  ..++-+.++..|+.+.++||+|||++ +.||||||+.|||+++.|.||++|||.+.+..+.
T Consensus       104 VMEYC-lGSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  104 VMEYC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHHHH-hccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            99999 56888888654  24688889999999999999999996 9999999999999999999999999999877654


Q ss_pred             cccceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          442 ANVNVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .     .++||+.|||||++.   .+.|+-|+||||+|++..||...++|+=.++......   .+...+.+        
T Consensus       180 n-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY---HIAQNesP--------  243 (948)
T KOG0577|consen  180 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNESP--------  243 (948)
T ss_pred             h-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH---HHHhcCCC--------
Confidence            4     368999999999875   5789999999999999999999999987666544333   33222211        


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                         .-..+++...+..++..||++-|.+|||..++++|-=-.++.
T Consensus       244 ---tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  244 ---TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             ---CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence               112346677888999999999999999999998875444433

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.1e-38  Score=309.99  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=197.5

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      +..+.||+|+||.||+|.+. +++.||+|.+.....   .....+.+|++++++++|+||+++.+++.. ++..+++|||
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~   81 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLTI   81 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEEe
Confidence            45688999999999999886 789999999865432   223457789999999999999999998876 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...+ ...+++..+..++.|++.||.|||+ .||+||||||+||++++++.+||+|||++........  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  157 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--  157 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence            99999999887543 2358999999999999999999999 5999999999999999999999999999875533221  


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+.........      ..   ....
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~  228 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE------VY---SAKF  228 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc------cc---CccC
Confidence            22346899999999999889999999999999999999999999765443322222221111100      00   0111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPE-----VLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~  556 (580)
                         ...+.+++.+||+.||++||+     +.+++++
T Consensus       229 ---~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         229 ---SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence               124567888999999999999     6777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.2e-38  Score=305.07  Aligned_cols=250  Identities=26%  Similarity=0.457  Sum_probs=199.7

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +++.+.||+|+||.||+|.+.++..+|+|.++... ....++.+|++++++++|||++++++++.. ....+++|||+++
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~   83 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFMEH   83 (256)
T ss_pred             eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEcCCC
Confidence            45678999999999999998778899999986442 234678999999999999999999999876 5688999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      ++|.+++....  ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++.............
T Consensus        84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          84 GCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence            99999987642  3578999999999999999999994 99999999999999999999999999987654332221222


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++.+|+|||.+.+..++.++||||+|+++|||++ |..||......+..+.+.   ...   ....+.      .   
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~---~~~~~~------~---  225 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN---AGF---RLYKPR------L---  225 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh---CCC---CCCCCC------C---
Confidence            335678999999988899999999999999999998 999997654333222221   110   000011      0   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ....+.+++.+||+.+|++|||+.++++.|.
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            1236778999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.3e-38  Score=309.67  Aligned_cols=259  Identities=21%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             HHHHhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCc
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  358 (580)
                      ...|.+.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.++++++||||+++++++.. .+.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   83 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-GQP   83 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCC
Confidence            345677899999999999999753      245799998864432 233467889999999999999999999876 568


Q ss_pred             EEEEEeeCCCCChhhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEee
Q 008031          359 KLLVFDYMPHGSLATFLHARGP-------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISD  431 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~D  431 (580)
                      .++||||+++|+|.++++..+.       ....++..+..++.|++.||+|||+ ++++||||||+||++++++.++++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999999999999976421       2345677889999999999999999 4999999999999999999999999


Q ss_pred             cccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhc
Q 008031          432 FGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       432 fg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      ||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..   ..+..+..
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~~~~~  239 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---KFVMDGGY  239 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCC
Confidence            99987553322211 111234677999999998899999999999999999999 78898765433222   22222111


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      ..         ....   ....+.+++.+||+.+|++|||+.++++.|+...
T Consensus       240 ~~---------~~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         240 LD---------QPDN---CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CC---------CCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            10         0011   1236778889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.5e-38  Score=311.84  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=202.2

Q ss_pred             HHhhhccccccCceEEEEEEeCC-----------------CCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeee
Q 008031          288 LCATAEIMGKSTYGTVYKATLED-----------------GSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALR  349 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~  349 (580)
                      .|.+.+.||+|+||.||+|.+..                 +..||+|.+...... ....+.+|++++++++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            45678999999999999998642                 245899998755433 345788999999999999999999


Q ss_pred             eEEECCCCcEEEEEeeCCCCChhhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee
Q 008031          350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGP--------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL  421 (580)
Q Consensus       350 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~  421 (580)
                      +++.. ++..+++|||+++++|.+++.....        ...+++..+..++.|++.||+|||+. +++|+||||+||++
T Consensus        86 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili  163 (296)
T cd05051          86 GVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLATRNCLV  163 (296)
T ss_pred             EEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccchhceee
Confidence            99986 5689999999999999999976421        12588999999999999999999995 99999999999999


Q ss_pred             CCCCCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc--CCCCCCCCCCCChh
Q 008031          422 DDSTNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT--GKSPGEPLNGAELP  498 (580)
Q Consensus       422 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~~~~~~~~~  498 (580)
                      +.++.++++|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++  +..||......+..
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI  243 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence            999999999999987654332211 112345678999999988889999999999999999998  77788765544333


Q ss_pred             HHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ..+.............     ...+   ....++.+++.+||+.||++|||+.|+++.|++
T Consensus       244 ~~~~~~~~~~~~~~~~-----~~~~---~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         244 ENAGHFFRDDGRQIYL-----PRPP---NCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHhccccccccccC-----CCcc---CCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            3332221111110000     0011   112367789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1e-37  Score=304.26  Aligned_cols=249  Identities=27%  Similarity=0.451  Sum_probs=202.1

Q ss_pred             ccccccCceEEEEEEeCC----CCEEEEEEcccccccc-HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLED----GSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|....    +..||+|.++...... .+.+.+|++.+..++|+||+++++++.. ....+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            468999999999999863    7889999987654433 5678999999999999999999999987 678999999999


Q ss_pred             CCChhhhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          368 HGSLATFLHARGP------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       368 ~g~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +++|.+++.....      ...+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+|++|||.+......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            9999999987521      2568999999999999999999999 59999999999999999999999999999876543


Q ss_pred             cc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 AN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .. .......++..|+|||.+....++.++||||+|+++|||++ |..||......+..+.+..   ....         
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~---------  226 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---GYRL---------  226 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCC---------
Confidence            31 11223456788999999988899999999999999999999 6999987644333332221   1100         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .....   ...++.+++.+||+.+|.+|||+.|++++|+
T Consensus       227 ~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 PKPEY---CPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCcc---CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            00111   1236778889999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-38  Score=305.55  Aligned_cols=250  Identities=22%  Similarity=0.357  Sum_probs=197.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-----cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-----GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |...+.||+|++|.||+|... +++.||+|.+......     ..+.+.+|++++++++||||+++++++.. ++..+++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v   82 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLSIF   82 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEEEE
Confidence            456789999999999999875 6899999988643221     23468889999999999999999999987 5689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      +||+++++|.+++...   ..+++..+..++.|++.|+.|||+. |++|+||+|+||++++++.++|+|||+++......
T Consensus        83 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          83 MEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            9999999999998764   3588899999999999999999994 99999999999999999999999999987654322


Q ss_pred             ccce--eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          443 NVNV--IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       443 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ....  ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...+..+..   .........     ...  
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~-----~~~--  228 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQPTN-----PQL--  228 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhccCCC-----CCC--
Confidence            1111  2345778899999999888999999999999999999999999754332211   111111110     001  


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                       ..   .....+.+++.+||+.+|++|||+.+++++.
T Consensus       229 -~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         229 -PS---HVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -Cc---cCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence             01   1123566788899999999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-38  Score=311.27  Aligned_cols=260  Identities=23%  Similarity=0.343  Sum_probs=199.6

Q ss_pred             HHHhhhccccccCceEEEEEEe-----CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcE
Q 008031          287 LLCATAEIMGKSTYGTVYKATL-----EDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEK  359 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~  359 (580)
                      ..|.+.+.||+|+||.||.+.+     .++..||+|.++.... .....+.+|++++++++|||++++++++... ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467789999999999999974     3578899999875432 2345789999999999999999999998764 3468


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++||||+++++|.+++.+..  ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||+++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            89999999999999997642  358999999999999999999999 599999999999999999999999999988654


Q ss_pred             ccccc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCC-----------CChhHHHHHHhh
Q 008031          440 AAANV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNG-----------AELPQWVASIVK  506 (580)
Q Consensus       440 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~-----------~~~~~~~~~~~~  506 (580)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++++.|+.....           ............
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            32221  11123456679999999888899999999999999999998776432110           000011111111


Q ss_pred             hhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ...        .   .+........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       241 ~~~--------~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGK--------R---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCc--------c---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000        0   001111234677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-37  Score=305.93  Aligned_cols=253  Identities=28%  Similarity=0.346  Sum_probs=189.4

Q ss_pred             ccccccCceEEEEEEeC---CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          293 EIMGKSTYGTVYKATLE---DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.||+|+||.||+|.+.   ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+ ....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence            35899999999999865   345799998865433 234578899999999999999999999976 5678999999999


Q ss_pred             CChhhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc-
Q 008031          369 GSLATFLHARGP--ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN-  445 (580)
Q Consensus       369 g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-  445 (580)
                      |+|.++++....  ....++..+..++.|++.|++|||+ .+++|+||||+||+++.++.+|++|||+++......... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999975421  2346677888999999999999999 499999999999999999999999999987543322211 


Q ss_pred             eeeecCccccCCccccccC-------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          446 VIATAGALGYRAPELSKLK-------KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      .....++..|+|||++.+.       .++.++|+||||+++|||++ |+.||......+.....   ... ......++.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~-~~~~~~~~~  234 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VRE-QQLKLPKPR  234 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---hhc-ccCCCCCCc
Confidence            1123467789999987642       35789999999999999996 99999765443322211   111 111111111


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ..      ......+.+++.+|| .+|++|||+.||++.|+
T Consensus       235 ~~------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LK------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cC------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            10      011224567888999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-38  Score=320.49  Aligned_cols=237  Identities=27%  Similarity=0.381  Sum_probs=186.7

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHH-HHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVS-LLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|... +|+.||+|++.....   .....+..|.. +++.++||||+++++++.. ++..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence            46899999999999876 789999999865422   22344555554 4677899999999999876 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++...... ....
T Consensus        80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (325)
T cd05604          80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT  154 (325)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence            99999888764   3689999999999999999999994 99999999999999999999999999987532211 1222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+.   ...+.....       ..   .+.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~~~~~~~-------~~---~~~---  218 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---YDNILHKPL-------VL---RPG---  218 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---HHHHHcCCc-------cC---CCC---
Confidence            35689999999999999999999999999999999999999976543222   222221110       00   111   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVL  551 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~  551 (580)
                      ....+.+++.+|++.+|++||++.
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCC
Confidence            123566788899999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-38  Score=307.01  Aligned_cols=250  Identities=27%  Similarity=0.439  Sum_probs=194.7

Q ss_pred             ccccccCceEEEEEEeC-CCC--EEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGS--QVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. ++.  .+|+|.++.... .....+.+|++++.++ +||||+++++++.. .+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence            46899999999999986 444  468888875432 3345788999999999 89999999999976 567899999999


Q ss_pred             CCChhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccc
Q 008031          368 HGSLATFLHARG-------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL  434 (580)
Q Consensus       368 ~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~  434 (580)
                      +|+|.++++...             ....+++.++..++.|++.|++|||+ .|++||||||+||++++++.+|++|||+
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCCeEEECCCCC
Confidence            999999997542             12347899999999999999999999 4999999999999999999999999999


Q ss_pred             ccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          435 SRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       435 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      +.......  .......+..|+|||++.+..++.++||||||+++|||++ |..||...+..+..+.+   ......   
T Consensus       159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~---~~~~~~---  230 (270)
T cd05047         159 SRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQGYRL---  230 (270)
T ss_pred             ccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH---hCCCCC---
Confidence            86332111  1111223567999999988899999999999999999997 99999765433222221   111100   


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                         ..   ..   ....++.+++.+||+.+|.+|||+.++++.|+++.
T Consensus       231 ---~~---~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         231 ---EK---PL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---CC---CC---cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence               00   01   11235678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.6e-38  Score=309.68  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=197.7

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      +..+.||+|+||.||++.+. +++.||+|.+......   ....+.+|+.++++++|++++.+++.+.. ++..++||||
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~   81 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTL   81 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEEe
Confidence            45678999999999999986 7899999998654322   23457789999999999999999999976 5689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...+ ...+++.++..++.|++.||.|||+ .+++||||||+||++++++.++++|||++........  
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--  157 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--  157 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence            99999999986543 2358899999999999999999999 5999999999999999999999999999875533222  


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||....................      ...   ....
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~------~~~---~~~~  228 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ------EEY---SEKF  228 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh------hhc---CccC
Confidence            1234688999999999999999999999999999999999999976543221111211111100      000   0111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPE-----VLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~L  557 (580)
                         ...+.+++.+||+.||++|||     +.|++++-
T Consensus       229 ---~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~  262 (285)
T cd05630         229 ---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP  262 (285)
T ss_pred             ---CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence               224667888999999999999     88998853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-38  Score=319.11  Aligned_cols=237  Identities=26%  Similarity=0.355  Sum_probs=185.6

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHH-HHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVS-LLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|... +++.||+|++.....   .....+.+|.. +++.++||||+++++++.+ .+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46899999999999986 688999999864322   22334555554 6788999999999999876 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++....... ...
T Consensus        80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05603          80 GGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTS  154 (321)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccc
Confidence            99999888753   3588889999999999999999994 999999999999999999999999999875322211 222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...|++.|+|||.+.+..++.++||||+||++|||++|+.||...+..   +....+.....       ..   .+   .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~-------~~---~~---~  218 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPL-------QL---PG---G  218 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHHhcCCC-------CC---CC---C
Confidence            346899999999999889999999999999999999999999765422   22222221110       00   11   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVL  551 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~  551 (580)
                      ...++.+++.+||+.||.+||+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCC
Confidence            223567888999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.6e-38  Score=308.38  Aligned_cols=253  Identities=25%  Similarity=0.481  Sum_probs=199.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CC---CEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DG---SQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +.+.+.||+|+||.||+|.+. ++   ..||+|.++... .....+|..|+.++++++||||+++.+++.. ++..++||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~   84 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMIIT   84 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEEEE
Confidence            456789999999999999875 33   369999987543 2334679999999999999999999999876 66889999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++++|.+++....  ..+++.++..++.|++.|++|||+ .|++|+||||+||+++.++.+|++|||++........
T Consensus        85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            9999999999997642  458899999999999999999999 5999999999999999999999999999876543222


Q ss_pred             cce-ee-e--cCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          444 VNV-IA-T--AGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       444 ~~~-~~-~--~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ... .. .  ..+..|+|||.+.+..++.++||||+||++||+++ |..||...+..+....+.    ....        
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~----~~~~--------  229 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----QDYR--------  229 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH----cCCc--------
Confidence            111 11 1  12457999999998999999999999999999887 999997655433333221    1110        


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                         .+...+....+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       230 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ---LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               000111123566888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2e-37  Score=306.01  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=199.4

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++.. ++..++||||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEec
Confidence            3678899999999999999987 577889998865544455678899999999999999999999987 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.+|++|||++........ ..
T Consensus        85 ~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~  160 (282)
T cd06643          85 AGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR  160 (282)
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence            999999988653  24689999999999999999999994 999999999999999999999999999875433211 22


Q ss_pred             eeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          447 IATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ....++..|+|||.+.     +..++.++|||||||++|||++|+.||...+..+   .+..+....... ..      .
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~~~~~~-~~------~  230 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKSEPPT-LA------Q  230 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHHhhcCCCC-CC------C
Confidence            2345888999999873     4567789999999999999999999997654322   222221111110 00      0


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ...   ...++.+++.+||+.+|.+|||+.+++++-.
T Consensus       231 ~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         231 PSR---WSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             ccc---cCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            011   1235678889999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.8e-38  Score=321.25  Aligned_cols=262  Identities=24%  Similarity=0.267  Sum_probs=194.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  359 (580)
                      .|...+.||+|+||.||++.+. +|..||+|++.....  .....+.+|+.+++.++||||+++++++....     ...
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  101 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV  101 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence            3667899999999999999875 689999999864322  23456789999999999999999999986532     247


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++||||+++ +|.+.++.     .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         102 YLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             EEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            999999965 67666643     378889999999999999999995 99999999999999999999999999987543


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHh--------------
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV--------------  505 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~--------------  505 (580)
                      ...  ......||..|+|||.+.+..++.++||||+||++|+|++|+.||...+..+....+....              
T Consensus       175 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         175 TNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             cCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            221  1223467899999999999999999999999999999999999998654322111111100              


Q ss_pred             -----hhhccccccc-hhhhccC--C----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          506 -----KEEWTNEVFD-LELMRDA--P----TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       506 -----~~~~~~~~~~-~~~~~~~--~----~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                           .......... .......  +    ........+.+++.+||+.||++|||+.|++++-.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence                 0000000000 0000000  0    00001235678999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.2e-38  Score=322.84  Aligned_cols=253  Identities=21%  Similarity=0.247  Sum_probs=196.2

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ..|.+.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.. ++..++|
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv  121 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMV  121 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEE
Confidence            34677899999999999999986 78899999986432   1233457889999999999999999999986 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++...    .++...+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus       122 ~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         122 MEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            9999999999998753    47888899999999999999999 599999999999999999999999999998765433


Q ss_pred             ccceeeecCccccCCccccccC----CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          443 NVNVIATAGALGYRAPELSKLK----KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||...+..   .....+........      
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~------  267 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKNSLT------  267 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCccc------
Confidence            3333345699999999998653    3788999999999999999999999764432   22222222111000      


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSA--RPEVLQVVQQL  557 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ev~~~L  557 (580)
                         .+........+.+++.+|+..++.+  |+++.|++++.
T Consensus       268 ---~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         268 ---FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               1111112234567788899844433  78999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.2e-38  Score=338.36  Aligned_cols=263  Identities=20%  Similarity=0.266  Sum_probs=202.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||+|+++.....   ..+.+.+|++++++++||||+++++++.+ ++..+++||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLVME   82 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYTMP   82 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEEEE
Confidence            556789999999999999986 6899999998754322   23568899999999999999999999986 568999999


Q ss_pred             eCCCCChhhhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          365 YMPHGSLATFLHARG--------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      |++||+|.+++....        .....++..+++++.||++||+|||+ .||+||||||+||+++.++.+||+|||+++
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999999986421        11245677889999999999999999 599999999999999999999999999997


Q ss_pred             ccccccc-----------------cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhH
Q 008031          437 LMTAAAN-----------------VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQ  499 (580)
Q Consensus       437 ~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~  499 (580)
                      .......                 .......||+.|||||.+.+..++.++||||+||++|||+||+.||......+...
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            6521110                 00112358999999999999999999999999999999999999997644322211


Q ss_pred             HHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhcccccc
Q 008031          500 WVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARP-EVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ev~~~L~~~~~~~~~  566 (580)
                      . ..         ..++.........   ...+.+++.+||+.||++|| ++.++.+.|+......+.
T Consensus       242 ~-~~---------i~~P~~~~p~~~i---P~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~  296 (932)
T PRK13184        242 R-DV---------ILSPIEVAPYREI---PPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE  296 (932)
T ss_pred             h-hh---------ccChhhccccccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence            1 00         0011110001111   23466788899999999995 678888888887654443

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-37  Score=315.40  Aligned_cols=267  Identities=24%  Similarity=0.373  Sum_probs=206.7

Q ss_pred             ccCHHHHHHhhhccccccCceEEEEEEeC--------CCCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeee
Q 008031          281 MFTADDLLCATAEIMGKSTYGTVYKATLE--------DGSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRA  350 (580)
Q Consensus       281 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~  350 (580)
                      .+......|.+.+.||+|+||.||+|...        ++..||+|.++..... ...++.+|+++++++ +|+||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            34455556788999999999999999752        1236899988754322 346788999999999 8999999999


Q ss_pred             EEECCCCcEEEEEeeCCCCChhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCC
Q 008031          351 YYLGPKGEKLLVFDYMPHGSLATFLHARG-------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSS  417 (580)
Q Consensus       351 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~  417 (580)
                      ++.. ++..+++|||+++|+|.+++....             +...+++.+++.++.|++.||+|||++ |++||||||+
T Consensus        86 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~  163 (334)
T cd05100          86 ACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAAR  163 (334)
T ss_pred             EEcc-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ceeccccccc
Confidence            9976 568999999999999999997642             234588899999999999999999995 9999999999


Q ss_pred             CeeeCCCCCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCC
Q 008031          418 NVLLDDSTNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGA  495 (580)
Q Consensus       418 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~  495 (580)
                      ||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999987654322111 111234567999999998999999999999999999998 88898765433


Q ss_pred             ChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          496 ELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      +....+.   ..... .        ...   ....++.+++.+||+.+|++|||+.|+++.|+++....
T Consensus       244 ~~~~~~~---~~~~~-~--------~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 ELFKLLK---EGHRM-D--------KPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHHH---cCCCC-C--------CCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            3222211   11100 0        011   12236778899999999999999999999999887433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.1e-38  Score=317.50  Aligned_cols=245  Identities=22%  Similarity=0.323  Sum_probs=192.3

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEe
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +..+.||+|+||.||+|... +|+.||+|++.....   .....+..|..+++.+. |++|+++.+++.. .+..++|||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E   81 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFVME   81 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEEEc
Confidence            45688999999999999876 789999999875422   23345778899998885 5778888888876 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++.++..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||+++....... 
T Consensus        82 y~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-  156 (323)
T cd05615          82 YVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-  156 (323)
T ss_pred             CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence            99999999998764   368999999999999999999999 5999999999999999999999999999875432221 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.....+   .+.....       ..   ...
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---~i~~~~~-------~~---p~~  223 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ---SIMEHNV-------SY---PKS  223 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCCC-------CC---Ccc
Confidence            2223468999999999998899999999999999999999999998654332222   2221111       00   011


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEV-----LQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~-----~ev~~~  556 (580)
                         ...++.+++.+||+.+|.+|++.     .++.++
T Consensus       224 ---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         224 ---LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ---CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence               12356788889999999999984     455544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.5e-38  Score=304.29  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=198.7

Q ss_pred             ccccccCceEEEEEEeCC--CC--EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLED--GS--QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|++|.||+|.+.+  ++  .||+|.+..... ...+.+.+|+.++++++||||+++++++..  ...+++|||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999998753  33  689999976655 455678999999999999999999999876  68899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc--
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN--  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--  445 (580)
                      +++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+|++|||++..........  
T Consensus        79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999999987542 4689999999999999999999995 99999999999999999999999999998764422211  


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+..   ....        ..... 
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~--------~~~~~-  224 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK---EGER--------LERPE-  224 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---cCCc--------CCCCc-
Confidence            112346778999999998899999999999999999999 9999976544333322221   1000        00001 


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                        .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 --~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 --ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              11235678888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=298.66  Aligned_cols=259  Identities=21%  Similarity=0.330  Sum_probs=211.2

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEcccccccc-HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      ++....+-+|.||.||.|.+.      +.+.|.+|.++...++- ...+..|.-.+..+.|||+.++.+.+.+.....+.
T Consensus       286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V  365 (563)
T KOG1024|consen  286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV  365 (563)
T ss_pred             eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence            334556889999999999764      34457788877655543 34578899999999999999999999987778999


Q ss_pred             EEeeCCCCChhhhhh-----hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          362 VFDYMPHGSLATFLH-----ARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       362 v~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      +|.++.-|+|..|+.     +....+.++..+...++.|++.|++|||++ ||+|.||.++|++|++.-++|++|-.+++
T Consensus       366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSR  444 (563)
T KOG1024|consen  366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSR  444 (563)
T ss_pred             EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhcc
Confidence            999999999999998     333345677888999999999999999995 99999999999999999999999999998


Q ss_pred             ccccc-cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhcccccc
Q 008031          437 LMTAA-ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVF  514 (580)
Q Consensus       437 ~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ...+. .+.-......+..||+||.+.+..|+.++||||||+++|||+| |+.||...++.++..++++..+        
T Consensus       445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR--------  516 (563)
T KOG1024|consen  445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR--------  516 (563)
T ss_pred             ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce--------
Confidence            65443 3333334456788999999999999999999999999999999 9999998887776666554221        


Q ss_pred             chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       515 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                          ...+..+++   ++..+|.-||..+|++||++.|++..|.++..+
T Consensus       517 ----laQP~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  517 ----LAQPFNCPD---ELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             ----ecCCCCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence                122333444   455677899999999999999999999988643

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.5e-38  Score=311.04  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=199.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|+..+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++++.. ....++||||+
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~~   99 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYL   99 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeeccc
Confidence            3566788999999999999875 789999999876555556778899999999999999999999886 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++...    .+++.++..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++......... .
T Consensus       100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~  173 (296)
T cd06654         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R  173 (296)
T ss_pred             CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence            999999998653    47899999999999999999999 59999999999999999999999999998765432211 1


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......   ........... .         .+...
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~~~~~~~~-~---------~~~~~  240 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATNGTP-E---------LQNPE  240 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHHHhcCCCC-C---------CCCcc
Confidence            23457889999999988889999999999999999999999997544321   11111111100 0         00011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .....+.+++.+||..+|++|||+.+++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            112356688899999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.3e-38  Score=330.49  Aligned_cols=260  Identities=20%  Similarity=0.312  Sum_probs=191.1

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC-------CCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP-------KGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------~~~~  359 (580)
                      .|.+.+.||+|+||.||+|... +++.||||++...    .....+|+.+++.++||||+++++++...       ....
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            3667899999999999999975 6889999987532    23345799999999999999998886431       1236


Q ss_pred             EEEEeeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeecccccc
Q 008031          360 LLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRL  437 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~  437 (580)
                      ++||||+++ +|.+++... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            699999964 787776532 223568999999999999999999999 5999999999999999654 699999999986


Q ss_pred             cccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc-----
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN-----  511 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  511 (580)
                      ......  .....||+.|+|||++.+ ..++.++||||+||++|||++|++||.+....+....+..........     
T Consensus       221 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~  298 (440)
T PTZ00036        221 LLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM  298 (440)
T ss_pred             ccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            543222  223468899999998765 468999999999999999999999998765433222222211100000     


Q ss_pred             --cccc--------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          512 --EVFD--------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       512 --~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        ...+        ..+....+.  ....++.+++.+||++||.+|||+.|+++|=
T Consensus       299 ~~~~~~~~~~~~~~~~l~~~~p~--~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp  352 (440)
T PTZ00036        299 NPNYADIKFPDVKPKDLKKVFPK--GTPDDAINFISQFLKYEPLKRLNPIEALADP  352 (440)
T ss_pred             chhhhcccCCccCchhHHHHhcc--CCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence              0000        000000000  0123677899999999999999999999763

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.1e-37  Score=302.11  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=204.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||+|... +|+.||+|.++....   .....+.+|++++++++|+|++++++++.. ++..++|||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   82 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIVLE   82 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEEEe
Confidence            456788999999999999987 899999998864222   234578899999999999999999999987 568899999


Q ss_pred             eCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          365 YMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      |+++++|.+++.... ....+++.++..++.|+++|++|||+ .|++|+||+|+||+++.++.++++|||++........
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            999999999986532 23458999999999999999999999 5999999999999999999999999999875543221


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ....+...........      .    .+
T Consensus       162 ~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~------~----~~  229 (267)
T cd08224         162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEKCDYP------P----LP  229 (267)
T ss_pred             c-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-ccHHHHHhhhhcCCCC------C----CC
Confidence            1 223457888999999988889999999999999999999999986433 2222222221111100      0    00


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                       .......+.+++.+||+.+|++|||+.++++.|++++
T Consensus       230 -~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         230 -ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             0112235678899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.9e-37  Score=303.61  Aligned_cols=258  Identities=23%  Similarity=0.371  Sum_probs=203.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|... +++.+|||.+.....   ....++.+|+.+++.++|+||+++++++.. ++..+++||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e   82 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLE   82 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEEEE
Confidence            556789999999999999974 789999998764322   233578899999999999999999999986 568999999


Q ss_pred             eCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          365 YMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      |+++++|.+++.... ....+++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.++++|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            999999999987432 23468999999999999999999999 4999999999999999999999999999876543322


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... +.............      +..     
T Consensus       162 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~------~~~-----  228 (267)
T cd08229         162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDY------PPL-----  228 (267)
T ss_pred             c-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCC------CCC-----
Confidence            1 1234578899999999888899999999999999999999999965432 12222222111110      000     


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      ........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            00112336778888999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.5e-38  Score=314.79  Aligned_cols=261  Identities=20%  Similarity=0.323  Sum_probs=198.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++.. ++..++||||+
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~   86 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVFEYL   86 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEeCC
Confidence            556789999999999999976 688999999864432 233467889999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++ +|.+++...+  ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++........ ..
T Consensus        87 ~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  161 (309)
T cd07872          87 DK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY  161 (309)
T ss_pred             CC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence            75 8888886642  357889999999999999999999 5999999999999999999999999999875433221 12


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc---cc------cch
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN---EV------FDL  516 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~  516 (580)
                      ....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+..........   ..      .+.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            23457889999998764 568899999999999999999999998765544333332221110000   00      000


Q ss_pred             hh--------hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          517 EL--------MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       517 ~~--------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ..        ....+.   ...++.+++.+||+.||++|||+.|++++-.
T Consensus       242 ~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  288 (309)
T cd07872         242 NFPKYKPQPLINHAPR---LDTEGIELLTKFLQYESKKRISAEEAMKHAY  288 (309)
T ss_pred             hcCccCCCchhhhccC---CCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence            00        000011   1235668899999999999999999998543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-37  Score=312.83  Aligned_cols=197  Identities=25%  Similarity=0.411  Sum_probs=160.5

Q ss_pred             hccccccCceEEEEEEeC---CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEEEeeCC
Q 008031          292 AEIMGKSTYGTVYKATLE---DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLVFDYMP  367 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~  367 (580)
                      ++.||+|+||.||+|...   +++.||+|.+....  ....+.+|++++++++||||+++++++... +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   46789999986432  234578899999999999999999988653 345789999995


Q ss_pred             CCChhhhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee----CCCCCeEEeecccccc
Q 008031          368 HGSLATFLHARG------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRL  437 (580)
Q Consensus       368 ~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~----~~~~~~kl~Dfg~~~~  437 (580)
                       ++|.+++....      ....+++..+..++.||+.||+|||+ .||+||||||+|||+    +.++.+||+|||+++.
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence             58888875321      12358899999999999999999999 499999999999999    4567899999999986


Q ss_pred             cccccc--cceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCC
Q 008031          438 MTAAAN--VNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPL  492 (580)
Q Consensus       438 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  492 (580)
                      ......  .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            643321  12223568899999998876 45889999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-37  Score=297.04  Aligned_cols=251  Identities=21%  Similarity=0.280  Sum_probs=205.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      ++..+.||+|.-|+||.+... ++..+|+|++.+...   +...+++.|-+||+.++||.+..+|+.+.. +...|++||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl~me  157 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCLVME  157 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEEEEe
Confidence            567889999999999999987 468999999975432   233467889999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc----
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA----  440 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~----  440 (580)
                      ||+||+|...++++ +...+++..++.++.+++-||+|||- .|||+|||||+||||.++|++-++||.++.....    
T Consensus       158 yCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~  235 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL  235 (459)
T ss_pred             cCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence            99999999988875 35679999999999999999999998 5999999999999999999999999998632210    


Q ss_pred             -----------------------------c-c---------------------ccceeeecCccccCCccccccCCCCCc
Q 008031          441 -----------------------------A-A---------------------NVNVIATAGALGYRAPELSKLKKANTK  469 (580)
Q Consensus       441 -----------------------------~-~---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~  469 (580)
                                                   . .                     ......++||-.|+|||++.+...+.+
T Consensus       236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA  315 (459)
T KOG0610|consen  236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA  315 (459)
T ss_pred             eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence                                         0 0                     012234579999999999999999999


Q ss_pred             ccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 008031          470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPE  549 (580)
Q Consensus       470 ~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps  549 (580)
                      +|+|+|||++|||+.|..||.+.+..+....+..   +..           .++..+.....+.+||.+.|-+||.+|.-
T Consensus       316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---~~l-----------~Fp~~~~vs~~akDLIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---QPL-----------KFPEEPEVSSAAKDLIRKLLVKDPSKRLG  381 (459)
T ss_pred             hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---CCC-----------cCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence            9999999999999999999998876654443321   110           12333344457778999999999999998


Q ss_pred             ----HHHHHHH
Q 008031          550 ----VLQVVQQ  556 (580)
Q Consensus       550 ----~~ev~~~  556 (580)
                          +.||.+|
T Consensus       382 ~~rGA~eIK~H  392 (459)
T KOG0610|consen  382 SKRGAAEIKRH  392 (459)
T ss_pred             cccchHHhhcC
Confidence                7888776

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.1e-38  Score=322.69  Aligned_cols=250  Identities=22%  Similarity=0.297  Sum_probs=192.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |+..+.||+|+||.||++... +++.||+|+++...   ......+.+|+.++..++|++|+++++.+.+ ++..++|||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~E   81 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLIME   81 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEe
Confidence            445689999999999999876 68999999986432   2234567889999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  443 (580)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          82 FLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             CCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            99999999999764   368899999999999999999999 5999999999999999999999999999865422110 


Q ss_pred             ---------------------------------cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCC
Q 008031          444 ---------------------------------VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGE  490 (580)
Q Consensus       444 ---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~  490 (580)
                                                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             00113468999999999999999999999999999999999999997


Q ss_pred             CCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 008031          491 PLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPE---VLQVVQQ  556 (580)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ev~~~  556 (580)
                      ..+..+....   +..... ...+.     ......   .++.+++.+|+ .||++|++   +.++++|
T Consensus       238 ~~~~~~~~~~---i~~~~~-~~~~p-----~~~~~s---~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         238 SETPQETYRK---VMNWKE-TLVFP-----PEVPIS---EKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCHHHHHHH---HHcCCC-ceecC-----CCCCCC---HHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            6554332222   111000 00000     001112   24556666765 49999985   6777766

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-38  Score=309.45  Aligned_cols=253  Identities=29%  Similarity=0.475  Sum_probs=200.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHH--HHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR--EFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |+..+.||+|+||.||++... +++.||+|.+.........  ...+|+.++++++||||+++++++.. ....+++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence            345789999999999999987 5668999999765433222  34569999999999999999999987 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...   ..+++..+..++.|+++||++||+. +++|+||||+||++++++.++|+|||.+.... .....
T Consensus        80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~  154 (260)
T PF00069_consen   80 CPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN  154 (260)
T ss_dssp             ETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred             ccccccccccccc---ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc-ccccc
Confidence            9999999999842   3689999999999999999999995 99999999999999999999999999987541 12223


Q ss_pred             eeeecCccccCCccccc-cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSK-LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      .....++..|+|||.+. +..++.++||||+|+++|+|++|..||......+................         ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~  225 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---------SQQ  225 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------TTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------ccc
Confidence            33456888999999998 88999999999999999999999999987632222222222222111100         000


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .......+.+++.+||+.||++|||+.+++++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00011577889999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.5e-38  Score=320.42  Aligned_cols=260  Identities=22%  Similarity=0.241  Sum_probs=193.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  359 (580)
                      .|...+.||+|+||.||++.+. +++.||+|.+.....  .....+.+|+.+++.++||||+++++++....     ...
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            3667789999999999999875 688999999865432  23356788999999999999999999886422     247


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++||||+++ ++.+.+..     .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus        98 ~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          98 YLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             EEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            999999965 67776653     47888999999999999999999 599999999999999999999999999997654


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHh--------------
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV--------------  505 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~--------------  505 (580)
                      ...  ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....              
T Consensus       171 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         171 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             Ccc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            322  1223468899999999999899999999999999999999999997654222111111000              


Q ss_pred             -----hhhcc-ccccchhhhcc------CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          506 -----KEEWT-NEVFDLELMRD------APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       506 -----~~~~~-~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                           ..... .....+.....      ..........+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 00000 00000000000      00000112356789999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-37  Score=308.36  Aligned_cols=263  Identities=25%  Similarity=0.363  Sum_probs=194.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcC---CCCcceeeeeEEECC----CCc
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKI---RHPNLLALRAYYLGP----KGE  358 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~----~~~  358 (580)
                      |+..+.||+|+||.||+|.+. +++.||+|.++.....  ....+.+|+.+++.+   +||||+++++++...    ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            456788999999999999876 7899999998654322  234566777777665   699999999988642    235


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      .+++|||+. ++|.+++.... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+||+|||++...
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            789999997 48988887643 3458999999999999999999999 59999999999999999999999999999865


Q ss_pred             ccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh----hcccc--
Q 008031          439 TAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE----EWTNE--  512 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~--  512 (580)
                      .....  .....++..|+|||++.+..++.++||||+||++|+|++|++||......+....+......    .+...  
T Consensus       159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         159 SCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            43221  12345788999999998889999999999999999999999999765543333222221110    11000  


Q ss_pred             ----ccchhhhccC-CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          513 ----VFDLELMRDA-PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       513 ----~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          .+........ ...+.....+.+++.+|++.||++|||+.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0000000000 0000112356789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-37  Score=315.17  Aligned_cols=253  Identities=18%  Similarity=0.247  Sum_probs=193.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||++... +++.+|+|++....   ......+.+|+.++..++|++|+++++++.+ .+..++|||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   81 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLVMD   81 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEEEe
Confidence            456789999999999999986 67889999986432   1223457889999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++++..  ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus        82 y~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          82 YYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             ccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            999999999997642  358899999999999999999999 59999999999999999999999999998765433333


Q ss_pred             ceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          445 NVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..   +....+.......     ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~-----~~p  230 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKERF-----QFP  230 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCccc-----cCC
Confidence            333356899999999875     356888999999999999999999999765432   2222222211100     000


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPS--PSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~--P~~Rps~~ev~~~  556 (580)
                      .......   .++.+++.+|+..+  +..|+++.|+++|
T Consensus       231 ~~~~~~s---~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 AQVTDVS---EDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CccccCC---HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0111122   34556677777544  4447899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.4e-37  Score=305.15  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=198.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++.. ++..++||||+
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   91 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIEFC   91 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEecC
Confidence            3677899999999999999986 588999999876555556678899999999999999999999876 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|..++....  ..+++..+..++.|++.|++|||+ .+++||||+|+||+++.++.+||+|||++....... ...
T Consensus        92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  167 (292)
T cd06644          92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR  167 (292)
T ss_pred             CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence            9999988876542  358999999999999999999999 499999999999999999999999999886543221 112


Q ss_pred             eeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          447 IATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ....++..|+|||.+.     ...++.++|||||||++|||++|+.||...+.   ......+.......          
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~----------  234 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPT----------  234 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCCcc----------
Confidence            2345788999999874     44578899999999999999999999976442   12222221111100          


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .........++.+++.+||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00011122356788999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-37  Score=319.38  Aligned_cols=260  Identities=21%  Similarity=0.247  Sum_probs=194.4

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  359 (580)
                      .|...+.||+|+||.||++.+. +++.||||++.....  .....+.+|+.+++.++||||+++++++....     ...
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            3667789999999999999876 688999999875432  23456788999999999999999999876422     357


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++||||+++ +|.+++..     .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus       105 ~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         105 YIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             EEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            999999965 77777753     378889999999999999999994 99999999999999999999999999997654


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh-------------
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK-------------  506 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------------  506 (580)
                      ...  ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.....             
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         178 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            322  12234688999999999999999999999999999999999999976543222111111000             


Q ss_pred             ------hhccccccc-hhhhcc------CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          507 ------EEWTNEVFD-LELMRD------APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       507 ------~~~~~~~~~-~~~~~~------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                            ......... ......      .........++.+++.+|++.||.+|||+.|+++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  000000000 000000      00000012356789999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-37  Score=306.63  Aligned_cols=254  Identities=25%  Similarity=0.401  Sum_probs=200.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |++.+.||+|+||.||++... +|..||+|.++.... .....+.+|+.++++++|+||+++++++.. ++..++||||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~   81 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEeec
Confidence            667899999999999999986 789999998865422 234568899999999999999999999876 67899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.++++.......+++..+..++.|++.||.|||+..+++|+||+|+||+++.++.+|++|||++........   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---  158 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---  158 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc---
Confidence            99999999876433346899999999999999999999634899999999999999999999999999875532211   


Q ss_pred             eeecCccccCCccccccC------CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          447 IATAGALGYRAPELSKLK------KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ....++..|+|||.+.+.      .++.++|+||+||++|+|++|+.||...........+..+......      .   
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~---  229 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------T---  229 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC------C---
Confidence            123577889999987544      3478999999999999999999999765443333333322221110      0   


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                         ........+.+++.+||+.+|++||++.+++++-.
T Consensus       230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         230 ---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             ---CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence               01112335668888999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-37  Score=299.68  Aligned_cols=247  Identities=27%  Similarity=0.440  Sum_probs=197.3

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCCh
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSL  371 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L  371 (580)
                      +.||+|+||.||++.+.+++.||+|.+...... ....+.+|++++++++|+||+++++++.. ....++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCcH
Confidence            468999999999999877999999998765443 45678999999999999999999999986 5689999999999999


Q ss_pred             hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce-eeec
Q 008031          372 ATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV-IATA  450 (580)
Q Consensus       372 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~  450 (580)
                      .+++....  ..+++..+..++.+++.|++|||++ +++||||+|+||+++.++.+||+|||++........... ....
T Consensus        80 ~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            99997642  3578999999999999999999995 999999999999999999999999999875542211111 1112


Q ss_pred             CccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHH
Q 008031          451 GALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL  529 (580)
Q Consensus       451 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  529 (580)
                      .+..|+|||.+.+..++.++|+||||+++|||++ |..||...........+..    ...           .+......
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~----~~~-----------~~~~~~~~  221 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES----GYR-----------MPAPQLCP  221 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc----CCC-----------CCCCccCC
Confidence            3557999999988899999999999999999999 8889876654333322211    000           00001112


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          530 LNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       530 ~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .++.+++.+||+.+|.+|||+.|+++.|.
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            36778899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.9e-37  Score=308.91  Aligned_cols=260  Identities=24%  Similarity=0.327  Sum_probs=202.5

Q ss_pred             HHHHHHhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECC
Q 008031          284 ADDLLCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP  355 (580)
Q Consensus       284 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  355 (580)
                      .....+...+.||+|+||.||++...      ++..||+|.++.... ...+.+.+|+.+++++ +|+||+++++++.. 
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence            33445677899999999999999752      355799999875432 2345688999999999 79999999999976 


Q ss_pred             CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          356 KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       356 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      .+..+++|||+.+|+|.++++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCccc
Confidence            568999999999999999997643 23389999999999999999999994 9999999999999999999999999998


Q ss_pred             cccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          436 RLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       436 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      .......... .....++..|+|||.+.+..++.++||||+||++|||++ |..||......+..   ........... 
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~-  264 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF---YKLIKEGYRMA-  264 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH---HHHHHcCCcCC-
Confidence            7654332211 112235678999999998899999999999999999998 99998765432211   11111111100 


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                             ....   ...++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       265 -------~~~~---~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         265 -------QPEH---APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------CCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                   0011   123677899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-37  Score=305.08  Aligned_cols=258  Identities=24%  Similarity=0.329  Sum_probs=204.4

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      ..|.+.+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++.. .+..++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEEEEEEe
Confidence            34678899999999999999876 68899999876443 2335678899999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++.+.   ..+++..+..++.+++.|+.|||+..+++||||+|+||++++++.++|+|||++........ 
T Consensus        84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~-  159 (284)
T cd06620          84 FMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA-  159 (284)
T ss_pred             cCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc-
Confidence            99999999998764   36899999999999999999999734899999999999999999999999999865432211 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC--------hhHHHHHHhhhhccccccch
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE--------LPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~  516 (580)
                        ....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......+        ....+..+......      
T Consensus       160 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  231 (284)
T cd06620         160 --DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------  231 (284)
T ss_pred             --CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC------
Confidence              12468899999999988899999999999999999999999998654321        11122222111100      


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ..    + .......+.+++.+||+.||++|||+.|++++..-+..
T Consensus       232 ~~----~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         232 RL----P-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CC----C-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            00    0 01122356788899999999999999999998655543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-37  Score=310.06  Aligned_cols=264  Identities=22%  Similarity=0.321  Sum_probs=200.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |++.+.||+|+||.||++.+. ++..+|+|.++.... ....++.+|++++++++||||+++++++.. ++..++||||+
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ey~   81 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICMEHM   81 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEeecc
Confidence            456789999999999999876 688899998865432 233568899999999999999999999987 67899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.++++..   ..+++..+..++.|++.||+|||+..+++|+||+|+||+++.++.+|++|||++........   
T Consensus        82 ~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---  155 (308)
T cd06615          82 DGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---  155 (308)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence            999999999764   35889999999999999999999734899999999999999999999999999875433211   


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc---------------
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN---------------  511 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------  511 (580)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..................               
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            23467889999999988889999999999999999999999996544332222221100000000               


Q ss_pred             -----cccchhhhccCCCcH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          512 -----EVFDLELMRDAPTIG--DELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       512 -----~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                           ...+.......+..+  ....++.+++.+||+.+|++|||+.+++++..-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                 000000000000000  112357789999999999999999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=305.15  Aligned_cols=257  Identities=24%  Similarity=0.436  Sum_probs=203.5

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCC----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGS----QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      ..+.+.+.||+|+||.||+|.+. +|.    .+|+|.+..... .....+.+|+.++++++|+||+++++++..  ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence            34567799999999999999865 333    589998865543 234578899999999999999999999975  5889


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+++|+|.+++....  ..+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            9999999999999997642  358999999999999999999999 5999999999999999999999999999986653


Q ss_pred             ccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          441 AANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       441 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ..... .....++..|+|||.+....++.++|+||||+++||+++ |+.||......++.+.+..   ....        
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~--------  230 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK---GERL--------  230 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---CCCC--------
Confidence            32211 111223567999999988899999999999999999999 9999977654333332221   1100        


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                       .....   ...++.+++.+||..+|.+|||+.++++.|+++...
T Consensus       231 -~~~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         231 -PQPPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             -CCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence             00111   113566888999999999999999999999997543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=313.26  Aligned_cols=254  Identities=20%  Similarity=0.271  Sum_probs=193.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++..++|+||+++++++.+ ++..++|||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   81 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLVMD   81 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEEEe
Confidence            456789999999999999976 68999999986422   1233458889999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++.+.  ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             cCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            99999999999763  2358899999999999999999999 59999999999999999999999999998765443333


Q ss_pred             ceeeecCccccCCcccccc-----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          445 NVIATAGALGYRAPELSKL-----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ......||+.|+|||++..     ..++.++||||+||++|||++|+.||...+..   +....+.......     ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~-----~~~  230 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKEHF-----QFP  230 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCcc-----cCC
Confidence            3333468999999998863     45788999999999999999999999764332   2222222211100     000


Q ss_pred             ccCCCcHHHHHHHHHHHhhccC--CCCCCCCCHHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVD--PSPSARPEVLQVVQQL  557 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~--~~P~~Rps~~ev~~~L  557 (580)
                      ...+..++   .+.+++.+|+.  .++..||++.+++++-
T Consensus       231 ~~~~~~~~---~~~~li~~ll~~~~~r~~r~~~~~~l~hp  267 (331)
T cd05597         231 PDVTDVSE---EAKDLIRRLICSPETRLGRNGLQDFKDHP  267 (331)
T ss_pred             CccCCCCH---HHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence            11111223   34456666554  4444588999999883

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-37  Score=303.21  Aligned_cols=248  Identities=23%  Similarity=0.403  Sum_probs=195.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc---------HHHHHHHHHHHhcCCCCcceeeeeEEECCCCc
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG---------QREFESEVSLLGKIRHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  358 (580)
                      |.+.+.||+|+||.||+|... +++.||+|.+.......         .+.+.+|+.++++++||||+++++++.. .+.
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   80 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-ADH   80 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCc
Confidence            345688999999999999875 68899999886433221         2457899999999999999999999987 668


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      .+++|||+++++|.+++...   ..+++..+..++.|++.|++|||+. |++||||+|+||++++++.++|+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            99999999999999999764   3578889999999999999999995 9999999999999999999999999998766


Q ss_pred             cccccc-----ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          439 TAAANV-----NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       439 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      ......     ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+...   .+......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~------  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFKIGEN------  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHHHhcc------
Confidence            422111     1112347888999999998889999999999999999999999997654321   11111110      


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..+...   .   .....+.+++.+||+.||.+||++.|++++
T Consensus       228 ~~~~~~---~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 ASPEIP---S---NISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CCCcCC---c---ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            011110   1   112356678889999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-37  Score=310.07  Aligned_cols=257  Identities=26%  Similarity=0.463  Sum_probs=200.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCC----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGS----QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      .+...+.||+|+||.||+|.+. +|.    .||+|.+..... .....+.+|+.+++.++||||+++++++..  ...++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~   85 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PTIQL   85 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CCcee
Confidence            3456789999999999999874 444    478888765432 223468899999999999999999999964  35779


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ++||+++|+|.+++...  ...+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999998764  2358899999999999999999999 59999999999999999999999999999865432


Q ss_pred             ccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 ANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..+.+.    ....       . 
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~-------~-  230 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE----KGER-------L-  230 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----CCCC-------C-
Confidence            221 1112335678999999998899999999999999999998 999997654333222221    1110       0 


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ...+   .....+.+++.+||..+|++||++.++++.|+++....
T Consensus       231 ~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         231 PQPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            0001   11235678899999999999999999999999976544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.3e-38  Score=315.53  Aligned_cols=253  Identities=21%  Similarity=0.255  Sum_probs=194.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++..++|++|+++++++.+ ++..++|||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv~E   81 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLVMD   81 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEe
Confidence            456789999999999999976 68899999986432   1223457889999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++....  ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.........
T Consensus        82 y~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          82 YYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            999999999997642  358899999999999999999999 59999999999999999999999999999766543333


Q ss_pred             ceeeecCccccCCcccccc-----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          445 NVIATAGALGYRAPELSKL-----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ......|++.|+|||++.+     +.++.++|||||||++|||++|+.||...+..+   ....+.......     .. 
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~i~~~~~~~-----~~-  229 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHEERF-----QF-  229 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---HHHHHHcCCCcc-----cC-
Confidence            3333568999999998875     567889999999999999999999997654322   222222211100     00 


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSA--RPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ev~~~  556 (580)
                        .........++.+++.+|+..++++  |+++.+++++
T Consensus       230 --p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 --PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              0111111235667777888765544  5688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.8e-37  Score=301.70  Aligned_cols=249  Identities=22%  Similarity=0.390  Sum_probs=198.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||++... ++..+|+|.++... ....+.+.+|+.+++.++|+||+++.+.+.+ ++..+++|||+
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   80 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEYC   80 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEeeC
Confidence            456789999999999999976 78999999885432 2344668889999999999999999999976 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++|+|.+++.... ...++...+..++.|++.||.|||+. |++|+||+|+||++++++.++++|||.+......... .
T Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~  157 (255)
T cd08219          81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-A  157 (255)
T ss_pred             CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeecccccc-c
Confidence            9999999887532 34578999999999999999999994 9999999999999999999999999998765433221 2


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ....++..|+|||++.+..++.++|+||||+++|+|++|+.||...+....   ......+...            +...
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~------------~~~~  222 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKVCQGSYK------------PLPS  222 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHHhcCCCC------------CCCc
Confidence            234688899999999988899999999999999999999999976443221   2221111110            0001


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .....+.+++.+||+.||++|||+.+++..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            112356688899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.4e-37  Score=308.05  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=199.1

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |+..+.||+|+||.||+|...      ++..||+|.++.... ....++.+|+.++++++||||+++++++.. +...++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~~~l   85 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKPMCL   85 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCccEE
Confidence            566789999999999999863      467899999875433 234568899999999999999999999876 567899


Q ss_pred             EEeeCCCCChhhhhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC
Q 008031          362 VFDYMPHGSLATFLHARG-------------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD  422 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~  422 (580)
                      +|||+++|+|.+++....                   ....+++..+..++.|++.||+|||+ .+++||||+|+||+++
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p~nil~~  164 (288)
T cd05050          86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccHhheEec
Confidence            999999999999997532                   11247888999999999999999999 5999999999999999


Q ss_pred             CCCCeEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHH
Q 008031          423 DSTNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQW  500 (580)
Q Consensus       423 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~  500 (580)
                      .++.++++|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+....+... 
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~-  243 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY-  243 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence            9999999999998754332211 1112234567999999988899999999999999999998 888987654333222 


Q ss_pred             HHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          501 VASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                        .+......         ....   ....++.+++.+||+.+|++|||+.|+++.|++
T Consensus       244 --~~~~~~~~---------~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         244 --YVRDGNVL---------SCPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HHhcCCCC---------CCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              21111110         0011   112367789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.9e-37  Score=302.36  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=198.5

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      ..|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++.. ++..+++|||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEec
Confidence            35778899999999999999875 688999999875544444567889999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...   ..+++.++..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++........ .
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~  162 (267)
T cd06645          88 CGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-K  162 (267)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-c
Confidence            9999999998764   3688999999999999999999995 999999999999999999999999999875543221 1


Q ss_pred             eeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          446 VIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      .....|+..|+|||.+.   ...++.++|+||+||++|+|++|+.||.........   .........     +......
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~---~~~~~~~~~-----~~~~~~~  234 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLMTKSNFQ-----PPKLKDK  234 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH---HhhhccCCC-----CCccccc
Confidence            22346889999999874   456888999999999999999999998654322111   111111100     0000000


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..   ....+.+++.+||+.+|++|||+.+++++
T Consensus       235 ~~---~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         235 MK---WSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CC---CCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            11   12356688999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=303.20  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=200.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|++.+.||.|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++.. +...++||||+
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   84 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIEFC   84 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEeecc
Confidence            3778899999999999999985 689999999876544455678899999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++...+  ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        85 ~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~  160 (280)
T cd06611          85 DGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KR  160 (280)
T ss_pred             CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-cc
Confidence            9999999987643  358999999999999999999999 4999999999999999999999999998865433221 22


Q ss_pred             eeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          447 IATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ....++..|+|||.+.     ...++.++|+||||+++|+|++|+.||...+...   .+..+.......      . ..
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~------~-~~  230 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKILKSEPPT------L-DQ  230 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHHhcCCCCC------c-CC
Confidence            2345888999999864     3457789999999999999999999997654322   222222111100      0 00


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ..   .....+.+++.+||+.+|.+||++.+++++-
T Consensus       231 ~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (280)
T cd06611         231 PS---KWSSSFNDFLKSCLVKDPDDRPTAAELLKHP  263 (280)
T ss_pred             cc---cCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence            01   1123566788899999999999999999873

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-37  Score=303.62  Aligned_cols=251  Identities=23%  Similarity=0.370  Sum_probs=195.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECC-----CCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGP-----KGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~~  360 (580)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...     ....+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            4667789999999999999876 68899999986432 3456788999999998 799999999998753     23578


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      ++|||+++++|.+++.... ...+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence            9999999999999987642 3458899999999999999999999 4999999999999999999999999999876543


Q ss_pred             ccccceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          441 AANVNVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ... ......|+..|+|||++.     +..++.++||||+||++|||++|+.||............   .. ...     
T Consensus       164 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---~~-~~~-----  233 (272)
T cd06637         164 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PR-NPA-----  233 (272)
T ss_pred             ccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---hc-CCC-----
Confidence            221 222346888999999875     346788999999999999999999999754322111111   00 000     


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...  ...   ....++.+++.+||+.+|.+|||+.+++++
T Consensus       234 ~~~--~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         234 PRL--KSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCC--CCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            000  001   112356788999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-38  Score=305.77  Aligned_cols=240  Identities=23%  Similarity=0.393  Sum_probs=187.2

Q ss_pred             ccccccCceEEEEEEeC-C-------CCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          293 EIMGKSTYGTVYKATLE-D-------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +.||+|+||.||+|... .       ...||+|.+........+.+.+|+.+++.++||||+++++++.. +...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence            46899999999999864 2       23488888765544445678899999999999999999999987 567899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC--------eEEeeccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN--------AKISDFGLSR  436 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~--------~kl~Dfg~~~  436 (580)
                      |+++|+|.++++..+  ..+++..++.++.||+.||+|||+ .||+||||||+||+++.++.        ++++|||.+.
T Consensus        80 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999998653  358899999999999999999999 59999999999999987654        6999999886


Q ss_pred             ccccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCC-CCCCCCCCCChhHHHHHHhhhhcccccc
Q 008031          437 LMTAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGK-SPGEPLNGAELPQWVASIVKEEWTNEVF  514 (580)
Q Consensus       437 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      .....     ....++..|+|||.+.+ ..++.++||||||+++|||++|. .||...+........    ...  .   
T Consensus       157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~----~~~--~---  222 (258)
T cd05078         157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY----EDR--H---  222 (258)
T ss_pred             ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH----Hcc--c---
Confidence            54322     12357788999999876 45789999999999999999984 565543322111111    100  0   


Q ss_pred             chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       515 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                        .    .+.  ....++.+++.+||+.+|++|||+.++++.|+
T Consensus       223 --~----~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 --Q----LPA--PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --c----CCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              0    010  11235778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-37  Score=300.60  Aligned_cols=250  Identities=25%  Similarity=0.387  Sum_probs=199.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |++.+.||+|++|.||++... +++.||+|.+.....  ...+.+.+|++++++++|+|++++++.+...+...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            456789999999999999976 678999999864322  23456889999999999999999999876545568999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++.... ...+++.++..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++........ .
T Consensus        82 ~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  158 (257)
T cd08223          82 CEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-M  158 (257)
T ss_pred             cCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCC-c
Confidence            99999999997642 34589999999999999999999995 999999999999999999999999999876543222 2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+.   .........+...            +..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~~------------~~~  223 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLVYRIIEGKLP------------PMP  223 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCC------------CCc
Confidence            2234578899999999999999999999999999999999999975432   2222222211110            001


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .....++.+++.+||+.+|++|||+.+++++
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1222467789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.8e-37  Score=304.14  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=199.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|...+.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. +...++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEc
Confidence            3667788999999999999875 678899998864432 234568899999999999999999999976 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++..    ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++++|||++........ .
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            999999998864    358899999999999999999999 4999999999999999999999999999876543221 1


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...........+.    ....     +..      .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----~~~~-----~~~------~  222 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----KNSP-----PTL------E  222 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh----cCCC-----CCC------C
Confidence            122457888999999998899999999999999999999999987654333222111    1100     000      1


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ......+.+++.+||+.+|++|||+.+++++-
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            11223567889999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.4e-37  Score=302.20  Aligned_cols=253  Identities=26%  Similarity=0.364  Sum_probs=186.1

Q ss_pred             ccccccCceEEEEEEeCC---CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          293 EIMGKSTYGTVYKATLED---GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.||+|+||.||+|...+   ...+|+|.+..... .....+.+|+..++.++|+||+++++.+.. .+..++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCC
Confidence            358999999999997543   34688887754332 234568899999999999999999999976 5689999999999


Q ss_pred             CChhhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-c
Q 008031          369 GSLATFLHARGP--ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-N  445 (580)
Q Consensus       369 g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~  445 (580)
                      |+|.+++.....  ....++.....++.||+.|++|||+ .+|+||||||+||++++++.+||+|||++......... .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999976432  1235677889999999999999999 59999999999999999999999999998654322211 1


Q ss_pred             eeeecCccccCCccccc-------cCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          446 VIATAGALGYRAPELSK-------LKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      .....++..|+|||++.       ...++.++|||||||++|||++ |..||......+...   ....... ....++.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~~~~~-~~~~~~~  234 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK---QVVREQD-IKLPKPQ  234 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH---HHhhccC-ccCCCCc
Confidence            12234567799999864       3456789999999999999999 788887654332211   1111111 0111111


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .   ...   ....+.+++..|| .||++|||+++|++.|.
T Consensus       235 ~---~~~---~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 L---DLK---YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             c---ccc---CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1   011   1224456777888 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-37  Score=312.60  Aligned_cols=265  Identities=18%  Similarity=0.276  Sum_probs=194.4

Q ss_pred             hhcccccc--CceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          291 TAEIMGKS--TYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       291 ~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      +.++||+|  +|++||++... +|+.||+|.+.....  ...+.+.+|+++++.++||||+++++++.. ++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence            35789999  78899999875 789999999875432  223467889999999999999999999987 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  444 (580)
                      +++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+........... 
T Consensus        81 ~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999997542 2348899999999999999999999 49999999999999999999999999865433211110 


Q ss_pred             -----ceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc------
Q 008031          445 -----NVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN------  511 (580)
Q Consensus       445 -----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------  511 (580)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||............   .......      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK---LNGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH---hcCCccccccccc
Confidence                 0112346677999999875  46889999999999999999999999765432211110   0000000      


Q ss_pred             ------------cccchhh----------hcc-----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhc
Q 008031          512 ------------EVFDLEL----------MRD-----APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIR  561 (580)
Q Consensus       512 ------------~~~~~~~----------~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~  561 (580)
                                  ...+...          ...     .+........+.+++.+||+.||++|||+.|++++  +.++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                        0000000          000     00001122467789999999999999999999986  44443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-37  Score=320.31  Aligned_cols=259  Identities=21%  Similarity=0.284  Sum_probs=197.6

Q ss_pred             HHhhhccccccCceEEEEEEeC---CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE---DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .|.+.+.||+|+||.||++...   .+..||+|.+...     ..+.+|++++++++||||+++++++.. ....+++||
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~e  166 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMVMP  166 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEEeh
Confidence            4677899999999999999753   4678999987543     245689999999999999999999876 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  443 (580)
                      ++. ++|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.++|+|||+++....... 
T Consensus       167 ~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        167 KYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             hcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            995 6888888543   468999999999999999999999 5999999999999999999999999999976544322 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc-ccch------
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE-VFDL------  516 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~------  516 (580)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+........ .++.      
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence            222345799999999999999999999999999999999999999976554333333332222100000 0000      


Q ss_pred             -------hhhccCC-CcH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          517 -------ELMRDAP-TIG------DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       517 -------~~~~~~~-~~~------~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                             ......+ ..+      ....++.+++.+||..||++|||+.|++.+=
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                   0000000 000      0123566788999999999999999999884

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-38  Score=303.27  Aligned_cols=248  Identities=19%  Similarity=0.293  Sum_probs=208.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|.|+.|-.|++- +|..||||++.+..-+  ....+.+|++.|+.++|||||++|++... +...|+|+|.
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKlyLiLEL   98 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLYLILEL   98 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEEEEEEe
Confidence            456689999999999999865 8999999999765443  34568899999999999999999999876 6789999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCCCeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      -++|+|+||+.++.  ..+.+....+++.||+.|+.|+|+. .+|||||||+|+.+- .-|-||+.|||++..+.+... 
T Consensus        99 GD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-  174 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-  174 (864)
T ss_pred             cCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence            99999999998763  4588999999999999999999995 899999999998775 568899999999987765443 


Q ss_pred             ceeeecCccccCCccccccCCCCC-cccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANT-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                       ....+|+..|-|||++.+..|+. ++||||+||+||-|.+|+.||+..++.+....+-.            -..    .
T Consensus       175 -L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD------------CKY----t  237 (864)
T KOG4717|consen  175 -LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD------------CKY----T  237 (864)
T ss_pred             -hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc------------ccc----c
Confidence             34568999999999999998885 68999999999999999999998888776554421            111    1


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      -......++.+||..||..||.+|.|.+||+..-+
T Consensus       238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W  272 (864)
T KOG4717|consen  238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW  272 (864)
T ss_pred             CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence            11233457788999999999999999999987543

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-37  Score=307.32  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=195.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|++|.||+|... ++..||+|.++....  .....+.+|+.++++++||||+++++++.. ++..++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~   80 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEF   80 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEec
Confidence            345688999999999999986 789999999864332  223568899999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ++ ++|.+++........+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-V  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-c
Confidence            97 6899988765444578999999999999999999999 5999999999999999999999999999875533221 1


Q ss_pred             eeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh----hcc----------
Q 008031          446 VIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE----EWT----------  510 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~----------  510 (580)
                      .....++..|+|||.+.+ ..++.++||||+||++|+|+||+.||......+...........    .+.          
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            122356788999998764 45788999999999999999999999764332111111000000    000          


Q ss_pred             --ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          511 --NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       511 --~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ..............   ...++.+++.+||+.||++|||+.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         238 TFPKWKKGSLRSAVKN---LDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hccccCcchhHHhcCC---CCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              00000000000011   12355688999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-37  Score=307.11  Aligned_cols=249  Identities=23%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||.|+||.||+|... +++.||+|.+..........+.+|+.+++.++|||++++++++.. ....++|+||++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~   99 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEYLA   99 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEecC
Confidence            456788999999999999874 789999999876555556678899999999999999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++...    .+++.++..++.|++.|++|||+. |++|+||+|+||+++.++.+||+|||++......... ..
T Consensus       100 ~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~  173 (296)
T cd06655         100 GGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RS  173 (296)
T ss_pred             CCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CC
Confidence            99999988753    489999999999999999999995 9999999999999999999999999998765433221 12


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.   .......... .     . .....   
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~~~~~~~~-~-----~-~~~~~---  240 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGTP-E-----L-QNPEK---  240 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcCCc-c-----c-CCccc---
Confidence            34578899999999988899999999999999999999999976543221   1111111100 0     0 00111   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ....+.+++.+||..||++|||+.+++++=
T Consensus       241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~  270 (296)
T cd06655         241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (296)
T ss_pred             CCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence            122566788899999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=316.53  Aligned_cols=244  Identities=28%  Similarity=0.458  Sum_probs=200.5

Q ss_pred             cccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCChh
Q 008031          294 IMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLA  372 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~  372 (580)
                      ++|+|.||+||-|++. +...+|||-+........+.+.+|+...++++|.|||+++|.|.+ ++.+-|.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcHH
Confidence            6999999999999986 566799999988877777889999999999999999999999876 66788999999999999


Q ss_pred             hhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCCCeEEeecccccccccccccceeee
Q 008031          373 TFLHARGPETPI--DWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANVNVIAT  449 (580)
Q Consensus       373 ~~l~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~  449 (580)
                      +.++.+  -.++  ++.++-.+.+||++||.|||.+ .|||||||-+|+||+ -.|.+||+|||-++....-... ..++
T Consensus       661 sLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETF  736 (1226)
T KOG4279|consen  661 SLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETF  736 (1226)
T ss_pred             HHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-cccc
Confidence            999875  3445  7788889999999999999996 899999999999997 5788999999999876543332 2346


Q ss_pred             cCccccCCccccccC--CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          450 AGALGYRAPELSKLK--KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      .||..|||||++..+  .|+.++|||||||.+.||.||++||.........     +.+-+....        -++...+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----MFkVGmyKv--------HP~iPee  803 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----MFKVGMYKV--------HPPIPEE  803 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----hhhhcceec--------CCCCcHH
Confidence            799999999998754  6888999999999999999999999766543321     222111110        1222234


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQ  555 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~  555 (580)
                      ...+...+|.+|+.+||..||++.++++
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            4466778999999999999999999886

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.6e-37  Score=300.66  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|...+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+ +...++||||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEY   83 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEec
Confidence            3566788999999999999976 68899999986443 2334578899999999999999999999987 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...    .+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........ .
T Consensus        84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06640          84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence            9999999998753    578899999999999999999995 999999999999999999999999999876543322 1


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....++..|+|||.+.+..++.++|+|||||++|||++|+.||...........+    .....           ....
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~-----------~~~~  222 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI----PKNNP-----------PTLT  222 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh----hcCCC-----------CCCc
Confidence            22345788899999998888999999999999999999999999765433222211    10000           1111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ......+.+++.+||+.+|++||++.+++++-.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            223346778999999999999999999988843

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.9e-37  Score=299.92  Aligned_cols=238  Identities=23%  Similarity=0.409  Sum_probs=189.0

Q ss_pred             ccccccCceEEEEEEeCC-C----------CEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          293 EIMGKSTYGTVYKATLED-G----------SQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      +.||+|+||.||+|.+.+ +          ..|++|.+...... ...+.+|+.++++++||||+++++++..  ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence            468999999999999863 3          25788877654333 6788999999999999999999999976  56899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-------CeEEeeccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-------NAKISDFGL  434 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-------~~kl~Dfg~  434 (580)
                      ||||+++|+|.+++....  ..+++..+..++.||+.||+|||+ +|++||||||+||+++.++       .+|++|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999998653  268899999999999999999999 5999999999999999877       799999999


Q ss_pred             ccccccccccceeeecCccccCCccccccC--CCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          435 SRLMTAAANVNVIATAGALGYRAPELSKLK--KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       435 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      +......     ....++..|+|||.+.+.  .++.++||||||+++|||++ |..||......+......   ...   
T Consensus       155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~---  223 (259)
T cd05037         155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQH---  223 (259)
T ss_pred             ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCC---
Confidence            8765431     123466789999998876  78899999999999999999 577776654322111111   000   


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                            ... .+.    ...+.+++.+||..+|.+|||+.++++.|+
T Consensus       224 ------~~~-~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 ------RLP-MPD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------CCC-CCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  000 011    146778999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.8e-37  Score=307.05  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=200.0

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      ..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++.. ++..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeecc
Confidence            34677899999999999999974 799999999876555555678899999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++.+.    .+++.++..++.|++.||.|||+. |++||||+|+||+++.++.++++|||++......... 
T Consensus        98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-  171 (297)
T cd06656          98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (297)
T ss_pred             cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence            9999999998653    478899999999999999999994 9999999999999999999999999998765433221 


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+......   ........ .      .....  
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~~~~~~-~------~~~~~--  239 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNGTP-E------LQNPE--  239 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---eeccCCCC-C------CCCcc--
Confidence            122457889999999998889999999999999999999999997644321111   00000000 0      00001  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       .....+.+++.+||+.+|++|||+.+++++
T Consensus       240 -~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         240 -RLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             -ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             112345678889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.2e-37  Score=298.55  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=199.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |+..+.||+|+||.||+|... +++.+++|.+.....  .+++.+|++++++++|+||+++++++.. +...++++||++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~   81 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVMEYCG   81 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEecCC
Confidence            567789999999999999987 488999999865432  5789999999999999999999999987 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++....  ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        82 ~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (256)
T cd06612          82 AGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence            999999997642  4689999999999999999999995 999999999999999999999999999886644322 222


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..    ....         .......
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~---------~~~~~~~  224 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----KPPP---------TLSDPEK  224 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----CCCC---------CCCchhh
Confidence            34578899999999988999999999999999999999999976443221111100    0000         0001111


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....+.+++.+||+.+|++|||+.|++++
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            12356788899999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.1e-37  Score=302.53  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=194.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      +...+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++.. ++..++||||+
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~   81 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTEFM   81 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEecC
Confidence            356688999999999999875 78899999986442 2334568899999999999999999999987 66889999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|..+.       .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......   .
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~  150 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A  150 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence            999986542       367888999999999999999995 99999999999999999999999999987553322   1


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh----hHHHHHHhhhhccccccchhhhccC
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL----PQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+.    ......+.....      ...    
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~----  220 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------PVL----  220 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC------CCC----
Confidence            234688899999999988999999999999999999999999975432211    111111111100      000    


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      + ......++.+++.+||+.+|++||++.|++++-.
T Consensus       221 ~-~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         221 P-VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             C-CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence            0 0011235678888999999999999999998743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-38  Score=286.30  Aligned_cols=249  Identities=27%  Similarity=0.434  Sum_probs=199.0

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc----cc----HHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT----KG----QREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      .-.+.+|.|..++|-++.++ +|.+.|+|++.....    ..    .++..+|+.+|+++ .||+|+.+.+++.. +...
T Consensus        20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-~sF~   98 (411)
T KOG0599|consen   20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-DAFV   98 (411)
T ss_pred             ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-cchh
Confidence            34678999999999999876 789999999853221    11    23456899999998 79999999999976 6678


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++|+|.|+.|.|.|+|.+.   -.++++...+|+.|+..|++|||. +.||||||||+|||++++.++||+|||+|+...
T Consensus        99 FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   99 FLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999999874   479999999999999999999999 599999999999999999999999999999876


Q ss_pred             cccccceeeecCccccCCccccc------cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          440 AAANVNVIATAGALGYRAPELSK------LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      ....  ....+||++|.|||.+.      ...|+...|+||.|+++|-|+.|.+||......   -.+.-++.+++.   
T Consensus       175 ~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm---lMLR~ImeGkyq---  246 (411)
T KOG0599|consen  175 PGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM---LMLRMIMEGKYQ---  246 (411)
T ss_pred             Cchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH---HHHHHHHhcccc---
Confidence            6543  34568999999999875      346677899999999999999999999653221   112222333221   


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      +      ..+...+......+||.+||+.||.+|.|.+|+++|=
T Consensus       247 F------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  247 F------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             c------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            0      1122223334566788899999999999999999874

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-37  Score=301.56  Aligned_cols=248  Identities=24%  Similarity=0.386  Sum_probs=200.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+ +...++|+||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~   81 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEEee
Confidence            566788999999999999976 68899999986543 2334568899999999999999999999886 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.++++..    .+++..+..++.|++.|+.|||+ ++++|+||+|+||++++++.++++|||+++....... ..
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  155 (274)
T cd06609          82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KR  155 (274)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cc
Confidence            999999999763    68999999999999999999999 5999999999999999999999999999987654322 22


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.   .. ...     .... .    
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~-~~~-----~~~~-~----  221 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP---KN-NPP-----SLEG-N----  221 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh---hc-CCC-----CCcc-c----
Confidence            23457888999999998889999999999999999999999997654322221111   11 110     0000 0    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .....+.+++.+||..+|++|||+.+++++-
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~  252 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHK  252 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence            0123567888899999999999999998863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.3e-37  Score=301.32  Aligned_cols=254  Identities=23%  Similarity=0.363  Sum_probs=199.3

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      +...+.||+|+||.||+|+..      +.+.|++|.+...... ....+.+|++++++++|+||+++++++.+ .+..++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l   85 (275)
T cd05046           7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPHYM   85 (275)
T ss_pred             ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcceE
Confidence            456788999999999999864      3467999988654332 34578999999999999999999999876 567899


Q ss_pred             EEeeCCCCChhhhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          362 VFDYMPHGSLATFLHARGPE------TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      ||||+++|+|.+++......      ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||++
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEcccccc
Confidence            99999999999999765322      2589999999999999999999995 9999999999999999999999999998


Q ss_pred             cccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhcccccc
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVF  514 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ...............++..|+|||.+.+..++.++||||||+++|+|++ |..||............   ........  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~---~~~~~~~~--  239 (275)
T cd05046         165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL---QAGKLELP--  239 (275)
T ss_pred             cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH---HcCCcCCC--
Confidence            7543332222333346678999999888888999999999999999999 88898765443322221   11111000  


Q ss_pred             chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       515 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                            .....   ...+.+++.+||+.+|++|||+.|+++.|.
T Consensus       240 ------~~~~~---~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         240 ------VPEGC---PSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ------CCCCC---CHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                  01111   125678888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-37  Score=311.91  Aligned_cols=191  Identities=25%  Similarity=0.380  Sum_probs=161.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|.+.+.||+|+||.||+|... ++..||+|.....      ....|+.++++++|+||+++++++.. ....++||||+
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~  139 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVLPHY  139 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEEEcc
Confidence            4677899999999999999986 6788999975432      23569999999999999999999987 56789999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                       .++|.+++...  ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||+++......  ..
T Consensus       140 -~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~  213 (357)
T PHA03209        140 -SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AF  213 (357)
T ss_pred             -CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--cc
Confidence             46899888754  3468999999999999999999999 499999999999999999999999999987533221  22


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCC-CCC
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP-GEP  491 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p-~~~  491 (580)
                      ....||..|+|||++.+..++.++|||||||++|||+++..| |..
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            345689999999999999999999999999999999985544 443

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-37  Score=306.73  Aligned_cols=248  Identities=21%  Similarity=0.317  Sum_probs=197.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+.. .+..++||||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~  102 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLE  102 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCCC
Confidence            344677999999999999875 688999999865544455678899999999999999999999886 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++..    ..+++.++..++.||+.||+|||+. +++||||+|+||++++++.++|+|||++........ ...
T Consensus       103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~  176 (292)
T cd06658         103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK  176 (292)
T ss_pred             CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence            9999998854    2588999999999999999999995 999999999999999999999999999875533222 122


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+..    ..     .... .....   
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~-----~~~~-~~~~~---  243 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD----NL-----PPRV-KDSHK---  243 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cC-----CCcc-ccccc---
Confidence            34588899999999888999999999999999999999999976443222111111    11     0000 00111   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....+.+++.+||..||.+|||+.|++++
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            12245678889999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.2e-37  Score=301.52  Aligned_cols=250  Identities=27%  Similarity=0.420  Sum_probs=194.5

Q ss_pred             ccccccCceEEEEEEeCC-------CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          293 EIMGKSTYGTVYKATLED-------GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +.||+|+||.||+|+..+       +..+|+|.+..... .....+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence            468999999999998642       25799998865432 345678899999999999999999999976 568999999


Q ss_pred             eCCCCChhhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-----CeEEeecccc
Q 008031          365 YMPHGSLATFLHARG----PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-----NAKISDFGLS  435 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-----~~kl~Dfg~~  435 (580)
                      |+++++|.+++....    ....+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++     .++++|||++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999997532    12347889999999999999999999 5999999999999999877     8999999998


Q ss_pred             ccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          436 RLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       436 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      ......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+.   .....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~---  232 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT---AGGRL---  232 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh---cCCcc---
Confidence            755332211 1112235678999999999999999999999999999998 999997554332222211   11000   


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                            ......   ...+.+++.+||+.+|.+||++.++++.|++
T Consensus       233 ------~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         233 ------QKPENC---PDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------CCcccc---hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                  001111   2356688899999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-37  Score=298.22  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=200.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.. ....+++|||++
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~~~   83 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEYCG   83 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeCCC
Confidence            456788999999999999975 678899999876554556778999999999999999999999876 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++...  ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus        84 ~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  159 (262)
T cd06613          84 GGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRK  159 (262)
T ss_pred             CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccc
Confidence            99999998764  24688999999999999999999994 999999999999999999999999999876543221 112


Q ss_pred             eecCccccCCccccccC---CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          448 ATAGALGYRAPELSKLK---KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ...++..|+|||.+.+.   .++.++|+||||+++|+|++|+.||........   ..........     +..   ...
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~~~~~~~~~-----~~~---~~~  228 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LFLISKSNFP-----PPK---LKD  228 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCC-----Ccc---ccc
Confidence            34578889999998776   889999999999999999999999976442221   1111111110     000   011


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......++.+++.+||+.+|.+|||+.+++.+
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            12233467789999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.4e-37  Score=297.51  Aligned_cols=250  Identities=22%  Similarity=0.344  Sum_probs=201.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |+..+.||.|+||.||.+... +++.+++|.+....  ......+.+|++++++++|+||+++++++.+ .+..+++|||
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e~   80 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEMEY   80 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEEe
Confidence            456789999999999999875 68899999876432  2334568899999999999999999999987 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~  157 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M  157 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence            99999999997643 34689999999999999999999995 999999999999999999999999999876644332 2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....++..|+|||...+..++.++||||+|+++|||++|..||...+..   +....+........            .
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~------------~  222 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQGNYTPV------------V  222 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC------------c
Confidence            22346888999999998888899999999999999999999999764432   22333222211110            0


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .....++.+++.+||+.+|.+|||+.++++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11223567888899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.8e-37  Score=299.46  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=192.4

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ...||+|+||.||+|.+. ++..||+|.+........+.+.+|+.++++++|+||+++++++.. .+..++++||+++++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~   91 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFKIFMEQVPGGS   91 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEEEEEecCCCCC
Confidence            357999999999999865 678899999876655556788999999999999999999999986 568999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-CCCeEEeecccccccccccccceeee
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-STNAKISDFGLSRLMTAAANVNVIAT  449 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~  449 (580)
                      |.+++.........++..+..++.||+.|++|||+ .||+||||||+||+++. ++.++|+|||++........ .....
T Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~  169 (268)
T cd06624          92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETF  169 (268)
T ss_pred             HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccC
Confidence            99999864211112788889999999999999999 59999999999999986 67899999999875533221 12234


Q ss_pred             cCccccCCccccccC--CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          450 AGALGYRAPELSKLK--KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      .++..|+|||.+.+.  .++.++||||||+++|+|++|+.||..........+...... .      .+..    +  ..
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------~~~~----~--~~  236 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-I------HPEI----P--ES  236 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-c------CCCC----C--cc
Confidence            578899999988654  378899999999999999999999975433221111110000 0      0000    0  01


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...++.+++.+||+.+|.+|||+.|++++
T Consensus       237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         237 LSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            12356678889999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.8e-37  Score=299.63  Aligned_cols=256  Identities=24%  Similarity=0.383  Sum_probs=201.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |++.+.||.|+||.||+|... ++..+|+|++..... .....+.+|+..++.++|+||+++++.+.. ++..+++|||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~   81 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMPYL   81 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEecc
Confidence            456788999999999999975 688999999864432 345678999999999999999999999876 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc--
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--  444 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  444 (580)
                      ++++|.++++.......+++..+..++.|++.|++|||+ .|++|+||+|+||++++++.++++|||++.........  
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            999999999875433568999999999999999999999 59999999999999999999999999998766543322  


Q ss_pred             -ceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          445 -NVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       445 -~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                       ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...+......   +.......      .... .
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~---~~~~~~~~------~~~~-~  230 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM---LTLQNDPP------SLET-G  230 (267)
T ss_pred             cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH---HHhcCCCC------CcCC-c
Confidence             12234578899999988766 78999999999999999999999997654432211   11111110      0000 0


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .........+.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0001223456788899999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.7e-37  Score=307.23  Aligned_cols=197  Identities=25%  Similarity=0.415  Sum_probs=159.9

Q ss_pred             hccccccCceEEEEEEeC---CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEEC-CCCcEEEEEeeCC
Q 008031          292 AEIMGKSTYGTVYKATLE---DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG-PKGEKLLVFDYMP  367 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~  367 (580)
                      +..||+|+||.||+|...   ++..||+|.+....  ....+.+|++++++++||||+++++++.. .+...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            367999999999999865   45789999886432  23467889999999999999999998864 3456789999986


Q ss_pred             CCChhhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee----CCCCCeEEeecccccc
Q 008031          368 HGSLATFLHAR------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRL  437 (580)
Q Consensus       368 ~g~L~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~----~~~~~~kl~Dfg~~~~  437 (580)
                       ++|.+++...      .....+++..+..++.||+.||.|||+ .+|+||||||+||++    +.++.+||+|||+++.
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence             5888877532      112358889999999999999999999 599999999999999    4567899999999986


Q ss_pred             ccccccc--ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCC
Q 008031          438 MTAAANV--NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPL  492 (580)
Q Consensus       438 ~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  492 (580)
                      .......  ......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            6433221  2223467899999998876 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-38  Score=315.53  Aligned_cols=241  Identities=23%  Similarity=0.313  Sum_probs=185.1

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcC---CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKI---RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      ||+|+||.||+|... +++.||+|++......   ....+..|..++...   +||||+++++++.. ....++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence            699999999999976 6899999998643221   223345666776655   69999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...   ..+++..+..++.||++||+|||+. ||+||||||+|||++.++.+||+|||++........ ...
T Consensus        80 ~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~  154 (330)
T cd05586          80 GGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN  154 (330)
T ss_pred             CChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence            99999998764   3688999999999999999999994 999999999999999999999999999875432221 122


Q ss_pred             eecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...||..|+|||.+.+. .++.++||||+||++|+|++|+.||...+..+.   ...+..+..       ...  .... 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~-------~~~--~~~~-  221 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YRNIAFGKV-------RFP--KNVL-  221 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HHHHHcCCC-------CCC--CccC-
Confidence            35689999999988654 478999999999999999999999976543222   222211111       000  0111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC----CHHHHHHH
Q 008031          527 DELLNTLKLALHCVDPSPSARP----EVLQVVQQ  556 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rp----s~~ev~~~  556 (580)
                        ...+.+++.+||+.||.+||    ++.+++++
T Consensus       222 --~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         222 --SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             --CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence              12456788899999999998    56666664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-37  Score=302.77  Aligned_cols=256  Identities=20%  Similarity=0.317  Sum_probs=199.5

Q ss_pred             CHHHHHHhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          283 TADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       283 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      ...+-.|++.+.||+||.+.||++...+.+.+|+|++.....  .....|..|+..|.+| .|.+|+++++|-.. ++..
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~l  435 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYL  435 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceE
Confidence            344556888999999999999999998888899988754333  3346799999999999 59999999999987 7899


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      |+||||- ..+|..+|.++.... ..| .+..+..||+.|+.++|.+ ||||.||||.|+|+-. |.+||+|||+|.-+.
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ  510 (677)
T ss_pred             EEEeecc-cccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence            9999998 559999998864222 223 7889999999999999996 9999999999999976 679999999998765


Q ss_pred             cccc-cceeeecCccccCCccccccCC-----------CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh
Q 008031          440 AAAN-VNVIATAGALGYRAPELSKLKK-----------ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE  507 (580)
Q Consensus       440 ~~~~-~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  507 (580)
                      .+.. ......+||+.||+||.+....           .++++||||+||+||+|+.|+.||+...  .....+.     
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~-----  583 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLH-----  583 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHH-----
Confidence            4432 2334568999999999765332           4578999999999999999999997421  1112222     


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          .+.|+.....++..++. .+++++|..||+.||.+|||..+++++
T Consensus       584 ----aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  584 ----AITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ----hhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                22333332233333222 138899999999999999999999986

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-37  Score=319.47  Aligned_cols=257  Identities=21%  Similarity=0.279  Sum_probs=191.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||...      ...+.+|++++++++|+||+++++++.. .+..++|||++.
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e~~~  243 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLPKYR  243 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEEccC
Confidence            667789999999999999986 68899999632      1235689999999999999999999876 568899999994


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-ce
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-NV  446 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~  446 (580)
                       ++|.+++....  ..+++.+++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++........ ..
T Consensus       244 -~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        244 -SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             -CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence             68998886542  368999999999999999999999 49999999999999999999999999999865433221 22


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCC-C---CChhHHHHHHhhhhcc-ccccch----h
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLN-G---AELPQWVASIVKEEWT-NEVFDL----E  517 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~-~---~~~~~~~~~~~~~~~~-~~~~~~----~  517 (580)
                      ....||..|+|||++.+..++.++|||||||++|||++|..|+-... .   ......+..++..... ...+..    .
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            24569999999999999999999999999999999999876542211 1   1111112222211100 000000    0


Q ss_pred             hh-----------cc---CCCc---HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LM-----------RD---APTI---GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~-----------~~---~~~~---~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      +.           ..   .+..   ......+.+++.+||+.||++|||+.|++++
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00           00   0000   0111256688999999999999999999986

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.4e-37  Score=299.59  Aligned_cols=250  Identities=24%  Similarity=0.406  Sum_probs=196.8

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT------KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |...+.||+|+||.||+|...+|+.+|+|.++....      .....+.+|++++++++|+||+++++++.+ .+..+++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   80 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTISIF   80 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEEEE
Confidence            456789999999999999988899999998864321      122458899999999999999999999987 5689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++++|.+++.+.   ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            9999999999999764   357889999999999999999999 499999999999999999999999999987542211


Q ss_pred             -----ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          443 -----NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       443 -----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                           ........++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+......   ........    .+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~~~~~~----~~~  229 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YIGAHRGL----MPR  229 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH---HhhhccCC----CCC
Confidence                 111223458889999999998889999999999999999999999997644222111   11111000    000


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .   ..   .....+.+++.+||+.+|++||++.+++++
T Consensus       230 ~---~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         230 L---PD---SFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             C---CC---CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1   01   122356778889999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-37  Score=307.09  Aligned_cols=261  Identities=22%  Similarity=0.321  Sum_probs=196.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++.. ++..++||||+
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e~~   86 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFEYL   86 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEecc
Confidence            556789999999999999876 688999999864432 234567889999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      + ++|.+++....  ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++........ ..
T Consensus        87 ~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~  161 (301)
T cd07873          87 D-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY  161 (301)
T ss_pred             c-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cc
Confidence            6 58998887642  3578999999999999999999995 999999999999999999999999999875433221 11


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc---cccccc-------
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW---TNEVFD-------  515 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------  515 (580)
                      ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+........   .....+       
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            22346788999998765 4578899999999999999999999976554333222222111000   000000       


Q ss_pred             --hhhh-----ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          516 --LELM-----RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       516 --~~~~-----~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                        +...     ...+..   ...+.+++.+|++.||.+|||+.|++++-.
T Consensus       242 ~~~~~~~~~~~~~~~~~---~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         242 NYPKYRADCLHNHAPRL---DSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             ccCccccccHHhhcCCC---CHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence              0000     000111   224568899999999999999999998543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.7e-37  Score=299.17  Aligned_cols=248  Identities=23%  Similarity=0.402  Sum_probs=191.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-----ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-----KGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~l  361 (580)
                      |...+.||+|+||.||+|... +++.||+|.+.....     .....+.+|+.++++++||||+++++++... ....++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            456789999999999999875 689999998754321     1234688899999999999999999998753 356789


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ++||+++++|.+++...+   .+++.....++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus        84 ~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          84 FMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            999999999999997643   57889999999999999999999 59999999999999999999999999998755321


Q ss_pred             cc--cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 AN--VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..  .......++..|+|||.+.+..++.++||||+||++|||++|+.||......   ..+........          
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~~~~~~~----------  226 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFKIATQPT----------  226 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHHHhcCCC----------
Confidence            11  1112245788999999999888999999999999999999999999754321   22222111110          


Q ss_pred             ccCCCcHHHH-HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDEL-LNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~-~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        .+..+... ..+.+++ +||..+|++||+++|+++|
T Consensus       227 --~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         227 --NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence              01111111 2333444 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.4e-37  Score=304.25  Aligned_cols=263  Identities=23%  Similarity=0.305  Sum_probs=199.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||+|++.....  .....+.+|+.++++++||||+++++++.. +...++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~   80 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVMEY   80 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEecc
Confidence            456788999999999999975 789999999875432  234678999999999999999999999987 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      + +++|.+++....  ..+++.++..++.||+.||+|||+. +++|+||+|+||+++.++.++++|||++..........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 999999987643  4689999999999999999999994 99999999999999999999999999988765443222


Q ss_pred             eeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---ccccc------
Q 008031          446 VIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEVFD------  515 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~------  515 (580)
                      .....++..|+|||.+.+. .++.++||||+|+++|||++|++||....+.+....+.........   ....+      
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            2334688899999987654 4688999999999999999998888765443322222211110000   00000      


Q ss_pred             hhhhccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 LELMRDAP-----TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ........     ..++....+.+++.+||+.+|++|||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000000     001122567789999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-38  Score=314.37  Aligned_cols=243  Identities=24%  Similarity=0.429  Sum_probs=194.4

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEcc--c--cccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-cEEEEEee
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR--E--KITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-EKLLVFDY  365 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e~  365 (580)
                      ..+||+|+|-+||+|.+. +|-+||=--++  .  ......+.|..|+.+|+.|+||||++++.++.+... ..-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            478999999999999986 67777622221  1  112233679999999999999999999999987443 46799999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccCCCCCCCeeeC-CCCCeEEeecccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-ENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      |..|+|..|+++.+   .++.+.+..|+.||++||.|||+. ++|+|||||.+||+|+ ..|.|||+|+|+|+.......
T Consensus       125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            99999999998864   688999999999999999999985 7899999999999998 568999999999987754422


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCC-CCChhHHHHHHhhhhccccccchhhhccC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLN-GAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      .   ...||+.|||||+.. ..|+..+||||||+++.||.|+..||..-. ...+...+-+.++......+-|+      
T Consensus       202 k---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP------  271 (632)
T KOG0584|consen  202 K---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP------  271 (632)
T ss_pred             c---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH------
Confidence            2   368999999999988 899999999999999999999999997543 33333333333332333333222      


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                              ++.++|++|+.. ..+|||+.|++++
T Consensus       272 --------evr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  272 --------EVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             --------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence                    445788899999 9999999999875

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.3e-37  Score=297.61  Aligned_cols=246  Identities=27%  Similarity=0.481  Sum_probs=195.9

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|++.+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++++++|||++++++++..  +..+++|||++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~~   81 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELMS   81 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECCC
Confidence            366789999999999999975 57889999986432  34578899999999999999999999864  45799999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++.... ...+++..+..++.|++.|+.|||+ .|++||||||+||+++.++.+||+|||++........    
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~----  155 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD----  155 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCcEEECCCccceeccccCC----
Confidence            999999997653 3357899999999999999999999 4999999999999999999999999999875432211    


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+....+.   . .....        ...   
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~-~~~~~--------~~~---  220 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE---K-GYRME--------PPE---  220 (254)
T ss_pred             CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---C-CCCCC--------CCC---
Confidence            1234567999999988899999999999999999998 999997654332222111   1 11100        001   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      .....+.+++.+||+.+|++||++.++++.|+.
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            112356688899999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.3e-37  Score=297.74  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=199.1

Q ss_pred             hhccccccCceEEEEEEeCC-----CCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          291 TAEIMGKSTYGTVYKATLED-----GSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +.+.||.|+||.||++...+     +..||+|.++..... ..+.+..|+.++..++|+||+++++++.. .+..+++||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i~e   81 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIVME   81 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEEEe
Confidence            46889999999999999863     378999999765443 45678999999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++++|||++.........
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            9999999999976431 1289999999999999999999995 9999999999999999999999999999866544222


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ......++..|+|||.+.+..++.++||||+|+++|+|++ |+.||...+..+..+.+..   ....         ....
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~---------~~~~  227 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK---GYRL---------PKPE  227 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CCCC---------CCCC
Confidence            2212336788999999988889999999999999999998 8888876443333322221   1110         0011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                         ....++.+++.+||+.+|++|||+.|+++.|
T Consensus       228 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      228 ---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               1233577888999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.8e-37  Score=298.67  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=185.8

Q ss_pred             cccccCceEEEEEEeCCC---CEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          294 IMGKSTYGTVYKATLEDG---SQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      .||+|+||.||+|...++   ..+++|.+.... ......+.+|+.+++.++||||+++++.+.. ....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCCC
Confidence            589999999999976533   345667665433 2345678999999999999999999999986 56889999999999


Q ss_pred             ChhhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-ccee
Q 008031          370 SLATFLHARGP-ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-VNVI  447 (580)
Q Consensus       370 ~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  447 (580)
                      +|.++++.... ....++..+..++.||+.||+|||+ .+++||||||+||+++.++.+|++|||++........ ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            99999976422 2346677788999999999999999 4999999999999999999999999998764322111 1112


Q ss_pred             eecCccccCCcccccc-------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          448 ATAGALGYRAPELSKL-------KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ...++..|+|||++..       ..++.++||||||+++|||++ |..||......+   .+.....+.. ....++...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~-~~~~~~~~~  235 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHVIKDQQ-VKLFKPQLE  235 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhhcc-cccCCCccC
Confidence            3457789999998743       345779999999999999997 577886544322   2222222211 111222211


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .   .   ....+.+++..|| .+|++|||+.++++.|.
T Consensus       236 ~---~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         236 L---P---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             C---C---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1   1   1234566788899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-36  Score=298.57  Aligned_cols=254  Identities=23%  Similarity=0.411  Sum_probs=198.6

Q ss_pred             HhhhccccccCceEEEEEEeCC--CCEEEEEEccccc----------cccHHHHHHHHHHHhc-CCCCcceeeeeEEECC
Q 008031          289 CATAEIMGKSTYGTVYKATLED--GSQVAVKRLREKI----------TKGQREFESEVSLLGK-IRHPNLLALRAYYLGP  355 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~  355 (580)
                      |++.+.||+|+||.||+|.+..  ++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++.. 
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-   80 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-   80 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-
Confidence            4567889999999999999864  6789999875321          1122456778888875 799999999999986 


Q ss_pred             CCcEEEEEeeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccc
Q 008031          356 KGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL  434 (580)
Q Consensus       356 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~  434 (580)
                      ++..+++|||+++++|.+++... .....+++..+..++.|++.||.|||+..+++|+||+|+||+++.++.+|++|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            66899999999999999988542 22356899999999999999999999645899999999999999999999999999


Q ss_pred             ccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccccc
Q 008031          435 SRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF  514 (580)
Q Consensus       435 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      +.......  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.   ..............   
T Consensus       161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~---  232 (269)
T cd08528         161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVYEP---  232 (269)
T ss_pred             eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHhhccCCc---
Confidence            97654432  23345688899999999988899999999999999999999999865432   22222222211110   


Q ss_pred             chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       515 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                        .    ..  ......+.+++.+||+.||++||++.|+.+++++
T Consensus       233 --~----~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         233 --L----PE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             --C----Cc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence              0    00  0112356788889999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-37  Score=314.75  Aligned_cols=260  Identities=23%  Similarity=0.292  Sum_probs=194.0

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----CCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-----KGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  359 (580)
                      .|...+.||+|+||.||+|... +++.||||.+.....  .....+.+|++++++++||||+++++++...     ....
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            4677899999999999999875 788999999865322  2335577899999999999999999887542     1346


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++++|++ +++|.+++..    ..+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++...
T Consensus        96 ~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          96 YLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            8999998 7899888764    3589999999999999999999995 99999999999999999999999999998654


Q ss_pred             cccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---cccc-
Q 008031          440 AAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEVF-  514 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-  514 (580)
                      ..    .....|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+....+.........   .... 
T Consensus       170 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             CC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            32    223468899999999876 56889999999999999999999999765433222222111110000   0000 


Q ss_pred             --chhhhccCCCcH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          515 --DLELMRDAPTIG---------DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       515 --~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        ........+..+         .....+.+++.+|++.||++|||+.|+++|=
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp  299 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP  299 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence              000000000000         0112466899999999999999999999873

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-36  Score=300.18  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=201.2

Q ss_pred             HhhhccccccCceEEEEEEeC-----CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-----DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~l  361 (580)
                      +...+.||+|+||.||+|.+.     ++..+|+|.++..... ....+.+|+++++.++|+||+++++++... ....++
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL   85 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence            456689999999999999854     4678999998755443 456799999999999999999999988652 336899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +|||+++++|.+++....  ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++++|||.+......
T Consensus        86 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          86 IMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             EEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            999999999999997653  3589999999999999999999995 9999999999999999999999999999876532


Q ss_pred             cccce--eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh-----------hHHHHHHhhhh
Q 008031          442 ANVNV--IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL-----------PQWVASIVKEE  508 (580)
Q Consensus       442 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-----------~~~~~~~~~~~  508 (580)
                      .....  ....++..|+|||.+.+..++.++||||||+++|||++|+.|+........           ...+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG  242 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence            22111  112345679999999888999999999999999999999999865322110           11111111111


Q ss_pred             ccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      ..           .+.......++.+++.+||+.+|++|||+.|+++.|+.++
T Consensus       243 ~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         243 ER-----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             Cc-----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            00           0001111246778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=312.78  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=206.2

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|.+...+|.|+||.||+|..+ ++-..|.|++........++|.-|+++|+.++||+||++++.|.. ++.++|+.|||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEFC  111 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEFC  111 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEeec
Confidence            4677888999999999999877 455567888876666667789999999999999999999998876 67899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      .||-....+-.-+  ..+++.++..+++|++.||.|||+ ++|+|||||+.|||++-+|.++++|||.+...... ..+.
T Consensus       112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkR  187 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKR  187 (1187)
T ss_pred             CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecCcEeeecccccccchhH-Hhhh
Confidence            9998888776553  568999999999999999999999 49999999999999999999999999987543222 2334


Q ss_pred             eeecCccccCCccc-----cccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          447 IATAGALGYRAPEL-----SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       447 ~~~~g~~~y~aPE~-----~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ..+.||+.|||||+     +...+|+.++||||||+.|.||..+.+|....+....   +-++...+.+ .         
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV---llKiaKSePP-T---------  254 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAKSEPP-T---------  254 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH---HHHHhhcCCC-c---------
Confidence            46789999999997     4567899999999999999999999999877665433   2333332221 1         


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .-....+...+.+++.+||..||..||++.++++|
T Consensus       255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            11234566788899999999999999999999876

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-36  Score=302.45  Aligned_cols=248  Identities=20%  Similarity=0.306  Sum_probs=197.8

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      ....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.. ++..++++||++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~~~  103 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGG  103 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCCCC
Confidence            3467999999999999875 789999999865544455678899999999999999999999886 66899999999999


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeee
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT  449 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  449 (580)
                      +|.+++...    .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........ .....
T Consensus       104 ~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~  177 (297)
T cd06659         104 ALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL  177 (297)
T ss_pred             CHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccce
Confidence            999987652    588999999999999999999995 999999999999999999999999999875543221 22234


Q ss_pred             cCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHH
Q 008031          450 AGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL  529 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  529 (580)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||......+..   ..+.. ....      ........   .
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~-~~~~------~~~~~~~~---~  244 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLRD-SPPP------KLKNAHKI---S  244 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhc-cCCC------CccccCCC---C
Confidence            6888999999999888999999999999999999999999754332222   11111 1000      00111111   1


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          530 LNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       530 ~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ..+.+++.+||+.+|++||++.+++++-.
T Consensus       245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~  273 (297)
T cd06659         245 PVLRDFLERMLTREPQERATAQELLDHPF  273 (297)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence            24667888999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-37  Score=331.25  Aligned_cols=251  Identities=21%  Similarity=0.327  Sum_probs=193.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. ++..||+|.+....  ......+..|+.++++++||||+++++++... ...+|+|||
T Consensus        15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME   94 (1021)
T PTZ00266         15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME   94 (1021)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence            567899999999999999986 67789999886432  22345688999999999999999999988653 346899999


Q ss_pred             eCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcC------CCcccCCCCCCCeeeCC--------------
Q 008031          365 YMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSN------ENIIHGNLTSSNVLLDD--------------  423 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~i~H~Dlk~~Nil~~~--------------  423 (580)
                      |+++|+|.+++.... ....+++..++.|+.||+.||+|||+.      ++|+||||||+|||++.              
T Consensus        95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n  174 (1021)
T PTZ00266         95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN  174 (1021)
T ss_pred             CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence            999999999997532 234689999999999999999999973      24999999999999964              


Q ss_pred             ---CCCeEEeecccccccccccccceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChh
Q 008031          424 ---STNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP  498 (580)
Q Consensus       424 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~  498 (580)
                         ...+||+|||++........  .....||+.|+|||++.+  ..++.++|||||||++|||++|+.||...+.  ..
T Consensus       175 ~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--~~  250 (1021)
T PTZ00266        175 LNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--FS  250 (1021)
T ss_pred             cCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--HH
Confidence               23489999999976543221  223468999999998854  4588999999999999999999999975432  22


Q ss_pred             HHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      +.+..+.. ..       .+.  ..   ....++.++|..||+.+|.+|||+.|++++
T Consensus       251 qli~~lk~-~p-------~lp--i~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        251 QLISELKR-GP-------DLP--IK---GKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHHHHHhc-CC-------CCC--cC---CCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            22222111 10       000  01   112356788999999999999999999954

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-36  Score=299.57  Aligned_cols=255  Identities=27%  Similarity=0.448  Sum_probs=196.9

Q ss_pred             hhhccccccCceEEEEEEeC----CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-----c
Q 008031          290 ATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-----E  358 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~  358 (580)
                      .+.+.||+|+||.||+|.+.    ++..||||.++....  ...+++.+|++++++++||||+++++++...+.     .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            35678999999999999863    468899999865432  234568899999999999999999998865321     2


Q ss_pred             EEEEEeeCCCCChhhhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          359 KLLVFDYMPHGSLATFLHAR---GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      .++++||+.+|+|.+++...   .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECccccc
Confidence            47899999999999887532   1123578899999999999999999995 9999999999999999999999999998


Q ss_pred             ccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          436 RLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       436 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      +........ ......++..|++||.+.+..++.++|||||||++|||++ |+.||...+..+....+   .......  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~--  235 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL---IKGNRLK--  235 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH---HcCCcCC--
Confidence            865432211 1112335567999999998889999999999999999999 88998765432222221   1111100  


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                          .   .   ......+.+++.+||+.+|++|||+.++++.|+++
T Consensus       236 ----~---~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         236 ----Q---P---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----C---C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0   0   11223677899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-36  Score=299.17  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=194.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc----------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK----------GQREFESEVSLLGKIRHPNLLALRAYYLGPKG  357 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  357 (580)
                      |...+.||+|+||.||+|... +|+.||+|.++.....          ..+.+.+|+.++++++|+|++++++++.. .+
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   81 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-EE   81 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-CC
Confidence            445688999999999999875 6899999987532110          12357889999999999999999999876 66


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ..++||||+++++|.++++..   ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            899999999999999999875   3688899999999999999999994 999999999999999999999999999876


Q ss_pred             ccccccc-ceeeecCccccCCccccccCC--CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccccc
Q 008031          438 MTAAANV-NVIATAGALGYRAPELSKLKK--ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF  514 (580)
Q Consensus       438 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ....... ......++..|+|||.+....  ++.++|+||+|+++|++++|..||...+..   ........... ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~~~~  233 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNKRS-APPI  233 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhcccc-CCcC
Confidence            5432211 122345788999999887654  788999999999999999999999643322   11111111110 0011


Q ss_pred             chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       515 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      +....      ......+.+++.+||+.+|.+|||+.+++++
T Consensus       234 ~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         234 PPDVS------MNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             Ccccc------ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11110      1112467788889999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=8.5e-37  Score=302.19  Aligned_cols=262  Identities=23%  Similarity=0.339  Sum_probs=197.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |+..+.||+|+||.||+|.+. +|+.||+|++.....  ...+.+.+|+.++++++|+|++++++++.. ....++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e~   81 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVFEY   81 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEEec
Confidence            456688999999999999987 689999998864432  233567899999999999999999999986 5688999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|..+....   ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~  156 (286)
T cd07847          82 CDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D  156 (286)
T ss_pred             cCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence            9998888776543   358999999999999999999999 5999999999999999999999999999986644322 1


Q ss_pred             eeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh------------cccc
Q 008031          446 VIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE------------WTNE  512 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------~~~~  512 (580)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+.......            +...
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            122356788999998765 567889999999999999999999998665433332222211100            0000


Q ss_pred             ccchhhhccCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          513 VFDLELMRDAP---TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       513 ~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...+......+   ........+.+++.+||+.+|++|||+.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000000000   000112457789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=328.75  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=207.1

Q ss_pred             hhhccccccCceEEEEEEeC----C----CCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          290 ATAEIMGKSTYGTVYKATLE----D----GSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      .+.+.+|+|.||.||+|...    .    ...||||.++..... +.+.+..|+++|..+ +|+||+.++|+|.. .+..
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~~~  377 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DGPL  377 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-CCce
Confidence            56669999999999999853    1    346999999876554 456799999999999 69999999999987 7789


Q ss_pred             EEEEeeCCCCChhhhhhhcC-----------CC--CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC
Q 008031          360 LLVFDYMPHGSLATFLHARG-----------PE--TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN  426 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~-----------~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~  426 (580)
                      ++|+||++.|+|.++++.+.           ..  ..++..+.+.++.|||.|++||++ .+++||||.++|||++++..
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEecCCCE
Confidence            99999999999999998764           01  238889999999999999999999 48999999999999999999


Q ss_pred             eEEeecccccccccccccceeeec--CccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCC-CCChhHHHH
Q 008031          427 AKISDFGLSRLMTAAANVNVIATA--GALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLN-GAELPQWVA  502 (580)
Q Consensus       427 ~kl~Dfg~~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~-~~~~~~~~~  502 (580)
                      +||+|||+|+..............  -+..|||||.+....|+.++||||||++|||++| |..||.+.. ..++.+   
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~---  533 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE---  533 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH---
Confidence            999999999976655554433333  3557999999999999999999999999999999 999997744 333322   


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                       .++.+.+        +..+..+   ..+++++|..||+.+|++||++.++++.++...
T Consensus       534 -~l~~G~r--------~~~P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  534 -FLKEGNR--------MEQPEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             -HHhcCCC--------CCCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence             2222221        1112222   346668888999999999999999999999853

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-36  Score=299.86  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=195.3

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEEC----CCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLG----PKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~~l  361 (580)
                      .|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++++ +||||+++++++..    .++..++
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            3566789999999999999875 6889999987543 22345688899999999 79999999998853    2346899


Q ss_pred             EEeeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          362 VFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      ||||+++++|.++++.. .....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|++|||++.....
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  176 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  176 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence            99999999999988642 2234688999999999999999999994 999999999999999999999999999876543


Q ss_pred             ccccceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          441 AANVNVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ... ......|+..|+|||.+.     +..++.++||||+||++|||++|+.||........   +....... .....+
T Consensus       177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~~~~~~~~-~~~~~~  251 (286)
T cd06638         177 TRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LFKIPRNP-PPTLHQ  251 (286)
T ss_pred             CCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---HhhccccC-CCcccC
Confidence            221 222346889999999875     34578899999999999999999999976543211   11111100 000000


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                            ...   ...++.+++.+||+.||++|||+.|++++.
T Consensus       252 ------~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         252 ------PEL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ------CCC---cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                  000   123577889999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-36  Score=295.91  Aligned_cols=249  Identities=22%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |++.+.||+|+||.||.+... +|+.||+|.+....  .....++.+|+.++++++||||+++++++.. .+..++||||
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~   80 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMDY   80 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEec
Confidence            456789999999999999875 78999999986432  2234578899999999999999999999876 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++.... ...+++.++..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++......... 
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  157 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-  157 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence            99999999987642 2357899999999999999999999 49999999999999999999999999998765433221 


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....|+..|+|||...+..++.++|+|||||++|+|++|+.||...+.   ...+..+..+....            ..
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~------------~~  222 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLVLKIIRGSYPP------------VS  222 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHHHHHHhcCCCCC------------Cc
Confidence            1223578889999999988999999999999999999999999875432   22222222221110            00


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .....++.+++.+||+.+|.+||++.+++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1112356788889999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-36  Score=296.41  Aligned_cols=252  Identities=21%  Similarity=0.354  Sum_probs=198.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT------KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |...+.||+|+||.||+|... +++.||+|.+.....      ...+.+.+|++++++++|+||+++++++.+ .+..++
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~   80 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFNL   80 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEEE
Confidence            455688999999999999874 789999999864331      123568899999999999999999999976 568999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeeccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTA  440 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~  440 (580)
                      ||||+++++|.+++...   ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++ .+||+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            99999999999999764   3688999999999999999999994 999999999999998765 599999999876643


Q ss_pred             cccc---ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          441 AANV---NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       441 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ....   ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.........       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------  229 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA-------  229 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC-------
Confidence            3211   111235788999999998888999999999999999999999999755443333322221111100       


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          .........++.+++.+||+.+|.+|||+.+++++
T Consensus       230 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         230 ----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                01111122467789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.2e-36  Score=295.52  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=197.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|... +++.||+|.++.....  ..+.+..|+.++++++|+||+++++++.. .+..++|+||
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e~   80 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFMEY   80 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEec
Confidence            456789999999999999875 7899999998755443  45678999999999999999999999876 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...   ..+++..+..++.|+++|++|||+. |++|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999999764   3578889999999999999999995 99999999999999999999999999987664433221


Q ss_pred             e---eeecCccccCCccccccCC---CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          446 V---IATAGALGYRAPELSKLKK---ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       446 ~---~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .   ....++..|+|||.+.+..   ++.++||||||+++|++++|+.||.......  ........ ..     .+.  
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~~~-~~-----~~~--  226 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHVGA-GH-----KPP--  226 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHHhc-CC-----CCC--
Confidence            1   1345788999999988766   8889999999999999999999997653211  11111111 00     000  


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        .+........+.+++.+||+.+|++|||+.+++.+
T Consensus       227 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         227 --IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             --CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              01111112355688889999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.4e-36  Score=293.78  Aligned_cols=248  Identities=25%  Similarity=0.442  Sum_probs=197.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |+..+.||+|+||.||++... +++.+|+|.+....  ......+.+|++++++++|||++++++.+.. ++..++||||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~   80 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVMEY   80 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEec
Confidence            456789999999999999875 78899999986432  2234578899999999999999999998875 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-CCeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-TNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +++++|.+++.... ...+++..+.+++.|++.|++|||+. |++|+||+|+||+++++ +.+|++|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-  157 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-  157 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence            99999999997643 33588999999999999999999994 99999999999999854 4579999999986643322 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.....   ......... .     .      
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~-~-----~------  221 (256)
T cd08220         158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LKIMSGTFA-P-----I------  221 (256)
T ss_pred             -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HHHHhcCCC-C-----C------
Confidence             12245788999999999888999999999999999999999999765433222   222111110 0     0      


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .......+.+++.+||+.+|.+|||+.|++++
T Consensus       222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            00112356788899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-36  Score=302.73  Aligned_cols=262  Identities=24%  Similarity=0.332  Sum_probs=197.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-----cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-----GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|... +|+.||+|.++.....     ....+..|++++++++|+||+++++++.+ .+..++|
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv   80 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINLV   80 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEEE
Confidence            445678999999999999976 6899999998754332     23456789999999999999999999987 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+ +|+|.+++....  ..+++..+..++.||++||+|||++ |++|+||+|+||+++.++.++|+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 899999997642  3689999999999999999999995 99999999999999999999999999997664432


Q ss_pred             ccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh----cc-----cc
Q 008031          443 NVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE----WT-----NE  512 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~-----~~  512 (580)
                      . ......++..|+|||.+.+ ..++.++|||||||++|||++|..||....+.+....+.......    +.     ..
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            2 1222346778999998754 467889999999999999999988887655433222222111000    00     00


Q ss_pred             ccchhhhccCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          513 VFDLELMRDAP---TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       513 ~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..........+   ........+.+++.+||+.+|++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000   001123567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-36  Score=294.49  Aligned_cols=247  Identities=26%  Similarity=0.428  Sum_probs=196.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-----ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-----KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |...+.||+|+||.||+|... +++.|++|.+.....     +..+.+.+|+++++.++|+||+++++++.. +...+++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv   80 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYIF   80 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEEE
Confidence            345688999999999999987 789999998864321     234568899999999999999999999876 5689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      +||+++++|.+++...   ..+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            9999999999999764   3588999999999999999999994 99999999999999999999999999987654332


Q ss_pred             ccceeeecCccccCCccccccCC-CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          443 NVNVIATAGALGYRAPELSKLKK-ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                        ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......   ..............     .   
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~-----~---  223 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AAVFKIGRSKELPP-----I---  223 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HHHHHHHhcccCCC-----c---
Confidence              122345788899999887766 899999999999999999999999765422   11111111010000     0   


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .+.   ....+.+++.+||+.+|.+||++.+++++
T Consensus       224 ~~~---~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         224 PDH---LSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CCC---cCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            011   12356678889999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-36  Score=295.64  Aligned_cols=251  Identities=23%  Similarity=0.363  Sum_probs=199.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e  364 (580)
                      |...+.||.|+||.||++... ++..||+|.+.....  ...+.+..|++++++++|+||+++++++... ....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            445688999999999999875 788999998864322  2345688899999999999999999987653 345789999


Q ss_pred             eCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          365 YMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLH-----SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       365 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      |+++++|.+++... .....+++..+..++.|++.||+|||     + .+++|+||+|+||++++++.+|++|||++...
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99999999999753 22356899999999999999999999     7 49999999999999999999999999999876


Q ss_pred             ccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          439 TAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..+.+.   ....      +  
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~------~--  228 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK---EGKF------R--  228 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh---cCCC------C--
Confidence            543321 223458889999999998889999999999999999999999998655322222211   1110      0  


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          .........+.+++.+||+.+|++|||+.+++++
T Consensus       229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                0011222467788999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-36  Score=300.98  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=200.5

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      ..|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++.. .+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEEEec
Confidence            34667789999999999999865 788999999865544455678899999999999999999999986 5689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++.+.    .+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-  171 (293)
T cd06647          98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (293)
T ss_pred             CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence            9999999998753    478899999999999999999994 9999999999999999999999999988755433222 


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+..+....+   ......          .....
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~----------~~~~~  238 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTP----------ELQNP  238 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCC----------CCCCc
Confidence            12235788899999998888999999999999999999999999765432211111   000000          01111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ......+.+++.+||+.+|++||++.+++.+-
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~  270 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            11223566888999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.6e-36  Score=296.00  Aligned_cols=248  Identities=21%  Similarity=0.333  Sum_probs=198.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +...+.||+|++|.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++++.. .+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEeccC
Confidence            334579999999999999875 788999998865444445668899999999999999999999876 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++...    .+++..+..++.|++.|++|||+. |++||||+|+||+++.++.++++|||.+........ ...
T Consensus       100 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~  173 (285)
T cd06648         100 GGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK  173 (285)
T ss_pred             CCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence            99999998762    588999999999999999999995 999999999999999999999999998875543222 122


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...|+..|+|||.+.+..++.++||||||+++|||++|+.||...+..   ......... ....      ......   
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~~~~-~~~~------~~~~~~---  240 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIRDN-LPPK------LKNLHK---  240 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHhc-CCCC------Cccccc---
Confidence            345888999999998888999999999999999999999999754332   222222111 1100      001111   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....+.+++.+||+.+|++|||+.+++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            12357788899999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-36  Score=297.94  Aligned_cols=259  Identities=23%  Similarity=0.306  Sum_probs=199.6

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEEEeeC
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLVFDYM  366 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~  366 (580)
                      ...+.||.|++|.||+|.+. +++.+|+|.+..... .....+.+|++++++++||||+++++++... .+..++||||+
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   83 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC   83 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence            44688999999999999985 688999998864433 3346789999999999999999999998653 34689999999


Q ss_pred             CCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          367 PHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       367 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ++++|.+++... .....++...+..++.|++.||+|||+ .+++|+||+|+||++++++.++++|||++......... 
T Consensus        84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-  161 (287)
T cd06621          84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG-  161 (287)
T ss_pred             CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCCeEEEeeccccccccccccc-
Confidence            999999987642 223458889999999999999999999 59999999999999999999999999998754332211 


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCC--CChhHHHHHHhhhhccccccchhhhccCC
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNG--AELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                        ...++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....  ....+......... .     +.......
T Consensus       162 --~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~  233 (287)
T cd06621         162 --TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-N-----PELKDEPG  233 (287)
T ss_pred             --cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-c-----hhhccCCC
Confidence              23467889999999989999999999999999999999999976532  11222222111100 0     11111111


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ........+.+++.+||+.+|.+|||+.|++++-.
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence            11122346778999999999999999999998654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.1e-37  Score=302.01  Aligned_cols=262  Identities=25%  Similarity=0.366  Sum_probs=195.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |+..+.||+|+||.||+|.+. +++.||+|.+......  ..+.+.+|+++++.++||||+++++++.. ++..++||||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   81 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVFEF   81 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEEec
Confidence            456789999999999999986 6899999998654322  24568899999999999999999999976 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.++....   ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++++|||++........ .
T Consensus        82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  156 (286)
T cd07846          82 VDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V  156 (286)
T ss_pred             CCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-c
Confidence            9999888876543   348999999999999999999999 5999999999999999999999999999876543322 2


Q ss_pred             eeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc--cccccc------h
Q 008031          446 VIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW--TNEVFD------L  516 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~------~  516 (580)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+......-.  .....+      .
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            223457888999998765 4578899999999999999999999975443221111111100000  000000      0


Q ss_pred             hhhccCC-------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAP-------TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .......       ..+.....+.+++.+||+.+|++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000       001123457789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.7e-36  Score=294.10  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=200.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |+..+.||+|+||.||++.+. +++.||+|.+..... ....++.+|++++++++||||+++++++.. ++..++++||+
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~   81 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICMEYM   81 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEEec
Confidence            456788999999999999987 689999999865433 344678899999999999999999999987 57899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++....  ..++...+.+++.|++.|++|||+..+++|+||+|+||++++++.++|+|||.+.......... 
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~-  158 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-  158 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc-
Confidence            9999999998642  4688999999999999999999982399999999999999999999999999987553322211 


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCC--CChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNG--AELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                        ..++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....  ....+.+..........      .    +.
T Consensus       159 --~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~----~~  226 (265)
T cd06605         159 --FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR------L----PS  226 (265)
T ss_pred             --ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC------C----Ch
Confidence              5678899999999988999999999999999999999999975431  22223333222211100      0    00


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       .....++.++|.+||..+|++|||+.+++.+
T Consensus       227 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         227 -GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence             0022356788899999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.1e-36  Score=294.70  Aligned_cols=249  Identities=21%  Similarity=0.326  Sum_probs=192.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-----ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-----KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~l  361 (580)
                      |++.+.||+|+||.||.|... +|+.||+|.+.....     .....+.+|++++++++||||+++++++.+.. ...++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            456789999999999999976 689999998753221     12346788999999999999999999886533 45789


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +|||+++++|.+++...   ..+++....+++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          84 FMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            99999999999998764   357888999999999999999999 59999999999999999999999999998755321


Q ss_pred             cc--cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 AN--VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..  .......++..|+|||.+.+..++.++||||||+++|||++|+.||......   ..+........     .    
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~-----~----  227 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPT-----N----  227 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHHHHhcCCC-----C----
Confidence            11  1122345788999999998888999999999999999999999999754321   11111111110     0    


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ..........+.+++.+||. +|++||+++|++++
T Consensus       228 --~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         228 --PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence              00111222356678888884 99999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.7e-36  Score=294.30  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=198.3

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|...+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.++++++||||+++++++.. +...++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEe
Confidence            3567789999999999999875 688999998764432 234568899999999999999999999987 5689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...    .+++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++.++++|||++........ .
T Consensus        84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06641          84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence            9999999998753    58899999999999999999999 4999999999999999999999999999876543221 1


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+   ......      ..      .
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~------~~------~  222 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI---PKNNPP------TL------E  222 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH---hcCCCC------CC------C
Confidence            22345788899999998888999999999999999999999999765432222211   111100      00      0


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......+.+++.+||+.+|.+||++.+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1112356688899999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.9e-36  Score=290.85  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=204.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|++|.||+|... +++.|++|++..... .....+.+|+..+.+++|+|++++++++.. .+..++||||+
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~   81 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLEYM   81 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEEec
Confidence            445689999999999999987 599999999876543 345678999999999999999999999987 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS-NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ++++|.+++...   ..+++..+..++.|+++|++|||+ . +++|+||+|+||+++.++.++++|||.+..........
T Consensus        82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            999999999864   468999999999999999999998 6 99999999999999999999999999988664433221


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........+....+.......            ..
T Consensus       158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~  224 (264)
T cd06623         158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS------------LP  224 (264)
T ss_pred             -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC------------CC
Confidence             23457788999999998899999999999999999999999997765433333333332211100            00


Q ss_pred             HH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GD-ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~-~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .. ....+.+++.+||+.+|++|||+.+++++
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            01 22467788889999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=300.00  Aligned_cols=263  Identities=23%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|.++....  .....+.+|++++++++|+||+++++++.. ++..+++|||
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~   81 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFEY   81 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEec
Confidence            456788999999999999986 688999999865432  234678899999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ++++.+..+....   ..+++..+..++.||+.|++|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus        82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            9887666655442   3588999999999999999999995 99999999999999999999999999988765543322


Q ss_pred             eeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---cc-ccchhhhc
Q 008031          446 VIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NE-VFDLELMR  520 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~  520 (580)
                      .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..............   .. ..+....+
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            2334578889999998877 8899999999999999999999999765433222222111110000   00 00000000


Q ss_pred             ----cC--C------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          521 ----DA--P------TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       521 ----~~--~------~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          ..  +      .......++.+++.+||+.+|++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                00  0      000013467789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.5e-36  Score=296.40  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=193.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEEC-----CCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLG-----PKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~~  360 (580)
                      .|++.+.||+|+||.||+|.+. +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..     .....+
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            3566789999999999999985 68899999875432 2345678899999998 79999999999863     234689


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      ++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus        96 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~  173 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence            9999999999999987643 3357888899999999999999999 5999999999999999999999999999875532


Q ss_pred             ccccceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          441 AANVNVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ... ......|+..|+|||.+.     +..++.++|||||||++|||++|+.||......+...   .......      
T Consensus       174 ~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~------  243 (282)
T cd06636         174 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---LIPRNPP------  243 (282)
T ss_pred             ccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---hHhhCCC------
Confidence            221 122345888999999875     3567889999999999999999999996543221111   1100000      


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...     .......++.+++.+||+.||.+|||+.|++++
T Consensus       244 ~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         244 PKL-----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             CCC-----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            000     001122367789999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.2e-36  Score=299.29  Aligned_cols=253  Identities=19%  Similarity=0.258  Sum_probs=194.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||++... +++.||+|.+.....   .....+.+|+++++.++||||+++++.+.. ++..++|||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   81 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMVME   81 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEEEe
Confidence            445688999999999999986 688999999865432   223467899999999999999999999876 568899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  443 (580)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+|++|||+++....... 
T Consensus        82 ~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          82 YVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            99999999999764   3588999999999999999999995 999999999999999999999999998864211100 


Q ss_pred             -------------cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc
Q 008031          444 -------------VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT  510 (580)
Q Consensus       444 -------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  510 (580)
                                   .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.+....+..   .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~---~~~~~~~~~  234 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF---GQVISDDIE  234 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcccC
Confidence                         0011234678899999998888999999999999999999999999765432222   221111100


Q ss_pred             ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                          .+.   ....   ....+.+++.+||+.+|++||++.++.+.|+.
T Consensus       235 ----~~~---~~~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         235 ----WPE---GDEA---LPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ----CCC---cccc---CCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                000   0011   12246688889999999999996555544444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.1e-36  Score=298.73  Aligned_cols=244  Identities=24%  Similarity=0.325  Sum_probs=197.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||++.+. +++.||+|.+.....   .....+.+|++++++++||||+++++++.. ....++|||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   81 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLVME   81 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEEEe
Confidence            456789999999999999986 689999999864322   234568899999999999999999999986 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++...   ..++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++......   
T Consensus        82 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          82 YVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            99999999999775   368899999999999999999999 59999999999999999999999999998866443   


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+..+   .+.....       ..   ...
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~-------~~---~~~  220 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE---KILEGKV-------RF---PSF  220 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhcCCc-------cC---Ccc
Confidence             223457889999999988888999999999999999999999997654221111   1111110       00   011


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQL  557 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~L  557 (580)
                      .   ...+.+++.+||..||.+||     ++.|++++-
T Consensus       221 ~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~  255 (290)
T cd05580         221 F---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP  255 (290)
T ss_pred             C---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence            1   23566788899999999999     777887653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.9e-36  Score=296.95  Aligned_cols=252  Identities=27%  Similarity=0.401  Sum_probs=194.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCC----CcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPK----GEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----~~~~lv  362 (580)
                      |.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...+    +..++|
T Consensus        24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            455688999999999999985 78899999986432 2345678899999999 8999999999987532    358999


Q ss_pred             EeeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          363 FDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      |||+++++|.++++.. .....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~  181 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST  181 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence            9999999999988642 123468999999999999999999999 59999999999999999999999999998765432


Q ss_pred             cccceeeecCccccCCccccccC-----CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          442 ANVNVIATAGALGYRAPELSKLK-----KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      ... .....++..|+|||.+...     .++.++|||||||++|||++|+.||......+.   +..+.... .....  
T Consensus       182 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~~~~~~-~~~~~--  254 (291)
T cd06639         182 RLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFKIPRNP-PPTLL--  254 (291)
T ss_pred             ccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHHHhcCC-CCCCC--
Confidence            211 1224578899999987543     367899999999999999999999976543221   11111110 00000  


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                             ........+.+++.+||+.+|++|||+.|++++
T Consensus       255 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         255 -------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                   011122357789999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-36  Score=294.67  Aligned_cols=248  Identities=25%  Similarity=0.420  Sum_probs=196.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCC---CCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIR---HPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.++++++   |||++++++++.. +...++||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv~   81 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWIIM   81 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEEE
Confidence            456788999999999999975 789999999865432 33456889999999996   9999999999876 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++++|.++++..    .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++++|||++........
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998653    58899999999999999999999 5999999999999999999999999999886654332


Q ss_pred             cceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          444 VNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                       ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+   ...      ..+.+... 
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~~~------~~~~~~~~-  225 (277)
T cd06917         157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---PKS------KPPRLEDN-  225 (277)
T ss_pred             -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc---ccC------CCCCCCcc-
Confidence             2223468889999998765 45688999999999999999999999764432211111   000      00111000 


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                          ....++.+++.+||+.||++||++.+++++-
T Consensus       226 ----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~  256 (277)
T cd06917         226 ----GYSKLLREFVAACLDEEPKERLSAEELLKSK  256 (277)
T ss_pred             ----cCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence                0223667888999999999999999998853

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-36  Score=300.50  Aligned_cols=260  Identities=24%  Similarity=0.307  Sum_probs=192.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|.+. +|+.||+|.++....  .....+.+|++++++++|+||+++++++.+ ....++++||
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   80 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFEY   80 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEec
Confidence            455688999999999999986 789999999864322  223567889999999999999999999976 5689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ++ ++|.+++....  ..+++..+..++.||++||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~  155 (284)
T cd07839          81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C  155 (284)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence            96 58888876542  458999999999999999999999 5999999999999999999999999999876543221 1


Q ss_pred             eeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh---cc------ccccc
Q 008031          446 VIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE---WT------NEVFD  515 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~------~~~~~  515 (580)
                      .....++..|+|||.+.+. .++.++||||+||++|+|++|+.||......  ......+....   ..      ....+
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            1223567889999987664 4789999999999999999999886443221  11111111100   00      00000


Q ss_pred             hhhhccCC-------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 LELMRDAP-------TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ~~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .......+       ..+....++.+++.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00000000       001122456688999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.5e-36  Score=293.22  Aligned_cols=245  Identities=25%  Similarity=0.343  Sum_probs=191.7

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ||+|+||+||++... +|+.||+|.+.....   .....+..|++++++++||||+++++.+.. .+..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence            699999999999876 789999999864322   223456789999999999999999999876 568999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeec
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA  450 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  450 (580)
                      |.+++..... ..+++..+..++.|++.|+.|||+. |++|+||+|+||++++++.++++|||.+.......  ......
T Consensus        80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            9999976542 4689999999999999999999994 99999999999999999999999999987654321  122345


Q ss_pred             CccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHH
Q 008031          451 GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL  530 (580)
Q Consensus       451 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  530 (580)
                      ++..|+|||.+.+..++.++||||+|+++|+|++|+.||...........+.......      ....   ...   ...
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~---~~~---~~~  223 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM------AVEY---PDK---FSP  223 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc------cccC---Ccc---CCH
Confidence            7788999999988889999999999999999999999997654422222221111100      0000   011   123


Q ss_pred             HHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          531 NTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       531 ~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      .+.+++.+||+.+|++||     ++.+++++
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            566888899999999999     66667654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=301.86  Aligned_cols=251  Identities=25%  Similarity=0.305  Sum_probs=197.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |+..+.||+|+||.||+|... +++.||+|.+......   ..+.+..|+++++.++|+||+++++.+.. ....++|||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   81 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLVMD   81 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEEEE
Confidence            455688999999999999986 5899999998654322   34568899999999999999999999876 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+.+++|.+++.... ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          82 YCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             ecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            999999999987532 3468999999999999999999999 59999999999999999999999999998654322110


Q ss_pred             ----------------------------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC
Q 008031          445 ----------------------------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE  496 (580)
Q Consensus       445 ----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~  496 (580)
                                                  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                        0112357888999999998889999999999999999999999997654332


Q ss_pred             hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 008031          497 LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPE----VLQVVQQ  556 (580)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps----~~ev~~~  556 (580)
                      ..   ..+......           .+........+.+++.+||+.+|++|||    +.|++++
T Consensus       240 ~~---~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         240 TF---SNILKKEVT-----------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HH---HHHhcCCcc-----------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            21   111111100           1111112346778888999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.2e-36  Score=297.04  Aligned_cols=247  Identities=19%  Similarity=0.322  Sum_probs=197.1

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      .....||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|+|++++++++.. .+..+++|||+++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~  101 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEG  101 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCC
Confidence            34578999999999999875 789999999865444455678899999999999999999999986 6689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      ++|.+++...    .+++..+..++.|++.|++|||+. |++|+||+|+||++++++.++++|||++........ ....
T Consensus       102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~  175 (292)
T cd06657         102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS  175 (292)
T ss_pred             CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence            9999987542    478999999999999999999995 999999999999999999999999998875543222 1223


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......+....+.    .....     .. .....   .
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~----~~~~~-----~~-~~~~~---~  242 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----DNLPP-----KL-KNLHK---V  242 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hhCCc-----cc-CCccc---C
Confidence            457889999999988889999999999999999999999997644322222221    11110     00 00111   1


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          529 LLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...+.+++.+||+.+|.+||++.+++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            2245678889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-36  Score=298.00  Aligned_cols=261  Identities=22%  Similarity=0.359  Sum_probs=193.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |+..+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++.+ +...++||||+
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   85 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFEYL   85 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEecC
Confidence            456789999999999999986 7899999998654322 23457789999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      .+ +|.+++....  ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+|++|||+++....... ..
T Consensus        86 ~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~  160 (291)
T cd07844          86 DT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TY  160 (291)
T ss_pred             CC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-cc
Confidence            74 9999887643  3688999999999999999999994 999999999999999999999999999865432211 11


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-ChhHHHHHHhhhhcccc------------
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGA-ELPQWVASIVKEEWTNE------------  512 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~------------  512 (580)
                      ....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... +....+...........            
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            12346778999998765 55889999999999999999999999654421 11111111100000000            


Q ss_pred             -----ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          513 -----VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       513 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                           ..........+.. .....+.+++.+||+.+|++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         241 YSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                 0000000000111 112466789999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.4e-36  Score=296.56  Aligned_cols=263  Identities=24%  Similarity=0.327  Sum_probs=196.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLLVF  363 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~  363 (580)
                      .|+..+.||+|+||.||+|.+. +++.+|+|.++.....  ....+.+|+.++++++||||+++++++...+ ...++||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            3667899999999999999987 6889999998644322  2335678999999999999999999987632 6899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||++ ++|.+++....  ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus        86 e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          86 EYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             hhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            9996 59999887643  3589999999999999999999994 999999999999999999999999999886654321


Q ss_pred             cceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh--------------
Q 008031          444 VNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE--------------  508 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------------  508 (580)
                       ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+....+.......              
T Consensus       162 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         162 -PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             -ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence             11234567889999987654 46889999999999999999999998655433222221111000              


Q ss_pred             ---ccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          509 ---WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       509 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ..............+.. .....+.+++.+||+.+|++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence               00000000000011110 013356688889999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-35  Score=297.18  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=195.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+.+++.++||||+++.+++.. ++..++|||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~e   95 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWLVME   95 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEEEHH
Confidence            666789999999999999876 689999998864322   223468899999999999999999999986 568899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+. |++.+++....  ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......  
T Consensus        96 ~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~--  169 (307)
T cd06607          96 YCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--  169 (307)
T ss_pred             hhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCCCEEEeecCcceecCCCC--
Confidence            996 57877776432  358999999999999999999999 599999999999999999999999999987543321  


Q ss_pred             ceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          445 NVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                         ...++..|+|||.+.   ...++.++||||||+++|||++|+.||...+....   ...+......      ..   
T Consensus       170 ---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~------~~---  234 (307)
T cd06607         170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNDSP------TL---  234 (307)
T ss_pred             ---CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHHHhcCCCC------CC---
Confidence               235778899999874   46688899999999999999999999875543221   1111111100      00   


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                        ........+.+++.+||+.+|++||++.+++.+..-.+
T Consensus       235 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         235 --SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             --CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence              01112346778999999999999999999998765433

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=273.39  Aligned_cols=266  Identities=23%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             eeeCCCcccCHHHHHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCC-CCcceeeee
Q 008031          274 VHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIR-HPNLLALRA  350 (580)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~  350 (580)
                      +...+...+..+-........||.|..|.||++.+. +|..+|||.+..... ...+++...++++...+ +|+||+.+|
T Consensus        79 lti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~G  158 (391)
T KOG0983|consen   79 LTIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFG  158 (391)
T ss_pred             EEecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence            333333334444444566788999999999999987 689999999976543 33456777888877764 899999999


Q ss_pred             EEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       351 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                      ||.. +...++.||.| ...+..+++..  ..++++.-+-++...+.+||.||..+.+|+|||+||+|||+|+.|++|+|
T Consensus       159 yFi~-n~dV~IcMelM-s~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  159 YFIT-NTDVFICMELM-STCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             EEee-CchHHHHHHHH-HHHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEee
Confidence            9997 56788999999 44666666654  35688888889999999999999886799999999999999999999999


Q ss_pred             ecccccccccccccceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh
Q 008031          431 DFGLSRLMTAAANVNVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE  507 (580)
Q Consensus       431 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  507 (580)
                      |||++-.+.+....  ...+|.+.|||||.+.   ...|+.++||||||+.++||.||+.||.+.+.+  .+.+.++..+
T Consensus       235 DFGIsGrlvdSkAh--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln~  310 (391)
T KOG0983|consen  235 DFGISGRLVDSKAH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLNE  310 (391)
T ss_pred             cccccceeeccccc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHhc
Confidence            99999776544322  2356889999999875   457889999999999999999999999874322  2223333332


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      +.+      .+....    .-...+.+++..||..|+.+||...++++|=
T Consensus       311 ePP------~L~~~~----gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  311 EPP------LLPGHM----GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             CCC------CCCccc----CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            221      111110    1234677889999999999999999998763

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.6e-36  Score=293.01  Aligned_cols=247  Identities=23%  Similarity=0.290  Sum_probs=198.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||.|+||.||+|.+. +++.||+|.+.....   ...+.+.+|++++++++||||+++++++.+ ....++|+|
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   80 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVVD   80 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEEe
Confidence            456789999999999999986 689999999865432   235678999999999999999999999876 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++...   ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++++|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999764   3688999999999999999999995 99999999999999999999999999987654332  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.............. ....  ..    .   ... 
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~--~~----~---~~~-  223 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETA--DV----L---YPA-  223 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-hccc--cc----c---Ccc-
Confidence            22234578889999999888899999999999999999999999987654322222221 1110  00    0   011 


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCH--HHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEV--LQVVQ  555 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~--~ev~~  555 (580)
                        .....+.+++.+||+.||.+||++  +|+++
T Consensus       224 --~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         224 --TWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             --cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence              112466788899999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=278.74  Aligned_cols=267  Identities=24%  Similarity=0.392  Sum_probs=202.3

Q ss_pred             HHHHHHhhhccccccCceEEEEEE-eCCCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEE
Q 008031          284 ADDLLCATAEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       284 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  361 (580)
                      ..++..-+.+.+|+|+|+.|-.+. ..+|.++|||++.+........+.+|++++.+. .|+||+++++||.+ +..+|+
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d~~FYL  153 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED-DTRFYL  153 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-cceEEE
Confidence            344444468899999999998886 468999999999877666677899999999999 59999999999987 778999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC---CeEEeeccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---NAKISDFGLSRLM  438 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~---~~kl~Dfg~~~~~  438 (580)
                      |||-|.||+|.++++++   ..+++.++.++.++|+.||.+||. +||.|||+||+|||..+..   -+|||||.+..-.
T Consensus       154 VfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             EEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            99999999999999885   379999999999999999999999 5999999999999997654   4899999886533


Q ss_pred             c------cccccceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCC-------CChhHH
Q 008031          439 T------AAANVNVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNG-------AELPQW  500 (580)
Q Consensus       439 ~------~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~-------~~~~~~  500 (580)
                      .      ........+.+|+..|||||+..     ...|+.+.|.||+||++|-|++|.+||.+.-+       .+.-..
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~  309 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV  309 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence            2      12223344557888999999743     34678899999999999999999999976432       222111


Q ss_pred             -----HHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcccc
Q 008031          501 -----VASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPEA  564 (580)
Q Consensus       501 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~~  564 (580)
                           ..++..+.+  + +..   .++..+.+   +..+++...+..|+..|.++.+++++  ..++.++.
T Consensus       310 CQ~~LFesIQEGkY--e-FPd---kdWahIS~---eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek  371 (463)
T KOG0607|consen  310 CQNKLFESIQEGKY--E-FPD---KDWAHISS---EAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK  371 (463)
T ss_pred             HHHHHHHHHhccCC--c-CCh---hhhHHhhH---HHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence                 112222111  0 000   11222223   34456667777999999999999984  34444443

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-36  Score=293.06  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=196.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCC-----CcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      .|++.+.||+|+||.||+|... +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....     ...+
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            3667899999999999999986 678999998865432 346789999999999 7999999999997522     2479


Q ss_pred             EEEeeCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          361 LVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      +||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+|++|||++....
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  164 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD  164 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence            9999999999999986532 23568999999999999999999999 499999999999999999999999999987554


Q ss_pred             cccccceeeecCccccCCcccccc-----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccccc
Q 008031          440 AAANVNVIATAGALGYRAPELSKL-----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF  514 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      .... ......++..|+|||.+..     ..++.++||||||+++|+|++|+.||........   ...+..... ..  
T Consensus       165 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~-~~--  237 (275)
T cd06608         165 STLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA---LFKIPRNPP-PT--  237 (275)
T ss_pred             cchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH---HHHhhccCC-CC--
Confidence            3222 2223457889999998643     3567899999999999999999999975433221   111111110 00  


Q ss_pred             chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       515 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                             ..........+.+++.+||..||++|||+.+++++
T Consensus       238 -------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         238 -------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                   11111123467789999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.1e-36  Score=300.01  Aligned_cols=266  Identities=27%  Similarity=0.343  Sum_probs=197.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc--HHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG--QREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||+|.++......  ...+.+|+.++++++|+||+++++++.... +..++|||
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME   88 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence            556789999999999999986 68999999986443222  234678999999999999999999987633 46899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |++ ++|.+++....  ..+++.++..++.|++.||+|||+. |++||||+|+||++++++.+||+|||++........ 
T Consensus        89 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-  163 (309)
T cd07845          89 YCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-  163 (309)
T ss_pred             cCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence            996 48888887542  4689999999999999999999994 999999999999999999999999999986643321 


Q ss_pred             ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc---c------
Q 008031          445 NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV---F------  514 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~------  514 (580)
                      ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+...........+   .      
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            1122345778999998765 56789999999999999999999999866544433333222111000000   0      


Q ss_pred             chhhhccC-CCc----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          515 DLELMRDA-PTI----GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       515 ~~~~~~~~-~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ........ ...    ......+.+++.+||+.||++|||+.|++++-.-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence            00000000 000    0113456789999999999999999999987544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-35  Score=294.19  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=200.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||.||+|.+. ++..|++|.+..... ....+.+|++.+++++|+|++++++++.. ....++++||++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~   98 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVVMEYMD   98 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEEEeccC
Confidence            455688999999999999987 789999999875433 45678899999999999999999999987 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++....  ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        99 ~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~  174 (286)
T cd06614          99 GGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRN  174 (286)
T ss_pred             CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhc
Confidence            999999998753  368999999999999999999999 5999999999999999999999999998865543221 112


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....   ...+...... .         ......
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-~---------~~~~~~  241 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LFLITTKGIP-P---------LKNPEK  241 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcCCC-C---------Ccchhh
Confidence            33577889999999888899999999999999999999999975443221   1111111110 0         000001


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ....+.+++.+||+.+|.+|||+.+++++-
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            123566788999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=279.36  Aligned_cols=246  Identities=23%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccH---HHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQ---REFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +...+++|+|.||.|-.++-+ +|+.+|+|++++...-..   .....|-++|...+||.+..+...++. ++..|+|||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-~drlCFVMe  248 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-QDRLCFVME  248 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-CceEEEEEE
Confidence            456799999999999999876 899999999987754333   346789999999999999999888887 679999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |..||.|.-+|...   ..++++..+.+...|..||.|||+ ++||+||+|.+|.|+|.+|++||+|||+++.--. ...
T Consensus       249 yanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~  323 (516)
T KOG0690|consen  249 YANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGD  323 (516)
T ss_pred             EccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCceEeeecccchhccc-ccc
Confidence            99999999888763   479999999999999999999999 5999999999999999999999999999975332 233


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ....++||+.|+|||++....|+.++|.|.+||++|||++|+.||...+...+...+-.   +       |.+.   +..
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~---e-------d~kF---Pr~  390 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM---E-------DLKF---PRT  390 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh---h-------hccC---Ccc
Confidence            45568999999999999999999999999999999999999999988776655554432   1       1111   112


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ..+   +...|+...|..||.+|.     .++||.++
T Consensus       391 ls~---eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  391 LSP---EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             CCH---HHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            223   344566688889999996     34555443

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-35  Score=293.10  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=191.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHH-HhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSL-LGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |++.+.||+|+||.||+|.+. +|+.||+|.++.... .....+..|+.. ++.++||||+++++++.. ++..+++|||
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e~   81 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICMEV   81 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEhhh
Confidence            455688999999999999986 799999999865432 234455666665 566799999999999986 6689999999


Q ss_pred             CCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ++ |+|.+++... .....+++..+..++.||+.||+|||++.+++||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-  159 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc-
Confidence            96 6888888653 23356899999999999999999999844899999999999999999999999999876543221 


Q ss_pred             ceeeecCccccCCcccccc----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          445 NVIATAGALGYRAPELSKL----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                       .....++..|+|||.+.+    ..++.++|+||+||++|+|++|+.||.....  ..+.+.........      ... 
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~------~~~-  229 (283)
T cd06617         160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSP------QLP-  229 (283)
T ss_pred             -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCC------CCC-
Confidence             122457888999998764    4568899999999999999999999965332  11222222111110      000 


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                       ..   ....++.+++.+||+.+|++|||+.+++++-
T Consensus       230 -~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  262 (283)
T cd06617         230 -AE---KFSPEFQDFVNKCLKKNYKERPNYPELLQHP  262 (283)
T ss_pred             -cc---ccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence             00   1123567889999999999999999998853

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8e-36  Score=294.59  Aligned_cols=260  Identities=21%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCC-CCcceeeeeEEECCC-CcEEEEEee
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIR-HPNLLALRAYYLGPK-GEKLLVFDY  365 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~~lv~e~  365 (580)
                      .+.+.||+|+||.||+|... +++.||+|.++.... .......+|+.+++++. |+|++++++++.+.. +..++||||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            45688999999999999975 789999999875432 22334567999999985 999999999998731 678999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ++ +++.+++....  ..+++.++..++.|++.||+|||+. |++||||+|+||+++. +.+||+|||+++........ 
T Consensus        82 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~-  155 (282)
T cd07831          82 MD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY-  155 (282)
T ss_pred             CC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence            96 58888887542  4689999999999999999999995 9999999999999999 99999999999765433222 


Q ss_pred             eeeecCccccCCccccc-cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc--------ccccch
Q 008031          446 VIATAGALGYRAPELSK-LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT--------NEVFDL  516 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~  516 (580)
                       ....++..|+|||.+. +..++.++||||+||++|||++|+.||...+..+....+.........        ....+.
T Consensus       156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence             1235788999999754 456788999999999999999999999776544433333322111000        000000


Q ss_pred             hhhccC-----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDA-----PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......     .........+.+++.+||+.+|++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000     0001223577889999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-35  Score=289.23  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=194.9

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ||.|+||.||+|... +++.||+|.+.....   ...+.+.+|+.++++++||||+++++++.+ +...++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence            699999999999986 589999999865432   234578999999999999999999999876 668999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeec
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA  450 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  450 (580)
                      |.+++.+.   ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++++|||.+.......  ......
T Consensus        80 L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          80 LWTILRDR---GLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            99999764   358899999999999999999999 599999999999999999999999999988664432  122345


Q ss_pred             CccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHH
Q 008031          451 GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL  530 (580)
Q Consensus       451 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  530 (580)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... +.......+..+....         ..+.  ....
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~---------~~~~--~~~~  221 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKL---------EFPN--YIDK  221 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCC---------CCCc--ccCH
Confidence            78899999999888899999999999999999999999976653 2223233222111000         0111  1123


Q ss_pred             HHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 008031          531 NTLKLALHCVDPSPSARPE-----VLQVVQQ  556 (580)
Q Consensus       531 ~l~~li~~cl~~~P~~Rps-----~~ev~~~  556 (580)
                      ++.+++.+||+.+|++||+     ++|++++
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            6778899999999999999     7777763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.9e-36  Score=294.88  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=192.8

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEeeC
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      ...+.||+|+||.||++.+. +++.||+|.+..... .....+.+|+.++.++. |+||+++++++.. ++..+++|||+
T Consensus         7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e~~   85 (288)
T cd06616           7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICMELM   85 (288)
T ss_pred             HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEecc
Confidence            45678999999999999976 689999999864332 34457889999999996 9999999999876 66889999998


Q ss_pred             CCCChhhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          367 PHGSLATFLHAR--GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       367 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      . +++.++....  .....+++..+..++.|++.||+|||+..+++||||||+||+++.++.+||+|||++.........
T Consensus        86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  164 (288)
T cd06616          86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK  164 (288)
T ss_pred             c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence            5 4665543211  113468999999999999999999997459999999999999999999999999998755432211


Q ss_pred             ceeeecCccccCCccccccC---CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          445 NVIATAGALGYRAPELSKLK---KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                        ....++..|+|||.+.+.   .++.++||||+||++|+|++|+.||....  ...+.+.........      .+.. 
T Consensus       165 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~------~~~~-  233 (288)
T cd06616         165 --TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP------ILSN-  233 (288)
T ss_pred             --ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC------cCCC-
Confidence              223578889999998766   68899999999999999999999997644  222222222211111      1110 


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ........++.+++.+||+.+|++|||+.+++++
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         234 -SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0101223467789999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-35  Score=293.27  Aligned_cols=260  Identities=22%  Similarity=0.272  Sum_probs=191.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++|+||+++++++.. ++..++||||+
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~   85 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFVFEYM   85 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEEEecc
Confidence            445789999999999999875 6899999998654332 23467889999999999999999999986 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      . +++.+++...  ...+.+..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++........ .
T Consensus        86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~  160 (291)
T cd07870          86 H-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-Y  160 (291)
T ss_pred             c-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-C
Confidence            5 6887777543  23577888999999999999999995 9999999999999999999999999998754332211 1


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh--hc----------cccc
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE--EW----------TNEV  513 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~----------~~~~  513 (580)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..  ...+......  ..          ....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            22346889999998865 45788999999999999999999999765431  1111111100  00          0000


Q ss_pred             cchhhhccCCCc-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 FDLELMRDAPTI-------GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 ~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .+.......+..       ......+.+++.+|+..||.+|||+.|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000000000000       0112356688899999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.9e-35  Score=295.49  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=199.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|... ++..||+|.+.....   .....+.+|++++++++|+|++++++++.. +...++|||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  105 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVME  105 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEEe
Confidence            566789999999999999975 688999999864322   223468889999999999999999999986 567899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+. |++.+.+...  ...+++.++..++.|++.|+.|||+ .+++||||+|+||+++.++.+|++|||++......   
T Consensus       106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            996 5888877543  2458999999999999999999999 49999999999999999999999999988754322   


Q ss_pred             ceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          445 NVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                        ....++..|+|||.+.   .+.++.++|||||||++|||++|+.||...+....   ...+.......          
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~~~~~~----------  243 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNESPT----------  243 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHhccCCC----------
Confidence              1235788899999873   46788999999999999999999999876432222   22222211100          


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                       .........+.+++.+||+.+|.+||++.++++++..+......
T Consensus       244 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         244 -LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             -CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence             00111223567888899999999999999999998776655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.5e-36  Score=294.74  Aligned_cols=264  Identities=23%  Similarity=0.352  Sum_probs=198.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||.|++|.||+|... +|..||+|.++..... ....+.+|++++++++|+||+++++++.. .+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   80 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEYM   80 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEecC
Confidence            445789999999999999986 6889999998754332 34567789999999999999999999987 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++ +|.+++........+++..+..++.|++.||+|||+ .|++||||+|+||++++++.++++|||++........ ..
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence            75 899988765545578999999999999999999999 4999999999999999999999999999875533221 11


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---ccccc-hhhhcc
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEVFD-LELMRD  521 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~  521 (580)
                      ....++..|++||.+.+ ..++.++||||+|+++|+|++|+.||...+..+....+.........   ..... +.....
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            22346788999998765 45788999999999999999999999866543322222111100000   00000 000000


Q ss_pred             CCC---------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APT---------IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~---------~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .+.         .+.....+.+++.+||+.||.+||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000         01112456789999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-35  Score=286.67  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=201.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |+..+.||+|++|.||++... ++..+++|++..........+.+|++.+++++|+|++++++++.. +...++++||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~   80 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFCS   80 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecCC
Confidence            345688999999999999986 788999999976655456789999999999999999999999976 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++....  ..+++..+..++.|++.|+.|||+ .|++|+||+|+||++++++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            999999987642  468999999999999999999999 5999999999999999999999999999876654332  22


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+......   . ......         +....
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~-~~~~~~---------~~~~~  222 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T-NGPPGL---------RNPEK  222 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h-cCCCCc---------Ccccc
Confidence            3457889999999988889999999999999999999999997654222111111   1 100000         00000


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....+.+++.+||+.||++|||+.+++++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            12357788889999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=274.59  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECC---CCcEEEEEeeC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM  366 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~---~~~~~lv~e~~  366 (580)
                      .++||-|-.|.|-.+..+ +|+.+|+|++...     ....+|++..-.. .|||||.+++++...   ...+.+|||.|
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            478999999999999876 8999999998643     3346677765544 799999999988642   33567999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC---CCCCeEEeecccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD---DSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      +||.|.+.+..++ .+.+++.++..|+.||+.|+.|||+. +|.||||||+|+|.+   .+..+|++|||+|+.....  
T Consensus       142 eGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~--  217 (400)
T KOG0604|consen  142 EGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP--  217 (400)
T ss_pred             cchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccccCCC--
Confidence            9999999999876 56799999999999999999999995 999999999999997   4556999999999875542  


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ....+..-|+.|.|||++...+|+...|+||+||++|-|++|.+||.......+.--++..+..+....        ..+
T Consensus       218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F--------P~p  289 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF--------PEP  289 (400)
T ss_pred             ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC--------CCh
Confidence            233345678999999999999999999999999999999999999988776655555554433221110        112


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ....-.+...++|+.+|..+|.+|.|+.+++.+=+-
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            222334556678889999999999999999987543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-35  Score=291.44  Aligned_cols=243  Identities=23%  Similarity=0.323  Sum_probs=186.1

Q ss_pred             cccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHh---cCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          294 IMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLG---KIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      +||+|+||.||++... +++.+|+|.+......   ....+.+|..+++   ..+||||+.+++++.. ++..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence            4899999999999975 6899999988653221   1223444544333   3479999999999876 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++|+|.+++...   ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++++|||++........   
T Consensus        80 ~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---  152 (279)
T cd05633          80 NGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (279)
T ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence            999999998764   358999999999999999999999 4999999999999999999999999999875533221   


Q ss_pred             eeecCccccCCccccc-cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          447 IATAGALGYRAPELSK-LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      ....|+..|+|||.+. +..++.++||||+||++|+|++|..||.......... +......      ....+      .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~------~~~~~------~  219 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT------VNVEL------P  219 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhc------CCcCC------c
Confidence            2345889999999886 4568899999999999999999999997654433221 1111100      00011      0


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARP-----EVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~L  557 (580)
                      .....++.+++.+||+.||.+||     |++++++|-
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            11123566788899999999999     699999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-35  Score=314.05  Aligned_cols=265  Identities=14%  Similarity=0.212  Sum_probs=184.9

Q ss_pred             HHhhhccccccCceEEEEEEeCC--CCEEEEEE--------------ccc---cccccHHHHHHHHHHHhcCCCCcceee
Q 008031          288 LCATAEIMGKSTYGTVYKATLED--GSQVAVKR--------------LRE---KITKGQREFESEVSLLGKIRHPNLLAL  348 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~  348 (580)
                      .|.+.+.||+|+||.||++..+.  +..++.|.              +..   ........+.+|+.++++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            47778999999999999987642  22222221              111   111223467899999999999999999


Q ss_pred             eeEEECCCCcEEEEEeeCCCCChhhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC
Q 008031          349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGP--ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN  426 (580)
Q Consensus       349 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~  426 (580)
                      ++++.. .+..++|+|++. ++|.+++.....  ........+..++.||+.||+|||+. ||+||||||+|||++.++.
T Consensus       229 ~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        229 EEILRS-EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             eEEEEE-CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCC
Confidence            999987 567899999994 577777654311  12234567788999999999999994 9999999999999999999


Q ss_pred             eEEeecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCC-CCCCCCCChhHHHHHHh
Q 008031          427 AKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP-GEPLNGAELPQWVASIV  505 (580)
Q Consensus       427 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p-~~~~~~~~~~~~~~~~~  505 (580)
                      +||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ |..... .....+.+++
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~~~~~~  384 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQLLKII  384 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHHHHHHH
Confidence            99999999987654433333446799999999999999999999999999999999998754 433322 2222222211


Q ss_pred             hh------hccc------cccchhhhccC-CCcHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          506 KE------EWTN------EVFDLELMRDA-PTIGDE------LLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       506 ~~------~~~~------~~~~~~~~~~~-~~~~~~------~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..      +...      ..++....... ......      ...+.+++.+||+.||++|||+.|++++
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            10      0000      00000000000 000011      1245567889999999999999999986

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.2e-35  Score=299.13  Aligned_cols=269  Identities=22%  Similarity=0.332  Sum_probs=197.9

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCC-CcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPK-GEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+. +|+.+|+|++....  ......+.+|+.+++++ +||||+++++++...+ ...++|
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv   87 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV   87 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence            4677899999999999999986 68899999885432  22334577899999999 9999999999986533 357999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||++ ++|.+++...    .+++..+..++.||+.||+|||+. |++|+||+|+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          88 FEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             ecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            99996 5999888653    578889999999999999999995 99999999999999999999999999987654332


Q ss_pred             c----cceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh----------
Q 008031          443 N----VNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE----------  507 (580)
Q Consensus       443 ~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----------  507 (580)
                      .    .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+......          
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence            2    12223457889999997754 56788999999999999999999999754433222211111000          


Q ss_pred             -hccccccchhhhccCC----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcc
Q 008031          508 -EWTNEVFDLELMRDAP----TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRP  562 (580)
Q Consensus       508 -~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~  562 (580)
                       .......+........    .......++.+++.+||+.+|++|||+.+++++  +.++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence             0000000000000000    000112467789999999999999999999987  455533

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=304.28  Aligned_cols=268  Identities=21%  Similarity=0.319  Sum_probs=196.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC----CcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPK----GEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||+|.+..... .....+.+|+.++++++|+||+++++++....    ...+++
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   86 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV   86 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence            556789999999999999875 789999999864322 23456788999999999999999999876422    357999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      +||+. ++|.+++...    .+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.......
T Consensus        87 ~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          87 QELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             ehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            99996 4888877643    589999999999999999999995 99999999999999999999999999987654322


Q ss_pred             cc--ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc---ccch
Q 008031          443 NV--NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE---VFDL  516 (580)
Q Consensus       443 ~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  516 (580)
                      ..  ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.......+...........   ..+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            11  1122457889999998654 5688999999999999999999999975443222211111111100000   0000


Q ss_pred             h-------hhccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcc
Q 008031          517 E-------LMRDAP-----TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRP  562 (580)
Q Consensus       517 ~-------~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~  562 (580)
                      .       ......     ..+....++.+++.+||+.+|++|||+.|++++  ++++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            0       000000     001113457789999999999999999999998  666654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=294.07  Aligned_cols=263  Identities=28%  Similarity=0.383  Sum_probs=198.2

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEEEee
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLVFDY  365 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~  365 (580)
                      .+.+.||+|+||.||+|... +++.+|+|.+....  ......+.+|++++++++|+|++++++++... .+..++||||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            35678999999999999987 58899999997653  23345688999999999999999999999874 2689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++ +|.+++....  ..+++..+..++.|++.||+|||+ .|++|+||+|+||++++++.+|++|||++..........
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          82 MDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            975 8988886542  468999999999999999999999 499999999999999999999999999998665443222


Q ss_pred             eeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc---cccch----h
Q 008031          446 VIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN---EVFDL----E  517 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----~  517 (580)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+..........   ...+.    .
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            233456788999997654 467899999999999999999999997655433222222211100000   00000    0


Q ss_pred             hhccCC--C-----cHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAP--T-----IGD-ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~--~-----~~~-~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......  .     ... ....+.+++.+||+.+|++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000000  0     000 13467789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-35  Score=289.23  Aligned_cols=249  Identities=25%  Similarity=0.424  Sum_probs=197.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|... +|..+|+|.+.....  ...+.+.+|+.++++++|+||+++++++.. ++..++|+||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~   80 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVMEY   80 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEec
Confidence            345688999999999999986 688999999864321  234568899999999999999999999876 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++ .+|++|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            99999999997643 23578999999999999999999994 999999999999999775 4699999998766433221


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....|++.|+|||...+..++.++|+||||+++|||++|+.||...+.   .+.+.........         ...+.
T Consensus       159 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~~~  225 (257)
T cd08225         159 -AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQGYFA---------PISPN  225 (257)
T ss_pred             -ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcccCC---------CCCCC
Confidence             2224578899999999888899999999999999999999999975432   2222222211110         00111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ...++.+++.+||+.+|++|||+.|++++
T Consensus       226 ---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         226 ---FSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               12356788889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-36  Score=294.33  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=193.4

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      ...+.||.|++|.||+|.+. +|+.||+|++.....  .....+.+|++++++++|||++++++++.+ .+..+++|||+
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~~   80 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEFL   80 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEecc
Confidence            45688999999999999976 799999999864432  223568889999999999999999999986 57899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      + ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++......... .
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~  156 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-Y  156 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-c
Confidence            5 68999987643 23589999999999999999999994 9999999999999999999999999998755332211 1


Q ss_pred             eeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh----hc---------c--
Q 008031          447 IATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE----EW---------T--  510 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~---------~--  510 (580)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.+....    .+         .  
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            123467889999987654 5788999999999999999999999764432111111110000    00         0  


Q ss_pred             -ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          511 -NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       511 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ............+   .....+.+++.+||+.+|++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         237 FPKWARQDLSKVVP---NLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             cccccccchhhhcC---CCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             0000000000001   112457789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=291.51  Aligned_cols=243  Identities=25%  Similarity=0.344  Sum_probs=196.4

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .-++||+|+||.||-++.. +|+.+|.|++.+...   +.+.-...|-.+|.+++.+.||.+-..+.. .+.+|+|+..|
T Consensus       189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LClVLtlM  267 (591)
T KOG0986|consen  189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALCLVLTLM  267 (591)
T ss_pred             eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceEEEEEee
Confidence            3578999999999999876 899999999865432   334557889999999999999999777765 77999999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      +||+|.-+|...+. ..+++..++.++.+|+-||++||. ++||+||+||+|||+|+.|+++|+|+|+|..+......  
T Consensus       268 NGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~--  343 (591)
T KOG0986|consen  268 NGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI--  343 (591)
T ss_pred             cCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc--
Confidence            99999999988764 569999999999999999999999 59999999999999999999999999999987655433  


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...+||.+|||||++.++.|+...|.||+||++|||+.|+.||..........-+.++......      +..   ... 
T Consensus       344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~------ey~---~kF-  413 (591)
T KOG0986|consen  344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE------EYS---DKF-  413 (591)
T ss_pred             ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh------hcc---ccc-
Confidence            3458999999999999999999999999999999999999999866544433333333222110      010   111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCH
Q 008031          527 DELLNTLKLALHCVDPSPSARPEV  550 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~  550 (580)
                        ..+...+....|..||++|.-.
T Consensus       414 --S~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  414 --SEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             --CHHHHHHHHHHHccCHHHhccC
Confidence              2244456667888999999743

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-35  Score=292.49  Aligned_cols=260  Identities=24%  Similarity=0.332  Sum_probs=193.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |+..+.||+|++|.||+|... +|+.||||.++....  .....+.+|++++++++||||+++++++.+ ++..++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~   80 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEF   80 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEeec
Confidence            345688999999999999876 789999998864432  223568899999999999999999999876 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +. ++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+|++|||++........ .
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~  156 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-T  156 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-c
Confidence            95 68998887643 3468999999999999999999999 4999999999999999999999999999875543221 1


Q ss_pred             eeeecCccccCCccccccCC-CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc---------------
Q 008031          446 VIATAGALGYRAPELSKLKK-ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW---------------  509 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------------  509 (580)
                      .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+..+....+........               
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            12234678899999876544 58899999999999999999999976443221111111000000               


Q ss_pred             -cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          510 -TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       510 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ...+.........+..   ..++.+++.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         237 SFPKWARQDFSKVVPPL---DEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hcccccccCHHHHcccC---CHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence             0000000000000111   1345678999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-35  Score=295.11  Aligned_cols=262  Identities=26%  Similarity=0.341  Sum_probs=196.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC--------
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK--------  356 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  356 (580)
                      .|.+.+.||+|+||.||+|... +|+.||+|.++....  .....+.+|++++++++||||+++++++.+..        
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            4667899999999999999986 688999999865432  23356788999999999999999999987632        


Q ss_pred             -CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          357 -GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       357 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                       +..++|+||+++ ++.+++...  ...+++..+..++.|++.||+|||+. ||+|+||+|+||++++++.+||+|||++
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCccccc
Confidence             368999999976 777777654  34689999999999999999999995 9999999999999999999999999998


Q ss_pred             cccccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc--
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE--  512 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  512 (580)
                      ...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+.+.........  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            8664433222222345778999998754 4578899999999999999999999976544333333332221111000  


Q ss_pred             -cc--------ch------hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          513 -VF--------DL------ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       513 -~~--------~~------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ..        +.      .........   ...+.+++.+||+.+|.+|||+.+++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFI---PTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cccccccccccccccccccchhhhcCCC---CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00        00      000001111   2356788889999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=303.75  Aligned_cols=269  Identities=24%  Similarity=0.362  Sum_probs=202.6

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEEEE
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKLLV  362 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv  362 (580)
                      ...+.||+|+||.||+|+.+ +|+.||||.++..... ..+...+|+++|++++|+|||++.++-.+..     ....+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            34688999999999999965 8999999999765433 3456789999999999999999988765422     246799


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC--CCCC--eEEeeccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD--DSTN--AKISDFGLSRLM  438 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~--~~~~--~kl~Dfg~~~~~  438 (580)
                      ||||.+|+|...+++-.....+++.+.+.++..++.||.|||++ ||+||||||.||++-  ++|+  -||+|||.|+..
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999999999876677799999999999999999999996 999999999999995  3344  699999999987


Q ss_pred             ccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC-hhHHHHHHhhhhcccc--cc
Q 008031          439 TAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAE-LPQWVASIVKEEWTNE--VF  514 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~--~~  514 (580)
                      ++..  .....+||..|.+||+... +.|+..+|.|||||++||+.||..||.+..... ....+..+........  ..
T Consensus       175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA  252 (732)
T ss_pred             CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence            6654  5667899999999999984 888999999999999999999999998754331 1112222111111000  00


Q ss_pred             ------chhhhccCC----CcHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHhhhc
Q 008031          515 ------DLELMRDAP----TIGDELLNTLKLALHCVDPSPSARP--EVLQVVQQLEEIR  561 (580)
Q Consensus       515 ------~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~Rp--s~~ev~~~L~~~~  561 (580)
                            ..+.....|    ........+-+.+..++..+|++|.  .+.+.-..+..+.
T Consensus       253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence                  000011111    1122233444566677888999998  7777776666654

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=298.23  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=193.9

Q ss_pred             HhhhccccccCceEEEEEEeC---CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE---DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~l  361 (580)
                      |.+.+.||+|+||.||+|...   ++..||+|.+....   ......+.+|+.++++++||||+++++++.... ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            456688999999999999975   47899999987643   233456788999999999999999999998741 57899


Q ss_pred             EEeeCCCCChhhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC----CCCeEEeecccc
Q 008031          362 VFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD----STNAKISDFGLS  435 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~----~~~~kl~Dfg~~  435 (580)
                      ||||+++ ++.+++....  ....++...+..++.|++.||+|||+ .+++||||||+||+++.    ++.+|++|||++
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999965 7777765332  12368899999999999999999999 49999999999999998    899999999998


Q ss_pred             cccccccc--cceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh----h--HHHHHHhh
Q 008031          436 RLMTAAAN--VNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL----P--QWVASIVK  506 (580)
Q Consensus       436 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~----~--~~~~~~~~  506 (580)
                      ........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........    .  ..+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86543322  12223457888999998765 4578999999999999999999999976544320    0  00000000


Q ss_pred             h---hcc---------ccccc---hhhhccCC--CcH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          507 E---EWT---------NEVFD---LELMRDAP--TIG-------DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       507 ~---~~~---------~~~~~---~~~~~~~~--~~~-------~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .   ...         .....   .......+  ...       ....++.+++.+||+.||++|||+.|++++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0   000         00000   00000000  000       122357789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.5e-35  Score=300.42  Aligned_cols=260  Identities=22%  Similarity=0.274  Sum_probs=193.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      |...+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|+.++++++|+||+++++++....     ...+
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   97 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY   97 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence            666789999999999999976 789999999864322  22346778999999999999999999886422     3579


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+. ++|.+.+..     .++...+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||+++....
T Consensus        98 lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          98 LVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             EEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            9999995 588888764     278889999999999999999994 999999999999999999999999999986543


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHh---------------
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV---------------  505 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~---------------  505 (580)
                      ...  .....++..|+|||.+.+..++.++||||+||++|+|++|+.||...+..+....+....               
T Consensus       171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         171 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            222  223457888999999999999999999999999999999999997654221111111000               


Q ss_pred             ----hhhccc------cccchhhhccCCC--cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          506 ----KEEWTN------EVFDLELMRDAPT--IGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       506 ----~~~~~~------~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                          ......      .............  .......+.+++.+||+.||++|||+.|++++=
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence                000000      0000000000000  001234567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.3e-35  Score=291.65  Aligned_cols=257  Identities=13%  Similarity=0.136  Sum_probs=182.2

Q ss_pred             HHhhhccccccCceEEEEEEeCC----CCEEEEEEcccccccc--H---------HHHHHHHHHHhcCCCCcceeeeeEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLED----GSQVAVKRLREKITKG--Q---------REFESEVSLLGKIRHPNLLALRAYY  352 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~e~~~l~~l~h~niv~~~~~~  352 (580)
                      .|.+.+.||+|+||.||+|...+    +..+|+|+........  +         .....+...+..+.|++++++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            46678999999999999999764    3456666543221110  0         1122344556677899999999977


Q ss_pred             ECCCC---cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEE
Q 008031          353 LGPKG---EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKI  429 (580)
Q Consensus       353 ~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl  429 (580)
                      .....   ..++++|++. .++.+.+...   ...++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|
T Consensus        93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCcEEE
Confidence            64332   2467788773 4676666543   235678889999999999999999 59999999999999999999999


Q ss_pred             eecccccccccccc------cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCC-CChhHHHH
Q 008031          430 SDFGLSRLMTAAAN------VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNG-AELPQWVA  502 (580)
Q Consensus       430 ~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~-~~~~~~~~  502 (580)
                      +|||+|+.+.....      .......||+.|+|||...+..++.++|||||||++|||++|+.||..... .+......
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99999986643221      111224689999999999999999999999999999999999999987632 22222111


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .-......    ....  ..+..   ...+.+++..||+.+|++||++.++++.++
T Consensus       248 ~~~~~~~~----~~~~--~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        248 CDFIKRLH----EGKI--KIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHHhh----hhhh--ccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            10000000    0000  11111   235678888999999999999999998763

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-35  Score=298.41  Aligned_cols=268  Identities=22%  Similarity=0.317  Sum_probs=200.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCC----CcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPK----GEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~l  361 (580)
                      |.+.+.||+|+||.||+|... +++.||||.++...  ......+.+|+.+++.++|+||+++++++....    ...++
T Consensus         7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l   86 (337)
T cd07858           7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI   86 (337)
T ss_pred             eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence            556789999999999999875 78999999986532  223456778999999999999999999886532    34799


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ++||+. ++|.+++...   ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          87 VYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            999995 6898888754   3689999999999999999999995 9999999999999999999999999999865433


Q ss_pred             cccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc---cccc--
Q 008031          442 ANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN---EVFD--  515 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--  515 (580)
                      . .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..........   ...+  
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         162 G-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             c-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            2 11223457888999998764 468899999999999999999999997654322222222111100000   0000  


Q ss_pred             -------------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhccccc
Q 008031          516 -------------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPEAA  565 (580)
Q Consensus       516 -------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~~~  565 (580)
                                   .......+   ....++.+++.+||+.+|++|||+.+++++  ++.+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFP---HANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcc---cCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence                         00000001   123456789999999999999999999999  776654443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-36  Score=298.32  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=207.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc--HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG--QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|.|+.|..|++. ++..||||.+.+.....  .+.+.+|+++|..++|||||+++++... ...+|+||||
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV~ey  136 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLVMEY  136 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEEEEe
Confidence            556789999999999999986 89999999997654432  2448899999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +.+|.+.+++.+.+   .+.+..+..++.|+.+|++|||+ ++|+|||||++|||++.+.++||+|||++..+..  ...
T Consensus       137 a~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~  210 (596)
T KOG0586|consen  137 ASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLM  210 (596)
T ss_pred             ccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhcccccccceeeeccccceeecc--ccc
Confidence            99999999999875   45568888999999999999999 5999999999999999999999999999998763  334


Q ss_pred             eeeecCccccCCccccccCCCC-CcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSKLKKAN-TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ...+.|++.|.|||++.+..|+ +++|+||+|+++|-|+.|..||++.+-.++...+...            .+..+.  
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g------------k~rIp~--  276 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG------------KYRIPF--  276 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee------------eecccc--
Confidence            4467899999999999987765 6899999999999999999999987655444433211            111111  


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                        ....++-+++.+++-.+|.+|++++++.++-+.-..
T Consensus       277 --~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  277 --YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             --eeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence              112245578889999999999999999988766443

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.1e-35  Score=292.97  Aligned_cols=262  Identities=19%  Similarity=0.240  Sum_probs=192.0

Q ss_pred             hhhccccccCceEEEEEEeCCCCEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREK--ITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .+++.+|.|+++.||++.. +++.||+|++...  .....+.+.+|++++++++|+||+++++++.. ++..+++|||++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~   82 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMA   82 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccC
Confidence            3455556666666666554 6999999998654  22344678999999999999999999999886 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc----
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN----  443 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~----  443 (580)
                      +|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+........    
T Consensus        83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          83 YGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999999998643 23578899999999999999999995 999999999999999999999999998865432211    


Q ss_pred             --cceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc-------
Q 008031          444 --VNVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE-------  512 (580)
Q Consensus       444 --~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  512 (580)
                        .......++..|+|||.+.+  ..++.++|+|||||++|||++|+.||...+....  .... ..+.....       
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~  237 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEK-VRGTVPCLLDKSTYP  237 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HhccCccccccCchh
Confidence              11122346778999998865  3588899999999999999999999976543221  1111 11000000       


Q ss_pred             ------------ccchhh--hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          513 ------------VFDLEL--MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       513 ------------~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                                  ..+...  ............++.+++.+||+.||++|||+.+++++-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence                        000000  0001111122346778999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-35  Score=288.28  Aligned_cols=245  Identities=25%  Similarity=0.368  Sum_probs=193.5

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ||+|+||.||++.+. +|+.+++|.+.....   .....+.+|++++++++|+||+++++.+.. ....+++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            689999999999987 599999999865433   234568899999999999999999998876 668999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-------
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-------  443 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------  443 (580)
                      |.+++.+.+   .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++++|||++........       
T Consensus        80 L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          80 LASLLENVG---SLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            999998753   68999999999999999999999 5999999999999999999999999999875433211       


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......++..|+|||......++.++||||||+++|++++|+.||......+....+   ..+...           .+
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-----------~~  221 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI---LNGKIE-----------WP  221 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcCCcC-----------CC
Confidence            1122345778899999998888999999999999999999999999765533222221   111100           01


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ........+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            11001235678888999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.7e-35  Score=291.12  Aligned_cols=265  Identities=23%  Similarity=0.305  Sum_probs=192.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCC----cEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKI-RHPNLLALRAYYLGPKG----EKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~----~~~  360 (580)
                      |...+.||+|+||.||+|.+. +++.||+|.++.....  ....+.+|+.+++.+ +|+||+++++++...+.    ..+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            456788999999999999976 7899999987654322  235688899999999 56999999999876332    279


Q ss_pred             EEEeeCCCCChhhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-CCCeEEeecccccc
Q 008031          361 LVFDYMPHGSLATFLHARGP--ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-STNAKISDFGLSRL  437 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~  437 (580)
                      +||||+++ +|.+++.....  ...+++..+..++.||+.||.|||+ .+++||||+|+||+++. ++.+|++|||++..
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            99999975 89888865432  2468999999999999999999999 59999999999999998 88999999999875


Q ss_pred             cccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---ccc
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEV  513 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  513 (580)
                      ....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.........   ...
T Consensus       161 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         161 FSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             cCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            5332111 112346788999998764 45789999999999999999999999765432211111111000000   000


Q ss_pred             cchhhh---cc-CC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 FDLELM---RD-AP-----TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 ~~~~~~---~~-~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......   .. .+     ..+....++.+++.+||+.||.+|||+.|++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000   00 00     001123456789999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.5e-35  Score=288.88  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=193.7

Q ss_pred             HhhhccccccCceEEEEEEe----CCCCEEEEEEcccccc----ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          289 CATAEIMGKSTYGTVYKATL----EDGSQVAVKRLREKIT----KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      |++.+.||+|+||.||.+..    .+|..||+|.++....    ...+.+.+|++++.++ +|+||+++++++.. +...
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~   80 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTKL   80 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCeE
Confidence            34568899999999999986    3688999999865322    2335678899999999 69999999998876 5688


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++||||+++++|.+++...   ..+++..+..++.|++.||.|||+ .|++||||+|+||++++++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            9999999999999999764   357889999999999999999999 599999999999999999999999999987654


Q ss_pred             cccccceeeecCccccCCccccccC--CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          440 AAANVNVIATAGALGYRAPELSKLK--KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ...........|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||...........+........        
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------  228 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------  228 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--------
Confidence            4332333345688899999988653  467899999999999999999999975433222222211111100        


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                          .+........+.+++.+||+.||++||     +..+++.+
T Consensus       229 ----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 ----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                000011123556788899999999997     77777775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=291.55  Aligned_cols=261  Identities=23%  Similarity=0.328  Sum_probs=197.9

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      ...+.||.|++|.||+|... +++.+++|.+......  ....+.+|++++++++|+||+++++++.. .+..++|+||+
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~   80 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEFM   80 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEecc
Confidence            34678999999999999986 7889999998654332  34578889999999999999999999876 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++ ++.+++....  ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY  155 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence            65 8888887642  4689999999999999999999994 99999999999999999999999999987665433 112


Q ss_pred             eeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh---ccccccc------h
Q 008031          447 IATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE---WTNEVFD------L  516 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~------~  516 (580)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+....+.......   ......+      .
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            224577889999988766 78899999999999999999999997655433222221111100   0000000      0


Q ss_pred             hhhccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAP-----TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .......     .......++.+++.+||+.||.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0000000     011223567789999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-34  Score=281.87  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=201.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e  364 (580)
                      |...+.||+|++|.||+|... +++.|++|.+.....  ...+.+.+|+.++++++|+||+++++.+.... ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            345688999999999999987 789999999865543  34567899999999999999999999998631 67899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++....   .+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          82 YVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            999999999998753   78999999999999999999999 59999999999999999999999999998866544321


Q ss_pred             -ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 -NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|..||....  +...............         ..+
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~---------~~~  226 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPP---------EIP  226 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCc---------CCC
Confidence             1223457889999999988889999999999999999999999997655  2222222211100000         000


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ......+.+++.+|++.+|++||++.+++++
T Consensus       227 --~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         227 --EHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             --cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence              1112467788889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.4e-35  Score=283.46  Aligned_cols=250  Identities=25%  Similarity=0.409  Sum_probs=200.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||++.+. ++..||+|.+.....  .....+.+|+++++.++|+|++++.+.+.. .+..++++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e~   80 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVMEY   80 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEEe
Confidence            445688999999999999986 689999999875433  345678899999999999999999999887 5789999999


Q ss_pred             CCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +++++|.+++.... ....+++..+..++.+++.||+|||+. |++|+||+|+||++++++.++++|||.+........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence            99999999997642 125689999999999999999999995 999999999999999999999999999876644331 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......++..|+|||...+..++.++|+||+|+++|+|++|+.||...+..   +...........      .+   .. 
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~------~~---~~-  225 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKILKGQYP------PI---PS-  225 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHHhcCCCC------CC---CC-
Confidence            222345788899999998888999999999999999999999999765422   222222111110      00   01 


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        .....+.+++.+||+.+|++|||+.+++++
T Consensus       226 --~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         226 --QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              112356788889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-35  Score=282.39  Aligned_cols=247  Identities=24%  Similarity=0.437  Sum_probs=198.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++++++|+|++++++++.. .+..+++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   80 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILEY   80 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEec
Confidence            455789999999999999876 688999999876543  344678999999999999999999999876 5689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...   ..+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998764   4689999999999999999999995 9999999999999999999999999999866543322 


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....++..|+|||...+..++.++||||+|+++|+|++|+.||.......  . .........      ...   ..  
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~-~~~~~~~~~------~~~---~~--  221 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--A-LFRIVQDDH------PPL---PE--  221 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--H-HHHHhccCC------CCC---CC--
Confidence            223457889999999888888999999999999999999999997544211  1 111111110      000   01  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       .....+.+++.+||+.+|++|||+.+++.+
T Consensus       222 -~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         222 -GISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence             112356688889999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-35  Score=284.84  Aligned_cols=243  Identities=22%  Similarity=0.276  Sum_probs=185.6

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHH-hcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLL-GKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|... +|+.||+|.+......   ....+..|..++ ...+|+|++++++++.. ++..++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence            56899999999999875 6899999998643221   122344555444 44589999999999976 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++...   ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+|++|||++......     .
T Consensus        81 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~  151 (260)
T cd05611          81 GGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----K  151 (260)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceecccc-----c
Confidence            99999999764   3588999999999999999999995 9999999999999999999999999998754321     1


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...++..|+|||.+.+..++.++||||+|+++|+|++|..||...+.....   .........   .....      ...
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~---~~~~~------~~~  219 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF---DNILSRRIN---WPEEV------KEF  219 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHhcccC---CCCcc------ccc
Confidence            235778899999998888899999999999999999999999765433222   221111100   00000      001


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ....+.+++.+||+.+|++|||+.++.+.|
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            123567888899999999999775444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.9e-35  Score=288.84  Aligned_cols=261  Identities=24%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             HhhhccccccCceEEEEEEeC----CCCEEEEEEcccccc----ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          289 CATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKIT----KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      |++.+.||+|+||.||++...    +++.||||.++....    .....+..|++++.++ +|+||+++++.+.. +...
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~~   80 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTKL   80 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCEE
Confidence            345688999999999999753    578899999864321    2235678999999999 69999999998876 5688


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++||||+++|+|.+++...   ..+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++++|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            9999999999999998764   358899999999999999999999 599999999999999999999999999987654


Q ss_pred             cccccceeeecCccccCCccccccCC--CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHH-HHhhhhccccccch
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKK--ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVA-SIVKEEWTNEVFDL  516 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  516 (580)
                      ...........++..|+|||.+.+..  .+.++||||||+++|||++|+.||...........+. ......       .
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~  229 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-------P  229 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-------C
Confidence            43332223345788999999987655  7889999999999999999999996433222222111 111110       0


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccc
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATA  567 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~  567 (580)
                      ..   ....   ...+.+++.+||+.+|++|||+.++.+.|+...-+...+
T Consensus       230 ~~---~~~~---~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         230 PF---PKTM---SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             CC---Cccc---CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            00   1111   124567888999999999999998888887754444333

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.9e-35  Score=293.85  Aligned_cols=264  Identities=22%  Similarity=0.297  Sum_probs=193.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCC-------Cc
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPK-------GE  358 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------~~  358 (580)
                      |...+.||+|+||.||+|... +++.||||.+......  ....+.+|++++++++||||+++++++....       ..
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            566789999999999999986 7899999988643322  2335678999999999999999999987532       24


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      .++||||+. ++|.+++....  ..+++.++..++.||+.||+|||++ |++|+||+|+||+++.++.+||+|||++...
T Consensus        94 ~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          94 FYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             EEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            599999996 58888876542  3589999999999999999999995 9999999999999999999999999999765


Q ss_pred             cccccc---ceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hccc
Q 008031          439 TAAANV---NVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTN  511 (580)
Q Consensus       439 ~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~  511 (580)
                      ......   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+.......+..+...   ....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            432221   11233567889999987654 4788999999999999999999999765543322222222110   0000


Q ss_pred             cccchh------hhccCC-CcH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          512 EVFDLE------LMRDAP-TIG------DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       512 ~~~~~~------~~~~~~-~~~------~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...+..      ...... ...      .....+.+++.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000000      000000 000      012345689999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-34  Score=289.64  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=196.8

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ..|...+.||+|+||.||+|... ++..+|+|.+....   .....++.+|+++++.++|+|++++++++.. ....++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEEE
Confidence            34667789999999999999976 67889999886321   2233567889999999999999999999987 5688999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+. |++.+.+....  ..+++.++..++.|++.|+.|||+ .+++||||+|+||+++.++.++++|||++...... 
T Consensus        94 ~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            99996 68888776432  358899999999999999999999 59999999999999999999999999998765432 


Q ss_pred             ccceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NVNVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                          ....++..|+|||.+.   ...++.++|||||||++|+|++|+.||...+..+...   .+......      .  
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~------~--  233 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNESP------A--  233 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH---HHhhcCCC------C--
Confidence                1235788999999864   4567889999999999999999999987654322221   11111110      0  


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                         .........+.+++.+||+.+|++||++.+++++-.....
T Consensus       234 ---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         234 ---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence               0011122356788999999999999999999998766553

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-35  Score=284.44  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=193.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-----TKGQREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~l  361 (580)
                      |.+.+.||+|+||.||+|... ++..||+|.+....     ......+.+|++++++++|+||+++++++.... ...++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            556789999999999999975 68999999874321     122346889999999999999999999987643 35789


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ++||+++++|.+++...+   .+++.....++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+|||+++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          84 FVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            999999999999987643   57889999999999999999999 59999999999999999999999999998765321


Q ss_pred             c--ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 A--NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .  ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||......   ..+.+.......     +.  
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-----~~--  229 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKIATQPTK-----PM--  229 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHHHcCCCC-----CC--
Confidence            1  11112345788999999999888999999999999999999999999754322   112221111100     00  


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          .......++.+++.+||+ +|..|||..+++.|
T Consensus       230 ----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         230 ----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ----CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                011122356678889999 57999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-35  Score=296.00  Aligned_cols=272  Identities=22%  Similarity=0.326  Sum_probs=204.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCC----CcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPK----GEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~l  361 (580)
                      |.+.+.||.|+||.||+|... +++.||+|++....  ....+.+.+|+.+++.++|+||+++.+++....    ...++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            456789999999999999986 58999999987643  234467899999999999999999999987643    36899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +|||++ ++|.+++...   ..+++..+..++.|++.||+|||+. |++|+||||.||+++.++.++|+|||++......
T Consensus        82 v~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          82 VTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             Eecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            999997 5898888764   2789999999999999999999995 9999999999999999999999999999866443


Q ss_pred             cc--cceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccccc--ch
Q 008031          442 AN--VNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF--DL  516 (580)
Q Consensus       442 ~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  516 (580)
                      ..  .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+....+.............  +.
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            21  112234578889999998877 88999999999999999999999997665433222222111100000000  00


Q ss_pred             h----h---hccCC------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhccccc
Q 008031          517 E----L---MRDAP------TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPEAA  565 (580)
Q Consensus       517 ~----~---~~~~~------~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~~~  565 (580)
                      .    .   .+...      ........+.+++.+||+.+|++|||+.+++++  +++++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~  300 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED  300 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence            0    0   00000      000112456789999999999999999999997  666655433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.7e-35  Score=284.69  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=199.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||++... +++.+|+|.+.....  .....+.+|++++++++|+||+++.+++.. ....++||||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   80 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVMEY   80 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEehh
Confidence            445688999999999999875 788999999865432  234567889999999999999999999886 5689999999


Q ss_pred             CCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +++++|.+++.... ....+++..+..++.|++.||+|||+. |++|+||+|.||++++++.+|++|||++.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence            99999999987632 124688999999999999999999995 99999999999999999999999999997765431  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+....+   ......            +.
T Consensus       158 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~~~------------~~  221 (256)
T cd08530         158 -AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV---QRGKYP------------PI  221 (256)
T ss_pred             -cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcCCCC------------CC
Confidence             11245788999999999889999999999999999999999999765432222211   111100            01


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......++.+++.+||+.+|++|||+.+++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11233467789999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=286.14  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=195.9

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEeeC
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .+.+.||+|+||.||+|... +++.||||.+..... .......+|+..+++++ |+|++++++++.. ++..++||||+
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEYM   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEecC
Confidence            45688999999999999986 588999999865433 22334567999999998 9999999999987 67899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--  155 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence             889999887653 24689999999999999999999995 9999999999999999999999999998765432221  


Q ss_pred             eeecCccccCCccccc-cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---------ccccch
Q 008031          447 IATAGALGYRAPELSK-LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---------NEVFDL  516 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  516 (580)
                      ....++..|+|||.+. ...++.++|+||||+++|||++|+.||......+....+.........         ....+.
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            2245788899999774 456789999999999999999999999765443322222211111000         000000


Q ss_pred             hhhccCCC-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAPT-----IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......+.     .......+.+++.+||+.+|++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000     00112467789999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.3e-35  Score=293.62  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=190.3

Q ss_pred             cccccc--CceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKS--TYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      ..||+|  +||+||++.+. +|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence            456666  99999999985 799999999864332  223568899999999999999999999987 568899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-c-
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-N-  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~-  445 (580)
                      ++++.+++.... ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++++||+.+......... . 
T Consensus        83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999999987653 2358899999999999999999999 59999999999999999999999999865332211110 0 


Q ss_pred             ----eeeecCccccCCccccccC--CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---------
Q 008031          446 ----VIATAGALGYRAPELSKLK--KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---------  510 (580)
Q Consensus       446 ----~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------  510 (580)
                          .....++..|+|||++.+.  .++.++||||+||++|||++|+.||......+.   ..........         
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccccc
Confidence                0112345679999998763  478899999999999999999999976542211   1111000000         


Q ss_pred             ---------------------------ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          511 ---------------------------NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       511 ---------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                                                 ....+...  ..+........+.+++.+||+.||++|||+.|++++-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL--RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccc--cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence                                       00000000  01111223456789999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.7e-35  Score=294.12  Aligned_cols=264  Identities=22%  Similarity=0.307  Sum_probs=193.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-------c
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKG-------E  358 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------~  358 (580)
                      |...+.||+|+||.||+|... +++.+|+|.+......  ....+.+|++++++++|+||+++++++.....       .
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   89 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS   89 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence            556789999999999999976 6899999988644322  23457789999999999999999998765332       3


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      .++|+||+.+ ++.+.+...  ...+++..+..++.|+++||+|||+ .|++|+||||+||++++++.++++|||++...
T Consensus        90 ~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          90 VYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             EEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            7899999965 777776643  3468999999999999999999999 59999999999999999999999999998765


Q ss_pred             cccccc----------ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh
Q 008031          439 TAAANV----------NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE  507 (580)
Q Consensus       439 ~~~~~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  507 (580)
                      ......          ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+..+.+......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            432211          1122356788999998764 45789999999999999999999999765543322222211110


Q ss_pred             hcc---------ccccchhhhccCC-Cc----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          508 EWT---------NEVFDLELMRDAP-TI----GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       508 ~~~---------~~~~~~~~~~~~~-~~----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...         ....+.......+ ..    ......+.+++.+||+.||++|||+.|++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000         0000000000000 00    0112467789999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.2e-35  Score=295.31  Aligned_cols=265  Identities=24%  Similarity=0.351  Sum_probs=197.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC---CCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP---KGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~~lv  362 (580)
                      |++.+.||+|+||.||+|... +|+.||+|++.....  .....+.+|+.++++++||||+++++++...   ....++|
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv   86 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV   86 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence            556788999999999999876 799999999875422  2345677899999999999999999987642   3467999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+. ++|.+++...   ..+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus        87 ~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          87 MDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             Eehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            99995 6899988754   358999999999999999999999 499999999999999999999999999987654322


Q ss_pred             cc---ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc---------
Q 008031          443 NV---NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW---------  509 (580)
Q Consensus       443 ~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  509 (580)
                      ..   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+........         
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            21   1123467889999998765 5688999999999999999999999976554332222221111000         


Q ss_pred             --cccccchhhhccCCC-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          510 --TNEVFDLELMRDAPT-----IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       510 --~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                        .....+ ......+.     ......++.+++.+||+.+|++|||+.+++++-.-
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         242 DRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             hhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence              000000 00000000     01123467789999999999999999999987543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.9e-34  Score=282.17  Aligned_cols=238  Identities=23%  Similarity=0.331  Sum_probs=183.6

Q ss_pred             hhhcc--ccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEee
Q 008031          290 ATAEI--MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       290 ~~~~~--ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .+.+.  +|+|+||.||++... ++..+|+|.+........     |+.....+ +||||+++++++.. .+..++||||
T Consensus        17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-~~~~~iv~e~   90 (267)
T PHA03390         17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-LKGHVLIMDY   90 (267)
T ss_pred             ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec-CCeeEEEEEc
Confidence            34444  499999999999875 788899998864422111     22222222 79999999999987 5689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +++++|.+++....   .+++.++..++.|+++|+.|||+. |++||||+|+||+++.++ .++++|||++.......  
T Consensus        91 ~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--  164 (267)
T PHA03390         91 IKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--  164 (267)
T ss_pred             CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence            99999999997643   689999999999999999999995 999999999999999888 99999999987654322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh--hHHHHHHhhhhccccccchhhhccC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL--PQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                         ...++..|+|||.+.+..++.++||||+|+++|||++|+.||......+.  ..+.... . .            ..
T Consensus       165 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~------------~~  227 (267)
T PHA03390        165 ---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q-K------------KL  227 (267)
T ss_pred             ---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c-c------------cC
Confidence               23578899999999988999999999999999999999999985543321  1111111 0 0            00


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPE-VLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ev~~~  556 (580)
                      +........+.+++.+||+.+|.+||+ +++++++
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            111122335678888999999999995 6988864

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.7e-34  Score=284.35  Aligned_cols=243  Identities=23%  Similarity=0.307  Sum_probs=186.0

Q ss_pred             cccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHH---HHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          294 IMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEV---SLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .||+|+||.||+|... +++.||+|.+......   ....+..|.   +.++...||+|+++++++.. .+..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence            4799999999999875 6889999998653221   122233343   34455689999999999876 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++|+|.+++...   ..+++..+..++.|++.|++|||+ .+++||||+|+||++++++.+|++|||++........   
T Consensus        80 ~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---  152 (278)
T cd05606          80 NGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (278)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence            999999988754   368999999999999999999999 5999999999999999999999999999875533221   


Q ss_pred             eeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          447 IATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.................       .+....   .  
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~---~--  220 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------MAVELP---D--  220 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-------cCCCCC---C--
Confidence            234688999999998754 688999999999999999999999976543322221111110       011111   0  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARP-----EVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~L  557 (580)
                       ....++.+++.+|++.+|.+||     ++.+++++-
T Consensus       221 -~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~  256 (278)
T cd05606         221 -SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP  256 (278)
T ss_pred             -cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence             1123667888899999999999     999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-36  Score=282.10  Aligned_cols=260  Identities=20%  Similarity=0.254  Sum_probs=203.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-C-C----cceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-H-P----NLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~~~~~~~  360 (580)
                      +|.+...+|+|+||.|-++.++ .+..||||+++.- ..-.++..-|++++.++. + |    -++.+.+|+.. .++.|
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-rghiC  167 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-RGHIC  167 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc-cCceE
Confidence            4677899999999999999876 5789999998754 334456677999999993 2 2    37888888876 77999


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-----------------
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-----------------  423 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-----------------  423 (580)
                      ||+|.+ |-++.+++...+ ..+++...+..++.|+++++++||+. +++|.||||+|||+.+                 
T Consensus       168 ivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r  244 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR  244 (415)
T ss_pred             EEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceec
Confidence            999999 669999998754 66799999999999999999999996 9999999999999921                 


Q ss_pred             ---CCCeEEeecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHH
Q 008031          424 ---STNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQW  500 (580)
Q Consensus       424 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~  500 (580)
                         +..++|+|||.|+.....    ....+.|.+|+|||++.+-.++.++||||+||+|+|+.||..-|...++.+....
T Consensus       245 ~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM  320 (415)
T KOG0671|consen  245 PLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM  320 (415)
T ss_pred             cCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence               335899999999864332    2456789999999999999999999999999999999999999988776665555


Q ss_pred             HHHHhhhhccc--------------------cccch--hhhcc--------CCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 008031          501 VASIVKEEWTN--------------------EVFDL--ELMRD--------APTIGDELLNTLKLALHCVDPSPSARPEV  550 (580)
Q Consensus       501 ~~~~~~~~~~~--------------------~~~~~--~~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~Rps~  550 (580)
                      +..++..-...                    ...+.  +...+        ......+..++++|+++||.+||.+|+|+
T Consensus       321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl  400 (415)
T KOG0671|consen  321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL  400 (415)
T ss_pred             HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence            54443311100                    00000  00000        11223456779999999999999999999


Q ss_pred             HHHHHH
Q 008031          551 LQVVQQ  556 (580)
Q Consensus       551 ~ev~~~  556 (580)
                      .|++.|
T Consensus       401 ~EAL~H  406 (415)
T KOG0671|consen  401 REALSH  406 (415)
T ss_pred             HHHhcC
Confidence            999876

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.3e-34  Score=288.25  Aligned_cols=244  Identities=26%  Similarity=0.401  Sum_probs=191.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +...+.||+|+||.||+|... +|+.||+|.+.....   .....+.+|+++++.++|||++++++++.+ ....++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEe
Confidence            555678999999999999875 788999999864322   223467889999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+. |++.+++...  ...+++.++..++.|++.|+.|||+. |++|+||+|+||+++.++.+||+|||++......   
T Consensus       102 ~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633         102 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             cCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence            995 5888887654  24589999999999999999999995 9999999999999999999999999988643221   


Q ss_pred             ceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          445 NVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                        ....|+..|+|||.+.   ...++.++||||||+++|+|++|..||...+.....   ..+........ .       
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~-~-------  241 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNDSPTL-Q-------  241 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhcCCCCC-C-------
Confidence              1345788899999874   466888999999999999999999998765432222   22211111100 0       


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..   .....+.+++.+||+.+|.+||++.+++.+
T Consensus       242 ~~---~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 SN---EWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             cc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   111246678889999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-34  Score=287.52  Aligned_cols=260  Identities=23%  Similarity=0.300  Sum_probs=191.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|++|.||+|... +|+.||+|.+.....  .....+.+|++++++++|+||+++++++.. ....++||||
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   82 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVFEY   82 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEEec
Confidence            456688999999999999986 789999999864332  223568899999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-CCCeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-STNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ++ ++|.+++.... ...+++..+..++.||+.||+|||+ .+++|+||+|+||+++. ++.+|++|||++........ 
T Consensus        83 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-  158 (294)
T PLN00009         83 LD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-  158 (294)
T ss_pred             cc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence            95 58888876543 2346788888999999999999999 49999999999999985 56799999999975533211 


Q ss_pred             ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc-----------
Q 008031          445 NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE-----------  512 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------  512 (580)
                      ......++..|+|||.+.+ ..++.++||||+|+++|+|+||+.||......+....+...........           
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            1122346788999998765 4578899999999999999999999976543222111111100000000           


Q ss_pred             -----ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          513 -----VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       513 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                           ..........+.   ...++.+++.+|++.+|++||++.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~---~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        239 SAFPKWPPKDLATVVPT---LEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhcccCCCCCHHHhCcC---CChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000000000011   12356788999999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-34  Score=288.18  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=193.0

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .|++.+.||+|+||.||+|.+. +++.||||.++.... .....+.+|+.++.+. .|+||+++++++.. +...+++||
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e   94 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFICME   94 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEEee
Confidence            3567899999999999999987 489999999875432 2334566788777776 49999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+. +++.+++....  ..+++..+..++.|++.|++|||+..|++||||+|+||++++++.+||+|||++.........
T Consensus        95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~  171 (296)
T cd06618          95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK  171 (296)
T ss_pred             ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence            984 57877776532  368999999999999999999997349999999999999999999999999998765432221


Q ss_pred             ceeeecCccccCCccccccCC----CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          445 NVIATAGALGYRAPELSKLKK----ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                        ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......  .+............         
T Consensus       172 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~---------  238 (296)
T cd06618         172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPS---------  238 (296)
T ss_pred             --cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCC---------
Confidence              2234778899999987554    788999999999999999999999653221  12222222211100         


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                       .+.......++.+++.+||+.||++||++.+++++-.
T Consensus       239 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         239 -LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence             0000011235778899999999999999999998864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=293.17  Aligned_cols=260  Identities=23%  Similarity=0.284  Sum_probs=195.0

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEcccccccc--------------HHHHHHHHHHHhcCCCCcceeeeeEEECC
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG--------------QREFESEVSLLGKIRHPNLLALRAYYLGP  355 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~  355 (580)
                      ..+.||+|+||.||+|.+. +++.||+|.++......              ...+.+|++++++++|+||+++++++.. 
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-   91 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE-   91 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec-
Confidence            3578999999999999976 78999999986432221              1247789999999999999999999976 


Q ss_pred             CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          356 KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       356 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      .+..++||||+. |+|.+++...   ..+++.....++.|++.||+|||+ .|++|+||+|+||+++.++.++++|||++
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCCCEEECCccce
Confidence            668999999996 6999988753   358899999999999999999999 49999999999999999999999999998


Q ss_pred             ccccccc-------------ccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHH
Q 008031          436 RLMTAAA-------------NVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWV  501 (580)
Q Consensus       436 ~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~  501 (580)
                      .......             ........++..|+|||.+.+. .++.++||||+||++|||++|+.||...+..+....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7654111             1111123467789999988754 4688999999999999999999999876544333322


Q ss_pred             HHHhhhhccc----cc-----------cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          502 ASIVKEEWTN----EV-----------FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       502 ~~~~~~~~~~----~~-----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ..........    ..           .........+   ....++.+++.+||+.+|++|||+.|++.+-.-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFP---NASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCc---CCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            2221111000    00           0000000001   112456789999999999999999999986443

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=286.04  Aligned_cols=262  Identities=27%  Similarity=0.403  Sum_probs=194.1

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcC---CCCcceeeeeEEECCCC----cE
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKI---RHPNLLALRAYYLGPKG----EK  359 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----~~  359 (580)
                      +..+.||+|+||.||+|.++ +++.||+|.++.....  ....+.+|+.+++++   +|+|++++++++...+.    ..
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            45688999999999999987 5899999998744332  234566787777665   59999999999986332    28


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      +++|||+. ++|.+++.... ...+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus        82 ~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             EEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            99999996 48999887643 23589999999999999999999995 99999999999999999999999999987764


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh----hccccc--
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE----EWTNEV--  513 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~--  513 (580)
                      .....  ....++..|+|||.+.+..++.++|+|||||++|||++|+.||......+....+......    .+....  
T Consensus       159 ~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         159 FEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             CCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            33221  2234678899999999889999999999999999999999999865544332222211110    000000  


Q ss_pred             ----cchhhhccCCC-cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 ----FDLELMRDAPT-IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 ----~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          ........... .......+.+++.+||+.||.+||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                00000000000 11123456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=324.89  Aligned_cols=245  Identities=26%  Similarity=0.381  Sum_probs=193.2

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .+.+||.|.||.||.|... +|.-.|+|-++-....  .-....+|..++..++|||+|+++|+-.. .+..+|-||||+
T Consensus      1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYIFMEYCE 1317 (1509)
T ss_pred             cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHHHHHHHhc
Confidence            3668999999999999864 7889999988644332  33457889999999999999999999876 668899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc---cc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA---NV  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~  444 (580)
                      +|+|.+.++..   ...++.-...+..|++.|++|||++ |||||||||.||+++.+|-+|++|||.|.......   ..
T Consensus      1318 ~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1318 GGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             cCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            99999998753   2345555667889999999999995 99999999999999999999999999998765432   12


Q ss_pred             ceeeecCccccCCccccccC---CCCCcccchhHHHHHHHHHcCCCCCCCCCCCC-hhHHHHHHhhhhccccccchhhhc
Q 008031          445 NVIATAGALGYRAPELSKLK---KANTKTDVYSLGVTILELLTGKSPGEPLNGAE-LPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ......||+.|||||++.+.   ....++||||+|||+.||+||+.||...+..- +...+..                +
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~----------------g 1457 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA----------------G 1457 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc----------------c
Confidence            23356799999999998754   35568999999999999999999998765432 1111111                1


Q ss_pred             cCCCcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          521 DAPTIG-DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       521 ~~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..|..+ ....+-.+++.+|+..||+.|+++.|++++
T Consensus      1458 h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            112222 233455678899999999999999988776

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=273.23  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=199.7

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      +-...||.|+||+|++-.++ .|+..|||+++.... .+++++..|.+...+- +.||||+++|.+.. ++..||.||.|
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcWiCMELM  145 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCWICMELM  145 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCceeeeHHHH
Confidence            45678999999999999886 899999999986654 5677888888876655 79999999999987 77899999999


Q ss_pred             CCCChhhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          367 PHGSLATFLHAR--GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       367 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                       ..+|..+....  -....+++.-.-.|+.....||.||..+..|+|||+||+|||++..|.+|+||||++-.+.+.-..
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk  224 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK  224 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh
Confidence             45666544321  123457888788888999999999988678999999999999999999999999998765433222


Q ss_pred             ceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          445 NVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                        +.-+|...|||||.+..  ..|+.++||||+|++|||+.||..||..++.  ..+.+...+.+..+.-..+.      
T Consensus       225 --T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~------  294 (361)
T KOG1006|consen  225 --TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDK------  294 (361)
T ss_pred             --hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcc------
Confidence              22457888999998763  3588999999999999999999999988764  55666666555443322221      


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ...+....+.+++..|+-+|-..||..+++.++
T Consensus       295 -~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 -ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             222344577889999999999999999998764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.1e-35  Score=312.64  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=188.0

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC--------
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPK--------  356 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  356 (580)
                      ..++..++||+||||.||+++.+ ||+.+|||++.-... ..-..+.+|+.++++|+|||||+++..+.+..        
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            34566789999999999999988 999999999975542 23356889999999999999999866553210        


Q ss_pred             --------------------------------------------------------------------------------
Q 008031          357 --------------------------------------------------------------------------------  356 (580)
Q Consensus       357 --------------------------------------------------------------------------------  356 (580)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ------------------------------CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 008031          357 ------------------------------GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN  406 (580)
Q Consensus       357 ------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~  406 (580)
                                                    -..||-||||+..++.++++.....  -.....++++.+|+.||+|+|+ 
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~-  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHD-  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHh-
Confidence                                          0137889999887777777764211  1356788999999999999999 


Q ss_pred             CCcccCCCCCCCeeeCCCCCeEEeecccccccc-----------------cccccceeeecCccccCCccccccC---CC
Q 008031          407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT-----------------AAANVNVIATAGALGYRAPELSKLK---KA  466 (580)
Q Consensus       407 ~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~g~~~y~aPE~~~~~---~~  466 (580)
                      +|+|||||||.||++++++.|||+|||+|+...                 .......+..+||.-|+|||++.+.   .|
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            699999999999999999999999999998721                 0111134456899999999998764   49


Q ss_pred             CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCC
Q 008031          467 NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSA  546 (580)
Q Consensus       467 ~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~  546 (580)
                      +.|+|+||+|+|++||+.   ||..  ..+-...+.....         ..+..+.....++...-.++|.+++++||.+
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~---------g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k  861 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRK---------GSIPEPADFFDPEHPEEASLIRWLLSHDPSK  861 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhccc---------CCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence            999999999999999985   3542  2222222222111         1111111122334445568999999999999


Q ss_pred             CCCHHHHHHH
Q 008031          547 RPEVLQVVQQ  556 (580)
Q Consensus       547 Rps~~ev~~~  556 (580)
                      |||+.|+++.
T Consensus       862 RPtA~eLL~s  871 (1351)
T KOG1035|consen  862 RPTATELLNS  871 (1351)
T ss_pred             CCCHHHHhhc
Confidence            9999999863

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-35  Score=271.29  Aligned_cols=272  Identities=24%  Similarity=0.320  Sum_probs=198.2

Q ss_pred             HHhhhccccccCceEEEEEEeC---C--CCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE---D--GSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .|+....||+|.||.||+|.-.   +  ...+|+|+++....  .-.....+|+..++.++||||+.++.++...+...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            4677889999999999999532   2  23689999975532  223457899999999999999999999988777899


Q ss_pred             EEEeeCCCCChhhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC----CCeEEeeccc
Q 008031          361 LVFDYMPHGSLATFLHAR--GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS----TNAKISDFGL  434 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~----~~~kl~Dfg~  434 (580)
                      +++||.+. +|+..++-+  .....++...+..|+.||+.|+.|||++ =|+||||||.|||+..+    |.|||+|||+
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeecccH
Confidence            99999987 899988643  2234688888999999999999999997 79999999999999876    8999999999


Q ss_pred             cccccccccc--ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCC----CC--hhHHHHHHh
Q 008031          435 SRLMTAAANV--NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNG----AE--LPQWVASIV  505 (580)
Q Consensus       435 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~----~~--~~~~~~~~~  505 (580)
                      ++.+...-..  .....+-|++|+|||++.+ ..|+.+.||||+||++.||+|-++-|.+...    ..  ....+.+++
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            9988654322  2234567899999998776 4688899999999999999999988865321    11  111222222


Q ss_pred             h---hhccccccchhhhc-------cC-----CC--cHHH-------HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          506 K---EEWTNEVFDLELMR-------DA-----PT--IGDE-------LLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       506 ~---~~~~~~~~~~~~~~-------~~-----~~--~~~~-------~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      .   ......+-+..-++       ++     ..  ....       .....+|+.++|.+||-+|.|+++.+++---..
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~  342 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE  342 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence            1   00000000000000       00     00  0000       012568888999999999999999988754433

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.9e-35  Score=287.52  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=197.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|+.++++++ |+||+++++++.. ++..++||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~   81 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYFVL   81 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEEEE
Confidence            455688999999999999986 79999999986532   223456889999999998 9999999999876 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++++|.+++.+.+   .+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++++|||++........
T Consensus        82 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          82 EYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            9999999999998753   689999999999999999999995 999999999999999999999999999876543321


Q ss_pred             -------------------cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHH
Q 008031          444 -------------------VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASI  504 (580)
Q Consensus       444 -------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~  504 (580)
                                         .......++..|+|||......++.++|+||+|++++++++|+.||........   ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~  234 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQKI  234 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH
Confidence                               122234578899999998888899999999999999999999999986542221   1111


Q ss_pred             hhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHH
Q 008031          505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEV----LQVVQQ  556 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~----~ev~~~  556 (580)
                      ....+       ..   ...   ....+.+++.+||+.+|.+|||+    .+++++
T Consensus       235 ~~~~~-------~~---~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         235 LKLEY-------SF---PPN---FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HhcCC-------CC---CCc---cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            11100       00   011   12356788899999999999999    787764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-34  Score=284.20  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=196.8

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      ..+.||+|+||.||+|... +++.||+|.+....  ......+..|+.++++++|+|++++++++.. .+..++||||++
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEYCD   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecCcC
Confidence            4578999999999999986 59999999987653  2234567889999999999999999999986 568999999997


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                       ++|.+++....  ..+++..+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||.+........ ...
T Consensus        82 -~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (282)
T cd07829          82 -MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT  156 (282)
T ss_pred             -cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence             59999998752  3689999999999999999999994 999999999999999999999999999876543322 122


Q ss_pred             eecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc--------cchhh
Q 008031          448 ATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV--------FDLEL  518 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  518 (580)
                      ...++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+...........+        .+...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            23456789999988766 8899999999999999999999999765533322222221110000000        00000


Q ss_pred             hccCCC-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          519 MRDAPT-----IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       519 ~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......     .+.....+.+++.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000000     00113467789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.7e-34  Score=287.66  Aligned_cols=264  Identities=22%  Similarity=0.361  Sum_probs=195.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++||||+++.+++.......++++||
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            667799999999999999876 799999998754322  23456789999999999999999999987656678999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      + +++|.++++..    .++......++.|++.||+|||+ .+++||||+|+||++++++.++++|||.+.......   
T Consensus        92 ~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~---  162 (328)
T cd07856          92 L-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM---  162 (328)
T ss_pred             h-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc---
Confidence            9 56898887642    47888888999999999999999 499999999999999999999999999987543221   


Q ss_pred             eeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hccccccch-----
Q 008031          446 VIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTNEVFDL-----  516 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-----  516 (580)
                       ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......   +......+.     
T Consensus       163 -~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         163 -TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             -CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence             22356788999998765 57889999999999999999999999755432111111111000   000000000     


Q ss_pred             --hhhccCCCcH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcc
Q 008031          517 --ELMRDAPTIG-----DELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRP  562 (580)
Q Consensus       517 --~~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~  562 (580)
                        ......+...     ....++.+++.+||+.+|++|||+.+++.+  ++..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence              0000000000     112467788999999999999999999887  444433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.6e-34  Score=293.04  Aligned_cols=262  Identities=21%  Similarity=0.267  Sum_probs=191.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----------
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----------  356 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----------  356 (580)
                      |...+.||.|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++....           
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT   86 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence            556789999999999999875 68999999987655555677889999999999999999998765432           


Q ss_pred             --CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCCCeEEeecc
Q 008031          357 --GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFG  433 (580)
Q Consensus       357 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg  433 (580)
                        ...++||||++ ++|.+++...    .+++..+..++.||+.||.|||+. |++||||||+||+++ +++.+|++|||
T Consensus        87 ~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          87 ELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             ccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCcc
Confidence              24689999996 5898887642    588999999999999999999994 999999999999998 45678999999


Q ss_pred             cccccccccccc--eeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh----
Q 008031          434 LSRLMTAAANVN--VIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK----  506 (580)
Q Consensus       434 ~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~----  506 (580)
                      +++.........  .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+..........    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987653321111  112356788999997654 5678899999999999999999999976543222211111000    


Q ss_pred             ---hhcc----ccccchhhhccCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          507 ---EEWT----NEVFDLELMRDAP---TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       507 ---~~~~----~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ....    ............+   .......++.+++.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence               0000    0000000000000   000112456789999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-34  Score=289.36  Aligned_cols=266  Identities=22%  Similarity=0.332  Sum_probs=194.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      |...+.||+|+||.||+|... +|+.||+|+++....  .....+.+|+.++++++||||+++++++....     ...+
T Consensus        17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   96 (342)
T cd07879          17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY   96 (342)
T ss_pred             eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence            456789999999999999975 789999999865322  22346789999999999999999999986532     2468


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +|+||+. .+|.++..     ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+|++|||+++....
T Consensus        97 lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          97 LVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             EEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            9999995 47766553     2488999999999999999999995 999999999999999999999999999875432


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh---ccccccc-
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE---WTNEVFD-  515 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~-  515 (580)
                      ..    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+.......   ......+ 
T Consensus       170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         170 EM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             CC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            21    22356788999998865 468899999999999999999999997644222111111100000   0000000 


Q ss_pred             --hhh---hccCCC------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhccccc
Q 008031          516 --LEL---MRDAPT------IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPEAA  565 (580)
Q Consensus       516 --~~~---~~~~~~------~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~~~  565 (580)
                        ...   ....+.      .+....++.+++.+||+.||++||++.+++.+  ++.+++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~  308 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE  308 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence              000   000000      00112356789999999999999999999977  887765433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.2e-34  Score=280.72  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=191.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-----TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |.+.+.||+|+||.||++.+. .+..+++|.++...     .....++..|+.++++++||||+++++++.+ ....++|
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   80 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-RDAFCII   80 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-CCceEEE
Confidence            456788999999999999876 34556666654321     1223457789999999999999999999876 5578999


Q ss_pred             EeeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          363 FDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      |||+++++|.+++... .....+++..+..++.|++.|+.|||+. |++|+||+|+||++++ +.++++|||.+......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            9999999999988653 2235689999999999999999999994 9999999999999985 56999999998765433


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ... .....++..|+|||...+..++.++|+||||+++|+|++|..||....   ..............           
T Consensus       159 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~-----------  223 (260)
T cd08222         159 CDL-ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGPTP-----------  223 (260)
T ss_pred             ccc-ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCCCC-----------
Confidence            221 223457888999999888888999999999999999999999996433   22222222111110           


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ........++.+++.+||+.+|++||++.|++++
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 -SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence             0011223467789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=276.36  Aligned_cols=236  Identities=26%  Similarity=0.354  Sum_probs=189.7

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ||.|+||.||++... +++.+|+|.+......   ....+..|+.++++++|+||+++++.+.. +...+++|||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            699999999999986 5899999998755432   34578899999999999999999999876 668999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeec
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA  450 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  450 (580)
                      |.+++....   .+++..+..++.|+++|+.|||+ .+++|+||+|+||+++.++.++++|||++....... .......
T Consensus        80 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~  154 (250)
T cd05123          80 LFSHLSKEG---RFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC  154 (250)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence            999997642   58999999999999999999999 599999999999999999999999999987654332 1122345


Q ss_pred             CccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHH
Q 008031          451 GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL  530 (580)
Q Consensus       451 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  530 (580)
                      ++..|+|||...+...+.++|+||||+++|++++|+.||...+..   +....+.....       ..   ....   ..
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~-------~~---~~~~---~~  218 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKILKDPL-------RF---PEFL---SP  218 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHhcCCC-------CC---CCCC---CH
Confidence            788899999998888899999999999999999999999755432   22222211110       00   0111   23


Q ss_pred             HHHHHHhhccCCCCCCCCCHHH
Q 008031          531 NTLKLALHCVDPSPSARPEVLQ  552 (580)
Q Consensus       531 ~l~~li~~cl~~~P~~Rps~~e  552 (580)
                      .+.+++.+||..||++|||+.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            5668888999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.6e-34  Score=288.09  Aligned_cols=260  Identities=22%  Similarity=0.269  Sum_probs=190.7

Q ss_pred             HhhhccccccCceEEEEEEeC-C--CCEEEEEEccccccc--cHHHHHHHHHHHhcC-CCCcceeeeeEEECC---CCcE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-D--GSQVAVKRLREKITK--GQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEK  359 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~---~~~~  359 (580)
                      |.+.+.||+|+||.||++... +  +..||+|.+......  ..+.+.+|+.+++++ +||||+++++.+...   ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            456788999999999999976 4  788999998643222  245678899999999 599999999875432   2357


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++++||+. ++|.+++...   ..+++..+..++.||+.||+|||+ .|++||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          82 YLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            88899985 6899888653   368999999999999999999999 599999999999999999999999999997654


Q ss_pred             ccccc---ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hcccc
Q 008031          440 AAANV---NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTNE  512 (580)
Q Consensus       440 ~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~  512 (580)
                      .....   ......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.......+......   +....
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32211   1123468889999998655 56889999999999999999999999765432222211111000   00000


Q ss_pred             ccch---------------hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          513 VFDL---------------ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       513 ~~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....               .+....+.   ....+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPN---ANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCC---CCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000               00000011   12357789999999999999999999866

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-34  Score=289.25  Aligned_cols=258  Identities=21%  Similarity=0.305  Sum_probs=190.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      |.+.+.||+|+||.||+|... +|..||||.+......  ....+.+|+.++++++||||+++++++....     ...+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07880          17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY   96 (343)
T ss_pred             eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence            556789999999999999865 7899999998643222  2346789999999999999999999987532     1358


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+ +++|.+++..    ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++++|||++.....
T Consensus        97 lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          97 LVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             EEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            999999 7799888764    3589999999999999999999994 999999999999999999999999999876533


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hccccccch
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTNEVFDL  516 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  516 (580)
                      ..    ....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||...+.......+......   .....+...
T Consensus       171 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         171 EM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             Cc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            21    22356788999998875 45888999999999999999999999765432111111110000   000000000


Q ss_pred             ---hhhccCC---------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ---ELMRDAP---------TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ---~~~~~~~---------~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ......+         ........+.+++.+|++.||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               0000000         000112356789999999999999999999954

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-34  Score=289.38  Aligned_cols=259  Identities=23%  Similarity=0.308  Sum_probs=190.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----CCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-----KGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~  360 (580)
                      |...+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.++++++||||+++++++...     ....+
T Consensus        19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   98 (345)
T cd07877          19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   98 (345)
T ss_pred             eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence            456788999999999999864 789999999865322  2245678899999999999999999988642     13467


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      ++++++ +++|.+++...    .+++..+..++.|+++||+|||+ .|++||||||+||++++++.+||+|||++.....
T Consensus        99 lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          99 LVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             EEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            888887 78998887643    48999999999999999999999 5999999999999999999999999999875432


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hccccccch
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTNEVFDL  516 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  516 (580)
                      .    .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.......+.+....   .......+.
T Consensus       173 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         173 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             c----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            2    123457888999998765 56888999999999999999999999654432221111111000   000000000


Q ss_pred             ---hhh---ccCCC-c-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          517 ---ELM---RDAPT-I-----GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       517 ---~~~---~~~~~-~-----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                         ...   ...+. .     ......+.+++.+|++.||.+|||+.+++.+=
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence               000   00000 0     01123567899999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-34  Score=289.61  Aligned_cols=258  Identities=22%  Similarity=0.310  Sum_probs=192.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-----cEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-----EKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~~  360 (580)
                      |...+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++|+|++++.+++...+.     ..+
T Consensus        17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07851          17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY   96 (343)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence            456789999999999999986 688999999864322  233557789999999999999999987765321     389


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +|+||+ +++|.+++..    ..+++..+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||++.....
T Consensus        97 lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          97 LVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             EEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            999999 6799998875    3589999999999999999999994 999999999999999999999999999876543


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hccccccch
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTNEVFDL  516 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  516 (580)
                      .    .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+..+....+......   .....+...
T Consensus       171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             c----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            2    223357788999998764 46788999999999999999999999765432222211111100   000000000


Q ss_pred             ---hh----hcc-CCCc----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ---EL----MRD-APTI----GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ---~~----~~~-~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ..    ... .+..    .....++.+++.+||+.+|++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence               00    000 0000    0113467789999999999999999999886

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=274.43  Aligned_cols=238  Identities=23%  Similarity=0.332  Sum_probs=192.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccH---HHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQ---REFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +....+||+|+||.|..|.-+ +...+|||++++...-..   +--+.|-++|+.. +-|.++++..+++. .+.+|+||
T Consensus       351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-mDRLyFVM  429 (683)
T KOG0696|consen  351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-MDRLYFVM  429 (683)
T ss_pred             cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-hhheeeEE
Confidence            345789999999999999876 566799999987654322   2345677888877 56889999888876 67999999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+.||+|--+++..+   .+.+..+..+|.+||-||-+||+ +||++||||..|||++.+|++||+|||+++.-- ...
T Consensus       430 EyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~~  504 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FDG  504 (683)
T ss_pred             EEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCceEeeecccccccc-cCC
Confidence            9999999998888754   57788899999999999999999 699999999999999999999999999997432 223


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ....++.||+.|+|||++....|+.++|.|||||+||||+.|++||++.++.++.+.+..   ..             ..
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e---hn-------------vs  568 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME---HN-------------VS  568 (683)
T ss_pred             cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---cc-------------Cc
Confidence            345568899999999999999999999999999999999999999999888776665542   11             11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCC
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARP  548 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rp  548 (580)
                      .......+...+....+..+|.+|.
T Consensus       569 yPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  569 YPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             CcccccHHHHHHHHHHhhcCCcccc
Confidence            1112233555666677888888885

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=303.87  Aligned_cols=251  Identities=22%  Similarity=0.267  Sum_probs=204.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.++||+|+||.|..++.. +++.+|+|++.+..   ..+..-|..|-.+|..-+.+=|+.+...|++ +.++|+|||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-~~~LYlVMd  155 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-ERYLYLVMD  155 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-ccceEEEEe
Confidence            678899999999999999986 78899999997642   2344568899999999999999999999987 679999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ||+||+|..++.+.+   .++++-++.++..|+-||.-+|+. |+|||||||+|||+|..|++|++|||.+-.+..++..
T Consensus       156 Y~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             cccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            999999999998763   689999999999999999999995 9999999999999999999999999999988888888


Q ss_pred             ceeeecCccccCCccccc----c-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          445 NVIATAGALGYRAPELSK----L-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .....+|||-|++||++.    + +.|++.+|+||+||++|||+.|..||....   +.....+|+..+..-.     +.
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads---lveTY~KIm~hk~~l~-----FP  303 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS---LVETYGKIMNHKESLS-----FP  303 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH---HHHHHHHHhchhhhcC-----CC
Confidence            888889999999999864    3 678999999999999999999999997533   4444455554421110     00


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPE---VLQVVQQL  557 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ev~~~L  557 (580)
                       +....+++..   +||.+.+ -+|+.|..   +.++..|-
T Consensus       304 -~~~~VSeeak---dLI~~ll-~~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  304 -DETDVSEEAK---DLIEALL-CDREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             -cccccCHHHH---HHHHHHh-cChhhhcccccHHHHHhCc
Confidence             1112333444   4444432 47888888   99988875

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=282.69  Aligned_cols=246  Identities=23%  Similarity=0.371  Sum_probs=198.2

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      .+++|+|.||+||-|+++ +|+.||||++.+-.  .+.+..+..|+.+|..++||.||.+...|.. .+..+.|||-+ +
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl-~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKL-H  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhh-c
Confidence            578999999999999986 89999999996543  3455779999999999999999999888866 67999999999 5


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeecccccccccccccc
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      |++.+.+-... ...+++.....++.||+-||.|||- ++|+|+||||+|||+..   -.++|+||||+|++.++.....
T Consensus       647 GDMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr  724 (888)
T KOG4236|consen  647 GDMLEMILSSE-KGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR  724 (888)
T ss_pred             chHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence            57666665433 4578999999999999999999998 59999999999999963   4579999999999987655443


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                        ..+||+.|+|||++.++.|+..-|+||+||++|--++|..||....  ++.+.+..   .   ...+.+.-|      
T Consensus       725 --sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQN---A---aFMyPp~PW------  788 (888)
T KOG4236|consen  725 --SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQN---A---AFMYPPNPW------  788 (888)
T ss_pred             --hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhc---c---ccccCCCch------
Confidence              4789999999999999999999999999999999999999997543  33332221   1   112222222      


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .+.....+++|...|+..-++|-|.+..+.|-
T Consensus       789 ~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  789 SEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             hhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            23334677888899999999999998877653

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-34  Score=240.62  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=193.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...++||+|.||+||+|+.. +++.||+|.++-..  ........+|+.+++.++|+|||++++.... +...-+|+||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe~   82 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEF   82 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHHH
Confidence            445689999999999999865 68889999986443  2335678899999999999999999998865 6688999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      |.. +|..+....  ...++.+.+..++.|+++||.++|++ ++.|||+||+|.+++.+|.+|++|||+++-++-.... 
T Consensus        83 cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrc-  157 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-  157 (292)
T ss_pred             hhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence            954 888888775  35688899999999999999999995 9999999999999999999999999999877644322 


Q ss_pred             eeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhh----hhccc--cccchh
Q 008031          446 VIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK----EEWTN--EVFDLE  517 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~  517 (580)
                      ....+-|.+|++|+++.+. -|++..|+||-||++.|+.. |++-|.+.+-.+....+-....    +.|+.  ..-|..
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            2234578899999987764 58889999999999999998 6666665443332222222211    11111  111111


Q ss_pred             hhccCCCcHH---HHH----HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAPTIGD---ELL----NTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~---~~~----~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..+..+....   .+.    .=.+++.+.+.-+|..|.++++.+++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1111111111   111    12356667777899999999988875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=273.91  Aligned_cols=255  Identities=23%  Similarity=0.290  Sum_probs=195.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      |-...++|+|+|+.||+|.+- ..+.||+|+-.-....       -.+...+|.++.+.|+||.||++|+++.-+.+.+|
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC  544 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC  544 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence            344678999999999999864 5788999986432211       12457899999999999999999999988777899


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccCCCCCCCeeeC---CCCCeEEeeccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-ENIIHGNLTSSNVLLD---DSTNAKISDFGLSR  436 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~  436 (580)
                      -|+|||+|.+|.-||+..   ..++++++..|+.||+.||.||.+. +.|+|-||||.|||+-   .-|.+||.|||+++
T Consensus       545 TVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  545 TVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             eeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            999999999999888765   3689999999999999999999874 6899999999999995   35779999999999


Q ss_pred             cccccccc------ceeeecCccccCCcccccc----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh
Q 008031          437 LMTAAANV------NVIATAGALGYRAPELSKL----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK  506 (580)
Q Consensus       437 ~~~~~~~~------~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  506 (580)
                      ++.++...      -.....||++|++||.+.-    ...+.|+||||+||++|.++.|+.||+......      .++.
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ------dILq  695 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ------DILQ  695 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH------HHHh
Confidence            98764332      1234579999999997653    356779999999999999999999998643221      1222


Q ss_pred             hhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ........+..    +|..+-...+...+|.+||++.-+.|....++..+
T Consensus       696 eNTIlkAtEVq----FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  696 ENTILKATEVQ----FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hhchhcceecc----CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            21111111111    22222223355578889999999999988887654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-35  Score=261.29  Aligned_cols=269  Identities=23%  Similarity=0.363  Sum_probs=203.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECC-------CC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGP-------KG  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------~~  357 (580)
                      .|....+||+|.||.||+|+.. +|+.||+|++....  ..-.....+|+++|..++|+|++.+++.|...       ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4666789999999999999876 68889998764322  22345668899999999999999999988652       23


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      .+|+||.+|+. +|.-.+...  ...++..++.+++.++..||.|+|.+ .|+|||+|+.|+||+.++.+|++|||+++.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            47999999977 888887654  35688999999999999999999996 899999999999999999999999999975


Q ss_pred             cccccc---cceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh----hc
Q 008031          438 MTAAAN---VNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE----EW  509 (580)
Q Consensus       438 ~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~  509 (580)
                      +....+   ...+..+-|.+|++||.+.+ ..|+++.|||.-||++.||+|+.+-+.+.........++.....    -|
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            543222   22334456899999997664 67899999999999999999999999877665555555543321    12


Q ss_pred             cccccchhhhcc----------CCCcHHHHH------HHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          510 TNEVFDLELMRD----------APTIGDELL------NTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       510 ~~~~~~~~~~~~----------~~~~~~~~~------~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      + ++....++..          .....+.+.      +..+|+++++..||.+|+++++++.|---..
T Consensus       254 P-~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  254 P-NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             C-CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            1 1111111111          011122222      5678999999999999999999998865443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.3e-33  Score=304.16  Aligned_cols=143  Identities=24%  Similarity=0.370  Sum_probs=126.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++.....   ....+.+|+.+++.++|+||+++++++.. .+..|+|||
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lVmE   84 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLVME   84 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEEEe
Confidence            456789999999999999987 7899999998654321   23568899999999999999999988876 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      |+.+++|.+++...   ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999764   3578899999999999999999995 99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-34  Score=284.94  Aligned_cols=239  Identities=18%  Similarity=0.268  Sum_probs=191.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.....+|.|+|+.|-.+... +++..++|++....    .+..+|+.++... +||||+++.+.+.+ +.+.|+|||.+
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v~e~l  398 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLVMELL  398 (612)
T ss_pred             hccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecC-Cceeeeeehhc
Confidence            555667999999999988875 78899999987652    2335577666666 79999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee-CCCCCeEEeecccccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL-DDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~-~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      .++-+.+.+....   .+. ..+..|+.+|+.|+.|||+ +|||||||||+|||+ ++.++++|+|||.++.....    
T Consensus       399 ~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  399 DGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             cccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            9999888887642   233 6777899999999999999 599999999999999 58899999999999876554    


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-ChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA-ELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ....+-|..|.|||+.....|++++|+||+|++||+|++|+.||...+.. ++...+..   ....              
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~---~~~s--------------  532 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM---PKFS--------------  532 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC---Cccc--------------
Confidence            22334577899999999999999999999999999999999999876654 22222211   1110              


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                       ..-.....+|+.+||+.||.+||++.++..+-.-
T Consensus       533 -~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 -ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence             1122355678889999999999999999988665

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.3e-33  Score=265.92  Aligned_cols=219  Identities=22%  Similarity=0.247  Sum_probs=173.0

Q ss_pred             cCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhh
Q 008031          298 STYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLH  376 (580)
Q Consensus       298 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  376 (580)
                      |.+|.||++.+. +++.||+|.++...     .+.+|...+....||||+++++++.. ....+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHH
Confidence            899999999986 78999999986542     23345555556679999999999986 568999999999999999987


Q ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeecCccccC
Q 008031          377 ARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR  456 (580)
Q Consensus       377 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~  456 (580)
                      +.   ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++++|||.+.......    ....++..|+
T Consensus        78 ~~---~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~  149 (237)
T cd05576          78 KF---LNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC  149 (237)
T ss_pred             Hh---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence            64   358999999999999999999999 599999999999999999999999999876554321    1234566799


Q ss_pred             CccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHH
Q 008031          457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLA  536 (580)
Q Consensus       457 aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  536 (580)
                      |||.+.+..++.++|+||+|+++|||++|+.|+......     +..         ......   .+.   ....+.+++
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~---------~~~~~~---~~~---~~~~~~~li  209 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT---------HTTLNI---PEW---VSEEARSLL  209 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc---------ccccCC---ccc---CCHHHHHHH
Confidence            999998888999999999999999999999887542210     000         000000   011   123566788


Q ss_pred             hhccCCCCCCCCCH
Q 008031          537 LHCVDPSPSARPEV  550 (580)
Q Consensus       537 ~~cl~~~P~~Rps~  550 (580)
                      .+||+.||++||++
T Consensus       210 ~~~l~~dp~~R~~~  223 (237)
T cd05576         210 QQLLQFNPTERLGA  223 (237)
T ss_pred             HHHccCCHHHhcCC
Confidence            99999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=284.83  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=203.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEEC----CCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLG----PKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~~lv  362 (580)
                      +++.+.||+|.+|.||+++.. +|+.+|+|++.... +.+++.+.|.++++.. +|||++.++|++..    .++++|+|
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            445789999999999999865 78899999886543 3456788899999988 79999999999974    35689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      ||||.+|+..|+++... ...+.|..+..|+..++.|+.+||.+ .++|||||-.|||++.++.||++|||.+.......
T Consensus       100 MEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV  177 (953)
T ss_pred             eeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence            99999999999998765 66799999999999999999999997 89999999999999999999999999987765443


Q ss_pred             ccceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          443 NVNVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      . ......||+.|||||++.     ...|+.++|+||+|++..||--|.+|+-++......-.    +....+..     
T Consensus       178 g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----IpRNPPPk-----  247 (953)
T KOG0587|consen  178 G-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPK-----  247 (953)
T ss_pred             c-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----CCCCCCcc-----
Confidence            3 233467999999999875     34677789999999999999999999876654321110    11111111     


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          ......+..++.++|..|+..|-++||++.++++|
T Consensus       248 ----Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  248 ----LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----ccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                11234567889999999999999999999998865

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=277.03  Aligned_cols=246  Identities=22%  Similarity=0.279  Sum_probs=205.3

Q ss_pred             hccccccCceEEEEEEeCCCC-EEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          292 AEIMGKSTYGTVYKATLEDGS-QVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      ...+|-|+||.|=.+..+... .+|+|++++..   ++.++.+..|-++|...+.|.||++|-.|.+ ....|+.||-|-
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmLmEaCl  503 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYMLMEACL  503 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhhHHhhc
Confidence            456999999999999877433 48999887654   3445678899999999999999999999987 558999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      ||.|+..++.++   .++..+...++.-++.|++|||++ ||++|||||+|.+++.+|-+|+.|||+|+......  +..
T Consensus       504 GGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTw  577 (732)
T KOG0614|consen  504 GGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTW  577 (732)
T ss_pred             CchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccCC--cee
Confidence            999999999874   688888999999999999999995 99999999999999999999999999999876543  455


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      +++||+.|.|||++.+...+.++|.||+|+++|||++|.+||.+.+.......+.+.+..-.            +|  ..
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------------~P--r~  643 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------------FP--RR  643 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh------------cc--cc
Confidence            68999999999999999999999999999999999999999999887766666554332110            11  11


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHh
Q 008031          528 ELLNTLKLALHCVDPSPSARPE-----VLQVVQQLE  558 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~L~  558 (580)
                      ..+...++|.+....+|.+|.-     +.++.+|-+
T Consensus       644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence            2235567888888899999986     777777753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.5e-32  Score=292.44  Aligned_cols=259  Identities=17%  Similarity=0.215  Sum_probs=165.5

Q ss_pred             HhhhccccccCceEEEEEEeC-C----CCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeE----E-ECCCCc
Q 008031          289 CATAEIMGKSTYGTVYKATLE-D----GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY----Y-LGPKGE  358 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~----~-~~~~~~  358 (580)
                      |...+.||+|+||.||+|.+. +    +..||+|++......  +....|  .+....+.++..+...    . ...+..
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence            566789999999999999986 4    689999987643211  111111  1112222222222111    1 123557


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee
Q 008031          359 KLLVFDYMPHGSLATFLHARGPE-----------------TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL  421 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~  421 (580)
                      .++||||+.+++|.+++......                 .......+..++.|++.||+|||+ ++|+||||||+|||+
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~NILl  288 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQNIIF  288 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHHEEE
Confidence            89999999999999998754210                 011233456799999999999999 599999999999999


Q ss_pred             CC-CCCeEEeecccccccccccccceeeecCccccCCccccccC----------------------CCCCcccchhHHHH
Q 008031          422 DD-STNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK----------------------KANTKTDVYSLGVT  478 (580)
Q Consensus       422 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Dv~s~G~~  478 (580)
                      ++ ++.+||+|||+++..............+++.|||||.+...                      .++.++||||+||+
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi  368 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI  368 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence            85 57899999999986644333333345788999999965322                      23456799999999


Q ss_pred             HHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc----ccccchh----hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 008031          479 ILELLTGKSPGEPLNGAELPQWVASIVKEEWT----NEVFDLE----LMRDAPTIGDELLNTLKLALHCVDPSPSARPEV  550 (580)
Q Consensus       479 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~  550 (580)
                      +|||+++..|++.    +..+....+......    ....+..    ................+|+.+|++.||++|||+
T Consensus       369 L~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        369 FLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            9999997766432    122221111110000    0000000    000000000111234579999999999999999


Q ss_pred             HHHHHH
Q 008031          551 LQVVQQ  556 (580)
Q Consensus       551 ~ev~~~  556 (580)
                      .|+++|
T Consensus       445 ~e~L~H  450 (566)
T PLN03225        445 KAALAH  450 (566)
T ss_pred             HHHhCC
Confidence            999997

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=5.9e-33  Score=285.28  Aligned_cols=244  Identities=27%  Similarity=0.441  Sum_probs=186.4

Q ss_pred             hhccccccCceE-EEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          291 TAEIMGKSTYGT-VYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       291 ~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      ..+++|.|+.|+ ||+|.++ |+.||||++-..   ...-..+|+..|+.- +|||||++++.-.+ +...||..|.|. 
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIalELC~-  586 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIALELCA-  586 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEehHhh-
Confidence            456789999975 7999998 889999987543   234568899999998 69999999877655 557899999995 


Q ss_pred             CChhhhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---C--CCeEEeeccccccccccc
Q 008031          369 GSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---S--TNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       369 g~L~~~l~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~--~~~kl~Dfg~~~~~~~~~  442 (580)
                      .+|.+++...+.... ...-..+.+..|+++||++||+ -+||||||||+||||+.   +  .+++|+|||+++......
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            599999987411111 1113457889999999999999 59999999999999975   2  468999999999886543


Q ss_pred             cc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..  ...+..||.+|+|||++....-+.++||||+||++|+.++ |.+||++.-..+     ..++.+......     +
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-----~NIl~~~~~L~~-----L  735 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-----ANILTGNYTLVH-----L  735 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-----hhhhcCccceee-----e
Confidence            32  3345679999999999998888889999999999999999 599998643221     122222221111     1


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .   ...++  +..+||.+|++++|..||++.+|+.|
T Consensus       736 ~---~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  736 E---PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             c---cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1   11112  66789999999999999999999865

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=1.9e-31  Score=256.77  Aligned_cols=238  Identities=29%  Similarity=0.409  Sum_probs=190.6

Q ss_pred             CceEEEEEEeC-CCCEEEEEEcccccccc-HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhh
Q 008031          299 TYGTVYKATLE-DGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLH  376 (580)
Q Consensus       299 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  376 (580)
                      +||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++.. ....++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence            58999999987 58999999987655444 6789999999999999999999999986 568999999999999999987


Q ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeecCccccC
Q 008031          377 ARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR  456 (580)
Q Consensus       377 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~  456 (580)
                      ...   .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+.......  ......++..|+
T Consensus        80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       80 KRG---RLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             hcc---CCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            643   288999999999999999999995 99999999999999999999999999988765432  222345788899


Q ss_pred             CccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHH
Q 008031          457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLA  536 (580)
Q Consensus       457 aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  536 (580)
                      +||...+..++.++||||+|+++|++++|..||......  ...............          ........++.+++
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~i  221 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKPPFP----------PPEWKISPEAKDLI  221 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCCCc----------cccccCCHHHHHHH
Confidence            999998888999999999999999999999999763221  111111111111000          00000123677889


Q ss_pred             hhccCCCCCCCCCHHHHHH
Q 008031          537 LHCVDPSPSARPEVLQVVQ  555 (580)
Q Consensus       537 ~~cl~~~P~~Rps~~ev~~  555 (580)
                      .+||..+|++||++.++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHccCCchhccCHHHHhh
Confidence            9999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.1e-31  Score=278.40  Aligned_cols=262  Identities=18%  Similarity=0.257  Sum_probs=176.6

Q ss_pred             HhhhccccccCceEEEEEEe-----------------CCCCEEEEEEccccccccH--------------HHHHHHHHHH
Q 008031          289 CATAEIMGKSTYGTVYKATL-----------------EDGSQVAVKRLREKITKGQ--------------REFESEVSLL  337 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~e~~~l  337 (580)
                      |...++||+|+||.||+|..                 .+++.||||++........              +....|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            56679999999999999964                 2356899999864322111              2234577777


Q ss_pred             hcCCCCcc-----eeeeeEEECC-------CCcEEEEEeeCCCCChhhhhhhcCC---------------------CCCC
Q 008031          338 GKIRHPNL-----LALRAYYLGP-------KGEKLLVFDYMPHGSLATFLHARGP---------------------ETPI  384 (580)
Q Consensus       338 ~~l~h~ni-----v~~~~~~~~~-------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~  384 (580)
                      .+++|.++     ++++++|...       ++..++||||+++++|.++++....                     ...+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            77766544     6777777531       3468999999999999999875311                     1234


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeecCccccCCccccccC
Q 008031          385 DWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK  464 (580)
Q Consensus       385 ~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  464 (580)
                      ++..+..++.|++.+|.|||+ .+|+||||||+||+++.++.+||+|||++...............+++.|+|||.+...
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            677889999999999999999 4999999999999999999999999999976543322222223457899999987533


Q ss_pred             C--------------------CC--CcccchhHHHHHHHHHcCCC-CCCCCCCCChhHHHHHHhhhhc---cccccchhh
Q 008031          465 K--------------------AN--TKTDVYSLGVTILELLTGKS-PGEPLNGAELPQWVASIVKEEW---TNEVFDLEL  518 (580)
Q Consensus       465 ~--------------------~~--~~~Dv~s~G~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  518 (580)
                      .                    ++  .+.||||+||++|+|++|.. ||...................+   .....+.  
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~--  463 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF--  463 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc--
Confidence            2                    11  24699999999999999875 6654321110000000000000   0011111  


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSP---SARPEVLQVVQQL  557 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rps~~ev~~~L  557 (580)
                          +..........+++.+++..+|   .+|+|+.|+++|=
T Consensus       464 ----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        464 ----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             ----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence                1111122355677788888765   7899999999873

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-31  Score=231.96  Aligned_cols=213  Identities=26%  Similarity=0.380  Sum_probs=171.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .......||+|++|.|-+.++. +|+..|+|.++.... +.+++..+|+.+..+. .+|.+|.++|.... .+..++.||
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egdvwIcME  125 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGDVWICME  125 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-cccEEEeHH
Confidence            3456778999999999888764 899999999986654 3456678889887765 79999999998876 678999999


Q ss_pred             eCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          365 YMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      .| ..+|..+.++. .....+++.-.-+|+..+..||.|||+.-.++|||+||+|||++.+|++|+||||++-.+.+.-.
T Consensus       126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence            99 45887776542 33567888889999999999999999977899999999999999999999999999976654322


Q ss_pred             cceeeecCccccCCccccc----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh
Q 008031          444 VNVIATAGALGYRAPELSK----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK  506 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  506 (580)
                      ..  ...|...|||||.+.    ...|+.|+||||+|+.+.||.+++.||+.+.  ...+.+++.+.
T Consensus       205 kt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqvVe  267 (282)
T KOG0984|consen  205 KT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQVVE  267 (282)
T ss_pred             HH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHHhc
Confidence            22  134777899999865    3478899999999999999999999997543  34455555443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.3e-32  Score=239.31  Aligned_cols=276  Identities=15%  Similarity=0.234  Sum_probs=201.9

Q ss_pred             CCeeeeeCCCcccCHHHHHHhhhccccccCceEEEEEEe-CCCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCccee
Q 008031          270 GGKLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLA  347 (580)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~  347 (580)
                      ....+.++...+....+..|++.+++|+|.++.||.|.. .+...++||++++-   ..+.+.+|+.+|..|. ||||++
T Consensus        21 p~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~   97 (338)
T KOG0668|consen   21 PREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIK   97 (338)
T ss_pred             chhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeee
Confidence            334455555444444556688999999999999999985 46788999998754   3457889999999996 999999


Q ss_pred             eeeEEECCCC-cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCC
Q 008031          348 LRAYYLGPKG-EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DST  425 (580)
Q Consensus       348 ~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~  425 (580)
                      +++...+... ...+|+||+++.+......      .++..++..+..++++||.|+|+ .||.|||+||.|+++| +..
T Consensus        98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~r  170 (338)
T KOG0668|consen   98 LLDIVKDPESKTPSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELR  170 (338)
T ss_pred             hhhhhcCccccCchhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhc
Confidence            9999987443 4679999999877666543      47778899999999999999999 5999999999999999 456


Q ss_pred             CeEEeecccccccccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCC-CCCCCCChhHHHHH
Q 008031          426 NAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPG-EPLNGAELPQWVAS  503 (580)
Q Consensus       426 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~-~~~~~~~~~~~~~~  503 (580)
                      .++++|+|+|.++-.......  .+.+..|.-||++.. ..|+..-|+|||||++..|+..+.|| .+.+..+-.-.+.+
T Consensus       171 kLrlIDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak  248 (338)
T KOG0668|consen  171 KLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK  248 (338)
T ss_pred             eeeeeecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence            799999999988755444332  346677899997654 56888999999999999999998887 34333332222222


Q ss_pred             Hhhhhcc-------ccccchhhhc-----------cCCCcH---HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          504 IVKEEWT-------NEVFDLELMR-----------DAPTIG---DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       504 ~~~~~~~-------~~~~~~~~~~-----------~~~~~~---~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .+.....       .-.+|++...           .+-...   -...+.++++.+.|.+|-.+|||++|.+.|=
T Consensus       249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence            2211100       0112222211           000000   0125677888899999999999999998763

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-33  Score=251.28  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC----cEEEEEe
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG----EKLLVFD  364 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~~lv~e  364 (580)
                      .+.||-|+||.||..++. +|+.||+|++..-.  -...+.+.+|++++..++|.|+...+++.+...-    +.|.++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            578999999999999986 89999999985432  1245678899999999999999999988865322    3578888


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      .| ..+|...+-+   .+.++.+.+.-+++||++||.|||+ .+|+||||||.|.|++.+..+||||||+++.-..+...
T Consensus       138 Lm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  138 LM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            88 4478777765   3578889999999999999999999 59999999999999999999999999999977766666


Q ss_pred             ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc-----------cc
Q 008031          445 NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT-----------NE  512 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~  512 (580)
                      .++..+-|..|+|||++.+ ..|+.+.||||+||++.|++..+.-|...+..+-.+.+-..+.....           ..
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            6666677889999998876 46889999999999999999999988766554444444332221100           00


Q ss_pred             cc-----chhhhcc--CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          513 VF-----DLELMRD--APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       513 ~~-----~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ++     .+....-  .........+...+...++..||..|.+..+.+.++.
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            00     0000000  0011122234556777899999999999999988763

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.9e-31  Score=265.20  Aligned_cols=203  Identities=22%  Similarity=0.318  Sum_probs=171.1

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .+.||-|+||.|.++... +...+|+|.+++..-   .....++.|-.||+.-+.+-||++|..|++ ++.+|+||+|++
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-kdnLYFVMdYIP  712 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVMDYIP  712 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-CCceEEEEeccC
Confidence            567999999999999754 567789999876532   233567899999999999999999999987 779999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc-------
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA-------  440 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-------  440 (580)
                      ||++-++|-+.+   -|.+..++.++.+++-|+++.|.. |+|||||||+|||||.+|++||.|||+++-+.-       
T Consensus       713 GGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  713 GGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             CccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            999999998754   688888899999999999999995 999999999999999999999999999854421       


Q ss_pred             --cccc--------------------------------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCC
Q 008031          441 --AANV--------------------------------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGK  486 (580)
Q Consensus       441 --~~~~--------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~  486 (580)
                        ..+.                                .....+||..|+|||++....|+-.+|.||.||+||||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence              0000                                001246999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCChhH
Q 008031          487 SPGEPLNGAELPQ  499 (580)
Q Consensus       487 ~p~~~~~~~~~~~  499 (580)
                      .||......+...
T Consensus       869 ~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  869 PPFLADTPGETQY  881 (1034)
T ss_pred             CCccCCCCCccee
Confidence            9998776655444

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-31  Score=242.95  Aligned_cols=242  Identities=18%  Similarity=0.312  Sum_probs=188.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +...++||+|+|+.|..+.+. +.+.+|+|++++..-.   +....+.|-.+..+- +||.+|.+..+++. ....++|.
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-esrlffvi  330 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ESRLFFVI  330 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cceEEEEE
Confidence            456789999999999999876 7888999999865432   334467777777776 79999999999886 67899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||++||+|--+++..   ..++++.+..+...|.-||.|||+ +||++||||..|+|+|..|++|+.|+|+++.--... 
T Consensus       331 eyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-  405 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-  405 (593)
T ss_pred             EEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCceeecccchhhcCCCCC-
Confidence            999999997766653   358899999999999999999999 699999999999999999999999999997543332 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCC----CCCChhHHHHHHhhhhccccccchhhh
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPL----NGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ....++.||+.|+|||++.+..|+..+|.|++|++++||+.|+.||+-.    .+.+...++-+++-+.-        +.
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--------ir  477 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--------IR  477 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--------cc
Confidence            2344678999999999999999999999999999999999999999732    22233333333222111        00


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARP  548 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  548 (580)
                      ...    ...-+...++..-+++||.+|.
T Consensus       478 ipr----slsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 IPR----SLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ccc----eeehhhHHHHHHhhcCCcHHhc
Confidence            000    1112334566678889999985

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-30  Score=249.87  Aligned_cols=131  Identities=21%  Similarity=0.261  Sum_probs=111.4

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-----C---CcceeeeeEEECC---
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-----H---PNLLALRAYYLGP---  355 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~~---  355 (580)
                      +|...++||.|.|++||++.+. ..+.||+|+.+.... -.+....||++|++++     |   ..||++++.|...   
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            4667899999999999999875 678899999876543 2455678999999883     3   3699999999752   


Q ss_pred             CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee
Q 008031          356 KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL  421 (580)
Q Consensus       356 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~  421 (580)
                      ..++|||+|++ |.+|..++.... .+.++...+.+|++||+.||.|||...||+|-||||+|||+
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            34789999999 779999998765 45689999999999999999999998899999999999999

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.3e-30  Score=254.14  Aligned_cols=262  Identities=21%  Similarity=0.257  Sum_probs=202.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCC------CcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRH------PNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~~~~~~  360 (580)
                      .|.+....|+|-|++|.+|.+. .|..||||++.....- .+.=.+|+++|++|+.      -|+++++..|.. .+++|
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-knHLC  510 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-KNHLC  510 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-cceeE
Confidence            3666777899999999999987 5889999999865332 2334679999999952      378888888876 77999


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-CCeEEeecccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-TNAKISDFGLSRLMT  439 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~  439 (580)
                      +|+|-+ ..+|.+.|.+.+..-.+....+..++.|+.-||..|.. .||+|.||||.||||++. ..+||||||.|....
T Consensus       511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccccccc
Confidence            999998 55999999999888889999999999999999999998 599999999999999965 558999999998765


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHH--------HHh-hhhcc
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVA--------SIV-KEEWT  510 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~--------~~~-~~~~~  510 (580)
                      ...-.+   ..-+..|.|||++.+..|+...|+||+||+||||.||+.-|.+...-.+..+.-        +++ .+.+.
T Consensus       589 eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~  665 (752)
T KOG0670|consen  589 ENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK  665 (752)
T ss_pred             cccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence            544332   233567999999999999999999999999999999999998765433333211        111 11222


Q ss_pred             ccccchhh--------------------------------hc---cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 008031          511 NEVFDLEL--------------------------------MR---DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ  555 (580)
Q Consensus       511 ~~~~~~~~--------------------------------~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~  555 (580)
                      ...+|..+                                ..   -.......+.++.+|+.+|+..||++|.|..++++
T Consensus       666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            22222222                                00   01122335677889999999999999999999987


Q ss_pred             H
Q 008031          556 Q  556 (580)
Q Consensus       556 ~  556 (580)
                      |
T Consensus       746 H  746 (752)
T KOG0670|consen  746 H  746 (752)
T ss_pred             C
Confidence            6

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.2e-28  Score=231.55  Aligned_cols=211  Identities=32%  Similarity=0.527  Sum_probs=181.4

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCChh
Q 008031          295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLA  372 (580)
Q Consensus       295 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~  372 (580)
                      ||+|.+|.||++... +++.+++|++...... ....+.+|++.++.+.|++++++++++.. ....++++||+.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHH
Confidence            689999999999987 4899999998755432 34678999999999999999999999986 56899999999999999


Q ss_pred             hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-CCCeEEeecccccccccccccceeeecC
Q 008031          373 TFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-STNAKISDFGLSRLMTAAANVNVIATAG  451 (580)
Q Consensus       373 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  451 (580)
                      +++....  ..+++..+..++.++++++++||+. |++|+||+|.||+++. ++.++++|||.+........ ......+
T Consensus        80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            9997642  3588999999999999999999995 9999999999999998 89999999999876644321 1223456


Q ss_pred             ccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHH
Q 008031          452 ALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL  530 (580)
Q Consensus       452 ~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  530 (580)
                      ...|++||..... .++.++|+|++|++++++                                               .
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~  188 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------P  188 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------H
Confidence            7789999998877 888999999999999999                                               2


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          531 NTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       531 ~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .+.+++.+|++.+|.+||++.++++++
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            567888899999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=238.56  Aligned_cols=257  Identities=24%  Similarity=0.284  Sum_probs=191.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      |.....+|.|.- .|-.+.+. .+++||+|++....  ....+...+|..++..++|+||++++.++.-..     .+.|
T Consensus        19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y   97 (369)
T KOG0665|consen   19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY   97 (369)
T ss_pred             eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence            445678888888 66666665 68999999875432  234467789999999999999999999996422     2468


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +|||+| .++|...+..     .++-.++.++..|++.|+.|||+. ||+||||||+||++..+..+||.|||+|+....
T Consensus        98 ~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   98 LVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCc
Confidence            999999 5599988874     366678899999999999999995 999999999999999999999999999986544


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh-------------
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE-------------  507 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------  507 (580)
                      .  ...+..+.|..|+|||++.+..|.+.+||||+||++.||++|+.-|.+.+.  +.||.+.+..-             
T Consensus       171 ~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~--idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  171 D--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH--IDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             c--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH--HHHHHHHHHHhcCCCHHHHHHhhH
Confidence            3  344556788899999999988899999999999999999999998875432  22222211100             


Q ss_pred             ----------hccc----cc-cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          508 ----------EWTN----EV-FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       508 ----------~~~~----~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                                +...    +. -|...........-....+.+++.+||-.||++|.|+.++++|=
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence                      0000    00 00000000011111233456788899999999999999999873

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=228.28  Aligned_cols=254  Identities=21%  Similarity=0.323  Sum_probs=188.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|.+.+.+|+|.||.+-.+.++ +.+.+++|.+..... ..++|.+|...--.| .|.||+.-|+...+..+...+++||
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            4788999999999999999987 678899998876543 467899998876666 6899999888777767788899999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC--CCCCeEEeecccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD--DSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~--~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ++.|+|.+-+...+    +.+....+++.|+++|+.|||++ ++||||||.+||||-  +..++|+||||.++..+....
T Consensus       104 aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  104 APRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             CccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            99999999887653    77888999999999999999995 999999999999994  556899999999876554332


Q ss_pred             cceeeecCccccCCcccccc-----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHH-Hhhhhccccccchh
Q 008031          444 VNVIATAGALGYRAPELSKL-----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS-IVKEEWTNEVFDLE  517 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  517 (580)
                      ..    .-+..|.|||....     -...+.+|+|.||+++|.++||+.||......+...|-.. +.+...      +.
T Consensus       179 ~~----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~------~~  248 (378)
T KOG1345|consen  179 YL----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN------PA  248 (378)
T ss_pred             hh----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC------cc
Confidence            21    12345899996532     2345679999999999999999999985444433332221 111111      12


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ..+.+..   -...++++..+-+.++|++|--..++.+..+..
T Consensus       249 ~P~~F~~---fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~  288 (378)
T KOG1345|consen  249 LPKKFNP---FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL  288 (378)
T ss_pred             Cchhhcc---cCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence            2222222   223556677788999999995555555554443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=247.08  Aligned_cols=195  Identities=23%  Similarity=0.374  Sum_probs=165.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-----c---HHHHHHHHHHHhcCC---CCcceeeeeEEECCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-----G---QREFESEVSLLGKIR---HPNLLALRAYYLGPK  356 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~---~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  356 (580)
                      |.+.+.+|+|+||.|+.|.++ ....|+||.+.+...-     .   .-.+-.|+++|+.++   |+||++++++|.+ +
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd-d  641 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED-D  641 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec-C
Confidence            667889999999999999987 5667999988654311     0   112457999999997   9999999999987 7


Q ss_pred             CcEEEEEeeCC-CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          357 GEKLLVFDYMP-HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       357 ~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      +.+|++||-.. +.+|.+++..+   ..+++.++..|++||+-|+++||+ +||||||||-+|+.++.+|-+|++|||.+
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCCeEEEeeccch
Confidence            78999999764 34888998764   579999999999999999999999 69999999999999999999999999998


Q ss_pred             cccccccccceeeecCccccCCccccccCCCCC-cccchhHHHHHHHHHcCCCCCCC
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSKLKKANT-KTDVYSLGVTILELLTGKSPGEP  491 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~s~G~~l~el~tg~~p~~~  491 (580)
                      .......   ...++||..|.|||++.+..|-- .-|||++|++||-+.....||..
T Consensus       718 a~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            7654433   23468999999999999988865 47999999999999999999853

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=254.36  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=201.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.....+|.|.||.||++++. +++..|+|+++-...++-.-.++|+-+++..+||||+.++|.+.. .+..++.||||.
T Consensus        17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicMEycg   95 (829)
T KOG0576|consen   17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICMEYCG   95 (829)
T ss_pred             hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEEEecC
Confidence            556788999999999999976 799999999988777777778899999999999999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+.-+..+   ++++.++..+.+..++|++|||+ +|-+|||||-.||++++.+.+|++|||.+-.+... -.+..
T Consensus        96 ggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~Krk  170 (829)
T KOG0576|consen   96 GGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRK  170 (829)
T ss_pred             CCcccceeeecc---cchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccCceeecccCchhhhhhh-hhhhh
Confidence            999999887654   78899999999999999999999 59999999999999999999999999998765443 22344


Q ss_pred             eecCccccCCcccc---ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          448 ATAGALGYRAPELS---KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       448 ~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      .+.||+.|||||+.   ..+.|..++|||+.|+...|+-.-++|--+.-    +..+..+..    ...+++.-.++...
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh----pmr~l~LmT----kS~~qpp~lkDk~k  242 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH----PMRALFLMT----KSGFQPPTLKDKTK  242 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc----hHHHHHHhh----ccCCCCCcccCCcc
Confidence            67899999999964   46778899999999999999988887732221    122222211    11222222222222


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         +...+-+++..|+..+|++|||++.+++|
T Consensus       243 ---ws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  243 ---WSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             ---chHHHHHHHHHHhcCCCccCCChhhheec
Confidence               33455677789999999999999988763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1e-27  Score=228.05  Aligned_cols=198  Identities=30%  Similarity=0.467  Sum_probs=169.6

Q ss_pred             hhhccccccCceEEEEEEeCC-CCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          290 ATAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      ...+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++.+++++|+|++++++++.. ....++++||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~   80 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYCE   80 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEeccC
Confidence            345789999999999999874 899999998765544 56678999999999999999999999876 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++.....  .+++..+..++.+++.++.+||+. +++|+||++.||+++.++.++++|||.+............
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            9999999987531  178999999999999999999995 9999999999999999999999999998876543211222


Q ss_pred             eecCccccCCcccc-ccCCCCCcccchhHHHHHHHHHcCCCCCCC
Q 008031          448 ATAGALGYRAPELS-KLKKANTKTDVYSLGVTILELLTGKSPGEP  491 (580)
Q Consensus       448 ~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~  491 (580)
                      ...++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34567789999998 777788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.6e-27  Score=228.59  Aligned_cols=193  Identities=24%  Similarity=0.422  Sum_probs=160.1

Q ss_pred             HhhhccccccCceEEEEEEeC----CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...++||+|.|++||++.+.    .++.||+|.+...  .....+..|+++|..+ .+.||+++.+++.. .+...+|+
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-nd~v~ivl  114 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRN-NDQVAIVL  114 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhcc-CCeeEEEe
Confidence            556789999999999999864    4678999998644  3446788999999999 69999999999876 67999999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCCCeEEeeccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      ||+++..-.++...      ++...+..++..+..||+++|++ |||||||||.|++.+ ..++-.|.|||++.......
T Consensus       115 p~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  115 PYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             cccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            99999998888865      66889999999999999999995 999999999999998 56778999999986221000


Q ss_pred             -------------------------------------------ccceeeecCccccCCccccc-cCCCCCcccchhHHHH
Q 008031          443 -------------------------------------------NVNVIATAGALGYRAPELSK-LKKANTKTDVYSLGVT  478 (580)
Q Consensus       443 -------------------------------------------~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~  478 (580)
                                                                 .......+||++|+|||++. -...++++||||.|++
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                                                       00111246999999999765 4667889999999999


Q ss_pred             HHHHHcCCCCCCC
Q 008031          479 ILELLTGKSPGEP  491 (580)
Q Consensus       479 l~el~tg~~p~~~  491 (580)
                      +..+++++.||-.
T Consensus       268 ~Lslls~~~PFf~  280 (418)
T KOG1167|consen  268 LLSLLSRRYPFFK  280 (418)
T ss_pred             eehhhcccccccc
Confidence            9999999999843

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=3.5e-27  Score=264.23  Aligned_cols=198  Identities=20%  Similarity=0.251  Sum_probs=139.8

Q ss_pred             CCC-CcceeeeeEEEC------CCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccC
Q 008031          340 IRH-PNLLALRAYYLG------PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG  412 (580)
Q Consensus       340 l~h-~niv~~~~~~~~------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~  412 (580)
                      ++| .||++++++|..      .+..+++++||+ +++|.++++..  ...+++.++..++.||++||+|||+ +||+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHS-QGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHh-CCeeec
Confidence            345 578888887722      123567888988 66999999753  3458999999999999999999999 599999


Q ss_pred             CCCCCCeeeCCC-------------------CCeEEeeccccccccccc---------------ccceeeecCccccCCc
Q 008031          413 NLTSSNVLLDDS-------------------TNAKISDFGLSRLMTAAA---------------NVNVIATAGALGYRAP  458 (580)
Q Consensus       413 Dlk~~Nil~~~~-------------------~~~kl~Dfg~~~~~~~~~---------------~~~~~~~~g~~~y~aP  458 (580)
                      ||||+|||++..                   +.+|++|||+++......               ........||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999653                   445666666665321100               0001123578889999


Q ss_pred             cccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhh
Q 008031          459 ELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALH  538 (580)
Q Consensus       459 E~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  538 (580)
                      |++.+..++.++|||||||++|||++|..|+....     ..+..+...     ..++..       .....+...++.+
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~-----~~~~~~-------~~~~~~~~~~~~~  247 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR-----VLPPQI-------LLNWPKEASFCLW  247 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh-----hcChhh-------hhcCHHHHHHHHH
Confidence            99999999999999999999999999988864321     111111110     011111       1122345578889


Q ss_pred             ccCCCCCCCCCHHHHHHHHh
Q 008031          539 CVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       539 cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ||+.+|.+|||+.|++++-.
T Consensus       248 ~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             hCCCChhhCcChHHHhhchh
Confidence            99999999999999988643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=3.5e-26  Score=208.86  Aligned_cols=170  Identities=22%  Similarity=0.247  Sum_probs=128.9

Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.++++.++  ..+++.+++.++.||+.||+|||+. +      ||+||+++.++.+|+  ||++.......      
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc------
Confidence            68999998642  4699999999999999999999994 6      999999999999999  99987654322      


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      ..|++.|||||++.+..++.++|||||||++|||++|+.||......  ...............   +   ...+.....
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~---~---~~~~~~~~~  135 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADD---P---RDRSNLESV  135 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCC---c---cccccHHHH
Confidence            25789999999999999999999999999999999999999654321  122222221111100   0   000111111


Q ss_pred             H--HHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          529 L--LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       529 ~--~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      .  .++.+++.+||+.+|++|||+.|+++++..+..+
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            1  2578899999999999999999999999887544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=6.9e-24  Score=212.33  Aligned_cols=263  Identities=18%  Similarity=0.220  Sum_probs=196.6

Q ss_pred             HHhhhccccccCceEEEEEEeCCC--CEEEEEEccccccccHHHHHHHHHHHhcCCC----CcceeeeeEEECCCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDG--SQVAVKRLREKITKGQREFESEVSLLGKIRH----PNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~l  361 (580)
                      .|.+.+.||+|+||.||.+...+.  ..+|+|............+..|..++..+..    +++..+++.....+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            466789999999999999997653  4788888765433333367888998888862    5888888877433557899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-----CCeEEeeccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-----TNAKISDFGLSR  436 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-----~~~kl~Dfg~~~  436 (580)
                      ||+.+ |.+|.++..... ...++..+..+++.|++.+|+++|+ .|++||||||.|+++...     ..+.+.|||+++
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            99998 889999876654 5679999999999999999999999 599999999999999854     469999999998


Q ss_pred             --ccccccc-------cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh
Q 008031          437 --LMTAAAN-------VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE  507 (580)
Q Consensus       437 --~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  507 (580)
                        .+.....       .......||.+|+++....+...+.+.|+||++.++.|++.|..||...........+......
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              3321111       1123456999999999999999999999999999999999999999776654433333332222


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .....        .....+.+.   .++...+-+.+..++|....+...+++.....
T Consensus       256 ~~~~~--------~~~~~~~~~---~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  256 LLTDR--------FGDLKPEEF---AKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hcccc--------ccCCChHHH---HHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11111        111222333   34444444589999999999999988875544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-25  Score=200.52  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=186.3

Q ss_pred             hhccccccCceEEEEEEeCCCCEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREK--ITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      ...+|.+...|..|+|+++ |..+++|++...  ...-.++|..|.-.++-+.||||..++|.|.. .....++..||+.
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-ppnlv~isq~mp~  271 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-PPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-CCCceEeeeeccc
Confidence            4567889999999999999 555666776532  23345789999999999999999999999987 5688999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccC-CCCCCCeeeCCCCCeEEe--ecccccccccccccc
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG-NLTSSNVLLDDSTNAKIS--DFGLSRLMTAAANVN  445 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~-Dlk~~Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~  445 (580)
                      |+|+..+++.. .-..+-.++.+++.+||+|++|||+...++-| -|.+..+++|++.+++|.  |--++.        .
T Consensus       272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--------q  342 (448)
T KOG0195|consen  272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------Q  342 (448)
T ss_pred             hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--------e
Confidence            99999999753 33467778999999999999999996455555 689999999999887764  322221        1


Q ss_pred             eeeecCccccCCccccccCCCC---CcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          446 VIATAGALGYRAPELSKLKKAN---TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      ..+..-.+.||+||.+....-+   .++|+|||++++||+.|...||.+....+.-..+.-   ++.+        ...+
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---eglr--------v~ip  411 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---EGLR--------VHIP  411 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---cccc--------ccCC
Confidence            1122345789999988765544   468999999999999999999998887664443321   1111        1112


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      |....   .+.++|.-|+++||.+||.++.++-.||.+.
T Consensus       412 pgis~---hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  412 PGISR---HMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCccH---HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            33333   3456777899999999999999999999764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=6.5e-24  Score=211.36  Aligned_cols=160  Identities=18%  Similarity=0.227  Sum_probs=123.3

Q ss_pred             HhhhccccccCceEEEEEEeC--CCCEEEEEEcccccc-----ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE--DGSQVAVKRLREKIT-----KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |...+.||+|+||.||+|.+.  +++.||||++.....     .....+.+|++++++++|+|++..+..    .+..++
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~L   95 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGL   95 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEE
Confidence            566799999999999999875  577789998653311     124568999999999999999853322    236799


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCC-CCCCeeeCCCCCeEEeeccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL-TSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dl-k~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      ||||++|++|... ..      ..   ...++.|+++||+|||+ +||+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus        96 VmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         96 VRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             EEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            9999999999632 11      11   14678899999999999 59999999 99999999989999999999987654


Q ss_pred             cccc-------ceeeecCccccCCcccccc
Q 008031          441 AANV-------NVIATAGALGYRAPELSKL  463 (580)
Q Consensus       441 ~~~~-------~~~~~~g~~~y~aPE~~~~  463 (580)
                      ....       ......+++.|+|||.+..
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            3211       1124567888999998764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3e-23  Score=192.81  Aligned_cols=272  Identities=15%  Similarity=0.193  Sum_probs=202.6

Q ss_pred             HHhhhccccccCceEEEEEEe-CCCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|+++++||+|.||.++.|.. -++.+||||.-...  ...-++..|.+..+.| ..++|...+.|-.+ .-+-.+|+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqe-G~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE-GKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccc-cchhhhhhhh
Confidence            367899999999999999985 37999999974322  2234577788888888 56888888766654 4466799999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-----CCeEEeeccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-----TNAKISDFGLSRLMTA  440 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-----~~~kl~Dfg~~~~~~~  440 (580)
                      + |.+|.|++.-.+  ..|+.++++.+|.|++.-++|+|++ .+|+|||||+|+||...     ..+.++|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9 889999998774  4699999999999999999999995 99999999999999643     3489999999998866


Q ss_pred             ccccc------eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccccc
Q 008031          441 AANVN------VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF  514 (580)
Q Consensus       441 ~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      .....      .....||.+||+-....+...+.+.|+-|+|-++..++.|..||.+......-+...++-..+. ...+
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr-~T~i  260 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR-STPI  260 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc-cCCH
Confidence            54432      2345799999999999999999999999999999999999999999876654444443322211 1111


Q ss_pred             chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccCCCCCC
Q 008031          515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDA  574 (580)
Q Consensus       515 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~~~~~~  574 (580)
                      + .+.   ...+++...-++.+.   ..+-.+-|..+.+...+..+.+..-....+.-+|
T Consensus       261 ~-~Lc---~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW  313 (449)
T KOG1165|consen  261 E-VLC---EGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDW  313 (449)
T ss_pred             H-HHH---hcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence            1 111   112333333334333   4778888998888888777766555554444443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-22  Score=180.91  Aligned_cols=210  Identities=19%  Similarity=0.265  Sum_probs=169.1

Q ss_pred             HhhhccccccCceEEEEEEe-CCCCEEEEEEccccccccHHHHHHHHHHHhcCCC-CcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEVSLLGKIRH-PNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...++||.|+||.+|.|.. .+|.+||||.-+....  .-++..|.++.+.|++ ..|..+..+..+ ...-.+||+..
T Consensus        17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e-~~ynvlVMdLL   93 (341)
T KOG1163|consen   17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTE-KDYNVLVMDLL   93 (341)
T ss_pred             eEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccc-cccceeeeecc
Confidence            55679999999999999985 4799999998654432  2456778999999865 556666666654 55778999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC---CCCCeEEeecccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD---DSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                       |.+|.+.+.-..  ..++.++++-++-|++.-++|+|. ++++||||||+|+|+.   ....+.++|||+|+.+.+...
T Consensus        94 -GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   94 -GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             -CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence             889999987653  468999999999999999999999 5999999999999996   345689999999987754332


Q ss_pred             c------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHh
Q 008031          444 V------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV  505 (580)
Q Consensus       444 ~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~  505 (580)
                      .      ......||.+|.+-....+...+.+.|+-|+|.++..+-.|..||.+.......|...++.
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~  237 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS  237 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence            2      2234579999998888777788889999999999999999999999987666555555443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=2.5e-21  Score=195.60  Aligned_cols=261  Identities=28%  Similarity=0.416  Sum_probs=195.6

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCC-cceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK---GQREFESEVSLLGKIRHP-NLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++++.+.. ....+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEe
Confidence            345678999999999999987  78899998765543   356799999999999988 79999999954 445799999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeecccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  443 (580)
                      ++.++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999997776542112588899999999999999999994 999999999999999888 699999999985544332


Q ss_pred             c-----ceeeecCccccCCcccccc---CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          444 V-----NVIATAGALGYRAPELSKL---KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       444 ~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      .     ......|+..|+|||.+.+   ..+....|+||+|++++++++|..||...................... ...
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  236 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLA  236 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccc
Confidence            2     2345679999999999887   578889999999999999999999976654321111222211111111 000


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ........  ......+.+++..|+..+|..|.+..+....
T Consensus       237 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 SPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000  1122456678889999999999999988775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=7.1e-23  Score=217.46  Aligned_cols=253  Identities=20%  Similarity=0.261  Sum_probs=180.4

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEcccc--ccccH----HHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREK--ITKGQ----REFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      ..+++|.|++|.|+..... .....+.|.....  .....    ..+..|+.+-..++|+|++..+..+.+.+... -.|
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~-~~m  400 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL-QSM  400 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch-hhh
Confidence            4678999999988777654 3333444433210  11111    12566888888899999988877776644333 339


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++ +|..++...   ..++..++..+++|+..|+.|+|+ .|+.|||+|++|++++.++.+||+|||.+..+.....
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 999999874   257788899999999999999999 5999999999999999999999999999876543332


Q ss_pred             ---cceeeecCccccCCccccccCCCCCc-ccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          444 ---VNVIATAGALGYRAPELSKLKKANTK-TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       444 ---~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                         .......|+-.|+|||++.+..|++. .||||.|+++..|.+|+.||......+-..  ..............+.  
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~~~~~~~~~~~--  551 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYSDQRNIFEGPN--  551 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhccccccccccChH--
Confidence               34556789999999999999999875 799999999999999999996543322111  0000001111000000  


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ............+|.++++++|.+|.|+.+|++-
T Consensus       552 ---~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  552 ---RLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ---HHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence               0011112244568889999999999999999864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=4.6e-22  Score=183.93  Aligned_cols=169  Identities=15%  Similarity=0.246  Sum_probs=131.0

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHH---------HHHHHHHHhcCCCCcceeeeeEEECC---
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE---------FESEVSLLGKIRHPNLLALRAYYLGP---  355 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~---  355 (580)
                      .|...+++|.|+||.||.+.. ++..+|+|.+++.....+..         +.+|++.+.++.|++|.....++...   
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~  110 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK  110 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence            356688999999999999766 57789999998665444333         68999999999999999998886542   


Q ss_pred             ----CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEee
Q 008031          356 ----KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISD  431 (580)
Q Consensus       356 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~D  431 (580)
                          .+..+++|||++|.+|.++..       ++.    ....+++.++..+|.. |++|||++|.||+++.++ ++++|
T Consensus       111 ~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        111 TLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEE
Confidence                235789999999999988732       222    2456999999999995 999999999999999888 99999


Q ss_pred             cccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHH
Q 008031          432 FGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELL  483 (580)
Q Consensus       432 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~  483 (580)
                      ||............             .+.....|+.++|+||||+.+.-+.
T Consensus       178 fg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence            99876543221111             1334455678999999999887553

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.5e-21  Score=178.98  Aligned_cols=140  Identities=19%  Similarity=0.243  Sum_probs=108.5

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEccccccc--c-------H-----------------HHHHHHHHHHhcCCCCcc
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK--G-------Q-----------------REFESEVSLLGKIRHPNL  345 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni  345 (580)
                      ...||+|+||.||+|...+|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3689999999999999888999999999754221  1       0                 122459999999987776


Q ss_pred             eeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCcccCCCCCCCeeeCCC
Q 008031          346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL-HSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       346 v~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      .....+..  . ..++||||++++++......   ...++......++.|++.+|.|+ |+ .||+||||||+||++++ 
T Consensus        82 ~~p~~~~~--~-~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NIli~~-  153 (190)
T cd05147          82 PCPEPILL--K-SHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCcEEEe--c-CCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEEC-
Confidence            43333222  2 34899999998777654322   23688899999999999999999 67 59999999999999984 


Q ss_pred             CCeEEeecccccccc
Q 008031          425 TNAKISDFGLSRLMT  439 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~  439 (580)
                      +.++++|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.5e-20  Score=171.75  Aligned_cols=141  Identities=17%  Similarity=0.264  Sum_probs=110.9

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEccccccc--c------------------------HHHHHHHHHHHhcCCCCcc
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK--G------------------------QREFESEVSLLGKIRHPNL  345 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  345 (580)
                      .+.||+|+||.||+|...+|+.||||+++.....  .                        ...+..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999888999999998754211  0                        1124678999999999987


Q ss_pred             eeeeeEEECCCCcEEEEEeeCCCCChhhh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          346 LALRAYYLGPKGEKLLVFDYMPHGSLATF-LHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       346 v~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      .....+...   ..++||||++++++... +..    ..++..+...++.|++.++.++|+..||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK---KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec---CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence            544444332   34899999988855433 332    34778889999999999999999823999999999999999 7


Q ss_pred             CCeEEeeccccccccc
Q 008031          425 TNAKISDFGLSRLMTA  440 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~  440 (580)
                      +.++++|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=8.3e-21  Score=180.89  Aligned_cols=230  Identities=21%  Similarity=0.316  Sum_probs=143.1

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCC----------CcceeeeeEEEC---
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRH----------PNLLALRAYYLG---  354 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~~---  354 (580)
                      .+.||.|+++.||.+++. +|+.+|+|++.....   ...+++.+|.-....+.+          -.++--.+....   
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            578999999999999997 699999998753332   233556666655544322          111111111111   


Q ss_pred             ------C-C-C-----cEEEEEeeCCCCChhhhhhh---cCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCC
Q 008031          355 ------P-K-G-----EKLLVFDYMPHGSLATFLHA---RGPE-TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSS  417 (580)
Q Consensus       355 ------~-~-~-----~~~lv~e~~~~g~L~~~l~~---~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~  417 (580)
                            . + .     ..+++|+-+ .++|.+++..   .... ..+....+..+..|+++.+++||+ .|++|+||+|+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi~~~  174 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDIKPE  174 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGG
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccccee
Confidence                  0 0 1     236788888 5688888643   2111 123344567778999999999999 59999999999


Q ss_pred             CeeeCCCCCeEEeecccccccccccccceeeecCccccCCcccccc--------CCCCCcccchhHHHHHHHHHcCCCCC
Q 008031          418 NVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL--------KKANTKTDVYSLGVTILELLTGKSPG  489 (580)
Q Consensus       418 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~el~tg~~p~  489 (580)
                      |++++.+|.+.++||+.....+.....    ...+..|.+||....        -.++.+.|.|++|+++|.|++|..||
T Consensus       175 nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf  250 (288)
T PF14531_consen  175 NFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF  250 (288)
T ss_dssp             GEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred             eEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence            999999999999999876654432221    234567999997543        35778899999999999999999999


Q ss_pred             CCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCC
Q 008031          490 EPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSAR  547 (580)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  547 (580)
                      +.........+                .    +..+.+....+..||..+|+.+|++|
T Consensus       251 ~~~~~~~~~~~----------------~----f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  251 GLSSPEADPEW----------------D----FSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CCCGGGSTSGG----------------G----GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCccccccc----------------c----chhcCCcCHHHHHHHHHHccCCcccC
Confidence            86543322221                1    11122222344567779999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.9e-20  Score=165.99  Aligned_cols=186  Identities=15%  Similarity=0.129  Sum_probs=137.4

Q ss_pred             hhccccccCceEEEEEEeCCCCEEEEEEcccccccc----HHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEee
Q 008031          291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKG----QREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      ....+++|+||+||.+.. .+.+++.+.+.......    ...+.+|+++|++++ |+++.+++++     +..+++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEee
Confidence            357899999999997766 57888877776543311    124789999999995 5889999886     246999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCC-CCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL-TSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dl-k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ++|.+|.+.+..          ....++.|+++++.++|+ .||+|||| ||+|||++.++.++|+|||++.........
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999988654321          113577899999999999 49999999 799999999999999999999855433210


Q ss_pred             ----c--------eeeecCccccCCcccccc-CCCC-CcccchhHHHHHHHHHcCCCCCCCCC
Q 008031          445 ----N--------VIATAGALGYRAPELSKL-KKAN-TKTDVYSLGVTILELLTGKSPGEPLN  493 (580)
Q Consensus       445 ----~--------~~~~~g~~~y~aPE~~~~-~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~  493 (580)
                          .        ..-...++.|++|+...- ...+ ...+.++-|+-+|.++|+..|+....
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                0        001125666777774321 1223 46799999999999999999865443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=5.2e-20  Score=186.49  Aligned_cols=219  Identities=27%  Similarity=0.383  Sum_probs=162.6

Q ss_pred             HhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCC
Q 008031          337 LGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTS  416 (580)
Q Consensus       337 l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~  416 (580)
                      |+.+.|.|+.+++|.+.+ +...+.|.+|+..|+|.|.+...  ...+++.-...+.++|+.||+|||+.+...|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence            457899999999999998 47899999999999999999874  456889999999999999999999964449999999


Q ss_pred             CCeeeCCCCCeEEeecccccccccc-cccceeeecCccccCCccccccCC-------CCCcccchhHHHHHHHHHcCCCC
Q 008031          417 SNVLLDDSTNAKISDFGLSRLMTAA-ANVNVIATAGALGYRAPELSKLKK-------ANTKTDVYSLGVTILELLTGKSP  488 (580)
Q Consensus       417 ~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dv~s~G~~l~el~tg~~p  488 (580)
                      .|++++....+|++|||+....... .........-..-|.|||.+....       .+.+.|+||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998766431 111111122345699999877532       35569999999999999999999


Q ss_pred             CCCCCCCChh-HHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          489 GEPLNGAELP-QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       489 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      |......... +.+.. +.. .....+.+.....    .+...++..++..||..+|++||+++++-..++.+....
T Consensus       158 ~~~~~~~~~~~eii~~-~~~-~~~~~~rP~i~~~----~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILR-VKK-GGSNPFRPSIELL----NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             cccccccCChHHHHHH-HHh-cCCCCcCcchhhh----hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            9864332221 22222 111 1111111222111    011225778899999999999999999999999887654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=4.6e-21  Score=203.12  Aligned_cols=244  Identities=22%  Similarity=0.279  Sum_probs=172.5

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccc-cccHHHHH---HHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKI-TKGQREFE---SEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +...+.+|.+.|=.|.+|+++.|. |+||++-... .-..+.|.   +|++ ...++|||++++.-+... +...|+|-+
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t-~kAAylvRq  101 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT-DKAAYLVRQ  101 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh-hHHHHHHHH
Confidence            456788999999999999998777 8999985443 22333343   3444 555689999998776543 445678888


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc--cccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM--TAAA  442 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~--~~~~  442 (580)
                      |..+ +|+|.+..+   .-+...+...|+.|++.|+..+|. .||+|||||.+|||++.=+=+.++||..-+..  ..++
T Consensus       102 yvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            8855 999998764   356777889999999999999999 59999999999999998777999999865432  2222


Q ss_pred             ccceeee----cCccccCCccccccC-----------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhh
Q 008031          443 NVNVIAT----AGALGYRAPELSKLK-----------KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK  506 (580)
Q Consensus       443 ~~~~~~~----~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  506 (580)
                      ......+    ..-.+|+|||.+...           ..+++-||||+||+++||++ |++||.-      .|... +..
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~a-Yr~  249 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLA-YRS  249 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHh-Hhc
Confidence            2222222    233469999976531           14567899999999999999 7888852      22211 111


Q ss_pred             hhccccccchhh-hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          507 EEWTNEVFDLEL-MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       507 ~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ++    -.+++. +...+.     ..+.+++..|++.||.+|.|+++.++.
T Consensus       250 ~~----~~~~e~~Le~Ied-----~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 GN----ADDPEQLLEKIED-----VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cC----ccCHHHHHHhCcC-----ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            11    011111 111111     145678889999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=7.5e-21  Score=192.21  Aligned_cols=186  Identities=28%  Similarity=0.405  Sum_probs=155.4

Q ss_pred             cccccCceEEEEEEe----CCCCEEEEEEccccccc--cHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEeeC
Q 008031          294 IMGKSTYGTVYKATL----EDGSQVAVKRLREKITK--GQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .+|+|.||.|+.+.-    +.|.-+|+|++++....  .......|..++..++ ||.++++...++. +...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence            368999999987752    34777899988765432  1125567888888886 9999999877765 77899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      .+|.|...+...   ..+++.....+...++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-.....  
T Consensus        80 rgg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             ccchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            999998887664   4577778888889999999999995 9999999999999999999999999999866443332  


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCC
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP  491 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~  491 (580)
                         .||..|||||++.  ....++|.||||++++||+||..||..
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence               6899999999998  567789999999999999999999987

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.81  E-value=2e-19  Score=207.44  Aligned_cols=160  Identities=36%  Similarity=0.582  Sum_probs=114.3

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      |+|++|++++.+|..+.++++|+.|+|++|.+++.+|..+..+++|+.|+|++|++.+.+|..+ .+++|+.|+|++|++
T Consensus       409 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l  487 (968)
T PLN00113        409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQF  487 (968)
T ss_pred             EECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCcc
Confidence            3444444444444444444444444444444444444444444555555555555544444433 345677777777888


Q ss_pred             CcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChhh
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                      ++..|..+..+++|+.|+|++|++.+.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|++++|++++.+|..+
T Consensus       488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  567 (968)
T PLN00113        488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL  567 (968)
T ss_pred             CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence            77788888889999999999999998999999999999999999999999999999999999999999999999999876


Q ss_pred             h
Q 008031          163 A  163 (580)
Q Consensus       163 ~  163 (580)
                      .
T Consensus       568 ~  568 (968)
T PLN00113        568 G  568 (968)
T ss_pred             h
Confidence            5

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=3.1e-19  Score=164.93  Aligned_cols=135  Identities=15%  Similarity=0.190  Sum_probs=105.5

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-----CCCcceeeeeEEECCCC--cEE-E
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-----RHPNLLALRAYYLGPKG--EKL-L  361 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~--~~~-l  361 (580)
                      ..+.||+|+||.||.  +. ++.. +||++........+.+.+|+.+++.+     .||||++++|++.++.+  ..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            357899999999996  44 4444 79988765444567799999999999     57999999999987542  333 7


Q ss_pred             EEee--CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCcccCCCCCCCeeeCC----CCCeEEeeccc
Q 008031          362 VFDY--MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL-LHLHSNENIIHGNLTSSNVLLDD----STNAKISDFGL  434 (580)
Q Consensus       362 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~i~H~Dlk~~Nil~~~----~~~~kl~Dfg~  434 (580)
                      |+||  +.+|+|.+++...    .+++.  ..++.|++.++ +|||++ +|+||||||+||+++.    +.+++|+||+.
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  5579999999652    25544  35678888787 999995 9999999999999973    34799999543


Q ss_pred             c
Q 008031          435 S  435 (580)
Q Consensus       435 ~  435 (580)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=4.6e-21  Score=161.93  Aligned_cols=153  Identities=30%  Similarity=0.549  Sum_probs=143.4

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      |-||+|+|+ .+|+.+.++.+|+.|++++|+|+ .+|..+..+++|+.|+++-|++. .+|..|+.++.|+.|+|..|++
T Consensus        38 LtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl  114 (264)
T KOG0617|consen   38 LTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNL  114 (264)
T ss_pred             hhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccc
Confidence            678999999 89999999999999999999999 78889999999999999999999 8999999999999999999999


Q ss_pred             Cc-ccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           83 DD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        83 ~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      .. ..|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+.+|.+. .+|..++.+..|+.|.+.+|.++-.+|+
T Consensus       115 ~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppe  191 (264)
T KOG0617|consen  115 NENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPE  191 (264)
T ss_pred             ccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence            64 67888989999999999999998 89999999999999999999998 7899999999999999999999855553

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=5.8e-19  Score=191.11  Aligned_cols=195  Identities=25%  Similarity=0.329  Sum_probs=154.0

Q ss_pred             HHHHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCC---CCcceeeeeEEECCCCcEEEE
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR---HPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ...+.+.+.||+|+||.||+|...+|+.||+|+=+.....   +|.--.+++.+|+   -+-|+.+...+.. .+.-++|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~-~~~S~lv  772 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVF-QNASVLV  772 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHcc-CCcceee
Confidence            3345567789999999999999988999999987655433   2222334444554   2344444444444 4467899


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-------CCCCeEEeecccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-------DSTNAKISDFGLS  435 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-------~~~~~kl~Dfg~~  435 (580)
                      +||.+.|+|.+++..   ...+++.-+..++.|+++-++.||.. +|||+||||+|+|+.       +...++|+|||.+
T Consensus       773 ~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            999999999999984   45789999999999999999999994 999999999999994       2345899999998


Q ss_pred             cccccc-cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCC
Q 008031          436 RLMTAA-ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP  488 (580)
Q Consensus       436 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  488 (580)
                      ..+.-- +..+....++|-.+-.+|+..+..++...|.|.++-+++.|+.|+.-
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            755332 23456677889999999999999999999999999999999999853

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=4.6e-18  Score=161.30  Aligned_cols=141  Identities=18%  Similarity=0.217  Sum_probs=109.2

Q ss_pred             HhhhccccccCceEEEEEE--eCCCCEEEEEEccccccc------------------------cHHHHHHHHHHHhcCCC
Q 008031          289 CATAEIMGKSTYGTVYKAT--LEDGSQVAVKRLREKITK------------------------GQREFESEVSLLGKIRH  342 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h  342 (580)
                      |++.+.||+|+||.||+|.  ..+|+.||+|.++.....                        ....+..|++.+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            5678899999999999998  458999999998643210                        01235689999999975


Q ss_pred             C--cceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-cccCCCCCCCe
Q 008031          343 P--NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN-IIHGNLTSSNV  419 (580)
Q Consensus       343 ~--niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-i~H~Dlk~~Ni  419 (580)
                      .  .+.+.+++     ...++||||+++++|.......   ..+...+...++.|++.++++||+. | ++||||||+||
T Consensus       110 ~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NI  180 (237)
T smart00090      110 AGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLSEYNI  180 (237)
T ss_pred             cCCCCCeeeEe-----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCChhhE
Confidence            3  33344432     2358999999998887654322   2355666789999999999999995 8 99999999999


Q ss_pred             eeCCCCCeEEeecccccccc
Q 008031          420 LLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       420 l~~~~~~~kl~Dfg~~~~~~  439 (580)
                      +++ ++.++++|||.+....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 7889999999886543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=4.3e-19  Score=176.18  Aligned_cols=174  Identities=24%  Similarity=0.398  Sum_probs=134.8

Q ss_pred             cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      +.+|.|++|...+|.+|+..+......++.....++.|++.|+.|    ++.+|+|+||.||+...+..+||.|||+...
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccchhhhhhhhhheee
Confidence            578999999999999999876656667888999999999999999    4899999999999999999999999999887


Q ss_pred             ccccc-----ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          438 MTAAA-----NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       438 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      .....     ...++...||..||+||.+.+..|+.|+||||+|++++|+++ =..+++..      ....     ..+.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t~~-----d~r~  474 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------ATLT-----DIRD  474 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------Hhhh-----hhhc
Confidence            65544     445666789999999999999999999999999999999997 33332211      1111     1112


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQV  553 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev  553 (580)
                      ..+++....+.|       .-+.++.+++...|.+||++.+.
T Consensus       475 g~ip~~~~~d~p-------~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  475 GIIPPEFLQDYP-------EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             CCCChHHhhcCc-------HHHHHHHHhcCCCcccCchHHHH
Confidence            222322322222       33467889999999999955443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=7.3e-18  Score=160.70  Aligned_cols=199  Identities=20%  Similarity=0.301  Sum_probs=136.7

Q ss_pred             CCCcceeeeeEEECC--------------------------CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHH
Q 008031          341 RHPNLLALRAYYLGP--------------------------KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK  394 (580)
Q Consensus       341 ~h~niv~~~~~~~~~--------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~  394 (580)
                      +|||||++.++|.++                          ....|+||...+. +|..++-.+    ..+....+-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence            599999998888652                          1245899988855 899998764    466778888999


Q ss_pred             HHHHHHHHhhcCCCcccCCCCCCCeeeC--CC--CCeEEeeccccccccc-----ccccceeeecCccccCCccccccCC
Q 008031          395 GMTRGLLHLHSNENIIHGNLTSSNVLLD--DS--TNAKISDFGLSRLMTA-----AANVNVIATAGALGYRAPELSKLKK  465 (580)
Q Consensus       395 ~i~~~l~~LH~~~~i~H~Dlk~~Nil~~--~~--~~~kl~Dfg~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~  465 (580)
                      |+++|+.|||.+ ||.|||+|++|||+.  +|  ..+.|+|||.+---..     .........-|.-.-||||+.....
T Consensus       349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999995 999999999999994  33  2478999997632211     1111112234666789999876422


Q ss_pred             ------CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhc
Q 008031          466 ------ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHC  539 (580)
Q Consensus       466 ------~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  539 (580)
                            ...|+|.|+.|-+.||+++...||......-+..  ..+.+.+         +..-....   ...+.+++...
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--r~Yqe~q---------LPalp~~v---pp~~rqlV~~l  493 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--RTYQESQ---------LPALPSRV---PPVARQLVFDL  493 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech--hhhhhhh---------CCCCcccC---ChHHHHHHHHH
Confidence                  2348999999999999999999997633221111  1111111         11111111   22455777789


Q ss_pred             cCCCCCCCCCHHHHHHHHhh
Q 008031          540 VDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       540 l~~~P~~Rps~~ev~~~L~~  559 (580)
                      ++.||.+|+|..-....|.-
T Consensus       494 L~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  494 LKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             hcCCccccCCccHHHhHHHH
Confidence            99999999998877666643

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.74  E-value=1.7e-19  Score=179.37  Aligned_cols=179  Identities=26%  Similarity=0.329  Sum_probs=158.3

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|+.|+++..-..++.+|++|+.||||+|.|..+.++.....++|++|+|++|+|+...+..|..|.+|++|+|++|.
T Consensus       273 ~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns  352 (873)
T KOG4194|consen  273 HLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS  352 (873)
T ss_pred             eeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence            79999999997778899999999999999999998888888889999999999999998888899999999999999999


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCc---cccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCcc
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPS---TIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      |+.+-...|..+.+|+.|||.+|.|++.+.+   .|..+++|+.|+|.+|+|....-.+|..+++|+.|||.+|.|....
T Consensus       353 i~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq  432 (873)
T KOG4194|consen  353 IDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQ  432 (873)
T ss_pred             hHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeec
Confidence            9988888999999999999999999887655   3778999999999999999666689999999999999999999888


Q ss_pred             Chhhhh-hcCCCcccccccccCC
Q 008031          159 PTSLAL-KFNASSFVGNIQLCGY  180 (580)
Q Consensus       159 p~~~~~-~~~~~~~~~~~~~~~~  180 (580)
                      |..|.. .+....+.....+|++
T Consensus       433 ~nAFe~m~Lk~Lv~nSssflCDC  455 (873)
T KOG4194|consen  433 PNAFEPMELKELVMNSSSFLCDC  455 (873)
T ss_pred             ccccccchhhhhhhcccceEEec
Confidence            887753 3444444455556664

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.8e-17  Score=156.03  Aligned_cols=134  Identities=21%  Similarity=0.431  Sum_probs=110.9

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccc--------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITK--------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      +.||+|++|.||+|.. .|..|++|+.......        ....+.+|+.++..+.|+++.....++.. .+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEEE
Confidence            5789999999999987 5788999986543221        12357789999999999988776666654 457889999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      |++|++|.+++....      . .+..++.+++.+|.++|+ .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999986532      1 788999999999999999 4999999999999999 78899999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=2.7e-17  Score=152.91  Aligned_cols=138  Identities=20%  Similarity=0.219  Sum_probs=108.1

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccc----------------------cHHHHHHHHHHHhcCCCCc-
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK----------------------GQREFESEVSLLGKIRHPN-  344 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n-  344 (580)
                      .|...+.||+|+||.||++...+|+.||||++......                      ....+..|+.++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            35667899999999999999888999999986532200                      1123677899999987774 


Q ss_pred             -ceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC
Q 008031          345 -LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD  423 (580)
Q Consensus       345 -iv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~  423 (580)
                       +...++     ....++||||+++++|.+....         .....++.+++.++.++|+ .|++||||+|.||++++
T Consensus        96 ~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          96 PVPKPID-----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCceee-----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccEEEcC
Confidence             444443     2356899999999998765431         2356788999999999999 59999999999999999


Q ss_pred             CCCeEEeeccccccccc
Q 008031          424 STNAKISDFGLSRLMTA  440 (580)
Q Consensus       424 ~~~~kl~Dfg~~~~~~~  440 (580)
                      ++.++|+|||++.....
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=4.5e-17  Score=151.71  Aligned_cols=130  Identities=22%  Similarity=0.403  Sum_probs=103.5

Q ss_pred             cccccCceEEEEEEeCCCCEEEEEEccccccc--------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITK--------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .||+|+||.||+|.+ +|..|++|........        ....+.+|++++..++|+++.....++.. ....++||||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEEE
Confidence            479999999999985 4788999986532211        12457789999999988765444444443 4467899999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ++|++|.+++....    .      .++.+++.+|.++|+ .|++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN----D------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH----H------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998876531    0      789999999999999 5999999999999999 78899999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.71  E-value=6.6e-18  Score=179.35  Aligned_cols=206  Identities=25%  Similarity=0.354  Sum_probs=141.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.+.+.|..|+||.||..+++ +.+++|+|+-+...      +.+-  ++.....|.+|                     
T Consensus        85 f~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             cceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee---------------------
Confidence            567799999999999999887 57788885433221      1110  22222233332                     


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc-----
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA-----  442 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-----  442 (580)
                       |+-.+.++..+   +++.        +++.+++|||+ .||+|||+||+|.+|+.-|++|+.|||+++.-....     
T Consensus       136 -gDc~tllk~~g---~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 -GDCATLLKNIG---PLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             -chhhhhcccCC---CCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence             34444444432   2222        22788999999 599999999999999999999999999986432111     


Q ss_pred             ---------ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          443 ---------NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       443 ---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                               .......+||+.|+|||++....|+..+|+|++|+++||++-|+.||.+...+++...+..... .|.+. 
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-~wpE~-  280 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-EWPEE-  280 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-ccccc-
Confidence                     1112245799999999999999999999999999999999999999998877665554443211 11111 


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPE  549 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps  549 (580)
                       |..       .+.   +..+++.+.|+.+|.+|.-
T Consensus       281 -dea-------~p~---Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  281 -DEA-------LPP---EAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -CcC-------CCH---HHHHHHHHHHHhChHhhcc
Confidence             111       112   4556777888899999963

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.71  E-value=3.2e-18  Score=170.39  Aligned_cols=163  Identities=25%  Similarity=0.286  Sum_probs=135.2

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|+..-...|.++.+|..|.|++|+|+...+..|.+|++|+.|+|..|+|...--..|..|++|+.|.|..|
T Consensus       176 ~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN  255 (873)
T KOG4194|consen  176 KKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRN  255 (873)
T ss_pred             eEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhc
Confidence            46888888888777777888888888888888888777777888888888888888887443556788888888888888


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +|.......|-.|.++++|+|..|+++.....++.++++|+.|+|+.|.|....++.....++|+.|+|++|+|+...+.
T Consensus       256 ~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~  335 (873)
T KOG4194|consen  256 DISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEG  335 (873)
T ss_pred             CcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChh
Confidence            88777777788888999999999999877788888899999999999999888888888889999999999999988887


Q ss_pred             hhh
Q 008031          161 SLA  163 (580)
Q Consensus       161 ~~~  163 (580)
                      ++.
T Consensus       336 sf~  338 (873)
T KOG4194|consen  336 SFR  338 (873)
T ss_pred             HHH
Confidence            765

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=9.9e-17  Score=171.64  Aligned_cols=132  Identities=21%  Similarity=0.368  Sum_probs=106.1

Q ss_pred             hhccccccCceEEEEEEeCCCCEEEEEE-cccc-cc------ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          291 TAEIMGKSTYGTVYKATLEDGSQVAVKR-LREK-IT------KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~-~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ..+.||+|+||.||+|.+.+.. +++|+ .... ..      ...+.+.+|+++++.++|++++....++.. ....++|
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv  414 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-PEEKTIV  414 (535)
T ss_pred             ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-CCCCEEE
Confidence            4688999999999999886443 44443 2211 11      112457899999999999999887777665 4567899


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      |||+++++|.+++.           ....++.+++.+|.|||+ .|++||||||+||++ +++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999998875           346789999999999999 599999999999999 577899999999865

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.70  E-value=2.6e-19  Score=151.38  Aligned_cols=156  Identities=28%  Similarity=0.582  Sum_probs=139.3

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCC-CCCCccCcCCCCCCEEECcCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN-GSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      +|++++|+|+ .+|.+++.+++|+.|+++-|++. .+|..|+.++-|++|||.+|++. ..+|..|..+..|+.|+|++|
T Consensus        60 vln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dn  137 (264)
T KOG0617|consen   60 VLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDN  137 (264)
T ss_pred             hhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCC
Confidence            5899999999 89999999999999999999998 89999999999999999999997 478999999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCC---CCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKS---LSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~---L~~l~l~~n~l~~~  157 (580)
                      .+ ..+|.+++++++|+.|.+.+|.+- .+|..++.++.|+.|++.+|+++ .+|..++++.-   =+.+.+..|++...
T Consensus       138 df-e~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~p  214 (264)
T KOG0617|consen  138 DF-EILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNP  214 (264)
T ss_pred             Cc-ccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence            99 678999999999999999999998 78999999999999999999999 77777777642   23466777887765


Q ss_pred             cChhh
Q 008031          158 VPTSL  162 (580)
Q Consensus       158 ~p~~~  162 (580)
                      +.+.+
T Consensus       215 IaeQf  219 (264)
T KOG0617|consen  215 IAEQF  219 (264)
T ss_pred             HHHHH
Confidence            55444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.4e-15  Score=140.07  Aligned_cols=138  Identities=20%  Similarity=0.245  Sum_probs=98.6

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEcccccccc--HHH----------------------HHHHHHHHhcCCCCc--c
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKG--QRE----------------------FESEVSLLGKIRHPN--L  345 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i  345 (580)
                      .+.||+|+||.||+|...+|+.||||+++......  ...                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999886532211  111                      134666666664332  3


Q ss_pred             eeeeeEEECCCCcEEEEEeeCCCCChhhh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          346 LALRAYYLGPKGEKLLVFDYMPHGSLATF-LHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       346 v~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      .+.+++     ...++||||++++.+... +....    .. .+...++.+++.++.++|+.++|+|+||||+||+++ +
T Consensus        82 ~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec-----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence            444332     246899999999654321 22110    11 567889999999999999834999999999999999 8


Q ss_pred             CCeEEeeccccccccc
Q 008031          425 TNAKISDFGLSRLMTA  440 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~  440 (580)
                      +.++++|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            8999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=3.9e-15  Score=141.58  Aligned_cols=137  Identities=18%  Similarity=0.258  Sum_probs=106.0

Q ss_pred             hhcccc-ccCceEEEEEEeCCCCEEEEEEccccc-------------cccHHHHHHHHHHHhcCCCCcc--eeeeeEEEC
Q 008031          291 TAEIMG-KSTYGTVYKATLEDGSQVAVKRLREKI-------------TKGQREFESEVSLLGKIRHPNL--LALRAYYLG  354 (580)
Q Consensus       291 ~~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~  354 (580)
                      ....|| .|+.|+||.+... +..++||.+....             ......+.+|++++.++.|+++  +..+++...
T Consensus        35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            356788 8999999999886 7788998874311             0123457889999999988774  667776544


Q ss_pred             CCCc---EEEEEeeCCC-CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          355 PKGE---KLLVFDYMPH-GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       355 ~~~~---~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                      ....   .++|||+++| .+|.+++...    .++..    .+.+|+.++.+||+ .||+||||||.|||++.++.++++
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHD-AGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCCCEEEE
Confidence            3322   3599999997 6898887642    34443    36789999999999 499999999999999988899999


Q ss_pred             ecccccc
Q 008031          431 DFGLSRL  437 (580)
Q Consensus       431 Dfg~~~~  437 (580)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998865

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.61  E-value=6.1e-17  Score=162.34  Aligned_cols=149  Identities=33%  Similarity=0.464  Sum_probs=71.4

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      ||||+|++. +.|..+.+..++-.|+||+|+|..+....|-+++.|-.|||++|++. .+|..+..|.+|++|.|++|.+
T Consensus       108 lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL  185 (1255)
T KOG0444|consen  108 LDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPL  185 (1255)
T ss_pred             eecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence            444444444 44444444444444444444444333333444444444444444444 3444444444444444444443


Q ss_pred             Cc-------------------------ccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccccc
Q 008031           83 DD-------------------------QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS  137 (580)
Q Consensus        83 ~~-------------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  137 (580)
                      ..                         .+|..+..|.||..+|||.|++. ..|+.+-++++|+.|+||+|.|+ .+.-.
T Consensus       186 ~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~  263 (1255)
T KOG0444|consen  186 NHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMT  263 (1255)
T ss_pred             hHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeecc
Confidence            32                         22333444445555555555555 45555555555555555555555 23333


Q ss_pred             ccCcCCCCeeecccccCc
Q 008031          138 FSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       138 l~~l~~L~~l~l~~n~l~  155 (580)
                      .....+|++|+|+.|+++
T Consensus       264 ~~~W~~lEtLNlSrNQLt  281 (1255)
T KOG0444|consen  264 EGEWENLETLNLSRNQLT  281 (1255)
T ss_pred             HHHHhhhhhhccccchhc
Confidence            344445555666666665

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=2.4e-16  Score=167.83  Aligned_cols=254  Identities=22%  Similarity=0.255  Sum_probs=182.6

Q ss_pred             HhhhccccccCceEEEEEEeCC--CCEEEEEEccccc--cccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLED--GSQVAVKRLREKI--TKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...+.||+|+|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++++++.... .+..++.+
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~~~~~  100 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSYLLSL  100 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-Cccccccc
Confidence            3455779999999998887643  3456666654432  223344556788878886 9999999998876 56788999


Q ss_pred             eeCCCCChhhhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCcccCCCCCCCeeeCCCC-CeEEeeccccccccc
Q 008031          364 DYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLH-SNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTA  440 (580)
Q Consensus       364 e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~  440 (580)
                      +|.+++++.+-+ +..  ....+....-.++.|+..++.|+| . .++.|+|+||+|.+++..+ ..+++|||+|..+..
T Consensus       101 ~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             CcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999888 432  113555667789999999999999 7 5999999999999999988 999999999987765


Q ss_pred             -c-cccceeeecC-ccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          441 -A-ANVNVIATAG-ALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       441 -~-~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                       . .........| ++.|+|||...+. ......|+||.|+++.-+++|..|+......+-..           ..+.+.
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~~  246 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKSN  246 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------eeeccc
Confidence             2 2333344567 9999999998874 45667899999999999999999987544332000           001111


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .................++..+++..+|..|.+.+++...=
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~  287 (601)
T KOG0590|consen  247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN  287 (601)
T ss_pred             ccccccCccccCChhhhhcccccccCCchhccccccccccc
Confidence            00000001111122455777789999999999999876543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.2e-14  Score=128.74  Aligned_cols=132  Identities=19%  Similarity=0.236  Sum_probs=110.3

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCC--CcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRH--PNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      .+.||+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  .++.+++++... .+..+++|||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCCe
Confidence            4678999999999999864 7899998865433  4678899999999976  588888887765 46799999999887


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN--ENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      .+..+          +......++.+++++++++|..  .+++|+|++|.||++++.+.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4456678899999999999984  2699999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.58  E-value=1e-16  Score=160.87  Aligned_cols=152  Identities=28%  Similarity=0.416  Sum_probs=124.0

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      +|||.|++. .+|+.+.++++|+.|+||+|.|+ .+.-......+|++|+|+.|+++ .+|..+..|++|+.|++.+|++
T Consensus       227 vDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL  303 (1255)
T KOG0444|consen  227 VDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKL  303 (1255)
T ss_pred             ccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcc
Confidence            678888888 78888888888888888888888 45555666778888888888888 7888888888888888888887


Q ss_pred             C-cccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           83 D-DQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        83 ~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      + .-+|..+++|.+|+.+++++|.+. ..|+.++.|.+|+.|.|++|++. .+|+.+.-++.|+.||+..|+=--.+|
T Consensus       304 ~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  304 TFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             cccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence            6 356788888888888888888887 78888888888888888888887 678888888888888888887554444

>PLN03150 hypothetical protein; Provisional

Probab=99.56  E-value=1.3e-14  Score=157.03  Aligned_cols=117  Identities=38%  Similarity=0.636  Sum_probs=103.0

Q ss_pred             CCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecc
Q 008031           71 SLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVS  150 (580)
Q Consensus        71 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~  150 (580)
                      .++.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCccChhhhhh---cCCCcccccccccCCCCCCCCC
Q 008031          151 YNNLSGPVPTSLALK---FNASSFVGNIQLCGYSGSTPCP  187 (580)
Q Consensus       151 ~n~l~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~C~  187 (580)
                      +|+++|.+|..+...   .....+.+|..+|+.+....|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence            999999999877542   2234566888899877666664

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.53  E-value=6.9e-16  Score=147.29  Aligned_cols=163  Identities=27%  Similarity=0.338  Sum_probs=116.4

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeC-CcCCCCCCccCcCC----------
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSY-NAINGSLPASFSNL----------   69 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l----------   69 (580)
                      +.++|..|+|+.+.+.+|+.+++|+.||||+|.|+.+-|+.|..+++|.+|-+.+ |+|+......|.+|          
T Consensus        70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa  149 (498)
T KOG4237|consen   70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA  149 (498)
T ss_pred             eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence            4689999999977778999999999999999999988899999999988887766 88884333333333          


Q ss_pred             --------------CCCCEEECcCCCCCcccc------------------------------------------------
Q 008031           70 --------------SSLVSLTLESNNLDDQIL------------------------------------------------   87 (580)
Q Consensus        70 --------------~~L~~L~l~~N~l~~~~~------------------------------------------------   87 (580)
                                    ++|..|.+.+|.+..+..                                                
T Consensus       150 n~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~  229 (498)
T KOG4237|consen  150 NHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPY  229 (498)
T ss_pred             hhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchH
Confidence                          333333333333211111                                                


Q ss_pred             --------------------------------------hhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccc
Q 008031           88 --------------------------------------DSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNK  129 (580)
Q Consensus        88 --------------------------------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  129 (580)
                                                            .-|..|++|+.|+|++|+|+++-+..|.....++.|.|..|+
T Consensus       230 rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~  309 (498)
T KOG4237|consen  230 RLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNK  309 (498)
T ss_pred             HHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcch
Confidence                                                  113445677777777777776666667777777777777777


Q ss_pred             cCCcccccccCcCCCCeeecccccCcCccChhhh
Q 008031          130 LSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus       130 l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~  163 (580)
                      |.......|.++..|+.|+|.+|+|+...|..|.
T Consensus       310 l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~  343 (498)
T KOG4237|consen  310 LEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ  343 (498)
T ss_pred             HHHHHHHhhhccccceeeeecCCeeEEEeccccc
Confidence            7655566778888888999999999877776554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=4.6e-14  Score=145.92  Aligned_cols=142  Identities=19%  Similarity=0.309  Sum_probs=102.4

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEcccccccc----------------------------------------HHHHHH
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKG----------------------------------------QREFES  332 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  332 (580)
                      +.||.|++|.||+|++.+|+.||||+.+......                                        +-+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999999999999999986542110                                        012445


Q ss_pred             HHHHHhcCC----CCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHhhcCC
Q 008031          333 EVSLLGKIR----HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR-GLLHLHSNE  407 (580)
Q Consensus       333 e~~~l~~l~----h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~  407 (580)
                      |++.+.++.    |.+-+.+-..+.+-.+..++||||++|++|.++.....  ...   ...+++.+++. .+..+|.. 
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~~-  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLRD-  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHhC-
Confidence            666666552    33333443344333446799999999999998875421  112   23456666666 46788884 


Q ss_pred             CcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       408 ~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      |++|+|++|.||+++.+++++++|||++..+..
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999877654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.51  E-value=1.6e-16  Score=151.74  Aligned_cols=149  Identities=29%  Similarity=0.452  Sum_probs=87.7

Q ss_pred             EecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCC
Q 008031            4 ALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLD   83 (580)
Q Consensus         4 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~   83 (580)
                      +..+|+|+ ..|+.++++.+|..|++.+|++....|+.+ ++++|+.||+..|-++ .+|..++.+.+|+-|+|..|+|.
T Consensus       143 ~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~  219 (565)
T KOG0472|consen  143 DATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR  219 (565)
T ss_pred             hccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc
Confidence            33444444 444444445555555555555543323222 2555666666666665 56666666666666666666663


Q ss_pred             cccchhhhccCCCCeeeeccccccccCCccc-cCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           84 DQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        84 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      . .| .|+.+..|.+|+++.|+|. .+|... ..++.+.+|||.+|+++ ..|..+..+.+|..||+++|.+++.++
T Consensus       220 ~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~  292 (565)
T KOG0472|consen  220 F-LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPY  292 (565)
T ss_pred             c-CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCc
Confidence            3 33 5666666666666666666 344333 36677777777777776 566667777777777777777765433

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.50  E-value=6.5e-16  Score=147.63  Aligned_cols=147  Identities=31%  Similarity=0.472  Sum_probs=134.0

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .|++.+|++. ..|+..-+++.|+.||+..|-++ .+|..++.+.+|..|||..|+|. .+| .|..+..|.+|+++.|+
T Consensus       164 ~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~  239 (565)
T KOG0472|consen  164 KLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQ  239 (565)
T ss_pred             Hhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccH
Confidence            4788999999 56655555999999999999998 78889999999999999999999 777 79999999999999999


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCc
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      |..........+++|..|||.+|+++ ..|+.+..+.+|..||+++|.++ .+|..++++ .|++|-+.+|++.
T Consensus       240 i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr  310 (565)
T KOG0472|consen  240 IEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR  310 (565)
T ss_pred             HHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH
Confidence            97666666679999999999999999 89999999999999999999999 678899999 9999999999986

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.44  E-value=1.1e-12  Score=134.59  Aligned_cols=232  Identities=22%  Similarity=0.256  Sum_probs=155.4

Q ss_pred             CCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHH
Q 008031          309 EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPT  388 (580)
Q Consensus       309 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  388 (580)
                      .++.+|.|...+...........+-++.|+.++||+|++++..+.. ++..|+|+|.+  -.|..++.+.      ....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV--~Pl~~~lk~l------~~~~  105 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERV--RPLETVLKEL------GKEE  105 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeecc--ccHHHHHHHh------HHHH
Confidence            4688888888765544334557788899999999999999999876 66899999998  3677777763      3556


Q ss_pred             HHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeecCccccCCccccccCCCCC
Q 008031          389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT  468 (580)
Q Consensus       389 ~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  468 (580)
                      +...+.||+.||.+||...+++|++|....|+|+..|..||++|.++......... .....---.|..|+.+....  -
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cccchhhhcccChhhcCccc--c
Confidence            77888999999999987679999999999999999999999999987654433210 00111112366676654332  3


Q ss_pred             cccchhHHHHHHHHHcCCCCCCC--CCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCC
Q 008031          469 KTDVYSLGVTILELLTGKSPGEP--LNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSA  546 (580)
Q Consensus       469 ~~Dv~s~G~~l~el~tg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~  546 (580)
                      ..|.|-|||+++|++.|..+-..  .....+++.......+    ........+.         ...+++..|....+--
T Consensus       183 s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k----~~~~~~~~r~---------n~~~~~~~~~~~~gff  249 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCK----KLGATELKRP---------NKLRFILECRLLGGFF  249 (690)
T ss_pred             chhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHH----Hhcccccccc---------chhhHHHHHHhccccc
Confidence            46999999999999999332111  1111111111111100    1111111110         1335566777777777


Q ss_pred             CCCHHHHHHHHhhhccccc
Q 008031          547 RPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       547 Rps~~ev~~~L~~~~~~~~  565 (580)
                      |=.+-+++..|++++-+..
T Consensus       250 ~n~fvd~~~fLeel~lks~  268 (690)
T KOG1243|consen  250 RNDFVDTLLFLEELRLKSV  268 (690)
T ss_pred             cchHHHHHHHHHhcccCcH
Confidence            8788888888888765543

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.40  E-value=6.8e-13  Score=143.49  Aligned_cols=43  Identities=30%  Similarity=0.385  Sum_probs=23.6

Q ss_pred             CCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChhh
Q 008031          119 TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus       119 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                      +|+.|++++|+|+ .+|..+..+++|..|+|++|+|++..|..+
T Consensus       423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            3444555555554 345555556666666666666665555544

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=4.2e-13  Score=125.66  Aligned_cols=206  Identities=21%  Similarity=0.333  Sum_probs=140.6

Q ss_pred             HHHHhcCCCCcceeeeeEEECCC----CcEEEEEeeCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcC-C
Q 008031          334 VSLLGKIRHPNLLALRAYYLGPK----GEKLLVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSN-E  407 (580)
Q Consensus       334 ~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~-~  407 (580)
                      ..-+-++.|-|||++..|+.+.+    ....+++|||+-|++.++|++.. ....+....-.+|+.||..||.|||+. +
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            34455567999999999887633    24679999999999999998642 234577778889999999999999985 7


Q ss_pred             CcccCCCCCCCeeeCCCCCeEEeeccccccccc---ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc
Q 008031          408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA---AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT  484 (580)
Q Consensus       408 ~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t  484 (580)
                      .|+|+++..+-|++..++-+|+.--.-......   ..........+-++|.|||.=.....+.++|||+||+...||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            899999999999999888788753222111111   01111122346678999998666666778999999999999998


Q ss_pred             CCCCCCCC-CCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          485 GKSPGEPL-NGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       485 g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      +..--... ...+....+......      ....+             -..++.+|++..|..||+|.+++.|.-
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~------len~l-------------qr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIG------LENGL-------------QRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             heeccCCCcceeehhhhhhhheee------ccCcc-------------ccCcCcccccCCCCCCcchhhhhcCce
Confidence            77542221 111111111111000      00000             014667899999999999999887653

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.39  E-value=3.2e-13  Score=120.04  Aligned_cols=140  Identities=28%  Similarity=0.377  Sum_probs=50.3

Q ss_pred             EecCCcccccccccccCCCCCcEEEccCCccCCCCCcccc-CCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            4 ALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLG-RLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         4 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      .|..+-|. ..+ .+-+..++++|+|++|.|+.+  +.++ .+.+|+.|+|++|.|+. +. .+..+++|+.|++++|.|
T Consensus         3 ~lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I   76 (175)
T PF14580_consen    3 RLTANMIE-QIA-QYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRI   76 (175)
T ss_dssp             -------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS--
T ss_pred             cccccccc-ccc-ccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCC
Confidence            34455555 233 455666889999999999843  3455 57899999999999984 43 588889999999999999


Q ss_pred             CcccchhhhccCCCCeeeeccccccccC-CccccCCCCCcEEEccccccCCccc---ccccCcCCCCeeec
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHI-PSTIGNISTLTILDLSQNKLSGEIP---ASFSNLKSLSSFNV  149 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~---~~l~~l~~L~~l~l  149 (580)
                      +.+.+.....+++|++|+|++|+|.... -..+..+++|++|+|.+|.++....   ..+..+|+|+.||-
T Consensus        77 ~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   77 SSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             CccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            7754433346889999999999987532 2346778899999999999874321   23567888888863

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=2.1e-12  Score=131.49  Aligned_cols=252  Identities=21%  Similarity=0.235  Sum_probs=180.0

Q ss_pred             cccCHHHHHHhhhccccc--cCceEEEEEEe--C-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcC-CCCcceeeeeE
Q 008031          280 LMFTADDLLCATAEIMGK--STYGTVYKATL--E-DGSQVAVKRLREKIT--KGQREFESEVSLLGKI-RHPNLLALRAY  351 (580)
Q Consensus       280 ~~~~~~~~~~~~~~~ig~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~  351 (580)
                      .-.+..+....+..-+|.  |.+|.||.+..  . ++..+|+|+-+....  .....=.+|+...+.+ .|++.++....
T Consensus       107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            344555555667788999  99999999987  3 788899998443322  2223345677777777 59999997777


Q ss_pred             EECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCcccCCCCCCCeeeCCC-CC
Q 008031          352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR----GLLHLHSNENIIHGNLTSSNVLLDDS-TN  426 (580)
Q Consensus       352 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~i~H~Dlk~~Nil~~~~-~~  426 (580)
                      +.. .+..++-+|++ +.+|.++.+...  ..++.........+..+    |+.++|+ .+++|-|+||.||+...+ ..
T Consensus       187 ~e~-~~~lfiqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  187 WEG-SGILFIQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             ccc-CCcceeeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccce
Confidence            765 66889999998 568888877643  23566677778888888    9999999 499999999999999988 88


Q ss_pred             eEEeecccccccccccccc----eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCC---CCCChhH
Q 008031          427 AKISDFGLSRLMTAAANVN----VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPL---NGAELPQ  499 (580)
Q Consensus       427 ~kl~Dfg~~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~---~~~~~~~  499 (580)
                      .+++|||+...+.......    .....|...|++||..+ +.++..+|+|++|.+..+..++...+...   ...+..+
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            9999999988775543221    12225677899999987 67889999999999999999987765433   1111111


Q ss_pred             HHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 008031          500 WVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ  555 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~  555 (580)
                      +.   +    ..+           .+.....++...+..+++.+|..|++...+..
T Consensus       341 ~~---i----p~e-----------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 GY---I----PLE-----------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc---C----chh-----------hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            10   0    001           11111223444777899999999998876543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=8.6e-13  Score=137.89  Aligned_cols=140  Identities=18%  Similarity=0.270  Sum_probs=92.8

Q ss_pred             ccccccCceEEEEEEeCC-CCEEEEEEcccccccc----------------------------------H------HHHH
Q 008031          293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKG----------------------------------Q------REFE  331 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~------~~~~  331 (580)
                      +.||+|++|.||+|++.+ |+.||||+.++...+.                                  .      -++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999986 9999999997542110                                  0      1244


Q ss_pred             HHHHHHhcCC----CCcceeeeeEEECCCCcEEEEEeeCCCCChhhhh--hhcCCC-CCCCHHHHHHHHHHHHHHHHHhh
Q 008031          332 SEVSLLGKIR----HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPE-TPIDWPTRMKIIKGMTRGLLHLH  404 (580)
Q Consensus       332 ~e~~~l~~l~----h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH  404 (580)
                      +|+..+.+++    +...+.+-..+.+-....++||||++|+.+.++-  ...+.. ..+....+..++.|+       .
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            4555555542    3444444444443334678999999999998753  222100 012222233333333       3


Q ss_pred             cCCCcccCCCCCCCeeeCCCC----CeEEeeccccccccc
Q 008031          405 SNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMTA  440 (580)
Q Consensus       405 ~~~~i~H~Dlk~~Nil~~~~~----~~kl~Dfg~~~~~~~  440 (580)
                      . .|++|+|+||.||+++.++    +++++|||++...+.
T Consensus       278 ~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4 3999999999999999887    899999999876644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=5.3e-12  Score=114.27  Aligned_cols=126  Identities=15%  Similarity=0.142  Sum_probs=94.7

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcce-eeeeEEECCCCcEEEEEeeCCCCCh
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL-ALRAYYLGPKGEKLLVFDYMPHGSL  371 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~g~L  371 (580)
                      +.++.|.++.||++... +..+++|....... ....+.+|+.+++.+.+.+++ +++.+.   ....++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~---~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD---PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe---CCCCeEEEEecCCCcc
Confidence            56899999999999876 78899998754432 223467899999988655544 444433   2245899999999887


Q ss_pred             hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----cccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          372 ATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN-----IIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       372 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-----i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      .+..        .   ....++.+++++++.||+. +     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            6430        1   1134567899999999984 6     49999999999999 5689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.33  E-value=1.1e-13  Score=138.32  Aligned_cols=152  Identities=31%  Similarity=0.522  Sum_probs=129.4

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      |.|.+|.|- .+|..+.+|..|..|||+.|+++ .+|..+..|+ |+.|.+++|+++ .+|..++.+.+|..|+.+.|+|
T Consensus       103 liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei  178 (722)
T KOG0532|consen  103 LILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI  178 (722)
T ss_pred             HHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence            356677777 78888899999999999999998 6777777776 899999999998 8888888888999999999998


Q ss_pred             CcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChhh
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                       ..+|..+..+.+|+.|++..|++. .+|..+.. -.|..||++.|+++ .+|-.|.+|+.|++|-|.+|+|... |..+
T Consensus       179 -~slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP-PAqI  253 (722)
T KOG0532|consen  179 -QSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP-PAQI  253 (722)
T ss_pred             -hhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC-hHHH
Confidence             457888899999999999999998 66777774 45889999999999 8999999999999999999999854 4444


Q ss_pred             h
Q 008031          163 A  163 (580)
Q Consensus       163 ~  163 (580)
                      .
T Consensus       254 C  254 (722)
T KOG0532|consen  254 C  254 (722)
T ss_pred             H
Confidence            3

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.33  E-value=8e-13  Score=117.47  Aligned_cols=119  Identities=35%  Similarity=0.513  Sum_probs=54.0

Q ss_pred             CEEEecCCccccccccccc-CCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccC-cCCCCCCEEECc
Q 008031            1 MFLALQYNNLSGRIPASLG-KLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASF-SNLSSLVSLTLE   78 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~   78 (580)
                      ++|+|++|+|+ .+. .++ .+.+|+.|||++|.|+.+  +.+..+++|++|++++|+|+ .+...+ ..+++|+.|+|+
T Consensus        22 ~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~   96 (175)
T PF14580_consen   22 RELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLS   96 (175)
T ss_dssp             ----------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-T
T ss_pred             ccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECc
Confidence            36899999999 443 566 589999999999999954  35888999999999999999 444444 468999999999


Q ss_pred             CCCCCccc-chhhhccCCCCeeeeccccccccCCc----cccCCCCCcEEEc
Q 008031           79 SNNLDDQI-LDSLDKLHNLSVLNLKRNQISGHIPS----TIGNISTLTILDL  125 (580)
Q Consensus        79 ~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~l  125 (580)
                      +|+|.... -..+..+++|+.|+|.+|.++.. +.    .+..+|+|+.||-
T Consensus        97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   97 NNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             TS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred             CCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence            99997633 35678899999999999999843 33    2667899999984

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.31  E-value=3e-12  Score=139.39  Aligned_cols=115  Identities=24%  Similarity=0.458  Sum_probs=61.6

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .|+|++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+ .+|..+.  .+|+.|+|++|+
T Consensus       182 ~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~  252 (754)
T PRK15370        182 ELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINR  252 (754)
T ss_pred             EEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCc
Confidence            4566666666 4554443  35666666666666 3343332  36666666666666 3444332  256666666666


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS  131 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  131 (580)
                      ++. +|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+
T Consensus       253 L~~-LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt  296 (754)
T PRK15370        253 ITE-LPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR  296 (754)
T ss_pred             cCc-CChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence            643 333332  35566666666665 3444332  35566666666555

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.31  E-value=2.7e-12  Score=139.67  Aligned_cols=140  Identities=29%  Similarity=0.472  Sum_probs=84.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|+ .+|..+.  .+|+.|+|++|.|. .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|
T Consensus       223 ~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N  293 (754)
T PRK15370        223 KTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDN  293 (754)
T ss_pred             CEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCC
Confidence            36788888888 5666553  36788888888877 4565553  47788888888877 4565543  46777777777


Q ss_pred             CCCcccchhhh-------------------ccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCc
Q 008031           81 NLDDQILDSLD-------------------KLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNL  141 (580)
Q Consensus        81 ~l~~~~~~~~~-------------------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l  141 (580)
                      +|+.. |..+.                   ..++|+.|++++|.++. +|..+.  ++|+.|+|++|+++ .+|..+  .
T Consensus       294 ~Lt~L-P~~lp~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p  366 (754)
T PRK15370        294 SIRTL-PAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--P  366 (754)
T ss_pred             ccccC-cccchhhHHHHHhcCCccccCCccccccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--c
Confidence            77653 22221                   11345555555555552 333332  45666666666665 344433  2


Q ss_pred             CCCCeeecccccCcC
Q 008031          142 KSLSSFNVSYNNLSG  156 (580)
Q Consensus       142 ~~L~~l~l~~n~l~~  156 (580)
                      ++|+.|++++|+|+.
T Consensus       367 ~~L~~LdLs~N~Lt~  381 (754)
T PRK15370        367 PTITTLDVSRNALTN  381 (754)
T ss_pred             CCcCEEECCCCcCCC
Confidence            456666666666663

>PLN03150 hypothetical protein; Provisional

Probab=99.31  E-value=5.4e-12  Score=136.74  Aligned_cols=113  Identities=32%  Similarity=0.525  Sum_probs=102.3

Q ss_pred             CCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEcc
Q 008031           47 RLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLS  126 (580)
Q Consensus        47 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  126 (580)
                      .++.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcccccccCc-CCCCeeecccccCcCccC
Q 008031          127 QNKLSGEIPASFSNL-KSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       127 ~N~l~~~~~~~l~~l-~~L~~l~l~~n~l~~~~p  159 (580)
                      +|++++.+|..+..+ .++..+++.+|+..+..|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999888764 467789999998664433

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.30  E-value=1.8e-13  Score=143.98  Aligned_cols=131  Identities=27%  Similarity=0.382  Sum_probs=89.4

Q ss_pred             CCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeee
Q 008031           21 LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLN  100 (580)
Q Consensus        21 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  100 (580)
                      .+.|..|+|.+|.++...-..+..+.+|+.|+|++|+|.......+.++..|++|+||+|+++. +|..+..+..|++|.
T Consensus       358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~  436 (1081)
T KOG0618|consen  358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLR  436 (1081)
T ss_pred             hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHh
Confidence            4567777777777775555566777777777777777774444556777777777777777754 456677777777777


Q ss_pred             eccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccC
Q 008031          101 LKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL  154 (580)
Q Consensus       101 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l  154 (580)
                      ..+|+|. .+| .+..++.|+.+|++.|+|+...-......++|++||+++|..
T Consensus       437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            7777776 566 567777777777777777653333333336777777777764

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.30  E-value=1.1e-13  Score=145.47  Aligned_cols=149  Identities=30%  Similarity=0.428  Sum_probs=115.7

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccC-------------------------CCCCCEEEeeCCc
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGR-------------------------LSRLRILDFSYNA   57 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-------------------------l~~L~~L~l~~n~   57 (580)
                      |.+..|++. -+|+.+..+.+|++|||..|.|....+..|.-                         ++.|+.|+|.+|.
T Consensus       292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~  370 (1081)
T KOG0618|consen  292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNH  370 (1081)
T ss_pred             HHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCc
Confidence            455566666 56666777777888888888777332222211                         2336777778888


Q ss_pred             CCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccccc
Q 008031           58 INGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS  137 (580)
Q Consensus        58 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  137 (580)
                      +++..-..|.+.++|+.|+|++|+|.......+.++..|++|+||+|.++ .+|+.+..+..|++|....|++. ..| .
T Consensus       371 Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e  447 (1081)
T KOG0618|consen  371 LTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-E  447 (1081)
T ss_pred             ccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-h
Confidence            87655556778889999999999997777777888899999999999998 77888889999999999999988 667 7


Q ss_pred             ccCcCCCCeeecccccCc
Q 008031          138 FSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       138 l~~l~~L~~l~l~~n~l~  155 (580)
                      +..++.|+.+|++.|+|+
T Consensus       448 ~~~l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  448 LAQLPQLKVLDLSCNNLS  465 (1081)
T ss_pred             hhhcCcceEEecccchhh
Confidence            999999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.27  E-value=6.8e-11  Score=107.34  Aligned_cols=136  Identities=15%  Similarity=0.178  Sum_probs=97.9

Q ss_pred             ccccccCceEEEEEEeCC-------CCEEEEEEcccccc---------------------ccHH-H----HHHHHHHHhc
Q 008031          293 EIMGKSTYGTVYKATLED-------GSQVAVKRLREKIT---------------------KGQR-E----FESEVSLLGK  339 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~-~----~~~e~~~l~~  339 (580)
                      .+||.|.-+.||.|...+       +..+|||+.+....                     ...+ .    ..+|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998653       47999998752110                     0111 2    2389999999


Q ss_pred             CCC--CcceeeeeEEECCCCcEEEEEeeCCCCChhh-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCcccCCCC
Q 008031          340 IRH--PNLLALRAYYLGPKGEKLLVFDYMPHGSLAT-FLHARGPETPIDWPTRMKIIKGMTRGLLHL-HSNENIIHGNLT  415 (580)
Q Consensus       340 l~h--~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~i~H~Dlk  415 (580)
                      +..  -++...+++     ...++||||+.++.+.. .++.    ..++..+...+..+++.++..| |. .|++|+||+
T Consensus        83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHh-CCeecCCCC
Confidence            853  455666653     25789999997654422 2221    1344556677889999999998 77 499999999


Q ss_pred             CCCeeeCCCCCeEEeecccccccc
Q 008031          416 SSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       416 ~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      +.||++++ +.+.++|||.+....
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCceeCC
Confidence            99999974 679999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.26  E-value=1.3e-10  Score=112.88  Aligned_cols=265  Identities=15%  Similarity=0.195  Sum_probs=163.9

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEE-----ECCCCc-EEE
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYY-----LGPKGE-KLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~-----~~~~~~-~~l  361 (580)
                      ...++.+|+|+-+.+|-.--- +.. +.|+.+......+.   +.+..|... .||-+-.-+.+=     ....+. ..+
T Consensus        13 i~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecchh-hch-hheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            344678999999999965321 222 34666544332222   233444444 565443311111     111222 568


Q ss_pred             EEeeCCCCC-hhhhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          362 VFDYMPHGS-LATFL---HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       362 v~e~~~~g~-L~~~l---~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      .|..+.+.. +.+++   .++.+....+|+..++.+..+|.+.+.||.+ |.+-+|+.++|+|+++++.|.+.|-..-..
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceee
Confidence            888887752 22222   2334456689999999999999999999995 999999999999999999999998654333


Q ss_pred             cccccccceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcC-CCCCCCCCC----CChhH-HHHHH--
Q 008031          438 MTAAANVNVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTG-KSPGEPLNG----AELPQ-WVASI--  504 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg-~~p~~~~~~----~~~~~-~~~~~--  504 (580)
                      .  .........+|...|.+||...     +-.-+..+|.|.+|+++++++.| ++||.+...    ....+ .+...  
T Consensus       167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            2  2233344567889999999644     44456789999999999999995 999986421    11111 11110  


Q ss_pred             -hhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHhhhcccc
Q 008031          505 -VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDP--SPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       505 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                       ...+.......+.....+...++.+..   +..+|+..  ++.-|||.+-.+..|..++++-
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqA---lF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQA---LFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHH---HHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence             000111111111222223344445554   44477765  3678999999999998887654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.26  E-value=2.4e-11  Score=131.63  Aligned_cols=72  Identities=26%  Similarity=0.455  Sum_probs=52.9

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|||++|.|+ .+|+.+.  ++|+.|++++|+|+. +|.   .+++|++|+|++|+|+ .+|..   .++|+.|+|++|.
T Consensus       205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~  273 (788)
T PRK15387        205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP  273 (788)
T ss_pred             EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence            6899999999 6887775  378999999999884 553   2578999999999988 45543   3456666666666


Q ss_pred             CCc
Q 008031           82 LDD   84 (580)
Q Consensus        82 l~~   84 (580)
                      |+.
T Consensus       274 L~~  276 (788)
T PRK15387        274 LTH  276 (788)
T ss_pred             hhh
Confidence            643

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.25  E-value=1.3e-12  Score=131.25  Aligned_cols=154  Identities=25%  Similarity=0.343  Sum_probs=65.9

Q ss_pred             EEEecCCcccc----cccccccCCCCCcEEEccCCccCC------CCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCC
Q 008031            2 FLALQYNNLSG----RIPASLGKLSELQEISLSHNKISG------VMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSS   71 (580)
Q Consensus         2 ~L~L~~N~i~~----~~~~~~~~l~~L~~L~l~~n~l~~------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~   71 (580)
                      +|+++++.++.    .++..+...++|+.|+++.|.+.+      .++..+..+++|+.|+|++|.+.+..+..+..+.+
T Consensus        27 ~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~  106 (319)
T cd00116          27 VLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLR  106 (319)
T ss_pred             EEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhc
Confidence            34555555532    133344444455555555554431      11223444455555555555554333333333332


Q ss_pred             ---CCEEECcCCCCCc----ccchhhhcc-CCCCeeeecccccccc----CCccccCCCCCcEEEccccccCCc----cc
Q 008031           72 ---LVSLTLESNNLDD----QILDSLDKL-HNLSVLNLKRNQISGH----IPSTIGNISTLTILDLSQNKLSGE----IP  135 (580)
Q Consensus        72 ---L~~L~l~~N~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~  135 (580)
                         |+.|++++|.++.    .....+..+ ++|+.|++++|.+++.    ++..+..+++|++|++++|.+++.    ++
T Consensus       107 ~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~  186 (319)
T cd00116         107 SSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA  186 (319)
T ss_pred             cCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHH
Confidence               5555555555542    111223333 4555555555554421    122233344455555555555421    12


Q ss_pred             ccccCcCCCCeeecccccCc
Q 008031          136 ASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       136 ~~l~~l~~L~~l~l~~n~l~  155 (580)
                      ..+..+++|+.|++++|.++
T Consensus       187 ~~l~~~~~L~~L~L~~n~i~  206 (319)
T cd00116         187 EGLKANCNLEVLDLNNNGLT  206 (319)
T ss_pred             HHHHhCCCCCEEeccCCccC
Confidence            22333345555555555544

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.24  E-value=1.6e-12  Score=130.72  Aligned_cols=159  Identities=29%  Similarity=0.377  Sum_probs=117.0

Q ss_pred             EEEecCCccc------ccccccccCCCCCcEEEccCCccCCCCCccccCCCC---CCEEEeeCCcCCC----CCCccCcC
Q 008031            2 FLALQYNNLS------GRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSR---LRILDFSYNAING----SLPASFSN   68 (580)
Q Consensus         2 ~L~L~~N~i~------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~l~~n~l~~----~~~~~~~~   68 (580)
                      +|++++|.+.      ..++..+..+++|+.|+|++|.+....+..+..+.+   |+.|++++|++++    .+...+..
T Consensus        55 ~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~  134 (319)
T cd00116          55 ELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD  134 (319)
T ss_pred             EEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHh
Confidence            5778888776      234566778889999999999988666666666666   9999999999873    23344566


Q ss_pred             C-CCCCEEECcCCCCCcc----cchhhhccCCCCeeeecccccccc----CCccccCCCCCcEEEccccccCCc----cc
Q 008031           69 L-SSLVSLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQISGH----IPSTIGNISTLTILDLSQNKLSGE----IP  135 (580)
Q Consensus        69 l-~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~  135 (580)
                      + ++|+.|+|++|.+++.    ....+..+.+|+.|++++|.+++.    ++..+..+++|++|+|++|.+++.    +.
T Consensus       135 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~  214 (319)
T cd00116         135 LPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALA  214 (319)
T ss_pred             CCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHH
Confidence            6 8899999999998742    234556677899999999988742    233455567899999999988743    33


Q ss_pred             ccccCcCCCCeeecccccCcCccCh
Q 008031          136 ASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus       136 ~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ..+..+++|+.|++++|++++....
T Consensus       215 ~~~~~~~~L~~L~ls~n~l~~~~~~  239 (319)
T cd00116         215 ETLASLKSLEVLNLGDNNLTDAGAA  239 (319)
T ss_pred             HHhcccCCCCEEecCCCcCchHHHH
Confidence            4566778899999999988854333

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.22  E-value=1.3e-12  Score=120.77  Aligned_cols=137  Identities=30%  Similarity=0.364  Sum_probs=113.9

Q ss_pred             cccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCC
Q 008031           17 SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNL   96 (580)
Q Consensus        17 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L   96 (580)
                      .+..-..|++||||+|.|+ .+.+...-+|.++.|++++|.|. .+. ++..|++|+.|+|++|.++. ...+-.+|.|.
T Consensus       279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNI  354 (490)
T KOG1259|consen  279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNI  354 (490)
T ss_pred             ecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHh-hhhhHhhhcCE
Confidence            3444567999999999999 56777878899999999999998 444 38999999999999999965 44555678899


Q ss_pred             CeeeeccccccccCCccccCCCCCcEEEccccccCCcc-cccccCcCCCCeeecccccCcCccC
Q 008031           97 SVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEI-PASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        97 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      +.|.|++|.|...  ..+.++-+|..||+++|++.... -..++++|.|+.|.|.+|++.+.+.
T Consensus       355 KtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  355 KTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             eeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            9999999998733  35788899999999999998532 3578999999999999999987654

>PLN03210 Resistant to P

Probab=99.21  E-value=5.7e-11  Score=138.14  Aligned_cols=101  Identities=25%  Similarity=0.283  Sum_probs=64.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      +.|+|++|+|. .++..+..+++|+.|+|++|.....+| .+..+++|+.|+|++|.....+|..+.++++|+.|++++|
T Consensus       614 ~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c  691 (1153)
T PLN03210        614 VKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC  691 (1153)
T ss_pred             cEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence            35777777777 566677777778888887765333555 3666777777777776654467777777777777777775


Q ss_pred             CCCcccchhhhccCCCCeeeeccc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRN  104 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N  104 (580)
                      .....+|..+ .+++|+.|+|++|
T Consensus       692 ~~L~~Lp~~i-~l~sL~~L~Lsgc  714 (1153)
T PLN03210        692 ENLEILPTGI-NLKSLYRLNLSGC  714 (1153)
T ss_pred             CCcCccCCcC-CCCCCCEEeCCCC
Confidence            4333344333 3444444444444

syringae 6; Provisional

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.19  E-value=3.3e-13  Score=134.83  Aligned_cols=154  Identities=28%  Similarity=0.525  Sum_probs=138.0

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      +..||+.|++. ++|..+..+..|+.|.|.+|.|. .+|..+.++..|..|||+.|+++ .+|..+..|+ |+.|.+++|
T Consensus        78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN  153 (722)
T KOG0532|consen   78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN  153 (722)
T ss_pred             hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence            35789999999 89999999999999999999999 78889999999999999999999 7888887776 999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +++ .+|..++.+..|..|+.+.|.+. .+|..++.+.+|+.|++..|++. .+|..+..| .|..||++.|+++ .+|.
T Consensus       154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv  228 (722)
T KOG0532|consen  154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPV  228 (722)
T ss_pred             ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecch
Confidence            995 57888888999999999999998 78889999999999999999998 677778866 5889999999998 5677


Q ss_pred             hhh
Q 008031          161 SLA  163 (580)
Q Consensus       161 ~~~  163 (580)
                      ++.
T Consensus       229 ~fr  231 (722)
T KOG0532|consen  229 DFR  231 (722)
T ss_pred             hhh
Confidence            665

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=2.3e-12  Score=119.16  Aligned_cols=126  Identities=33%  Similarity=0.439  Sum_probs=109.1

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .||||+|.|+ .+-.+..-+|.++.|++|+|+|+.+  +.+..+++|+.|||++|.++ .+..+-..|-+.+.|.|++|.
T Consensus       288 elDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~  363 (490)
T KOG1259|consen  288 ELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNK  363 (490)
T ss_pred             hccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhh
Confidence            5899999999 7888889999999999999999843  34899999999999999998 556666678899999999999


Q ss_pred             CCcccchhhhccCCCCeeeecccccccc-CCccccCCCCCcEEEccccccCCc
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGH-IPSTIGNISTLTILDLSQNKLSGE  133 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~  133 (580)
                      |..  -..+.+|.+|..||+++|+|... -...++++|.|++|.|.+|.+.+.
T Consensus       364 iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  364 IET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             Hhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            954  55788999999999999999742 234689999999999999999854

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=2.5e-10  Score=108.14  Aligned_cols=141  Identities=18%  Similarity=0.256  Sum_probs=106.4

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCC--CcceeeeeEEECCC--CcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRH--PNLLALRAYYLGPK--GEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~~lv~e~~~  367 (580)
                      +.|+.|.++.||++...+|+.+++|....... .....+..|+++++.+.+  .++.+++.+.....  +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999998765432 134568899999999965  34566777665421  35689999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-----------------------------------------  406 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------------  406 (580)
                      |.++.+.+..    ..++..+...++.+++++|..||+-                                         
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776532    1356667777777888877777741                                         


Q ss_pred             --------------CCcccCCCCCCCeeeCC--CCCeEEeecccccc
Q 008031          407 --------------ENIIHGNLTSSNVLLDD--STNAKISDFGLSRL  437 (580)
Q Consensus       407 --------------~~i~H~Dlk~~Nil~~~--~~~~kl~Dfg~~~~  437 (580)
                                    ..++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          34699999999999998  56689999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=5.3e-10  Score=97.73  Aligned_cols=131  Identities=23%  Similarity=0.399  Sum_probs=94.2

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEcc-cccc-c------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-EKIT-K------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~-~~~~-~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      ..+++|+-+.+|.+.+. |.++++|.=. +.-. +      ......+|++++++++--.|.--+=+..+ .....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-PDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCEEEEE
Confidence            46789999999999776 4556666432 2111 1      11346789999998864444332223333 456789999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      |++|..|.+++...          ...++..+=.-+.-||.. ||+|+||.++||.+..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA----------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999898764          134556666667789995 999999999999998765 99999999864

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.14  E-value=3.4e-12  Score=122.40  Aligned_cols=148  Identities=30%  Similarity=0.448  Sum_probs=120.5

Q ss_pred             ecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC-CCCC
Q 008031            5 LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES-NNLD   83 (580)
Q Consensus         5 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~   83 (580)
                      -++-.++ .+|..+.  +...+|+|..|+|+.+.++.|..+++|+.|||++|+|+.+-|..|..|.+|..|-+.+ |+|+
T Consensus        53 Cr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~  129 (498)
T KOG4237|consen   53 CRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT  129 (498)
T ss_pred             ccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence            3444555 5665543  3678889999999988888999999999999999999988888999999888777776 8898


Q ss_pred             cccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCc
Q 008031           84 DQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus        84 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      ......|..|..|+.|.+.-|++.-+..+.|..+++|..|.+.+|.+...-...|..+..++.+.+..|++.
T Consensus       130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i  201 (498)
T KOG4237|consen  130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI  201 (498)
T ss_pred             hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc
Confidence            888888899999999999999988677777888999999999999988433347888888888888888764

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.13  E-value=2.7e-11  Score=125.36  Aligned_cols=150  Identities=39%  Similarity=0.616  Sum_probs=102.0

Q ss_pred             EEEecCCcccccccccccCCC-CCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            2 FLALQYNNLSGRIPASLGKLS-ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      .|++.+|.++ .+++....+. +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|.....++.|+.|++++|
T Consensus       120 ~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N  196 (394)
T COG4886         120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN  196 (394)
T ss_pred             EEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCC
Confidence            5778888888 6777777774 8888888888887 55566778888888888888887 55655557778888888888


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      ++.. +|.....+..|++|.+++|++. ..+..+..+.++..|.+.+|++. .++..+..+++++.|++++|.++..
T Consensus       197 ~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i  270 (394)
T COG4886         197 KISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI  270 (394)
T ss_pred             cccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccc
Confidence            8854 3444444555777777777544 34445566666666666666665 3345556666666666666666643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=5.3e-11  Score=121.42  Aligned_cols=244  Identities=19%  Similarity=0.213  Sum_probs=168.7

Q ss_pred             hhccccccCceEEEEEEeC--CCCEEEEEEccccccccHH--HHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEee
Q 008031          291 TAEIMGKSTYGTVYKATLE--DGSQVAVKRLREKITKGQR--EFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      ....||.|.|+.|++...+  ++..+++|.+.........  .-..|+.+...+ .|.++++.+..+.. ....++--||
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~~~ip~e~  347 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQGYIPLEF  347 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cccccCchhh
Confidence            3567999999999998754  6788999987654432222  234577777666 57777776655554 4466788999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-CCeEEeeccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-TNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ++++++......   .+.++...++++..|++.++.++|+ +.++|+|++|+||++..+ +..++.|||.+..+.-.   
T Consensus       348 ~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---  420 (524)
T KOG0601|consen  348 CEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---  420 (524)
T ss_pred             hcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccccccccccee---
Confidence            999988776633   2457778899999999999999999 599999999999999976 77899999988642211   


Q ss_pred             ceeeecCccccC--CccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          445 NVIATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       445 ~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      .. .....-+++  +++......+..+.|++|||.-+.|..++..--+...     +|.. +..             +..
T Consensus       421 ~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----~~~~-i~~-------------~~~  480 (524)
T KOG0601|consen  421 SG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----QSLT-IRS-------------GDT  480 (524)
T ss_pred             cc-cccccccccccchhhccccccccccccccccccccccccCcccCcccc-----ccee-eec-------------ccc
Confidence            11 112223344  5556666778889999999999999999875422211     1111 000             011


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      +..+....++..+...+...++..||.+.++..+.+..+.
T Consensus       481 p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  481 PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            1111222344556667888999999999998887766543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.13  E-value=6.9e-10  Score=96.39  Aligned_cols=142  Identities=22%  Similarity=0.350  Sum_probs=100.9

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEccccc-c-c------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKI-T-K------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~-~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      ..+|-+|+-+.|+++.+. |+...||.-..+. . +      ......+|++.+.+++--.|.--.-++.+ ...-.|+|
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-~~~~~i~M   89 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-TYGGQIYM   89 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-cCCCeEEE
Confidence            467889999999999987 7777777532211 1 1      12456789999999865444333333433 34567999


Q ss_pred             eeCCC-CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC---CeEEeecccccc
Q 008031          364 DYMPH-GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---NAKISDFGLSRL  437 (580)
Q Consensus       364 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~---~~kl~Dfg~~~~  437 (580)
                      ||++| .++.+++....... ........++..|-+.+.-||.+ +++|+||.++||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 47888887654222 22233368888999999999996 999999999999996443   358999999854

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.08  E-value=5.6e-11  Score=123.08  Aligned_cols=151  Identities=38%  Similarity=0.586  Sum_probs=73.9

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .|++++|+|. .+|..+.++++|+.|++++|.++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|.
T Consensus       144 ~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             cccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence            3455555555 34444555555555555555555 33333334555555555555555 444433334445555555553


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      + -..+..+..+.++..|.+.+|++. ..+..+..+++++.|++++|.++.. +. +..+.+|+.|++++|.++..+|
T Consensus       221 ~-~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~  294 (394)
T COG4886         221 I-IELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALP  294 (394)
T ss_pred             c-eecchhhhhcccccccccCCceee-eccchhccccccceecccccccccc-cc-ccccCccCEEeccCccccccch
Confidence            2 122334444555555555555554 2244445555555555555555522 22 5555555555555555554433

>PLN03210 Resistant to P

Probab=99.07  E-value=8.5e-10  Score=128.47  Aligned_cols=145  Identities=19%  Similarity=0.268  Sum_probs=66.9

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      |++.+|.+. .+|..| ...+|+.|+|++|+|. .++..+..+++|+.|+|++|.....+| .++.+++|+.|+|++|..
T Consensus       594 L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~  669 (1153)
T PLN03210        594 LRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSS  669 (1153)
T ss_pred             EEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCC
Confidence            344444443 334333 2345555555555554 334444455555555555443222333 244455555555555444


Q ss_pred             CcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCc
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      ...+|..+..+++|+.|++++|.....+|..+ ++++|+.|+|++|.....+|..   ..+|+.|++++|.+.
T Consensus       670 L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~  738 (1153)
T PLN03210        670 LVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE  738 (1153)
T ss_pred             ccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence            34445555555555555555543222344333 4455555555555433333321   234455555555544

syringae 6; Provisional

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.01  E-value=2.5e-09  Score=99.24  Aligned_cols=135  Identities=21%  Similarity=0.242  Sum_probs=97.7

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEcccccc-----------------c-----cHHHHHHHHHHHhcCCCC--
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT-----------------K-----GQREFESEVSLLGKIRHP--  343 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~-----~~~~~~~e~~~l~~l~h~--  343 (580)
                      ..++++.||.|.-|.||.|..+.|.++|||.-+...+                 .     .....++|.++|.+|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            4567899999999999999999999999996542110                 0     123467899999999655  


Q ss_pred             cceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC
Q 008031          344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD  423 (580)
Q Consensus       344 niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~  423 (580)
                      .|.+.++     .+...+||||++|-.|...-        ++......++..|+..+.-.-. .|+||+|+++-||++++
T Consensus       172 ~VP~P~~-----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNIlV~~  237 (304)
T COG0478         172 KVPKPIA-----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCccc-----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH-cCccccCCchheEEEec
Confidence            6666554     34678999999986665432        1222333444445544443334 49999999999999999


Q ss_pred             CCCeEEeeccccc
Q 008031          424 STNAKISDFGLSR  436 (580)
Q Consensus       424 ~~~~kl~Dfg~~~  436 (580)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999997554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=2.2e-09  Score=97.23  Aligned_cols=125  Identities=25%  Similarity=0.369  Sum_probs=82.3

Q ss_pred             EEEEEEeCCCCEEEEEEcccccc---------------------c-----cHHHHHHHHHHHhcCCCC--cceeeeeEEE
Q 008031          302 TVYKATLEDGSQVAVKRLREKIT---------------------K-----GQREFESEVSLLGKIRHP--NLLALRAYYL  353 (580)
Q Consensus       302 ~Vy~~~~~~~~~vavK~~~~~~~---------------------~-----~~~~~~~e~~~l~~l~h~--niv~~~~~~~  353 (580)
                      .||.|...+|..+|||+.+....                     .     ......+|++.|.++...  ++.+.+.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999998899999998753210                     0     113467899999999765  456665442 


Q ss_pred             CCCCcEEEEEeeCC--CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          354 GPKGEKLLVFDYMP--HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH-LHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       354 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                          ...+||||++  |..+..+....     ++......++.+++..+.. +|. .|++|+||.+.||+++++ .+.++
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-CEEE-
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-eEEEE
Confidence                4579999998  54554433321     2234456778888886655 567 599999999999999987 89999


Q ss_pred             eccccccc
Q 008031          431 DFGLSRLM  438 (580)
Q Consensus       431 Dfg~~~~~  438 (580)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99987644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.98  E-value=7e-11  Score=115.02  Aligned_cols=111  Identities=24%  Similarity=0.275  Sum_probs=46.9

Q ss_pred             CCCCCEEEeeCCcCCC-CCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccC-CccccCCCCCcE
Q 008031           45 LSRLRILDFSYNAING-SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHI-PSTIGNISTLTI  122 (580)
Q Consensus        45 l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~  122 (580)
                      +++|+.|.|+.|.|+. .+...+..+++|+.|+|..|..-........-+..|++|+|++|++.... -...+.++.|+.
T Consensus       196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence            3444444444444441 11112233444555555544321222222333445555555555544221 023444555555


Q ss_pred             EEccccccCCcc-ccc-----ccCcCCCCeeecccccCc
Q 008031          123 LDLSQNKLSGEI-PAS-----FSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       123 L~l~~N~l~~~~-~~~-----l~~l~~L~~l~l~~n~l~  155 (580)
                      |+++.|.+...- |+.     ...+++|++|+++.|++.
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            555555554321 111     233455555555555553

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.96  E-value=4.1e-10  Score=82.35  Aligned_cols=59  Identities=37%  Similarity=0.603  Sum_probs=29.2

Q ss_pred             CCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031           23 ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus        23 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|++|++++|+|+.+.++.|..+++|++|++++|+|+...+..|..+++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44555555555554444444555555555555555544444444555555555555544

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.94  E-value=6.1e-10  Score=81.42  Aligned_cols=61  Identities=39%  Similarity=0.541  Sum_probs=40.4

Q ss_pred             CCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccc
Q 008031           46 SRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQI  106 (580)
Q Consensus        46 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  106 (580)
                      |+|++|+|++|+|+...+..|..+++|++|++++|.++.+.+..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4566777777777655455666677777777777777666666666666666666666654

...

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.92  E-value=2.7e-08  Score=99.62  Aligned_cols=170  Identities=25%  Similarity=0.347  Sum_probs=127.0

Q ss_pred             ceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEEC---CCCcEEEEEeeCCCC-Chhhh
Q 008031          300 YGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG---PKGEKLLVFDYMPHG-SLATF  374 (580)
Q Consensus       300 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~e~~~~g-~L~~~  374 (580)
                      ..+.|++... ||..|++|+++.........-..-+++++++.|.|+|++.+++..   .+...++||+|.++. +|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999876 899999999965544333233456889999999999999988873   244688999999874 56654


Q ss_pred             hhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          375 LHARG------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       375 l~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      --...            .....++...+.++.|++.||.++|+ .|+.-+-|.+.+|+++.+.+++|...|.......+.
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence            32111            11235678899999999999999999 599999999999999998899999888766554332


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCC
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP  488 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  488 (580)
                      .               |.+..   .-+-|.=.||.+++.|.||..-
T Consensus       448 ~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  448 T---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             C---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            1               11111   1256888999999999999654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=2.8e-08  Score=95.64  Aligned_cols=142  Identities=13%  Similarity=0.124  Sum_probs=98.8

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEcccccc-----------ccHHHHHHHHHHHhcCCC--CcceeeeeEEECC----
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKIT-----------KGQREFESEVSLLGKIRH--PNLLALRAYYLGP----  355 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~----  355 (580)
                      +.+-.-....|++.... |+.+.||.......           .....+.+|.+.+.++..  -.+...+++....    
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            44444444456676664 77899997643221           111247789998888843  2333444454321    


Q ss_pred             CCcEEEEEeeCCCC-ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-------CCCe
Q 008031          356 KGEKLLVFDYMPHG-SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-------STNA  427 (580)
Q Consensus       356 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-------~~~~  427 (580)
                      ...-++|||++++. +|.+++.... ..+.+...+..++.+++..+.-||.. ||+|+|+++.|||++.       +..+
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceE
Confidence            22468999999886 7988885421 12455667789999999999999995 9999999999999975       4679


Q ss_pred             EEeecccccc
Q 008031          428 KISDFGLSRL  437 (580)
Q Consensus       428 kl~Dfg~~~~  437 (580)
                      .++||+.+..
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.88  E-value=5e-10  Score=120.32  Aligned_cols=244  Identities=18%  Similarity=0.206  Sum_probs=158.4

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .+.+.+-+|.++.++.+.-. .|...++|+.....   ..+.+....+-.++-..+||.++.....+. .....+++++|
T Consensus       807 ~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~L~~~~  885 (1205)
T KOG0606|consen  807 EITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLPLVGHY  885 (1205)
T ss_pred             eecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcchhhHH
Confidence            34457888999998877643 34334444432211   111122222333333335566665544422 24568899999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc-----
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA-----  440 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-----  440 (580)
                      ..+++|..-++..+   ..+..-.......+.++++|||+ ..+.|+|++|.|.+...+++.++.|||.......     
T Consensus       886 ~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  886 LNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             hccCCchhhhhcCC---CcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            99999999998764   34444455667778899999998 3699999999999999999999999983221110     


Q ss_pred             ----------------c---------cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC
Q 008031          441 ----------------A---------ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA  495 (580)
Q Consensus       441 ----------------~---------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~  495 (580)
                                      .         .........+|+.|.+||...+......+|+|++|++++|.++|..||......
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence                            0         001122346899999999999999999999999999999999999999766554


Q ss_pred             ChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 008031          496 ELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVL  551 (580)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~  551 (580)
                      .+.+.+..   ...       .......   .......+++...+..+|.+|-.+.
T Consensus      1042 ~~f~ni~~---~~~-------~~p~g~~---~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QIFENILN---RDI-------PWPEGPE---EGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhcccc---CCC-------CCCCCcc---ccChhhhhhhhhhhccCchhccCcc
Confidence            43332221   110       0000011   1122344566677778888887766

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.77  E-value=9.7e-10  Score=104.38  Aligned_cols=155  Identities=19%  Similarity=0.284  Sum_probs=107.8

Q ss_pred             CEEEecCCcccccccc----cccCCCCCcEEEccCCccCCCC-------------CccccCCCCCCEEEeeCCcCCC---
Q 008031            1 MFLALQYNNLSGRIPA----SLGKLSELQEISLSHNKISGVM-------------PSDLGRLSRLRILDFSYNAING---   60 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~----~~~~l~~L~~L~l~~n~l~~~~-------------~~~~~~l~~L~~L~l~~n~l~~---   60 (580)
                      ++||||+|.+....++    -++++.+|++|+|.+|.+...-             ....+.-+.|+++...+|++..   
T Consensus        95 ~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga  174 (382)
T KOG1909|consen   95 QKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGA  174 (382)
T ss_pred             eEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccH
Confidence            4688888888865443    3566788888888888886221             1223345778888888888863   


Q ss_pred             -CCCccCcCCCCCCEEECcCCCCCccc----chhhhccCCCCeeeecccccccc----CCccccCCCCCcEEEccccccC
Q 008031           61 -SLPASFSNLSSLVSLTLESNNLDDQI----LDSLDKLHNLSVLNLKRNQISGH----IPSTIGNISTLTILDLSQNKLS  131 (580)
Q Consensus        61 -~~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~  131 (580)
                       .+...|...+.|+.+.++.|.|....    ...|..+++|+.|||.+|-++..    +...++.|+.|+.|++++|.+.
T Consensus       175 ~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~  254 (382)
T KOG1909|consen  175 TALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE  254 (382)
T ss_pred             HHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence             22345667788888888888885422    23567788888888888887642    3445777888888888888887


Q ss_pred             Ccccccc-----cCcCCCCeeecccccCc
Q 008031          132 GEIPASF-----SNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       132 ~~~~~~l-----~~l~~L~~l~l~~n~l~  155 (580)
                      ..-...|     ...|+|+.|.|.+|.++
T Consensus       255 ~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  255 NEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             cccHHHHHHHHhccCCCCceeccCcchhH
Confidence            5433222     23678888888888887

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.75  E-value=7.2e-08  Score=100.52  Aligned_cols=142  Identities=18%  Similarity=0.312  Sum_probs=94.7

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccc----------------------------------------cHHHHHH
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITK----------------------------------------GQREFES  332 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~  332 (580)
                      +.|+.++-|.||+|++++|+.||||+.++...+                                        .+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            568999999999999999999999988753211                                        0112345


Q ss_pred             HHHHHhcCC----CCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHH-HHHhhcCC
Q 008031          333 EVSLLGKIR----HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG-LLHLHSNE  407 (580)
Q Consensus       333 e~~~l~~l~----h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~  407 (580)
                      |+..+.+++    ...=+++=..+.+-.+...++|||++|..+.+...-..  ..++.+.   ++..++++ +..+=.+ 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhc-
Confidence            666665552    22223333334332456789999999999998843321  2344333   33333333 2222223 


Q ss_pred             CcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       408 ~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      |++|.|.+|.||+++.++++.+.|||+.....+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999876654

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.72  E-value=2.1e-09  Score=104.88  Aligned_cols=151  Identities=24%  Similarity=0.210  Sum_probs=107.1

Q ss_pred             EecCCccccccc--ccccCCCCCcEEEccCCccCCC--CCccccCCCCCCEEEeeCCcCCCCCCcc-CcCCCCCCEEECc
Q 008031            4 ALQYNNLSGRIP--ASLGKLSELQEISLSHNKISGV--MPSDLGRLSRLRILDFSYNAINGSLPAS-FSNLSSLVSLTLE   78 (580)
Q Consensus         4 ~L~~N~i~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~   78 (580)
                      .|.+..+. ..+  .....|++++.||||.|-+...  +......||+|+.|+|+.|++.....+. -..+++|+.|.|+
T Consensus       127 sLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~  205 (505)
T KOG3207|consen  127 SLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLN  205 (505)
T ss_pred             eecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEec
Confidence            34444444 222  3567789999999999988733  2345667899999999999987222221 1256789999999


Q ss_pred             CCCCCcccc-hhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcc-cccccCcCCCCeeecccccCc
Q 008031           79 SNNLDDQIL-DSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEI-PASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus        79 ~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      +|.|+.... ..+..+++|+.|+|..|............+..|+.|||++|++.... -...+.++.|..|+++.+.+.
T Consensus       206 ~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~  284 (505)
T KOG3207|consen  206 SCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIA  284 (505)
T ss_pred             cCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcc
Confidence            999975333 34567889999999999543344445566788999999999887432 245678888888888888876

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.70  E-value=5.4e-09  Score=108.38  Aligned_cols=149  Identities=19%  Similarity=0.248  Sum_probs=98.3

Q ss_pred             HHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee--------eecCccccCCccccccCC
Q 008031          394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI--------ATAGALGYRAPELSKLKK  465 (580)
Q Consensus       394 ~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~--------~~~g~~~y~aPE~~~~~~  465 (580)
                      .+++.|+.|+|...++||++|.|++|.++.++..|++.|+.+............        ...-...|.|||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            345589999999889999999999999999999999999987654332111110        112344699999999988


Q ss_pred             CCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCC
Q 008031          466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSP  544 (580)
Q Consensus       466 ~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P  544 (580)
                      .+.++|+||+|+++|-+.. |+.-+..........  ..+...       +..........+++   +.+=+.+++..++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--~~~~~~-------~~~~~~~s~~~p~e---l~~~l~k~l~~~~  253 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--FSRNLL-------NAGAFGYSNNLPSE---LRESLKKLLNGDS  253 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhh--hhhccc-------ccccccccccCcHH---HHHHHHHHhcCCc
Confidence            9999999999999999995 555444332221111  111111       11111111233333   3445557888999


Q ss_pred             CCCCCHHHHH
Q 008031          545 SARPEVLQVV  554 (580)
Q Consensus       545 ~~Rps~~ev~  554 (580)
                      .-||++.++.
T Consensus       254 ~~rp~~~~l~  263 (700)
T KOG2137|consen  254 AVRPTLDLLL  263 (700)
T ss_pred             ccCcchhhhh
Confidence            9999776654

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.65  E-value=4.1e-08  Score=86.49  Aligned_cols=130  Identities=22%  Similarity=0.225  Sum_probs=94.8

Q ss_pred             CCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeee
Q 008031           21 LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLN  100 (580)
Q Consensus        21 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  100 (580)
                      ...=++++|+..++. .+..--..+.+...+||++|.|. .+ ..|..++.|.+|.|++|+|+.+.|.--..+++|..|.
T Consensus        18 ~~~e~e~~LR~lkip-~ienlg~~~d~~d~iDLtdNdl~-~l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~   94 (233)
T KOG1644|consen   18 SVRERELDLRGLKIP-VIENLGATLDQFDAIDLTDNDLR-KL-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLI   94 (233)
T ss_pred             hcccccccccccccc-chhhccccccccceecccccchh-hc-ccCCCccccceEEecCCcceeeccchhhhccccceEE
Confidence            334577888888776 22222223457888888888887 33 3577888888999999998888777767778899999


Q ss_pred             eccccccccC-CccccCCCCCcEEEccccccCCccc---ccccCcCCCCeeeccccc
Q 008031          101 LKRNQISGHI-PSTIGNISTLTILDLSQNKLSGEIP---ASFSNLKSLSSFNVSYNN  153 (580)
Q Consensus       101 l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~---~~l~~l~~L~~l~l~~n~  153 (580)
                      |.+|+|.... -+.+..||+|++|.+-+|.++..-.   ..+..+|+|+.||.++=.
T Consensus        95 LtnNsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kVt  151 (233)
T KOG1644|consen   95 LTNNSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKVT  151 (233)
T ss_pred             ecCcchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhhhh
Confidence            9999886321 1236778999999999999985432   346789999999977543

>PRK09902 hypothetical protein; Provisional

Probab=98.65  E-value=6.6e-07  Score=81.49  Aligned_cols=137  Identities=19%  Similarity=0.235  Sum_probs=99.9

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEccccc------cccHHHHHHHHHHHhcCCC--CcceeeeeEEEC-CC---CcEEEEE
Q 008031          296 GKSTYGTVYKATLEDGSQVAVKRLREKI------TKGQREFESEVSLLGKIRH--PNLLALRAYYLG-PK---GEKLLVF  363 (580)
Q Consensus       296 g~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~-~~---~~~~lv~  363 (580)
                      |+||-+-|++-.++ |..+-+|.-....      ......|.+|+..+.++..  -.+.+.+ ++.. ..   -.-+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            67888889987776 4568888754211      2245679999999999843  2344444 3321 11   1256999


Q ss_pred             eeCCC-CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC--eEEeeccccc
Q 008031          364 DYMPH-GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN--AKISDFGLSR  436 (580)
Q Consensus       364 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~--~kl~Dfg~~~  436 (580)
                      |-+++ -+|.+++.... ..+.+...+..++.+++.+++-||.. |+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            98854 47888876532 23567777889999999999999994 9999999999999986666  9999998664

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.63  E-value=3.3e-07  Score=85.34  Aligned_cols=107  Identities=23%  Similarity=0.327  Sum_probs=82.0

Q ss_pred             HHHHHHHHHHHhcCC--CCcceeeeeEEECCC---CcEEEEEeeCCCC-ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 008031          327 QREFESEVSLLGKIR--HPNLLALRAYYLGPK---GEKLLVFDYMPHG-SLATFLHARGPETPIDWPTRMKIIKGMTRGL  400 (580)
Q Consensus       327 ~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~---~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l  400 (580)
                      ...+.+|...+.++.  .-.+.+.+++.....   ...++|+|++++. +|.+++....   ..+......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence            345778888887774  333455555555422   2347999999884 7999887632   255567789999999999


Q ss_pred             HHhhcCCCcccCCCCCCCeeeCCCC---CeEEeecccccc
Q 008031          401 LHLHSNENIIHGNLTSSNVLLDDST---NAKISDFGLSRL  437 (580)
Q Consensus       401 ~~LH~~~~i~H~Dlk~~Nil~~~~~---~~kl~Dfg~~~~  437 (580)
                      +-||.. ||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       132 ~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999995 999999999999999876   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.62  E-value=1.1e-08  Score=106.20  Aligned_cols=121  Identities=31%  Similarity=0.476  Sum_probs=59.5

Q ss_pred             EecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCC
Q 008031            4 ALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLD   83 (580)
Q Consensus         4 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~   83 (580)
                      +|+.|.|. .+-..+..+.+|+.|++.+|+|..+ ...+..+++|++|+|++|+|+..  ..+..++.|+.|++++|.|+
T Consensus        78 ~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~  153 (414)
T KOG0531|consen   78 NLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLIS  153 (414)
T ss_pred             ccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhheeccCcch
Confidence            34455555 2333345555555556666655532 22244555555666666655533  12444555555555555554


Q ss_pred             cccchhhhccCCCCeeeeccccccccCC-ccccCCCCCcEEEccccccC
Q 008031           84 DQILDSLDKLHNLSVLNLKRNQISGHIP-STIGNISTLTILDLSQNKLS  131 (580)
Q Consensus        84 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  131 (580)
                      .  ...+..+.+|+.+++++|+++..-+ . ...+.+++.+++.+|.+.
T Consensus       154 ~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  154 D--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             h--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence            3  2233335555555555555553322 1 244455555555555443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.61  E-value=5.5e-09  Score=108.45  Aligned_cols=132  Identities=30%  Similarity=0.412  Sum_probs=98.3

Q ss_pred             cCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCe
Q 008031           19 GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSV   98 (580)
Q Consensus        19 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~   98 (580)
                      ..+..++.++++.|.|.. .-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|.|+.+  ..+..+..|+.
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~  144 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE  144 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhh
Confidence            356677778888888874 3345777888889999999888 3444477788899999999988763  34566777888


Q ss_pred             eeeccccccccCCccccCCCCCcEEEccccccCCccccc-ccCcCCCCeeecccccCcCc
Q 008031           99 LNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        99 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-l~~l~~L~~l~l~~n~l~~~  157 (580)
                      |++++|.|+.+  ..+..+++|+.+++++|.+... ... +..+.+|+.+++.+|.+...
T Consensus       145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~i-e~~~~~~~~~l~~l~l~~n~i~~i  201 (414)
T KOG0531|consen  145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDI-ENDELSELISLEELDLGGNSIREI  201 (414)
T ss_pred             heeccCcchhc--cCCccchhhhcccCCcchhhhh-hhhhhhhccchHHHhccCCchhcc
Confidence            89999988743  3455588888889999988743 322 57788888888888888743

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.58  E-value=2.4e-09  Score=110.52  Aligned_cols=126  Identities=31%  Similarity=0.376  Sum_probs=78.7

Q ss_pred             CCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccc
Q 008031           48 LRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ  127 (580)
Q Consensus        48 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  127 (580)
                      |.+.+.++|++. ....++.-++.|+.|+|++|+++...  .+..|+.|++|||+.|+++ .+|..-..-..|..|.|.+
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrn  241 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRN  241 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeecc
Confidence            666677777776 55666667777777777777776543  6677777777777777777 4443222223377777777


Q ss_pred             cccCCcccccccCcCCCCeeecccccCcCcc---ChhhhhhcCCCcccccccccC
Q 008031          128 NKLSGEIPASFSNLKSLSSFNVSYNNLSGPV---PTSLALKFNASSFVGNIQLCG  179 (580)
Q Consensus       128 N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~---p~~~~~~~~~~~~~~~~~~~~  179 (580)
                      |.++..  ..+.++++|.-||+++|-|.+.-   |-+....+......|||.-|.
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            777643  23667777777777777765432   222223344444556655554

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.58  E-value=9.4e-08  Score=84.23  Aligned_cols=83  Identities=23%  Similarity=0.261  Sum_probs=39.9

Q ss_pred             CCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcc-cccccCcCCCCeeec
Q 008031           71 SLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEI-PASFSNLKSLSSFNV  149 (580)
Q Consensus        71 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~l~l  149 (580)
                      +...++|++|.+..  -..|+.++.|.+|.|++|+|+.+.|..-.-+++|+.|.|++|+|.... -.-+..+|+|++|.+
T Consensus        43 ~~d~iDLtdNdl~~--l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltl  120 (233)
T KOG1644|consen   43 QFDAIDLTDNDLRK--LDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTL  120 (233)
T ss_pred             ccceecccccchhh--cccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeee
Confidence            44555555555532  223445555555555555555444443333445555555555554211 122444555555555


Q ss_pred             ccccCc
Q 008031          150 SYNNLS  155 (580)
Q Consensus       150 ~~n~l~  155 (580)
                      -+|+.+
T Consensus       121 l~Npv~  126 (233)
T KOG1644|consen  121 LGNPVE  126 (233)
T ss_pred             cCCchh
Confidence            555544

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.52  E-value=1.5e-08  Score=94.27  Aligned_cols=154  Identities=21%  Similarity=0.193  Sum_probs=82.5

Q ss_pred             EEEecCCcccc--cccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCC-CCCCccCcCCCCCCEEECc
Q 008031            2 FLALQYNNLSG--RIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN-GSLPASFSNLSSLVSLTLE   78 (580)
Q Consensus         2 ~L~L~~N~i~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~   78 (580)
                      .|||.+|.|++  .+...+.+||.|++|+|+.|.+...+-..-..+.+|++|.|++..+. ......+..++.+++|+++
T Consensus        75 elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS  154 (418)
T KOG2982|consen   75 ELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMS  154 (418)
T ss_pred             hhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhc
Confidence            46788888874  45566777888888888888877444322245678888888877775 2344556677778888888


Q ss_pred             CCCCCccc--chhhhcc-CCCCeeeecccccccc--CCccccCCCCCcEEEccccccCCc-ccccccCcCCCCeeecccc
Q 008031           79 SNNLDDQI--LDSLDKL-HNLSVLNLKRNQISGH--IPSTIGNISTLTILDLSQNKLSGE-IPASFSNLKSLSSFNVSYN  152 (580)
Q Consensus        79 ~N~l~~~~--~~~~~~l-~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~l~l~~n  152 (580)
                      .|++....  .+..... +.+++|++..|...-.  .-..-.-++++..+-+..|.+... ..+.+..+|.+..|+|+.|
T Consensus       155 ~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~  234 (418)
T KOG2982|consen  155 DNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGAN  234 (418)
T ss_pred             cchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhhhccc
Confidence            77443211  1111111 1233333333221100  000011134555555555555432 2334455555556666666


Q ss_pred             cCc
Q 008031          153 NLS  155 (580)
Q Consensus       153 ~l~  155 (580)
                      +|-
T Consensus       235 ~id  237 (418)
T KOG2982|consen  235 NID  237 (418)
T ss_pred             ccc
Confidence            553

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.52  E-value=5.8e-09  Score=99.18  Aligned_cols=154  Identities=18%  Similarity=0.251  Sum_probs=118.8

Q ss_pred             EEEecCCccccccc-------------ccccCCCCCcEEEccCCccCCC----CCccccCCCCCCEEEeeCCcCCC----
Q 008031            2 FLALQYNNLSGRIP-------------ASLGKLSELQEISLSHNKISGV----MPSDLGRLSRLRILDFSYNAING----   60 (580)
Q Consensus         2 ~L~L~~N~i~~~~~-------------~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~----   60 (580)
                      +|+|.+|.+...-.             .-.++-+.|++++.++|++...    +...|...+.|+.+.+..|.|..    
T Consensus       124 eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~  203 (382)
T KOG1909|consen  124 ELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVT  203 (382)
T ss_pred             HHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhH
Confidence            57888888884222             2345568899999999999833    23467778999999999999972    


Q ss_pred             CCCccCcCCCCCCEEECcCCCCCcc----cchhhhccCCCCeeeeccccccccCCccc-----cCCCCCcEEEccccccC
Q 008031           61 SLPASFSNLSSLVSLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQISGHIPSTI-----GNISTLTILDLSQNKLS  131 (580)
Q Consensus        61 ~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~  131 (580)
                      .+...|..+++|+.|||.+|.++..    +...++.+++|++|++++|.+.......+     ...++|+.|.|.+|.++
T Consensus       204 al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  204 ALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             HHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            2345688999999999999999753    34567889999999999999975433322     23689999999999998


Q ss_pred             Cc----ccccccCcCCCCeeecccccCc
Q 008031          132 GE----IPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       132 ~~----~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      ..    +...+...+.|..|+|++|.+.
T Consensus       284 ~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  284 RDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            52    2334566899999999999994

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.50  E-value=1.8e-09  Score=111.41  Aligned_cols=126  Identities=30%  Similarity=0.300  Sum_probs=60.6

Q ss_pred             CcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeecc
Q 008031           24 LQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKR  103 (580)
Q Consensus        24 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  103 (580)
                      |.+.+++.|.+. .+...+.-++.|+.|||++|+++..  ..+..|++|+.|||+.|.+..+.--....+. |..|.|.+
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn  241 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN  241 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence            444455555554 3444444455555555555555522  1455555555555555555433222222332 55555555


Q ss_pred             ccccccCCccccCCCCCcEEEccccccCCcc-cccccCcCCCCeeecccccCc
Q 008031          104 NQISGHIPSTIGNISTLTILDLSQNKLSGEI-PASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       104 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      |.++..  -.+.++.+|+.||++.|-|.+.- -..+..+..|+.|+|.+|++.
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            555422  12445555555555555554321 122344455555555555553

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.47  E-value=1.7e-06  Score=79.87  Aligned_cols=137  Identities=20%  Similarity=0.287  Sum_probs=92.4

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccc-------------------cH-----HHHHHHHHHHhcCC--CCcce
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITK-------------------GQ-----REFESEVSLLGKIR--HPNLL  346 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~-----~~~~~e~~~l~~l~--h~niv  346 (580)
                      -+|+.|.-+.||+|...++..+|+|+.+.....                   ..     ....+|+..|.++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            367889999999999888999999998643211                   11     11346777777773  33444


Q ss_pred             eeeeEEECCCCcEEEEEeeCCCCCh-hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC
Q 008031          347 ALRAYYLGPKGEKLLVFDYMPHGSL-ATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST  425 (580)
Q Consensus       347 ~~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~  425 (580)
                      +-+++.     .-.+||||+..... .-.|..    .++...+...+..++++.+.-|-...++||+||+.-|||+. ++
T Consensus       134 ~Pi~~~-----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         134 EPIAFR-----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             Cceeec-----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence            444433     34699999955311 111111    12333356677778888887776545999999999999999 77


Q ss_pred             CeEEeecccccccc
Q 008031          426 NAKISDFGLSRLMT  439 (580)
Q Consensus       426 ~~kl~Dfg~~~~~~  439 (580)
                      .+.|+|||-|....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            89999999876543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	580
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-43
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-43
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-22
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-20
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-18
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
1w8a_A	192	Third Lrr Domain Of Drosophila Slit Length = 192		2e-05
1w8a_A	192	Third Lrr Domain Of Drosophila Slit Length = 192		4e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-05
1xeu_A	263	Crystal Structure Of Internalin C From Listeria Mon		7e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
2xot_A	361	Crystal Structure Of Neuronal Leucine Rich Repeat P		1e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-04
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		3e-04
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		3e-04
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		4e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 108/275 (39%), Positives = 165/275 (60%), Gaps = 14/275 (5%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALRAYY 352
           I+G+  +G VYK  L DG  VAVKRL+E+ T+G + +F++EV ++    H NLL LR + 
Sbjct: 37  ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPET--PIDWPTRMKIIKGMTRGL--LHLHSNEN 408
           + P  E+LLV+ YM +GS+A+ L  R PE+  P+DWP R +I  G  RGL  LH H +  
Sbjct: 97  MTPT-ERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           IIH ++ ++N+LLD+   A + DFGL++LM              +G+ APE     K++ 
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSE 214
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAE-----LPQWVASIVKEEWTNEVFDLELMRDAP 523
           KTDV+  GV +LEL+TG+   +    A      L  WV  ++KE+    + D++L  +  
Sbjct: 215 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYK 274
Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
              +E+   +++AL C   SP  RP++ +VV+ LE
Sbjct: 275 D--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  172 bits (435), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 163/275 (59%), Gaps = 14/275 (5%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLRE-KITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           I+G+  +G VYK  L DG+ VAVKRL+E +   G+ +F++EV ++    H NLL LR + 
Sbjct: 45  ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPET--PIDWPTRMKIIKGMTRGL--LHLHSNEN 408
           + P  E+LLV+ YM +GS+A+ L  R PE+  P+DWP R +I  G  RGL  LH H +  
Sbjct: 105 MTPT-ERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 162
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           IIH ++ ++N+LLD+   A + DFGL++LM              +G+ APE     K++ 
Sbjct: 163 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSE 222
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAE-----LPQWVASIVKEEWTNEVFDLELMRDAP 523
           KTDV+  GV +LEL+TG+   +    A      L  WV  ++KE+    + D++L  +  
Sbjct: 223 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYK 282
Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
              +E+   +++AL C   SP  RP++ +VV+ LE
Sbjct: 283 D--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/243 (33%), Positives = 124/243 (51%), Gaps = 25/243 (10%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQR--EFESEVSLLGKIRHPNLLALRA 350
           E +G  ++GTV++A    GS VAVK L E+    +R  EF  EV+++ ++RHPN++    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS-NENI 409
               P    + V +Y+  GSL   LH  G    +D   R+ +   + +G+ +LH+ N  I
Sbjct: 102 AVTQPPNLSI-VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H NL S N+L+D     K+ DFGLSRL                 + APE+ + + +N K
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP-EWMAPEVLRDEPSNEK 219
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAEL------------------PQWVASIVKEEWTN 511
           +DVYS GV + EL T + P   LN A++                  PQ VA+I++  WTN
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ-VAAIIEGCWTN 278
Query: 512 EVF 514
           E +
Sbjct: 279 EPW 281

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  115 bits (287), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 139/274 (50%), Gaps = 17/274 (6%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           ++G   +G VYK  L DG++VA+KR   + ++G  EFE+E+  L   RHP+L++L   + 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG-FC 104
Query: 354 GPKGEKLLVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             + E +L++ YM +G+L   L+    P   + W  R++I  G  RGL +LH+   IIH 
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-IIHR 163
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRL-MXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
           ++ S N+LLD++   KI+DFG+S+                 LGY  PE     +   K+D
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSD 223
Query: 472 VYSLGVTILELLTGKS------PGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
           VYS GV + E+L  +S      P E +N AE   W           ++ D  L   A  I
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAE---WAVESHNNGQLEQIVDPNL---ADKI 277
Query: 526 GDELLNTL-KLALHCVDPSPSARPEVLQVVQQLE 558
             E L      A+ C+  S   RP +  V+ +LE
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 127/243 (52%), Gaps = 25/243 (10%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQR--EFESEVSLLGKIRHPNLLALRA 350
           E +G  ++GTV++A    GS VAVK L E+    +R  EF  EV+++ ++RHPN++    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS-NENI 409
               P    + V +Y+  GSL   LH  G    +D   R+ +   + +G+ +LH+ N  I
Sbjct: 102 AVTQPPNLSI-VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H +L S N+L+D     K+ DFGLSRL                 + APE+ + + +N K
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP-EWMAPEVLRDEPSNEK 219
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAEL------------------PQWVASIVKEEWTN 511
           +DVYS GV + EL T + P   LN A++                  PQ VA+I++  WTN
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ-VAAIIEGCWTN 278
Query: 512 EVF 514
           E +
Sbjct: 279 EPW 281

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 139/274 (50%), Gaps = 17/274 (6%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           ++G   +G VYK  L DG++VA+KR   + ++G  EFE+E+  L   RHP+L++L   + 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG-FC 104
Query: 354 GPKGEKLLVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             + E +L++ YM +G+L   L+    P   + W  R++I  G  RGL +LH+   IIH 
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-IIHR 163
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRL-MXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
           ++ S N+LLD++   KI+DFG+S+                 LGY  PE     +   K+D
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSD 223
Query: 472 VYSLGVTILELLTGKS------PGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
           VYS GV + E+L  +S      P E +N AE   W           ++ D  L   A  I
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAE---WAVESHNNGQLEQIVDPNL---ADKI 277
Query: 526 GDELLNTL-KLALHCVDPSPSARPEVLQVVQQLE 558
             E L      A+ C+  S   RP +  V+ +LE
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 142/276 (51%), Gaps = 20/276 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKI----TKGQREFESEVSLLGKIRHPNLLALRA 350
           MG+  +G VYK  + + + VAVK+L   +     + +++F+ E+ ++ K +H NL+ L  
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           +     G+ L LV+ YMP+GSL   L       P+ W  R KI +G   G+  LH N + 
Sbjct: 98  F--SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPELSKLKKANT 468
           IH ++ S+N+LLD++  AKISDFGL+R                   Y APE  +  +   
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITP 213
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL----MRDAPT 524
           K+D+YS GV +LE++TG      ++    PQ +  I +E    E    +     M DA +
Sbjct: 214 KSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270
Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              E + +  +A  C+    + RP++ +V Q L+E+
Sbjct: 271 TSVEAMYS--VASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 88/276 (31%), Positives = 143/276 (51%), Gaps = 20/276 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKI----TKGQREFESEVSLLGKIRHPNLLALRA 350
           MG+  +G VYK  + + + VAVK+L   +     + +++F+ E+ ++ K +H NL+ L  
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           +     G+ L LV+ YMP+GSL   L       P+ W  R KI +G   G+  LH N + 
Sbjct: 98  F--SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPELSKLKKANT 468
           IH ++ S+N+LLD++  AKISDFGL+R                   Y APE  +  +   
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITP 213
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL----MRDAPT 524
           K+D+YS GV +LE++TG      ++    PQ +  I +E    E    +     M DA +
Sbjct: 214 KSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270
Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              E + +  +A  C+    + RP++ +V Q L+E+
Sbjct: 271 TSVEAMYS--VASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 144/276 (52%), Gaps = 20/276 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKI----TKGQREFESEVSLLGKIRHPNLLALRA 350
           MG+  +G VYK  + + + VAVK+L   +     + +++F+ E+ ++ K +H NL+ L  
Sbjct: 33  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           +     G+ L LV+ YMP+GSL   L       P+ W  R KI +G   G+  LH N + 
Sbjct: 92  F--SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 148
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPELSKLKKANT 468
           IH ++ S+N+LLD++  AKISDFGL+R                   Y APE  +  +   
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITP 207
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL----MRDAPT 524
           K+D+YS GV +LE++TG      ++    PQ +  I +E    E    +     M DA +
Sbjct: 208 KSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 264
Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              E + +  +A  C+    + RP++ +V Q L+E+
Sbjct: 265 TSVEAMYS--VASQCLHEKKNKRPDIKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 108/196 (55%), Gaps = 11/196 (5%)
Query: 296 GKSTYGTVYKATLEDGSQVAVKRLREKIT----KGQREFESEVSLLGKIRHPNLLALRAY 351
           G+  +G VYK  + + + VAVK+L   +     + +++F+ E+ +  K +H NL+ L  +
Sbjct: 31  GEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
                G+ L LV+ Y P+GSL   L       P+ W  R KI +G   G+  LH N + I
Sbjct: 90  --SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH-I 146
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPELSKLKKANTK 469
           H ++ S+N+LLD++  AKISDFGL+R                   Y APE  +  +   K
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPK 205
Query: 470 TDVYSLGVTILELLTG 485
           +D+YS GV +LE++TG
Sbjct: 206 SDIYSFGVVLLEIITG 221

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 84/160 (52%)
Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L LQ N  +G+IP +L   SEL  + LS N +SG +PS LG LS+LR L    N + G +
Sbjct: 396 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 455
Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P     + +L +L L+ N+L  +I   L    NL+ ++L  N+++G IP  IG +  L I
Sbjct: 456 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 515
Query: 123 LDLSQNKLSGEIPAXXXXXXXXXXXXXXYNNLSGPVPTSL 162
           L LS N  SG IPA               N  +G +P ++
Sbjct: 516 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 555

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 84/160 (52%)
Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L LQ N  +G+IP +L   SEL  + LS N +SG +PS LG LS+LR L    N + G +
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P     + +L +L L+ N+L  +I   L    NL+ ++L  N+++G IP  IG +  L I
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 123 LDLSQNKLSGEIPAXXXXXXXXXXXXXXYNNLSGPVPTSL 162
           L LS N  SG IPA               N  +G +P ++
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 137/282 (48%), Gaps = 29/282 (10%)
Query: 289 CATAE-IMGKSTYGTVYKATLEDGSQ-----VAVKRLREKITKGQR-EFESEVSLLGKIR 341
           C T + ++G   +G VYK  L+  S      VA+K L+   T+ QR +F  E  ++G+  
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
           H N++ L    +      +++ +YM +G+L  FL  +  E  +     + +++G+  G+ 
Sbjct: 105 HHNIIRLEGV-ISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMK 161
Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APE 459
           +L +N N +H +L + N+L++ +   K+SDFGLSR++              +  R  APE
Sbjct: 162 YL-ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 460 LSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
               +K  + +DV+S G+ + E++T G+ P   L+  E+ + +         N+ F L  
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------NDGFRLPT 271
Query: 519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             D P+         +L + C     + RP+   +V  L+++
Sbjct: 272 PMDCPS------AIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           +L + + N+SG IP  L ++  L  +  S+N +SG +P  +  L  L  + F  N I+G+
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 62  LPASFSNLSSL-VSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG------------ 108
           +P S+ + S L  S+T+  N L  +I  +   L NL+ ++L RN + G            
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 109 ---HIPST--------IGNISTLTILDLSQNKLSGEIPAXXXXXXXXXXXXXXYNNLSGP 157
              H+           +G    L  LDL  N++ G +P               +NNL G 
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 158 VPTSLAL-KFNASSFVGNIQLCG 179
           +P    L +F+ S++  N  LCG
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLCG 306

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 128/268 (47%), Gaps = 23/268 (8%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     +  +VA+K +RE     + +F  E  ++ K+ HP L+ L    L 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL- 70
Query: 355 PKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            +    LVF++M HG L+ +L   RG        T + +   +  G+ +L     +IH +
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLE-EACVIHRD 126
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L+ ++   K+SDFG++R +              + + +PE+    + ++K+DV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           S GV + E+ + GK P E  + +E+ + +++          F L   R A T   +++N 
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------GFRLYKPRLASTHVYQIMN- 236
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
                HC    P  RP   ++++QL EI
Sbjct: 237 -----HCWKERPEDRPAFSRLLRQLAEI 259

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 128/268 (47%), Gaps = 23/268 (8%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     +  +VA+K +RE     + +F  E  ++ K+ HP L+ L    L 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL- 75
Query: 355 PKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            +    LVF++M HG L+ +L   RG        T + +   +  G+ +L     +IH +
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLE-EACVIHRD 131
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L+ ++   K+SDFG++R +              + + +PE+    + ++K+DV+
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           S GV + E+ + GK P E  + +E+ + +++          F L   R A T   +++N 
Sbjct: 192 SFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------GFRLYKPRLASTHVYQIMN- 241
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
                HC    P  RP   ++++QL EI
Sbjct: 242 -----HCWRERPEDRPAFSRLLRQLAEI 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 127/267 (47%), Gaps = 21/267 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     +  +VA+K +RE     + +F  E  ++ K+ HP L+ L    L 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL- 72
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    LVF++M HG L+ +L  R         T + +   +  G+ +L     +IH +L
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDL 129
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            + N L+ ++   K+SDFG++R +              + + +PE+    + ++K+DV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 475 LGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
            GV + E+ + GK P E  + +E+ + +++          F L   R A T   +++N  
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVEDIST---------GFRLYKPRLASTHVYQIMN-- 238
Query: 534 KLALHCVDPSPSARPEVLQVVQQLEEI 560
               HC    P  RP   ++++QL EI
Sbjct: 239 ----HCWKERPEDRPAFSRLLRQLAEI 261

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 113/222 (50%), Gaps = 22/222 (9%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V+ A        +D   VAVK L++     +++F  E  LL  ++H +++  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV-- 78
Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPE----------TPIDWPTRMKIIKGMT 397
           + Y +  +G+ L +VF+YM HG L  FL A GP+          T +     + I + + 
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYR 456
            G+++L ++++ +H +L + N L+ ++   KI DFG+SR +               + + 
Sbjct: 139 AGMVYL-ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 457 APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
            PE    +K  T++DV+SLGV + E+ T GK P   L+  E+
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 127/267 (47%), Gaps = 21/267 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     +  +VA+K +RE     + +F  E  ++ K+ HP L+ L    L 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL- 72
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    LVF++M HG L+ +L  R         T + +   +  G+ +L    ++IH +L
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE-EASVIHRDL 129
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            + N L+ ++   K+SDFG++R +              + + +PE+    + ++K+DV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 475 LGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
            GV + E+ + GK P E  + +E+ + +++          F L   R A T   +++N  
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVEDIST---------GFRLYKPRLASTHVYQIMN-- 238
Query: 534 KLALHCVDPSPSARPEVLQVVQQLEEI 560
               HC    P  RP   ++++QL  I
Sbjct: 239 ----HCWKERPEDRPAFSRLLRQLAAI 261

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR----EKITKGQREFESEVSLLGKIRHPNLLAL 348
           EI+G   +G VY+A    G +VAVK  R    E I++       E  L   ++HPN++AL
Sbjct: 13  EIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSN 406
           R   L  +    LV ++   G L   L  +   P+  ++W  ++       RG+ +LH  
Sbjct: 72  RGVCL-KEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDE 124
Query: 407 E--NIIHGNLTSSNVLL------DDSTNA--KISDFGLSRLMXXXXXXXXXXXXXXLGYR 456
               IIH +L SSN+L+       D +N   KI+DFGL+R                  + 
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWM 181
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL 516
           APE+ +    +  +DV+S GV + ELLTG+ P   ++G  +   VA        N     
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-------MN----- 229
Query: 517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +L    P+   E     KL   C +P P +RP    ++ QL  I
Sbjct: 230 KLALPIPSTCPEPFA--KLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 128/267 (47%), Gaps = 21/267 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     +  +VA+K ++E  +  + +F  E  ++ K+ HP L+ L    L 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLYGVCL- 92
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    LVF++M HG L+ +L  R         T + +   +  G+ +L     +IH +L
Sbjct: 93  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL-EEACVIHRDL 149
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            + N L+ ++   K+SDFG++R +              + + +PE+    + ++K+DV+S
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 475 LGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
            GV + E+ + GK P E  + +E+ + +++          F L   R A T   +++N  
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNSEVVEDIST---------GFRLYKPRLASTHVYQIMN-- 258
Query: 534 KLALHCVDPSPSARPEVLQVVQQLEEI 560
               HC    P  RP   ++++QL EI
Sbjct: 259 ----HCWKERPEDRPAFSRLLRQLAEI 281

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 130/272 (47%), Gaps = 29/272 (10%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  +G V       G++VAVK ++   T   + F +E S++ ++RH NL+ L    
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  KG   +V +YM  GSL  +L +RG  + +     +K    +   + +L  N N +H 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHR 313
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           +L + NVL+ +   AK+SDFGL++                + + APE  + KK +TK+DV
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 473 YSLGVTILELLT-GKSPGE--PLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           +S G+ + E+ + G+ P    PL        V   V++ +  +  D       P + D +
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD----GCPPAVYDVM 419
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
            N       C     + RP  LQ+ +QLE IR
Sbjct: 420 KN-------CWHLDAATRPTFLQLREQLEHIR 444

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 35/280 (12%)
Query: 294 IMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR--EFESEVSLLGKIRHPNLLA 347
           ++GK  +G VY     D +Q     A+K L  +IT+ Q+   F  E  L+  + HPN+LA
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTRGLLHLH 404
           L    L P+G   ++  YM HG L  F+  R P+     PT   +I     + RG+ +L 
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRN---PTVKDLISFGLQVARGMEYL- 140
Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKL 463
           + +  +H +L + N +LD+S   K++DFGL+R ++              L  +   L  L
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 464 K--KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
           +  +  TK+DV+S GV + ELLT G  P   ++  +L  ++A   +            + 
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------------LP 248
Query: 521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                 D L   ++    C +  P+ RP    +V ++E+I
Sbjct: 249 QPEYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVEQI 285

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 31  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRG 399
           HPN+L+L    L  +G  L+V  YM HG L  F+      P         +++ KGM   
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK-- 148
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGYR 456
                +++  +H +L + N +LD+    K++DFGL+R M                 + + 
Sbjct: 149 ---FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 31  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRG 399
           HPN+L+L    L  +G  L+V  YM HG L  F+      P         +++ KGM   
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK-- 148
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGYR 456
                +++  +H +L + N +LD+    K++DFGL+R M                 + + 
Sbjct: 149 ---FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 28  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRG 399
           HPN+L+L    L  +G  L+V  YM HG L  F+      P         +++ KGM   
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK-- 145
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGYR 456
                +++  +H +L + N +LD+    K++DFGL+R M                 + + 
Sbjct: 146 ---FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 89  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRG 399
           HPN+L+L    L  +G  L+V  YM HG L  F+      P         +++ KGM   
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK-- 206
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGYR 456
                +++  +H +L + N +LD+    K++DFGL+R M                 + + 
Sbjct: 207 ---FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 30  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLH--ARGPETPIDWPTRMKIIKGMTRG 399
           HPN+L+L    L  +G  L+V  YM HG L  F+      P         +++ KGM   
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK-- 147
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGYR 456
                +++  +H +L + N +LD+    K++DFGL+R M                 + + 
Sbjct: 148 ---FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 35  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 94
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRG 399
           HPN+L+L    L  +G  L+V  YM HG L  F+      P         +++ KGM   
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK-- 152
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGYR 456
                +++  +H +L + N +LD+    K++DFGL+R M                 + + 
Sbjct: 153 ---FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 49  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 108
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 163
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 164 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 30  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 144
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 145 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 29  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 143
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 144 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKW 202
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 20  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LHA   ET  +    + I +   RG+ +LH+ ++IIH 
Sbjct: 78  TKP--QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA-KSIIHR 132
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXX-XXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ +                + + APE+ +++ +N    
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 130/272 (47%), Gaps = 29/272 (10%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  +G V       G++VAVK ++   T   + F +E S++ ++RH NL+ L    
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  KG   +V +YM  GSL  +L +RG  + +     +K    +   + +L  N N +H 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHR 141
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           +L + NVL+ +   AK+SDFGL++                + + APE  + KK +TK+DV
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 473 YSLGVTILELLT-GKSPGE--PLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           +S G+ + E+ + G+ P    PL    +P+            + + ++     P    E+
Sbjct: 198 WSFGILLWEIYSFGRVPYPRIPLKDV-VPR----------VEKGYKMDAPDGCPPAVYEV 246
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
           +       +C     + RP  LQ+ +QLE I+
Sbjct: 247 MK------NCWHLDAAMRPSFLQLREQLEHIK 272

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 130/272 (47%), Gaps = 29/272 (10%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  +G V       G++VAVK ++   T   + F +E S++ ++RH NL+ L    
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  KG   +V +YM  GSL  +L +RG  + +     +K    +   + +L  N N +H 
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHR 126
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           +L + NVL+ +   AK+SDFGL++                + + APE  + KK +TK+DV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 473 YSLGVTILELLT-GKSPGE--PLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           +S G+ + E+ + G+ P    PL    +P+            + + ++     P    E+
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDV-VPR----------VEKGYKMDAPDGCPPAVYEV 231
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
           +       +C     + RP  LQ+ +QLE I+
Sbjct: 232 MK------NCWHLDAAMRPSFLQLREQLEHIK 257

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 30  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRG 399
           HPN+L+L    L  +G  L+V  YM HG L  F+      P         +++ KGM   
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK-- 147
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGYR 456
                +++  +H +L + N +LD+    K++DFGL+R M                 + + 
Sbjct: 148 ---FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 48  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 107
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 162
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 163 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 28  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 142
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 143 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 18/222 (8%)
Query: 283 TADDLLCATAEI-----MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVS 335
            ADD      +I     +G  ++GTVYK        VAVK L       Q  + F++EV 
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 336 LLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG 395
           +L K RH N+L    Y   P  +  +V  +    SL   LHA   ET  +    + I + 
Sbjct: 73  VLRKTRHVNILLFMGYSTAP--QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQ 128
Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL-SRLMXXXXXXXXXXXXXXLG 454
             RG+ +LH+ ++IIH +L S+N+ L +    KI DFGL +                 + 
Sbjct: 129 TARGMDYLHA-KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 455 YRAPELSKLKKAN---TKTDVYSLGVTILELLTGKSPGEPLN 493
           + APE+ +++ +N    ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 137/283 (48%), Gaps = 32/283 (11%)
Query: 289 CATAE-IMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRH 342
           C T E ++G   +G V    L+   +    VA+K L+   T+ QR +F  E S++G+  H
Sbjct: 23  CITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 82
Query: 343 PNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLL 401
           PN++ L       K   ++V +YM +GSL TFL    G  T I     + +++G++ G+ 
Sbjct: 83  PNIIHLEGVVTKSK-PVMIVTEYMENGSLDTFLKKNDGQFTVIQ---LVGMLRGISAGMK 138
Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APE 459
           +L S+   +H +L + N+L++ +   K+SDFGLSR++              +  R  APE
Sbjct: 139 YL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 197
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE--VFDLE 517
               +K  + +DV+S G+ + E+++           E P W       E TN+  +  +E
Sbjct: 198 AIAFRKFTSASDVWSYGIVMWEVVS---------YGERPYW-------EMTNQDVIKAVE 241
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                P+  D      +L L C     ++RP+  ++V  L+++
Sbjct: 242 EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 30  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 144
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 145 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 22  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 81
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 136
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 137 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 29  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 143
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 144 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 27  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 141
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 142 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 287 LLCATAEIMGKSTYGTVYKATL--EDGSQV--AVKRLREKITKGQ-REFESEVSLLGKIR 341
           L+    E++G+  +G VY  TL   DG ++  AVK L      G+  +F +E  ++    
Sbjct: 25  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK---GMTR 398
           HPN+L+L    L  +G  L+V  YM HG L  F+           PT   +I     + +
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 139
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX---LGY 455
           G+ +L +++  +H +L + N +LD+    K++DFGL+R M                 + +
Sbjct: 140 GMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
            A E  + +K  TK+DV+S GV + EL+T  +P  P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 127/268 (47%), Gaps = 23/268 (8%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     +  +VA+K +RE     + +F  E  ++ K+ HP L+ L    L 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL- 73
Query: 355 PKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            +    LV ++M HG L+ +L   RG        T + +   +  G+ +L     +IH +
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLE-EACVIHRD 129
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L+ ++   K+SDFG++R +              + + +PE+    + ++K+DV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           S GV + E+ + GK P E  + +E+ + +++          F L   R A T   +++N 
Sbjct: 190 SFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------GFRLYKPRLASTHVYQIMN- 239
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
                HC    P  RP   ++++QL EI
Sbjct: 240 -----HCWRERPEDRPAFSRLLRQLAEI 262

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 292 AEIMGKSTYGTVYKAT-LEDGSQV----AVKRLREKI-TKGQREFESEVSLLGKIRHPNL 345
            +++G   +GTVYK   + +G  V    A+K L E    K   EF  E  ++  + HP+L
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLL 401
           + L    L P  +  LV   MPHG L  ++H      G +  ++W  ++       +G++
Sbjct: 80  VRLLGVCLSPTIQ--LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMM 131
Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPEL 460
           +L     ++H +L + NVL+    + KI+DFGL+RL+               + + A E 
Sbjct: 132 YLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 461 SKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
              +K   ++DV+S GVTI EL+T G  P + +   E+P
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP 229

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 32  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LHA   ET  +    + I +   RG+ +LH+ ++IIH 
Sbjct: 90  TKP--QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA-KSIIHR 144
Query: 413 NLTSSNVLLDDSTNAKISDFGL-SRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL +                 + + APE+ +++ +N    
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 99  LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 154
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 215 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 263
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 264 PA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 292 AEIMGKSTYGTVYKAT-LEDGSQV----AVKRLREKI-TKGQREFESEVSLLGKIRHPNL 345
            +++G   +GTVYK   + +G  V    A+K L E    K   EF  E  ++  + HP+L
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLL 401
           + L    L P  +  LV   MPHG L  ++H      G +  ++W  ++       +G++
Sbjct: 103 VRLLGVCLSPTIQ--LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMM 154
Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPEL 460
           +L     ++H +L + NVL+    + KI+DFGL+RL+               + + A E 
Sbjct: 155 YL-EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 461 SKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
              +K   ++DV+S GVTI EL+T G  P + +   E+P
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP 252

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 130/296 (43%), Gaps = 35/296 (11%)
Query: 281 MFTADDLLCATAEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGK 339
           +F   DL+    E++GK  +G   K T  E G  + +K L     + QR F  EV ++  
Sbjct: 6   IFRPSDLI--HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 340 IRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR 398
           + HPN+L         K ++L  + +Y+  G+L   + +   + P  W  R+   K +  
Sbjct: 64  LEHPNVLKFIGVLY--KDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIAS 119
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXX----------XXXX 448
           G+ +LHS  NIIH +L S N L+ ++ N  ++DFGL+RLM                    
Sbjct: 120 GMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 449 XXXXLG---YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV 505
               +G   + APE+   +  + K DV+S G+ + E++ G+   +P     LP+ +   +
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADP---DYLPRTMDFGL 234
Query: 506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
                    D     + P       +   + + C D  P  RP  +++   LE +R
Sbjct: 235 N---VRGFLDRYCPPNCPP------SFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 82  LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 137
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 198 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 246
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 247 PA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 23/261 (8%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+  T    ++VA+K L+   T     F  E  ++ K++H  L+ L  Y + 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPG-TMSPESFLEEAQIMKKLKHDKLVQL--YAVV 73
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL   G    +  P  + +   +  G+ ++    N IH +L
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDL 131
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            S+N+L+ +    KI+DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 475 LGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
            G+ + EL+T G+ P   +N  E+ + V            + +   +D P    EL+   
Sbjct: 192 FGILLTELVTKGRVPYPGMNNREVLEQV---------ERGYRMPCPQDCPISLHELM--- 239
Query: 534 KLALHCVDPSPSARP--EVLQ 552
              +HC    P  RP  E LQ
Sbjct: 240 ---IHCWKKDPEERPTFEYLQ 257

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 109 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 164
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 225 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 273
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 274 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 20/208 (9%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +I+G    G V    L    Q    VA+K L+   T+ QR +F SE S++G+  HPN++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL---LHL 403
           L    +  +G   ++V +YM +GSL TFL     +  I     M+++ GM RG+   +  
Sbjct: 115 LEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI-----MQLV-GMLRGVGAGMRY 166
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELS 461
            S+   +H +L + NVL+D +   K+SDFGLSR++              +  R  APE  
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSP 488
             +  ++ +DV+S GV + E+L  G+ P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 139/289 (48%), Gaps = 36/289 (12%)
Query: 286 DLLCATAE-IMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGK 339
           D+ C   E ++G   +G V    L+   +    VA+K L+   T+ QR +F SE S++G+
Sbjct: 31  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 90
Query: 340 IRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTR 398
             HPN++ L    +      +++ ++M +GSL +FL    G  T I     + +++G+  
Sbjct: 91  FDHPNVIHLEGV-VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVGMLRGIAA 146
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXX----XXLG 454
           G+ +L ++ N +H +L + N+L++ +   K+SDFGLSR +                  + 
Sbjct: 147 GMKYL-ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 205
Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV- 513
           + APE  + +K  + +DV+S G+ + E+++           E P W   +  ++  N + 
Sbjct: 206 WTAPEAIQYRKFTSASDVWSYGIVMWEVMS---------YGERPYW--DMTNQDVINAIE 254
Query: 514 --FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             + L    D P+   +L+      L C     + RP+  Q+V  L+++
Sbjct: 255 QDYRLPPPMDCPSALHQLM------LDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +I+G    G V    L    Q    VA+K L+   T+ QR +F SE S++G+  HPN++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL---LHL 403
           L    +  +G   ++V +YM +GSL TFL     +  I     M+++ GM RG+   +  
Sbjct: 115 LEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI-----MQLV-GMLRGVGAGMRY 166
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELS 461
            S+   +H +L + NVL+D +   K+SDFGLSR++              +  R  APE  
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSP 488
             +  ++ +DV+S GV + E+L  G+ P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 286 DLLCATAE-IMGKSTYGTVYKATLEDGSQ----VAVKRLREKIT-KGQREFESEVSLLGK 339
           D  C   E ++G   +G V    L+   +    VA+K L+   T K +R+F SE S++G+
Sbjct: 27  DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 86
Query: 340 IRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK--GMT 397
             HPN++ L       K   +++ +YM +GSL  FL             R  +I+  GM 
Sbjct: 87  FDHPNIIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKND--------GRFTVIQLVGML 137
Query: 398 RGL---LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG 454
           RG+   +   S+ + +H +L + N+L++ +   K+SDFG+SR++              + 
Sbjct: 138 RGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 197
Query: 455 YR--APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEW 509
            R  APE    +K  + +DV+S G+ + E+++           E P W  S   ++K   
Sbjct: 198 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS---------YGERPYWDMSNQDVIKA-- 246
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             E + L    D P      +   +L L C     S RP+  Q+V  L+++
Sbjct: 247 IEEGYRLPPPMDCP------IALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 286 DLLCATAE-IMGKSTYGTVYKATLEDGSQ----VAVKRLREKIT-KGQREFESEVSLLGK 339
           D  C   E ++G   +G V    L+   +    VA+K L+   T K +R+F SE S++G+
Sbjct: 6   DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 65
Query: 340 IRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK--GMT 397
             HPN++ L       K   +++ +YM +GSL  FL             R  +I+  GM 
Sbjct: 66  FDHPNIIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKND--------GRFTVIQLVGML 116
Query: 398 RGL---LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG 454
           RG+   +   S+ + +H +L + N+L++ +   K+SDFG+SR++              + 
Sbjct: 117 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 455 YR--APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEW 509
            R  APE    +K  + +DV+S G+ + E+++           E P W  S   ++K   
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS---------YGERPYWDMSNQDVIKA-- 225
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             E + L    D P      +   +L L C     S RP+  Q+V  L+++
Sbjct: 226 IEEGYRLPPPMDCP------IALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 286 DLLCATAE-IMGKSTYGTVYKATLEDGSQ----VAVKRLREKIT-KGQREFESEVSLLGK 339
           D  C   E ++G   +G V    L+   +    VA+K L+   T K +R+F SE S++G+
Sbjct: 12  DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 71
Query: 340 IRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK--GMT 397
             HPN++ L       K   +++ +YM +GSL  FL             R  +I+  GM 
Sbjct: 72  FDHPNIIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKND--------GRFTVIQLVGML 122
Query: 398 RGL---LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG 454
           RG+   +   S+ + +H +L + N+L++ +   K+SDFG+SR++              + 
Sbjct: 123 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 182
Query: 455 YR--APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEW 509
            R  APE    +K  + +DV+S G+ + E+++           E P W  S   ++K   
Sbjct: 183 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS---------YGERPYWDMSNQDVIKA-- 231
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             E + L    D P      +   +L L C     S RP+  Q+V  L+++
Sbjct: 232 IEEGYRLPPPMDCP------IALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 132/281 (46%), Gaps = 35/281 (12%)
Query: 293 EIMGKSTYGTVYKATLE----DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           E++G   +G V +  L+      S VA+K L+   T+ QR EF SE S++G+  HPN++ 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L           +L  ++M +G+L +FL    G  T I     + +++G+  G+ +L + 
Sbjct: 82  LEGVVTNSMPVMILT-EFMENGALDSFLRLNDGQFTVIQ---LVGMLRGIASGMRYL-AE 136
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXX----XXLGYRAPELSK 462
            + +H +L + N+L++ +   K+SDFGLSR +                  + + APE   
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV---FDLELM 519
            +K  + +D +S G+ + E+++           E P W  S   ++  N +   + L   
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMS---------FGERPYWDMS--NQDVINAIEQDYRLPPP 245
Query: 520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            D PT      +  +L L C     +ARP   QVV  L+++
Sbjct: 246 PDCPT------SLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 132/281 (46%), Gaps = 35/281 (12%)
Query: 293 EIMGKSTYGTVYKATLE----DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           E++G   +G V +  L+      S VA+K L+   T+ QR EF SE S++G+  HPN++ 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L           +L  ++M +G+L +FL    G  T I     + +++G+  G+ +L + 
Sbjct: 80  LEGVVTNSMPVMILT-EFMENGALDSFLRLNDGQFTVIQ---LVGMLRGIASGMRYL-AE 134
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXX----XXLGYRAPELSK 462
            + +H +L + N+L++ +   K+SDFGLSR +                  + + APE   
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV---FDLELM 519
            +K  + +D +S G+ + E+++           E P W  S   ++  N +   + L   
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMS---------FGERPYWDMS--NQDVINAIEQDYRLPPP 243
Query: 520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            D PT      +  +L L C     +ARP   QVV  L+++
Sbjct: 244 PDCPT------SLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGL+R++              +  R  +PE    +K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 138/289 (47%), Gaps = 36/289 (12%)
Query: 286 DLLCATAE-IMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGK 339
           D+ C   E ++G   +G V    L+   +    VA+K L+   T+ QR +F SE S++G+
Sbjct: 5   DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 64
Query: 340 IRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTR 398
             HPN++ L    +      +++ ++M +GSL +FL    G  T I     + +++G+  
Sbjct: 65  FDHPNVIHLEGV-VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVGMLRGIAA 120
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX----LG 454
           G+ +L ++ N +H  L + N+L++ +   K+SDFGLSR +                  + 
Sbjct: 121 GMKYL-ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 179
Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV- 513
           + APE  + +K  + +DV+S G+ + E+++           E P W   +  ++  N + 
Sbjct: 180 WTAPEAIQYRKFTSASDVWSYGIVMWEVMS---------YGERPYW--DMTNQDVINAIE 228
Query: 514 --FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             + L    D P+   +L+      L C     + RP+  Q+V  L+++
Sbjct: 229 QDYRLPPPMDCPSALHQLM------LDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V+ A        +D   VAVK L+E     +++F+ E  LL  ++H +++  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV-- 83
Query: 349 RAYYLGPKGEKLL-VFDYMPHGSLATFLHARGPET------------PIDWPTRMKIIKG 395
           R + +  +G  LL VF+YM HG L  FL + GP+             P+     + +   
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLG 454
           +  G+++L +  + +H +L + N L+      KI DFG+SR +               + 
Sbjct: 144 VAAGMVYL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAE 496
           +  PE    +K  T++DV+S GV + E+ T GK P   L+  E
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 245

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 25/225 (11%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V+ A        +D   VAVK L++     +++F+ E  LL  ++H +++  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV-- 80
Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPI--DWPTR-----------MKIIK 394
           + Y +   G+ L +VF+YM HG L  FL A GP+  I  D   R           + I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            +  G+++L ++++ +H +L + N L+  +   KI DFG+SR +               +
Sbjct: 141 QIASGMVYL-ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
            +  PE    +K  T++DV+S GV + E+ T GK P   L+  E+
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 321
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 379
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H NL + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 440 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 490
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 491 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 518

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V+ A        +D   VAVK L+E     +++F+ E  LL  ++H +++  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV-- 77
Query: 349 RAYYLGPKGEKLL-VFDYMPHGSLATFLHARGPET------------PIDWPTRMKIIKG 395
           R + +  +G  LL VF+YM HG L  FL + GP+             P+     + +   
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLG 454
           +  G+++L +  + +H +L + N L+      KI DFG+SR +               + 
Sbjct: 138 VAAGMVYL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAE 496
           +  PE    +K  T++DV+S GV + E+ T GK P   L+  E
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 239

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V +YM +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGL R++              +  R  +PE    +K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  KL++ +Y+P+GSL  +L A      ID    ++    + +G+ +L   +
Sbjct: 81  GVCYSAGRRNLKLIM-EYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL-GTK 136
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G+  +G V+ A        +D   VAVK L+E     +++F+ E  LL  ++H +++  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV-- 106
Query: 349 RAYYLGPKGEKLL-VFDYMPHGSLATFLHARGPET------------PIDWPTRMKIIKG 395
           R + +  +G  LL VF+YM HG L  FL + GP+             P+     + +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLG 454
           +  G+++L +  + +H +L + N L+      KI DFG+SR +               + 
Sbjct: 167 VAAGMVYL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAE 496
           +  PE    +K  T++DV+S GV + E+ T GK P   L+  E
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 11/214 (5%)
Query: 284 ADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHP 343
           A +++ +T   +G  ++GTVYK        V + ++ +   +  + F +EV++L K RH 
Sbjct: 35  ASEVMLSTR--IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHV 92
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N+L    Y    K    +V  +    SL   LH +  ET       + I +   +G+ +L
Sbjct: 93  NILLFMGYM--TKDNLAIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYL 148
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX-XXXLGYRAPELSK 462
           H+ +NIIH ++ S+N+ L +    KI DFGL+ +                + + APE+ +
Sbjct: 149 HA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 463 LKKAN---TKTDVYSLGVTILELLTGKSPGEPLN 493
           ++  N    ++DVYS G+ + EL+TG+ P   +N
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 282
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 340
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H NL + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 401 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 451
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 452 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 479

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 80
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 138
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 199 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 249
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 250 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  KL++ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 79  GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 134
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH NL + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 195 FSVASDVWSFGVVLYELFTYIEKSKSP 221

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  +G V       G++VAVK ++   T   + F +E S++ ++RH NL+ L    
Sbjct: 18  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  KG   +V +YM  GSL  +L +RG  + +     +K    +   + +L  N N +H 
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHR 132
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           +L + NVL+ +   AK+SDFGL++                + + APE  +    +TK+DV
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 473 YSLGVTILELLT-GKSPGE--PLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           +S G+ + E+ + G+ P    PL    +P+            + + ++     P    E+
Sbjct: 189 WSFGILLWEIYSFGRVPYPRIPLKDV-VPR----------VEKGYKMDAPDGCPPAVYEV 237
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
           +       +C     + RP  LQ+ +QLE I+
Sbjct: 238 MK------NCWHLDAAMRPSFLQLREQLEHIK 263

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 125/271 (46%), Gaps = 46/271 (16%)
Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           ++GK TYG VY    L +  ++A+K + E+ ++  +    E++L   ++H N++     Y
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 84
Query: 353 LGPKGEKLLVFDYM---PHGSLATFLHAR-GP----ETPIDWPTRMKIIKGMTRGLLHLH 404
           LG   E   +  +M   P GSL+  L ++ GP    E  I + T     K +  GL +LH
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT-----KQILEGLKYLH 139
Query: 405 SNENIIHGNLTSSNVLLDDSTNA-KISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL-SK 462
            N+ I+H ++   NVL++  +   KISDFG S+ +              L Y APE+  K
Sbjct: 140 DNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT-LQYMAPEIIDK 197
Query: 463 LKKANTKT-DVYSLGVTILELLTGKSP----GEPLNGAELPQWVASIVKEEWTNEVFDLE 517
             +   K  D++SLG TI+E+ TGK P    GEP                     +F + 
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------------------QAAMFKVG 239
Query: 518 LMRDAPTIGDELLNTLK-LALHCVDPSPSAR 547
           + +  P I + +    K   L C +P P  R
Sbjct: 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 125/271 (46%), Gaps = 46/271 (16%)
Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           ++GK TYG VY    L +  ++A+K + E+ ++  +    E++L   ++H N++     Y
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 70
Query: 353 LGPKGEKLLVFDYM---PHGSLATFLHAR-GP----ETPIDWPTRMKIIKGMTRGLLHLH 404
           LG   E   +  +M   P GSL+  L ++ GP    E  I + T     K +  GL +LH
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT-----KQILEGLKYLH 125
Query: 405 SNENIIHGNLTSSNVLLDDSTNA-KISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL-SK 462
            N+ I+H ++   NVL++  +   KISDFG S+ +              L Y APE+  K
Sbjct: 126 DNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT-LQYMAPEIIDK 183
Query: 463 LKKANTKT-DVYSLGVTILELLTGKSP----GEPLNGAELPQWVASIVKEEWTNEVFDLE 517
             +   K  D++SLG TI+E+ TGK P    GEP                     +F + 
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------------------QAAMFKVG 225
Query: 518 LMRDAPTIGDELLNTLK-LALHCVDPSPSAR 547
           + +  P I + +    K   L C +P P  R
Sbjct: 226 MFKVHPEIPESMSAEAKAFILKCFEPDPDKR 256

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 76
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 134
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 195 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 245
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 246 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 273

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 80
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 138
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 199 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 249
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 250 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 75
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 194 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 244
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 245 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 75
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 194 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 244
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 245 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 75
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 194 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 244
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 245 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V + M +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 80
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 138
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 199 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 249
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 250 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V + M +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 82  LEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 137
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 198 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 246
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 247 PA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 88
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 146
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 207 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 257
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 258 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 285

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 79
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 137
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 198 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 248
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 249 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 276

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 80
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 138
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 199 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 249
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 250 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 77
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 135
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 196 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 246
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 247 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 42/256 (16%)
Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNL 345
           E +G+  +G VYK  L      E    VA+K L++K     RE F  E  L  +++HPN+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 346 LALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPI-------------DWPTRMK 391
           + L    +  K + L ++F Y  HG L  FL  R P + +             + P  + 
Sbjct: 92  VCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
           ++  +  G+ +L S+ +++H +L + NVL+ D  N KISD GL R +             
Sbjct: 150 LVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL------------ 497
             + + APE     K +  +D++S GV + E+ + G  P    +  ++            
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC 268
Query: 498 ----PQWVASIVKEEW 509
               P WV +++ E W
Sbjct: 269 PDDCPAWVYALMIECW 284

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L+  S+    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       K   ++V + M +GSL +FL     +  +     + +++G+  G+ +L S+ 
Sbjct: 111 LEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL-SDM 166
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR--APELSKLKK 465
             +H +L + N+L++ +   K+SDFGLSR++              +  R  +PE    +K
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEVFDLELMRDA 522
             + +DV+S G+ + E+++           E P W  S   ++K    +E + L    D 
Sbjct: 227 FTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQDVIKA--VDEGYRLPPPMDC 275
Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P          +L L C     + RP+  Q+V  L+++
Sbjct: 276 PAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 77
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 135
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 196 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 246
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 247 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 16  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 74  TAP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 128
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXX-XXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ +                + + APE+ +++  N    
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 42/256 (16%)
Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNL 345
           E +G+  +G VYK  L      E    VA+K L++K     RE F  E  L  +++HPN+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 346 LALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPI-------------DWPTRMK 391
           + L    +  K + L ++F Y  HG L  FL  R P + +             + P  + 
Sbjct: 75  VCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
           ++  +  G+ +L S+ +++H +L + NVL+ D  N KISD GL R +             
Sbjct: 133 LVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL------------ 497
             + + APE     K +  +D++S GV + E+ + G  P    +  ++            
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC 251
Query: 498 ----PQWVASIVKEEW 509
               P WV +++ E W
Sbjct: 252 PDDCPAWVYALMIECW 267

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  KL++ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 83  GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 138
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 199 FSVASDVWSFGVVLYELFTYIEKSKSP 225

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 76
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE-KKNFI 134
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 195 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 245
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 246 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 273

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 27/269 (10%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 75
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 194 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 244
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLE 558
           +        C   +PS RP   ++ Q  E
Sbjct: 245 MRA------CWQWNPSDRPSFAEIHQAFE 267

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  KL++ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 84  GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 139
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 200 FSVASDVWSFGVVLYELFTYIEKSKSP 226

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 77
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  ++    + +   ++  + +L   +N I
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL-EKKNFI 135
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 196 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 246
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 247 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  KL++ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 85  GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 140
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 201 FSVASDVWSFGVVLYELFTYIEKSKSP 227

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 75
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 194 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 244
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 245 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  K L+ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 136
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  KL++ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 109 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 164
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSP 251

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  K L+ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 76  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 131
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 192 FSVASDVWSFGVVLYELFTYIEKSKSP 218

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 73
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G SP   ++    P  V  +++++     + +E     P    EL
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGID----PSQVYELLEKD-----YRMERPEGCPEKVYEL 242
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 243 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  K L+ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 77  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 132
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 193 FSVASDVWSFGVVLYELFTYIEKSKSP 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  K L+ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 133
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  K L+ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 82  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 137
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 198 FSVASDVWSFGVVLYELFTYIEKSKSP 224

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  K L+ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 133
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 75
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 194 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 244
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 245 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  KL++ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 78  GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 133
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 80
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 138
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G S   P  G +L Q V  +++++     + +E     P    EL
Sbjct: 199 DVWAFGVLLWEIATYGMS---PYPGIDLSQ-VYELLEKD-----YRMERPEGCPEKVYEL 249
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 250 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 21  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 79  TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 133
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXX-XXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ +                + + APE+ +++  N    
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  K L+ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 151
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 212 FSVASDVWSFGVVLYELFTYIEKSKSP 238

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  K L+ +Y+P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 151
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 212 FSVASDVWSFGVVLYELFTYIEKSKSP 238

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 21  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 79  TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 133
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXX-XXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ +                + + APE+ +++  N    
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 34/287 (11%)
Query: 286 DLLCATAE-IMGKSTYGTVYKATLE----DGSQVAVKRLREKITKGQR-EFESEVSLLGK 339
           D  C   E ++G   +G V    L+        VA+K L+   T+ QR +F  E S++G+
Sbjct: 41  DASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQ 100
Query: 340 IRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTR 398
             HPN++ L       K   ++V ++M +G+L  FL    G  T I     + +++G+  
Sbjct: 101 FDHPNVVHLEGVVTRGK-PVMIVIEFMENGALDAFLRKHDGQFTVI---QLVGMLRGIAA 156
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR-- 456
           G+ +L ++   +H +L + N+L++ +   K+SDFGLSR++              +  R  
Sbjct: 157 GMRYL-ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWT 215
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS---IVKEEWTNEV 513
           APE  + +K  + +DV+S G+ + E+++           E P W  S   ++K     E 
Sbjct: 216 APEAIQYRKFTSASDVWSYGIVMWEVMS---------YGERPYWDMSNQDVIKA--IEEG 264
Query: 514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           + L    D P          +L L C     + RP+  Q+V  L+++
Sbjct: 265 YRLPAPMDCPA------GLHQLMLDCWQKERAERPKFEQIVGILDKM 305

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 16  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 74  TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 128
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXX-XXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ +                + + APE+ +++  N    
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 18  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 76  TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 130
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXX-XXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ +                + + APE+ +++  N    
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 43  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 101 TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 155
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXX-XXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ +                + + APE+ +++  N    
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 102 TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 156
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXX-XXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ +                + + APE+ +++  N    
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 32/283 (11%)
Query: 294 IMGKSTYGTVYKATL--EDGS--QVAVKRLREKITKGQ--REFESEVSLLGKIRHPNL-- 345
           ++GK  +G+V +A L  EDGS  +VAVK L+  I       EF  E + + +  HP++  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 346 ---LALRAYYLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWP--TRMKIIKGMTRG 399
              ++LR+   G     +++  +M HG L  FL A R  E P + P  T ++ +  +  G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L S+ N IH +L + N +L +     ++DFGLSR +               + + A 
Sbjct: 150 MEYL-SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL 208
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E          +DV++ GVT+ E++T G++P   +  AE+             N +    
Sbjct: 209 ESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------------YNYLIGGN 256
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            ++  P   +E+ +   L   C    P  RP    +  +LE I
Sbjct: 257 RLKQPPECMEEVYD---LMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 123/267 (46%), Gaps = 23/267 (8%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY- 352
           +G   YG VY    +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L     
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           L P     +V +YMP+G+L  +L     E  +     + +   ++  + +L   +N IH 
Sbjct: 99  LEPPF--YIVTEYMPYGNLLDYLRECNREE-VTAVVLLYMATQISSAMEYL-EKKNFIHR 154
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           +L + N L+ ++   K++DFGLSRLM              + + APE       + K+DV
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 473 YSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLN 531
           ++ GV + E+ T G S   P  G +L Q V  ++++      + +E     P    EL+ 
Sbjct: 215 WAFGVLLWEIATYGMS---PYPGIDLSQ-VYDLLEKG-----YRMEQPEGCPPKVYELMR 265
Query: 532 TLKLALHCVDPSPSARPEVLQVVQQLE 558
                  C   SP+ RP   +  Q  E
Sbjct: 266 A------CWKWSPADRPSFAETHQAFE 286

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 73
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G SP   ++    P  V  +++++     + +E     P    EL
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGID----PSQVYELLEKD-----YRMERPEGCPEKVYEL 242
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 243 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 295 MGKSTYGTVYKAT---LED--GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V       L+D  G  VAVK+L+    +  R+FE E+ +L  ++H N++  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 350 --AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              Y  G +  KL++ +++P+GSL  +L     +  ID    ++    + +G+ +L   +
Sbjct: 81  GVCYSAGRRNLKLIM-EFLPYGSLREYLQKH--KERIDHIKLLQYTSQICKGMEYL-GTK 136
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKK 465
             IH +L + N+L+++    KI DFGL++++                + + APE     K
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 466 ANTKTDVYSLGVTILELLT----GKSP 488
            +  +DV+S GV + EL T     KSP
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 133/297 (44%), Gaps = 52/297 (17%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQV--AVKRLREKITKG-QREFESEVSLLGKI-RHPNLLA 347
           +++G+  +G V KA ++ DG ++  A+KR++E  +K   R+F  E+ +L K+  HPN++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 348 LRAYYLGP---KGEKLLVFDYMPHGSLATFLH-------------ARGPETPIDWPTRMK 391
           L    LG    +G   L  +Y PHG+L  FL              A    + +     + 
Sbjct: 88  L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX 451
               + RG+ +L S +  IH NL + N+L+ ++  AKI+DFGLSR               
Sbjct: 144 FAADVARGMDYL-SQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 200
Query: 452 XLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEE-- 508
            + + A E        T +DV+S GV + E+++ G +P   +  AEL + +    + E  
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 260
Query: 509 --WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
               +EV+D  LMR                  C    P  RP   Q++  L  +  E
Sbjct: 261 LNCDDEVYD--LMR-----------------QCWREKPYERPSFAQILVSLNRMLEE 298

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 16  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 74  TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 128
Query: 413 NLTSSNVLLDDSTNAKISDFGL-SRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL +                 + + APE+ +++  N    
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 36  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 94  TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 148
Query: 413 NLTSSNVLLDDSTNAKISDFGL-SRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL +                 + + APE+ +++  N    
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAE 496
           ++DVY+ G+ + EL+TG+ P   +N  +
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNINNRD 236

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRAYY 352
           +G  ++GTVYK        VAVK L       Q  + F++EV +L K RH N+L    Y 
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  +  +V  +    SL   LH    ET  +    + I +   +G+ +LH+ ++IIH 
Sbjct: 102 TKP--QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHR 156
Query: 413 NLTSSNVLLDDSTNAKISDFGL-SRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL +                 + + APE+ +++  N    
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 469 KTDVYSLGVTILELLTGKSPGEPLN 493
           ++DVY+ G+ + EL+TG+ P   +N
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 295 MGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G   +G VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L    L
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL----L 73
Query: 354 GPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           G    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L   +N I
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL-EKKNFI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+ ++   K++DFGLSRLM              + + APE     K + K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ GV + E+ T G SP   ++    P  V  +++++     + +E     P    EL
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGID----PSQVYELLEKD-----YRMERPEGCPEKVYEL 242
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +        C   +PS RP   ++ Q  E +  E
Sbjct: 243 MRA------CWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ KIRH  L+ L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKIRHEKLVQL--YAVV 82
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 140
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 201 FGILLTELTTKGRVP 215

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 140
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 201 FGILLTELTTKGRVP 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 12/212 (5%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 70
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRM--KIIKGMTRGLLHLHSNEN 408
            +  +    ++ +YM +GSL  FL    G +  I+    M  +I +GM           N
Sbjct: 71  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA-----FIEERN 125
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
            IH NL ++N+L+ D+ + KI+DFGL+RL+              + + APE         
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 185
Query: 469 KTDVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           K+DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 186 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 217

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 140
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 201 FGILLTELTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 140
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 201 FGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 75
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 133
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 193
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 194 FGILLTELTTKGRVP 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L TF+ A    T I  P     +  + +GL   HS+  
Sbjct: 71  LDV-IHTENKLYLVFEFL-HQDLKTFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 126
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 140
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 201 FGILLTELTTKGRVP 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 72
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 130
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 191 FGILLTELTTKGRVP 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 73
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 131
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 192 FGILLTELTTKGRVP 206

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 52/297 (17%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQV--AVKRLREKITKG-QREFESEVSLLGKI-RHPNLLA 347
           +++G+  +G V KA ++ DG ++  A+KR++E  +K   R+F  E+ +L K+  HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 348 LRAYYLGP---KGEKLLVFDYMPHGSLATFLH-------------ARGPETPIDWPTRMK 391
           L    LG    +G   L  +Y PHG+L  FL              A    + +     + 
Sbjct: 91  L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX 451
               + RG+ +L S +  IH +L + N+L+ ++  AKI+DFGLSR               
Sbjct: 147 FAADVARGMDYL-SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 452 XLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEE-- 508
            + + A E        T +DV+S GV + E+++ G +P   +  AEL + +    + E  
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 263
Query: 509 --WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
               +EV+D  LMR                  C    P  RP   Q++  L  +  E
Sbjct: 264 LNCDDEVYD--LMR-----------------QCWREKPYERPSFAQILVSLNRMLEE 301

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 71
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 129
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 189
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 190 FGILLTELTTKGRVP 204

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 52/297 (17%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQV--AVKRLREKITKG-QREFESEVSLLGKI-RHPNLLA 347
           +++G+  +G V KA ++ DG ++  A+KR++E  +K   R+F  E+ +L K+  HPN++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 348 LRAYYLGP---KGEKLLVFDYMPHGSLATFLH-------------ARGPETPIDWPTRMK 391
           L    LG    +G   L  +Y PHG+L  FL              A    + +     + 
Sbjct: 81  L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX 451
               + RG+ +L S +  IH +L + N+L+ ++  AKI+DFGLSR               
Sbjct: 137 FAADVARGMDYL-SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 193
Query: 452 XLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEE-- 508
            + + A E        T +DV+S GV + E+++ G +P   +  AEL + +    + E  
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 253
Query: 509 --WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
               +EV+D  LMR                  C    P  RP   Q++  L  +  E
Sbjct: 254 LNCDDEVYD--LMR-----------------QCWREKPYERPSFAQILVSLNRMLEE 291

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 140
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 201 FGILLTELTTKGRVP 215

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 39/283 (13%)
Query: 295 MGKSTYGTVYKATL-EDGSQVAVKRL--------REKITKGQREFESEVSLLGKIRHPNL 345
           +GK  +G V+K  L +D S VA+K L         E I K Q EF+ EV ++  + HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNI 85
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L      P     +V +++P G L   L  +    PI W  +++++  +  G+ ++ +
Sbjct: 86  VKLYGLMHNP---PRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 406 -NENIIHGNLTSSNVLL-----DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
            N  I+H +L S N+ L     +    AK++DFGLS+                  + APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPE 196
Query: 460 L--SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
              ++ +    K D YS  + +  +LTG+ P +  +  ++     ++++EE         
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPT---- 250
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +  D P     L N ++L   C    P  RP    +V++L E+
Sbjct: 251 IPEDCPP---RLRNVIEL---CWSGDPKKRPHFSYIVKELSEL 287

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE-RMNYVHRDL 306
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 367 FGILLTELTTKGRVP 381

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  G L  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 140
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 201 FGILLTELTTKGRVP 215

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE-RMNYVHRDL 306
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 367 FGILLTELTTKGRVP 381

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 331
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE-RMNYVHRDL 389
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 450 FGILLTELTTKGRVP 464

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVERM-NYVHRDL 137
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 198 FGILLTELTTKGRVP 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+ AT    ++VAVK ++   +     F +E +++  ++H  L+ L A  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA--VV 79
Query: 355 PKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K    ++ ++M  GSL  FL +  G + P+  P  +     +  G+  +    N IH +
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR-NYIHRD 136
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L ++N+L+  S   KI+DFGL+R++              + + APE         K+DV+
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 474 SLGVTILELLT-GKSP 488
           S G+ ++E++T G+ P
Sbjct: 197 SFGILLMEIVTYGRIP 212

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE-RMNYVHRDL 306
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 367 FGILLTELTTKGRVP 381

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 12/212 (5%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 69
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRM--KIIKGMTRGLLHLHSNEN 408
            +  +    ++ +YM +GSL  FL    G +  I+    M  +I +GM           N
Sbjct: 70  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA-----FIEERN 124
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
            IH +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 184
Query: 469 KTDVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           K+DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 185 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 216

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVERM-NYVHRDL 137
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 198 FGILLTELTTKGRVP 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 74
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 76
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 77  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 223

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 75
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 76  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 132
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 222

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 74
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L TF+ A    T I  P     +  + +GL   HS+  
Sbjct: 67  LDV-IHTENKLYLVFEHV-HQDLKTFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 122
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 83
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 84  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 140
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 230

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 80
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 81  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 137
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 227

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 74
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 79
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 80  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 136
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 226

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 82
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 83  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 139
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 229

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 80
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 81  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 137
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 227

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  G L  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHRDL 140
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 201 FGILLTELTTKGRVP 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+ AT    ++VAVK ++   +     F +E +++  ++H  L+ L A  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA--VV 252
Query: 355 PKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K    ++ ++M  GSL  FL +  G + P+  P  +     +  G+  +    N IH +
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR-NYIHRD 309
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L ++N+L+  S   KI+DFGL+R++              + + APE         K+DV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 474 SLGVTILELLT-GKSP 488
           S G+ ++E++T G+ P
Sbjct: 370 SFGILLMEIVTYGRIP 385

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 84
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 85  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 141
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 231

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     + ++VAVK L+   T   + F  E +L+  ++H  L+  R Y + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLV--RLYAVV 77
Query: 355 PKGEKLLVF-DYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
            + E + +  +YM  GSL  FL +  G +  +  P  +     +  G+ ++   +N IH 
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE-RKNYIHR 134
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           +L ++NVL+ +S   KI+DFGL+R++              + + APE         K+DV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 473 YSLGVTILELLT-GKSP 488
           +S G+ + E++T GK P
Sbjct: 195 WSFGILLYEIVTYGKIP 211

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 75  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 130
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 67  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 122
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 67  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 122
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 72  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 127
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V     +    VAVK ++E  +  + EF  E   + K+ HP L+  + Y + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLV--KFYGVC 72
Query: 355 PKGEKL-LVFDYMPHGSLATFL--HARGPETPIDWPTRM-KIIKGMTRGLLHLHSNENII 410
            K   + +V +Y+ +G L  +L  H +G E     P+++ ++   +  G+  L S++  I
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLE-----PSQLLEMCYDVCEGMAFLESHQ-FI 126
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L + N L+D     K+SDFG++R +              + + APE+    K ++K+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV++ G+ + E+ + GK P +    +E+      ++K    + ++   L  D        
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKVSQGHRLYRPHLASD-------- 232
Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
               ++   C    P  RP   Q++  +E +R
Sbjct: 233 -TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 129/296 (43%), Gaps = 47/296 (15%)
Query: 295 MGKSTYGTVYKAT------LEDGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLA 347
           +G+  +G V++A        E  + VAVK L+E+ +   Q +F+ E +L+ +  +PN++ 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPET---------------------PID 385
           L    +   G+ + L+F+YM +G L  FL +  P T                     P+ 
Sbjct: 115 LLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 386 WPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXX 444
              ++ I + +  G+ +L S    +H +L + N L+ ++   KI+DFGLSR +       
Sbjct: 173 CAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 445 XXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASI 504
                   + +  PE     +  T++DV++ GV + E+ +     +P  G         +
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL--QPYYG---------M 280
Query: 505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             EE    V D  ++        EL N ++L   C    P+ RP    + + L+ +
Sbjct: 281 AHEEVIYYVRDGNILACPENCPLELYNLMRL---CWSKLPADRPSFCSIHRILQRM 333

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 71  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 126
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 70  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 125
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 69  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 124
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 69  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 124
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 72  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 127
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 71  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 126
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 67  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 122
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 70  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 125
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 67  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 122
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 70  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 125
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-----EKITKGQREFESEVSLLGKIRHPNLLA 347
           E +G+ TYG VYKA    G  VA+KR+R     E I         E+SLL ++ HPN+++
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIVS 83
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHSN 406
           L       +    LVF++M    L   L     +T +   +++KI +  + RG+ H H +
Sbjct: 84  LIDVIHSERCLT-LVFEFM-EKDLKKVLDEN--KTGLQ-DSQIKIYLYQLLRGVAHCHQH 138
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKK 465
             I+H +L   N+L++     K++DFGL+R                L YRAP+ L   KK
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 466 ANTKTDVYSLGVTILELLTGK 486
            +T  D++S+G    E++TGK
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 75  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 130
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-----EKITKGQREFESEVSLLGKIRHPNLLA 347
           E +G+ TYG VYKA    G  VA+KR+R     E I         E+SLL ++ HPN+++
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIVS 83
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHSN 406
           L       +    LVF++M    L   L     +T +   +++KI +  + RG+ H H +
Sbjct: 84  LIDVIHSERCLT-LVFEFM-EKDLKKVLDEN--KTGLQ-DSQIKIYLYQLLRGVAHCHQH 138
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKK 465
             I+H +L   N+L++     K++DFGL+R                L YRAP+ L   KK
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 466 ANTKTDVYSLGVTILELLTGK 486
            +T  D++S+G    E++TGK
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 69  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 124
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 69  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 124
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLSFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 13/228 (5%)
Query: 277 DGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQ---VAVKRLREKITKGQ-REFES 332
           D  L    D+LL A  E +G   +G+V +       +   VA+K L++   K    E   
Sbjct: 327 DKKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           E  ++ ++ +P ++ L    +      +LV +    G L  FL  +  E P+      ++
Sbjct: 386 EAQIMHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAEL 441
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX 452
           +  ++ G+ +L   +N +H NL + NVLL +   AKISDFGLS+ +              
Sbjct: 442 LHQVSMGMKYL-EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 453 --LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             L + APE    +K ++++DV+S GVT+ E L+ G+ P + + G E+
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 295 MGKSTYGTVYKATL-EDGSQVAVKRL--------REKITKGQREFESEVSLLGKIRHPNL 345
           +GK  +G V+K  L +D S VA+K L         E I K Q EF+ EV ++  + HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNI 85
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L      P     +V +++P G L   L  +    PI W  +++++  +  G+ ++ +
Sbjct: 86  VKLYGLMHNP---PRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 406 -NENIIHGNLTSSNVLL-----DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
            N  I+H +L S N+ L     +    AK++DFG S+                  + APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWMAPE 196
Query: 460 L--SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
              ++ +    K D YS  + +  +LTG+ P +  +  ++     ++++EE         
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPT---- 250
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +  D P     L N ++L   C    P  RP    +V++L E+
Sbjct: 251 IPEDCPP---RLRNVIEL---CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 295 MGKSTYGTVYKATLE-----DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V     +      G+ VAVK+L+      QR+F+ E+ +L  +    ++  R
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               GP  + L LV +Y+P G L  FL        +D    +     + +G+ +L S   
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR-R 135
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKA 466
            +H +L + N+L++   + KI+DFGL++L+                + + APE       
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 467 NTKTDVYSLGVTILELLT 484
           + ++DV+S GV + EL T
Sbjct: 196 SRQSDVWSFGVVLYELFT 213

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 11/179 (6%)
Query: 311 GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAYYLGPKGEK--LLVFDYMP 367
           G  VAVK L+       R  ++ E+ +L  + H +++  +      +GEK   LV +Y+P
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGC-CEDQGEKSLQLVMEYVP 101
Query: 368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA 427
            GSL  +L    P   I     +   + +  G+ +LHS ++ IH NL + NVLLD+    
Sbjct: 102 LGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHS-QHYIHRNLAARNVLLDNDRLV 156
Query: 428 KISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           KI DFGL++ +                + + APE  K  K    +DV+S GVT+ ELLT
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 295 MGKSTYGTVYKATLE-----DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V     +      G+ VAVK+L+      QR+F+ E+ +L  +    ++  R
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               GP  + L LV +Y+P G L  FL        +D    +     + +G+ +L S   
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR-R 134
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKA 466
            +H +L + N+L++   + KI+DFGL++L+                + + APE       
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 467 NTKTDVYSLGVTILELLT 484
           + ++DV+S GV + EL T
Sbjct: 195 SRQSDVWSFGVVLYELFT 212

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 295 MGKSTYGTVYKATL-EDGSQVAVKRL--------REKITKGQREFESEVSLLGKIRHPNL 345
           +GK  +G V+K  L +D S VA+K L         E I K Q EF+ EV ++  + HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNI 85
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L      P     +V +++P G L   L  +    PI W  +++++  +  G+ ++ +
Sbjct: 86  VKLYGLMHNPPR---MVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 406 -NENIIHGNLTSSNVLL-----DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
            N  I+H +L S N+ L     +    AK++DF LS+                  + APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWMAPE 196
Query: 460 L--SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
              ++ +    K D YS  + +  +LTG+ P +  +  ++     ++++EE         
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPT---- 250
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +  D P     L N ++L   C    P  RP    +V++L E+
Sbjct: 251 IPEDCPP---RLRNVIEL---CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 295 MGKSTYGTVYKATLE-----DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V     +      G+ VAVK+L+      QR+F+ E+ +L  +    ++  R
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               GP  + L LV +Y+P G L  FL        +D    +     + +G+ +L S   
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR-R 147
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKA 466
            +H +L + N+L++   + KI+DFGL++L+                + + APE       
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 467 NTKTDVYSLGVTILELLT 484
           + ++DV+S GV + EL T
Sbjct: 208 SRQSDVWSFGVVLYELFT 225

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQ---REFESEVSLLGKIRHPNLLALR 349
           ++GK ++  VY+A ++  G +VA+K + +K        +  ++EV +  +++HP++L L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            Y+        LV +   +G +  +L  R    P         +  +  G+L+LHS+  I
Sbjct: 78  NYF-EDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH-GI 133
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H +LT SN+LL  + N KI+DFGL+  +                Y +PE++       +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP-NYISPEIATRSAHGLE 192
Query: 470 TDVYSLGVTILELLTGKSP 488
           +DV+SLG     LL G+ P
Sbjct: 193 SDVWSLGCMFYTLLIGRPP 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 295 MGKSTYGTVYKATLE-----DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           +GK  +G+V     +      G+ VAVK+L+      QR+F+ E+ +L  +    ++  R
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 350 AYYLGP-KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               GP + E  LV +Y+P G L  FL        +D    +     + +G+ +L S   
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR-R 131
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKA 466
            +H +L + N+L++   + KI+DFGL++L+                + + APE       
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 467 NTKTDVYSLGVTILELLT 484
           + ++DV+S GV + EL T
Sbjct: 192 SRQSDVWSFGVVLYELFT 209

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 295 MGKSTYG-TVYKATLEDGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+ ++G  +   + EDG Q  +K +      +K + E   EV++L  ++HPN++  R  
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG-----PETPIDWPTRMKIIKGMTRGLLHLHSN 406
           +    G   +V DY   G L   ++A+       +  +DW  ++ +       L H+H +
Sbjct: 92  F-EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL------ALKHVH-D 143
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
             I+H ++ S N+ L      ++ DFG++R++                Y +PE+ + K  
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY-YLSPEICENKPY 202
Query: 467 NTKTDVYSLGVTILELLTGKSPGE 490
           N K+D+++LG  + EL T K   E
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFE 226

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 13/228 (5%)
Query: 277 DGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQ---VAVKRLREKITKGQ-REFES 332
           D  L    D+LL A  E+ G   +G+V +       +   VA+K L++   K    E   
Sbjct: 1   DKKLFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 59
Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           E  ++ ++ +P ++ L    +      +LV +    G L  FL  +  E P+      ++
Sbjct: 60  EAQIMHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAEL 115
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX 452
           +  ++ G+ +L   +N +H +L + NVLL +   AKISDFGLS+ +              
Sbjct: 116 LHQVSMGMKYL-EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 453 --LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             L + APE    +K ++++DV+S GVT+ E L+ G+ P + + G E+
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 8/210 (3%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E +G    G V+       ++VAVK L++  +     F +E +L+ +++H  L+  R Y
Sbjct: 18  VERLGAGQAGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV--RLY 74
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +  +    ++ +YM +GSL  FL    G +  I+    + +   +  G+  +    N I
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER-NYI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQ 499
           DV+S G+ + E++T G+ P   +   E+ Q
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 6/195 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G+  +G V+  T    ++VA+K L+         F  E  ++ K+RH  L+ L  Y + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-NMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 249
Query: 355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL 414
            +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H +L
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE-RMNYVHRDL 307
Query: 415 TSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYS 474
            ++N+L+ ++   K++DFGL RL+              + + APE +   +   K+DV+S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 475 LGVTILELLT-GKSP 488
            G+ + EL T G+ P
Sbjct: 368 FGILLTELTTKGRVP 382

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 11/179 (6%)
Query: 311 GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAYYLGPKGEK--LLVFDYMP 367
           G  VAVK L+       R  ++ E+ +L  + H +++  +      +GEK   LV +Y+P
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGC-CEDQGEKSLQLVMEYVP 101
Query: 368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA 427
            GSL  +L    P   I     +   + +  G+ +LH+ ++ IH NL + NVLLD+    
Sbjct: 102 LGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRNLAARNVLLDNDRLV 156
Query: 428 KISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           KI DFGL++ +                + + APE  K  K    +DV+S GVT+ ELLT
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+     + ++VAVK L+   T   + F  E +L+  ++H  L+  R Y + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLV--RLYAVV 76
Query: 355 PKGEKLLVF-DYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
            K E + +  ++M  GSL  FL +  G +  +  P  +     +  G+ ++   +N IH 
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE-RKNYIHR 133
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           +L ++NVL+ +S   KI+DFGL+R++              + + APE         K++V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 473 YSLGVTILELLT-GKSP 488
           +S G+ + E++T GK P
Sbjct: 194 WSFGILLYEIVTYGKIP 210

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQR---EFESEVSLLGKIRHPNLLAL 348
           EI+G      V+ A  L D   VAVK LR  + +       F  E      + HP ++A+
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 349 RAYYLG----PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
             Y  G    P G    +V +Y+   +L   +H  GP TP      +++I    + L   
Sbjct: 78  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFS 132
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX--XLGYRAPELS 461
           H N  IIH ++  +N+L+  +   K+ DFG++R +                  Y +PE +
Sbjct: 133 HQN-GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           +    + ++DVYSLG  + E+LTG+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+ ++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 68  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+ ++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++ H  L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 67  LDV-IHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 122
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 116/255 (45%), Gaps = 39/255 (15%)
Query: 274 VHFDGPLMFTADDLLCAT-----AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQ 327
           ++F GP MF        +       ++GK ++G V     +  G + AVK + ++  K +
Sbjct: 14  LYFQGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 73
Query: 328 REFES---EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPI 384
            + ES   EV LL ++ HPN++ L  ++   KG   LV +    G L   + +R   + +
Sbjct: 74  TDKESLLREVQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEV 132
Query: 385 DWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---NAKISDFGLSRLMXXX 441
           D     +II+ +  G+ ++H N+ I+H +L   N+LL+  +   N +I DFGLS      
Sbjct: 133 D---AARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 188
Query: 442 XXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA------ 495
                        Y APE+      + K DV+S GV +  LL+G  P  P NGA      
Sbjct: 189 KKMKDKIGTAY--YIAPEVLH-GTYDEKCDVWSTGVILYILLSG-CP--PFNGANEYDIL 242
Query: 496 ----------ELPQW 500
                     ELPQW
Sbjct: 243 KKVEKGKYTFELPQW 257

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQR---EFESEVSLLGKIRHPNLLAL 348
           EI+G      V+ A  L D   VAVK LR  + +       F  E      + HP ++A+
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 349 RAYYLG----PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
             Y  G    P G    +V +Y+   +L   +H  GP TP      +++I    + L   
Sbjct: 78  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFS 132
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX--XLGYRAPELS 461
           H N  IIH ++  +N+++  +   K+ DFG++R +                  Y +PE +
Sbjct: 133 HQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           +    + ++DVYSLG  + E+LTG+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQR---EFESEVSLLGKIRHPNLLAL 348
           EI+G      V+ A  L D   VAVK LR  + +       F  E      + HP ++A+
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 349 RAYYLG----PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
             Y  G    P G    +V +Y+   +L   +H  GP TP      +++I    + L   
Sbjct: 78  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFS 132
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX--XLGYRAPELS 461
           H N  IIH ++  +N+++  +   K+ DFG++R +                  Y +PE +
Sbjct: 133 HQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           +    + ++DVYSLG  + E+LTG+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL-ALRA 350
           E +G+   GTVY A  +  G +VA++++  +    +    +E+ ++ + ++PN++  L +
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y +G   E  +V +Y+  GSL   +     ET +D      + +   + L  LHSN+ +I
Sbjct: 87  YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 139
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H N+ S N+LL    + K++DFG    +                + APE+   K    K 
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKV 198
Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E++G+  +G V KA       VA+K++  +  +  + F  E+  L ++ HPN++ L    
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE--NII 410
           L P     LV +Y   GSL   LH   P         M      ++G+ +LHS +   +I
Sbjct: 72  LNPV---CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 411 HGNLTSSNVLL-DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           H +L   N+LL    T  KI DFG +                   + APE+ +    + K
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 184
Query: 470 TDVYSLGVTILELLTGKSPGEPLNG 494
            DV+S G+ + E++T + P + + G
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGG 209

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E++G+  +G V KA       VA+K++  +  +  + F  E+  L ++ HPN++ L    
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE--NII 410
           L P     LV +Y   GSL   LH   P         M      ++G+ +LHS +   +I
Sbjct: 71  LNPV---CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 411 HGNLTSSNVLL-DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           H +L   N+LL    T  KI DFG +                   + APE+ +    + K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 470 TDVYSLGVTILELLTGKSPGEPLNG 494
            DV+S G+ + E++T + P + + G
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGG 208

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 125/273 (45%), Gaps = 28/273 (10%)
Query: 288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLRE--KITKGQREFESEVSLLGKIRHPNL 345
           L    E +GK ++G V+K       QV   ++ +  +      + + E+++L +     +
Sbjct: 24  LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 346 LALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
                 YL  KG KL ++ +Y+  GS    L A     P D      ++K + +GL +LH
Sbjct: 84  TKYYGSYL--KGSKLWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH 137
Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLK 464
           S E  IH ++ ++NVLL +  + K++DFG++  +                + APE+ +  
Sbjct: 138 S-EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQS 195
Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
             ++K D++SLG+T +EL    + GEP N    P  V  ++ +             + PT
Sbjct: 196 AYDSKADIWSLGITAIEL----AKGEPPNSDMHPMRVLFLIPK------------NNPPT 239
Query: 525 IGDELLNTLKLALH-CVDPSPSARPEVLQVVQQ 556
           +  +   + K  +  C++  PS RP   ++++ 
Sbjct: 240 LVGDFTKSFKEFIDACLNKDPSFRPTAKELLKH 272

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 29/277 (10%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALR 349
            E +G+  +G V+   L  D + VAVK  RE +    + +F  E  +L +  HPN++ L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 350 AYYLGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
              +G   +K    +V + +  G   TFL   G    +   T ++++     G+ +L S 
Sbjct: 178 ---IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLES- 231
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELSKLKK 465
           +  IH +L + N L+ +    KISDFG+SR                 + + APE     +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
            ++++DV+S G+ + E  + G SP   L+  +  ++V      E    +   EL  DA  
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV------EKGGRLPCPELCPDA-- 343
Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
                    +L   C    P  RP    + Q+L+ IR
Sbjct: 344 -------VFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 29/277 (10%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALR 349
            E +G+  +G V+   L  D + VAVK  RE +    + +F  E  +L +  HPN++ L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 350 AYYLGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
              +G   +K    +V + +  G   TFL   G    +   T ++++     G+ +L S 
Sbjct: 178 ---IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLES- 231
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELSKLKK 465
           +  IH +L + N L+ +    KISDFG+SR                 + + APE     +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
            ++++DV+S G+ + E  + G SP   L+  +  ++V      E    +   EL  DA  
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV------EKGGRLPCPELCPDA-- 343
Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
                    +L   C    P  RP    + Q+L+ IR
Sbjct: 344 -------VFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 292 AEIMGKSTYGTVYKAT-LEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNL 345
            +++G   +GTVYK   + DG  V    A+K LRE  + K  +E   E  ++  +  P +
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR------GPETPIDWPTRMKIIKGMTRG 399
             L    L    +  LV   MP+G L    H R      G +  ++W   M+I KGM+  
Sbjct: 82  SRLLGICLTSTVQ--LVTQLMPYGCLLD--HVRENRGRLGSQDLLNWC--MQIAKGMS-- 133
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAP 458
                 +  ++H +L + NVL+    + KI+DFGL+RL+               + + A 
Sbjct: 134 ---YLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
           E    ++   ++DV+S GVT+ EL+T G  P + +   E+P
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP 231

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 110/260 (42%), Gaps = 34/260 (13%)
Query: 295 MGKSTYGTVYKATLEDG-SQVAVKRLRE-------------KITKGQREFESEVSLLGKI 340
           +G   YG V     ++G S+ A+K +++              I K   E  +E+SLL  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            HPN++ L   +   K    LV ++   G L   +  R      D      I+K +  G+
Sbjct: 104 DHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---IMKQILSGI 159
Query: 401 LHLHSNENIIHGNLTSSNVLLDDST---NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRA 457
            +LH + NI+H ++   N+LL++     N KI DFGLS                   Y A
Sbjct: 160 CYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY--YIA 216
Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           PE+ K KK N K DV+S GV +  LL G  P    N  ++      I K E     FD  
Sbjct: 217 PEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI------IKKVEKGKYYFDF- 268
Query: 518 LMRDAPTIGDELLNTLKLAL 537
              D   I DE    +KL L
Sbjct: 269 --NDWKNISDEAKELIKLML 286

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++    L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 70  LDV-IHTENKLYLVFEFLSM-DLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 125
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++    L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 71  LDV-IHTENKLYLVFEFLSM-DLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 126
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++    L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 71  LDV-IHTENKLYLVFEFLSM-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 126
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL-ALRA 350
           E +G+   GTVY A  +  G +VA++++  +    +    +E+ ++ + ++PN++  L +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y +G   E  +V +Y+  GSL   +     ET +D      + +   + L  LHSN+ +I
Sbjct: 86  YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 138
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++ S N+LL    + K++DFG    +                + APE+   K    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKV 197
Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G+ +YG+VYKA   E G  VA+K++   +    +E   E+S++ +   P+++     
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           Y     +  +V +Y   GS++  +  R      D      I++   +GL +LH    I H
Sbjct: 93  YFK-NTDLWIVMEYCGAGSVSDIIRLRNKTLTED--EIATILQSTLKGLEYLHFMRKI-H 148
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
            ++ + N+LL+   +AK++DFG++  +                + APE+ +    N   D
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF-WMAPEVIQEIGYNCVAD 207
Query: 472 VYSLGVTILELLTGKSP 488
           ++SLG+T +E+  GK P
Sbjct: 208 IWSLGITAIEMAEGKPP 224

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL-ALRA 350
           E +G+   GTVY A  +  G +VA++++  +    +    +E+ ++ + ++PN++  L +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y +G   E  +V +Y+  GSL   +     ET +D      + +   + L  LHSN+ +I
Sbjct: 86  YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 138
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++ S N+LL    + K++DFG    +                + APE+   K    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPY-WMAPEVVTRKAYGPKV 197
Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++    L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 69  LDV-IHTENKLYLVFEFLSM-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 124
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 295 MGKSTYGTVYKATLED---GSQVAVKRL----REKITKGQREFESEVSLLGKIRHPNLLA 347
           +G     TVY A  ED     +VA+K +    REK    +R FE EV    ++ H N+++
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVS 75
Query: 348 L-------RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
           +         YYL        V +Y+   +L+ ++ + GP   +   T +     +  G+
Sbjct: 76  MIDVDEEDDCYYL--------VMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGI 124
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL 460
            H H +  I+H ++   N+L+D +   KI DFG+++ +              + Y +PE 
Sbjct: 125 KHAH-DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
           +K +  +  TD+YS+G+ + E+L G+ P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL-ALRA 350
           E +G+   GTVY A  +  G +VA++++  +    +    +E+ ++ + ++PN++  L +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y +G   E  +V +Y+  GSL   +     ET +D      + +   + L  LHSN+ +I
Sbjct: 86  YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 138
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++ S N+LL    + K++DFG    +                + APE+   K    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPY-WMAPEVVTRKAYGPKV 197
Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 33/270 (12%)
Query: 301 GTVYKATLEDGSQVAVK--RLREKITKGQREFESEVSLLGKIRHPNLL-ALRAYYLGPKG 357
           G ++K   + G+ + VK  ++R+  T+  R+F  E   L    HPN+L  L A    P  
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII-HGNLTS 416
              L+  +MP+GSL   LH  G    +D    +K    M RG+  LH+ E +I    L S
Sbjct: 83  HPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNS 141
Query: 417 SNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK---TDVY 473
            +V++D+   A+IS      +                 + APE  + K  +T     D++
Sbjct: 142 RSVMIDEDMTARIS------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMW 195
Query: 474 SLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA--PTIGDELLN 531
           S  V + EL+T + P   L+  E+   VA             LE +R    P I   +  
Sbjct: 196 SFAVLLWELVTREVPFADLSNMEIGMKVA-------------LEGLRPTIPPGISPHVSK 242
Query: 532 TLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
            +K+   C++  P+ RP+   +V  LE+++
Sbjct: 243 LMKI---CMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL-ALRA 350
           E +G+   GTVY A  +  G +VA++++  +    +    +E+ ++ + ++PN++  L +
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y +G   E  +V +Y+  GSL   +     ET +D      + +   + L  LHSN+ +I
Sbjct: 87  YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 139
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++ S N+LL    + K++DFG    +                + APE+   K    K 
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPY-WMAPEVVTRKAYGPKV 198
Query: 471 DVYSLGVTILELLTGKSP 488
           D++SLG+  +E++ G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 40/233 (17%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLL 346
           ++GK ++G V     K T   G + AVK + ++  K + + ES   EV LL ++ HPN++
Sbjct: 33  VLGKGSFGEVILCKDKIT---GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  ++   KG   LV +    G L   + +R   + +D     +II+ +  G+ ++H N
Sbjct: 90  KLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHKN 145
Query: 407 ENIIHGNLTSSNVLLDDST---NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           + I+H +L   N+LL+  +   N +I DFGLS                   Y APE+   
Sbjct: 146 K-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY--YIAPEVLH- 201
Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGA----------------ELPQW 500
              + K DV+S GV +  LL+G  P  P NGA                ELPQW
Sbjct: 202 GTYDEKCDVWSTGVILYILLSG-CP--PFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLAL 348
            E +G+ TYG VYKA  +  G  VA+K++R +  T+G       E+SLL ++ HPN++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  + +  LVF+++    L  F+ A    T I  P     +  + +GL   HS+  
Sbjct: 71  LDV-IHTENKLYLVFEHVDQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH-R 126
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKAN 467
           ++H +L   N+L++     K++DFGL+R                L YRAPE L   K  +
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 468 TKTDVYSLGVTILELLTGKS--PGE 490
           T  D++SLG    E++T ++  PG+
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 11/179 (6%)
Query: 311 GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAYYLGPKGEK--LLVFDYMP 367
           G  VAVK L+E      R  ++ E+ +L  + H +++  +      +GEK   LV +Y+P
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGC-CEDQGEKSVQLVMEYVP 96
Query: 368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA 427
            GSL  +L    P   +     +   + +  G+ +LH+ ++ IH  L + NVLLD+    
Sbjct: 97  LGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHA-QHYIHRALAARNVLLDNDRLV 151
Query: 428 KISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           KI DFGL++ +                + + APE  K  K    +DV+S GVT+ ELLT
Sbjct: 152 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 11/179 (6%)
Query: 311 GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAYYLGPKGEK--LLVFDYMP 367
           G  VAVK L+E      R  ++ E+ +L  + H +++  +      +GEK   LV +Y+P
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGC-CEDQGEKSVQLVMEYVP 95
Query: 368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA 427
            GSL  +L    P   +     +   + +  G+ +LH+ ++ IH  L + NVLLD+    
Sbjct: 96  LGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHA-QHYIHRALAARNVLLDNDRLV 150
Query: 428 KISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           KI DFGL++ +                + + APE  K  K    +DV+S GVT+ ELLT
Sbjct: 151 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V+ AT    ++VAVK ++   +     F +E +++  ++H  L+ L A  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA--VV 246
Query: 355 PKGEKLLVFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K    ++ ++M  GSL  FL +  G + P+  P  +     +  G+  +    N IH +
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE-QRNYIHRD 303
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L ++N+L+  S   KI+DFGL+R+               + + APE         K+DV+
Sbjct: 304 LRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 474 SLGVTILELLT-GKSPGEPLNGAEL 497
           S G+ ++E++T G+ P   ++  E+
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEV 378

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 26/287 (9%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-----------REFESEVSLLGKIRH 342
            +   +YG V      +G  VA+KR+   ++ G+           +    E+ LL    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 343 PNLLALR---AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           PN+L LR    ++  P   KL +   +    LA  +H    +  +  P  ++        
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH---DQRIVISPQHIQYFMYHILL 145
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
            LH+     ++H +L   N+LL D+ +  I DF L+R                  YRAPE
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRWYRAPE 203
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
           L    K  TK  D++S G  + E+   K+      G+     +  IV+   T ++ D+ +
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKA---LFRGSTFYNQLNKIVEVVGTPKIEDV-V 259
Query: 519 MRDAPTIGDELLNTLK--LALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           M  +P+  D L N+L    A       P+A P  L ++ ++ E  P+
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ 306

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 26/287 (9%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-----------REFESEVSLLGKIRH 342
            +   +YG V      +G  VA+KR+   ++ G+           +    E+ LL    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 343 PNLLALR---AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           PN+L LR    ++  P   KL +   +    LA  +H    +  +  P  ++        
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH---DQRIVISPQHIQYFMYHILL 145
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
            LH+     ++H +L   N+LL D+ +  I DF L+R                  YRAPE
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRWYRAPE 203
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
           L    K  TK  D++S G  + E+   K+      G+     +  IV+   T ++ D+ +
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKA---LFRGSTFYNQLNKIVEVVGTPKIEDV-V 259
Query: 519 MRDAPTIGDELLNTLK--LALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           M  +P+  D L N+L    A       P+A P  L ++ ++ E  P+
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ 306

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 40/233 (17%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLL 346
           ++GK ++G V     K T   G + AVK + ++  K + + ES   EV LL ++ HPN++
Sbjct: 56  VLGKGSFGEVILCKDKIT---GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 112
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  ++   KG   LV +    G L   + +R   + +D     +II+ +  G+ ++H N
Sbjct: 113 KLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHKN 168
Query: 407 ENIIHGNLTSSNVLLDDST---NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           + I+H +L   N+LL+  +   N +I DFGLS                   Y APE+   
Sbjct: 169 K-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY--YIAPEVLH- 224
Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGA----------------ELPQW 500
              + K DV+S GV +  LL+G  P  P NGA                ELPQW
Sbjct: 225 GTYDEKCDVWSTGVILYILLSG-CP--PFNGANEYDILKKVEKGKYTFELPQW 274

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           E +G   +G V +   +D G QVA+K+ R++++   RE +  E+ ++ K+ HPN+++ R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 351 Y-----YLGPKGEKLLVFDYMPHGSLATFLHARG-----PETPIDWPTRMKIIKGMTRGL 400
                  L P    LL  +Y   G L  +L+         E PI       ++  ++  L
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI-----RTLLSDISSAL 134
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNA---KISDFGLSRLMXXXXXXXXXXXXXXLGYRA 457
            +LH N  IIH +L   N++L         KI D G ++ +              L Y A
Sbjct: 135 RYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT--LQYLA 191
Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           PEL + KK     D +S G    E +TG  P  P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           E +G   +G V +   +D G QVA+K+ R++++   RE +  E+ ++ K+ HPN+++ R 
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 351 Y-----YLGPKGEKLLVFDYMPHGSLATFLHARG-----PETPIDWPTRMKIIKGMTRGL 400
                  L P    LL  +Y   G L  +L+         E PI       ++  ++  L
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI-----RTLLSDISSAL 135
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNA---KISDFGLSRLMXXXXXXXXXXXXXXLGYRA 457
            +LH N  IIH +L   N++L         KI D G ++ +              L Y A
Sbjct: 136 RYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT--LQYLA 192
Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           PEL + KK     D +S G    E +TG  P  P
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 40/233 (17%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLL 346
           ++GK ++G V     K T   G + AVK + ++  K + + ES   EV LL ++ HPN++
Sbjct: 57  VLGKGSFGEVILCKDKIT---GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 113
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  ++   KG   LV +    G L   + +R   + +D     +II+ +  G+ ++H N
Sbjct: 114 KLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHKN 169
Query: 407 ENIIHGNLTSSNVLLDDST---NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           + I+H +L   N+LL+  +   N +I DFGLS                   Y APE+   
Sbjct: 170 K-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY--YIAPEVLH- 225
Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGA----------------ELPQW 500
              + K DV+S GV +  LL+G  P  P NGA                ELPQW
Sbjct: 226 GTYDEKCDVWSTGVILYILLSG-CP--PFNGANEYDILKKVEKGKYTFELPQW 275

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 281 MFTADD---LLCATAEIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES---E 333
           +F  DD   L     EI G  ++G VY A  + +   VA+K++     +   +++    E
Sbjct: 46  LFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 104
Query: 334 VSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKII 393
           V  L K+RHPN +  R  YL  +    LV +Y   GS +  L     + P+       + 
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVT 160
Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXL 453
            G  +GL +LHS+ N+IH ++ + N+LL +    K+ DFG + +M               
Sbjct: 161 HGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY---- 215
Query: 454 GYRAPEL---SKLKKANTKTDVYSLGVTILELLTGKSP 488
            + APE+       + + K DV+SLG+T +EL   K P
Sbjct: 216 -WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 30/283 (10%)
Query: 278 GPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESE 333
           GP  +  +D        +GK  +G VY A  +    + A+K L + ++ K   + +   E
Sbjct: 1   GPRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 334 VSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKII 393
           V +   +RHPN+L L  Y+        L+ +Y P G++   L      +  D       I
Sbjct: 59  VEIQSHLRHPNILRLYGYF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYI 114
Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXL 453
             +   L + HS + +IH ++   N+LL  +   KI+DFG S                 L
Sbjct: 115 TELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTL 170
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV 513
            Y  PE+ + +  + K D++SLGV   E L GK P E     E  + ++ +   E+T   
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPD 227
Query: 514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
           F  E  RD       L++ L      +  +PS RP + +V++ 
Sbjct: 228 FVTEGARD-------LISRL------LKHNPSQRPMLREVLEH 257

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 30/283 (10%)
Query: 278 GPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESE 333
           GP  +  +D        +GK  +G VY A  +    + A+K L + ++ K   + +   E
Sbjct: 1   GPRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 334 VSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKII 393
           V +   +RHPN+L L  Y+        L+ +Y P G++   L      +  D       I
Sbjct: 59  VEIQSHLRHPNILRLYGYF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYI 114
Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXL 453
             +   L + HS + +IH ++   N+LL  +   KI+DFG S                 L
Sbjct: 115 TELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTL 170
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV 513
            Y  PE+ + +  + K D++SLGV   E L GK P E     E  + ++ +   E+T   
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPD 227
Query: 514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
           F  E  RD       L++ L      +  +PS RP + +V++ 
Sbjct: 228 FVTEGARD-------LISRL------LKHNPSQRPMLREVLEH 257

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 8/210 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V          VA+K ++E  +  + EF  E  ++  + H  L+ L  Y + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL--YGVC 68
Query: 355 PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K   + +  +YM +G L  +L  R           +++ K +   + +L S +  +H +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRD 125
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L++D    K+SDFGLSR +              + +  PE+    K ++K+D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVA 502
           + GV + E+ + GK P E    +E  + +A
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 215

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 281 MFTADD---LLCATAEIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES---E 333
           +F  DD   L     EI G  ++G VY A  + +   VA+K++     +   +++    E
Sbjct: 7   LFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 334 VSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKII 393
           V  L K+RHPN +  R  YL  +    LV +Y   GS +  L     + P+       + 
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVT 121
Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXL 453
            G  +GL +LHS+ N+IH ++ + N+LL +    K+ DFG + +M               
Sbjct: 122 HGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY---- 176
Query: 454 GYRAPEL---SKLKKANTKTDVYSLGVTILELLTGKSP 488
            + APE+       + + K DV+SLG+T +EL   K P
Sbjct: 177 -WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 8/210 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V          VA+K ++E  +  + EF  E  ++  + H  L+ L  Y + 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL--YGVC 72
Query: 355 PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K   + +  +YM +G L  +L  R           +++ K +   + +L S +  +H +
Sbjct: 73  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRD 129
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L++D    K+SDFGLSR +              + +  PE+    K ++K+D++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVA 502
           + GV + E+ + GK P E    +E  + +A
Sbjct: 190 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 219

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 8/210 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V          VA+K ++E  +  + EF  E  ++  + H  L+ L  Y + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL--YGVC 88
Query: 355 PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K   + +  +YM +G L  +L  R           +++ K +   + +L S +  +H +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRD 145
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L++D    K+SDFGLSR +              + +  PE+    K ++K+D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVA 502
           + GV + E+ + GK P E    +E  + +A
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 8/210 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V          VA+K ++E  +  + EF  E  ++  + H  L+ L  Y + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL--YGVC 88
Query: 355 PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K   + +  +YM +G L  +L  R           +++ K +   + +L S +  +H +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRD 145
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L++D    K+SDFGLSR +              + +  PE+    K ++K+D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVA 502
           + GV + E+ + GK P E    +E  + +A
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 97/211 (45%), Gaps = 8/211 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V          VA+K ++E  +  + EF  E  ++  + H  L+ L  Y + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL--YGVC 73
Query: 355 PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K   + +  +YM +G L  +L  R           +++ K +   + +L S +  +H +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRD 130
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L++D    K+SDFGLSR +              + +  PE+    K ++K+D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVAS 503
           + GV + E+ + GK P E    +E  + +A 
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 311 GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAYYLGPKGEKL-LVFDYMPH 368
           G  VAVK L+       R  ++ E+ +L  + H +++  +          L LV +Y+P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAK 428
           GSL  +L    P   I     +   + +  G+ +LH+ ++ IH +L + NVLLD+    K
Sbjct: 120 GSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDRLVK 174
Query: 429 ISDFGLSRLMXXXXXXXXXXX--XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           I DFGL++ +                + + APE  K  K    +DV+S GVT+ ELLT
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           E++G      V  A       +VA+KR+  EK      E   E+  + +  HPN+++   
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLH---ARGPETP--IDWPTRMKIIKGMTRGLLHLHS 405
            ++  K E  LV   +  GS+   +    A+G      +D  T   I++ +  GL +LH 
Sbjct: 81  SFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXL----GYRAPE-L 460
           N  I H ++ + N+LL +  + +I+DFG+S  +                    + APE +
Sbjct: 140 NGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
            +++  + K D++S G+T +EL TG +P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           E++G      V  A       +VA+KR+  EK      E   E+  + +  HPN+++   
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLH---ARGPETP--IDWPTRMKIIKGMTRGLLHLHS 405
            ++  K E  LV   +  GS+   +    A+G      +D  T   I++ +  GL +LH 
Sbjct: 76  SFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 134
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXL----GYRAPE-L 460
           N  I H ++ + N+LL +  + +I+DFG+S  +                    + APE +
Sbjct: 135 NGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 193
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
            +++  + K D++S G+T +EL TG +P
Sbjct: 194 EQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 8/210 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V          VA+K ++E  +  + EF  E  ++  + H  L+ L  Y + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL--YGVC 73
Query: 355 PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K   + +  +YM +G L  +L  R           +++ K +   + +L S +  +H +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRD 130
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L++D    K+SDFGLSR +              + +  PE+    K ++K+D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVA 502
           + GV + E+ + GK P E    +E  + +A
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 220

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G +   L      +  D       I  +   L + HS + +I
Sbjct: 81  YF-HDATRVYLILEYAPRGEVYKELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 135
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 192
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 242
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 243 SRL------LKHNPSQRPMLREVLEH 262

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 8/210 (3%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG 354
           +G   +G V          VA+K ++E  +  + EF  E  ++  + H  L+ L  Y + 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL--YGVC 79
Query: 355 PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            K   + +  +YM +G L  +L  R           +++ K +   + +L S +  +H +
Sbjct: 80  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRD 136
Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVY 473
           L + N L++D    K+SDFGLSR +              + +  PE+    K ++K+D++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 474 SLGVTILELLT-GKSPGEPLNGAELPQWVA 502
           + GV + E+ + GK P E    +E  + +A
Sbjct: 197 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 226

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQR---EFESEVSLLGKIRHPNLLAL 348
           EI+G      V+ A  L     VAVK LR  + +       F  E      + HP ++A+
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 349 RAYYLG----PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
             Y  G    P G    +V +Y+   +L   +H  GP TP      +++I    + L   
Sbjct: 78  --YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFS 132
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX--XLGYRAPELS 461
           H N  IIH ++  +N+++  +   K+ DFG++R +                  Y +PE +
Sbjct: 133 HQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           +    + ++DVYSLG  + E+LTG+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 115/255 (45%), Gaps = 47/255 (18%)
Query: 275 HFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQV-AVKRLREKI-TKGQREFES 332
           H+D    FTA+DL     EI G+  YG+V K   +   Q+ AVKR+R  +  K Q++   
Sbjct: 16  HWD----FTAEDLK-DLGEI-GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69
Query: 333 EVSLLGKIRHPNLLALRAYY--LGPKGEKLLVFDYMP------HGSLATFLHARGPETPI 384
           ++ ++  +R  +   +  +Y  L  +G+  +  + M       +  + + L    PE  +
Sbjct: 70  DLDVV--MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127
Query: 385 DWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXX 444
                 KI     + L HL  N  IIH ++  SN+LLD S N K+ DFG+S  +      
Sbjct: 128 G-----KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182
Query: 445 XXXXXXXXLGYRAPEL----SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQW 500
                     Y APE     +  +  + ++DV+SLG+T+ EL TG+ P         P+W
Sbjct: 183 TRDAGCRP--YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--------YPKW 232
Query: 501 VASIVKEEWTNEVFD 515
                     N VFD
Sbjct: 233 ----------NSVFD 237

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            E++G  TYG VYK       Q+A  ++ +     + E + E+++L K  H   +A   Y
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA--TY 86
Query: 352 Y--------LGPKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLH 402
           Y         G   +  LV ++   GS+   + + +G     +W     I + + RGL H
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSH 144
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSK 462
           LH ++ +IH ++   NVLL ++   K+ DFG+S  +                + APE+  
Sbjct: 145 LHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVIA 202
Query: 463 LKK-----ANTKTDVYSLGVTILELLTGKSP 488
             +      + K+D++SLG+T +E+  G  P
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            +++G  ++G V++A L +  +VA+K    K+ + +R    E+ ++  ++HPN++ L+A+
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 352 YL--GPKGEKL---LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK----GMTRGLLH 402
           +   G K +++   LV +Y+P     T   A      +     M +IK     + R L +
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNA-KISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL- 460
           +HS   I H ++   N+LLD  +   K+ DFG ++++                YRAPEL 
Sbjct: 157 IHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--YRAPELI 213
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKS--PGE 490
                  T  D++S G  + EL+ G+   PGE
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 102 YFHD-ATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 156
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 213
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 214 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 263
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 264 SRL------LKHNPSQRPMLREVLEH 283

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 79  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 190
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 240
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 241 SRL------LKHNPSQRPMLREVLEH 260

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G +   L      +  D       I  +   L + HS + +I
Sbjct: 81  YF-HDATRVYLILEYAPRGEVYKELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 135
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKV 192
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 242
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 243 SRL------LKHNPSQRPMLREVLEH 262

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 93  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 148 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 204
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 205 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 254
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 255 SRL------LKHNPSQRPMLREVLEH 274

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 26/267 (9%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLRE---KITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G+  +  VY+A  L DG  VA+K+++       K + +   E+ LL ++ HPN++   A
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++    E  +V +    G L+  + H +  +  I   T  K    +   L H+HS   +
Sbjct: 100 SFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-V 157
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  +NV +  +   K+ D GL R                  Y +PE       N K
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGYNFK 216
Query: 470 TDVYSLGVTILELLTGKSP--GEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
           +D++SLG  + E+   +SP  G+ +N       + S+ K+        +E     P   D
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMN-------LYSLCKK--------IEQCDYPPLPSD 261
Query: 528 ELLNTLK-LALHCVDPSPSARPEVLQV 553
                L+ L   C++P P  RP+V  V
Sbjct: 262 HYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 81  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 135
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 192
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 242
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 243 SRL------LKHNPSQRPMLREVLEH 262

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQR---EFESEVSLLGKIRHPNLLAL 348
           EI+G      V+ A  L     VAVK LR  + +       F  E      + HP ++A+
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 349 RAYYLG----PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
             Y  G    P G    +V +Y+   +L   +H  GP TP      +++I    + L   
Sbjct: 78  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFS 132
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX--XLGYRAPELS 461
           H N  IIH ++  +N+++  +   K+ DFG++R +                  Y +PE +
Sbjct: 133 HQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           +    + ++DVYSLG  + E+LTG+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQ----VAVKRLREKITKGQREFES---EVSLLGKIRHPN 344
           +++G   +GTV+K   + +G      V +K + +K   G++ F++    +  +G + H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAH 76
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLH----ARGPETPIDWPTRMKIIKGMTRGL 400
           ++ L    L P     LV  Y+P GSL   +     A GP+  ++W   ++I KGM    
Sbjct: 77  IVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW--GVQIAKGM---- 128
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM-XXXXXXXXXXXXXXLGYRAPE 459
            +      ++H NL + NVLL   +  +++DFG++ L+               + + A E
Sbjct: 129 -YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
                K   ++DV+S GVT+ EL+T G  P   L  AE+P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 18/217 (8%)
Query: 288 LCATAEIMGKSTYGTVYKATL--EDGS--QVAVKRLREKITKGQREFE---SEVSLLGKI 340
           L    +I+G+  +G+V +  L  EDG+  +VAVK ++      QRE E   SE + +   
Sbjct: 35  LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD-NSSQREIEEFLSEAACMKDF 93
Query: 341 RHPNLLALRAYYLGPKGE----KLLVFDYMPHGSLATFL-HARGPETPIDWP--TRMKII 393
            HPN++ L    +    +     +++  +M +G L T+L ++R    P   P  T +K +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMXXXXXXXXXXXXXX 452
             +  G+ +L SN N +H +L + N +L D     ++DFGLS ++               
Sbjct: 154 VDIALGMEYL-SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSP 488
           + + A E    +   +K+DV++ GVT+ E+ T G +P
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 77  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKV 188
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 238
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 239 SRL------LKHNPSQRPMLREVLEH 258

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 79  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 240
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 241 SRL------LKHNPSQRPMLREVLEH 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 102 YFHD-ATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 156
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKV 213
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 214 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 263
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 264 SRL------LKHNPSQRPMLREVLEH 283

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQ----VAVKRLREKITKGQREFES---EVSLLGKIRHPN 344
           +++G   +GTV+K   + +G      V +K + +K   G++ F++    +  +G + H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAH 94
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLH----ARGPETPIDWPTRMKIIKGMTRGL 400
           ++ L    L P     LV  Y+P GSL   +     A GP+  ++W   ++I KGM    
Sbjct: 95  IVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW--GVQIAKGM---- 146
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM-XXXXXXXXXXXXXXLGYRAPE 459
            +      ++H NL + NVLL   +  +++DFG++ L+               + + A E
Sbjct: 147 -YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 460 LSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
                K   ++DV+S GVT+ EL+T G  P   L  AE+P
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 245

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 77  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV 188
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 238
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 239 SRL------LKHNPSQRPMLREVLEH 258

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 77  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 131
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 238
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 239 SRL------LKHNPSQRPMLREVLEH 258

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 78  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 132
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 133 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 189
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 190 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 239
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 240 SRL------LKHNPSQRPMLREVLEH 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 81  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 135
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 192
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 242
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 243 SRL------LKHNPSQRPMLREVLEH 262

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 76  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 130
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 187
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 237
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 238 SRL------LKHNPSQRPMLREVLEH 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 76  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 130
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 187
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 237
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 238 SRL------LKHNPSQRPMLREVLEH 257

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 26/287 (9%)
Query: 277 DGPLMFTADDL--LCATAEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQR-EFES 332
           +GP    A+D+  +    +++G   +  V  A  +   + VA+K + +K  +G+    E+
Sbjct: 6   EGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN 65
Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           E+++L KI+HPN++AL   Y    G   L+   +  G L   +  +G  T  D     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIY-ESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRL 121
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVL---LDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           I  +   + +LH +  I+H +L   N+L   LD+ +   ISDFGLS++            
Sbjct: 122 IFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW 509
               GY APE+   K  +   D +S+GV    LL G  P    N A+L            
Sbjct: 181 TP--GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------------ 226
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
             ++   E   D+P   D   +      H ++  P  R    Q +Q 
Sbjct: 227 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 81  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 135
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE  + +  + K 
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKV 192
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 242
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 243 SRL------LKHNPSQRPXLREVLEH 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 80  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 134
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 192 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 241
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 242 SRL------LKHNPSQRPMLREVLEH 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 76  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 130
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 187
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 237
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 238 SRL------LKHNPSQRPMLREVLEH 257

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQR---EFESEVSLLGKIRHPNLLAL 348
           EI+G      V+ A  L     VAVK LR  + +       F  E      + HP ++A+
Sbjct: 35  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 94
Query: 349 RAYYLG----PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
             Y  G    P G    +V +Y+   +L   +H  GP TP      +++I    + L   
Sbjct: 95  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFS 149
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX--XLGYRAPELS 461
           H N  IIH ++  +N+++  +   K+ DFG++R +                  Y +PE +
Sbjct: 150 HQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
           +    + ++DVYSLG  + E+LTG+ P
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 108/233 (46%), Gaps = 40/233 (17%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLL 346
           ++GK ++G V     K T   G + AVK + ++  K + + ES   EV LL ++ HPN+ 
Sbjct: 33  VLGKGSFGEVILCKDKIT---GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIX 89
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  ++   KG   LV +    G L   + +R   + +D     +II+ +  G+ + H N
Sbjct: 90  KLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYXHKN 145
Query: 407 ENIIHGNLTSSNVLLDDST---NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           + I+H +L   N+LL+  +   N +I DFGLS                   Y APE+   
Sbjct: 146 K-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAY--YIAPEVLH- 201
Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGA----------------ELPQW 500
              + K DV+S GV +  LL+G  P  P NGA                ELPQW
Sbjct: 202 GTYDEKCDVWSTGVILYILLSG-CP--PFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 76  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 130
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKV 187
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 237
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 238 SRL------LKHNPSQRPMLREVLEH 257

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  ++   + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 76  YF-HDSTRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKK-VI 130
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 187
Query: 471 DVYSLGVTILELLTGKSPGE 490
           D++SLGV   E L GK P E
Sbjct: 188 DLWSLGVLCYEFLVGKPPFE 207

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 117/277 (42%), Gaps = 32/277 (11%)
Query: 282 FTADDLLCATAEIMGKSTYGTVYKATLEDGSQ--VAVKRL-REKITKG--QREFESEVSL 336
           FT DD        +GK  +G VY A  E  S   VA+K L + +I K   + +   E+ +
Sbjct: 20  FTIDDF--EIGRPLGKGKFGNVYLAR-EKKSHFIVALKVLFKSQIEKEGVEHQLRREIEI 76
Query: 337 LGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGM 396
              + HPN+L L  Y+   +    L+ +Y P G L   L         D      I++ +
Sbjct: 77  QAHLHHPNILRLYNYFYD-RRRIYLILEYAPRGELYKELQK---SCTFDEQRTATIMEEL 132
Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR 456
              L++ H  + +IH ++   N+LL      KI+DFG S                 L Y 
Sbjct: 133 ADALMYCHGKK-VIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYL 188
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL 516
            PE+ + +  N K D++ +GV   ELL G  P E  +  E  + +  +          DL
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV----------DL 238
Query: 517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQV 553
           +     PT   +L++  KL  H    +PS R  + QV
Sbjct: 239 KFPASVPTGAQDLIS--KLLRH----NPSERLPLAQV 269

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 75  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 129
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 186
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 187 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 236
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 237 SRL------LKHNPSQRPMLREVLEH 256

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 79  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 240
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 241 SRL------LKHNPSQRPMLREVLEH 260

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 81  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 131
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 82  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 132
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 79  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKV 190
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 240
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 241 SRL------LKHNPSQRPMLREVLEH 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 76  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 130
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 187
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 237
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 238 SRL------LKHNPSQRPMLREVLEH 257

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 84  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 134
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 231

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP--AFVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 288 LCATAEIMGKSTYGTVYKATLEDGSQ--VAVKRLR-EKITKGQREFESEVSLLGKIRHPN 344
           L    E +GK ++G V+K  +++ +Q  VA+K +  E+      + + E+++L +   P 
Sbjct: 23  LFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 345 LLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           +      YL  K  KL ++ +Y+  GS    L       P+D      I++ + +GL +L
Sbjct: 82  VTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYL 135
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS E  IH ++ ++NVLL +    K++DFG++  +                + APE+ K 
Sbjct: 136 HS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQ 193
Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLN 493
              ++K D++SLG+T +EL  G+ P   L+
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELH 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 85  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 135
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 232

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 83  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 133
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 79  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 190
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 240
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 241 SRL------LKHNPSQRPMLREVLEH 260

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 284 ADDLLCATAEIMGKSTYGTVYKA-TLEDGSQ-VAVKRLREKITKGQREFES--EVSLLGK 339
           AD      AEI G+  YG V+KA  L++G + VA+KR+R +  +      +  EV++L  
Sbjct: 9   ADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 340 IR---HPNLLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           +    HPN++ L       + ++     LVF+++    L T+L  + PE  +   T   +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIKDM 125
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX 452
           +  + RGL  LHS+  ++H +L   N+L+  S   K++DFGL+R+               
Sbjct: 126 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVT 182
Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
           L YRAPE+       T  D++S+G    E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++G+  +G V+    KAT +  +   + + R K  KG +    E  +L K+ H   +   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNEN 408
           AY    K +  LV   M  G +   ++    + P    P  +     +  GL HLH   N
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-N 309
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   NVLLDD  N +ISD GL+  +               G+ APEL   ++ + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP-GFMAPELLLGEEYDF 368
Query: 469 KTDVYSLGVTILELLTGKSP----GEPLNGAELPQWV 501
             D ++LGVT+ E++  + P    GE +   EL Q V
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++G+  +G V+    KAT +  +   + + R K  KG +    E  +L K+ H   +   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNEN 408
           AY    K +  LV   M  G +   ++    + P    P  +     +  GL HLH   N
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-N 309
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   NVLLDD  N +ISD GL+  +               G+ APEL   ++ + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP-GFMAPELLLGEEYDF 368
Query: 469 KTDVYSLGVTILELLTGKSP----GEPLNGAELPQWV 501
             D ++LGVT+ E++  + P    GE +   EL Q V
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++G+  +G V+    KAT +  +   + + R K  KG +    E  +L K+ H   +   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNEN 408
           AY    K +  LV   M  G +   ++    + P    P  +     +  GL HLH   N
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-N 309
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   NVLLDD  N +ISD GL+  +               G+ APEL   ++ + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP-GFMAPELLLGEEYDF 368
Query: 469 KTDVYSLGVTILELLTGKSP----GEPLNGAELPQWV 501
             D ++LGVT+ E++  + P    GE +   EL Q V
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++G+  +G V+    KAT +  +   + + R K  KG +    E  +L K+ H   +   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNEN 408
           AY    K +  LV   M  G +   ++    + P    P  +     +  GL HLH   N
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-N 309
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   NVLLDD  N +ISD GL+  +               G+ APEL   ++ + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP-GFMAPELLLGEEYDF 368
Query: 469 KTDVYSLGVTILELLTGKSP----GEPLNGAELPQWV 501
             D ++LGVT+ E++  + P    GE +   EL Q V
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 294 IMGKSTYGTVYKATLED-GSQVAVKRLRE----KITKGQREFESEVSLLGKIRHPNLLAL 348
           ++G+ +YG V K   +D G  VA+K+  E    K+ K  +    E+ LL ++RH NL+ L
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK--KIAMREIKLLKQLRHENLVNL 89
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATF-LHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
                  K    LVF+++ H  L    L   G +  +      +II G+  G  H H   
Sbjct: 90  LEV-CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GFCHSH--- 143
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL----SKL 463
           NIIH ++   N+L+  S   K+ DFG +R +                YRAPEL     K 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW-YRAPELLVGDVKY 202
Query: 464 KKANTKTDVYSLGVTILELLTGK--SPGE 490
            KA    DV+++G  + E+  G+   PG+
Sbjct: 203 GKA---VDVWAIGCLVTEMFMGEPLFPGD 228

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 13/210 (6%)
Query: 288 LCATAEIMGKSTYGTVYKATLEDGSQ--VAVKRLR-EKITKGQREFESEVSLLGKIRHPN 344
           L    E +GK ++G V+K  +++ +Q  VA+K +  E+      + + E+++L +   P 
Sbjct: 28  LFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 345 LLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           +      YL  K  KL ++ +Y+  GS    L       P+D      I++ + +GL +L
Sbjct: 87  VTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYL 140
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS E  IH ++ ++NVLL +    K++DFG++  +                + APE+ K 
Sbjct: 141 HS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQ 198
Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLN 493
              ++K D++SLG+T +EL  G+ P   L+
Sbjct: 199 SAYDSKADIWSLGITAIELARGEPPHSELH 228

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 82  RLLGICLTSTVQ--LIMQLMPFGXLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 132
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 229

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 74  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 129
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 130 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 186
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 73  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 127
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 184
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 185 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 234
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 235 SRL------LKHNPSQRPMLREVLEH 254

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 286 DLLCATAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLG 338
           D    T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 339 KIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR 398
           +I+HPN++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  
Sbjct: 70  EIQHPNVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILN 125
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLG 454
           G+ +LHS + I H +L   N++L D        KI DFGL+  +                
Sbjct: 126 GVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE-- 182
Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           + APE+   +    + D++S+GV    LL+G SP
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 13/210 (6%)
Query: 288 LCATAEIMGKSTYGTVYKATLEDGSQ--VAVKRLR-EKITKGQREFESEVSLLGKIRHPN 344
           L    E +GK ++G V+K  +++ +Q  VA+K +  E+      + + E+++L +   P 
Sbjct: 8   LFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 345 LLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           +      YL  K  KL ++ +Y+  GS    L       P+D      I++ + +GL +L
Sbjct: 67  VTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYL 120
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS E  IH ++ ++NVLL +    K++DFG++  +                + APE+ K 
Sbjct: 121 HS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQ 178
Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLN 493
              ++K D++SLG+T +EL  G+ P   L+
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELH 208

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 288 LCATAEIMGKSTYGTVYKATLEDGSQ--VAVKRLR-EKITKGQREFESEVSLLGKIRHPN 344
           L    E +GK ++G V+K  +++ +Q  VA+K +  E+      + + E+++L +   P 
Sbjct: 8   LFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 345 LLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           +      YL  K  KL ++ +Y+  GS    L       P+D      I++ + +GL +L
Sbjct: 67  VTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYL 120
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS E  IH ++ ++NVLL +    K++DFG++  +                + APE+ K 
Sbjct: 121 HS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQ 178
Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLN 493
              ++K D++SLG+T +EL  G+ P   L+
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELH 208

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 74  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 129
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 130 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 186
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 284 ADDLLCATAEIMGKSTYGTVYKA-TLEDGSQ-VAVKRLREKITKGQREFES--EVSLLGK 339
           AD      AEI G+  YG V+KA  L++G + VA+KR+R +  +      +  EV++L  
Sbjct: 9   ADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 340 IR---HPNLLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           +    HPN++ L       + ++     LVF+++    L T+L  + PE  +   T   +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIKDM 125
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX 452
           +  + RGL  LHS+  ++H +L   N+L+  S   K++DFGL+R+               
Sbjct: 126 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVT 182
Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
           L YRAPE+       T  D++S+G    E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 284 ADDLLCATAEIMGKSTYGTVYKAT-LEDGSQ-VAVKRLREKITKGQREFES--EVSLLGK 339
           AD      AEI G+  YG V+KA  L++G + VA+KR+R +  +      +  EV++L  
Sbjct: 9   ADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 340 IR---HPNLLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           +    HPN++ L       + ++     LVF+++    L T+L  + PE  +   T   +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIKDM 125
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX 452
           +  + RGL  LHS+  ++H +L   N+L+  S   K++DFGL+R+               
Sbjct: 126 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVT 182
Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
           L YRAPE+       T  D++S+G    E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 26/287 (9%)
Query: 277 DGPLMFTADDL--LCATAEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQR-EFES 332
           +GP    A+D+  +    +++G   +  V  A  +   + VA+K + ++  +G+    E+
Sbjct: 6   EGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           E+++L KI+HPN++AL   Y    G   L+   +  G L   +  +G  T  D     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIY-ESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRL 121
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVL---LDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           I  +   + +LH +  I+H +L   N+L   LD+ +   ISDFGLS++            
Sbjct: 122 IFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW 509
               GY APE+   K  +   D +S+GV    LL G  P    N A+L +          
Sbjct: 181 TP--GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE---------- 228
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
             ++   E   D+P   D   +      H ++  P  R    Q +Q 
Sbjct: 229 --QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 88  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 138
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 235

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 78  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 132
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI++FG S                 L Y  PE+ + +  + K 
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 189
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 190 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 239
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 240 SRL------LKHNPSQRPMLREVLEH 259

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 75  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 125
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 222

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 87  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 137
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 138 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 234

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 81  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 131
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 26/287 (9%)
Query: 277 DGPLMFTADDL--LCATAEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQR-EFES 332
           +GP    A+D+  +    +++G   +  V  A  +   + VA+K + ++  +G+    E+
Sbjct: 6   EGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           E+++L KI+HPN++AL   Y    G   L+   +  G L   +  +G  T  D     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIY-ESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRL 121
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVL---LDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           I  +   + +LH +  I+H +L   N+L   LD+ +   ISDFGLS++            
Sbjct: 122 IFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW 509
               GY APE+   K  +   D +S+GV    LL G  P    N A+L      I+K E+
Sbjct: 181 TP--GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FEQILKAEY 235
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
                      D+P   D   +      H ++  P  R    Q +Q 
Sbjct: 236 E---------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 81  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 131
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 84  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 134
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 231

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 26/287 (9%)
Query: 277 DGPLMFTADDL--LCATAEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQR-EFES 332
           +GP    A+D+  +    +++G   +  V  A  +   + VA+K + ++  +G+    E+
Sbjct: 6   EGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           E+++L KI+HPN++AL   Y    G   L+   +  G L   +  +G  T  D     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIY-ESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRL 121
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVL---LDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           I  +   + +LH +  I+H +L   N+L   LD+ +   ISDFGLS++            
Sbjct: 122 IFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW 509
               GY APE+   K  +   D +S+GV    LL G  P    N A+L +          
Sbjct: 181 TP--GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE---------- 228
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
             ++   E   D+P   D   +      H ++  P  R    Q +Q 
Sbjct: 229 --QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 84  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 134
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 231

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 84  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 134
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 231

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 83  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 133
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 91  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 141
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 142 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 238

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRL-REKIT------KGQREFESEVSLLGKIRHP 343
            + +G  T+G V     E  G +VAVK L R+KI       K +RE ++    L   RHP
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN----LKLFRHP 76
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           +++ L      P  +  +V +Y+  G L  ++   G    +D     ++ + +  G+ + 
Sbjct: 77  HIIKLYQVISTP-SDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYC 132
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSK 462
           H +  ++H +L   NVLLD   NAKI+DFGLS +M                Y APE +S 
Sbjct: 133 HRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSP--NYAAPEVISG 189
Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
              A  + D++S GV +  LL G  P
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 106 RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 156
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 157 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 253

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 42/288 (14%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 40  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 96
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPE-TPIDWPTRM---------------K 391
           L      P G  +++ ++   G+L+T+L ++  E  P   P  +               +
Sbjct: 97  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQ 156
Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
           + KGM        ++   IH +L + N+LL +    KI DFGL+R +             
Sbjct: 157 VAKGM-----EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW 509
             L + APE    +    ++DV+S GV + E+ + G SP           +    + EE+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEF 260
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
              + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 291 TAEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE----SEVSLLGKIR---H 342
            AEI G   YGTVYKA     G  VA+K +R  +  G+         EV+LL ++    H
Sbjct: 9   VAEI-GVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 343 PNLLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR 398
           PN++ L       + ++     LVF+++    L T+L  + P   +   T   +++   R
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLR 123
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAP 458
           GL  LH+N  I+H +L   N+L+      K++DFGL+R+               L YRAP
Sbjct: 124 GLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPVVVTLWYRAP 180
Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGK 486
           E+       T  D++S+G    E+   K
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLALRA 350
           E +G+ TYG VYKA    G   A+K++R EK  +G       E+S+L +++H N++ L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             +  K   +LVF+++    L   L     E  ++  T    +  +  G+ + H +  ++
Sbjct: 68  -VIHTKKRLVLVFEHLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH-DRRVL 122
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKANTK 469
           H +L   N+L++     KI+DFGL+R                L YRAP+ L   KK +T 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPDVLMGSKKYSTT 181
Query: 470 TDVYSLGVTILELLTG 485
            D++S+G    E++ G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLALRA 350
           E +G+ TYG VYKA    G   A+K++R EK  +G       E+S+L +++H N++ L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             +  K   +LVF+++    L   L     E  ++  T    +  +  G+ + H +  ++
Sbjct: 68  -VIHTKKRLVLVFEHLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH-DRRVL 122
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKANTK 469
           H +L   N+L++     KI+DFGL+R                L YRAP+ L   KK +T 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPDVLMGSKKYSTT 181
Query: 470 TDVYSLGVTILELLTG 485
            D++S+G    E++ G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 81  RLLGICLTSTVQ--LITQLMPFGXLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 131
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 117/266 (43%), Gaps = 28/266 (10%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A  +    + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 79  YF-HDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVI 133
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI++FG S                 L Y  PE+ + +  + K 
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLGV   E L GK P E     E  + ++ +   E+T   F  E  RD       L+
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARD-------LI 240
Query: 531 NTLKLALHCVDPSPSARPEVLQVVQQ 556
           + L      +  +PS RP + +V++ 
Sbjct: 241 SRL------LKHNPSQRPMLREVLEH 260

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-EKITKGQREFE-SEVSLLGKIRHPNLLALRA 350
           E +G+ TYG VYKA    G   A+K++R EK  +G       E+S+L +++H N++ L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             +  K   +LVF+++    L   L     E  ++  T    +  +  G+ + H +  ++
Sbjct: 68  -VIHTKKRLVLVFEHLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH-DRRVL 122
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKANTK 469
           H +L   N+L++     KI+DFGL+R                L YRAP+ L   KK +T 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 470 TDVYSLGVTILELLTG 485
            D++S+G    E++ G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLAL-RA 350
           +G   +G VYKA  ++ S +A  ++ +  TK + E E    E+ +L    HPN++ L  A
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 351 YYLGPKGEKLLVFDYMPHGSL-ATFLHARGPETPIDWPTRMKII-KGMTRGLLHLHSNEN 408
           +Y   +    ++ ++   G++ A  L    P T     ++++++ K     L +LH N+ 
Sbjct: 103 FYY--ENNLWILIEFCAGGAVDAVMLELERPLTE----SQIQVVCKQTLDALNYLHDNK- 155
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPEL----- 460
           IIH +L + N+L     + K++DFG+S                 +G   + APE+     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLN 493
           SK +  + K DV+SLG+T++E+   + P   LN
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLAL-RA 350
           +G   +G VYKA  ++ S +A  ++ +  TK + E E    E+ +L    HPN++ L  A
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 351 YYLGPKGEKLLVFDYMPHGSL-ATFLHARGPETPIDWPTRMKII-KGMTRGLLHLHSNEN 408
           +Y   +    ++ ++   G++ A  L    P T     ++++++ K     L +LH N+ 
Sbjct: 103 FYY--ENNLWILIEFCAGGAVDAVMLELERPLTE----SQIQVVCKQTLDALNYLHDNK- 155
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPEL----- 460
           IIH +L + N+L     + K++DFG+S                 +G   + APE+     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLN 493
           SK +  + K DV+SLG+T++E+   + P   LN
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 291 TAEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE----SEVSLLGKIR---H 342
            AEI G   YGTVYKA     G  VA+K +R  +  G+         EV+LL ++    H
Sbjct: 9   VAEI-GVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 343 PNLLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR 398
           PN++ L       + ++     LVF+++    L T+L  + P   +   T   +++   R
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLR 123
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAP 458
           GL  LH+N  I+H +L   N+L+      K++DFGL+R+               L YRAP
Sbjct: 124 GLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALFPVVVTLWYRAP 180
Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGK 486
           E+       T  D++S+G    E+   K
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 291 TAEIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFE----SEVSLLGKIR---H 342
            AEI G   YGTVYKA     G  VA+K +R  +  G+         EV+LL ++    H
Sbjct: 9   VAEI-GVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 343 PNLLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR 398
           PN++ L       + ++     LVF+++    L T+L  + P   +   T   +++   R
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLR 123
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAP 458
           GL  LH+N  I+H +L   N+L+      K++DFGL+R+               L YRAP
Sbjct: 124 GLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALDPVVVTLWYRAP 180
Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGK 486
           E+       T  D++S+G    E+   K
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVY---KATLEDGSQVAVKRLREKITKGQRE---FESEVSLLGKIRHPNLL 346
           +++G+ ++G V+   K T  D   +   ++ +K T   R+    + E  +L  + HP ++
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  Y    +G+  L+ D++  G L T L      T  D       +  +  GL HLHS 
Sbjct: 94  KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF---YLAELALGLDHLHSL 149
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
             II+ +L   N+LLD+  + K++DFGLS+                + Y APE+   +  
Sbjct: 150 -GIIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFCGTVEYMAPEVVNRQGH 207
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D +S GV + E+LTG  P
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLP 229

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 89/191 (46%), Gaps = 11/191 (5%)
Query: 311 GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHG 369
           G   AVK + +K  KG+    E+E+++L KI+H N++AL   Y  P     LV   +  G
Sbjct: 47  GKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESP-NHLYLVMQLVSGG 105
Query: 370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTN 426
            L   +  +G  T  D  T   +I+ +   + +LH    I+H +L   N+L    D+ + 
Sbjct: 106 ELFDRIVEKGFYTEKDAST---LIRQVLDAVYYLH-RMGIVHRDLKPENLLYYSQDEESK 161
Query: 427 AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
             ISDFGLS++                GY APE+   K  +   D +S+GV    LL G 
Sbjct: 162 IMISDFGLSKMEGKGDVMSTACGTP--GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 219
Query: 487 SPGEPLNGAEL 497
            P    N ++L
Sbjct: 220 PPFYDENDSKL 230

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 27/213 (12%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLAL-RA 350
           +G   +G VYKA  ++ S +A  ++ +  TK + E E    E+ +L    HPN++ L  A
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 351 YYLGPKGEKLLVFDYMPHGSL-ATFLHARGPETPIDWPTRMKII-KGMTRGLLHLHSNEN 408
           +Y   +    ++ ++   G++ A  L    P T     ++++++ K     L +LH N+ 
Sbjct: 103 FYY--ENNLWILIEFCAGGAVDAVMLELERPLTE----SQIQVVCKQTLDALNYLHDNK- 155
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPEL----- 460
           IIH +L + N+L     + K++DFG+S                 +G   + APE+     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLN 493
           SK +  + K DV+SLG+T++E+   + P   LN
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 291 TAEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHP 343
           T E +G   +  V K   +  G Q A K ++++ TK  R      + E EVS+L +I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           N++ L   Y   K + +L+ + +  G L  FL  +   T        + +K +  G+ +L
Sbjct: 75  NVITLHEVYEN-KTDVILIGELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYL 130
Query: 404 HSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE 459
           HS + I H +L   N++L D        KI DFGL+  +                + APE
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE--FVAPE 187
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +   +    + D++S+GV    LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 85  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 135
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFG ++L+               + + A E  
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 232

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT +  G QVAVK++  +  + +    +EV ++    H N++ + + YL
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + R L +LH N+ +IH
Sbjct: 113 --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH-NQGVIH 164
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
            ++ S ++LL      K+SDFG    +                + APE+       T+ D
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPY-WMAPEVISRLPYGTEVD 223
Query: 472 VYSLGVTILELLTGKSP 488
           ++SLG+ ++E++ G+ P
Sbjct: 224 IWSLGIMVIEMIDGEPP 240

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 100/232 (43%), Gaps = 41/232 (17%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF--ESEVSLLGKIRHPNLLAL-- 348
           E++G+  YG VYK +L D   VAVK         ++ F  E  +  +  + H N+     
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 349 ---RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
              R    G + E LLV +Y P+GSL  +L         DW +  ++   +TRGL +LH+
Sbjct: 75  GDERVTADG-RMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHT 129
Query: 406 N--------ENIIHGNLTSSNVLLDDSTNAKISDFGLS------RLMX-XXXXXXXXXXX 450
                      I H +L S NVL+ +     ISDFGLS      RL+             
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 451 XXLGYRAPE-------LSKLKKANTKTDVYSLGVTILELL---TGKSPGEPL 492
             + Y APE       L   + A  + D+Y+LG+   E+    T   PGE +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I +GM     +
Sbjct: 78  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAEGM-----N 128
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 129 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 225

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLRE--KITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           +GK ++G VYK       +V   ++ +  +      + + E+++L +   P +      Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 353 LGPKGEKL-LVFDYMPHGSLATFLHARGP--ETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           L  K  KL ++ +Y+  GS    L   GP  ET I       I++ + +GL +LHS E  
Sbjct: 87  L--KSTKLWIIMEYLGGGSALDLLKP-GPLEETYI-----ATILREILKGLDYLHS-ERK 137
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           IH ++ ++NVLL +  + K++DFG++  +                + APE+ K    + K
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQSAYDFK 196
Query: 470 TDVYSLGVTILELLTGKSPGEPLN 493
            D++SLG+T +EL  G+ P   L+
Sbjct: 197 ADIWSLGITAIELAKGEPPNSDLH 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++    +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 88  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 138
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 235

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 83  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 133
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFG ++L+               + + A E  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 83  RLLGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 133
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFG ++L+               + + A E  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 34/282 (12%)
Query: 295 MGKSTYGTVYKA------TLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLL 346
           +G+  +G V +A             VAVK L+E  T  + R   SE+ +L  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPE-TPI-----DWPTRMKIIK---GMT 397
            L      P G  +++ ++   G+L+T+L ++  E  P      D+ T   +I     + 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYR 456
           +G+  L S + I H +L + N+LL +    KI DFGL+R +               L + 
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 457 APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
           APE    +    ++DV+S GV + E+ + G SP           +    + EE+   + +
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRRLKE 262
Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
              MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 263 GTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 88/178 (49%), Gaps = 7/178 (3%)
Query: 311 GSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL-LVFDYMPH 368
           G QVAVK L+ E       + + E+ +L  + H N++  +       G  + L+ +++P 
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAK 428
           GSL  +L     +  I+   ++K    + +G+ +L S +  +H +L + NVL++     K
Sbjct: 110 GSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVK 166
Query: 429 ISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           I DFGL++ +                + + APE     K    +DV+S GVT+ ELLT
Sbjct: 167 IGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 44/288 (15%)
Query: 295 MGKSTYGTVYKA------TLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLL 346
           +G+  +G V +A             VAVK L+E  T  + R   SE+ +L  I  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARG----PETPIDW-----------PTRMK 391
            L      P G  +++ ++   G+L+T+L ++     P  P D                +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
           + KGM        ++   IH +L + N+LL +    KI DFGL+R +             
Sbjct: 157 VAKGM-----EFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW 509
             L + APE    +    ++DV+S GV + E+ + G SP           +    + EE+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEF 260
Query: 510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
              + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 88/178 (49%), Gaps = 7/178 (3%)
Query: 311 GSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL-LVFDYMPH 368
           G QVAVK L+ E       + + E+ +L  + H N++  +       G  + L+ +++P 
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAK 428
           GSL  +L     +  I+   ++K    + +G+ +L S +  +H +L + NVL++     K
Sbjct: 98  GSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVK 154
Query: 429 ISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           I DFGL++ +                + + APE     K    +DV+S GVT+ ELLT
Sbjct: 155 IGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKG---QREFESEVSLLGKIRHPNLLAL 348
           E +G+ ++G V  AT     Q VA+K +  ++ K        E E+S L  +RHP+++ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 349 RAYYLGPKGEKLLV-------FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
                 P    +++       FDY+      T    R            +  + +   + 
Sbjct: 75  YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGR------------RFFQQIICAIE 122
Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS 461
           + H ++ I+H +L   N+LLDD+ N KI+DFGLS +M                Y APE+ 
Sbjct: 123 YCHRHK-IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP--NYAAPEVI 179
Query: 462 KLK-KANTKTDVYSLGVTILELLTGKSP 488
             K  A  + DV+S G+ +  +L G+ P
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 11/212 (5%)
Query: 289 CATAEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA 347
            +  EI+G   +G V+K      G ++A K ++ +  K + E ++E+S++ ++ H NL+ 
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLAT-FLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L   +   K + +LV +Y+  G L    +      T +D    +  +K +  G+ H+H  
Sbjct: 151 LYDAF-ESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQM 206
Query: 407 ENIIHGNLTSSNVLL--DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLK 464
             I+H +L   N+L    D+   KI DFGL+R                  + APE+    
Sbjct: 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE--FLAPEVVNYD 263
Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAE 496
             +  TD++S+GV    LL+G SP    N AE
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 43/289 (14%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 41  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 97
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARG------PETPIDW-----------PTRM 390
           L      P G  +++ ++   G+L+T+L ++        E P D                
Sbjct: 98  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSF 157
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXX 449
           ++ KGM        ++   IH +L + N+LL +    KI DFGL+R +            
Sbjct: 158 QVAKGM-----EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEE 508
              L + APE    +    ++DV+S GV + E+ + G SP           +    + EE
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEE 261
Query: 509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           +   + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 262 FCRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 307

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 34/282 (12%)
Query: 295 MGKSTYGTVYKA------TLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLL 346
           +G+  +G V +A             VAVK L+E  T  + R   SE+ +L  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPE-TPI-----DWPTRMKIIK---GMT 397
            L      P G  +++ ++   G+L+T+L ++  E  P      D+ T   +I     + 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYR 456
           +G+  L S + I H +L + N+LL +    KI DFGL+R +               L + 
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 457 APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
           APE    +    ++DV+S GV + E+ + G SP           +    + EE+   + +
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFXRRLKE 262
Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
              MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 263 GTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 39  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---------GPETPI-DWPTRMKIIK--- 394
           L      P G  +++ ++   G+L+T+L ++          PE    D+ T   +I    
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            + +G+  L S +  IH +L + N+LL +    KI DFGL+R +               L
Sbjct: 156 QVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +    ++DV+S GV + E+ + G SP           +    + EE+   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRR 263
Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 52/282 (18%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLALR-A 350
           +G   +G VYKA  ++   +A  ++ E  TK + E E    E+ +L    HP ++ L  A
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHA--RGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           YY    G+  ++ ++ P G++   +    RG    +  P    + + M   L  LHS   
Sbjct: 85  YY--HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSK-R 137
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPELSKLKK 465
           IIH +L + NVL+    + +++DFG+S                 +G   + APE+   + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 466 A-----NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS------IVKEEWTNEVF 514
                 + K D++SLG+T++E+   + P   LN   +   +A       +   +W+ E  
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
           D                 LK+AL   D +P  RP   Q+++ 
Sbjct: 254 DF----------------LKIAL---DKNPETRPSAAQLLEH 276

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 39  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---------GPETPI-DWPTRMKIIK--- 394
           L      P G  +++ ++   G+L+T+L ++          PE    D+ T   +I    
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            + +G+  L S +  IH +L + N+LL +    KI DFGL+R +               L
Sbjct: 156 QVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +    ++DV+S GV + E+ + G SP           +    + EE+   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRR 263
Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 39  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---------GPETPI-DWPTRMKIIK--- 394
           L      P G  +++ ++   G+L+T+L ++          PE    D+ T   +I    
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            + +G+  L S +  IH +L + N+LL +    KI DFGL+R +               L
Sbjct: 156 QVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +    ++DV+S GV + E+ + G SP           +    + EE+   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRR 263
Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 293 EIMGKSTYGTVYKATLEDGSQ-VAVKRL----REKITKG-QREFESEVSLLGKIRHPNLL 346
           + +G+  + TVYKA  ++ +Q VA+K++    R +   G  R    E+ LL ++ HPN++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT-RGLLHLHS 405
            L   + G K    LVFD+M    L   +      + +  P+ +K    MT +GL +LH 
Sbjct: 76  GLLDAF-GHKSNISLVFDFM-ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLK 464
           +  I+H +L  +N+LLD++   K++DFGL++                  YRAPE L   +
Sbjct: 131 HW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRW-YRAPELLFGAR 188
Query: 465 KANTKTDVYSLGVTILELL 483
                 D++++G  + ELL
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 45/295 (15%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQ-REFESEVSLLGKIRHPNLLA 347
           +G+  +G V KAT          + VAVK L+E  +  + R+  SE ++L ++ HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-------------IDWPTRMKIIK 394
           L        G  LL+ +Y  +GSL  FL       P             +D P    +  
Sbjct: 91  LYGA-CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 395 G--------MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXX 445
           G        +++G+ +L +  +++H +L + N+L+ +    KISDFGLSR +        
Sbjct: 150 GDLISFAWQISQGMQYL-AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVK 208
Query: 446 XXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV 505
                  + + A E        T++DV+S GV + E++T       L G   P     I 
Sbjct: 209 RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------LGGNPYP----GIP 257
Query: 506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            E   N +     M       +E+    +L L C    P  RP    + + LE++
Sbjct: 258 PERLFNLLKTGHRMERPDNCSEEM---YRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVY---KATLEDGSQVAVKRLREKITKGQRE---FESEVSLLGKIRHPNLL 346
           +++G+ ++G V+   K +  D  Q+   ++ +K T   R+    + E  +L ++ HP ++
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  Y    +G+  L+ D++  G L T L      T  D       +  +   L HLHS 
Sbjct: 91  KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF---YLAELALALDHLHSL 146
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
             II+ +L   N+LLD+  + K++DFGLS+                + Y APE+   +  
Sbjct: 147 -GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 204
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D +S GV + E+LTG  P
Sbjct: 205 TQSADWWSFGVLMFEMLTGTLP 226

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 124/282 (43%), Gaps = 52/282 (18%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLALR-A 350
           +G   +G VYKA  ++   +A  ++ E  TK + E E    E+ +L    HP ++ L  A
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHA--RGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           YY    G+  ++ ++ P G++   +    RG    +  P    + + M   L  LHS + 
Sbjct: 77  YY--HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHS-KR 129
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPELSKLKK 465
           IIH +L + NVL+    + +++DFG+S                 +G   + APE+   + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCET 185
Query: 466 A-----NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
                 + K D++SLG+T++E+   + P   LN   +   +  I K              
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAK-------------S 229
Query: 521 DAPTI------GDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
           D PT+        E  + LK+AL   D +P  RP   Q+++ 
Sbjct: 230 DPPTLLTPSKWSVEFRDFLKIAL---DKNPETRPSAAQLLEH 268

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 88  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 138
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFG ++L+               + + A E  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 235

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 15/231 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A       + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 80  YF-HDATRVYLILEYAPLGTVYRELQKL---SRFDEQRTATYITELANALSYCHS-KRVI 134
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
           D++SLGV   E L G  P E     E  + ++ +   E+T   F  E  RD
Sbjct: 192 DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV---EFTFPDFVTEGARD 239

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++    +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 88  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 138
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 235

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVY---KATLEDGSQVAVKRLREKITKGQRE---FESEVSLLGKIRHPNLL 346
           +++G+ ++G V+   K +  D  Q+   ++ +K T   R+    + E  +L ++ HP ++
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  Y    +G+  L+ D++  G L T L      T  D       +  +   L HLHS 
Sbjct: 90  KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF---YLAELALALDHLHSL 145
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
             II+ +L   N+LLD+  + K++DFGLS+                + Y APE+   +  
Sbjct: 146 -GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D +S GV + E+LTG  P
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLP 225

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 81  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 131
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFG ++L+               + + A E  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 83  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 133
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFG ++L+               + + A E  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 30  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---------GPETPI-DWPTRMKIIK--- 394
           L      P G  +++ ++   G+L+T+L ++          PE    D+ T   +I    
Sbjct: 87  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            + +G+  L S +  IH +L + N+LL +    KI DFGL+R +               L
Sbjct: 147 QVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +    ++DV+S GV + E+ + G SP           +    + EE+   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRR 254
Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 255 LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++    +GTVYK   + +G +V    A+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 81  RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 131
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX-LGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVY---KATLEDGSQVAVKRLREKITKGQRE---FESEVSLLGKIRHPNLL 346
           +++G+ ++G V+   K +  D  Q+   ++ +K T   R+    + E  +L ++ HP ++
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  Y    +G+  L+ D++  G L T L      T  D       +  +   L HLHS 
Sbjct: 90  KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF---YLAELALALDHLHSL 145
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
             II+ +L   N+LLD+  + K++DFGLS+                + Y APE+   +  
Sbjct: 146 -GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D +S GV + E+LTG  P
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLP 225

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 126/293 (43%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 90  IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +LT+ NVL+ ++   KI+DFGL+R +          
Sbjct: 146 LVSCTYQLARGMEYLAS-QKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 253
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 254 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 303

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 76  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---------GPETPI-DWPTRMKIIK--- 394
           L      P G  +++ ++   G+L+T+L ++          PE    D+ T   +I    
Sbjct: 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 192
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            + +G+  L S +  IH +L + N+LL +    KI DFGL+R +               L
Sbjct: 193 QVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +    ++DV+S GV + E+ + G SP           +    + EE+   
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRR 300
Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 301 LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 342

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E++G   +G V+KA    DG    +KR++    K +RE    V  L K+ H N++     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72
Query: 352 YLG--------------PKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGM 396
           + G               K + L +  ++   G+L  ++  R  E  +D    +++ + +
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELFEQI 131
Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR 456
           T+G+ ++HS + +I+ +L  SN+ L D+   KI DFGL  +               L Y 
Sbjct: 132 TKGVDYIHSKK-LINRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRXRSKGTLRYM 188
Query: 457 APELSKLKKANTKTDVYSLGVTILELL 483
           +PE    +    + D+Y+LG+ + ELL
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQV----AVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK   + +G +V    A+  LRE  + K  +E   E  ++  + +P++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLH 402
            L    L    +  L+   MP G L  ++       G +  ++W   ++I KGM     +
Sbjct: 115 RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM-----N 165
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM-XXXXXXXXXXXXXXLGYRAPELS 461
              +  ++H +L + NVL+    + KI+DFGL++L+               + + A E  
Sbjct: 166 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
             +    ++DV+S GVT+ EL+T G  P + +  +E+
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 262

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 45/295 (15%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQ-REFESEVSLLGKIRHPNLLA 347
           +G+  +G V KAT          + VAVK L+E  +  + R+  SE ++L ++ HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-------------IDWPTRMKIIK 394
           L        G  LL+ +Y  +GSL  FL       P             +D P    +  
Sbjct: 91  LYGA-CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 395 G--------MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXX 445
           G        +++G+ +L +   ++H +L + N+L+ +    KISDFGLSR +        
Sbjct: 150 GDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208
Query: 446 XXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV 505
                  + + A E        T++DV+S GV + E++T       L G   P     I 
Sbjct: 209 RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------LGGNPYP----GIP 257
Query: 506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            E   N +     M       +E+    +L L C    P  RP    + + LE++
Sbjct: 258 PERLFNLLKTGHRMERPDNCSEEM---YRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           E +G   YG V  A     G QVA+K++    + +T  +R    E+ +L   +H N++A+
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAI 119
Query: 349 RAYYLG--PKGE---KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           +       P GE     +V D M    L   +H+     P+        +  + RGL ++
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYM 175
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPEL 460
           HS + +IH +L  SN+L++++   KI DFG++R +              +    YRAPEL
Sbjct: 176 HSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 461 S-KLKKANTKTDVYSLGVTILELLTGKS--PGE 490
              L +     D++S+G    E+L  +   PG+
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 267

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 19/222 (8%)
Query: 278 GPLMFTADDLLCATAEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREF-----E 331
           GPL   A       AEI G   YGTVYKA     G  VA+K +R     G          
Sbjct: 1   GPLGSMATSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59
Query: 332 SEVSLLGKIR---HPNLLALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPI 384
            EV+LL ++    HPN++ L       + ++     LVF+++    L T+L  + P   +
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGL 117
Query: 385 DWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXX 444
              T   +++   RGL  LH+N  I+H +L   N+L+      K++DFGL+R+       
Sbjct: 118 PAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQM 174
Query: 445 XXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
                   L YRAPE+       T  D++S+G    E+   K
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 15/231 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRA 350
           +GK  +G VY A       + A+K L + ++ K   + +   EV +   +RHPN+L L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y+        L+ +Y P G++   L      +  D       I  +   L + HS + +I
Sbjct: 80  YF-HDATRVYLILEYAPLGTVYRELQKL---SRFDEQRTATYITELANALSYCHS-KRVI 134
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++   N+LL  +   KI+DFG S                 L Y  PE+ + +  + K 
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
           D++SLGV   E L G  P E     E  + ++ +   E+T   F  E  RD
Sbjct: 192 DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV---EFTFPDFVTEGARD 239

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQ-REFESEVSLLGKIRHPNLLA 347
           +G+  +G V KAT          + VAVK L+E  +  + R+  SE ++L ++ HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP-------------IDWPTRMKIIK 394
           L        G  LL+ +Y  +GSL  FL       P             +D P    +  
Sbjct: 91  LYGA-CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 395 G--------MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXX 445
           G        +++G+ +L +   ++H +L + N+L+ +    KISDFGLSR +        
Sbjct: 150 GDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVK 208
Query: 446 XXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV 505
                  + + A E        T++DV+S GV + E++T       L G   P     I 
Sbjct: 209 RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------LGGNPYP----GIP 257
Query: 506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            E   N +     M       +E+    +L L C    P  RP    + + LE++
Sbjct: 258 PERLFNLLKTGHRMERPDNCSEEM---YRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 284 ADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKG-QREFESEVSLLGKIRH 342
            +DL       +G+ TYG VYKA  +DG       L++    G       E++LL +++H
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKH 77
Query: 343 PNLLALRAYYLGPKGEKL-LVFDYMPH--GSLATFLHA-RGPETPIDWPTRM--KIIKGM 396
           PN+++L+  +L     K+ L+FDY  H    +  F  A +  + P+  P  M   ++  +
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 397 TRGLLHLHSNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMXX--XXXXXXXXXX 450
             G+ +LH+N  ++H +L  +N+L+     +    KI+D G +RL               
Sbjct: 138 LDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 451 XXLGYRAPELSKLKKANTKT-DVYSLGVTILELLTGK 486
               YRAPEL    +  TK  D++++G    ELLT +
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 10/212 (4%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLRE-KITKGQRE-FESEVSLLGKIRHPNLLALRAY 351
           +G  +YG   K   + DG  +  K L    +T+ +++   SEV+LL +++HPN++     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNEN- 408
            +      L +V +Y   G LA+ +     E   +D    ++++  +T  L   H   + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 409 ---IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
              ++H +L  +NV LD   N K+ DFGL+R++                Y +PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY-YMSPEQMNRMS 192
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
            N K+D++SLG  + EL     P    +  EL
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 30  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---------GPETPI-DWPTRMKIIK--- 394
           L      P G  +++ ++   G+L+T+L ++          PE    D+ T   +I    
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            + +G+  L S +  IH +L + N+LL +    KI DFGL+R +               L
Sbjct: 147 QVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +    ++DV+S GV + E+ + G SP           +    + EE+   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRR 254
Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 255 LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 144/311 (46%), Gaps = 41/311 (13%)
Query: 275 HFDGPLMFTADDLLCATAEI-----MGKSTYGTVYKATL------EDGSQVAVKRLREKI 323
           +F    ++  D+   A  +I     +G+ ++G VY+         E  ++VA+K + E  
Sbjct: 30  YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 89
Query: 324 TKGQR-EFESEVSLLGKIRHPNLLALRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE 381
           +  +R EF +E S++ +    +++ L    +  +G+  L++ + M  G L ++L +  PE
Sbjct: 90  SMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPE 147
Query: 382 ---TPIDWP---TRMKIIKG-MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL 434
               P+  P   ++M  + G +  G+ +L++N+  +H +L + N ++ +    KI DFG+
Sbjct: 148 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGM 206
Query: 435 SR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPL 492
           +R +               + + +PE  K     T +DV+S GV + E+ T  + P + L
Sbjct: 207 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 266
Query: 493 NGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQ 552
           +  ++ ++            V +  L+       D L   +++   C   +P  RP  L+
Sbjct: 267 SNEQVLRF------------VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLE 311
Query: 553 VVQQL-EEIRP 562
           ++  + EE+ P
Sbjct: 312 IISSIKEEMEP 322

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 30  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---------GPETPI-DWPTRMKIIK--- 394
           L      P G  +++ ++   G+L+T+L ++          PE    D+ T   +I    
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            + +G+  L S +  IH +L + N+LL +    KI DFGL+R +               L
Sbjct: 147 QVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +    ++DV+S GV + E+ + G SP           +    + EE+   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRR 254
Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 255 LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 30/275 (10%)
Query: 294 IMGKSTYGTVYKATLEDGS----QVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLAL 348
           I+G+  +G VY+    +       VAVK  ++  T   +E F SE  ++  + HP+++ L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 349 RAYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
               +G   E+   ++ +  P+G L  +L        +   T +     + + + +L S 
Sbjct: 75  ----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESI 128
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
            N +H ++   N+L+      K+ DFGLSR +              + + +PE    ++ 
Sbjct: 129 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 467 NTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
            T +DV+   V + E+L+ GK P   L   ++   +  + K +              P +
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEKGD----------RLPKPDL 234
Query: 526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              +L T  L   C D  PS RP   ++V  L ++
Sbjct: 235 CPPVLYT--LMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 10/212 (4%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLRE-KITKGQRE-FESEVSLLGKIRHPNLLALRAY 351
           +G  +YG   K   + DG  +  K L    +T+ +++   SEV+LL +++HPN++     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNEN- 408
            +      L +V +Y   G LA+ +     E   +D    ++++  +T  L   H   + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 409 ---IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
              ++H +L  +NV LD   N K+ DFGL+R++                Y +PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY-YMSPEQMNRMS 192
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
            N K+D++SLG  + EL     P    +  EL
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRL---REKITKGQREFESEVSLLGKIRHPNLLAL 348
           E +G   YG V  A     G QVA+K++    + +T  +R    E+ +L   +H N++A+
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAI 118
Query: 349 RAYY--LGPKGE---KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           +       P GE     +V D M    L   +H+     P+        +  + RGL ++
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYM 174
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPEL 460
           HS + +IH +L  SN+L++++   KI DFG++R +              +    YRAPEL
Sbjct: 175 HSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 461 S-KLKKANTKTDVYSLGVTILELLTGKS--PGE 490
              L +     D++S+G    E+L  +   PG+
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPNLLA 347
           A  +++    +G    AT      VAVK L+E  T  + R   SE+ +L  I  H N++ 
Sbjct: 30  AFGQVIEADAFGIDKTATCR---TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHAR---------GPETPI-DWPTRMKIIK--- 394
           L      P G  +++ ++   G+L+T+L ++          PE    D+ T   +I    
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXL 453
            + +G+  L S +  IH +L + N+LL +    KI DFGL+R +               L
Sbjct: 147 QVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +    ++DV+S GV + E+ + G SP           +    + EE+   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFCRR 254
Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 255 LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 30/275 (10%)
Query: 294 IMGKSTYGTVYKATLEDGS----QVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLAL 348
           I+G+  +G VY+    +       VAVK  ++  T   +E F SE  ++  + HP+++ L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 349 RAYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
               +G   E+   ++ +  P+G L  +L        +   T +     + + + +L S 
Sbjct: 91  ----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESI 144
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
            N +H ++   N+L+      K+ DFGLSR +              + + +PE    ++ 
Sbjct: 145 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 467 NTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
            T +DV+   V + E+L+ GK P   L   ++   +  + K +              P +
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEKGD----------RLPKPDL 250
Query: 526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              +L T  L   C D  PS RP   ++V  L ++
Sbjct: 251 CPPVLYT--LMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 30/275 (10%)
Query: 294 IMGKSTYGTVYKATLEDGS----QVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLAL 348
           I+G+  +G VY+    +       VAVK  ++  T   +E F SE  ++  + HP+++ L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 349 RAYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
               +G   E+   ++ +  P+G L  +L        +   T +     + + + +L S 
Sbjct: 79  ----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESI 132
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
            N +H ++   N+L+      K+ DFGLSR +              + + +PE    ++ 
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 467 NTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
            T +DV+   V + E+L+ GK P   L   ++   +  + K +              P +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEKGD----------RLPKPDL 238
Query: 526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              +L T  L   C D  PS RP   ++V  L ++
Sbjct: 239 CPPVLYT--LMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 90  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 147
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 37/220 (16%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E++G   +G V+KA    DG    ++R++    K +RE    V  L K+ H N++     
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 73
Query: 352 YLG------------------PKGEK----------LLVFDYMPHGSLATFLHARGPETP 383
           + G                  P+  K           +  ++   G+L  ++  R  E  
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-K 132
Query: 384 IDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXX 443
           +D    +++ + +T+G+ ++HS + +IH +L  SN+ L D+   KI DFGL  +      
Sbjct: 133 LDKVLALELFEQITKGVDYIHSKK-LIHRDLKPSNIFLVDTKQVKIGDFGL--VTSLKND 189
Query: 444 XXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELL 483
                    L Y +PE    +    + D+Y+LG+ + ELL
Sbjct: 190 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 10/212 (4%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLRE-KITKGQRE-FESEVSLLGKIRHPNLLALRAY 351
           +G  +YG   K   + DG  +  K L    +T+ +++   SEV+LL +++HPN++     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETP-IDWPTRMKIIKGMTRGLLHLHSNEN- 408
            +      L +V +Y   G LA+ +     E   +D    ++++  +T  L   H   + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 409 ---IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
              ++H +L  +NV LD   N K+ DFGL+R++                Y +PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPY-YMSPEQMNRMS 192
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
            N K+D++SLG  + EL     P    +  EL
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 91
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 92  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 149
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGK 233

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 95  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 152
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGK 236

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 95
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 96  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 153
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 214 SIDIWSVGCILAEMLSNRPIFPGK 237

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 86
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 87  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 144
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 205 SIDIWSVGCILAEMLSNRPIFPGK 228

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 94  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 151
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 97
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 98  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 155
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 470 T-DVYSLGVTILELLTGK 486
           + D++S+G  + E+L+ +
Sbjct: 216 SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 90  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 147
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 470 T-DVYSLGVTILELLTGK 486
           + D++S+G  + E+L+ +
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 88  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 145
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGK 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 94  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 151
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 88  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 145
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGK 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 95  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 152
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGK 236

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 103 IITL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 90  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 147
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 109
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 110 IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 167
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGK 251

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 94  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 151
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 144/311 (46%), Gaps = 41/311 (13%)
Query: 275 HFDGPLMFTADDLLCATAEI-----MGKSTYGTVYKATL------EDGSQVAVKRLREKI 323
           +F    ++  D+   A  +I     +G+ ++G VY+         E  ++VA+K + E  
Sbjct: 8   YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67
Query: 324 TKGQR-EFESEVSLLGKIRHPNLLALRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE 381
           +  +R EF +E S++ +    +++ L    +  +G+  L++ + M  G L ++L +  PE
Sbjct: 68  SMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPE 125
Query: 382 ---TPIDWP---TRMKIIKG-MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL 434
               P+  P   ++M  + G +  G+ +L++N+  +H +L + N ++ +    KI DFG+
Sbjct: 126 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 435 SR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPL 492
           +R +               + + +PE  K     T +DV+S GV + E+ T  + P + L
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 493 NGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQ 552
           +  ++ ++            V +  L+       D L   +++   C   +P  RP  L+
Sbjct: 245 SNEQVLRF------------VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLE 289
Query: 553 VVQQL-EEIRP 562
           ++  + EE+ P
Sbjct: 290 IISSIKEEMEP 300

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 94  IRAPTIEQMKDV-YIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS-ANVLH 151
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 95  IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 151 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 258
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 259 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 308

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 142/305 (46%), Gaps = 41/305 (13%)
Query: 281 MFTADDLLCATAEI-----MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR- 328
           +F  D+   A  +I     +G+ ++G VY+         E  ++VA+K + E  +  +R 
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 329 EFESEVSLLGKIRHPNLLALRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE---TPI 384
           EF +E S++ +    +++ L    +  +G+  L++ + M  G L ++L +  PE    P+
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 122
Query: 385 DWP---TRMKIIKG-MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMX 439
             P   ++M  + G +  G+ +L++N+  +H +L + N ++ +    KI DFG++R +  
Sbjct: 123 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 440 XXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
                        + + +PE  K     T +DV+S GV + E+ T  + P + L+  ++ 
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 241
Query: 499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL- 557
           ++            V +  L+       D L   +++   C   +P  RP  L+++  + 
Sbjct: 242 RF------------VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 286
Query: 558 EEIRP 562
           EE+ P
Sbjct: 287 EEMEP 291

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 90  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 147
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 92  IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 148 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 255
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 256 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 305

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/310 (21%), Positives = 143/310 (46%), Gaps = 41/310 (13%)
Query: 276 FDGPLMFTADDLLCATAEI-----MGKSTYGTVYKATL------EDGSQVAVKRLREKIT 324
           F    ++  D+   A  +I     +G+ ++G VY+         E  ++VA+K + E  +
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 325 KGQR-EFESEVSLLGKIRHPNLLALRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE- 381
             +R EF +E S++ +    +++ L    +  +G+  L++ + M  G L ++L +  PE 
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 120
Query: 382 --TPIDWP---TRMKIIKG-MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS 435
              P+  P   ++M  + G +  G+ +L++N+  +H +L + N ++ +    KI DFG++
Sbjct: 121 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 436 R-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLN 493
           R +               + + +PE  K     T +DV+S GV + E+ T  + P + L+
Sbjct: 180 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239
Query: 494 GAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQV 553
             ++ ++            V +  L+       D L   +++   C   +P  RP  L++
Sbjct: 240 NEQVLRF------------VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEI 284
Query: 554 VQQL-EEIRP 562
           +  + EE+ P
Sbjct: 285 ISSIKEEMEP 294

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V+   +  +G   A+K L+++I    ++ E    E  +L  + HP ++ +  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLH--ARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +   + +  ++ DY+  G L + L    R P      P        +   L +LHS ++
Sbjct: 74  TFQDAQ-QIFMIMDYIEGGELFSLLRKSQRFPN-----PVAKFYAAEVCLALEYLHS-KD 126
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   N+LLD + + KI+DFG ++ +                Y APE+   K  N 
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTP----DYIAPEVVSTKPYNK 182
Query: 469 KTDVYSLGVTILELLTGKSP 488
             D +S G+ I E+L G +P
Sbjct: 183 SIDWWSFGILIYEMLAGYTP 202

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA++++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 94  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 151
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 103 IIHL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 138/286 (48%), Gaps = 36/286 (12%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    +++ 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE---TPIDWP---TRMKIIKG-MTRG 399
           L    +  +G+  L++ + M  G L ++L +  PE    P+  P   ++M  + G +  G
Sbjct: 78  LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++N+  +H +L + N ++ +    KI DFG++R +               + + +P
Sbjct: 136 MAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +DV+S GV + E+ T  + P + L+  ++ ++            V +  
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 242
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL-EEIRP 562
           L+       D LL  +++   C   +P  RP  L+++  + EE+ P
Sbjct: 243 LLDKPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 285

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 103 IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 149 IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 205 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 312
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 362

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L   RH N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDI 91
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 92  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 149
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ +++ KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGK 233

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 103 IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDI 93
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 94  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 151
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L   RH N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDI 91
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 92  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 149
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGK 233

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/310 (22%), Positives = 145/310 (46%), Gaps = 41/310 (13%)
Query: 276 FDGPLMFTADDLLCATAEI-----MGKSTYGTVYKATL------EDGSQVAVKRLREKIT 324
           F    ++  D+   A  +I     +G+ ++G VY+         E  ++VA+K + E  +
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 325 KGQR-EFESEVSLLGKIRHPNLLALRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE- 381
             +R EF +E S++ +    +++ L    +  +G+  L++ + M  G L ++L +  PE 
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 120
Query: 382 --TPIDWP---TRMKIIKG-MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS 435
              P+  P   ++M  + G +  G+ +L++N+  +H +L + N ++ +    KI DFG++
Sbjct: 121 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 436 R-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLN 493
           R +               + + +PE  K     T +DV+S GV + E+ T  + P + L+
Sbjct: 180 RDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239
Query: 494 GAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQV 553
             ++ ++            V +  L+       D L   +++   C   +P  RP  L++
Sbjct: 240 NEQVLRF------------VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEI 284
Query: 554 VQQL-EEIRP 562
           +  + EE+ P
Sbjct: 285 ISSIKEEMEP 294

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 103 IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    + T L+       +        +  + RGL ++HS  N++H
Sbjct: 90  IRAPTIEQMKDV-YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 147
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFE-SEVSLLGKIRHPNLLALRA 350
           E +G  TY TVYK      G  VA+K ++    +G       E+SL+ +++H N++  R 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV--RL 68
Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGP-ETPIDWPTRMKIIK----GMTRGLLHLH 404
           Y +     KL LVF++M +  L  ++ +R    TP      + ++K     + +GL   H
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRG--LELNLVKYFQWQLLQGLAFCH 125
Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKL 463
            N+ I+H +L   N+L++     K+ DFGL+R                L YRAP+ L   
Sbjct: 126 ENK-ILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
           +  +T  D++S G  + E++TGK
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGK 206

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 135/286 (47%), Gaps = 36/286 (12%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    +++ 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE---TPIDWP---TRMKIIKG-MTRG 399
           L    +  +G+  L++ + M  G L ++L +  PE    P+  P   ++M  + G +  G
Sbjct: 86  LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++N+  +H +L + N ++ +    KI DFG++R +               + + +P
Sbjct: 144 MAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +DV+S GV + E+ T  + P + L+  ++ ++            V +  
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 250
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL-EEIRP 562
           L+       D L   +++   C   +P  RP  L+++  + EE+ P
Sbjct: 251 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 135/286 (47%), Gaps = 36/286 (12%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    +++ 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE---TPIDWP---TRMKIIKG-MTRG 399
           L    +  +G+  L++ + M  G L ++L +  PE    P+  P   ++M  + G +  G
Sbjct: 86  LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++N+  +H +L + N ++ +    KI DFG++R +               + + +P
Sbjct: 144 MAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +DV+S GV + E+ T  + P + L+  ++ ++            V +  
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 250
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL-EEIRP 562
           L+       D L   +++   C   +P  RP  L+++  + EE+ P
Sbjct: 251 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQ-VAVKRLREKITKG--QREFESEVSLLGKIRHPNLLALRAY 351
           +G+ +YG V+K    D  Q VA+K+  E       ++    E+ +L +++HPNL+ L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 352 YLGPKGEKLLVFDYMPHGSLATF-LHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           +   K    LVF+Y  H  L     + RG PE  +      K I   T   ++     N 
Sbjct: 71  FRR-KRRLHLVFEYCDHTVLHELDRYQRGVPEHLV------KSITWQTLQAVNFCHKHNC 123
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKANT 468
           IH ++   N+L+   +  K+ DFG +RL+                YR+PE L    +   
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-YRSPELLVGDTQYGP 182
Query: 469 KTDVYSLGVTILELLTG 485
             DV+++G    ELL+G
Sbjct: 183 PVDVWAIGCVFAELLSG 199

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 135/286 (47%), Gaps = 36/286 (12%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    +++ 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE---TPIDWP---TRMKIIKG-MTRG 399
           L    +  +G+  L++ + M  G L ++L +  PE    P+  P   ++M  + G +  G
Sbjct: 80  LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++N+  +H +L + N ++ +    KI DFG++R +               + + +P
Sbjct: 138 MAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +DV+S GV + E+ T  + P + L+  ++ ++            V +  
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 244
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL-EEIRP 562
           L+       D L   +++   C   +P  RP  L+++  + EE+ P
Sbjct: 245 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 282 FTADDLLCATAEIMGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLL 337
           FT DD        +GK  +G VY A  +    + A+K L + ++ K   + +   E+ + 
Sbjct: 11  FTIDDF--DIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 68
Query: 338 GKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
             +RHPN+L +  Y+   K    L+ ++ P G L   L   G     D       ++ + 
Sbjct: 69  SHLRHPNILRMYNYFHDRK-RIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELA 124
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRA 457
             L + H  + +IH ++   N+L+      KI+DFG S                 L Y  
Sbjct: 125 DALHYCHERK-VIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLP 180
Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           PE+ + K  + K D++  GV   E L G  P
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 282 FTADDLLCATAEIMGKSTYGTVYKATLEDGSQV-AVKRL-REKITKG--QREFESEVSLL 337
           FT DD        +GK  +G VY A  +    + A+K L + ++ K   + +   E+ + 
Sbjct: 12  FTIDDF--DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 69
Query: 338 GKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
             +RHPN+L +  Y+   K    L+ ++ P G L   L   G     D       ++ + 
Sbjct: 70  SHLRHPNILRMYNYFHDRK-RIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELA 125
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRA 457
             L + H  + +IH ++   N+L+      KI+DFG S                 L Y  
Sbjct: 126 DALHYCHERK-VIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLP 181
Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           PE+ + K  + K D++  GV   E L G  P
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRL-REKITKGQR--EFESEVSLLGKIRHPNLLA 347
            + +G  T+G V     +  G +VAVK L R+KI       + + E+  L   RHP+++ 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           L      P  +  +V +Y+  G L  ++  H R  E         ++ + +   + + H 
Sbjct: 76  LYQVISTPT-DFFMVMEYVSGGELFDYICKHGRVEEM-----EARRLFQQILSAVDYCHR 129
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLK 464
           +  ++H +L   NVLLD   NAKI+DFGLS +M                Y APE +S   
Sbjct: 130 H-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP--NYAAPEVISGRL 186
Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
            A  + D++S GV +  LL G  P
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 103 IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   +I+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G+ ++G V   Y  T   G +VA+K + +K+   +  Q   E E+S L  +RHP+++ L
Sbjct: 22  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  K E ++V +Y  +  L  ++  R   +        +  + +   + + H ++ 
Sbjct: 80  YDV-IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE---QEARRFFQQIISAVEYCHRHK- 133
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLK-KAN 467
           I+H +L   N+LLD+  N KI+DFGLS +M                Y APE+   K  A 
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP--NYAAPEVISGKLYAG 191
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            + DV+S GV +  +L  + P
Sbjct: 192 PEVDVWSCGVILYVMLCRRLP 212

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRL-REKITKGQR--EFESEVSLLGKIRHPNLLA 347
            + +G  T+G V     +  G +VAVK L R+KI       + + E+  L   RHP+++ 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFL--HARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           L      P  +  +V +Y+  G L  ++  H R  E         ++ + +   + + H 
Sbjct: 76  LYQVISTPT-DFFMVMEYVSGGELFDYICKHGRVEEM-----EARRLFQQILSAVDYCHR 129
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLK 464
           +  ++H +L   NVLLD   NAKI+DFGLS +M                Y APE +S   
Sbjct: 130 H-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSP--NYAAPEVISGRL 186
Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
            A  + D++S GV +  LL G  P
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G+ ++G V   Y  T   G +VA+K + +K+   +  Q   E E+S L  +RHP+++ L
Sbjct: 21  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  K E ++V +Y  +  L  ++  R   +        +  + +   + + H ++ 
Sbjct: 79  YDV-IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE---QEARRFFQQIISAVEYCHRHK- 132
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLK-KAN 467
           I+H +L   N+LLD+  N KI+DFGLS +M                Y APE+   K  A 
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP--NYAAPEVISGKLYAG 190
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            + DV+S GV +  +L  + P
Sbjct: 191 PEVDVWSCGVILYVMLCRRLP 211

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 135/286 (47%), Gaps = 36/286 (12%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    +++ 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPE---TPIDWP---TRMKIIKG-MTRG 399
           L    +  +G+  L++ + M  G L ++L +  PE    P+  P   ++M  + G +  G
Sbjct: 80  LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++N+  +H +L + N  + +    KI DFG++R +               + + +P
Sbjct: 138 MAYLNANK-FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +DV+S GV + E+ T  + P + L+  ++ ++            V +  
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 244
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL-EEIRP 562
           L+       D LL  +++   C   +P  RP  L+++  + EE+ P
Sbjct: 245 LLDKPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKITKGQ-REFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T+    +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++ +Y   G+L  +L AR P             E  + +  
Sbjct: 103 IINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++  Y   G+L  +L AR P             E  + +  
Sbjct: 103 IINL----LGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKI 392
           EV++L  + HPN++ L  ++   K    LV +    G L   +  R     +D      I
Sbjct: 86  EVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---I 141
Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXXXXXXXXX 449
           IK +  G+ +LH + NI+H +L   N+LL+        KI DFGLS +            
Sbjct: 142 IKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                Y APE+ + KK + K DV+S+GV +  LL G  P
Sbjct: 201 TAY--YIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G+ ++G V   Y  T   G +VA+K + +K+   +  Q   E E+S L  +RHP+++ L
Sbjct: 16  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  K E ++V +Y  +  L  ++  R   +        +  + +   + + H ++ 
Sbjct: 74  YDV-IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE---QEARRFFQQIISAVEYCHRHK- 127
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLK-KAN 467
           I+H +L   N+LLD+  N KI+DFGLS +M                Y APE+   K  A 
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP--NYAAPEVISGKLYAG 185
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            + DV+S GV +  +L  + P
Sbjct: 186 PEVDVWSCGVILYVMLCRRLP 206

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G+ ++G V   Y  T   G +VA+K + +K+   +  Q   E E+S L  +RHP+++ L
Sbjct: 12  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +  K E ++V +Y  +  L  ++  R   +        +  + +   + + H ++ 
Sbjct: 70  YDV-IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE---QEARRFFQQIISAVEYCHRHK- 123
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLK-KAN 467
           I+H +L   N+LLD+  N KI+DFGLS +M                Y APE+   K  A 
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP--NYAAPEVISGKLYAG 181
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            + DV+S GV +  +L  + P
Sbjct: 182 PEVDVWSCGVILYVMLCRRLP 202

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALR 349
           + +G+  YG V  A      ++VA+K++   E  T  QR    E+ +L + RH N++ +R
Sbjct: 49  QYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIR 107
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                   E +    Y+    + T L+       +        +  + RGL ++HS  N+
Sbjct: 108 DILRASTLEAMRDV-YIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS-ANV 165
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
           +H +L  SN+L++ + + KI DFGL+R+                   YRAPE+    K  
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGY 225
Query: 468 TKT-DVYSLGVTILELLTGK 486
           TK+ D++S+G  + E+L+ +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 46/293 (15%)
Query: 295 MGKSTYGTVYKATL--------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPN 344
           +G+  +G V  A          ++   VAVK L++  T K   +  SE+ ++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPT 388
           ++ L    LG     G   ++  Y   G+L  +L AR P             E  + +  
Sbjct: 103 IINL----LGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXX 447
            +     + RG+ +L S +  IH +L + NVL+ ++   KI+DFGL+R +          
Sbjct: 159 LVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 448 XXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
                + + APE    +    ++DV+S GV + E+ T       L G+  P     I  E
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSPYP----GIPVE 266
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           E    + +   M       +EL   ++   H V   PS RP   Q+V+ L+ I
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 316

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 9/199 (4%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G   +G V++ T    G+  A K +       +     E+  +  +RHP L+ L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +     E ++++++M  G L  F         +     ++ ++ + +GL H+H N N +H
Sbjct: 223 FED-DNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVH 278
Query: 412 GNLTSSNVLL--DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L   N++     S   K+ DFGL+  +                  APE+++ K     
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA--APEVAEGKPVGYY 336
Query: 470 TDVYSLGVTILELLTGKSP 488
           TD++S+GV    LL+G SP
Sbjct: 337 TDMWSVGVLSYILLSGLSP 355

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 293 EIMGKSTYGTVY---KATLEDGSQVAVKRLREKITKGQR-----EFESEVSLLGKIRHPN 344
           +++G   YG V+   K +  D  ++   ++ +K T  Q+        +E  +L  IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHL 403
            L    Y    + +  L+ DY+  G L T L  R   T       ++I  G +   L HL
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIVLALEHL 175
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           H    II+ ++   N+LLD + +  ++DFGLS+                + Y AP++ + 
Sbjct: 176 HKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 464 KKA--NTKTDVYSLGVTILELLTGKSP----GEPLNGAELPQWV 501
             +  +   D +SLGV + ELLTG SP    GE  + AE+ + +
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLR-----EKITKGQREFESEVSLLGKIRHPNLL 346
           E +G+ TYGTV+KA   E    VA+KR+R     E +         E+ LL +++H N++
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIV 64
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG----MTRGLLH 402
            L    L    +  LVF++        F    G   P       +I+K     + +GL  
Sbjct: 65  RLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-------EIVKSFLFQLLKGLGF 116
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LS 461
            HS  N++H +L   N+L++ +   K++DFGL+R                L YR P+ L 
Sbjct: 117 CHS-RNVLHRDLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE 496
             K  +T  D++S G    EL     P  P N  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVD 209

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 114/267 (42%), Gaps = 31/267 (11%)
Query: 301 GTVYKATLEDGSQVAVK--RLREKITKGQREFESEVSLLGKIRHPNLL-ALRAYYLGPKG 357
           G ++K   + G+ + VK  ++R+  T+  R+F  E   L    HPN+L  L A    P  
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN-LTS 416
              L+  + P+GSL   LH  G    +D    +K      RG   LH+ E +I  + L S
Sbjct: 83  HPTLITHWXPYGSLYNVLH-EGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNS 141
Query: 417 SNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK---TDVY 473
            +V +D+   A+IS   +                    + APE  + K  +T     D +
Sbjct: 142 RSVXIDEDXTARISXADVKFSFQSPGRXYAP------AWVAPEALQKKPEDTNRRSADXW 195
Query: 474 SLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL-LNT 532
           S  V + EL+T + P   L+  E+   VA             LE +R  PTI   +  + 
Sbjct: 196 SFAVLLWELVTREVPFADLSNXEIGXKVA-------------LEGLR--PTIPPGISPHV 240
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEE 559
            KL   C +  P+ RP+   +V  LE+
Sbjct: 241 SKLXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/311 (21%), Positives = 143/311 (45%), Gaps = 41/311 (13%)
Query: 275 HFDGPLMFTADDLLCATAEI-----MGKSTYGTVYKATL------EDGSQVAVKRLREKI 323
           +F    ++  D+   A  +I     +G+ ++G VY+         E  ++VA+K + E  
Sbjct: 8   YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67
Query: 324 TKGQR-EFESEVSLLGKIRHPNLLALRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGP- 380
           +  +R EF +E S++ +    +++ L    +  +G+  L++ + M  G L ++L +  P 
Sbjct: 68  SMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125
Query: 381 --ETPIDWP---TRMKIIKG-MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL 434
               P+  P   ++M  + G +  G+ +L++N+  +H +L + N ++ +    KI DFG+
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 435 SR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPL 492
           +R +               + + +PE  K     T +DV+S GV + E+ T  + P + L
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 493 NGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQ 552
           +  ++ ++            V +  L+       D L   +++   C   +P  RP  L+
Sbjct: 245 SNEQVLRF------------VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLE 289
Query: 553 VVQQL-EEIRP 562
           ++  + EE+ P
Sbjct: 290 IISSIKEEMEP 300

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 106/229 (46%), Gaps = 15/229 (6%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++    A+
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I
Sbjct: 77  Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKI 129
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + +
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRS---YMSPERLQGTHYSVQ 186
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
           +D++S+G++++E+  G+ P  P+   EL  ++ +    +  + VF LE 
Sbjct: 187 SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEF 235

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 157
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 158 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 213
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 214 VDIWSVGCIMAELLTGRTLFPG 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS-ADII 143
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPG 221

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 82/180 (45%), Gaps = 21/180 (11%)
Query: 316 VKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATF 374
           V+ LRE   K       EV +L K+  HPN++ L+  Y        LVFD M  G L  +
Sbjct: 50  VQELREATLK-------EVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDY 101
Query: 375 LHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL 434
           L  +   T  +  TR KI++ +   +  LH   NI+H +L   N+LLDD  N K++DFG 
Sbjct: 102 LTEKV--TLSEKETR-KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGF 157
Query: 435 SRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT------KTDVYSLGVTILELLTGKSP 488
           S  +                Y APE+ +    +       + D++S GV +  LL G  P
Sbjct: 158 SCQLDPGEKLREVCGTP--SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 9/199 (4%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G   +G V++ T    G+  A K +       +     E+  +  +RHP L+ L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +     E ++++++M  G L  F         +     ++ ++ + +GL H+H N N +H
Sbjct: 117 FED-DNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVH 172
Query: 412 GNLTSSNVLL--DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L   N++     S   K+ DFGL+  +                  APE+++ K     
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA--APEVAEGKPVGYY 230
Query: 470 TDVYSLGVTILELLTGKSP 488
           TD++S+GV    LL+G SP
Sbjct: 231 TDMWSVGVLSYILLSGLSP 249

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 167
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 168 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 223
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPG 245

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++ +  KI DFGL R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 166
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 167 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 222
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPG 244

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 143
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPG 221

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 143
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQT 199
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPG 221

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 153
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 154 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPG 231

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 167
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 168 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGXVATRWYRAPEIMLNWMHYNQT 223
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPG 245

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 41/290 (14%)
Query: 294 IMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAY 351
           ++ +  +  VY+A  +  G + A+KRL     +  R    EV  + K+  HPN++   + 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 352 YLGPKGE------KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
               K E      + L+   +  G L  FL       P+   T +KI     R + H+H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 406 NEN-IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXL----------- 453
            +  IIH +L   N+LL +    K+ DFG +  +              L           
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 454 GYRAPELSKLKK---ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT 510
            YR PE+  L        K D+++LG  +  L   + P E  +GA+L      IV  +++
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE--DGAKL-----RIVNGKYS 267
Query: 511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
               D +      T+   L+  +      +  +P  R  + +VV QL+EI
Sbjct: 268 IPPHDTQY-----TVFHSLIRAM------LQVNPEERLSIAEVVHQLQEI 306

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 82/180 (45%), Gaps = 21/180 (11%)
Query: 316 VKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATF 374
           V+ LRE   K       EV +L K+  HPN++ L+  Y        LVFD M  G L  +
Sbjct: 63  VQELREATLK-------EVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDY 114
Query: 375 LHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL 434
           L  +   T  +  TR KI++ +   +  LH   NI+H +L   N+LLDD  N K++DFG 
Sbjct: 115 LTEKV--TLSEKETR-KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 435 SRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT------KTDVYSLGVTILELLTGKSP 488
           S  +                Y APE+ +    +       + D++S GV +  LL G  P
Sbjct: 171 SCQLDPGEKLREVCGTP--SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 82/180 (45%), Gaps = 21/180 (11%)
Query: 316 VKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATF 374
           V+ LRE   K       EV +L K+  HPN++ L+  Y        LVFD M  G L  +
Sbjct: 63  VQELREATLK-------EVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDY 114
Query: 375 LHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL 434
           L  +   T  +  TR KI++ +   +  LH   NI+H +L   N+LLDD  N K++DFG 
Sbjct: 115 LTEKV--TLSEKETR-KIMRALLEVICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 435 SRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT------KTDVYSLGVTILELLTGKSP 488
           S  +                Y APE+ +    +       + D++S GV +  LL G  P
Sbjct: 171 SCQLDPGEKLRSVCGTP--SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 154
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPG 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 154
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPG 232

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 154
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPG 232

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIR-HPNLLALR 349
           +GK  YG V+K+     G  VAVK++ +     T  QR F  E+ +L ++  H N++ L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
                     + LVFDYM      T LHA      ++   +  ++  + + + +LHS   
Sbjct: 76  NVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG-G 129
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXX--------------------XX 448
           ++H ++  SN+LL+   + K++DFGLSR                                
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 449 XXXXLGYRAPELSKLKKANTK-TDVYSLGVTILELLTGK 486
                 YRAPE+       TK  D++SLG  + E+L GK
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 149
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++ +  KI DFGL+R                  YRAPE+       N  
Sbjct: 150 HRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPG 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 294 IMGKSTYGTVYKATLEDGSQ----VAVKRLREKI----TKGQREFESEVSLLGKIRHPNL 345
           ++GK  YG V++     G+      A+K L++ +     K     ++E ++L +++HP +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L  Y     G+  L+ +Y+  G L   L   G        T    +  ++  L HLH 
Sbjct: 84  VDL-IYAFQTGGKLYLILEYLSGGELFMQLEREGIFME---DTACFYLAEISMALGHLH- 138
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            + II+ +L   N++L+   + K++DFGL +                + Y APE+     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
            N   D +SLG  + ++LTG  P
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/282 (21%), Positives = 128/282 (45%), Gaps = 35/282 (12%)
Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGMTRG 399
           L    +  KG+  L+V + M HG L ++L +  PE        P      +++   +  G
Sbjct: 86  LLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++ +  +H NL + N ++      KI DFG++R +               + + AP
Sbjct: 144 MAYLNAKK-FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +D++S GV + E+ +  + P + L+  ++ ++            V D  
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 250
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            +       + + + +++   C   +P+ RP  L++V  L++
Sbjct: 251 YLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 289

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 153
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++ +  KI DFGL+R                  YRAPE+       N  
Sbjct: 154 HRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPG 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/282 (21%), Positives = 128/282 (45%), Gaps = 35/282 (12%)
Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGMTRG 399
           L    +  KG+  L+V + M HG L ++L +  PE        P      +++   +  G
Sbjct: 85  LLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++ +  +H NL + N ++      KI DFG++R +               + + AP
Sbjct: 143 MAYLNAKK-FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +D++S GV + E+ +  + P + L+  ++ ++            V D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            +       + + + +++   C   +P+ RP  L++V  L++
Sbjct: 250 YLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 288

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 159
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 160 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPG 237

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 154
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPG 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 159
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 160 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPG 237

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 159
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 160 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPG 237

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 294 IMGKSTYGTVYKATLEDGSQ----VAVKRLREKI----TKGQREFESEVSLLGKIRHPNL 345
           ++GK  YG V++     G+      A+K L++ +     K     ++E ++L +++HP +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L  Y     G+  L+ +Y+  G L   L   G        T    +  ++  L HLH 
Sbjct: 84  VDL-IYAFQTGGKLYLILEYLSGGELFMQLEREGIFME---DTACFYLAEISMALGHLH- 138
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            + II+ +L   N++L+   + K++DFGL +                + Y APE+     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAPEILMRSG 197
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
            N   D +SLG  + ++LTG  P
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 149
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 150 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPG 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 149
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 150 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPG 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 152
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 153 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPG 230

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 152
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 153 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPG 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 170
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 171 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGYVATRWYRAPEIMLNWMHYNQT 226
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPG 248

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 146
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 147 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 202
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 203 VDIWSVGCIMAELLTGRTLFPG 224

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 153
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 154 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPG 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 144
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 145 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPG 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 12  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 63  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 109
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              P  E++    Y+    +   L+       +        +  + RGL ++HS  N++H
Sbjct: 110 IRAPTIEQMKDV-YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-ANVLH 167
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLM--XXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            +L  SN+LL+ + + KI DFGL+R+                   YRAPE+    K  TK
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 470 T-DVYSLGVTILELLTGKS--PGE 490
           + D++S+G  + E+L+ +   PG+
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGK 251

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 25/202 (12%)
Query: 302 TVYKATLEDGSQVAVKRLR--------EKITKGQREFESEVSLLGKIR-HPNLLALRAYY 352
            V++AT   G + AVK +         E++ + +     E  +L ++  HP+++ L   Y
Sbjct: 113 CVHRAT---GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
                   LVFD M  G L  +L  +     +       I++ +   +  LH+N NI+H 
Sbjct: 170 -ESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN-NIVHR 224
Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT---- 468
           +L   N+LLDD+   ++SDFG S  +               GY APE+ K     T    
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP--GYLAPEILKCSMDETHPGY 282
Query: 469 --KTDVYSLGVTILELLTGKSP 488
             + D+++ GV +  LL G  P
Sbjct: 283 GKEVDLWACGVILFTLLAGSPP 304

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 170
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 171 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 226
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPG 248

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 167
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 168 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 223
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPG 245

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 143
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPG 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 149
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 150 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPG 227

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 116
Query: 367 PHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
             G+L  +L AR              PE  +     +     + RG+ +L S +  IH +
Sbjct: 117 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRD 175
Query: 414 LTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           L + NVL+ +    KI+DFGL+R +               + + APE    +    ++DV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S GV + E+ T       L G+  P     +  EE    + +   M       +EL   
Sbjct: 236 WSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMM 284
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++   H V   PS RP   Q+V+ L+ I
Sbjct: 285 MRDCWHAV---PSQRPTFKQLVEDLDRI 309

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 145
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 146 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 202 VDIWSVGCIMAELLTGRTLFPG 223

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 166
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 167 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 222
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPG 244

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 144
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 145 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPG 222

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 157
Query: 367 PHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
             G+L  +L AR              PE  +     +     + RG+ +L S +  IH +
Sbjct: 158 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRD 216
Query: 414 LTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           L + NVL+ +    KI+DFGL+R +               + + APE    +    ++DV
Sbjct: 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276
Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S GV + E+ T       L G+  P     +  EE    + +   M       +EL   
Sbjct: 277 WSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMM 325
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++   H V   PS RP   Q+V+ L+ I
Sbjct: 326 MRDCWHAV---PSQRPTFKQLVEDLDRI 350

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 153
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 154 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPG 231

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 54  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 109
Query: 367 PHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
             G+L  +L AR              PE  +     +     + RG+ +L S +  IH +
Sbjct: 110 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRD 168
Query: 414 LTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           L + NVL+ +    KI+DFGL+R +               + + APE    +    ++DV
Sbjct: 169 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 228
Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S GV + E+ T       L G+  P     +  EE    + +   M       +EL   
Sbjct: 229 WSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMM 277
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++   H V   PS RP   Q+V+ L+ I
Sbjct: 278 MRDCWHAV---PSQRPTFKQLVEDLDRI 302

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 152
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 153 HRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPG 230

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 116
Query: 367 PHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
             G+L  +L AR              PE  +     +     + RG+ +L S +  IH +
Sbjct: 117 SKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRD 175
Query: 414 LTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           L + NVL+ +    KI+DFGL+R +               + + APE    +    ++DV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S GV + E+ T       L G+  P     +  EE    + +   M       +EL   
Sbjct: 236 WSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMM 284
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++   H V   PS RP   Q+V+ L+ I
Sbjct: 285 MRDCWHAV---PSQRPTFKQLVEDLDRI 309

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 116
Query: 367 PHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
             G+L  +L AR              PE  +     +     + RG+ +L S +  IH +
Sbjct: 117 SKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRD 175
Query: 414 LTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           L + NVL+ +    KI+DFGL+R +               + + APE    +    ++DV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S GV + E+ T       L G+  P     +  EE    + +   M       +EL   
Sbjct: 236 WSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMM 284
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++   H V   PS RP   Q+V+ L+ I
Sbjct: 285 MRDCWHAV---PSQRPTFKQLVEDLDRI 309

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 50  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 105
Query: 367 PHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
             G+L  +L AR              PE  +     +     + RG+ +L S +  IH +
Sbjct: 106 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRD 164
Query: 414 LTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           L + NVL+ +    KI+DFGL+R +               + + APE    +    ++DV
Sbjct: 165 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 224
Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S GV + E+ T       L G+  P     +  EE    + +   M       +EL   
Sbjct: 225 WSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMM 273
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++   H V   PS RP   Q+V+ L+ I
Sbjct: 274 MRDCWHAV---PSQRPTFKQLVEDLDRI 298

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 46  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 101
Query: 367 PHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
             G+L  +L AR              PE  +     +     + RG+ +L S +  IH +
Sbjct: 102 SKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRD 160
Query: 414 LTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           L + NVL+ +    KI+DFGL+R +               + + APE    +    ++DV
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220
Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S GV + E+ T       L G+  P     +  EE    + +   M       +EL   
Sbjct: 221 WSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMM 269
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++   H V   PS RP   Q+V+ L+ I
Sbjct: 270 MRDCWHAV---PSQRPTFKQLVEDLDRI 294

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 134/286 (46%), Gaps = 36/286 (12%)
Query: 295 MGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    +++ 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGP---ETPIDWP---TRMKIIKG-MTRG 399
           L    +  +G+  L++ + M  G L ++L +  P     P+  P   ++M  + G +  G
Sbjct: 83  LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++N+  +H +L + N ++ +    KI DFG++R +               + + +P
Sbjct: 141 MAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +DV+S GV + E+ T  + P + L+  ++ ++            V +  
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 247
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL-EEIRP 562
           L+       D L   +++   C   +P  RP  L+++  + EE+ P
Sbjct: 248 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 290

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGP---KGEKLLVFDYM 366
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L    LG     G   ++ +Y 
Sbjct: 53  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 108
Query: 367 PHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
             G+L  +L AR              PE  +     +     + RG+ +L S +  IH +
Sbjct: 109 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRD 167
Query: 414 LTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDV 472
           L + NVL+ +    KI+DFGL+R +               + + APE    +    ++DV
Sbjct: 168 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 227
Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S GV + E+ T       L G+  P     +  EE    + +   M       +EL   
Sbjct: 228 WSFGVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMM 276
Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++   H V   PS RP   Q+V+ L+ I
Sbjct: 277 MRDCWHAV---PSQRPTFKQLVEDLDRI 301

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 158
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 159 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPG 236

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNAMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 26/201 (12%)
Query: 308 LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL---GPKGEKLLVFD 364
           L DG   A+KR+     + + E + E  +     HPN+L L AY L   G K E  L+  
Sbjct: 51  LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 365 YMPHGSLAT---FLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSN 418
           +   G+L      L  +G    E  I W     ++ G+ RGL  +H+ +   H +L  +N
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILW-----LLLGICRGLEAIHA-KGYAHRDLKPTN 164
Query: 419 VLLDDSTNAKISDFG--------LSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK---AN 467
           +LL D     + D G        +                  + YRAPEL  ++     +
Sbjct: 165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            +TDV+SLG  +  ++ G+ P
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGP 245

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 152
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 153 HRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPG 230

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 32/265 (12%)
Query: 312 SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPHG 369
           ++VAVK L+   T K   +  SE+ ++  I +H N++ L        G   ++ +Y   G
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKG 119
Query: 370 SLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTS 416
           +L  +L AR              PE  +     +     + RG+ +L S +  IH +L +
Sbjct: 120 NLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAA 178
Query: 417 SNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSL 475
            NVL+ +    KI+DFGL+R +               + + APE    +    ++DV+S 
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 476 GVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKL 535
           GV + E+ T       L G+  P     +  EE    + +   M       +EL   ++ 
Sbjct: 239 GVLLWEIFT-------LGGSPYP----GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD 287
Query: 536 ALHCVDPSPSARPEVLQVVQQLEEI 560
             H V   PS RP   Q+V+ L+ I
Sbjct: 288 CWHAV---PSQRPTFKQLVEDLDRI 309

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 12  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 63  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 158
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DFGL+R                  YRAPE+       N  
Sbjct: 159 HRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPG 236

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 12  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 63  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRA 350
           +GK  +  V  A  +  G +VA+K + +     T  Q+ F  EV ++  + HPN++ L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 351 YYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +   + EK   L+ +Y   G +  +L A G     +  ++ + I      + + H  + 
Sbjct: 80  -FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI---VSAVQYCH-QKR 134
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK + 
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP--YAAPELFQGKKYDG 192
Query: 469 -KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
            + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 10  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 61  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 117 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 12  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 63  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 12  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 63  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 12  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 63  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K L++++   + E     +E  +L   RHP L
Sbjct: 15  KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 71
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 72  TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLHS 127
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            +N+++ +L   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 128 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDND 186
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 295 MGKSTYGTVYKATL-----EDGS-QVAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL 346
           +G   +G V +AT      ED   +VAVK L+      ++E   SE+ ++  + +H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 347 ALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
            L    LG     G  L++ +Y  +G L  FL  +      D    +      TR LLH 
Sbjct: 114 NL----LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 404 HS----------NENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXX 452
            S          ++N IH ++ + NVLL +   AKI DFGL+R +M              
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           + + APE         ++DV+S G+ + E+ +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 12  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 63  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K L++++   + E     +E  +L   RHP L
Sbjct: 14  KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 70
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 71  TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLHS 126
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            +N+++ +L   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDND 185
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K L++++   + E     +E  +L   RHP L
Sbjct: 16  KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 72
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 73  TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLHS 128
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            +N+++ +L   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDND 187
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLR-----EKITKGQREFESEVSLLGKIRHPNLL 346
           E +G+ TYGTV+KA   E    VA+KR+R     E +         E+ LL +++H N++
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIV 64
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG----MTRGLLH 402
            L    L    +  LVF++        F    G   P       +I+K     + +GL  
Sbjct: 65  RLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-------EIVKSFLFQLLKGLGF 116
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LS 461
            HS  N++H +L   N+L++ +   K+++FGL+R                L YR P+ L 
Sbjct: 117 CHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE 496
             K  +T  D++S G    EL     P  P N  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++G+  +G V KA    D    A+K++R   EK++       SEV LL  + H  ++   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVMLLASLNHQYVVRYY 68
Query: 350 AYYL------------GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
           A +L              K    +  +Y  +G+L   +H+       D   R+   + + 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL--FRQIL 126
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG--- 454
             L ++HS + IIH +L   N+ +D+S N KI DFGL++ +               G   
Sbjct: 127 EALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 455 ----------YRAPE-LSKLKKANTKTDVYSLGVTILELLTGKSPG 489
                     Y A E L      N K D+YSLG+   E++   S G
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI D+GL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K L++++   + E     +E  +L   RHP L
Sbjct: 154 KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLHS 266
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            +N+++ +L   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRA 350
           +GK  +  V  A  +  G +VA+K + +     T  Q+ F  EV ++  + HPN++ L  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 76
Query: 351 YYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +   + EK   L+ +Y   G +  +L A G     +  ++ + I      + + H  + 
Sbjct: 77  -FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI---VSAVQYCH-QKR 131
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK + 
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPP--YAAPELFQGKKYDG 189
Query: 469 -KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
            + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 223

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVK---RLREKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +GK  +  V  A  +  G +VAVK   + +   T  Q+ F  EV ++  + HPN++ L  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 351 YYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +   + EK   LV +Y   G +  +L A G     +   + + I      + + H  + 
Sbjct: 80  -FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQ-KY 134
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK + 
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPP--YAAPELFQGKKYDG 192
Query: 469 -KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
            + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K L++++   + E     +E  +L   RHP L
Sbjct: 157 KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 213
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 214 TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLHS 269
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            +N+++ +L   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 270 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 328
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT+   G  VAVK++  +  + +    +EV ++   +H N++ +   YL
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + + L  LH+ + +IH
Sbjct: 99  --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHA-QGVIH 150
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
            ++ S ++LL      K+SDFG    +                + APEL        + D
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVD 209
Query: 472 VYSLGVTILELLTGKSP 488
           ++SLG+ ++E++ G+ P
Sbjct: 210 IWSLGIMVIEMVDGEPP 226

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 11  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 62  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 118 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 293 EIMGKSTYGTVY--KATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRA 350
           E++G   +  V+  K  L  G   A+K +++         E+E+++L KI+H N++ L  
Sbjct: 15  EVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            Y        LV   +  G L   +  RG  T  D      +I+ +   + +LH N  I+
Sbjct: 74  IY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLSAVKYLHEN-GIV 128
Query: 411 HGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
           H +L   N+L    ++++   I+DFGLS++                GY APE+   K  +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP---GYVAPEVLAQKPYS 185
Query: 468 TKTDVYSLGVTILELLTGKSP 488
              D +S+GV    LL G  P
Sbjct: 186 KAVDCWSIGVITYILLCGYPP 206

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 39/215 (18%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  +  ++ G ++AVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL-- 115
Query: 351 YYLGPKGEKLLVFDYMPHGSLATF------LHARGPE-------TPIDWPTRMKIIKGMT 397
                    L VF   P  SL  F       H  G +         +       +I  + 
Sbjct: 116 ---------LDVF--TPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 164
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRA 457
           RGL ++HS  +IIH +L  SN+ +++    KI DFGL+R                  YRA
Sbjct: 165 RGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 219
Query: 458 PELS-KLKKANTKTDVYSLGVTILELLTGKS--PG 489
           PE+       N   D++S+G  + ELLTG++  PG
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPG 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLRE-----KITKGQREFES------EVSLLGKI 340
            + +G+  YG V         Q+AV R+ E     KI   +R  +       E+ +   +
Sbjct: 12  VQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            H N++     + G + E  + + ++ + S         P+  +  P   +    +  G+
Sbjct: 63  NHENVVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPE 459
           ++LH    I H ++   N+LLD+  N KISDFGL+ +                L Y APE
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 460 LSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
           L K ++ + +  DV+S G+ +  +L G+ P +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT+   G  VAVK++  +  + +    +EV ++   +H N++ +   YL
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + + L  LH+ + +IH
Sbjct: 97  --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHA-QGVIH 148
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
            ++ S ++LL      K+SDFG    +                + APEL        + D
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVD 207
Query: 472 VYSLGVTILELLTGKSP 488
           ++SLG+ ++E++ G+ P
Sbjct: 208 IWSLGIMVIEMVDGEPP 224

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPN 344
            E +G   +  V K   +  G + A K ++++     R      E E EV++L +IRHPN
Sbjct: 17  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 76
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L   +   K + +L+ + +  G L  FL  +   T  D  T+   +K +  G+ +LH
Sbjct: 77  IITLHDIFEN-KTDVVLILELVSGGELFDFLAEKESLTE-DEATQF--LKQILDGVHYLH 132
Query: 405 SNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL 460
           S + I H +L   N++L D        K+ DFG++  +                + APE+
Sbjct: 133 S-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE--FVAPEI 189
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
              +    + D++S+GV    LL+G SP
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 127/282 (45%), Gaps = 35/282 (12%)
Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGMTRG 399
           L    +  KG+  L+V + M HG L ++L +  PE        P      +++   +  G
Sbjct: 85  LLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++ +  +H +L + N ++      KI DFG++R +               + + AP
Sbjct: 143 MAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +D++S GV + E+ +  + P + L+  ++ ++            V D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            +       + + + +++   C   +P  RP  L++V  L++
Sbjct: 250 YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 25/222 (11%)
Query: 295 MGKSTYGTVYKATLED----GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 76
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 77  ---IGVITENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES-K 130
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 468 TKTDVYSLGVTILELLT-GKSP----------GEPLNGAELP 498
           + +DV+  GV + E+L  G  P          G   NG  LP
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/282 (21%), Positives = 130/282 (46%), Gaps = 35/282 (12%)
Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGMTRG 399
           L    +  KG+  L+V + M HG L ++L +  PE        P      +++   +  G
Sbjct: 85  LLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++ +  +H +L + N ++      KI DFG++R +               + + AP
Sbjct: 143 MAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +D++S GV + E+ +  + P + L+  ++ ++            V D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            +       + + + +++   C   +P+ RP  L++V  L++
Sbjct: 250 YLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 288

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPN 344
            E +G   +  V K   +  G + A K ++++     R      E E EV++L +IRHPN
Sbjct: 31  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPN 90
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L   +   K + +L+ + +  G L  FL  +   T  D  T  + +K +  G+ +LH
Sbjct: 91  IITLHDIFEN-KTDVVLILELVSGGELFDFLAEKESLTE-DEAT--QFLKQILDGVHYLH 146
Query: 405 SNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL 460
           S + I H +L   N++L D        K+ DFG++  +                + APE+
Sbjct: 147 S-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE--FVAPEI 203
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
              +    + D++S+GV    LL+G SP
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT+   G  VAVK++  +  + +    +EV ++   +H N++ +   YL
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + + L  LH+ + +IH
Sbjct: 219 --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHA-QGVIH 270
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
            ++ S ++LL      K+SDFG    +                + APEL        + D
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVD 329
Query: 472 VYSLGVTILELLTGKSP 488
           ++SLG+ ++E++ G+ P
Sbjct: 330 IWSLGIMVIEMVDGEPP 346

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPN 344
            E +G   +  V K   +  G + A K ++++     R      E E EV++L +IRHPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L   +   K + +L+ + +  G L  FL  +   T  D  T  + +K +  G+ +LH
Sbjct: 70  IITLHDIFEN-KTDVVLILELVSGGELFDFLAEKESLTE-DEAT--QFLKQILDGVHYLH 125
Query: 405 SNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL 460
           S + I H +L   N++L D        K+ DFG++  +                + APE+
Sbjct: 126 S-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE--FVAPEI 182
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
              +    + D++S+GV    LL+G SP
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT+   G  VAVK++  +  + +    +EV ++   +H N++ +   YL
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + + L  LH+ + +IH
Sbjct: 88  --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHA-QGVIH 139
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
            ++ S ++LL      K+SDFG    +                + APEL        + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVD 198
Query: 472 VYSLGVTILELLTGKSP 488
           ++SLG+ ++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 44/214 (20%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVS---------LLGKIRHPN 344
           +G   YG+V  A     G +VA+K+L        R F+SE+          LL  ++H N
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 345 LL----------ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK 394
           ++          +LR +Y     +  LV  +M    L   +  +  E  I +     ++ 
Sbjct: 85  VIGLLDVFTPASSLRNFY-----DFYLVMPFM-QTDLQKIMGLKFSEEKIQY-----LVY 133
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG 454
            M +GL ++HS   ++H +L   N+ +++    KI DFGL+R                  
Sbjct: 134 QMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRW 188
Query: 455 YRAPE-LSKLKKANTKTDVYSLGVTILELLTGKS 487
           YRAPE +      N   D++S+G  + E+LTGK+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT+   G  VAVK++  +  + +    +EV ++   +H N++ +   YL
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + + L  LH+ + +IH
Sbjct: 142 --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHA-QGVIH 193
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
            ++ S ++LL      K+SDFG    +                + APEL        + D
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVD 252
Query: 472 VYSLGVTILELLTGKSP 488
           ++SLG+ ++E++ G+ P
Sbjct: 253 IWSLGIMVIEMVDGEPP 269

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++    A+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I
Sbjct: 74  Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKI 126
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQ 183
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAEL 497
           +D++S+G++++E+  G+ P  P +  EL
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ------REFESEVSLLGKIRHPNLLA 347
           +GK  +  V  A  +  G +VAVK     I K Q      ++   EV ++  + HPN++ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 348 LRAYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           L   +   + EK   LV +Y   G +  +L A G     +   + + I      + + H 
Sbjct: 78  L---FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQ 131
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            + I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK
Sbjct: 132 -KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPP--YAAPELFQGKK 188
Query: 466 ANT-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
            +  + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 127/282 (45%), Gaps = 35/282 (12%)
Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGMTRG 399
           L    +  KG+  L+V + M HG L ++L +  PE        P      +++   +  G
Sbjct: 84  LLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++ +  +H +L + N ++      KI DFG++R +               + + AP
Sbjct: 142 MAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +D++S GV + E+ +  + P + L+  ++ ++            V D  
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 248
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            +       + + + +++   C   +P  RP  L++V  L++
Sbjct: 249 YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 287

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 127/282 (45%), Gaps = 35/282 (12%)
Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGMTRG 399
           L    +  KG+  L+V + M HG L ++L +  PE        P      +++   +  G
Sbjct: 85  LLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++ +  +H +L + N ++      KI DFG++R +               + + AP
Sbjct: 143 MAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +D++S GV + E+ +  + P + L+  ++ ++            V D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            +       + + + +++   C   +P  RP  L++V  L++
Sbjct: 250 YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++    A+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I
Sbjct: 74  Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKI 126
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQ 183
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAEL 497
           +D++S+G++++E+  G+ P  P +  EL
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ + G V  AT+   G  VAVK++  +  + +    +EV ++   +H N++ +   YL
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 354 GPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
              G++L +V +++  G+L   + H R  E  I       +   + + L  LH+ + +IH
Sbjct: 92  --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHA-QGVIH 143
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTD 471
            ++ S ++LL      K+SDFG    +                + APEL        + D
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVD 202
Query: 472 VYSLGVTILELLTGKSP 488
           ++SLG+ ++E++ G+ P
Sbjct: 203 IWSLGIMVIEMVDGEPP 219

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++    A+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I
Sbjct: 74  Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKI 126
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQ 183
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAEL 497
           +D++S+G++++E+  G+ P  P +  EL
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++    A+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I
Sbjct: 74  Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKI 126
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQ 183
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAEL 497
           +D++S+G++++E+  G+ P  P +  EL
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 89/196 (45%), Gaps = 14/196 (7%)
Query: 295 MGKSTYGTVYKATLED----GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 76
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 77  ---IGVITENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES-K 130
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 468 TKTDVYSLGVTILELL 483
           + +DV+  GV + E+L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/282 (21%), Positives = 128/282 (45%), Gaps = 35/282 (12%)
Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGMTRG 399
           L       KG+  L+V + M HG L ++L +  PE        P      +++   +  G
Sbjct: 82  LLGVV--SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++ +  +H +L + N ++      KI DFG++R +               + + AP
Sbjct: 140 MAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +D++S GV + E+ +  + P + L+  ++ ++            V D  
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 246
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            +       + + + +++   C   +P  RP  L++V  L++
Sbjct: 247 YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 285

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/282 (21%), Positives = 128/282 (45%), Gaps = 35/282 (12%)
Query: 295 MGKSTYGTVYKATLED------GSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +G+ ++G VY+    D       ++VAVK + E  +  +R EF +E S++      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGMTRG 399
           L       KG+  L+V + M HG L ++L +  PE        P      +++   +  G
Sbjct: 85  LLGVV--SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAP 458
           + +L++ +  +H +L + N ++      KI DFG++R +               + + AP
Sbjct: 143 MAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E  K     T +D++S GV + E+ +  + P + L+  ++ ++            V D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
            +       + + + +++   C   +P  RP  L++V  L++
Sbjct: 250 YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 295 MGKSTYGTVYKATL-EDGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG V  A     G++VA+K+L          +R +  E+ LL  +RH N++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLD 91
Query: 351 YY-----LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            +     L    +  LV  +M         H +  E  I +     ++  M +GL ++H+
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF-----LVYQMLKGLRYIHA 146
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE--LSKL 463
              IIH +L   N+ +++    KI DFGL+R                  YRAPE  L+ +
Sbjct: 147 A-GIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMXGXVVTRWYRAPEVILNWM 201
Query: 464 KKANTKTDVYSLGVTILELLTGKS 487
           +   T  D++S+G  + E++TGK+
Sbjct: 202 RYTQT-VDIWSVGCIMAEMITGKT 224

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 295 MGKSTYGTVYKATLED----GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 76
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 77  ---IGVITENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES-K 130
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 468 TKTDVYSLGVTILELL 483
           + +DV+  GV + E+L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ------REFESEVSLLGKIRHPNLLA 347
           +GK  +  V  A  +  G +VAVK     I K Q      ++   EV ++  + HPN++ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L    +  +    LV +Y   G +  +L A G     +   + + I      + + H  +
Sbjct: 78  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQ-K 132
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP--YAAPELFQGKKYD 190
Query: 468 T-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
             + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 44/214 (20%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVS---------LLGKIRHPN 344
           +G   YG+V  A     G +VA+K+L        R F+SE+          LL  ++H N
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 345 LL----------ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIK 394
           ++          +LR +Y     +  LV  +M    L   +     E  I +     ++ 
Sbjct: 103 VIGLLDVFTPASSLRNFY-----DFYLVMPFM-QTDLQKIMGMEFSEEKIQY-----LVY 151
Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG 454
            M +GL ++HS   ++H +L   N+ +++    KI DFGL+R                  
Sbjct: 152 QMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRW 206
Query: 455 YRAPE-LSKLKKANTKTDVYSLGVTILELLTGKS 487
           YRAPE +      N   D++S+G  + E+LTGK+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 81
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 82  ---IGVITENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES-K 135
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 468 TKTDVYSLGVTILELL 483
           + +DV+  GV + E+L
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRAYY 352
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++     +
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
               GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I+
Sbjct: 136 YS-DGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKIM 189
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + ++
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQS 246
Query: 471 DVYSLGVTILELLTGKSPGEPLNGAEL 497
           D++S+G++++E+  G+ P  P +  EL
Sbjct: 247 DIWSMGLSLVEMAVGRYPIPPPDAKEL 273

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI DF L+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 104
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 105 ---IGVITENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES-K 158
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 468 TKTDVYSLGVTILELL 483
           + +DV+  GV + E+L
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 79
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 80  ---IGVITENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES-K 133
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 468 TKTDVYSLGVTILELL 483
           + +DV+  GV + E+L
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 73
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 74  ---IGVITENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES-K 127
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 468 TKTDVYSLGVTILELL 483
           + +DV+  GV + E+L
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 25/222 (11%)
Query: 295 MGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 76
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 77  ---IGVITENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES-K 130
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 468 TKTDVYSLGVTILELLT-GKSP----------GEPLNGAELP 498
           + +DV+  GV + E+L  G  P          G   NG  LP
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 295 MGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 78
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 79  ---IGVITENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES-K 132
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 468 TKTDVYSLGVTILELL 483
           + +DV+  GV + E+L
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ------REFESEVSLLGKIRHPNLLA 347
           +GK  +  V  A  +  G +VAVK     I K Q      ++   EV ++  + HPN++ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L    +  +    LV +Y   G +  +L A G     +   + + I      + + H  +
Sbjct: 78  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQ-K 132
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP--YAAPELFQGKKYD 190
Query: 468 T-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
             + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E+  +  +G V+KA L +   VAVK    +  K   + E EV  L  ++H N+L     +
Sbjct: 30  EVKARGRFGCVWKAQLLN-EYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQ----F 83
Query: 353 LGPKG-------EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           +G +        +  L+  +   GSL+ FL A      + W     I + M RGL +LH 
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE 139
Query: 406 N---------ENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMXXXXXXXXXXXXXXLGY 455
           +           I H ++ S NVLL ++  A I+DFGL+ +                  Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 456 RAPE-----LSKLKKANTKTDVYSLGVTILELLTGKSPGE-PLNGAELP 498
            APE     ++  + A  + D+Y++G+ + EL +  +  + P++   LP
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 37/299 (12%)
Query: 290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF-ESEVSLLGKIRHPNLLAL 348
           A  E +GK  YG V++  L  G  VAVK    +    Q  F E+E+     +RH N+L  
Sbjct: 11  ALVECVGKGRYGEVWRG-LWHGESVAVKIFSSR--DEQSWFRETEIYNTVLLRHDNILGF 67
Query: 349 RAYYLGPKG---EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH- 404
            A  +  +    +  L+  Y  HGSL  FL  +  E  +     +++      GL HLH 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL----ALRLAVSAACGLAHLHV 123
Query: 405 ------SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---Y 455
                     I H +  S NVL+  +    I+D GL+ +               +G   Y
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 183
Query: 456 RAPEL------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW 509
            APE+      +   ++   TD+++ G+ + E+         +     P     +V  + 
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPP--FYDVVPNDP 241
Query: 510 TNEVFDLELMRD--APTI-----GDELLNTL-KLALHCVDPSPSARPEVLQVVQQLEEI 560
           + E     +  D   PTI      D +L+ L ++   C  P+PSAR   L++ + L++I
Sbjct: 242 SFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKI 300

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 25/222 (11%)
Query: 295 MGKSTYGTVYKATLED----GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 456
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 457 ---IGVITENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES-K 510
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 468 TKTDVYSLGVTILELLT-GKSP----------GEPLNGAELP 498
           + +DV+  GV + E+L  G  P          G   NG  LP
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 48/242 (19%)
Query: 292 AEIMGKSTYGTVYKATLEDGS------QVAVKRLREKITKGQRE-FESEVSLLGKI-RHP 343
            +++G   +G V  AT    S      QVAVK L+EK    +RE   SE+ ++ ++  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 344 NLLALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP---ETPIDWPTR-------- 389
           N++ L    LG     G   L+F+Y  +G L  +L ++     E  I++  +        
Sbjct: 110 NIVNL----LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 390 -------------MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR 436
                         ++ KGM    L   S    +H +L + NVL+      KI DFGL+R
Sbjct: 166 LNVLTFEDLLCFAYQVAKGME--FLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 437 -LMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT---GKSPGEPL 492
            +M              + + APE         K+DV+S G+ + E+ +      PG P+
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 493 NG 494
           + 
Sbjct: 281 DA 282

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 36/242 (14%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FE----SEVSLLGKIRHPNLLAL 348
           +G+ T+G V+KA   + G +VA+K++   + + ++E F      E+ +L  ++H N++ L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 349 -------RAYYLGPKGEKLLVFDYMPH---GSLATFLHARGPETPIDWPTRMKIIKGMTR 398
                   + Y   KG   LVFD+  H   G L+  L               ++++ +  
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLN 136
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR---LMXXXXXXXXXXXXXXLGY 455
           GL ++H N+ I+H ++ ++NVL+      K++DFGL+R   L               L Y
Sbjct: 137 GLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 456 RAPE-LSKLKKANTKTDVYSLGVTILELLTGKSP-----GEPLNGAELPQWVASIVKEEW 509
           R PE L   +      D++  G  + E+ T +SP      E    A + Q   SI  E W
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 510 TN 511
            N
Sbjct: 255 PN 256

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++    A+
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I
Sbjct: 101 Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKI 153
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQ 210
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAEL 497
           +D++S+G++++E+  G+ P  P +  EL
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 15/215 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +  S     VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L    L P  +  +V +  P GSL   L        +   +R  +   +  G+ +L S
Sbjct: 78  IRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES 133
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKL 463
            +  IH +L + N+LL      KI DFGL R +                  + APE  K 
Sbjct: 134 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           +  +  +D +  GVT+ E+ T G+ P   LNG+++
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 227

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 25/222 (11%)
Query: 295 MGKSTYGTVYKATLED----GSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL- 456
Query: 350 AYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              +G   E    ++ +    G L +FL  R  +  +D  + +     ++  L +L S +
Sbjct: 457 ---IGVITENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES-K 510
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M              + + APE    ++  
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 468 TKTDVYSLGVTILELLT-GKSP----------GEPLNGAELP 498
           + +DV+  GV + E+L  G  P          G   NG  LP
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 88/180 (48%), Gaps = 11/180 (6%)
Query: 311 GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF-DYMPHG 369
           G QVAVK +  +  + +    +EV ++   +H N++ +   YL   GE+L V  +++  G
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL--VGEELWVLMEFLQGG 127
Query: 370 SLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAK 428
           +L   +   R  E  I       + + + + L +LH+ + +IH ++ S ++LL      K
Sbjct: 128 ALTDIVSQVRLNEEQI-----ATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDGRVK 181
Query: 429 ISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +SDFG    +                + APE+       T+ D++SLG+ ++E++ G+ P
Sbjct: 182 LSDFGFCAQISKDVPKRKXLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 333 EVSLLGKIRHPNLLALR-AYYLGPKGEKLLVFDYMPHGSLATFLH--ARGPETPIDWPTR 389
           E+ +L +   P ++    A+Y    GE  +  ++M  GSL   L    R PE  +     
Sbjct: 64  ELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---- 117
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
            K+   + RGL +L     I+H ++  SN+L++     K+ DFG+S  +           
Sbjct: 118 -KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 176
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
                Y APE  +    + ++D++S+G++++EL  G+ P  P +  EL
Sbjct: 177 RS---YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKEL 221

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 36/273 (13%)
Query: 293 EIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           EI  +  +G V+KA L  D   V +  L++K +    + E E+     ++H NLL   A 
Sbjct: 21  EIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQFIA- 76
Query: 352 YLGPKGEKL-----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
               +G  L     L+  +   GSL  +L        I W     + + M+RGL +LH +
Sbjct: 77  -AEKRGSNLEVELWLITAFHDKGSLTDYLKG----NIITWNELCHVAETMSRGLSYLHED 131
Query: 407 ----------ENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMXXXXXXXXXXXXXXLGY 455
                      +I H +  S NVLL     A ++DFGL+ R                  Y
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 456 RAPE-----LSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP--QWVASIVKE 507
            APE     ++  + A  + D+Y++G+ + EL++  K+   P++   LP  + +      
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSL 251
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCV 540
           E   EV   + MR  PTI D  L    LA  CV
Sbjct: 252 EELQEVVVHKKMR--PTIKDHWLKHPGLAQLCV 282

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ------REFESEVSLLGKIRHPNLLA 347
           +GK  +  V  A  +  G +VAVK     I K Q      ++   EV ++  + HPN++ 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 70
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L    +  +    LV +Y   G +  +L A G     +   + + I      + + H  +
Sbjct: 71  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQI---VSAVQYCHQ-K 125
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK +
Sbjct: 126 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP--YAAPELFQGKKYD 183
Query: 468 T-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
             + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 218

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 15/215 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +  S     VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L    L P  +  +V +  P GSL   L        +   +R  +   +  G+ +L S
Sbjct: 78  IRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES 133
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKL 463
            +  IH +L + N+LL      KI DFGL R +                  + APE  K 
Sbjct: 134 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           +  +  +D +  GVT+ E+ T G+ P   LNG+++
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 227

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 15/215 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +  S     VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L    L P  +  +V +  P GSL   L        +   +R  +   +  G+ +L S
Sbjct: 74  IRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES 129
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKL 463
            +  IH +L + N+LL      KI DFGL R +                  + APE  K 
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           +  +  +D +  GVT+ E+ T G+ P   LNG+++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +  S     VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L    L P  +  +V +  P GSL   L        +   +R  +   +  G+ +L S
Sbjct: 84  IRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES 139
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKL 463
            +  IH +L + N+LL      KI DFGL R +                  + APE  K 
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           +  +  +D +  GVT+ E+ T G+ P   LNG+++
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +  S     VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L    L P  +  +V +  P GSL   L        +   +R  +   +  G+ +L S
Sbjct: 74  IRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES 129
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKL 463
            +  IH +L + N+LL      KI DFGL R +                  + APE  K 
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           +  +  +D +  GVT+ E+ T G+ P   LNG+++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 295 MGKSTYGTVYKATL-----EDGS-QVAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL 346
           +G   +G V +AT      ED   +VAVK L+      ++E   SE+ ++  + +H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 347 ALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
            L    LG     G  L++ +Y  +G L  FL  +      D    +      TR LLH 
Sbjct: 114 NL----LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 404 HS----------NENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXX 452
            S          ++N IH ++ + NVLL +   AKI DFGL+R +M              
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
           + + APE         ++DV+S G+ + E+ +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 15/215 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +  S     VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L    L P  +  +V +  P GSL   L        +   +R  +   +  G+ +L S
Sbjct: 74  IRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES 129
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKL 463
            +  IH +L + N+LL      KI DFGL R +                  + APE  K 
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           +  +  +D +  GVT+ E+ T G+ P   LNG+++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 36/242 (14%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FE----SEVSLLGKIRHPNLLAL 348
           +G+ T+G V+KA   + G +VA+K++   + + ++E F      E+ +L  ++H N++ L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 349 -------RAYYLGPKGEKLLVFDYMPH---GSLATFLHARGPETPIDWPTRMKIIKGMTR 398
                   + Y   KG   LVFD+  H   G L+  L               ++++ +  
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLN 135
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR---LMXXXXXXXXXXXXXXLGY 455
           GL ++H N+ I+H ++ ++NVL+      K++DFGL+R   L               L Y
Sbjct: 136 GLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 456 RAPE-LSKLKKANTKTDVYSLGVTILELLTGKSP-----GEPLNGAELPQWVASIVKEEW 509
           R PE L   +      D++  G  + E+ T +SP      E    A + Q   SI  E W
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 510 TN 511
            N
Sbjct: 254 PN 255

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 15/215 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +  S     VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L    L P  +  +V +  P GSL   L        +   +R  +   +  G+ +L S
Sbjct: 84  IRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES 139
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXX--LGYRAPELSKL 463
            +  IH +L + N+LL      KI DFGL R +                  + APE  K 
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           +  +  +D +  GVT+ E+ T G+ P   LNG+++
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRA 350
           +GK  +  V  A  +  G +VAV R+ +K    +   ++   EV ++  + HPN++ L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL-- 78
Query: 351 YYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +   + EK   LV +Y   G +  +L A G     +   + + I      + + H  + 
Sbjct: 79  -FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQ-KF 133
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK + 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP--YAAPELFQGKKYDG 191
Query: 469 -KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
            + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 36/242 (14%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FE----SEVSLLGKIRHPNLLAL 348
           +G+ T+G V+KA   + G +VA+K++   + + ++E F      E+ +L  ++H N++ L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 349 -------RAYYLGPKGEKLLVFDYMPH---GSLATFLHARGPETPIDWPTRMKIIKGMTR 398
                   + Y   KG   LVFD+  H   G L+  L               ++++ +  
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLN 136
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR---LMXXXXXXXXXXXXXXLGY 455
           GL ++H N+ I+H ++ ++NVL+      K++DFGL+R   L               L Y
Sbjct: 137 GLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 456 RAPE-LSKLKKANTKTDVYSLGVTILELLTGKSP-----GEPLNGAELPQWVASIVKEEW 509
           R PE L   +      D++  G  + E+ T +SP      E    A + Q   SI  E W
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 510 TN 511
            N
Sbjct: 255 PN 256

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 12/172 (6%)
Query: 333 EVSLLGKIRHPNLLALRAYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRM 390
           EV ++  + HPN++ L   +   + EK   LV +Y   G +  +L A G     +   + 
Sbjct: 63  EVRIMKVLNHPNIVKL---FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXX 450
           + I      + + H  + I+H +L + N+LLD   N KI+DFG S               
Sbjct: 120 RQI---VSAVQYCHQ-KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGS 175
Query: 451 XXLGYRAPELSKLKKANT-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
               Y APEL + KK +  + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 176 PP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 295 MGKSTYGTVYKATLEDGSQ--VAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           +G+     VY+   + G+Q   A+K L++ + K  +   +E+ +L ++ HPN++ L+  +
Sbjct: 61  LGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P  E  LV + +  G L   +  +G  +  D       +K +   + +LH N  I+H 
Sbjct: 118 ETPT-EISLVLELVTGGELFDRIVEKGYYSERD---AADAVKQILEAVAYLHEN-GIVHR 172
Query: 413 NLTSSNVLLDDSTNA-----KISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
           +L   N+L   +T A     KI+DFGLS+++               GY APE+ +     
Sbjct: 173 DLKPENLLY--ATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP--GYCAPEILRGCAYG 228
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            + D++S+G+    LL G  P
Sbjct: 229 PEVDMWSVGIITYILLCGFEP 249

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPNL 345
           E +G   +  V K   +  G + A K ++++ ++  R      E E EVS+L ++ HPN+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L   Y   + + +L+ + +  G L  FL     +  +        IK +  G+ +LH+
Sbjct: 78  ITLHDVYEN-RTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 406 NENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS 461
            + I H +L   N++L D      + K+ DFGL+  +                + APE+ 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVAPEIV 190
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +    + D++S+GV    LL+G SP
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 10/203 (4%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQRE-FESEVSLLGKIRHPNLLA 347
              +GK  +   Y+ T  D  +V   ++  K   +   Q+E   +E+++   + +P+++ 
Sbjct: 31  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 90
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              ++     +   V+  +      + L        +  P     ++   +G+ +LH+N 
Sbjct: 91  FHGFF----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN- 145
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            +IH +L   N+ L+D  + KI DFGL+  +                Y APE+   K  +
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP-NYIAPEVLCKKGHS 204
Query: 468 TKTDVYSLGVTILELLTGKSPGE 490
            + D++SLG  +  LL GK P E
Sbjct: 205 FEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI  FGL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ------REFESEVSLLGKIRHPNLLA 347
           +GK  +  V  A  +  G +VAVK     I K Q      ++   EV +   + HPN++ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIXKVLNHPNIVK 77
Query: 348 LRAYYLGPKGEK--LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           L   +   + EK   LV +Y   G +  +L A G     +   + + I      + + H 
Sbjct: 78  L---FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI---VSAVQYCHQ 131
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
            + I+H +L + N+LLD   N KI+DFG S                   Y APEL + KK
Sbjct: 132 -KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPP--YAAPELFQGKK 188
Query: 466 ANT-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
            +  + DV+SLGV +  L++G  P +  N  EL + V
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 10/203 (4%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQRE-FESEVSLLGKIRHPNLLA 347
              +GK  +   Y+ T  D  +V   ++  K   +   Q+E   +E+++   + +P+++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              ++     +   V+  +      + L        +  P     ++   +G+ +LH+N 
Sbjct: 107 FHGFF----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN- 161
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            +IH +L   N+ L+D  + KI DFGL+  +                Y APE+   K  +
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP-NYIAPEVLCKKGHS 220
Query: 468 TKTDVYSLGVTILELLTGKSPGE 490
            + D++SLG  +  LL GK P E
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 10/203 (4%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQRE-FESEVSLLGKIRHPNLLA 347
              +GK  +   Y+ T  D  +V   ++  K   +   Q+E   +E+++   + +P+++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              ++     +   V+  +      + L        +  P     ++   +G+ +LH+N 
Sbjct: 107 FHGFF----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN- 161
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            +IH +L   N+ L+D  + KI DFGL+  +                Y APE+   K  +
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP-NYIAPEVLCKKGHS 220
Query: 468 TKTDVYSLGVTILELLTGKSPGE 490
            + D++SLG  +  LL GK P E
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G   YG+V   Y A L    +VAVK+L    + +   +R +  E+ LL  ++H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              +      +     Y+    +   L+       +       ++  + RGL ++HS   
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA-G 151
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKAN 467
           IIH +L  SNV +++ +  +I DFGL+R                  YRAPE+       N
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYN 207
Query: 468 TKTDVYSLGVTILELLTGKS--PG 489
              D++S+G  + ELL GK+  PG
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPG 231

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 294 IMGKSTYGTVYKATLED-GSQVAVKRL---REKITKGQREFESE---VSLLGKIRHPNLL 346
           I+G+  +G VY     D G   A+K L   R K+ +G+    +E   +SL+     P ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHLH 404
            +   +  P  +KL  + D M  G L   L   G  +  D    M+     +  GL H+H
Sbjct: 256 CMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAEIILGLEHMH 309
Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKL 463
            N  +++ +L  +N+LLD+  + +ISD GL+                  GY APE L K 
Sbjct: 310 -NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
              ++  D +SLG  + +LL G SP
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 89/203 (43%), Gaps = 10/203 (4%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQRE-FESEVSLLGKIRHPNLLA 347
              +GK  +   Y+ T  D  +V   ++  K   +   Q+E   +E+++   + +P+++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
              ++     +   V+  +      + L        +  P     ++   +G+ +LH+N 
Sbjct: 107 FHGFF----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN- 161
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            +IH +L   N+ L+D  + KI DFGL+  +                Y APE+   K  +
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP-NYIAPEVLCKKGHS 220
Query: 468 TKTDVYSLGVTILELLTGKSPGE 490
            + D++SLG  +  LL GK P E
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFE 243

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 18/191 (9%)
Query: 313 QVAVKRLRE-----KITKGQREFES------EVSLLGKIRHPNLLALRAYYLGPKGEKLL 361
           Q+AV R+ E     KI   +R  +       E+ +   + H N++     + G + E  +
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK----FYGHRREGNI 78
Query: 362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL 421
            + ++ + S         P+  +  P   +    +  G+++LH    I H ++   N+LL
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLL 137
Query: 422 DDSTNAKISDFGLSRLMXXXXXXXXXXXXX-XLGYRAPELSKLKKANTK-TDVYSLGVTI 479
           D+  N KISDFGL+ +                L Y APEL K ++ + +  DV+S G+ +
Sbjct: 138 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 197
Query: 480 LELLTGKSPGE 490
             +L G+ P +
Sbjct: 198 TAMLAGELPWD 208

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 295 MGKSTYGTVYK--ATLEDGSQVAVKRLREKITKGQ-REFESEVSLLGKIRHPNLLALRAY 351
           +G+ TY TVYK  + L D + VA+K +R +  +G       EVSLL  ++H N++ L   
Sbjct: 10  LGEGTYATVYKGKSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
            +  +    LVF+Y+    L  +L   G    I+       +  + RGL + H  + ++H
Sbjct: 69  -IHTEKSLTLVFEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH-RQKVLH 123
Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKLKKANTKT 470
            +L   N+L+++    K++DFGL+R                L YR P+ L      +T+ 
Sbjct: 124 RDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 471 DVYSLGVTILELLTGK 486
           D++ +G    E+ TG+
Sbjct: 183 DMWGVGCIFYEMATGR 198

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 294 IMGKSTYGTVYKATLED-GSQVAVKRL---REKITKGQREFESE---VSLLGKIRHPNLL 346
           I+G+  +G VY     D G   A+K L   R K+ +G+    +E   +SL+     P ++
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHLH 404
            +   +  P  +KL  + D M  G L   L   G  +  D    M+     +  GL H+H
Sbjct: 255 CMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAEIILGLEHMH 308
Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKL 463
            N  +++ +L  +N+LLD+  + +ISD GL+                  GY APE L K 
Sbjct: 309 -NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKG 364
Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
              ++  D +SLG  + +LL G SP
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI D GL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 294 IMGKSTYGTVYKATLED-GSQVAVKRL---REKITKGQREFESE---VSLLGKIRHPNLL 346
           I+G+  +G VY     D G   A+K L   R K+ +G+    +E   +SL+     P ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHLH 404
            +   +  P  +KL  + D M  G L   L   G  +  D    M+     +  GL H+H
Sbjct: 256 CMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAEIILGLEHMH 309
Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKL 463
            N  +++ +L  +N+LLD+  + +ISD GL+                  GY APE L K 
Sbjct: 310 -NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
              ++  D +SLG  + +LL G SP
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 294 IMGKSTYGTVYKATLED-GSQVAVKRL---REKITKGQREFESE---VSLLGKIRHPNLL 346
           I+G+  +G VY     D G   A+K L   R K+ +G+    +E   +SL+     P ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-MTRGLLHLH 404
            +   +  P  +KL  + D M  G L   L   G  +  D    M+     +  GL H+H
Sbjct: 256 CMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAEIILGLEHMH 309
Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-LSKL 463
            N  +++ +L  +N+LLD+  + +ISD GL+                  GY APE L K 
Sbjct: 310 -NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
              ++  D +SLG  + +LL G SP
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRA 350
           ++GK ++G V K       Q    ++  K +   ++  +   EV LL K+ HPN++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             L       +V +    G L   +  R   +  D     +IIK +  G+ ++H + NI+
Sbjct: 89  I-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMHKH-NIV 143
Query: 411 HGNLTSSNVLLDD---STNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
           H +L   N+LL+      + KI DFGLS                   Y APE+ +    +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY--YIAPEVLR-GTYD 200
Query: 468 TKTDVYSLGVTILELLTGKSPGEPLN-------------GAELPQW 500
            K DV+S GV +  LL+G  P    N               +LPQW
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++    A+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I
Sbjct: 74  Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKI 126
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQ 183
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAE 496
           +D++S+G++++E+  G+ P  P +  E
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI D GL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY- 352
           +G+  YG V K   +  G  +AVKR+R  +   Q +    + L   +R  +      +Y 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 353 -LGPKGEKLLVFDYMPHGSLATFLHA---RGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            L  +G+  +  + M   SL  F      +G   P D     KI   + + L HLHS  +
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPED--ILGKIAVSIVKALEHLHSKLS 174
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS----KLK 464
           +IH ++  SNVL++     K+ DFG+S  +                Y APE        K
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKP--YMAPERINPELNQK 232
Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
             + K+D++SLG+T++EL   + P
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFP 256

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 26/226 (11%)
Query: 274 VHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ-----R 328
           ++F G    T DDL     + +G   +G V+   L +     ++R+ + I K +      
Sbjct: 14  LYFQG----TIDDLFIFKRK-LGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPME 65
Query: 329 EFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL---HARGPETPID 385
           + E+E+ +L  + HPN++ +   +        +V +    G L   +    ARG      
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 386 WPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXX 442
           +    +++K M   L + HS ++++H +L   N+L  D++     KI DFGL+ L     
Sbjct: 125 YVA--ELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
Query: 443 XXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                       Y APE+ K +    K D++S GV +  LLTG  P
Sbjct: 182 HSTNAAGTAL--YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 128 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 186
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 187 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 237

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVS---LLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K LR+++   + E    V+   +L   RHP L
Sbjct: 16  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 73  TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 128
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
             ++++ ++   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 129 R-DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 130 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 188
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 189 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 130 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 188
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 189 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRA 350
           ++GK ++G V K       Q    ++  K +   ++  +   EV LL K+ HPN++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             L       +V +    G L   +  R   +  D     +IIK +  G+ ++H + NI+
Sbjct: 89  I-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD---AARIIKQVFSGITYMHKH-NIV 143
Query: 411 HGNLTSSNVLLDD---STNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
           H +L   N+LL+      + KI DFGLS                   Y APE+ +    +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY--YIAPEVLR-GTYD 200
Query: 468 TKTDVYSLGVTILELLTGKSPGEPLN-------------GAELPQW 500
            K DV+S GV +  LL+G  P    N               +LPQW
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRA 350
           ++GK ++G V K       Q    ++  K +   ++  +   EV LL K+ HPN++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             L       +V +    G L   +  R   +  D     +IIK +  G+ ++H + NI+
Sbjct: 89  I-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD---AARIIKQVFSGITYMHKH-NIV 143
Query: 411 HGNLTSSNVLLDD---STNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
           H +L   N+LL+      + KI DFGLS                   Y APE+ +    +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY--YIAPEVLR-GTYD 200
Query: 468 TKTDVYSLGVTILELLTGKSPGEPLN-------------GAELPQW 500
            K DV+S GV +  LL+G  P    N               +LPQW
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 22/231 (9%)
Query: 293 EIMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLG-KIRHPNLLA 347
           +++GK ++G V+ A  +  +Q  A+K L++ +     + E    E  +L     HP L  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           +   +   K     V +Y+  G L   + +       D          +  GL  LHS +
Sbjct: 84  MFCTF-QTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS-K 138
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            I++ +L   N+LLD   + KI+DFG+ +                  Y APE+   +K N
Sbjct: 139 GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNEFCGTPDYIAPEILLGQKYN 197
Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAEL-----------PQWVASIVKE 507
              D +S GV + E+L G+SP    +  EL           P+W+    K+
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 248

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVS---LLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K LR+++   + E    V+   +L   RHP L
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
             ++++ ++   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 37/226 (16%)
Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++G+  +G V KA    D    A+K++R   EK++       SEV LL  + H  ++   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVXLLASLNHQYVVRYY 68
Query: 350 AYYL------------GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
           A +L              K    +  +Y  + +L   +H+       D   R+   + + 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL--FRQIL 126
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG--- 454
             L ++HS + IIH NL   N+ +D+S N KI DFGL++ +               G   
Sbjct: 127 EALSYIHS-QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 455 ----------YRAPE-LSKLKKANTKTDVYSLGVTILELLTGKSPG 489
                     Y A E L      N K D YSLG+   E +   S G
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTG 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVS---LLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K LR+++   + E    V+   +L   RHP L
Sbjct: 14  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 71  TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 126
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
             ++++ ++   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 127 R-DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVS---LLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K LR+++   + E    V+   +L   RHP L
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
             ++++ ++   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYY 352
           +G+  YG V K   +  G  +AVKR+R  + ++ Q+    ++ +   +R  +      +Y
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI--SMRTVDCPFTVTFY 72
Query: 353 --LGPKGEKLLVFDYMPHGSLATFLHA---RGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
             L  +G+  +  + M   SL  F      +G   P D     KI   + + L HLHS  
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPED--ILGKIAVSIVKALEHLHSKL 129
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRA-----PELSK 462
           ++IH ++  SNVL++     K+ DFG+S  +                Y A     PEL++
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP--YMAPERINPELNQ 187
Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            K  + K+D++SLG+T++EL   + P
Sbjct: 188 -KGYSVKSDIWSLGITMIELAILRFP 212

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +II
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-ADII 147
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKANTK 469
           H +L  SN+ +++    KI D GL+R                  YRAPE+       N  
Sbjct: 148 HRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 470 TDVYSLGVTILELLTGKS--PG 489
            D++S+G  + ELLTG++  PG
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPG 225

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 295 MGKSTYGTVYKATL-----EDGS-QVAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL 346
           +G   +G V +AT      ED   +VAVK L+      ++E   SE+ ++  + +H N++
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 347 ALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGM 396
            L    LG     G  L++ +Y  +G L  FL  +           P++    +     +
Sbjct: 106 NL----LGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGY 455
            +G+  L S +N IH ++ + NVLL +   AKI DFGL+R +M              + +
Sbjct: 162 AQGMAFLAS-KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLT 484
            APE         ++DV+S G+ + E+ +
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVS---LLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K LR+++   + E    V+   +L   RHP L
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
             ++++ ++   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 114 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 172
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G   YG+V   Y A L    +VAVK+L    + +   +R +  E+ LL  ++H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              +      +     Y+    +   L+       +       ++  + RGL ++HS   
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA-G 151
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKAN 467
           IIH +L  SNV +++ +  +I DFGL+R                  YRAPE+       N
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYN 207
Query: 468 TKTDVYSLGVTILELLTGKS--PG 489
              D++S+G  + ELL GK+  PG
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPG 231

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 472 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 120 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 295 MGKSTYGTVYKATL-----EDGS-QVAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL 346
           +G   +G V +AT      ED   +VAVK L+      ++E   SE+ ++  + +H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 347 ALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGP---ETPIDWPTRMKIIKGMTRGL 400
            L    LG     G  L++ +Y  +G L  FL  + P   E   + P+     +  +R L
Sbjct: 114 NL----LGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYN-PSHNPEEQLSSRDL 168
Query: 401 LHLHS----------NENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXX 449
           LH  S          ++N IH ++ + NVLL +   AKI DFGL+R +M           
Sbjct: 169 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 228
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
              + + APE         ++DV+S G+ + E+ +
Sbjct: 229 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 473 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 531
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 532 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 582

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 44/292 (15%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL-A 347
           A   GK    T Y     D +  VAVK L+      +RE   SE+ +L  +  H N++  
Sbjct: 33  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG------------ 395
           L A  +G  G  L++ +Y  +G L  FL  R  ++ I   T   I++             
Sbjct: 93  LGACTIG--GPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 396 ----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
               + +G+  L S +N IH +L + N+LL      KI DFGL+R +             
Sbjct: 150 FSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKS--PGEPLNGAELPQWVASIVKE 507
             + + APE         ++DV+S G+ + EL + G S  PG P++          ++KE
Sbjct: 209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKE 263
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
                 F +     AP    E+ + +K    C D  P  RP   Q+VQ +E+
Sbjct: 264 G-----FRMLSPEHAPA---EMYDIMKT---CWDADPLKRPTFKQIVQLIEK 304

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 110 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 22/231 (9%)
Query: 293 EIMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLG-KIRHPNLLA 347
           +++GK ++G V+ A  +  +Q  A+K L++ +     + E    E  +L     HP L  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           +   +   K     V +Y+  G L   + +       D          +  GL  LHS +
Sbjct: 83  MFCTF-QTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS-K 137
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
            I++ +L   N+LLD   + KI+DFG+ +                  Y APE+   +K N
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNXFCGTPDYIAPEILLGQKYN 196
Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAEL-----------PQWVASIVKE 507
              D +S GV + E+L G+SP    +  EL           P+W+    K+
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVS----LLGKIRHPNLLA 347
           +++GK ++G V  A  + +    AVK L++K    ++E +  +S    LL  ++HP L+ 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  ++     +KL  V DY+  G L  F H +     ++   R    + +   L +LHS 
Sbjct: 104 L--HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS- 157
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
            NI++ +L   N+LLD   +  ++DFGL +                  Y APE+   +  
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 467 NTKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
           +   D + LG  + E+L G  P    N AE+
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVS---LLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K LR+++   + E    V+   +L   RHP L
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
             ++++ ++   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 12/215 (5%)
Query: 281 MFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ---REFESEVSLL 337
           M   ++    T++ +G+  +  V +   +   Q    +  +K  +GQ    E   E+++L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 338 GKIRH-PNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGM 396
              +  P ++ L   Y     E +L+ +Y   G + +       E  +     +++IK +
Sbjct: 83  ELAKSCPRVINLHEVYENT-SEIILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQI 140
Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDST---NAKISDFGLSRLMXXXXXXXXXXXXXXL 453
             G+ +LH N NI+H +L   N+LL       + KI DFG+SR +               
Sbjct: 141 LEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE- 198
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
            Y APE+       T TD++++G+    LLT  SP
Sbjct: 199 -YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           +G   YG+V   Y A L    +VAVK+L    + +   +R +  E+ LL  ++H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              +      +     Y+    +   L+       +       ++  + RGL ++HS   
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA-G 143
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS-KLKKAN 467
           IIH +L  SNV +++    +I DFGL+R                  YRAPE+       N
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYN 199
Query: 468 TKTDVYSLGVTILELLTGKS--PG 489
              D++S+G  + ELL GK+  PG
Sbjct: 200 QTVDIWSVGCIMAELLQGKALFPG 223

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 293 EIMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVS---LLGKIRHPNL 345
           +++GK T+G V     KAT   G   A+K LR+++   + E    V+   +L   RHP L
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            AL+ Y          V +Y   G L  F H        +   R    + +   L +LHS
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKK 465
             ++++ ++   N++LD   + KI+DFGL +                  Y APE+ +   
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D + LGV + E++ G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 13/226 (5%)
Query: 294 IMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFE---SEVSLLGKIR-HPNLLAL 348
           ++GK ++G V  A + E G   AVK L++ +     + E   +E  +L   R HP L  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              +  P      V +++  G L    H +      +   R    + +   L+ LH ++ 
Sbjct: 90  FCCFQTPD-RLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAAE-IISALMFLH-DKG 144
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   NVLLD   + K++DFG+ +                  Y APE+ +      
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS--IVKEEWTNE 512
             D +++GV + E+L G +P E  N  +L + + +  +V   W +E
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 37/226 (16%)
Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLALR 349
           ++G+  +G V KA    D    A+K++R   EK++       SEV LL  + H  ++   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVMLLASLNHQYVVRYY 68
Query: 350 AYYL------------GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
           A +L              K    +  +Y  + +L   +H+       D   R+   + + 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL--FRQIL 126
Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG--- 454
             L ++HS + IIH +L   N+ +D+S N KI DFGL++ +               G   
Sbjct: 127 EALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 455 ----------YRAPE-LSKLKKANTKTDVYSLGVTILELLTGKSPG 489
                     Y A E L      N K D+YSLG+   E++   S G
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 108 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 166
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 167 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 217

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 4/111 (3%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           ++++  ++ G+ +L  + N +H +L + NVLL     AKISDFGLS+ +           
Sbjct: 114 IELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQT 172
Query: 450 XXX--LGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
                + + APE     K ++K+DV+S GV + E  + G+ P   + G+E+
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 42/274 (15%)
Query: 294 IMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFES------EVSLLGKIR----H 342
           ++GK  +GTV+    L D  QVA+K +      G            EV+LL K+     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 343 PNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
           P ++ L  ++   +G  L++   +P   L  ++  +GP    + P+R      +   + H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG--EGPSRC-FFGQVVAAIQH 154
Query: 403 LHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE-L 460
            HS   ++H ++   N+L+D     AK+ DFG   L+                Y  PE +
Sbjct: 155 CHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV---YSPPEWI 210
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
           S+ +       V+SLG+ + +++ G  P E                     E+ + EL  
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFER------------------DQEILEAELHF 252
Query: 521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVV 554
            A    D       L   C+ P PS+RP + +++
Sbjct: 253 PAHVSPD----CCALIRRCLAPKPSSRPSLEEIL 282

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 44/292 (15%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL-A 347
           A   GK    T Y     D +  VAVK L+      +RE   SE+ +L  +  H N++  
Sbjct: 49  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 108
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG------------ 395
           L A  +G  G  L++ +Y  +G L  FL  R  ++ I   T   I++             
Sbjct: 109 LGACTIG--GPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 396 ----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
               + +G+  L S +N IH +L + N+LL      KI DFGL+R +             
Sbjct: 166 FSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 224
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKS--PGEPLNGAELPQWVASIVKE 507
             + + APE         ++DV+S G+ + EL + G S  PG P++          ++KE
Sbjct: 225 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKE 279
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
                 F +     AP    E+ + +K    C D  P  RP   Q+VQ +E+
Sbjct: 280 G-----FRMLSPEHAPA---EMYDIMKT---CWDADPLKRPTFKQIVQLIEK 320

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 295 MGKSTYGTVYKATL-----EDGS-QVAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL 346
           +G   +G V +AT      ED   +VAVK L+      ++E   SE+ ++  + +H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 347 ALRAYYLGP---KGEKLLVFDYMPHGSLATFLHARGPET-------PIDWPTRMKIIKGM 396
            L    LG     G  L++ +Y  +G L  FL  +           P++    +     +
Sbjct: 114 NL----LGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGY 455
            +G+  L S +N IH ++ + NVLL +   AKI DFGL+R +M              + +
Sbjct: 170 AQGMAFLAS-KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLT 484
            APE         ++DV+S G+ + E+ +
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 44/292 (15%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL-A 347
           A   GK    T Y     D +  VAVK L+      +RE   SE+ +L  +  H N++  
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 115
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG------------ 395
           L A  +G  G  L++ +Y  +G L  FL  R  ++ I   T   I++             
Sbjct: 116 LGACTIG--GPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 396 ----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
               + +G+  L S +N IH +L + N+LL      KI DFGL+R +             
Sbjct: 173 FSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 231
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKS--PGEPLNGAELPQWVASIVKE 507
             + + APE         ++DV+S G+ + EL + G S  PG P++          ++KE
Sbjct: 232 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKE 286
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
                 F +     AP    E+ + +K    C D  P  RP   Q+VQ +E+
Sbjct: 287 G-----FRMLSPEHAPA---EMYDIMKT---CWDADPLKRPTFKQIVQLIEK 327

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 150
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 210
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A+  +D+++LG  I +L+ G  P
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPP 233

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 44/292 (15%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL-A 347
           A   GK    T Y     D +  VAVK L+      +RE   SE+ +L  +  H N++  
Sbjct: 51  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 110
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG------------ 395
           L A  +G  G  L++ +Y  +G L  FL  R  ++ I   T   I++             
Sbjct: 111 LGACTIG--GPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 396 ----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
               + +G+  L S +N IH +L + N+LL      KI DFGL+R +             
Sbjct: 168 FSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 226
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKS--PGEPLNGAELPQWVASIVKE 507
             + + APE         ++DV+S G+ + EL + G S  PG P++          ++KE
Sbjct: 227 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKE 281
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
                 F +     AP    E+ + +K    C D  P  RP   Q+VQ +E+
Sbjct: 282 G-----FRMLSPEHAPA---EMYDIMKT---CWDADPLKRPTFKQIVQLIEK 322

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E +GK  YG V++ + + G  VAVK    +  K     E+E+     +RH N+L   A  
Sbjct: 43  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASD 100
Query: 353 LGPK---GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH----- 404
           +  +    +  L+  Y   GSL  +L      T +D  + ++I+  +  GL HLH     
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 405 --SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPE 459
                 I H +L S N+L+  +    I+D GL+ +               +G   Y APE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 460 L------SKLKKANTKTDVYSLGVTILEL 482
           +           +  + D+++ G+ + E+
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A K +  K    +  ++ E E  +  K++HPN++ L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +    LVFD +  G L   + AR   +  D       I+ +   + + HSN  I
Sbjct: 72  DS-IQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYCHSN-GI 126
Query: 410 IHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H NL   N+LL         K++DFGL+  +               GY +PE+ K    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D+++ GV +  LL G  P
Sbjct: 185 SKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A K +  K    +  ++ E E  +  K++HPN++ L 
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +    LVFD +  G L   + AR   +  D       I+ +   + + HSN  I
Sbjct: 71  DS-IQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYCHSN-GI 125
Query: 410 IHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H NL   N+LL         K++DFGL+  +               GY +PE+ K    
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D+++ GV +  LL G  P
Sbjct: 184 SKPVDIWACGVILYILLVGYPP 205

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 42  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 101
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 102 L--YFCFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 155
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 156 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 215
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A K +  K    +  ++ E E  +  K++HPN++ L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +    LVFD +  G L   + AR   +  D       I+ +   + + HSN  I
Sbjct: 72  DS-IQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYCHSN-GI 126
Query: 410 IHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H NL   N+LL         K++DFGL+  +               GY +PE+ K    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D+++ GV +  LL G  P
Sbjct: 185 SKPVDIWACGVILYILLVGYPP 206

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 44/292 (15%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL-A 347
           A   GK    T Y     D +  VAVK L+      +RE   SE+ +L  +  H N++  
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 115
Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG------------ 395
           L A  +G  G  L++ +Y  +G L  FL  R  ++ I   T   I++             
Sbjct: 116 LGACTIG--GPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 396 ----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXX 450
               + +G+  L S +N IH +L + N+LL      KI DFGL+R +             
Sbjct: 173 FSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNAR 231
Query: 451 XXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKS--PGEPLNGAELPQWVASIVKE 507
             + + APE         ++DV+S G+ + EL + G S  PG P++          ++KE
Sbjct: 232 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKE 286
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
                 F +     AP    E+ + +K    C D  P  RP   Q+VQ +E+
Sbjct: 287 G-----FRMLSPEHAPA---EMYDIMKT---CWDADPLKRPTFKQIVQLIEK 327

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 36/242 (14%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FE----SEVSLLGKIRHPNLLAL 348
           +G+ T+G V+KA   + G +VA+K++   + + ++E F      E+ +L  ++H N++ L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 349 -------RAYYLGPKGEKLLVFDYMPH---GSLATFLHARGPETPIDWPTRMKIIKGMTR 398
                   + Y   K    LVFD+  H   G L+  L               ++++ +  
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLN 136
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR---LMXXXXXXXXXXXXXXLGY 455
           GL ++H N+ I+H ++ ++NVL+      K++DFGL+R   L               L Y
Sbjct: 137 GLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 456 RAPE-LSKLKKANTKTDVYSLGVTILELLTGKSP-----GEPLNGAELPQWVASIVKEEW 509
           R PE L   +      D++  G  + E+ T +SP      E    A + Q   SI  E W
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 510 TN 511
            N
Sbjct: 255 PN 256

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 332 SEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK 391
           +E  +L K+    +++L AY    K    LV   M  G L   ++  G      +P    
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQ---AGFPEARA 288
Query: 392 IIKG--MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           +     +  GL  LH  E I++ +L   N+LLDD  + +ISD GL+  +           
Sbjct: 289 VFYAAEICCGLEDLH-RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR 345
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
              +GY APE+ K ++     D ++LG  + E++ G+SP +        + V  +VKE
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 332 SEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK 391
           +E  +L K+    +++L AY    K    LV   M  G L   ++  G      +P    
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQ---AGFPEARA 288
Query: 392 IIKG--MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXX 449
           +     +  GL  LH  E I++ +L   N+LLDD  + +ISD GL+  +           
Sbjct: 289 VFYAAEICCGLEDLH-RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR 345
Query: 450 XXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE 507
              +GY APE+ K ++     D ++LG  + E++ G+SP +        + V  +VKE
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 150
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW 509
           A   +D+++LG  I +L+ G  P    N   +    A I+K E+
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---FAKIIKLEY 251

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E +GK  YG V++ + + G  VAVK    +  K     E+E+     +RH N+L   A  
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASD 71
Query: 353 LGPK---GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH----- 404
           +  +    +  L+  Y   GSL  +L      T +D  + ++I+  +  GL HLH     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 405 --SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPE 459
                 I H +L S N+L+  +    I+D GL+ +               +G   Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 460 L------SKLKKANTKTDVYSLGVTILEL 482
           +           +  + D+++ G+ + E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E +GK  YG V++ + + G  VAVK    +  K     E+E+     +RH N+L   A  
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASD 71
Query: 353 LGPK---GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH----- 404
           +  +    +  L+  Y   GSL  +L      T +D  + ++I+  +  GL HLH     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 405 --SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPE 459
                 I H +L S N+L+  +    I+D GL+ +               +G   Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 460 L------SKLKKANTKTDVYSLGVTILEL 482
           +           +  + D+++ G+ + E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 150
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW 509
           A   +D+++LG  I +L+ G  P    N   +    A I+K E+
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---FAKIIKLEY 251

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLAL 348
           +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 349 RAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
             Y+     EKL     Y  +G L  ++   G     D          +   L +LH  +
Sbjct: 96  --YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-GK 149
Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKKA 466
            IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K A
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
              +D+++LG  I +L+ G  P
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPP 231

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A K +  K    +  ++ E E  +  K++HPN++ L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +    LVFD +  G L   + AR   +  D       I+ +   + + HSN  I
Sbjct: 95  DS-IQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYCHSN-GI 149
Query: 410 IHGNLTSSNVLLDDSTNA---KISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H NL   N+LL         K++DFGL+  +               GY +PE+ K    
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D+++ GV +  LL G  P
Sbjct: 208 SKPVDIWACGVILYILLVGYPP 229

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 98  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 151
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 211
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 16/222 (7%)
Query: 277 DGPLMFTADDLLCATAEIMGKSTYGTVYKA-TLEDGSQVAVKRLR-EKITKG----QREF 330
           D  ++F     LC   E++GK  +  V +    E G Q AVK +   K T        + 
Sbjct: 17  DDDVLFEDVYELC---EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPI-DWPTR 389
           + E S+   ++HP+++ L   Y    G   +VF++M    L   +  R     +      
Sbjct: 74  KREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXX 446
              ++ +   L + H N NIIH ++   NVLL   ++S   K+ DFG++ +         
Sbjct: 133 SHYMRQILEALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVA 190
Query: 447 XXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                   + APE+ K +      DV+  GV +  LL+G  P
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALR-AY 351
           +G    G V+K + +  G  +A K +  +I    R +   E+ +L +   P ++    A+
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y    GE  +  ++M  GSL   L   G  PE  I     + +IKG+T    +L     I
Sbjct: 93  Y--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ-ILGKVSIAVIKGLT----YLREKHKI 145
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           +H ++  SN+L++     K+ DFG+S  +                Y +PE  +    + +
Sbjct: 146 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQ 202
Query: 470 TDVYSLGVTILELLTGKSP 488
           +D++S+G++++E+  G+ P
Sbjct: 203 SDIWSMGLSLVEMAVGRYP 221

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 40  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 99
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 100 L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 153
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 154 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 213
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 98  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 151
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 211
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 14  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 73
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 74  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 127
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 128 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 187
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 150
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 150
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 95  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 148
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 95  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 148
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 150
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 37/294 (12%)
Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF-ESEVSLLGKIRHPNLLALRAYYL 353
           +GK  YG V+      G +VAVK      T+    F E+E+     +RH N+L   A  +
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFF--TTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 354 ---GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS----- 405
              G   +  L+ DY  +GSL  +L +    T +D  + +K+      GL HLH+     
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 406 --NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRAPEL 460
                I H +L S N+L+  +    I+D GL+                 +G   Y  PE+
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 461 --SKLKKANTKT----DVYSLGVTILELLTGKSPGEPLNGAELP--QWVASIVKEEWTNE 512
               L + + ++    D+YS G+ + E+      G  +   +LP    V S    E   E
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 513 VFDLELMRDAPTI-----GDELLNTL-KLALHCVDPSPSARPEVLQVVQQLEEI 560
           +  ++ +R  P+       DE L  + KL   C   +P++R   L+V + L ++
Sbjct: 278 IVCIKKLR--PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 295 MGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEV-----SLLGKIRHPNLLAL 348
           MG  T G V+K    + G  +AVK++R     G +E    +      +L     P ++  
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLHSN 406
              ++    +  +  + M  G+ A  L  R  + PI  P R+  K+   + + L +L   
Sbjct: 90  FGTFI-TNTDVFIAMELM--GTCAEKLKKR-MQGPI--PERILGKMTVAIVKALYYLKEK 143
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMXXXXXXXXXXXXXXLGYRAPEL----- 460
             +IH ++  SN+LLD+    K+ DFG+S RL+                Y APE      
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA---AYMAPERIDPPD 200
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
                 + + DV+SLG++++EL TG+ P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 19  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 78
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 79  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 132
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 133 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 192
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 73  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 126
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 186
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 15  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 74
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 75  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 128
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 129 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 188
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF--ESEVSLLGKIRHPNLLALRA 350
           E +GK  +G V++     G +VAVK      ++ +R +  E+E+     +RH N+L   A
Sbjct: 10  ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 351 YYLGPKG---EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH--- 404
                 G   +  LV DY  HGSL  +L+       +     +K+      GL HLH   
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 405 ----SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRA 457
                   I H +L S N+L+  +    I+D GL+                 +G   Y A
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 458 PEL------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP 498
           PE+       K  ++  + D+Y++G+   E+    S G      +LP
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 12  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 71
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 72  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 125
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 126 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 185
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 94  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 147
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 207
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 18/183 (9%)
Query: 311 GSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKLLV 362
           G  VAVK+L       T  +R +  E+ LL  + H N+++L   +   K      +  LV
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 107
Query: 363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD 422
            + M   +L   +H       +D      ++  M  G+ HLHS   IIH +L  SN+++ 
Sbjct: 108 MELM-DANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK 160
Query: 423 DSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILEL 482
                KI DFGL+R                  YRAPE+          D++S+G  + EL
Sbjct: 161 SDCTLKILDFGLARTACTNFMMTPYVVTRY--YRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 483 LTG 485
           + G
Sbjct: 219 VKG 221

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF--ESEVSLLGKIRHPNLLALRA 350
           E +GK  +G V++     G +VAVK      ++ +R +  E+E+     +RH N+L   A
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 351 YYLGPKG---EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH--- 404
                 G   +  LV DY  HGSL  +L+       +     +K+      GL HLH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 405 ----SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRA 457
                   I H +L S N+L+  +    I+D GL+                 +G   Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 458 PEL------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP 498
           PE+       K  ++  + D+Y++G+   E+    S G      +LP
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGTVYKA-TLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ TV  A  L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 94  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 147
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 207
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPP 230

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF--ESEVSLLGKIRHPNLLALRA 350
           E +GK  +G V++     G +VAVK      ++ +R +  E+E+     +RH N+L   A
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 351 YYLGPKG---EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH--- 404
                 G   +  LV DY  HGSL  +L+       +     +K+      GL HLH   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 405 ----SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRA 457
                   I H +L S N+L+  +    I+D GL+                 +G   Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 458 PEL------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP 498
           PE+       K  ++  + D+Y++G+   E+    S G      +LP
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF--ESEVSLLGKIRHPNLLALRA 350
           E +GK  +G V++     G +VAVK      ++ +R +  E+E+     +RH N+L   A
Sbjct: 12  ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 351 YYLGPKG---EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH--- 404
                 G   +  LV DY  HGSL  +L+       +     +K+      GL HLH   
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 405 ----SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRA 457
                   I H +L S N+L+  +    I+D GL+                 +G   Y A
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 458 PEL------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP 498
           PE+       K  ++  + D+Y++G+   E+    S G      +LP
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 230

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF--ESEVSLLGKIRHPNLLALRA 350
           E +GK  +G V++     G +VAVK      ++ +R +  E+E+     +RH N+L   A
Sbjct: 15  ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 351 YYLGPKG---EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH--- 404
                 G   +  LV DY  HGSL  +L+       +     +K+      GL HLH   
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 405 ----SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRA 457
                   I H +L S N+L+  +    I+D GL+                 +G   Y A
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 458 PEL------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP 498
           PE+       K  ++  + D+Y++G+   E+    S G      +LP
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 233

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 18/183 (9%)
Query: 311 GSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKLLV 362
           G  VAVK+L       T  +R +  E+ LL  + H N+++L   +   K      +  LV
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 105
Query: 363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD 422
            + M   +L   +H       +D      ++  M  G+ HLHS   IIH +L  SN+++ 
Sbjct: 106 MELM-DANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK 158
Query: 423 DSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILEL 482
                KI DFGL+R                  YRAPE+          D++S+G  + EL
Sbjct: 159 SDCTLKILDFGLARTASTNFMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEL 216
Query: 483 LTG 485
           + G
Sbjct: 217 VKG 219

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLG 454
           + RG+  L S+   IH +L + N+LL ++   KI DFGL+R +               L 
Sbjct: 208 VARGMEFL-SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLK 266
Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF 514
           + APE    K  +TK+DV+S GV + E+ +    G P  G ++ +   S ++E       
Sbjct: 267 WMAPESIFDKIYSTKSDVWSYGVLLWEIFS--LGGSPYPGVQMDEDFCSRLREGMR---- 320
Query: 515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
               MR AP          ++ L C    P  RP   ++V++L
Sbjct: 321 ----MR-APEYSTP--EIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAV-KRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G   +G V++   +   +V V K +       +   ++E+S++ ++ HP L+ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +   K E +L+ +++  G L  F      +  +     +  ++    GL H+H + +I+H
Sbjct: 117 FED-KYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVH 172
Query: 412 GNLTSSNVLLD--DSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            ++   N++ +   +++ KI DFGL+  +                  APE+   +     
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA--APEIVDREPVGFY 230
Query: 470 TDVYSLGVTILELLTGKSP 488
           TD++++GV    LL+G SP
Sbjct: 231 TDMWAIGVLGYVLLSGLSP 249

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF--ESEVSLLGKIRHPNLLALRA 350
           E +GK  +G V++     G +VAVK      ++ +R +  E+E+     +RH N+L   A
Sbjct: 35  ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 351 YYLGPKG---EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH--- 404
                 G   +  LV DY  HGSL  +L+       +     +K+      GL HLH   
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 146
Query: 405 ----SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---YRA 457
                   I H +L S N+L+  +    I+D GL+                 +G   Y A
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 458 PEL------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP 498
           PE+       K  ++  + D+Y++G+   E+    S G      +LP
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 253

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 295 MGKSTYGTVYKATL-----EDGS-QVAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLL 346
           +G   +G V +AT      ED   +VAVK L+      ++E   SE+ ++  + +H N++
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 347 ALRAYYLGP---KGEKLLVFDYMPHGSLATFLHAR-----GPE-TPIDWPTRMKIIKGM- 396
            L    LG     G  L++ +Y  +G L  FL  +     GP   P   P  +    G  
Sbjct: 99  NL----LGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 397 --TRGLLHLHS----------NENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXX 443
              R LLH  S          ++N IH ++ + NVLL +   AKI DFGL+R +M     
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 214
Query: 444 XXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT 484
                    + + APE         ++DV+S G+ + E+ +
Sbjct: 215 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 294 IMGKSTYGTVY----KATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           + G+ T+GTV     K+T   G  VA+K++ +      RE +  +  L  + HPN++ L+
Sbjct: 30  MAGQGTFGTVQLGKEKST---GMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQ 85
Query: 350 AYY--LGPKGEKLL----VFDYMP---HGSLATFLHARGPETPIDWPTRM-KIIKGMTRG 399
           +Y+  LG +  + +    V +Y+P   H     +   +    PI     + ++I+ +  G
Sbjct: 86  SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI--G 143
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNA-KISDFGLSRLMXXXXXXXXXXXXXXLGYRAP 458
            LHL S  N+ H ++   NVL++++    K+ DFG ++ +                YRAP
Sbjct: 144 CLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--YRAP 200
Query: 459 EL-SKLKKANTKTDVYSLGVTILELLTGK 486
           EL    +   T  D++S+G    E++ G+
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 292 AEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPN 344
            E +G   +  V K   +  G + A K ++++ ++  R      E E EVS+L ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L   Y   + + +L+ + +  G L  FL     +  +        IK +  G+ +LH
Sbjct: 77  VITLHDVYEN-RTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 405 SNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL 460
           + + I H +L   N++L D      + K+ DFGL+  +                + APE+
Sbjct: 133 TKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVAPEI 189
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
              +    + D++S+GV    LL+G SP
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 292 AEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPN 344
            E +G   +  V K   +  G + A K ++++ ++  R      E E EVS+L ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L   Y   + + +L+ + +  G L  FL     +  +        IK +  G+ +LH
Sbjct: 77  VITLHDVYEN-RTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 405 SNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL 460
           + + I H +L   N++L D      + K+ DFGL+  +                + APE+
Sbjct: 133 TKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVAPEI 189
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
              +    + D++S+GV    LL+G SP
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPNL 345
           E +G   +  V K   +  G + A K ++++ ++  R      E E EVS+L ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L   Y   + + +L+ + +  G L  FL     +  +        IK +  G+ +LH+
Sbjct: 78  ITLHDVYEN-RTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 406 NENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS 461
            + I H +L   N++L D      + K+ DFGL+  +                + APE+ 
Sbjct: 134 KK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVAPEIV 190
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +    + D++S+GV    LL+G SP
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRA 350
           +GK ++G V      D  ++ A+K + ++    + E  +   E+ ++  + HP L+ L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL-W 81
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y    + +  +V D +  G L   L            T    I  +   L +L  N+ II
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYL-QNQRII 137
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA---N 467
           H ++   N+LLD+  +  I+DF ++ ++                Y APE+   +K    +
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTK--PYMAPEMFSSRKGAGYS 195
Query: 468 TKTDVYSLGVTILELLTGKSP 488
              D +SLGVT  ELL G+ P
Sbjct: 196 FAVDWWSLGVTAYELLRGRRP 216

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPNL 345
           E +G   +  V K   +  G + A K ++++ ++  R      E E EVS+L ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L   Y   + + +L+ + +  G L  FL     +  +        IK +  G+ +LH+
Sbjct: 78  ITLHDVYEN-RTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 406 NENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS 461
            + I H +L   N++L D      + K+ DFGL+  +                + APE+ 
Sbjct: 134 KK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVAPEIV 190
Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +    + D++S+GV    LL+G SP
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 292 AEIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPN 344
            E +G   +  V K   +  G + A K ++++ ++  R      E E EVS+L ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L   Y   + + +L+ + +  G L  FL     +  +        IK +  G+ +LH
Sbjct: 77  VITLHDVYEN-RTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 405 SNENIIHGNLTSSNVLLDDST----NAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPEL 460
           + + I H +L   N++L D      + K+ DFGL+  +                + APE+
Sbjct: 133 TKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVAPEI 189
Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
              +    + D++S+GV    LL+G SP
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQREFES-EVSLLGKIRHPNLLALR 349
            +GK  +   ++ +  D  +V   ++  K   +   QRE  S E+S+   + H +++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++     +   VF  +      + L        +  P     ++ +  G  +LH N  +
Sbjct: 84  GFF----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-RV 138
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           IH +L   N+ L++    KI DFGL+  +                Y APE+   K  + +
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP-NYIAPEVLSKKGHSFE 197
Query: 470 TDVYSLGVTILELLTGKSPGE 490
            DV+S+G  +  LL GK P E
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFE 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQREFES-EVSLLGKIRHPNLLALR 349
            +GK  +   ++ +  D  +V   ++  K   +   QRE  S E+S+   + H +++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++     +   VF  +      + L        +  P     ++ +  G  +LH N  +
Sbjct: 84  GFF----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-RV 138
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           IH +L   N+ L++    KI DFGL+  +                Y APE+   K  + +
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP-NYIAPEVLSKKGHSFE 197
Query: 470 TDVYSLGVTILELLTGKSPGE 490
            DV+S+G  +  LL GK P E
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFE 218

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQREFES-EVSLLGKIRHPNLLALR 349
            +GK  +   ++ +  D  +V   ++  K   +   QRE  S E+S+   + H +++   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++     +   VF  +      + L        +  P     ++ +  G  +LH N  +
Sbjct: 106 GFF----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-RV 160
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           IH +L   N+ L++    KI DFGL+  +                Y APE+   K  + +
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-NYIAPEVLSKKGHSFE 219
Query: 470 TDVYSLGVTILELLTGKSPGE 490
            DV+S+G  +  LL GK P E
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFE 240

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQREFES-EVSLLGKIRHPNLLALR 349
            +GK  +   ++ +  D  +V   ++  K   +   QRE  S E+S+   + H +++   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++     +   VF  +      + L        +  P     ++ +  G  +LH N  +
Sbjct: 88  GFF----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-RV 142
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           IH +L   N+ L++    KI DFGL+  +                Y APE+   K  + +
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP-NYIAPEVLSKKGHSFE 201
Query: 470 TDVYSLGVTILELLTGKSPGE 490
            DV+S+G  +  LL GK P E
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFE 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQREFES-EVSLLGKIRHPNLLALR 349
            +GK  +   ++ +  D  +V   ++  K   +   QRE  S E+S+   + H +++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++     +   VF  +      + L        +  P     ++ +  G  +LH N  +
Sbjct: 108 GFF----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-RV 162
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           IH +L   N+ L++    KI DFGL+  +                Y APE+   K  + +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-NYIAPEVLSKKGHSFE 221
Query: 470 TDVYSLGVTILELLTGKSPGE 490
            DV+S+G  +  LL GK P E
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFE 242

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 292 AEIMGKSTYGT-VYKATLEDGSQVAVKRLREK-ITKGQR--EFESEVSLLGKIRHPNLLA 347
            +I+G+ ++ T V    L    + A+K L ++ I K  +      E  ++ ++ HP  + 
Sbjct: 35  GKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 348 LRAYYLGPKGEKLLV-FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L  Y+     EKL     Y  +G L  ++   G     D          +   L +LH  
Sbjct: 95  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-G 148
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG-YRAPELSKLKK 465
           + IIH +L   N+LL++  + +I+DFG ++++                 Y +PEL   K 
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
           A   +D+++LG  I +L+ G  P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREK---ITKGQREFES-EVSLLGKIRHPNLLALR 349
            +GK  +   ++ +  D  +V   ++  K   +   QRE  S E+S+   + H +++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++     +   VF  +      + L        +  P     ++ +  G  +LH N  +
Sbjct: 82  GFF----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-RV 136
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           IH +L   N+ L++    KI DFGL+  +                Y APE+   K  + +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-NYIAPEVLSKKGHSFE 195
Query: 470 TDVYSLGVTILELLTGKSPGE 490
            DV+S+G  +  LL GK P E
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFE 216

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A K +  K    +  ++ E E  +   ++HPN++ L 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +G   LVFD +  G L   + AR   +  D       I+ +   + H H N  I
Sbjct: 70  DS-ISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILESVNHCHLN-GI 124
Query: 410 IHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H +L   N+LL   +     K++DFGL+ +                GY +PE+ +    
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D+++ GV +  LL G  P
Sbjct: 184 GKPVDMWACGVILYILLVGYPP 205

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 39/212 (18%)
Query: 301 GTVYKATLEDGSQVAVKRLREK----------ITKGQREFESEVSLLGKI-RHPNLLALR 349
           G V K T+  GS    KR   K          I K +R+   E+ +L +  +HPN++ L+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK---------IIKGMTRGL 400
                       V+D   H  L T L  RG E  +D   R K         ++  + + +
Sbjct: 88  D-----------VYDDGKHVYLVTEL-MRGGEL-LDKILRQKFFSEREASFVLHTIGKTV 134
Query: 401 LHLHSNENIIHGNLTSSNVL-LDDSTNA---KISDFGLSRLMXXXXXXXXXXXXXXLGYR 456
            +LHS + ++H +L  SN+L +D+S N    +I DFG ++ +                + 
Sbjct: 135 EYLHS-QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTA-NFV 192
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           APE+ K +  +   D++SLG+ +  +L G +P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A K +  K    +  ++ E E  +   ++HPN++ L 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +G   LVFD +  G L   + AR   +  D       I+ +   + H H N  I
Sbjct: 70  DS-ISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILESVNHCHLN-GI 124
Query: 410 IHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H +L   N+LL   +     K++DFGL+ +                GY +PE+ +    
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D+++ GV +  LL G  P
Sbjct: 184 GKPVDMWACGVILYILLVGYPP 205

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 39/212 (18%)
Query: 301 GTVYKATLEDGSQVAVKRLREK----------ITKGQREFESEVSLLGKI-RHPNLLALR 349
           G V K T+  GS    KR   K          I K +R+   E+ +L +  +HPN++ L+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK---------IIKGMTRGL 400
                       V+D   H  L T L  RG E  +D   R K         ++  + + +
Sbjct: 88  D-----------VYDDGKHVYLVTEL-MRGGEL-LDKILRQKFFSEREASFVLHTIGKTV 134
Query: 401 LHLHSNENIIHGNLTSSNVL-LDDSTNA---KISDFGLSRLMXXXXXXXXXXXXXXLGYR 456
            +LHS + ++H +L  SN+L +D+S N    +I DFG ++ +                + 
Sbjct: 135 EYLHS-QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTA-NFV 192
Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           APE+ K +  +   D++SLG+ +  +L G +P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 295 MGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFE---------------------- 331
           +GK +YG V  A  E D +  A+K L +K    Q  F                       
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 332 ----SEVSLLGKIRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDW 386
                E+++L K+ HPN++ L      P  + L +VF+ +  G +      +    P+  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSE 136
Query: 387 PTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXX 446
                  + + +G+ +LH  + IIH ++  SN+L+ +  + KI+DFG+S           
Sbjct: 137 DQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 447 XXXXXXLGYRAPE-LSKLKK--ANTKTDVYSLGVTILELLTGKSP 488
                   + APE LS+ +K  +    DV+++GVT+   + G+ P
Sbjct: 196 NTVGTP-AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A K +  K    +  ++ E E  +   ++HPN++ L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +G   L+FD +  G L   + AR   +  D       I+ +   +LH H    +
Sbjct: 88  DS-ISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILEAVLHCHQM-GV 142
Query: 410 IHGNLTSSNVLLDDS---TNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H +L   N+LL         K++DFGL+ +                GY +PE+ +    
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D+++ GV +  LL G  P
Sbjct: 202 GKPVDLWACGVILYILLVGYPP 223

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   L  G + A K +  K    +  ++ E E  +   ++H N++ L 
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLH 69
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +G   LVFD +  G L   + AR   +  D       I+ +   +LH H    +
Sbjct: 70  DS-ISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILEAVLHCHQM-GV 124
Query: 410 IHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H +L   N+LL         K++DFGL+ +                GY +PE+ + +  
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D+++ GV +  LL G  P
Sbjct: 184 GKPVDIWACGVILYILLVGYPP 205

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXX 448
            ++ KGM        ++   IH +L + N+LL +    KI DFGL+R +           
Sbjct: 200 FQVAKGM-----EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 449 XXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE 507
               L + APE    +    ++DV+S GV + E+ + G SP           +    + E
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDE 303
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           E+   + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 350

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXX 448
            ++ KGM        ++   IH +L + N+LL +    KI DFGL+R +           
Sbjct: 207 FQVAKGM-----EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 261
Query: 449 XXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE 507
               L + APE    +    ++DV+S GV + E+ + G SP           +    + E
Sbjct: 262 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDE 310
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           E+   + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 311 EFCRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 357

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXX 448
            ++ KGM        ++   IH +L + N+LL +    KI DFGL+R +           
Sbjct: 198 FQVAKGM-----EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 252
Query: 449 XXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE 507
               L + APE    +    ++DV+S GV + E+ + G SP           +    + E
Sbjct: 253 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDE 301
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           E+   + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 302 EFCRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 348

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXX 448
            ++ KGM        ++   IH +L + N+LL +    KI DFGL+R +           
Sbjct: 205 FQVAKGM-----EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 259
Query: 449 XXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE 507
               L + APE    +    ++DV+S GV + E+ + G SP           +    + E
Sbjct: 260 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDE 308
Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           E+   + +   MR       E+  T+   L C    PS RP   ++V+ L
Sbjct: 309 EFCRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 355

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 20/196 (10%)
Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLG---KI-RHPNLLALR 349
           +G  +YG V+K  + EDG   AVKR      +G ++   +++ +G   K+ +HP  + L 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPF-RGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSN 406
             +   +G  L +   +   SL     A G   PE  + W      ++     L HLHS 
Sbjct: 124 QAW--EEGGILYLQTELCGPSLQQHCEAWGASLPEAQV-W----GYLRDTLLALAHLHS- 175
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           + ++H ++  +N+ L      K+ DFGL  L+                Y APEL +    
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQ-GSY 232
Query: 467 NTKTDVYSLGVTILEL 482
            T  DV+SLG+TILE+
Sbjct: 233 GTAADVFSLGLTILEV 248

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRL---REKITKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  +Q    ++   ++   +  ++ E E  +   ++HPN++ L 
Sbjct: 37  EELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 96
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +G   LVFD +  G L   + AR   +  D       I  +   + H+H + +I
Sbjct: 97  DS-ISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIHQILESVNHIHQH-DI 151
Query: 410 IHGNLTSSNVLLDDSTN---AKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H +L   N+LL         K++DFGL+ +                GY +PE+ +    
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPEVLRKDPY 210
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D+++ GV +  LL G  P
Sbjct: 211 GKPVDIWACGVILYILLVGYPP 232

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 3/139 (2%)
Query: 22  SELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS-FSNLSSLVSLTLESN 80
           ++ +++ L  NK+S +      RL++LR+L  + N +  +LPA  F  L +L +L +  N
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 81  NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAXXXX 140
            L    +   D+L NL+ L L RNQ+    P    +++ LT L L  N+L   +P     
Sbjct: 96  KLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFD 154
Query: 141 XXXXXXXXXXYNNLSGPVP 159
                     YNN    VP
Sbjct: 155 KLTSLKELRLYNNQLKRVP 173

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 26/226 (11%)
Query: 288 LCATAEIMGKSTYGTVYKATLED-GSQVAVKRLR-----EKITKGQREFESEVSLLGKIR 341
           L   ++I+G+     V++   +  G   A+K          +    REFE    +L K+ 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLN 65
Query: 342 HPNLLALRAYYLGPKG-EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
           H N++ L A         K+L+ ++ P GSL T L        +     + +++ +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 401 LHLHSNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR 456
            HL  N  I+H N+   N++     D  +  K++DFG +R +                Y 
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEE--YL 182
Query: 457 APELSK--------LKKANTKTDVYSLGVTILELLTGKSPGEPLNG 494
            P++ +         KK     D++S+GVT     TG  P  P  G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 12/202 (5%)
Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A   +  K    +  ++ E E  +   ++HPN++ L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
              +  +G   L+FD +  G L   + AR   +  D       I+ +   +LH H    +
Sbjct: 77  DS-ISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILEAVLHCHQM-GV 131
Query: 410 IHGNLTSSNVLLDDS---TNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
           +H NL   N+LL         K++DFGL+ +                GY +PE+ +    
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 467 NTKTDVYSLGVTILELLTGKSP 488
               D+++ GV +  LL G  P
Sbjct: 191 GKPVDLWACGVILYILLVGYPP 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 14/203 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYY 352
           +G+  YG V K   +  G   AVKR+R  + ++ Q+    ++ +  +             
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHA---RGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           L  +G+  +  + +   SL  F      +G   P D     KI   + + L HLHS  ++
Sbjct: 102 LFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPED--ILGKIAVSIVKALEHLHSKLSV 158
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELS----KLKK 465
           IH ++  SNVL++     K  DFG+S  +                Y APE        K 
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKP--YXAPERINPELNQKG 216
Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
            + K+D++SLG+T +EL   + P
Sbjct: 217 YSVKSDIWSLGITXIELAILRFP 239

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 14/232 (6%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           AE +G+  +G V++       +  + +  +     Q   + E+S+L   RH N+L L   
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +   + E +++F+++    L  F         ++    +  +  +   L  LHS+ NI H
Sbjct: 70  FESME-ELVMIFEFI--SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH-NIGH 125
Query: 412 GNLTSSNVLLDD--STNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
            ++   N++     S+  KI +FG +R +                Y APE+ +    +T 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE--YYAPEVHQHDVVSTA 183
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
           TD++SLG  +  LL+G +   P       Q + +I+  E+T   FD E  ++
Sbjct: 184 TDMWSLGTLVYVLLSGIN---PFLAETNQQIIENIMNAEYT---FDEEAFKE 229

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 26/226 (11%)
Query: 288 LCATAEIMGKSTYGTVYKATLED-GSQVAVKRLR-----EKITKGQREFESEVSLLGKIR 341
           L   ++I+G+     V++   +  G   A+K          +    REFE    +L K+ 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLN 65
Query: 342 HPNLLALRAYYLGPKG-EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
           H N++ L A         K+L+ ++ P GSL T L        +     + +++ +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 401 LHLHSNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYR 456
            HL  N  I+H N+   N++     D  +  K++DFG +R +                Y 
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE--YL 182
Query: 457 APELSK--------LKKANTKTDVYSLGVTILELLTGKSPGEPLNG 494
            P++ +         KK     D++S+GVT     TG  P  P  G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 295 MGKSTYGTVYKATLED---GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+ ++G V++  +ED   G Q AVK++R ++ + +     E+     +  P ++ L  Y
Sbjct: 101 LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPL--Y 151
Query: 352 YLGPKGEKLLVF-DYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +G  + +F + +  GSL   +  +G  PE        +  +     GL +LHS   
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPED-----RALYYLGQALEGLEYLHSR-R 205
Query: 409 IIHGNLTSSNVLLD-DSTNAKISDFGLSRLMXXXXXXXXXXXXXXL----GYRAPELSKL 463
           I+HG++ + NVLL  D ++A + DFG +  +              +     + APE+   
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
           +  + K DV+S    +L +L G  P
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 295 MGKSTYGTVYKATLED---GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +G+ ++G V++  +ED   G Q AVK++R ++ + +     E+     +  P ++ L  Y
Sbjct: 82  LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPL--Y 132
Query: 352 YLGPKGEKLLVF-DYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
               +G  + +F + +  GSL   +  +G  PE        +  +     GL +LHS   
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPED-----RALYYLGQALEGLEYLHSR-R 186
Query: 409 IIHGNLTSSNVLLD-DSTNAKISDFGLSRLMXXXXXXXXXXXXXXL----GYRAPELSKL 463
           I+HG++ + NVLL  D ++A + DFG +  +              +     + APE+   
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
           +  + K DV+S    +L +L G  P
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 9/210 (4%)
Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKIRHPNLLALR 349
           ++GK ++G V  A  +   ++ A+K L++ +     + E    E  +L  +  P  L   
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                       V +Y+  G L   +   G       P  +     ++ GL  LH    I
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISIGLFFLHKR-GI 141
Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTK 469
           I+ +L   NV+LD   + KI+DFG+ +                  Y APE+   +     
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTP-DYIAPEIIAYQPYGKS 200
Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
            D ++ GV + E+L G+ P +  +  EL Q
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 230

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLR----EKITKGQREFESEVSLLGKIRHPNLLALR 349
           +G+ TYG VYKA        VA+KR+R    E+   G      EVSLL +++H N++ L+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA--IREVSLLKELQHRNIIELK 99
Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG----MTRGLLHLHS 405
           +  +       L+F+Y     L  ++  + P+        M++IK     +  G+   HS
Sbjct: 100 S-VIHHNHRLHLIFEYA-ENDLKKYM-DKNPD------VSMRVIKSFLYQLINGVNFCHS 150
Query: 406 NENIIHGNLTSSNVLLDDSTNA-----KISDFGLSRLMXXXXXXXXXXXXXXLGYRAPE- 459
               +H +L   N+LL  S  +     KI DFGL+R                L YR PE 
Sbjct: 151 R-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIITLWYRPPEI 208
Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSPGEP 491
           L   +  +T  D++S+     E+L  K+P  P
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLM-KTPLFP 239

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L+  +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+GV + E++ G
Sbjct: 200 MGYKENVDIWSVGVIMGEMIKG 221

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 44/283 (15%)
Query: 293 EIMGKSTYGTVYKATLED--------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPN 344
           E +G+ T+  ++K    +         ++V +K L +        F    S++ K+ H +
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 345 L-LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
           L L     + G   E +LV +++  GSL T+L        I W  ++++ K +   +  L
Sbjct: 74  LVLNYGVCFCG--DENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL 129
Query: 404 HSNENIIHGNLTSSNVLL----DDSTN----AKISDFGLSRLMXXXXXXXXXXXXXXLGY 455
             N  +IHGN+ + N+LL    D  T      K+SD G+S                 + +
Sbjct: 130 EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-----ITVLPKDILQERIPW 183
Query: 456 RAPE-LSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF 514
             PE +   K  N  TD +S G T+ E+ +G    +PL+  +      S  K ++  +  
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGD--KPLSALD------SQRKLQFYEDRH 235
Query: 515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
            L   + A     EL N +    +C+D  P  RP    +++ L
Sbjct: 236 QLPAPKAA-----ELANLIN---NCMDYEPDHRPSFRAIIRDL 270

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L+  +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+GV + E++ G
Sbjct: 200 MGYKENVDIWSVGVIMGEMIKG 221

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 83/206 (40%), Gaps = 14/206 (6%)
Query: 291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLL 346
             +++G+  +G V     +   +V   +L  K    +R     F  E  ++     P ++
Sbjct: 79  VVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 138
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L   +   K    +V +YMP G L   +     + P  W         +   L  +HS 
Sbjct: 139 QLFCAFQDDK-YLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY--TAEVVLALDAIHSM 193
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
             +IH ++   N+LLD   + K++DFG    M                Y +PE+ K +  
Sbjct: 194 -GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 467 N----TKTDVYSLGVTILELLTGKSP 488
           +     + D +S+GV + E+L G +P
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 144
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 145 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRY--YRAPEVILG 201
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 202 MGYKENVDIWSVGCIMGEMIKG 223

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 14/206 (6%)
Query: 291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLL 346
             +++G+  +G V     +   +V   +L  K    +R     F  E  ++     P ++
Sbjct: 73  VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  Y         +V +YMP G L   +     + P  W  R    + +   L  +HS 
Sbjct: 133 QL-FYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKW-ARFYTAE-VVLALDAIHS- 186
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
              IH ++   N+LLD S + K++DFG    M                Y +PE+ K +  
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 467 N----TKTDVYSLGVTILELLTGKSP 488
           +     + D +S+GV + E+L G +P
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +YMP G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +YMP G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 14/206 (6%)
Query: 291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLL 346
             +++G+  +G V     +   +V   +L  K    +R     F  E  ++     P ++
Sbjct: 78  VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  Y         +V +YMP G L   +     + P  W  R    + +   L  +HS 
Sbjct: 138 QL-FYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKW-ARFYTAE-VVLALDAIHS- 191
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
              IH ++   N+LLD S + K++DFG    M                Y +PE+ K +  
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 467 N----TKTDVYSLGVTILELLTGKSP 488
           +     + D +S+GV + E+L G +P
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 143
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 144 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 200
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 14/206 (6%)
Query: 291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLL 346
             +++G+  +G V     +   +V   +L  K    +R     F  E  ++     P ++
Sbjct: 78  VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L  Y         +V +YMP G L   +     + P  W  R    + +   L  +HS 
Sbjct: 138 QL-FYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKW-ARFYTAE-VVLALDAIHS- 191
Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKA 466
              IH ++   N+LLD S + K++DFG    M                Y +PE+ K +  
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 467 N----TKTDVYSLGVTILELLTGKSP 488
           +     + D +S+GV + E+L G +P
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 118/282 (41%), Gaps = 42/282 (14%)
Query: 293 EIMGKSTYGTVYKATLED--------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPN 344
           E +G+ T+  ++K    +         ++V +K L +        F    S++ K+ H +
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           L+ L         E +LV +++  GSL T+L        I W  ++++ K +   +  L 
Sbjct: 74  LV-LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE 130
Query: 405 SNENIIHGNLTSSNVLL----DDSTN----AKISDFGLSRLMXXXXXXXXXXXXXXLGYR 456
            N  +IHGN+ + N+LL    D  T      K+SD G+S                 + + 
Sbjct: 131 EN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-----ITVLPKDILQERIPWV 184
Query: 457 APE-LSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
            PE +   K  N  TD +S G T+ E+ +G    +PL+  +      S  K ++  +   
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGD--KPLSALD------SQRKLQFYEDRHQ 236
Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
           L   + A     EL N +    +C+D  P  RP    +++ L
Sbjct: 237 LPAPKAA-----ELANLIN---NCMDYEPDHRPSFRAIIRDL 270

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 295 MGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G    G V+ A   D   +VA+K++     +  +    E+ ++ ++ H N++ +    L
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI-L 77
Query: 354 GPKGEKL--------------LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           GP G +L              +V +YM    LA  L  +GP   ++   R+ + + + RG
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL-EQGP--LLEEHARLFMYQ-LLRG 132
Query: 400 LLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMXXXXXXXXXXXXXXL--GYR 456
           L ++HS  N++H +L  +N+ ++ +    KI DFGL+R+M              +   YR
Sbjct: 133 LKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 457 APELSKLKKANTKT-DVYSLGVTILELLTGKS 487
           +P L       TK  D+++ G    E+LTGK+
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L+  +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 83/177 (46%), Gaps = 23/177 (12%)
Query: 323 ITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPHGSL------ATFL 375
           I K +R+   E+ +L +  +HPN++ L+  Y   K    +V + M  G L        F 
Sbjct: 55  IDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGK-YVYVVTELMKGGELLDKILRQKFF 113
Query: 376 HARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL-LDDSTN---AKISD 431
             R             ++  +T+ + +LH+ + ++H +L  SN+L +D+S N    +I D
Sbjct: 114 SEREASA---------VLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICD 163
Query: 432 FGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           FG ++ +                + APE+ + +  +   D++SLGV +  +LTG +P
Sbjct: 164 FGFAKQLRAENGLLMTPCYTA-NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L+  +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L+  +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L+  +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTG 485
                  D++S+G  + E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     +E E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     K++DFGL++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%)
Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L+ N L+G  P +    S +QE+ L  NKI  +       L +L+ L+   N I+  +
Sbjct: 59  LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 63  PASFSNLSSLVSLTLESN 80
           P SF +L+SL SL L SN
Sbjct: 119 PGSFEHLNSLTSLNLASN 136

>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 3/105 (2%)
Query: 26  EISLSHNKISGVMPSD--LGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLD 83
           E+ L+ N++ G + SD   GRL  L  L+   N + G  P +F   S +  L L  N + 
Sbjct: 33  ELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 84  DQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQN 128
           +        LH L  LNL  NQIS  +P +  ++++LT L+L+ N
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 180
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 181 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 237
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM 390
           E+E+ +L K+ HP ++ ++ ++     +  +V + M  G L  F    G +   +   ++
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGEL--FDKVVGNKRLKEATCKL 118
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXX 447
              + M   + +LH N  IIH +L   NVLL   ++    KI+DFG S+++         
Sbjct: 119 YFYQ-MLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 448 XXXXXLGYRAPE-LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
                  Y APE L  +  A  N   D +SLGV +   L+G  P
Sbjct: 177 CGTPT--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM 390
           E+E+ +L K+ HP ++ ++ ++     +  +V + M  G L  F    G +   +   ++
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGEL--FDKVVGNKRLKEATCKL 118
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXX 447
              + M   + +LH N  IIH +L   NVLL   ++    KI+DFG S+++         
Sbjct: 119 YFYQ-MLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 448 XXXXXLGYRAPE-LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
                  Y APE L  +  A  N   D +SLGV +   L+G  P
Sbjct: 177 CGTPT--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM 390
           E+E+ +L K+ HP ++ ++ ++     +  +V + M  G L  F    G +   +   ++
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGEL--FDKVVGNKRLKEATCKL 117
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXX 447
              + M   + +LH N  IIH +L   NVLL   ++    KI+DFG S+++         
Sbjct: 118 YFYQ-MLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 175
Query: 448 XXXXXLGYRAPE-LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
                  Y APE L  +  A  N   D +SLGV +   L+G  P
Sbjct: 176 CGTPT--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM 390
           E+E+ +L K+ HP ++ ++ ++     +  +V + M  G L  F    G +   +   ++
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKL 124
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXX 447
              + M   + +LH N  IIH +L   NVLL   ++    KI+DFG S+++         
Sbjct: 125 YFYQ-MLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 182
Query: 448 XXXXXLGYRAPE-LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
                  Y APE L  +  A  N   D +SLGV +   L+G  P
Sbjct: 183 CGTPT--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 2/101 (1%)
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAP 458
           GL  L S + II+ +L   NV+LD   + KI+DFG+ +                  Y AP
Sbjct: 133 GLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAP 190
Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
           E+   +      D ++ GV + E+L G++P E  +  EL Q
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM 390
           E+E+ +L K+ HP ++ ++ ++     +  +V + M  G L  F    G +   +   ++
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGEL--FDKVVGNKRLKEATCKL 118
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXX 447
              + M   + +LH N  IIH +L   NVLL   ++    KI+DFG S+++         
Sbjct: 119 YFYQ-MLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 448 XXXXXLGYRAPE-LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
                  Y APE L  +  A  N   D +SLGV +   L+G  P
Sbjct: 177 CGTPT--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 16/222 (7%)
Query: 277 DGPLMFTADDLLCATAEIMGKSTYGTVYKA-TLEDGSQVAVKRLR-EKITKG----QREF 330
           D  ++F     LC   E++GK  +  V +    E G Q AVK +   K T        + 
Sbjct: 19  DDDVLFEDVYELC---EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 75
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPI-DWPTR 389
           + E S+   ++HP+++ L   Y    G   +VF++M    L   +  R     +      
Sbjct: 76  KREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXX 446
              ++ +   L + H N NIIH ++    VLL   ++S   K+  FG++ +         
Sbjct: 135 SHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA 192
Query: 447 XXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                   + APE+ K +      DV+  GV +  LL+G  P
Sbjct: 193 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 294 IMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFES--EVSLLGKIRHPNLLALRA 350
           ++G+  YG V  AT +  G  VA+K++ E   K      +  E+ +L   +H N++ +  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITI-- 74
Query: 351 YYLGPKGEKLLVFD--YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +   + +    F+  Y+    + T LH       +        I    R +  LH + N
Sbjct: 75  -FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-N 132
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---------YRAPE 459
           +IH +L  SN+L++ + + K+ DFGL+R++               G         YRAPE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 460 LS-KLKKANTKTDVYSLGVTILELL 483
           +     K +   DV+S G  + EL 
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 294 IMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFES--EVSLLGKIRHPNLLALRA 350
           ++G+  YG V  AT +  G  VA+K++ E   K      +  E+ +L   +H N++ +  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITI-- 74
Query: 351 YYLGPKGEKLLVFD--YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +   + +    F+  Y+    + T LH       +        I    R +  LH + N
Sbjct: 75  -FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-N 132
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---------YRAPE 459
           +IH +L  SN+L++ + + K+ DFGL+R++               G         YRAPE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 460 LS-KLKKANTKTDVYSLGVTILELL 483
           +     K +   DV+S G  + EL 
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 11/167 (6%)
Query: 329 EFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATF---LHARGPETPID 385
           +F++E+ ++  I++   L      +    E  ++++YM + S+  F              
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 386 WPTRM--KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXX 443
            P ++   IIK +     ++H+ +NI H ++  SN+L+D +   K+SDFG S  M     
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 444 XXXXXXXXXLGYRAPELSKLKKANT--KTDVYSLGVTILELLTGKSP 488
                    +    PE    + +    K D++SLG+ +  +     P
Sbjct: 208 KGSRGTYEFM---PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 294 IMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFES--EVSLLGKIRHPNLLALRA 350
           ++G+  YG V  AT +  G  VA+K++ E   K      +  E+ +L   +H N++ +  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITI-- 74
Query: 351 YYLGPKGEKLLVFD--YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +   + +    F+  Y+    + T LH       +        I    R +  LH + N
Sbjct: 75  -FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-N 132
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLG---------YRAPE 459
           +IH +L  SN+L++ + + K+ DFGL+R++               G         YRAPE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 460 LS-KLKKANTKTDVYSLGVTILELL 483
           +     K +   DV+S G  + EL 
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 16/222 (7%)
Query: 277 DGPLMFTADDLLCATAEIMGKSTYGTVYKA-TLEDGSQVAVKRLR-EKITKG----QREF 330
           D  ++F     LC   E++GK  +  V +    E G Q AVK +   K T        + 
Sbjct: 17  DDDVLFEDVYELC---EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPI-DWPTR 389
           + E S+   ++HP+++ L   Y    G   +VF++M    L   +  R     +      
Sbjct: 74  KREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXX 446
              ++ +   L + H N NIIH ++    VLL   ++S   K+  FG++ +         
Sbjct: 133 SHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA 190
Query: 447 XXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                   + APE+ K +      DV+  GV +  LL+G  P
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 2/101 (1%)
Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAP 458
           GL  L S + II+ +L   NV+LD   + KI+DFG+ +                  Y AP
Sbjct: 454 GLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAP 511
Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQ 499
           E+   +      D ++ GV + E+L G++P E  +  EL Q
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 180
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 181 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 237
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 13/205 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLLAL 348
           +++G+  +G V    +++  ++   ++  K    +R     F  E  +L       + AL
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             Y    +    LV DY   G L T L     + P D       I  M   +  +H   +
Sbjct: 140 H-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED--MARFYIGEMVLAIDSIH-QLH 195
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSK-----L 463
            +H ++   NVLLD + + +++DFG    M                Y +PE+ +     +
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
            K   + D +SLGV + E+L G++P
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM 390
           E+E+ +L K+ HP ++ ++ ++     +  +V + M  G L  F    G +   +   ++
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGEL--FDKVVGNKRLKEATCKL 243
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXX 447
              + M   + +LH N  IIH +L   NVLL   ++    KI+DFG S+++         
Sbjct: 244 YFYQ-MLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 448 XXXXXLGYRAPE-LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
                  Y APE L  +  A  N   D +SLGV +   L+G  P
Sbjct: 302 CGTPT--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 331 ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM 390
           E+E+ +L K+ HP ++ ++ ++     +  +V + M  G L  F    G +   +   ++
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKL 257
Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXX 447
              + M   + +LH N  IIH +L   NVLL   ++    KI+DFG S+++         
Sbjct: 258 YFYQ-MLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 315
Query: 448 XXXXXLGYRAPE-LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
                  Y APE L  +  A  N   D +SLGV +   L+G  P
Sbjct: 316 CGTPT--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 13/205 (6%)
Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKIRHPNLLAL 348
           +++G+  +G V    +++  ++   ++  K    +R     F  E  +L       + AL
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             Y    +    LV DY   G L T L     + P D       I  M   +  +H   +
Sbjct: 156 H-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED--MARFYIGEMVLAIDSIH-QLH 211
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSK-----L 463
            +H ++   NVLLD + + +++DFG    M                Y +PE+ +     +
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
            K   + D +SLGV + E+L G++P
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 26  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 136
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 137 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 193
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 194 MGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 26  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 136
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 137 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 193
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 194 MGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 136
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 137 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 193
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 194 MGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 135
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 136 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 192
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     +E E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     +++DFGL++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 31  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 141
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 142 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 198
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 199 MGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 33  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 143
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 144 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 200
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 201 MGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 33  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 143
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 144 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 200
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 201 MGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 147
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 148 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 204
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 205 MGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A LE    VA+K+L       T  +R +  E+ L+  + H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 349 RAYYLGPKG-----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  +V + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 200 MGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 42/287 (14%)
Query: 293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           + +G+  +G V++A  + D    A+KR+R    +  RE    EV  L K+ HP ++    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 351 YYL--------GPKGEKLLVFDYMP---HGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
            +L         P   K+ ++  M      +L  +++ R      +    + I   +   
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXX--------XXXXX 451
           +  LHS + ++H +L  SN+        K+ DFGL   M                     
Sbjct: 131 VEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 452 XLG---YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE 508
            +G   Y +PE       + K D++SLG+ + ELL   S                  + E
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS-----------------TQME 232
Query: 509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
               + D+  ++  P    +      +    + PSP  RPE + +++
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVI-----QMELDHERMSYLLYQMLXGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ ++G V++    + G Q AVK++R ++ +     E  V+  G +  P ++ L  Y  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAG-LSSPRIVPL--YGA 132
Query: 354 GPKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             +G  + +F + +  GSL   +   G   P D    +  +     GL +LH+   I+HG
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPED--RALYYLGQALEGLEYLHTR-RILHG 188
Query: 413 NLTSSNVLLD-DSTNAKISDFGLSRLMXXXXXXXXXXXXXXL----GYRAPELSKLKKAN 467
           ++ + NVLL  D + A + DFG +  +              +     + APE+   K  +
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            K D++S    +L +L G  P
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHP 269

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 29/219 (13%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTGK--SPGEPLNGAELPQW 500
                  D++S+G  + E++  K   PG       + QW
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQW 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVI-----QMELDHERMSYLLYQMLXGIKHL 135
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 136 HS-AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 192
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ ++G V++    + G Q AVK++R ++ +     E  V+  G +  P ++ L  Y  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAG-LSSPRIVPL--YGA 118
Query: 354 GPKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             +G  + +F + +  GSL   +   G   P D    +  +     GL +LH+   I+HG
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPED--RALYYLGQALEGLEYLHTR-RILHG 174
Query: 413 NLTSSNVLLD-DSTNAKISDFGLSRLMXXXXXXXXXXXXXXL----GYRAPELSKLKKAN 467
           ++ + NVLL  D + A + DFG +  +              +     + APE+   K  +
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            K D++S    +L +L G  P
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP 255

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVI-----QMELDHERMSYLLYQMLXGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 295 MGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYY 352
           +G+ ++    K   +  +Q  AVK + +++    ++   E++ L     HPN++ L   +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
              +    LV + +  G L   +  +    ET   +     I++ +   + H+H +  ++
Sbjct: 76  -HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-----IMRKLVSAVSHMH-DVGVV 128
Query: 411 HGNLTSSNVLL---DDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKAN 467
           H +L   N+L    +D+   KI DFG +RL               L Y APEL      +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTLHYAAPELLNQNGYD 187
Query: 468 TKTDVYSLGVTILELLTGKSP 488
              D++SLGV +  +L+G+ P
Sbjct: 188 ESCDLWSLGVILYTMLSGQVP 208

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 93
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 149
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 150 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE----YLAPEIILSKGYNKAV 205
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 206 DWWALGVLIYEMAAGYPP 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|1XEU|A Chain A, Crystal Structure Of Internalin C From Listeria Monocytogenes Length = 263

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 65/117 (55%), Gaps = 11/117 (9%)
Query: 16  ASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVS 74
           A +   + L+E+ LSHN+IS + P  DL +L  L +       +NG +P+     + L  
Sbjct: 57  AGMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKNLNG-IPS-----ACLSR 110
Query: 75  LTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS 131
           L L++N L D   DSL  L NL +L+++ N++   +   +G +S L +LDL  N+++
Sbjct: 111 LFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEIT 163

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 295 MGKSTYGTV---YKATLEDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
           +G    G V   Y A L+    VA+K+L       T  +R +  E+ L+  + H N+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 349 RAYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
              +   K      +  LV + M   +L   +     +  +D      ++  M  G+ HL
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVI-----QMELDHERMSYLLYQMLCGIKHL 142
Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKL 463
           HS   IIH +L  SN+++      KI DFGL+R                  YRAPE+   
Sbjct: 143 HS-AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILG 199
Query: 464 KKANTKTDVYSLGVTILELLTGK 486
                  D++S+G  + E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           +G+ ++G V++    + G Q AVK++R ++ +     E  V+  G +  P ++ L  Y  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAG-LSSPRIVPL--YGA 134
Query: 354 GPKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             +G  + +F + +  GSL   +   G   P D    +  +     GL +LH+   I+HG
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPED--RALYYLGQALEGLEYLHTR-RILHG 190
Query: 413 NLTSSNVLLD-DSTNAKISDFGLSRLMXXXXXXXXXXXXXXL----GYRAPELSKLKKAN 467
           ++ + NVLL  D + A + DFG +  +              +     + APE+   K  +
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 468 TKTDVYSLGVTILELLTGKSP 488
            K D++S    +L +L G  P
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHP 271

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 25/178 (14%)
Query: 323 ITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPHGS-------LATF 374
           I K +R+   E+ +L +  +HPN++ L+  Y    G+ + V   +  G           F
Sbjct: 55  IDKSKRDPTEEIEILLRYGQHPNIITLKDVY--DDGKYVYVVTELXKGGELLDKILRQKF 112
Query: 375 LHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL-LDDSTN---AKIS 430
              R             ++  +T+ + +LH+ + ++H +L  SN+L +D+S N    +I 
Sbjct: 113 FSEREASA---------VLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 431 DFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           DFG ++ +                + APE+ + +  +   D++SLGV +   LTG +P
Sbjct: 163 DFGFAKQLRAENGLLXTPCYTA-NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2XOT|A Chain A, Crystal Structure Of Neuronal Leucine Rich Repeat Protein Amigo-1 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 67/132 (50%), Gaps = 4/132 (3%)
Query: 3   LALQYNNLSG-RIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L +NNLS  R   +  +L+ L  + LSHN ++ +       +  LR LD S N ++  
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTL 103
Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI--GN-IS 118
               FS+L +L  L L +N++     ++ + +  L  L L +NQIS      I  GN + 
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLP 163
Query: 119 TLTILDLSQNKL 130
            L +LDLS NKL
Sbjct: 164 KLMLLDLSSNKL 175

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G       P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G       P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G       P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 93/210 (44%), Gaps = 11/210 (5%)
Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREF---ESEVSLLGKI-RHPNLLAL 348
           ++G+ +Y  V    L+   ++ A+K +++++     +    ++E  +  +   HP L+ L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            + +   +     V +Y+  G L  F   R  + P +          +    LH      
Sbjct: 87  HSCF-QTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH---ERG 141
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   NVLLD   + K++D+G+ +                  Y APE+ + +    
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 200
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELP 498
             D ++LGV + E++ G+SP + +  ++ P
Sbjct: 201 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP 230

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQRE----FESEVSLLGKI-RHPNLLAL 348
           ++G+ +Y  V    L+   ++   R+ +K      E     ++E  +  +   HP L+ L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            + +   +     V +Y+  G L  F   R  + P +          +    LH      
Sbjct: 119 HSCF-QTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH---ERG 173
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   NVLLD   + K++D+G+ +                  Y APE+ + +    
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELP 498
             D ++LGV + E++ G+SP + +  ++ P
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 93/210 (44%), Gaps = 11/210 (5%)
Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREF---ESEVSLLGKI-RHPNLLAL 348
           ++G+ +Y  V    L+   ++ A+K +++++     +    ++E  +  +   HP L+ L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            + +   +     V +Y+  G L  F   R  + P +          +    LH      
Sbjct: 72  HSCF-QTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH---ERG 126
Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANT 468
           II+ +L   NVLLD   + K++D+G+ +                  Y APE+ + +    
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELP 498
             D ++LGV + E++ G+SP + +  ++ P
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP 215

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G       P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 15/225 (6%)
Query: 279 PLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREF---ESEV 334
           PL     DLL     ++G+ +Y  V    L+   ++ A+K +++++     +    ++E 
Sbjct: 5   PLGLQDFDLL----RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 335 SLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKII 393
            +  +   HP L+ L + +   +     V +Y+  G L  F   R  + P +        
Sbjct: 61  HVFEQASNHPFLVGLHSCF-QTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAE 118
Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXL 453
             +    LH      II+ +L   NVLLD   + K++D+G+ +                 
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTP 174
Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP 498
            Y APE+ + +      D ++LGV + E++ G+SP + +  ++ P
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 219

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 81/183 (44%), Gaps = 17/183 (9%)
Query: 314 VAVKRLR--EKITKG-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS 370
           VAVK +   EKI +  +RE  +  SL    RHPN++  +   L P     +V +Y   G 
Sbjct: 46  VAVKYIERGEKIDENVKREIINHRSL----RHPNIVRFKEVILTPT-HLAIVMEYASGGE 100
Query: 371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST--NAK 428
           L   +   G  +  +   R    + +  G+ + H+ + + H +L   N LLD S     K
Sbjct: 101 LFERICNAGRFSEDE--ARF-FFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLK 156
Query: 429 ISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT-DVYSLGVTILELLTGKS 487
           I DFG S+                  Y APE+   K+ + K  DV+S GVT+  +L G  
Sbjct: 157 ICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY 214
Query: 488 PGE 490
           P E
Sbjct: 215 PFE 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 80/183 (43%), Gaps = 17/183 (9%)
Query: 314 VAVKRLR--EKITKG-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS 370
           VAVK +   EKI    +RE  +  SL    RHPN++  +   L P     +V +Y   G 
Sbjct: 47  VAVKYIERGEKIAANVKREIINHRSL----RHPNIVRFKEVILTPT-HLAIVMEYASGGE 101
Query: 371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST--NAK 428
           L   +   G  +  +   R    + +  G+ + H+ + + H +L   N LLD S     K
Sbjct: 102 LFERICNAGRFSEDE--ARF-FFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLK 157
Query: 429 ISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT-DVYSLGVTILELLTGKS 487
           I DFG S+                  Y APE+   K+ + K  DV+S GVT+  +L G  
Sbjct: 158 ICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY 215
Query: 488 PGE 490
           P E
Sbjct: 216 PFE 218

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 12/217 (5%)
Query: 277 DGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSL 336
           D P+M  +D       + +G   +G       +  +++   +  E+  K     + E+  
Sbjct: 11  DLPIMHDSDRY--ELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIIN 68
Query: 337 LGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGM 396
              +RHPN++  +   L P     +V +Y   G L   +   G  +  +   R    + +
Sbjct: 69  HRSLRHPNIVRFKEVILTPT-HLAIVMEYASGGELFERICNAGRFSEDE--ARF-FFQQL 124
Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDST--NAKISDFGLSRLMXXXXXXXXXXXXXXLG 454
             G+ + H+ + + H +L   N LLD S     KI+DFG S+                  
Sbjct: 125 ISGVSYAHAMQ-VAHRDLKLENTLLDGSPAPRLKIADFGYSK--ASVLHSQPKSAVGTPA 181
Query: 455 YRAPELSKLKKANTKT-DVYSLGVTILELLTGKSPGE 490
           Y APE+   K+ + K  DV+S GVT+  +L G  P E
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 100
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 156
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 212
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 213 DWWALGVLIYEMAAGYPP 230

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G       P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 107/247 (43%), Gaps = 22/247 (8%)
Query: 285 DDLLCATAEIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-H 342
           +D+   T+E++G+  Y  V  A +L++G + AVK + ++    +     EV  L + + +
Sbjct: 11  EDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 343 PNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
            N+L L  ++        LVF+ +  GS+   +     +   +     ++++ +   L  
Sbjct: 71  KNILELIEFF-EDDTRFYLVFEKLQGGSILAHIQK---QKHFNEREASRVVRDVAAALDF 126
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNA---KISDFGLS---RLMXXXXXXXXXXXXXXLG-- 454
           LH+ + I H +L   N+L +        KI DF L    +L                G  
Sbjct: 127 LHT-KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 455 -YRAPELSKLKK-----ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE 508
            Y APE+ ++        + + D++SLGV +  +L+G  P     GA+   W    V   
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCG-WDRGEVCRV 244
Query: 509 WTNEVFD 515
             N++F+
Sbjct: 245 CQNKLFE 251

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 72/167 (43%), Gaps = 14/167 (8%)
Query: 327 QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDW 386
           QRE  +  SL    RHPN++  +   L P     ++ +Y   G L   +   G  +  + 
Sbjct: 64  QREIINHRSL----RHPNIVRFKEVILTPT-HLAIIMEYASGGELYERICNAGRFSEDE- 117
Query: 387 PTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST--NAKISDFGLSRLMXXXXXX 444
             R    + +  G+ + HS + I H +L   N LLD S     KI DFG S+        
Sbjct: 118 -ARF-FFQQLLSGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHS 172
Query: 445 XXXXXXXXLGYRAPELSKLKKANTK-TDVYSLGVTILELLTGKSPGE 490
                     Y APE+   ++ + K  DV+S GVT+  +L G  P E
Sbjct: 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 128
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 184
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 240
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 241 DWWALGVLIYEMAAGYPP 258

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 70/140 (50%), Gaps = 26/140 (18%)
Query: 16  ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING-SLPASFSNLSSLVS 74
           ++L  L+ LQ++S S N+++ + P  L  L+ L  LD S N ++  S+ A  +NL SL++
Sbjct: 145 SALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIA 202
Query: 75  -------------------LTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIG 115
                              L+L  N L D  + +L  L NL+ L+L  NQIS   P  + 
Sbjct: 203 TNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LS 258
Query: 116 NISTLTILDLSQNKLSGEIP 135
            ++ LT L L  N++S   P
Sbjct: 259 GLTKLTELKLGANQISNISP 278

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 70/140 (50%), Gaps = 26/140 (18%)
Query: 16  ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING-SLPASFSNLSSLVS 74
           ++L  L+ LQ++S S N+++ + P  L  L+ L  LD S N ++  S+ A  +NL SL++
Sbjct: 145 SALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIA 202
Query: 75  -------------------LTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIG 115
                              L+L  N L D  + +L  L NL+ L+L  NQIS   P  + 
Sbjct: 203 TNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LS 258
Query: 116 NISTLTILDLSQNKLSGEIP 135
            ++ LT L L  N++S   P
Sbjct: 259 GLTKLTELKLGANQISNISP 278

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 26/140 (18%)
Query: 16  ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING-SLPASFSNLSSLVS 74
           ++L  L+ LQ+++ S N+++ + P  L  L+ L  LD S N ++  S+ A  +NL SL++
Sbjct: 145 SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIA 202
Query: 75  -------------------LTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIG 115
                              L+L  N L D  + +L  L NL+ L+L  NQIS   P  + 
Sbjct: 203 TNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LS 258
Query: 116 NISTLTILDLSQNKLSGEIP 135
            ++ LT L L  N++S   P
Sbjct: 259 GLTKLTELKLGANQISNISP 278

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 108
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y P G + + L   G  +    P        +     +LHS  ++I
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 164
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+++D     K++DFG ++ +                Y APE+   K  N   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 220
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V      E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 100
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+P G + + L   G       P        +     +LHS  ++I
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLHS-LDLI 156
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 212
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 213 DWWALGVLIYEMAAGYPP 230

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 292 AEIMGKSTYGTVYKATLEDGSQVAVKR--------LREKITKGQREFESEVSLLGKIRHP 343
            +++G+ +YG V K  L+  S+   +R           +I  G+   + E+ LL ++RH 
Sbjct: 10  GDLLGEGSYGKV-KEVLD--SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 344 NLLAL-RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
           N++ L    Y   K +  +V +Y   G +   L +  PE              +  GL +
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEY 124
Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMXXXXXXXXXXXXXXLGYRAPELS 461
           LHS + I+H ++   N+LL      KIS  G++  L                 ++ PE++
Sbjct: 125 LHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 462 KLKK--ANTKTDVYSLGVTILELLTGKSPGE 490
                 +  K D++S GVT+  + TG  P E
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 324 TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHG-SLATFLHARGPET 382
           T+ QRE  +     G+++ P+++ +  +  G    +L V   + +G  LA  L  +GP  
Sbjct: 79  TRXQREARTA----GRLQEPHVVPIHDF--GEIDGQLYVDXRLINGVDLAAXLRRQGPLA 132
Query: 383 PIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMXXXX 442
           P   P  + I++ +    L         H ++   N+L+     A + DFG++       
Sbjct: 133 P---PRAVAIVRQIG-SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188
Query: 443 XXXXXXXXXXLGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP--GEPLN--GAELP 498
                     L Y APE      A  + D+Y+L   + E LTG  P  G+ L+  GA + 
Sbjct: 189 LTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVXGAHIN 248
Query: 499 QWV 501
           Q +
Sbjct: 249 QAI 251

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           +G  ++G V     +E G+  A+K L ++     ++ E   +E  +L  +  P L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +         +V +Y+  G + + L   G  +    P        +     +LHS  ++I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLHS-LDLI 163
Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKKANTKT 470
           + +L   N+L+D     +++DFG ++ +                Y APE+   K  N   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE----YLAPEIILSKGYNKAV 219
Query: 471 DVYSLGVTILELLTGKSP 488
           D ++LGV I E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 304 YKATLEDGSQVAVKRLR-EKITKGQREF-ESEVSLLGKIRHPNLLALRAYYLGPKGEKLL 361
           YK T   G  V V+R+  E  +     F + E+ +     HPN++  RA ++    E  +
Sbjct: 32  YKPT---GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWV 87
Query: 362 VFDYMPHGS----LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSS 417
           V  +M +GS    + T       E  I +     I++G+ + L ++H +   +H ++ +S
Sbjct: 88  VTSFMAYGSAKDLICTHFMDGMNELAIAY-----ILQGVLKALDYIH-HMGYVHRSVKAS 141
Query: 418 NVLLDDSTNAKISDFGLSRLMXXXXXXXXX--------XXXXXLGYRAPEL--SKLKKAN 467
           ++L+  S + K+   GL   +                      L + +PE+    L+  +
Sbjct: 142 HILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 199
Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
            K+D+YS+G+T  EL  G  P + +   ++
Sbjct: 200 AKSDIYSVGITACELANGHVPFKDMPATQM 229

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 304 YKATLEDGSQVAVKRLR-EKITKGQREF-ESEVSLLGKIRHPNLLALRAYYLGPKGEKLL 361
           YK T   G  V V+R+  E  +     F + E+ +     HPN++  RA ++    E  +
Sbjct: 48  YKPT---GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWV 103
Query: 362 VFDYMPHGS----LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSS 417
           V  +M +GS    + T       E  I +     I++G+ + L ++H +   +H ++ +S
Sbjct: 104 VTSFMAYGSAKDLICTHFMDGMNELAIAY-----ILQGVLKALDYIH-HMGYVHRSVKAS 157
Query: 418 NVLLDDSTNAKISDFGLSRLMXXXXXXXXX--------XXXXXLGYRAPEL--SKLKKAN 467
           ++L+  S + K+   GL   +                      L + +PE+    L+  +
Sbjct: 158 HILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215
Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAEL 497
            K+D+YS+G+T  EL  G  P + +   ++
Sbjct: 216 AKSDIYSVGITACELANGHVPFKDMPATQM 245

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	580
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-85
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-75
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-74
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-66
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-51
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-44
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-40
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-10
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-57
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-57
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-53
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-49
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-49
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-47
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-45
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-43
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-41
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-48
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-36
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-36
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-35
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-33
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-38
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-37
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-36
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-35
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-32
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-32
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-36
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-35
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-34
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-32
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-32
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-30
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-29
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-27
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-10
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-16
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-33
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-26
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-27
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-13
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-31
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-30
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-30
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-29
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-29
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-28
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-26
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-09
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-28
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-24
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-09
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-28
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-28
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-05
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-16
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-27
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-27
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-25
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-06
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-25
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-24
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-23
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-21
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-10
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-21
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-23
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-23
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-20
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-20
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-09
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-24
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-24
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-24
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-23
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-21
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-10
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-10
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-22
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-20
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-09
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-14
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-20
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-20
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-20
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-20
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-20
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-04
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-05
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-07
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-20
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-05
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-19
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-19
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-18
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-15
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-05
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-19
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-10
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-16
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-15
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-15
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-15
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-15
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-15
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	9e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	1e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-04
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	2e-04
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	8e-04
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	6e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	6e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  265 bits (681), Expect = 9e-85
 Identities = 109/301 (36%), Positives = 171/301 (56%), Gaps = 21/301 (6%)

Query: 274 VHFDGPLMFTADDLLCAT-----AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKG-Q 327
           VH      F+  +L  A+       I+G+  +G VYK  L DG+ VAVKRL+E+ T+G +
Sbjct: 12  VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71

Query: 328 REFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGP-ETPIDW 386
            +F++EV ++    H NLL LR + + P  E+LLV+ YM +GS+A+ L  R   + P+DW
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSVASCLRERPESQPPLDW 130

Query: 387 PTRMKIIKGMTRGL--LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV 444
           P R +I  G  RGL  LH H +  IIH ++ ++N+LLD+   A + DFGL++LM      
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKD 188

Query: 445 NVIAT--AGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE-----L 497
             + T   G +G+ APE     K++ KTDV+  GV +LEL+TG+   +    A      L
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 498 PQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
             WV  ++KE+    + D++L  +     +E+   +++AL C   SP  RP++ +VV+ L
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

Query: 558 E 558
           E
Sbjct: 307 E 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  241 bits (617), Expect = 3e-75
 Identities = 89/289 (30%), Positives = 139/289 (48%), Gaps = 14/289 (4%)

Query: 282 FTADDLLCAT-----AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSL 336
               DL  AT       ++G   +G VYK  L DG++VA+KR   + ++G  EFE+E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 337 LGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKG 395
           L   RHP+L++L  +    + E +L++ YM +G+L   L+    P   + W  R++I  G
Sbjct: 89  LSFCRHPHLVSLIGFCD-ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI-ATAGALG 454
             RGL +LH    IIH ++ S N+LLD++   KI+DFG+S+  T     ++     G LG
Sbjct: 148 AARGLHYLH-TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSP---GEPLNGAELPQWVASIVKEEWTN 511
           Y  PE     +   K+DVYS GV + E+L  +S      P     L +W           
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266

Query: 512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           ++ D  L        + L      A+ C+  S   RP +  V+ +LE  
Sbjct: 267 QIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  238 bits (611), Expect = 2e-74
 Identities = 86/305 (28%), Positives = 140/305 (45%), Gaps = 41/305 (13%)

Query: 282 FTADDLLCAT-----------AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK----G 326
           F+  +L   T              MG+  +G VYK  + + + VAVK+L   +       
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73

Query: 327 QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDW 386
           +++F+ E+ ++ K +H NL+ L  +      +  LV+ YMP+GSL   L       P+ W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGD-DLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 387 PTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV 446
             R KI +G   G+  LH   + IH ++ S+N+LLD++  AKISDFGL+R     A   +
Sbjct: 133 HMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191

Query: 447 -IATAGALGYRAPE-----LSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE-LPQ 499
                G   Y APE     ++       K+D+YS GV +LE++TG    +     + L  
Sbjct: 192 TSRIVGTTAYMAPEALRGEIT------PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245

Query: 500 WVASIVKEEWTNEVFDLELMRDAPTIGD----ELLNTLKLALHCVDPSPSARPEVLQVVQ 555
               I  EE       +E   D   + D     +     +A  C+    + RP++ +V Q
Sbjct: 246 IKEEIEDEEK-----TIEDYID-KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

Query: 556 QLEEI 560
            L+E+
Sbjct: 300 LLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  218 bits (556), Expect = 2e-66
 Identities = 72/327 (22%), Positives = 126/327 (38%), Gaps = 48/327 (14%)

Query: 270 GGKLVHFDGPLMFTADDLLCAT-----AEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT 324
           G    H    +    ++L   +      E+  +  +G V+KA L     VAVK    +  
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK 60

Query: 325 KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG---EKLLVFDYMPHGSLATFLHARGPE 381
           +   + E EV  L  ++H N+L              +  L+  +   GSL+ FL A    
Sbjct: 61  QSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--- 116

Query: 382 TPIDWPTRMKIIKGMTRGLLHLHSNE---------NIIHGNLTSSNVLLDDSTNAKISDF 432
             + W     I + M RGL +LH +           I H ++ S NVLL ++  A I+DF
Sbjct: 117 -VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175

Query: 433 GLSRLMTAAAN-VNVIATAGALGYRAPE-----LSKLKKANTKTDVYSLGVTILELLTGK 486
           GL+    A  +  +     G   Y APE     ++  + A  + D+Y++G+ + EL +  
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235

Query: 487 SPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA-------PTIGDELLNT------L 533
           +  +      +  +      EE   +   LE M++        P + D            
Sbjct: 236 TAADGPVDEYMLPF------EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289

Query: 534 KLALHCVDPSPSARPEVLQVVQQLEEI 560
           +    C D    AR     V +++ ++
Sbjct: 290 ETIEECWDHDAEARLSAGCVGERITQM 316

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  209 bits (535), Expect = 2e-63
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 4/180 (2%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRL-RILDFSYNAING 60
            L   YN LSG +P S+  L  L  I+   N+ISG +P   G  S+L   +  S N + G
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
            +P +F+NL+ L  + L  N L+           N   ++L +N ++  +   +G    L
Sbjct: 189 KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNL 246

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALK-FNASSFVGNIQLCG 179
             LDL  N++ G +P   + LK L S NVS+NNL G +P    L+ F+ S++  N  LCG
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  176 bits (450), Expect = 5e-51
 Identities = 52/164 (31%), Positives = 88/164 (53%), Gaps = 5/164 (3%)

Query: 3   LALQYNNLSGR--IPASLGKLSELQEISLSH-NKISGVMPSDLGRLSRLRILDFSYNAIN 59
           L L   NL     IP+SL  L  L  + +   N + G +P  + +L++L  L  ++  ++
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 60  GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
           G++P   S + +LV+L    N L   +  S+  L NL  +    N+ISG IP + G+ S 
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 120 L-TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           L T + +S+N+L+G+IP +F+NL +L+  ++S N L G      
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  160 bits (406), Expect = 1e-44
 Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 4/160 (2%)

Query: 8   NNLSGRIPASLGKLSELQEISLSHNKISGVM--PSDLGRLSRLRILDFS-YNAINGSLPA 64
               G +  +  +   +  + LS   +      PS L  L  L  L     N + G +P 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
           + + L+ L  L +   N+   I D L ++  L  L+   N +SG +P +I ++  L  + 
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 125 LSQNKLSGEIPASFSNLKSLSSF-NVSYNNLSGPVPTSLA 163
              N++SG IP S+ +   L +   +S N L+G +P + A
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  147 bits (373), Expect = 5e-40
 Identities = 48/156 (30%), Positives = 68/156 (43%), Gaps = 7/156 (4%)

Query: 14  IPASLGKLSELQ----EISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS--LPASFS 67
           I   LG  + L          +    GV+     +  R+  LD S   +     +P+S +
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 68  NLSSLVSLTLES-NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLS 126
           NL  L  L +   NNL   I  ++ KL  L  L +    +SG IP  +  I TL  LD S
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133

Query: 127 QNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
            N LSG +P S S+L +L       N +SG +P S 
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 61.4 bits (150), Expect = 2e-10
 Identities = 16/56 (28%), Positives = 28/56 (50%), Gaps = 1/56 (1%)

Query: 1   MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN 56
             L L+ N + G +P  L +L  L  +++S N + G +P   G L R  +  ++ N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (491), Expect = 5e-57
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 28/272 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E++G+  +G V KA       VA+K++  +    ++ F  E+  L ++ HPN++ L    
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE--NII 410
           L P     LV +Y   GSL   LH   P         M      ++G+ +LHS +   +I
Sbjct: 71  LNPV---CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 411 HGNLTSSNVLLDDS-TNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           H +L   N+LL    T  KI DFG +  +      ++    G+  + APE+ +    + K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYSEK 183

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
            DV+S G+ + E++T + P + + G      +   V              R  P +   L
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGG--PAFRIMWAVHNG----------TR--PPLIKNL 229

Query: 530 LNTLK-LALHCVDPSPSARPEVLQVVQQLEEI 560
              ++ L   C    PS RP + ++V+ +  +
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  203 bits (519), Expect = 5e-57
 Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 4/203 (1%)

Query: 1   MFLALQYNNLSGRIPASLGKLSELQEISLSHN--KISGVMPSDLGRLSRLRILDFSYNAI 58
               +  N ++G+    +      +E   + N  +  G+    L RLS     + +    
Sbjct: 561 QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY 620

Query: 59  NGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
            G    +F N  S++ L +  N L   I   +  +  L +LNL  N ISG IP  +G++ 
Sbjct: 621 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR 680

Query: 119 TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALK-FNASSFVGNIQL 177
            L ILDLS NKL G IP + S L  L+  ++S NNLSGP+P     + F  + F+ N  L
Sbjct: 681 GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740

Query: 178 CGYSGSTPCPSPPAEKPKSRGRK 200
           CG      C    A+      R 
Sbjct: 741 CG-YPLPRCDPSNADGYAHHQRS 762

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  192 bits (490), Expect = 5e-53
 Identities = 60/161 (37%), Positives = 91/161 (56%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L LQ N  +G+IP +L   SEL  + LS N +SG +PS LG LS+LR L    N + G 
Sbjct: 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P     + +L +L L+ N+L  +I   L    NL+ ++L  N+++G IP  IG +  L 
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           IL LS N  SG IPA   + +SL   +++ N  +G +P ++
Sbjct: 518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  182 bits (464), Expect = 1e-49
 Identities = 59/163 (36%), Positives = 89/163 (54%), Gaps = 2/163 (1%)

Query: 2   FLALQYNNLSGRIPASLGK--LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN 59
            L L  NN SG I  +L +   + LQE+ L +N  +G +P  L   S L  L  S+N ++
Sbjct: 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431

Query: 60  GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
           G++P+S  +LS L  L L  N L+ +I   L  +  L  L L  N ++G IPS + N + 
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           L  + LS N+L+GEIP     L++L+   +S N+ SG +P  L
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  180 bits (460), Expect = 6e-49
 Identities = 57/184 (30%), Positives = 95/184 (51%), Gaps = 4/184 (2%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L +N LSG IP+SLG LS+L+++ L  N + G +P +L  +  L  L   +N + G 
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           +P+  SN ++L  ++L +N L  +I   + +L NL++L L  N  SG+IP+ +G+  +L 
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 541

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYS 181
            LDL+ N  +G IPA+        S  ++ N ++G     +          G   L  + 
Sbjct: 542 WLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597

Query: 182 GSTP 185
           G   
Sbjct: 598 GIRS 601

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  175 bits (446), Expect = 4e-47
 Identities = 59/166 (35%), Positives = 91/166 (54%), Gaps = 4/166 (2%)

Query: 2   FLALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLS-RLRILDFSYNAIN 59
            LAL  NN SG +P  +L K+  L+ + LS N+ SG +P  L  LS  L  LD S N  +
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381

Query: 60  GSLPASFSN--LSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNI 117
           G +  +      ++L  L L++N    +I  +L     L  L+L  N +SG IPS++G++
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441

Query: 118 STLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           S L  L L  N L GEIP     +K+L +  + +N+L+G +P+ L+
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  171 bits (435), Expect = 1e-45
 Identities = 59/185 (31%), Positives = 84/185 (45%), Gaps = 18/185 (9%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            LA+  N +SG +   + +   L+ + +S N  S  +P  LG  S L+ LD S N ++G 
Sbjct: 182 HLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTL 120
              + S  + L  L + SN     I      L +L  L+L  N+ +G IP  + G   TL
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTL 296

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP----------TSLALKFNASS 170
           T LDLS N   G +P  F +   L S  +S NN SG +P            L L FN   
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN--E 354

Query: 171 FVGNI 175
           F G +
Sbjct: 355 FSGEL 359

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  165 bits (419), Expect = 1e-43
 Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 18/187 (9%)

Query: 2   FLALQYNNLSGRIPA--SLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAI 58
            L L  N+LSG +    SLG  S L+ +++S N +      S   +L+ L +LD S N+I
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163

Query: 59  NGSLPASF---SNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIG 115
           +G+    +        L  L +  N +   +   + +  NL  L++  N  S  IP  +G
Sbjct: 164 SGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPF-LG 220

Query: 116 NISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTS-------LALKFNA 168
           + S L  LD+S NKLSG+   + S    L   N+S N   GP+P         L+L  N 
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN- 279

Query: 169 SSFVGNI 175
             F G I
Sbjct: 280 -KFTGEI 285

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  156 bits (398), Expect = 9e-41
 Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 10/168 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSD--LGRLSRLRILDFSYNAIN 59
            L L  ++++G +       + L  + LS N +SG + +   LG  S L+ L+ S N ++
Sbjct: 81  SLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 139

Query: 60  GSLPAS-FSNLSSLVSLTLESNNLDDQILDSLD---KLHNLSVLNLKRNQISGHIPSTIG 115
                S    L+SL  L L +N++    +           L  L +  N+ISG +   + 
Sbjct: 140 FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VS 197

Query: 116 NISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
               L  LD+S N  S  IP    +  +L   ++S N LSG    +++
Sbjct: 198 RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIS 244

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  150 bits (380), Expect = 2e-38
 Identities = 52/190 (27%), Positives = 83/190 (43%), Gaps = 22/190 (11%)

Query: 3   LALQYNNLS---GRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN 59
           + L    L+     + +SL  L+ L+ + LS++ I+G +       + L  LD S N+++
Sbjct: 55  IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLS 113

Query: 60  GSLPA--SFSNLSSLVSLTLESNNLDDQI-LDSLDKLHNLSVLNLKRNQISGHIPSTI-- 114
           G +    S  + S L  L + SN LD    +    KL++L VL+L  N ISG        
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173

Query: 115 -GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP--------TSLALK 165
                 L  L +S NK+SG++    S   +L   +VS NN S  +P          L + 
Sbjct: 174 SDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDIS 231

Query: 166 FNASSFVGNI 175
            N     G+ 
Sbjct: 232 GN--KLSGDF 239

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  122 bits (309), Expect = 2e-29
 Identities = 47/172 (27%), Positives = 69/172 (40%), Gaps = 16/172 (9%)

Query: 17  SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLT 76
              K++ +   S   N     + S L  L+ L  L  S + INGS+   F   +SL SL 
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 77  LESNNLDDQI--LDSLDKLHNLSVLNLKRNQISGHIP-STIGNISTLTILDLSQNKLSGE 133
           L  N+L   +  L SL     L  LN+  N +      S    +++L +LDLS N +SG 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 134 IPASF---SNLKSLSSFNVSYNNLSGPVP-------TSLALKFNASSFVGNI 175
               +        L    +S N +SG V          L +  N  +F   I
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN--NFSTGI 216

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  110 bits (278), Expect = 1e-25
 Identities = 33/149 (22%), Positives = 64/149 (42%), Gaps = 5/149 (3%)

Query: 41  DLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLN 100
              +++ + +     N    ++ +S  +L+ L SL L +++++  +        +L+ L+
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLD 106

Query: 101 LKRNQISGHIPS--TIGNISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLSGP 157
           L RN +SG + +  ++G+ S L  L++S N L      S    L SL   ++S N++SG 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 158 VPTSLALKFNASSFVG-NIQLCGYSGSTP 185
                 L           I     SG   
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD 195

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  192 bits (489), Expect = 1e-56
 Identities = 83/278 (29%), Positives = 132/278 (47%), Gaps = 34/278 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRA 350
           E +G  ++GTV++A    GS VAVK L E+    +   EF  EV+++ ++RHPN++    
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS-NENI 409
               P     +V +Y+  GSL   LH  G    +D   R+ +   + +G+ +LH+ N  I
Sbjct: 102 AVTQP-PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           +H NL S N+L+D     K+ DFGLSRL  A+  ++  + AG   + APE+ + + +N K
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE-------EWTNEVFDLELMRDA 522
           +DVYS GV + EL T + P   LN A   Q VA++  +          N      ++   
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPA---QVVAAVGFKCKRLEIPRNLNPQV-AAIIEG- 274

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                           C    P  RP    ++  L  +
Sbjct: 275 ----------------CWTNEPWKRPSFATIMDLLRPL 296

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  188 bits (480), Expect = 6e-56
 Identities = 72/279 (25%), Positives = 122/279 (43%), Gaps = 31/279 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALRA 350
             + ++  G ++K     G+ + VK L+  +  T+  R+F  E   L    HPN+L +  
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS-NEN 408
               P      L+  +MP+GSL   LH  G    +D    +K    M RG+  LH+    
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           I    L S +V++D+   A+IS   +     +   +       A  + APE  + K  +T
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAPAWVAPEALQKKPEDT 187

Query: 469 ---KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
                D++S  V + EL+T + P   L+  E+   VA             LE +R  PTI
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA-------------LEGLR--PTI 232

Query: 526 GDELLNTL-KLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
              +   + KL   C++  P+ RP+   +V  LE+++ +
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  187 bits (478), Expect = 3e-55
 Identities = 69/300 (23%), Positives = 118/300 (39%), Gaps = 45/300 (15%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E +GK  YG V++ +   G  VAVK    +  +     E+E+     +RH N+L   A  
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASD 71

Query: 353 LGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE-- 407
           +  +       L+  Y   GSL  +L        +D  + ++I+  +  GL HLH     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 408 -----NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPE 459
                 I H +L S N+L+  +    I+D GL+ + + + N   +     +G   Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 460 L------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV 513
           +           +  + D+++ G+ + E+         +   + P         +     
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP-------FYDVVPND 240

Query: 514 FDLELMRDA-------PTI-----GDELLNTL-KLALHCVDPSPSARPEVLQVVQQLEEI 560
              E MR         P I      D  L +L KL   C   +PSAR   L++ + L +I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (475), Expect = 2e-54
 Identities = 68/300 (22%), Positives = 116/300 (38%), Gaps = 45/300 (15%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  YG V+      G +VAVK       +     E+E+     +RH N+L   A  
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 353 LGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS---- 405
           +   G      L+ DY  +GSL  +L +      +D  + +K+      GL HLH+    
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 406 ---NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPE 459
                 I H +L S N+L+  +    I+D GL+    +  N   I     +G   Y  PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 460 L------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV 513
           +          ++    D+YS G+ + E+      G  +   +LP         +     
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY-------HDLVPSD 269

Query: 514 FDLELMRDA-------PTIGDELLNT------LKLALHCVDPSPSARPEVLQVVQQLEEI 560
              E MR+        P+  +   +        KL   C   +P++R   L+V + L ++
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  184 bits (469), Expect = 5e-54
 Identities = 70/285 (24%), Positives = 134/285 (47%), Gaps = 39/285 (13%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ-------REFESEVSLLGKIRHPN 344
           + +GK  +G V+K   ++D S VA+K L    ++G+       +EF+ EV ++  + HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L      P     +V +++P G L   L       PI W  +++++  +  G+ ++ 
Sbjct: 85  IVKLYGLMHNPP---RMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 405 S-NENIIHGNLTSSNVLLDDS-----TNAKISDFGLSRLMTAAANVNVIATAGALGYRAP 458
           + N  I+H +L S N+ L          AK++DFGLS+    + +       G   + AP
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS----GLLGNFQWMAP 195

Query: 459 EL--SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL 516
           E   ++ +    K D YS  + +  +LTG+ P +  +  ++ +++  I +E         
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREEG-------- 246

Query: 517 ELMRDAPTIGDELLNTLK-LALHCVDPSPSARPEVLQVVQQLEEI 560
             +R  PTI ++    L+ +   C    P  RP    +V++L E+
Sbjct: 247 --LR--PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  185 bits (472), Expect = 5e-54
 Identities = 73/313 (23%), Positives = 117/313 (37%), Gaps = 60/313 (19%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREF--ESEVSLLGKIRHPNLLALRA 350
           E++G+  YG VYK +L D   VAVK         ++ F  E  +  +  + H N+     
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIV 74

Query: 351 YYLGPKG----EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
                      E LLV +Y P+GSL  +L         DW +  ++   +TRGL +LH+ 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTE 130

Query: 407 EN--------IIHGNLTSSNVLLDDSTNAKISDFGLSRLM-------TAAANVNVIATAG 451
                     I H +L S NVL+ +     ISDFGLS  +           +   I+  G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 452 ALGYRAPE-------LSKLKKANTKTDVYSLGVTILELLTGKS---PGEPLNGAELPQWV 501
            + Y APE       L   + A  + D+Y+LG+   E+    +   PGE +   ++    
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA--- 247

Query: 502 ASIVKEEWTNEVFDLELMRDA-------PTIGDELLNT-------LKLALHCVDPSPSAR 547
                +         E M+         P   +             +    C D    AR
Sbjct: 248 ----FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303

Query: 548 PEVLQVVQQLEEI 560
                  +++ E+
Sbjct: 304 LTAQXAEERMAEL 316

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  181 bits (461), Expect = 4e-53
 Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 41/284 (14%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR----EKITKGQREFESEVSLLGKIRHPNLLAL 348
           EI+G   +G VY+A    G +VAVK  R    E I++       E  L   ++HPN++AL
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN- 406
           R   L      L LV ++   G L   L  +     I     +     + RG+ +LH   
Sbjct: 72  RGVCLKE--PNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEA 125

Query: 407 -ENIIHGNLTSSNVLLDDS--------TNAKISDFGLSRLMTAAANVNVIATAGALGYRA 457
              IIH +L SSN+L+              KI+DFGL+R          ++ AGA  + A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWMA 182

Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           PE+ +    +  +DV+S GV + ELLTG+ P   ++G  +   VA               
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-------------N 229

Query: 518 LMRDAPTIGDELLNTL-KLALHCVDPSPSARPEVLQVVQQLEEI 560
            +     I         KL   C +P P +RP    ++ QL  I
Sbjct: 230 KLA--LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  182 bits (464), Expect = 8e-53
 Identities = 73/300 (24%), Positives = 119/300 (39%), Gaps = 45/300 (15%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E +GK  +G V++     G +VAVK    +  +     E+E+     +RH N+L   A  
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAAD 105

Query: 353 LGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE-- 407
               G      LV DY  HGSL  +L+       +     +K+      GL HLH     
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 408 -----NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPE 459
                 I H +L S N+L+  +    I+D GL+    +A +   IA    +G   Y APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 460 L------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV 513
           +       K  ++  + D+Y++G+   E+    S G      +LP         +     
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-------YDLVPSD 274

Query: 514 FDLELMRDA-------PTI-----GDELLNTL-KLALHCVDPSPSARPEVLQVVQQLEEI 560
             +E MR         P I       E L  + K+   C   + +AR   L++ + L ++
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  181 bits (461), Expect = 1e-52
 Identities = 69/286 (24%), Positives = 120/286 (41%), Gaps = 37/286 (12%)

Query: 293 EIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E++GK  +G   K T  E G  + +K L     + QR F  EV ++  + HPN+L     
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF--- 72

Query: 352 YLG--PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +G   K ++L  + +Y+  G+L   +     ++   W  R+   K +  G+ +LHS  N
Sbjct: 73  -IGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLHSM-N 128

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMT-------------AAANVNVIATAGALGY 455
           IIH +L S N L+ ++ N  ++DFGL+RLM                         G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
            APE+   +  + K DV+S G+ + E++   +          P+ +   +         D
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL----PRTMDFGLNVR---GFLD 241

Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
                + P           + + C D  P  RP  +++   LE +R
Sbjct: 242 RYCPPNCP---PSF---FPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  179 bits (455), Expect = 4e-52
 Identities = 72/275 (26%), Positives = 130/275 (47%), Gaps = 25/275 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREK--ITKGQREFESEVSLLGKIRHPNLLALRA 350
           + +G  ++GTVYK        VAVK L       +  + F++EV +L K RH N+L    
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y   P+    +V  +    SL   LH    ET  +    + I +   RG+ +LH+  +II
Sbjct: 88  YSTAPQ--LAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAK-SII 142

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI-ATAGALGYRAPELSKLKKAN-- 467
           H +L S+N+ L +    KI DFGL+   +  +  +     +G++ + APE+ +++ +N  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 468 -TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG 526
             ++DVY+ G+ + EL+TG+ P   +N  +  Q +  + +           L  D   + 
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRG---------SLSPDLSKVR 251

Query: 527 DELLNTLK-LALHCVDPSPSARPEVLQVVQQLEEI 560
                 +K L   C+      RP   +++ ++EE+
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  168 bits (428), Expect = 7e-48
 Identities = 52/288 (18%), Positives = 109/288 (37%), Gaps = 46/288 (15%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREK--ITKGQREFESEVSLLGKIRHPNLLALRA 350
           E++GK  +G VY        +VA++ +  +       + F+ EV    + RH N++    
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
             + P    L ++       +L + +     +  +D     +I + + +G+ +LH+   I
Sbjct: 97  ACMSP--PHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLHAK-GI 151

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA----NVNVIATAGALGYRAPELSKLKK 465
           +H +L S NV  D+     I+DFGL  +            +    G L + APE+ +   
Sbjct: 152 LHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 466 A---------NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK----EEWTNE 512
                     +  +DV++LG    EL   + P +      +   + + +K    +    +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
               +++                   C       RP   +++  LE++
Sbjct: 271 EI-SDILLF-----------------CWAFEQEERPTFTKLMDMLEKL 300

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  150 bits (382), Expect = 3e-39
 Identities = 39/164 (23%), Positives = 73/164 (44%), Gaps = 3/164 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAING 60
           +L L +N +   + ++   L +L+ +   H+ +  +   S    L  L  LD S+     
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQIL-DSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
           +    F+ LSSL  L +  N+  +  L D   +L NL+ L+L + Q+    P+   ++S+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           L +L++S N         +  L SL   + S N++       L 
Sbjct: 496 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  146 bits (371), Expect = 1e-37
 Identities = 47/168 (27%), Positives = 64/168 (38%), Gaps = 5/168 (2%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L +N L      S     ELQ + LS  +I  +       LS L  L  + N I   
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQI-SGHIPSTIGNISTL 120
              +FS LSSL  L     NL       +  L  L  LN+  N I S  +P    N++ L
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNV----SYNNLSGPVPTSLAL 164
             LDLS NK+          L  +   N+    S N ++   P +   
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  145 bits (368), Expect = 2e-37
 Identities = 36/158 (22%), Positives = 62/158 (39%), Gaps = 3/158 (1%)

Query: 2   FLALQYNNLSGRIPAS-LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            L  Q++NL      S    L  L  + +SH             LS L +L  + N+   
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459

Query: 61  SL-PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
           +  P  F+ L +L  L L    L+     + + L +L VLN+  N            +++
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519

Query: 120 LTILDLSQNKLSGEIPASFSNL-KSLSSFNVSYNNLSG 156
           L +LD S N +         +   SL+  N++ N+ + 
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  141 bits (357), Expect = 6e-36
 Identities = 39/160 (24%), Positives = 68/160 (42%), Gaps = 4/160 (2%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
               N   +IP +L      + + LS N +  +          L++LD S   I      
Sbjct: 14  CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
           ++ +LS L +L L  N +    L +   L +L  L      ++      IG++ TL  L+
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 125 LSQNKL-SGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           ++ N + S ++P  FSNL +L   ++S N +     T L 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  141 bits (357), Expect = 7e-36
 Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 5/166 (3%)

Query: 2   FLALQYNNLS--GRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN 59
           FL L  N LS  G    S    + L+ + LS N +  +  S+   L +L  LDF ++ + 
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLK 409

Query: 60  GSLPAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHI-PSTIGNI 117
                S F +L +L+ L +   +         + L +L VL +  N    +  P     +
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469

Query: 118 STLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
             LT LDLSQ +L    P +F++L SL   N+S+NN          
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 515

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  138 bits (350), Expect = 5e-35
 Identities = 35/194 (18%), Positives = 64/194 (32%), Gaps = 7/194 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L    +      +   LS L  + L+ N I  +       LS L+ L      +   
Sbjct: 56  VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115

Query: 62  LPASFSNLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
                 +L +L  L +  N +   ++ +    L NL  L+L  N+I     + +  +  +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175

Query: 121 TI----LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQ 176
            +    LDLS N ++   P +F  +  L    +  N  S  V  +             + 
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVH-RLV 233

Query: 177 LCGYSGSTPCPSPP 190
           L  +          
Sbjct: 234 LGEFRNEGNLEKFD 247

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  133 bits (336), Expect = 4e-33
 Identities = 34/163 (20%), Positives = 58/163 (35%), Gaps = 4/163 (2%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSD-LGRLSRLRILDFSYNAINGSLP 63
           + + +           LS L+ + ++ N        D    L  L  LD S   +    P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 64  ASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNI-STLTI 122
            +F++LSSL  L +  NN           L++L VL+   N I       + +  S+L  
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547

Query: 123 LDLSQNKLSGEIPAS--FSNLKSLSSFNVSYNNLSGPVPTSLA 163
           L+L+QN  +           +K      V    +    P+   
Sbjct: 548 LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  131 bits (332), Expect = 1e-32
 Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 5/165 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKIS--GVMPSDLGRLSRLRILDFSYNAIN 59
              L + +  G    S   L  L+ + LS N +S  G         + L+ LD S+N + 
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386

Query: 60  GSLPASFSNLSSLVSLTLESNNLDDQI-LDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
             + ++F  L  L  L  + +NL           L NL  L++               +S
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445

Query: 119 TLTILDLSQNKLSGEI-PASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           +L +L ++ N       P  F+ L++L+  ++S   L    PT+ 
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  121 bits (305), Expect = 3e-29
 Identities = 30/139 (21%), Positives = 50/139 (35%), Gaps = 4/139 (2%)

Query: 26  EISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQ 85
                      + P +L      + LD S+N +      SF +   L  L L    +   
Sbjct: 11  TYQCMELNFYKI-PDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67

Query: 86  ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLS 145
              +   L +LS L L  N I          +S+L  L   +  L+        +LK+L 
Sbjct: 68  EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 146 SFNVSYNNL-SGPVPTSLA 163
             NV++N + S  +P   +
Sbjct: 128 ELNVAHNLIQSFKLPEYFS 146

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  115 bits (290), Expect = 3e-27
 Identities = 31/182 (17%), Positives = 53/182 (29%), Gaps = 25/182 (13%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGR------------------ 44
            +L    +              Q + L + K        L                    
Sbjct: 287 FSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344

Query: 45  -LSRLRILDFSYNAIN--GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNL 101
            L  L  LD S N ++  G    S    +SL  L L  N +   +  +   L  L  L+ 
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 403

Query: 102 KRNQISGHIP-STIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT 160
           + + +      S   ++  L  LD+S           F+ L SL    ++ N+       
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463

Query: 161 SL 162
            +
Sbjct: 464 DI 465

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  112 bits (281), Expect = 3e-26
 Identities = 42/175 (24%), Positives = 73/175 (41%), Gaps = 16/175 (9%)

Query: 2   FLALQYNNL-SGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRI----LDFSYN 56
            L + +N + S ++P     L+ L+ + LS NKI  +  +DL  L ++ +    LD S N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 57  AINGSLPASFSNLSSLVSLTLESNNLDDQIL-DSLDKLHNLSVLNLKRNQISGH------ 109
            +N   P +F  +  L  LTL +N     ++   +  L  L V  L   +          
Sbjct: 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246

Query: 110 IPSTIGNISTLTILDLSQNKLS---GEIPASFSNLKSLSSFNVSYNNLSGPVPTS 161
             S +  +  LTI +     L     +I   F+ L ++SSF++    +      S
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 96.6 bits (241), Expect = 3e-21
 Identities = 35/194 (18%), Positives = 63/194 (32%), Gaps = 33/194 (17%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISG---VMPSDLGRLSRLRILDFSYNAI 58
           L L+ N  S  +    +  L+ L+   L   +      +   D   L  L  L      +
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 59  N------GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS----- 107
                    +   F+ L+++ S +L S  +  + +           L L   +       
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQFPTL 322

Query: 108 --------------GHIPSTIGNISTLTILDLSQNKLS--GEIPASFSNLKSLSSFNVSY 151
                         G    +  ++ +L  LDLS+N LS  G    S     SL   ++S+
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382

Query: 152 NNLSGPVPTSLALK 165
           N +       L L+
Sbjct: 383 NGVITMSSNFLGLE 396

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  143 bits (363), Expect = 5e-39
 Identities = 71/269 (26%), Positives = 125/269 (46%), Gaps = 38/269 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQRE-FESEVSLLGKIRHPNLLALR 349
             +G+ ++ TVYK    E   +VA   L+  K+TK +R+ F+ E  +L  ++HPN++   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 350 AYYL-GPKGEKLLVF--DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR----GLLH 402
             +    KG+K +V   + M  G+L T+L             ++K+++   R    GL  
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGLQF 144

Query: 403 LHS-NENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL 460
           LH+    IIH +L   N+ +   T + KI D GL+ L  A+    VI   G   + APE+
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEM 201

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNG-AELPQWVASIVKEEWTNEVFDLELM 519
            + +K +   DVY+ G+ +LE+ T + P       A++ + V S VK    ++V   E+ 
Sbjct: 202 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV- 259

Query: 520 RDAPTIGDELLNTLKLALHCVDPSPSARP 548
           ++             +   C+  +   R 
Sbjct: 260 KE-------------IIEGCIRQNKDERY 275

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (356), Expect = 9e-38
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 34/290 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           + +G+  +  V     L DG   A+KR+     + + E + E  +     HPN+L L AY
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 352 YLGPKGEK---LLVFDYMPHGSLATFLHARGPE-TPIDWPTRMKIIKGMTRGLLHLHSNE 407
            L  +G K    L+  +   G+L   +     +   +     + ++ G+ RGL  +H+  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK- 153

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLM--------TAAANVNVIATAGALGYRAPE 459
              H +L  +N+LL D     + D G              A    +  A    + YRAPE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213

Query: 460 LSKLKK---ANTKTDVYSLGVTILELLTGKSP--GEPLNGAELPQWVASIVKEEWTNEVF 514
           L  ++     + +TDV+SLG  +  ++ G+ P       G  +    A  V+ + +    
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV----ALAVQNQLS---- 265

Query: 515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA 564
               +  +P     L   L   +      P  RP +  ++ QLE ++P A
Sbjct: 266 ----IPQSPRHSSALWQLLNSMMT---VDPHQRPHIPLLLSQLEALQPPA 308

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  144 bits (365), Expect = 9e-37
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 2/164 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L +N L     A+  + S+L  + +  N IS + P    +L  L++L+  +N ++  
Sbjct: 29  VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQL 88

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
              +F+  ++L  L L SN++     +   K  NL  L+L  N +S     T   +  L 
Sbjct: 89  SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQ 148

Query: 122 ILDLSQNKLSGEIPASFSNLK--SLSSFNVSYNNLSGPVPTSLA 163
            L LS NK+              SL    +S N +    P    
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  142 bits (360), Expect = 4e-36
 Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 3/165 (1%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
             +  L+ ++P  L   + +  ++L+HN++  +  ++  R S+L  LD  +N I+   P 
Sbjct: 11  CSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE 67

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
               L  L  L L+ N L      +     NL+ L+L  N I     +       L  LD
Sbjct: 68  LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127

Query: 125 LSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNAS 169
           LS N LS     +   L++L    +S N +       L +  N+S
Sbjct: 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  138 bits (351), Expect = 6e-35
 Identities = 42/173 (24%), Positives = 70/173 (40%), Gaps = 11/173 (6%)

Query: 2   FLALQYNNLSGRIPAS-LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            L L  N +   +       L  + EI LS+NK   +  +    +  L+ L     A+  
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468

Query: 61  --SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS--------GHI 110
             S P+ F  L +L  L L +NN+ +   D L+ L  L +L+L+ N ++        G  
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528

Query: 111 PSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
              +  +S L IL+L  N         F +L  L   ++  NNL+    +   
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  138 bits (349), Expect = 1e-34
 Identities = 45/206 (21%), Positives = 78/206 (37%), Gaps = 15/206 (7%)

Query: 3   LALQYNNLSG--RIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN---- 56
           L L+   L      P+    L  L  + LS+N I+ +    L  L +L ILD  +N    
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518

Query: 57  ----AINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS 112
               A  G        LS L  L LESN  D+  ++    L  L +++L  N ++    S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 113 TIGNISTLTILDLSQNKLSGEIPASFS-NLKSLSSFNVSYNNLSGPVPTSLAL-KFNASS 170
              N  +L  L+L +N ++      F    ++L+  ++ +N       +      +   +
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638

Query: 171 FVGNIQLCGYSGSTPCPSPPAEKPKS 196
              +  +   S    C +PP      
Sbjct: 639 ---HTNIPELSSHYLCNTPPHYHGFP 661

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  135 bits (342), Expect = 9e-34
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 14/182 (7%)

Query: 3   LALQYNNLSGRIPASLG---KLSELQEISLSHNKISGVMPSDLG--RLSRLRILDFSYNA 57
           L L    L   +   L      + ++ +SLS++++S    +     + + L +LD SYN 
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259

Query: 58  INGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN---------QISG 108
           +N     SF+ L  L    LE NN+      SL  L N+  LNLKR+          +  
Sbjct: 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319

Query: 109 HIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNA 168
               +   +  L  L++  N + G     F+ L +L   ++S +  S    T+      A
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379

Query: 169 SS 170
            S
Sbjct: 380 HS 381

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  130 bits (330), Expect = 3e-32
 Identities = 36/183 (19%), Positives = 66/183 (36%), Gaps = 7/183 (3%)

Query: 2   FLALQYNNLSGRIPASLG--KLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN 59
            L L  N +       L     S L+++ LS N+I    P     + RL  L  +   + 
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208

Query: 60  GSLPASFS---NLSSLVSLTLESNNLDDQILDSLDKLH--NLSVLNLKRNQISGHIPSTI 114
            SL          +S+ +L+L ++ L      +   L   NL++L+L  N ++     + 
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268

Query: 115 GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGN 174
             +  L    L  N +      S   L ++   N+  +     +  +   K +  SF   
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328

Query: 175 IQL 177
             L
Sbjct: 329 KCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  129 bits (327), Expect = 8e-32
 Identities = 39/176 (22%), Positives = 70/176 (39%), Gaps = 14/176 (7%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHN---------KISGVMPSDLGRLSRLRILD 52
           +  L+YNN+      SL  L  ++ ++L  +          +  +       L  L  L+
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 53  FSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLD----KLHNLSVLNLKRNQISG 108
              N I G     F+ L +L  L+L ++    + L +          L +LNL +N+IS 
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395

Query: 109 HIPSTIGNISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLSGPVPTSLA 163
                   +  L +LDL  N++  E+    +  L+++    +SYN        S A
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  101 bits (253), Expect = 1e-22
 Identities = 32/138 (23%), Positives = 51/138 (36%), Gaps = 21/138 (15%)

Query: 47  RLRILDFSY---------------------NAINGSLPASFSNLSSLVSLTLESNNLDDQ 85
              + D S+                     N +     A+F+  S L SL +  N +   
Sbjct: 5   SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL 64

Query: 86  ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLS 145
             +   KL  L VLNL+ N++S     T    + LT L L  N +       F   K+L 
Sbjct: 65  EPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI 124

Query: 146 SFNVSYNNLSGPVPTSLA 163
           + ++S+N LS     +  
Sbjct: 125 TLDLSHNGLSSTKLGTQV 142

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 74.3 bits (183), Expect = 5e-14
 Identities = 23/108 (21%), Positives = 35/108 (32%), Gaps = 4/108 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L+ N            L EL+ I L  N ++ +  S       L+ L+   N I   
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSV 599

Query: 62  LPASFS-NLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG 108
               F     +L  L +  N   D   +S+    N   +N     I  
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPF-DCTCESIAWFVNW--INETHTNIPE 644

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  141 bits (358), Expect = 6e-36
 Identities = 36/163 (22%), Positives = 69/163 (42%), Gaps = 10/163 (6%)

Query: 3   LALQYNNL-SGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           + + YNNL +  +  SL K+ +L  +   +N++ G +P+  G   +L  L+ +YN I   
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEI 368

Query: 62  LPASFSNLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRNQISG-------HIPST 113
                     + +L+   N L     +     +  +S ++   N+I          +  T
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428

Query: 114 IGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
                 ++ ++LS N++S      FS    LSS N+  N L+ 
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  140 bits (354), Expect = 2e-35
 Identities = 36/171 (21%), Positives = 67/171 (39%), Gaps = 13/171 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKI--------SGVMPSDLGRLSRLRILDFS 54
           + +       ++P  L  L E+Q I+++ N+              +D     +++I+   
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313

Query: 55  YNAI-NGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPST 113
           YN +    +  S   +  L  L    N L+   L +      L+ LNL  NQI+    + 
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANF 372

Query: 114 IGNISTLTILDLSQNKLSGEIPASFS--NLKSLSSFNVSYNNLSGPVPTSL 162
            G    +  L  + NKL   IP  F   ++  +S+ + SYN +      + 
Sbjct: 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  136 bits (345), Expect = 3e-34
 Identities = 40/178 (22%), Positives = 80/178 (44%), Gaps = 19/178 (10%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L   YN L G++P + G   +L  ++L++N+I+ +  +  G   ++  L F++N +   +
Sbjct: 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YI 392

Query: 63  PASFS--NLSSLVSLTLESNNLD-------DQILDSLDKLHNLSVLNLKRNQISGHIPST 113
           P  F   ++S + ++    N +        D +  +  K  N+S +NL  NQIS      
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452

Query: 114 IGNISTLTILDLSQNKLSG-------EIPASFSNLKSLSSFNVSYNNLSGPVPTSLAL 164
               S L+ ++L  N L+        +   +F N   L+S ++ +N L+  +      
Sbjct: 453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRA 509

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  132 bits (333), Expect = 1e-32
 Identities = 28/176 (15%), Positives = 56/176 (31%), Gaps = 18/176 (10%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGV-------MPSDLGRLSRLRILDFS 54
            + L  N +S          S L  I+L  N ++ +          +      L  +D  
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496

Query: 55  YNAINGSLPAS--FSNLSSLVSLTLESNNLD---DQI--LDSLDKLHNLSVLNLKRNQIS 107
           +N +   L      + L  LV + L  N+      Q     +L      +  + + N+  
Sbjct: 497 FNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTL 555

Query: 108 GHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
              P  I    +LT L +  N +   +        ++S  ++  N       + + 
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVC 608

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  130 bits (329), Expect = 3e-32
 Identities = 33/180 (18%), Positives = 74/180 (41%), Gaps = 20/180 (11%)

Query: 2   FLALQYNNL--------SGRIPASLGKLSELQEISLSHNKI-SGVMPSDLGRLSRLRILD 52
            + +  N            +  A      ++Q I + +N + +  + + L ++ +L +L+
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLE 336

Query: 53  FSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS 112
             YN + G LP +F +   L SL L  N + +   +       +  L+   N++   IP+
Sbjct: 337 CLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPN 394

Query: 113 T--IGNISTLTILDLSQNKLSG-------EIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
                ++S ++ +D S N++          +  +     ++SS N+S N +S       +
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  125 bits (316), Expect = 1e-30
 Identities = 29/185 (15%), Positives = 58/185 (31%), Gaps = 26/185 (14%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVM----PSDLGRLSRLRILDFSYNAI 58
           L+L+    SGR+P ++G+L+EL+ ++L  +          P  +                
Sbjct: 86  LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145

Query: 59  NGSLPASFS--NLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGN 116
             +        + S L+   + S+     I  S       + +    N I+  +   +  
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMR 204

Query: 117 ISTLTILDLSQNKLSGE-------------------IPASFSNLKSLSSFNVSYNNLSGP 157
           ++ L    +  +    E                       + NLK L+   V        
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 158 VPTSL 162
           +PT L
Sbjct: 265 LPTFL 269

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  120 bits (304), Expect = 5e-29
 Identities = 23/168 (13%), Positives = 48/168 (28%), Gaps = 7/168 (4%)

Query: 6   QYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING----S 61
           + +    +   SL     +  +SL     SG +P  +G+L+ L +L    +         
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLH--NLSVLNLKRNQISGHIPSTIGNIST 119
            P   S   S         +     +D   +    +L    +  +     I  +      
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFN 167
            T +    N ++  +  +   L  L  F +  +              N
Sbjct: 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  116 bits (293), Expect = 1e-27
 Identities = 15/156 (9%), Positives = 42/156 (26%), Gaps = 8/156 (5%)

Query: 3   LALQYNNLSGRIPASLGKL--SELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
                 +          +   S+L +  ++ +     +        +   +    N I  
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-T 196

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
            +  +   L+ L    + ++    + +    +  N                    N+  L
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ-----YKTEDLKWDNLKDL 251

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
           T +++       ++P     L  +   NV+ N    
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 15/101 (14%), Positives = 27/101 (26%), Gaps = 11/101 (10%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
              Q N      P  +     L ++ +  N I  V    +     + +LD   N      
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV-NEKI--TPNISVLDIKDNPNISID 603

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKR 103
            +            L  +   D        +     L++KR
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQD--------IRGCDALDIKR 636

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 12/92 (13%), Positives = 25/92 (27%), Gaps = 2/92 (2%)

Query: 113 TIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL--ALKFNASS 170
           ++ +   +T L L     SG +P +   L  L    +  +             +  N S 
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 171 FVGNIQLCGYSGSTPCPSPPAEKPKSRGRKLS 202
                    Y  +     P  +        ++
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCIN 167

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (343), Expect = 9e-36
 Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 31/303 (10%)

Query: 293 EIMGKSTYGTVYKATL-----EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA 347
             +GK  +G+V            G+ VAVK+L+      QR+F+ E+ +L  +    ++ 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLH 404
            R    GP  + L LV +Y+P G L  FL                 +I KGM     +L 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME----YLG 144

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSK 462
           S    +H +L + N+L++   + KI+DFGL++L+    +  V+   G       APE   
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203

Query: 463 LKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFD------ 515
               + ++DV+S GV + EL T       P   AE  + +         + + +      
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSP--SAEFLRMMGCERDVPALSRLLELLEEGQ 261

Query: 516 -LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDA 574
            L      P    E+     L   C  PSP  RP    +  QL+ +   +    T +  A
Sbjct: 262 RLPAPPACP---AEVHE---LMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTA 315

Query: 575 GPS 577
            P 
Sbjct: 316 HPE 318

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  132 bits (334), Expect = 5e-35
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 24/213 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E++G   +G V+KA    DG    +K    ++     + E EV  L K+ H N++     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIK----RVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 352 YLG--------------PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGM 396
           + G               K + L +  ++   G+L  ++  R  E  +D    +++ + +
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELFEQI 131

Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR 456
           T+G+ ++HS   +I+ +L  SN+ L D+   KI DFGL   +          + G L Y 
Sbjct: 132 TKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--RSKGTLRYM 188

Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSPG 489
           +PE    +    + D+Y+LG+ + ELL      
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (334), Expect = 6e-35
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 28/264 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            ++GK TYG VY    L +  ++A+K + E+ ++  +    E++L   ++H N++     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 352 YLG--PKGEKLLVF-DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           YLG   +   + +F + +P GSL+  L ++      +  T     K +  GL +LH N  
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 142

Query: 409 IIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK-- 465
           I+H ++   NVL++  +   KISDFG S+ + A  N       G L Y APE+       
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
                D++SLG TI+E+ TGK P       EL +  A++         F + + +  P I
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP-----FYELGEPQAAM---------FKVGMFKVHPEI 247

Query: 526 GDELLNTLK-LALHCVDPSPSARP 548
            + +    K   L C +P P  R 
Sbjct: 248 PESMSAEAKAFILKCFEPDPDKRA 271

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (333), Expect = 1e-34
 Identities = 56/287 (19%), Positives = 104/287 (36%), Gaps = 42/287 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           + +G+  +G V++A    D    A+KR+R       + +   EV  L K+ HP ++    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 351 YYL--------GPKGEKLLVF---DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
            +L         P   K+ ++         +L  +++ R      +    + I   +   
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM--------TAAANVNVIATAG 451
           +  LHS   ++H +L  SN+        K+ DFGL   M                    G
Sbjct: 131 VEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189

Query: 452 ALG---YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE 508
            +G   Y +PE       + K D++SLG+ + ELL       P +         + V+  
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMERVRTLTDVRNL 243

Query: 509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
               +F                  ++     + PSP  RPE + +++
Sbjct: 244 KFPPLFT--------QKYPCEYVMVQD---MLSPSPMERPEAINIIE 279

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  132 bits (334), Expect = 1e-34
 Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 43/290 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           + +G+  +  VY+A  L DG  VA+K+++       K + +   E+ LL ++ HPN++  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARG------PETPIDWPTRMKIIKGMTRGLL 401
            A ++  +  +L +V +    G L+  +          PE  +      K    +   L 
Sbjct: 98  YASFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-----WKYFVQLCSALE 150

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPEL 460
           H+HS   ++H ++  +NV +  +   K+ D GL R  ++        +  G   Y +PE 
Sbjct: 151 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 207

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP--GEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
                 N K+D++SLG  + E+   +SP  G+ +N   L      I + ++         
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEQCDY--------- 255

Query: 519 MRDAPTIGDELLNTLK-LALHCVDPSPSARP---EVLQVVQQLEEIRPEA 564
               P   D     L+ L   C++P P  RP    V  V +++      +
Sbjct: 256 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  130 bits (328), Expect = 4e-34
 Identities = 64/285 (22%), Positives = 125/285 (43%), Gaps = 26/285 (9%)

Query: 293 EIMGKSTYGTVYKATLE-----DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA 347
           + +GK  +G+V     +      G  VAVK+L+    +  R+FE E+ +L  ++H N++ 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            +          L L+ +Y+P+GSL  +L        ID    ++    + +G+ +L + 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTK 133

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLK 464
              IH +L + N+L+++    KI DFGL++++        +   G       APE     
Sbjct: 134 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN-EVFD-------L 516
           K +  +DV+S GV + EL T     +    AE  + + +  + +     + +       L
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKS-PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251

Query: 517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
                 P   DE+     +   C + + + RP    +  ++++IR
Sbjct: 252 PRPDGCP---DEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 290

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  130 bits (330), Expect = 4e-34
 Identities = 66/291 (22%), Positives = 125/291 (42%), Gaps = 30/291 (10%)

Query: 293 EIMGKSTYGTVYKATLE-----DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA 347
           + +GK  +G+V     +      G  VAVK+L+    +  R+FE E+ +L  ++H N++ 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLH 404
            +          L L+ +Y+P+GSL  +L             +   +I KGM     +L 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME----YLG 162

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSK 462
           +    IH +L + N+L+++    KI DFGL++++        +   G       APE   
Sbjct: 163 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN-EVFD------ 515
             K +  +DV+S GV + EL T     +    AE  + + +  + +     + +      
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKS-PPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280

Query: 516 -LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA 565
            L      P   DE+     +   C + + + RP    +  ++++IR + A
Sbjct: 281 RLPRPDGCP---DEIYM---IMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  128 bits (325), Expect = 1e-33
 Identities = 65/290 (22%), Positives = 115/290 (39%), Gaps = 38/290 (13%)

Query: 293 EIMGKSTYGTVYKATLE-----DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
             +G+  +G V     +      G QVAVK L+ +       + + E+ +L  + H N++
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
             +       G  + L+ +++P GSL  +L     +  I+   ++K    + +G+ +L S
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKL 463
               +H +L + NVL++     KI DFGL++ +        +           APE    
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEP----LNGAELPQWVASIVKEEWTN-EVFD-- 515
            K    +DV+S GVT+ ELLT   S   P    L               + T   + +  
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG-------QMTVTRLVNTL 256

Query: 516 -----LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                L    + P   DE+     L   C +  PS R     +++  E +
Sbjct: 257 KEGKRLPCPPNCP---DEVYQ---LMRKCWEFQPSNRTSFQNLIEGFEAL 300

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  128 bits (323), Expect = 2e-33
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 33/287 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +  S     VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHL 403
           + L    L P     +V +  P GSL   L        +   +R   ++ +GM     +L
Sbjct: 84  IRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG----YL 137

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELS 461
            S    IH +L + N+LL      KI DFGL R +    +  V+     + +   APE  
Sbjct: 138 ESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
           K +  +  +D +  GVT+ E+ T G+ P   LNG+++   +      +   E   L    
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------DKEGER--LPRPE 248

Query: 521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATA 567
           D P    ++ N   + + C    P  RP  + +   L E +P    A
Sbjct: 249 DCP---QDIYN---VMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (321), Expect = 4e-33
 Identities = 62/275 (22%), Positives = 112/275 (40%), Gaps = 29/275 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREF-ESEVSLLGKIRHPNLLALR 349
             +G  +YG   K     DG  +  K L    +T+ +++   SEV+LL +++HPN++   
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHS-- 405
              +      L +V +Y   G LA+ +         +D    ++++  +T  L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 406 --NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAPELS 461
                ++H +L  +NV LD   N K+ DFGL+R++    +    A    G   Y +PE  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKTFVGTPYYMSPEQM 188

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
                N K+D++SLG  + EL        P       +    I + ++          R 
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFR---------RI 236

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ 556
                DEL   +      ++     RP V ++++ 
Sbjct: 237 PYRYSDELNEIITR---MLNLKDYHRPSVEEILEN 268

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 4e-33
 Identities = 56/289 (19%), Positives = 110/289 (38%), Gaps = 29/289 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +I+G+     V++    + G   A+K        +       E  +L K+ H N++ L A
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                      L+ ++ P GSL T L        +     + +++ +  G+ HL  N  I
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GI 133

Query: 410 IHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPEL---- 460
           +H N+   N++     D  +  K++DFG +R +    +     +  G   Y  P++    
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHPDMYERA 190

Query: 461 ----SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL-PQWVASIVKEEWTNEVFD 515
                  KK     D++S+GVT     TG  P  P  G     + +  I+  + +  +  
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 516 LELMRDAPTI-GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           ++   + P     ++  +  L       S   +  +  V+  + E   E
Sbjct: 251 VQKAENGPIDWSGDMPVSCSL-------SRGLQVLLTPVLANILEADQE 292

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  127 bits (322), Expect = 5e-33
 Identities = 71/298 (23%), Positives = 121/298 (40%), Gaps = 36/298 (12%)

Query: 293 EIMGKSTYGTVYKATLED-----GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
             +G+  +G V     +      G  VAVK L+     + +  ++ E+ +L  + H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETP--IDWPTRMKIIKGMTRGLLHL 403
             +          L LV +Y+P GSL  +L          + +  +  I +GM     +L
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ--ICEGMA----YL 150

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELS 461
           H+  + IH +L + NVLLD+    KI DFGL++ +        +   G       APE  
Sbjct: 151 HAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTN-EVFD---- 515
           K  K    +DV+S GVT+ ELLT   S   P         +A   + + T   + +    
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQMTVLRLTELLER 266

Query: 516 ---LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATS 570
              L      P    E+ +   L  +C +   S RP    ++  L+ +  +    A S
Sbjct: 267 GERLPRPDKCP---AEVYH---LMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  127 bits (320), Expect = 6e-33
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 31/225 (13%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            ++G+  +G V KA    D    A+K++R    +      SEV LL  + H  ++   A 
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAA 70

Query: 352 YLGP-----------KGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           +L             K   L +  +Y  +G+L   +H+       D     ++ + +   
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD--EYWRLFRQILEA 128

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG----- 454
           L ++HS   IIH +L   N+ +D+S N KI DFGL++ +  + ++  + +    G     
Sbjct: 129 LSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187

Query: 455 --------YRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGE 490
                   Y A E+       N K D+YSLG+   E++   S G 
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  128 bits (323), Expect = 7e-33
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 24/226 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREF-ESEVSLLGKIRHPNLLALR 349
           + +G+ ++G        EDG Q  +K +   +++  +RE    EV++L  ++HPN++  R
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARG----PETPIDWPTRMKIIKGMTRGLLHLH 404
             +   +   L +V DY   G L   ++A+      E  I     +     +   L H+H
Sbjct: 90  ESFE--ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-----LDWFVQICLALKHVH 142

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAPELSK 462
               I+H ++ S N+ L      ++ DFG++R++ +   +   A    G   Y +PE+ +
Sbjct: 143 DR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL---ARACIGTPYYLSPEICE 198

Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE 508
            K  N K+D+++LG  + EL T K   E  +   L   V  I+   
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VLKIISGS 241

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  132 bits (333), Expect = 1e-32
 Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 3/164 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAINGS 61
           L L +N     + A+   L ELQ +   H+ +  V   S    L +L  LD SY      
Sbjct: 381 LDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439

Query: 62  LPASFSNLSSLVSLTLESNNLDDQIL-DSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
               F  L+SL +L +  N+  D  L +      NL+ L+L + Q+          +  L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLAL 164
            +L++S N L     + ++ L SLS+ + S+N +          
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  130 bits (330), Expect = 2e-32
 Identities = 36/155 (23%), Positives = 66/155 (42%), Gaps = 2/155 (1%)

Query: 3   LALQYNNLSGRIPAS-LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L  Q++ L      S    L +L  + +S+             L+ L  L  + N+   +
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463

Query: 62  LPAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
             ++ F+N ++L  L L    L+       D LH L +LN+  N +     S    + +L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           + LD S N++           KSL+ FN++ N+++
Sbjct: 524 STLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  128 bits (323), Expect = 2e-31
 Identities = 42/159 (26%), Positives = 63/159 (39%), Gaps = 5/159 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            + L +N L      S    SELQ + LS  +I  +       L  L  L  + N I   
Sbjct: 36  NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF 95

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG-HIPSTIGNISTL 120
            P SFS L+SL +L      L       + +L  L  LN+  N I    +P+   N++ L
Sbjct: 96  SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNL 155

Query: 121 TILDLSQNKLSGEIPASFSNLKSLS----SFNVSYNNLS 155
             +DLS N +          L+       S ++S N + 
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  113 bits (284), Expect = 1e-26
 Identities = 37/153 (24%), Positives = 63/153 (41%), Gaps = 5/153 (3%)

Query: 12  GRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSS 71
           G +   +  +  +        K+S V P D+   S  + +D S+N +      SFSN S 
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLSKV-PDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 72  LVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS 131
           L  L L    ++     +   LH+LS L L  N I    P +   +++L  L   + KL+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 132 GEIPASFSNLKSLSSFNVSYNNLSG-PVPTSLA 163
                    L +L   NV++N +    +P   +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  100 bits (252), Expect = 1e-22
 Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 15/171 (8%)

Query: 3   LALQYNNLSG-RIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRI----LDFSYNA 57
           L + +N +   ++PA    L+ L  + LS+N I  +  +DL  L         LD S N 
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192

Query: 58  INGSLPASFSNLSSLVSLTLESNNLDDQIL-DSLDKLHNLSVLNLKRNQISGHIPSTIGN 116
           I+     +F  +  L  LTL  N     I+   L  L  L V  L   +        I  
Sbjct: 193 IDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251

Query: 117 ISTL--------TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP 159
            S +            L+      +    F  L ++S+ +++  ++     
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED 302

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 92.4 bits (230), Expect = 6e-20
 Identities = 33/157 (21%), Positives = 56/157 (35%), Gaps = 11/157 (7%)

Query: 5   LQYNNLSGRIPASLGKLSELQ--EISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
               NL    P+ +  L ++   E  L++             L+ +  +  +  +I    
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-- 299

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                      SL++    L          L  L  L L  N+ S  I      + +L+ 
Sbjct: 300 LEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSY 354

Query: 123 LDLSQNKLSGEIPASFSNLK--SLSSFNVSYNNLSGP 157
           LDLS+N LS     S+S+L   SL   ++S+N     
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM 391

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 23/82 (28%), Positives = 33/82 (40%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           FL L    L          L  LQ +++SHN +  +  S   +L  L  LD S+N I  S
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536

Query: 62  LPASFSNLSSLVSLTLESNNLD 83
                    SL    L +N++ 
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (318), Expect = 1e-32
 Identities = 74/294 (25%), Positives = 130/294 (44%), Gaps = 28/294 (9%)

Query: 285 DDLLCATAEIMGKSTYGTVYKATLEDGS---QVAVKRLREKITKGQR-EFESEVSLLGKI 340
           D+LL A  E+ G   +G+V +           VA+K L++   K    E   E  ++ ++
Sbjct: 9   DNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67

Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            +P ++ L           +LV +    G L  FL  +  E  I      +++  ++ G+
Sbjct: 68  DNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 123

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--AP 458
            +L   +N +H +L + NVLL +   AKISDFGLS+ + A  +     +AG    +  AP
Sbjct: 124 KYL-EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182

Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E    +K ++++DV+S GVT+ E L+ G+ P + + G E+  ++          +   +E
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---------EQGKRME 233

Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSS 571
              + P    EL     L   C       RP+ L V Q++       A+     
Sbjct: 234 CPPECP---PELYA---LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  128 bits (324), Expect = 1e-32
 Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 31/279 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGS-QVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLALRA 350
           E +G+  +G V+   L   +  VAVK  RE +    + +F  E  +L +  HPN++ L  
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL-- 177

Query: 351 YYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
             +G   + +   +V + +  G   TFL   G    +   T ++++     G+ +L S  
Sbjct: 178 --IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESK- 232

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKK 465
             IH +L + N L+ +    KISDFG+SR                +  +  APE     +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGR 291

Query: 466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
            ++++DV+S G+ + E  + G SP   L+  +  ++V    +         L      P 
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---------LPCPELCP- 341

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
             D +    +L   C    P  RP    + Q+L+ IR  
Sbjct: 342 --DAV---FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  126 bits (319), Expect = 1e-32
 Identities = 70/271 (25%), Positives = 105/271 (38%), Gaps = 37/271 (13%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKI--TKGQREFESEVSLLGKI-RHPNLLAL 348
             +G  +YG V+K    EDG   AVKR        K +    +EV    K+ +HP  + L
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLH 404
              +   +G  L L  +     SL     A G   PE  +        ++     L HLH
Sbjct: 123 EQAWE--EGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-----WGYLRDTLLALAHLH 174

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK 464
           S   ++H ++  +N+ L      K+ DFGL   +  A    V    G   Y APEL +  
Sbjct: 175 SQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ--EGDPRYMAPELLQ-G 230

Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
              T  DV+SLG+TILE+        P  G    Q     +  E+T              
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL--PHGGEGWQQLRQGYLPPEFT------------AG 276

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
           +  EL + L +    ++P P  R     ++ 
Sbjct: 277 LSSELRSVLVM---MLEPDPKLRATAEALLA 304

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  129 bits (325), Expect = 2e-32
 Identities = 63/271 (23%), Positives = 116/271 (42%), Gaps = 25/271 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
             +G+  +G V+  T    ++VA+K L+         F  E  ++ K+RH  L+ L  Y 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQL--YA 246

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H 
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERM-NYVHR 304

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKANTKT 470
           +L ++N+L+ ++   K++DFGL+RL+    N            +  APE +   +   K+
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV+S G+ + EL T G+ P   +   E+   V    +         +    + P   + L
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---------MPCPPECP---ESL 410

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            +   L   C    P  RP    +   LE+ 
Sbjct: 411 HD---LMCQCWRKEPEERPTFEYLQAFLEDY 438

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (324), Expect = 2e-32
 Identities = 73/272 (26%), Positives = 130/272 (47%), Gaps = 29/272 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  +G V       G++VAVK ++   T   + F +E S++ ++RH NL+ L    
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  KG   +V +YM  GSL  +L +RG    +     +K    +   + +L  N N +H 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN-NFVHR 313

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKANTKT 470
           +L + NVL+ +   AK+SDFGL++        +     G L  +  APE  + KK +TK+
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKS 367

Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV+S G+ + E+ + G+ P   +   ++   V          + + ++     P     +
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------EKGYKMDAPDGCP---PAV 415

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
            +   +  +C     + RP  LQ+ +QLE IR
Sbjct: 416 YD---VMKNCWHLDAATRPTFLQLREQLEHIR 444

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  127 bits (322), Expect = 3e-32
 Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 40/277 (14%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKR-LREKITKGQREFESEVSLLGKI-RHPNLLALRA 350
           +++G    GT+    + D   VAVKR L E  +   R    EV LL +   HPN++    
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNVIRYFC 85

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
                  +   +  +     +L  ++  +      ++    + +++  T GL HLHS  N
Sbjct: 86  TEKDR--QFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL-N 138

Query: 409 IIHGNLTSSNVLLDDSTN-----AKISDFGLSRLMTA--AANVNVIATAGALGYRAPEL- 460
           I+H +L   N+L+          A ISDFGL + +     +        G  G+ APE+ 
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 461 --SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
                +      D++S G     +++    G    G  L +  A+I+          L+ 
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISE---GSHPFGKSLQR-QANILLGA-----CSLDC 249

Query: 519 MRDAPTIGDELLNTLKLALHCVDPSPSARP---EVLQ 552
           +               L    +   P  RP    VL+
Sbjct: 250 LHPEKHEDVIARE---LIEKMIAMDPQKRPSAKHVLK 283

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  125 bits (315), Expect = 7e-32
 Identities = 59/279 (21%), Positives = 115/279 (41%), Gaps = 34/279 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK       +     VA+K LRE  +     E   E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 347 ALRAYYLG--PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
            L    LG        L+   MP G L  ++        I     +     + +G+ +L 
Sbjct: 81  RL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLE 134

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSK 462
               ++H +L + NVL+    + KI+DFGL++L+ A       A  G +  +  A E   
Sbjct: 135 DR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESIL 192

Query: 463 LKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
            +    ++DV+S GVT+ EL+T G  P + +  +E+   +          +   L     
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------EKGERLPQPPI 243

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                 ++     +   C      +RP+  +++ +  ++
Sbjct: 244 CT---IDVYM---IMRKCWMIDADSRPKFRELIIEFSKM 276

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  127 bits (322), Expect = 9e-32
 Identities = 69/275 (25%), Positives = 127/275 (46%), Gaps = 31/275 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G   YG VY+   +  S  VAVK L+E   +   EF  E +++ +I+HPNL+ L   
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL--- 281

Query: 352 YLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            LG    +    ++ ++M +G+L  +L     +  +     + +   ++  + +L    N
Sbjct: 282 -LGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK-N 338

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKA 466
            IH NL + N L+ ++   K++DFGLSRLMT   +            +  APE     K 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKF 396

Query: 467 NTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
           + K+DV++ GV + E+ T G SP   ++ +++ + +          + + +E     P  
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPEGCP-- 445

Query: 526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            +++     L   C   +PS RP   ++ Q  E +
Sbjct: 446 -EKVYE---LMRACWQWNPSDRPSFAEIHQAFETM 476

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (313), Expect = 1e-31
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 26/207 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G+ ++G V++    + G Q AVK++R ++ +       E+     +  P ++     
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP---- 114

Query: 352 YLG--PKGEKLLVF-DYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSN 406
             G   +G  + +F + +  GSL   +   G  PE        +  +     GL +LH+ 
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLEYLHTR 169

Query: 407 ENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANVNVIATAGAL-G---YRAPELS 461
             I+HG++ + NVLL  D + A + DFG +  +        + T   + G   + APE+ 
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             K  + K D++S    +L +L G  P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  123 bits (312), Expect = 1e-31
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 21/211 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRL-REKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           + +G      V++   E     A+K +  E+      + + +E++ L K++  +   +R 
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 351 Y-YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y Y        +V +   +  L ++L  +     ID   R    K M   +  +H +  I
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH-GI 148

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPEL-------- 460
           +H +L  +N L+ D    K+ DFG++  M       V  +  G + Y  PE         
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 461 ---SKLKKANTKTDVYSLGVTILELLTGKSP 488
                  K + K+DV+SLG  +  +  GK+P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (314), Expect = 2e-31
 Identities = 56/289 (19%), Positives = 110/289 (38%), Gaps = 29/289 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREFESEVSLLGKIRHPNLLALRA 350
           +I+G+     V++    + G   A+K        +       E  +L K+ H N++ L A
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                      L+ ++ P GSL T L        +     + +++ +  G+ HL  N  I
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GI 133

Query: 410 IHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPEL---- 460
           +H N+   N++     D  +  K++DFG +R +    +     +  G   Y  P++    
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHPDMYERA 190

Query: 461 ----SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL-PQWVASIVKEEWTNEVFD 515
                  KK     D++S+GVT     TG  P  P  G     + +  I+  + +  +  
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 516 LELMRDAPTI-GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           ++   + P     ++  +  L       S   +  +  V+  + E   E
Sbjct: 251 VQKAENGPIDWSGDMPVSCSL-------SRGLQVLLTPVLANILEADQE 292

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  122 bits (308), Expect = 2e-31
 Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 29/272 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  +G V       G++VAVK ++   T   + F +E S++ ++RH NL+ L    
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  KG   +V +YM  GSL  +L +RG    +     +K    +   + +L  N N +H 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN-NFVHR 141

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKANTKT 470
           +L + NVL+ +   AK+SDFGL++        +     G L  +  APE  + KK +TK+
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV+S G+ + E+ + G+ P   +   ++   V          + + ++     P     +
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------EKGYKMDAPDGCP---PAV 243

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
                +  +C     + RP  LQ+ +QLE I+
Sbjct: 244 YE---VMKNCWHLDAAMRPSFLQLREQLEHIK 272

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  127 bits (322), Expect = 2e-31
 Identities = 32/159 (20%), Positives = 55/159 (34%), Gaps = 3/159 (1%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
            +   L+  IP +L   +  + +  S N +  +  +   RL  L  LD +   I      
Sbjct: 19  CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
           +F +   L +L L +N L      +L     L  L   +  IS      + N  TL  L 
Sbjct: 76  TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135

Query: 125 LSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           L  N +S          + L   +   N +       ++
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS 174

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  127 bits (322), Expect = 3e-31
 Identities = 32/165 (19%), Positives = 55/165 (33%), Gaps = 2/165 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L   +N L      +  +L  L  + L+  +I  +         RL  L  + N +   
Sbjct: 37  CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
              + S   +L  L      +       L     L  L L  N IS            L 
Sbjct: 97  AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLK 156

Query: 122 ILDLSQNKLSGEIPASFSNLKSLS--SFNVSYNNLSGPVPTSLAL 164
           +LD   N +        S+L+  +  S N++ N+++G  P +   
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS 201

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  127 bits (320), Expect = 4e-31
 Identities = 39/165 (23%), Positives = 76/165 (46%), Gaps = 5/165 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAINGS 61
           L L YN        +  +  +L+ + L+  ++      S    L  L++L+ S++ ++ S
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440

Query: 62  LPASFSNLSSLVSLTLESNNL---DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
               F  L +L  L L+ N+    + Q  +SL  L  L +L L    +S        ++ 
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500

Query: 119 TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
            +  +DLS N+L+     + S+LK +   N++ N++S  +P+ L 
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLP 544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  122 bits (308), Expect = 1e-29
 Identities = 32/159 (20%), Positives = 61/159 (38%), Gaps = 5/159 (3%)

Query: 2   FLALQYNNLSGRIPAS-LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAI-- 58
            L L +  L  +   S    L  L+ ++LSH+ +          L  L+ L+   N    
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463

Query: 59  -NGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNI 117
            N     S   L  L  L L   +L      +   L  ++ ++L  N+++      + ++
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523

Query: 118 STLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
             +  L+L+ N +S  +P+    L    + N+  N L  
Sbjct: 524 KGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  121 bits (305), Expect = 3e-29
 Identities = 43/165 (26%), Positives = 64/165 (38%), Gaps = 5/165 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L   +LS  +P+ L  LS L+++ LS NK   +          L  L    N     L
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341

Query: 63  -PASFSNLSSLVSLTLESNNLD--DQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
                 NL +L  L L  ++++  D     L  L +L  LNL  N+              
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401

Query: 120 LTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLSGPVPTSLA 163
           L +LDL+  +L  +   S F NL  L   N+S++ L         
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  119 bits (301), Expect = 1e-28
 Identities = 38/165 (23%), Positives = 65/165 (39%), Gaps = 6/165 (3%)

Query: 1   MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLG--RLSRLRILDFSYNAI 58
           + L L  N+++G I       +  Q ++    +   V+   L    +  L +  F     
Sbjct: 182 LSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240

Query: 59  NGSLPASFSNLS--SLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGN 116
               PA F  L   S+ S+ L+ +   +   ++      L  L+L    +S  +PS +  
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG 299

Query: 117 ISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTS 161
           +STL  L LS NK       S SN  SL+  ++  N     + T 
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  118 bits (299), Expect = 2e-28
 Identities = 32/164 (19%), Positives = 55/164 (33%), Gaps = 3/164 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           FL L    +      +      L  + L+ N +  +  + L     L+ L F    I+  
Sbjct: 61  FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
                 N  +L SL L SN++    L        L VL+ + N I       + ++   T
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180

Query: 122 I--LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
              L+L+ N ++  I     +     S N         +   L 
Sbjct: 181 NLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  115 bits (289), Expect = 3e-27
 Identities = 29/166 (17%), Positives = 48/166 (28%), Gaps = 5/166 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L  N L      +L     L+ +      IS +    L     L  L    N I+  
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSV--LNLKRNQISGHIPSTIGNIST 119
                     L  L  ++N +     + +  L   +   LNL  N I+  I     + + 
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAV 203

Query: 120 LTILDLSQNKLSGEIPA--SFSNLKSLSSFNVSYNNLSGPVPTSLA 163
              L+    +    I      S ++SL        +     P    
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 71.2 bits (175), Expect = 4e-13
 Identities = 33/154 (21%), Positives = 50/154 (32%), Gaps = 29/154 (18%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L + +LS     +   L  +  + LSHN+++      L  L  +  L+ + N I+  
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISII 538

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           LP+    LS   ++ L  N LD                             T  NI  L 
Sbjct: 539 LPSLLPILSQQRTINLRQNPLD----------------------------CTCSNIYFLE 570

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
               +  KL         N   L    +S   LS
Sbjct: 571 WYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  124 bits (312), Expect = 3e-31
 Identities = 74/297 (24%), Positives = 138/297 (46%), Gaps = 30/297 (10%)

Query: 293 EIMGKSTYGTVYKATL----EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +++G   +G V    L    +    VA+K L+   T+ QR +F  E S++G+  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 348 LRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L       K +  ++V +YM +GSL +FL     +        + +++G+  G+ +L   
Sbjct: 111 LEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDM 166

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLK 464
              +H +L + N+L++ +   K+SDFGL R++            G +  R  +PE    +
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225

Query: 465 KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           K  + +DV+S G+ + E+++ G+ P   ++  ++ + V         +E + L    D P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV---------DEGYRLPPPMDCP 276

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE-IRPEAATAATSSGDAGPSTS 579
                L     L L C     + RP+  Q+V  L++ IR   +    +S  A PS  
Sbjct: 277 ---AALYQ---LMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  126 bits (319), Expect = 3e-31
 Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 29/273 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
             +G+  +G V+  T    ++VA+K L+         F  E  ++ K+RH  L+ L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQL---- 327

Query: 353 LG--PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
                +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +
Sbjct: 328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERM-NYV 385

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKANT 468
           H +L ++N+L+ ++   K++DFGL+RL+    N            +  APE +   +   
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 469 KTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
           K+DV+S G+ + EL T G+ P   +   E+   V    +         +    + P   +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---------MPCPPECP---E 491

Query: 528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            L +   L   C    P  RP    +   LE+ 
Sbjct: 492 SLHD---LMCQCWRKEPEERPTFEYLQAFLEDY 521

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (307), Expect = 3e-31
 Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 29/281 (10%)

Query: 296 GKSTYGTVYKATLEDGS---QVAVKRLREKITKGQR--EFESEVSLLGKIRHPNLLALRA 350
           G   +GTV K   +       VAVK L+ +        E  +E +++ ++ +P ++ +  
Sbjct: 26  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
                    +LV +    G L  +L        +     ++++  ++ G+ +L    N +
Sbjct: 86  ICEAES--WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL-EESNFV 139

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKANT 468
           H +L + NVLL     AKISDFGLS+ + A  N     T G    +  APE     K ++
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199

Query: 469 KTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
           K+DV+S GV + E  + G+ P   + G+E+   +          +   +      P    
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCPAGCP---R 247

Query: 528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAA 568
           E+ +   L   C       RP    V  +L     +     
Sbjct: 248 EMYD---LMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  122 bits (309), Expect = 4e-31
 Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 33/279 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           +I+G    G V    L         VA+K L+   T+ QR +F SE S++G+  HPN++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 348 LRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           L     G   +G   ++V +YM +GSL TFL  R  +        + +++G+  G+ +L 
Sbjct: 115 L----EGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSK 462
                +H +L + NVL+D +   K+SDFGLSR++    +     T G +  R  APE   
Sbjct: 169 DL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 463 LKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
            +  ++ +DV+S GV + E+L  G+ P   +   ++   V          E + L     
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV---------EEGYRLPAPMG 278

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            P     L     L L C     + RP   Q+V  L+ +
Sbjct: 279 CP---HALHQ---LMLDCWHKDRAQRPRFSQIVSVLDAL 311

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  123 bits (310), Expect = 5e-31
 Identities = 41/284 (14%), Positives = 87/284 (30%), Gaps = 42/284 (14%)

Query: 296 GKSTYGTVYKAT------LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           G+  +  VY+AT       ++  +  +K  +             +  L        +   
Sbjct: 74  GEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFY 133

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           + +L      +LV +   +G+L   ++     PE  +     +     M   +  +H   
Sbjct: 134 SAHLFQN-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC- 191

Query: 408 NIIHGNLTSSNVLL-----------DDSTNAKISDFGLSRLMTAAANVNVIATA-GALGY 455
            IIHG++   N +L           D S    + D G S  M       +        G+
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGF 251

Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
           +  E+   K  N + D + +  T+  +L G      +           + +         
Sbjct: 252 QCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM--KVKNEGGECKPEGLFRRLP-----H 304

Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE 559
           L++  +       +LN                   L +++Q  +
Sbjct: 305 LDMWNE---FFHVMLN----------IPDCHHLPSLDLLRQKLK 335

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  123 bits (311), Expect = 5e-31
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 27/277 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           E++G+  +G VY  TL D        AVK L      G+  +F +E  ++    HPN+L+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L    L  +G  L+V  YM HG L  F+        +     +     + +G+  L S  
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK- 211

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA-LGYR--APELSKLK 464
             +H +L + N +LD+    K++DFGL+R M      +V    GA L  +  A E  + +
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271

Query: 465 KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           K  TK+DV+S GV + EL+T G  P   +N  ++  ++          +   L      P
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGRRLLQPEYCP 322

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              D L     + L C  P    RP   ++V ++  I
Sbjct: 323 ---DPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 353

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  121 bits (306), Expect = 6e-31
 Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 33/280 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
           E++G+  +G VY  TL D        AVK L      G+  +F +E  ++    HPN+L+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L    L  +G  L+V  YM HG L  F+        +     +     + +G+ +L S  
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK- 147

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR------APELS 461
             +H +L + N +LD+    K++DFGL+R M    +    +     G +      A E  
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 462 KLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
           + +K  TK+DV+S GV + EL+T G  P   +N  ++  ++          +   L    
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGRRLLQPE 255

Query: 521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             P   D L     + L C  P    RP   ++V ++  I
Sbjct: 256 YCP---DPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 289

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (318), Expect = 6e-31
 Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 28/283 (9%)

Query: 285 DDLLCATAEIMGKSTYGTVYKATLEDGS---QVAVKRLREKITKGQR-EFESEVSLLGKI 340
           D+LL A  E+ G   +G+V +           VA+K L++   K    E   E  ++ ++
Sbjct: 335 DNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393

Query: 341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL 400
            +P ++ L           +LV +    G L  FL  +  E  I      +++  ++ G+
Sbjct: 394 DNPYIVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 449

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--AP 458
            +L   +N +H NL + NVLL +   AKISDFGLS+ + A  +     +AG    +  AP
Sbjct: 450 KYL-EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508

Query: 459 ELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           E    +K ++++DV+S GVT+ E L+ G+ P + + G E+  ++          +   +E
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---------EQGKRME 559

Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              + P    EL     L   C       RP+ L V Q++   
Sbjct: 560 CPPECP---PELYA---LMSDCWIYKWEDRPDFLTVEQRMRAC 596

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  126 bits (318), Expect = 8e-31
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 18/254 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           E +G   +G V +    + G QVA+K+ R++++   RE +  E+ ++ K+ HPN+++ R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 351 YY-----LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
                  L P    LL  +Y   G L  +L+       +       ++  ++  L +LH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 406 NENIIHGNLTSSNVLLDDSTNA---KISDFGLSRLMTAAANVNVIATA-GALGYRAPELS 461
           N  IIH +L   N++L         KI D G ++ +       +     G L Y APEL 
Sbjct: 140 N-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYLAPELL 195

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
           + KK     D +S G    E +TG  P  P             V+E+    +   + +  
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ---WHGKVREKSNEHIVVYDDLTG 252

Query: 522 APTIGDELLNTLKL 535
           A      L     L
Sbjct: 253 AVKFSSVLPTPNHL 266

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (307), Expect = 8e-31
 Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 21/211 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKR--LREKITKGQREFESEVSLLGKIRHPNLLALRA 350
           + +G      V++   E     A+K   L E   +    + +E++ L K++  +   +R 
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 351 Y-YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
           Y Y        +V +   +  L ++L  +     ID   R    K M   +  +H +  I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH-GI 129

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPEL-------- 460
           +H +L  +N L+ D    K+ DFG++  M       V  +  G + Y  PE         
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 461 ---SKLKKANTKTDVYSLGVTILELLTGKSP 488
                  K + K+DV+SLG  +  +  GK+P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  124 bits (312), Expect = 9e-31
 Identities = 61/271 (22%), Positives = 117/271 (43%), Gaps = 25/271 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +G   +G V+ AT    ++VAVK ++         F +E +++  ++H  L+ L A  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
              K    ++ ++M  GSL  FL +         P  +     +  G+  +    N IH 
Sbjct: 253 T--KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQR-NYIHR 308

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKANTKT 470
           +L ++N+L+  S   KI+DFGL+R++    N            +  APE         K+
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 471 DVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           DV+S G+ ++E++T G+ P   ++  E+ + +            + +    + P   +EL
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRPENCP---EEL 414

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            N   + + C    P  RP    +   L++ 
Sbjct: 415 YN---IMMRCWKNRPEERPTFEYIQSVLDDF 442

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  120 bits (304), Expect = 1e-30
 Identities = 58/298 (19%), Positives = 119/298 (39%), Gaps = 34/298 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLL 346
           +++G   +GTV+K       +     V +K + +K  +         +  +G + H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 347 ALRAYYLG--PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
            L    LG  P     LV  Y+P GSL   +              +     + +G+ +L 
Sbjct: 79  RL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLE 132

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSK 462
            +  ++H NL + NVLL   +  +++DFG++ L+    +  ++ +      +  A E   
Sbjct: 133 EH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLP-PDDKQLLYSEAKTPIKWMALESIH 190

Query: 463 LKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
             K   ++DV+S GVT+ EL+T G  P   L  AE+P  +          +   L   + 
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---------EKGERLAQPQI 241

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDAGPSTS 579
                 ++     + + C     + RP   ++  +   +  +         ++GP  +
Sbjct: 242 CT---IDVYM---VMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIA 293

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  119 bits (300), Expect = 2e-30
 Identities = 65/279 (23%), Positives = 115/279 (41%), Gaps = 35/279 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +G   +G V     +    VAVK ++E       EF  E   + K+ HP L+      
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKF---- 68

Query: 353 LG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLHSNE 407
            G   K     +V +Y+ +G L  +L + G          M   + +GM      L S+ 
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA----FLESH- 123

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKK 465
             IH +L + N L+D     K+SDFG++R +    +  V +       +  APE+    K
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFPVKWSAPEVFHYFK 181

Query: 466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
            ++K+DV++ G+ + E+ + GK P +    +E+   V         ++   L     A  
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV---------SQGHRLYRPHLAS- 231

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
             D +     +   C    P  RP   Q++  +E +R +
Sbjct: 232 --DTIYQ---IMYSCWHELPEKRPTFQQLLSSIEPLREK 265

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  120 bits (302), Expect = 2e-30
 Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 27/277 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
            ++GK  +G VY     D +Q     A+K L       Q   F  E  L+  + HPN+LA
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L    L P+G   ++  YM HG L  F+ +      +     +     + RG+ +L    
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQ- 143

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA-LGYR--APELSKLK 464
             +H +L + N +LD+S   K++DFGL+R +      +V     A L  +  A E  +  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203

Query: 465 KANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           +  TK+DV+S GV + ELLT G  P   ++  +L  ++          +   L      P
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL---------AQGRRLPQPEYCP 254

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              D L     +   C +  P+ RP    +V ++E+I
Sbjct: 255 ---DSLYQ---VMQQCWEADPAVRPTFRVLVGEVEQI 285

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  118 bits (298), Expect = 3e-30
 Identities = 65/274 (23%), Positives = 125/274 (45%), Gaps = 31/274 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +G   +G V+     +  +VA+K +RE     + +F  E  ++ K+ HP L+ L    
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQL---- 68

Query: 353 LG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            G    +    LV ++M HG L+ +L  +         T + +   +  G+ +L     +
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEA-CV 125

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKAN 467
           IH +L + N L+ ++   K+SDFG++R +    +    +T      +  +PE+    + +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYS 183

Query: 468 TKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG 526
           +K+DV+S GV + E+ + GK P E  + +E+ + +         +  F L   R A    
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---------STGFRLYKPRLAS--- 231

Query: 527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             +     +  HC    P  RP   ++++QL EI
Sbjct: 232 THVYQ---IMNHCWRERPEDRPAFSRLLRQLAEI 262

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  121 bits (304), Expect = 4e-30
 Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 19/210 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKR--LREKITKGQREFESEVSLLGKIRHPNLLALRA 350
           + +G      V++   E     A+K   L E   +    + +E++ L K++  +   +R 
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y      + + +     +  L ++L  +     ID   R    K M   +  +H +  I+
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH-GIV 177

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPEL--------- 460
           H +L  +N L+ D    K+ DFG++  M       V  +  GA+ Y  PE          
Sbjct: 178 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236

Query: 461 --SKLKKANTKTDVYSLGVTILELLTGKSP 488
                 K + K+DV+SLG  +  +  GK+P
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  118 bits (299), Expect = 6e-30
 Identities = 66/288 (22%), Positives = 123/288 (42%), Gaps = 41/288 (14%)

Query: 293 EIMGKSTYGTVYKATLEDGS----QVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLL 346
           +I+G+  +G+V +  L+       +VAVK ++   +  +   EF SE + +    HPN++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 347 ALRAYYLG--------PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT- 397
            L    LG           + +++  +M +G L T+L     ET         ++K M  
Sbjct: 100 RL----LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 398 --RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGY 455
              G+ +L +  N +H +L + N +L D     ++DFGLS+ +  + +         +  
Sbjct: 156 IALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPV 213

Query: 456 R--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
           +  A E    +   +K+DV++ GVT+ E+ T G +P   +   E+  ++           
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL---------LH 264

Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              L+   D     DEL     +   C    P  RP    +  QLE++
Sbjct: 265 GHRLKQPEDCL---DELYE---IMYSCWRTDPLDRPTFSVLRLQLEKL 306

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  118 bits (299), Expect = 7e-30
 Identities = 59/279 (21%), Positives = 116/279 (41%), Gaps = 34/279 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK       +     VA+K LRE  +     E   E  ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 347 ALRAYYLG--PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
            L    LG        L+   MP G L  ++        I     +     + +G+ +L 
Sbjct: 81  RL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLE 134

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSK 462
               ++H +L + NVL+    + KI+DFGL++L+ A       A  G +  +  A E   
Sbjct: 135 DR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESIL 192

Query: 463 LKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
            +    ++DV+S GVT+ EL+T G  P + +  +E+   +          +   L     
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------EKGERLPQPPI 243

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                 ++     + + C      +RP+  +++ +  ++
Sbjct: 244 CT---IDVYM---IMVKCWMIDADSRPKFRELIIEFSKM 276

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  118 bits (299), Expect = 8e-30
 Identities = 71/278 (25%), Positives = 135/278 (48%), Gaps = 30/278 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGS-----QVAVKRLREKITKGQR-EFESEVSLLGKIRHPNLL 346
           +++G   +G VYK  L+  S      VA+K L+   T+ QR +F  E  ++G+  H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 347 ALRAYYLGPKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            L       K +  +++ +YM +G+L  FL  R  +        + +++G+  G+ +L +
Sbjct: 110 RLEGVIS--KYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKL 463
             N +H +L + N+L++ +   K+SDFGLSR++          + G +  R  APE    
Sbjct: 166 M-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
           +K  + +DV+S G+ + E++T G+ P   L+  E+ + +         N+ F L    D 
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------NDGFRLPTPMDC 275

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P     +     L + C     + RP+   +V  L+++
Sbjct: 276 P---SAIYQ---LMMQCWQQERARRPKFADIVSILDKL 307

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  118 bits (299), Expect = 9e-30
 Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 34/295 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR--EFESEVSLLGKIRHPNLL 346
            ++GK  +G+V +A L+        VAVK L+  I       EF  E + + +  HP++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 347 AL-----RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT---R 398
            L     R+   G     +++  +M HG L  FL A              +++ M     
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR-- 456
           G+ +L S  N IH +L + N +L +     ++DFGLSR +  + +      A  L  +  
Sbjct: 149 GMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGDYYRQGCASKLPVKWL 206

Query: 457 APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
           A E          +DV++ GVT+ E++T G++P   +  AE+  ++              
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL---------IGGNR 257

Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATS 570
           L+   +     +E+ +   L   C    P  RP    +  +LE I    +  +TS
Sbjct: 258 LKQPPECM---EEVYD---LMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  116 bits (293), Expect = 2e-29
 Identities = 68/275 (24%), Positives = 128/275 (46%), Gaps = 31/275 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G   YG VY+   +  S  VAVK L+E   + + EF  E +++ +I+HPNL+ L   
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL--- 74

Query: 352 YLG--PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            LG   +     ++ ++M +G+L  +L     +  +     + +   ++  + +L    N
Sbjct: 75  -LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK-N 131

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKA 466
            IH +L + N L+ ++   K++DFGLSRLMT   +            +  APE     K 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 467 NTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
           + K+DV++ GV + E+ T G SP   ++ +++ + +          + + +E     P  
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPEGCP-- 238

Query: 526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
            +++     L   C   +PS RP   ++ Q  E +
Sbjct: 239 -EKVYE---LMRACWQWNPSDRPSFAEIHQAFETM 269

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  117 bits (295), Expect = 3e-29
 Identities = 67/288 (23%), Positives = 128/288 (44%), Gaps = 41/288 (14%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNL 345
             +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 346 LALRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPET---PIDWPTRMKIIKGMT-- 397
           + L    LG        L++ + M  G L ++L +  P     P+  P  +  +  M   
Sbjct: 91  VRL----LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 398 --RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGY 455
              G+ +L++N   +H +L + N ++ +    KI DFG++R +    +       G L  
Sbjct: 147 IADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPV 204

Query: 456 R--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
           R  +PE  K     T +DV+S GV + E+ T  + P + L+  ++ ++V          E
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---------ME 255

Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              L+   + P   D L     L   C   +P  RP  L+++  ++E 
Sbjct: 256 GGLLDKPDNCP---DMLFE---LMRMCWQYNPKMRPSFLEIISSIKEE 297

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  117 bits (296), Expect = 4e-29
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L+L YN +    P  L  L+ L   +   N+I+ +  + +  ++RL  L    N I    
Sbjct: 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNNKITDLS 237

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P   +NLS L  L + +N + D  ++++  L  L +LN+  NQIS    S + N+S L  
Sbjct: 238 P--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNS 291

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
           L L+ N+L  E       L +L++  +S N+++ 
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  114 bits (289), Expect = 3e-28
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 10/153 (6%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
                N ++   P  +  ++ L  + + +NKI+ + P  L  LS+L  L+   N I+   
Sbjct: 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-- 257

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
             +  +L+ L  L + SN + D  +  L+ L  L+ L L  NQ+       IG ++ LT 
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L LSQN ++   P   ++L  + S + +   + 
Sbjct: 316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  109 bits (275), Expect = 2e-26
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 11/157 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N+      + L  ++ L  ++++ +K+  V  + +  L+ L  L  +YN I    
Sbjct: 137 LNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDIS 193

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P   ++L+SL   T   N + D  +  +  +  L+ L +  N+I+   P  + N+S LT 
Sbjct: 194 P--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTW 247

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP 159
           L++  N++S  I A   +L  L   NV  N +S    
Sbjct: 248 LEIGTNQISD-INA-VKDLTKLKMLNVGSNQISDISV 282

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 98.4 bits (246), Expect = 1e-22
 Identities = 33/154 (21%), Positives = 61/154 (39%), Gaps = 12/154 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           LA     ++   P     L+E     L    ++         L  +  L  +   +  S+
Sbjct: 5   LATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SI 59

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                 L++L  L L  N + D  +  L  L  L+ L +  N+I+    S + N++ L  
Sbjct: 60  QG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRE 114

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
           L L+++ +S   P   +NL  + S N+  N+   
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLS 146

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.6 bits (140), Expect = 3e-09
 Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 6/88 (6%)

Query: 72  LVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS 131
             +L      ++   +     L       L++  ++     T   + ++T L ++  K++
Sbjct: 2   AATLATLPAPINQ--IFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 132 GEIPASFSNLKSLSSFNVSYNNLSGPVP 159
             I      L +L   N++ N ++   P
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISP 83

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  115 bits (290), Expect = 6e-29
 Identities = 55/274 (20%), Positives = 109/274 (39%), Gaps = 31/274 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +G   +G V          VA+K ++E     + EF  E  ++  + H  L+ L    
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQL---- 84

Query: 353 LG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            G   K     ++ +YM +G L  +L              +++ K +   + +L S    
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK-QF 141

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKAN 467
           +H +L + N L++D    K+SDFGLSR +    +    +       R   PE+    K +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKFPVRWSPPEVLMYSKFS 199

Query: 468 TKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG 526
           +K+D+++ GV + E+ + GK P E    +E  + +          +   L     A    
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLAS--- 247

Query: 527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +++     +   C       RP    ++  + ++
Sbjct: 248 EKVYT---IMYSCWHEKADERPTFKILLSNILDV 278

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  115 bits (291), Expect = 6e-29
 Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 46/294 (15%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL 346
             +G+  +G V+ A        +D   VAVK L++     +++F+ E  LL  ++H +++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 347 ALRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTR-------------M 390
                  G    G+  ++VF+YM HG L  FL A GP+  I    +             +
Sbjct: 81  KF----YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA 450
            I   +  G+++L S  + +H +L + N L+  +   KI DFG+SR +  + +   +   
Sbjct: 137 HIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGH 194

Query: 451 GALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE 507
             L  R   PE    +K  T++DV+S GV + E+ T GK P   L+  E+ + +      
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI------ 248

Query: 508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
               +   LE  R  P    E+ +   + L C    P  R  + ++ + L  + 
Sbjct: 249 ---TQGRVLERPRVCP---KEVYD---VMLGCWQREPQQRLNIKEIYKILHALG 293

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  120 bits (303), Expect = 9e-29
 Identities = 28/190 (14%), Positives = 59/190 (31%), Gaps = 22/190 (11%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKIS-------GVMPSDLGRLSRLRILDFS 54
            + L YN +           S +  I LS+N ++            +      L  +D  
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736

Query: 55  YNAINGSLPAS--FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKR------NQI 106
           +N +  SL      + L  L ++ +  N               L    ++       N+I
Sbjct: 737 FNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI 794

Query: 107 SGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL-SGPVPTSL-AL 164
               P+ I    +L  L +  N +  ++         L   +++ N   S  V +    +
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYI 851

Query: 165 KFNASSFVGN 174
           +      + +
Sbjct: 852 EAGMYVLLYD 861

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  118 bits (298), Expect = 4e-28
 Identities = 32/177 (18%), Positives = 70/177 (39%), Gaps = 20/177 (11%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGR-LSRLRILDFSYNAINGS 61
           L   +N +   +  + G   +L ++ L +N+I  + P D      ++  L FS+N +   
Sbjct: 578 LDCVHNKVRH-LE-AFGTNVKLTDLKLDYNQIEEI-PEDFCAFTDQVEGLGFSHNKLK-Y 633

Query: 62  LP--ASFSNLSSLVSLTLESNNLD---DQILDSLDKLH--NLSVLNLKRNQISGHIPSTI 114
           +P   +  ++  + S+    N +      I  S+D     N S + L  N+I        
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693

Query: 115 GNISTLTILDLSQNKLS-------GEIPASFSNLKSLSSFNVSYNNLSGPVPTSLAL 164
              S ++ + LS N ++            ++ N   L++ ++ +N L+  +      
Sbjct: 694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRA 749

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  112 bits (282), Expect = 4e-26
 Identities = 32/178 (17%), Positives = 63/178 (35%), Gaps = 20/178 (11%)

Query: 3   LALQYNNLSG---------RIPASLGKLSELQEISLSHNKISGVMPS-DLGRLSRLRILD 52
           L +  N             R+        ++Q   + +N +     S  L ++ +L +LD
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579

Query: 53  FSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS 112
             +N +   L  +F     L  L L+ N +++   D       +  L    N++   IP+
Sbjct: 580 CVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPN 636

Query: 113 T--IGNISTLTILDLSQNKLSGEIPASFS-----NLKSLSSFNVSYNNLSGPVPTSLA 163
                ++  +  +D S NK+  E              + S+  +SYN +        A
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  107 bits (268), Expect = 2e-24
 Identities = 31/186 (16%), Positives = 61/186 (32%), Gaps = 28/186 (15%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L+L      GR+P ++G+L+EL+ +S   +  +              + +   + I    
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387

Query: 63  PASF-SNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGH------IPSTIG 115
              F      L    L  + ++      +  +   S ++LK  QI         I   I 
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQ 445

Query: 116 NISTLTILDLSQNKLSG-------------------EIPASFSNLKSLSSFNVSYNNLSG 156
            ++ L I+  + +  +                        S+SNLK L+   +       
Sbjct: 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505

Query: 157 PVPTSL 162
            +P  L
Sbjct: 506 QLPDFL 511

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  104 bits (261), Expect = 2e-23
 Identities = 22/175 (12%), Positives = 54/175 (30%), Gaps = 7/175 (4%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           + + Y  +       L     LQ+    + ++  +       L   +I + + N I   +
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLT-NRI-TFI 440

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
             +   L+ L  +   ++          +   +    N    +   +   +  N+  LT 
Sbjct: 441 SKAIQRLTKLQIIYFANSPFT-----YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQL 177
           ++L       ++P    +L  L S N++ N               A       ++
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 85.3 bits (211), Expect = 2e-17
 Identities = 20/174 (11%), Positives = 47/174 (27%), Gaps = 29/174 (16%)

Query: 26  EISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQ 85
             +   +        DL    R+  L  +     G +P +   L+ L  L+  +++    
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 86  ILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLTILDLSQNKLSG------------ 132
                D+     +   ++++I  H     +     L + DL Q+ ++             
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 133 ----------------EIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASS 170
                            I  +   L  L     + +  +           N+  
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 13/155 (8%), Positives = 48/155 (30%), Gaps = 2/155 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           + +Q    +  I       +  + +   + +      ++          +   +      
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQP 315

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                N   +  L+L       ++ D++ +L  L VL+   +  +           T  +
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375

Query: 123 LDLSQNKLSGEIPASF-SNLKSLSSFNVSYNNLSG 156
            +  ++++       F    + L+  ++  + ++ 
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 12/124 (9%), Positives = 38/124 (30%), Gaps = 1/124 (0%)

Query: 44  RLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKR 103
           +L++   +          +    +  +   +L  ++       +++     N +  N + 
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKEL 308

Query: 104 NQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           +         + N   +T L L+     G +P +   L  L   +   ++ +        
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 164 LKFN 167
            +  
Sbjct: 369 EELT 372

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  114 bits (288), Expect = 1e-28
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 29/273 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E +G   +G V+       ++VAVK L++        F +E +L+ +++H  L+ L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRL---- 73

Query: 353 LG--PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
                +    ++ +YM +GSL  FL        +     + +   +  G+  +    N I
Sbjct: 74  YAVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEER-NYI 131

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKKANT 468
           H +L ++N+L+ D+ + KI+DFGL+RL+    N            +  APE         
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 469 KTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
           K+DV+S G+ + E++T G+ P   +   E+ Q +            + +    + P   +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCP---E 237

Query: 528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           EL     L   C    P  RP    +   LE+ 
Sbjct: 238 ELYQ---LMRLCWKERPEDRPTFDYLRSVLEDF 267

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  114 bits (288), Expect = 1e-28
 Identities = 58/276 (21%), Positives = 109/276 (39%), Gaps = 30/276 (10%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
             +G+  +G V++            VA+K  +   +   R +F  E   + +  HP+++ 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L            ++ +    G L +FL  R     +   + +     ++  L +L S  
Sbjct: 81  LIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK- 135

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKLKK 465
             +H ++ + NVL+  +   K+ DFGLSR M    +    A+ G L  +  APE    ++
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 466 ANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
             + +DV+  GV + E+L  G  P + +   ++   +              L +  + P 
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------ENGERLPMPPNCP- 243

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
               L +   L   C    PS RP   ++  QL  I
Sbjct: 244 --PTLYS---LMTKCWAYDPSRRPRFTELKAQLSTI 274

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  115 bits (290), Expect = 1e-28
 Identities = 65/300 (21%), Positives = 112/300 (37%), Gaps = 55/300 (18%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRA 350
            ++ +  +  VY+A  +  G + A+KRL     +  R    EV  + K+  HPN++   +
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 351 YY------LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
                         + L+   +  G L  FL       P+   T +KI     R + H+H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 405 SNEN-IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG--------- 454
             +  IIH +L   N+LL +    K+ DFG +  ++   + +  A   AL          
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 455 --YRAPELSKLKK---ANTKTDVYSLGVTILELLTGKSPGEP------LNGA-ELPQWVA 502
             YR PE+  L        K D+++LG  +  L   + P E       +NG   +P    
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPH-- 271

Query: 503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP 562
                                T      + ++     +  +P  R  + +VV QL+EI  
Sbjct: 272 --------------------DTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAA 308

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  115 bits (290), Expect = 1e-28
 Identities = 70/300 (23%), Positives = 119/300 (39%), Gaps = 61/300 (20%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLL 346
             +G+  +G V+ A        +D   VAVK L+E     +++F+ E  LL  ++H +++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 347 ALRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT------ 397
                  G   +G   L+VF+YM HG L  FL + GP+  +           +       
Sbjct: 107 RF----FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 398 ------RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG 451
                  G+++L    + +H +L + N L+      KI DFG+SR +  + +   +    
Sbjct: 163 VASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRT 220

Query: 452 ALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK-- 506
            L  R   PE    +K  T++DV+S GV + E+ T GK P   L+  E        +   
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE----AIDCITQG 276

Query: 507 ------EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                      EV+   +MR                  C    P  R  +  V  +L+ +
Sbjct: 277 RELERPRACPPEVY--AIMRG-----------------CWQREPQQRHSIKDVHARLQAL 317

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  114 bits (288), Expect = 2e-28
 Identities = 70/305 (22%), Positives = 114/305 (37%), Gaps = 66/305 (21%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKI-RHPN 344
           + +G+  +G V +A             VAVK L+E  T  +     SE+ +L  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 345 LLALRAYYLG----PKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMT-- 397
           ++ L    LG    P G  +++ ++   G+L+T+L   R    P            +T  
Sbjct: 93  VVNL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 398 ----------RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI 447
                     +G+  L S    IH +L + N+LL +    KI DFGL+R +       V 
Sbjct: 149 HLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVR 206

Query: 448 ATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSP--GEPLNGAELPQWVA 502
                L  +  APE    +    ++DV+S GV + E+ + G SP  G  ++         
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------- 257

Query: 503 SIVKEEWTNEVFD-------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
                    E          +           E+       L C    PS RP   ++V+
Sbjct: 258 --------EEFCRRLKEGTRMRAPDYTT---PEMYQ---TMLDCWHGEPSQRPTFSELVE 303

Query: 556 QLEEI 560
            L  +
Sbjct: 304 HLGNL 308

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  115 bits (289), Expect = 3e-28
 Identities = 41/219 (18%), Positives = 85/219 (38%), Gaps = 33/219 (15%)

Query: 296 GKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES-----------------EVSLLG 338
            +  +  +     +D    A+K+  + + + +R+F                   E+ ++ 
Sbjct: 40  NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 339 KIRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARG-----PETPIDWPTRMKI 392
            I++   L            ++ ++++YM + S+  F              I       I
Sbjct: 99  DIKNEYCLTCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-G 451
           IK +     ++H+ +NI H ++  SN+L+D +   K+SDFG S  M        I  + G
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKIKGSRG 212

Query: 452 ALGYRAPEL--SKLKKANTKTDVYSLGVTILELLTGKSP 488
              +  PE   ++      K D++SLG+ +  +     P
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  113 bits (284), Expect = 4e-28
 Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 34/278 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
            I+G+  +G VY+    +       VAVK  ++  T   + +F SE  ++  + HP+++ 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 348 LRAYYLG--PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           L    +G   +    ++ +  P+G L  +L        +   T +     + + + +L S
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLES 131

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKL 463
             N +H ++   N+L+      K+ DFGLSR +         A+   L  +  +PE    
Sbjct: 132 I-NCVHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTRLPIKWMSPESINF 188

Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
           ++  T +DV+   V + E+L+ GK P   L   ++   +          +   L      
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---------EKGDRLPKPDLC 239

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P     L     L   C D  PS RP   ++V  L ++
Sbjct: 240 P---PVLYT---LMTRCWDYDPSDRPRFTELVCSLSDV 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  118 bits (297), Expect = 4e-28
 Identities = 60/278 (21%), Positives = 113/278 (40%), Gaps = 34/278 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLLA 347
             +G+  +G V++            VA+K  +   +   R +F  E   + +  HP+++ 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 348 LRAYYLG--PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           L    +G   +    ++ +    G L +FL  R     +D  + +     ++  L +L S
Sbjct: 456 L----IGVITENPVWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLES 509

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKL 463
               +H ++ + NVL+  +   K+ DFGLSR M    +    A+ G L  +  APE    
Sbjct: 510 K-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINF 566

Query: 464 KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
           ++  + +DV+  GV + E+L  G  P + +   ++   +              L +  + 
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------ENGERLPMPPNC 617

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           P     L +   L   C    PS RP   ++  QL  I
Sbjct: 618 P---PTLYS---LMTKCWAYDPSRRPRFTELKAQLSTI 649

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  113 bits (286), Expect = 4e-28
 Identities = 73/296 (24%), Positives = 119/296 (40%), Gaps = 53/296 (17%)

Query: 296 GKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKI-RHPNLLA 347
           G   +G V +AT       +    VAVK L+      +R    SE+ +L  +  H N++ 
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91

Query: 348 LRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT------- 397
           L    LG     G  L++ +Y  +G L  FL  +         +   +            
Sbjct: 92  L----LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 398 --------RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT 449
                   +G+  L S  N IH +L + N+LL      KI DFGL+R +    +  V+  
Sbjct: 148 LSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDI-KNDSNYVVKG 205

Query: 450 AGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSP--GEPLNGAELPQWVASI 504
              L  +  APE         ++DV+S G+ + EL + G SP  G P++ ++  + +   
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMI--- 261

Query: 505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                  E F +     AP    E+ +   +   C D  P  RP   Q+VQ +E+ 
Sbjct: 262 ------KEGFRMLSPEHAP---AEMYD---IMKTCWDADPLKRPTFKQIVQLIEKQ 305

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  113 bits (286), Expect = 4e-28
 Identities = 78/296 (26%), Positives = 127/296 (42%), Gaps = 56/296 (18%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ---VAVKRLREKITKGQR-EFESEVSLLGKI-RHPNLLA 347
           +++G+  +G V KA ++        A+KR++E  +K    +F  E+ +L K+  HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 348 LRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK------------- 391
           L    LG    +G   L  +Y PHG+L  FL                             
Sbjct: 91  L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 392 ----IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI 447
               + +GM     +L S +  IH +L + N+L+ ++  AKI+DFGLSR       V V 
Sbjct: 147 FAADVARGMD----YL-SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 197

Query: 448 ATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASI 504
            T G L  R  A E        T +DV+S GV + E+++ G +P   +  AEL + +   
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--- 254

Query: 505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                  + + LE   +     DE+ +   L   C    P  RP   Q++  L  +
Sbjct: 255 ------PQGYRLEKPLNCD---DEVYD---LMRQCWREKPYERPSFAQILVSLNRM 298

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  116 bits (293), Expect = 4e-28
 Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 8/166 (4%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING-S 61
           L    NN+S R+  S       + I L++NKI+ +   D G  SR++ LD   N I+  +
Sbjct: 104 LHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
                ++  +L  L L+ N +    +        L  L+L  N+++  +     + + +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFI--YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFN 167
            + L  NKL   I  +    ++L  F++  N            K  
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  112 bits (282), Expect = 1e-26
 Identities = 28/153 (18%), Positives = 62/153 (40%), Gaps = 10/153 (6%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             +  ++L   + +       ++E+ LS N +S +  +DL   ++L +L+ S N +    
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                +LS+L +L L +N      +  L    ++  L+   N IS  +  + G       
Sbjct: 73  TLDLESLSTLRTLDLNNNY-----VQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKN 124

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           + L+ NK++            +   ++  N + 
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 98.0 bits (244), Expect = 7e-22
 Identities = 31/154 (20%), Positives = 56/154 (36%), Gaps = 6/154 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDL-GRLSRLRILDFSYNAING 60
            + L  N ++       G  S +Q + L  N+I  V  ++L      L  L+  YN I  
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
            +       + L +L L SN L   +         ++ ++L+ N++   I   +     L
Sbjct: 183 DVKGQ-VVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239

Query: 121 TILDLSQNKLS-GEIPASFSNLKSLSSFNVSYNN 153
              DL  N    G +   FS  + + +       
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 97.6 bits (243), Expect = 9e-22
 Identities = 23/135 (17%), Positives = 52/135 (38%), Gaps = 10/135 (7%)

Query: 21  LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN 80
            +  +   ++ + +   + S       ++ LD S N ++    A  +  + L  L L SN
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 81  NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSN 140
            L +     L+ L  L  L+L  N +       +    ++  L  + N +S    +    
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQG 121

Query: 141 LKSLSSFNVSYNNLS 155
            K++    ++ N ++
Sbjct: 122 KKNI---YLANNKIT 133

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 76.4 bits (188), Expect = 6e-15
 Identities = 17/95 (17%), Positives = 39/95 (41%), Gaps = 2/95 (2%)

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
           ++     N +      +  ++L   +        N+  L+L  N +S    + +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            +L+LS N L  E      +L +L + +++ N + 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 19/193 (9%), Positives = 41/193 (21%), Gaps = 31/193 (16%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKIS-----------------------GVMP 39
           ++L+ N L   I  +L     L+   L  N                           +  
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277

Query: 40  SDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDK----LHN 95
            +    +   +  +               L +L        +      + L+        
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337

Query: 96  LSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSS---FNVSYN 152
              ++  + Q    I            L+  +  L  ++         L       V   
Sbjct: 338 QREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI 397

Query: 153 NLSGPVPTSLALK 165
            L         L+
Sbjct: 398 ELQHATEEQSPLQ 410

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 13/125 (10%), Positives = 41/125 (32%), Gaps = 2/125 (1%)

Query: 8   NNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFS 67
            + + R+       +  +EI     +   V+     R      L+    A++  +     
Sbjct: 322 GSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381

Query: 68  NLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS-GHIPSTIGNISTLTILDLS 126
             + L     ++     ++  + ++   L +L     +    ++       + +   D+ 
Sbjct: 382 AHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMY 440

Query: 127 QNKLS 131
           Q+K +
Sbjct: 441 QHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 10/54 (18%), Positives = 21/54 (38%)

Query: 110 IPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           I     N +   I  ++ + L   + +   +  ++   ++S N LS      LA
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA 55

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  113 bits (285), Expect = 5e-28
 Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 41/288 (14%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNL 345
             +G   +G VY+  +          QVAVK L E  ++    +F  E  ++ K  H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 346 LALRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT----R 398
           +      +G   +   + ++ + M  G L +FL    P         M  +  +      
Sbjct: 96  VRC----IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLSRLMTAAANVNVIATAGALGY 455
           G  +L  N + IH ++ + N LL        AKI DFG++R +   A+         L  
Sbjct: 152 GCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPV 209

Query: 456 R--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
           +   PE        +KTD +S GV + E+ + G  P    +  E+ ++V           
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---------TS 260

Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              ++  ++ P     +     +   C    P  RP    +++++E  
Sbjct: 261 GGRMDPPKNCP---GPVYR---IMTQCWQHQPEDRPNFAIILERIEYC 302

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  112 bits (283), Expect = 6e-28
 Identities = 76/295 (25%), Positives = 125/295 (42%), Gaps = 47/295 (15%)

Query: 293 EIMGKSTYGTVYKATLEDGS------QVAVKRLREKITKGQR-EFESEVSLLGKIRHPNL 345
           E +G+  +G VYK  L   +       VA+K L++K     R EF  E  L  +++HPN+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 346 LALRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG------- 395
           + L    LG   K +   ++F Y  HG L  FL  R P + +      + +K        
Sbjct: 75  VCL----LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 396 --MTR----GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT 449
             +      G+ +L S+ +++H +L + NVL+ D  N KISD GL R +  AA+   +  
Sbjct: 131 VHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREV-YAADYYKLLG 188

Query: 450 AGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK 506
              L  R  APE     K +  +D++S GV + E+ + G  P    +  ++ + +     
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI----- 243

Query: 507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
                    L    D P     +     L + C +  PS RP    +  +L    
Sbjct: 244 ----RNRQVLPCPDDCP---AWVYA---LMIECWNEFPSRRPRFKDIHSRLRAWG 288

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  114 bits (287), Expect = 6e-28
 Identities = 64/309 (20%), Positives = 116/309 (37%), Gaps = 42/309 (13%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNL 345
             +G   +G VY+  +          QVAVK L E  ++    +F  E  ++ K  H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 346 LALRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT----R 398
           +      +G   +   + ++ + M  G L +FL    P         M  +  +      
Sbjct: 137 VRC----IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLSRLMTAAANVNVIATAGALGY 455
           G  +L  N + IH ++ + N LL        AKI DFG++R +   A          L  
Sbjct: 193 GCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPV 250

Query: 456 R--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
           +   PE        +KTD +S GV + E+ + G  P    +  E+ ++V           
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---------TS 301

Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATS-S 571
              ++  ++ P     +     +   C    P  RP    +++++E    +     T+  
Sbjct: 302 GGRMDPPKNCP---GPVYR---IMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355

Query: 572 GDAGPSTSE 580
            + GP   E
Sbjct: 356 IEYGPLVEE 364

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (283), Expect = 8e-28
 Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLAL 348
           E++G      V  A       +VA+KR+   + K Q   +    E+  + +  HPN+++ 
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPET-----PIDWPTRMKIIKGMTRGLLH 402
              ++    ++L LV   +  GS+   +     +       +D  T   I++ +  GL +
Sbjct: 79  YTSFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT----AGALGYRAP 458
           LH N   IH ++ + N+LL +  + +I+DFG+S  +    ++          G   + AP
Sbjct: 137 LHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 459 E-LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           E + +++  + K D++S G+T +EL TG +P
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  111 bits (281), Expect = 9e-28
 Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 45/236 (19%)

Query: 293 EIMGKSTYGTVYKATLEDGS--------QVAVKRLREKITKGQREFESEVSLLGKIRHPN 344
           E +G+ T+  ++K    +          +V +K L +        F    S++ K+ H +
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 345 LLALRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
           L+       G      E +LV +++  GSL T+L        I    ++++ K +   + 
Sbjct: 74  LVLN----YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI--LWKLEVAKQLAAAMH 127

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTN--------AKISDFGLSRLMTAAANVNVIATAGAL 453
            L  N  +IHGN+ + N+LL    +         K+SD G+S  +               
Sbjct: 128 FLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------- 175

Query: 454 GYR------APE-LSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWV 501
             +       PE +   K  N  TD +S G T+ E+ + G  P   L+     Q+ 
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  114 bits (287), Expect = 9e-28
 Identities = 56/218 (25%), Positives = 110/218 (50%), Gaps = 38/218 (17%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFES-EVSLLGKIRHPNLLALRAY 351
           +++G  ++G V++A L +  +VA+K++ +      + F++ E+ ++  ++HPN++ L+A+
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAF 100

Query: 352 YLGPKGEKL-----LVFDYMP---HGSLATFLHARGPETPIDWPTRMKIIKG----MTRG 399
           +     +K      LV +Y+P   + +   +   +     +       +IK     + R 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML-------LIKLYMYQLLRS 153

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNA-KISDFGLSR-LMTAAANVNVIATAGALGYRA 457
           L ++HS   I H ++   N+LLD  +   K+ DFG ++ L+    NV+ I +     YRA
Sbjct: 154 LAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS---RYYRA 209

Query: 458 PELSKL---KKANTKTDVYSLGVTILELLTGKS--PGE 490
           PEL  +       T  D++S G  + EL+ G+   PGE
Sbjct: 210 PEL--IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (286), Expect = 1e-27
 Identities = 43/205 (20%), Positives = 87/205 (42%), Gaps = 16/205 (7%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKR--LREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           G     TV  A     G  V V+R  L     +     + E+ +     HPN++  RA +
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 353 LGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +     +L +V  +M +GS    +     +  ++      I++G+ + L ++H     +H
Sbjct: 96  I--ADNELWVVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHM-GYVH 151

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTA------AANVNVIATAGALGYRAPEL--SKL 463
            ++ +S++L+       +S    +  M +        +     +   L + +PE+    L
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211

Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
           +  + K+D+YS+G+T  EL  G  P
Sbjct: 212 QGYDAKSDIYSVGITACELANGHVP 236

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  112 bits (282), Expect = 1e-27
 Identities = 28/153 (18%), Positives = 62/153 (40%), Gaps = 10/153 (6%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             +  ++L   + +       ++E+ LS N +S +  +DL   ++L +L+ S N +    
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                +LS+L +L L +N      +  L    ++  L+   N IS  +  + G       
Sbjct: 74  L-DLESLSTLRTLDLNNNY-----VQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKN 124

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           + L+ NK++            +   ++  N + 
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  100 bits (250), Expect = 2e-23
 Identities = 32/176 (18%), Positives = 57/176 (32%), Gaps = 7/176 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDL-GRLSRLRILDFSYNAING 60
            + L  N ++       G  S +Q + L  N+I  V  ++L      L  L+  YN I  
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
            +       + L +L L SN L   +         ++ ++L+ N++   I   +     L
Sbjct: 183 DVKGQ-VVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239

Query: 121 TILDLSQNKLS-GEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNI 175
              DL  N    G +   FS  + + +                          G  
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL-TGQNEEECTVPTLGHYGAY 294

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 24/136 (17%), Positives = 53/136 (38%), Gaps = 12/136 (8%)

Query: 21  LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN 80
            +  +   ++ + +   + S       ++ LD S N ++    A  +  + L  L L SN
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 81  NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS-FS 139
            L +     L+ L  L  L+L  N +       +    ++  L  + N +S  +  S   
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQ 120

Query: 140 NLKSLSSFNVSYNNLS 155
             K++    ++ N ++
Sbjct: 121 GKKNI---YLANNKIT 133

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 17/95 (17%), Positives = 39/95 (41%), Gaps = 2/95 (2%)

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
           ++     N +      +  ++L   +        N+  L+L  N +S    + +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            +L+LS N L  E      +L +L + +++ N + 
Sbjct: 61  ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ 93

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  111 bits (279), Expect = 2e-27
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 30/206 (14%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE--FESEVSLLGKIRHPNLLALRAY 351
           GK  +G VY A   +    +A+K L + ++ K   E     EV +   +RHPN+L L  Y
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           +      ++ L+ +Y P G++   L       E           I  +   L + HS   
Sbjct: 78  FHDAT--RVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANALSYCHSK-R 129

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLS------RLMTAAANVNVIATAGALGYRAPELSK 462
           +IH ++   N+LL  +   KI+DFG S      R              G L Y  PE+ +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD---------LCGTLDYLPPEMIE 180

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +  + K D++SLGV   E L GK P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (281), Expect = 2e-27
 Identities = 65/302 (21%), Positives = 119/302 (39%), Gaps = 63/302 (20%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKI-RHPN 344
           + +G   +G V +AT       +   +VAVK L+      ++    SE+ ++  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 345 LLALRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTR-----------M 390
           ++ L    LG     G  L++ +Y  +G L  FL  +      D               +
Sbjct: 112 IVNL----LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA 450
                + +G+  L S  N IH ++ + NVLL +   AKI DFGL+R +    +  ++   
Sbjct: 168 HFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNYIVKGN 225

Query: 451 GALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSP--GEPLNGAELPQWVASIV 505
             L  +  APE         ++DV+S G+ + E+ + G +P  G  +N            
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------------ 273

Query: 506 KEEWTNEVFD-------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
                ++ +        +     AP     + +   +   C    P+ RP   Q+   L+
Sbjct: 274 -----SKFYKLVKDGYQMAQPAFAP---KNIYS---IMQACWALEPTHRPTFQQICSFLQ 322

Query: 559 EI 560
           E 
Sbjct: 323 EQ 324

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  111 bits (279), Expect = 3e-27
 Identities = 70/302 (23%), Positives = 121/302 (40%), Gaps = 55/302 (18%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNL 345
           + +G+  +G V KAT          + VAVK L+E  +    R+  SE ++L ++ HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 346 LALRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT----- 397
           + L     G     G  LL+ +Y  +GSL  FL       P    +              
Sbjct: 89  IKL----YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144

Query: 398 ----------------RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA 441
                           +G+ +L     ++H +L + N+L+ +    KISDFGLSR +   
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDV-YE 202

Query: 442 ANVNVIATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
            +  V  + G +  +  A E        T++DV+S GV + E++T G +P   +    L 
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262

Query: 499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
             +              +E   +     +E+     L L C    P  RP    + + LE
Sbjct: 263 NLL---------KTGHRMERPDNCS---EEMYR---LMLQCWKQEPDKRPVFADISKDLE 307

Query: 559 EI 560
           ++
Sbjct: 308 KM 309

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  115 bits (289), Expect = 3e-27
 Identities = 39/160 (24%), Positives = 68/160 (42%), Gaps = 4/160 (2%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
               N   +IP +L      + + LS N +  +          L++LD S   I      
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
           ++ +LS L +L L  N +    L +   L +L  L      ++      IG++ TL  L+
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 125 LSQNKL-SGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
           ++ N + S ++P  FSNL +L   ++S N +     T L 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  113 bits (285), Expect = 8e-27
 Identities = 45/159 (28%), Positives = 62/159 (38%), Gaps = 5/159 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L +N L      S     ELQ + LS  +I  +       LS L  L  + N I   
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQI-SGHIPSTIGNISTL 120
              +FS LSSL  L     NL       +  L  L  LN+  N I S  +P    N++ L
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSF----NVSYNNLS 155
             LDLS NK+          L  +       ++S N ++
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  109 bits (275), Expect = 1e-25
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 3/155 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAINGS 61
           L L +N +   + ++   L +L+ +   H+ +  +   S    L  L  LD S+     +
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 62  LPASFSNLSSLVSLTLESNNLDDQIL-DSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
               F+ LSSL  L +  N+  +  L D   +L NL+ L+L + Q+    P+   ++S+L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            +L+++ N+L       F  L SL    +  N   
Sbjct: 497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (257), Expect = 3e-23
 Identities = 38/161 (23%), Positives = 60/161 (37%), Gaps = 7/161 (4%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN-G 60
            L L  N +      +   LS LQ++      ++ +    +G L  L+ L+ ++N I   
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSV----LNLKRNQISGHIPSTIGN 116
            LP  FSNL++L  L L SN +       L  LH + +    L+L  N ++  I      
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198

Query: 117 ISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLSG 156
              L  L L  N  S  +       L  L    +       
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 95.9 bits (239), Expect = 5e-21
 Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 7/161 (4%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN--GSL 62
           L+  N       +L KL  L+ ++ + NK      S++  L  L  LD S N ++  G  
Sbjct: 309 LELVNCKFGQFPTL-KLKSLKRLTFTSNKGGNA-FSEVD-LPSLEFLDLSRNGLSFKGCC 365

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIP-STIGNISTLT 121
             S    +SL  L L  N +   +  +   L  L  L+ + + +      S   ++  L 
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
            LD+S           F+ L SL    ++ N+        +
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 1/108 (0%)

Query: 1   MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSD-LGRLSRLRILDFSYNAIN 59
           ++L + + +           LS L+ + ++ N        D    L  L  LD S   + 
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

Query: 60  GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS 107
              P +F++LSSL  L + SN L        D+L +L  + L  N   
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 39/184 (21%), Positives = 70/184 (38%), Gaps = 33/184 (17%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISL------SHNKISGVMPSDLGRLSRLRILDFSY 55
           L L+ N  S  +    +  L+ L+   L      +   +     S L  L  L I +F  
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 56  NAINGS---LPASFSNLSSLVSLTLESNNLDD----------QILDSLD---------KL 93
             ++     +   F+ L+++ S +L S  ++           Q L+ ++         KL
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKL 324

Query: 94  HNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS--GEIPASFSNLKSLSSFNVSY 151
            +L  L    N+          ++ +L  LDLS+N LS  G    S     SL   ++S+
Sbjct: 325 KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382

Query: 152 NNLS 155
           N + 
Sbjct: 383 NGVI 386

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 40/193 (20%), Positives = 63/193 (32%), Gaps = 34/193 (17%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSD-LGRLSRLRILDFSYNAINGS 61
           L L  N ++  I     K   L +++L +N  S  +    +  L+ L +           
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 62  ---LPASFSNLSSLVSLTLESNNL------DDQILDSLDKLHNLSVLNLKRNQISGHIPS 112
                   S L  L +LT+E   L       D I+D  + L N+S  +L    I   +  
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD 299

Query: 113 TIGNIS--------------------TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN 152
              N                      +L  L  + NK       S  +L SL   ++S N
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRN 357

Query: 153 NLSGPVPTSLALK 165
            LS     S +  
Sbjct: 358 GLSFKGCCSQSDF 370

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 16/61 (26%), Positives = 27/61 (44%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L    L    P +   LS LQ ++++ N++  V      RL+ L+ +    N  + S 
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534

Query: 63  P 63
           P
Sbjct: 535 P 535

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  113 bits (284), Expect = 3e-27
 Identities = 60/299 (20%), Positives = 114/299 (38%), Gaps = 60/299 (20%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKR-LREKITKGQREFESEVSLLGKI-RHPNLLAL-- 348
           +I+G  + GTV       G  VAVKR L +           E+ LL +   HPN++    
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPNVIRYYC 76

Query: 349 -----RAYYLGPKGEKLLVFDYMPHGSLATFLHARG----PETPIDWPTRMKIIKGMTRG 399
                R  Y        +  +     +L   + ++               + +++ +  G
Sbjct: 77  SETTDRFLY--------IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 400 LLHLHSNENIIHGNLTSSNVLLD-------------DSTNAKISDFGLSRLMT---AAAN 443
           + HLHS   IIH +L   N+L+              ++    ISDFGL + +    ++  
Sbjct: 128 VAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 444 VNVIATAGALGYRAPEL-------SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE 496
            N+   +G  G+RAPEL          ++     D++S+G     +L+      P     
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKY 244

Query: 497 LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
             +  ++I++  ++    D        ++  E  +   L    +D  P  RP  ++V++
Sbjct: 245 SRE--SNIIRGIFS---LDEMKCLHDRSLIAEATD---LISQMIDHDPLKRPTAMKVLR 295

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  111 bits (279), Expect = 4e-27
 Identities = 32/173 (18%), Positives = 58/173 (33%), Gaps = 16/173 (9%)

Query: 3   LALQYNNLSGRIPASLGK---------LSELQEISLSHNKISGVMPSDLGRLSRLRILDF 53
           L+++       +P  L           L  LQ + L    I  + P+ +  L  L+ L  
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKI 213

Query: 54  SYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLK-RNQISGHIPS 112
             + ++ +L  +  +L  L  L L                  L  L LK  + +   +P 
Sbjct: 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPL 271

Query: 113 TIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN---NLSGPVPTSL 162
            I  ++ L  LDL        +P+  + L +     V  +    L    P + 
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  111 bits (279), Expect = 4e-27
 Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 12/169 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGR---------LSRLRILDF 53
           L L  N L   +PAS+  L+ L+E+S+        +P  L           L  L+ L  
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190

Query: 54  SYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPST 113
            +  I  SLPAS +NL +L SL + ++ L   +  ++  L  L  L+L+      + P  
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI 248

Query: 114 IGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
            G  + L  L L        +P     L  L   ++        +P+ +
Sbjct: 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 31/177 (17%), Positives = 60/177 (33%), Gaps = 10/177 (5%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L  Q +         L +         +               +  +I   +  A+  + 
Sbjct: 17  LYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK-AT 71

Query: 63  PASFSNLSS--LVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
                + +    V+L L S  L  Q  D   +L +L  + +    +   +P T+   + L
Sbjct: 72  ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQL 177
             L L++N L   +PAS ++L  L   ++        +P  LA    +    G + L
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 53.4 bits (129), Expect = 7e-08
 Identities = 14/117 (11%), Positives = 28/117 (23%), Gaps = 22/117 (18%)

Query: 60  GSLPASFSNLSSLVSLTLESNN-----------------LDDQILDSLDKLHNLSVLNLK 102
           GS      + S   +L  + +                   D     S  +  N +   ++
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 103 RNQISG--HIPSTIGNIS--TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
                        + + +      L+L    L  + P     L  L    +    L 
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  111 bits (280), Expect = 4e-27
 Identities = 67/313 (21%), Positives = 121/313 (38%), Gaps = 66/313 (21%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKI-RHPN 344
           +++G   +G V  AT           QVAVK L+EK    +R    SE+ ++ ++  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 345 LLALRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT---- 397
           ++ L    LG     G   L+F+Y  +G L  +L ++  +   D        +       
Sbjct: 111 IVNL----LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 398 ----------------RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA 441
                           +G+  L    + +H +L + NVL+      KI DFGL+R +  +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDI-MS 224

Query: 442 ANVNVIATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSP--GEPLNGAE 496
            +  V+     L  +  APE         K+DV+S G+ + E+ + G +P  G P++ A 
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-AN 283

Query: 497 LPQWVAS---IVK-EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQ 552
             + + +   + +    T E++   +M+                  C       RP    
Sbjct: 284 FYKLIQNGFKMDQPFYATEEIYI--IMQS-----------------CWAFDSRKRPSFPN 324

Query: 553 VVQQLEEIRPEAA 565
           +   L     +A 
Sbjct: 325 LTSFLGCQLADAE 337

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  111 bits (280), Expect = 5e-27
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 38/218 (17%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EK----ITKGQREFESEVSLLGKIRHPN 344
             +G+ T+G V+KA   + G +VA+K++    EK    IT   RE    + +L  ++H N
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALRE----IKILQLLKHEN 77

Query: 345 LLAL------RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
           ++ L      +A         + LVFD+  H  LA  L               ++++ + 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLL 134

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV------NVIATAG 451
            GL ++H N  I+H ++ ++NVL+      K++DFGL+R  + A N       N + T  
Sbjct: 135 NGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT-- 191

Query: 452 ALGYRAPELSKL---KKANTKTDVYSLGVTILELLTGK 486
            L YR PEL  L   +      D++  G  + E+ T  
Sbjct: 192 -LWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  111 bits (279), Expect = 6e-27
 Identities = 37/308 (12%), Positives = 83/308 (26%), Gaps = 48/308 (15%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRAY 351
                  V+    +E     A+K         + E E          ++   +    R  
Sbjct: 71  RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130

Query: 352 Y-------------------LGPKGEKLLVFDY---MP--HGSLATFLHARG----PETP 383
                               L P  +   V +Y   MP     L                
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190

Query: 384 IDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN 443
                   +   + R   +L S   ++HG+ T  N+ +       + D      +     
Sbjct: 191 EGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249

Query: 444 VNVIATAGALGYRAPELSKLKKA--NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
               A++  + Y   E      A      + + LG++I  +     P   +       W 
Sbjct: 250 ----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 502 ASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ--QLEE 559
              ++   T+ +           + D +   +   L   +     R   L+ ++  +  +
Sbjct: 306 RPSLRVPGTDSL----AFGSCTPLPDFVKTLIGRFL---NFDRRRRLLPLEAMETPEFLQ 358

Query: 560 IRPEAATA 567
           ++ E +++
Sbjct: 359 LQNEISSS 366

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (276), Expect = 6e-27
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 23/205 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLAL 348
           E +GK ++G V+K         VA+K +   + + + E E    E+++L +   P +   
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSN 406
              YL  K  KL ++ +Y+  GS    L      ET I       I++ + +GL +LHS 
Sbjct: 86  YGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQI-----ATILREILKGLDYLHSE 138

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN--VNVIATAGALGY-RAPELSKL 463
              IH ++ ++NVLL +    K++DFG++  +T         + T     +  APE+ K 
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP----FWMAPEVIKQ 193

Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
              ++K D++SLG+T +EL  G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  111 bits (279), Expect = 7e-27
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 31/218 (14%)

Query: 293 EIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
            + G+ T+GTV        G  VA+K++ +      RE    +  L  + HPN++ L++Y
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSY 87

Query: 352 YLGPKGEKL------LVFDYMP---HGSLATFLHARGPETPIDWPTRMKIIKG----MTR 398
           +              +V +Y+P   H     +   +    PI       +IK     + R
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI-------LIKVFLFQLIR 140

Query: 399 GLLHLHSN-ENIIHGNLTSSNVLLDDSTNA-KISDFGLSR-LMTAAANVNVIATAGALGY 455
            +  LH    N+ H ++   NVL++++    K+ DFG ++ L  +  NV  I +     Y
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS---RYY 197

Query: 456 RAPEL-SKLKKANTKTDVYSLGVTILELLTGKS--PGE 490
           RAPEL    +   T  D++S+G    E++ G+    G+
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  112 bits (281), Expect = 8e-27
 Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 47/282 (16%)

Query: 231 RKRTASKAEDGQATASGTAARGEKGAPSAAGEVEAGGENGGKLVHFDGPLMFTADDLLCA 290
           R RT S AE  +     +A    K +    G           +V   G       ++   
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKV------TTVVATPGQGPDRPQEVSYT 57

Query: 291 TAEIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFES-EVSLLGKIRHPNLLAL 348
             +++G  ++G VY+A L + G  VA+K++ +      + F++ E+ ++ K+ H N++ L
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 112

Query: 349 RAYYLGPKGEKL------LVFDYMP---HGSLATFLHARGPETPIDWPTRMKIIKG---- 395
           R Y+    GEK       LV DY+P   +     +  A+     I        +K     
Sbjct: 113 R-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-------YVKLYMYQ 164

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA-KISDFGLSR-LMTAAANVNVIATAGAL 453
           + R L ++HS   I H ++   N+LLD  T   K+ DFG ++ L+    NV+ I +    
Sbjct: 165 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---R 220

Query: 454 GYRAPELSKL---KKANTKTDVYSLGVTILELLTGKS--PGE 490
            YRAPEL  +       +  DV+S G  + ELL G+   PG+
Sbjct: 221 YYRAPEL--IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  113 bits (285), Expect = 2e-26
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 8/163 (4%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL-P 63
            ++ NL+ ++P  L   +  + + LS N I  V  S    L +L++L+        ++  
Sbjct: 11  YRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66

Query: 64  ASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHI--PSTIGNISTLT 121
            +F NL +L  L L S+ +     D+   L +L  L L    +S  +       N+  LT
Sbjct: 67  EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126

Query: 122 ILDLSQNKLSG-EIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
            LDLS+N++    +  SF  L SL S + S N +       L 
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  109 bits (274), Expect = 3e-25
 Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 6/172 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSD-LGRLSRLRILDFSYNAINGS 61
           L L +N +     +S   L +LQ + L        +  +    L  LRILD   + I   
Sbjct: 29  LLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL 88

Query: 62  LPASFSNLSSLVSLTLESNNLDDQIL--DSLDKLHNLSVLNLKRNQISG-HIPSTIGNIS 118
            P +F  L  L  L L    L D +L       L  L+ L+L +NQI   ++  + G ++
Sbjct: 89  HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLN 148

Query: 119 TLTILDLSQNKLSGEIPASFSNL--KSLSSFNVSYNNLSGPVPTSLALKFNA 168
           +L  +D S N++          L  K+LS F+++ N+L   V        N 
Sbjct: 149 SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  104 bits (262), Expect = 1e-23
 Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 7/157 (4%)

Query: 1   MFLALQYNNLSGRIPASLGKL--SELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAI 58
           M     ++N+      +   L  S ++ + LSH  +  +       L  L++L+ +YN I
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302

Query: 59  NGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
           N     +F  L +L  L L  N L +    +   L  ++ ++L++N I+     T   + 
Sbjct: 303 NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362

Query: 119 TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            L  LDL  N L+     +   + S+    +S N L 
Sbjct: 363 KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV 394

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  102 bits (257), Expect = 4e-23
 Identities = 43/192 (22%), Positives = 72/192 (37%), Gaps = 21/192 (10%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L YN ++     +   L  LQ ++LS+N +  +  S+   L ++  +D   N I    
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354

Query: 63  PASFSNLSSLVSLTLESNNL-DDQILDSLDKLH--------------NLSVLNLKRNQIS 107
             +F  L  L +L L  N L     + S+  +                 ++++L  N++ 
Sbjct: 355 DQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE 414

Query: 108 G-HIPSTIGNISTLTILDLSQNKLSG-EIPASFSNLKSLSSFNVSYNNLSGPVPTSLALK 165
              I   +  +  L IL L+QN+ S      + S   SL    +  N L     T L   
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL--- 471

Query: 166 FNASSFVGNIQL 177
                F G   L
Sbjct: 472 -CWDVFEGLSHL 482

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 93.7 bits (233), Expect = 4e-20
 Identities = 42/177 (23%), Positives = 63/177 (35%), Gaps = 23/177 (12%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVM--PSDLGRLSRLRILDFSYNAIN 59
            L L  + +    P +   L  L E+ L    +S  +        L  L  LD S N I 
Sbjct: 77  ILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136

Query: 60  G-SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLH--NLSVLNLKRNQISGHIPSTIGN 116
              L  SF  L+SL S+   SN +       L+ L    LS  +L  N +   +    G 
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196

Query: 117 IS------TLTILDLSQNKLSGEIPASFSN------------LKSLSSFNVSYNNLS 155
                    L ILD+S N  + +I  +FSN               +      ++N+ 
Sbjct: 197 CMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 87.9 bits (218), Expect = 3e-18
 Identities = 33/180 (18%), Positives = 64/180 (35%), Gaps = 32/180 (17%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAI---- 58
           + LQ N+++     +   L +LQ + L  N ++      +  +  +  +  S N +    
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLP 397

Query: 59  -----------------NGSLPASFSNLSSLVSLTLESNNLDDQILDSL-DKLHNLSVLN 100
                            N  +      +  L  L L  N       D    +  +L  L 
Sbjct: 398 KINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457

Query: 101 LKRNQISGHIPSTI-----GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L  N +     + +       +S L +L L+ N L+   P  FS+L +L   +++ N L+
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 86.8 bits (215), Expect = 6e-18
 Identities = 34/178 (19%), Positives = 63/178 (35%), Gaps = 25/178 (14%)

Query: 3   LALQYNNLSGRI--PASLGKLSELQEISLSHNKISGVMPSD-LGRLSRLRILDFSYNAIN 59
           L L +  LS  +        L  L  + LS N+I  +      G+L+ L+ +DFS N I 
Sbjct: 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161

Query: 60  GSLPASFSNLS--SLVSLTLESNNLDDQILDSLDKLHN------LSVLNLKRNQISGHIP 111
                    L   +L   +L +N+L  ++     K  N      L +L++  N  +  I 
Sbjct: 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT 221

Query: 112 STIGN------------ISTLTILDLSQNKLSGEIPASFSNLK--SLSSFNVSYNNLS 155
               N               +       + +      +F+ L   S+   ++S+  + 
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 27/118 (22%), Positives = 41/118 (34%), Gaps = 5/118 (4%)

Query: 49  RILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG 108
           RI  + +     +L      L++   L L  N +      S   L  L +L L       
Sbjct: 7   RIAFYRFC----NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62

Query: 109 HI-PSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALK 165
            I      N+  L ILDL  +K+    P +F  L  L    + +  LS  V      +
Sbjct: 63  TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 39/179 (21%), Positives = 64/179 (35%), Gaps = 16/179 (8%)

Query: 3   LALQYNNLSGRIPASL-----GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNA 57
           L L  N L       L       LS LQ + L+HN ++ + P     L+ LR L  + N 
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515

Query: 58  INGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIP----ST 113
           +           ++L  L +  N L      + D   +LSVL++  N+            
Sbjct: 516 LTVLSHNDL--PANLEILDISRNQLLAP---NPDVFVSLSVLDITHNKFICECELSTFIN 570

Query: 114 IGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFV 172
             N + +TI     + +    P SFS   SL S +    +    + +     F   +  
Sbjct: 571 WLNHTNVTIAGPPAD-IYCVYPDSFSG-VSLFSLSTEGCDEEEVLKSLKFSLFIVCTVT 627

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 34/154 (22%), Positives = 55/154 (35%), Gaps = 13/154 (8%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L +N L+   P     L+ L+ +SL+ N+++ +  +DL   + L ILD S N +   
Sbjct: 484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAP 541

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
            P  F +LS    L +  N    +          LS      N  +  I     +I  + 
Sbjct: 542 NPDVFVSLS---VLDITHNKFICEC--------ELSTFINWLNHTNVTIAGPPADIYCVY 590

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
               S   L           + L S   S   + 
Sbjct: 591 PDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVC 624

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  109 bits (275), Expect = 2e-26
 Identities = 69/310 (22%), Positives = 124/310 (40%), Gaps = 71/310 (22%)

Query: 293 EIMGKSTYGTVYKATLEDG------SQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNL 345
             +G+  +G V++A           + VAVK L+E+ +   + +F+ E +L+ +  +PN+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 346 LALRAYYLG--PKGE-KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT----- 397
           + L    LG    G+   L+F+YM +G L  FL +  P T           +        
Sbjct: 113 VKL----LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 398 ----------------RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA 441
                            G+ +L      +H +L + N L+ ++   KI+DFGLSR +  +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNI-YS 226

Query: 442 ANVNVIATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP 498
           A+        A+  R   PE     +  T++DV++ GV + E+ + G  P   +   E  
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-- 284

Query: 499 QWVASIVK--------EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEV 550
             V   V+        E    E+++  LMR                  C    P+ RP  
Sbjct: 285 --VIYYVRDGNILACPENCPLELYN--LMRL-----------------CWSKLPADRPSF 323

Query: 551 LQVVQQLEEI 560
             + + L+ +
Sbjct: 324 CSIHRILQRM 333

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  107 bits (271), Expect = 3e-26
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 25/205 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-EKITKGQREFES----EVSLLGKIRHPNLLA 347
           E +G+ TYG VYKA    G   A+K++R EK  +G     S    E+S+L +++H N++ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG---IPSTTIREISILKELKHSNIVK 64

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L       K  +L LVF+++    L   L        ++  T    +  +  G+ + H  
Sbjct: 65  LYDVIHTKK--RLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPELSKL- 463
             ++H +L   N+L++     KI+DFGL+R          + I T   L YRAP++  L 
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT---LWYRAPDV--LM 173

Query: 464 --KKANTKTDVYSLGVTILELLTGK 486
             KK +T  D++S+G    E++ G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  107 bits (270), Expect = 3e-26
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 27/206 (13%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITK-GQRE-FESEVSLLGKIRHPNLLALRAY 351
           GK ++  VY+A  +  G +VA+K + ++ + K G  +  ++EV +  +++HP++L L  Y
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +       + LV +   +G +  +L  R    P         +  +  G+L+LHS+  I+
Sbjct: 80  FEDSN--YVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH-GIL 134

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLS--------RLMTAAANVNVIATAGALGYRAPELSK 462
           H +LT SN+LL  + N KI+DFGL+        +  T           G   Y +PE++ 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---------LCGTPNYISPEIAT 185

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
                 ++DV+SLG     LL G+ P
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP 211

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  108 bits (272), Expect = 3e-26
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 25/205 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-EKITKGQREFES----EVSLLGKIRHPNLLA 347
           E +G+ TYG VYKA    G  VA+KR+R +   +G     S    E+SLL ++ HPN+++
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG---IPSTAIREISLLKELHHPNIVS 83

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L       +   L LVF++M    L   L      T +        +  + RG+ H H +
Sbjct: 84  LIDVIHSER--CLTLVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH 138

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPELSKL- 463
             I+H +L   N+L++     K++DFGL+R          + + T   L YRAP++  L 
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT---LWYRAPDV--LM 192

Query: 464 --KKANTKTDVYSLGVTILELLTGK 486
             KK +T  D++S+G    E++TGK
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  108 bits (273), Expect = 3e-26
 Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 50/294 (17%)

Query: 296 GKSTYGTVYKATL--------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKI-RHPNL 345
           G+  +G V  A          ++   VAVK L++  T+    +  SE+ ++  I +H N+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103

Query: 346 LALRAYYLG---PKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMT---- 397
           + L    LG     G   ++ +Y   G+L  +L   R P     +       + MT    
Sbjct: 104 INL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 398 --------RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT 449
                   RG+ +L S    IH +L + NVL+ ++   KI+DFGL+R +    +     T
Sbjct: 160 VSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTT 217

Query: 450 AGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVK 506
            G L  +  APE    +    ++DV+S GV + E+ T G SP   +   EL + +     
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL----- 272

Query: 507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                E   ++   +     +EL     +   C    PS RP   Q+V+ L+ I
Sbjct: 273 ----KEGHRMDKPANCT---NELYM---MMRDCWHAVPSQRPTFKQLVEDLDRI 316

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  108 bits (271), Expect = 3e-26
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFES----EVSLLGKIR---HP 343
             +G   YGTVYKA     G  VA+K +R      G          EV+LL ++    HP
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 344 NLLALRAYYLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
           N++ L       + ++     LVF+++    L T+L    P   +   T   +++   RG
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA-PPPGLPAETIKDLMRQFLRG 132

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL------MTAAANVNVIATAGAL 453
           L  LH+N  I+H +L   N+L+      K++DFGL+R+      +T      V+ T   L
Sbjct: 133 LDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT-----PVVVT---L 183

Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
            YRAPE+       T  D++S+G    E+   K
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  108 bits (273), Expect = 5e-26
 Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 50/297 (16%)

Query: 293 EIMGKSTYGTVYKATL--------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKI-RH 342
           + +G+  +G V  A          ++   VAVK L++  T+    +  SE+ ++  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 343 PNLLALRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGM--- 396
            N++ L    LG     G   ++ +Y   G+L  +L AR P          ++ +     
Sbjct: 147 KNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 397 ----------TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV 446
                      RG+ +L S    IH +L + NVL+ ++   KI+DFGL+R +    +   
Sbjct: 203 KDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 260

Query: 447 IATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVAS 503
             T G L  +  APE    +    ++DV+S GV + E+ T G SP   +   EL + +  
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-- 318

Query: 504 IVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                   E   ++   +     +EL     +   C    PS RP   Q+V+ L+ I
Sbjct: 319 -------KEGHRMDKPANCT---NELYM---MMRDCWHAVPSQRPTFKQLVEDLDRI 362

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (268), Expect = 6e-26
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 28/206 (13%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITK-GQRE-FESEVSLLGKIRHPNLLALRAY 351
           GK  +   ++ +  +     A K + +  + K  QRE    E+S+   + H +++    +
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +       + +V +     SL      R   T  +   R   ++ +  G  +LH N  +I
Sbjct: 84  FEDND--FVFVVLELCRRRSLLELHKRRKALTEPE--AR-YYLRQIVLGCQYLHRN-RVI 137

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLS--------RLMTAAANVNVIATAGALGYRAPELSK 462
           H +L   N+ L++    KI DFGL+        R              G   Y APE+  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---------LCGTPNYIAPEVLS 188

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            K  + + DV+S+G  +  LL GK P
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPP 214

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (267), Expect = 6e-26
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 30/206 (14%)

Query: 296 GKSTYGTVYKA-TLEDGSQVAVKRL-REKITKGQRE--FESEVSLLGKIRHPNLLALRAY 351
           GK  +G VY A   ++   +A+K L + ++ K   E     E+ +   +RHPN+L +  Y
Sbjct: 23  GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           +   K  ++ L+ ++ P G L   L   G   E           ++ +   L + H    
Sbjct: 83  FHDRK--RIYLMLEFAPRGELYKELQKHGRFDE-----QRSATFMEELADALHYCHER-K 134

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLS------RLMTAAANVNVIATAGALGYRAPELSK 462
           +IH ++   N+L+      KI+DFG S      R  T           G L Y  PE+ +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT---------MCGTLDYLPPEMIE 185

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            K  + K D++  GV   E L G  P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  109 bits (275), Expect = 8e-26
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 12/157 (7%)

Query: 5   LQYNNLSGRI--PASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           LQ  +   ++     L  L+ L+ + +S NK+S    S L +L+ L  L  + N I+   
Sbjct: 158 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDIT 215

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P     L++L  L+L  N L D  + +L  L NL+ L+L  NQIS   P  +  ++ LT 
Sbjct: 216 P--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP 159
           L L  N++S   P   + L +L++  ++ N L    P
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  106 bits (268), Expect = 6e-25
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 13/154 (8%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N ++   P  L  L+ L  + LS N IS +  S L  L+ L+ L F     +   
Sbjct: 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFGNQVTD--- 169

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               +NL++L  L + SN + D  +  L KL NL  L    NQIS   P  +G ++ L  
Sbjct: 170 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
           L L+ N+L      + ++L +L+  +++ N +S 
Sbjct: 226 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  105 bits (263), Expect = 3e-24
 Identities = 43/180 (23%), Positives = 75/180 (41%), Gaps = 17/180 (9%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N +S   P  L  L+ L  + L+ N++  +  S +  L  L  L   +N I+   
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS 325

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P   S+L+ L  L   +N + D  + SL  L N++ L+   NQIS   P  + N++ +T 
Sbjct: 326 P--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 379

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP-------TSLALKFNASSFVGNI 175
           L L+    +       +N+   ++       L  P         T   + +N  S+   +
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEV 439

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  103 bits (259), Expect = 1e-23
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L      +       +  L+ L +I+ S+N+++ +  + L  L++L  +  + N I    
Sbjct: 51  LQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADIT 106

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P   +NL++L  LTL +N + D  +D L  L NL+ L L  N IS    S +  +++L  
Sbjct: 107 P--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQ 160

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP 159
           L    N+++   P   +NL +L   ++S N +S    
Sbjct: 161 LSFG-NQVTDLKP--LANLTTLERLDISSNKVSDISV 194

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 97.0 bits (242), Expect = 1e-21
 Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 10/143 (6%)

Query: 17  SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLT 76
           +   L+E  +  L    ++  +      L ++  L      I          L++L  + 
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74

Query: 77  LESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPA 136
             +N L D  +  L  L  L  + +  NQI+   P  + N++ LT L L  N+++   P 
Sbjct: 75  FSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP- 129

Query: 137 SFSNLKSLSSFNVSYNNLSGPVP 159
              NL +L+   +S N +S    
Sbjct: 130 -LKNLTNLNRLELSSNTISDISA 151

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 84.2 bits (209), Expect = 2e-17
 Identities = 21/131 (16%), Positives = 56/131 (42%), Gaps = 10/131 (7%)

Query: 29  LSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILD 88
                I+ +       L+           +  ++    ++L  + +L  +   +    +D
Sbjct: 9   TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--ID 62

Query: 89  SLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFN 148
            ++ L+NL+ +N   NQ++   P  + N++ L  + ++ N+++   P   +NL +L+   
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118

Query: 149 VSYNNLSGPVP 159
           +  N ++   P
Sbjct: 119 LFNNQITDIDP 129

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  106 bits (267), Expect = 8e-26
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFES----EVSLLGKIRHPNLL 346
           E +G+ TYGTV+KA   E    VA+KR+R +   +G     S    E+ LL +++H N++
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIV 64

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            L       K  KL LVF++     L  +  +      +D       +  + +GL   HS
Sbjct: 65  RLHDVLHSDK--KLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPELSKL 463
             N++H +L   N+L++ +   K+++FGL+R            + T   L YR P++  L
Sbjct: 120 R-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT---LWYRPPDV--L 173

Query: 464 ---KKANTKTDVYSLGVTILELLTGKSP 488
              K  +T  D++S G    EL     P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  106 bits (266), Expect = 1e-25
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 16/201 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G+ +YG+VYKA   E G  VA+K++   +    +E   E+S++ +   P+++     
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           Y   K   L +V +Y   GS++  +  R     +       I++   +GL +LH     I
Sbjct: 93  YF--KNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM-RKI 147

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAA---ANVNVIATAGALGYRAPELSKLKKAN 467
           H ++ + N+LL+   +AK++DFG++  +T      N  +    G   + APE+ +    N
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI----GTPFWMAPEVIQEIGYN 203

Query: 468 TKTDVYSLGVTILELLTGKSP 488
              D++SLG+T +E+  GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (265), Expect = 2e-25
 Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 20/203 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE--FESEVSLLGKIRHPNLLALR 349
           E +G+   GTVY A  +  G +VA++++   + +  ++    +E+ ++ + ++PN++   
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             YL   G++L +V +Y+  GSL   +     ET +D      + +   + L  LHSN  
Sbjct: 84  DSYL--VGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN-Q 136

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN--VNVIATAGALGY-RAPELSKLKK 465
           +IH ++ S N+LL    + K++DFG    +T   +    ++ T     Y  APE+   K 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP----YWMAPEVVTRKA 192

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
              K D++SLG+  +E++ G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  106 bits (266), Expect = 2e-25
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 26/208 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES----EVSLLGKIRHPNLLA 347
           E +G  TY TVYK      G  VA+K ++    +G     S    E+SL+ +++H N++ 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVR 67

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGP---ETPIDWPTRMKIIKGMTRGLLHL 403
           L          KL LVF++M +  L  ++ +R        ++          + +GL   
Sbjct: 68  LYDVIHTEN--KLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPELS 461
           H N  I+H +L   N+L++     K+ DFGL+R      N   + + T   L YRAP++ 
Sbjct: 125 HEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT---LWYRAPDV- 179

Query: 462 KL---KKANTKTDVYSLGVTILELLTGK 486
            L   +  +T  D++S G  + E++TGK
Sbjct: 180 -LMGSRTYSTSIDIWSCGCILAEMITGK 206

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (267), Expect = 2e-25
 Identities = 60/278 (21%), Positives = 111/278 (39%), Gaps = 23/278 (8%)

Query: 282 FTADDLLCATAEIMGKSTYGTVYKATL-EDGSQVAVKRLR-EKITKGQREFESEVSLLGK 339
              DD        +G    G V+K +    G  +A K +  E     + +   E+ +L +
Sbjct: 30  LKDDDFE--KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 87

Query: 340 IRHPNLLA-LRAYYLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGM 396
              P ++    A+Y    GE  +  ++M  GSL   L   G  PE  +      K+   +
Sbjct: 88  CNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAV 140

Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA-ANVNVIATAGALGY 455
            +GL +L     I+H ++  SN+L++     K+ DFG+S  +  + AN  V    G   Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSY 196

Query: 456 RAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
            +PE  +    + ++D++S+G++++E+  G+ P  P +  EL       V+ +       
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 516 LELMRDAPTIGDELLNT----LKLALHCVDPSPSARPE 549
                                 +L  + V+  P   P 
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  105 bits (263), Expect = 3e-25
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 17/196 (8%)

Query: 301 GTVYKAT-LEDGSQVAVKRLREKITKGQ---REFESEVSLLGKIRHPNLLALRAYYLGPK 356
            TVY A       +VA+K +     + +   + FE EV    ++ H N++++    +  +
Sbjct: 25  STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM--IDVDEE 82

Query: 357 GEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLT 415
            +   LV +Y+   +L+ ++ + GP   +   T +     +  G+ H H    I+H ++ 
Sbjct: 83  DDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM-RIVHRDIK 138

Query: 416 SSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPELSKLKKANTKTDV 472
             N+L+D +   KI DFG+++   A +  ++  T   LG   Y +PE +K +  +  TD+
Sbjct: 139 PQNILIDSNKTLKIFDFGIAK---ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDI 195

Query: 473 YSLGVTILELLTGKSP 488
           YS+G+ + E+L G+ P
Sbjct: 196 YSIGIVLYEMLVGEPP 211

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  105 bits (265), Expect = 3e-25
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 32/214 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES---------EVSLLGKIRH 342
            ++G+ +YG V K    + G  VA+K+  E         +          E+ LL ++RH
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE-------SDDDKMVKKIAMREIKLLKQLRH 83

Query: 343 PNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
            NL+ L       K  +  LVF+++ H ++   L        +D+    K +  +  G+ 
Sbjct: 84  ENLVNLLEVCKKKK--RWYLVFEFVDH-TILDDLELFP--NGLDYQVVQKYLFQIINGIG 138

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE 459
             HS+ NIIH ++   N+L+  S   K+ DFG +R + A   V  + +AT     YRAPE
Sbjct: 139 FCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT---RWYRAPE 194

Query: 460 -LSKLKKANTKTDVYSLGVTILELLTGKS--PGE 490
            L    K     DV+++G  + E+  G+   PG+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  105 bits (265), Expect = 3e-25
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 28/206 (13%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITK-GQRE-FESEVSLLGKIRHPNLLALRAY 351
           GK  +   ++ +  +     A K + +  + K  QRE    E+S+   + H +++    +
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +       + +V +     SL      R   T  +   R   ++ +  G  +LH N  +I
Sbjct: 110 FEDND--FVFVVLELCRRRSLLELHKRRKALTEPE--AR-YYLRQIVLGCQYLHRN-RVI 163

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLS--------RLMTAAANVNVIATAGALGYRAPELSK 462
           H +L   N+ L++    KI DFGL+        R              G   Y APE+  
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---------LCGTPNYIAPEVLS 214

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            K  + + DV+S+G  +  LL GK P
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  105 bits (264), Expect = 3e-25
 Identities = 50/203 (24%), Positives = 100/203 (49%), Gaps = 20/203 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE--FESEVSLLGKIRHPNLLALR 349
             +G+ + G V  A     G QVAVK +   + K QR     +EV ++   +H N++ + 
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             YL   GE+L ++ +++  G+L   +     +  ++      + + + + L +LH+   
Sbjct: 109 KSYL--VGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQ-G 161

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN--VNVIATAGALGY-RAPELSKLKK 465
           +IH ++ S ++LL      K+SDFG    ++       +++ T     Y  APE+     
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP----YWMAPEVISRSL 217

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
             T+ D++SLG+ ++E++ G+ P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  104 bits (262), Expect = 4e-25
 Identities = 39/155 (25%), Positives = 63/155 (40%), Gaps = 3/155 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           + L  N +S    AS      L  + L  N ++ +  +    L+ L  LD S NA   S+
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 63  PAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTL 120
             + F  L  L +L L+   L +        L  L  L L+ N +   +P     ++  L
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNL 155

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           T L L  N++S     +F  L SL    +  N ++
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  101 bits (254), Expect = 4e-24
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 3/156 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHN-KISGVMPSDLGRLSRLRILDFSYNAING 60
            L L  N L+    A+   L+ L+++ LS N ++  V P+    L RL  L      +  
Sbjct: 60  ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ- 118

Query: 61  SLPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
            L    F  L++L  L L+ N L     D+   L NL+ L L  N+IS         + +
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L  L L QN+++   P +F +L  L +  +  NNLS
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 8/153 (5%)

Query: 6   QYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS 65
               L   +P  +   +  Q I L  N+IS V  +       L IL    N +     A+
Sbjct: 19  PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 66  FSNLSSLVSLTLESNNLDDQI-LDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTLTIL 123
           F+ L+ L  L L  N     +   +   L  L  L+L R  +   +   +   ++ L  L
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134

Query: 124 DLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
            L  N L   +P  +F +L +L+   +  N +S
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 33/129 (25%), Positives = 48/129 (37%), Gaps = 6/129 (4%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L    L   +       L+ LQ + L  N +  +       L  L  L    N I+ S
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-S 167

Query: 62  LPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNIST 119
           +P  +F  L SL  L L  N +      +   L  L  L L  N +S  +P+     +  
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRA 226

Query: 120 LTILDLSQN 128
           L  L L+ N
Sbjct: 227 LQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 22/83 (26%), Positives = 33/83 (39%), Gaps = 2/83 (2%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L  N +S     +   L  L  + L  N+++ V P     L RL  L    N ++ +
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-A 215

Query: 62  LPAS-FSNLSSLVSLTLESNNLD 83
           LP    + L +L  L L  N   
Sbjct: 216 LPTEALAPLRALQYLRLNDNPWV 238

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  106 bits (266), Expect = 4e-25
 Identities = 45/202 (22%), Positives = 90/202 (44%), Gaps = 15/202 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G   +G V++      G     K +       +   ++E+S++ ++ HP L+ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           +     E +L+ +++  G L   + A      E  +     +  ++    GL H+H + +
Sbjct: 117 FEDKY-EMVLILEFLSGGELFDRIAAEDYKMSEAEV-----INYMRQACEGLKHMHEH-S 169

Query: 409 IIHGNLTSSNVLLDDSTNA--KISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           I+H ++   N++ +    +  KI DFGL+  +     V V        + APE+   +  
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPV 227

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
              TD++++GV    LL+G SP
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP 249

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  104 bits (261), Expect = 4e-25
 Identities = 52/293 (17%), Positives = 106/293 (36%), Gaps = 60/293 (20%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKR--LREKITKGQREFESEVSLLGKI-RHPNLLAL 348
           E +G   +G+V+K     DG   A+KR       +  ++    EV     + +H +++  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 349 RAYYLGPKGEKLLVF-DYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            + +   + + +L+  +Y   GSLA  +       +         ++  + RGL ++HS 
Sbjct: 77  FSAWA--EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134

Query: 407 ENIIHGNLTSSNVLLD-------------------DSTNAKISDFGLSRLMTAAANVNVI 447
            +++H ++  SN+ +                    +    KI D G    +++   V   
Sbjct: 135 -SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-QVEE- 191

Query: 448 ATAGALG---YRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS 503
                 G   + A E+ +       K D+++L +T++     +    P NG +       
Sbjct: 192 ------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--PRNGDQ----WHE 239

Query: 504 IVKEEWTNEVFDLELMRDAPTIGDELLNTLK-LALHCVDPSPSARPEVLQVVQ 555
           I +                P I   L      L    + P P  RP  + +V+
Sbjct: 240 IRQG-------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  106 bits (266), Expect = 5e-25
 Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 58/298 (19%)

Query: 296 GKSTYGTVYKATL--------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKI-RHPNL 345
           G+  +G V  A             ++VAVK L+   T+    +  SE+ ++  I +H N+
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137

Query: 346 LALRAYYLG---PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK----------- 391
           + L    LG     G   ++ +Y   G+L  +L AR P                      
Sbjct: 138 INL----LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 392 ------IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN 445
                 + +GM     +L S    IH +L + NVL+ +    KI+DFGL+R +    +  
Sbjct: 194 VSCAYQVARGME----YLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYY 247

Query: 446 VIATAGALGYR--APELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVA 502
              T G L  +  APE    +    ++DV+S GV + E+ T G SP   +   EL + + 
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL- 306

Query: 503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                    E   ++   +     +EL     +   C    PS RP   Q+V+ L+ I
Sbjct: 307 --------KEGHRMDKPSNCT---NELYM---MMRDCWHAVPSQRPTFKQLVEDLDRI 350

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  106 bits (266), Expect = 5e-25
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 37/216 (17%)

Query: 296 GKSTYGTVYKA---TLEDGSQVAVKRLREK---ITKGQREFESEVSLLGKIRHPNLLALR 349
           G+ TYG VYKA     +D    A+K++      ++   R    E++LL +++HPN+++L+
Sbjct: 30  GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS-ACR----EIALLRELKHPNVISLQ 84

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLH------ARGPETPIDWPTRMKIIKGMTRGLLH 402
             +L     K+ L+FDY  H  L   +       A      +       ++  +  G+ +
Sbjct: 85  KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNA----KISDFGLSRLMTA-----AANVNVIATAGAL 453
           LH+N  ++H +L  +N+L+          KI+D G +RL  +     A    V+ T    
Sbjct: 144 LHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT---F 199

Query: 454 GYRAPELSKL---KKANTKTDVYSLGVTILELLTGK 486
            YRAPEL  L   +      D++++G    ELLT +
Sbjct: 200 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSE 233

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  104 bits (262), Expect = 7e-25
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES----EVSLLGKIRHPNLLA 347
           + +G+ TY TVYK       + VA+K +R +  +G          EVSLL  ++H N++ 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVT 64

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           L       K   L LVF+Y+    L  +L   G    I+       +  + RGL + H  
Sbjct: 65  LHDIIHTEK--SLTLVFEYLDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ 119

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPELSKL- 463
             ++H +L   N+L+++    K++DFGL+R  +       N + T   L YR P++  L 
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT---LWYRPPDI--LL 173

Query: 464 --KKANTKTDVYSLGVTILELLTGK 486
                +T+ D++ +G    E+ TG+
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (261), Expect = 8e-25
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 36/216 (16%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES---------EVSLLGKIRH 342
             +G+ +YG V+K    + G  VA+K+  E         +          E+ +L +++H
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLE-------SEDDPVIKKIALREIRMLKQLKH 61

Query: 343 PNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
           PNL+ L   +   +  +L LVF+Y  H ++   L        +       I     + + 
Sbjct: 62  PNLVNLLEVFRRKR--RLHLVFEYCDH-TVLHELDRYQ--RGVPEHLVKSITWQTLQAVN 116

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE 459
             H + N IH ++   N+L+   +  K+ DFG +RL+T  ++   + +AT     YR+PE
Sbjct: 117 FCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT---RWYRSPE 172

Query: 460 LSKL---KKANTKTDVYSLGVTILELLTGKS--PGE 490
           L  L    +     DV+++G    ELL+G    PG+
Sbjct: 173 L--LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  107 bits (268), Expect = 9e-25
 Identities = 33/163 (20%), Positives = 61/163 (37%), Gaps = 2/163 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L +N ++      L   + LQ + L  ++I+ +       L  L  LD S N ++  
Sbjct: 30  SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSL 89

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSL-DKLHNLSVLNLKRNQISGHIP-STIGNIST 119
             + F  LSSL  L L  N      + SL   L NL  L +   +    I       +++
Sbjct: 90  SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           L  L++    L      S  +++ +    +  +  +  +    
Sbjct: 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  106 bits (267), Expect = 2e-24
 Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 5/153 (3%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
            +  + +  IP+ L   + ++ + LS NKI+ +   DL   + L++L    + IN     
Sbjct: 12  GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG-HIPSTIGNISTLTIL 123
           +F +L SL  L L  N+L          L +L  LNL  N      + S   N++ L  L
Sbjct: 69  AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128

Query: 124 DLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
            +   +   EI    F+ L SL+   +   +L 
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 99.0 bits (247), Expect = 5e-22
 Identities = 22/141 (15%), Positives = 54/141 (38%), Gaps = 6/141 (4%)

Query: 20  KLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES 79
           +   ++ + +    +   + +    L +++ +    + +     +   +L SL  L L  
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343

Query: 80  NNLDDQILDS---LDKLHNLSVLNLKRNQIS--GHIPSTIGNISTLTILDLSQNKLSGEI 134
           N + ++ L +        +L  L L +N +         +  +  LT LD+S+N     +
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PM 402

Query: 135 PASFSNLKSLSSFNVSYNNLS 155
           P S    + +   N+S   + 
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 96.3 bits (240), Expect = 3e-21
 Identities = 40/175 (22%), Positives = 58/175 (33%), Gaps = 25/175 (14%)

Query: 2   FLALQYNNLSGRI---PASLGKLSELQEISLSHNKIS--GVMPSDLGRLSRLRILDFSYN 56
           FL L  N +        A  G    LQ + LS N +         L  L  L  LD S N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397

Query: 57  AINGSLPASFSNLSSLVSLTLESNNL---DDQILDSL--------------DKLHNLSVL 99
             +  +P S      +  L L S  +      I  +L                L  L  L
Sbjct: 398 TFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQEL 456

Query: 100 NLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL 154
            + RN++   +P        L ++ +S+N+L       F  L SL    +  N  
Sbjct: 457 YISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 86.7 bits (215), Expect = 4e-18
 Identities = 28/186 (15%), Positives = 62/186 (33%), Gaps = 11/186 (5%)

Query: 3   LALQYNNLSG-RIPASLGKLSELQEISLSH-NKISGVMPSDLGRLSRLRILDFSYNAING 60
           L L  N      + +    L+ LQ + + +    S +   D   L+ L  L+    ++  
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
               S  ++  +  LTL  +     +    D L ++  L L+   ++    S +      
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS---------GPVPTSLALKFNASSF 171
           + +     + S     SF+ L  L  + +  + +          G    S +   +    
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282

Query: 172 VGNIQL 177
           V  + +
Sbjct: 283 VETVTI 288

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 33/220 (15%), Positives = 69/220 (31%), Gaps = 52/220 (23%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGR------------------ 44
           L L  +  +  +      LS ++ + L    ++    S L                    
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236

Query: 45  ----------------LSRLRILDFSYNAI---NGSLPASFSNLSSLVSLTLESNNLDDQ 85
                           LS +   D + N +   N S     S L  + ++T+   ++   
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296

Query: 86  ILDSL-----DKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEI---PAS 137
            L          L  +  + ++ +++     S   ++ +L  LDLS+N +  E     A 
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

Query: 138 FSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQL 177
                SL +  +S N+L        +++      +    L
Sbjct: 357 KGAWPSLQTLVLSQNHLR-------SMQKTGEILLTLKNL 389

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 22/81 (27%), Positives = 33/81 (40%), Gaps = 6/81 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L +  NNL       L     LQE+ +S NK+  +   D      L ++  S N +    
Sbjct: 436 LDVSNNNLD-SFSLFL---PRLQELYISRNKLKTL--PDASLFPVLLVMKISRNQLKSVP 489

Query: 63  PASFSNLSSLVSLTLESNNLD 83
              F  L+SL  + L +N  D
Sbjct: 490 DGIFDRLTSLQKIWLHTNPWD 510

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  103 bits (260), Expect = 1e-24
 Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 27/176 (15%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N L   +P  +     LQE+ +  N+I+ V  S    L+++ +++   N +  S 
Sbjct: 105 LYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161

Query: 63  --PASFSNLSSLVSLTLESNNL---DDQILDSLDKLH------------------NLSVL 99
               +F  +  L  + +   N+      +  SL +LH                  NL+ L
Sbjct: 162 IENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 221

Query: 100 NLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            L  N IS     ++ N   L  L L+ NKL  ++P   ++ K +    +  NN+S
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  100 bits (251), Expect = 2e-23
 Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 12/160 (7%)

Query: 1   MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            ++ +   N++  IP  L     L E+ L  NKI+ V  + L  L+ L  L  S+N+I+ 
Sbjct: 174 SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG------HIPSTI 114
               S +N   L  L L +N L  ++   L     + V+ L  N IS         P   
Sbjct: 231 VDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289

Query: 115 GNISTLTILDLSQNKLS-GEIPAS-FSNLKSLSSFNVSYN 152
              ++ + + L  N +   EI  S F  +   ++  +   
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 38/163 (23%), Positives = 69/163 (42%), Gaps = 9/163 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            +      L  ++P  L    +   + L +NKI+ +   D   L  L  L    N I+  
Sbjct: 35  VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 91

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
            P +F+ L  L  L L  N L  ++ + +     L  L +  N+I+    S    ++ + 
Sbjct: 92  SPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMI 148

Query: 122 ILDLSQNKL-SGEIPA-SFSNLKSLSSFNVSYNNLSGPVPTSL 162
           +++L  N L S  I   +F  +K LS   ++  N++  +P  L
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL 190

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 11/136 (8%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L  N ++ ++ A SL  L+ L ++ LS N IS V    L     LR L  + N +   
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 254

Query: 62  LPASFSNLSSLVSLTLESNNLDD------QILDSLDKLHNLSVLNLKRNQISGHI--PST 113
           +P   ++   +  + L +NN+               K  + S ++L  N +      PST
Sbjct: 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314

Query: 114 IGNISTLTILDLSQNK 129
              +     + L   K
Sbjct: 315 FRCVYVRAAVQLGNYK 330

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  104 bits (261), Expect = 1e-24
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 25/206 (12%)

Query: 299 TYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FES----EVSLLGKIRHPNLLALRAYY 352
            + TVYKA        VA+K+++       ++        E+ LL ++ HPN++ L   +
Sbjct: 22  QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 81

Query: 353 LGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
                  + LVFD+M    L   +        +        +    +GL +LH +  I+H
Sbjct: 82  GH--KSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH-WILH 135

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPELSKL---KKA 466
            +L  +N+LLD++   K++DFGL++   +      + + T     YRAPEL  L   +  
Sbjct: 136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT---RWYRAPEL--LFGARMY 190

Query: 467 NTKTDVYSLGVTILELLTGKS--PGE 490
               D++++G  + ELL      PG+
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGD 216

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  105 bits (265), Expect = 2e-24
 Identities = 33/156 (21%), Positives = 62/156 (39%), Gaps = 6/156 (3%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L +  N+L   I   +   L+ L++++L    ++ +    L  L  L +L   +  IN  
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTL 120
              SF  L  L  L +      D +  +     NL+ L++    ++  +P   + ++  L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYL 250

Query: 121 TILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
             L+LS N +S  I       L  L    +    L+
Sbjct: 251 RFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  104 bits (260), Expect = 6e-24
 Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 6/156 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N +             L+E+ L+ N +S V P     L  LR L    N +   +
Sbjct: 37  LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LI 95

Query: 63  PA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTL 120
           P   F+ LS+L  L +  N +   +      L+NL  L +  N +  +I       +++L
Sbjct: 96  PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSL 154

Query: 121 TILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
             L L +  L+  IP  + S+L  L    + + N++
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  103 bits (259), Expect = 8e-24
 Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 2/155 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L +  N +   +      L  L+ + +  N +  +       L+ L  L      +   
Sbjct: 108 KLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
              + S+L  L+ L L   N++     S  +L+ L VL +        +         LT
Sbjct: 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227

Query: 122 ILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
            L ++   L+  +P  +  +L  L   N+SYN +S
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  102 bits (257), Expect = 2e-23
 Identities = 37/152 (24%), Positives = 65/152 (42%), Gaps = 5/152 (3%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
                    +P  +   +E + + L  N+I  +   +      L  L+ + N ++   P 
Sbjct: 18  CHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG 74

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
           +F+NL +L +L L SN L    L     L NL+ L++  N+I   +     ++  L  L+
Sbjct: 75  AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134

Query: 125 LSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
           +  N L   I   +FS L SL    +   NL+
Sbjct: 135 VGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  102 bits (255), Expect = 3e-23
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 6/156 (3%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L+  NL+  IP  +L  L  L  + L H  I+ +      RL RL++L+ S+     +
Sbjct: 157 LTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTL 120
           +  +     +L SL++   NL      ++  L  L  LNL  N IS  I  ++   +  L
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRL 274

Query: 121 TILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
             + L   +L+  +   +F  L  L   NVS N L+
Sbjct: 275 QEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 92.5 bits (230), Expect = 5e-20
 Identities = 30/129 (23%), Positives = 52/129 (40%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L + +      +  +      L  +S++H  ++ V    +  L  LR L+ SYN I+   
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIE 264

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
            +    L  L  + L    L      +   L+ L VLN+  NQ++    S   ++  L  
Sbjct: 265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324

Query: 123 LDLSQNKLS 131
           L L  N L+
Sbjct: 325 LILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 92.1 bits (229), Expect = 6e-20
 Identities = 32/154 (20%), Positives = 67/154 (43%), Gaps = 2/154 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L++ N++     S  +L  L+ + +SH      M  +      L  L  ++  +  ++
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AV 239

Query: 63  PA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           P  +  +L  L  L L  N +       L +L  L  + L   Q++   P     ++ L 
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           +L++S N+L+    + F ++ +L +  +  N L+
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 4/83 (4%)

Query: 2   FLALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
           FL L YN +S  I    L +L  LQEI L   +++ V P     L+ LR+L+ S N +  
Sbjct: 252 FLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT- 309

Query: 61  SLPAS-FSNLSSLVSLTLESNNL 82
           +L  S F ++ +L +L L+SN L
Sbjct: 310 TLEESVFHSVGNLETLILDSNPL 332

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (257), Expect = 2e-24
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 25/209 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G   +G VYKA   E G+  A K +  K  +   ++  E+ +L    HP ++ L   
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           Y      KL ++ ++ P G++   +        E  I       + + M   L  LHS  
Sbjct: 85  YY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-----QVVCRQMLEALNFLHSK- 136

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN--VNVIATAGALGY-RAPELSKLK 464
            IIH +L + NVL+    + +++DFG+S           + I T     Y  APE+   +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP----YWMAPEVVMCE 192

Query: 465 KA-----NTKTDVYSLGVTILELLTGKSP 488
                  + K D++SLG+T++E+   + P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  104 bits (261), Expect = 2e-24
 Identities = 38/162 (23%), Positives = 68/162 (41%), Gaps = 6/162 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           +  + + +     A L    +++ ++L+  +I  +          ++ L   +NAI    
Sbjct: 50  VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLP 109

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTLT 121
           P  F N+  L  L LE N+L             L+ L++  N +   I        ++L 
Sbjct: 110 PHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQ 168

Query: 122 ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG-PVPTSL 162
            L LS N+L+  +    S + SL   NVSYN LS   +P ++
Sbjct: 169 NLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLSTLAIPIAV 207

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  102 bits (257), Expect = 7e-24
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 12/153 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             + YN LS     +L     ++E+  SHN I+ V          L IL   +N +    
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSINVVRG---PVNVELTILKLQHNNLT-DT 241

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                N   LV + L  N L+  +     K+  L  L +  N++   +      I TL +
Sbjct: 242 AW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           LDLS N L   +  +      L +  + +N++ 
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  100 bits (251), Expect = 5e-23
 Identities = 31/159 (19%), Positives = 65/159 (40%), Gaps = 6/159 (3%)

Query: 1   MFLALQYNNLSGRIPASLGK--LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAI 58
           +F  +  +  +  +        L+  + ++  ++ +  +  + L    ++ +L+ +   I
Sbjct: 22  VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81

Query: 59  NGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNI 117
                 +F+   ++  L +  N +          +  L+VL L+RN +S  +P  I  N 
Sbjct: 82  EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 140

Query: 118 STLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLS 155
             LT L +S N L   I    F    SL +  +S N L+
Sbjct: 141 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 25/171 (14%)

Query: 3   LALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L+ N+LS  +P  +     +L  +S+S+N +  +        + L+ L  S N +   
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 179

Query: 62  LPASFSNLSSLVSLTLESNNLDD-QILDSLDKLH---------------NLSVLNLKRNQ 105
           +    S + SL    +  N L    I  ++++L                 L++L L+ N 
Sbjct: 180 VD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNN 237

Query: 106 ISGHIPSTIGNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
           ++    + + N   L  +DLS N+L  +I    F  ++ L    +S N L 
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 8/144 (5%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L LQ+NNL+      L     L E+ LS+N++  +M     ++ RL  L  S N +  +L
Sbjct: 231 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                 + +L  L L  N+L   +  +  +   L  L L  N I   +   +    TL  
Sbjct: 288 NLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKN 343

Query: 123 LDLSQNKLSG-EIPASFSNLKSLS 145
           L LS N      + A F N+   +
Sbjct: 344 LTLSHNDWDCNSLRALFRNVARPA 367

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 29/143 (20%), Positives = 56/143 (39%), Gaps = 2/143 (1%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLV 73
           I ++L       ++ +           +   L+  +I+ F  + +     A   +   + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 74  SLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGE 133
            L L    +++    +    H +  L +  N I    P    N+  LT+L L +N LS  
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131

Query: 134 IPAS-FSNLKSLSSFNVSYNNLS 155
           +P   F N   L++ ++S NNL 
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 14/107 (13%), Positives = 39/107 (36%), Gaps = 7/107 (6%)

Query: 55  YNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLD-----KLHNLSVLNLKRNQISGH 109
           YN           + +          ++D Q  D         L+N  ++  K + +   
Sbjct: 1   YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60

Query: 110 IPSTIGNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
             + + +   + +L+L+  ++  EI   +F+   ++    + +N + 
Sbjct: 61  PAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  105 bits (264), Expect = 2e-24
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 5/155 (3%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFS-YNAING 60
           L L  N L+  IP+ +   LS+L+E+ L +N I  +      R+  L  LD      +  
Sbjct: 128 LELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEY 186

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
               +F  L +L  L L   N+ D  + +L  L  L  L +  N      P +   +S+L
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             L +  +++S     +F  L SL   N+++NNLS
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  102 bits (255), Expect = 2e-23
 Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 5/155 (3%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L  N++  +I   +   L+ L  + L  N ++ +       LS+LR L    N I   
Sbjct: 104 LQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESI 162

Query: 62  LPASFSNLSSLVSLTLESNNLDDQI-LDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
              +F+ + SL+ L L      + I   + + L NL  LNL    I   +P  +  +  L
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGL 220

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             L++S N      P SF  L SL    V  + +S
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 93.7 bits (233), Expect = 1e-20
 Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 6/153 (3%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
                LS  +P  +   S  + ++L  N I  +       L  L +L    N+I      
Sbjct: 61  CTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG 117

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTLTIL 123
           +F+ L+SL +L L  N L      + + L  L  L L+ N I   IPS     + +L  L
Sbjct: 118 AFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRL 176

Query: 124 DLSQ-NKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           DL +  KL      +F  L +L   N+   N+ 
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.0 bits (226), Expect = 1e-19
 Identities = 34/155 (21%), Positives = 66/155 (42%), Gaps = 7/155 (4%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSH-NKISGVMPSDLGRLSRLRILDFSYNAING 60
           L L+ N +   IP+ +  ++  L  + L    K+  +       L  L+ L+     I  
Sbjct: 152 LWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK- 209

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
            +P   + L  L  L +  N+  +    S   L +L  L +  +Q+S    +    +++L
Sbjct: 210 DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268

Query: 121 TILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNL 154
             L+L+ N LS  +P   F+ L+ L   ++ +N  
Sbjct: 269 VELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 2/103 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           +L L   N+   +P  L  L  L+E+ +S N    + P     LS L+ L    + ++  
Sbjct: 200 YLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN 104
              +F  L+SLV L L  NNL     D    L  L  L+L  N
Sbjct: 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 22/83 (26%), Positives = 42/83 (50%), Gaps = 2/83 (2%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L +  N+     P S   LS L+++ + ++++S +  +    L+ L  L+ ++N ++ S
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-S 280

Query: 62  LPAS-FSNLSSLVSLTLESNNLD 83
           LP   F+ L  LV L L  N  +
Sbjct: 281 LPHDLFTPLRYLVELHLHHNPWN 303

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (258), Expect = 3e-24
 Identities = 44/319 (13%), Positives = 93/319 (29%), Gaps = 72/319 (22%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVK--------------RLREKITKGQR--------- 328
            ++G+       +AT  E G    V               +++E++ + +          
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 329 -----EFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATF---LHARGP 380
                 F     L+   +   ++ +R                    +L TF   L +   
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 381 E-TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT 439
               +    R+++   + R L  LH    ++H  L   +++LD      ++ F       
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 440 AAANVNVIATAGALGYRAPEL-----------SKLKKANTKTDVYSLGVTILELLTGKSP 488
           A        ++ + G+  PEL            +        D ++LG+ I  +     P
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 489 GEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARP 548
                     +W+                  R    I   +     L    +      R 
Sbjct: 313 ITKDAALGGSEWI-----------------FRSCKNIPQPVRA---LLEGFLRYPKEDRL 352

Query: 549 EVLQVVQ--QLEEIRPEAA 565
             LQ ++  + E++R E +
Sbjct: 353 LPLQAMETPEYEQLRTELS 371

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  103 bits (259), Expect = 4e-24
 Identities = 47/328 (14%), Positives = 92/328 (28%), Gaps = 62/328 (18%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIR------- 341
            ++G+       +AT  E G    V          +   ++ + EV  L  +R       
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 342 ------------------HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATF---LHARGP 380
                                ++ +R                    +L TF   L +   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 381 ET-PIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT 439
               +    R+++   + R L  LH    ++H  L   +++LD      ++ F       
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 440 AAANVNVIATAGALGYRAPELSKLKKANTK-----TDVYSLGVTILELLTGKSPGEPLNG 494
           A+A   +          A  +    + +        D ++LG+ I  +     P      
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322

Query: 495 AELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVV 554
               +W+                  R    I   +   L+  L         R   LQ +
Sbjct: 323 LGGSEWI-----------------FRSCKNIPQPVRALLEGFL---RYPKEDRLLPLQAM 362

Query: 555 QQ--LEEIRPE-AATAATSSGDAGPSTS 579
           +    E++R E +A       D  P+  
Sbjct: 363 ETPEYEQLRTELSAALPLYQTDGEPTRE 390

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (256), Expect = 5e-24
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 23/220 (10%)

Query: 282 FTADDLLCATAEIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFESEVS-LLG 338
           FTA+DL       +G+  YG+V K      G  +AVKR+R     K Q++   ++  ++ 
Sbjct: 19  FTAEDL--KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR 76

Query: 339 KIRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPET--PIDWPTRMKIIKG 395
               P ++         +     +  + M   S   F           I      KI   
Sbjct: 77  SSDCPYIVQFYGALF--REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA---TAGA 452
             + L HL  N  IIH ++  SN+LLD S N K+ DFG+S        V+ IA    AG 
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGC 188

Query: 453 LGYRAPE----LSKLKKANTKTDVYSLGVTILELLTGKSP 488
             Y APE     +  +  + ++DV+SLG+T+ EL TG+ P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (256), Expect = 6e-24
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 31/210 (14%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES---EVSLLGKIRHPNLLAL 348
             +G  ++G VY A  + +   VA+K++     +   +++    EV  L K+RHPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           R  YL  +     LV +Y   GS +  L     + P+       +  G  +GL +LHS+ 
Sbjct: 120 RGCYL--REHTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH- 173

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV---------NVIATAGALGYRAP 458
           N+IH ++ + N+LL +    K+ DFG + +M  A +           VI       Y   
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY--- 230

Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSP 488
                   + K DV+SLG+T +EL   K P
Sbjct: 231 --------DGKVDVWSLGITCIELAERKPP 252

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (253), Expect = 7e-24
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 23/204 (11%)

Query: 301 GTVYKATLED---GSQVAVKRLREKITKG---QREFESEVSLLGKIRHPNLLALRAYYLG 354
           G VY+A  ED      VA+K + E ++     +   + E    G+++ P+++ +  +  G
Sbjct: 48  GDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI--HDFG 103

Query: 355 PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
               +L +    +    LA  L  +GP  P   P  + I++ +   L   H+     H +
Sbjct: 104 EIDGQLYVDMRLINGVDLAAMLRRQGPLAP---PRAVAIVRQIGSALDAAHAA-GATHRD 159

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPELSKLKKANTKT 470
           +   N+L+     A + DFG++    A  +  +      +G   Y APE      A  + 
Sbjct: 160 VKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRA 216

Query: 471 DVYSLGVTILELLTGKSP--GEPL 492
           D+Y+L   + E LTG  P  G+ L
Sbjct: 217 DIYALTCVLYECLTGSPPYQGDQL 240

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (254), Expect = 7e-24
 Identities = 54/245 (22%), Positives = 99/245 (40%), Gaps = 22/245 (8%)

Query: 261 GEVEAGGENGGKLVHFDGPLMFTADDLLCATAEIMGKSTYGTVYKATLEDGSQV-AVKRL 319
           G   + G+  G L           +DL       MG  T G V+K        V AVK++
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDL--ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM 58

Query: 320 R-EKITKGQREFESEVSLLGK-IRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLH 376
           R     +  +    ++ ++ K    P ++     ++      + +  + M   +      
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI--TNTDVFIAMELMGTCAEKLKKR 116

Query: 377 ARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL 434
            +G  PE  +      K+   + + L +L     +IH ++  SN+LLD+    K+ DFG+
Sbjct: 117 MQGPIPERIL-----GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171

Query: 435 SRLMTAAANVNVIATAGALGYRAPELSKLKKA-----NTKTDVYSLGVTILELLTGKSPG 489
           S  +      +   +AG   Y APE            + + DV+SLG++++EL TG+ P 
Sbjct: 172 SGRLVDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

Query: 490 EPLNG 494
           +    
Sbjct: 230 KNCKT 234

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  101 bits (254), Expect = 9e-24
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFES----EVSLLGKIRHPNLL 346
             +G+ TYG VYKA        VA+KR+R E   +G          EVSLL +++H N++
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG---VPGTAIREVSLLKELQHRNII 96

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
            L++        +L L+F+Y  +  L  ++      +          +  +  G+   HS
Sbjct: 97  ELKSVIHHNH--RLHLIFEYAEN-DLKKYMDKNPDVSM---RVIKSFLYQLINGVNFCHS 150

Query: 406 NENIIHGNLTSSNVLLDDSTNA-----KISDFGLSRLMTAAANV--NVIATAGALGYRAP 458
               +H +L   N+LL  S  +     KI DFGL+R          + I T   L YR P
Sbjct: 151 R-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT---LWYRPP 206

Query: 459 ELSKL---KKANTKTDVYSLGVTILELLTGK 486
           E+  L   +  +T  D++S+     E+L   
Sbjct: 207 EI--LLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (252), Expect = 1e-23
 Identities = 36/205 (17%), Positives = 68/205 (33%), Gaps = 29/205 (14%)

Query: 362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL 421
                   +L  +++ R      +    + I   +   +  LHS   ++H +L  SN+  
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFF 197

Query: 422 DDSTNAKISDFGLSRLMTAAANVNVIATAGALG-----------YRAPELSKLKKANTKT 470
                 K+ DFGL   M        + T                Y +PE       + K 
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELL 530
           D++SLG+ + ELL   S        E  + +  +   ++                  +  
Sbjct: 258 DIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFP------------LLFTQKYP 300

Query: 531 NTLKLALHCVDPSPSARPEVLQVVQ 555
               +    + PSP+ RPE   +++
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 19/63 (30%), Positives = 31/63 (49%), Gaps = 2/63 (3%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           + MG+  +G V++A    D    A+KR+R    +  RE    EV  L K+ HP ++    
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 351 YYL 353
            +L
Sbjct: 72  AWL 74

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 18/217 (8%)

Query: 282 FTADDLLCATAEIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFESEVS-LLG 338
             ADDL       +G+  YG V K   +  G  +AVKR+R    ++ Q+    ++   + 
Sbjct: 4   VKADDL--EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 339 KIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFL-HARGPETPIDWPTRMKIIKGMT 397
            +  P  +          G+  +  + M   SL  F          I      KI   + 
Sbjct: 62  TVDCPFTVTFYGALFRE-GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA--AANVNVIATAGALGY 455
           + L HLHS  ++IH ++  SNVL++     K+ DFG+S  +    A +++     G   Y
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA----GCKPY 175

Query: 456 RAPE----LSKLKKANTKTDVYSLGVTILELLTGKSP 488
            APE        K  + K+D++SLG+T++EL   + P
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  100 bits (250), Expect = 2e-23
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 31/206 (15%)

Query: 301 GTVYKAT-LEDGSQVAVKRLREKITKGQ---REFESEVSLLGKIRHPNLLA--------- 347
             V+ A  L D   VAVK LR  + +       F  E      + HP ++A         
Sbjct: 26  SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85

Query: 348 --LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
                 Y+        V +Y+   +L   +H  GP   +     +++I    + L   H 
Sbjct: 86  PAGPLPYI--------VMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ 134

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG---YRAPELSK 462
           N  IIH ++  +N+++  +   K+ DFG++R +  +   +V  TA  +G   Y +PE ++
Sbjct: 135 N-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-NSVTQTAAVIGTAQYLSPEQAR 192

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
               + ++DVYSLG  + E+LTG+ P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  102 bits (255), Expect = 2e-23
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 7/156 (4%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFS-YNAING 60
           L L  N L+  IP  +   LS+L+E+ L +N I  +      R+  LR LD      ++ 
Sbjct: 117 LELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY 175

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNIST 119
               +F  LS+L  L L   NL +  + +L  L  L  L+L  N +S  I   +   +  
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMH 232

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L  L + Q+++      +F NL+SL   N+++NNL+
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  101 bits (254), Expect = 3e-23
 Identities = 40/155 (25%), Positives = 62/155 (40%), Gaps = 3/155 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L  N++      +   L+ L  + L  N+++ +       LS+L+ L    N I   
Sbjct: 92  ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESI 151

Query: 62  LPASFSNLSSLVSLTLESNNLDDQI-LDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
              +F+ + SL  L L        I   + + L NL  LNL    +   IP  +  +  L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKL 209

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             LDLS N LS   P SF  L  L    +  + + 
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 95.2 bits (237), Expect = 4e-21
 Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 8/154 (5%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
               NL   +P  +   +  + ++L  N+I  +  +    L  L IL  S N I      
Sbjct: 50  CVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLTIL 123
           +F+ L++L +L L  N L      +   L  L  L L+ N I   IPS     I +L  L
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165

Query: 124 DLSQ-NKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
           DL +  +LS  I   +F  L +L   N++  NL 
Sbjct: 166 DLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR 198

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 89.4 bits (222), Expect = 4e-19
 Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 5/154 (3%)

Query: 3   LALQYNNLSGRIPASL-GKLSELQEISLSH-NKISGVMPSDLGRLSRLRILDFSYNAING 60
           L L+ N +   IP+    ++  L+ + L    ++S +       LS LR L+ +   +  
Sbjct: 141 LWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
            +P   + L  L  L L  N+L      S   L +L  L + ++QI     +   N+ +L
Sbjct: 199 EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL 154
             ++L+ N L+      F+ L  L   ++ +N  
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 35/103 (33%), Positives = 47/103 (45%), Gaps = 2/103 (1%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           +L L   NL   IP  L  L +L E+ LS N +S + P     L  L+ L    + I   
Sbjct: 189 YLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI 246

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN 104
              +F NL SLV + L  NNL     D    LH+L  ++L  N
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 21/83 (25%), Positives = 37/83 (44%), Gaps = 2/83 (2%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L  N+LS   P S   L  LQ++ +  ++I  +  +    L  L  ++ ++N +   
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-L 269

Query: 62  LPAS-FSNLSSLVSLTLESNNLD 83
           LP   F+ L  L  + L  N  +
Sbjct: 270 LPHDLFTPLHHLERIHLHHNPWN 292

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (258), Expect = 2e-23
 Identities = 53/286 (18%), Positives = 101/286 (35%), Gaps = 43/286 (15%)

Query: 301 GTVYKA--TLEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRAY--YLGP 355
           G +Y A     +G  V +K L        +    +E   L ++ HP+++ +  +  +   
Sbjct: 94  GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153

Query: 356 KGEKL--LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
            G+ +  +V +Y+   SL      + P         +  +  +   L +LHS   +++ +
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSKGQKLP-----VAEAIAYLLEILPALSYLHSI-GLVYND 207

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVY 473
           L   N++L +    K+ D G    + +   +    T G   ++APE+ +       TD+Y
Sbjct: 208 LKPENIMLTEEQ-LKLIDLGAVSRINSFGYL--YGTPG---FQAPEIVR-TGPTVATDIY 260

Query: 474 SLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
           ++G T+  L              LP+    +                        LL   
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGLPEDDPVL----------------KTYDSYGRLL--- 301

Query: 534 KLALHCVDPSPSARPE-VLQVVQQLEEIRPEAATAATSSGDAGPST 578
                 +DP P  R     ++  QL  +  E     T     G ST
Sbjct: 302 ---RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLST 344

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =   99 bits (250), Expect = 3e-23
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)

Query: 293 EIMGKSTYGTVYKA--TLEDGSQVAVKRLR-EKITKGQREFES----EVSLLGKIR---H 342
             +G+  YG V+KA      G  VA+KR+R +   +G          EV++L  +    H
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEH 73

Query: 343 PNLLALRAYYLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTR 398
           PN++ L       + ++     LVF+++    L T+L    PE  +   T   ++  + R
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV-PEPGVPTETIKDMMFQLLR 131

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL------MTAAANVNVIATAGA 452
           GL  LHS+  ++H +L   N+L+  S   K++DFGL+R+      +T     +V+ T   
Sbjct: 132 GLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-----SVVVT--- 182

Query: 453 LGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
           L YRAPE+       T  D++S+G    E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (251), Expect = 3e-23
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 11/200 (5%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           EI+G   +G V+K      G ++A K ++ +  K + E ++E+S++ ++ H NL+ L   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPE-TPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +     + +LV +Y+  G L   +       T +D    +  +K +  G+ H+H    I+
Sbjct: 155 FESKN-DIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQM-YIL 209

Query: 411 HGNLTSSNVLLDDSTNA--KISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           H +L   N+L  +      KI DFGL+R       + V    G   + APE+      + 
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSF 267

Query: 469 KTDVYSLGVTILELLTGKSP 488
            TD++S+GV    LL+G SP
Sbjct: 268 PTDMWSVGVIAYMLLSGLSP 287

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (256), Expect = 3e-23
 Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 15/202 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G   +G V++ T    G+  A K +       +     E+  +  +RHP L+ L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 352 YLGPKGEKLLVFDYMPHGSLATF---LHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           +     E ++++++M  G L  F          +  +    ++ ++ + +GL H+H N N
Sbjct: 223 FEDDN-EMVMIYEFMSGGEL--FEKVADEHNKMSEDE---AVEYMRQVCKGLCHMHEN-N 275

Query: 409 IIHGNLTSSNVLLDDSTNA--KISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
            +H +L   N++     +   K+ DFGL+  +    +V V    G   + APE+++ K  
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPV 333

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
              TD++S+GV    LL+G SP
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSP 355

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  102 bits (256), Expect = 4e-23
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 7/155 (4%)

Query: 3   LALQYNNLSGRIPAS-LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           +  + + +  ++PA+ L    +++ ++L+  +I  +          ++ L   +NAI   
Sbjct: 56  VTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 114

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTL 120
            P  F N+  L  L LE N+L             L+ L++  N +   I   T    ++L
Sbjct: 115 PPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSL 173

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             L LS N+L+  +    S + SL   NVSYN LS
Sbjct: 174 QNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  101 bits (253), Expect = 9e-23
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 12/153 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             + YN LS     +L     ++E+  SHN I+ V          L IL   +N +    
Sbjct: 197 ANVSYNLLS-----TLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQHNNLT-DT 247

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                N   LV + L  N L+  +     K+  L  L +  N++   +      I TL +
Sbjct: 248 AW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           LDLS N L   +  +      L +  + +N++ 
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  100 bits (250), Expect = 2e-22
 Identities = 31/159 (19%), Positives = 65/159 (40%), Gaps = 6/159 (3%)

Query: 1   MFLALQYNNLSGRIPASLGK--LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAI 58
           +F  +  +  +  +        L+  + ++  ++ +  +  + L    ++ +L+ +   I
Sbjct: 28  VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87

Query: 59  NGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNI 117
                 +F+   ++  L +  N +          +  L+VL L+RN +S  +P  I  N 
Sbjct: 88  EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146

Query: 118 STLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLS 155
             LT L +S N L   I    F    SL +  +S N L+
Sbjct: 147 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 184

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 93.1 bits (231), Expect = 4e-20
 Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 25/171 (14%)

Query: 3   LALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L+ N+LS  +P  +     +L  +S+S+N +  +        + L+ L  S N +   
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 185

Query: 62  LPASFSNLSSLVSLTLESNNLDD-QILDSLDKLH---------------NLSVLNLKRNQ 105
           +    S + SL    +  N L    I  ++++L                 L++L L+ N 
Sbjct: 186 VD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNN 243

Query: 106 ISGHIPSTIGNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
           ++    + + N   L  +DLS N+L  +I    F  ++ L    +S N L 
Sbjct: 244 LTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 91.5 bits (227), Expect = 1e-19
 Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 8/151 (5%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L LQ+NNL+      L     L E+ LS+N++  +M     ++ RL  L  S N +  +L
Sbjct: 237 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 293

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                 + +L  L L  N+L   +  +  +   L  L L  N I   +   +    TL  
Sbjct: 294 NLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKN 349

Query: 123 LDLSQNKLSG-EIPASFSNLKSLSSFNVSYN 152
           L LS N      + A F N+   +  +   +
Sbjct: 350 LTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 89.2 bits (221), Expect = 7e-19
 Identities = 29/143 (20%), Positives = 56/143 (39%), Gaps = 2/143 (1%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLV 73
           I ++L       ++ +           +   L+  +I+ F  + +     A   +   + 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 74  SLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGE 133
            L L    +++    +    H +  L +  N I    P    N+  LT+L L +N LS  
Sbjct: 79  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 137

Query: 134 IPAS-FSNLKSLSSFNVSYNNLS 155
           +P   F N   L++ ++S NNL 
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLE 160

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 15/109 (13%), Positives = 41/109 (37%), Gaps = 9/109 (8%)

Query: 54  SYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLD-----KLHNLSVLNLKRNQISG 108
            YN           + +          ++D Q  D         L+N  ++  K + +  
Sbjct: 6   RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR- 64

Query: 109 HIPSTI-GNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
            +P+ +  +   + +L+L+  ++  EI   +F+   ++    + +N + 
Sbjct: 65  KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =   99 bits (249), Expect = 4e-23
 Identities = 51/246 (20%), Positives = 88/246 (35%), Gaps = 52/246 (21%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVK-----RLREKITKGQREFESEVSLLGKIRHPNLL 346
             +G+ +YG V  A   +  +  A+K     ++R+   K     ++EV L+ K+ HPN+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM---------------- 390
            L   Y   +    LV +    G L   L+    ++       +                
Sbjct: 92  RLYEVYEDEQ-YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 391 ---------------------KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA-- 427
                                 I++ +   L +LH+   I H ++   N L   + +   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEI 209

Query: 428 KISDFGLSRLMTAAANVNVIATAGALG---YRAPEL--SKLKKANTKTDVYSLGVTILEL 482
           K+ DFGLS+      N          G   + APE+  +  +    K D +S GV +  L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269

Query: 483 LTGKSP 488
           L G  P
Sbjct: 270 LMGAVP 275

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 95.8 bits (239), Expect = 6e-23
 Identities = 21/139 (15%), Positives = 53/139 (38%), Gaps = 5/139 (3%)

Query: 18  LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTL 77
           +     ++++++++   +    + +  LS L  L      +      + S L+SL  L +
Sbjct: 62  IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 78  ESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS 137
             +  DD IL  ++ L  ++ ++L  N     I   +  +  L  L++  + +       
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG-- 176

Query: 138 FSNLKSLSSFNVSYNNLSG 156
             +   L+        + G
Sbjct: 177 IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 95.4 bits (238), Expect = 7e-23
 Identities = 25/139 (17%), Positives = 61/139 (43%), Gaps = 5/139 (3%)

Query: 17  SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLT 76
           +  +++ L  I+L++  ++ +  + +     ++ L  +        P   S LS+L  L 
Sbjct: 39  TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94

Query: 77  LESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPA 136
           +   ++    + +L  L +L++L++  +     I + I  +  +  +DLS N    +I  
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154

Query: 137 SFSNLKSLSSFNVSYNNLS 155
               L  L S N+ ++ + 
Sbjct: 155 -LKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 27/131 (20%), Positives = 54/131 (41%), Gaps = 5/131 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L +   + +   P  +  LS L+ + +    ++     +L  L+ L +LD S++A + S+
Sbjct: 71  LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               + L  + S+ L  N     I   L  L  L  LN++ + +  +    I +   L  
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQ 185

Query: 123 LDLSQNKLSGE 133
           L      + G+
Sbjct: 186 LYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 84.6 bits (210), Expect = 4e-19
 Identities = 20/134 (14%), Positives = 52/134 (38%), Gaps = 7/134 (5%)

Query: 21  LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN 80
                   L  +  + +  + +   + L  +  +   +   L        ++  LT+ + 
Sbjct: 22  FKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNI 76

Query: 81  NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSN 140
           +  +   + +  L NL  L +    ++      +  +++LT+LD+S +     I    + 
Sbjct: 77  HATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 141 LKSLSSFNVSYNNL 154
           L  ++S ++SYN  
Sbjct: 135 LPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.3 bits (178), Expect = 7e-15
 Identities = 20/116 (17%), Positives = 49/116 (42%), Gaps = 4/116 (3%)

Query: 48  LRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS 107
            +         + +   + + ++SL  +TL + N+ D  L  ++  HN+  L +     +
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHAT 79

Query: 108 GHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA 163
               + I  +S L  L +    ++ +   + S L SL+  ++S++     + T + 
Sbjct: 80  N--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 98.6 bits (246), Expect = 9e-23
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 38/219 (17%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKI-RHPNLLALR 349
           E++G  TYG VYK   ++ G   A+K +   +T  + E  + E+++L K   H N+    
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 350 AYYL----GPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
             ++        ++L LV ++   GS+   +        +       I + + RGL HLH
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH 146

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR-------- 456
            +  +IH ++   NVLL ++   K+ DFG+S  +              +G R        
Sbjct: 147 QH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-----------TVGRRNTFIGTPY 194

Query: 457 --APELSKLKKA-----NTKTDVYSLGVTILELLTGKSP 488
             APE+    +      + K+D++SLG+T +E+  G  P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.5 bits (246), Expect = 9e-23
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 18/207 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVK-----RLREKITKGQRE-FESEVSLLGKIRHPNL 345
           E +G   +  V K      G + A K     + R       RE  E EVS+L ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L   Y     + +L+ + +  G L  FL  +   +  +       IK +  G+ +LH+
Sbjct: 78  ITLHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEE---ATSFIKQILDGVNYLHT 133

Query: 406 NENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
              I H +L   N++L        + K+ DFGL+  +        I   G   + APE+ 
Sbjct: 134 K-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPEFVAPEIV 190

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +    + D++S+GV    LL+G SP
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 18/207 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVK-----RLREKITKGQRE-FESEVSLLGKIRHPNL 345
           E +G   +  V K      G + A K     + R       RE  E EVS+L ++ HPN+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L   Y     + +L+ + +  G L  FL  +   +  +       IK +  G+ +LH+
Sbjct: 78  ITLHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEE---ATSFIKQILDGVNYLHT 133

Query: 406 NENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
              I H +L   N++L        + K+ DFGL+  +        I   G   + APE+ 
Sbjct: 134 K-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPEFVAPEIV 190

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +    + D++S+GV    LL+G SP
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 25/212 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-------FESEVSLLGKIRHP 343
           + +G    G V  A   +   +VA++ + + K   G           E+E+ +L K+ HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
            ++ ++ ++        +V + M  G L   +             +      M   + +L
Sbjct: 201 CIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEAT--CK-LYFYQMLLAVQYL 255

Query: 404 HSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPE 459
           H N  IIH +L   NVLL   ++    KI+DFG S+++      +++ T  G   Y APE
Sbjct: 256 HEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPE 311

Query: 460 -LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
            L  +  A  N   D +SLGV +   L+G  P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 39/225 (17%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREFES--------------------- 332
           GK +YG V  A    D +  A+K L ++K+ +                            
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 333 ----EVSLLGKIRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFL-HARGPETPIDW 386
               E+++L K+ HPN++ L      P  + L +VF+ +  G +          E     
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE----- 136

Query: 387 PTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV 446
                  + + +G+ +LH    IIH ++  SN+L+ +  + KI+DFG+S      ++  +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALL 194

Query: 447 IATAGALGYRAPE-LSKLKK--ANTKTDVYSLGVTILELLTGKSP 488
             T G   + APE LS+ +K  +    DV+++GVT+   + G+ P
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 45/176 (25%), Positives = 70/176 (39%), Gaps = 28/176 (15%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L +  N+L   IP +L   S L E+ +  N+I  V       L  +  ++   N +  S 
Sbjct: 107 LYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG 163

Query: 63  --PASFSNLSSLVSLTLESNNL---DDQILDSLDKLH------------------NLSVL 99
             P +F  L  L  L +    L      + ++L++LH                   L  L
Sbjct: 164 FEPGAFDGLK-LNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRL 222

Query: 100 NLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            L  NQI      ++  + TL  L L  NKLS  +PA   +LK L    +  NN++
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 14/161 (8%)

Query: 1   MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            +L +    L+  IP  L     L E+ L HNKI  +   DL R S+L  L   +N I  
Sbjct: 175 NYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI------ 114
               S S L +L  L L++N L  ++   L  L  L V+ L  N I+  +          
Sbjct: 232 IENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGF 289

Query: 115 -GNISTLTILDLSQNKLS-GEI-PASFSNLKSLSSFNVSYN 152
               +    + L  N +   E+ PA+F  +    +      
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 10/163 (6%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            +      L   +P  +    +   + L +N IS +   D   L  L  L    N I+  
Sbjct: 37  VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKI 93

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
              +FS L  L  L +  N+L  +I  +L    +L  L +  N+I          +  + 
Sbjct: 94  HEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMN 150

Query: 122 ILDLSQNKLSGEI--PASFSNLKSLSSFNVSYNNLSGPVPTSL 162
            +++  N L      P +F  LK L+   +S   L+G +P  L
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTG-IPKDL 191

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 21/113 (18%), Positives = 44/113 (38%), Gaps = 11/113 (9%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L +N +      SL  L  L+E+ L +NK+S V P+ L  L  L+++    N I   
Sbjct: 221 RLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRV-PAGLPDLKLLQVVYLHTNNIT-K 278

Query: 62  LPAS-------FSNLSSLVSLTLESNNLDDQIL--DSLDKLHNLSVLNLKRNQ 105
           +  +           +    ++L +N +    +   +   + +   +     +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 18/205 (8%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITK---GQREFESEVSLLGKIRHPNLLALRA 350
           G+ +YG V +    E   + AVK L ++K+ +   G+   + E+ LL ++RH N++ L  
Sbjct: 14  GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATF---LHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
                + +K+ +V +Y   G           R P               +  GL +LHS 
Sbjct: 74  VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV-----CQAHGYFCQLIDGLEYLHSQ 128

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPELSKLKK 465
             I+H ++   N+LL      KIS  G++  +   A  +   T+ G+  ++ PE++    
Sbjct: 129 -GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187

Query: 466 --ANTKTDVYSLGVTILELLTGKSP 488
             +  K D++S GVT+  + TG  P
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYP 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVK-----RLREKITKGQRE-FESEVSLLGKIRHPNL 345
           E +G   +  V K      G + A K     RL        RE  E EV++L +IRHPN+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L   +     + +L+ + +  G L  FL  +   T  +     + +K +  G+ +LHS
Sbjct: 71  ITLHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDE---ATQFLKQILDGVHYLHS 126

Query: 406 NENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
              I H +L   N++L      +   K+ DFG++  + A      I   G   + APE+ 
Sbjct: 127 K-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI--FGTPEFVAPEIV 183

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +    + D++S+GV    LL+G SP
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP 210

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 96.5 bits (241), Expect = 6e-22
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 52/225 (23%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALR 349
            ++G+  YG V  AT    G  VA+K++   +K     R    E+ +L   +H N++ + 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIF 75

Query: 350 AYYLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG---------- 395
                   E      ++ + M      T LH              ++I            
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQ-----TDLH--------------RVISTQMLSDDHIQY 116

Query: 396 ----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG 451
                 R +  LH + N+IH +L  SN+L++ + + K+ DFGL+R++  +A  N   T  
Sbjct: 117 FIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175

Query: 452 ALG---------YRAPE-LSKLKKANTKTDVYSLGVTILELLTGK 486
             G         YRAPE +    K +   DV+S G  + EL   +
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 18/207 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVK-----RLREKITKGQRE-FESEVSLLGKIRHPNL 345
           E +G   +  V K      G Q A K     R +       RE  E EVS+L +I+HPN+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L   Y     + +L+ + +  G L  FL  +   T  +     + +K +  G+ +LHS
Sbjct: 77  ITLHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEE---ATEFLKQILNGVYYLHS 132

Query: 406 NENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
              I H +L   N++L          KI DFGL+  +        I   G   + APE+ 
Sbjct: 133 L-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--FGTPEFVAPEIV 189

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +    + D++S+GV    LL+G SP
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 48/202 (23%), Positives = 93/202 (46%), Gaps = 16/202 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G+  +G V++            K ++ K    Q   + E+S+L   RH N+L L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHES 69

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGP---ETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           +   + E +++F+++    +   ++       E  I     +  +  +   L  LHS+ N
Sbjct: 70  FESME-ELVMIFEFISGLDIFERINTSAFELNEREI-----VSYVHQVCEALQFLHSH-N 122

Query: 409 IIHGNLTSSNVLLDDSTNA--KISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           I H ++   N++     ++  KI +FG +R +    N  ++    A  Y APE+ +    
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVV 180

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +T TD++SLG  +  LL+G +P
Sbjct: 181 STATDMWSLGTLVYVLLSGINP 202

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 31/166 (18%), Positives = 60/166 (36%), Gaps = 11/166 (6%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN-- 59
            +      L+  +P  +   S    + L  NK+  +      +L++L  L  S N ++  
Sbjct: 11  EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67

Query: 60  GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIP--STIGNI 117
           G    S    +SL  L L  N +   +  +   L  L  L+ + + +   +   S   ++
Sbjct: 68  GCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL 125

Query: 118 STLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLSGPVPTSL 162
             L  LD+S            F+ L SL    ++ N+        +
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 35/156 (22%), Positives = 62/156 (39%), Gaps = 3/156 (1%)

Query: 3   LALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L  Q++NL      S+   L  L  + +SH             LS L +L  + N+   +
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165

Query: 62  LPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
                F+ L +L  L L    L+     + + L +L VLN+  N            +++L
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225

Query: 121 TILDLSQNKLSGEIPASFSNL-KSLSSFNVSYNNLS 155
            +LD S N +         +   SL+  N++ N+ +
Sbjct: 226 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 24/108 (22%), Positives = 44/108 (40%), Gaps = 2/108 (1%)

Query: 2   FLALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            L +  N+           +L  L  + LS  ++  + P+    LS L++L+ S+N    
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKL-HNLSVLNLKRNQIS 107
                +  L+SL  L    N++       L     +L+ LNL +N  +
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 96.7 bits (241), Expect = 2e-21
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 16/203 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           + +G   YG V          + A+K + +  ++         EV++L  + HPN++ L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
            ++   +    LV +    G L   +  R     +D      IIK +  G+ +LH + NI
Sbjct: 103 DFFEDKR-NYYLVMECYKGGELFDEIIHRMKFNEVD---AAVIIKQVLSGVTYLHKH-NI 157

Query: 410 IHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           +H +L   N+LL   +     KI DFGLS +        +    G   Y APE+  L+K 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEV--LRKK 213

Query: 467 -NTKTDVYSLGVTILELLTGKSP 488
            + K DV+S+GV +  LL G  P
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPP 236

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 50/248 (20%), Positives = 97/248 (39%), Gaps = 65/248 (26%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           + +G  ++G V +   +E G + A+K++ +      RE    + ++  + H N++ L  Y
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDY 68

Query: 352 YLGPKGEKL-------------------------------------LVFDYMP---HGSL 371
           +     E+                                      ++ +Y+P   H  L
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 372 ATFLHARGPETPIDWPTRMKIIKG----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA 427
            +F+ +              +I      + R +  +HS   I H ++   N+L++   N 
Sbjct: 129 KSFIRSGRSIPMN-------LISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNT 180

Query: 428 -KISDFGLSR-LMTAAANVNVIATAGALGYRAPELS-KLKKANTKTDVYSLGVTILELLT 484
            K+ DFG ++ L+ +  +V  I +     YRAPEL     +     D++S+G    EL+ 
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICS---RFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 485 GKS--PGE 490
           GK    GE
Sbjct: 238 GKPLFSGE 245

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 93.5 bits (233), Expect = 7e-21
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 30/214 (14%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQ--REFES---------EVSLLGKIR 341
             +   +YG V      +G  VA+KR+   ++ G+                E+ LL    
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 342 HPNLLALRAYYLGPKGEKL----LVFDYMPHGSLATFLHA--RGPETPIDWPTRMK-IIK 394
           HPN+L LR  ++  +   +    LV + M      T L          I  P  ++  + 
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIVIS-PQHIQYFMY 141

Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-NVIATAGAL 453
            +  GL  LH    ++H +L   N+LL D+ +  I DF L+R  TA AN  + +      
Sbjct: 142 HILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH---R 197

Query: 454 GYRAPE-LSKLKKANTKTDVYSLGVTILELLTGK 486
            YRAPE + + K      D++S G  + E+   K
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.2 bits (230), Expect = 7e-21
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E++G   +  V+       G   A+K +++         E+E+++L KI+H N++ L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           Y        LV   +  G L   +  RG  T  D      +I+ +   + +LH N  I+H
Sbjct: 75  YESTT-HYYLVMQLVSGGELFDRILERGVYTEKD--AS-LVIQQVLSAVKYLHEN-GIVH 129

Query: 412 GNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELSKLKKAN 467
            +L   N+L    ++++   I+DFGLS++        +++T  G  GY APE+   K  +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYS 185

Query: 468 TKTDVYSLGVTILELLTGKSP 488
              D +S+GV    LL G  P
Sbjct: 186 KAVDCWSIGVITYILLCGYPP 206

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 91.8 bits (229), Expect = 8e-21
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 13/202 (6%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +      G + A K +  +K++    +  E E  +  K++HPN++ L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                      LVFD +  G L   + AR   +  D       I+ +   + + HSN  I
Sbjct: 72  DSIQEES-FHYLVFDLVTGGELFEDIVAREFYSEAD--AS-HCIQQILESIAYCHSN-GI 126

Query: 410 IHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           +H NL   N+LL         K++DFGL+  +  +   +  A  G  GY +PE+ K    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKKDPY 184

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D+++ GV +  LL G  P
Sbjct: 185 SKPVDIWACGVILYILLVGYPP 206

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 91.5 bits (228), Expect = 8e-21
 Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 31/208 (14%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           G+  YG V  A        VAVK +  ++        + E+ +   + H N++    +  
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 354 GPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMK----------IIKGMTRGLLH 402
                   L  +Y   G L   +              M           ++ G+     +
Sbjct: 76  EGN--IQYLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVV----Y 120

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPE-L 460
           LH    I H ++   N+LLD+  N KISDFGL+ +        ++    G L Y APE L
Sbjct: 121 LHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
            + +      DV+S G+ +  +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 17/204 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL--REKITKGQRE-FESEVSLLGKIRHPNLLAL 348
            ++GK ++G V        G + AVK +  R+   K  +E    EV LL ++ HPN++ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             ++        LV +    G L   + +R   + +D     +II+ +  G+ ++H N  
Sbjct: 92  YEFFEDKG-YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKN-K 146

Query: 409 IIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK 465
           I+H +L   N+LL       N +I DFGLS      A+  +    G   Y APE+  L  
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEV--LHG 202

Query: 466 A-NTKTDVYSLGVTILELLTGKSP 488
             + K DV+S GV +  LL+G  P
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPP 226

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 10/158 (6%)

Query: 3   LALQYNNLSGRIPA--SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
           L L +NNLS R+ A  +  +L+ L  + LSHN ++ +       +  LR LD S N ++ 
Sbjct: 44  LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH- 101

Query: 61  SLPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIP----STIG 115
           +L    FS+L +L  L L +N++     ++ + +  L  L L +NQIS   P        
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGN 160

Query: 116 NISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNN 153
            +  L +LDLS NKL          L +     +  +N
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 46/159 (28%), Positives = 68/159 (42%), Gaps = 17/159 (10%)

Query: 6   QYNNLSGRIPASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAINGSLPA 64
               L   +P SL   S    + LSHN +S +       RL+ L  L  S+N +N  + +
Sbjct: 26  SKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81

Query: 65  -SFSNLSSLVSLTLESNNLDDQILDS--LDKLHNLSVLNLKRNQISGHIPSTI-GNISTL 120
            +F  + +L  L L SN+L    LD      L  L VL L  N I   +      +++ L
Sbjct: 82  EAFVPVPNLRYLDLSSNHL--HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQL 138

Query: 121 TILDLSQNKLSGEIPA----SFSNLKSLSSFNVSYNNLS 155
             L LSQN++S   P       + L  L   ++S N L 
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 26/130 (20%), Positives = 54/130 (41%), Gaps = 7/130 (5%)

Query: 2   FLALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            L L +N+L+  I + +   +  L+ + LS N +  +       L  L +L    N I  
Sbjct: 68  SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV- 125

Query: 61  SLPA-SFSNLSSLVSLTLESNNL---DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGN 116
            +   +F +++ L  L L  N +     +++   +KL  L +L+L  N++     + +  
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185

Query: 117 ISTLTILDLS 126
           +       L 
Sbjct: 186 LPAWVKNGLY 195

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 35/209 (16%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-FESEVSLLGKIRHPNLLALRAYY 352
           GK  +  V  A  +  G +VA+K + + ++     +    EV ++  + HPN++ L    
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83

Query: 353 LGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMK----------IIKGMTRGLL 401
              K   L L+ +Y   G +  +L A G         RMK          I+  +     
Sbjct: 84  ETEK--TLYLIMEYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQ---- 128

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPEL 460
           + H    I+H +L + N+LLD   N KI+DFG S   T       +    GA  Y APEL
Sbjct: 129 YCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPEL 184

Query: 461 SKLKK-ANTKTDVYSLGVTILELLTGKSP 488
            + KK    + DV+SLGV +  L++G  P
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.7 bits (233), Expect = 1e-20
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 8/160 (5%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDL-GRLSRLRILDFSYNAINGS 61
           + L  N+++     S  +L +LQ + +       V+ ++    LS L IL   YN     
Sbjct: 35  VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQ 93

Query: 62  LPAS-FSNLSSLVSLTLESNNLDDQIL--DSLDKLHNLSVLNLKRNQISGHIPSTI-GNI 117
           L    F+ L++L  LTL   NLD  +L  +    L +L +L L+ N I    P++   N+
Sbjct: 94  LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153

Query: 118 STLTILDLSQNKLSGEIPASFSNL--KSLSSFNVSYNNLS 155
               +LDL+ NK+         N   K  +   +S   L 
Sbjct: 154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ 193

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 34/146 (23%), Positives = 62/146 (42%), Gaps = 10/146 (6%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA-SFSNLSSL 72
           +PA +        + LS N I+ +  +   RL  L+ L          +   +F  LSSL
Sbjct: 28  LPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 73  VSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQI-SGHIPSTI-GNISTLTILDLSQNKL 130
           + L L+ N        + + L NL VL L +  +    +       +++L +L L  N +
Sbjct: 82  IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 131 SGEIPAS-FSNLKSLSSFNVSYNNLS 155
               PAS F N++     ++++N + 
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVK 167

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 39/159 (24%), Positives = 61/159 (38%), Gaps = 8/159 (5%)

Query: 1   MFLALQYNNLSGRIPASLGKL--SELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAI 58
           M  +  + N       +   L  S ++   LS +KI  ++ S     + L  L  + N I
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI 311

Query: 59  NGSLPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGN 116
           N  +   +F  L+ L+ L L  N L        + L  L VL+L  N I   +   +   
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLG 369

Query: 117 ISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNL 154
           +  L  L L  N+L   +P   F  L SL    +  N  
Sbjct: 370 LPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 32/206 (15%), Positives = 61/206 (29%), Gaps = 54/206 (26%)

Query: 3   LALQYNNL-SGRIPA-SLGKLSELQEISLSHNKISGVMPSDL-GRLSRLRILDFSYNAIN 59
           L L   NL    +       L+ L+ + L  N I  + P+     + R  +LD ++N + 
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167

Query: 60  GSLPASFSNLSS--LVSLTLESNNL--------DDQILDSLDKLHNLSVLNLKRNQISGH 109
                   N        L L S  L          +   +  K  +++ L+L  N     
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227

Query: 110 IPSTIGN---------------------------------------ISTLTILDLSQNKL 130
           +     +                                        S +   DLS++K+
Sbjct: 228 MAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI 287

Query: 131 SGEIPA-SFSNLKSLSSFNVSYNNLS 155
              +    FS+   L    ++ N ++
Sbjct: 288 F-ALLKSVFSHFTDLEQLTLAQNEIN 312

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 39/195 (20%), Positives = 64/195 (32%), Gaps = 45/195 (23%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRL----------------- 45
             +    L      +  K + +  + LS N     M                        
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252

Query: 46  ----------------------SRLRILDFSYNAINGSLPA-SFSNLSSLVSLTLESNNL 82
                                 S ++  D S + I  +L    FS+ + L  LTL  N +
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311

Query: 83  DDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTLTILDLSQNKLSGEIPA-SFSN 140
           +    ++   L +L  LNL +N +   I S +  N+  L +LDLS N +   +   SF  
Sbjct: 312 NKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLG 369

Query: 141 LKSLSSFNVSYNNLS 155
           L +L    +  N L 
Sbjct: 370 LPNLKELALDTNQLK 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 23/82 (28%), Positives = 34/82 (41%), Gaps = 2/82 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N L          L +L+ + LS+N I  +       L  L+ L    N +  S+
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SV 386

Query: 63  PAS-FSNLSSLVSLTLESNNLD 83
           P   F  L+SL  + L +N  D
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 21/91 (23%), Positives = 42/91 (46%), Gaps = 3/91 (3%)

Query: 70  SSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLTILDLSQN 128
           + +  + L  N++ +    S  +L +L  L +++      I + T   +S+L IL L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 129 KLSGEIPAS-FSNLKSLSSFNVSYNNLSGPV 158
           +   ++    F+ L +L    ++  NL G V
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 44/219 (20%), Positives = 88/219 (40%), Gaps = 42/219 (19%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREFES-------EVSLLGKIRHP 343
             +G   +G V+ A   E   +V VK + +EK+ +     +        E+++L ++ H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 344 NLLAL-------RAYYL-----GPKGEKLLVFDY-MPHGSLATFLHARGPETPIDWPTRM 390
           N++ +         + L     G   +   +F +   H  L   L A             
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLD---LFAFIDRHPRLDEPL-AS------------ 133

Query: 391 KIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA 450
            I + +   + +L    +IIH ++   N+++ +    K+ DFG +  +            
Sbjct: 134 YIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FC 190

Query: 451 GALGYRAPE-LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           G + Y APE L        + +++SLGVT+  L+  ++P
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 93.5 bits (233), Expect = 2e-20
 Identities = 37/166 (22%), Positives = 57/166 (34%), Gaps = 28/166 (16%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           +    N L       L  L  L  I   +N +  +          L  L+   N +   L
Sbjct: 220 IVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDL----PPSLEALNVRDNYLT-DL 272

Query: 63  PASFSNLSSLVSLTLESNNLDD-------------QILDSLDKLHNLSVLNLKRNQISGH 109
           P    +L+ L       + L +             +I    D   +L  LN+  N++   
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-E 331

Query: 110 IPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           +P+       L  L  S N L+ E+P    NLK L   +V YN L 
Sbjct: 332 LPALPPR---LERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 91.6 bits (228), Expect = 7e-20
 Identities = 32/153 (20%), Positives = 57/153 (37%), Gaps = 20/153 (13%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L    LS  +P     L  L     S N ++ + P     L  L + + +  A++   
Sbjct: 76  LELNNLGLS-SLPELPPHLESL---VASCNSLTEL-PELPQSLKSLLVDNNNLKALS--- 127

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                    L  L + +N L+   L  L     L ++++  N +   +P    +   L  
Sbjct: 128 ----DLPPLLEYLGVSNNQLEK--LPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEF 177

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           +    N+L  E+P    NL  L++     N+L 
Sbjct: 178 IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK 208

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 85.8 bits (213), Expect = 5e-18
 Identities = 32/181 (17%), Positives = 59/181 (32%), Gaps = 38/181 (20%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLS-------------RLR 49
                +NL+  +P     +    E   + ++     P   G                +  
Sbjct: 16  PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAH 74

Query: 50  ILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGH 109
            L+ +   ++ SLP    +L    SL    N+L + + +    L +L V N     +S  
Sbjct: 75  ELELNNLGLS-SLPELPPHLE---SLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDL 129

Query: 110 IPS---------------TIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL 154
            P                 + N S L I+D+  N L  ++P    +L+ +       N L
Sbjct: 130 PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQL 185

Query: 155 S 155
            
Sbjct: 186 E 186

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 35/153 (22%), Positives = 57/153 (37%), Gaps = 20/153 (13%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           +A   N L   +P  L  L  L  I   +N +  +          L  +    N +    
Sbjct: 178 IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNIL--EE 229

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                NL  L ++  ++N L   + D    L  L+V +   N ++  +P    +   LT 
Sbjct: 230 LPELQNLPFLTTIYADNNLL-KTLPDLPPSLEALNVRD---NYLT-DLPELPQS---LTF 281

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           LD+S+N  S  +     NL  L   N S N + 
Sbjct: 282 LDVSENIFS-GLSELPPNLYYL---NASSNEIR 310

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 24/153 (15%), Positives = 52/153 (33%), Gaps = 21/153 (13%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L +  N L   +PA   +L  L     S N ++ V P     L   + L   YN +    
Sbjct: 322 LNVSNNKLI-ELPALPPRLERL---IASFNHLAEV-PELPQNL---KQLHVEYNPLR-EF 372

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P    ++  L         ++  + +  +   NL  L+++ N +    P    +   +  
Sbjct: 373 PDIPESVEDL--------RMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES---VED 420

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L ++  ++      +      L      +++  
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 7/76 (9%), Positives = 19/76 (25%), Gaps = 14/76 (18%)

Query: 93  LHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNL----------- 141
              L       + ++  +P    N+ + T    + ++     P                 
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 142 --KSLSSFNVSYNNLS 155
             +      ++   LS
Sbjct: 69  LDRQAHELELNNLGLS 84

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 26/214 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVK---------RLREKITKGQREFESEVSLLGKI-R 341
           EI+G+     V +        + AVK            E++ + +     EV +L K+  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
           HPN++ L+  Y        LVFD M  G L  +L  +   +  +  TR KI++ +   + 
Sbjct: 83  HPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEKE--TR-KIMRALLEVIC 138

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPEL 460
            LH   NI+H +L   N+LLDD  N K++DFG S  +        +    G   Y APE+
Sbjct: 139 ALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEI 194

Query: 461 SKLKKANTKT------DVYSLGVTILELLTGKSP 488
            +    +         D++S GV +  LL G  P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 11/157 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N L     A+L   + L +++L   +++ +       L  L  LD S+N +  SL
Sbjct: 36  LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLGTLDLSHNQLQ-SL 92

Query: 63  PASFSNLSSLVSLTLESNNLDDQIL--DSLDKLHNLSVLNLKRNQISGHIPSTI-GNIST 119
           P     L +L  L +  N L    L   +L  L  L  L LK N++   +P  +      
Sbjct: 93  PLLGQTLPALTVLDVSFNRL--TSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149

Query: 120 LTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLS 155
           L  L L+ N L+ E+PA   + L++L +  +  N+L 
Sbjct: 150 LEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 42/153 (27%), Positives = 62/153 (40%), Gaps = 8/153 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L    L+ ++    G L  L  + LSHN++  + P     L  L +LD S+N +  S
Sbjct: 59  QLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLT-S 114

Query: 62  LPAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNIST 119
           LP      L  L  L L+ N L       L     L  L+L  N ++  +P+ +   +  
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLEN 173

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN 152
           L  L L +N L   IP  F     L    +  N
Sbjct: 174 LDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 33/136 (24%), Positives = 54/136 (39%), Gaps = 8/136 (5%)

Query: 21  LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN 80
           ++   E++     ++ + P DL       IL  S N +     A+    + L  L L+  
Sbjct: 9   VASHLEVNCDKRNLTAL-PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 81  NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS-FS 139
            L    L     L  L  L+L  NQ+   +P     +  LT+LD+S N+L+  +P     
Sbjct: 66  EL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121

Query: 140 NLKSLSSFNVSYNNLS 155
            L  L    +  N L 
Sbjct: 122 GLGELQELYLKGNELK 137

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 20/97 (20%), Positives = 40/97 (41%), Gaps = 12/97 (12%)

Query: 63  PA-SFSNLSSLVSLTLESNNLD---DQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
           P    S ++S + +  +  NL      +      LH      L  N +     +T+   +
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILH------LSENLLYTFSLATLMPYT 55

Query: 119 TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            LT L+L + +L+ ++      L  L + ++S+N L 
Sbjct: 56  RLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ 90

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 62/249 (24%), Positives = 111/249 (44%), Gaps = 22/249 (8%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALR 349
           ++G+  +G V+   ++   ++ A K+L +K  K ++ ++    E  +L K+    +++L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHSNE 407
             +       L LV   M  G +   ++    + P     R       +  GL HLH   
Sbjct: 252 YAFETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR- 308

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           NII+ +L   NVLLDD  N +ISD GL+  L            AG  G+ APEL   ++ 
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYAGTPGFMAPELLLGEEY 366

Query: 467 NTKTDVYSLGVTILELLTGKSP----GEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
           +   D ++LGVT+ E++  + P    GE +   EL Q    ++++      +  +    +
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLEQA---VTYPDKFSPAS 420

Query: 523 PTIGDELLN 531
               + LL 
Sbjct: 421 KDFCEALLQ 429

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 37/188 (19%), Positives = 65/188 (34%), Gaps = 30/188 (15%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N ++    + L +   LQ + L+ N I+ +       L  L  LD SYN +  +L
Sbjct: 57  LDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL-SNL 115

Query: 63  PAS-FSNLSSLVSLTLESNNL----DDQILDSL----------------------DKLHN 95
            +S F  LSSL  L L  N      +  +   L                        L  
Sbjct: 116 SSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF 175

Query: 96  LSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNL 154
           L  L +  + +  + P ++ +I  ++ L L   +    +         S+    +   +L
Sbjct: 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDL 234

Query: 155 SGPVPTSL 162
                + L
Sbjct: 235 DTFHFSEL 242

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 31/164 (18%), Positives = 55/164 (33%), Gaps = 12/164 (7%)

Query: 1   MFLALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN 59
             L +   +   +I       L+ L+E+ +  + +    P  L  +  +  L        
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211

Query: 60  GSLPASFSNLSSLVSLTLESNNLDDQIL--------DSLDKLHNLSVLNLKRNQISGHIP 111
             L       SS+  L L   +LD            +SL K      + +    +   + 
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270

Query: 112 STIGNISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNL 154
             +  IS L  L+ S+N+L   +P   F  L SL    +  N  
Sbjct: 271 KLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 10/147 (6%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA-SFSNLSSL 72
           IP+ L     ++ + LS+N+I+ +  SDL R   L+ L  + N IN ++   SFS+L SL
Sbjct: 46  IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 73  VSLTLESNNLDDQILDS--LDKLHNLSVLNLKRNQISGHIPSTI-GNISTLTILDLSQNK 129
             L L  N L    L S     L +L+ LNL  N       +++  +++ L IL +    
Sbjct: 103 EHLDLSYNYL--SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160

Query: 130 LSGEIPA-SFSNLKSLSSFNVSYNNLS 155
              +I    F+ L  L    +  ++L 
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQ 187

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 3/80 (3%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
             ++ LS     SL K    + + ++   +  V    L ++S L  L+FS N +  S+P 
Sbjct: 237 FHFSELSTGETNSLIKKFTFRNVKITDESLFQV-MKLLNQISGLLELEFSRNQLK-SVPD 294

Query: 65  S-FSNLSSLVSLTLESNNLD 83
             F  L+SL  + L +N  D
Sbjct: 295 GIFDRLTSLQKIWLHTNPWD 314

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVK-----RLREKITKGQREFESEVSLLGKIRHPNLL 346
           E++GK  +  V +    E G Q AVK     +          + + E S+   ++HP+++
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLH 404
            L   Y    G   +VF++M    L   +  R     + +   +    ++ +   L + H
Sbjct: 90  ELLETYSS-DGMLYMVFEFMDGADLCFEIVKRADAGFV-YSEAVASHYMRQILEALRYCH 147

Query: 405 SNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANV--NVIATAGALGYRAPE 459
            N NIIH ++    VLL   ++S   K+  FG++  +  +  V    + T     + APE
Sbjct: 148 DN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP---HFMAPE 203

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           + K +      DV+  GV +  LL+G  P
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 12/203 (5%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQRE-FESEVSLLGKIRH-PNLLAL 348
           + +G+  +  V +      G + A K L+  +  +  R     E+++L   +  P ++ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              Y     E +L+ +Y   G + +       E   +     ++IK +  G+ +LH N N
Sbjct: 95  HEVYENTS-EIILILEYAAGGEIFSLCLPELAEMVSENDVI-RLIKQILEGVYYLHQN-N 151

Query: 409 IIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK 465
           I+H +L   N+LL       + KI DFG+SR +  A  +  I   G   Y APE+     
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEILNYDP 209

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
             T TD++++G+    LLT  SP
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSP 232

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 93.3 bits (232), Expect = 3e-20
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 13/201 (6%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALR 349
           ++GK  +G V    +    ++ A K+L +K  K ++      +E  +L K+    +++L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHSNE 407
             Y     + L LV   M  G L    H            R       +  GL  LH   
Sbjct: 251 YAYETK--DALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE- 305

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
            I++ +L   N+LLDD  + +ISD GL+  +     +      G +GY APE+ K ++  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRVGTVGYMAPEVVKNERYT 363

Query: 468 TKTDVYSLGVTILELLTGKSP 488
              D ++LG  + E++ G+SP
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP 384

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 27/212 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           + +G    G V  A        VA+K+L    +  T  +R +  E+ L+  + H N++ L
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89

Query: 349 RAYYLGPKGEKL-----LVFDYMPHGSLATFLHA--RGPETPIDWPTRMK-IIKGMTRGL 400
              +   K  +      +V + M        L    +          RM  ++  M  G+
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQMELDHE----RMSYLLYQMLCGI 140

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL 460
            HLHS   IIH +L  SN+++      KI DFGL+R  TA  +  +        YRAPE+
Sbjct: 141 KHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 197

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKS--PGE 490
                     D++S+G  + E++ G    PG 
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 25/212 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-------FESEVSLLGKIRHP 343
           + +G    G V  A   +   +VA+K + + K   G           E+E+ +L K+ HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 344 NLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHL 403
            ++ ++ ++        +V + M  G L   +             +      M   + +L
Sbjct: 76  CIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEAT--CK-LYFYQMLLAVQYL 130

Query: 404 HSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPE 459
           H N  IIH +L   NVLL   ++    KI+DFG S+++      +++ T  G   Y APE
Sbjct: 131 HEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPE 186

Query: 460 -LSKLKKA--NTKTDVYSLGVTILELLTGKSP 488
            L  +  A  N   D +SLGV +   L+G  P
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 31/208 (14%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           G+  YG V  A        VAVK +  ++        + E+ +   + H N++    +  
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 354 GPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMK----------IIKGMTRGLLH 402
                   L  +Y   G L   +              M           ++ G+     +
Sbjct: 76  EGN--IQYLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVV----Y 120

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPE-L 460
           LH    I H ++   N+LLD+  N KISDFGL+ +        ++    G L Y APE L
Sbjct: 121 LHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
            + +      DV+S G+ +  +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 53/222 (23%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLALR 349
             +G+  YG V  A    +  +VA+K++   E  T  QR    E+ +L + RH N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91

Query: 350 AYYLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG---------- 395
                P  E++    +V D M      T L+              K++K           
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME-----TDLY--------------KLLKTQHLSNDHICY 132

Query: 396 ----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAG 451
               + RGL ++HS  N++H +L  SN+LL+ + + KI DFGL+R+     +     T  
Sbjct: 133 FLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-- 189

Query: 452 ALG------YRAPE-LSKLKKANTKTDVYSLGVTILELLTGK 486
                    YRAPE +   K      D++S+G  + E+L+ +
Sbjct: 190 --EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 41/200 (20%), Positives = 80/200 (40%), Gaps = 12/200 (6%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G+ ++G V  A       + A K++ +   +    F+ E+ ++  + HPN++ L   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +     +  LV +    G L   +  +      D     +I+K +   + + H   N+ H
Sbjct: 75  FEDNT-DIYLVMELCTGGELFERVVHKRVFRESD---AARIMKDVLSAVAYCHKL-NVAH 129

Query: 412 GNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
            +L   N L       +  K+ DFGL+        +      G   Y +P++ +      
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLE-GLYGP 186

Query: 469 KTDVYSLGVTILELLTGKSP 488
           + D +S GV +  LL G  P
Sbjct: 187 ECDEWSAGVMMYVLLCGYPP 206

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 92.2 bits (229), Expect = 7e-20
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGV--MPSDLGRLSRLRILDFSYNAIN 59
            L    N L+  +  + G L+EL+ + L  N++  +  +     ++  L+ LD S N+++
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387

Query: 60  GSLPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
                   S   SL+SL + SN L D I   L     + VL+L  N+I   IP  +  + 
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLE 444

Query: 119 TLTILDLSQNKLSGEIP-ASFSNLKSLSSFNVSYNNL 154
            L  L+++ N+L   +P   F  L SL    +  N  
Sbjct: 445 ALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.5 bits (222), Expect = 5e-19
 Identities = 33/158 (20%), Positives = 60/158 (37%), Gaps = 8/158 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
                 +           K+S    +  S+N ++  +  + G L+ L  L    N +   
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-E 362

Query: 62  LPAS---FSNLSSLVSLTLESNNL-DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNI 117
           L       + + SL  L +  N++  D+         +L  LN+  N ++  I   +   
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-- 420

Query: 118 STLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             + +LDL  NK+   IP     L++L   NV+ N L 
Sbjct: 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.8 bits (220), Expect = 8e-19
 Identities = 42/156 (26%), Positives = 58/156 (37%), Gaps = 7/156 (4%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
              N L   +P  L    +   +++S N IS +  SD+  LS+LRIL  S+N I     +
Sbjct: 7   RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQI-SGHIPSTIGNISTLTIL 123
            F     L  L L  N L    + S     NL  L+L  N   +  I    GN+S L  L
Sbjct: 64  VFKFNQELEYLDLSHNKL--VKI-SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120

Query: 124 DLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP 159
            LS   L        ++L       V          
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 80.7 bits (199), Expect = 3e-16
 Identities = 30/145 (20%), Positives = 54/145 (37%), Gaps = 5/145 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L +  N +S    + +  LS+L+ + +SHN+I  +  S       L  LD S+N +   +
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KI 84

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSL-DKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
                   +L  L L  N  D   +      +  L  L L    +       I +++   
Sbjct: 85  S--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142

Query: 122 I-LDLSQNKLSGEIPASFSNLKSLS 145
           + L L +     E P    +  + S
Sbjct: 143 VLLVLGETYGEKEDPEGLQDFNTES 167

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 74.1 bits (182), Expect = 4e-14
 Identities = 30/157 (19%), Positives = 59/157 (37%), Gaps = 8/157 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L + +N +     +      EL+ + LSHNK+  +          L+ LD S+NA + +
Sbjct: 49  ILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI-SCH--PTVNLKHLDLSFNAFD-A 104

Query: 62  LP--ASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
           LP    F N+S L  L L + +L+   +  +  L+   VL +               +  
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQD 162

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
                L     + +      ++   +  N+  +N+  
Sbjct: 163 FNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.9 bits (171), Expect = 8e-13
 Identities = 27/167 (16%), Positives = 58/167 (34%), Gaps = 10/167 (5%)

Query: 3   LALQYNNLSGRIPASLGKL---SELQEISLSHNKISGVMPSDLGRLS-----RLRILDFS 54
           L L     +      + +L   + +   S+S+ K+ G +       S      L I    
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284

Query: 55  YNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI 114
            +         +   S++       +      +    K+     L+   N ++  +    
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344

Query: 115 GNISTLTILDLSQNKLS--GEIPASFSNLKSLSSFNVSYNNLSGPVP 159
           G+++ L  L L  N+L    +I    + +KSL   ++S N++S    
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 25/150 (16%), Positives = 52/150 (34%), Gaps = 8/150 (5%)

Query: 14  IPASLGKLSELQEISLSHNKISG---VMPSDLGRLSRLRILDFSYNAING-----SLPAS 65
           I A L    +L  ++L++ + +    +    L   + +     S   + G         S
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271

Query: 66  FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDL 125
            ++L +L    + S+          +   N+++ N   +            IS    LD 
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331

Query: 126 SQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           S N L+  +  +  +L  L +  +  N L 
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 5/83 (6%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L +  N L+  I   L     ++ + L  NKI  + P  + +L  L+ L+ + N +  S
Sbjct: 403 SLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSI-PKQVVKLEALQELNVASNQLK-S 458

Query: 62  LP-ASFSNLSSLVSLTLESNNLD 83
           +P   F  L+SL  + L +N  D
Sbjct: 459 VPDGIFDRLTSLQKIWLHTNPWD 481

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.5 bits (229), Expect = 7e-20
 Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 12/153 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             L+  +++  +     +L+ + +I  +++ I  V    +  L  +  L  + N +    
Sbjct: 26  DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIK 81

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P   +NL +L  L L+ N + D  L SL  L  L  L+L+ N IS  I + + ++  L  
Sbjct: 82  P--LTNLKNLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLES 135

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L L  NK++ +I    S L  L + ++  N +S
Sbjct: 136 LYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.4 bits (208), Expect = 3e-17
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 10/160 (6%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L+L++N +S  I   L  L +L+ + L +NKI+ +  + L RL++L  L    N I+  +
Sbjct: 114 LSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DI 168

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               + L+ L +L L  N++ D  L +L  L NL VL L   +      +   N+     
Sbjct: 169 V-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           +  +   L    P   S+       NV ++        S 
Sbjct: 226 VKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSF 263

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 59.0 bits (142), Expect = 3e-09
 Identities = 17/90 (18%), Positives = 40/90 (44%), Gaps = 6/90 (6%)

Query: 66  FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDL 125
               +  +   L+  ++ D    + ++L+++  +    + I   +   I  +  +T L L
Sbjct: 17  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72

Query: 126 SQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           + NKL+ +I    +NLK+L    +  N + 
Sbjct: 73  NGNKLT-DIK-PLTNLKNLGWLFLDENKIK 100

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 9/84 (10%), Positives = 30/84 (35%), Gaps = 6/84 (7%)

Query: 72  LVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS 131
           +      S  +    +   D        NLK+  ++     T   ++++  +  + + + 
Sbjct: 1   MGETITVSTPIKQ--IFPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 56

Query: 132 GEIPASFSNLKSLSSFNVSYNNLS 155
             +      L +++   ++ N L+
Sbjct: 57  -SVQG-IQYLPNVTKLFLNGNKLT 78

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 35/144 (24%), Positives = 64/144 (44%), Gaps = 9/144 (6%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS-FSNLSSL 72
           +P S       + + LS N +  +          L++LD S   I  ++    + +LS L
Sbjct: 26  LPFST------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 73  VSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKL-S 131
            +L L  N +    L +   L +L  L      ++      IG++ TL  L+++ N + S
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 132 GEIPASFSNLKSLSSFNVSYNNLS 155
            ++P  FSNL +L   ++S N + 
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ 162

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 50/162 (30%), Positives = 68/162 (41%), Gaps = 13/162 (8%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N L      S     ELQ + LS  +I  +       LS L  L  + N I  SL
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SL 91

Query: 63  PA-SFSNLSSLVSLTLESNNLDDQILDS--LDKLHNLSVLNLKRNQI-SGHIPSTIGNIS 118
              +FS LSSL  L     NL    L++  +  L  L  LN+  N I S  +P    N++
Sbjct: 92  ALGAFSGLSSLQKLVAVETNL--ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 119 TLTILDLSQNKLSGEIPA-SFSNLKSLSSFNV----SYNNLS 155
            L  LDLS NK+   I       L  +   N+    S N ++
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 40/156 (25%), Positives = 64/156 (41%), Gaps = 8/156 (5%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N +      +   LS LQ++      ++ +    +G L  L+ L+ ++N I  S 
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SF 139

Query: 63  PAS--FSNLSSLVSLTLESNNL---DDQILDSLDKLHNLSV-LNLKRNQISGHIPSTIGN 116
                FSNL++L  L L SN +       L  L ++  L++ L+L  N ++  I      
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198

Query: 117 ISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN 152
              L  L L  N+L       F  L SL    +  N
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 38/162 (23%), Positives = 60/162 (37%), Gaps = 12/162 (7%)

Query: 2   FLALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            L L    +   I       LS L  + L+ N I  +       LS L+ L      +  
Sbjct: 56  VLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA- 113

Query: 61  SLPA-SFSNLSSLVSLTLESNNLDDQILDSL-DKLHNLSVLNLKRNQISGHIPS-TIGNI 117
           SL      +L +L  L +  N +    L      L NL  L+L  N+I   I    +  +
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172

Query: 118 STLTI----LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             + +    LDLS N ++   P +F  ++ L    +  N L 
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLK 213

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 22/87 (25%), Positives = 36/87 (41%), Gaps = 9/87 (10%)

Query: 3   LALQYNNLSGRIPA----SLGKLSELQ-EISLSHNKISGVMPSDLGRLSRLRILDFSYNA 57
           L L  N +   I       L ++  L   + LS N ++ +      +  RL+ L    N 
Sbjct: 154 LDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLKELALDTNQ 211

Query: 58  INGSLPA-SFSNLSSLVSLTLESNNLD 83
           +  S+P   F  L+SL  + L +N  D
Sbjct: 212 LK-SVPDGIFDRLTSLQKIWLHTNPWD 237

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 92.0 bits (228), Expect = 9e-20
 Identities = 34/180 (18%), Positives = 68/180 (37%), Gaps = 22/180 (12%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           +L    N LS  +P     L  L    + +N+++ ++P     L     ++   N +   
Sbjct: 104 YLDACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPALL---EYINADNNQLT-M 154

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           LP      +SL  L++ +N L    L  L    +L  L++  N +   +P+         
Sbjct: 155 LPEL---PTSLEVLSVRNNQL--TFLPEL--PESLEALDVSTNLLE-SLPAVPVRNHHSE 206

Query: 122 ----ILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQL 177
                    +N+++  IP +  +L    +  +  N LS  +  SL+ +     + G    
Sbjct: 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 77.3 bits (190), Expect = 4e-15
 Identities = 32/157 (20%), Positives = 60/157 (38%), Gaps = 18/157 (11%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L +  N L+  +P     L  +   +  +N+++ + P     L    +L    N +   L
Sbjct: 125 LDVDNNQLT-MLPELPALLEYI---NADNNQLTML-PELPTSL---EVLSVRNNQLT-FL 175

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLS----VLNLKRNQISGHIPSTIGNIS 118
           P       SL +L + +N L+  +     + H+          + N+I+ HIP  I ++ 
Sbjct: 176 PEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLD 230

Query: 119 TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
               + L  N LS  I  S S   +   ++      S
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 70.4 bits (172), Expect = 6e-13
 Identities = 32/145 (22%), Positives = 56/145 (38%), Gaps = 17/145 (11%)

Query: 14  IPASLGKLSELQEISLSHNKISGV---MPSDLGRLSRLRILDFSYNAINGSLPASFSNLS 70
           I   +     L   +  +N ISG      S   +  +  +   + N     L      ++
Sbjct: 3   IMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59

Query: 71  SLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKL 130
               L L   NL   + D+L     ++VL + +N +   +P    +   L  LD   N+L
Sbjct: 60  QFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRL 112

Query: 131 SGEIPASFSNLKSLSSFNVSYNNLS 155
           S  +P   ++LK L   +V  N L+
Sbjct: 113 S-TLPELPASLKHL---DVDNNQLT 133

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 26/143 (18%), Positives = 47/143 (32%), Gaps = 12/143 (8%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLR----ILDFSYNAI 58
           L+++ N L+  +P     L  L    +S N +  + P+   R               N I
Sbjct: 165 LSVRNNQLT-FLPELPESLEAL---DVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRI 219

Query: 59  NGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
              +P +  +L    ++ LE N L  +I +SL +       +  R   S        N  
Sbjct: 220 T-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTL 276

Query: 119 TLTILDLSQNKLSGEIPASFSNL 141
              + D           +  S +
Sbjct: 277 HRPLADAVTAWFPENKQSDVSQI 299

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 30/153 (19%), Positives = 65/153 (42%), Gaps = 12/153 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           +A   +N++  +      L  +  +S     ++ +    +  L+ L  L+   N I   L
Sbjct: 24  IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DL 78

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
                NL+ +  L L  N L +  + ++  L ++  L+L   QI+    + +  +S L +
Sbjct: 79  AP-LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQV 133

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L L  N+++  I    + L +L   ++    +S
Sbjct: 134 LYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS 164

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.1 bits (216), Expect = 5e-19
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 23/183 (12%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L    ++      L  LS LQ + L  N+I+ +  S L  L+ L+ L      ++  L
Sbjct: 112 LDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DL 166

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               +NLS L +L  + N + D  +  L  L NL  ++LK NQIS   P  + N S L I
Sbjct: 167 TP-LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP----------TSLALKFNASSFV 172
           + L+   ++ +     +NL      NV       P+            S  L +N +SF+
Sbjct: 222 VTLTNQTITNQPVFYNNNLVVP---NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278

Query: 173 GNI 175
            N+
Sbjct: 279 NNV 281

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 25/138 (18%), Positives = 55/138 (39%), Gaps = 10/138 (7%)

Query: 18  LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTL 77
              L+   +I+   + ++         L  +  L      +  ++      L++L+ L L
Sbjct: 15  DPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 78  ESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS 137
           + N + D  L  L  L  ++ L L  N +     S I  + ++  LDL+  +++   P  
Sbjct: 71  KDNQITD--LAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP-- 124

Query: 138 FSNLKSLSSFNVSYNNLS 155
            + L +L    +  N ++
Sbjct: 125 LAGLSNLQVLYLDLNQIT 142

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 36/174 (20%), Positives = 72/174 (41%), Gaps = 32/174 (18%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N ++  I   L  L+ LQ +S+ + ++S +  + L  LS+L  L    N I+  +
Sbjct: 134 LYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DI 188

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG-------------- 108
               ++L +L+ + L++N + D  +  L    NL ++ L    I+               
Sbjct: 189 SP-LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV 245

Query: 109 --------HIPSTIGNISTLTILDLSQNKLS--GEIPASFSNLKSLSSFNVSYN 152
                     P+TI +  T    +L+ N  S    +  +F+   +  +  V ++
Sbjct: 246 VKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFS 299

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 9/70 (12%), Positives = 25/70 (35%), Gaps = 4/70 (5%)

Query: 86  ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLS 145
           ++     L N   +   ++ ++     T  ++  +T L      ++  I      L +L 
Sbjct: 11  VIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66

Query: 146 SFNVSYNNLS 155
              +  N ++
Sbjct: 67  GLELKDNQIT 76

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 16/203 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-FESEVSLLGKIRHPNLLALR 349
            ++GK ++G V K        + AVK + +             EV LL K+ HPN++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                      +V +    G L   +  R   +  D     +IIK +  G+ ++H + NI
Sbjct: 88  EILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHD---AARIIKQVFSGITYMHKH-NI 142

Query: 410 IHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           +H +L   N+LL   +   + KI DFGLS        +      G   Y APE+  L+  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEV--LRGT 198

Query: 467 -NTKTDVYSLGVTILELLTGKSP 488
            + K DV+S GV +  LL+G  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 20/205 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-FESEVSLLGKIRHPNLLALR 349
            ++GK ++G V K        + AVK + +             EV LL K+ HPN++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNE 407
                      +V +    G L   +  R    E         +IIK +  G+ ++H + 
Sbjct: 88  EILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDA-----ARIIKQVFSGITYMHKH- 140

Query: 408 NIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK 464
           NI+H +L   N+LL   +   + KI DFGLS       N  +    G   Y APE+  L+
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEV--LR 196

Query: 465 KA-NTKTDVYSLGVTILELLTGKSP 488
              + K DV+S GV +  LL+G  P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPP 221

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 47/203 (23%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGK-IRHPNLLALRA 350
           E +G  +Y    +        + AVK     I K +R+   E+ +L +  +HPN++ L+ 
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVK----IIDKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            Y   K    +V + M  G L   +  +   +  +      ++  +T+ + +LH+   ++
Sbjct: 84  VYDDGK-YVYVVTELMKGGELLDKILRQKFFSERE--AS-AVLFTITKTVEYLHAQ-GVV 138

Query: 411 HGNLTSSNVLL----DDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPELSKLKK 465
           H +L  SN+L      +  + +I DFG ++ +   A   ++ T      + APE+ + + 
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLERQG 196

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
            +   D++SLGV +  +LTG +P
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTP 219

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 27/214 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-------------EKITKGQREFESEVSLLG 338
             +G   YG V         S+ A+K ++             + I K   E  +E+SLL 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 339 KIRHPNLLALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
            + HPN++ L   +   K     LV ++   G L   +  R      D      I+K + 
Sbjct: 102 SLDHPNIIKLFDVFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECD---AANIMKQIL 156

Query: 398 RGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALG 454
            G+ +LH + NI+H ++   N+LL   +   N KI DFGLS   +   +  +    G   
Sbjct: 157 SGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAY 213

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           Y APE+ K KK N K DV+S GV +  LL G  P
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 59/227 (25%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
             +G   YG+V  A   + G +VAVK+L    + I   +R +  E+ LL  ++H N++ L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93

Query: 349 RAYYLGPKGEKL-----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT------ 397
              +   +  +      LV   M        L+               I+K         
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMG-----ADLN--------------NIVKCQKLTDDHV 134

Query: 398 --------RGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL----MTAAANVN 445
                   RGL ++HS  +IIH +L  SN+ +++    KI DFGL+R     MT      
Sbjct: 135 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----G 188

Query: 446 VIATAGALGYRAPE-LSKLKKANTKTDVYSLGVTILELLTGKS--PG 489
            +AT     YRAPE +      N   D++S+G  + ELLTG++  PG
Sbjct: 189 YVAT---RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 58/226 (25%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
             +G   YG+V  A     G +VA+K+L    +     +R +  E+ LL  ++H N++ L
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 88

Query: 349 RAYYLGPKGEKL-----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-------- 395
              +      +      LV  +M      T L               KI+          
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQ-----TDLQ--------------KIMGLKFSEEKIQ 129

Query: 396 -----MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL----MTAAANVNV 446
                M +GL ++HS   ++H +L   N+ +++    KI DFGL+R     MT       
Sbjct: 130 YLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GY 183

Query: 447 IATAGALGYRAPE-LSKLKKANTKTDVYSLGVTILELLTGKS--PG 489
           + T     YRAPE +      N   D++S+G  + E+LTGK+   G
Sbjct: 184 VVT---RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 13/202 (6%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +      G + A K +  +K++    +  E E  +  K++HPN++ L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                      LVFD +  G L   + AR   +  D       I+ +   + + HSN  I
Sbjct: 95  DSIQEE-SFHYLVFDLVTGGELFEDIVAREFYSEAD--AS-HCIQQILESIAYCHSN-GI 149

Query: 410 IHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA 466
           +H NL   N+LL         K++DFGL+  +  +   +    AG  GY +PE+ K    
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLKKDPY 207

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D+++ GV +  LL G  P
Sbjct: 208 SKPVDIWACGVILYILLVGYPP 229

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +++G    G V +      G + A+K L     K ++E +      G    P+++ +   
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQEVDHHWQASG---GPHIVCILDV 90

Query: 352 Y---LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLHSN 406
           Y      K   L++ + M  G L + +  RG +    +  R   +I++ +   +  LHS+
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA---FTEREAAEIMRDIGTAIQFLHSH 147

Query: 407 ENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPELSK 462
            NI H ++   N+L    +     K++DFG ++  T     N + T      Y APE+  
Sbjct: 148 -NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLG 202

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +K +   D++SLGV +  LL G  P
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPP 228

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 91.1 bits (226), Expect = 2e-19
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 21/153 (13%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L    N L+  +P     L EL   S+S N+++ + P+    L +L   +   N +  SL
Sbjct: 166 LWAYNNQLT-SLPMLPSGLQEL---SVSDNQLASL-PTLPSELYKLWAYN---NRLT-SL 216

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           PA     S L  L +  N L    L  L     L  L +  N+++  +P        L  
Sbjct: 217 PAL---PSGLKELIVSGNRL--TSLPVL--PSELKELMVSGNRLT-SLPMLPSG---LLS 265

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L + +N+L+  +P S  +L S ++ N+  N LS
Sbjct: 266 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 88.0 bits (218), Expect = 2e-18
 Identities = 48/176 (27%), Positives = 69/176 (39%), Gaps = 34/176 (19%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRL--------------SRL 48
           L +  N L+  +P     L EL   S     +  + PS L +L                L
Sbjct: 86  LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-PSGLCKLWIFGNQLTSLPVLPPGL 143

Query: 49  RILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG 108
           + L  S N +  SLPA  S    L  L   +N L    L  L     L  L++  NQ++ 
Sbjct: 144 QELSVSDNQLA-SLPALPSE---LCKLWAYNNQL--TSLPML--PSGLQELSVSDNQLA- 194

Query: 109 HIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG--PVPTSL 162
            +P+       L  L    N+L+  +PA  S LK L    VS N L+    +P+ L
Sbjct: 195 SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLTSLPVLPSEL 243

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 78.8 bits (194), Expect = 1e-15
 Identities = 32/168 (19%), Positives = 56/168 (33%), Gaps = 37/168 (22%)

Query: 6   QYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGR------------------LSR 47
               +  ++ A L   +    +++  + ++ + P  L                       
Sbjct: 26  GRAAVVQKMRACL--NNGNAVLNVGESGLTTL-PDCLPAHITTLVIPDNNLTSLPALPPE 82

Query: 48  LRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS 107
           LR L+ S N +  SLP     L  L   +    +L             L  L +  NQ++
Sbjct: 83  LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT 134

Query: 108 GHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             +P        L  L +S N+L+  +PA  S L  L       N L+
Sbjct: 135 -SLPVLPPG---LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT 174

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 29/145 (20%), Positives = 53/145 (36%), Gaps = 11/145 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L +  N L+  +P    +L EL    +S N+++ + P     L  L       N +   L
Sbjct: 226 LIVSGNRLT-SLPVLPSELKEL---MVSGNRLTSL-PMLPSGLLSL---SVYRNQLT-RL 276

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P S  +LSS  ++ LE N L ++ L +L ++ +    +    +      S       L  
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH- 335

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSF 147
              + + L        +       F
Sbjct: 336 -LAAADWLVPAREGEPAPADRWHMF 359

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 16/128 (12%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L    N L+  +PA    L EL    +S N+++ + P     L   + L  S N +  SL
Sbjct: 206 LWAYNNRLT-SLPALPSGLKEL---IVSGNRLTSL-PVLPSEL---KELMVSGNRLT-SL 256

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P      S L+SL++  N L  ++ +SL  L + + +NL+ N +S     T+  +  +T 
Sbjct: 257 PML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS---ERTLQALREITS 309

Query: 123 LDLSQNKL 130
                  +
Sbjct: 310 APGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 20/94 (21%), Positives = 41/94 (43%), Gaps = 9/94 (9%)

Query: 69  LSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQN 128
            +    L +  + L   + D L    +++ L +  N ++  +P+       L  L++S N
Sbjct: 39  NNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91

Query: 129 KLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
           +L+  +P     L  LS F+    +L   +P+ L
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGL 123

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 33/163 (20%), Positives = 56/163 (34%), Gaps = 13/163 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSD----LGRLSRLRILDFSYNAI 58
           L++   +        +     L  + LS N   G           +   L++L      +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213

Query: 59  N---GSLPASFSNLSSLVSLTLESNNLDDQILDSL-DKLHNLSVLNLKRNQISGHIPSTI 114
               G   A  +    L  L L  N+L D       D    L+ LNL    +   +P  +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272

Query: 115 GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP 157
              + L++LDLS N+L    P S   L  + + ++  N     
Sbjct: 273 P--AKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 34/170 (20%), Positives = 49/170 (28%), Gaps = 17/170 (10%)

Query: 8   NNLSGRIPASLGKLSE-----LQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           N       A L +L +     L+ +S++           +     L  LD S N   G  
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189

Query: 63  -------PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI- 114
                  P  F  L  L                       L  L+L  N +     +   
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249

Query: 115 GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLAL 164
              S L  L+LS   L        + L  L   ++SYN L    P+   L
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DLSYNRLDR-NPSPDEL 295

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 37/175 (21%), Positives = 60/175 (34%), Gaps = 17/175 (9%)

Query: 3   LALQYNNLSGRIPASLGKLS--ELQEISLSHNKISGVMPSDLGRLS-----RLRILDFSY 55
           L L+   ++G  P  L + +  +L  ++L +   +    + L  L       L++L  + 
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQ 158

Query: 56  NAINGSLPASFSNLSSLVSLTLESNNLDDQI-------LDSLDKLHNLSVLNLKRNQISG 108
                          +L +L L  N    +              L  L++ N      SG
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218

Query: 109 HIPSTIGNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLSGPVPTSL 162
              +       L  LDLS N L     A S      L+S N+S+  L   VP  L
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL 272

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 27/169 (15%), Positives = 46/169 (27%), Gaps = 25/169 (14%)

Query: 1   MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRL---SRLRILDFSYNA 57
             L              + K   L+ +++   +I   +     R+   S L+ L      
Sbjct: 47  YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106

Query: 58  INGSLPASFSNLS--SLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIG 115
           + G+ P      +   L  L L  N         L +L       LK             
Sbjct: 107 VTGTAPPPLLEATGPDLNILNL-RNVSWATRDAWLAELQQWLKPGLKV------------ 153

Query: 116 NISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLAL 164
                  L ++Q               +LS+ ++S N   G      AL
Sbjct: 154 -------LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 16/207 (7%)

Query: 288 LCATAEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIR-HPN 344
           L    + +G+ ++    K    +     AVK     I+K      + E++ L     HPN
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVK----IISKRMEANTQKEITALKLCEGHPN 67

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
           ++ L   +        LV + +  G L   +  +   +  +      I++ +   + H+H
Sbjct: 68  IVKLHEVFHDQL-HTFLVMELLNGGELFERIKKKKHFSETE---ASYIMRKLVSAVSHMH 123

Query: 405 SNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
               ++H +L   N+L    +D+   KI DFG +RL     N  +      L Y APEL 
Sbjct: 124 DV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAPELL 181

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
                +   D++SLGV +  +L+G+ P
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVP 208

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 46/219 (21%), Positives = 86/219 (39%), Gaps = 46/219 (21%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREF-----ESEVSLLGKIRH--PNL 345
           +G   +G+VY    + D   VA+K + +++I+             EV LL K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 346 LAL-------RAYYL-----GPKGEKLLVFDYM-PHGSLATFLHARGPETPIDWPTRMKI 392
           + L        ++ L      P  +   +FD++   G+L   L AR              
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEEL-AR------------SF 154

Query: 393 IKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAANVNVIATA- 450
              +   + H H+   ++H ++   N+L+D +    K+ DFG   L+       V     
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFD 209

Query: 451 GALGYRAPELSKLKK-ANTKTDVYSLGVTILELLTGKSP 488
           G   Y  PE  +  +       V+SLG+ + +++ G  P
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 14/203 (6%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           E +GK  +  V +   +  G + A   +  +K++    +  E E  +   ++HPN++ L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                 +G   L+FD +  G L   + AR   +  D       I+ +   +LH H    +
Sbjct: 77  DSISE-EGHHYLIFDLVTGGELFEDIVAREYYSEAD--AS-HCIQQILEAVLHCHQM-GV 131

Query: 410 IHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELSKLKK 465
           +H NL   N+LL         K++DFGL+  +            AG  GY +PE+ +   
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
                D+++ GV +  LL G  P
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 12/153 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             L+  +++  +     +L+ + +I  +++ I  V    +  L  +  L  + N +    
Sbjct: 29  DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIK 84

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P   +NL +L  L L+ N + D  L SL  L  L  L+L+ N IS  I   + ++  L  
Sbjct: 85  P--LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLES 138

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L L  NK++ +I    S L  L + ++  N +S
Sbjct: 139 LYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 17/180 (9%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N +   +  SL  L +L+ +SL HN IS +  + L  L +L  L    N I  + 
Sbjct: 95  LFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI--TD 148

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               S L+ L +L+LE N + D  +  L  L  L  L L +N IS  +   +  +  L +
Sbjct: 149 ITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDV 204

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP-------TSLALKFNASSFVGNI 175
           L+L   +   +     SNL   ++   +  +L  P             +K++   F   +
Sbjct: 205 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 42/180 (23%), Positives = 76/180 (42%), Gaps = 13/180 (7%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L+L++N +S  I   L  L +L+ + L +NKI+ +  + L RL++L  L    N I+  +
Sbjct: 117 LSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DI 171

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               + L+ L +L L  N++ D  L +L  L NL VL L   +      +   N+     
Sbjct: 172 V-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGYSG 182
           +  +   L    P   S+       NV ++         ++  F     +G  +   + G
Sbjct: 229 VKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE--FTNEVSFIFYQPVTIGKAK-ARFHG 283

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 29/138 (21%), Positives = 56/138 (40%), Gaps = 10/138 (7%)

Query: 18  LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTL 77
               +E  + +L    ++         L+ +  +  + + I  S+      L ++  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75

Query: 78  ESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS 137
             N L D  +  L  L NL  L L  N++   + S++ ++  L  L L  N +S +I   
Sbjct: 76  NGNKLTD--IKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING- 129

Query: 138 FSNLKSLSSFNVSYNNLS 155
             +L  L S  +  N ++
Sbjct: 130 LVHLPQLESLYLGNNKIT 147

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 9/81 (11%), Positives = 29/81 (35%), Gaps = 6/81 (7%)

Query: 75  LTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEI 134
                  +    + S D        NLK+  ++     T   ++++  +  + + +   +
Sbjct: 7   TITVPTPIKQ--IFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV 61

Query: 135 PASFSNLKSLSSFNVSYNNLS 155
                 L +++   ++ N L+
Sbjct: 62  QG-IQYLPNVTKLFLNGNKLT 81

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 38/211 (18%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQRE--FESEVSLLGKIRHPNLLALRAY 351
           G  T+G V        G +VAVK L R+KI         + E+  L   RHP+++ L   
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL--- 76

Query: 352 Y--LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK----------IIKGMTRG 399
           Y  +    +  +V +Y+  G L  ++   G         R++          I+  +   
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVD-- 125

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAP 458
             + H +  ++H +L   NVLLD   NAKI+DFGLS +M+       + T+ G+  Y AP
Sbjct: 126 --YCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAP 179

Query: 459 E-LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           E +S    A  + D++S GV +  LL G  P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 47/251 (18%), Positives = 87/251 (34%), Gaps = 66/251 (26%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
            ++G+ +YG VY A        VA+K++    E +   +R    E+++L +++   ++ L
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRL 90

Query: 349 RAYYLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG--------- 395
               +     K     +V +        + L               K+ K          
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIAD-----SDLK--------------KLFKTPIFLTEEHI 131

Query: 396 ------MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT 449
                 +  G   +H +  IIH +L  +N LL+   + K+ DFGL+R + +  + N++  
Sbjct: 132 KTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 450 AGALG---------------------YRAPE-LSKLKKANTKTDVYSLGVTILELLTGKS 487
                                     YRAPE +   +      D++S G    ELL    
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

Query: 488 PGEPLNGAELP 498
                     P
Sbjct: 251 SHINDPTNRFP 261

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.7 bits (220), Expect = 6e-19
 Identities = 48/249 (19%), Positives = 91/249 (36%), Gaps = 71/249 (28%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
            ++G  +YG V +A    +   VA+K++    E +   +R    E+++L ++ H +++ +
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKV 117

Query: 349 RAYYLGPKGEKL----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG--------- 395
               +    EK     +V +        +                 K+ +          
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIAD-----SDFK--------------KLFRTPVYLTELHI 158

Query: 396 ------MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT 449
                 +  G+ ++HS   I+H +L  +N L++   + K+ DFGL+R +    N N    
Sbjct: 159 KTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 450 AGALG--------------------------YRAPELSKLKKANTKT-DVYSLGVTILEL 482
                                          YRAPEL  L++  T+  DV+S+G    EL
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

Query: 483 LTGKSPGEP 491
           L        
Sbjct: 278 LNMIKENVA 286

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 54/239 (22%), Positives = 100/239 (41%), Gaps = 22/239 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRA 350
           +++G+  +  V     L    + AVK + ++    +     EV +L + + H N+L L  
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           ++        LVF+ M  GS+ + +H R     ++      +++ +   L  LH+   I 
Sbjct: 79  FFEEED-RFYLVFEKMRGGSILSHIHKRRHFNELE---ASVVVQDVASALDFLHNK-GIA 133

Query: 411 HGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIAT------AGALGYRAPELS 461
           H +L   N+L    +  +  KI DF L   +    + + I+T       G+  Y APE+ 
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 462 KLKKANTKT-----DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
           +             D++SLGV +  LL+G  P     G++   W          N +F+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD-CGWDRGEACPACQNMLFE 251

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.4 bits (219), Expect = 8e-19
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 27/207 (13%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           + +G    G V  A        VA+K+L    +  T  +R +  E+ L+  + H N+++L
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126

Query: 349 R-----AYYLGPKGEKLLVFDYMPHGSLATFLHA--RGPETPIDWPTRMK-IIKGMTRGL 400
                    L    +  LV + M        L    +          RM  ++  M  G+
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQMELDHE----RMSYLLYQMLCGI 177

Query: 401 LHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR-LMTAAANVNVIATAGALGYRAPE 459
            HLHS   IIH +L  SN+++      KI DFGL+R   T+      + T     YRAPE
Sbjct: 178 KHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT---RYYRAPE 233

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGK 486
           +          D++S+G  + E++  K
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHK 260

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 85.7 bits (213), Expect = 9e-19
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 23/208 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
             +G   +G V+       G +  +K + +  ++   E  E+E+ +L  + HPN++ +  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM------KIIKGMTRGLLHLH 404
            +        +V +    G L   + +            +      +++K M   L + H
Sbjct: 88  VFEDYH-NMYIVMETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFH 141

Query: 405 SNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
           S  +++H +L   N+L       +  KI DFGL+ L  +  +      AG   Y APE+ 
Sbjct: 142 SQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA--AGTALYMAPEV- 197

Query: 462 KLKKA-NTKTDVYSLGVTILELLTGKSP 488
             K+    K D++S GV +  LLTG  P
Sbjct: 198 -FKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
                +N+   +   +   + L+E+ LSHN+IS +  S L  L++L  L  + N +    
Sbjct: 46  FNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLK--- 98

Query: 63  PASFSNLS--SLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
             + + +    L  L L++N L D   DSL  L NL +L+++ N++   I   +G +S L
Sbjct: 99  --NLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKL 152

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            +LDL  N+++       + LK ++  +++     
Sbjct: 153 EVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 31/140 (22%), Positives = 55/140 (39%), Gaps = 15/140 (10%)

Query: 18  LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTL 77
              L+   + +L    ++ +       LS ++  +   + I  SL       ++L  L L
Sbjct: 15  DPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHL 70

Query: 78  ESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS--TLTILDLSQNKLSGEIP 135
             N + D  L  L  L  L  L++ RN++       +  I    L+ L L  N+L     
Sbjct: 71  SHNQISD--LSPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRD--T 121

Query: 136 ASFSNLKSLSSFNVSYNNLS 155
            S  +LK+L   ++  N L 
Sbjct: 122 DSLIHLKNLEILSIRNNKLK 141

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 32/153 (20%), Positives = 66/153 (43%), Gaps = 13/153 (8%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             L   +++  +     +LS +Q  +  ++ I  +  + +   + L+ L  S+N I  S 
Sbjct: 24  QNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHNQI--SD 77

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
            +   +L+ L  L++  N L +  L+ +     LS L L  N++      ++ ++  L I
Sbjct: 78  LSPLKDLTKLEELSVNRNRLKN--LNGIPSA-CLSRLFLDNNELRD--TDSLIHLKNLEI 132

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           L +  NKL   I      L  L   ++  N ++
Sbjct: 133 LSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 33/180 (18%), Positives = 69/180 (38%), Gaps = 18/180 (10%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N +S  +   L  L++L+E+S++ N++  +  + +     L  L    N +    
Sbjct: 68  LHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNL--NGIPSAC-LSRLFLDNNEL--RD 120

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
             S  +L +L  L++ +N L    +  L  L  L VL+L  N+I+ +    +  +  +  
Sbjct: 121 TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNW 176

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP-------TSLALKFNASSFVGNI 175
           +DL+  K   E       L   ++          P             + +    +   +
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEV 236

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 26/127 (20%), Positives = 50/127 (39%), Gaps = 11/127 (8%)

Query: 29  LSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILD 88
                I+ V P     L+     +    ++      S   LS + +   +++N+    L 
Sbjct: 4   QRPTPINQVFP--DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQS--LA 57

Query: 89  SLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFN 148
            +    NL  L+L  NQIS  + S + +++ L  L +++N+L        + L  L    
Sbjct: 58  GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---F 112

Query: 149 VSYNNLS 155
           +  N L 
Sbjct: 113 LDNNELR 119

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 26/138 (18%), Positives = 50/138 (36%), Gaps = 15/138 (10%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L+++ N L   I   LG LS+L+ + L  N+I+      L RL ++  +D +       
Sbjct: 132 ILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
                  L    ++     + D + +      +  S ++     +   +P     +S   
Sbjct: 188 PVKYQPELYITNTVK----DPDGRWISPYYISNGGSYVD---GCVLWELPVYTDEVS--- 237

Query: 122 ILDLSQNKLSGEIPASFS 139
               S+    GE  A F 
Sbjct: 238 -YKFSEYINVGETEAIFD 254

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 9/81 (11%), Positives = 28/81 (34%), Gaps = 6/81 (7%)

Query: 75  LTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEI 134
                  ++   +     L N    NL +  ++  +  +   +S +   +   + +   +
Sbjct: 2   SIQRPTPINQ--VFPDPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQ-SL 56

Query: 135 PASFSNLKSLSSFNVSYNNLS 155
                   +L   ++S+N +S
Sbjct: 57  A-GMQFFTNLKELHLSHNQIS 76

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 57/222 (25%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIRHPNLLAL 348
           + +G   YG V  A     G++VA+K+L    +     +R +  E+ LL  +RH N++ L
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGL 89

Query: 349 RAYYLGPKGEKL-----LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG-------- 395
              +   +         LV  +M      T L               K++K         
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMG-----TDLG--------------KLMKHEKLGEDRI 130

Query: 396 ------MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL----MTAAANVN 445
                 M +GL ++H+   IIH +L   N+ +++    KI DFGL+R     MT      
Sbjct: 131 QFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----G 184

Query: 446 VIATAGALGYRAPE-LSKLKKANTKTDVYSLGVTILELLTGK 486
            + T     YRAPE +    +     D++S+G  + E++TGK
Sbjct: 185 YVVT---RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 57/240 (23%), Positives = 100/240 (41%), Gaps = 32/240 (13%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFE---SEVSLLGKIRHPNLLALRAY 351
           GK ++G V      D  ++ A+K + ++    + E      E+ ++  + HP L+ L   
Sbjct: 24  GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-- 81

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLH----ARGPETPIDWPTRMKI-IKGMTRGLLHLHS 405
           Y     E + +V D +  G L    H        E        +K+ I  +   L +L +
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEE------TVKLFICELVMALDYLQN 133

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE--LSKL 463
              IIH ++   N+LLD+  +  I+DF ++ ++     +  +  AG   Y APE   S+ 
Sbjct: 134 Q-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM--AGTKPYMAPEMFSSRK 190

Query: 464 KKANTKT-DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE------WTNEVFDL 516
               +   D +SLGVT  ELL G+ P    +     + V +           W+ E+  L
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 46/222 (20%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL-REKITK-----GQREFESEVSLLGKIR---- 341
            ++GK  +GTV+    L D  QVA+K + R ++              EV+LL K+     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 342 HPNLLAL-------RAYYL-----GPKGEKLLVFDY-MPHGSLATFLHARGPETPIDWPT 388
           HP ++ L         + L      P  +   +FDY    G L     +R          
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGP-SR---------- 142

Query: 389 RMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA-KISDFGLSRLMTAAANVNVI 447
                  +   + H HS   ++H ++   N+L+D      K+ DFG   L+    +    
Sbjct: 143 --CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYT 196

Query: 448 ATAGALGYRAPELSKLKK-ANTKTDVYSLGVTILELLTGKSP 488
              G   Y  PE     +       V+SLG+ + +++ G  P
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 45/214 (21%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKG--QREFESEVSLLGKIRHPNLLALRAY 351
           G+ ++G V  AT  +   +VA+K + R+ + K       E E+S L  +RHP+++ L  Y
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL--Y 75

Query: 352 --------------YLGPKGEKLLVFDY-MPHGSLATFLHARGPETPIDWPTRMKIIKGM 396
                         Y G  GE   +FDY +    +      R            +  + +
Sbjct: 76  DVITTPTDIVMVIEYAG--GE---LFDYIVEKKRMTEDE-GR------------RFFQQI 117

Query: 397 TRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGY 455
              + + H +  I+H +L   N+LLDD+ N KI+DFGLS +MT     N + T+ G+  Y
Sbjct: 118 ICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 173

Query: 456 RAPE-LSKLKKANTKTDVYSLGVTILELLTGKSP 488
            APE ++    A  + DV+S G+ +  +L G+ P
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G+     VY+          A+K L++     ++   +E+ +L ++ HPN++ L+  
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +  P  E  LV + +  G L   +  +G  +  D       +K +   + +LH N  I+H
Sbjct: 117 FETPT-EISLVLELVTGGELFDRIVEKGYYSERD---AADAVKQILEAVAYLHEN-GIVH 171

Query: 412 GNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
            +L   N+L          KI+DFGLS+++     V +    G  GY APE+ +      
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRGCAYGP 229

Query: 469 KTDVYSLGVTILELLTGKSP 488
           + D++S+G+    LL G  P
Sbjct: 230 EVDMWSVGIITYILLCGFEP 249

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 34/156 (21%), Positives = 58/156 (37%), Gaps = 9/156 (5%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
            Q + ++  IP+ L       E+     K+  +          L  ++ S N +   + A
Sbjct: 16  CQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72

Query: 65  S-FSNLSSLVSLTLE-SNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLT 121
             FSNL  L  + +E +NNL     ++   L NL  L +    I  H+P     +     
Sbjct: 73  DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKV 131

Query: 122 ILDLSQNKLSGEIPA-SFSNLKS-LSSFNVSYNNLS 155
           +LD+  N     I   SF  L        ++ N + 
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 31/161 (19%), Positives = 52/161 (32%), Gaps = 12/161 (7%)

Query: 3   LALQYNNLSGRIPAS-LGKLSELQEISLSH-NKISGVMPSDLGRLSRLRILDFSYNAING 60
           + +  N++   I A     L +L EI +   N +  + P     L  L+ L  S   I  
Sbjct: 59  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK- 117

Query: 61  SLPA-SFSNLSSLVSLTLESNN----LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIG 115
            LP     +    V L ++ N     ++      L       +L L +N I     S   
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL--SFESVILWLNKNGIQEIHNSAFN 175

Query: 116 NISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
                 +     N L  E+P   F         ++S   + 
Sbjct: 176 GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 16/163 (9%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMP----SDLGRLSRLRILDFSYNA 57
           L      L   I   +     +L++I +S N +  V+     S+L +L  +RI     N 
Sbjct: 35  LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK--ANN 91

Query: 58  INGSLPASFSNLSSLVSLTLESNNLDDQIL--DSLDKLHNLSVLNLKRNQISGHIPSTI- 114
           +    P +F NL +L  L + +  +  + L            +L+++ N     I     
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGI--KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149

Query: 115 -GNISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLS 155
            G      IL L++N +  EI  S F+  +         NNL 
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 28/154 (18%), Positives = 47/154 (30%), Gaps = 32/154 (20%)

Query: 2   FLALQYNNLSGRIPA-SLGKLS-ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN 59
            L +Q N     I   S   LS E   + L+ N I  +  S         +     N + 
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191

Query: 60  GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNIS 118
             LP                        D         +L++ R +I   +PS    N+ 
Sbjct: 192 -ELPN-----------------------DVFHGASGPVILDISRTRIH-SLPSYGLENLK 226

Query: 119 TLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN 152
            L        K   ++P +   L +L   +++Y 
Sbjct: 227 KLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 34/212 (16%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLR-EKITKGQREFE---SEVSLLGKIRHPNLLAL 348
           I+G+ ++ TV  A     S+  A+K L    I K + +      E  ++ ++ HP  + L
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTR------- 398
             Y+     EKL     Y  +G L  ++   G   ET              TR       
Sbjct: 96  --YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------------CTRFYTAEIV 140

Query: 399 -GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYR 456
             L +LH    IIH +L   N+LL++  + +I+DFG +++++  +      +  G   Y 
Sbjct: 141 SALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 457 APELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +PEL   K A   +D+++LG  I +L+ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 44/231 (19%), Positives = 87/231 (37%), Gaps = 62/231 (26%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           + +G    G V+ A   +   +VA+K++        +     E+ ++ ++ H N++ +  
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFE 75

Query: 351 YYLGPKGEKL-------------LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
                  +               +V +YM      T L                +++   
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLA--------------NVLEQGP 116

Query: 398 --------------RGLLHLHSNENIIHGNLTSSNVLLDDSTN--AKISDFGLSRLMTAA 441
                         RGL ++HS  N++H +L  +N+ ++ + +   KI DFGL+R+M   
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPH 174

Query: 442 ANVNV-----IATAGALGYRAPE-LSKLKKANTKTDVYSLGVTILELLTGK 486
            +        + T     YR+P  L          D+++ G    E+LTGK
Sbjct: 175 YSHKGHLSEGLVT---KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 85.6 bits (212), Expect = 6e-18
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 38/211 (18%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREF--ESEVSLLGKIRHPNLLALRAY 351
           G  T+G V        G +VAVK L R+KI           E+  L   RHP+++ L   
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL--- 81

Query: 352 Y--LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMK----------IIKGMTRG 399
           Y  +    +  +V +Y+  G L  ++   G         R+           I+ G+   
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVD-- 130

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAP 458
             + H +  ++H +L   NVLLD   NAKI+DFGLS +M+       + T+ G+  Y AP
Sbjct: 131 --YCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAP 184

Query: 459 E-LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           E +S    A  + D++S GV +  LL G  P
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 23/202 (11%)

Query: 295 MGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFESEVSLLGKIR-HPNLLALRAY 351
           +G+  Y  V++A  + +  +V VK L+  K  K +RE    + +L  +R  PN++ L   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE----IKILENLRGGPNIITLADI 99

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMK-IIKGMTRGLLHLHSNENI 409
              P      LVF+++ +             T  D    ++  +  + + L + HS   I
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYD----IRFYMYEILKALDYCHSM-GI 151

Query: 410 IHGNLTSSNVLLDDSTNA-KISDFGLSRLMTAAANVNV-IATAGALGYRAPE-LSKLKKA 466
           +H ++   NV++D      ++ D+GL+         NV +A+     ++ PE L   +  
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS---RYFKGPELLVDYQMY 208

Query: 467 NTKTDVYSLGVTILELLTGKSP 488
           +   D++SLG  +  ++  K P
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEP 230

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 25/213 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRL--------REKITKGQREFESEVSLLGKIR-H 342
           +++G+     V +      G + AVK +         E++ + +     E  +L ++  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 343 PNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
           P+++ L   Y        LVFD M  G L  +L  +   +  +  TR  I++ +   +  
Sbjct: 160 PHIITLIDSYESSS-FMFLVFDLMRKGELFDYLTEKVALSEKE--TR-SIMRSLLEAVSF 215

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRAPE-- 459
           LH+N NI+H +L   N+LLDD+   ++SDFG S  +        +    G  GY APE  
Sbjct: 216 LHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEIL 271

Query: 460 ----LSKLKKANTKTDVYSLGVTILELLTGKSP 488
                        + D+++ GV +  LL G  P
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 85.3 bits (211), Expect = 2e-17
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFE---SEVSLLGKI---RHPNLL 346
           I+G+  +G VY     D  ++ A+K L +K  K ++      +E  +L  +     P ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKI-IKGMTRGLLH 402
            +   +  P  +KL  + D M  G L   L   G   E        M+     +  GL H
Sbjct: 256 CMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEA------DMRFYAAEIILGLEH 307

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS-RLMTAAANVNVIATAGALGYRAPELS 461
           +H+   +++ +L  +N+LLD+  + +ISD GL+        +    A+ G  GY APE+ 
Sbjct: 308 MHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVL 362

Query: 462 KLKKANTKT-DVYSLGVTILELLTGKSP 488
           +   A   + D +SLG  + +LL G SP
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 28/156 (17%), Positives = 57/156 (36%), Gaps = 11/156 (7%)

Query: 6   QYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA- 64
              ++  RIP         Q + L    +  +       L  +  +  S +     L + 
Sbjct: 19  TCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESH 74

Query: 65  SFSNLSSLVSLTLESNNLDDQI-LDSLDKLHNLSVLNLKRNQISGHIP--STIGNISTLT 121
           SF NLS +  + + +      I  D+L +L  L  L +    +    P  + + +     
Sbjct: 75  SFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFF 133

Query: 122 ILDLSQNKLSGEIPA-SFSNLKSLS-SFNVSYNNLS 155
           IL+++ N     IP  +F  L + + +  +  N  +
Sbjct: 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 30/157 (19%), Positives = 62/157 (39%), Gaps = 17/157 (10%)

Query: 3   LALQYNNLSGRIPAS-LGKLSELQEISLSHNKISGVMPSD--LGRLSRLRILDFSYNAIN 59
           + ++       I    L +L  L+ + + +  +  + P    +       IL+ + N   
Sbjct: 85  IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143

Query: 60  GSLPA-SFSNLSS-LVSLTLESNNL---DDQILDSLDKLHNLSVLNLKRNQISGHIPSTI 114
            S+P  +F  L +  ++L L +N          +       L  + L +N+    I    
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGT----KLDAVYLNKNKYLTVIDKDA 199

Query: 115 --GNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFN 148
             G  S  ++LD+SQ  ++  +P+    +LK L + N
Sbjct: 200 FGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 62/235 (26%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---EKITKGQREFESEVSLLGKIR-HPNLLA 347
           + +GK  YG V+K+     G  VAVK++    +  T  QR F  E+ +L ++  H N++ 
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVN 73

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG----------- 395
           L           + LVFDYM      T LH               +I+            
Sbjct: 74  LLNVLRADNDRDVYLVFDYME-----TDLH--------------AVIRANILEPVHKQYV 114

Query: 396 ---MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGA 452
              + + + +LHS   ++H ++  SN+LL+   + K++DFGLSR       V        
Sbjct: 115 VYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 453 LG--------------------YRAPE-LSKLKKANTKTDVYSLGVTILELLTGK 486
                                 YRAPE L    K     D++SLG  + E+L GK
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 8/155 (5%)

Query: 2   FLALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            L L  N L   +PA +  +L  L+ + ++ NK+  +      +L  L  L    N +  
Sbjct: 65  LLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK- 122

Query: 61  SLPAS-FSNLSSLVSLTLESNNLDDQIL--DSLDKLHNLSVLNLKRNQISGHIPSTIGNI 117
           SLP   F +L+ L  L+L  N L  Q L     DKL +L  L L  NQ+          +
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNEL--QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKL 180

Query: 118 STLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN 152
           + L  L L  N+L      +F +L+ L    +  N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 6/156 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L LQ N LS     +  +L++L+ + L+ NK+  +       L  L  L  + N +  +L
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-AL 100

Query: 63  PAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI-GNISTL 120
           P   F  L +L  L L+ N L        D L  L+ L+L  N++   +P  +   +++L
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159

Query: 121 TILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLS 155
             L L  N+L   +P   F  L  L +  +  N L 
Sbjct: 160 KELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 50/158 (31%), Positives = 73/158 (46%), Gaps = 19/158 (12%)

Query: 6   QYNNLS---GRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
               L+     IPA   KL       L  NK+S +      RL++LR+L  + N +  +L
Sbjct: 24  SSKKLTAIPSNIPADTKKLD------LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TL 76

Query: 63  PAS-FSNLSSLVSLTLESNNLDDQILDS--LDKLHNLSVLNLKRNQISGHIPSTI-GNIS 118
           PA  F  L +L +L +  N L  Q L     D+L NL+ L L RNQ+   +P  +  +++
Sbjct: 77  PAGIFKELKNLETLWVTDNKL--QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT 133

Query: 119 TLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
            LT L L  N+L   +P   F  L SL    +  N L 
Sbjct: 134 KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 25/84 (29%), Positives = 43/84 (51%), Gaps = 4/84 (4%)

Query: 2   FLALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
           +L+L YN L   +P  +  KL+ L+E+ L +N++  V      +L+ L+ L    N +  
Sbjct: 137 YLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK- 194

Query: 61  SLPA-SFSNLSSLVSLTLESNNLD 83
            +P  +F +L  L  L L+ N  D
Sbjct: 195 RVPEGAFDSLEKLKMLQLQENPWD 218

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 25/206 (12%)

Query: 295 MGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRA 350
           +GK T+G V     +   +  A+K L++++   + E      E  +L   RHP L AL+ 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSN 406
            +     ++L  V +Y   G L   L       E       R +     +   L +LHS 
Sbjct: 216 SFQTH--DRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALDYLHSE 267

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELSK 462
           +N+++ +L   N++LD   + KI+DFGL +       +   AT     G   Y APE+ +
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-----GIKDGATMKTFCGTPEYLAPEVLE 322

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
                   D + LGV + E++ G+ P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 32/153 (20%), Positives = 69/153 (45%), Gaps = 16/153 (10%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L    ++++  +   + KL+ L ++  + N I+ +   DL + + L  L    N +  +L
Sbjct: 47  LDCHNSSITD-MTG-IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT-NL 100

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               + L+ L  L  ++N L       + +   L+ LN  RN ++  I   + + + LT 
Sbjct: 101 D--VTPLTKLTYLNCDTNKLTK---LDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTE 152

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           LD   NK   ++    +    L++ + S+N ++
Sbjct: 153 LDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 17/153 (11%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L    NN++  +   L + + L  ++   NK++ +   D+  L++L  L+   N +   L
Sbjct: 69  LICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KL 121

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               S    L  L    N L +  +D +     L+ L+   N+        +   + LT 
Sbjct: 122 D--VSQNPLLTYLNCARNTLTE--ID-VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTT 174

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           LD S NK++ E+    S  K L+  N   NN++
Sbjct: 175 LDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 82.4 bits (204), Expect = 8e-17
 Identities = 31/153 (20%), Positives = 61/153 (39%), Gaps = 17/153 (11%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L    NN++ ++   L +  +L  +  S NK++ +   D+  L++L   D S N +   L
Sbjct: 196 LNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-EL 248

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               S LS L +L     +L       +D  HN  ++  +           + + + L +
Sbjct: 249 D--VSTLSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYL 301

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           LD     ++ E+    S    L    ++   L+
Sbjct: 302 LDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 14/155 (9%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
                +      S  +L+ L  +   ++ I+ +  + + +L+ L  L  + N I  +L  
Sbjct: 25  AAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD- 80

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
             S  ++L  L  +SN L +  LD +  L  L+ LN   N+++      +     LT L+
Sbjct: 81  -LSQNTNLTYLACDSNKLTN--LD-VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLN 133

Query: 125 LSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP 159
            ++N L+ EI    S+   L+  +   N     + 
Sbjct: 134 CARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 17/153 (11%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L    N L+  I   +   ++L E+    NK       D+   ++L  LD S+N I   L
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT-EL 185

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               S    L  L  ++NN+    LD L++   L+ L+   N+++  I   +  ++ LT 
Sbjct: 186 D--VSQNKLLNRLNCDTNNITK--LD-LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTY 237

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            D S N L+ E+    S L  L++ +    +L 
Sbjct: 238 FDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 17/152 (11%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L    N    ++   +   ++L  +  S NKI+ +   D+ +   L  L+   N I   L
Sbjct: 153 LDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KL 206

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
               +    L  L   SN L +  +D +  L  L+  +   N ++  +   +  +S LT 
Sbjct: 207 D--LNQNIQLTFLDCSSNKLTE--ID-VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTT 258

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL 154
           L   Q  L  EI    ++   L  F       
Sbjct: 259 LHCIQTDLL-EID--LTHNTQLIYFQAEGCRK 287

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 29/132 (21%), Positives = 56/132 (42%), Gaps = 11/132 (8%)

Query: 24  LQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLD 83
                 +  ++         +L+ L  LD   ++I   +      L+ L  L   SNN+ 
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77

Query: 84  DQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKS 143
              LD L +  NL+ L    N+++ ++   +  ++ LT L+   NKL+ ++    S    
Sbjct: 78  T--LD-LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128

Query: 144 LSSFNVSYNNLS 155
           L+  N + N L+
Sbjct: 129 LTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 70.1 bits (172), Expect = 7e-13
 Identities = 33/205 (16%), Positives = 62/205 (30%), Gaps = 36/205 (17%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGV-------------------MPSDLG 43
                N L+  +  S   LS+L  +      +  +                      D+ 
Sbjct: 238 FDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVT 294

Query: 44  RLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKR 103
             ++L +LD     I   L    S    LV L L +  L +  LD +     L  L+   
Sbjct: 295 HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE--LD-VSHNTKLKSLSCVN 348

Query: 104 NQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLK-----SLSSFNVSYNNLSGPV 158
             I     S +G I  L     ++ +       + +N       S    +   N ++   
Sbjct: 349 AHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IE 405

Query: 159 PTSLALKFNASSFVGNIQLCGYSGS 183
           P    +   A++ +    L   + +
Sbjct: 406 PGDGGVYDQATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 8/89 (8%)

Query: 67  SNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLS 126
            N +S V+   E    D     S ++L  L+ L+   + I+    + I  ++ LT L  +
Sbjct: 18  DNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICT 72

Query: 127 QNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            N ++  +    S   +L+      N L+
Sbjct: 73  SNNIT-TLD--LSQNTNLTYLACDSNKLT 98

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 12/78 (15%), Positives = 31/78 (39%), Gaps = 7/78 (8%)

Query: 78  ESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS 137
           ++ + +D   D      N +       ++      +   ++TLT LD   + ++ ++   
Sbjct: 7   QTQSFNDWFPDD-----NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG- 59

Query: 138 FSNLKSLSSFNVSYNNLS 155
              L  L+    + NN++
Sbjct: 60  IEKLTGLTKLICTSNNIT 77

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 52/210 (24%), Positives = 78/210 (37%), Gaps = 38/210 (18%)

Query: 296 GKSTYGTVYKAT-LEDGSQVAVKRL-REKITKGQREFESEVSLLGKIRHPNLLALRAYYL 353
           G   +G             VAVK + R          + E+     +RHPN++  +   L
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREIINHRSLRHPNIVRFKEVIL 86

Query: 354 GPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMK----------IIKGMTRGLLH 402
            P    L ++ +Y   G L   +   G         R            ++ G++    +
Sbjct: 87  TPT--HLAIIMEYASGGELYERICNAG---------RFSEDEARFFFQQLLSGVS----Y 131

Query: 403 LHSNENIIHGNLTSSNVLLDDST--NAKISDFGLSRLMTAAANVNVIATA-GALGYRAPE 459
            HS   I H +L   N LLD S     KI DFG S+        +   +  G   Y APE
Sbjct: 132 CHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPE 187

Query: 460 -LSKLKKANTKTDVYSLGVTILELLTGKSP 488
            L + +      DV+S GVT+  +L G  P
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 45/207 (21%), Positives = 85/207 (41%), Gaps = 17/207 (8%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREK--ITKGQRE-FESEVSLLGKIRHPNLLALR 349
           ++G+  +  V    ++   QV A+K + +   + +G+   F  E  +L       +  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            ++       L LV +Y   G L T L   G   P +   R  + + +   +  +H    
Sbjct: 127 -HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAE-IVMAIDSVHRL-G 182

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
            +H ++   N+LLD   + +++DFG    + A   V  +   G   Y +PE+ +      
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242

Query: 469 KTDVY-------SLGVTILELLTGKSP 488
            T  Y       +LGV   E+  G++P
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTP 269

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 23/207 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRA 350
           +++G    G V +        + A+K L +   K +RE    V L  +  + P+++ +  
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARRE----VELHWRASQCPHIVRIVD 122

Query: 351 YY---LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLHS 405
            Y      +   L+V + +  G L + +  RG +    +  R   +I+K +   + +LHS
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHS 179

Query: 406 NENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELS 461
             NI H ++   N+L      +   K++DFG ++  T+    N + T      Y APE+ 
Sbjct: 180 I-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVL 235

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +K +   D++SLGV +  LL G  P
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPP 262

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 28/215 (13%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIR---------- 341
             +G   + TV+ A  + + + VA+K +R          E E+ LL ++           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 342 -HPNLLALRA--YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMT 397
              ++L L     + GP G  + +VF+ +   +L   +  +     I      +I K + 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK-KYEHRGIPLIYVKQISKQLL 141

Query: 398 RGLLHLHSNENIIHGNLTSSNVLLDDS------TNAKISDFGLSRLMTAAANVNVIATAG 451
            GL ++H    IIH ++   NVL++           KI+D G +         N I T  
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-NSIQT-- 198

Query: 452 ALGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
              YR+PE+          D++S    I EL+TG 
Sbjct: 199 -REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 80.7 bits (199), Expect = 3e-16
 Identities = 30/157 (19%), Positives = 61/157 (38%), Gaps = 8/157 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
              L  ++            S    ++ + N  +  +      L RL+ L    N +  +
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-N 391

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKL----HNLSVLNLKRNQISGHIPSTIGNI 117
                    ++ SL     +L+     + D+      ++ VLNL  N ++G +   +   
Sbjct: 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-- 449

Query: 118 STLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL 154
             + +LDL  N++   IP   ++L++L   NV+ N L
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 77.6 bits (191), Expect = 4e-15
 Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 8/156 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGV--MPSDLGRLSRLRILDFSYNAIN 59
           FL    N  +  +      L  LQ + L  N +     +      +S L  LD S N++N
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416

Query: 60  -GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
             +   + +   S++ L L SN L   +   L     + VL+L  N+I   IP  + ++ 
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQ 473

Query: 119 TLTILDLSQNKLSGEIP-ASFSNLKSLSSFNVSYNN 153
            L  L+++ N+L   +P   F  L SL    +  N 
Sbjct: 474 ALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 10/163 (6%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
               NL+  +P  L      + +SLS N IS +   D+  LS LR+L  S+N I  SL  
Sbjct: 38  YSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93

Query: 65  S-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQI-SGHIPSTIGNISTLTI 122
             F     L  L +  N L  Q + S   + +L  L+L  N      +    GN++ LT 
Sbjct: 94  HVFLFNQDLEYLDVSHNRL--QNI-SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTF 150

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSF-NVSYNNLSGPVPTSLAL 164
           L LS  K         ++L       ++   ++ G    SL +
Sbjct: 151 LGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 73.4 bits (180), Expect = 8e-14
 Identities = 41/220 (18%), Positives = 78/220 (35%), Gaps = 5/220 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L+L  N++S      +  LSEL+ + LSHN+I  +          L  LD S+N +  ++
Sbjct: 57  LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL-QNI 115

Query: 63  PASFSNLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
                 ++SL  L L  N+ D   +      L  L+ L L   +        + ++    
Sbjct: 116 S--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173

Query: 122 I-LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGY 180
           I LDL    + G    S     +     V + N    V  ++++       + NI+L   
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233

Query: 181 SGSTPCPSPPAEKPKSRGRKLSTKDIILIGAGALLIVLLI 220
           +                   ++ + I      ++ +    
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.1 bits (174), Expect = 4e-13
 Identities = 38/183 (20%), Positives = 75/183 (40%), Gaps = 11/183 (6%)

Query: 2   FLALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            L L +N +   +   +     +L+ + +SHN++  +       ++ LR LD S+N  + 
Sbjct: 80  VLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNI-SCC--PMASLRHLDLSFNDFD- 134

Query: 61  SLP--ASFSNLSSLVSLTLESNNLDDQILDSLDKLH-NLSVLNLKRNQISGHIPSTIGNI 117
            LP    F NL+ L  L L +       L  +  LH +  +L+L    I G    ++   
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194

Query: 118 ST--LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALKFNASSFVGNI 175
           +T  L ++    +  S ++  S + L  L   N+  N+ +     +   +      + N+
Sbjct: 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNV 254

Query: 176 QLC 178
            L 
Sbjct: 255 TLQ 257

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 30/169 (17%), Positives = 53/169 (31%), Gaps = 10/169 (5%)

Query: 3   LALQYNNLSGRIP-----ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNA 57
           L +    ++ RI       S   L  L    + +        +     + + I   S + 
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340

Query: 58  INGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNI 117
                     + SS   L    N   D +      L  L  L L+RN +  +        
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399

Query: 118 STLTILDLSQNKL----SGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL 162
             ++ L+     L    S     + +  +S+   N+S N L+G V   L
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 22/146 (15%), Positives = 48/146 (32%), Gaps = 8/146 (5%)

Query: 18  LGKLSELQEISLSHNKISGVMPSDLGRL---SRLRILDFSYNAINGSLPASFSNLSSLVS 74
           L +   L  ++L H + +      L +      +  L+     I   +       S    
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304

Query: 75  LTLESNNLDDQILDSL-----DKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNK 129
            +L   ++ +Q+              +++  L  +           + S+ T L+ +QN 
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364

Query: 130 LSGEIPASFSNLKSLSSFNVSYNNLS 155
            +  +    S LK L +  +  N L 
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 24/83 (28%), Positives = 41/83 (49%), Gaps = 5/83 (6%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L  N L+G +   L    +++ + L +N+I  + P D+  L  L+ L+ + N +  S
Sbjct: 432 VLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLK-S 487

Query: 62  LP-ASFSNLSSLVSLTLESNNLD 83
           +P   F  L+SL  + L  N  D
Sbjct: 488 VPDGVFDRLTSLQYIWLHDNPWD 510

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 76.2 bits (188), Expect = 5e-16
 Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 11/142 (7%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA-SFSNLSSL 72
           +P ++       EI L  N I  + P       +LR +D S N I+  L   +F  L SL
Sbjct: 30  LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 73  VSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLTILDLSQNKLS 131
            SL L  N + +      + L +L +L L  N+I+  +      ++  L +L L  NKL 
Sbjct: 83  NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141

Query: 132 GEIPASFSNLKSLSSFNVSYNN 153
                +FS L+++ + ++   N
Sbjct: 142 TIAKGTFSPLRAIQTMHL-AQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 2/127 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           + L+ N +    P +     +L+ I LS+N+IS + P     L  L  L    N I   L
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95

Query: 63  PAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT 121
           P S F  L SL  L L +N ++   +D+   LHNL++L+L  N++      T   +  + 
Sbjct: 96  PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155

Query: 122 ILDLSQN 128
            + L+QN
Sbjct: 156 TMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 26/109 (23%), Positives = 53/109 (48%), Gaps = 4/109 (3%)

Query: 49  RILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG 108
             +    N I    P +FS    L  + L +N + +   D+   L +L+ L L  N+I+ 
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 109 HIPSTI-GNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNLS 155
            +P ++   + +L +L L+ NK++  +   +F +L +L+  ++  N L 
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.0 bits (164), Expect = 8e-13
 Identities = 27/105 (25%), Positives = 46/105 (43%), Gaps = 4/105 (3%)

Query: 2   FLALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            + L  N +S  +   +   L  L  + L  NKI+ +  S    L  L++L  + N IN 
Sbjct: 60  RIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN- 117

Query: 61  SLPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN 104
            L   +F +L +L  L+L  N L      +   L  +  ++L +N
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 22/83 (26%), Positives = 36/83 (43%), Gaps = 2/83 (2%)

Query: 2   FLALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            L L  N ++  +P SL   L  LQ + L+ NKI+ +       L  L +L    N +  
Sbjct: 84  SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT 142

Query: 61  SLPASFSNLSSLVSLTLESNNLD 83
               +FS L ++ ++ L  N   
Sbjct: 143 IAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 4/63 (6%)

Query: 95  NLSVLNLKRNQISGHIPSTI-GNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYN 152
            ++ + L++N I   IP         L  +DLS N++S E+   +F  L+SL+S  +  N
Sbjct: 33  TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 153 NLS 155
            ++
Sbjct: 91  KIT 93

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 28/207 (13%)

Query: 296 GKSTYGTVY---KATLEDGSQV-AVKRLREK--ITKGQREFESEVSLLGKIRHPNLLALR 349
           G+ ++G V+   K +  D  Q+ A+K L++     + +   + E  +L ++ HP ++ L 
Sbjct: 33  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL- 91

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKI-IKGMTRGLLHLHS 405
            +Y      KL L+ D++  G L T L       E        +K  +  +   L HLHS
Sbjct: 92  -HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELALALDHLHS 144

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELS 461
              II+ +L   N+LLD+  + K++DFGLS+      +++    A    G + Y APE+ 
Sbjct: 145 L-GIIYRDLKPENILLDEEGHIKLTDFGLSKE-----SIDHEKKAYSFCGTVEYMAPEVV 198

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSP 488
             +      D +S GV + E+LTG  P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 74.0 bits (182), Expect = 1e-15
 Identities = 35/126 (27%), Positives = 56/126 (44%), Gaps = 6/126 (4%)

Query: 8   NNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFS 67
            +  G+I     +   L+ +SL +  +  V  S+L +L +L+ L+ S N I G L     
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 68  NLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRNQIS---GHIPSTIGNISTLTIL 123
            L +L  L L  N L D   L+ L KL  L  L+L   +++    +  S    +  LT L
Sbjct: 93  KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152

Query: 124 DLSQNK 129
           D    +
Sbjct: 153 DGYDRE 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 29/101 (28%), Positives = 42/101 (41%), Gaps = 7/101 (6%)

Query: 49  RILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG 108
            +LD   +   G +    +   +L  L+L +  L    + +L KL  L  L L  N+I G
Sbjct: 29  LVLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLIS--VSNLPKLPKLKKLELSENRIFG 85

Query: 109 HIPSTIGNISTLTILDLSQNKLSG----EIPASFSNLKSLS 145
            +      +  LT L+LS NKL      E       LKSL 
Sbjct: 86  GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 21/92 (22%), Positives = 42/92 (45%), Gaps = 9/92 (9%)

Query: 68  NLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST---LTIL 123
             +++  L L++   +D +I     +  NL  L+L    +      ++ N+     L  L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76

Query: 124 DLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           +LS+N++ G +      L +L+  N+S N L 
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 74.7 bits (184), Expect = 1e-15
 Identities = 35/137 (25%), Positives = 59/137 (43%), Gaps = 9/137 (6%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L      +  ++ A+L  L   + ++LS N I  +  S L  +  LRIL    N I   +
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KI 85

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS--GHIPSTIGNISTL 120
               +   +L  L +  N +    L  ++KL NL VL +  N+I+  G I   +  +  L
Sbjct: 86  ENLDAVADTLEELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKL 142

Query: 121 TILDLSQNKLSGEIPAS 137
             L L+ N L  +   +
Sbjct: 143 EDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 63.5 bits (155), Expect = 7e-12
 Identities = 28/105 (26%), Positives = 49/105 (46%), Gaps = 6/105 (5%)

Query: 51  LDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHI 110
           L      I   + A+ S L +   L L +NN++   + SL  + NL +L+L RN I   I
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK--ISSLSGMENLRILSLGRNLIK-KI 85

Query: 111 PSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            +      TL  L +S N+++  + +    L +L    +S N ++
Sbjct: 86  ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 34/128 (26%), Positives = 59/128 (46%), Gaps = 3/128 (2%)

Query: 3   LALQYNNLSGRIP-ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L  N  +         KL +L++I+ S+NKI+ +        S +  +  + N +  +
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95

Query: 62  LPAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
           +    F  L SL +L L SN +     DS   L ++ +L+L  NQI+   P     + +L
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSL 155

Query: 121 TILDLSQN 128
           + L+L  N
Sbjct: 156 STLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 36/143 (25%), Positives = 71/143 (49%), Gaps = 12/143 (8%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDL-GRLSRLRILDFSYNAINGSLPA-SFSNLSS 71
           IP          E+ L++N+ + +  + +  +L +LR ++FS N I   +   +F   S 
Sbjct: 30  IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 72  LVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLTILDLSQNKL 130
           +  + L SN L++        L +L  L L+ N+I+  + + +   +S++ +L L  N++
Sbjct: 83  VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141

Query: 131 SGEIPASFSNLKSLSSFNVSYNN 153
           +   P +F  L SLS+ N+   N
Sbjct: 142 TTVAPGAFDTLHSLSTLNL-LAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 64.7 bits (158), Expect = 5e-12
 Identities = 30/105 (28%), Positives = 45/105 (42%), Gaps = 4/105 (3%)

Query: 2   FLALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
            +    N ++  I   +    S + EI L+ N++  V       L  L+ L    N I  
Sbjct: 61  KINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT- 118

Query: 61  SLPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN 104
            +   SF  LSS+  L+L  N +      + D LH+LS LNL  N
Sbjct: 119 CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 2/82 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           + L  N L          L  L+ + L  N+I+ V       LS +R+L    N I  ++
Sbjct: 86  ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TV 144

Query: 63  PA-SFSNLSSLVSLTLESNNLD 83
              +F  L SL +L L +N  +
Sbjct: 145 APGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 18/83 (21%), Positives = 33/83 (39%), Gaps = 3/83 (3%)

Query: 75  LTLESNNLDD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGE 133
           L L +N     +      KL  L  +N   N+I+          S +  + L+ N+L   
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95

Query: 134 IPAS-FSNLKSLSSFNVSYNNLS 155
           +    F  L+SL +  +  N ++
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT 118

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 40/288 (13%), Positives = 85/288 (29%), Gaps = 58/288 (20%)

Query: 301 GTVYKATLED---GSQVAVKRLREKITKG---QREFESEVSLLGKIRHPNLLALRAYYLG 354
              ++A   D     QVA+  +  +        +E  S    L +I  P +  +    + 
Sbjct: 45  LQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV--LDVV 100

Query: 355 PKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGN 413
                  +V +++  GSL          +P      ++ ++ +       H    +    
Sbjct: 101 HTRAGGLVVAEWIRGGSLQEVA--DTSPSP---VGAIRAMQSLAAAADAAHRA-GVALSI 154

Query: 414 LTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVY 473
              S V +    +  ++                                   AN + D+ 
Sbjct: 155 DHPSRVRVSIDGDVVLAYPA---------------------TMPD-------ANPQDDIR 186

Query: 474 SLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTL 533
            +G ++  LL  +    PL  A +   +A   ++     +   ++ RD P          
Sbjct: 187 GIGASLYALLVNRW---PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA----- 238

Query: 534 KLALHCVDPSPSARP--EVLQVVQQLEEIRPEAATAATSSGDAGPSTS 579
            +A   V      R    +L ++QQ   +     T      D  P ++
Sbjct: 239 -VAARSVQGDGGIRSASTLLNLMQQATAVAD--RTEVLGPIDEAPVSA 283

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 26/205 (12%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKIRHPNLLALRAY 351
           GK T+G V     +   +  A+K LR+++   + E      E  +L   RHP L AL+  
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73

Query: 352 YLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSNE 407
           +     ++L  V +Y   G L   L       E       R +     +   L +LHS  
Sbjct: 74  FQTH--DRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSR- 124

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELSKL 463
           ++++ ++   N++LD   + KI+DFGL +       ++  AT     G   Y APE+ + 
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKE-----GISDGATMKTFCGTPEYLAPEVLED 179

Query: 464 KKANTKTDVYSLGVTILELLTGKSP 488
                  D + LGV + E++ G+ P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 32/131 (24%), Positives = 50/131 (38%), Gaps = 7/131 (5%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L+   +   I      L +   I  S N+I  +       L RL+ L  + N I    
Sbjct: 24  LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIG 80

Query: 63  PASFSNLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRN---QISGHIPSTIGNIS 118
                 L  L  L L +N+L +   LD L  L +L+ L + RN       +    I  + 
Sbjct: 81  EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVP 140

Query: 119 TLTILDLSQNK 129
            + +LD  + K
Sbjct: 141 QVRVLDFQKVK 151

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 58.1 bits (141), Expect = 4e-10
 Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 8/116 (6%)

Query: 16  ASLGKLSELQEISLSHNKISGVMPSDLGR-LSRLRILDFSYNAINGSLPASFSNLSSLVS 74
           A        +E+ L   KI  +   +LG  L +   +DFS N I   L   F  L  L +
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68

Query: 75  LTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS--GHIPSTIGNISTLTILDLSQN 128
           L + +N +          L +L+ L L  N +   G +   + ++ +LT L + +N
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 16/110 (14%), Positives = 38/110 (34%), Gaps = 13/110 (11%)

Query: 50  ILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDK-LHNLSVLNLKRNQISG 108
           ++  +   I  +  A ++N      L L    +    +++L   L     ++   N+I  
Sbjct: 1   MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIPV--IENLGATLDQFDAIDFSDNEIR- 55

Query: 109 HIPSTIGNIST---LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
                +        L  L ++ N++          L  L+   ++ N+L 
Sbjct: 56  ----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 296 GKSTYGTVY---KATLEDGSQV-AVKRLR-EKITKGQREFE---SEVSLLGKIRHPNLLA 347
           GK  YG V+   K T  +  ++ A+K L+   I +  ++     +E ++L +++HP ++ 
Sbjct: 26  GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD 85

Query: 348 LRAYYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKI-IKGMTRGLLHL 403
           L   Y    G KL L+ +Y+  G L   L   G   E            +  ++  L HL
Sbjct: 86  L--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAEISMALGHL 137

Query: 404 HSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPE 459
           H    II+ +L   N++L+   + K++DFGL +      +++         G + Y APE
Sbjct: 138 HQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-----SIHDGTVTHTFCGTIEYMAPE 191

Query: 460 LSKLKKANTKTDVYSLGVTILELLTGKSP 488
           +      N   D +SLG  + ++LTG  P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 71.6 bits (176), Expect = 4e-15
 Identities = 30/127 (23%), Positives = 60/127 (47%), Gaps = 7/127 (5%)

Query: 3   LALQYN-NLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L  + +  G++     +  EL+ +S  +  ++ +  ++L +L++L+ L+ S N ++G 
Sbjct: 22  LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGG 79

Query: 62  LPASFSNLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRN---QISGHIPSTIGNI 117
           L        +L  L L  N + D   ++ L KL NL  L+L       ++ +  +    +
Sbjct: 80  LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLL 139

Query: 118 STLTILD 124
             LT LD
Sbjct: 140 PQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 30/107 (28%), Positives = 43/107 (40%), Gaps = 7/107 (6%)

Query: 44  RLSRLRILDFSYNAIN-GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLK 102
             S ++ L    +  N G L         L  L+  +  L    + +L KL+ L  L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--IANLPKLNKLKKLELS 72

Query: 103 RNQISGHIPSTIGNISTLTILDLSQNKLSG----EIPASFSNLKSLS 145
            N++SG +         LT L+LS NK+      E      NLKSL 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.0 bits (125), Expect = 4e-08
 Identities = 19/92 (20%), Positives = 41/92 (44%), Gaps = 9/92 (9%)

Query: 68  NLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST---LTIL 123
             S +  L L+++  ++ ++    D+   L  L+     ++     +I N+     L  L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69

Query: 124 DLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
           +LS N++SG +        +L+  N+S N + 
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 44/206 (21%), Positives = 85/206 (41%), Gaps = 17/206 (8%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREK--ITKGQRE-FESEVSLLGKIRHPNLLALR 349
           ++G+  +G V    L++  +V A+K L +   + + +   F  E  +L       +  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKI-IKGMTRGLLHLHSNE 407
            +Y       L LV DY   G L         E  +      +  +  M   +  +H   
Sbjct: 140 -HYAFQDDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEE-MARFYLAEMVIAIDSVHQL- 194

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
           + +H ++   N+L+D + + +++DFG    +     V      G   Y +PE+ +  +  
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254

Query: 468 TKT-----DVYSLGVTILELLTGKSP 488
                   D +SLGV + E+L G++P
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETP 280

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 25/203 (12%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLR-EKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           G  ++G V     ++     A+K L  +K+ K  ++ E   +E  +L  +  P L+ L  
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSN 406
            +       L +V +Y+  G + + L   G   E         +     +     +LHS 
Sbjct: 109 SFKDNS--NLYMVMEYVAGGEMFSHLRRIGRFSEP------HARFYAAQIVLTFEYLHSL 160

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELSKLKK 465
            ++I+ +L   N+L+D     +++DFG ++ +          T  G     APE+   K 
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-----TLCGTPEALAPEIILSKG 214

Query: 466 ANTKTDVYSLGVTILELLTGKSP 488
            N   D ++LGV I E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 16/204 (7%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREK--ITKGQRE-FESEVSLLGKIRHPNLLALR 349
           ++G+  +G V     +   +V A+K L +   I +     F  E  ++     P ++ L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
            +Y       L +V +YMP G L         + P  W  R    + +   L  +HS   
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKW-ARFYTAE-VVLALDAIHSM-G 188

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
            IH ++   N+LLD S + K++DFG    M     V      G   Y +PE+ K +  + 
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248

Query: 469 K----TDVYSLGVTILELLTGKSP 488
                 D +S+GV + E+L G +P
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTP 272

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.0 bits (175), Expect = 1e-13
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 39/210 (18%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLR-EKITKGQREFE---SEVSLLGKIRHPNLLALRA 350
           G  ++G V+        +  A+K L+ E + +  ++ E    E  +L  + HP ++ +  
Sbjct: 15  GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTR--------G 399
            +     +++ ++ DY+  G L + L      P               + +         
Sbjct: 74  TFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNP-------------VAKFYAAEVCLA 118

Query: 400 LLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAP 458
           L +LHS  +II+ +L   N+LLD + + KI+DFG ++ +          T  G   Y AP
Sbjct: 119 LEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAP 172

Query: 459 ELSKLKKANTKTDVYSLGVTILELLTGKSP 488
           E+   K  N   D +S G+ I E+L G +P
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.4 bits (177), Expect = 2e-13
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 27/208 (12%)

Query: 294 IMGKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFESEVS----LLGKIRHPNLLAL 348
           ++GK ++G V  +  +   ++ AVK L++ +     + E  +     L    + P L  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 349 RAYYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLH 404
            + +     ++L  V +Y+  G L   +   G   E               +  GL  L 
Sbjct: 408 HSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFLQ 459

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPEL 460
           S   II+ +L   NV+LD   + KI+DFG+ +      N+    T     G   Y APE+
Sbjct: 460 SK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-----NIWDGVTTKTFCGTPDYIAPEI 513

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSP 488
              +      D ++ GV + E+L G++P
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L LQ   L+    A+   L++L  ++L +N++  +       L+ L  L  + N +  SL
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98

Query: 63  PAS-FSNLSSLVSLTLESNNLDDQILDSL-----DKLHNLSVLNLKRNQISGHIPSTI-G 115
           P   F +L+ L  L L  N    Q L SL     D+L  L  L L  NQ+   IP+    
Sbjct: 99  PLGVFDHLTQLDKLYLGGN----Q-LKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFD 152

Query: 116 NISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNN 153
            ++ L  L LS N+L      +F  L  L +  + + N
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL-FGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS-FSNLSSL 72
           IPA   KL       L    ++ +  +    L++L  L+  YN +  +L A  F +L+ L
Sbjct: 33  IPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTEL 85

Query: 73  VSLTLESNNLDDQILDSL--DKLHNLSVLNLKRNQISGHIPSTI-GNISTLTILDLSQNK 129
            +L L +N L    L     D L  L  L L  NQ+   +PS +   ++ L  L L+ N+
Sbjct: 86  GTLGLANNQL--ASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQ 142

Query: 130 LSGEIPAS-FSNLKSLSSFNVSYNNL 154
           L   IPA  F  L +L + ++S N L
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQL 167

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 31/109 (28%), Positives = 48/109 (44%), Gaps = 8/109 (7%)

Query: 51  LDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDS--LDKLHNLSVLNLKRNQISG 108
           LD     +     A+F  L+ L  L L+ N L  Q L +   D L  L  L L  NQ++ 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL--QTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 109 HIPSTI-GNISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLS 155
            +P  +  +++ L  L L  N+L   +P+  F  L  L    ++ N L 
Sbjct: 98  -LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 30/105 (28%), Positives = 54/105 (51%), Gaps = 4/105 (3%)

Query: 3   LALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L  N L+  +P  +   L++L ++ L  N++  +      RL++L+ L  + N +  S
Sbjct: 88  LGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-S 145

Query: 62  LPAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQ 105
           +PA  F  L++L +L+L +N L      + D+L  L  + L  NQ
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)

Query: 3   LALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L  N L   +P+ +  +L++L+E+ L+ N++  +      +L+ L+ L  S N +   
Sbjct: 112 LYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170

Query: 62  LPASFSNLSSLVSLTLESNNLD 83
              +F  L  L ++TL  N  D
Sbjct: 171 PHGAFDRLGKLQTITLFGNQFD 192

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 72/236 (30%), Positives = 109/236 (46%), Gaps = 39/236 (16%)

Query: 296 GKSTYGTVY---KATLEDGSQV-AVKRLR-EKITKGQREFE---SEVSLLGKIRH-PNLL 346
           G   YG V+   K +  D  ++ A+K L+   I +  +  E   +E  +L  IR  P L+
Sbjct: 63  GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122

Query: 347 ALRAYYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKI-IKGMTRGLLH 402
            L  +Y      KL L+ DY+  G L T L  R    E        ++I +  +   L H
Sbjct: 123 TL--HYAFQTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVGEIVLALEH 174

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAP 458
           LH    II+ ++   N+LLD + +  ++DFGLS+   A         A    G + Y AP
Sbjct: 175 LHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET----ERAYDFCGTIEYMAP 229

Query: 459 E-LSKLKKANTKT-DVYSLGVTILELLTGKSP----GEPLNGAELPQWVASIVKEE 508
           + +      + K  D +SLGV + ELLTG SP    GE  + AE+ +    I+K E
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---RILKSE 282

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.2 bits (170), Expect = 7e-13
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFESEVS----LLGKIRHPNLLALRA 350
           GK ++G V  A  +      AVK L++K    ++E +  +S    LL  ++HP L+ L  
Sbjct: 47  GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHF 106

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKI-IKGMTRGLLHLHSN 406
            +     +KL  V DY+  G L   L       E       R +     +   L +LHS 
Sbjct: 107 SFQTA--DKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASALGYLHSL 158

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELSK 462
            NI++ +L   N+LLD   +  ++DFGL +      N+   +T     G   Y APE+  
Sbjct: 159 -NIVYRDLKPENILLDSQGHIVLTDFGLCKE-----NIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +  +   D + LG  + E+L G  P
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPP 238

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 27/206 (13%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFESEVS----LLGKIRHPNLLALRA 350
           GK ++G V+ A  +  +Q  A+K L++ +     + E  +     L     HP L  +  
Sbjct: 26  GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC 85

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSN 406
            +     E L  V +Y+  G L   + +      +      R       +  GL  LHS 
Sbjct: 86  TFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIILGLQFLHSK 137

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELSK 462
             I++ +L   N+LLD   + KI+DFG+ +      N+   A      G   Y APE+  
Sbjct: 138 -GIVYRDLKLDNILLDKDGHIKIADFGMCKE-----NMLGDAKTNTFCGTPDYIAPEILL 191

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +K N   D +S GV + E+L G+SP
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 46/206 (22%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKI-RHPNLLALRA 350
           G+ +Y  V    L+   ++ A+K +++++     + +    E  +  +   HP L+ L +
Sbjct: 18  GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 77

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSN 406
            +      +L  V +Y+  G L   +  +   PE         +     ++  L +LH  
Sbjct: 78  CFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHER 129

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELSK 462
             II+ +L   NVLLD   + K++D+G+ +       +    T     G   Y APE+ +
Sbjct: 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTPNYIAPEILR 183

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +      D ++LGV + E++ G+SP
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSP 209

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 46/206 (22%), Positives = 85/206 (41%), Gaps = 42/206 (20%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRA 350
           +++G    G V +        + A+K L +   K +RE    V L  +  + P+++ +  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARRE----VELHWRASQCPHIVRIVD 78

Query: 351 YY---LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRM--KIIKGMTRGLLHLHS 405
            Y      +   L+V + +  G L + +  RG +    +  R   +I+K +   + +LHS
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHS 135

Query: 406 NENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSK 462
             NI H ++   N+L      +   K++DFG                       A E + 
Sbjct: 136 I-NIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------AKETTG 172

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +K +   D++SLGV +  LL G  P
Sbjct: 173 -EKYDKSCDMWSLGVIMYILLCGYPP 197

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 53/263 (20%), Positives = 90/263 (34%), Gaps = 68/263 (25%)

Query: 295 MGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-----HPNLLAL 348
           +G   + TV+ +  ++    VA+K ++            E+ LL  +R      PN   +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 349 RA-----YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
                     G  G  + +VF+ + H  L  ++  +     +  P   KII+ + +GL +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWII-KSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 403 LHSNENIIHGNLTSSNVLL----------------------------------------- 421
           LH+   IIH ++   N+LL                                         
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 422 --------DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVY 473
                    +    KI+D G +  +        I T     YR+ E+      NT  D++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKHFT-EDIQT---RQYRSLEVLIGSGYNTPADIW 277

Query: 474 SLGVTILELLTGKSPGEPLNGAE 496
           S      EL TG    EP +G E
Sbjct: 278 STACMAFELATGDYLFEPHSGEE 300

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 1e-12
 Identities = 27/148 (18%), Positives = 51/148 (34%), Gaps = 14/148 (9%)

Query: 17  SLGKLSELQEI--------SLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSN 68
           +L   S L+ +            +K            + +R+L  ++  +  ++      
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQ 461

Query: 69  LSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQN 128
           L  +  L L  N L   +  +L  L  L VL    N +  ++   + N+  L  L L  N
Sbjct: 462 LLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN 518

Query: 129 KLSG-EIPASFSNLKSLSSFNVSYNNLS 155
           +L          +   L   N+  N+L 
Sbjct: 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.8 bits (157), Expect = 4e-11
 Identities = 25/102 (24%), Positives = 42/102 (41%), Gaps = 9/102 (8%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L +N L   +P +L  L  L+ +  S N +  V    +  L RL+ L    N +    
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQ-QS 523

Query: 63  PA--SFSNLSSLVSLTLESNNL---DDQILDSLDKLHNLSVL 99
            A     +   LV L L+ N+L   +       + L ++S +
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 45/206 (21%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKI-RHPNLLALRA 350
           G+ +Y  V    L+   ++ A++ +++++     + +    E  +  +   HP L+ L +
Sbjct: 61  GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSN 406
            +      +L  V +Y+  G L   +  +   PE         +     ++  L +LH  
Sbjct: 121 CFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHER 172

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELSK 462
             II+ +L   NVLLD   + K++D+G+ +       +    T     G   Y APE+ +
Sbjct: 173 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTPNYIAPEILR 226

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +      D ++LGV + E++ G+SP
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSP 252

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 64/344 (18%), Positives = 108/344 (31%), Gaps = 100/344 (29%)

Query: 296 GKSTYGTVYKATL------EDGSQVAVKRLREKITKG-QREFESEVSLLGKI-------- 340
           G+  +G V +A             VAVK L+E  T    R   SE+ +L  I        
Sbjct: 31  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90

Query: 341 -------------------RHPNLLA-LRAYYLGPKGEKLLVFDYMPHGSLATFLH---- 376
                              +  NL   LR+        K     +         +     
Sbjct: 91  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLK 150

Query: 377 ---------------ARGPETPIDWPTRMKIIKGMTRGLLHLH----------------S 405
                              E  +      +  + + +  L L                 +
Sbjct: 151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 210

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYR--APELSKL 463
           +   IH +L + N+LL +    KI DFGL+R +       V      L  +  APE    
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMAPETIFD 269

Query: 464 KKANTKTDVYSLGVTILELLT-GKSP--GEPLNGAELPQWVASIVK----EEWTNEVFDL 516
           +    ++DV+S GV + E+ + G SP  G  ++  E  + +    +    +  T E++  
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMY-- 326

Query: 517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           + M D                 C    PS RP   ++V+ L  +
Sbjct: 327 QTMLD-----------------CWHGEPSQRPTFSELVEHLGNL 353

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 27/206 (13%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKI-RHPNLLALRA 350
           GK ++G V  +  +   ++ AVK L++ +     + E    E  +L    + P L  L +
Sbjct: 29  GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSN 406
            +     ++L  V +Y+  G L   +   G   E               +  GL  L S 
Sbjct: 89  CFQTM--DRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFLQSK 140

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELSK 462
             II+ +L   NV+LD   + KI+DFG+ +      N+    T     G   Y APE+  
Sbjct: 141 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-----NIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
            +      D ++ GV + E+L G++P
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAP 220

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.4 bits (161), Expect = 4e-12
 Identities = 30/187 (16%), Positives = 57/187 (30%), Gaps = 43/187 (22%)

Query: 295 MGKSTYGTVYKATLEDGSQVAVKRLR--------EKITKGQREFESEVSLLGKI------ 340
           +G+  +G V++    D + VA+K +             K   E   E+ +  ++      
Sbjct: 28  IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 341 ---RHPNLLALRAYYL--GPKGEKLL-VFDYMP--HGSLATFLHARGPETP--------- 383
              R    + L + +   G     LL  +D+     GS          +           
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 384 -----------IDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDF 432
                          T   I+  +T  L    ++    H +L   NVLL  ++  K+   
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYT 206

Query: 433 GLSRLMT 439
              +  T
Sbjct: 207 LNGKSST 213

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 27/206 (13%)

Query: 296 GKSTYGTVYKATLEDGSQV-AVKRLREKITKGQREFES---EVSLLGKI-RHPNLLALRA 350
           GK ++G V  A +++   + AVK L++ +     + E    E  +L     HP L  L  
Sbjct: 32  GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKG-MTRGLLHLHSN 406
            +  P  ++L  V +++  G L   +       E       R +     +   L+ LH  
Sbjct: 92  CFQTP--DRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISALMFLHDK 143

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA----GALGYRAPELSK 462
             II+ +L   NVLLD   + K++DFG+ +       +    T     G   Y APE+ +
Sbjct: 144 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-----GICNGVTTATFCGTPDYIAPEILQ 197

Query: 463 LKKANTKTDVYSLGVTILELLTGKSP 488
                   D +++GV + E+L G +P
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 54/226 (23%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREF----ESEVSLLGKIRHPNLLA 347
           +++GK ++G V KA   +    VA+K     + + ++ F      E+ +L  +R      
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRK----- 152

Query: 348 LRAYYLGPKGEKLLV-----FDYMPH---------GSLATFLHARGPETPIDWPTRMKII 393
                        ++     F +  H          +L   +  +        P   K  
Sbjct: 153 -----QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELI-KKNKFQGFSLPLVRKFA 206

Query: 394 KGMTRGLLHLHSNENIIHGNLTSSNVLL--DDSTNAKISDFGLS-----RLMTAAANVNV 446
             + + L  LH N  IIH +L   N+LL     +  K+ DFG S     R+ T       
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT------Y 259

Query: 447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKS--PGE 490
           I +     YRAPE+    +     D++SLG  + ELLTG    PGE
Sbjct: 260 IQS---RFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 20/146 (13%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS-FSNLSSL 72
           IP +   L       L  N+I+ + P     L  L+ L    N +  +LP   F +L+ L
Sbjct: 38  IPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 73  VSLTLESNNLDDQILDSL-----DKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ 127
             L L +N L       L     D+L +L  L +  N+++  +P  I  ++ LT L L Q
Sbjct: 91  TVLDLGTNQLT-----VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQ 144

Query: 128 NKLSGEIPASFSNLKSLSSFNVSYNN 153
           N+L      +F  L SL+   + + N
Sbjct: 145 NQLKSIPHGAFDRLSSLTHAYL-FGN 169

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.8 bits (152), Expect = 8e-11
 Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 2/98 (2%)

Query: 8   NNLSGRIPASLGKLSELQEISLSHNK-ISGVMPSDLGRLSRLRILDFSYNAINGSLPASF 66
            + +      L     L E+ + + + +  +   DL  L  LR L    + +    P +F
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 67  SNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN 104
                L  L L  N L+     ++  L +L  L L  N
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.8 bits (144), Expect = 7e-10
 Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 2/82 (2%)

Query: 3   LALQYNNLSGRIPA-SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L ++       +    L  L EL+ +++  + +  V P       RL  L+ S+NA+   
Sbjct: 36  LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESL 95

Query: 62  LPASFSNLSSLVSLTLESNNLD 83
              +   L SL  L L  N L 
Sbjct: 96  SWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.4 bits (130), Expect = 4e-08
 Identities = 21/95 (22%), Positives = 33/95 (34%), Gaps = 2/95 (2%)

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQI-LDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
                     +L  L +E+      + L  L  L  L  L + ++ +    P        
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL 154
           L+ L+LS N L      +   L SL    +S N L
Sbjct: 82  LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 6e-08
 Identities = 17/72 (23%), Positives = 30/72 (41%), Gaps = 3/72 (4%)

Query: 86  ILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLTILDLSQNKLSGEIPA-SFSNLKS 143
            L  L    NL+ L ++  Q   H+    +  +  L  L + ++ L   +   +F     
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 144 LSSFNVSYNNLS 155
           LS  N+S+N L 
Sbjct: 82  LSRLNLSFNALE 93

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 29/153 (18%), Positives = 57/153 (37%), Gaps = 19/153 (12%)

Query: 22  SELQEISLSHNKISGVMPSDLGR-LSRLRILDFSYNAIN----GSLPASFSNLSSLVSLT 76
            ++Q + +   ++S    ++L   L + +++      +       + ++     +L  L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 77  LESNNLDDQ----ILDSLDKLH-NLSVLNLKRNQIS----GHIPSTIGNISTLTILDLSQ 127
           L SN L D     +L  L      +  L+L+   ++    G + ST+  + TL  L LS 
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 128 NKLSGE-----IPASFSNLKSLSSFNVSYNNLS 155
           N L                  L    + Y +LS
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 29/180 (16%), Positives = 60/180 (33%), Gaps = 27/180 (15%)

Query: 3   LALQYNNLSGR----IPASLGKLSELQEISLSHNKISGVMPSDLGRL-----SRLRILDF 53
           + L    L+      I ++L     L E++L  N++  V    + +       +++ L  
Sbjct: 33  VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 92

Query: 54  SYNAIN----GSLPASFSNLSSLVSLTLESNNLDDQ----ILDSLDKLH-NLSVLNLKRN 104
               +     G L ++   L +L  L L  N L D     + + L      L  L L+  
Sbjct: 93  QNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC 152

Query: 105 QIS----GHIPSTIGNISTLTILDLSQNKLSGE-----IPASFSNLKSLSSFNVSYNNLS 155
            +S      + S +        L +S N ++             +   L +  +    ++
Sbjct: 153 SLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 38/180 (21%), Positives = 63/180 (35%), Gaps = 27/180 (15%)

Query: 3   LALQYNNLSGR----IPASLGKLSELQEISLSHNKI--SGVM---PSDLGRLSRLRILDF 53
           L L+   ++      +   +   + L+E++L  NK+   G+    P  L   SRLR L  
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 54  SYNAIN----GSLPASFSNLSSLVSLTLESNNLDD----QILDSLDKLH-NLSVLNLKRN 104
               I     G L        SL  L+L  N L D     + ++L +    L  L +K  
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323

Query: 105 QISG----HIPSTIGNISTLTILDLSQNKLSGEIPASFS-----NLKSLSSFNVSYNNLS 155
             +     H  S +     L  L +S N+L                  L    ++  ++S
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 22/151 (14%)

Query: 3   LALQYNNLSGR----IPASLGKLSELQEISLSHNKISGVMPSDLGRL-----SRLRILDF 53
           L +    ++ +    +   L     L+E+SL+ N++       L         +L  L  
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320

Query: 54  SYNAING----SLPASFSNLSSLVSLTLESNNLDD----QILDSLDKLH-NLSVLNLKRN 104
              +          +  +    L+ L + +N L+D    ++   L +    L VL L   
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380

Query: 105 QIS----GHIPSTIGNISTLTILDLSQNKLS 131
            +S      + +T+    +L  LDLS N L 
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.9 bits (152), Expect = 2e-10
 Identities = 53/289 (18%), Positives = 93/289 (32%), Gaps = 83/289 (28%)

Query: 295 M---GKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVS-L-LGKIRHPNLLALR 349
           +   GK+               VA+        K Q + + ++  L L     P  +   
Sbjct: 158 VLGSGKTW--------------VALDVCLSY--KVQCKMDFKIFWLNLKNCNSPETVL-- 199

Query: 350 AYYLGPKGEKL--LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
                   E L  L++   P+        +R  +   +   R+  I+   R LL     E
Sbjct: 200 --------EMLQKLLYQIDPN------WTSR-SDHSSNIKLRIHSIQAELRRLLKSKPYE 244

Query: 408 N--IIHGNLTSSNVLLDDSTNAKISD-FGLS-R-LMTAAANVNVIATAGALGYRAPELSK 462
           N  ++          L +  NAK  + F LS + L+T      V     A       L  
Sbjct: 245 NCLLV----------LLNVQNAKAWNAFNLSCKILLTTR-FKQVTDFLSAATTTHISLDH 293

Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
                T  +V SL +  L+      P E L     P+ ++ I            E +RD 
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN--PRRLSIIA-----------ESIRDG 340

Query: 523 PTI--------GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
                       D+L   ++ +L+ ++P      E  ++  +L  + P 
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEP-----AEYRKMFDRL-SVFPP 383

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 2e-06
 Identities = 52/330 (15%), Positives = 101/330 (30%), Gaps = 63/330 (19%)

Query: 273 LVHFDGPLMFTAD----DLLCATAEIMGKSTYGTVYKA-TLEDGSQVAVKRLREKITKGQ 327
           L  F+    F  +    D+      I+ K     +  +     G+      L  K  +  
Sbjct: 22  LSVFEDA--FVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV 79

Query: 328 REFESEVSLLGKIRHPN---LL-ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETP 383
           ++F      + ++   N   L+  ++     P     +  +          L+       
Sbjct: 80  QKF------VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR------LYNDNQVFA 127

Query: 384 IDWPTRMKIIKGMTRGLLHLHSNENI-IHG-------NLTSSNVLLDDSTNAKISDFG-- 433
               +R++    + + LL L   +N+ I G        +    V L      K+ DF   
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD-VCLSYKVQCKM-DFKIF 185

Query: 434 ---LSRLMTAAANVNVIATAGALGYRA-PELSKLKK--ANTKTDVYSLGVTILELLTGKS 487
              L    +      V+     L Y+  P  +      +N K  ++S+   +  LL  K 
Sbjct: 186 WLNLKNCNSPET---VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK- 241

Query: 488 PGEPLNGAELPQWVASIVKEEWTNEVFDLE---LM--RDAPTIGDELLNTLKLALHCVDP 542
              P     L   V   V+       F+L    L+  R    + D L       +     
Sbjct: 242 ---PYENCLL---VLLNVQNAKAWNAFNLSCKILLTTRFK-QVTDFLSAATTTHISLDHH 294

Query: 543 SPS-ARPEVLQVV-----QQLEEIRPEAAT 566
           S +    EV  ++      + +++  E  T
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 31/192 (16%), Positives = 60/192 (31%), Gaps = 39/192 (20%)

Query: 3   LALQYNNLSGR----IPASLGKLSELQEISLSHNKISG----VMPSDLGRLSRLRILDFS 54
            +L+ + ++      + A L +   ++EI LS N I       +  ++     L I +FS
Sbjct: 9   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 68

Query: 55  YNAIN----------GSLPASFSNLSSLVSLTLESNNLDDQ----ILDSLDKLHNLSVLN 100
                            L  +      L ++ L  N         ++D L K   L  L 
Sbjct: 69  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 128

Query: 101 LKRNQIS-------------GHIPSTIGNISTLTILDLSQNKLSGE----IPASFSNLKS 143
           L  N +                +     N   L  +   +N+L          +F + + 
Sbjct: 129 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 188

Query: 144 LSSFNVSYNNLS 155
           L +  +  N + 
Sbjct: 189 LHTVKMVQNGIR 200

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 29/188 (15%), Positives = 56/188 (29%), Gaps = 37/188 (19%)

Query: 5   LQYNNLSGRIPASLGKLSE-------LQEISLSHNKIS--GVMP--SDLGRLSRLRILDF 53
           +    +   IP +L  L +       L  + LS N        P    L + + L  L  
Sbjct: 70  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 129

Query: 54  SYNAI-------------NGSLPASFSNLSSLVSLTLESNNLDDQ----ILDSLDKLHNL 96
             N +               ++     N   L S+    N L++        +      L
Sbjct: 130 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189

Query: 97  SVLNLKRNQI-----SGHIPSTIGNISTLTILDLSQNKLSGE----IPASFSNLKSLSSF 147
             + + +N I        +   +     L +LDL  N  +      +  +  +  +L   
Sbjct: 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249

Query: 148 NVSYNNLS 155
            ++   LS
Sbjct: 250 GLNDCLLS 257

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 32/190 (16%), Positives = 64/190 (33%), Gaps = 38/190 (20%)

Query: 3   LALQYNNLSGR----IPASLGKLSELQEISLSHNKIS-------------GVMPSDLGRL 45
           + L  N         +   L K + L+ + L +N +                +       
Sbjct: 99  VRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNA 158

Query: 46  SRLRILDFSYNAI-NGSLPA---SFSNLSSLVSLTLESNNLDDQ-----ILDSLDKLHNL 96
             LR +    N + NGS+     +F +   L ++ +  N +  +     +L+ L     L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218

Query: 97  SVLNLKRNQISG----HIPSTIGNISTLTILDLSQNKLS-------GEIPASFSNLKSLS 145
            VL+L+ N  +      +   + +   L  L L+   LS        +  +   N   L 
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN-IGLQ 277

Query: 146 SFNVSYNNLS 155
           +  + YN + 
Sbjct: 278 TLRLQYNEIE 287

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 29/134 (21%), Positives = 49/134 (36%), Gaps = 20/134 (14%)

Query: 18  LGKLSELQEISLSHNKIS--GVMP---SDLGRLSRLRILDFSYNAING----SLPASFSN 68
                 L  + +  N I   G+       L     L++LD   N        +L  +  +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242

Query: 69  LSSLVSLTLESNNLDDQ----ILDSLDKLHN--LSVLNLKRNQISGHIPSTIG-----NI 117
             +L  L L    L  +    ++D+  KL N  L  L L+ N+I      T+       +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302

Query: 118 STLTILDLSQNKLS 131
             L  L+L+ N+ S
Sbjct: 303 PDLLFLELNGNRFS 316

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 50/220 (22%), Positives = 85/220 (38%), Gaps = 50/220 (22%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREF----ESEVSLLGKIRHPNLLA 347
            ++GK ++G V KA    +   VA+K     I K ++ F    + EV LL  +       
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNK----- 109

Query: 348 LRAYYLGPKGEKLLV-----FDYMPH---------GSLATFLHARGPETPIDWPTRMKII 393
                   + +  +V     F +  H          +L   L              + + 
Sbjct: 110 -----HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFR-----GVSLNLT 159

Query: 394 KGMTR----GLLHLHSNE-NIIHGNLTSSNVLLDDSTNA--KISDFGLSRLMTAAANVNV 446
           +   +     LL L + E +IIH +L   N+LL +   +  KI DFG S           
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQY 218

Query: 447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGK 486
           I +     YR+PE+      +   D++SLG  ++E+ TG+
Sbjct: 219 IQSR---FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 21/162 (12%)

Query: 4   ALQYNNLSGRIPASLG---KLSELQEISLSHNKISGVMPSDLG---RLSRLRILDFSYNA 57
           ++     +     S+     L  ++ ++L  NK+      D+     L+ L  L  + N 
Sbjct: 42  SIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQ 96

Query: 58  INGSLPAS-FSNLSSLVSLTLESNNLDDQILDS--LDKLHNLSVLNLKRNQISGHIPSTI 114
           +  SLP   F  L++L  L L  N L  Q L     DKL NL+ LNL  NQ+   +P  +
Sbjct: 97  LQ-SLPNGVFDKLTNLKELVLVENQL--QSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGV 152

Query: 115 -GNISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNL 154
              ++ LT LDLS N+L   +P   F  L  L    +  N L
Sbjct: 153 FDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 19/107 (17%), Positives = 42/107 (39%), Gaps = 12/107 (11%)

Query: 51  LDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHI 110
            +    ++        + L+S+  +   ++++  + +  +  L N+  L L  N++    
Sbjct: 24  ANLKKKSVT-DAVT-QNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH--- 76

Query: 111 PSTIG---NISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL 154
              I     ++ LT L L+ N+L       F  L +L    +  N L
Sbjct: 77  --DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 21/122 (17%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA-SFSNLSSL 72
           IP  +       E+ L  N+ + V P +L     L ++D S N I+ +L   SFSN++ L
Sbjct: 29  IPRDV------TELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 73  VSLTLESNNLDDQILDSL-----DKLHNLSVLNLKRNQISGHIPSTI-GNISTLTILDLS 126
           ++L L  N      L  +     D L +L +L+L  N IS  +P     ++S L+ L + 
Sbjct: 81  LTLILSYNR-----LRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIG 134

Query: 127 QN 128
            N
Sbjct: 135 AN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.1 bits (110), Expect = 7e-06
 Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 3/83 (3%)

Query: 74  SLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGE 133
            L L+ N     +   L    +L++++L  N+IS     +  N++ L  L LS N+L   
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 134 IPA-SFSNLKSLSSFNVSYNNLS 155
           IP  +F  LKSL   ++  N++S
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDIS 115

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 25/106 (23%), Positives = 41/106 (38%), Gaps = 27/106 (25%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L  N  +  +P  L     L  I LS+N+IS +       +++L  L  SYN +   +
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93

Query: 63  PA-------------------------SFSNLSSLVSLTLESNNLD 83
           P                          +F++LS+L  L + +N L 
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 10/110 (9%)

Query: 49  RILDFSYNAINGSLPAS--FSNLSSLVSLTLESNNLDDQILDS--LDKLHNLSVLNLKRN 104
             L  + N +   + +   F  L  LV L L+ N L    ++    +   ++  L L  N
Sbjct: 32  TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQL--TGIEPNAFEGASHIQELQLGEN 88

Query: 105 QISGHIPSTI-GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNN 153
           +I   I + +   +  L  L+L  N++S  +P SF +L SL+S N+  +N
Sbjct: 89  KIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL-ASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 28/105 (26%), Positives = 47/105 (44%), Gaps = 5/105 (4%)

Query: 3   LALQYNNLSGRIP-ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L L  N L         G+L  L ++ L  N+++G+ P+     S ++ L    N I   
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92

Query: 62  LPA-SFSNLSSLVSLTLESNNLDDQILD-SLDKLHNLSVLNLKRN 104
           +    F  L  L +L L  N +   ++  S + L++L+ LNL  N
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 29/81 (35%), Positives = 43/81 (53%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L+ N L+G  P +    S +QE+ L  NKI  +       L +L+ L+   N I+  +
Sbjct: 59  LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118

Query: 63  PASFSNLSSLVSLTLESNNLD 83
           P SF +L+SL SL L SN  +
Sbjct: 119 PGSFEHLNSLTSLNLASNPFN 139

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.7 bits (132), Expect = 9e-09
 Identities = 43/147 (29%), Positives = 59/147 (40%), Gaps = 21/147 (14%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS-FSNLSSL 72
           IPA    L       L  N +  +       L+ L  L    N +  SLP   F+ L+SL
Sbjct: 26  IPAQTTYLD------LETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 73  VSLTLESNNLDDQILDSL-----DKLHNLSVLNLKRNQISGHIPSTI-GNISTLTILDLS 126
             L L +N      L SL     DKL  L  L L  NQ+   +P  +   ++ L  L L 
Sbjct: 79  TYLNLSTNQ-----LQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLY 132

Query: 127 QNKLSGEIPASFSNLKSLSSFNVSYNN 153
           QN+L       F  L SL    + ++N
Sbjct: 133 QNQLKSVPDGVFDRLTSLQYIWL-HDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 14/133 (10%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L+ N+L         +L+ L ++ L  NK+  +      +L+ L  L+ S N +  SL
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91

Query: 63  PAS-FSNLSSLVSLTLESNNLDDQILDSL-----DKLHNLSVLNLKRNQISGHIPSTI-G 115
           P   F  L+ L  L L +N      L SL     DKL  L  L L +NQ+   +P  +  
Sbjct: 92  PNGVFDKLTQLKELALNTNQ-----LQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFD 145

Query: 116 NISTLTILDLSQN 128
            +++L  + L  N
Sbjct: 146 RLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 8/110 (7%)

Query: 49  RILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDS--LDKLHNLSVLNLKRNQI 106
             LD   N++       F  L+SL  L L  N L  Q L +   +KL +L+ LNL  NQ+
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL--QSLPNGVFNKLTSLTYLNLSTNQL 88

Query: 107 SGHIPSTI-GNISTLTILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYNNL 154
              +P+ +   ++ L  L L+ N+L   +P   F  L  L    +  N L
Sbjct: 89  QS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 53.4 bits (127), Expect = 8e-08
 Identities = 21/152 (13%), Positives = 47/152 (30%), Gaps = 20/152 (13%)

Query: 2   FLALQYNNLSGRIPASLGKLS--ELQEISLSHNKISGVMPSDLG--RLSRLRILDFSYNA 57
              L    + G    S+GK     L+ + +    +   +  D+    L  L  L      
Sbjct: 171 MPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGV 230

Query: 58  INGSLPASFSNLS---------SLVSLTLESNNLDDQILDSL---DKLHNLSVLNLKRNQ 105
            +       +            +L  L +      + +++     D L  L  +++    
Sbjct: 231 EDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290

Query: 106 ISG----HIPSTIGNISTLTILDLSQNKLSGE 133
           ++      +   +  I  L  +++  N LS E
Sbjct: 291 LTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 26/154 (16%), Positives = 53/154 (34%), Gaps = 21/154 (13%)

Query: 24  LQEISLSHNKISGVMPSDLGRL-----SRLRILDFSYNAINGS-----LPASFSNLSSLV 73
           +  ++L  N ++    ++L +      + +  LD S N +             S  + +V
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228

Query: 74  SLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQISG-------HIPSTIGNISTLTI 122
           SL L  N L       +    D L +L  + L  + +          + +   NI  + +
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
           +D +  ++        SNL    S      +L  
Sbjct: 289 VDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 32/170 (18%), Positives = 67/170 (39%), Gaps = 31/170 (18%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRL-----SRLRILDFSYNAINGSLPASF-- 66
           +         +  + LS N +  +   +L +      + +  L+ S N++          
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 67  ---SNLSSLVSLTLESNNLDDQ----ILDSLDKLH-NLSVLNLKRNQISG----HIPSTI 114
              +  +++ SL L  N L  +    ++ +L  +   ++VL+L  N  S           
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133

Query: 115 GNI-STLTILDLSQNKLSGE--------IPASFSNLKSLSSFNVSYNNLS 155
            N+ +++T L+L  N L  +        + A  +N+ SL   N+  NNL+
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL---NLRGNNLA 180

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 49.6 bits (119), Expect = 3e-07
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 7/108 (6%)

Query: 49  RILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDS--LDKLHNLSVLNLKRNQI 106
             L+   N +       F  L+ L  L+L  N +  Q L     DKL  L++L L  N++
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI--QSLPDGVFDKLTKLTILYLHENKL 88

Query: 107 SGHIPSTI-GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNN 153
              +P+ +   ++ L  L L  N+L       F  L SL    + + N
Sbjct: 89  QS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL-HTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 36/121 (29%), Positives = 49/121 (40%), Gaps = 18/121 (14%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS-FSNLSSL 72
           IP+S  +L       L  NK+  +      +L++L  L  S N I  SLP   F  L+ L
Sbjct: 26  IPSSATRLE------LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78

Query: 73  VSLTLESNNLDDQILDSL-----DKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ 127
             L L  N      L SL     DKL  L  L L  NQ+          +++L  + L  
Sbjct: 79  TILYLHENK-----LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 133

Query: 128 N 128
           N
Sbjct: 134 N 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.4 bits (103), Expect = 4e-05
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 2/104 (1%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L+ N L         KL++L ++SLS N+I  +      +L++L IL    N +  SL
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SL 91

Query: 63  PAS-FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQ 105
           P   F  L+ L  L L++N L        D+L +L  + L  N 
Sbjct: 92  PNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 47/261 (18%), Positives = 79/261 (30%), Gaps = 77/261 (29%)

Query: 277 DGPLMFTADDLLCATAEI---MGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREF-- 330
                +    LL     +   MG  T+G V     +++    AV     K+ +  +++  
Sbjct: 22  IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAV-----KVVRNIKKYTR 76

Query: 331 --ESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV-----FDYMPH---------GSLATF 374
             + E  +L KI++                  +V     F Y  H          SL   
Sbjct: 77  SAKIEADILKKIQN-----------DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEI 125

Query: 375 LHARGPETPIDWPTRMKIIKGMTRGLL----HLHSNENIIHGNLTSSNVLLDDSTNAKIS 430
           +              ++ IK     +L    +L    ++ H +L   N+LLDD    K  
Sbjct: 126 ITRNNYN-----GFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSL 179

Query: 431 DFGLSRLMTAAANVNVIATAGA----LG-----------------YRAPE----LSKLKK 465
                        +    + G      G                 YRAPE    L     
Sbjct: 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNL----G 235

Query: 466 ANTKTDVYSLGVTILELLTGK 486
            +  +D++S G  + EL TG 
Sbjct: 236 WDVSSDMWSFGCVLAELYTGS 256

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 33/160 (20%), Positives = 61/160 (38%), Gaps = 10/160 (6%)

Query: 2   FLALQYNNLS-GRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSY--NAI 58
            + L  + +    +   L + S+LQ +SL   ++S  + + L + S L  L+ S      
Sbjct: 97  HMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 156

Query: 59  NGSLPASFSNLSSLVSLTLES-NNLDDQILDSL--DKLHNLSVLNLK--RNQIS-GHIPS 112
             +L    S+ S L  L L    +  ++ +          ++ LNL   R  +    + +
Sbjct: 157 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 216

Query: 113 TIGNISTLTILDLSQ-NKLSGEIPASFSNLKSLSSFNVSY 151
            +     L  LDLS    L  +    F  L  L   ++S 
Sbjct: 217 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 256

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 4/116 (3%)

Query: 15  PASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAIN-GSLPASFSNLSSL 72
           P   G+L     I+    +     P ++     R++ +D S + I   +L    S  S L
Sbjct: 61  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120

Query: 73  VSLTLESNNLDDQILDSLDKLHNLSVLNLKR-NQISGHIPSTIG-NISTLTILDLS 126
            +L+LE   L D I+++L K  NL  LNL   +  S     T+  + S L  L+LS
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 176

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 48/252 (19%), Positives = 84/252 (33%), Gaps = 88/252 (34%)

Query: 293 EIMGKSTYGTVYKA--TLEDGSQVAVKRLREKITKGQREF----ESEVSLLGKIRHPNLL 346
             +G+ T+G V +        SQVA+K     I +   ++      E+++L KI+  +  
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALK-----IIRNVGKYREAARLEINVLKKIKEKD-- 77

Query: 347 ALRAYYLGPKGEKLLV-----FDYMPH---------GSLATFLHARGPETPIDWPTRMKI 392
                    + + L V     F++  H          +   FL     +     P  +  
Sbjct: 78  --------KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQ-----PYPLPH 124

Query: 393 IKGMTRGLL----HLHSNENIIHGNLTSSNVLLDDSTNA-------------------KI 429
           ++ M   L      LH N  + H +L   N+L  +S                      ++
Sbjct: 125 VRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 430 SDFGLS-----RLMTAAANVNVIATAGALGYRAPE----LSKLKKANTKTDVYSLGVTIL 480
           +DFG +        T      ++AT     YR PE    L          DV+S+G  + 
Sbjct: 184 ADFGSATFDHEHHTT------IVATR---HYRPPEVILEL----GWAQPCDVWSIGCILF 230

Query: 481 ELLTGKS--PGE 490
           E   G +     
Sbjct: 231 EYYRGFTLFQTH 242

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 13/155 (8%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLS----RLRILDFSYNAIN---GSLPASF 66
           + A       L+E+ L  + +  V    L         L  L+ S  A      +L    
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLV 207

Query: 67  SNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLK------RNQISGHIPSTIGNISTL 120
           +   +L SL L      +++   L +   L  L         R  +   +   +     L
Sbjct: 208 TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKEL 267

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             L    + +   +PA +S    L++ N+SY  + 
Sbjct: 268 RCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 26/145 (17%), Positives = 52/145 (35%), Gaps = 12/145 (8%)

Query: 14  IPASLGKLSELQEISLS------HNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFS 67
           +   L +  +L+E+            +   +   L     LR L   ++A+   LPA +S
Sbjct: 227 LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS 286

Query: 68  NLSSLVSLTLESNNL-DDQILDSLDKLHNLSVLNLKRNQIS----GHIPSTIGNISTLTI 122
             S L +L L    +    ++  L +   L  L +  + I       + ST  ++  L +
Sbjct: 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLRELRV 345

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSF 147
                  +   +  +   L S+S  
Sbjct: 346 FPSEPFVMEPNVALTEQGLVSVSMG 370

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 50/247 (20%), Positives = 80/247 (32%), Gaps = 78/247 (31%)

Query: 293 EIMGKSTYGTVYKA--TLEDGSQVAVKRLREKITKGQREF----ESEVSLLGKIRHPNLL 346
           + +G+  +G V +       G  VAVK     I K    +     SE+ +L  +   +  
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVK-----IVKNVDRYCEAARSEIQVLEHLNTTD-- 72

Query: 347 ALRAYYLGPKGEKLLV-----FDYMPH---------GSLATFLHARGPETPIDWPTRMKI 392
                   P      V     F++  H          S   F+   G       P R+  
Sbjct: 73  --------PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFL-----PFRLDH 119

Query: 393 IKGMTRGLL----HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN--VNV 446
           I+ M   +      LHSN  + H +L   N+L   S   +  +  + R      N  + V
Sbjct: 120 IRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 447 IATAGALG-----------------YRAPE----LSKLKKANTKTDVYSLGVTILELLTG 485
           +      G                 YRAPE    L      +   DV+S+G  ++E   G
Sbjct: 179 VD----FGSATYDDEHHSTLVSTRHYRAPEVILAL----GWSQPCDVWSIGCILIEYYLG 230

Query: 486 KS--PGE 490
            +  P  
Sbjct: 231 FTVFPTH 237

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 29/180 (16%), Positives = 56/180 (31%), Gaps = 29/180 (16%)

Query: 3   LALQYNNLSGRIPASLGK-LSELQEISLSHNKIS--GVMPSDLGRL-----SRLRILDFS 54
           + L    L      +L       +++ L  N +         L  L      ++  L  S
Sbjct: 106 VNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKD--LRDLLLHDQCQITTLRLS 163

Query: 55  YNAINGS----LPASFSNLSSLVSLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQI 106
            N +  +    L    +  +S+  L+L    L D+    +   LD+   L  LN+  N  
Sbjct: 164 NNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223

Query: 107 SG----HIPSTIGNISTLTILDLSQNKLS-------GEIPASFSNLKSLSSFNVSYNNLS 155
                  +        +L +L L  N+LS        ++  +      +         +S
Sbjct: 224 GDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 24/151 (15%), Positives = 55/151 (36%), Gaps = 19/151 (12%)

Query: 24  LQEISLSHNKISGVMPSDLGRL-----SRLRILDFSYNAING-SLPASFSNLSSLVSLTL 77
           L++++L+  +++ V  + +  +       L  ++ +   ++   L            L L
Sbjct: 74  LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133

Query: 78  ESNNLDDQILDSL-----DKLHNLSVLNLKRNQISG----HIPSTIGNISTLTILDLSQN 128
           + N+L  +    L          ++ L L  N ++      +   +   +++T L L   
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHT 193

Query: 129 KLSGE----IPASFSNLKSLSSFNVSYNNLS 155
            L  E    + A     + L   NV+YN   
Sbjct: 194 GLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 30/167 (17%), Positives = 57/167 (34%), Gaps = 25/167 (14%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
            AL+  N       +      +   +  H  ++ + P  + +L    I+   Y+    +L
Sbjct: 75  SALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQAL 132

Query: 63  PASFSNLSSL----------VSLTLESNNLDDQILDSL-DKLHNLSVLNLKRNQISG--H 109
                +L  L          + + L   +     L  + + +  L  LNL  N++     
Sbjct: 133 -----DLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDD 187

Query: 110 IPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
           + S +     L IL+LS N+L      S   L  +    +    L G
Sbjct: 188 MSSIVQKAPNLKILNLSGNELK-----SERELDKIKGLKLEELWLDG 229

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 24/114 (21%), Positives = 35/114 (30%), Gaps = 33/114 (28%)

Query: 20  KLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES 79
            + EL  ++LS+N++       L  +S +                      +L  L L  
Sbjct: 168 NIPELLSLNLSNNRL-----YRLDDMSSI-----------------VQKAPNLKILNLSG 205

Query: 80  NNLDDQILDSLDKLH--NLSVLNLKRNQISGHIPSTIGNIST-------LTILD 124
           N L       LDK+    L  L L  N +          IS        L  LD
Sbjct: 206 NELKS--ERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 40.0 bits (94), Expect = 6e-04
 Identities = 18/112 (16%), Positives = 39/112 (34%), Gaps = 14/112 (12%)

Query: 70  SSLVSLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNI----STLT 121
           + +   ++     +D     + + L   + L  LN++ N ISG     +       ++L 
Sbjct: 65  TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLI 124

Query: 122 ILDLS--QNKLSGEIPASFSNL----KSLSSFNVSYNNLSGPVPTSLALKFN 167
            L +      L   +    +N+     +L  F   +      +  S A+  N
Sbjct: 125 ELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGPRLRASNAMMNN 176

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 19/76 (25%), Positives = 30/76 (39%), Gaps = 3/76 (3%)

Query: 361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL 420
            +FD           +  G          + I   +   +  LH N ++IH +LT+SN +
Sbjct: 405 YIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFI 463

Query: 421 LDDSTNAKISDFGLSR 436
            D      I DFGL +
Sbjct: 464 FDKDL--YIIDFGLGK 477

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	580
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.88
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.87
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.86
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.86
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.86
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.86
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.85
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.85
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.85
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.85
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.84
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.84
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.82
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.82
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.82
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.82
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.81
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.81
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.81
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.8
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.8
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.79
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.79
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.78
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.78
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.78
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.78
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.78
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.78
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.78
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.78
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.77
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.77
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.77
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.77
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.77
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.77
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.77
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.77
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.76
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.76
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.76
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.76
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.76
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.76
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.76
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.76
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.76
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.76
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.76
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.75
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.75
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.75
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.75
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.74
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.74
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.74
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.74
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.74
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.74
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.74
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.73
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.72
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.72
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.72
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.71
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.71
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.71
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.71
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.71
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.71
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.7
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.7
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.69
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.69
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.68
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.67
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.67
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.67
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.67
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.66
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.63
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.63
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.63
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.62
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.62
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.62
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.62
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.61
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.61
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.6
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.6
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.59
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.59
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.59
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.55
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.55
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.55
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.53
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.52
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.51
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.51
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.48
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.46
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.45
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.4
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.39
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.37
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.36
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.26
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.18
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.12
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.02
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.91
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.89
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.88
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.83
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.76
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.73
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.7
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.66
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.64
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.59
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.52
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.5
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.34
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.19
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.11
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.08
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.04
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.96
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.94
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.92
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.91
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.84
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.8
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.78
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.73
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.66
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.56
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.54
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.15
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.08
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.06
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.04
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.04
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.02
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.0
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.91
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.85
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.51
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.32
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.96
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.58
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.44
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.27
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.04
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.88
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	89.82
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.12
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	81.39
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.7

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-56  Score=446.24  Aligned_cols=258  Identities=25%  Similarity=0.409  Sum_probs=205.9

Q ss_pred             hhhccccccCceEEEEEEeC------CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          290 ATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      .+.+.||+|+||.||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+ .+..+|||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~lV~  122 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-GRPLLMVF  122 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            45678999999999999864      478899999987655566789999999999999999999999986 56899999


Q ss_pred             eeCCCCChhhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEee
Q 008031          364 DYMPHGSLATFLHARGP------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISD  431 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~D  431 (580)
                      |||++|+|.++++....            ..+++|.++++++.|||+||+|||+ ++|+||||||+|||+++++.+||+|
T Consensus       123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEECC
T ss_pred             EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECCCCcEEEcc
Confidence            99999999999986532            2468999999999999999999999 5999999999999999999999999


Q ss_pred             ccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhc
Q 008031          432 FGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       432 fg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      ||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+..++...+   ..+..
T Consensus       202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---~~g~~  278 (329)
T 4aoj_A          202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---TQGRE  278 (329)
T ss_dssp             CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH---HHTCC
T ss_pred             cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH---HcCCC
Confidence            9999876543322 2334579999999999999999999999999999999999 99999876644433332   22211


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .      .   .+...+   .++.+++.+||+.||++||||.||+++|+.+.+..
T Consensus       279 ~------~---~p~~~~---~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          279 L------E---RPRACP---PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             C------C---CCTTCC---HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             C------C---Cccccc---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            1      0   111222   35668888999999999999999999999987643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-56  Score=440.03  Aligned_cols=259  Identities=27%  Similarity=0.456  Sum_probs=211.6

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      +.+.+.||+|+||.||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+ ++..++|
T Consensus        15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~lV   93 (299)
T 4asz_A           15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLIMV   93 (299)
T ss_dssp             EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEEEE
T ss_pred             eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEE
Confidence            345789999999999999864      477899999987655566789999999999999999999999987 6689999


Q ss_pred             EeeCCCCChhhhhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeec
Q 008031          363 FDYMPHGSLATFLHARG----------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDF  432 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Df  432 (580)
                      ||||++|+|.++++..+          ....++|.++++++.|||+||+|||+ ++|+||||||+|||+++++.+||+||
T Consensus        94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCCcEEECCc
Confidence            99999999999997642          23569999999999999999999999 59999999999999999999999999


Q ss_pred             ccccccccccccce-eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhcc
Q 008031          433 GLSRLMTAAANVNV-IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWT  510 (580)
Q Consensus       433 g~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  510 (580)
                      |+|+.......... ....||++|||||++.+..|+.++|||||||++|||+| |+.||...+..++...+   ..+...
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---~~~~~~  249 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI---TQGRVL  249 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HHTCCC
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HcCCCC
Confidence            99986654433222 23458999999999999999999999999999999999 99999876644433332   222211


Q ss_pred             ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                               ..+...+   .++.+++.+||+.||++||||.|+++.|+++....
T Consensus       250 ---------~~p~~~~---~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          250 ---------QRPRTCP---QEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             ---------CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ---------CCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                     0111222   35678888999999999999999999999886543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.9e-56  Score=436.67  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=208.0

Q ss_pred             hhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          290 ATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .+.+.||+|+||.||+|.+.      +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+ ++..++|
T Consensus        29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~~lV  107 (308)
T 4gt4_A           29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-DQPLSMI  107 (308)
T ss_dssp             EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEE
T ss_pred             eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-CCEEEEE
Confidence            35688999999999999863      467899999975543 345689999999999999999999999986 6689999


Q ss_pred             EeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEE
Q 008031          363 FDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKI  429 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl  429 (580)
                      ||||++|+|.++|..+.+             ...+++.++++++.|||+||+|||+ ++|+||||||+|||+++++.+||
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~~~~~~Ki  186 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVYDKLNVKI  186 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEECCCCCEEE
Confidence            999999999999976432             2358999999999999999999999 49999999999999999999999


Q ss_pred             eeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhh
Q 008031          430 SDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE  507 (580)
Q Consensus       430 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  507 (580)
                      +|||+|+........ ......||++|||||++.++.|+.++|||||||++|||+| |+.||.+.+..++.+.+.   .+
T Consensus       187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~---~~  263 (308)
T 4gt4_A          187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR---NR  263 (308)
T ss_dssp             CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH---TT
T ss_pred             CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC
Confidence            999999876544332 2334579999999999999999999999999999999999 899998776544433332   22


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                      ...         ..++.+   ..++.++|.+||+.||++||||.||+++|+.+
T Consensus       264 ~~~---------~~p~~~---~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          264 QVL---------PCPDDC---PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             CCC---------CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCC---------CCcccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111         111222   23566888999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-55  Score=428.63  Aligned_cols=257  Identities=27%  Similarity=0.440  Sum_probs=201.1

Q ss_pred             hhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .+.+.||+|+||.||+|++.+  .||||+++....  ...+.|.+|++++++++|||||+++|+|.+  +..+||||||+
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVmEy~~  114 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVTQWCE  114 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCS
T ss_pred             EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEEEcCC
Confidence            457889999999999998763  699999874332  334679999999999999999999999854  57899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc-ccce
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA-NVNV  446 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  446 (580)
                      +|+|.++++..  ...+++.++.+++.|||+||+|||+ ++|+||||||+|||+++++.+||+|||+|+...... ....
T Consensus       115 gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  191 (307)
T 3omv_A          115 GSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV  191 (307)
T ss_dssp             SCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred             CCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence            99999999764  3469999999999999999999999 599999999999999999999999999998765432 2233


Q ss_pred             eeecCccccCCcccccc---CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          447 IATAGALGYRAPELSKL---KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ....||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+..+.   +...+.....    .+......+
T Consensus       192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~~~~~----~p~~~~~~~  264 (307)
T 3omv_A          192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVGRGYA----SPDLSKLYK  264 (307)
T ss_dssp             --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHTTCC----CCCSTTSCT
T ss_pred             cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCC----CCCcccccc
Confidence            45679999999999853   4689999999999999999999999987654322   2222222111    111111112


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ..   ..++.+++.+||+.||++||||.||+++|+.++..
T Consensus       265 ~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          265 NC---PKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             TS---CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             cc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            22   23566788899999999999999999999988643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-54  Score=429.91  Aligned_cols=248  Identities=19%  Similarity=0.295  Sum_probs=207.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |+..+.||+|+||.||+|.+. +|+.||||++........+.+.+|+++|++++|||||++++++.+ ++..|||||||+
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy~~  154 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE  154 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEECCCT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeCCC
Confidence            556788999999999999986 799999999976655556678999999999999999999999987 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      ||+|.+++...    .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+....... ...
T Consensus       155 gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~  228 (346)
T 4fih_A          155 GGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK  228 (346)
T ss_dssp             TEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred             CCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccc
Confidence            99999999763    599999999999999999999994 999999999999999999999999999987654322 233


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....   +...... .         .+....
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---i~~~~~~-~---------~~~~~~  295 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRDNLPP-R---------LKNLHK  295 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSSCC-C---------CSCGGG
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH---HHcCCCC-C---------CCcccc
Confidence            56899999999999999999999999999999999999999987554333322   2221111 0         111111


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...++.+++.+||+.||++|||+.|+++|
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            22366788899999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.4e-53  Score=418.96  Aligned_cols=252  Identities=21%  Similarity=0.262  Sum_probs=205.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||.||+|++. +|+.||||+++....     ..+|+.++++++|||||++++++.+ ++..|||||||+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy~~  133 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLE  133 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEEECCCT
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeccC
Confidence            445678999999999999986 799999999965422     2469999999999999999999987 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeeccccccccccccc--
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAANV--  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~--  444 (580)
                      ||+|.++++..+   .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ ++||+|||+|+........  
T Consensus       134 gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          134 GGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            999999998753   69999999999999999999999 4999999999999999887 6999999999876543221  


Q ss_pred             --ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          445 --NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       445 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                        ......||+.|||||++.+..|+.++||||+||++|||+||+.||...+..++...+..   +...       .....
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~~~~-------~~~~~  279 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS---EPPP-------IREIP  279 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH---SCCG-------GGGSC
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc---CCCC-------chhcC
Confidence              12235799999999999999999999999999999999999999988776665544432   2111       01111


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      +..+   ..+.+++.+||+.||++|||+.|++++|.....+
T Consensus       280 ~~~s---~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          280 PSCA---PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            2222   3556788899999999999999999999876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-54  Score=428.53  Aligned_cols=249  Identities=23%  Similarity=0.385  Sum_probs=201.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|++. +|+.||||+++....  ...+.+.+|+++|++++|||||++++++.+ ++..||||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVmEy  104 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVMDY  104 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEeC
Confidence            667899999999999999986 799999999965432  234678999999999999999999999987 6789999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      |+||+|.+++...+ ...+++.+++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+....... .
T Consensus       105 ~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  181 (350)
T 4b9d_A          105 CEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-L  181 (350)
T ss_dssp             CTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-H
T ss_pred             CCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-c
Confidence            99999999997643 3457899999999999999999999 4999999999999999999999999999987654322 2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.   .+.+..+..+....         .....
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~~~~~---------~~~~~  249 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLKIISGSFPP---------VSLHY  249 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCCCC---------CCTTS
T ss_pred             ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCCCCC---------CCccC
Confidence            2345799999999999999999999999999999999999999976543   33344444333211         01112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ..++.+++.+||+.||++|||+.|+++|
T Consensus       250 ---s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          250 ---SYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               2356688889999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-53  Score=417.71  Aligned_cols=246  Identities=21%  Similarity=0.328  Sum_probs=206.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+++|++++|||||++++++.+ ++..|+|||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yivmE  112 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLS  112 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEe
Confidence            678899999999999999986 79999999996532   2345678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc-c
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA-N  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  443 (580)
                      |++||+|.+++.+.+   .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.+.... .
T Consensus       113 y~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          113 YAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            999999999998753   699999999999999999999995 99999999999999999999999999998775433 2


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..   +....+......       .   +.
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~~~~-------~---p~  255 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAKIIKLEYD-------F---PE  255 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCC-------C---CT
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCC-------C---Cc
Confidence            3344568999999999999999999999999999999999999999765433   333333332211       1   11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQ  555 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~  555 (580)
                      ...   .++.+++.+||+.||++|||+.|++.
T Consensus       256 ~~s---~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          256 KFF---PKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             TCC---HHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ccC---HHHHHHHHHHccCCHhHCcChHHHcC
Confidence            112   35668889999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-52  Score=408.33  Aligned_cols=245  Identities=22%  Similarity=0.368  Sum_probs=196.1

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC---CCcEEEEEe
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP---KGEKLLVFD  364 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~~lv~e  364 (580)
                      +.+.||+|+||.||+|.+. ++..||+|++.....  ...+.|.+|++++++++|||||++++++...   +...+||||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            3467999999999999986 789999999865432  2345699999999999999999999998642   345799999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccCCCCCCCeeeC-CCCCeEEeecccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||++|+|.+++++.   ..+++..+..++.||+.||+|||++ +  |+||||||+|||++ .++.+||+|||+|+.....
T Consensus       110 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          110 LMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            99999999999875   3689999999999999999999994 7  99999999999998 4789999999999864332


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                         ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+...  .......+..+...     ..... 
T Consensus       186 ---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~~~-----~~~~~-  253 (290)
T 3fpq_A          186 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP-----ASFDK-  253 (290)
T ss_dssp             ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC-----GGGGG-
T ss_pred             ---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCCCC-----CCCCc-
Confidence               2345689999999998875 699999999999999999999999975432  22222222221111     11111 


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ..   ..++.+++.+||+.||++|||+.|+++|
T Consensus       254 --~~---~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          254 --VA---IPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --CC---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --cC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              11   1256688899999999999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-53  Score=426.38  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=210.8

Q ss_pred             HHhhhccccccCceEEEEEEeCC------CCEEEEEEccccccc-cHHHHHHHHHHHhcCCC-CcceeeeeEEECCCCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATLED------GSQVAVKRLREKITK-GQREFESEVSLLGKIRH-PNLLALRAYYLGPKGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~  359 (580)
                      .|.+.+.||+|+||.||+|.+..      ++.||||.++..... ..+.|.+|+++|.++.| ||||+++|+|...++..
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~  144 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  144 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence            35678899999999999998642      357999999765443 34679999999999965 89999999998756678


Q ss_pred             EEEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC
Q 008031          360 LLVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN  426 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~  426 (580)
                      ++|||||++|+|.++|+....             ...+++.+++.++.|||+||+|||+ ++|+||||||+|||+++++.
T Consensus       145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccceeeCCCCC
Confidence            999999999999999976421             2458999999999999999999999 59999999999999999999


Q ss_pred             eEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHH
Q 008031          427 AKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASI  504 (580)
Q Consensus       427 ~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~  504 (580)
                      +||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+   .+...
T Consensus       224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~---~~~~~  300 (353)
T 4ase_A          224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRR  300 (353)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHH
T ss_pred             EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence            999999999876544332 2334568999999999999999999999999999999998 999998765432   22222


Q ss_pred             hhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      +..+...        ..+...   ..++.++|.+||+.||++||||.|++++|+.+.+.
T Consensus       301 i~~g~~~--------~~p~~~---~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          301 LKEGTRM--------RAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHTCCC--------CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCC--------CCCccC---CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            2222111        111122   23567888899999999999999999999998654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.9e-53  Score=430.87  Aligned_cols=248  Identities=19%  Similarity=0.309  Sum_probs=207.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |+..+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+ ++..|||||||+
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVmEy~~  231 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE  231 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEEeCCC
Confidence            566789999999999999986 799999999976555556678999999999999999999999987 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      ||+|.++++..    .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.+..... ...
T Consensus       232 gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~  305 (423)
T 4fie_A          232 GGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK  305 (423)
T ss_dssp             TEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBC
T ss_pred             CCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccc
Confidence            99999999764    589999999999999999999995 999999999999999999999999999987654322 233


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+   ...... .     . ......  
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~-~-----~-~~~~~~--  373 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPP-R-----L-KNLHKV--  373 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCC-C-----C-SCTTSS--
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCC-C-----C-cccccC--
Confidence            567999999999999999999999999999999999999999865543333222   221110 0     0 111122  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ..++.+|+.+||+.||++|||+.|+++|
T Consensus       374 -s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          374 -SPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             2356678889999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.9e-53  Score=416.84  Aligned_cols=264  Identities=25%  Similarity=0.344  Sum_probs=199.3

Q ss_pred             hhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC---cEEEEEeeC
Q 008031          290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG---EKLLVFDYM  366 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~e~~  366 (580)
                      .+.+.||+|+||.||+|++. |+.||||+++.... ....++.|+..+.+++|||||+++++|.+.+.   ..+||||||
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~   83 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence            45689999999999999985 89999999865421 12234456666778999999999999986432   579999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-------ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++|+|.++++..    .+++..+.+++.|+++||+|||++       ++|+||||||+|||++.++++||+|||+|+...
T Consensus        84 ~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           84 EHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             TTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            999999999864    589999999999999999999973       389999999999999999999999999998765


Q ss_pred             ccccc---ceeeecCccccCCccccccC------CCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh-----------hH
Q 008031          440 AAANV---NVIATAGALGYRAPELSKLK------KANTKTDVYSLGVTILELLTGKSPGEPLNGAEL-----------PQ  499 (580)
Q Consensus       440 ~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-----------~~  499 (580)
                      .....   ......||++|||||++.+.      .++.++|||||||++|||+||+.||......+.           ..
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            43322   22345799999999998754      467799999999999999999887754332211           11


Q ss_pred             HHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          500 WVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .+......    ...++.+... ....+....+.+++.+||+.||++||||.||++.|+++.++.
T Consensus       240 ~~~~~~~~----~~~rp~~p~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          240 EMRKVVCE----QKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHTT----SCCCCCCCGG-GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhc----ccCCCCCCcc-ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            11111111    1111111111 112245567889999999999999999999999999987654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-52  Score=404.55  Aligned_cols=245  Identities=26%  Similarity=0.400  Sum_probs=190.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||+++...   ......+.+|++++++++|||||++++++.+ ++..|+|||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE   93 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMVIE   93 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence            567899999999999999975 79999999996543   2334678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+ +|+|.+++.+.   ..+++.++..++.||+.||+|||++ ||+||||||+|||+++++++||+|||+|+......  
T Consensus        94 y~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--  166 (275)
T 3hyh_A           94 YA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--  166 (275)
T ss_dssp             CC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             CC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence            99 68999999875   3699999999999999999999995 99999999999999999999999999998764432  


Q ss_pred             ceeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ......||+.|||||++.+..| +.++||||+||++|||+||+.||.+.+.   ......+......       .   +.
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~~~~~~-------~---p~  233 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNISNGVYT-------L---PK  233 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCC-------C---CT
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCC-------C---CC
Confidence            2234679999999999998876 5799999999999999999999976443   3333333222211       0   11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ..+   .++.+++.+||+.||++|||+.|+++|=
T Consensus       234 ~~s---~~~~~li~~~L~~dP~~R~s~~eil~hp  264 (275)
T 3hyh_A          234 FLS---PGAAGLIKRMLIVNPLNRISIHEIMQDD  264 (275)
T ss_dssp             TSC---HHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred             CCC---HHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence            112   3566888899999999999999999863

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-52  Score=410.05  Aligned_cols=246  Identities=23%  Similarity=0.357  Sum_probs=195.5

Q ss_pred             HhhhccccccCceEEEEEEeC----CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |++.+.||+|+||.||+|+..    +++.||||+++....  .....+.+|++++++++|||||++++++.+ ++..|+|
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv  104 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLYLI  104 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence            678899999999999999862    578999999975432  234568899999999999999999999987 6789999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||++||+|.+++.+.+   .+++.++..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+......
T Consensus       105 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             ECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999998753   69999999999999999999999 499999999999999999999999999998654332


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      . ......||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+..+   ....+......       .   +
T Consensus       181 ~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~~~-------~---p  246 (304)
T 3ubd_A          181 K-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMILKAKLG-------M---P  246 (304)
T ss_dssp             C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCC-------C---C
T ss_pred             c-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHHHcCCCC-------C---C
Confidence            2 2334679999999999999999999999999999999999999998655433   33333322110       0   1


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~  556 (580)
                      ...+   .++.+++.+||+.||++|||     ++|+++|
T Consensus       247 ~~~s---~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          247 QFLS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             TTSC---HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             CcCC---HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            1122   35667888999999999998     4677765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.2e-51  Score=400.74  Aligned_cols=250  Identities=21%  Similarity=0.370  Sum_probs=189.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC---------
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG---------  357 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---------  357 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+.         
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            567899999999999999986 799999999865433 234578999999999999999999999875332         


Q ss_pred             --cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          358 --EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       358 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                        ..|+||||+++|+|.+++.........++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCCcEEEccCccc
Confidence              368999999999999999876544556777889999999999999999 49999999999999999999999999999


Q ss_pred             ccccccccc-----------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHH
Q 008031          436 RLMTAAANV-----------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASI  504 (580)
Q Consensus       436 ~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~  504 (580)
                      +........           ......||+.|||||++.+..|+.++||||+||++|||++   ||....  +....+..+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~~~  240 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLTDV  240 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHHHH
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHHHH
Confidence            876543221           2234579999999999999999999999999999999996   775321  111111111


Q ss_pred             hhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .....            ++........+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          241 RNLKF------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HTTCC------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hcCCC------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11110            01111223455679999999999999999999885

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-48  Score=396.98  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----CCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-----KGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~  360 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++....  ...+.+.+|+++|++++|||||++++++...     .+..|
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            667899999999999999986 799999999975432  2345688999999999999999999998642     35789


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +|||||+ |+|.+++...   ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.+..
T Consensus       136 ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            9999995 6899999764   4799999999999999999999995 999999999999999999999999999987643


Q ss_pred             cc---ccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc-
Q 008031          441 AA---NVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD-  515 (580)
Q Consensus       441 ~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  515 (580)
                      ..   ........||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+..+.+...........+.. 
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence            22   2233456899999999998765 568999999999999999999999987665444444333221110000000 


Q ss_pred             ---------hhhhccCCCcH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 ---------LELMRDAPTIG-----DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ---------~~~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                               .......+...     ....++.+|+.+||..||++|||+.|+++|
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                     00000000000     012356789999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.4e-47  Score=383.53  Aligned_cols=195  Identities=23%  Similarity=0.397  Sum_probs=165.3

Q ss_pred             HhhhccccccCceEEEEEEeC----CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|+++    +++.||+|.+...  .....+.+|+++++.+ +||||+++++++.+ +++.|+||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~~~lvm   99 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDHVVIAM   99 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCEEEEEE
Confidence            667889999999999999863    4678999998654  3446788999999998 69999999999987 67899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-CCeEEeeccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-TNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~~~  442 (580)
                      ||+++|+|.+++.      .+++.++..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+......
T Consensus       100 E~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A          100 PYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             ECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             eCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            9999999999984      388999999999999999999995 99999999999999866 799999999997553321


Q ss_pred             c---------------------------cceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCC
Q 008031          443 N---------------------------VNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLN  493 (580)
Q Consensus       443 ~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~  493 (580)
                      .                           ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            1                           112335799999999998765 58999999999999999999999996543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.6e-47  Score=404.70  Aligned_cols=250  Identities=23%  Similarity=0.400  Sum_probs=207.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+++|+.++|||||++++++.+ ++..++|||||+
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E~~~  237 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMS  237 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEECCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeecC
Confidence            677899999999999999986 799999999976655556778999999999999999999999987 678999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC--CCeEEeecccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS--TNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~--~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ||+|.+++...  ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+  +.+||+|||+|+.+....  .
T Consensus       238 gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~  312 (573)
T 3uto_A          238 GGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S  312 (573)
T ss_dssp             CCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred             CCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence            99999998653  24689999999999999999999994 99999999999999854  889999999998775433  2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+...   .+......   ++....   +..
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~---~i~~~~~~---~~~~~~---~~~  383 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NVKSCDWN---MDDSAF---SGI  383 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHHTTCCC---CCSGGG---TTS
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHhCCCC---CCcccc---cCC
Confidence            345679999999999999999999999999999999999999998765433333   22222211   111111   111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ..++.+||.+||+.||++|||+.|+++|
T Consensus       384 ---s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          384 ---SEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               2356688899999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-46  Score=398.89  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=200.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHH---HHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFE---SEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|+.. +|+.||||++....   ......+.   .++.+++.++|||||++++++.+ .+..|+
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~lyl  269 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSF  269 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCEEEE
Confidence            556789999999999999986 79999999996432   12223333   34677788899999999999987 668999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||++||+|.+++.+.+   .+++..+..++.||+.||+|||++ ||+||||||+|||++.+|++||+|||+|+.....
T Consensus       270 VmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            999999999999998753   699999999999999999999994 9999999999999999999999999999876543


Q ss_pred             cccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          442 ANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .   ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+.+..+.......+.....       ..  
T Consensus       346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-------~~--  413 (689)
T 3v5w_A          346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------EL--  413 (689)
T ss_dssp             C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-------CC--
T ss_pred             C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-------CC--
Confidence            2   234689999999999864 5799999999999999999999999987655554443333322211       00  


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQL  557 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~L  557 (580)
                       +...   ..++.+++.+||+.||.+|++     +.|+++|=
T Consensus       414 -p~~~---S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          414 -PDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             -CTTS---CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             -CccC---CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence             1112   235668888999999999998     68887763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-44  Score=361.71  Aligned_cols=270  Identities=31%  Similarity=0.513  Sum_probs=220.0

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |...+.||+|+||.||+|.+.+|+.||||++........+.+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus        41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~  119 (321)
T 2qkw_B           41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMEN  119 (321)
T ss_dssp             CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCCEEEEECCTT
T ss_pred             cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEEcCCC
Confidence            456789999999999999988899999999876655566789999999999999999999999976 6689999999999


Q ss_pred             CChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-cce
Q 008031          369 GSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-VNV  446 (580)
Q Consensus       369 g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  446 (580)
                      |+|.+++.... ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||+++....... ...
T Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  198 (321)
T 2qkw_B          120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS  198 (321)
T ss_dssp             CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred             CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999997643 22358999999999999999999999 4999999999999999999999999999976543222 122


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh---hHHHHHHhhhhccccccchhhhccCC
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL---PQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.   ..+..............++...  ..
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  276 (321)
T 2qkw_B          199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA--DK  276 (321)
T ss_dssp             CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT--TC
T ss_pred             cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc--cc
Confidence            234588999999999889999999999999999999999999976544433   2333222222223333333332  12


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ........+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            335667788899999999999999999999999998754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.1e-45  Score=365.27  Aligned_cols=270  Identities=37%  Similarity=0.649  Sum_probs=221.9

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||.||+|.+.+|+.||||++...... ....+.+|+++++.++||||+++++++.. .+..++||||++
T Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~  110 (326)
T 3uim_A           32 FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPYMA  110 (326)
T ss_dssp             SCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-SSCCEEEEECCT
T ss_pred             cccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-CCceEEEEEecc
Confidence            4557889999999999999888999999998755432 33478999999999999999999999986 567899999999


Q ss_pred             CCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCC---CcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          368 HGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNE---NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       368 ~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~---~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      +|+|.+++.... ....+++..+..++.|++.||+|||+ .   ||+||||||+||+++.++.+||+|||++........
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  189 (326)
T 3uim_A          111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT  189 (326)
T ss_dssp             TCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence            999999998753 23459999999999999999999999 6   999999999999999999999999999987765544


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCC-----CCCCCChhHHHHHHhhhhccccccchhh
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGE-----PLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.     .........++.............+...
T Consensus       190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (326)
T 3uim_A          190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL  269 (326)
T ss_dssp             CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTC
T ss_pred             cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhh
Confidence            44445569999999999988899999999999999999999999995     2233344455544444444444444443


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      .  .....+....+.+++.+||+.||++|||+.|++++|+....
T Consensus       270 ~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          270 Q--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             T--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             c--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            2  23445677889999999999999999999999999987543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.5e-45  Score=355.57  Aligned_cols=256  Identities=24%  Similarity=0.420  Sum_probs=211.2

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|...+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+ ++..++||||++
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   88 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFME   88 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECCT
T ss_pred             hceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCceEEEEEeCC
Confidence            356789999999999999999888999999997543 345679999999999999999999999976 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++...  ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++............
T Consensus        89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  165 (269)
T 4hcu_A           89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  165 (269)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence            99999999764  34689999999999999999999994 9999999999999999999999999999876544333333


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||......+....+.   .....   .      ..... 
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~---~~~~~---~------~~~~~-  232 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---TGFRL---Y------KPRLA-  232 (269)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCCC---C------CCTTS-
T ss_pred             CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh---cCccC---C------CCCcC-
Confidence            4557788999999998999999999999999999999 999998655433222221   11000   0      01111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                        ...+.+++.+||+.||++|||+.+++++|+++.+.
T Consensus       233 --~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          233 --STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence              23567888899999999999999999999998765

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.5e-44  Score=353.97  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=205.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.++++++||||+++++++.. .+..++||||++
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~  100 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLA  100 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred             eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEEEECCC
Confidence            566789999999999999975 799999999976666667788999999999999999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++...    .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........ ...
T Consensus       101 ~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  174 (297)
T 3fxz_A          101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS  174 (297)
T ss_dssp             TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred             CCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccC
Confidence            99999999864    489999999999999999999994 999999999999999999999999999886654332 233


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+   ....+........          .....
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~----------~~~~~  241 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATNGTPEL----------QNPEK  241 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHHCSCCC----------SCGGG
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCCC----------CCccc
Confidence            4579999999999999999999999999999999999999997654322   2222222111110          00111


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ....+.+++.+||+.||++|||+.|++++-
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~  271 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQ  271 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence            123567889999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-44  Score=360.80  Aligned_cols=261  Identities=31%  Similarity=0.446  Sum_probs=200.1

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|.+.+.||+|+||.||+|.+. |+.||||++.....  ...+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~  115 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-PPNLSIVTEY  115 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTCCEEEEEC
T ss_pred             HceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCceEEEEec
Confidence            3567889999999999999874 88999999875432  233568899999999999999999999976 5679999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      +++|+|.+++...+....+++..+..++.|++.||+|||+. |  |+||||||+||+++.++.+||+|||+++...... 
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-  193 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-  193 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-
Confidence            99999999998754333489999999999999999999994 8  9999999999999999999999999997554332 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.   ......     ..   ..
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~-----~~---~~  262 (309)
T 3p86_A          194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---FKCKRL-----EI---PR  262 (309)
T ss_dssp             --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---HSCCCC-----CC---CT
T ss_pred             cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCC-----CC---Cc
Confidence            22234568999999999999999999999999999999999999998765433222221   111000     00   11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                      ..   ..++.+++.+||+.||++|||+.++++.|+.+......
T Consensus       263 ~~---~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          263 NL---NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             cC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence            11   23567888899999999999999999999998766443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=358.79  Aligned_cols=258  Identities=25%  Similarity=0.436  Sum_probs=209.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+ ++..++||||++
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   90 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITEYIK   90 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred             eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEEEEecC
Confidence            456789999999999999986 789999999876555566789999999999999999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc--
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN--  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--  445 (580)
                      +|+|.+++...  ...+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.........  
T Consensus        91 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           91 GGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred             CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence            99999999874  24689999999999999999999994 99999999999999999999999999998664332211  


Q ss_pred             -----------eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChh--HHHHHHhhhhcccc
Q 008031          446 -----------VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP--QWVASIVKEEWTNE  512 (580)
Q Consensus       446 -----------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~  512 (580)
                                 .....||+.|+|||.+.+..++.++||||||+++|||++|..||.........  ..........    
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~----  243 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY----  243 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT----
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc----
Confidence                       11456999999999999999999999999999999999999998764332211  1111111110    


Q ss_pred             ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                           .....+      ..+.+++.+||+.||++|||+.++++.|++++....
T Consensus       244 -----~~~~~~------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          244 -----CPPNCP------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             -----CCTTCC------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence                 001111      256688899999999999999999999999976543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.6e-44  Score=367.28  Aligned_cols=259  Identities=26%  Similarity=0.388  Sum_probs=209.0

Q ss_pred             HHhhhccccccCceEEEEEEeC--------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE--------DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKG  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  357 (580)
                      .|.+.+.||+|+||.||+|.+.        ++..||||+++.... ...+.+.+|+.+++++ +||||+++++++.. .+
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~  160 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DG  160 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-SS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-CC
Confidence            4567889999999999999862        355799999976533 2345789999999999 89999999999976 66


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          358 EKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      ..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||+. ||+||||||+|||++.+
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTT
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchhhEEECCC
Confidence            89999999999999999987532             24589999999999999999999994 99999999999999999


Q ss_pred             CCeEEeecccccccccccc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHH
Q 008031          425 TNAKISDFGLSRLMTAAAN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~  502 (580)
                      +.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~  319 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  319 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence            9999999999986644322 12223456788999999999999999999999999999999 999998765544333222


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      .    ....        .....   ...++.+++.+||+.||++|||+.|+++.|+++...
T Consensus       320 ~----~~~~--------~~~~~---~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          320 E----GHRM--------DKPAN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             T----TCCC--------CCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----CCCC--------CCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1    1110        00111   123567888899999999999999999999998653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.1e-44  Score=358.52  Aligned_cols=247  Identities=25%  Similarity=0.346  Sum_probs=202.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++.....  ...+.+.+|+++++.++||||+++++++.. .+..++||||
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~   95 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLIMEY   95 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEEC
Confidence            566799999999999999984 899999999865432  234568899999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++|+|.+++...+   .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........  
T Consensus        96 ~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--  169 (328)
T 3fe3_A           96 ASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--  169 (328)
T ss_dssp             CTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--
Confidence            99999999997753   589999999999999999999995 999999999999999999999999999986644322  


Q ss_pred             eeeecCccccCCccccccCCCC-CcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSKLKKAN-TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      .....||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+   ....+..+...          .+..
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~----------~p~~  236 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLRGKYR----------IPFY  236 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCC----------CCTT
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC----------CCCC
Confidence            2335699999999999888775 78999999999999999999998655332   22222222111          0111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                         ...++.+++.+||+.||.+|||+.|++++-.
T Consensus       237 ---~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          237 ---MSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             ---SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             ---CCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence               1235668888999999999999999998743

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.6e-44  Score=351.06  Aligned_cols=257  Identities=23%  Similarity=0.392  Sum_probs=210.8

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|...+.||+|+||.||+|.+.++..||+|+++... ...+++.+|++++++++||||+++++++.. .+..++||||++
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   86 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEYIS   86 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCT
T ss_pred             heeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEccC
Confidence            356778999999999999999988899999997543 245678999999999999999999999976 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++...+  ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++............
T Consensus        87 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  163 (268)
T 3sxs_A           87 NGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV  163 (268)
T ss_dssp             TCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred             CCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence            999999997652  358999999999999999999999 59999999999999999999999999999876555444444


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||......+....+   ......   .      ..... 
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~~~~~---~------~~~~~-  230 (268)
T 3sxs_A          164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV---SQGHRL---Y------RPHLA-  230 (268)
T ss_dssp             SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HTTCCC---C------CCTTS-
T ss_pred             CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH---HcCCCC---C------CCCcC-
Confidence            4567778999999998899999999999999999999 99999765533322221   111100   0      01111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                        ...+.+++.+||+.||++|||+.|++++|+.++++.
T Consensus       231 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          231 --SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             --hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence              125678888999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=359.92  Aligned_cols=259  Identities=26%  Similarity=0.426  Sum_probs=206.7

Q ss_pred             HHhhhccccccCceEEEEEEeC----CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+.    .+..||||+++.... ...+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv  128 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAMIV  128 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCEEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccEEE
Confidence            4667899999999999999985    344699999976533 334678999999999999999999999976 5678999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.++++..  ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++......
T Consensus       129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999754  2468999999999999999999999 499999999999999999999999999998765433


Q ss_pred             ccc--eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NVN--VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ...  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+..   ....         
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~~~~---------  273 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE---GYRL---------  273 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---TCCC---------
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc---CCCC---------
Confidence            222  222346778999999998999999999999999999999 9999977654333322221   1100         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                         +........+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       274 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          274 ---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             ---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence               0011122356788899999999999999999999999875543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-44  Score=354.14  Aligned_cols=257  Identities=20%  Similarity=0.359  Sum_probs=208.7

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|.+.+.||+|+||.||+|.+.++..||+|+++... ...+++.+|++++++++||||+++++++.. .+..++||||++
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~  102 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMA  102 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEECCCT
T ss_pred             HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEeccC
Confidence            456789999999999999999988899999997543 245678999999999999999999999976 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++...  ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++............
T Consensus       103 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (283)
T 3gen_A          103 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  179 (283)
T ss_dssp             TCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence            99999999763  2358999999999999999999999 49999999999999999999999999999876544333333


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||...+..+....+..   ....   .      ..... 
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~---~------~~~~~-  246 (283)
T 3gen_A          180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRL---Y------RPHLA-  246 (283)
T ss_dssp             STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---TCCC---C------CCTTC-
T ss_pred             CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc---ccCC---C------CCCcC-
Confidence            4557788999999998899999999999999999998 9999987654333332221   1100   0      01111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                        ...+.+++.+||+.||++|||+.+++++|+++.++.
T Consensus       247 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          247 --SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence              135678889999999999999999999999987653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-44  Score=360.85  Aligned_cols=267  Identities=24%  Similarity=0.303  Sum_probs=205.5

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCC---CcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPK---GEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|.+. ++.||||++.... .....+.+|+.++++++||||+++++++....   ...++||||
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~  103 (322)
T 3soc_A           26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF  103 (322)
T ss_dssp             EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             chhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence            567899999999999999887 8999999986542 23345677999999999999999999998633   237999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------CcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE----------NIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      +++|+|.++++..    .+++..+..++.|++.||+|||+ .          ||+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          104 HEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             CTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            9999999999864    48999999999999999999998 6          9999999999999999999999999999


Q ss_pred             ccccccccc-ceeeecCccccCCcccccc-----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh--
Q 008031          436 RLMTAAANV-NVIATAGALGYRAPELSKL-----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE--  507 (580)
Q Consensus       436 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--  507 (580)
                      +........ ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+........+.......  
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            866543322 2223568999999999876     35566889999999999999999999875443322221110000  


Q ss_pred             ------hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          508 ------EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       508 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                            ........+.... .........++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRD-YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCG-GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhcccCCCCccc-cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                  0000000000000 001123445688999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=349.85  Aligned_cols=270  Identities=20%  Similarity=0.303  Sum_probs=212.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-cEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-EKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++... ....+.+.+|++++++++||||+++++++..... ..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence            456789999999999999987 69999999997543 2345678899999999999999999999986433 67999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee----CCCCCeEEeecccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~----~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +++++|.+++........+++..+..++.||+.||+|||+. ||+||||||+||++    +.++.+||+|||+++.....
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            99999999998765455599999999999999999999994 99999999999999    77788999999999876543


Q ss_pred             cccceeeecCccccCCccccc--------cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC-hhHHHHHHhhhhcccc
Q 008031          442 ANVNVIATAGALGYRAPELSK--------LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE-LPQWVASIVKEEWTNE  512 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~  512 (580)
                      ...  ....||..|+|||++.        +..++.++|||||||++|||++|+.||.+..... ....+..+..+.....
T Consensus       170 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          170 EQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             CCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred             Cce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence            322  2356899999999876        5788999999999999999999999997654432 2333333333222110


Q ss_pred             cc------------chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          513 VF------------DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       513 ~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      +.            .................+.+++.+||+.||++|||+.|++++..+-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            00            00111111223345566778999999999999999999999998643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-43  Score=369.80  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=208.7

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |.+.+.||+|+||.||+|.+. |+.||||+++...  ..+.|.+|++++++++||||+++++++...++..++||||+++
T Consensus       195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            456789999999999999987 7899999997543  4567999999999999999999999998756679999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.++++..+ ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......    ..
T Consensus       272 g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~  345 (450)
T 1k9a_A          272 GSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT  345 (450)
T ss_dssp             CBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred             CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----cC
Confidence            99999998753 23478999999999999999999995 99999999999999999999999999998543221    12


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..+++.|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+..    +...        ......  
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~----~~~~--------~~p~~~--  411 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKM--------DAPDGC--  411 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT----TCCC--------CCCTTC--
T ss_pred             CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCC--------CCCCcC--
Confidence            357889999999999999999999999999999999 9999988776665544332    1110        011112  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                       ..++.++|.+||+.||++|||+.++++.|+.+....
T Consensus       412 -~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          412 -PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             -CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence             235667888999999999999999999999987553

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.7e-44  Score=374.42  Aligned_cols=255  Identities=22%  Similarity=0.396  Sum_probs=209.6

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++.  .+..++||||+++
T Consensus       190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e~~~~  266 (454)
T 1qcf_A          190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAK  266 (454)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEECCCTT
T ss_pred             eEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEeecCC
Confidence            55678999999999999999888999999997543 35678999999999999999999999985  4578999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.++++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus       267 g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~  344 (454)
T 1qcf_A          267 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  344 (454)
T ss_dssp             CBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred             CcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence            99999997532 22578899999999999999999994 99999999999999999999999999998765433322333


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||++....++.++|||||||++|||++ |+.||.+.+..+....+.   .+...         ......  
T Consensus       345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~~---------~~~~~~--  410 (454)
T 1qcf_A          345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---RGYRM---------PRPENC--  410 (454)
T ss_dssp             SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---HTCCC---------CCCTTS--
T ss_pred             CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCC---------CCCCCC--
Confidence            456788999999998999999999999999999999 999998765443333222   11110         011112  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                       ..++.++|.+||+.||++|||+.++++.|+++...
T Consensus       411 -~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          411 -PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence             23567888999999999999999999999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-43  Score=356.75  Aligned_cols=249  Identities=23%  Similarity=0.374  Sum_probs=203.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|... +|+.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l   92 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTDVVL   92 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCEEEE
Confidence            567899999999999999986 7999999998754322      34678999999999999999999999987 668999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC----CeEEeecccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRL  437 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~----~~kl~Dfg~~~~  437 (580)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++    .+||+|||++..
T Consensus        93 v~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           93 ILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            99999999999999764   3689999999999999999999995 999999999999998776    799999999987


Q ss_pred             cccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ......  .....||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+...   .+.....   .++..
T Consensus       169 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~---~i~~~~~---~~~~~  240 (361)
T 2yab_A          169 IEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NITAVSY---DFDEE  240 (361)
T ss_dssp             CCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHHTTCC---CCCHH
T ss_pred             cCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcCC---CCCch
Confidence            654322  234569999999999999999999999999999999999999997754333222   2222111   11111


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .+..   .   ...+.+++.+||..||++|||+.|+++|
T Consensus       241 ~~~~---~---s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          241 FFSQ---T---SELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HHTT---S---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hccC---C---CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111   1   1356688889999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.9e-44  Score=363.20  Aligned_cols=258  Identities=24%  Similarity=0.453  Sum_probs=196.6

Q ss_pred             HHhhhccccccCceEEEEEEeC----CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+.    ++..||||.++.... ...+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  124 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVMIV  124 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEE
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceEEE
Confidence            3566789999999999999875    577899999975433 334679999999999999999999999976 5689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.++++..  ...+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999999864  34689999999999999999999994 99999999999999999999999999998765432


Q ss_pred             ccc--eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NVN--VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ...  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.   . ...         
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~---~-~~~---------  268 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---E-GYR---------  268 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH---T-TEE---------
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c-CCC---------
Confidence            221  122345678999999999999999999999999999998 999997665433222221   1 111         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                        .+........+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       269 --~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          269 --LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             --CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             --CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence              0001112235778899999999999999999999999986543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.7e-43  Score=348.54  Aligned_cols=262  Identities=20%  Similarity=0.346  Sum_probs=204.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|.+......   ..+.+.+|+.++++++||||+++++++.. ++..++|||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e   91 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYLVME   91 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEEEEe
Confidence            567899999999999999976 7899999998543322   23568899999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++...+   .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.........
T Consensus        92 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           92 YIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             CCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            999999999998753   68999999999999999999999 49999999999999999999999999999876554444


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......+   ...........    . ......+.
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~~~~~~~~~~~----~-~~~~~~~~  239 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS---IAIKHIQDSVP----N-VTTDVRKD  239 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH---HHHHHHSSCCC----C-HHHHSCTT
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhhccCC----C-cchhcccC
Confidence            4444578999999999999999999999999999999999999997654221   11111111110    0 00001111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhcccccc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-EVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-s~~ev~~~L~~~~~~~~~  566 (580)
                      .+   ..+.+++.+||+.||++|| ++.++.+.|+.+..+...
T Consensus       240 ~~---~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          240 IP---QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             SC---HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             CC---HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence            22   3566788899999999998 999999999998765543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.7e-43  Score=353.22  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|... +|+.||+|+++...   ......+.+|+++++.++||||+++++++.. .+..++|||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lv~E   85 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVME   85 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEEEEEe
Confidence            456789999999999999986 79999999997542   2345678899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... .
T Consensus        86 ~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~  160 (337)
T 1o6l_A           86 YANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A  160 (337)
T ss_dssp             CCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence            99999999999864   3689999999999999999999995 99999999999999999999999999997543222 2


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+   ....+......       .   ...
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~~~-------~---p~~  227 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILMEEIR-------F---PRT  227 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCC-------C---CTT
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCC-------C---CCC
Confidence            2334568999999999999999999999999999999999999997654322   22222221110       0   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      .   ..++.+++.+||+.||++||     ++.|+++|
T Consensus       228 ~---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          228 L---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             S---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            1   23566788899999999999     89999887

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.4e-44  Score=367.66  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=206.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|.+. +++.||||.++..... ....+.+|++++++++||||+++++++.. ++..++||||+
T Consensus       116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~  194 (377)
T 3cbl_A          116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELV  194 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECC
T ss_pred             eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcEEEEEcC
Confidence            556789999999999999987 7899999998754332 23468899999999999999999999976 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++|+|.++++..+  ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++..........
T Consensus       195 ~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          195 QGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            9999999998642  3589999999999999999999994 999999999999999999999999999976433221111


Q ss_pred             -eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          447 -IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       447 -~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.    .....        .....
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~----~~~~~--------~~~~~  339 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----KGGRL--------PCPEL  339 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH----TTCCC--------CCCTT
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----cCCCC--------CCCCC
Confidence             11234678999999998899999999999999999999 999998765433322221    11110        01111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      .+   .++.+++.+||+.||++|||+.++++.|++++.+
T Consensus       340 ~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          340 CP---DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            22   3566788899999999999999999999998654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=364.67  Aligned_cols=264  Identities=22%  Similarity=0.342  Sum_probs=209.1

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+.      +++.||||+++.... .....+.+|+.++++++||||+++++++.. ....++
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~l  151 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFI  151 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCCCEE
Confidence            566789999999999999853      467899999975433 344578899999999999999999999976 567899


Q ss_pred             EEeeCCCCChhhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC---CeEEeeccc
Q 008031          362 VFDYMPHGSLATFLHARG----PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---NAKISDFGL  434 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~---~~kl~Dfg~  434 (580)
                      ||||+++|+|.+++....    ....+++.+++.++.||+.||+|||+. ||+||||||+|||++.++   .+||+|||+
T Consensus       152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            999999999999998653    224589999999999999999999994 999999999999999554   599999999


Q ss_pred             ccccccccc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhcccc
Q 008031          435 SRLMTAAAN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE  512 (580)
Q Consensus       435 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  512 (580)
                      ++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+.   ...... 
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~---~~~~~~-  306 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT---SGGRMD-  306 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---TTCCCC-
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCC-
Confidence            976533222 22233457889999999999999999999999999999998 999997755433332222   111100 


Q ss_pred             ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccC
Q 008031          513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAAT  569 (580)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~  569 (580)
                              .....   ...+.+++.+||+.||++|||+.+++++|+.+.........
T Consensus       307 --------~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~  352 (367)
T 3l9p_A          307 --------PPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT  352 (367)
T ss_dssp             --------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTC
T ss_pred             --------CCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccC
Confidence                    01111   22566888999999999999999999999998766544333

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.7e-43  Score=351.19  Aligned_cols=251  Identities=18%  Similarity=0.270  Sum_probs=205.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++.. .+..++||||++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  125 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWVLMEFLQ  125 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEECCCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEecCC
Confidence            344568999999999999987 799999999976666666789999999999999999999999987 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++...    .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........ ...
T Consensus       126 ~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~  199 (321)
T 2c30_A          126 GGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK  199 (321)
T ss_dssp             SCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred             CCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccc
Confidence            99999998753    589999999999999999999995 999999999999999999999999999986654322 223


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||......+   ....+...... ..         .....
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~-~~---------~~~~~  266 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRDSPPP-KL---------KNSHK  266 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSSCC-CC---------TTGGG
T ss_pred             cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCCC-Cc---------Ccccc
Confidence            4579999999999999999999999999999999999999997654322   22222211110 00         00011


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      ....+.+++.+||+.||++|||+.|++++-.-
T Consensus       267 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  298 (321)
T 2c30_A          267 VSPVLRDFLERMLVRDPQERATAQELLDHPFL  298 (321)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            12356788889999999999999999987543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-43  Score=375.22  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=211.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. ++..||||.++... ...+.|.+|+.++++++||||++++++|.. .+..++||||++
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~E~~~  299 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMT  299 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCT
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEEEEEEccC
Confidence            566789999999999999987 48899999997543 346789999999999999999999999976 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.++++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus       300 ~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          300 YGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             TCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence            999999998753 34589999999999999999999994 9999999999999999999999999999876543333333


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+..+.+..    ....        ...... 
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~--------~~~~~~-  444 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRM--------ERPEGC-  444 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----TCCC--------CCCTTC-
T ss_pred             CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCC--------CCCCCC-
Confidence            3456788999999998999999999999999999999 9999987665444333221    1110        011112 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                        ..++.++|.+||+.||++|||+.++++.|+.+..+.
T Consensus       445 --~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          445 --PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             --CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence              235667888999999999999999999999986543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-43  Score=370.40  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=203.4

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.+  +..++||||+++
T Consensus       186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~~~  262 (452)
T 1fmk_A          186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSK  262 (452)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTT
T ss_pred             ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehhhcC
Confidence            55678999999999999999888889999997543 345689999999999999999999999864  578999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.++++... ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++............
T Consensus       263 gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  340 (452)
T 1fmk_A          263 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  340 (452)
T ss_dssp             CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence            99999997532 23589999999999999999999994 99999999999999999999999999998765443333334


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+....+.   .+ ..        ....+..  
T Consensus       341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~-~~--------~~~~~~~--  406 (452)
T 1fmk_A          341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RG-YR--------MPCPPEC--  406 (452)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TT-CC--------CCCCTTS--
T ss_pred             CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC-CC--------CCCCCCC--
Confidence            557889999999998999999999999999999999 999998765433332221   11 11        0011112  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                       ...+.++|.+||+.||++|||+.++++.|+.+....
T Consensus       407 -~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          407 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence             235668889999999999999999999999986543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=361.82  Aligned_cols=263  Identities=25%  Similarity=0.373  Sum_probs=210.7

Q ss_pred             HHhhhccccccCceEEEEEEeC--------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE--------DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKG  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  357 (580)
                      .|.+.+.||+|+||.||+|.+.        ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.. ++
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~  148 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DG  148 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-CC
Confidence            4667899999999999999863        235799999976533 2346789999999999 99999999999976 66


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          358 EKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      ..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+. ||+||||||+||+++.+
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTED  227 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTT
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCcceEEEcCC
Confidence            89999999999999999987532             24589999999999999999999994 99999999999999999


Q ss_pred             CCeEEeecccccccccccc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHH
Q 008031          425 TNAKISDFGLSRLMTAAAN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~  502 (580)
                      +.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.
T Consensus       228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~  307 (382)
T 3tt0_A          228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  307 (382)
T ss_dssp             CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999986654322 22223457889999999999999999999999999999999 999997655333322222


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATA  567 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~  567 (580)
                         ......         .....   ..++.+++.+||+.||++|||+.|++++|+++.......
T Consensus       308 ---~~~~~~---------~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          308 ---EGHRMD---------KPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             ---TTCCCC---------CCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             ---cCCCCC---------CCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence               111100         01111   235678888999999999999999999999987554433

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=350.60  Aligned_cols=251  Identities=23%  Similarity=0.336  Sum_probs=204.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|.++.. ......+.+|+.+++.++||||+++++++.+ .+..++||||++
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~   84 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFEFIS   84 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEECCCC
T ss_pred             eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEEEEEEeCC
Confidence            556789999999999999986 6889999998644 2344568899999999999999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC--CCCeEEeecccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD--STNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +|+|.+++...  ...+++..+..++.||+.||+|||+. ||+||||||+||+++.  ++.+||+|||++.......  .
T Consensus        85 g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~  159 (321)
T 1tki_A           85 GLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N  159 (321)
T ss_dssp             CCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence            99999999764  24689999999999999999999995 9999999999999986  7899999999998765433  2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+.|+|||++.+..++.++||||+||++|+|++|..||...+..+   .+..+......   .+.....   ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~---~~~~~~~---~~  230 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEYT---FDEEAFK---EI  230 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC---CCHHHHT---TS
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHcCCCC---CChhhhc---cC
Confidence            334568999999999998889999999999999999999999997654332   22332222211   1111111   11


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                         ..++.+++.+||+.||++|||+.|++++-.
T Consensus       231 ---s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          231 ---SIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ---CHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence               235678899999999999999999999764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.9e-43  Score=353.91  Aligned_cols=257  Identities=23%  Similarity=0.408  Sum_probs=202.1

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCE----EEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQ----VAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      .|...+.||+|+||.||+|.+. +++.    ||+|.++... ....+.+.+|+.++++++||||+++++++..  +..++
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~   93 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQL   93 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--SSEEE
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEE
Confidence            3567799999999999999975 4443    5888876443 2445779999999999999999999999986  35889


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      |+||+++|+|.+++....  ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            999999999999998753  4689999999999999999999995 9999999999999999999999999999876543


Q ss_pred             ccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 ANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+...   ...         
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---~~~---------  238 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERL---------  238 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCC---------
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC---CCC---------
Confidence            322 2233457889999999999999999999999999999999 99999876655444333221   100         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ...+   .....+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       239 ~~~~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          239 PQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             CCCT---TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CCCc---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            0011   12235778889999999999999999999999986543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.9e-43  Score=352.54  Aligned_cols=270  Identities=25%  Similarity=0.413  Sum_probs=196.5

Q ss_pred             HHhhhccccccCceEEEEEEeCC-CC---EEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCc---
Q 008031          288 LCATAEIMGKSTYGTVYKATLED-GS---QVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGE---  358 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~-~~---~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  358 (580)
                      .|.+.+.||+|+||.||+|.+.. +.   .||||+++...  ....+.+.+|++++++++||||+++++++......   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            46778999999999999998763 32   79999997543  23456789999999999999999999999863321   


Q ss_pred             --EEEEEeeCCCCChhhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecc
Q 008031          359 --KLLVFDYMPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFG  433 (580)
Q Consensus       359 --~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg  433 (580)
                        .++||||+++|+|.+++....   ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~~~kl~Dfg  182 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDMTVCVADFG  182 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCCCEEEeecc
Confidence              389999999999999996542   12258999999999999999999999 499999999999999999999999999


Q ss_pred             ccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          434 LSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       434 ~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      +++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+..   .... 
T Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~~~~-  258 (323)
T 3qup_A          183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG---GNRL-  258 (323)
T ss_dssp             C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCCC-
T ss_pred             ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc---CCCC-
Confidence            99866443322 2223456788999999999999999999999999999999 9999987665444333221   1110 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccCCCCC
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGD  573 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~~~~~  573 (580)
                              ...+.   ....+.+++.+||+.||++|||+.++++.|+++........++..+
T Consensus       259 --------~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          259 --------KQPPE---CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             --------CCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred             --------CCCCc---cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence                    01111   1235678889999999999999999999999998776555544443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.6e-42  Score=343.89  Aligned_cols=264  Identities=30%  Similarity=0.515  Sum_probs=211.1

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEccccc----cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKI----TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .+.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.++++++||||+++++++.. .+..++||||++
T Consensus        36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~  113 (307)
T 2nru_A           36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-GDDLCLVYVYMP  113 (307)
T ss_dssp             CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCT
T ss_pred             CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-CCceEEEEEecC
Confidence            37899999999999987 48899999986532    2234678999999999999999999999976 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc-ce
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV-NV  446 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~  446 (580)
                      +|+|.+++........+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++......... ..
T Consensus       114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  192 (307)
T 2nru_A          114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT  192 (307)
T ss_dssp             TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred             CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence            99999999865445679999999999999999999999 49999999999999999999999999999866443222 12


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc--cccccchhhhccCCC
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW--TNEVFDLELMRDAPT  524 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  524 (580)
                      ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+........  .....+...   ...
T Consensus       193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  268 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM---NDA  268 (307)
T ss_dssp             SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC---SCC
T ss_pred             cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc---ccc
Confidence            23468999999998874 588999999999999999999999987665554443333222111  111112111   122


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      .......+.+++.+||+.||.+|||+.+++++|+++..
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            34556678899999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=348.90  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=204.3

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  359 (580)
                      ..|.+.+.||+|+||.||+|... +|+.||+|+++.....      ..+.+.+|+.++++++||||+++++++.. ....
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~   89 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDV   89 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence            34778899999999999999986 7999999998654321      35678999999999999999999999987 6689


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC----CeEEeecccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST----NAKISDFGLS  435 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~----~~kl~Dfg~~  435 (580)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            9999999999999999764   4689999999999999999999994 999999999999999877    7999999999


Q ss_pred             cccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      +.......  .....||+.|+|||++.+..++.++||||+||++|+|++|+.||......+....+.   ....   ...
T Consensus       166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~~~~---~~~  237 (326)
T 2y0a_A          166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---AVNY---EFE  237 (326)
T ss_dssp             EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---HTCC---CCC
T ss_pred             eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---hcCC---CcC
Confidence            87643322  233569999999999999999999999999999999999999997654332222221   1111   011


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ......   .   ...+.+++.+||+.||++|||+.|++++-
T Consensus       238 ~~~~~~---~---~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          238 DEYFSN---T---SALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             HHHHTT---S---CHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             cccccc---C---CHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            111111   1   13566888999999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-43  Score=343.45  Aligned_cols=255  Identities=24%  Similarity=0.420  Sum_probs=209.2

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |...+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.. ++..++||||+++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~   87 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVTEFMEH   87 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEECCCTT
T ss_pred             eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeEEEEeCCCC
Confidence            566789999999999999998888999999976533 34678999999999999999999999976 5689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      ++|.+++...  ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.............
T Consensus        88 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           88 GCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence            9999999865  24689999999999999999999994 99999999999999999999999999998664433222233


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||.+.+..++.++||||+|+++|+|++ |+.||......+...   .+......   .      .....  
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~i~~~~~~---~------~~~~~--  230 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGFRL---Y------KPRLA--  230 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHHTTCCC---C------CCTTS--
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH---HHhcCCcC---C------CCccC--
Confidence            457788999999998899999999999999999999 899997654332222   22111100   0      01111  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                       ...+.+++.+||+.||++|||+.+++++|+++.+.
T Consensus       231 -~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          231 -STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             23566888899999999999999999999998764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.3e-43  Score=348.26  Aligned_cols=262  Identities=26%  Similarity=0.362  Sum_probs=203.4

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|.+.+|+.||+|++......  ....+.+|++++++++||||+++++++.. .+..++||||+
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~  101 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLVFEFM  101 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEEEECC
T ss_pred             hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEEEcCC
Confidence            5567999999999999999988999999998654322  24578899999999999999999999976 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++ +|.+++...  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....... ..
T Consensus       102 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~  176 (311)
T 3niz_A          102 EK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SY  176 (311)
T ss_dssp             SE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             CC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cc
Confidence            74 888888764  34589999999999999999999994 999999999999999999999999999987643322 22


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch---hhhcc-
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL---ELMRD-  521 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-  521 (580)
                      ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+....+...........+...   ..... 
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  256 (311)
T 3niz_A          177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR  256 (311)
T ss_dssp             -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred             cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence            33568999999998875 56899999999999999999999999887777666655544332211111000   00000 


Q ss_pred             -----CCC-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 -----APT-----IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 -----~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                           ...     .+....++.+++.+||+.||++|||+.|+++|
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 000     00112356789999999999999999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=356.82  Aligned_cols=246  Identities=22%  Similarity=0.354  Sum_probs=197.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|++. +|+.||||+++...   ......+.+|..+++.+ +||||+++++++.+ .+..++||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~lv~  103 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRLFFVM  103 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEEEEEE
Confidence            556789999999999999986 68999999997542   23445678999999988 79999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... 
T Consensus       104 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-  178 (353)
T 3txo_A          104 EFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-  178 (353)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence            999999999999875   3689999999999999999999995 99999999999999999999999999997543222 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+..   ..+......   +       ..
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~~i~~~~~~---~-------p~  245 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---EAILNDEVV---Y-------PT  245 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCCCC---C-------CT
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---HHHHcCCCC---C-------CC
Confidence            2233457999999999999999999999999999999999999999876543332   233222110   0       01


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEV------LQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~------~ev~~~  556 (580)
                      ..   ...+.+++.+||+.||++||++      .|+++|
T Consensus       246 ~~---~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          246 WL---HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             TS---CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CC---CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            11   2356678889999999999998      777764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.9e-43  Score=353.61  Aligned_cols=256  Identities=21%  Similarity=0.358  Sum_probs=203.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCE----EEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQ----VAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |...+.||+|+||.||+|.+. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++.  ++..++|
T Consensus        15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v   92 (325)
T 3kex_A           15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQLV   92 (325)
T ss_dssp             EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSSEEEE
T ss_pred             ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCccEEE
Confidence            556789999999999999975 4544    7888775433 223356788999999999999999999985  4578999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++...  ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus        93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            9999999999999764  24688899999999999999999995 99999999999999999999999999998765443


Q ss_pred             cc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          443 NV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       443 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .. ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+....   ...   .+    
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~---~~----  239 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RLA---QP----  239 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC---BCC---CC----
T ss_pred             ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---CCC---CC----
Confidence            22 2334567889999999999999999999999999999999 999998876655444433211   100   00    


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                        ..   ...++.+++.+||+.||++|||+.+++++|+++....
T Consensus       240 --~~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          240 --QI---CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             --TT---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             --Cc---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence              00   1114567888999999999999999999999987554

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.9e-43  Score=345.21  Aligned_cols=257  Identities=21%  Similarity=0.360  Sum_probs=197.2

Q ss_pred             HHhhhccccccCceEEEEEEeCC----CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLED----GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+..    +..||+|.++.... ...+.+.+|+.++++++||||+++++++.  ++..++|
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~lv   93 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWII   93 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccEEE
Confidence            46678999999999999998752    45699999875433 23456899999999999999999999984  4578999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++...  ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            9999999999999865  24689999999999999999999994 99999999999999999999999999998765544


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+.   .....         ..
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~---~~~~~---------~~  238 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NGERL---------PM  238 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCC---------CC
T ss_pred             ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH---cCCCC---------CC
Confidence            333334457788999999998899999999999999999997 999998766544433322   11110         01


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .+..   ...+.+++.+||+.||++|||+.|++++|+++.++.
T Consensus       239 ~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          239 PPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1112   235667888999999999999999999999986543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-42  Score=344.51  Aligned_cols=258  Identities=25%  Similarity=0.379  Sum_probs=198.3

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhc--CCCCcceeeeeEEECC---CCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGK--IRHPNLLALRAYYLGP---KGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~---~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|.+ +|+.||||++...   ....+.+|.+++..  ++||||+++++++...   ....++||
T Consensus        10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            55679999999999999988 5899999998643   33455566666665  7999999999987642   33578999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH--------SNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                      ||+++|+|.++++..    .+++..+..++.|++.||+|||        + ++|+||||||+||+++.++.+||+|||++
T Consensus        86 e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           86 HYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             CCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             hhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999653    5899999999999999999999        8 59999999999999999999999999999


Q ss_pred             cccccccccc---eeeecCccccCCccccccC------CCCCcccchhHHHHHHHHHcC----------CCCCCCCCCCC
Q 008031          436 RLMTAAANVN---VIATAGALGYRAPELSKLK------KANTKTDVYSLGVTILELLTG----------KSPGEPLNGAE  496 (580)
Q Consensus       436 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~tg----------~~p~~~~~~~~  496 (580)
                      +.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            7654433221   2234789999999998876      455789999999999999999          88886543322


Q ss_pred             -hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          497 -LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       497 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                       ....+................     ........++.+++.+||+.||++|||+.|+++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPNIPNR-----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGG-----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHhccCCCCCCChh-----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence             222222222111111100000     01123456788999999999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=354.67  Aligned_cols=260  Identities=24%  Similarity=0.386  Sum_probs=207.3

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+.      +++.||||+++.... ...+.+.+|+.++++++||||+++++++.. .+..++
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l  127 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCL  127 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-CCceEE
Confidence            556789999999999999975      347899999976533 234678999999999999999999999976 668999


Q ss_pred             EEeeCCCCChhhhhhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCee
Q 008031          362 VFDYMPHGSLATFLHARGP---------------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL  420 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil  420 (580)
                      ||||+++|+|.+++.....                     ...+++.+++.++.||+.||+|||+. ||+||||||+||+
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl  206 (343)
T 1luf_A          128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCL  206 (343)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEE
Confidence            9999999999999987431                     14689999999999999999999995 9999999999999


Q ss_pred             eCCCCCeEEeecccccccccccc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChh
Q 008031          421 LDDSTNAKISDFGLSRLMTAAAN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELP  498 (580)
Q Consensus       421 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~  498 (580)
                      ++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  286 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI  286 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH
Confidence            99999999999999976543322 22234567889999999998899999999999999999999 99999765533322


Q ss_pred             HHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                      .   .+......         ......   ..++.+++.+||+.||++|||+.+++++|+++.+...
T Consensus       287 ~---~~~~~~~~---------~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          287 Y---YVRDGNIL---------ACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             H---HHHTTCCC---------CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             H---HHhCCCcC---------CCCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            2   22211110         001111   2356788889999999999999999999999876543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.3e-43  Score=357.62  Aligned_cols=261  Identities=25%  Similarity=0.360  Sum_probs=207.9

Q ss_pred             HHhhhccccccCceEEEEEEe------CCCCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      .|.+.+.||+|+||.||+|.+      .+++.||||+++..... ..+.+.+|++++.++ +||||+++++++...+...
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~  102 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  102 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence            356788999999999999974      25678999999764432 345789999999999 8999999999998766669


Q ss_pred             EEEEeeCCCCChhhhhhhcCC-----------------------------------------------------------
Q 008031          360 LLVFDYMPHGSLATFLHARGP-----------------------------------------------------------  380 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------------  380 (580)
                      ++||||+++|+|.++++....                                                           
T Consensus       103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (359)
T 3vhe_A          103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP  182 (359)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence            999999999999999976532                                                           


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-cceeeecCcccc
Q 008031          381 ----ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-VNVIATAGALGY  455 (580)
Q Consensus       381 ----~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y  455 (580)
                          ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....... .......||+.|
T Consensus       183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y  261 (359)
T 3vhe_A          183 EDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  261 (359)
T ss_dssp             -CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred             cchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence                11288999999999999999999994 999999999999999999999999999986643322 223345678899


Q ss_pred             CCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHH
Q 008031          456 RAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLK  534 (580)
Q Consensus       456 ~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  534 (580)
                      +|||++.+..++.++|||||||++|||++ |+.||......+..   ...........        .....   ..++.+
T Consensus       262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~~~~~~~--------~~~~~---~~~l~~  327 (359)
T 3vhe_A          262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---CRRLKEGTRMR--------APDYT---TPEMYQ  327 (359)
T ss_dssp             CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH---HHHHHHTCCCC--------CCTTC---CHHHHH
T ss_pred             EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH---HHHHHcCCCCC--------CCCCC---CHHHHH
Confidence            99999999999999999999999999998 99999776543321   11111111100        01111   235678


Q ss_pred             HHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          535 LALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       535 li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ++.+||+.||++|||+.|++++|+.+.+.
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            88899999999999999999999998653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-43  Score=350.44  Aligned_cols=263  Identities=22%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             HHhhhccccccCceEEEEEEe-----CCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATL-----EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~l  361 (580)
                      .|.+.+.||+|+||.||+|.+     .+++.||||++........+.+.+|++++++++||||+++++++... ....++
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   90 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL   90 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence            356789999999999999984     26889999999866555567899999999999999999999998642 245899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus        91 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           91 IMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred             EEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence            999999999999998752  358999999999999999999999 59999999999999999999999999999876543


Q ss_pred             ccc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC---------ChhH---HHHHHhhh
Q 008031          442 ANV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA---------ELPQ---WVASIVKE  507 (580)
Q Consensus       442 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~---------~~~~---~~~~~~~~  507 (580)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|..||......         ....   .+......
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  247 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence            221  122335677899999999999999999999999999999999998642110         0000   00000110


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ..           ..+.......++.+++.+||+.||++|||+.|+++.|++++++-
T Consensus       248 ~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          248 NG-----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             TC-----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cC-----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            00           01111112235678888999999999999999999999987653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1e-42  Score=350.50  Aligned_cols=259  Identities=14%  Similarity=0.163  Sum_probs=211.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|... +|+.||||++....  ....+.+|+++++++ +||||+++++++.. .+..++||||+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~   87 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVLELL   87 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEEECC
T ss_pred             eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEEEeC
Confidence            556789999999999999974 78999999986442  234688999999999 99999999999987 66889999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC-----eEEeecccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN-----AKISDFGLSRLMTAA  441 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~-----~kl~Dfg~~~~~~~~  441 (580)
                       +++|.+++...  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.     +||+|||+++.....
T Consensus        88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           88 -GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence             99999999864  24699999999999999999999995 9999999999999998877     999999999876443


Q ss_pred             ccc------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          442 ANV------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       442 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ...      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+........   
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~---  240 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP---  240 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC---
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC---
Confidence            321      12345799999999999999999999999999999999999999998877766665555433222110   


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ...  .....+    ++.+++.+||+.||.+||++.++++.|+++...
T Consensus       241 ~~~--~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          241 IEV--LCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHH--HTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHH--HhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            000  011111    677889999999999999999999999987644

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=360.77  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=203.3

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      ..|.+.+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+ ++..++||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~   89 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHYLIF   89 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEEEEE
Confidence            45778899999999999999875 789999999865432  234568999999999999999999999986 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC---CCCCeEEeeccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD---DSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~  440 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++   +++.+||+|||++.....
T Consensus        90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            999999999999875   3689999999999999999999994 999999999999998   467899999999987654


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+..+.+   ..+...   .+...  
T Consensus       166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~~~~~---~~~~~--  236 (444)
T 3soa_A          166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI---KAGAYD---FPSPE--  236 (444)
T ss_dssp             TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHTCCC---CCTTT--
T ss_pred             CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH---HhCCCC---CCccc--
Confidence            322 223457999999999999999999999999999999999999999765543333222   222111   00000  


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                       .+..   ..++.+++.+||+.||++|||+.|++++-
T Consensus       237 -~~~~---s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          237 -WDTV---TPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             -TTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             -cccC---CHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence             1112   23566888899999999999999999863

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-42  Score=353.87  Aligned_cols=251  Identities=24%  Similarity=0.304  Sum_probs=202.9

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      -.|.+.+.||+|+||.||+|.+. +|+.||+|++.....  ...+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~  107 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVF  107 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEE
Confidence            35778899999999999999986 789999999865432  234568899999999999999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC---CCeEEeeccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS---TNAKISDFGLSRLMTA  440 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~  440 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.+   +.+||+|||++.....
T Consensus       108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            999999999998764   3689999999999999999999995 99999999999999864   4599999999987654


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ...  .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+...   .+..+...   .....+.
T Consensus       184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~---~~~~~~~  255 (362)
T 2bdw_A          184 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIKAGAYD---YPSPEWD  255 (362)
T ss_dssp             CCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCCC---CCTTGGG
T ss_pred             Ccc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhCCCC---CCccccc
Confidence            322  234579999999999999999999999999999999999999997654332222   22222111   0001111


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                            ....++.+++.+||+.||++|||+.|++++
T Consensus       256 ------~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          256 ------TVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ------GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  112356788899999999999999999877

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=355.68  Aligned_cols=251  Identities=21%  Similarity=0.383  Sum_probs=204.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||+|++..........+.+|+.++++++||||+++++++.+ ....++||||++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~  131 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLS  131 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEEcCC
Confidence            667899999999999999986 789999999876554455678999999999999999999999987 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC--CCCeEEeecccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD--STNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +|+|.+++...  ...+++..+..++.||+.||+|||+. ||+||||||+|||++.  ++.+||+|||+++.......  
T Consensus       132 gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--  206 (387)
T 1kob_A          132 GGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--  206 (387)
T ss_dssp             CCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred             CCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence            99999999754  24689999999999999999999994 9999999999999974  57799999999987654332  


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+..   ..+....+.   .+...   ....
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~~~~~---~~~~~---~~~~  277 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKRCDWE---FDEDA---FSSV  277 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHHCCCC---CCSST---TTTS
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHHhCCCC---CCccc---cccC
Confidence            23457999999999999999999999999999999999999999875433222   222221111   11111   1111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                         ..++.+++.+||+.||++|||+.|++++-
T Consensus       278 ---s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          278 ---SPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             ---CHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence               23567888999999999999999999873

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.3e-43  Score=351.22  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E   89 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIVMVIE   89 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEE
Confidence            566799999999999999984 79999999986432   2234578999999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+ +|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||++.........
T Consensus        90 ~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           90 YA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             CC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred             CC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence            99 78999998765   3689999999999999999999995 9999999999999999999999999999876543322


Q ss_pred             ceeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                        ....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||......+....+..   .         . .....
T Consensus       165 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~---~---------~-~~~p~  229 (336)
T 3h4j_B          165 --KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS---C---------V-YVMPD  229 (336)
T ss_dssp             --CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS---S---------C-CCCCT
T ss_pred             --ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---C---------C-CCCcc
Confidence              33569999999999988776 6899999999999999999999976544332221110   0         0 00011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ..   ...+.+++.+||+.||.+|||+.|++++-.
T Consensus       230 ~~---s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          230 FL---SPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             TS---CHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             cC---CHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence            11   235668888999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-43  Score=355.61  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=199.4

Q ss_pred             HhhhccccccCceEEEEEEeC--CC--CEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE--DG--SQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...+.||+|+||.||+|.+.  ++  ..||+|.++.... ...+.+.+|+.++++++||||+++++++...++..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            455789999999999999864  22  3689999865433 334678999999999999999999999876666889999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.++++..  ...+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++.......
T Consensus       171 e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             ECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            999999999999764  34588999999999999999999994 999999999999999999999999999986643322


Q ss_pred             c---ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          444 V---NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       444 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .   ......+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+..   +...         
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---~~~~---------  315 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRRL---------  315 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT---TCCC---------
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc---CCCC---------
Confidence            1   2233457788999999999999999999999999999999 7888877766555443322   1110         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                      ......+   ..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       316 ~~p~~~~---~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          316 LQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            0111122   256678889999999999999999999999865443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=345.28  Aligned_cols=243  Identities=24%  Similarity=0.361  Sum_probs=201.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+ ....++|||
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv~e   86 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMD   86 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEEEEe
Confidence            556789999999999999986 79999999987542   2345678899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.....   
T Consensus        87 ~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           87 YIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            99999999999874   3689999999999999999999994 9999999999999999999999999999865432   


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..   .....+......       .   .+.
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~-------~---p~~  225 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILNAELR-------F---PPF  225 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHCCCC-------C---CTT
T ss_pred             -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCC-------C---CCC
Confidence             22457999999999999999999999999999999999999999765432   223333322110       0   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      ..   .++.+++.+||+.||++||     ++.|+++|
T Consensus       226 ~~---~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          226 FN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             SC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC---HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            11   3566788899999999999     89999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=351.58  Aligned_cols=247  Identities=22%  Similarity=0.324  Sum_probs=202.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+ .+..++|||
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e   95 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFMVVD   95 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEe
Confidence            566799999999999999986 68899999986432   2345678899999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++.......  
T Consensus        96 ~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  169 (384)
T 4fr4_A           96 LLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--  169 (384)
T ss_dssp             CCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence            99999999999864   3689999999999999999999994 99999999999999999999999999998764332  


Q ss_pred             ceeeecCccccCCcccccc---CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          445 NVIATAGALGYRAPELSKL---KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ......||+.|+|||++.+   ..++.++||||+||++|||++|+.||..............+......          .
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------~  239 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT----------Y  239 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC----------C
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC----------C
Confidence            2334679999999999863   45899999999999999999999999876655544444433221110          0


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPE-VLQVVQ  555 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ev~~  555 (580)
                      ...   ....+.+++.+||+.||.+||+ +.++.+
T Consensus       240 p~~---~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          240 PSA---WSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CTT---SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCc---CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            111   1235678888999999999998 777665

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.4e-43  Score=359.88  Aligned_cols=251  Identities=21%  Similarity=0.266  Sum_probs=202.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|+++...   ......+.+|+.+++.++||||+++++++.+ .+..++|||
T Consensus        71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lV~E  149 (410)
T 3v8s_A           71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVME  149 (410)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence            456789999999999999986 68999999986532   2233458899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.++++..    .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++........
T Consensus       150 ~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          150 YMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             CCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            99999999999764    489999999999999999999994 9999999999999999999999999999876554433


Q ss_pred             ceeeecCccccCCccccccCC----CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          445 NVIATAGALGYRAPELSKLKK----ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ......||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+..+   ....+.........      .
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~~~~~------p  295 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIMNHKNSLTF------P  295 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHHHHCCC------C
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHHHHHhccccccC------C
Confidence            344567999999999987655    7889999999999999999999998654332   33333322111000      0


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSA--RPEVLQVVQQL  557 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ev~~~L  557 (580)
                      .....+   .++.+++.+||+.+|.+  ||++.|+++|-
T Consensus       296 ~~~~~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          296 DDNDIS---KEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             TTCCCC---HHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             Cccccc---HHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            011122   35667888999999998  99999999885

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4e-42  Score=340.98  Aligned_cols=265  Identities=16%  Similarity=0.207  Sum_probs=213.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++....  ....+.+|+.+++.+ +|+|++++++++.. ....++||||+
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~   88 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL   88 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEEEec
Confidence            556789999999999999974 78999999985432  334678899999999 89999999999976 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC-----eEEeecccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN-----AKISDFGLSRLMTAA  441 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~-----~kl~Dfg~~~~~~~~  441 (580)
                       +++|.+++...+  ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++.     +||+|||+++.....
T Consensus        89 -~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 -GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence             999999998753  358999999999999999999999 49999999999999987765     999999999876543


Q ss_pred             ccc------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          442 ANV------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       442 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ...      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........+....+.........  
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  242 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL--  242 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH--
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH--
Confidence            321      223456999999999999999999999999999999999999999887666555544443332211110  


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccccc
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAA  568 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~  568 (580)
                      ...   .+..   ..++.+++.+||+.||++|||+.++++.|+++..+.....
T Consensus       243 ~~~---~~~~---~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~  289 (298)
T 1csn_A          243 REL---CAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE  289 (298)
T ss_dssp             HHH---TTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             HHH---HhhC---cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence            011   1111   1356688889999999999999999999999876554433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-42  Score=342.32  Aligned_cols=262  Identities=23%  Similarity=0.339  Sum_probs=198.1

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|...+|+.||+|++.....  .....+.+|++++++++||||+++++++.. .+..++||||+
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~   82 (288)
T 1ob3_A            4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFEHL   82 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEECC
T ss_pred             chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEEEec
Confidence            456789999999999999998899999999864432  234678899999999999999999999987 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++ +|.+++...  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....... ..
T Consensus        83 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  157 (288)
T 1ob3_A           83 DQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY  157 (288)
T ss_dssp             SE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             CC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cc
Confidence            75 999988764  24689999999999999999999995 999999999999999999999999999976543221 22


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc--------ccchh
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE--------VFDLE  517 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  517 (580)
                      ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+...........        .+++.
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            33468999999999865 4589999999999999999999999987654333333322211110000        00100


Q ss_pred             hhccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAP-----TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .....+     .......++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000     000112356688999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-43  Score=356.22  Aligned_cols=273  Identities=23%  Similarity=0.350  Sum_probs=206.1

Q ss_pred             HHhhhccccccCceEEEEEEe-----CCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEEC-CCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATL-----EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG-PKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~l  361 (580)
                      .|.+.+.||+|+||.||+|.+     .+++.||||++........+.+.+|++++++++||||+++++++.. .....++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  103 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL  103 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence            356789999999999999984     3688999999987655556779999999999999999999999875 3456889


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++++|.+++....  ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus       104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          104 VMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            999999999999997642  358999999999999999999999 49999999999999999999999999999876543


Q ss_pred             ccc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-----------ChhHHHHHHhhhh
Q 008031          442 ANV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA-----------ELPQWVASIVKEE  508 (580)
Q Consensus       442 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~-----------~~~~~~~~~~~~~  508 (580)
                      ...  ......+|..|+|||.+.+..++.++||||+|+++|+|++|+.||......           .....+.......
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            322  122345788899999999889999999999999999999999998642211           0001111111111


Q ss_pred             ccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccCCCCCC
Q 008031          509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGDA  574 (580)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~~~~~~  574 (580)
                      ..           .+........+.+++.+||+.||++|||+.|++++|+.+........+...++
T Consensus       261 ~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  315 (327)
T 3lxl_A          261 QR-----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTA  315 (327)
T ss_dssp             CC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------------
T ss_pred             cC-----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccccccc
Confidence            00           01111122356788889999999999999999999999987666555544333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-42  Score=348.04  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=209.3

Q ss_pred             HHhhhccccccCceEEEEEEe------CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .|.+.+.||+|+||.||+|.+      .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.. .+..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~  102 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGPLL  102 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCE
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-CCceE
Confidence            466789999999999999986      2457899999975433 334678999999999999999999999976 66899


Q ss_pred             EEEeeCCCCChhhhhhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCe
Q 008031          361 LVFDYMPHGSLATFLHARGP---------------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNV  419 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Ni  419 (580)
                      +||||+++|+|.+++.....                     ...+++.++..++.||+.||+|||+. ||+||||||+||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~NI  181 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNI  181 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCcccccchheE
Confidence            99999999999999987532                     13488999999999999999999995 999999999999


Q ss_pred             eeCCCCCeEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCCh
Q 008031          420 LLDDSTNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL  497 (580)
Q Consensus       420 l~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~  497 (580)
                      +++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+.
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  261 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL  261 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999866443222 2223457788999999998899999999999999999999 9999987665443


Q ss_pred             hHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          498 PQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ...+..    ....     .   .....   ...+.+++.+||+.||++|||+.|++++|+++..+
T Consensus       262 ~~~~~~----~~~~-----~---~~~~~---~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          262 FNLLKT----GHRM-----E---RPDNC---SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             HHHHHT----TCCC-----C---CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHhhc----CCcC-----C---CCccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            333221    1100     0   01111   23567888899999999999999999999998654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-42  Score=351.88  Aligned_cols=254  Identities=22%  Similarity=0.319  Sum_probs=202.7

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-----TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||++....     ....+.+.+|+.+++.++||||+++++++.. ++..+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGMLY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEE
Confidence            35788899999999999999986 79999999986432     1235678999999999999999999999987 66899


Q ss_pred             EEEeeCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC---eEEeeccccc
Q 008031          361 LVFDYMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLSR  436 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~---~kl~Dfg~~~  436 (580)
                      +||||+++|+|.+++.... ....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.   +||+|||++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999998886532 234589999999999999999999995 9999999999999986554   9999999998


Q ss_pred             ccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          437 LMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       437 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      ....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....    ......+......   .++
T Consensus       182 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~~~~---~~~  253 (351)
T 3c0i_A          182 QLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKGKYK---MNP  253 (351)
T ss_dssp             ECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHTCCC---CCH
T ss_pred             EecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcCCCC---CCc
Confidence            7654322 2234569999999999999999999999999999999999999997632    1222222222111   111


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..+.   ..   ..++.+++.+||+.||++|||+.|+++|
T Consensus       254 ~~~~---~~---s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          254 RQWS---HI---SESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHHT---TS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccc---cC---CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111   11   2356788899999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.9e-43  Score=343.63  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=213.3

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|...+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++.. ++..++||||+
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~   91 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFM   91 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECC
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEEEEEcC
Confidence            3566789999999999999987 58899999987542 345678999999999999999999999976 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus        92 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  169 (288)
T 3kfa_A           92 TYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  169 (288)
T ss_dssp             TTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred             CCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence            9999999998753 34689999999999999999999994 999999999999999999999999999987765544444


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      ....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...+..+....+...    ...     .   .....
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~----~~~-----~---~~~~~  237 (288)
T 3kfa_A          170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----YRM-----E---RPEGC  237 (288)
T ss_dssp             TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----CCC-----C---CCTTC
T ss_pred             cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc----CCC-----C---CCCCC
Confidence            44557788999999998999999999999999999999 99999876554443333221    100     0   01111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                         ...+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus       238 ---~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          238 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence               2356788889999999999999999999999876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=343.33  Aligned_cols=254  Identities=25%  Similarity=0.407  Sum_probs=198.5

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |.+.+.||+|+||.||+|.+. ++.||+|.+...  ...+.+.+|++++++++||||+++++++.   +..++||||+++
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~lv~e~~~~   83 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCLVMEYAEG   83 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEEEEECCTT
T ss_pred             eeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEEEEEcCCC
Confidence            456789999999999999986 788999998643  34567899999999999999999999875   358999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCcccCCCCCCCeeeCCCCC-eEEeecccccccccccccc
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN--ENIIHGNLTSSNVLLDDSTN-AKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--~~i~H~Dlk~~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~  445 (580)
                      |+|.+++........+++..+..++.|+++||+|||+.  .||+||||||+||+++.++. +||+|||++.......   
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---  160 (307)
T 2eva_A           84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---  160 (307)
T ss_dssp             CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence            99999998765444588999999999999999999982  38999999999999998876 7999999997554321   


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                       ....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ............      ..   ....
T Consensus       161 -~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~------~~---~~~~  229 (307)
T 2eva_A          161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWAVHNGTRP------PL---IKNL  229 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHHHHTTCCC------CC---BTTC
T ss_pred             -ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHHHhcCCCC------Cc---cccc
Confidence             234589999999999999999999999999999999999999976543321 111111111110      01   1111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                         ...+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus       230 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          230 ---PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             ---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence               2356688889999999999999999999999875543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-41  Score=336.18  Aligned_cols=250  Identities=26%  Similarity=0.470  Sum_probs=199.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc-------HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG-------QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      |...+.||+|+||.||+|.+. +++.||+|++.......       .+.+.+|++++++++||||+++++++.+   ..+
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   97 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN---PPR   97 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---TTE
T ss_pred             ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---CCe
Confidence            556789999999999999985 79999999986443221       1578999999999999999999999854   337


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccCCCCCCCeeeCCCCC-----eEEeecc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLDDSTN-----AKISDFG  433 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--i~H~Dlk~~Nil~~~~~~-----~kl~Dfg  433 (580)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||+|||+. |  |+||||||+||+++.++.     +||+|||
T Consensus        98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             EEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            999999999999988764  34689999999999999999999995 8  999999999999987776     9999999


Q ss_pred             cccccccccccceeeecCccccCCcccc--ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          434 LSRLMTAAANVNVIATAGALGYRAPELS--KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       434 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      +++....    ......||+.|+|||.+  ....++.++||||+||++|||++|+.||......+.. ............
T Consensus       175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~  249 (287)
T 4f0f_A          175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMIREEGLRP  249 (287)
T ss_dssp             TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHHHHSCCCC
T ss_pred             ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHHhccCCCC
Confidence            9975433    23345789999999998  4556788999999999999999999999876554322 122222111111


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                           ..   ....   ...+.+++.+||+.||++|||+.|+++.|+++
T Consensus       250 -----~~---~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          250 -----TI---PEDC---PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -----CC---CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -----CC---Cccc---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                 11   1111   23567888899999999999999999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.8e-42  Score=345.78  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=199.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+ .+..++||||+
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~   87 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYC   87 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred             ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEEcC
Confidence            566799999999999999987 799999999864432 234568899999999999999999999986 66889999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-cc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-VN  445 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  445 (580)
                      ++|+|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||+++....... ..
T Consensus        88 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           88 SGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             TTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            999999999764   358999999999999999999999 5999999999999999999999999999986643322 22


Q ss_pred             eeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..........  .........           .+.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~-----------~~~  230 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEKKTY-----------LNP  230 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--HHHHTTCTT-----------STT
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHHhccccc-----------CCc
Confidence            234579999999999887765 678999999999999999999998655432211  111111100           000


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .......+.+++.+||+.||++|||+.|++++-.
T Consensus       231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            0111235668899999999999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.3e-43  Score=352.05  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=200.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++...   ......+..|..++..+ +||||+++++++.+ .+..++||
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~~~~lv~   97 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFFVM   97 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CCEEEEEE
Confidence            556789999999999999986 68999999997542   23456678899999887 99999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++...... 
T Consensus        98 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  172 (345)
T 1xjd_A           98 EYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  172 (345)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence            999999999999874   3689999999999999999999995 99999999999999999999999999997543222 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+..+   .+.....       ..   ..
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~i~~~~~-------~~---p~  239 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH---SIRMDNP-------FY---PR  239 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHCCC-------CC---CT
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHHhCCC-------CC---Cc
Confidence            22334679999999999999999999999999999999999999997655333222   2222111       00   01


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVL-QVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~-ev~~~  556 (580)
                      ..   ..++.+++.+||+.||++||++. ++++|
T Consensus       240 ~~---s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          240 WL---EKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             TS---CHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             cc---CHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            11   23566888899999999999998 77654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=353.27  Aligned_cols=247  Identities=26%  Similarity=0.372  Sum_probs=197.1

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      .+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.. .+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCc
Confidence            567999999999999975 799999999976655566789999999999999999999999987 668999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee--CCCCCeEEeecccccccccccccceee
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL--DDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |.+++...  ...+++..+..++.||+.||+|||+. ||+||||||+|||+  +.++.+||+|||+++........  ..
T Consensus       173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--~~  247 (373)
T 2x4f_A          173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KV  247 (373)
T ss_dssp             EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--CC
T ss_pred             HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--cc
Confidence            99998754  23589999999999999999999994 99999999999999  56778999999999876543322  23


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+   .+..+....+..   ....   .+..   
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~~~~~~~---~~~~---~~~~---  315 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNNILACRWDL---EDEE---FQDI---  315 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCCS---CSGG---GTTS---
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCCC---Chhh---hccC---
Confidence            469999999999998999999999999999999999999997655332   233333222110   0011   1111   


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          529 LLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..++.+++.+||+.||++|||+.|++++
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            2356788899999999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-42  Score=341.50  Aligned_cols=256  Identities=22%  Similarity=0.363  Sum_probs=204.0

Q ss_pred             HhhhccccccCceEEEEEEeCC----CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLED----GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...+.||+|+||.||+|.+..    +..||+|.++.... ...+.+.+|+.++++++||||+++++++.+  +..++||
T Consensus        14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~   91 (281)
T 3cc6_A           14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPTWIIM   91 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSCEEEE
T ss_pred             eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCEEEE
Confidence            5667999999999999998642    33599999876532 345678999999999999999999999864  4678999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++........
T Consensus        92 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           92 ELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             ECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred             ecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence            9999999999997652  4589999999999999999999994 999999999999999999999999999987655443


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+..   ....         ...
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~~~~---------~~~  236 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRL---------PKP  236 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---TCCC---------CCC
T ss_pred             cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---CCCC---------CCC
Confidence            33344567889999999998999999999999999999998 9999986655444333222   1110         001


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ...   ...+.+++.+||+.||++|||+.|++++|+++....
T Consensus       237 ~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          237 DLC---PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCC---CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            111   235668888999999999999999999999986543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=344.00  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=193.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--------------------------cHHHHHHHHHHHhcCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--------------------------GQREFESEVSLLGKIR  341 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~  341 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||++......                          ..+.+.+|++++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   94 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD   94 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred             eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence            566799999999999999976 7889999998643211                          1246889999999999


Q ss_pred             CCcceeeeeEEECC-CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCee
Q 008031          342 HPNLLALRAYYLGP-KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL  420 (580)
Q Consensus       342 h~niv~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil  420 (580)
                      ||||+++++++... .+..++||||+++++|.+++..    ..+++..+..++.||+.||+|||+. ||+||||||+||+
T Consensus        95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLL  169 (298)
T ss_dssp             CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEE
T ss_pred             CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEE
Confidence            99999999999863 4578999999999999887653    3699999999999999999999995 9999999999999


Q ss_pred             eCCCCCeEEeecccccccccccccceeeecCccccCCccccccCC---CCCcccchhHHHHHHHHHcCCCCCCCCCCCCh
Q 008031          421 LDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKK---ANTKTDVYSLGVTILELLTGKSPGEPLNGAEL  497 (580)
Q Consensus       421 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~  497 (580)
                      ++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++|||||||++|+|++|+.||.....   
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---  245 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---  245 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred             ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---
Confidence            99999999999999987654322 223457999999999987655   36789999999999999999999976432   


Q ss_pred             hHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          498 PQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......+......     .   ...+..   ..++.+++.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~~~-----~---~~~~~~---~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          246 MCLHSKIKSQALE-----F---PDQPDI---AEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHHHHHHHHCCCC-----C---CSSSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHHHHHHhcccCC-----C---CCcccc---CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            2222222111110     0   001112   2356688889999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-42  Score=353.57  Aligned_cols=268  Identities=15%  Similarity=0.148  Sum_probs=202.4

Q ss_pred             HhhhccccccCceEEEEEEeCC------CCEEEEEEccccccc-----------cHHHHHHHHHHHhcCCCCcceeeeeE
Q 008031          289 CATAEIMGKSTYGTVYKATLED------GSQVAVKRLREKITK-----------GQREFESEVSLLGKIRHPNLLALRAY  351 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~  351 (580)
                      |.+.+.||+|+||.||+|.+.+      ++.||||++......           ....+..|+..++.++||||++++++
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  116 (364)
T 3op5_A           37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS  116 (364)
T ss_dssp             EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred             EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence            5567999999999999998864      478999998654321           11234456677888899999999999


Q ss_pred             EECCC---CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC--CCCC
Q 008031          352 YLGPK---GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD--DSTN  426 (580)
Q Consensus       352 ~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~--~~~~  426 (580)
                      +....   ...++||||+ +++|.+++...  ...+++..++.++.||+.||+|||+. ||+||||||+|||++  .++.
T Consensus       117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSCTTC
T ss_pred             eeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCCCCe
Confidence            87632   3479999999 99999999874  34699999999999999999999995 999999999999999  8899


Q ss_pred             eEEeecccccccccccccc------eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChh-H
Q 008031          427 AKISDFGLSRLMTAAANVN------VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELP-Q  499 (580)
Q Consensus       427 ~kl~Dfg~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-~  499 (580)
                      +||+|||+++.+.......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            9999999998765432221      12345999999999999999999999999999999999999999864332211 1


Q ss_pred             HHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          500 WVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                      ....... .......+..+.  ....+   .++.+++..||+.||++||++.++++.|+++..+...
T Consensus       273 ~~~~~~~-~~~~~~~~~~~~--~~~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          273 DSKIRYR-ENIASLMDKCFP--AANAP---GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             HHHHHHH-HCHHHHHHHHSC--TTCCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHhh-hhHHHHHHHhcc--cccCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            1111111 111111111110  01112   3566788899999999999999999999998655433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.4e-42  Score=349.57  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=192.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++.. .+..++||||++
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~   99 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIMEYAS   99 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCC
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEEEEEeCC
Confidence            567899999999999999987 799999999865432 34668899999999999999999999987 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC--eEEeecccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN--AKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +|+|.+++...+   .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.  +||+|||+++......  .
T Consensus       100 ~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~  173 (361)
T 3uc3_A          100 GGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  173 (361)
T ss_dssp             SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--C
Confidence            999999997643   58999999999999999999999 59999999999999987665  9999999987443222  2


Q ss_pred             eeeecCccccCCccccccCCCCCc-ccchhHHHHHHHHHcCCCCCCCCCCCC-hhHHHHHHhhhhccccccchhhhccCC
Q 008031          446 VIATAGALGYRAPELSKLKKANTK-TDVYSLGVTILELLTGKSPGEPLNGAE-LPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||....... ....+..+.......        ....
T Consensus       174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~  245 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI--------PDDI  245 (361)
T ss_dssp             -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC--------CTTS
T ss_pred             CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC--------CCcC
Confidence            233569999999999988887766 899999999999999999998765433 233333322211100        0000


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ..   ...+.+++.+||+.||++|||+.|+++|-.
T Consensus       246 ~~---s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          246 RI---SPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             CC---CHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             CC---CHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            11   235668899999999999999999999854

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.2e-42  Score=340.23  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=205.8

Q ss_pred             HHhhhccccccCceEEEEEEeCC----CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLED----GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+.+    +..||+|.+..... ...+.+.+|+.++++++||||+++++++...++..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            35667899999999999998642    23589999875433 23467899999999999999999999987767788999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++...  ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||+++......
T Consensus       106 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999764  3468999999999999999999999 499999999999999999999999999998664433


Q ss_pred             c---cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          443 N---VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       443 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .   .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||...+..+....+...   ...        
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~--------  251 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRL--------  251 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT---CCC--------
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC---CCC--------
Confidence            2   12334467789999999999999999999999999999999 66777766655544433221   100        


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                       ......+   ..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       252 -~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          252 -LQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             -CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -CCCccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             0011111   2567888899999999999999999999998654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=347.16  Aligned_cols=256  Identities=23%  Similarity=0.413  Sum_probs=200.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCE----EEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQ----VAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |...+.||+|+||.||+|.+. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++..  +..++|
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~v   94 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLI   94 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--SSEEEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--CCceEE
Confidence            567799999999999999975 4554    5777775433 3356789999999999999999999999985  358899


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      +||+.+|+|.+++....  ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             ECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            99999999999998752  468999999999999999999999 499999999999999999999999999998764432


Q ss_pred             c-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          443 N-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       443 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      . .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+...   ...         .
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---~~~---------~  239 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERL---------P  239 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCC---------C
T ss_pred             ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCC---------C
Confidence            2 22233456788999999999999999999999999999999 99999877655544433221   100         0


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ..+.   ...++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       240 ~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          240 QPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             CCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            1111   1235678888999999999999999999999987554

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.7e-42  Score=355.57  Aligned_cols=271  Identities=19%  Similarity=0.268  Sum_probs=204.3

Q ss_pred             HHhhhcccccc--CceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKS--TYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|  +||.||+|.+. +|+.||||+++....  ...+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  104 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVV  104 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEEEEE
Confidence            46678999999  99999999987 799999999975432  233568889999999999999999999987 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++.... ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||.+.......
T Consensus       105 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             EEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            99999999999998753 34589999999999999999999995 99999999999999999999999999886543221


Q ss_pred             cc------ceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc-----
Q 008031          443 NV------NVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW-----  509 (580)
Q Consensus       443 ~~------~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  509 (580)
                      ..      ......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.+.+..+.............     
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST  262 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence            11      1112368899999999887  6799999999999999999999999987655443322111000000     


Q ss_pred             -cccccc-------------hhh-----------hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhc
Q 008031          510 -TNEVFD-------------LEL-----------MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIR  561 (580)
Q Consensus       510 -~~~~~~-------------~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~  561 (580)
                       ......             ...           ....+........+.+++.+||+.||++|||+.|++++  ++++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence             000000             000           00000011122457789999999999999999999987  55554

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.6e-43  Score=342.08  Aligned_cols=256  Identities=23%  Similarity=0.392  Sum_probs=207.8

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|...+.||+|+||.||+|.+.++..||+|.++... ...+.+.+|++++++++||||+++++++.  ++..++||||++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~   90 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYME   90 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEEECCT
T ss_pred             hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc--CCCcEEEEecCC
Confidence            356789999999999999999888899999987543 34577899999999999999999999986  346899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++.... ...+++..+..++.|++.||+|||+. |++||||||+||++++++.+||+|||++............
T Consensus        91 ~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T 1qpc_A           91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE  168 (279)
T ss_dssp             TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred             CCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence            999999997531 12589999999999999999999994 9999999999999999999999999999876544333333


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..+.+.   .. ...     .   ..... 
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~-~~~-----~---~~~~~-  235 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---RG-YRM-----V---RPDNC-  235 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TT-CCC-----C---CCTTC-
T ss_pred             CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh---cc-cCC-----C---Ccccc-
Confidence            3456788999999998899999999999999999999 999997654333222221   11 100     0   01111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                        ..++.+++.+||+.||++|||+.++++.|+++...
T Consensus       236 --~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          236 --PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence              23567888899999999999999999999998654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-42  Score=348.26  Aligned_cols=244  Identities=20%  Similarity=0.273  Sum_probs=202.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|.+. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+ .+..++|||
T Consensus        43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e  121 (350)
T 1rdq_E           43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVME  121 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEc
Confidence            556789999999999999986 79999999986542   2345678899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...+   .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++......  
T Consensus       122 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~--  195 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--  195 (350)
T ss_dssp             CCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred             CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence            999999999998753   589999999999999999999994 99999999999999999999999999998664322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                        ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..   +....+..+...       .   ...
T Consensus       196 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~-------~---p~~  260 (350)
T 1rdq_E          196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIVSGKVR-------F---PSH  260 (350)
T ss_dssp             --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCC-------C---CTT
T ss_pred             --ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHHHHHcCCCC-------C---CCC
Confidence              2356899999999999999999999999999999999999999765432   223333222110       0   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQL  557 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~L  557 (580)
                      .   ..++.+++.+||+.||++||+     +.|+++|-
T Consensus       261 ~---~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          261 F---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             C---CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             C---CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            1   235668888999999999998     88888764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7e-42  Score=350.17  Aligned_cols=250  Identities=18%  Similarity=0.323  Sum_probs=198.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|+.. +++.||+|+++.....   ....+.+|..++.++ +||||+++++++.+ .+..++||
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~lV~  132 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVI  132 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEEEEE
Confidence            566789999999999999986 6889999999754322   234578899999887 89999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... 
T Consensus       133 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-  207 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  207 (396)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence            999999999999875   3689999999999999999999994 99999999999999999999999999997533222 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC-----hhHHHHHHhhhhccccccchhh
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE-----LPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ....+...+.....      ..
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~  281 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI  281 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------CC
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------CC
Confidence            22334679999999999999999999999999999999999999997543221     11112221111110      00


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEV------LQVVQQ  556 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~ev~~~  556 (580)
                         +..   ...++.+++.+||+.||++||++      .|+++|
T Consensus       282 ---p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          282 ---PRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ---CTT---SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ---CCc---CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence               111   12356688889999999999985      566665

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.1e-43  Score=373.41  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=208.7

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+  +..++||||+++
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~  345 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSK  345 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTT
T ss_pred             hhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehhcC
Confidence            56678999999999999999888889999997643 345689999999999999999999999864  578999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.++++... ...+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++............
T Consensus       346 gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  423 (535)
T 2h8h_A          346 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  423 (535)
T ss_dssp             EEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred             CcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence            99999997532 23589999999999999999999994 99999999999999999999999999998765433222233


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+.   . ....        ......  
T Consensus       424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~---~-~~~~--------~~~~~~--  489 (535)
T 2h8h_A          424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R-GYRM--------PCPPEC--  489 (535)
T ss_dssp             TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH---T-TCCC--------CCCTTC--
T ss_pred             CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c-CCCC--------CCCCCC--
Confidence            456788999999998999999999999999999999 999998765433333221   1 1110        011112  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                       ...+.++|.+||+.||++|||+.++++.|+.+...
T Consensus       490 -~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          490 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence             23567888999999999999999999999998644

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-42  Score=345.60  Aligned_cols=257  Identities=23%  Similarity=0.435  Sum_probs=199.4

Q ss_pred             HhhhccccccCceEEEEEEeCC-----CCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLED-----GSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |...+.||+|+||.||+|.+..     +..||+|.++.... .....+.+|+.++++++||||+++++++.. .+..++|
T Consensus        46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv  124 (333)
T 1mqb_A           46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMMII  124 (333)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEE
T ss_pred             hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcEEE
Confidence            4557899999999999998752     23599999875433 234568999999999999999999999976 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++...  ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++......
T Consensus       125 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          125 TEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence            9999999999999864  24689999999999999999999995 99999999999999999999999999998765432


Q ss_pred             cc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+   ......         
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~---~~~~~~---------  269 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRL---------  269 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HTTCCC---------
T ss_pred             ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---HCCCcC---------
Confidence            21  1222346788999999998999999999999999999999 99999765533322222   111110         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .....   ....+.+++.+||+.||++|||+.++++.|+++....
T Consensus       270 ~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          270 PTPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             CCCTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CCccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            00111   1235678888999999999999999999999976543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.9e-42  Score=359.04  Aligned_cols=254  Identities=19%  Similarity=0.252  Sum_probs=202.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.++||+|+||.||+|.+. +++.||+|+++....   .....+.+|+.++..++||||+++++++.+ .+..++|||
T Consensus        76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lV~E  154 (437)
T 4aw2_A           76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-DNNLYLVMD  154 (437)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCEEEEEEe
Confidence            456789999999999999987 578999999865321   223348899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...  ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++........
T Consensus       155 y~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          155 YYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             cCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence            99999999999863  2468999999999999999999999 49999999999999999999999999999876554444


Q ss_pred             ceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          445 NVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+.   ...+.......     ...
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~-----~~p  303 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERF-----QFP  303 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHC-----CCC
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccc-----cCC
Confidence            444467999999999986     56789999999999999999999999986543333   23332211100     000


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSA--RPEVLQVVQQL  557 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ev~~~L  557 (580)
                      .......   .++.+++.+||..+|++  ||++.|+++|=
T Consensus       304 ~~~~~~s---~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          304 TQVTDVS---ENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             SSCCCSC---HHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             cccccCC---HHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence            0111122   35667888999888888  99999999873

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2e-42  Score=338.34  Aligned_cols=248  Identities=31%  Similarity=0.480  Sum_probs=190.5

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc----ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT----KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|.+. |+.||||+++....    ...+.+.+|+++++.++||||+++++++.. ++..++|||
T Consensus         9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   86 (271)
T 3dtc_A            9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLCLVME   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--CEEEEE
T ss_pred             eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceEEEEE
Confidence            456789999999999999986 88999999865432    234678999999999999999999999976 568899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---cccCCCCCCCeeeCC--------CCCeEEeecc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN---IIHGNLTSSNVLLDD--------STNAKISDFG  433 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~---i~H~Dlk~~Nil~~~--------~~~~kl~Dfg  433 (580)
                      |+++++|.+++..    ..+++..+..++.|++.||+|||+. |   |+||||||+||+++.        ++.+||+|||
T Consensus        87 ~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           87 FARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             CCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             cCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999864    3689999999999999999999995 8   899999999999986        6789999999


Q ss_pred             cccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          434 LSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       434 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      ++........   ....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+......   .........  
T Consensus       162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~--  233 (271)
T 3dtc_A          162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY---GVAMNKLAL--  233 (271)
T ss_dssp             C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH---HHHTSCCCC--
T ss_pred             cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---hhhcCCCCC--
Confidence            9986544322   23468999999999999999999999999999999999999997654322111   111111100  


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                         ..   ...   ....+.+++.+||+.||++|||+.|++++|+++
T Consensus       234 ---~~---~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          234 ---PI---PST---CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---CC---CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---CC---Ccc---cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence               00   111   123567888899999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3e-42  Score=347.31  Aligned_cols=251  Identities=21%  Similarity=0.351  Sum_probs=197.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC--------
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG--------  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--------  357 (580)
                      .|...+.||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+...        
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            4667899999999999999987 899999999864433 345679999999999999999999999865321        


Q ss_pred             ------------------------------------------------cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHH
Q 008031          358 ------------------------------------------------EKLLVFDYMPHGSLATFLHARGPETPIDWPTR  389 (580)
Q Consensus       358 ------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  389 (580)
                                                                      ..++||||+++|+|.+++.........++..+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  166 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC  166 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence                                                            37999999999999999988765556777789


Q ss_pred             HHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-----------cceeeecCccccCCc
Q 008031          390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-----------VNVIATAGALGYRAP  458 (580)
Q Consensus       390 ~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~g~~~y~aP  458 (580)
                      ..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.......           .......||+.|+||
T Consensus       167 ~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          167 LHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            99999999999999994 999999999999999999999999999987654321           122234699999999


Q ss_pred             cccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhh
Q 008031          459 ELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALH  538 (580)
Q Consensus       459 E~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  538 (580)
                      |.+.+..++.++||||+||++|||++|..|+..     ............     .       .........++.+++.+
T Consensus       246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~-----~-------~~~~~~~~~~~~~li~~  308 (332)
T 3qd2_B          246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK-----F-------PLLFTQKYPQEHMMVQD  308 (332)
T ss_dssp             HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC-----C-------CHHHHHHCHHHHHHHHH
T ss_pred             HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC-----C-------CcccccCChhHHHHHHH
Confidence            999999999999999999999999998776421     111111111100     0       00111223456789999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 008031          539 CVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       539 cl~~~P~~Rps~~ev~~~  556 (580)
                      ||+.||++|||+.|++++
T Consensus       309 ~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          309 MLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHCSSGGGSCCHHHHHHS
T ss_pred             HccCCCCcCCCHHHHhhc
Confidence            999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4e-42  Score=339.41  Aligned_cols=258  Identities=27%  Similarity=0.447  Sum_probs=192.9

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|.+.  ..||+|+++....  ...+.+.+|+.++++++||||+++++++.  ....++||||+
T Consensus        26 y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e~~  101 (289)
T 3og7_A           26 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWC  101 (289)
T ss_dssp             CEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEECC
T ss_pred             eeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--CCccEEEEEec
Confidence            556799999999999999875  3599999865432  23467899999999999999999999764  45789999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc-ccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA-NVN  445 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  445 (580)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++....... ...
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (289)
T 3og7_A          102 EGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ  178 (289)
T ss_dssp             CEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred             CCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence            999999999754  34689999999999999999999994 99999999999999999999999999997654322 222


Q ss_pred             eeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          446 VIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      .....||+.|+|||.+.   +..++.++||||+|+++|+|++|+.||......+   .+..........    +......
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~----~~~~~~~  251 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLS----PDLSKVR  251 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHHHHHHHTSCC----CCTTSSC
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHHHHhcccccC----cchhhcc
Confidence            33456899999999886   6678889999999999999999999997654332   112222111111    1110001


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ..   ....+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       252 ~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          252 SN---CPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             cc---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence            11   123667888899999999999999999999998653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-42  Score=348.27  Aligned_cols=246  Identities=22%  Similarity=0.339  Sum_probs=200.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|... +|+.||||+++...   ....+.+..|..++..+ +||+|+++++++.. .+..++||
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~lv~  100 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVM  100 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEEEEEE
Confidence            556789999999999999987 58899999987542   23456688999999998 89999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...+   .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... 
T Consensus       101 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  175 (353)
T 2i0e_A          101 EYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-  175 (353)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence            9999999999998753   589999999999999999999995 99999999999999999999999999998543222 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.   ...+......       .   ..
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~~~~~-------~---p~  242 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIMEHNVA-------Y---PK  242 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCCC-------C---CT
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---HHHHHhCCCC-------C---CC
Confidence            223346799999999999999999999999999999999999999976543332   2233222110       0   11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~  556 (580)
                      ..   ..++.+++.+||+.||++||+     +.++++|
T Consensus       243 ~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          243 SM---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             TS---CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11   235668888999999999995     5777766

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-41  Score=339.89  Aligned_cols=260  Identities=19%  Similarity=0.293  Sum_probs=196.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc---HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG---QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|++.......   .+.+.+|+.++++++||||+++++++.. ++..++|||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e  114 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLYVDMR  114 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEEEEEE
Confidence            566799999999999999986 78899999987553332   3568899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.........
T Consensus       115 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          115 LINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             CCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            99999999999875   3689999999999999999999995 9999999999999999999999999999876554333


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..    .+..........   ....   .+.
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~---~~~~---~~~  260 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPR---PSTV---RPG  260 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCC---GGGT---STT
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCC---cccc---CCC
Confidence            334456899999999999999999999999999999999999999764322    222222111110   0011   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhcccccc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-EVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-s~~ev~~~L~~~~~~~~~  566 (580)
                      .+   .++.+++.+||+.||++|| |+.++++.|+++......
T Consensus       261 ~~---~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          261 IP---VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             CC---THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             CC---HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            11   2566788899999999999 999999999998765543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-42  Score=349.40  Aligned_cols=264  Identities=21%  Similarity=0.302  Sum_probs=205.7

Q ss_pred             HHHhhhccccccCceEEEEEEe------CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCc
Q 008031          287 LLCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  358 (580)
                      ..|.+.+.||+|+||.||+|.+      .++..||+|+++.... ...+.+.+|+.+++++ +||||+++++++.. .+.
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~  123 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-SGP  123 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-CCc
Confidence            3466789999999999999986      2456899999975432 3446789999999999 89999999999986 668


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCC
Q 008031          359 KLLVFDYMPHGSLATFLHARGPE--------------------TPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSN  418 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~N  418 (580)
                      .++||||+++|+|.+++......                    ..+++..+..++.||+.||+|||+. ||+||||||+|
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~N  202 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARN  202 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhh
Confidence            99999999999999999865321                    2478999999999999999999994 99999999999


Q ss_pred             eeeCCCCCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCC
Q 008031          419 VLLDDSTNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAE  496 (580)
Q Consensus       419 il~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  496 (580)
                      |+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||......+
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  282 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  282 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence            999999999999999998665433222 223457788999999998999999999999999999998 999998765433


Q ss_pred             hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          497 LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                      ..   ..........     .   .....   ..++.+++.+||+.||.+|||+.+++++|+.+......
T Consensus       283 ~~---~~~~~~~~~~-----~---~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          283 NF---YKLIQNGFKM-----D---QPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             HH---HHHHHTTCCC-----C---CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             HH---HHHHhcCCCC-----C---CCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            22   1222221110     0   01111   23567788899999999999999999999998765543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.4e-42  Score=343.02  Aligned_cols=265  Identities=23%  Similarity=0.346  Sum_probs=192.0

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|...+.||+|+||.||+|.+. +|+.||+|+++.... .....+.+|++++++++||||+++++++.. ++..++||||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~   84 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVFEF   84 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEEEC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEEEe
Confidence            3667899999999999999976 789999999865432 234678899999999999999999999976 6689999999


Q ss_pred             CCCCChhhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          366 MPHGSLATFLHARG---PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       366 ~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      ++ |+|.+++....   ....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence            97 59999987542   123589999999999999999999994 99999999999999999999999999998664332


Q ss_pred             ccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc--------c
Q 008031          443 NVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE--------V  513 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~  513 (580)
                      . ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+...........        .
T Consensus       163 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          163 N-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             C-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             c-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence            2 2223468999999999876 4689999999999999999999999987665444333332221100000        0


Q ss_pred             cchhhhccCC-CcH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 FDLELMRDAP-TIG---------DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 ~~~~~~~~~~-~~~---------~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..+......+ ...         ....++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            0000000000 000         112367789999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.4e-42  Score=334.57  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=202.1

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|.+. ++.||||+++....  ...+.+.+|+.++++++||||+++++++... .+..++||||
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW   90 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred             hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence            556789999999999999986 88999999875432  3345789999999999999999999999864 2578999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      +++|+|.++++... ...+++..+..++.|++.||+|||+. +  ++||||||+||+++.++.++++|||++......  
T Consensus        91 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~--  166 (271)
T 3kmu_A           91 MPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP--  166 (271)
T ss_dssp             CTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT--
T ss_pred             cCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeeccc--
Confidence            99999999998743 33589999999999999999999994 8  999999999999999999999999887543222  


Q ss_pred             cceeeecCccccCCccccccCCCCC---cccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          444 VNVIATAGALGYRAPELSKLKKANT---KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                          ...||+.|+|||.+.+..++.   ++||||||+++|||++|+.||...+..+..   ..........     ..  
T Consensus       167 ----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~-----~~--  232 (271)
T 3kmu_A          167 ----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG---MKVALEGLRP-----TI--  232 (271)
T ss_dssp             ----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH---HHHHHSCCCC-----CC--
T ss_pred             ----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH---HHHHhcCCCC-----CC--
Confidence                235789999999988765555   799999999999999999999765433221   2222111111     11  


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                       ....   ..++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       233 -~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          233 -PPGI---SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             1111   2356788889999999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.5e-42  Score=334.95  Aligned_cols=250  Identities=20%  Similarity=0.293  Sum_probs=203.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|.+.+.||+|+||.||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++.. .+..++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   88 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVMELC   88 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEEecc
Confidence            4677899999999999999986 678999999987666667889999999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee---CCCCCeEEeecccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ++++|.+++...   ..+++..+..++.|++.||+|||+. |++||||||+||++   +.++.+||+|||++........
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           89 TGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             CSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            999999998764   3589999999999999999999994 99999999999999   7888999999999986654332


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                        .....||+.|+|||.+.+ .++.++||||+|+++|+|++|+.||......+...   .+......   .......   
T Consensus       165 --~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~---~~~~~~~---  232 (277)
T 3f3z_A          165 --MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML---KIREGTFT---FPEKDWL---  232 (277)
T ss_dssp             --BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHCCCC---CCHHHHT---
T ss_pred             --hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhCCCC---CCchhhh---
Confidence              233568999999999875 48999999999999999999999997654332222   22221110   0000000   


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .   ....+.+++.+||+.||++|||+.+++++-
T Consensus       233 ~---~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  263 (277)
T 3f3z_A          233 N---VSPQAESLIRRLLTKSPKQRITSLQALEHE  263 (277)
T ss_dssp             T---SCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             c---CCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            1   123567888999999999999999998753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-42  Score=353.20  Aligned_cols=273  Identities=19%  Similarity=0.297  Sum_probs=214.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-cEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-EKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|++++++++||||+++++++..... ..++||||
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~   90 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred             eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence            556799999999999999987 699999999975432 345678899999999999999999999986433 67999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee----CCCCCeEEeecccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~----~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +++|+|.+++........+++..++.++.||+.||+|||+. ||+||||||+||++    +.++.+||+|||+++.....
T Consensus        91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            99999999998765445599999999999999999999994 99999999999999    77778999999999876543


Q ss_pred             cccceeeecCccccCCcccccc--------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-ChhHHHHHHhhhhcccc
Q 008031          442 ANVNVIATAGALGYRAPELSKL--------KKANTKTDVYSLGVTILELLTGKSPGEPLNGA-ELPQWVASIVKEEWTNE  512 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  512 (580)
                      ..  .....||..|+|||++.+        ..++.++|||||||++|||++|+.||.+.... .....+..+..+.....
T Consensus       170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (396)
T 4eut_A          170 EQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (396)
T ss_dssp             GG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred             Cc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence            32  223568999999998765        56778999999999999999999999765432 23333444433322111


Q ss_pred             cc------------chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          513 VF------------DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       513 ~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      +.            .................+.+++.+||+.||++|||+.|+++.++++....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            00            00111111222445566778999999999999999999999999986543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-42  Score=343.40  Aligned_cols=251  Identities=23%  Similarity=0.371  Sum_probs=198.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CC-------CEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DG-------SQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      |.+.+.||+|+||.||+|.+. ++       ..||+|++........+.+.+|+.++++++||||+++++++.. ++..+
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~   88 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC-GDENI   88 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-TTCCE
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-CCCCE
Confidence            566789999999999999875 33       4799999977666667789999999999999999999999986 56889


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC--------eEEeec
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN--------AKISDF  432 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~--------~kl~Df  432 (580)
                      +||||+++|+|.+++....  ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++.        +||+||
T Consensus        89 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           89 LVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             EEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             EEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            9999999999999998752  348999999999999999999999 49999999999999998877        999999


Q ss_pred             ccccccccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCC-CCCCCCCCChhHHHHHHhhhhcc
Q 008031          433 GLSRLMTAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKS-PGEPLNGAELPQWVASIVKEEWT  510 (580)
Q Consensus       433 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~  510 (580)
                      |++.......     ...+++.|+|||.+.+ ..++.++||||||+++|||++|.. ||...+...   ... ...... 
T Consensus       166 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~-~~~~~~-  235 (289)
T 4fvq_A          166 GISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQ-FYEDRH-  235 (289)
T ss_dssp             CSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH-HHHTTC-
T ss_pred             cccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---HHH-HhhccC-
Confidence            9987654322     2347888999999887 778999999999999999999554 444332211   111 111100 


Q ss_pred             ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                            ......      ..++.+++.+||+.||++|||+.|++++|+++.....
T Consensus       236 ------~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          236 ------QLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             ------CCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             ------CCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                  000001      1246688889999999999999999999999876443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-41  Score=337.47  Aligned_cols=268  Identities=16%  Similarity=0.184  Sum_probs=212.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++....  ....+.+|+.+++.++|++++..+.++.......++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            556789999999999999974 79999999986543  23468899999999999988888888766677889999999 


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC---CCCCeEEeeccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD---DSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +++|.+++....  ..+++..+..++.|++.||+|||+. ||+||||||+||+++   .++.+||+|||++.........
T Consensus        88 ~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           88 GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            999999997542  4689999999999999999999995 999999999999994   7889999999999876544321


Q ss_pred             ------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          445 ------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       445 ------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                            ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..+....+........  ....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  242 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--IEVL  242 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--HHHH
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--hHHH
Confidence                  12345789999999999999999999999999999999999999987655443333333222211100  0000


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccCC
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATS  570 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~~  570 (580)
                         ....+   .++.+++.+||+.||++|||+.++++.|+++..+.......
T Consensus       243 ---~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~  288 (296)
T 3uzp_A          243 ---CKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY  288 (296)
T ss_dssp             ---TTTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSC
T ss_pred             ---HhhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccc
Confidence               01111   35678888999999999999999999999987766554443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.8e-42  Score=344.80  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=192.0

Q ss_pred             HhhhccccccCceEEEEEEe----CCCCEEEEEEccccc----cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATL----EDGSQVAVKRLREKI----TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      |.+.+.||+|+||.||+|..    .+|+.||+|+++...    ......+.+|+.++++++||||+++++++.. .+..+
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~   97 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-GGKLY   97 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-SSCEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-CCEEE
Confidence            56789999999999999987    478999999997543    1234567889999999999999999999987 66899


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus        98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           98 LILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            999999999999999864   3588999999999999999999995 999999999999999999999999999875433


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+   .+..+......          
T Consensus       174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~----------  239 (327)
T 3a62_A          174 DGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDKILKCKLN----------  239 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTCCC----------
T ss_pred             CCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhCCCC----------
Confidence            221 2223568999999999999999999999999999999999999997654322   22222222110          


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQL  557 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~L  557 (580)
                      ..+..   ..++.+++.+||+.||++||     ++.|+++|-
T Consensus       240 ~p~~~---~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          240 LPPYL---TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             CCTTS---CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             CCCCC---CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence            01111   23566788899999999999     778888763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3e-42  Score=347.62  Aligned_cols=262  Identities=26%  Similarity=0.392  Sum_probs=208.0

Q ss_pred             HHHhhhccccccCceEEEEEEeC--------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCC
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE--------DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPK  356 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  356 (580)
                      ..|.+.+.||+|+||.||+|.+.        ++..||+|+++.... ...+.+.+|+++++++ +||||+++++++.. .
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~  113 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-D  113 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-C
Confidence            34667899999999999999863        467899999975433 3345788999999999 89999999999976 6


Q ss_pred             CcEEEEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC
Q 008031          357 GEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD  423 (580)
Q Consensus       357 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~  423 (580)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+. ||+||||||+||+++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTE  192 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECT
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCccceEEEcC
Confidence            689999999999999999986532             23489999999999999999999995 9999999999999999


Q ss_pred             CCCeEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHH
Q 008031          424 STNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWV  501 (580)
Q Consensus       424 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~  501 (580)
                      ++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  272 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  272 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence            999999999999866543221 2223456788999999988899999999999999999999 99999765433322222


Q ss_pred             HHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          502 ASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                      .   ..... .        .....   ..++.+++.+||+.||.+|||+.|++++|+++.....
T Consensus       273 ~---~~~~~-~--------~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          273 K---EGHRM-D--------KPANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             H---HTCCC-C--------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             h---cCCCC-C--------CCccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            1   11110 0        01111   2356788889999999999999999999999875443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.5e-42  Score=338.68  Aligned_cols=268  Identities=16%  Similarity=0.192  Sum_probs=211.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|...+.||+|+||.||+|.+. +++.||||++....  ....+.+|+.+++.++|++++..++++....+..++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            3667899999999999999974 78999999865432  22457889999999999998888888876677889999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee---CCCCCeEEeecccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                       +++|.+++....  ..+++..+..++.||+.||+|||+. ||+||||||+||++   ++++.+||+|||+++.......
T Consensus        88 -~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           88 -GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence             999999998542  4589999999999999999999995 99999999999999   7889999999999987654332


Q ss_pred             c------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          444 V------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       444 ~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      .      ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........+.+............  ..
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  241 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--EV  241 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--HH
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh--hh
Confidence            1      122456899999999999999999999999999999999999999876655544444433322211100  00


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccC
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAAT  569 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~  569 (580)
                      .   ....   ..++.+++.+||+.||++|||+.++++.|+++..+......
T Consensus       242 ~---~~~~---~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~  287 (296)
T 4hgt_A          242 L---CKGY---PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD  287 (296)
T ss_dssp             H---TTTS---CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTT
T ss_pred             h---hccC---CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCcc
Confidence            0   0111   13567888899999999999999999999998766554443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.7e-41  Score=342.60  Aligned_cols=250  Identities=18%  Similarity=0.324  Sum_probs=198.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...+.||+|+||.||+|++. +++.||+|+++.....   ..+.+.+|..++.++ +||||+++++++.+ .+..++||
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~lv~   89 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVI   89 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEEEEE
Confidence            556789999999999999986 6889999999754322   234578899999988 89999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... 
T Consensus        90 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence            999999999999864   3689999999999999999999994 99999999999999999999999999997543222 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC-----hhHHHHHHhhhhccccccchhh
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE-----LPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ....+...+.....      ..
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~  238 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI  238 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------CC
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------CC
Confidence            22334579999999999999999999999999999999999999997532211     11111111111110      00


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEV------LQVVQQ  556 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~ev~~~  556 (580)
                         ...   ...++.+++.+||+.||++||++      .|+++|
T Consensus       239 ---p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          239 ---PRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ---CTT---SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ---CCC---CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence               111   12356788889999999999995      677665

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-42  Score=338.38  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=208.4

Q ss_pred             ccccccCceEEEEEEeC---CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          293 EIMGKSTYGTVYKATLE---DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.||+|+||.||+|.+.   ++..||+|+++.... ...+.+.+|++++++++||||+++++++.  .+..++||||+++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~   93 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAGG   93 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCTT
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEEEEEeCCC
Confidence            48999999999999864   577899999976433 34567899999999999999999999995  4579999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc--ce
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--NV  446 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~  446 (580)
                      ++|.+++...  ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.........  ..
T Consensus        94 ~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  170 (287)
T 1u59_A           94 GPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  170 (287)
T ss_dssp             EEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             CCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence            9999999754  34689999999999999999999995 9999999999999999999999999999876443222  11


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+..   ....      .   ..+..
T Consensus       171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---~~~~------~---~~~~~  238 (287)
T 1u59_A          171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRM------E---CPPEC  238 (287)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TCCC------C---CCTTC
T ss_pred             ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---CCcC------C---CCCCc
Confidence            22346789999999998899999999999999999999 9999987665443332221   1110      0   01111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccCCC
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSS  571 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~~~  571 (580)
                         ..++.+++.+||+.||++|||+.+++++|+++........+..
T Consensus       239 ---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~  281 (287)
T 1u59_A          239 ---PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH  281 (287)
T ss_dssp             ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence               2356678889999999999999999999999876665554443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-41  Score=338.78  Aligned_cols=264  Identities=25%  Similarity=0.355  Sum_probs=201.1

Q ss_pred             HHHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcC--CCCcceeeeeEEECCC---CcEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKI--RHPNLLALRAYYLGPK---GEKLL  361 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~---~~~~l  361 (580)
                      -.|.+.+.||+|+||.||+|.+. ++.||||++...   ....+.+|.+++...  +||||+++++++....   ...++
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            35778899999999999999987 899999998543   234455566666655  8999999999998643   57899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------CcccCCCCCCCeeeCCCCCeEEeecc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE--------NIIHGNLTSSNVLLDDSTNAKISDFG  433 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------~i~H~Dlk~~Nil~~~~~~~kl~Dfg  433 (580)
                      ||||+++|+|.++++..    .+++..+..++.|++.||+|||+ .        ||+||||||+||+++.++.+||+|||
T Consensus       113 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg  187 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  187 (337)
T ss_dssp             EECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence            99999999999999764    58999999999999999999998 5        99999999999999999999999999


Q ss_pred             cccccccccccc---eeeecCccccCCccccccCCCCCc------ccchhHHHHHHHHHcC----------CCCCCCCCC
Q 008031          434 LSRLMTAAANVN---VIATAGALGYRAPELSKLKKANTK------TDVYSLGVTILELLTG----------KSPGEPLNG  494 (580)
Q Consensus       434 ~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~s~G~~l~el~tg----------~~p~~~~~~  494 (580)
                      ++..........   .....||+.|+|||++.+..++.+      +|||||||++|||++|          +.||.....
T Consensus       188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            997664433221   123468999999999987777665      9999999999999999          666655432


Q ss_pred             CC-hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          495 AE-LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       495 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .. ......................     .......++.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          268 SDPSYEDMREIVCIKKLRPSFPNRW-----SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGG-----GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CCCchhhhHHHHhhhccCccccccc-----hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            22 1122222211111111111000     11245567889999999999999999999999999987654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.3e-41  Score=339.26  Aligned_cols=251  Identities=23%  Similarity=0.369  Sum_probs=204.0

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  359 (580)
                      -.|.+.+.||+|+||.||+|.+. +|+.||+|.++.....      ..+.+.+|+.++++++||||+++++++.. .+..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTDV   90 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEE
Confidence            45778899999999999999986 7899999998654322      35679999999999999999999999987 6689


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC----CeEEeecccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST----NAKISDFGLS  435 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~----~~kl~Dfg~~  435 (580)
                      ++||||+++++|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            9999999999999999764   3689999999999999999999995 999999999999999887    7999999999


Q ss_pred             cccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ........  .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......+.   ...+.....   ..+
T Consensus       167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~---~~~  238 (321)
T 2a2a_A          167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANITSVSY---DFD  238 (321)
T ss_dssp             EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHTTCC---CCC
T ss_pred             eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhccc---ccC
Confidence            87654322  2335689999999999999999999999999999999999999976543222   222221111   111


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .......      ...+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~------~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          239 EEFFSHT------SELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHHHTTC------CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hhhhccc------CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111111      1356788999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.7e-42  Score=342.39  Aligned_cols=261  Identities=26%  Similarity=0.354  Sum_probs=209.3

Q ss_pred             HHhhhccccccCceEEEEEEe------CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      .|...+.||+|+||.||+|.+      .+++.||+|+++.... ...+.+.+|+.+++++ +||||+++++++.. .+..
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~  102 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GGPT  102 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSC
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-CCCc
Confidence            466789999999999999985      2567899999975533 2346789999999999 99999999999976 6689


Q ss_pred             EEEEeeCCCCChhhhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          360 LLVFDYMPHGSLATFLHARGP---------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      ++||||+++|+|.+++.....               ...+++..+..++.|++.||+|||+. |++||||||+||+++.+
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEcCC
Confidence            999999999999999987532               12589999999999999999999995 99999999999999999


Q ss_pred             CCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHH
Q 008031          425 TNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~  502 (580)
                      +.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........   .
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~  258 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF---Y  258 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH---H
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH---H
Confidence            999999999998765443322 122346788999999998999999999999999999999 99999876543222   2


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ..........        .....   ...+.+++.+||+.||.+|||+.|++++|+++..+.
T Consensus       259 ~~~~~~~~~~--------~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          259 KMIKEGFRML--------SPEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHTCCCC--------CCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHhccCCCCC--------CcccC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            2222111100        01111   235678888999999999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.6e-42  Score=338.02  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=196.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|.+. +|+.||+|+++.....  ....+.+|+.++++++||||+++++++.. ++..++||||
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   82 (292)
T 3o0g_A            4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEF   82 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEEec
Confidence            456789999999999999986 7899999998654332  23678899999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++ ++.+++...  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....... .
T Consensus        83 ~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  157 (292)
T 3o0g_A           83 CDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C  157 (292)
T ss_dssp             CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-C
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-c
Confidence            975 666666543  24689999999999999999999995 999999999999999999999999999986643322 2


Q ss_pred             eeeecCccccCCccccccCC-CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hccccccchhh---
Q 008031          446 VIATAGALGYRAPELSKLKK-ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTNEVFDLEL---  518 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~---  518 (580)
                      .....||+.|+|||++.+.. ++.++||||+||++|||++|..||....  +....+..+...   .....+.....   
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            23456899999999987665 8999999999999999999888854322  222222222211   00000000000   


Q ss_pred             ----------hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          519 ----------MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       519 ----------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                                ............++.+++.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                      00000001122356688889999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=369.44  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=201.6

Q ss_pred             cccccCceEEEEEEeC---CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          294 IMGKSTYGTVYKATLE---DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      .||+|+||.||+|.+.   ++..||||+++.... ...+.+.+|++++++++||||+++++++..  +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCC
Confidence            7999999999999874   456799999976543 345789999999999999999999999975  4699999999999


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc--ee
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN--VI  447 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~  447 (580)
                      +|.+++...  ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........  ..
T Consensus       421 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          421 PLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             BHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             cHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            999999764  34689999999999999999999994 99999999999999999999999999998764432221  12


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..   +...         ...+.. 
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~~~---------~~p~~~-  564 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRM---------ECPPEC-  564 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT---TCCC---------CCCTTC-
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCC---------CCCCcC-
Confidence            2345688999999999999999999999999999998 9999988765544433322   1110         011112 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                        ..++.++|.+||+.||++|||+.++++.|+.+....
T Consensus       565 --~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          565 --PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             --CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             --CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence              235678888999999999999999999999976443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=354.25  Aligned_cols=253  Identities=18%  Similarity=0.226  Sum_probs=201.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +|+.||||+++....   .....+.+|..++..++||||+++++++.+ .+..|+|||
T Consensus        63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lVmE  141 (412)
T 2vd5_A           63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-ENYLYLVME  141 (412)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEc
Confidence            456789999999999999986 799999999865321   223458899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++.+.+  ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++++||+|||+++........
T Consensus       142 ~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          142 YYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             CCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence            999999999998652  3689999999999999999999994 9999999999999999999999999999876554443


Q ss_pred             ceeeecCccccCCccccc-------cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          445 NVIATAGALGYRAPELSK-------LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ......||+.|+|||++.       ...++.++|||||||++|||++|+.||...+..+..   ..+........  .+.
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~~~~~~~~--~p~  293 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY---GKIVHYKEHLS--LPL  293 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHTHHHHCC--CC-
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH---HHHHhcccCcC--CCc
Confidence            333457999999999987       467899999999999999999999999765543322   22222111000  000


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSAR---PEVLQVVQQL  557 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---ps~~ev~~~L  557 (580)
                      .   ....   ..++.+++.+||. +|++|   |++.|+++|=
T Consensus       294 ~---~~~~---s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          294 V---DEGV---PEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             ------CC---CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             c---ccCC---CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            0   0111   2356678889999 99998   5899998874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.9e-42  Score=344.17  Aligned_cols=258  Identities=22%  Similarity=0.347  Sum_probs=193.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc---HHHHHHHHHHHhcCCCCcceeeeeEEECCCC---cEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG---QREFESEVSLLGKIRHPNLLALRAYYLGPKG---EKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++......   ...+.+|+.++++++||||+++++++.....   ..++
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l   93 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   93 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence            566799999999999999974 78999999997653332   3468899999999999999999999875322   2489


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++++|.++++..+   .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus        94 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           94 VMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            999999999999998653   68999999999999999999999 49999999999999999999999999999866443


Q ss_pred             cc--cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 AN--VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+   ...........    .+...
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~~~~~~~~~~~----~~~~~  242 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VAYQHVREDPI----PPSAR  242 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHCCCC----CHHHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhcCCCC----Ccccc
Confidence            22  12233568999999999999999999999999999999999999997654322   22222221110    00000


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHhhhcc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVV-QQLEEIRP  562 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~-~~L~~~~~  562 (580)
                        ....   ..++.+++.+||+.||++||+..+++ ..+.++..
T Consensus       243 --~~~~---~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          243 --HEGL---SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             --STTC---CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             --cCCC---CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence              1111   23566888899999999999766655 45555543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.5e-42  Score=338.98  Aligned_cols=253  Identities=27%  Similarity=0.462  Sum_probs=199.2

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|.+.+.||+|+||.||+|.+. |+.||||.++...  ..+.+.+|++++++++||||+++++++....+..++||||++
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            3667899999999999999886 8899999987542  456789999999999999999999998775667899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++.... ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++........    
T Consensus        99 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----  172 (278)
T 1byg_A           99 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----  172 (278)
T ss_dssp             TEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeecccccccccccc----
Confidence            999999997642 12378899999999999999999994 999999999999999999999999999875543221    


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.   .. ..     ...   .... 
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---~~-~~-----~~~---~~~~-  239 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KG-YK-----MDA---PDGC-  239 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT---TT-CC-----CCC---CTTC-
T ss_pred             CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cC-CC-----CCC---cccC-
Confidence            2357889999999998999999999999999999998 999998765443332221   11 10     000   1111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                        ...+.+++.+||+.||++|||+.|+++.|++++...
T Consensus       240 --~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          240 --PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence              235667888999999999999999999999987654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=349.70  Aligned_cols=271  Identities=14%  Similarity=0.143  Sum_probs=207.6

Q ss_pred             HhhhccccccCceEEEEEEeCC---------CCEEEEEEccccccccHHHHHHHHHHHhcCCCCccee------------
Q 008031          289 CATAEIMGKSTYGTVYKATLED---------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLA------------  347 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------------  347 (580)
                      |.+.+.||+|+||.||+|.+..         ++.||+|.+...     ..+.+|++++++++||||++            
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            5667999999999999999863         789999998643     46789999999999999988            


Q ss_pred             ---eeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          348 ---LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       348 ---~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                         +++++...+...++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. ||+||||||+||+++.+
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEETT
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcCC
Confidence               6777776567899999999 999999998642 24699999999999999999999995 99999999999999998


Q ss_pred             C--CeEEeeccccccccccccc------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC
Q 008031          425 T--NAKISDFGLSRLMTAAANV------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE  496 (580)
Q Consensus       425 ~--~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~  496 (580)
                      +  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  275 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT  275 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence            8  8999999999876543221      1123468999999999999999999999999999999999999998654221


Q ss_pred             -hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccCCCCC
Q 008031          497 -LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAATSSGD  573 (580)
Q Consensus       497 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~~~~~  573 (580)
                       ............. ....+....  ....   ..++.+++.+||+.||++|||+.++++.|+++..+.........+
T Consensus       276 ~~~~~~~~~~~~~~-~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~d  347 (352)
T 2jii_A          276 EDIMKQKQKFVDKP-GPFVGPCGH--WIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIG  347 (352)
T ss_dssp             HHHHHHHHHHHHSC-CCEECTTSC--EECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCC
T ss_pred             HHHHHHHHhccCCh-hhhhhhccc--cCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcccc
Confidence             1111111111111 111110000  0011   135678888999999999999999999999998766555444443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-41  Score=341.98  Aligned_cols=248  Identities=21%  Similarity=0.357  Sum_probs=180.4

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      .+.||+|+||.||+|.+. +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+ +...++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCC
Confidence            478999999999999986 7899999998643   3467789999999996 9999999999986 66899999999999


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC---CeEEeecccccccccccccce
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---NAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      +|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++   .+||+|||+++....... ..
T Consensus        92 ~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~  166 (325)
T 3kn6_A           92 ELFERIKKK---KHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL  166 (325)
T ss_dssp             BHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence            999999874   468999999999999999999999 4999999999999998655   799999999986543322 22


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC----ChhHHHHHHhhhhccccccchhhhccC
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGA----ELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      ....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..    ........+..+...   .....+.  
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~--  241 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS---FEGEAWK--  241 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC---CCSHHHH--
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC---CCccccc--
Confidence            3456899999999999999999999999999999999999999865432    222223332222111   0111111  


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                          ....++.+++.+||+.||++|||+.|++++-
T Consensus       242 ----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~  272 (325)
T 3kn6_A          242 ----NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE  272 (325)
T ss_dssp             ----TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred             ----CCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence                1123677889999999999999999998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=346.41  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=186.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++...  ..+.+.+|++++++++||||+++++++.. .+..++||||++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  131 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVLELVT  131 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCC
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEEEeCC
Confidence            566789999999999999987 68899999987543  34568899999999999999999999987 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeeccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.   ++.+||+|||+++....... 
T Consensus       132 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  206 (349)
T 2w4o_A          132 GGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-  206 (349)
T ss_dssp             SCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence            99999999764   3589999999999999999999995 9999999999999975   88999999999986543321 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+  .....+......   .....   .+ 
T Consensus       207 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i~~~~~~---~~~~~---~~-  276 (349)
T 2w4o_A          207 -MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRILNCEYY---FISPW---WD-  276 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHHHTTCCC---CCTTT---TT-
T ss_pred             -cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHHHhCCCc---cCCch---hh-
Confidence             223568999999999999999999999999999999999999997654322  122222221111   00000   01 


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ....++.+++.+||+.||++|||+.|++++
T Consensus       277 --~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          277 --EVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             --TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              112356788899999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-42  Score=338.46  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=204.7

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CC---CEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DG---SQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      ..|...+.||+|+||.||+|.+. ++   ..||+|.+..... ...+.+.+|+.++++++||||+++++++...+...++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            33455689999999999999864 22   3799999875433 2346789999999999999999999999875555699


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+.+|+|.+++...  ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||+++.....
T Consensus       101 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             EECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            99999999999999764  34689999999999999999999995 9999999999999999999999999999865433


Q ss_pred             cc---cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCC-CCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          442 AN---VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKS-PGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       442 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ..   .......++..|+|||.+.+..++.++||||+|+++|+|++|.. ||...+..+....+..   ....       
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~---~~~~-------  247 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ---GRRL-------  247 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT---TCCC-------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc---CCCC-------
Confidence            21   12223467889999999999999999999999999999999555 4554443333332221   1100       


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                        ......   ...+.+++.+||+.||.+|||+.++++.|+++...-
T Consensus       248 --~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          248 --PQPEYC---PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             --CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --CCCccc---hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence              001111   135678888999999999999999999999986553

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.9e-42  Score=358.01  Aligned_cols=246  Identities=24%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++.....   .....+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv~E   96 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIFMVME   96 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEe
Confidence            556799999999999999986 799999999865422   234578999999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++........ 
T Consensus        97 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~-  171 (476)
T 2y94_A           97 YVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-  171 (476)
T ss_dssp             CCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence            99999999999764   3689999999999999999999995 999999999999999999999999999987654322 


Q ss_pred             ceeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                       .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+..+.   ...+..+...          ...
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~----------~p~  237 (476)
T 2y94_A          172 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---FKKICDGIFY----------TPQ  237 (476)
T ss_dssp             -BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---HHHHHTTCCC----------CCT
T ss_pred             -ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---HHHHhcCCcC----------CCc
Confidence             234569999999999988766 6799999999999999999999986543322   2222222110          011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ...   .++.+++.+||+.||++|||+.|+++|-
T Consensus       238 ~~s---~~~~~Li~~~L~~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          238 YLN---PSVISLLKHMLQVDPMKRATIKDIREHE  268 (476)
T ss_dssp             TCC---HHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             cCC---HHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence            111   2566888899999999999999999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-41  Score=360.26  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=205.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|.+. +|+.||+|++....   ......+.+|++++++++||||+++++++.+ .+..++|||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lVmE  264 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLT  264 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEEEEEE
Confidence            455789999999999999986 79999999986532   2345668899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...+ ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++......  
T Consensus       265 y~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--  340 (576)
T 2acx_A          265 LMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  340 (576)
T ss_dssp             CCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred             cCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence            999999999998653 33589999999999999999999995 99999999999999999999999999998765432  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+...+......      .   ...
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~------~---p~~  411 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE------Y---SER  411 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC------C---CTT
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc------C---Ccc
Confidence            2334579999999999999999999999999999999999999998765443333333322221110      0   011


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                         ...++.+++.+||+.||++||     ++.|+++|
T Consensus       412 ---~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          412 ---FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ---CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence               123567888899999999999     78888876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.4e-41  Score=337.31  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=194.3

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      .+.||+|+||.||+|.+. +++.||||++..........+.+|++++.++ +||||+++++++.. .+..++||||+++|
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~   96 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFYLVFEKMRGG   96 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTC
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEEcCCCC
Confidence            378999999999999975 7999999999766555567899999999985 79999999999987 66899999999999


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC---eEEeecccccccccccc---
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLSRLMTAAAN---  443 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~---~kl~Dfg~~~~~~~~~~---  443 (580)
                      +|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.   +||+|||++........   
T Consensus        97 ~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (316)
T 2ac3_A           97 SILSHIHKR---RHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP  172 (316)
T ss_dssp             BHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred             cHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence            999999875   3689999999999999999999995 9999999999999997766   99999999876542211   


Q ss_pred             ---cceeeecCccccCCcccccc-----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh------------hHHHHH
Q 008031          444 ---VNVIATAGALGYRAPELSKL-----KKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL------------PQWVAS  503 (580)
Q Consensus       444 ---~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~------------~~~~~~  503 (580)
                         .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||......+.            ......
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (316)
T 2ac3_A          173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES  252 (316)
T ss_dssp             ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred             ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence               12223458999999999875     5688999999999999999999999987543321            111111


Q ss_pred             HhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          504 IVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      +.....   .......   ..   ....+.+++.+||+.||++|||+.|++++-
T Consensus       253 i~~~~~---~~~~~~~---~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          253 IQEGKY---EFPDKDW---AH---ISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             HHHCCC---CCCHHHH---TT---SCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             HhccCc---ccCchhc---cc---CCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            111110   0000000   01   123567889999999999999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-41  Score=349.69  Aligned_cols=269  Identities=22%  Similarity=0.319  Sum_probs=193.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCC-CCcceeeeeEEECCC-CcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIR-HPNLLALRAYYLGPK-GEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++....  ......+.+|+.+++++. ||||+++++++...+ ...++||
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~   90 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF   90 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence            567889999999999999976 79999999986432  223456789999999997 999999999998533 3689999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc--
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA--  441 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~--  441 (580)
                      ||++ ++|.++++..    .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++.....  
T Consensus        91 e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           91 DYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             ECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             cccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            9997 6899998763    58999999999999999999999 49999999999999999999999999999765321  


Q ss_pred             ------------------cccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHH
Q 008031          442 ------------------ANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       442 ------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~  502 (580)
                                        .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                              1112234579999999998876 678999999999999999999999998765433332222


Q ss_pred             HHhhhhcccc---ccch---h----h-------hccCCCcH--------------HHHHHHHHHHhhccCCCCCCCCCHH
Q 008031          503 SIVKEEWTNE---VFDL---E----L-------MRDAPTIG--------------DELLNTLKLALHCVDPSPSARPEVL  551 (580)
Q Consensus       503 ~~~~~~~~~~---~~~~---~----~-------~~~~~~~~--------------~~~~~l~~li~~cl~~~P~~Rps~~  551 (580)
                      ..........   ...+   .    +       ........              ....++.+++.+||+.||++|||+.
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            1111000000   0000   0    0       00000000              1123577899999999999999999


Q ss_pred             HHHHH--Hhhhccc
Q 008031          552 QVVQQ--LEEIRPE  563 (580)
Q Consensus       552 ev~~~--L~~~~~~  563 (580)
                      |+++|  +..+...
T Consensus       325 e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          325 DALKHPFVSIFHNP  338 (388)
T ss_dssp             HHTTSTTTTTTCCG
T ss_pred             HHhCCHHHHHhcCC
Confidence            99998  5555443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.8e-42  Score=344.43  Aligned_cols=261  Identities=20%  Similarity=0.334  Sum_probs=207.4

Q ss_pred             HHhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .|.+.+.||+|+||.||+|.+.      +++.||+|.+..... .....+.+|+.++++++||||+++++++.. .+..+
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~  104 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTL  104 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCE
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc-CCccE
Confidence            4667899999999999999864      367899999975433 234568899999999999999999999976 56889


Q ss_pred             EEEeeCCCCChhhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecc
Q 008031          361 LVFDYMPHGSLATFLHARG-------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFG  433 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg  433 (580)
                      +||||+++|+|.+++....       ....+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCCeEEECcCc
Confidence            9999999999999997532       124578999999999999999999995 99999999999999999999999999


Q ss_pred             ccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          434 LSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       434 ~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      ++......... ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||...+..+..   ..+...... 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~~~~~~-  259 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RFVMEGGLL-  259 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HHHHTTCCC-
T ss_pred             cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---HHHHcCCcC-
Confidence            99865443221 1122346788999999998999999999999999999999 89999765433222   222221111 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                              ......   ...+.+++.+||+.||++|||+.|++++|+++.....
T Consensus       260 --------~~~~~~---~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~  302 (322)
T 1p4o_A          260 --------DKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF  302 (322)
T ss_dssp             --------CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred             --------CCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence                    011111   2356678889999999999999999999999865443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-41  Score=345.55  Aligned_cols=256  Identities=22%  Similarity=0.289  Sum_probs=197.5

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-----TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      -.|.+.+.||+|+||.||+|.+. +++.||+|++....     ....+.+.+|++++++++||||+++++++.+ .+..+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~  104 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-EQYIC  104 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-CCeEE
Confidence            45778899999999999999985 78899999986432     2345678999999999999999999999987 66899


Q ss_pred             EEEeeCCCCChhhhhhhcC-------------------------------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 008031          361 LVFDYMPHGSLATFLHARG-------------------------------------PETPIDWPTRMKIIKGMTRGLLHL  403 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~~~l~~L  403 (580)
                      +||||+++|+|.+++....                                     ....+++..+..++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            9999999999999985210                                     011235677889999999999999


Q ss_pred             hcCCCcccCCCCCCCeeeCCCC--CeEEeecccccccccccc---cceeeecCccccCCcccccc--CCCCCcccchhHH
Q 008031          404 HSNENIIHGNLTSSNVLLDDST--NAKISDFGLSRLMTAAAN---VNVIATAGALGYRAPELSKL--KKANTKTDVYSLG  476 (580)
Q Consensus       404 H~~~~i~H~Dlk~~Nil~~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G  476 (580)
                      |+. +|+||||||+||+++.++  .+||+|||++........   .......||+.|+|||++.+  ..++.++||||||
T Consensus       185 H~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          185 HNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             HHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             HHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            995 999999999999998766  899999999986643222   22334579999999999865  6788999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          477 VTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       477 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      |++|||++|+.||......+.   ...+.......   ..      +........+.+++.+||+.||.+|||+.|++++
T Consensus       264 ~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~---~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADT---ISQVLNKKLCF---EN------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHH---HHHHHHCCCCT---TS------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             HHHHHHHHCCCCCCCCChHHH---HHHHHhccccc---CC------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            999999999999976553322   22222221110   00      0000112356788899999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8e-42  Score=344.97  Aligned_cols=257  Identities=24%  Similarity=0.349  Sum_probs=188.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEE-------CCCCc
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYL-------GPKGE  358 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-------~~~~~  358 (580)
                      .|.+.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++++. ||||+++++++.       .....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            4667899999999999999975 78999999986655555677899999999995 999999999995       22345


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      .++||||+. |+|.+++........+++..+..++.||+.||+|||+. |  |+||||||+||+++.++.+||+|||++.
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccce
Confidence            789999995 79999987644345799999999999999999999994 8  9999999999999999999999999998


Q ss_pred             ccccccccc-----------eeeecCccccCCcccc---ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHH
Q 008031          437 LMTAAANVN-----------VIATAGALGYRAPELS---KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       437 ~~~~~~~~~-----------~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~  502 (580)
                      .........           .....||+.|+|||++   .+..++.++|||||||++|+|++|+.||..........   
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---  263 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN---  263 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc---
Confidence            765432211           1134588999999998   56778899999999999999999999997644322111   


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                          .....     .   .....   ...+.+++.+||+.||++|||+.|++++|+++....
T Consensus       264 ----~~~~~-----~---~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          264 ----GKYSI-----P---PHDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ------CCC-----C---TTCCS---SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ----CcccC-----C---ccccc---chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                10000     0   00111   123567888999999999999999999999987544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=339.75  Aligned_cols=264  Identities=24%  Similarity=0.308  Sum_probs=200.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-----ccHHHHHHHHHHHhcCC---CCcceeeeeEEECCCC--
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-----KGQREFESEVSLLGKIR---HPNLLALRAYYLGPKG--  357 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~--  357 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++....     .....+.+|+.++++++   ||||+++++++.....  
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~   90 (308)
T 3g33_A           11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR   90 (308)
T ss_dssp             CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence            667899999999999999975 799999999864321     12346778888877774   9999999999976433  


Q ss_pred             --cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccc
Q 008031          358 --EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLS  435 (580)
Q Consensus       358 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~  435 (580)
                        ..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  167 (308)
T 3g33_A           91 EIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLA  167 (308)
T ss_dssp             EEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred             ceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence              4789999996 59999998754 23489999999999999999999994 9999999999999999999999999999


Q ss_pred             cccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc--
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV--  513 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  513 (580)
                      +.......  .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+...........+  
T Consensus       168 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (308)
T 3g33_A          168 RIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  245 (308)
T ss_dssp             TTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred             cccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            86643322  22356899999999999999999999999999999999999999876544433333322211100000  


Q ss_pred             --cch--hhhccCCCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          514 --FDL--ELMRDAPTI-----GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       514 --~~~--~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        ..+  ......+..     +.....+.+++.+||+.||++|||+.|+++|-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence              000  000000000     01124567889999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-42  Score=359.70  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=193.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +|+.||||+++...   ......+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e  228 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVME  228 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEEEEEEC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEEEEEEe
Confidence            567899999999999999976 79999999987542   2233567889999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+..||+||||||+|||++.++.+||+|||+++...... .
T Consensus       229 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  304 (446)
T 4ejn_A          229 YANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A  304 (446)
T ss_dssp             CCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             eCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-c
Confidence            99999999999764   3689999999999999999999972399999999999999999999999999997643322 2


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..   ..+......       .   ...
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i~~~~~~-------~---p~~  371 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELILMEEIR-------F---PRT  371 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCCCC-------C---CTT
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---HHHHhCCCC-------C---Ccc
Confidence            233467999999999999999999999999999999999999999765433222   222221110       0   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQL  557 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~L  557 (580)
                      .   ..++.+++.+||+.||.+||     |+.|+++|-
T Consensus       372 ~---~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          372 L---GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             S---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             C---CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence            1   13566888899999999999     999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-41  Score=349.29  Aligned_cols=249  Identities=21%  Similarity=0.300  Sum_probs=190.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhc-CCCCcceeeeeEEEC---CCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGK-IRHPNLLALRAYYLG---PKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~---~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +|+.||||+++.     ...+.+|+.++.+ .+||||+++++++..   .....++||||++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~  142 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD  142 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence            68999999999999986 789999999853     2456788888744 589999999998864   2446899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeeccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +|+|.+++...+ ...+++..+..++.||+.||+|||+. ||+||||||+|||++.   ++.+||+|||+++......  
T Consensus       143 gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--  218 (400)
T 1nxk_A          143 GGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--  218 (400)
T ss_dssp             SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred             CCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccccCCCC--
Confidence            999999998653 34589999999999999999999995 9999999999999997   7889999999998654322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHH-HHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVA-SIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .+..+...   ....   ...
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~---~~~~---~~~  292 (400)
T 1nxk_A          219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE---FPNP---EWS  292 (400)
T ss_dssp             --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC---CCTT---TTT
T ss_pred             ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc---CCCc---ccc
Confidence            2234568999999999999999999999999999999999999998765443221111 11111110   0000   011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      .   ...++.+++.+||+.||++|||+.|+++|-.-
T Consensus       293 ~---~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  325 (400)
T 1nxk_A          293 E---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  325 (400)
T ss_dssp             T---SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             c---CCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence            1   12356788999999999999999999998543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.9e-41  Score=330.75  Aligned_cols=261  Identities=24%  Similarity=0.302  Sum_probs=205.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||+|++.....  ...+.+.+|+.++++++||||+++++++.. .+..++||||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~   86 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDL   86 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECC
T ss_pred             hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEEEec
Confidence            556789999999999999986 689999999865432  234568899999999999999999999986 6688999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC---eEEeeccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLSRLMTAAA  442 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~---~kl~Dfg~~~~~~~~~  442 (580)
                      +++++|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.   +||+|||++.......
T Consensus        87 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           87 VTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            9999999988765   3589999999999999999999994 9999999999999986555   9999999997665433


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      .  .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||...+..+...   .+.......   ...   ..
T Consensus       163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~---~~~---~~  231 (284)
T 3kk8_A          163 A--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIKAGAYDY---PSP---EW  231 (284)
T ss_dssp             B--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCCCC---CTT---TT
T ss_pred             c--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH---HHHhccccC---Cch---hh
Confidence            2  233568999999999999999999999999999999999999997654332222   222211110   000   01


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccccc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAA  568 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~  568 (580)
                      ...   ..++.+++.+||+.||++|||+.|++++-.--........
T Consensus       232 ~~~---~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          232 DTV---TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             TTS---CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             ccc---CHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence            111   2356688889999999999999999997554443333333

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-41  Score=338.30  Aligned_cols=261  Identities=23%  Similarity=0.371  Sum_probs=197.8

Q ss_pred             HHhhhccccccCceEEEEEEeC----CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC----
Q 008031          288 LCATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG----  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  357 (580)
                      .|.+.+.||+|+||.||+|.+.    ++..||+|.++....  ...+.+.+|+.++++++||||+++++++.....    
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            4567889999999999999864    345899999875432  234568999999999999999999999986332    


Q ss_pred             cEEEEEeeCCCCChhhhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccc
Q 008031          358 EKLLVFDYMPHGSLATFLHAR---GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL  434 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~  434 (580)
                      ..++||||+++|+|.+++...   .....+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||+
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kl~Dfg~  193 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFGL  193 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEEeecCc
Confidence            359999999999999998542   2235699999999999999999999994 999999999999999999999999999


Q ss_pred             ccccccccc-cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhcccc
Q 008031          435 SRLMTAAAN-VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE  512 (580)
Q Consensus       435 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  512 (580)
                      +........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..   ..... 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~-  269 (313)
T 3brb_A          194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH---GHRLK-  269 (313)
T ss_dssp             C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCC-
T ss_pred             ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc---CCCCC-
Confidence            986644322 12223457889999999999999999999999999999999 9999987655443333221   11100 


Q ss_pred             ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                              ...   .....+.+++.+||+.||++|||+.+++++|+++...-
T Consensus       270 --------~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          270 --------QPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             --------CBT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --------CCc---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                    011   11235778889999999999999999999999987543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-41  Score=370.35  Aligned_cols=249  Identities=24%  Similarity=0.351  Sum_probs=199.7

Q ss_pred             ccccccCceEEEEEEeC---CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE---DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+.   +++.||||+++.....  ..+++.+|++++++++||||+++++++..  +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence            47999999999999763   4678999999764332  35679999999999999999999999964  46899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc--c
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--N  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~  445 (580)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++........  .
T Consensus       453 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          453 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999999764   3689999999999999999999994 9999999999999999999999999999876543321  2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+..+.+..   ....         .....
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~~~---------~~p~~  596 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERM---------GCPAG  596 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCC---------CCCTT
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCC---------CCCCC
Confidence            223356788999999999999999999999999999998 9999987665443333322   1110         00111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      .   ..++.++|.+||+.||++|||+.++++.|+++..
T Consensus       597 ~---~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          597 C---PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             C---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             C---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2   2356788889999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.5e-42  Score=345.75  Aligned_cols=260  Identities=23%  Similarity=0.353  Sum_probs=204.7

Q ss_pred             hhhccccccCceEEEEEEeC-----CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEE
Q 008031          290 ATAEIMGKSTYGTVYKATLE-----DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLV  362 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv  362 (580)
                      ...+.||+|+||.||++.+.     +++.||||+++.... ...+.+.+|++++++++||||+++++++... ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            66799999999999998653     688999999976533 3346689999999999999999999999864 3468899


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++...    .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus       114 ~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             ECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             EecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            9999999999999864    48999999999999999999999 499999999999999999999999999998765433


Q ss_pred             cc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC--------hhH---HHHHHhhhhc
Q 008031          443 NV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE--------LPQ---WVASIVKEEW  509 (580)
Q Consensus       443 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~--------~~~---~~~~~~~~~~  509 (580)
                      ..  ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......        ...   .+........
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE  268 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence            21  2223457888999999998899999999999999999999999986432100        000   0001111000


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                                 ..+.......++.+++.+||+.||++|||+.|+++.|+.+.++-.
T Consensus       269 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          269 -----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence                       011111122467788889999999999999999999999876544

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-41  Score=333.17  Aligned_cols=246  Identities=26%  Similarity=0.404  Sum_probs=198.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. ++..||+|++....   ......+.+|+.++++++||||+++++++.+ .+..++|||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   89 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLILE   89 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEEEEEe
Confidence            556789999999999999876 67899999986432   2234678899999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.......  
T Consensus        90 ~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--  163 (279)
T 3fdn_A           90 YAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  163 (279)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence            99999999999875   358999999999999999999999 599999999999999999999999999986543322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+..+....+   ......       .   ...
T Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-------~---~~~  229 (279)
T 3fdn_A          164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---SRVEFT-------F---PDF  229 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HHTCCC-------C---CTT
T ss_pred             -ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH---HhCCCC-------C---CCc
Confidence             22356899999999999999999999999999999999999999765432222222   111100       0   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .   ...+.+++.+||+.||++|||+.|++++-.
T Consensus       230 ~---~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          230 V---TEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             S---CHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             C---CHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            1   235667888999999999999999999854

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.5e-42  Score=343.14  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=201.2

Q ss_pred             HhhhccccccCceEEEEEEe-----CCCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATL-----EDGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~l  361 (580)
                      |...+.||+|+||.||+|.+     .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.... ...++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            56678999999999999984     3688999999875433 34567899999999999999999999998642 46899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus       103 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            999999999999996542  458999999999999999999999 49999999999999999999999999999876544


Q ss_pred             ccc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCC-----------CCChhHHHHHHhhhh
Q 008031          442 ANV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLN-----------GAELPQWVASIVKEE  508 (580)
Q Consensus       442 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~-----------~~~~~~~~~~~~~~~  508 (580)
                      ...  ......+|..|+|||.+.+..++.++||||+|+++|+|++|+.|+....           .......+.......
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (302)
T 4e5w_A          180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG  259 (302)
T ss_dssp             CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred             CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence            321  2223457888999999998999999999999999999999999864211           000000111111110


Q ss_pred             ccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      .           ..+........+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       260 ~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          260 K-----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             C-----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0           00111112236678889999999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-41  Score=356.99  Aligned_cols=260  Identities=22%  Similarity=0.255  Sum_probs=194.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++....     ...+
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            667899999999999999876 78999999997542  223456889999999999999999999997532     3579


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+++ +|.+.+..     .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus       144 lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             EEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            99999975 57666653     388999999999999999999995 999999999999999999999999999986644


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---ccc----
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEV----  513 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----  513 (580)
                      ..  ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+....+.........   ...    
T Consensus       217 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          217 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             Cc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence            32  233457899999999999999999999999999999999999999876533322222211110000   000    


Q ss_pred             ----------cc---hhhhcc--CCCc----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          514 ----------FD---LELMRD--APTI----GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       514 ----------~~---~~~~~~--~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                                ..   +.....  .+..    .....++.+++.+||+.||++|||+.|+++|=
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence                      00   000000  0000    01145678999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=340.02  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=203.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEEC---CCCcEEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG---PKGEKLLVF  363 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~  363 (580)
                      .|.+.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||||+++++++..   .....++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            3667899999999999999984 799999999876545556778999999999999999999999873   234688999


Q ss_pred             eeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          364 DYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       364 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      ||+++|+|.+++... .....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  188 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV  188 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence            999999999999763 2235689999999999999999999995 99999999999999999999999999987553211


Q ss_pred             cc--------ceeeecCccccCCccccccCC---CCCcccchhHHHHHHHHHcCCCCCCCC--CCCChhHHHHHHhhhhc
Q 008031          443 NV--------NVIATAGALGYRAPELSKLKK---ANTKTDVYSLGVTILELLTGKSPGEPL--NGAELPQWVASIVKEEW  509 (580)
Q Consensus       443 ~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~  509 (580)
                      ..        ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||...  ........+.    ...
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~  264 (317)
T 2buj_A          189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----NQL  264 (317)
T ss_dssp             ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH----CC-
T ss_pred             ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh----ccC
Confidence            10        111235789999999987544   688999999999999999999999542  1111111111    000


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                                 ..+........+.+++.+||+.||.+|||+.+++++|+.+.+..+.
T Consensus       265 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          265 -----------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             -----------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence                       0011111123577888999999999999999999999998765444

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-41  Score=340.61  Aligned_cols=262  Identities=25%  Similarity=0.358  Sum_probs=208.5

Q ss_pred             HHhhhccccccCceEEEEEEe------CCCCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      .|.+.+.||+|+||.||+|.+      .+++.||||+++..... ..+.+.+|+.++.++ +||||+++++++...+...
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  107 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  107 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence            356788999999999999984      25678999999765432 345789999999999 7999999999998756669


Q ss_pred             EEEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC
Q 008031          360 LLVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN  426 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~  426 (580)
                      ++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCC
Confidence            999999999999999987532             12378999999999999999999995 9999999999999999999


Q ss_pred             eEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHH
Q 008031          427 AKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASI  504 (580)
Q Consensus       427 ~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~  504 (580)
                      +||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+.   +...
T Consensus       187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~  263 (316)
T 2xir_A          187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRR  263 (316)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---HHHH
T ss_pred             EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH---HHHH
Confidence            999999999866443222 2223457889999999999999999999999999999998 9999976553321   1111


Q ss_pred             hhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          505 VKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ........        .....   ..++.+++.+||+.||.+|||+.|++++|+.+.+..
T Consensus       264 ~~~~~~~~--------~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          264 LKEGTRMR--------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             HHHTCCCC--------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hccCccCC--------CCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            11111100        01111   235678888999999999999999999999987543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.4e-42  Score=345.51  Aligned_cols=263  Identities=17%  Similarity=0.199  Sum_probs=196.3

Q ss_pred             HhhhccccccCceEEEEEEeC----CCCEEEEEEccccccc-----------cHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKITK-----------GQREFESEVSLLGKIRHPNLLALRAYYL  353 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~~~  353 (580)
                      |.+.+.||+|+||.||+|.+.    ++..||+|++......           ....+.+|+..++.++||||+++++++.
T Consensus        39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~  118 (345)
T 2v62_A           39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL  118 (345)
T ss_dssp             EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred             EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence            566799999999999999985    5788999998654321           1234668889999999999999999987


Q ss_pred             CC---CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC--CeE
Q 008031          354 GP---KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST--NAK  428 (580)
Q Consensus       354 ~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~--~~k  428 (580)
                      ..   ....++||||+ +++|.+++...+   .+++..++.++.||+.||+|||+. ||+||||||+||+++.++  .+|
T Consensus       119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          119 TEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCcEE
Confidence            62   45789999999 999999998753   689999999999999999999994 999999999999998777  999


Q ss_pred             Eeeccccccccccccc------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC-hhHHH
Q 008031          429 ISDFGLSRLMTAAANV------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE-LPQWV  501 (580)
Q Consensus       429 l~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~  501 (580)
                      |+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            9999999876433221      1133568999999999999999999999999999999999999996532221 11111


Q ss_pred             HHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          502 ASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      .........     .......+ ......++.+++.+||+.||++|||+.++++.|+++..
T Consensus       274 ~~~~~~~~~-----~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          274 KTNLLDELP-----QSVLKWAP-SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHTTT-----HHHHHHSC-TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHhhccccc-----HHHHhhcc-ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            111111111     11000000 00111256788889999999999999999999998764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=344.61  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=203.0

Q ss_pred             HHhhhccccccCceEEEEEEe----CCCCEEEEEEccccc----cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCc
Q 008031          288 LCATAEIMGKSTYGTVYKATL----EDGSQVAVKRLREKI----TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  358 (580)
                      .|.+.+.||+|+||.||+|..    .+|+.||||+++...    ......+.+|+++++++ +||||+++++++.. .+.
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~  133 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETK  133 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TTE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-Cce
Confidence            366789999999999999997    378999999987542    12345677899999999 79999999999986 668


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      .++||||+++|+|.+++....   .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            999999999999999998753   689999999999999999999994 9999999999999999999999999999876


Q ss_pred             ccccccceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          439 TAAANVNVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      ............||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+.........      
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------  283 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------  283 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC------
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC------
Confidence            5444444445679999999999875  45788999999999999999999999865544333322222111110      


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhh
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQLEE  559 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~L~~  559 (580)
                            +........+.+++.+||+.||++||     |+.|++++..-
T Consensus       284 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          284 ------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             ------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence                  00111123566788899999999999     99999988643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.8e-41  Score=340.69  Aligned_cols=253  Identities=19%  Similarity=0.272  Sum_probs=201.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|.+.+.||+|+||.||+|.+. +|+.||+|++.....    ...+|++++.++ +||||+++++++.+ .+..++||||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~   97 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVTEL   97 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEEeC
Confidence            4677899999999999999986 788999999865432    235688888887 79999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC----CCeEEeecccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS----TNAKISDFGLSRLMTAA  441 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~----~~~kl~Dfg~~~~~~~~  441 (580)
                      +++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||++.++    +.+||+|||+++.....
T Consensus        98 ~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           98 MKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            9999999999764   3689999999999999999999995 99999999999998533    34999999999876443


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      .. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..............+..+....   ....   
T Consensus       174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~---~~~~---  246 (342)
T 2qr7_A          174 NG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL---SGGY---  246 (342)
T ss_dssp             TC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC---CSTT---
T ss_pred             CC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc---Cccc---
Confidence            22 2234568999999999988889999999999999999999999998765544444444443332210   0000   


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                      .+..   ..++.+++.+||+.||++|||+.|+++|-.-
T Consensus       247 ~~~~---s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          247 WNSV---SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             TTTS---CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             cccC---CHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence            1112   2356678889999999999999999987554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-41  Score=333.55  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=195.9

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.. ....++||||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~  101 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVMET  101 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEEEe
Confidence            4677899999999999999986 789999999875543 345778999999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee---CCCCCeEEeecccccccccc
Q 008031          366 MPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       366 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +++|+|.+++... .....+++..+..++.|++.||+|||+ .||+||||||+||++   +.++.+||+|||++......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            9999999998643 123468999999999999999999999 599999999999999   45678999999999866443


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ..  .....||+.|+|||.+. ..++.++||||+|+++|||++|+.||......+......   .....       ....
T Consensus       181 ~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~---~~~~~-------~~~~  247 (285)
T 3is5_A          181 EH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT---YKEPN-------YAVE  247 (285)
T ss_dssp             --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCC-------CCC-
T ss_pred             cc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc---cCCcc-------cccc
Confidence            22  23456899999999886 568899999999999999999999998654332222111   11100       0000


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....   ..++.+++.+||+.||++|||+.|++++
T Consensus       248 ~~~~---~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          248 CRPL---TPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -CCC---CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cCcC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111   2356688889999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.2e-42  Score=343.09  Aligned_cols=263  Identities=22%  Similarity=0.345  Sum_probs=203.6

Q ss_pred             HHhhhccccccCceEEEEEEe------CCCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .|.+.+.||+|+||.||+|.+      .++..||||.+.... ......+.+|+.++++++||||+++++++.. .+..+
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  109 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRF  109 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCE
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-CCCcE
Confidence            356789999999999999984      257789999996443 2345678999999999999999999999986 56789


Q ss_pred             EEEeeCCCCChhhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeecc
Q 008031          361 LVFDYMPHGSLATFLHARGP----ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFG  433 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg  433 (580)
                      +||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+. ||+||||||+||+++.   +..+||+|||
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~~kl~Dfg  188 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFG  188 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcceEEECccc
Confidence            99999999999999987532    14589999999999999999999995 9999999999999984   4569999999


Q ss_pred             ccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          434 LSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       434 ~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      ++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+   .......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~~~~  265 (327)
T 2yfx_A          189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---TSGGRMD  265 (327)
T ss_dssp             HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HTTCCCC
T ss_pred             cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH---hcCCCCC
Confidence            98755433221 2223457889999999998899999999999999999998 99999765433222222   1111100


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccc
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATA  567 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~  567 (580)
                               .....   ...+.+++.+||+.||.+|||+.+++++|+.+.......
T Consensus       266 ---------~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~  309 (327)
T 2yfx_A          266 ---------PPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI  309 (327)
T ss_dssp             ---------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred             ---------CCCCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence                     01111   235668888999999999999999999999987655433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-41  Score=335.02  Aligned_cols=266  Identities=23%  Similarity=0.367  Sum_probs=197.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +|+.||+|+++...   ......+.+|+.++++++||||+++++++.. ++..++|||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e  112 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLE  112 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEEEEe
Confidence            567899999999999999975 79999999987532   2234568899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          365 YMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      |+++++|.+++... .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++........
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~  191 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  191 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence            99999999998752 1234689999999999999999999995 999999999999999999999999999876543322


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                       ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+... ........+.......      .  ...
T Consensus       192 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~------~--~~~  261 (310)
T 2wqm_A          192 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPP------L--PSD  261 (310)
T ss_dssp             --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSCC------C--CTT
T ss_pred             -cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCCC------C--ccc
Confidence             22234688999999999999999999999999999999999999975432 2222222222211110      0  001


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccC
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAAT  569 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~  569 (580)
                      ..   ..++.+++.+||+.||++|||+.++++.|+++++....+..
T Consensus       262 ~~---~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          262 HY---SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             cc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            11   23567888899999999999999999999999877665543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1e-41  Score=347.52  Aligned_cols=259  Identities=22%  Similarity=0.251  Sum_probs=200.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-----CCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-----HPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++.. ......+..|+.+++.+.     ||||+++++++.. .+..++|
T Consensus        37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-~~~~~lv  114 (360)
T 3llt_A           37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-YDHMCLI  114 (360)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-TTEEEEE
T ss_pred             EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-CCeeEEE
Confidence            667899999999999999985 7899999998643 233456788999999986     9999999999987 5689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-------------------
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-------------------  423 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-------------------  423 (580)
                      |||+ +++|.+++.... ...+++..+..++.||+.||+|||+ .||+||||||+|||++.                   
T Consensus       115 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~  191 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI  191 (360)
T ss_dssp             ECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred             EcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence            9999 999999998753 3358999999999999999999999 59999999999999975                   


Q ss_pred             ------CCCeEEeecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh
Q 008031          424 ------STNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL  497 (580)
Q Consensus       424 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~  497 (580)
                            ++.+||+|||++.......    ....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+.
T Consensus       192 ~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  267 (360)
T 3llt_A          192 QIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH  267 (360)
T ss_dssp             EEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence                  7889999999998654322    235689999999999999999999999999999999999999987654443


Q ss_pred             hHHHHHHhhhhcc-----------ccccch-hhhccCC---CcHHH---------------HHHHHHHHhhccCCCCCCC
Q 008031          498 PQWVASIVKEEWT-----------NEVFDL-ELMRDAP---TIGDE---------------LLNTLKLALHCVDPSPSAR  547 (580)
Q Consensus       498 ~~~~~~~~~~~~~-----------~~~~~~-~~~~~~~---~~~~~---------------~~~l~~li~~cl~~~P~~R  547 (580)
                      ...+.........           ....+. ......+   .....               ...+.+++.+||+.||++|
T Consensus       268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  347 (360)
T 3llt_A          268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR  347 (360)
T ss_dssp             HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence            3333322111000           000000 0000000   00000               1456789999999999999


Q ss_pred             CCHHHHHHH
Q 008031          548 PEVLQVVQQ  556 (580)
Q Consensus       548 ps~~ev~~~  556 (580)
                      ||+.|++++
T Consensus       348 pta~elL~h  356 (360)
T 3llt_A          348 PSPAELLKH  356 (360)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhcC
Confidence            999999865

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-41  Score=347.06  Aligned_cols=241  Identities=25%  Similarity=0.335  Sum_probs=188.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHH-HhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSL-LGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|+.. +++.||||+++....   .....+.+|..+ ++.++||||+++++++.+ .+..|+||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~lv~  118 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVL  118 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEEEEE
Confidence            567899999999999999986 688999999975432   223456677776 567899999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... 
T Consensus       119 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          119 DYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence            999999999999874   3688999999999999999999994 99999999999999999999999999997643222 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+   ....+......       .   .+
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~~~~-------~---~~  260 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILNKPLQ-------L---KP  260 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHHHHHHSCCC-------C---CS
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhcccC-------C---CC
Confidence            22334579999999999999999999999999999999999999997654332   22233222110       0   11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVL  551 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~  551 (580)
                      ...   ..+.+++.+||+.||.+||++.
T Consensus       261 ~~~---~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          261 NIT---NSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             SSC---HHHHHHHHHHTCSSGGGSTTTT
T ss_pred             CCC---HHHHHHHHHHcccCHHhCCCCC
Confidence            122   2566788899999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.9e-41  Score=342.84  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=201.5

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ..|...+.||+|+||.||+|... +|+.||||++.....   ...+.+.+|++++++++||||+++++++.. .+..++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEE
Confidence            34677889999999999999974 789999999864432   223568899999999999999999999986 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+. |+|.+++...  ...+++..+..++.|+++||+|||+. ||+||||||+||+++.++.+||+|||++...... 
T Consensus       133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            99996 6888888654  24689999999999999999999995 9999999999999999999999999999765432 


Q ss_pred             ccceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NVNVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                          ....||+.|+|||++.   ...++.++|||||||++|||++|+.||...+..   ..+..+.......      . 
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~~~------~-  273 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPA------L-  273 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCC------C-
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCC------C-
Confidence                2346899999999874   577899999999999999999999999765432   2222222221110      0 


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                       .....   ...+.+++.+||+.||++|||+.+++++..-...
T Consensus       274 -~~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          274 -QSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             -CCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -CCCCC---CHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence             01111   2356678889999999999999999988665443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.6e-41  Score=328.52  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=203.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT------KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .|...+.||+|+||.||+|.+. +|+.||+|.++....      ...+.+.+|+.++++++||||+++++++.. .+..+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTDVV   84 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCeEE
Confidence            4677899999999999999987 799999999865432      135679999999999999999999999987 56899


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC----CeEEeeccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST----NAKISDFGLSR  436 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~----~~kl~Dfg~~~  436 (580)
                      +||||+++++|.+++...   ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++    .+||+|||++.
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            999999999999999764   368999999999999999999999 4999999999999998776    79999999998


Q ss_pred             ccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          437 LMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       437 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      .......  .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+...   .+.....   ..+.
T Consensus       161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~---~~~~  232 (283)
T 3bhy_A          161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT---NISAVNY---DFDE  232 (283)
T ss_dssp             ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTTCC---CCCH
T ss_pred             eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH---HhHhccc---CCcc
Confidence            6644322  223468999999999999999999999999999999999999997654322222   2111110   0111


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcccc
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPEA  564 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~~  564 (580)
                      .....   .   ...+.+++.+||+.||++|||+.|++++  ++.++...
T Consensus       233 ~~~~~---~---~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          233 EYFSN---T---SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHHTT---C---CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             hhccc---C---CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            11111   1   1356788899999999999999999985  55554443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.5e-41  Score=338.29  Aligned_cols=263  Identities=24%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhc--CCCCcceeeeeEEECCC---CcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGK--IRHPNLLALRAYYLGPK---GEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+. |+.||||++...   ....+.+|++++..  ++||||+++++++....   ...++|
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv  118 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV  118 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred             cEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence            4677899999999999999985 899999998643   34567788888887  79999999999998744   278999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCcccCCCCCCCeeeCCCCCeEEeeccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH--------SNENIIHGNLTSSNVLLDDSTNAKISDFGL  434 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~  434 (580)
                      |||+++|+|.+++...    .+++..++.++.|++.||+|||        + .+|+||||||+||+++.++.+||+|||+
T Consensus       119 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  193 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNGTCCIADLGL  193 (342)
T ss_dssp             ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence            9999999999999764    5899999999999999999999        7 5999999999999999999999999999


Q ss_pred             cccccccccc---ceeeecCccccCCccccccC------CCCCcccchhHHHHHHHHHcC----------CCCCCCCCCC
Q 008031          435 SRLMTAAANV---NVIATAGALGYRAPELSKLK------KANTKTDVYSLGVTILELLTG----------KSPGEPLNGA  495 (580)
Q Consensus       435 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~tg----------~~p~~~~~~~  495 (580)
                      +.........   ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            9866543322   12334689999999998765      233689999999999999999          7788665332


Q ss_pred             C-hhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          496 E-LPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       496 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      + ....+.........    .+...... ...+....+.+++.+||+.||++|||+.+++++|+++.++.
T Consensus       274 ~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          274 DPSVEEMRKVVCEQKL----RPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             SCCHHHHHHHHTTSCC----CCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccHHHHHHHHHHHHh----CCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            2 11222222111111    11110000 11245567888999999999999999999999999997654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=332.81  Aligned_cols=248  Identities=26%  Similarity=0.438  Sum_probs=180.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +|+.||+|.+.....   ...+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   91 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYLVLE   91 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEEEEe
Confidence            556789999999999999974 799999999864422   234678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++...  ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++........ 
T Consensus        92 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  167 (278)
T 3cok_A           92 MCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-  167 (278)
T ss_dssp             CCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             cCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence            99999999999864  24689999999999999999999995 999999999999999999999999999986643322 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......+....+   ...       +...   ...
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~-------~~~~---~~~  234 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV---VLA-------DYEM---PSF  234 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---CSS-------CCCC---CTT
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---hhc-------ccCC---ccc
Confidence            222356899999999999989999999999999999999999999865543322111   100       0000   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .   ..++.+++.+||+.||++|||+.+++++-
T Consensus       235 ~---~~~~~~li~~~l~~dp~~Rps~~~~l~h~  264 (278)
T 3cok_A          235 L---SIEAKDLIHQLLRRNPADRLSLSSVLDHP  264 (278)
T ss_dssp             S---CHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred             c---CHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence            1   23566888899999999999999998863

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=342.37  Aligned_cols=269  Identities=27%  Similarity=0.359  Sum_probs=196.3

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHH--HhcCCCCcceeeeeEEEC----CCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSL--LGKIRHPNLLALRAYYLG----PKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~----~~~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|.. +++.||||++....   ...+..|.++  +..++||||+++++.+..    .....++|
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            45678999999999999987 58999999986432   2344444444  455899999999976542    22356899


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------CcccCCCCCCCeeeCCCCCeEEeecc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE---------NIIHGNLTSSNVLLDDSTNAKISDFG  433 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------~i~H~Dlk~~Nil~~~~~~~kl~Dfg  433 (580)
                      |||+++|+|.+++...    ..++..+..++.||+.||+|||+ .         ||+||||||+|||++.++.+||+|||
T Consensus        91 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            9999999999999765    35889999999999999999998 6         99999999999999999999999999


Q ss_pred             cccccccccc-------cceeeecCccccCCcccccc-------CCCCCcccchhHHHHHHHHHcCCCCCCCCCC-CChh
Q 008031          434 LSRLMTAAAN-------VNVIATAGALGYRAPELSKL-------KKANTKTDVYSLGVTILELLTGKSPGEPLNG-AELP  498 (580)
Q Consensus       434 ~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~-~~~~  498 (580)
                      +++.......       .......||+.|+|||++.+       ..++.++|||||||++|||++|..||..... .+..
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9986643221       12223469999999999876       4566789999999999999999777643322 1111


Q ss_pred             HHHHHHhhh---------hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          499 QWVASIVKE---------EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       499 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                      .........         ........+......+.......++.+++.+||+.||++|||+.|+++.|+++......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence            111100000         00001111111122223334556788999999999999999999999999998754443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.7e-41  Score=335.07  Aligned_cols=250  Identities=23%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|.+.+.||+|+||.||+|... +|+.||+|+++.........+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   88 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVMQLV   88 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEEEcC
Confidence            4677899999999999999986 799999999976544455678999999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee---CCCCCeEEeecccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ++++|.+++...+   .+++..+..++.|++.||+|||+. |++||||||+||++   +.++.+||+|||++....... 
T Consensus        89 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-  163 (304)
T 2jam_A           89 SGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-  163 (304)
T ss_dssp             CSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred             CCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence            9999999997643   589999999999999999999995 99999999999999   778899999999987654321 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                        .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......+.   ...+......   ......   .
T Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~---~~~~~~---~  232 (304)
T 2jam_A          164 --MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEKIKEGYYE---FESPFW---D  232 (304)
T ss_dssp             --THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHCCCC---CCTTTT---T
T ss_pred             --cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHcCCCC---CCcccc---c
Confidence              1234589999999999999999999999999999999999999976543222   2222221110   000110   1


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .   ....+.+++.+||+.||++|||+.|++++-
T Consensus       233 ~---~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          233 D---ISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             T---SCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             c---CCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            1   123567888999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.2e-41  Score=334.50  Aligned_cols=258  Identities=23%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             Hhhhc-cccccCceEEEEEEeC---CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAE-IMGKSTYGTVYKATLE---DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |.+.+ .||+|+||.||+|.+.   +++.||||+++.....  ..+.+.+|+++++.++||||+++++++.  .+..++|
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv   95 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLV   95 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCcEEE
Confidence            44555 8999999999999653   4678999998754332  2467899999999999999999999994  4578999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++++|.+++...   ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.......
T Consensus        96 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             EECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence            9999999999999874   3589999999999999999999995 99999999999999999999999999998765433


Q ss_pred             ccc--eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NVN--VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ...  .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+..   ....      .  
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~------~--  240 (291)
T 1xbb_A          172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERM------G--  240 (291)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCC------C--
T ss_pred             CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCC------C--
Confidence            221  122346788999999988889999999999999999999 9999987654333222221   1110      0  


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATA  567 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~  567 (580)
                       .....   ...+.+++.+||+.||++|||+.++++.|+++......+
T Consensus       241 -~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  284 (291)
T 1xbb_A          241 -CPAGC---PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  284 (291)
T ss_dssp             -CCTTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             -CCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence             01111   235678888999999999999999999999987655443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-41  Score=356.65  Aligned_cols=191  Identities=21%  Similarity=0.367  Sum_probs=151.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC----CCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP----KGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++.....  ...+.+.+|+.++++++||||+++++++...    ....|+
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            667899999999999999976 789999999865332  2346788999999999999999999998642    246899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+ +++|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus       135 v~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          135 VLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             EEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            99998 57999998764   4699999999999999999999995 9999999999999999999999999999876432


Q ss_pred             cc--------------------------cceeeecCccccCCcccc-ccCCCCCcccchhHHHHHHHHHc
Q 008031          442 AN--------------------------VNVIATAGALGYRAPELS-KLKKANTKTDVYSLGVTILELLT  484 (580)
Q Consensus       442 ~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~t  484 (580)
                      ..                          .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            11                          123345789999999975 56779999999999999999999

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=332.14  Aligned_cols=246  Identities=24%  Similarity=0.292  Sum_probs=191.3

Q ss_pred             HHHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEE
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  361 (580)
                      ...|...+.||+|+||+||+|.+. +|+.||||++.....  .....+..|+..+.++ +||||+++++++.+ .+..++
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~l  134 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYL  134 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEE
Confidence            345778899999999999999987 799999999865432  2233455666666555 89999999999986 668999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+ +++|.+++...+  ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus       135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999 779999987753  4699999999999999999999994 9999999999999999999999999998766443


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ..  .....||+.|+|||++.+ .++.++|||||||++|||++|..|+....      ....+..     ....+.....
T Consensus       211 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~~~-----~~~~~~~~~~  276 (311)
T 3p1a_A          211 GA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------GWQQLRQ-----GYLPPEFTAG  276 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------HHHHHTT-----TCCCHHHHTT
T ss_pred             CC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHhc-----cCCCcccccC
Confidence            22  223468999999999875 78999999999999999999977654321      1111111     1111111111


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                            ...++.+++.+||+.||++|||+.|++++
T Consensus       277 ------~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          277 ------LSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ------SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ------CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                  12367788999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.2e-41  Score=340.28  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=202.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEE--EEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQV--AVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |...+.||+|+||.||+|.+. ++..+  |+|.++.... ...+.+.+|+++++++ +||||+++++++.. .+..++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~  105 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAI  105 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CCceEEEE
Confidence            556789999999999999976 56644  9998865332 3445789999999999 99999999999986 66899999


Q ss_pred             eeCCCCChhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          364 DYMPHGSLATFLHARG-------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                      ||+++|+|.+++....             ....+++..++.++.||+.||+|||+ .||+||||||+||+++.++.+||+
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~kL~  184 (327)
T 1fvr_A          106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIA  184 (327)
T ss_dssp             CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEEC
T ss_pred             ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcCCCeEEEc
Confidence            9999999999997642             23468999999999999999999999 499999999999999999999999


Q ss_pred             ecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhc
Q 008031          431 DFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       431 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      |||+++......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+...   .+.....
T Consensus       185 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~---~~~~~~~  259 (327)
T 1fvr_A          185 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---KLPQGYR  259 (327)
T ss_dssp             CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HGGGTCC
T ss_pred             ccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH---HhhcCCC
Confidence            999987443221  1223356788999999998889999999999999999998 999997655332222   2111100


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                      .         ......   ..++.+++.+||+.||++|||+.|++++|+++..+..
T Consensus       260 ~---------~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          260 L---------EKPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             C---------CCCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             C---------CCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            0         001111   2356788889999999999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.5e-41  Score=354.00  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=201.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|++. +|+.||+|++.....   .....+.+|++++++++||||+++++++.. ....|+|||
T Consensus       187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lVmE  265 (543)
T 3c4z_A          187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLVMT  265 (543)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEEEEE
Confidence            344678999999999999986 799999999965432   334678899999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          365 YMPHGSLATFLHARGP-ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      |++||+|.+++..... ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            9999999999976432 34699999999999999999999995 999999999999999999999999999987654322


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhH-HHHHHhhhhccccccchhhhccC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQ-WVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... ....+......       .   .
T Consensus       345 -~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~-------~---p  413 (543)
T 3c4z_A          345 -KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT-------Y---P  413 (543)
T ss_dssp             -CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC-------C---C
T ss_pred             -ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC-------C---C
Confidence             2233579999999999999999999999999999999999999998765432222 22222221110       0   1


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEV-----LQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ev~~~  556 (580)
                      ...   ...+.+++.+||+.||++||++     .++++|
T Consensus       414 ~~~---s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          414 DKF---SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             TTS---CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ccc---CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            111   2356678889999999999975     666654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=331.77  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=197.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc----cccHHHHHHHHHHHhcCCCCcceeeeeEEEC-CCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI----TKGQREFESEVSLLGKIRHPNLLALRAYYLG-PKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|+++...    ......+.+|++++++++||||+++++++.. .....++|
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV   86 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred             eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence            556799999999999999985 78999999987542    2345678999999999999999999999864 24578999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||++++ |.+++.... ...+++..+..++.||+.||+|||+. |++||||||+||+++.++.+||+|||++.......
T Consensus        87 ~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           87 MEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             ehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            9999876 777776643 34689999999999999999999995 99999999999999999999999999998664322


Q ss_pred             -ccceeeecCccccCCccccccCC--CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 -NVNVIATAGALGYRAPELSKLKK--ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 -~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                       ........|+..|+|||++.+..  ++.++||||+|+++|||++|+.||...+..   .....+......       . 
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~~~~~-------~-  232 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIGKGSYA-------I-  232 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCCC-------C-
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHhcCCCC-------C-
Confidence             22233456899999999987644  367999999999999999999999765422   222222211110       0 


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                        ....   ...+.+++.+||+.||++|||+.|++++-.-
T Consensus       233 --~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          233 --PGDC---GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             --CSSS---CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             --CCcc---CHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence              1111   2356678889999999999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=339.30  Aligned_cols=251  Identities=20%  Similarity=0.314  Sum_probs=193.6

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCC--CcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRH--PNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|...+++.||||++.....  ...+.+.+|+.++.+++|  +||+++++++.. ++..++|||
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEEEEEe
Confidence            556799999999999999998899999999864432  233678899999999976  999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      + .+++|.+++...   ..+++.++..++.||+.||+|||+. ||+||||||+|||++ ++.+||+|||+++........
T Consensus        90 ~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           90 C-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             C-CSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             C-CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            5 588999999875   3689999999999999999999995 999999999999997 577999999999876543322


Q ss_pred             -ceeeecCccccCCcccccc-----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc
Q 008031          445 -NVIATAGALGYRAPELSKL-----------KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE  512 (580)
Q Consensus       445 -~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  512 (580)
                       ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....  ....+.......... 
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~-  240 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPNHEI-  240 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHCTTSCC-
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHHHhcCCccc-
Confidence             2234579999999999864           6788899999999999999999999975432  222222222211110 


Q ss_pred             ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                              ..+..  ....+.+++.+||+.||++|||+.|++++-.-
T Consensus       241 --------~~~~~--~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~  277 (343)
T 3dbq_A          241 --------EFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  277 (343)
T ss_dssp             --------CCCCC--SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             --------CCccc--CCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence                    11111  11256688899999999999999999988643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6e-41  Score=337.00  Aligned_cols=248  Identities=22%  Similarity=0.340  Sum_probs=196.4

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +.||+|+||.||+|... +|+.||+|+++....  .....+.+|+.++.++ +||||+++++++.. .+..++||||+++
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-~~~~~lv~e~~~~  113 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-TSEIILILEYAAG  113 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEECCTT
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-CCeEEEEEEecCC
Confidence            78999999999999986 799999999875432  3356789999999999 57999999999986 6689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeecccccccccccccc
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      |+|.+++.... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.   ++.+||+|||++........  
T Consensus       114 ~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~--  189 (327)
T 3lm5_A          114 GEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--  189 (327)
T ss_dssp             EEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------
T ss_pred             CcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc--
Confidence            99999986532 3468999999999999999999999 49999999999999997   78999999999987654322  


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...+..+....+..   ....   .....   ... 
T Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~---~~~~~---~~~-  259 (327)
T 3lm5_A          190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ---VNVD---YSEET---FSS-  259 (327)
T ss_dssp             ----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCC---CCTTT---TTT-
T ss_pred             cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh---cccc---cCchh---hcc-
Confidence            2335689999999999999999999999999999999999999976543322222211   1100   00000   111 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        ....+.+++.+||+.||++|||+.|++++-
T Consensus       260 --~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          260 --VSQLATDFIQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred             --cCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence              123566788899999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=340.84  Aligned_cols=242  Identities=20%  Similarity=0.343  Sum_probs=198.3

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--------ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--------KGQREFESEVSLLGKIRHPNLLALRAYYLGPKG  357 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  357 (580)
                      ..|.+.+.||+|+||.||+|.+. +++.||||+++....        .....+.+|+.++++++||||+++++++.. .+
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~  102 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-QG  102 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-SS
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-CC
Confidence            35777899999999999999975 788999999875431        123457789999999999999999999986 66


Q ss_pred             cEEEEEeeCCCC-ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          358 EKLLVFDYMPHG-SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       358 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      ..++||||+.+| +|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            899999999777 999999864   3689999999999999999999994 99999999999999999999999999998


Q ss_pred             ccccccccceeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          437 LMTAAANVNVIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       437 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      .......  .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....         .....       
T Consensus       179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~-------  240 (335)
T 3dls_A          179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEAA-------  240 (335)
T ss_dssp             ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTTC-------
T ss_pred             ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhhc-------
Confidence            7654332  234569999999999988776 7889999999999999999999965221         00000       


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        . ......   ..++.+++.+||+.||++|||+.|++++-
T Consensus       241 --~-~~~~~~---~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          241 --I-HPPYLV---SKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             --C-CCSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             --c-CCCccc---CHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence              0 001111   12566888899999999999999999984

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-41  Score=343.04  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=206.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CC-----CEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DG-----SQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  360 (580)
                      |...+.||+|+||.||+|.+. ++     ..||+|.++.... ...+.+.+|+.+++++ +||||+++++++.. .+..+
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~  126 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-GGPVL  126 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-CCceE
Confidence            556789999999999999975 23     4799999875533 3346789999999999 89999999999976 66899


Q ss_pred             EEEeeCCCCChhhhhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEE
Q 008031          361 LVFDYMPHGSLATFLHARG-----------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKI  429 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl  429 (580)
                      +||||+++|+|.+++....           ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus       127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl  205 (333)
T 2i1m_A          127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKI  205 (333)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEEGGGEEEB
T ss_pred             EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEECCCCeEEE
Confidence            9999999999999997542           124589999999999999999999995 9999999999999999999999


Q ss_pred             eecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhh
Q 008031          430 SDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKE  507 (580)
Q Consensus       430 ~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  507 (580)
                      +|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.........   ......
T Consensus       206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~~~~  282 (333)
T 2i1m_A          206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---YKLVKD  282 (333)
T ss_dssp             CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH---HHHHHH
T ss_pred             CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH---HHHHhc
Confidence            9999998664433221 223346788999999998999999999999999999999 99999775543322   222222


Q ss_pred             hccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          508 EWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      .....        .....   ...+.+++.+||+.||.+|||+.|++++|+++..+.
T Consensus       283 ~~~~~--------~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          283 GYQMA--------QPAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             TCCCC--------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCC--------CCCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            11100        01111   235678888999999999999999999999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-41  Score=339.86  Aligned_cols=266  Identities=22%  Similarity=0.258  Sum_probs=198.6

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-----cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-----GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      .|...+.||+|+||.||+|.+. +|+.||||++......     ..+.+.+|++++++++||||+++++++.. .+..++
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l   89 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISL   89 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEE
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-CCceEE
Confidence            4677899999999999999986 6899999998743221     12467899999999999999999999976 668999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++ +|.+++...  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus        90 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999975 898888764  34588899999999999999999995 9999999999999999999999999999876433


Q ss_pred             cccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh--
Q 008031          442 ANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL--  518 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  518 (580)
                      .. ......||+.|+|||++.+ ..++.++||||+||++|||++|..||.+.+..+....+...........+-+...  
T Consensus       166 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          166 NR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             cc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence            22 2234568999999999865 4588999999999999999999999977654333222222111110000000000  


Q ss_pred             ----hccCCC-c-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          519 ----MRDAPT-I-----GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       519 ----~~~~~~-~-----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                          ....+. .     .....++.+++.+||+.||++|||+.|++++-.-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence                000000 0     0112467789999999999999999999987543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.3e-41  Score=353.95  Aligned_cols=251  Identities=26%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      ..|.+.+.||+|+||.||+|.+. +++.||||++....  ......+.+|++++++++||||+++++++.. ....++||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~  100 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVG  100 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEEEE
Confidence            35778899999999999999986 79999999986432  2345678999999999999999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC---CCCCeEEeeccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD---DSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~  440 (580)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+. ||+||||||+||+++   .++.+||+|||+++....
T Consensus       101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            999999999998765   3689999999999999999999995 999999999999995   456799999999986644


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ..  ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+...   .+.......   +...+.
T Consensus       177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~---~~~~~~  247 (486)
T 3mwu_A          177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK---RVETGKYAF---DLPQWR  247 (486)
T ss_dssp             C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCCCS---CSGGGG
T ss_pred             CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCCCCC---CCcccC
Confidence            32  2334579999999999875 58999999999999999999999997755433322   222222111   111111


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                            ....++.+++.+||+.||++|||+.|++++-
T Consensus       248 ------~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          248 ------TISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             ------GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             ------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence                  1123567889999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.2e-41  Score=354.94  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=197.9

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .|...+.||+|+||.||+|.+. ++..||+|+++...  ......+.+|+.+++.++||||+++++++.. ....++|||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e  116 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVME  116 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEe
Confidence            4778899999999999999986 78999999987543  2345678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeecccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMTAA  441 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~  441 (580)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+|||++.   ++.+||+|||++......
T Consensus       117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            99999999988765   358999999999999999999999 49999999999999975   445999999999876543


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ..  .....||+.|+|||++. ..++.++||||+||++|+|++|+.||.+....+....   +......   .+...+  
T Consensus       193 ~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~---~~~~~~--  261 (494)
T 3lij_A          193 KK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK---VEKGKYT---FDSPEW--  261 (494)
T ss_dssp             BC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHTCCC---CCSGGG--
T ss_pred             cc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCCC---CCchhc--
Confidence            22  23456999999999886 5699999999999999999999999987654333322   2222111   111111  


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ...   ...+.+++.+||+.||++|||+.|+++|
T Consensus       262 -~~~---s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          262 -KNV---SEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -TTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -ccC---CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence             111   2356688889999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.7e-41  Score=347.25  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=190.1

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--------ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCc
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--------KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  358 (580)
                      .|.+.+.||+|+||.||+|.+. +++.||||++.....        .....+.+|+.++++++||||+++++++..  +.
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~  213 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--ED  213 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--SE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--Cc
Confidence            3667889999999999999986 789999999864321        112347899999999999999999999864  46


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC---CCeEEeecccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS---TNAKISDFGLS  435 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~---~~~kl~Dfg~~  435 (580)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+|||++.+   ..+||+|||++
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             eEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccc
Confidence            89999999999999998764   4689999999999999999999994 99999999999999754   45999999999


Q ss_pred             cccccccccceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC-hhHHHHHHhhhhccc
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAE-LPQWVASIVKEEWTN  511 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~  511 (580)
                      +......  ......||+.|+|||++.   ...++.++||||+||++|+|++|+.||....... ....+..   .... 
T Consensus       290 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~---~~~~-  363 (419)
T 3i6u_A          290 KILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYN-  363 (419)
T ss_dssp             TSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT---TCCC-
T ss_pred             eecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc---CCCC-
Confidence            8765432  223456899999999975   3677889999999999999999999997654332 2222211   1100 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        ..+.....      ....+.+++.+||+.||++|||+.|+++|=
T Consensus       364 --~~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          364 --FIPEVWAE------VSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             --CCHHHHTT------SCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             --CCchhhcc------cCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence              01111111      123567889999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.1e-41  Score=333.75  Aligned_cols=262  Identities=23%  Similarity=0.331  Sum_probs=197.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|.+. +|+.||+|++......  ..+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   83 (311)
T 4agu_A            5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLVFEY   83 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEEEEe
Confidence            456789999999999999986 6999999998654332  24567899999999999999999999986 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +++++|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........ .
T Consensus        84 ~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  158 (311)
T 4agu_A           84 CDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y  158 (311)
T ss_dssp             CSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence            9999999988754   3589999999999999999999994 999999999999999999999999999987653322 2


Q ss_pred             eeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc--------ccccch
Q 008031          446 VIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT--------NEVFDL  516 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~  516 (580)
                      .....||..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+....+.........        ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            223468999999998875 67899999999999999999999999876554433333322111000        000000


Q ss_pred             hhhccCC---C----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAP---T----IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~---~----~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .......   .    .+.....+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000   0    00112356788999999999999999999987

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-40  Score=342.19  Aligned_cols=250  Identities=20%  Similarity=0.314  Sum_probs=194.4

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCC--CCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIR--HPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|...+++.||||++.....  ...+.+.+|+.++++++  ||||+++++++.. ++..++|||
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~E  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEEEEe
Confidence            567899999999999999988899999999864432  23467899999999996  5999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                       +.+++|.+++....   .+++..+..++.||+.||+|||+. ||+||||||+|||++ ++.+||+|||+++........
T Consensus       137 -~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          137 -CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             -CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             -cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence             56889999998753   688999999999999999999994 999999999999996 578999999999876543322


Q ss_pred             -ceeeecCccccCCcccccc-----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc
Q 008031          445 -NVIATAGALGYRAPELSKL-----------KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE  512 (580)
Q Consensus       445 -~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  512 (580)
                       ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....  ....+..+....... 
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~~~~~~~-  287 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPNHEI-  287 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHCTTSCC-
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHhCccccC-
Confidence             2234579999999998864           4688899999999999999999999975432  222222222211110 


Q ss_pred             ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                              ..+...  ..++.+++.+||+.||++|||+.|++++-.
T Consensus       288 --------~~~~~~--~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          288 --------EFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             --------CCCCCS--CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             --------CCCccc--hHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence                    111111  235678889999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-40  Score=325.80  Aligned_cols=252  Identities=22%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. .+..++||||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   86 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEY   86 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEEEEe
Confidence            4677899999999999999986 789999999865433 335678999999999999999999999986 6688999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-c
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-V  444 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  444 (580)
                      +++++|.+++...   ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++........ .
T Consensus        87 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           87 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999999753   3689999999999999999999994 999999999999999999999999999986543322 1


Q ss_pred             ceeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ......|+..|+|||.+.+..+ +.++||||+|+++|+|++|+.||.........  ..........   .        +
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~---~--------~  229 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTY---L--------N  229 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHHHTTCTT---S--------T
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhhcccc---c--------C
Confidence            2234568999999999987665 67899999999999999999999876543211  1111111100   0        0


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ........+.+++.+||+.||++|||+.|++++-
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (276)
T 2yex_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (276)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence            0011123566889999999999999999998863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.2e-41  Score=340.40  Aligned_cols=261  Identities=21%  Similarity=0.274  Sum_probs=190.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++.....  ....+.+|+.++++++||||+++++++.. .+..++||||
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~  114 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHRLHLIFEY  114 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCEEEEEEec
Confidence            667899999999999999876 7899999999654332  23467899999999999999999999987 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-----CCCCeEEeeccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-----DSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-----~~~~~kl~Dfg~~~~~~~  440 (580)
                      ++ |+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++     +++.+||+|||+++....
T Consensus       115 ~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          115 AE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             CS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             CC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            97 5999999875   3589999999999999999999995 999999999999994     455699999999986643


Q ss_pred             ccccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch---
Q 008031          441 AANVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL---  516 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  516 (580)
                      ... ......||..|+|||++.+. .++.++||||+||++|||++|+.||......+....+...........+-..   
T Consensus       190 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          190 PIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            322 22334679999999998764 5899999999999999999999999765543322222221110000000000   


Q ss_pred             -hhhccC----C-CcHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 -ELMRDA----P-TIGD-----ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 -~~~~~~----~-~~~~-----~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ......    . ....     ...++.+++.+||+.||++|||+.|+++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence             000000    0 0000     12456789999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.1e-41  Score=356.02  Aligned_cols=251  Identities=26%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      .|...+.||+|+||.||+|... +|+.||||++....   ......+.+|+.++++++||||+++++++.. .+..++||
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~  105 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYLVG  105 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEE
Confidence            5778899999999999999986 79999999986432   2345679999999999999999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee---CCCCCeEEeeccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~  440 (580)
                      ||+.+|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||++   +.++.+||+|||+++....
T Consensus       106 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            999999999999764   3689999999999999999999995 99999999999999   4678899999999986654


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ...  .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+..+...   .+.......   +...+.
T Consensus       182 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~---~~~~~~  252 (484)
T 3nyv_A          182 SKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK---KVEKGKYTF---ELPQWK  252 (484)
T ss_dssp             CCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHCCCCC---CSGGGG
T ss_pred             ccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHcCCCCC---CCcccc
Confidence            332  223569999999999875 69999999999999999999999998765433333   222222110   101111


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                            .....+.+++.+||+.||++|||+.|+++|-.
T Consensus       253 ------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          253 ------KVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             ------GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             ------cCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence                  11235678889999999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.2e-42  Score=351.66  Aligned_cols=241  Identities=17%  Similarity=0.239  Sum_probs=185.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccc---ccccHHHHHHHH---HHHhcCCCCcceeee-------eEEEC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREK---ITKGQREFESEV---SLLGKIRHPNLLALR-------AYYLG  354 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~~  354 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++...   .....+.+.+|+   +.+++++||||++++       +++..
T Consensus        75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~  154 (377)
T 3byv_A           75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  154 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred             EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence            456789999999999999974 7999999998743   223446788999   555666899999998       66654


Q ss_pred             CCC----------------cEEEEEeeCCCCChhhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCC
Q 008031          355 PKG----------------EKLLVFDYMPHGSLATFLHARGP----ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNL  414 (580)
Q Consensus       355 ~~~----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dl  414 (580)
                      .+.                ..++||||+ +|+|.+++...+.    ...+++..+..++.||+.||+|||+. ||+||||
T Consensus       155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDi  232 (377)
T 3byv_A          155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYL  232 (377)
T ss_dssp             TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCC
Confidence            321                378999999 6899999986421    11233578889999999999999995 9999999


Q ss_pred             CCCCeeeCCCCCeEEeecccccccccccccceeeecCccccCCccccccC-----------CCCCcccchhHHHHHHHHH
Q 008031          415 TSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK-----------KANTKTDVYSLGVTILELL  483 (580)
Q Consensus       415 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~l~el~  483 (580)
                      ||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||++|||+
T Consensus       233 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          233 RPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            99999999999999999999985432    2334567 999999999887           8999999999999999999


Q ss_pred             cCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          484 TGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       484 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      +|+.||......+....+..                 ..+..+   .++.+++.+||+.||++|||+.|++++
T Consensus       308 tg~~Pf~~~~~~~~~~~~~~-----------------~~~~~~---~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          308 CADLPITKDAALGGSEWIFR-----------------SCKNIP---QPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HSSCCC------CCSGGGGS-----------------SCCCCC---HHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HCCCCCcccccccchhhhhh-----------------hccCCC---HHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            99999976554332222110                 111222   256678889999999999999999974

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.1e-40  Score=325.22  Aligned_cols=247  Identities=23%  Similarity=0.372  Sum_probs=196.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC---CCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP---KGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|.+. ++..||+|.+.....  ...+.+.+|+.++++++||||+++++++...   ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            345678999999999999986 788999999865432  2345689999999999999999999998642   3458999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccCCCCCCCeeeC-CCCCeEEeecccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLD-DSTNAKISDFGLSRLMT  439 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~  439 (580)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+. +  ++||||||+||+++ .++.+||+|||++....
T Consensus       108 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            9999999999999874   3689999999999999999999994 8  99999999999998 78899999999997544


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..   ......||+.|+|||.+. +.++.++||||+|+++|+|++|+.||.....  ............ ..    ....
T Consensus       184 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~-~~----~~~~  252 (290)
T 1t4h_A          184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV-KP----ASFD  252 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTC-CC----GGGG
T ss_pred             cc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccC-Cc----cccC
Confidence            32   223456899999999887 4689999999999999999999999976432  222222221111 11    1111


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...      ..++.+++.+||+.||.+|||+.|++++
T Consensus       253 ~~~------~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          253 KVA------IPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GCC------CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCC------CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            111      1257788999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=338.40  Aligned_cols=261  Identities=23%  Similarity=0.335  Sum_probs=195.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc-HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|.+. +++.||+|++....... ...+.+|++++++++||||+++++++.. .+..++||||+
T Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~   82 (324)
T 3mtl_A            4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFEYL   82 (324)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEECC
T ss_pred             eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEeccc
Confidence            456789999999999999986 78999999986543221 2245679999999999999999999987 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      + |+|.+++...+  ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........ ..
T Consensus        83 ~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~  157 (324)
T 3mtl_A           83 D-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY  157 (324)
T ss_dssp             S-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             c-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cc
Confidence            6 59999988753  4589999999999999999999994 999999999999999999999999999976543322 22


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc---cch------
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV---FDL------  516 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------  516 (580)
                      ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+...........+   ...      
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            33468999999998876 56899999999999999999999999876654444444333221111000   000      


Q ss_pred             --------hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          517 --------ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       517 --------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                              ......+..   ..++.+++.+||+.||++|||+.|++++=.
T Consensus       238 ~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRL---DSDGADLLTKLLQFEGRNRISAEDAMKHPF  284 (324)
T ss_dssp             CCCCCCCCCHHHHCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             ccccccchhhhhhcCCC---CHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence                    000001111   235668899999999999999999998643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.6e-41  Score=331.60  Aligned_cols=248  Identities=21%  Similarity=0.352  Sum_probs=201.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||+|.+. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   95 (294)
T 2rku_A           17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLE   95 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEEEEe
Confidence            456799999999999999987 688999999865432   234568899999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++........ 
T Consensus        96 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  170 (294)
T 2rku_A           96 LCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-  170 (294)
T ss_dssp             CCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             cCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence            99999999998764   3689999999999999999999995 999999999999999999999999999986643322 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......+   ....+......       .   ...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-------~---~~~  237 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYS-------I---PKH  237 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTCCC-------C---CTT
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhhccCC-------C---ccc
Confidence            2223568999999999998899999999999999999999999997654322   22221111110       0   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      .+   ..+.+++.+||+.||++|||+.|++++-.
T Consensus       238 ~~---~~~~~li~~~l~~~p~~Rps~~~ll~~~~  268 (294)
T 2rku_A          238 IN---PVAASLIQKMLQTDPTARPTINELLNDEF  268 (294)
T ss_dssp             SC---HHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             cC---HHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            11   25667888999999999999999998753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-40  Score=336.55  Aligned_cols=247  Identities=21%  Similarity=0.359  Sum_probs=201.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |...+.||+|+||.||++.+. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+ .+..++|||
T Consensus        43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  121 (335)
T 2owb_A           43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLE  121 (335)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEe
Confidence            556799999999999999986 688999999865432   234568899999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++........ 
T Consensus       122 ~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  196 (335)
T 2owb_A          122 LCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-  196 (335)
T ss_dssp             CCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             cCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence            99999999998764   3689999999999999999999995 999999999999999999999999999986643322 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......+   ....+......       .   ...
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~-------~---~~~  263 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYS-------I---PKH  263 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC-------C---CTT
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHhcCCCC-------C---Ccc
Confidence            2233568999999999999999999999999999999999999997654322   22222111110       0   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ..   ..+.+++.+||+.||++|||+.|++++-
T Consensus       264 ~~---~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          264 IN---PVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             SC---HHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             CC---HHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            11   2566788899999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.7e-41  Score=336.45  Aligned_cols=258  Identities=17%  Similarity=0.238  Sum_probs=196.5

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECC-CCcEEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGP-KGEKLLVF  363 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv~  363 (580)
                      ..|.+.+.||+|+||.||+|.+. +++.||||+++..   ..+.+.+|+.++++++ ||||+++++++... ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            34677899999999999999875 7899999998643   3567899999999996 99999999999863 34689999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeeccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAA  442 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~  442 (580)
                      ||+++++|.+++..      +++..+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||+++......
T Consensus       113 e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             ECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999998853      78899999999999999999994 999999999999999666 89999999998665433


Q ss_pred             ccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-ChhHHHHHHhhhhcccc-------c
Q 008031          443 NVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGA-ELPQWVASIVKEEWTNE-------V  513 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~-------~  513 (580)
                      .  .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... +....+...........       .
T Consensus       186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            2  223468899999999876 67899999999999999999999999543221 11111111111000000       0


Q ss_pred             cchhh-----------h---ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 FDLEL-----------M---RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 ~~~~~-----------~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .++..           +   ...........++.+++.+||+.||++|||+.|+++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000           0   0000000123467789999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.4e-41  Score=328.79  Aligned_cols=245  Identities=23%  Similarity=0.388  Sum_probs=200.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.. .+..++|||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   94 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLMLE   94 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEEEE
Confidence            566789999999999999986 67889999986432   2234678999999999999999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...+   .+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.......  
T Consensus        95 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  168 (284)
T 2vgo_A           95 FAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--  168 (284)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred             eCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence            999999999998753   589999999999999999999994 99999999999999999999999999987554322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||......+.   ...+.....       ..   .+.
T Consensus       169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~-------~~---~~~  234 (284)
T 2vgo_A          169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---HRRIVNVDL-------KF---PPF  234 (284)
T ss_dssp             -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTTCC-------CC---CTT
T ss_pred             -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH---HHHHhcccc-------CC---CCc
Confidence             2235689999999999999999999999999999999999999976543222   222211110       00   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .+   ..+.+++.+||+.||.+|||+.+++++-
T Consensus       235 ~~---~~~~~li~~~l~~~p~~Rps~~~ll~h~  264 (284)
T 2vgo_A          235 LS---DGSKDLISKLLRYHPPQRLPLKGVMEHP  264 (284)
T ss_dssp             SC---HHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred             CC---HHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence            12   3566788899999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-40  Score=330.97  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=196.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.. ++..++||||++
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   99 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWIMIEFCP   99 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEEECCT
T ss_pred             eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEEEEEeCC
Confidence            567789999999999999986 689999999976666667789999999999999999999999987 568999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +++|.+++....  ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....... ....
T Consensus       100 ~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  175 (302)
T 2j7t_A          100 GGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRD  175 (302)
T ss_dssp             TEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC--
T ss_pred             CCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccc
Confidence            999999987642  4589999999999999999999995 99999999999999999999999999876432221 1122


Q ss_pred             eecCccccCCcccc-----ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          448 ATAGALGYRAPELS-----KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       448 ~~~g~~~y~aPE~~-----~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      ...|+..|+|||.+     .+..++.++||||||+++|+|++|+.||...+..+   ....+.........         
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~---------  243 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKSDPPTLL---------  243 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSCCCCCS---------
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHhccCCcccC---------
Confidence            34689999999987     46778999999999999999999999997654322   22222222111100         


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ........+.+++.+||+.||++|||+.+++++
T Consensus       244 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          244 -TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             001112356788999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-40  Score=349.01  Aligned_cols=260  Identities=16%  Similarity=0.221  Sum_probs=206.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||++.....  ...+.+|+++++.++|++.+..+.++....+..++||||+ 
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            566799999999999999974 799999998764432  3457889999999987655554444444467889999999 


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee---CCCCCeEEeeccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +++|.+++....  ..+++..++.++.||+.||+|||+. ||+||||||+|||+   +.++.+||+|||+++........
T Consensus        86 g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           86 GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            999999998642  4699999999999999999999995 99999999999999   57889999999999876544322


Q ss_pred             ------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          445 ------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       445 ------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                            ......||..|+|||++.+..++.++|||||||++|||++|+.||.........+.+..+.........  ..+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~--~~l  240 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI--EAL  240 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH--HHH
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH--HHH
Confidence                  122457999999999999999999999999999999999999999988776666655554433221110  011


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ....      ..++.+++.+||+.+|++||++.++++.|+++..
T Consensus       241 ~~~~------p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          241 CRGY------PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HTTS------CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hcCC------cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            1111      1367788999999999999999999999998743

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-40  Score=331.63  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=204.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~  102 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYL  102 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEEeC
Confidence            566789999999999999875 789999999865432 345778999999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ ..
T Consensus       103 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  176 (303)
T 3a7i_A          103 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR  176 (303)
T ss_dssp             TTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CB
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCcccc-cc
Confidence            99999999875    3589999999999999999999995 999999999999999999999999999976654322 22


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+   .....      +..   .... 
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~------~~~---~~~~-  243 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI---PKNNP------PTL---EGNY-  243 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCC------CCC---CSSC-
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh---hcCCC------CCC---cccc-
Confidence            3456899999999999999999999999999999999999999765432222211   11110      001   0111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                        ...+.+++.+||+.||++|||+.|++++..-.
T Consensus       244 --~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          244 --SKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             --CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             --CHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence              12567888899999999999999999976543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.5e-41  Score=330.61  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=195.7

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      ..+||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++.. .+..++||||+++++
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVPGGS  105 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCSEEE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEEEeCCCCC
Confidence            458999999999999975 788999999976655556779999999999999999999999986 668999999999999


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-CCCeEEeecccccccccccccceeee
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-STNAKISDFGLSRLMTAAANVNVIAT  449 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~  449 (580)
                      |.+++........+++..+..++.|++.||+|||+. |++||||||+||+++. ++.+||+|||++........ .....
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  183 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF  183 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence            999998764445678899999999999999999994 9999999999999987 89999999999986643222 12235


Q ss_pred             cCccccCCccccccCC--CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          450 AGALGYRAPELSKLKK--ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      .|++.|+|||++.+..  ++.++||||||+++|+|++|+.||..........  ........     .+..   ...   
T Consensus       184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~-----~~~~---~~~---  250 (295)
T 2clq_A          184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM--FKVGMFKV-----HPEI---PES---  250 (295)
T ss_dssp             CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH--HHHHHHCC-----CCCC---CTT---
T ss_pred             CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH--Hhhccccc-----cccc---ccc---
Confidence            6899999999987643  7889999999999999999999997543221111  11000000     0011   111   


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...++.+++.+||+.||++|||+.+++++
T Consensus       251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          251 MSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            12356678889999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-40  Score=339.37  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=199.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--------cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--------GQREFESEVSLLGKI-RHPNLLALRAYYLGPKG  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  357 (580)
                      .|.+.+.||+|+||.||+|.+. +|+.||||++......        ..+.+.+|+.+++++ +||||+++++++.. .+
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~  173 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-SS  173 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-SS
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-CC
Confidence            3556789999999999999986 7999999998654321        134578999999999 89999999999986 66


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence            899999999999999999864   3689999999999999999999995 999999999999999999999999999987


Q ss_pred             cccccccceeeecCccccCCcccccc------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKL------KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      ......  .....||+.|+|||++.+      ..++.++|||||||++|+|++|+.||.......   ....+...... 
T Consensus       250 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~-  323 (365)
T 2y7j_A          250 LEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLRMIMEGQYQ-  323 (365)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCC-
T ss_pred             cCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhCCCC-
Confidence            654322  234578999999998753      368889999999999999999999997644322   22222221111 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        .....+..      ....+.+++.+||+.||++|||+.|++++
T Consensus       324 --~~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          324 --FSSPEWDD------RSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             --CCHHHHSS------SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCccccc------CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              00011111      11356788999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=337.83  Aligned_cols=261  Identities=22%  Similarity=0.395  Sum_probs=204.8

Q ss_pred             HhhhccccccCceEEEEEEe-----CCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-CcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATL-----EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPK-GEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|.+     .+|+.||+|++........+.+.+|++++++++||||+++++++.... ...++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            56679999999999999984     368899999998765555678999999999999999999999987533 368999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++++|.+++....  ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus       123 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             ECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             EECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            99999999999998752  458999999999999999999999 499999999999999999999999999998765433


Q ss_pred             ccc--eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCC---------CC---hhHHHHHHhhhh
Q 008031          443 NVN--VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNG---------AE---LPQWVASIVKEE  508 (580)
Q Consensus       443 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~---------~~---~~~~~~~~~~~~  508 (580)
                      ...  .....++..|+|||.+.+..++.++||||||+++|||++|..||.....         ..   ....+.......
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  279 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence            221  1223567789999999988899999999999999999999999763210         00   000011111110


Q ss_pred             ccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ..           .+.......++.+++.+||+.||++|||+.|+++.|++++++
T Consensus       280 ~~-----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          280 GR-----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             CC-----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC-----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            00           011111223567888899999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.7e-41  Score=333.11  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEEC-CCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLG-PKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|... +|+.||+|.+.....  ...+.+.+|+.++++++||||+++++++.. .....++|||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   87 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   87 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred             eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence            556789999999999999986 789999999865432  234568999999999999999999998854 3457899999


Q ss_pred             eCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----cccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          365 YMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNEN-----IIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-----i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      |+++++|.+++.... ....+++..+..++.|++.||+|||+. +     ++||||||+||+++.++.+||+|||++...
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence            999999999997642 234589999999999999999999994 8     999999999999999999999999998765


Q ss_pred             ccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          439 TAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ...... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+...   .+..+... .     .
T Consensus       167 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~i~~~~~~-~-----~  236 (279)
T 2w5a_A          167 NHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---KIREGKFR-R-----I  236 (279)
T ss_dssp             ---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCCC-C-----C
T ss_pred             cccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH---HHhhcccc-c-----C
Confidence            433221 123468899999999998899999999999999999999999998654322222   22221110 0     0


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                         ....   ..++.+++.+||+.||++|||+.|++++++.-.
T Consensus       237 ---~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          237 ---PYRY---SDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             ---CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             ---Cccc---CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence               0111   235668888999999999999999999876543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-40  Score=326.38  Aligned_cols=245  Identities=23%  Similarity=0.374  Sum_probs=192.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||+|++....   ......+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   91 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFMVME   91 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEEEEe
Confidence            556799999999999999987 79999999986532   2334578999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++....   .+++..+..++.|++.||+|||+. |++|+||||+||+++.++.+||+|||++........ 
T Consensus        92 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  166 (276)
T 2h6d_A           92 YVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-  166 (276)
T ss_dssp             CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             ccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence            999999999997653   589999999999999999999995 999999999999999999999999999986644322 


Q ss_pred             ceeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                       .....+++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||......+   ....+......          ...
T Consensus       167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~----------~~~  232 (276)
T 2h6d_A          167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGVFY----------IPE  232 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCC----------CCT
T ss_pred             -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhcCccc----------Cch
Confidence             223468899999999987765 579999999999999999999997644322   22222111100          011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..   ...+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~---~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          233 YL---NRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hc---CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11   1356678889999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=340.75  Aligned_cols=251  Identities=18%  Similarity=0.234  Sum_probs=200.3

Q ss_pred             HhhhccccccCceEEEEEE------eCCCCEEEEEEccccccccHHHHHHHHHHHhcCC---CCcceeeeeEEECCCCcE
Q 008031          289 CATAEIMGKSTYGTVYKAT------LEDGSQVAVKRLREKITKGQREFESEVSLLGKIR---HPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~  359 (580)
                      |.+.+.||+|+||.||+|.      ..+++.||||+++..   ...++.+|++++++++   |+||+++++++.. .+..
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-~~~~  142 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-QNGS  142 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-SSCE
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-CCCc
Confidence            5567899999999999994      346889999998654   4557788888888887   9999999999987 5689


Q ss_pred             EEEEeeCCCCChhhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-----------CCC
Q 008031          360 LLVFDYMPHGSLATFLHARG--PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-----------STN  426 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-----------~~~  426 (580)
                      ++||||+++|+|.+++....  ....+++..+..++.||+.||+|||+ .||+||||||+|||++.           ++.
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccccccCC
Confidence            99999999999999997532  23569999999999999999999999 59999999999999998           899


Q ss_pred             eEEeecccccccccc-cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHh
Q 008031          427 AKISDFGLSRLMTAA-ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV  505 (580)
Q Consensus       427 ~kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~  505 (580)
                      +||+|||+|+..... .........||+.|+|||++.+..++.++|||||||++|||+||+.||........        
T Consensus       222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--------  293 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------  293 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--------
T ss_pred             EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--------
Confidence            999999999765422 22233456799999999999999999999999999999999999999864332110        


Q ss_pred             hhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHhhhcccc
Q 008031          506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSAR-PEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-ps~~ev~~~L~~~~~~~  564 (580)
                          .   ..... ...+ .   ...+.+++..|++.+|.+| |++.++.+.|+++.++.
T Consensus       294 ----~---~~~~~-~~~~-~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          294 ----K---PEGLF-RRLP-H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----E---ECSCC-TTCS-S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----e---echhc-cccC-c---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                0   00000 0111 1   2244567779999999999 68888999998876654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3e-40  Score=344.34  Aligned_cols=196  Identities=22%  Similarity=0.373  Sum_probs=163.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC----CcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK----GEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++....  ...+.+.+|++++++++||||+++++++....    ...|+
T Consensus        28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  107 (432)
T 3n9x_A           28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI  107 (432)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence            566799999999999999986 688999999975432  23467889999999999999999999997643    56899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||++ |+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus       108 v~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          108 VLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            999995 5999999764   4689999999999999999999995 9999999999999999999999999999876443


Q ss_pred             ccc---------------------ceeeecCccccCCcccc-ccCCCCCcccchhHHHHHHHHHcCCCCC
Q 008031          442 ANV---------------------NVIATAGALGYRAPELS-KLKKANTKTDVYSLGVTILELLTGKSPG  489 (580)
Q Consensus       442 ~~~---------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~tg~~p~  489 (580)
                      ...                     ......||++|+|||++ ....++.++||||+||++|||++|..||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            211                     23456799999999985 5667999999999999999999865554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.7e-41  Score=335.81  Aligned_cols=257  Identities=23%  Similarity=0.374  Sum_probs=182.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   95 (303)
T 2vwi_A           17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-KDELWLVMKLL   95 (303)
T ss_dssp             CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-SSCEEEEEECC
T ss_pred             hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-cCCcEEEehhc
Confidence            556789999999999999875 78999999986543 2334568899999999999999999999987 56899999999


Q ss_pred             CCCChhhhhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          367 PHGSLATFLHAR-----GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       367 ~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ++++|.+++...     .....+++..+..++.||+.||+|||+. |++||||||+||+++.++.+||+|||++......
T Consensus        96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            999999998641     1234589999999999999999999995 9999999999999999999999999998765432


Q ss_pred             cc----cceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc---cc
Q 008031          442 AN----VNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN---EV  513 (580)
Q Consensus       442 ~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  513 (580)
                      ..    .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....   ........   ..
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~  251 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---TLQNDPPSLETGV  251 (303)
T ss_dssp             -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---HHTSSCCCTTC--
T ss_pred             CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---HhccCCCcccccc
Confidence            21    11223468999999999875 5689999999999999999999999987654332221   11111100   00


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .+...   ....   ..++.+++.+||+.||.+|||+.|++++
T Consensus       252 ~~~~~---~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          252 QDKEM---LKKY---GKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             ---CC---CCCC---CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccchh---hhhh---hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            01111   1111   2356788889999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.3e-41  Score=339.59  Aligned_cols=267  Identities=22%  Similarity=0.289  Sum_probs=202.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-------CC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-------KG  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------~~  357 (580)
                      .|.+.+.||+|+||.||+|.+. +|+.||+|++.....  .....+.+|++++++++||||+++++++...       .+
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            3667899999999999999985 799999999865432  2345788999999999999999999999763       34


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ..++||||+++ +|.+.+...  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence            68999999975 787777654  24589999999999999999999994 999999999999999999999999999986


Q ss_pred             ccccc---ccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc-
Q 008031          438 MTAAA---NVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE-  512 (580)
Q Consensus       438 ~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  512 (580)
                      .....   ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+........... 
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            64322   122234568999999998875 5689999999999999999999999987655444444433222111100 


Q ss_pred             --ccchhhh-------ccCCCcHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          513 --VFDLELM-------RDAPTIGDE------LLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       513 --~~~~~~~-------~~~~~~~~~------~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                        .......       .........      ...+.+++.+||+.||++|||+.|++++=.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence              0000000       000111111      134778999999999999999999998743

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.7e-41  Score=328.93  Aligned_cols=253  Identities=22%  Similarity=0.398  Sum_probs=201.6

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEEC-----------
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG-----------  354 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----------  354 (580)
                      ..|...+.||+|+||.||+|.+. +++.||+|.++...    ..+.+|++++++++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            34677899999999999999987 79999999986442    356789999999999999999998853           


Q ss_pred             ----CCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          355 ----PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       355 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                          .....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEEC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCEEEC
Confidence                1234789999999999999997642 34689999999999999999999995 99999999999999999999999


Q ss_pred             ecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc
Q 008031          431 DFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT  510 (580)
Q Consensus       431 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  510 (580)
                      |||++........  .....|++.|+|||.+.+..++.++||||||+++|+|++|..|+...     ......... .. 
T Consensus       165 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~-~~-  235 (284)
T 2a19_B          165 DFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLRD-GI-  235 (284)
T ss_dssp             CCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHHT-TC-
T ss_pred             cchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhhc-cc-
Confidence            9999987654322  22346899999999999999999999999999999999999886321     111111111 10 


Q ss_pred             ccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccc
Q 008031          511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATA  567 (580)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~  567 (580)
                         ..       ...+   ..+.+++.+||+.||++|||+.|++++|+.++......
T Consensus       236 ---~~-------~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          236 ---IS-------DIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             ---CC-------TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             ---cc-------ccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence               00       1111   24667888999999999999999999999998665443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-40  Score=352.30  Aligned_cols=250  Identities=28%  Similarity=0.372  Sum_probs=199.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-------------ccHHHHHHHHHHHhcCCCCcceeeeeEEEC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-------------KGQREFESEVSLLGKIRHPNLLALRAYYLG  354 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  354 (580)
                      |.+.+.||+|+||.||+|.+. +++.||+|++.....             ...+.+.+|+.++++++||||+++++++.+
T Consensus        38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  117 (504)
T 3q5i_A           38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED  117 (504)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            667899999999999999986 688999999865321             234678999999999999999999999987


Q ss_pred             CCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC---CeEEee
Q 008031          355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST---NAKISD  431 (580)
Q Consensus       355 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~---~~kl~D  431 (580)
                       ....++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++   .+||+|
T Consensus       118 -~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          118 -KKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             -CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence             66899999999999999999765   3589999999999999999999994 999999999999998765   699999


Q ss_pred             cccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          432 FGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       432 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      ||++........  .....||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+..+....+   ...... 
T Consensus       193 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~-  265 (504)
T 3q5i_A          193 FGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV---EKGKYY-  265 (504)
T ss_dssp             CTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHCCCC-
T ss_pred             CCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HcCCCC-
Confidence            999987654322  23456999999999987 56999999999999999999999999876543333322   222111 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                        .+...+..   .   ..++.+++.+||+.||.+|||+.|++++-.
T Consensus       266 --~~~~~~~~---~---s~~~~~li~~~L~~dp~~R~t~~e~l~h~~  304 (504)
T 3q5i_A          266 --FDFNDWKN---I---SDEAKELIKLMLTYDYNKRCTAEEALNSRW  304 (504)
T ss_dssp             --CCHHHHTT---S---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             --CCccccCC---C---CHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence              11111111   1   135678888999999999999999998743

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.8e-41  Score=342.57  Aligned_cols=263  Identities=22%  Similarity=0.360  Sum_probs=201.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |...+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.. ++..++||||+
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~  113 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHM  113 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEEEEECCC
T ss_pred             ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEEEEEECC
Confidence            556789999999999999987 789999999875533 234678999999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++...+   .+++..+..++.|++.||+|||+..||+||||||+||+++.++.+||+|||++.......   .
T Consensus       114 ~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~  187 (360)
T 3eqc_A          114 DGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A  187 (360)
T ss_dssp             TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred             CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---c
Confidence            9999999998753   589999999999999999999982289999999999999999999999999987553322   2


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc----------------
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT----------------  510 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------------  510 (580)
                      ....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+....+.........                
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF  267 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence            2356899999999999999999999999999999999999999765433222111100000000                


Q ss_pred             ----------ccccchhhhccCCCc--HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          511 ----------NEVFDLELMRDAPTI--GDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       511 ----------~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                                ....+.......+..  .....++.+++.+||+.||++|||+.|+++|-.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                      000000000000000  011235778899999999999999999998753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=338.11  Aligned_cols=261  Identities=20%  Similarity=0.296  Sum_probs=195.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++.....  ...+.+.+|+++++.++||||+++++++....     ...+
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  106 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY  106 (367)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence            566789999999999999985 799999999864322  23456889999999999999999999997632     3469


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+ +++|.+++...    .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus       107 lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          107 LVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             EEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            999999 88999999763    589999999999999999999994 999999999999999999999999999986543


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh---cccc----
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE---WTNE----  512 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~----  512 (580)
                      .    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.......   ....    
T Consensus       181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            2    223568999999998876 689999999999999999999999998755433222222111000   0000    


Q ss_pred             -----------ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcc
Q 008031          513 -----------VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRP  562 (580)
Q Consensus       513 -----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~  562 (580)
                                 .....+....+.   ....+.+++.+||+.||++|||+.|+++|  ++.+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTN---ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTT---CCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCC---CCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                       000000001111   12356788899999999999999999996  444443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.1e-40  Score=338.09  Aligned_cols=260  Identities=23%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC----CcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPK----GEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++....    ...++|
T Consensus        29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  108 (364)
T 3qyz_A           29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV  108 (364)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence            567899999999999999976 788999999875332 23367889999999999999999999997532    468999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||++ |+|.+++...    .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.......
T Consensus       109 ~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          109 QDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            99996 5999998764    589999999999999999999994 99999999999999999999999999998765432


Q ss_pred             ccc--eeeecCccccCCccccc-cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc---cccch
Q 008031          443 NVN--VIATAGALGYRAPELSK-LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN---EVFDL  516 (580)
Q Consensus       443 ~~~--~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  516 (580)
                      ...  .....||+.|+|||++. +..++.++||||+||++|+|++|+.||...+..+....+..........   ...+.
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            221  23457899999999865 4558999999999999999999999998776655544443322111000   00000


Q ss_pred             ---------------hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          517 ---------------ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       517 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                                     ......+..   ..++.+++.+||+.||++|||+.|++++=
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNA---DSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCC---CHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                           000000111   23567899999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.4e-41  Score=345.13  Aligned_cols=269  Identities=21%  Similarity=0.341  Sum_probs=196.0

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-----cEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG-----EKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~~lv~  363 (580)
                      |...+.||+|+||.||+|.+..+..||+|++.....    ...+|+++++.++||||+++++++.....     ..++||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            567899999999999999998777799998754322    22469999999999999999999965322     278999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCCCeEEeeccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      ||++++.+............+++..+..++.||+.||+|||+. ||+||||||+|||++ .++.+||+|||+++......
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~  196 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE  196 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence            9997754433332222245699999999999999999999994 999999999999999 78999999999998764332


Q ss_pred             ccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc-------cccc
Q 008031          443 NVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT-------NEVF  514 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~  514 (580)
                      .  .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....+.+.......       ....
T Consensus       197 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          197 P--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             C--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             C--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            2  2235689999999988654 5899999999999999999999999876543333222221110000       0000


Q ss_pred             chhhhccCCCc------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcccc
Q 008031          515 DLELMRDAPTI------GDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPEA  564 (580)
Q Consensus       515 ~~~~~~~~~~~------~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~~  564 (580)
                      +.......+..      .....++.+++.+||+.||++|||+.|+++|  +++++...
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence            00000000000      0012367789999999999999999999987  55555433

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-40  Score=364.03  Aligned_cols=246  Identities=22%  Similarity=0.335  Sum_probs=201.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++...   ....+.+..|..++..+ +||+|+++++++.+ .+..|+||
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~~lV~  421 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVM  421 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEEEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEEEEEE
Confidence            556789999999999999986 68899999997542   23446688899999998 79999999999876 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.++++..+   .+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... 
T Consensus       422 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-  496 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-  496 (674)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred             eCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence            9999999999998753   689999999999999999999994 99999999999999999999999999998543222 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++   ...+......       .   ..
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~~~~~-------~---p~  563 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIMEHNVA-------Y---PK  563 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHSSCCC-------C---CT
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH---HHHHHhCCCC-------C---Cc
Confidence            223356799999999999999999999999999999999999999987554333   2333222110       0   11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEV-----LQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ev~~~  556 (580)
                      .   ...++.+++.+||+.||++||++     .|+++|
T Consensus       564 ~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          564 S---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             T---SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             c---CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            1   12356788889999999999998     777764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.9e-41  Score=337.27  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .|...+.||+|+||.||+|.+. +|+.||+|++......  ..+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  104 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLVFE  104 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEEEe
Confidence            3667899999999999999986 6899999998654332  23557899999999999999999999986 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........ 
T Consensus       105 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  179 (331)
T 4aaa_A          105 FVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  179 (331)
T ss_dssp             CCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence            99999888876653   3589999999999999999999994 999999999999999999999999999976544322 


Q ss_pred             ceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh------------hccc
Q 008031          445 NVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE------------EWTN  511 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------------~~~~  511 (580)
                      ......|+..|+|||.+.+. .++.++||||+||++|+|++|+.||......+....+......            ....
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            22345689999999998765 7899999999999999999999999876543322222211100            0000


Q ss_pred             cccchhhh------ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          512 EVFDLELM------RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       512 ~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ....+...      ...+.   ....+.+++.+||+.||++|||+.|++++-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPK---LSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTT---SCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             cccCccccccchhhhcccc---hhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            00000000      00111   124577889999999999999999999863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-40  Score=363.76  Aligned_cols=257  Identities=21%  Similarity=0.353  Sum_probs=203.9

Q ss_pred             HHHhhhccccccCceEEEEEEeC----CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      ..|.+.+.||+|+||.||+|.+.    .+..||+|.++..... ..+.+.+|+.++++++||||+++++++.  ++..++
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~l  467 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWI  467 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCceEE
Confidence            34667889999999999999874    2457999998754332 3467899999999999999999999985  457899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999864  24589999999999999999999995 9999999999999999999999999999876554


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+   .......         
T Consensus       545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i---~~~~~~~---------  612 (656)
T 2j0j_A          545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---ENGERLP---------  612 (656)
T ss_dssp             ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HHTCCCC---------
T ss_pred             cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HcCCCCC---------
Confidence            4333334457789999999998999999999999999999997 99999876543333222   2211110         


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ..+..   ...+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus       613 ~~~~~---~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          613 MPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            01111   23566888899999999999999999999998654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.2e-41  Score=332.44  Aligned_cols=259  Identities=26%  Similarity=0.359  Sum_probs=195.1

Q ss_pred             HHhhhccccccCceEEEEEEeC--CCC--EEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE--DGS--QVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .|.+.+.||+|+||.||+|.+.  +++  .||+|+++...   ....+.+.+|++++++++||||+++++++..  +..+
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   96 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPMK   96 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc--CCce
Confidence            3567899999999999999863  333  68999987543   2234678999999999999999999999975  3589


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+++++|.+++....  ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            9999999999999997642  3589999999999999999999995 999999999999999999999999999987654


Q ss_pred             cccc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          441 AANV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       441 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ....  ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+   ....+.......      
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~~------  244 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEGERL------  244 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTSCCCC------
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHHHccCCCC------
Confidence            3322  1223457788999999998889999999999999999999 999997655332   222222211110      


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                        ....   ....++.+++.+||+.||++|||+.++++.|+++.+...
T Consensus       245 --~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  287 (291)
T 1u46_A          245 --PRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM  287 (291)
T ss_dssp             --CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             --CCCc---CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence              0011   122357788899999999999999999999999876543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=329.67  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=198.3

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .|...+.||+|+||.||+|.+. +|+.||+|.+...  .....+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~  106 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVMEYC  106 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEeecC
Confidence            3567889999999999999986 6999999998653  234678999999999999999999999986 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++........ ..
T Consensus       107 ~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~  182 (314)
T 3com_A          107 GAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KR  182 (314)
T ss_dssp             TTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CB
T ss_pred             CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-cc
Confidence            999999999743  24689999999999999999999995 999999999999999999999999999976644322 22


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......   ........ .......         ..
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~-~~~~~~~---------~~  249 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIFMIPTN-PPPTFRK---------PE  249 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHS-CCCCCSS---------GG
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhcC-CCcccCC---------cc
Confidence            34568999999999999999999999999999999999999997654322   11111111 1101000         01


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .....+.+++.+||+.||++|||+.+++++-
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            1123567889999999999999999998854

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.6e-40  Score=338.14  Aligned_cols=261  Identities=21%  Similarity=0.233  Sum_probs=190.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      |...+.||+|+||.||+|.+. +++.||||++.....  ...+.+.+|+.+++.++||||+++++++....     ...+
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            567899999999999999976 788999999865322  23456889999999999999999999997633     2679


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||++ |+|.+++..     .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus       107 lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          107 IVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            9999996 478888863     488999999999999999999995 999999999999999999999999999986543


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc-----------
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW-----------  509 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------  509 (580)
                      ..  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+........           
T Consensus       180 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          180 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             cc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            22  22345689999999999999999999999999999999999999987543222211111000000           


Q ss_pred             ------cccccchhhh---c--cCCC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          510 ------TNEVFDLELM---R--DAPT----IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       510 ------~~~~~~~~~~---~--~~~~----~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                            ..........   .  ..+.    ......++.+++.+||+.||++|||+.|+++|=.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  321 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  321 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence                  0000000000   0  0000    0112456789999999999999999999999753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-40  Score=346.15  Aligned_cols=262  Identities=21%  Similarity=0.305  Sum_probs=192.2

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----CCcEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP-----KGEKLL  361 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~l  361 (580)
                      .|...+.||+|+||.||+|.+. +|+.||||++....    ..+.+|++++++++||||+++++++...     ....++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            3667899999999999999986 69999999986432    2235799999999999999999998542     113679


Q ss_pred             EEeeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-CCeEEeecccccccc
Q 008031          362 VFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-TNAKISDFGLSRLMT  439 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~  439 (580)
                      ||||+++ ++.+.+... .....+++..+..++.||++||+|||+ .||+||||||+|||++.+ +.+||+|||+++...
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            9999975 676665431 223569999999999999999999999 599999999999999955 568999999998664


Q ss_pred             cccccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc-------c
Q 008031          440 AAANVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT-------N  511 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~  511 (580)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.........       .
T Consensus       209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred             cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            3322  2235689999999988754 7899999999999999999999999875533322222211110000       0


Q ss_pred             cccchhhhccCCC------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          512 EVFDLELMRDAPT------IGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       512 ~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ...+..+......      ......++.+|+.+||+.||++|||+.|+++|-
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence            0000000000000      001124677899999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.4e-40  Score=339.42  Aligned_cols=260  Identities=22%  Similarity=0.277  Sum_probs=200.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC--------CCcceeeeeEEEC---CC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR--------HPNLLALRAYYLG---PK  356 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~---~~  356 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++.. ....+.+.+|++++++++        |+||+++++++..   ..
T Consensus        39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~  117 (397)
T 1wak_A           39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG  117 (397)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred             EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence            667899999999999999875 6889999998743 233467889999999985        7889999999873   24


Q ss_pred             CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CcccCCCCCCCeeeCCCC----------
Q 008031          357 GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE-NIIHGNLTSSNVLLDDST----------  425 (580)
Q Consensus       357 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~i~H~Dlk~~Nil~~~~~----------  425 (580)
                      ...++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+ + ||+||||||+|||++.++          
T Consensus       118 ~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          118 THICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             EEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             ceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence            4789999999 667777776542 3468999999999999999999998 5 999999999999999775          


Q ss_pred             ---------------------------------------CeEEeecccccccccccccceeeecCccccCCccccccCCC
Q 008031          426 ---------------------------------------NAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKA  466 (580)
Q Consensus       426 ---------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  466 (580)
                                                             .+||+|||++......    .....||+.|+|||++.+..+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~  270 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGY  270 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCC
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCC
Confidence                                                   7999999999866433    223468999999999999999


Q ss_pred             CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHH---HHHHhh---h---------hccccccch---------------
Q 008031          467 NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQW---VASIVK---E---------EWTNEVFDL---------------  516 (580)
Q Consensus       467 ~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~---~~~~~~---~---------~~~~~~~~~---------------  516 (580)
                      +.++|||||||++|||++|+.||...+..+....   +..+..   .         ......+..               
T Consensus       271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (397)
T 1wak_A          271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL  350 (397)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred             CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence            9999999999999999999999987665442221   111111   0         000000000               


Q ss_pred             --hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 --ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 --~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        .+.............+.+++.+||+.||++|||+.|+++|
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence              0001112234556678899999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-40  Score=345.58  Aligned_cols=261  Identities=22%  Similarity=0.287  Sum_probs=199.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC------CCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI------RHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++... .....+.+|+++++.+      +|+||+++++++.. .+..++
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~l  176 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-RNHICM  176 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-TTEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-CCeEEE
Confidence            667899999999999999876 68899999987532 2345677788888776      57799999999986 568999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC--eEEeecccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN--AKISDFGLSRLMT  439 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~--~kl~Dfg~~~~~~  439 (580)
                      ||||+. ++|.+++.... ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.  +||+|||+++...
T Consensus       177 v~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~  253 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH  253 (429)
T ss_dssp             EECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             EEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence            999995 69999998753 34589999999999999999999994 9999999999999998887  9999999997543


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc---------c
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW---------T  510 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~  510 (580)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+........         .
T Consensus       254 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~  329 (429)
T 3kvw_A          254 QR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA  329 (429)
T ss_dssp             CC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred             Cc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence            32    2235689999999999999999999999999999999999999987654433332222111000         0


Q ss_pred             ccccchhhh--------------------------ccCC---CcHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          511 NEVFDLELM--------------------------RDAP---TIGD-----ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       511 ~~~~~~~~~--------------------------~~~~---~~~~-----~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...++....                          ...+   ....     ....+.+++.+||+.||++|||+.|+++|
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H  409 (429)
T 3kvw_A          330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH  409 (429)
T ss_dssp             HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence            000000000                          0000   0000     12457789999999999999999999986


Q ss_pred             Hh
Q 008031          557 LE  558 (580)
Q Consensus       557 L~  558 (580)
                      =.
T Consensus       410 pw  411 (429)
T 3kvw_A          410 PW  411 (429)
T ss_dssp             TT
T ss_pred             hh
Confidence            43

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=340.60  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=182.6

Q ss_pred             hccccccCceEEEEEEeC---CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEEC-CCCcEEEEEeeCC
Q 008031          292 AEIMGKSTYGTVYKATLE---DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG-PKGEKLLVFDYMP  367 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~  367 (580)
                      +++||+|+||.||+|.+.   +++.||||++....  ....+.+|+.++++++||||+++++++.. .....++||||++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            568999999999999965   57889999986442  23568899999999999999999999964 3557899999996


Q ss_pred             CCChhhhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee----CCCCCeEEeecccccc
Q 008031          368 HGSLATFLHARG------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL----DDSTNAKISDFGLSRL  437 (580)
Q Consensus       368 ~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~----~~~~~~kl~Dfg~~~~  437 (580)
                       |+|.+++....      ....+++..+..++.||+.||+|||+. ||+||||||+|||+    +.++.+||+|||+++.
T Consensus       104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  181 (405)
T 3rgf_A          104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  181 (405)
T ss_dssp             -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred             -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence             58888875321      123489999999999999999999995 99999999999999    6778999999999987


Q ss_pred             cccccc--cceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCC------hhHHHHHHhhh-
Q 008031          438 MTAAAN--VNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAE------LPQWVASIVKE-  507 (580)
Q Consensus       438 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~-  507 (580)
                      ......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......      ....+..+... 
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~  261 (405)
T 3rgf_A          182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  261 (405)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred             cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence            654322  22334578999999999876 458999999999999999999999997654320      01111111110 


Q ss_pred             --hccccccch---------------hhhccCCCcH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          508 --EWTNEVFDL---------------ELMRDAPTIG--------DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       508 --~~~~~~~~~---------------~~~~~~~~~~--------~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                        .....+.+.               ..... ....        .....+.+|+.+||+.||++|||+.|+++|=.-.
T Consensus       262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~  338 (405)
T 3rgf_A          262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTN-CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL  338 (405)
T ss_dssp             CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTT-CCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCCChhhcchhhcCcchhhhhhhccccCCCc-chhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence              000000000               00000 0000        0023567899999999999999999999986543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-40  Score=335.98  Aligned_cols=259  Identities=18%  Similarity=0.286  Sum_probs=200.3

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccccc-----------------HHHHHHHHHHHhcCCCCcceeeeeE
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKG-----------------QREFESEVSLLGKIRHPNLLALRAY  351 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~~~~  351 (580)
                      |.+.+.||+|+||.||+|.+ +|+.||+|.+.......                 .+.+.+|+.++++++||||++++++
T Consensus        33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  111 (348)
T 2pml_X           33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI  111 (348)
T ss_dssp             EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred             eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            56789999999999999999 89999999986543221                 1789999999999999999999999


Q ss_pred             EECCCCcEEEEEeeCCCCChhhh------hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccCCCCCCCeeeCCC
Q 008031          352 YLGPKGEKLLVFDYMPHGSLATF------LHARGPETPIDWPTRMKIIKGMTRGLLHLHS-NENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       352 ~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~i~H~Dlk~~Nil~~~~  424 (580)
                      +.. .+..++||||+++|+|.++      +.... ...+++..+..++.|++.||+|||+ . |++||||||+||+++.+
T Consensus       112 ~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          112 ITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EES-SSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEEECTT
T ss_pred             Eee-CCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChHhEEEcCC
Confidence            987 5689999999999999999      55421 3569999999999999999999998 5 99999999999999999


Q ss_pred             CCeEEeecccccccccccccceeeecCccccCCccccccC-CCCC-cccchhHHHHHHHHHcCCCCCCCCCCCChhHHHH
Q 008031          425 TNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK-KANT-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~  502 (580)
                      +.+||+|||++......   ......|+..|+|||.+.+. .++. ++||||+|+++|||++|+.||......  .....
T Consensus       189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~  263 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELFN  263 (348)
T ss_dssp             SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHHH
T ss_pred             CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHH
Confidence            99999999999865433   23345689999999999877 6666 999999999999999999999876542  12222


Q ss_pred             HHhhhhccccc----cchhhhcc--CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          503 SIVKEEWTNEV----FDLELMRD--APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       503 ~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .+.........    ........  ..........+.+++.+||+.||.+|||+.|++++
T Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22211110000    00000000  00001112356788889999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.3e-40  Score=328.94  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=194.2

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--------ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCc
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--------KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGE  358 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  358 (580)
                      .|.+.+.||+|+||.||+|.+. +++.||||++.....        .....+.+|++++++++||||+++++++..  +.
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~   88 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--ED   88 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--SS
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--Cc
Confidence            4778899999999999999986 688999999864321        122358899999999999999999999975  35


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC---eEEeecccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLS  435 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~---~kl~Dfg~~  435 (580)
                      .++||||+++++|.+++...   ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.   +||+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            89999999999999998754   4689999999999999999999995 9999999999999986654   999999999


Q ss_pred             cccccccccceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-ChhHHHHHHhhhhccc
Q 008031          436 RLMTAAANVNVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLTGKSPGEPLNGA-ELPQWVASIVKEEWTN  511 (580)
Q Consensus       436 ~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~  511 (580)
                      ........  .....||+.|+|||++.   ...++.++|||||||++|+|++|+.||...... .....+..   .... 
T Consensus       165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~-  238 (322)
T 2ycf_A          165 KILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYN-  238 (322)
T ss_dssp             EECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCC-
T ss_pred             eecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---Cccc-
Confidence            87643321  12346899999999863   567889999999999999999999999765443 22222211   1100 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ..+.....      ....+.+++.+||+.||++|||+.+++++
T Consensus       239 --~~~~~~~~------~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          239 --FIPEVWAE------VSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             --CCHHHHTT------SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --cCchhhhh------cCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence              01111111      12356788999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.2e-40  Score=326.46  Aligned_cols=249  Identities=25%  Similarity=0.363  Sum_probs=199.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---------ccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---------KGQREFESEVSLLGKIR-HPNLLALRAYYLGPKG  357 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  357 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++.....         ...+.+.+|+++++++. ||||+++++++.. ++
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~   97 (298)
T 1phk_A           19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NT   97 (298)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred             cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc-CC
Confidence            556789999999999999986 689999999864321         12346789999999995 9999999999986 66


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||+|||+. |++||||+|+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           98 FFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            899999999999999999864   3689999999999999999999995 999999999999999999999999999986


Q ss_pred             cccccccceeeecCccccCCccccc------cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          438 MTAAANVNVIATAGALGYRAPELSK------LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      ......  .....+++.|+|||++.      ...++.++||||||+++|+|++|+.||...+..+   ....+.......
T Consensus       174 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~  248 (298)
T 1phk_A          174 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIMSGNYQF  248 (298)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCCC
T ss_pred             cCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHHHHhcCCccc
Confidence            654322  23356899999999874      4568899999999999999999999997654322   222222221110


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         .      .+........+.+++.+||+.||++|||+.|++++
T Consensus       249 ---~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          249 ---G------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             ---C------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---C------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence               0      01111122367788999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-40  Score=335.98  Aligned_cols=259  Identities=23%  Similarity=0.288  Sum_probs=182.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----CCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-----KGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~  360 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++.....  ...+.+.+|+++++.++||||+++++++...     ....+
T Consensus        31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~  110 (367)
T 2fst_X           31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY  110 (367)
T ss_dssp             EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence            567899999999999999975 789999999865322  2345688999999999999999999999753     24579


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +|+||+ +++|.+++..    ..+++..+..++.||++||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus       111 lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          111 LVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             EEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             EEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            999999 7899998875    358999999999999999999999 4999999999999999999999999999986543


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh---ccccccch
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE---WTNEVFDL  516 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  516 (580)
                      .    .....||..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.......   ....+...
T Consensus       185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            2    234568999999999876 678999999999999999999999998765433333322221110   00000000


Q ss_pred             -------hhhccCCCcH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          517 -------ELMRDAPTIG-----DELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       517 -------~~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                             .+........     .....+.+++.+||+.||++|||+.|+++|-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence                   0000000000     0123567899999999999999999999873

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.9e-40  Score=323.14  Aligned_cols=247  Identities=18%  Similarity=0.286  Sum_probs=195.4

Q ss_pred             HHHHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEE
Q 008031          286 DLLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       286 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  361 (580)
                      ...|...+.||+|+||.||+|.+. +++.||+|+++....  .....+.+|+..+.++ +||||+++++++.+ ++..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEE
Confidence            345778899999999999999986 799999999875432  3346788999999999 99999999999986 668999


Q ss_pred             EEeeCCCCChhhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC----------------
Q 008031          362 VFDYMPHGSLATFLHARGP-ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS----------------  424 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~----------------  424 (580)
                      ||||+++++|.+++..... ...+++..+..++.||+.||+|||+. ||+||||||+||+++.+                
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            9999999999999976421 24689999999999999999999994 99999999999999844                


Q ss_pred             ---CCeEEeecccccccccccccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHH
Q 008031          425 ---TNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQW  500 (580)
Q Consensus       425 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~  500 (580)
                         ..+||+|||.+.......     ...||..|+|||.+.+. .++.++|||||||++|+|++|..|+....   .   
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~---  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q---  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H---
T ss_pred             CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H---
Confidence               479999999998665432     23489999999998765 56679999999999999999998764321   1   


Q ss_pred             HHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          501 VASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ...+......      ..   ....+   ..+.+++.+||+.||++|||+.|++++-
T Consensus       237 ~~~~~~~~~~------~~---~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          237 WHEIRQGRLP------RI---PQVLS---QEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             HHHHHTTCCC------CC---SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             HHHHHcCCCC------CC---CcccC---HHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            1111111110      00   11112   3566788899999999999999998763

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-40  Score=339.39  Aligned_cols=258  Identities=19%  Similarity=0.278  Sum_probs=192.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC------------
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP------------  355 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------------  355 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++....    ....+|+++++.++||||+++++++...            
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            567899999999999999975 79999999886432    2234799999999999999999998542            


Q ss_pred             -------------------------CCcEEEEEeeCCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCc
Q 008031          356 -------------------------KGEKLLVFDYMPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNENI  409 (580)
Q Consensus       356 -------------------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i  409 (580)
                                               ....++||||++ |+|.+.+... .....+++..+..++.||+.||+|||+ .||
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi  162 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGI  162 (383)
T ss_dssp             -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTE
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcC
Confidence                                     223789999997 5888777642 123569999999999999999999999 499


Q ss_pred             ccCCCCCCCeeeC-CCCCeEEeecccccccccccccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCC
Q 008031          410 IHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKS  487 (580)
Q Consensus       410 ~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~  487 (580)
                      +||||||+||+++ +++.+||+|||+++.......  .....+|+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            9999999999997 688999999999986644332  2235689999999988764 58999999999999999999999


Q ss_pred             CCCCCCCCChhHHHHHHhhhhccccc-------cc--------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 008031          488 PGEPLNGAELPQWVASIVKEEWTNEV-------FD--------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQ  552 (580)
Q Consensus       488 p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e  552 (580)
                      ||.+.+..+....+...........+       .+        .......+.  .....+.+++.+||+.||++|||+.|
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE--GTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCT--TCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCC--CCCHHHHHHHHHHccCChhhCCCHHH
Confidence            99876544333332221111000000       00        000000000  11235678999999999999999999


Q ss_pred             HHHH
Q 008031          553 VVQQ  556 (580)
Q Consensus       553 v~~~  556 (580)
                      +++|
T Consensus       319 ~l~h  322 (383)
T 3eb0_A          319 AMAH  322 (383)
T ss_dssp             HHTS
T ss_pred             HhcC
Confidence            9975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=332.71  Aligned_cols=260  Identities=19%  Similarity=0.292  Sum_probs=194.8

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|.+.+  .||+|+++....  ...+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e~~  111 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-PPHLAIITSLC  111 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-SSCEEEECBCC
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCceEEEeecc
Confidence            5567999999999999998863  499999865432  233567889999999999999999999987 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc----
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA----  442 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~----  442 (580)
                      ++++|.+++...  ...+++..+..++.||+.||+|||+. |++||||||+||+++ ++.+||+|||+++......    
T Consensus       112 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~  187 (319)
T 2y4i_B          112 KGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR  187 (319)
T ss_dssp             CSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred             cCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence            999999999764  34689999999999999999999995 999999999999998 5789999999987553211    


Q ss_pred             ccceeeecCccccCCcccccc---------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          443 NVNVIATAGALGYRAPELSKL---------KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||......+...   .+.... ....
T Consensus       188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~-~~~~  263 (319)
T 2y4i_B          188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW---QMGTGM-KPNL  263 (319)
T ss_dssp             CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH---HHHTTC-CCCC
T ss_pred             ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HhccCC-CCCC
Confidence            112223458899999998764         457889999999999999999999997654332222   211111 1110


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccccccC
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAATAAT  569 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~~~~  569 (580)
                      ..    ...+      .++.+++.+||+.||++|||+.++++.|+++..+......
T Consensus       264 ~~----~~~~------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~  309 (319)
T 2y4i_B          264 SQ----IGMG------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH  309 (319)
T ss_dssp             CC----SSCC------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------
T ss_pred             Cc----CCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCC
Confidence            00    0111      2566888999999999999999999999999877655443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1e-40  Score=341.47  Aligned_cols=252  Identities=12%  Similarity=0.089  Sum_probs=177.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHH---HHHhcCCCCcceeee-------eEEEC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEV---SLLGKIRHPNLLALR-------AYYLG  354 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~~  354 (580)
                      |...+.||+|+||.||+|.+. +|+.||||+++....   ...+.+.+|+   ..++. +||||++++       +++..
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence            456789999999999999976 789999999976543   2344577785   45555 799987754       44432


Q ss_pred             CC----------------CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCcccC
Q 008031          355 PK----------------GEKLLVFDYMPHGSLATFLHARGPETPIDWPTR------MKIIKGMTRGLLHLHSNENIIHG  412 (580)
Q Consensus       355 ~~----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~i~H~  412 (580)
                      ..                ...++||||++ |+|.+++...+  ..+.+..+      ..++.||+.||+|||+. ||+||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~ivHr  218 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHG  218 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCccC
Confidence            11                23799999998 89999998642  12444555      68889999999999994 99999


Q ss_pred             CCCCCCeeeCCCCCeEEeecccccccccccccceeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCC
Q 008031          413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGE  490 (580)
Q Consensus       413 Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~  490 (580)
                      ||||+|||++.++.+||+|||+++......    ....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999998654322    13457799999999987  789999999999999999999999998


Q ss_pred             CCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          491 PLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .........+............   ... ...+..   ...+.+++.+||+.||++|||+.|++++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDS---LAF-GSCTPL---PDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCS---CCC-TTSSCC---CHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CcCcccccchhhhhhhhccccc---cch-hhccCC---CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            7643321111000000000000   000 001122   2356678889999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.5e-40  Score=333.25  Aligned_cols=263  Identities=24%  Similarity=0.294  Sum_probs=192.2

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccc-----------cHHHHHHHHHHHhcCCCCcceeeeeEEECC--
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK-----------GQREFESEVSLLGKIRHPNLLALRAYYLGP--  355 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--  355 (580)
                      |.+.+.||+|+||.||+|.+.+|+.||||++......           ..+.+.+|++++++++||||+++++++...  
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (362)
T 3pg1_A           24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE  103 (362)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred             eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence            5567899999999999999988999999998643321           126789999999999999999999998642  


Q ss_pred             --CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecc
Q 008031          356 --KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFG  433 (580)
Q Consensus       356 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg  433 (580)
                        ....++||||++ |+|.+++...  ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          104 PAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             CCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCCCEEEEecC
Confidence              235799999997 6888888754  34689999999999999999999995 99999999999999999999999999


Q ss_pred             cccccccccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc
Q 008031          434 LSRLMTAAANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE  512 (580)
Q Consensus       434 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  512 (580)
                      ++........  .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+....+...........
T Consensus       180 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          180 LAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            9975443322  233568899999998876 6789999999999999999999999987654333333222111100000


Q ss_pred             -----------ccchhhhccCCCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          513 -----------VFDLELMRDAPTI-----GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       513 -----------~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                                 .............     ......+.+++.+||+.||++|||+.|+++|-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence                       0000000000000     01123567899999999999999999999863

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=329.14  Aligned_cols=250  Identities=23%  Similarity=0.377  Sum_probs=192.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECC-----CCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGP-----KGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++++ +||||+++++++...     .+..++
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            556799999999999999985 78999999986432 3456789999999999 899999999999763     357899


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. |++||||||+||+++.++.+||+|||++......
T Consensus       105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  182 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  182 (326)
T ss_dssp             EEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred             EEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence            999999999999998642 34689999999999999999999995 9999999999999999999999999998865432


Q ss_pred             cccceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          442 ANVNVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      .. ......|++.|+|||++.     +..++.++|||||||++|+|++|+.||......+.   ...+...... ..   
T Consensus       183 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-~~---  254 (326)
T 2x7f_A          183 VG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNPAP-RL---  254 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSCCC-CC---
T ss_pred             cc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhhcCccc-cC---
Confidence            22 222346899999999986     56788999999999999999999999976543221   1111111110 00   


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          .....   ...+.+++.+||+.||++|||+.+++++
T Consensus       255 ----~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          255 ----KSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ----SCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ----Ccccc---CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                01111   1356688889999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-39  Score=320.45  Aligned_cols=249  Identities=27%  Similarity=0.354  Sum_probs=199.2

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .|.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++.. .+..++|||
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e  101 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGE  101 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEEEEEE
Confidence            4677899999999999999986 789999999865432  345678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC---CCeEEeecccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS---TNAKISDFGLSRLMTAA  441 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~~  441 (580)
                      |+++++|.+++....   .+++..+..++.||+.||+|||+. |++||||||+||+++.+   +.+||+|||++......
T Consensus       102 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999987643   589999999999999999999995 99999999999999754   46999999998866443


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ..  .....+++.|+|||.+.+ .++.++||||+|+++|+|++|+.||...+..+.   ...+..+....   +...   
T Consensus       178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~---~~~~---  245 (287)
T 2wei_A          178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRVETGKYAF---DLPQ---  245 (287)
T ss_dssp             SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCCCC---CSGG---
T ss_pred             Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHcCCCCC---Cchh---
Confidence            22  123457889999998875 489999999999999999999999976543322   22222221110   0000   


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....   ..++.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~~---~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          246 WRTI---SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             GTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hhhc---CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0111   2356788889999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-39  Score=327.56  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             HHhhhccccccCceEEEEEEeC--CCCEEEEEEccccccc--cHHHHHHHHHHHhcC---CCCcceeeeeEEEC----CC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE--DGSQVAVKRLREKITK--GQREFESEVSLLGKI---RHPNLLALRAYYLG----PK  356 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----~~  356 (580)
                      .|.+.+.||+|+||.||+|.+.  +|+.||+|+++.....  ....+.+|+.+++.+   +||||+++++++..    ..
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            3667899999999999999983  6889999998654322  234566788777766   89999999999872    24


Q ss_pred             CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          357 GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       357 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      ...++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            56899999997 69999998753 33589999999999999999999995 99999999999999999999999999998


Q ss_pred             ccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh----hcccc
Q 008031          437 LMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE----EWTNE  512 (580)
Q Consensus       437 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~  512 (580)
                      ......  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......+....+......    .+...
T Consensus       169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            665332  223456899999999999999999999999999999999999999876543333322221110    01000


Q ss_pred             ccc----------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          513 VFD----------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       513 ~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...          .......+..   ...+.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKFVTDI---DELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSC---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccchhhhcccCcchhhhccccC---CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000          0000011112   2356678889999999999999999976

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-39  Score=320.80  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=183.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-c-HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-G-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|.+. +|+.||+|+++..... . .+.+.++...++.++||||+++++++.. .+..++||||
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~~lv~e~   87 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDVWICMEL   87 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSEEEEEEC
T ss_pred             hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCEEEEEeh
Confidence            566789999999999999985 7899999998754322 2 2334555566888899999999999987 6689999999


Q ss_pred             CCCCChhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          366 MPHGSLATFLHAR-GPETPIDWPTRMKIIKGMTRGLLHLHSNE-NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       366 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ++ |+|.+++... .....+++..+..++.|++.||+|||+ . |++||||||+||+++.++.+||+|||++........
T Consensus        88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  165 (290)
T 3fme_A           88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA  165 (290)
T ss_dssp             CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred             hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence            97 5888877542 223569999999999999999999998 5 999999999999999999999999999986644322


Q ss_pred             cceeeecCccccCCcccc----ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          444 VNVIATAGALGYRAPELS----KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .  ....||+.|+|||.+    .+..++.++||||+|+++|+|++|+.||.....  ....+...........       
T Consensus       166 ~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-------  234 (290)
T 3fme_A          166 K--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEEPSPQL-------  234 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHSCCCCC-------
T ss_pred             c--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhccCCCCc-------
Confidence            2  234689999999995    566788999999999999999999999975432  2222222222211110       


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                       ....   ...++.+++.+||+.||++|||+.|++++-
T Consensus       235 -~~~~---~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp  268 (290)
T 3fme_A          235 -PADK---FSAEFVDFTSQCLKKNSKERPTYPELMQHP  268 (290)
T ss_dssp             -CTTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             -cccc---CCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence             0011   123567888899999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-39  Score=328.51  Aligned_cols=259  Identities=19%  Similarity=0.274  Sum_probs=201.0

Q ss_pred             HhhhccccccCceEEEEEEe-C-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCC------cceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATL-E-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHP------NLLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~~~  360 (580)
                      |.+.+.||+|+||.||+|.+ . +++.||||+++... ...+.+.+|+++++.++|+      +++++++++.. .+..+
T Consensus        16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-~~~~~   93 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-HGHIC   93 (339)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-TTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-CCcEE
Confidence            56789999999999999987 3 68899999986432 3345688899999888665      49999999986 66899


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-----------------
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-----------------  423 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-----------------  423 (580)
                      +||||+ +++|.+++...+ ...+++..+..++.||+.||+|||+. ||+||||||+||+++.                 
T Consensus        94 lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             EEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            999999 889999998753 34689999999999999999999995 9999999999999987                 


Q ss_pred             --CCCeEEeecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHH
Q 008031          424 --STNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWV  501 (580)
Q Consensus       424 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~  501 (580)
                        ++.+||+|||++.......    ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  246 (339)
T 1z57_A          171 LINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM  246 (339)
T ss_dssp             ESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred             ccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence              6689999999997644322    2346899999999999999999999999999999999999999876544433333


Q ss_pred             HHHhhhhcc--------ccccc--------------------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 008031          502 ASIVKEEWT--------NEVFD--------------------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQV  553 (580)
Q Consensus       502 ~~~~~~~~~--------~~~~~--------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev  553 (580)
                      .........        ...+.                    ...............++.+++.+||+.||++|||+.|+
T Consensus       247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  326 (339)
T 1z57_A          247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA  326 (339)
T ss_dssp             HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence            322211000        00000                    00000011122345678899999999999999999999


Q ss_pred             HHH
Q 008031          554 VQQ  556 (580)
Q Consensus       554 ~~~  556 (580)
                      +++
T Consensus       327 l~h  329 (339)
T 1z57_A          327 LKH  329 (339)
T ss_dssp             TTS
T ss_pred             hcC
Confidence            976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=326.62  Aligned_cols=263  Identities=20%  Similarity=0.262  Sum_probs=191.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEEC-------------
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLG-------------  354 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------------  354 (580)
                      |...+.||+|+||.||+|.+. +|+.||+|++........+.+.+|++++++++||||+++++++..             
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   92 (320)
T 2i6l_A           13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT   92 (320)
T ss_dssp             EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred             eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence            566789999999999999987 589999999876555556778999999999999999999998843             


Q ss_pred             CCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCCCeEEeecc
Q 008031          355 PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFG  433 (580)
Q Consensus       355 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg  433 (580)
                      .....++||||++ |+|.+++..    ..+++..+..++.|++.||+|||+. ||+||||||+||+++ +++.+||+|||
T Consensus        93 ~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           93 ELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             SCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             ccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence            2356799999997 699999865    3589999999999999999999994 999999999999997 56789999999


Q ss_pred             ccccccccccc--ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---
Q 008031          434 LSRLMTAAANV--NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---  507 (580)
Q Consensus       434 ~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---  507 (580)
                      +++........  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..+.+......   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE  246 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence            99876432211  1223457889999998765 67899999999999999999999999876543322222111000   


Q ss_pred             hcccc-------ccchhhhccCCCc----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          508 EWTNE-------VFDLELMRDAPTI----GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       508 ~~~~~-------~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .....       .............    .....++.+++.+||+.||++|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (320)
T 2i6l_A          247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP  307 (320)
T ss_dssp             HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred             hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence            00000       0000000000000    01123577889999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.9e-39  Score=329.85  Aligned_cols=260  Identities=20%  Similarity=0.280  Sum_probs=196.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECC----CCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGP----KGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~~lv  362 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|++++++++||||+++++++...    ....++|
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   92 (353)
T 2b9h_A           13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII   92 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred             eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence            456789999999999999986 789999999864332 2345688999999999999999999988653    2578999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+. |+|.+++...    .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           93 QELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             ECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            99996 6999998763    589999999999999999999995 99999999999999999999999999998664322


Q ss_pred             cc---------ceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc
Q 008031          443 NV---------NVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE  512 (580)
Q Consensus       443 ~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  512 (580)
                      ..         ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+...........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence            11         1223468999999998654 7789999999999999999999999987653322222222111100000


Q ss_pred             ----ccc---------------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          513 ----VFD---------------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       513 ----~~~---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                          ...               .......+..   ..++.+++.+||+.||++|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRV---NPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccC---CHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence                000               0000001111   23567888999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3e-39  Score=331.76  Aligned_cols=260  Identities=23%  Similarity=0.276  Sum_probs=198.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-CC-----cceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-HP-----NLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||+++... .....+..|+.+++.++ |+     +|+++++++.. .+..++
T Consensus        56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~l  133 (382)
T 2vx3_A           56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RNHLCL  133 (382)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-TTEEEE
T ss_pred             EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-CCceEE
Confidence            567789999999999999986 68899999987432 23456778888888874 55     49999999986 568999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccCCCCCCCeeeC--CCCCeEEeeccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-ENIIHGNLTSSNVLLD--DSTNAKISDFGLSRLM  438 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~i~H~Dlk~~Nil~~--~~~~~kl~Dfg~~~~~  438 (580)
                      ||||++ |+|.+++.... ...+++..+..++.|++.||.|||++ .||+||||||+|||++  .++.+||+|||+++..
T Consensus       134 v~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          134 VFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            999995 59999998753 23589999999999999999999952 5999999999999995  4778999999999876


Q ss_pred             ccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc---------
Q 008031          439 TAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW---------  509 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  509 (580)
                      ...    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+........         
T Consensus       212 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  287 (382)
T 2vx3_A          212 GQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK  287 (382)
T ss_dssp             TCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred             ccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence            432    2235689999999999999999999999999999999999999987654443333322111000         


Q ss_pred             ----cccccchh-----------------------------------hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 008031          510 ----TNEVFDLE-----------------------------------LMRDAPTIGDELLNTLKLALHCVDPSPSARPEV  550 (580)
Q Consensus       510 ----~~~~~~~~-----------------------------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~  550 (580)
                          .....+..                                   ..........+..++.+++.+||+.||++|||+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta  367 (382)
T 2vx3_A          288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP  367 (382)
T ss_dssp             HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence                00000000                                   000001122344578899999999999999999


Q ss_pred             HHHHHH
Q 008031          551 LQVVQQ  556 (580)
Q Consensus       551 ~ev~~~  556 (580)
                      .|+++|
T Consensus       368 ~e~L~h  373 (382)
T 2vx3_A          368 YYALQH  373 (382)
T ss_dssp             HHHTTS
T ss_pred             HHHhcC
Confidence            999876

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-39  Score=332.02  Aligned_cols=258  Identities=22%  Similarity=0.306  Sum_probs=193.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-----cEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKG-----EKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~~  360 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++......  ..+.+.+|+.+++.++||||+++++++.....     ..+
T Consensus        44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  123 (371)
T 4exu_A           44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  123 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred             EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence            566789999999999999976 7899999998754322  24578899999999999999999999976332     239


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+. ++|.+++..     .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus       124 lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          124 LVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             EEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             EEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            9999996 688887743     489999999999999999999995 999999999999999999999999999976543


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hccccccch
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTNEVFDL  516 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  516 (580)
                      .    .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+....+......   .......+.
T Consensus       197 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          197 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             C----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            2    233568999999999876 78899999999999999999999999875543333322221110   000000000


Q ss_pred             -------hhhccCCCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          517 -------ELMRDAPTI-----GDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       517 -------~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                             .........     ......+.+++.+||+.||++|||+.|++++=
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence                   000000000     01124677889999999999999999999873

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.5e-39  Score=331.48  Aligned_cols=264  Identities=20%  Similarity=0.256  Sum_probs=185.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC------cEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG------EKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|++.++.++||||+++++++.....      ..++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l  103 (360)
T 3e3p_A           25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV  103 (360)
T ss_dssp             EEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence            667889999999999999986 78999999885432 223456778888899999999999999965221      2789


Q ss_pred             EEeeCCCCChhhhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCcccCCCCCCCeeeCC-CCCeEEeecccccc
Q 008031          362 VFDYMPHGSLATFLHA-RGPETPIDWPTRMKIIKGMTRGLLHLH--SNENIIHGNLTSSNVLLDD-STNAKISDFGLSRL  437 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~  437 (580)
                      ||||+++ +|.+.+.. ......+++..+..++.|++.||.|||  + .||+||||||+||+++. ++.+||+|||+++.
T Consensus       104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~  181 (360)
T 3e3p_A          104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK  181 (360)
T ss_dssp             EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred             Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence            9999976 55544432 223456889999999999999999999  8 59999999999999996 89999999999987


Q ss_pred             cccccccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc-------
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW-------  509 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  509 (580)
                      ......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+....+........       
T Consensus       182 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          182 LSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             CCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            654332  2235689999999988654 489999999999999999999999987654433333322111000       


Q ss_pred             cccccchhhhccC---------CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          510 TNEVFDLELMRDA---------PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       510 ~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .....+.......         ........++.+++.+||+.||++|||+.|+++|-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  316 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP  316 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence            0000000000000         00011235677899999999999999999999873

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.9e-39  Score=317.88  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=189.1

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----------
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP-----------  355 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----------  355 (580)
                      .|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++.+.           
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            4667899999999999999975 7999999998643 23346788999999999999999999988642           


Q ss_pred             -CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccc
Q 008031          356 -KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGL  434 (580)
Q Consensus       356 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~  434 (580)
                       .+..++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence             346789999999999999998642  4578889999999999999999995 999999999999999999999999999


Q ss_pred             cccccccc-------------ccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHH
Q 008031          435 SRLMTAAA-------------NVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQW  500 (580)
Q Consensus       435 ~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~  500 (580)
                      +.......             ........|+..|+|||.+.+. .++.++||||+||++|+|++   ||....  +....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~~~~  237 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ERVNI  237 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hHHHH
Confidence            97654321             1122345688999999998754 78999999999999999998   543211  11111


Q ss_pred             HHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          501 VASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      ...+....   ....+.      ........+.+++.+||+.||.+|||+.+++++-
T Consensus       238 ~~~~~~~~---~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          238 LKKLRSVS---IEFPPD------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             HHHHHSTT---CCCCTT------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             HHhccccc---cccCcc------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence            11111110   000111      1111223567889999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=328.00  Aligned_cols=258  Identities=22%  Similarity=0.307  Sum_probs=193.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCC-----cEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKG-----EKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~~  360 (580)
                      |...+.||+|+||.||+|.+. +|+.||||++......  ..+.+.+|+.++++++||||+++++++.....     ..+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  105 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  105 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence            556789999999999999986 7899999998654322  24568899999999999999999999976332     359


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||++ ++|.+++..     .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus       106 lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          106 LVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             EEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             EEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            9999996 688888753     489999999999999999999995 999999999999999999999999999976543


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhh---hccccccch
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKE---EWTNEVFDL  516 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  516 (580)
                      .    .....+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+......   .......+.
T Consensus       179 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          179 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             C----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            2    223568999999998876 67899999999999999999999999875543322222211100   000000000


Q ss_pred             -----------hhhccC-CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          517 -----------ELMRDA-PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       517 -----------~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                                 ...... ........++.+++.+||+.||++|||+.|++++-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  307 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  307 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence                       000000 00111234667888999999999999999999873

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-39  Score=328.55  Aligned_cols=269  Identities=20%  Similarity=0.293  Sum_probs=203.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CC-CEEEEEEccccccccHHHHHHHHHHHhcCCCCc------ceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DG-SQVAVKRLREKITKGQREFESEVSLLGKIRHPN------LLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~~~  360 (580)
                      |.+.+.||+|+||.||+|.+. ++ +.||+|+++.. ......+.+|+.++++++|++      ++.+++++.. .+..+
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~   98 (355)
T 2eu9_A           21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-HGHMC   98 (355)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-TTEEE
T ss_pred             EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-CCeEE
Confidence            667899999999999999975 44 68999998643 233466888999999987665      8999998876 66899


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeee-------------------
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLL-------------------  421 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~-------------------  421 (580)
                      +||||+ ++++.+++.... ...+++..+..++.||+.||+|||+. ||+||||||+|||+                   
T Consensus        99 lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             EEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccccccccc
Confidence            999999 678888776643 34689999999999999999999994 99999999999999                   


Q ss_pred             CCCCCeEEeecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHH
Q 008031          422 DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWV  501 (580)
Q Consensus       422 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~  501 (580)
                      +.++.+||+|||+++......    ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+
T Consensus       176 ~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM  251 (355)
T ss_dssp             ESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            567889999999997644322    2356899999999999999999999999999999999999999876544433333


Q ss_pred             HHHhhhhcc--------cccc-c-------------------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 008031          502 ASIVKEEWT--------NEVF-D-------------------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQV  553 (580)
Q Consensus       502 ~~~~~~~~~--------~~~~-~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev  553 (580)
                      .........        .... .                   ...............++.+++.+||+.||++|||+.|+
T Consensus       252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence            322211000        0000 0                   00000011122334578899999999999999999999


Q ss_pred             HHH--Hhhhcccccc
Q 008031          554 VQQ--LEEIRPEAAT  566 (580)
Q Consensus       554 ~~~--L~~~~~~~~~  566 (580)
                      +++  +.++.++...
T Consensus       332 l~hp~f~~~~~~~~~  346 (355)
T 2eu9_A          332 LLHPFFAGLTPEERS  346 (355)
T ss_dssp             TTSGGGGGCCHHHHC
T ss_pred             hcChhhcCCChhhcc
Confidence            976  4444444333

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.2e-39  Score=329.90  Aligned_cols=262  Identities=22%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-----------CCcceeeeeEEECC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-----------HPNLLALRAYYLGP  355 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~~  355 (580)
                      .|.+.+.||+|+||.||+|.+. +++.||||++.... .....+.+|+.++++++           |+||+++++++...
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            3667899999999999999975 78999999987432 23456888999999886           89999999998752


Q ss_pred             C---CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CcccCCCCCCCeeeC------CCC
Q 008031          356 K---GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE-NIIHGNLTSSNVLLD------DST  425 (580)
Q Consensus       356 ~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~i~H~Dlk~~Nil~~------~~~  425 (580)
                      .   ...++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+ + ||+||||||+|||++      ..+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCCcCcc
Confidence            2   2678999999 889999998743 3358999999999999999999999 5 999999999999994      444


Q ss_pred             CeEEeecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh---hHHHH
Q 008031          426 NAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL---PQWVA  502 (580)
Q Consensus       426 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~---~~~~~  502 (580)
                      .+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...+.
T Consensus       176 ~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  251 (373)
T 1q8y_A          176 QIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  251 (373)
T ss_dssp             EEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence            79999999998664332    234689999999999999999999999999999999999999986543221   11111


Q ss_pred             HHhhh--hccc----------ccc-----------------chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 008031          503 SIVKE--EWTN----------EVF-----------------DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQV  553 (580)
Q Consensus       503 ~~~~~--~~~~----------~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev  553 (580)
                      .+...  ....          ..+                 ................++.+++.+||+.||++|||+.|+
T Consensus       252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  331 (373)
T 1q8y_A          252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  331 (373)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence            11110  0000          000                 000111122334556778899999999999999999999


Q ss_pred             HHHH
Q 008031          554 VQQL  557 (580)
Q Consensus       554 ~~~L  557 (580)
                      +++-
T Consensus       332 l~hp  335 (373)
T 1q8y_A          332 VNHP  335 (373)
T ss_dssp             HTCG
T ss_pred             hhCh
Confidence            9864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.2e-39  Score=325.52  Aligned_cols=250  Identities=21%  Similarity=0.307  Sum_probs=168.3

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC---CCcEEEEEeeCC
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP---KGEKLLVFDYMP  367 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~~lv~e~~~  367 (580)
                      .+.||+|+||.||+|.+. +|+.||||++...    .....+....++.++||||+++++++...   ....++||||++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            357999999999999987 7999999998543    22222333445667999999999998652   334789999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeeccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +|+|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.   ++.+||+|||++.......  
T Consensus       110 gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~--  185 (336)
T 3fhr_A          110 GGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--  185 (336)
T ss_dssp             TEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred             CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence            999999998753 34699999999999999999999994 9999999999999986   4559999999997654322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                       .....+|+.|+|||++.+..++.++||||+|+++|+|++|+.||......................  .      ..+.
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~------~~~~  256 (336)
T 3fhr_A          186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG--F------PNPE  256 (336)
T ss_dssp             -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C--C------CTTT
T ss_pred             -cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc--c------Cchh
Confidence             223467999999999988899999999999999999999999997665443322111111110000  0      0000


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                      ......++.+++.+||+.||++|||+.|++++-.
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            1112235678888999999999999999999654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-38  Score=317.58  Aligned_cols=251  Identities=20%  Similarity=0.304  Sum_probs=192.3

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCC--CCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIR--HPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+.+++.||||++.....  .....+.+|++++++++  |+||+++++++.. ++..++|||
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e  108 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME  108 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CCEEEEEEe
Confidence            566789999999999999998899999999864432  23467899999999996  5999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                       +.+++|.+++...   ..+++..+..++.|++.||+|||+. ||+||||||+||++++ +.+||+|||++.........
T Consensus       109 -~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          109 -CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             -CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             -cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence             5588999999875   3689999999999999999999995 9999999999999965 78999999999876443221


Q ss_pred             -ceeeecCccccCCcccccc-----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc
Q 008031          445 -NVIATAGALGYRAPELSKL-----------KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE  512 (580)
Q Consensus       445 -~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  512 (580)
                       ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.....  ....+.......... 
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~-  259 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPNHEI-  259 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHCTTSCC-
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHHHHhccccc-
Confidence             2234468999999999865           4788899999999999999999999975432  122222222211110 


Q ss_pred             ccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 008031          513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEE  559 (580)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~  559 (580)
                          ..   ....   ..++.+++.+||+.||++|||+.|++++-.-
T Consensus       260 ----~~---~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          260 ----EF---PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             ----CC---CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ----CC---cccc---hHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence                00   1111   1356788889999999999999999987543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.3e-39  Score=324.43  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=174.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHH-HHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVS-LLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |...+.||+|+||.||+|.+. +|+.||||+++.... .....+..|+. +++.++||||+++++++.. .+..++||||
T Consensus        24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~~~lv~e~  102 (327)
T 3aln_A           24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGDCWICMEL  102 (327)
T ss_dssp             EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSEEEEEECC
T ss_pred             hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCceEEEEee
Confidence            556789999999999999986 789999999875432 23345556666 7777899999999999987 5689999999


Q ss_pred             CCCCChhhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          366 MPHGSLATFLHAR--GPETPIDWPTRMKIIKGMTRGLLHLHSNE-NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       366 ~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      +++ +|.+++...  .....+++..+..++.|++.||.|||+ . |++||||||+||+++.++.+||+|||+++......
T Consensus       103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  180 (327)
T 3aln_A          103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI  180 (327)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred             cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence            975 888877631  123568999999999999999999998 5 99999999999999999999999999998664332


Q ss_pred             ccceeeecCccccCCcccc----ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          443 NVNVIATAGALGYRAPELS----KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .  .....||+.|+|||.+    .+..++.++||||||+++|+|++|+.||......  ...+......... . .... 
T Consensus       181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~-~-~~~~-  253 (327)
T 3aln_A          181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGDPP-Q-LSNS-  253 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCC-C-CCCC-
T ss_pred             c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCCCC-C-CCCc-
Confidence            2  2234689999999998    5667899999999999999999999999764321  1111111111100 0 0000 


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                        ....   ....+.+++.+||+.||++|||+.+++++-
T Consensus       254 --~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          254 --EERE---FSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             --SSCC---CCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             --cccc---CCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence              0011   123567888899999999999999998864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.8e-39  Score=337.09  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=183.6

Q ss_pred             hhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      ..+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.. ++..++||||++ |
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~~~-g   93 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALELCN-L   93 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCS-E
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEecCC-C
Confidence            35789999999998776678999999998643   235678899999886 89999999999986 668999999995 6


Q ss_pred             ChhhhhhhcCCCCC----CCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC-------------CCeEEeec
Q 008031          370 SLATFLHARGPETP----IDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS-------------TNAKISDF  432 (580)
Q Consensus       370 ~L~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~-------------~~~kl~Df  432 (580)
                      +|.+++........    .++..++.++.||+.||+|||+. ||+||||||+|||++.+             +.+||+||
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            99999986532111    12334678999999999999994 99999999999999754             47999999


Q ss_pred             cccccccccccc---ceeeecCccccCCcccccc-------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHH
Q 008031          433 GLSRLMTAAANV---NVIATAGALGYRAPELSKL-------KKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWV  501 (580)
Q Consensus       433 g~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~  501 (580)
                      |+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......+     
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----  247 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-----  247 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-----
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-----
Confidence            999876543221   1224579999999999865       678999999999999999999 999997543221     


Q ss_pred             HHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          502 ASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..+........     .. ..........++.+++.+||+.||++|||+.|+++|
T Consensus       248 ~~i~~~~~~~~-----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 SNIIRGIFSLD-----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHHHHTCCCCC-----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHhcCCCCcc-----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            11111111100     00 011122344677889999999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.2e-40  Score=327.28  Aligned_cols=239  Identities=20%  Similarity=0.371  Sum_probs=193.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc------cHHHHHHHHHHHhcCC--CCcceeeeeEEECCCCcE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK------GQREFESEVSLLGKIR--HPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~  359 (580)
                      |.+.+.||+|+||.||+|.+. +++.||||.+......      ....+.+|+.++++++  |+||+++++++.. .+..
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-~~~~  123 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-PDSF  123 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-SSEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-CCcE
Confidence            566799999999999999875 7889999998654322      2245678999999996  5999999999987 5689


Q ss_pred             EEEEeeCCC-CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCCCeEEeecccccc
Q 008031          360 LLVFDYMPH-GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRL  437 (580)
Q Consensus       360 ~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~  437 (580)
                      ++|||++.+ ++|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+||+++ +++.+||+|||++..
T Consensus       124 ~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          124 VLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             EEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            999999986 8999999874   368999999999999999999999 5999999999999999 788999999999987


Q ss_pred             cccccccceeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      .....   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....         .......   ..  
T Consensus       200 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~~~~---~~--  262 (320)
T 3a99_A          200 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQV---FF--  262 (320)
T ss_dssp             CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCCC---CC--
T ss_pred             ccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhcccc---cc--
Confidence            65432   223568999999999877665 678999999999999999999996421         1111100   00  


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                           ....+   .++.+++.+||+.||++|||+.|++++-
T Consensus       263 -----~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          263 -----RQRVS---SECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             -----SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             -----cccCC---HHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                 01111   2566888899999999999999999863

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-38  Score=312.94  Aligned_cols=233  Identities=13%  Similarity=0.070  Sum_probs=180.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc---HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG---QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++.......   .+.+.+|+..+++++||||+++++++.. ++..|+|||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e  111 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGGLVVAE  111 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcEEEEEE
Confidence            566789999999999999986 58999999997654322   3678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++++|.++++..     ....++.+++.|++.||+|||+. ||+||||||+||+++.++.+||+++|           
T Consensus       112 ~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          112 WIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             ecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            99999999999642     35567889999999999999994 99999999999999999999998543           


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                                |++       .++.++|||||||++|||++|+.||...+..+.............    ..+.  ...+.
T Consensus       175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~  231 (286)
T 3uqc_A          175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP----IEPA--DIDRD  231 (286)
T ss_dssp             ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCB----CCHH--HHCTT
T ss_pred             ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCC----CChh--hcccC
Confidence                      333       367899999999999999999999987654332211111111100    0000  00111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccccc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT  566 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~~  566 (580)
                      .+   .++.+++.+||+.||++| |+.|+++.|+++......
T Consensus       232 ~~---~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~  269 (286)
T 3uqc_A          232 IP---FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR  269 (286)
T ss_dssp             SC---HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred             CC---HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence            22   256688889999999999 999999999998765543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=330.70  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=182.5

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+ ....++||||+.
T Consensus        26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~~~  101 (432)
T 3p23_A           26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEECCS
T ss_pred             EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEECCC
Confidence            456789999999997655556799999999865322   2356899999999 89999999999986 668899999995


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-----CCCeEEeeccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-----STNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-----~~~~kl~Dfg~~~~~~~~~  442 (580)
                       |+|.+++....  .......+..++.||+.||+|||+. ||+||||||+||+++.     ...+||+|||+++......
T Consensus       102 -g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          102 -ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             -EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             -CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence             69999998653  2344456678999999999999994 9999999999999953     2358899999998765332


Q ss_pred             c--cceeeecCccccCCccccc---cCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          443 N--VNVIATAGALGYRAPELSK---LKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       443 ~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      .  .......||+.|+|||++.   ...++.++||||+||++|||++ |..||.......    ...... .....    
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~~~-~~~~~----  248 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLG-ACSLD----  248 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHHTT-CCCCT----
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHHhc-cCCcc----
Confidence            1  2233457999999999987   4667889999999999999999 999996543211    111111 10000    


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                          ...........+.+++.+||+.||++|||+.|+++|
T Consensus       249 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          249 ----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                001111233456789999999999999999999964

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.6e-38  Score=314.20  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=177.5

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-c-HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-G-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      .|...+.||+|+||.||+|.+. +|+.||||++...... . .+.+.++..+++.++||||+++++++.. .+..++|||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lv~e  104 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDVFIAME  104 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEEEe
Confidence            3566789999999999999986 7999999998654322 2 2334555567888899999999999987 568999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+ ++.+..+....  ...+++..+..++.|++.||+|||+..|++||||||+||+++.++.+||+|||++........ 
T Consensus       105 ~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (318)
T 2dyl_A          105 LM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-  180 (318)
T ss_dssp             CC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence            99 55565555432  246899999999999999999999822899999999999999999999999999976544322 


Q ss_pred             ceeeecCccccCCccccc-----cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          445 NVIATAGALGYRAPELSK-----LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                       .....+++.|+|||.+.     ...++.++||||||+++|||++|+.||.....  ....+..+........       
T Consensus       181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~-------  250 (318)
T 2dyl_A          181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPLL-------  250 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCCC-------
T ss_pred             -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCCC-------
Confidence             22346899999999984     56788999999999999999999999976432  2222233222211100       


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ......   ...+.+++.+||+.||.+|||+.+++++
T Consensus       251 ~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          251 PGHMGF---SGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CSSSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccCCC---CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            000111   2356678889999999999999999885

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-38  Score=341.46  Aligned_cols=272  Identities=24%  Similarity=0.323  Sum_probs=202.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEEC-----CCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLG-----PKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~~  360 (580)
                      .|.+.+.||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|++++++++||||+++++++..     ..+..+
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            3678899999999999999985 789999999875432 334668999999999999999999998754     245679


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC---eEEeecccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN---AKISDFGLSRL  437 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~---~kl~Dfg~~~~  437 (580)
                      +||||+++|+|.+++........+++..+..++.|++.||+|||+ .||+||||||+||+++.++.   +||+|||++..
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            999999999999999876555568999999999999999999999 49999999999999997665   99999999987


Q ss_pred             cccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc----
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV----  513 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  513 (580)
                      ......  .....||+.|+|||.+.+..++.++||||+||++|+|++|+.||.+...  ..+|.............    
T Consensus       174 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~--~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          174 LDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ--PVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             TTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH--HHHSSTTCC------CCSCCC
T ss_pred             cccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc--hhhhhhhhhcccchhhhhhhh
Confidence            654332  2335789999999999999999999999999999999999999975321  11111111000000000    


Q ss_pred             ------cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHhhhcccc
Q 008031          514 ------FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQ-----VVQQLEEIRPEA  564 (580)
Q Consensus       514 ------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e-----v~~~L~~~~~~~  564 (580)
                            +.................+.+++.+||+.||++|||+.|     ..+.++.+....
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence                  000000011112223456778999999999999999988     556666655443

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-39  Score=319.62  Aligned_cols=241  Identities=24%  Similarity=0.412  Sum_probs=190.0

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc------cHHHHHHHHHHHhcC----CCCcceeeeeEEECCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK------GQREFESEVSLLGKI----RHPNLLALRAYYLGPK  356 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~~~~~~~  356 (580)
                      .|.+.+.||+|+||.||+|.+. +++.||||++......      ....+.+|+.++.++    +|+||+++++++.. .
T Consensus        32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~-~  110 (312)
T 2iwi_A           32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET-Q  110 (312)
T ss_dssp             -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred             ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec-C
Confidence            3677899999999999999875 7899999999654321      223456789999888    89999999999876 5


Q ss_pred             CcEEEEEee-CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC-CCCCeEEeeccc
Q 008031          357 GEKLLVFDY-MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGL  434 (580)
Q Consensus       357 ~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~-~~~~~kl~Dfg~  434 (580)
                      +..++|||| +.+++|.+++...+   .+++..+..++.||+.||+|||+. ||+||||||+||+++ .++.+||+|||+
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            678999999 78999999998753   589999999999999999999995 999999999999999 889999999999


Q ss_pred             ccccccccccceeeecCccccCCccccccCCCC-CcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccc
Q 008031          435 SRLMTAAANVNVIATAGALGYRAPELSKLKKAN-TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEV  513 (580)
Q Consensus       435 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  513 (580)
                      +.......   .....|+..|+|||++.+..+. .++||||+|+++|||++|+.||....         .......    
T Consensus       187 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~~----  250 (312)
T 2iwi_A          187 GALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EILEAEL----  250 (312)
T ss_dssp             CEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHTCC----
T ss_pred             hhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHhhhcc----
Confidence            98765432   2235689999999998776664 48999999999999999999996421         1111100    


Q ss_pred             cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          514 FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                         ..   ....   ...+.+++.+||+.||++|||+.|++++-.
T Consensus       251 ---~~---~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          251 ---HF---PAHV---SPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             ---CC---CTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             ---CC---cccC---CHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence               00   1111   235668888999999999999999998644

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.8e-38  Score=344.13  Aligned_cols=238  Identities=19%  Similarity=0.278  Sum_probs=188.6

Q ss_pred             HhhhccccccCceEEEEEEeC--CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCc----EEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE--DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGE----KLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~~l  361 (580)
                      |.+.+.||+|+||.||+|.+.  +|+.||||++..... .....+.+|++++++++||||+++++++...+..    .|+
T Consensus        82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l  161 (681)
T 2pzi_A           82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI  161 (681)
T ss_dssp             EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence            567799999999999999985  689999999865432 3345688999999999999999999999864322    699


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++++|.+++..     .+++.+++.++.||+.||.|||+. ||+||||||+|||++.+ .+||+|||+++.....
T Consensus       162 v~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          162 VMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             EEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            9999999999987754     589999999999999999999995 99999999999999985 8999999999866443


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                           ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+........                      
T Consensus       235 -----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~----------------------  286 (681)
T 2pzi_A          235 -----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------------------  286 (681)
T ss_dssp             -----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT----------------------
T ss_pred             -----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccc----------------------
Confidence                 235689999999998765 4889999999999999999999886432111100                      


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHhhhc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPE-VLQVVQQLEEIR  561 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ev~~~L~~~~  561 (580)
                      ..........+.+++.+||+.||++||+ +.++...|..+.
T Consensus       287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            0000111235778999999999999994 666666666654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1e-36  Score=302.11  Aligned_cols=228  Identities=21%  Similarity=0.293  Sum_probs=173.8

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHH-hcCCCCcceeeeeEEEC---CCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLL-GKIRHPNLLALRAYYLG---PKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~---~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.+. +++.||+|+++.     ...+.+|+.++ +..+||||+++++++..   .....++||||++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            78999999999999985 789999999853     24567888888 55699999999999864   2446899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeeccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      +|+|.+++.... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.   ++.+||+|||++....     
T Consensus        99 ~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----  171 (299)
T 3m2w_A           99 GGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----  171 (299)
T ss_dssp             SCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----
T ss_pred             CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----
Confidence            999999998753 3468999999999999999999999 49999999999999997   7889999999886432     


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                                        +..++.++||||+||++|||++|+.||......+..............  .......   ..
T Consensus       172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---~~  228 (299)
T 3m2w_A          172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--EFPNPEW---SE  228 (299)
T ss_dssp             ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC--SSCHHHH---TT
T ss_pred             ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc--cCCchhc---cc
Confidence                              245677999999999999999999999765433211111100000000  0000000   01


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                         ...++.+++.+||+.||++|||+.|++++-.
T Consensus       229 ---~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~  259 (299)
T 3m2w_A          229 ---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  259 (299)
T ss_dssp             ---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ---CCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence               1235678889999999999999999998744

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.7e-37  Score=315.80  Aligned_cols=240  Identities=18%  Similarity=0.220  Sum_probs=177.3

Q ss_pred             hhhccccccCceEEEEEEeC-CCCEEEEEEcccccc---ccHHHHHHHHHHHhcCCC-Ccceee---------e------
Q 008031          290 ATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRH-PNLLAL---------R------  349 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~~---------~------  349 (580)
                      ...+.||+|+||.||+|.+. +|+.||||+++....   ...+.+.+|+.+++.++| +|....         .      
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  160 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  160 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence            34688999999999999965 799999999873332   235679999999999977 221111         1      


Q ss_pred             ------eEEECC----CCcEEEEEeeCCCCChhhhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCC
Q 008031          350 ------AYYLGP----KGEKLLVFDYMPHGSLATFLHAR----GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLT  415 (580)
Q Consensus       350 ------~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk  415 (580)
                            .++...    ....+++|+++ +++|.++++..    .....+++..+..++.||++||+|||+ .||+|||||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrDiK  238 (413)
T 3dzo_A          161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLR  238 (413)
T ss_dssp             C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSCCC
T ss_pred             CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcc
Confidence                  111110    12356777766 68999998521    123357888999999999999999999 599999999


Q ss_pred             CCCeeeCCCCCeEEeecccccccccccccceeeecCccccCCcccc----------ccCCCCCcccchhHHHHHHHHHcC
Q 008031          416 SSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS----------KLKKANTKTDVYSLGVTILELLTG  485 (580)
Q Consensus       416 ~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~s~G~~l~el~tg  485 (580)
                      |+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++|||||||++|||++|
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             cceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            99999999999999999998765433    233467 999999998          666788899999999999999999


Q ss_pred             CCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          486 KSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       486 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      +.||...+..+....+                . ......+   .++.+++.+||+.||++|||+.+++++
T Consensus       314 ~~Pf~~~~~~~~~~~~----------------~-~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          314 DLPNTDDAALGGSEWI----------------F-RSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             SCCCCTTGGGSCSGGG----------------G-SSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCcchhhhHHHH----------------H-hhcccCC---HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999765432221111                0 0111222   356788889999999999997776543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-36  Score=304.92  Aligned_cols=244  Identities=17%  Similarity=0.158  Sum_probs=182.1

Q ss_pred             HHHhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--------ccHHHHHHHHHHHhcCC---------CCcceeee
Q 008031          287 LLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--------KGQREFESEVSLLGKIR---------HPNLLALR  349 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv~~~  349 (580)
                      -.|.+.+.||+|+||.||+|.+ +|+.||||+++....        ...+.+.+|+.+++.++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4588899999999999999998 689999999975421        22367889999998885         77777776


Q ss_pred             eEEEC-----------------------------CCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 008031          350 AYYLG-----------------------------PKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGL  400 (580)
Q Consensus       350 ~~~~~-----------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l  400 (580)
                      +.+..                             ..+..++||||+++|++.+.+.+    ..+++..+..++.||+.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence            66431                             15689999999999987777644    3589999999999999999


Q ss_pred             HHhh-cCCCcccCCCCCCCeeeCCCC--------------------CeEEeecccccccccccccceeeecCccccCCcc
Q 008031          401 LHLH-SNENIIHGNLTSSNVLLDDST--------------------NAKISDFGLSRLMTAAANVNVIATAGALGYRAPE  459 (580)
Q Consensus       401 ~~LH-~~~~i~H~Dlk~~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE  459 (580)
                      +||| + .||+||||||+|||++.++                    .+||+|||+|+.....      ...||+.|+|||
T Consensus       175 ~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE  247 (336)
T 2vuw_A          175 AVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred             HHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence            9999 8 4999999999999999876                    8999999999866432      246899999999


Q ss_pred             ccccCCCCCcccchhHHHH-HHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhh
Q 008031          460 LSKLKKANTKTDVYSLGVT-ILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALH  538 (580)
Q Consensus       460 ~~~~~~~~~~~Dv~s~G~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  538 (580)
                      ++.+.. +.++||||+|++ .+++++|..||.....  .......+..........      ..+.......++.+++.+
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~dli~~  318 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKC------NTPAMKQIKRKIQEFHRT  318 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCC------CSHHHHHHHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCccc------chhhhhhcCHHHHHHHHH
Confidence            998666 889999998777 8889999999842100  000111111110000000      001112345678899999


Q ss_pred             ccCCCCCCCCCHHHHH-HH
Q 008031          539 CVDPSPSARPEVLQVV-QQ  556 (580)
Q Consensus       539 cl~~~P~~Rps~~ev~-~~  556 (580)
                      ||+.|     |+.|++ +|
T Consensus       319 ~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          319 MLNFS-----SATDLLCQH  332 (336)
T ss_dssp             GGGSS-----SHHHHHHHC
T ss_pred             HhccC-----CHHHHHhcC
Confidence            99976     999988 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=5.7e-30  Score=274.06  Aligned_cols=185  Identities=18%  Similarity=0.109  Sum_probs=128.6

Q ss_pred             cccccCceEEEEEEe-CCCCEEEEEEccccc----------cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEE
Q 008031          294 IMGKSTYGTVYKATL-EDGSQVAVKRLREKI----------TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  361 (580)
                      ..+.|++|.+..++. ..|+.+|+|.+....          ....++|.+|+++|+++ .|+||+++++++.+ ++..||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEE
Confidence            356677776666542 358899999986432          12235689999999999 79999999999987 678999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||++|++|.+++...+   +++..   +|+.||+.||+|+|+ +||+||||||+|||+++++++||+|||+|+.....
T Consensus       320 VMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999998753   45553   588999999999999 59999999999999999999999999999876543


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCC
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP  488 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  488 (580)
                      .. ......||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            22 2234579999999999875 467789999999998887666544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=5.2e-27  Score=249.77  Aligned_cols=183  Identities=15%  Similarity=0.219  Sum_probs=143.7

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEccccccc--------cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK--------GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      .+.||+|+||.||+|... ++.+++|+.......        ..+.+.+|++++++++||||+++..++.. .+..++||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lVm  418 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNKRIMM  418 (540)
T ss_dssp             -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTTEEEE
T ss_pred             CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCccEEEE
Confidence            568999999999999544 788999986432211        12458999999999999999965555554 55779999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++++|.+++..           +..++.|+++||+|||+ ++|+||||||+|||+++  .+||+|||+++.......
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            99999999999875           45899999999999999 49999999999999999  999999999987755332


Q ss_pred             cc------eeeecCccccCCcccccc--CCCCCcccchhHHHHHHHHHcCCCCCC
Q 008031          444 VN------VIATAGALGYRAPELSKL--KKANTKTDVYSLGVTILELLTGKSPGE  490 (580)
Q Consensus       444 ~~------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~  490 (580)
                      ..      .....||+.|||||++..  ..|+..+|+||..+-..+-..++.+|.
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            21      124579999999999886  567788999999988888888777764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.92  E-value=9.4e-25  Score=243.87  Aligned_cols=189  Identities=40%  Similarity=0.667  Sum_probs=150.6

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCcc----------------
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS----------------   65 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~----------------   65 (580)
                      +|+|++|++++.+|..++++++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..                
T Consensus       494 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~  573 (768)
T 3rgz_A          494 WISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGK  573 (768)
T ss_dssp             EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSC
T ss_pred             EEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccc
Confidence            5677777777667777777777777777777777667777777777777777777766555543                


Q ss_pred             ------------------------------------------------------CcCCCCCCEEECcCCCCCcccchhhh
Q 008031           66 ------------------------------------------------------FSNLSSLVSLTLESNNLDDQILDSLD   91 (580)
Q Consensus        66 ------------------------------------------------------~~~l~~L~~L~l~~N~l~~~~~~~~~   91 (580)
                                                                            |..+++|+.|+|++|++++.+|..++
T Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~  653 (768)
T 3rgz_A          574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG  653 (768)
T ss_dssp             EEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGG
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHh
Confidence                                                                  23356778888888888888888899


Q ss_pred             ccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChhh-hhhcCCCc
Q 008031           92 KLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL-ALKFNASS  170 (580)
Q Consensus        92 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~-~~~~~~~~  170 (580)
                      .+++|+.|+|++|+++|.+|..++.+++|++|||++|+++|.+|..+..+++|++||+++|+++|.+|..- ...+....
T Consensus       654 ~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~  733 (768)
T 3rgz_A          654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAK  733 (768)
T ss_dssp             GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGG
T ss_pred             ccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999998753 34677788


Q ss_pred             ccccccccCCCCCCCCCCCCC
Q 008031          171 FVGNIQLCGYSGSTPCPSPPA  191 (580)
Q Consensus       171 ~~~~~~~~~~~~~~~C~s~~~  191 (580)
                      |.||+.+||.+.. .|.....
T Consensus       734 ~~gN~~Lcg~~l~-~C~~~~~  753 (768)
T 3rgz_A          734 FLNNPGLCGYPLP-RCDPSNA  753 (768)
T ss_dssp             GCSCTEEESTTSC-CCCSCC-
T ss_pred             hcCCchhcCCCCc-CCCCCcc
Confidence            9999999998866 7876543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=6.1e-23  Score=197.43  Aligned_cols=157  Identities=24%  Similarity=0.299  Sum_probs=139.7

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      +.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        38 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  117 (251)
T 3m19_A           38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN  117 (251)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCC
Confidence            46899999999877788999999999999999999888888899999999999999999777778889999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      +|++..+..|..+++|+.|+|++|+|++..+..+..+++|++|+|++|++++..+..|..+++|+.|++++|++.+.
T Consensus       118 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          118 QLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             cCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            99887777788899999999999999977777788999999999999999977777889999999999999999876

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.89  E-value=1.2e-23  Score=209.11  Aligned_cols=182  Identities=31%  Similarity=0.536  Sum_probs=121.9

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCC-CCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLS-SLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~   79 (580)
                      ++|+|++|+|++.+|..|.++++|++|+|++|.+++.+|..|..+++|++|+|++|+|++.+|..+..++ +|+.|+|++
T Consensus       104 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~  183 (313)
T 1ogq_A          104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR  183 (313)
T ss_dssp             SEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCS
T ss_pred             CEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcC
Confidence            3677777777777777777777777777777777766777777777777777777777766676676666 677777766


Q ss_pred             CCCCcccchhhh-----------------------ccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccc
Q 008031           80 NNLDDQILDSLD-----------------------KLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPA  136 (580)
Q Consensus        80 N~l~~~~~~~~~-----------------------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  136 (580)
                      |.+++..|..+.                       .+++|+.|+|++|++++.++. +..+++|++|+|++|.+++.+|.
T Consensus       184 N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~  262 (313)
T 1ogq_A          184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ  262 (313)
T ss_dssp             SEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCG
T ss_pred             CeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCCh
Confidence            666655555444                       444555555555555433333 45566677777777777666777


Q ss_pred             cccCcCCCCeeecccccCcCccChhhh-hhcCCCcccccccccCCCCC
Q 008031          137 SFSNLKSLSSFNVSYNNLSGPVPTSLA-LKFNASSFVGNIQLCGYSGS  183 (580)
Q Consensus       137 ~l~~l~~L~~l~l~~n~l~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~  183 (580)
                      .|..+++|+.|++++|++++.+|.... ..+....+.+|+.+||.+..
T Consensus       263 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred             HHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence            777777777777777777777776421 23445556788888886544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=4.1e-24  Score=208.64  Aligned_cols=141  Identities=19%  Similarity=0.228  Sum_probs=114.4

Q ss_pred             hhccccccCceEEEEEEeCCCCEEEEEEccccccc------------------cHHHHHHHHHHHhcCCCCcceeeeeEE
Q 008031          291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK------------------GQREFESEVSLLGKIRHPNLLALRAYY  352 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~~~  352 (580)
                      +.+.||+|+||.||+|.+.+|+.||+|.++.....                  ....+.+|+.++++++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            45899999999999999977999999998643221                  2356889999999999  4 6666655


Q ss_pred             ECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeec
Q 008031          353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDF  432 (580)
Q Consensus       353 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Df  432 (580)
                      ..  +..++||||+++|+|.+ +..         .....++.|++.||+|||+ .||+||||||+|||++ ++.+||+||
T Consensus       171 ~~--~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          171 AW--EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             EE--ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             ec--cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            43  46799999999999998 432         1245799999999999999 5999999999999999 999999999


Q ss_pred             ccccccccccccceeeecCccccCCccccc
Q 008031          433 GLSRLMTAAANVNVIATAGALGYRAPELSK  462 (580)
Q Consensus       433 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  462 (580)
                      |+++.              +..++|||.+.
T Consensus       237 G~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TTCEE--------------TTSTTHHHHHH
T ss_pred             CCCeE--------------CCCCCHHHHHH
Confidence            99863              23478888764

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.88  E-value=7.7e-22  Score=191.90  Aligned_cols=162  Identities=23%  Similarity=0.299  Sum_probs=135.8

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|+...+..|.++++|++|+|++|.|+.+.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        40 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  119 (270)
T 2o6q_A           40 KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN  119 (270)
T ss_dssp             SEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSS
T ss_pred             CEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCC
Confidence            36888889888666668888999999999999988766667788899999999999988766677888899999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +++...+..|..+++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++|++++.++.
T Consensus       120 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  199 (270)
T 2o6q_A          120 QLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEG  199 (270)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             ccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHH
Confidence            99888888888889999999999999876666688889999999999999877677788889999999999998876554


Q ss_pred             hh
Q 008031          161 SL  162 (580)
Q Consensus       161 ~~  162 (580)
                      .+
T Consensus       200 ~~  201 (270)
T 2o6q_A          200 AF  201 (270)
T ss_dssp             TT
T ss_pred             Hh
Confidence            44

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.87  E-value=1.1e-21  Score=192.64  Aligned_cols=161  Identities=25%  Similarity=0.287  Sum_probs=106.5

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCc-CCCCCCccCcCCCCCCEEECcCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNA-INGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      +|+|++|+|++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+ ++...+..|..+++|++|+|++|
T Consensus        36 ~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n  115 (285)
T 1ozn_A           36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC  115 (285)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             EEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCC
Confidence            56777777775555566777777777777777766656666677777777777775 66455666666777777777777


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      .+++..+..+..+++|++|++++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++|.+++..|.
T Consensus       116 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  195 (285)
T 1ozn_A          116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH  195 (285)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             cCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHh
Confidence            77666666666666777777777766655555566666667777776666654444566666666666666666665554


Q ss_pred             hh
Q 008031          161 SL  162 (580)
Q Consensus       161 ~~  162 (580)
                      .+
T Consensus       196 ~~  197 (285)
T 1ozn_A          196 AF  197 (285)
T ss_dssp             TT
T ss_pred             Hc
Confidence            44

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=3e-21  Score=185.57  Aligned_cols=160  Identities=22%  Similarity=0.350  Sum_probs=146.4

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      .++++++|.++ .+|..+.  ++|+.|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        17 ~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n   93 (251)
T 3m19_A           17 KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN   93 (251)
T ss_dssp             TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence            36899999999 7777665  68999999999999888889999999999999999999888888999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +|+...+..|..+++|++|+|++|+|++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++|++++.++.
T Consensus        94 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  173 (251)
T 3m19_A           94 QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG  173 (251)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             cccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence            99988888899999999999999999977777789999999999999999977777899999999999999999987775


Q ss_pred             hhh
Q 008031          161 SLA  163 (580)
Q Consensus       161 ~~~  163 (580)
                      .+.
T Consensus       174 ~~~  176 (251)
T 3m19_A          174 AFD  176 (251)
T ss_dssp             TTT
T ss_pred             HHh
Confidence            553

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.86  E-value=2.2e-21  Score=190.50  Aligned_cols=158  Identities=27%  Similarity=0.306  Sum_probs=139.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..+..|.++++|+.|+|++|.|++..+  ...+++|++|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus        34 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N  110 (290)
T 1p9a_G           34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN  110 (290)
T ss_dssp             CEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCC
Confidence            478999999998778889999999999999999985433  378999999999999998 77888999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++...+..|..+++|+.|++++|+++.. |.
T Consensus       111 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~i-p~  189 (290)
T 1p9a_G          111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI-PK  189 (290)
T ss_dssp             CCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCC-CT
T ss_pred             cCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCcc-Ch
Confidence            99988888899999999999999999977777788999999999999999976667788999999999999999854 44


Q ss_pred             hh
Q 008031          161 SL  162 (580)
Q Consensus       161 ~~  162 (580)
                      .+
T Consensus       190 ~~  191 (290)
T 1p9a_G          190 GF  191 (290)
T ss_dssp             TT
T ss_pred             hh
Confidence            43

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.86  E-value=9e-22  Score=195.66  Aligned_cols=159  Identities=35%  Similarity=0.613  Sum_probs=146.2

Q ss_pred             CEEEecC-CcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQY-NNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~-N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++ |.+.+.+|..|.++++|++|+|++|.+++.+|..|..+++|++|+|++|+|++.+|..|..+++|++|+|++
T Consensus        79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  158 (313)
T 1ogq_A           79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG  158 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred             CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence            4799995 999999999999999999999999999989999999999999999999999999999999999999999999


Q ss_pred             CCCCcccchhhhccC-CCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCcc
Q 008031           80 NNLDDQILDSLDKLH-NLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        80 N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      |.+++..|..+..+. +|+.|++++|++++.+|..+..+. |++|+|++|.+++..+..|..+++|+.|++++|++++.+
T Consensus       159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  237 (313)
T 1ogq_A          159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL  237 (313)
T ss_dssp             SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred             CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence            999989999999998 999999999999988888888887 899999999888888888888888888888888888766


Q ss_pred             Ch
Q 008031          159 PT  160 (580)
Q Consensus       159 p~  160 (580)
                      |.
T Consensus       238 ~~  239 (313)
T 1ogq_A          238 GK  239 (313)
T ss_dssp             GG
T ss_pred             Cc
Confidence            65

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.86  E-value=5.1e-21  Score=186.26  Aligned_cols=158  Identities=25%  Similarity=0.333  Sum_probs=129.5

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      +.|++++|.++ .+ +.+..+++|++|+|++|.+++.  ..+..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        44 ~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  119 (272)
T 3rfs_A           44 DQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN  119 (272)
T ss_dssp             CEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             eeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCC
Confidence            36788888887 33 3588888889999998888853  47888888899999888888777777888888999999888


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++|++++.+|.
T Consensus       120 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  199 (272)
T 3rfs_A          120 QLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDG  199 (272)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             cCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHH
Confidence            88887777788888888999988888877777778888888999998888877777788888888889888888877665


Q ss_pred             hh
Q 008031          161 SL  162 (580)
Q Consensus       161 ~~  162 (580)
                      .+
T Consensus       200 ~~  201 (272)
T 3rfs_A          200 VF  201 (272)
T ss_dssp             TT
T ss_pred             HH
Confidence            44

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.86  E-value=3.4e-21  Score=192.72  Aligned_cols=159  Identities=21%  Similarity=0.363  Sum_probs=130.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcC---------CCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSN---------LSS   71 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~---------l~~   71 (580)
                      ++|+|++|.|+ .+|..++++++|++|+|++|.++ .+|..+..+++|++|+|++|++.+.+|..+..         +++
T Consensus       107 ~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~  184 (328)
T 4fcg_A          107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN  184 (328)
T ss_dssp             SEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTT
T ss_pred             CEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCC
Confidence            47888888888 78888888888999999988888 67888888888888888888877777776654         888


Q ss_pred             CCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeeccc
Q 008031           72 LVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSY  151 (580)
Q Consensus        72 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~  151 (580)
                      |+.|+|++|+++ .+|..+..+++|++|+|++|++++ +|..+..+++|++|+|++|++.+.+|..+..+++|+.|++++
T Consensus       185 L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~  262 (328)
T 4fcg_A          185 LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD  262 (328)
T ss_dssp             CCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTT
T ss_pred             CCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCC
Confidence            888888888887 566778888888888888888884 555688888888888888888888888888888888888888


Q ss_pred             ccCcCccChhhh
Q 008031          152 NNLSGPVPTSLA  163 (580)
Q Consensus       152 n~l~~~~p~~~~  163 (580)
                      |++.+.+|..+.
T Consensus       263 n~~~~~~p~~~~  274 (328)
T 4fcg_A          263 CSNLLTLPLDIH  274 (328)
T ss_dssp             CTTCCBCCTTGG
T ss_pred             CCchhhcchhhh
Confidence            888888776653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.86  E-value=4.5e-21  Score=180.19  Aligned_cols=156  Identities=24%  Similarity=0.346  Sum_probs=143.0

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCC-ccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      .|++++|.++ .+|..+.  ..+++|+|++|.|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            6899999999 6787664  357899999999997754 56899999999999999999877789999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +|++..+..|..+++|++|+|++|+|++..|..+..+++|++|+|++|++++..|..|..+++|+.|++++|++.+..+.
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence            99998888899999999999999999988899999999999999999999988899999999999999999999977664

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.86  E-value=3.9e-21  Score=180.62  Aligned_cols=155  Identities=26%  Similarity=0.397  Sum_probs=142.8

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .+++++|.++ .+|..+.  ++|++|+|++|.|+++.+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|.
T Consensus        15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            5889999999 6787665  689999999999998878899999999999999999998889999999999999999999


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |+.+.+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|.+++..+..|..+++|+.|++++|++.....
T Consensus        92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B           92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            998877888999999999999999998889999999999999999999998888889999999999999999985433

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.85  E-value=1.7e-20  Score=177.48  Aligned_cols=154  Identities=24%  Similarity=0.300  Sum_probs=141.6

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .++.++|.++ .+|..+.  ++|+.|+|++|.|+++.|..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|+
T Consensus        23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~   99 (229)
T 3e6j_A           23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ   99 (229)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence            5789999999 7776664  899999999999998889999999999999999999996666778999999999999999


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |+...+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|++++|++.+..+
T Consensus       100 l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            99888888999999999999999999 778889999999999999999997777889999999999999999997765

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.85  E-value=8.6e-21  Score=186.10  Aligned_cols=162  Identities=29%  Similarity=0.343  Sum_probs=123.8

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCc-cCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNK-ISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++|.|++..+..|.++++|++|+|++|. ++...|..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus        59 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  138 (285)
T 1ozn_A           59 TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD  138 (285)
T ss_dssp             CEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCC
Confidence            367788888876667778888888888888886 7766577777788888888888888766677777788888888888


Q ss_pred             CCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           80 NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        80 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |.++...+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|.+++..|..|..+++|+.|++++|++++.++
T Consensus       139 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  218 (285)
T 1ozn_A          139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT  218 (285)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred             CcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCH
Confidence            88877666667777888888888888876666667777888888888888877667777788888888888888876555


Q ss_pred             hhh
Q 008031          160 TSL  162 (580)
Q Consensus       160 ~~~  162 (580)
                      ..+
T Consensus       219 ~~~  221 (285)
T 1ozn_A          219 EAL  221 (285)
T ss_dssp             HHH
T ss_pred             HHc
Confidence            443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.85  E-value=1.8e-20  Score=182.14  Aligned_cols=159  Identities=23%  Similarity=0.303  Sum_probs=145.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|+...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        64 ~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  143 (270)
T 2o6q_A           64 RLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYN  143 (270)
T ss_dssp             CEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCC
Confidence            47999999999655666799999999999999999877788899999999999999999888888999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      .|+...+..|..+++|+.|+|++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++|++....+
T Consensus       144 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          144 ELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             cCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            9998887789999999999999999998777789999999999999999997777779999999999999999976543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.85  E-value=9.5e-21  Score=189.45  Aligned_cols=158  Identities=23%  Similarity=0.379  Sum_probs=141.8

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|+ .+|+.++++++|++|+|++|.++ .+|..+..+++|++|+|++|+|+ .+|..|.++++|++|+|++|
T Consensus        84 ~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n  160 (328)
T 4fcg_A           84 VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRAC  160 (328)
T ss_dssp             CEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEE
T ss_pred             eEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCC
Confidence            47899999999 78888999999999999999999 78888999999999999999999 78888999999999999998


Q ss_pred             CCCcccchhhhc---------cCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeeccc
Q 008031           81 NLDDQILDSLDK---------LHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSY  151 (580)
Q Consensus        81 ~l~~~~~~~~~~---------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~  151 (580)
                      ++.+..|..+..         +++|++|+|++|+++ .+|..+..+++|++|+|++|.+++ +|..+..+++|+.|++++
T Consensus       161 ~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~  238 (328)
T 4fcg_A          161 PELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRG  238 (328)
T ss_dssp             TTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTT
T ss_pred             CCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcC
Confidence            888888877654         899999999999999 788889999999999999999995 666799999999999999


Q ss_pred             ccCcCccChhhh
Q 008031          152 NNLSGPVPTSLA  163 (580)
Q Consensus       152 n~l~~~~p~~~~  163 (580)
                      |++.+.+|..+.
T Consensus       239 n~~~~~~p~~~~  250 (328)
T 4fcg_A          239 CTALRNYPPIFG  250 (328)
T ss_dssp             CTTCCBCCCCTT
T ss_pred             CcchhhhHHHhc
Confidence            999988887654

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.84  E-value=2.6e-20  Score=181.23  Aligned_cols=158  Identities=27%  Similarity=0.344  Sum_probs=143.9

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++ + +.+.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        66 ~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  143 (272)
T 3rfs_A           66 RYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHN  143 (272)
T ss_dssp             CEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCC
Confidence            479999999995 3 47999999999999999999888888899999999999999999777778899999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ++++..+..+..+++|+.|++++|++++..+..+..+++|++|+|++|.+++..+..+..+++|+.|++++|++.+..|.
T Consensus       144 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  223 (272)
T 3rfs_A          144 QLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  223 (272)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence            99988888889999999999999999988777789999999999999999988888899999999999999999987774

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.84  E-value=7.7e-21  Score=188.49  Aligned_cols=157  Identities=28%  Similarity=0.347  Sum_probs=78.8

Q ss_pred             EEEecCCccccc--ccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCC-ccCcCCCCCCEEECc
Q 008031            2 FLALQYNNLSGR--IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLP-ASFSNLSSLVSLTLE   78 (580)
Q Consensus         2 ~L~L~~N~i~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~   78 (580)
                      +|+|++|.|+..  .+..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|+++
T Consensus        56 ~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~  134 (306)
T 2z66_A           56 KLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS  134 (306)
T ss_dssp             EEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECT
T ss_pred             EEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECC
Confidence            455555555521  2344445555555555555555 234445555555555555555553322 344555555555555


Q ss_pred             CCCCCcccchhhhccCCCCeeeeccccccc-cCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           79 SNNLDDQILDSLDKLHNLSVLNLKRNQISG-HIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        79 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      +|.+++..+..+..+++|++|++++|.+++ ..|..+..+++|++|+|++|.+++..+..|..+++|+.|++++|++++.
T Consensus       135 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  214 (306)
T 2z66_A          135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL  214 (306)
T ss_dssp             TSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             CCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence            555544444445555555555555555543 3444455555555555555555544444555555555555555555544


Q ss_pred             cC
Q 008031          158 VP  159 (580)
Q Consensus       158 ~p  159 (580)
                      .+
T Consensus       215 ~~  216 (306)
T 2z66_A          215 DT  216 (306)
T ss_dssp             CS
T ss_pred             Ch
Confidence            33

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=1.4e-20  Score=175.50  Aligned_cols=156  Identities=22%  Similarity=0.271  Sum_probs=130.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .++++++.++ .+|..+  .++|++|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus        11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~   87 (208)
T 2o6s_A           11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ   87 (208)
T ss_dssp             EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence            5678888888 566544  4588999999999987777778889999999999999986666678889999999999999


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..+..+++|+.|++++|++.+..|.
T Consensus        88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  166 (208)
T 2o6s_A           88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  166 (208)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred             CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence            9877777788899999999999999877777788889999999999999876666788899999999999998877663

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.84  E-value=1.3e-20  Score=210.28  Aligned_cols=161  Identities=37%  Similarity=0.630  Sum_probs=81.9

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|+
T Consensus       398 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~  477 (768)
T 3rgz_A          398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND  477 (768)
T ss_dssp             EEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             EEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence            34444444444444455555555555555555554445555555555555555555554455555555555555555555


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChh
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTS  161 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~  161 (580)
                      +++..|..+..+++|+.|+|++|++++.+|..++.+++|++|+|++|.+++.+|..+..+++|+.|++++|+++|.+|..
T Consensus       478 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~  557 (768)
T 3rgz_A          478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA  557 (768)
T ss_dssp             CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred             ccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence            54444555555555555555555555455555555555555555555555445555555555555555555555544443


Q ss_pred             h
Q 008031          162 L  162 (580)
Q Consensus       162 ~  162 (580)
                      +
T Consensus       558 ~  558 (768)
T 3rgz_A          558 M  558 (768)
T ss_dssp             G
T ss_pred             H
Confidence            3

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.83  E-value=3.3e-20  Score=194.41  Aligned_cols=160  Identities=25%  Similarity=0.296  Sum_probs=104.5

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|+.|+|++|.|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        78 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  157 (452)
T 3zyi_A           78 RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN  157 (452)
T ss_dssp             SEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSC
T ss_pred             cEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCC
Confidence            36777777777666777777777777777777777666677777777777777777777555556777777777777777


Q ss_pred             CCCcccchh-------------------------hhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccc
Q 008031           81 NLDDQILDS-------------------------LDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP  135 (580)
Q Consensus        81 ~l~~~~~~~-------------------------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  135 (580)
                      +|+...+..                         |..+++|+.|+|++|++++. | .+..+++|+.|+|++|.+++..+
T Consensus       158 ~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~  235 (452)
T 3zyi_A          158 PIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRP  235 (452)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECG
T ss_pred             CcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCc
Confidence            766544332                         44455555555555555532 2 34555666666666666665556


Q ss_pred             ccccCcCCCCeeecccccCcCccChhh
Q 008031          136 ASFSNLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus       136 ~~l~~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                      ..|..+++|+.|++++|++++..|..+
T Consensus       236 ~~~~~l~~L~~L~L~~n~l~~~~~~~~  262 (452)
T 3zyi_A          236 GSFHGLSSLKKLWVMNSQVSLIERNAF  262 (452)
T ss_dssp             GGGTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             ccccCccCCCEEEeCCCcCceECHHHh
Confidence            666666666666666666665555443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=1.4e-19  Score=168.70  Aligned_cols=156  Identities=24%  Similarity=0.310  Sum_probs=141.0

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|++|+|++|.|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        31 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N  110 (208)
T 2o6s_A           31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTN  110 (208)
T ss_dssp             SEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCC
Confidence            47999999999766677899999999999999999777778899999999999999999777777899999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +|++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|.+.+       .+++|+.|+++.|+++|.+|.
T Consensus       111 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~  183 (208)
T 2o6s_A          111 QLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRN  183 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBC
T ss_pred             cCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeec
Confidence            9998888888999999999999999997777778999999999999998874       456899999999999999997


Q ss_pred             hhh
Q 008031          161 SLA  163 (580)
Q Consensus       161 ~~~  163 (580)
                      .+.
T Consensus       184 ~~~  186 (208)
T 2o6s_A          184 SAG  186 (208)
T ss_dssp             TTS
T ss_pred             cCc
Confidence            664

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.82  E-value=5e-20  Score=192.32  Aligned_cols=157  Identities=27%  Similarity=0.315  Sum_probs=83.9

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|+|+...+..|.++++|++|+|++|.|+.+.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.
T Consensus        68 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  147 (440)
T 3zyj_A           68 LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP  147 (440)
T ss_dssp             EEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCC
T ss_pred             EEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCc
Confidence            45566666665555555556666666666665555555555555555555555555554444445555555555555555


Q ss_pred             CCcccc-------------------------hhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccc
Q 008031           82 LDDQIL-------------------------DSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPA  136 (580)
Q Consensus        82 l~~~~~-------------------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  136 (580)
                      |+...+                         ..|..+++|+.|+|++|+++ .+| .+..+++|+.|+|++|.+++..+.
T Consensus       148 i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~  225 (440)
T 3zyj_A          148 IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPG  225 (440)
T ss_dssp             CCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTT
T ss_pred             ccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChh
Confidence            543332                         23444555555555555554 222 244455555555555555554455


Q ss_pred             cccCcCCCCeeecccccCcCccCh
Q 008031          137 SFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus       137 ~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      .|..+++|+.|++++|++++..+.
T Consensus       226 ~~~~l~~L~~L~L~~n~l~~~~~~  249 (440)
T 3zyj_A          226 SFQGLMHLQKLWMIQSQIQVIERN  249 (440)
T ss_dssp             TTTTCTTCCEEECTTCCCCEECTT
T ss_pred             hhccCccCCEEECCCCceeEEChh
Confidence            555555555555555555544443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.82  E-value=3.5e-20  Score=183.74  Aligned_cols=178  Identities=22%  Similarity=0.349  Sum_probs=144.0

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCC-ccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++|.|+ .+|..+..+++|++|+|++|.+++..+ ..+..+++|++|++++|++++..+..|..+++|++|+|++
T Consensus        81 ~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  159 (306)
T 2z66_A           81 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG  159 (306)
T ss_dssp             CEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTT
T ss_pred             CEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCC
Confidence            47899999988 577778889999999999999886554 5788889999999999998877888888889999999999


Q ss_pred             CCCCc-ccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCcc
Q 008031           80 NNLDD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        80 N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      |.+++ ..|..+..+++|+.|+|++|++++..|..+..+++|++|+|++|.+++..+..+..+++|+.|++++|++++..
T Consensus       160 n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  239 (306)
T 2z66_A          160 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK  239 (306)
T ss_dssp             CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCS
T ss_pred             CccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccC
Confidence            98876 57778888889999999999998877888888899999999999988766667888889999999999998877


Q ss_pred             Chhhhh---hcCCCcccccccccC
Q 008031          159 PTSLAL---KFNASSFVGNIQLCG  179 (580)
Q Consensus       159 p~~~~~---~~~~~~~~~~~~~~~  179 (580)
                      |..+..   .+......+|+..|.
T Consensus       240 ~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          240 KQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             SSSCCCCCTTCCEEECTTCCEECS
T ss_pred             HHHHHhhhccCCEEEccCCCeecc
Confidence            765542   222333345555554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=6.6e-20  Score=186.03  Aligned_cols=175  Identities=28%  Similarity=0.238  Sum_probs=145.4

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCcccc-CCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLG-RLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++++++|+|+ .+|..+.  ..++.|+|++|.|+++.+..|. .+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   98 (361)
T 2xot_A           22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN   98 (361)
T ss_dssp             EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence            6899999999 6777664  4689999999999988787887 8999999999999999777788999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccc---cCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASF---SNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l---~~l~~L~~l~l~~n~l~~~  157 (580)
                      +|+...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.|++..+..|   ..+++|+.|+|++|+|++.
T Consensus        99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  178 (361)
T 2xot_A           99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL  178 (361)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred             cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence            9998888889999999999999999998888999999999999999999996555555   6799999999999999976


Q ss_pred             cChhhhhh----cCCCcccccccccC
Q 008031          158 VPTSLALK----FNASSFVGNIQLCG  179 (580)
Q Consensus       158 ~p~~~~~~----~~~~~~~~~~~~~~  179 (580)
                      ++..+...    +......+|+..|.
T Consensus       179 ~~~~~~~l~~~~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          179 PLTDLQKLPAWVKNGLYLHNNPLECD  204 (361)
T ss_dssp             CHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred             CHHHhhhccHhhcceEEecCCCccCC
Confidence            55544321    12334456655554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.82  E-value=5e-20  Score=179.78  Aligned_cols=162  Identities=28%  Similarity=0.317  Sum_probs=139.4

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|++++|
T Consensus        31 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n  110 (276)
T 2z62_A           31 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET  110 (276)
T ss_dssp             CEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCC
Confidence            47899999999777778999999999999999999777778999999999999999999777788999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeecccccccc-CCccccCCCCCcEEEccccccCCcccccccCcCCCC----eeecccccCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGH-IPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLS----SFNVSYNNLS  155 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~----~l~l~~n~l~  155 (580)
                      .+++..+..+..+++|++|++++|++++. +|..+..+++|++|+|++|.+++..+..+..+++|+    .|++++|+++
T Consensus       111 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~  190 (276)
T 2z62_A          111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN  190 (276)
T ss_dssp             CCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC
T ss_pred             CccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccc
Confidence            99887777788999999999999999864 588899999999999999999877667777776666    7788888887


Q ss_pred             CccChhh
Q 008031          156 GPVPTSL  162 (580)
Q Consensus       156 ~~~p~~~  162 (580)
                      +..+..+
T Consensus       191 ~~~~~~~  197 (276)
T 2z62_A          191 FIQPGAF  197 (276)
T ss_dssp             EECTTSS
T ss_pred             ccCcccc
Confidence            6655443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.82  E-value=4.2e-20  Score=180.30  Aligned_cols=158  Identities=24%  Similarity=0.325  Sum_probs=116.7

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      ++.++.++. .+|..+.  ++|++|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.+
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l   88 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (276)
T ss_dssp             EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence            445555555 5565543  4678888888888766666777788888888888888766666777788888888888888


Q ss_pred             CcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCc-ccccccCcCCCCeeecccccCcCccChh
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGE-IPASFSNLKSLSSFNVSYNNLSGPVPTS  161 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~l~l~~n~l~~~~p~~  161 (580)
                      ++..+..+..+++|+.|++++|++++..+..+..+++|++|++++|.+++. +|..+..+++|+.|++++|++++..+..
T Consensus        89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~  168 (276)
T 2z62_A           89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  168 (276)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred             CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence            777777777788888888888888766666677788888888888888753 4777788888888888888887665554


Q ss_pred             hh
Q 008031          162 LA  163 (580)
Q Consensus       162 ~~  163 (580)
                      +.
T Consensus       169 ~~  170 (276)
T 2z62_A          169 LR  170 (276)
T ss_dssp             GH
T ss_pred             hh
Confidence            43

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.82  E-value=8.6e-20  Score=205.89  Aligned_cols=82  Identities=27%  Similarity=0.348  Sum_probs=45.6

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|+|++..+..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.
T Consensus       294 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~  373 (844)
T 3j0a_A          294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA  373 (844)
T ss_dssp             EEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCC
T ss_pred             EEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCC
Confidence            45555555555555555555555555555555555555555555555555555555554444455555555555555555


Q ss_pred             CC
Q 008031           82 LD   83 (580)
Q Consensus        82 l~   83 (580)
                      ++
T Consensus       374 l~  375 (844)
T 3j0a_A          374 LT  375 (844)
T ss_dssp             SC
T ss_pred             CC
Confidence            43

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.81  E-value=1.4e-19  Score=189.91  Aligned_cols=90  Identities=23%  Similarity=0.295  Sum_probs=45.9

Q ss_pred             CCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeeccc
Q 008031           72 LVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSY  151 (580)
Q Consensus        72 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~  151 (580)
                      |+.|++++|.+++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++
T Consensus       277 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  356 (455)
T 3v47_A          277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY  356 (455)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCS
T ss_pred             ceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCC
Confidence            44444444444444444555555555555555555544455555555555555555555544444555555555555555


Q ss_pred             ccCcCccChh
Q 008031          152 NNLSGPVPTS  161 (580)
Q Consensus       152 n~l~~~~p~~  161 (580)
                      |++++..|..
T Consensus       357 N~l~~~~~~~  366 (455)
T 3v47_A          357 NHIRALGDQS  366 (455)
T ss_dssp             SCCCEECTTT
T ss_pred             CcccccChhh
Confidence            5555444433

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.81  E-value=2.3e-19  Score=175.97  Aligned_cols=153  Identities=25%  Similarity=0.272  Sum_probs=139.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++. +. ...+++|++|+|++|.|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        58 ~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N  134 (290)
T 1p9a_G           58 TQLNLDRAELTKL-QV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN  134 (290)
T ss_dssp             CEEECTTSCCCEE-EC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCccCcc-cC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence            4799999999954 43 388999999999999999 67888999999999999999999777788999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      +|+...+..|..+++|+.|+|++|+|+...+..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|++...
T Consensus       135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence            999888888999999999999999999777777889999999999999999 6788888889999999999999754

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=5.2e-20  Score=186.76  Aligned_cols=158  Identities=28%  Similarity=0.310  Sum_probs=140.6

Q ss_pred             CEEEecCCccccccccccc-CCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLG-KLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++|+|++..+..+. ++++|+.|+|++|.|+++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus        42 ~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  121 (361)
T 2xot_A           42 ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN  121 (361)
T ss_dssp             SEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCC
Confidence            4799999999977777787 999999999999999988888999999999999999999977777899999999999999


Q ss_pred             CCCCcccchhhhccCCCCeeeeccccccccCCccc---cCCCCCcEEEccccccCCcccccccCcCC--CCeeecccccC
Q 008031           80 NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI---GNISTLTILDLSQNKLSGEIPASFSNLKS--LSSFNVSYNNL  154 (580)
Q Consensus        80 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~~~~~l~~l~~--L~~l~l~~n~l  154 (580)
                      |+|+...+..|..+++|+.|+|++|+|+...+..+   ..+++|+.|+|++|+|++..+..+..++.  |+.|+|++|++
T Consensus       122 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~  201 (361)
T 2xot_A          122 NHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL  201 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCE
T ss_pred             CcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCc
Confidence            99999989999999999999999999996555445   67999999999999999766677888887  48899999999


Q ss_pred             cCcc
Q 008031          155 SGPV  158 (580)
Q Consensus       155 ~~~~  158 (580)
                      ....
T Consensus       202 ~C~C  205 (361)
T 2xot_A          202 ECDC  205 (361)
T ss_dssp             ECCH
T ss_pred             cCCc
Confidence            8543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.81  E-value=1.2e-19  Score=191.68  Aligned_cols=162  Identities=22%  Similarity=0.265  Sum_probs=147.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|++|+|++|.|+++.|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        35 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n  114 (477)
T 2id5_A           35 RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN  114 (477)
T ss_dssp             SEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTS
T ss_pred             cEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCC
Confidence            47999999999877889999999999999999999888999999999999999999999666677899999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      .++...+..|..+++|+.|+|++|.+++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+..+.
T Consensus       115 ~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~  194 (477)
T 2id5_A          115 KIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY  194 (477)
T ss_dssp             CCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTT
T ss_pred             ccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChh
Confidence            99998888999999999999999999988888999999999999999999977777899999999999999999876664


Q ss_pred             hh
Q 008031          161 SL  162 (580)
Q Consensus       161 ~~  162 (580)
                      .+
T Consensus       195 ~~  196 (477)
T 2id5_A          195 SF  196 (477)
T ss_dssp             CS
T ss_pred             hc
Confidence            44

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.81  E-value=7.5e-20  Score=191.95  Aligned_cols=139  Identities=26%  Similarity=0.306  Sum_probs=122.7

Q ss_pred             CCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeee
Q 008031           22 SELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNL  101 (580)
Q Consensus        22 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  101 (580)
                      ++|+.|+|++|.+++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+++..+..+..+++|++|+|
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            57889999999998888888899999999999999998777888889999999999999998888888888999999999


Q ss_pred             ccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031          102 KRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus       102 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ++|++++..|..+..+++|++|+|++|++++..+..|..+++|+.|++++|++++.+|.
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            99999888888888999999999999999876667788899999999999999988773

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.80  E-value=4.7e-19  Score=163.51  Aligned_cols=148  Identities=16%  Similarity=0.315  Sum_probs=128.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|+ .++ .+..+++|++|++++|.++.  +..+..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus        47 ~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n  122 (197)
T 4ezg_A           47 TYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS  122 (197)
T ss_dssp             CEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSS
T ss_pred             cEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCC
Confidence            47899999999 566 69999999999999998873  347889999999999999999778888999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeecccc-ccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQ-ISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG  156 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~  156 (580)
                      ++++..+..+..+++|++|++++|+ ++ .++ .+..+++|++|++++|.+++ ++ .+..+++|+.|++++|++.+
T Consensus       123 ~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          123 AHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             BCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             ccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            9988888899999999999999998 66 455 68899999999999999986 33 78899999999999999864

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.80  E-value=6.8e-20  Score=182.08  Aligned_cols=161  Identities=23%  Similarity=0.267  Sum_probs=132.3

Q ss_pred             CEEEecCCcccccccccc--cCCCCCcEEEccCCccCCCCCccccCC-----CCCCEEEeeCCcCCCCCCccCcCCCCCC
Q 008031            1 MFLALQYNNLSGRIPASL--GKLSELQEISLSHNKISGVMPSDLGRL-----SRLRILDFSYNAINGSLPASFSNLSSLV   73 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~--~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~~~~l~~L~   73 (580)
                      ++|+|++|+|++.+|..+  ..+++|++|+|++|.+++. |..+..+     ++|++|+|++|+|++..+..|..+++|+
T Consensus        98 ~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  176 (312)
T 1wwl_A           98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS  176 (312)
T ss_dssp             CEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCC
T ss_pred             cEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCC
Confidence            478999999998888876  8899999999999999976 7777777     8999999999999987778999999999


Q ss_pred             EEECcCCCCCcc--cchhh--hccCCCCeeeeccccccc---cCCccccCCCCCcEEEccccccCCccc-ccccCcCCCC
Q 008031           74 SLTLESNNLDDQ--ILDSL--DKLHNLSVLNLKRNQISG---HIPSTIGNISTLTILDLSQNKLSGEIP-ASFSNLKSLS  145 (580)
Q Consensus        74 ~L~l~~N~l~~~--~~~~~--~~l~~L~~L~l~~N~l~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~  145 (580)
                      +|+|++|++.+.  .+..+  ..+++|++|+|++|++++   .....+..+++|++|+|++|.+++..| ..+..+++|+
T Consensus       177 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~  256 (312)
T 1wwl_A          177 TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN  256 (312)
T ss_dssp             EEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCC
T ss_pred             EEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCC
Confidence            999999998764  23344  788999999999999983   222334577899999999999987664 5567789999


Q ss_pred             eeecccccCcCccChhhh
Q 008031          146 SFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus       146 ~l~l~~n~l~~~~p~~~~  163 (580)
                      .|++++|+++ .+|..+.
T Consensus       257 ~L~Ls~N~l~-~ip~~~~  273 (312)
T 1wwl_A          257 SLNLSFTGLK-QVPKGLP  273 (312)
T ss_dssp             EEECTTSCCS-SCCSSCC
T ss_pred             EEECCCCccC-hhhhhcc
Confidence            9999999998 5555443

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=5.3e-20  Score=177.33  Aligned_cols=135  Identities=17%  Similarity=0.237  Sum_probs=103.9

Q ss_pred             hhhccccccCceEEEEEEe-CCCCE--EEEEEccccccc------------------------cHHHHHHHHHHHhcCCC
Q 008031          290 ATAEIMGKSTYGTVYKATL-EDGSQ--VAVKRLREKITK------------------------GQREFESEVSLLGKIRH  342 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h  342 (580)
                      ++.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+.++.+++|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            3467899999999999998 67989  999987543211                        11357899999999988


Q ss_pred             Ccc--eeeeeEEECCCCcEEEEEeeCCC-C----ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCcccCCC
Q 008031          343 PNL--LALRAYYLGPKGEKLLVFDYMPH-G----SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH-SNENIIHGNL  414 (580)
Q Consensus       343 ~ni--v~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~i~H~Dl  414 (580)
                      +++  ...+++     ...++||||+.+ |    +|.++...      .++..+..++.|++.||.||| + .||+||||
T Consensus       130 ~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~-~givHrDl  197 (258)
T 1zth_A          130 AGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE-AELVHADL  197 (258)
T ss_dssp             TTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT-SCEECSSC
T ss_pred             CCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH-CCEEeCCC
Confidence            764  333332     256899999942 4    56655432      224467789999999999999 8 59999999


Q ss_pred             CCCCeeeCCCCCeEEeeccccccc
Q 008031          415 TSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       415 k~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      ||.|||++.  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  8999999999754

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.80  E-value=1.7e-19  Score=196.48  Aligned_cols=155  Identities=26%  Similarity=0.390  Sum_probs=122.8

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCC-ccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMP-SDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      +|+|++|.++ .+|..+.++++|+.|++++|.+++..| ..+..+++|++|++++|++++..|..|..+++|+.|++++|
T Consensus       380 ~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  458 (606)
T 3vq2_A          380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN  458 (606)
T ss_dssp             EEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTC
T ss_pred             EeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCC
Confidence            5677777776 355677777888888888888776666 57777888888888888887777777888888888888888


Q ss_pred             CCCc-ccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      .+++ ..|..+..+++|+.|+|++|++++..|..+..+++|++|+|++|++++..|..|..+++|+.|++++|+++..
T Consensus       459 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  536 (606)
T 3vq2_A          459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS  536 (606)
T ss_dssp             EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCE
T ss_pred             cCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCccc
Confidence            8876 4677778888888888888888877777788888888888888888877788888888888888888888743

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.79  E-value=5.2e-19  Score=192.55  Aligned_cols=160  Identities=23%  Similarity=0.321  Sum_probs=100.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCc-cccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPS-DLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      +|+|++|.+++..+..|.++++|+.|++++|.+++..+. .+..+++|++|++++|++++..|..|..+++|++|+|++|
T Consensus       380 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n  459 (606)
T 3t6q_A          380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN  459 (606)
T ss_dssp             EEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTC
T ss_pred             EEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCC
Confidence            456666666655555666666666666666666544433 3556666666666666666555666666666666666666


Q ss_pred             CCCccc---chhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQI---LDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~---~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      .+++..   +..+..+++|+.|++++|++++..|..+..+++|++|+|++|++++..|..+..++.| .|++++|++++.
T Consensus       460 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~  538 (606)
T 3t6q_A          460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISII  538 (606)
T ss_dssp             BCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCC
T ss_pred             CCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCccccc
Confidence            665421   2345666666666666666666666666666666666666666666666666666666 666677766666


Q ss_pred             cChhh
Q 008031          158 VPTSL  162 (580)
Q Consensus       158 ~p~~~  162 (580)
                      +|..+
T Consensus       539 ~~~~~  543 (606)
T 3t6q_A          539 LPSLL  543 (606)
T ss_dssp             CGGGH
T ss_pred             CHhhc
Confidence            55544

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.79  E-value=1.3e-18  Score=174.40  Aligned_cols=157  Identities=22%  Similarity=0.337  Sum_probs=117.1

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCC--CCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISG--VMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      +|+|++|.|++..+..|.++++|++|++++|.++.  ..+..|..+++|+.|++++|+++ .+|..+.  ++|+.|+|++
T Consensus       125 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~  201 (330)
T 1xku_A          125 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDG  201 (330)
T ss_dssp             EEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTT
T ss_pred             EEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCC
Confidence            56666666665555567777777777777777752  55667777777777777777777 4454443  6788888888


Q ss_pred             CCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           80 NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        80 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |.+++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+
T Consensus       202 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~  280 (330)
T 1xku_A          202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS  280 (330)
T ss_dssp             SCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccCh
Confidence            8887777777888888888888888888777777888888888888888887 677778888888888888888886655


Q ss_pred             hhh
Q 008031          160 TSL  162 (580)
Q Consensus       160 ~~~  162 (580)
                      ..+
T Consensus       281 ~~f  283 (330)
T 1xku_A          281 NDF  283 (330)
T ss_dssp             TSS
T ss_pred             hhc
Confidence            544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.78  E-value=4.8e-19  Score=168.80  Aligned_cols=159  Identities=16%  Similarity=0.218  Sum_probs=132.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCc-cCCCCCccccCCCCCCEEEeeC-CcCCCCCCccCcCCCCCCEEECc
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNK-ISGVMPSDLGRLSRLRILDFSY-NAINGSLPASFSNLSSLVSLTLE   78 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~   78 (580)
                      ++|+|++|+|++..+..|.++++|+.|+|++|. ++.+.+..|..+++|++|+|++ |+|++..+..|..+++|+.|+++
T Consensus        34 ~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~  113 (239)
T 2xwt_C           34 QTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF  113 (239)
T ss_dssp             CEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEE
T ss_pred             cEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCC
Confidence            478999999997666689999999999999997 8877777899999999999998 99997666788999999999999


Q ss_pred             CCCCCcccchhhhccCCCC---eeeeccc-cccccCCccccCCCCCc-EEEccccccCCcccc-cccCcCCCCeeecccc
Q 008031           79 SNNLDDQILDSLDKLHNLS---VLNLKRN-QISGHIPSTIGNISTLT-ILDLSQNKLSGEIPA-SFSNLKSLSSFNVSYN  152 (580)
Q Consensus        79 ~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~-~l~~l~~L~~l~l~~n  152 (580)
                      +|.+++ +|. +..+.+|+   .|++++| ++++..+..|..+++|+ +|++++|.++ .+|. .|.. ++|+.|++++|
T Consensus       114 ~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~L~~n  189 (239)
T 2xwt_C          114 NTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-TKLDAVYLNKN  189 (239)
T ss_dssp             EECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-CEEEEEECTTC
T ss_pred             CCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-CCCCEEEcCCC
Confidence            999977 444 77888888   9999999 89877777788899999 9999999998 4444 4444 88999999999


Q ss_pred             c-CcCccChhhh
Q 008031          153 N-LSGPVPTSLA  163 (580)
Q Consensus       153 ~-l~~~~p~~~~  163 (580)
                      + +++..+..+.
T Consensus       190 ~~l~~i~~~~~~  201 (239)
T 2xwt_C          190 KYLTVIDKDAFG  201 (239)
T ss_dssp             TTCCEECTTTTT
T ss_pred             CCcccCCHHHhh
Confidence            5 8866555443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.78  E-value=4.3e-19  Score=193.22  Aligned_cols=163  Identities=20%  Similarity=0.209  Sum_probs=144.0

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..|..|+++++|++|+|++|.++++.|..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        36 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  115 (606)
T 3t6q_A           36 ECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT  115 (606)
T ss_dssp             CEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTS
T ss_pred             cEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecccc
Confidence            47899999999877889999999999999999999888889999999999999999999888889999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCC--eeecccccCcCcc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLS--SFNVSYNNLSGPV  158 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~--~l~l~~n~l~~~~  158 (580)
                      .+++..+..+..+++|++|++++|++++.....+..+++|++|++++|.+++..+..|..+++|+  .|++++|++++..
T Consensus       116 ~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~  195 (606)
T 3t6q_A          116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE  195 (606)
T ss_dssp             CCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEEC
T ss_pred             CcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccC
Confidence            99888788899999999999999999875545555689999999999999977788899999998  8999999999887


Q ss_pred             Chhhh
Q 008031          159 PTSLA  163 (580)
Q Consensus       159 p~~~~  163 (580)
                      |..+.
T Consensus       196 ~~~~~  200 (606)
T 3t6q_A          196 PGAFD  200 (606)
T ss_dssp             TTTTT
T ss_pred             hhHhh
Confidence            76553

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.78  E-value=2e-19  Score=182.00  Aligned_cols=156  Identities=21%  Similarity=0.255  Sum_probs=112.7

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|+.|+|++|.+++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        55 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  134 (353)
T 2z80_A           55 KSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGN  134 (353)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTC
T ss_pred             cEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCC
Confidence            36777777777555556777777777777777777666667777777777777777777444444777777777777777


Q ss_pred             CCCcccc-hhhhccCCCCeeeeccc-cccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcC
Q 008031           81 NLDDQIL-DSLDKLHNLSVLNLKRN-QISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG  156 (580)
Q Consensus        81 ~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~  156 (580)
                      +++.... ..+..+++|+.|++++| .++...+..+..+++|++|++++|.+++..|..+..+++|+.|++++|.+..
T Consensus       135 ~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~  212 (353)
T 2z80_A          135 PYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL  212 (353)
T ss_dssp             CCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred             CCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence            7765444 46677777777777777 3665556667777777777777777776667777777777777777777753

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.78  E-value=1.4e-19  Score=197.60  Aligned_cols=156  Identities=24%  Similarity=0.414  Sum_probs=120.4

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCc------------------------------------------------
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNK------------------------------------------------   33 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~------------------------------------------------   33 (580)
                      .|+|++|.++|.+|+.|++|++|+.|+|++|.                                                
T Consensus        85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~  164 (636)
T 4eco_A           85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD  164 (636)
T ss_dssp             EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHH
T ss_pred             EEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHH
Confidence            57788888888888888888888888887773                                                


Q ss_pred             ------------------------------cCCCCCccccCCCCCCEEEeeCCcCCCC-----------------CCccC
Q 008031           34 ------------------------------ISGVMPSDLGRLSRLRILDFSYNAINGS-----------------LPASF   66 (580)
Q Consensus        34 ------------------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------~~~~~   66 (580)
                                                    +++ +|..|+.+++|++|+|++|+|++.                 +|..+
T Consensus       165 l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l  243 (636)
T 4eco_A          165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL  243 (636)
T ss_dssp             HHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred             HhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhh
Confidence                                          334 566777788888888888888764                 77777


Q ss_pred             c--CCCCCCEEECcCCCCCcccchhhhccCCCCeeeecccc-ccc-cCCccccCC------CCCcEEEccccccCCcccc
Q 008031           67 S--NLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQ-ISG-HIPSTIGNI------STLTILDLSQNKLSGEIPA  136 (580)
Q Consensus        67 ~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~-~~~~~~~~l------~~L~~L~l~~N~l~~~~~~  136 (580)
                      .  ++++|++|+|++|++.+.+|..+..+++|++|+|++|+ +++ .+|..++.+      ++|++|+|++|.++ .+|.
T Consensus       244 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~  322 (636)
T 4eco_A          244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV  322 (636)
T ss_dssp             CGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred             hhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence            7  78888888888888777777778888888888888887 776 677776665      77888888888887 6776


Q ss_pred             --cccCcCCCCeeecccccCcCccC
Q 008031          137 --SFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       137 --~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                        .+..+++|+.|++++|+++|.+|
T Consensus       323 ~~~l~~l~~L~~L~L~~N~l~g~ip  347 (636)
T 4eco_A          323 ETSLQKMKKLGMLECLYNQLEGKLP  347 (636)
T ss_dssp             HHHHTTCTTCCEEECCSCCCEEECC
T ss_pred             hhhhccCCCCCEEeCcCCcCccchh
Confidence              77788888888888888877777

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.78  E-value=1.7e-18  Score=191.21  Aligned_cols=178  Identities=28%  Similarity=0.294  Sum_probs=122.7

Q ss_pred             EEEecCCccccccc-ccccCCCCCcEEEccCCccCC--------------------------CCCccccCCCCCCEEEee
Q 008031            2 FLALQYNNLSGRIP-ASLGKLSELQEISLSHNKISG--------------------------VMPSDLGRLSRLRILDFS   54 (580)
Q Consensus         2 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~--------------------------~~~~~~~~l~~L~~L~l~   54 (580)
                      +|+|++|.+++.++ ..+.++++|++|+|++|.+++                          ..|..|..+++|+.|+|+
T Consensus       409 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls  488 (680)
T 1ziw_A          409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS  488 (680)
T ss_dssp             EEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECC
T ss_pred             EEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECC
Confidence            46666666654443 455555555555555555443                          456667777778888888


Q ss_pred             CCcCCCCCCccCcCCCCCCEEECcCCCCCcccch--------hhhccCCCCeeeeccccccccCCccccCCCCCcEEEcc
Q 008031           55 YNAINGSLPASFSNLSSLVSLTLESNNLDDQILD--------SLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLS  126 (580)
Q Consensus        55 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~--------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  126 (580)
                      +|+|++..+..|..+++|++|+|++|.+++..+.        .+..+++|+.|+|++|+++...+..|..+++|+.|+|+
T Consensus       489 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls  568 (680)
T 1ziw_A          489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG  568 (680)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECC
Confidence            8888766666777788888888888887654322        26677888888888888885555567888888888888


Q ss_pred             ccccCCcccccccCcCCCCeeecccccCcCccChhhh---hhcCCCcccccccccC
Q 008031          127 QNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA---LKFNASSFVGNIQLCG  179 (580)
Q Consensus       127 ~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~---~~~~~~~~~~~~~~~~  179 (580)
                      +|++++..+..|..+++|+.|++++|++++.+|..+.   ..+......+|+..|+
T Consensus       569 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             CCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            8888876666778888888888888888887776554   2233333445555554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=1e-18  Score=160.36  Aligned_cols=132  Identities=23%  Similarity=0.316  Sum_probs=85.1

Q ss_pred             cEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCc-cCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeecc
Q 008031           25 QEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA-SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKR  103 (580)
Q Consensus        25 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  103 (580)
                      +.|++++|.++ .+|..+..  +|++|+|++|+|++..+. .|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56666666665 34443332  666666666666644433 366666666666666666666666666666666666666


Q ss_pred             ccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031          104 NQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       104 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |+|++..+..+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            66666666666666777777777777766666666777777777777777766554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=9.1e-19  Score=164.41  Aligned_cols=132  Identities=27%  Similarity=0.355  Sum_probs=123.5

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|+.|+|++|.|+++.|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|
T Consensus        35 ~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N  114 (220)
T 2v9t_B           35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNAN  114 (220)
T ss_dssp             CEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCC
Confidence            47999999999777778999999999999999999888999999999999999999999666677899999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSG  132 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  132 (580)
                      +|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.-
T Consensus       115 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          115 KINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            9999999999999999999999999998888889999999999999999974

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.78  E-value=3e-19  Score=177.38  Aligned_cols=153  Identities=23%  Similarity=0.280  Sum_probs=132.1

Q ss_pred             CEEEecCCcccccccccccCC-----CCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCC--CCccC--cCCCC
Q 008031            1 MFLALQYNNLSGRIPASLGKL-----SELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS--LPASF--SNLSS   71 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~--~~l~~   71 (580)
                      ++|+|++|+|++. |..+..+     ++|++|+|++|.|++..|..|..+++|++|+|++|++.+.  .+..+  ..+++
T Consensus       124 ~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~  202 (312)
T 1wwl_A          124 NILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT  202 (312)
T ss_dssp             SEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTT
T ss_pred             cEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCC
Confidence            4799999999976 8888887     9999999999999988889999999999999999998754  23334  88999


Q ss_pred             CCEEECcCCCCCcc---cchhhhccCCCCeeeeccccccccCC-ccccCCCCCcEEEccccccCCcccccccCcCCCCee
Q 008031           72 LVSLTLESNNLDDQ---ILDSLDKLHNLSVLNLKRNQISGHIP-STIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSF  147 (580)
Q Consensus        72 L~~L~l~~N~l~~~---~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l  147 (580)
                      |++|+|++|+|++.   ....+..+++|+.|+|++|++++..| ..+..+++|++|+|++|.++ .+|..+.  ++|+.|
T Consensus       203 L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L  279 (312)
T 1wwl_A          203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVL  279 (312)
T ss_dssp             CCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEE
T ss_pred             CCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEE
Confidence            99999999999842   23445678999999999999998764 45667899999999999999 6777666  899999


Q ss_pred             ecccccCcCc
Q 008031          148 NVSYNNLSGP  157 (580)
Q Consensus       148 ~l~~n~l~~~  157 (580)
                      |+++|++++.
T Consensus       280 ~Ls~N~l~~~  289 (312)
T 1wwl_A          280 DLSYNRLDRN  289 (312)
T ss_dssp             ECCSSCCCSC
T ss_pred             ECCCCCCCCC
Confidence            9999999977

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.78  E-value=5e-19  Score=168.73  Aligned_cols=131  Identities=18%  Similarity=0.278  Sum_probs=66.5

Q ss_pred             CCcEEEccCCccCCCCCccccCCCCCCEEEeeCCc-CCCCCCccCcCCCCCCEEECcC-CCCCcccchhhhccCCCCeee
Q 008031           23 ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNA-INGSLPASFSNLSSLVSLTLES-NNLDDQILDSLDKLHNLSVLN  100 (580)
Q Consensus        23 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~  100 (580)
                      +|++|+|++|+|+++.+..|..+++|++|+|++|+ +++..+..|..+++|++|+|++ |+++...+..|..+++|+.|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            45555555555554444445555555555555554 4433333455555555555555 555544444455555555555


Q ss_pred             eccccccccCCccccCCCCCc---EEEcccc-ccCCcccccccCcCCCC-eeecccccCc
Q 008031          101 LKRNQISGHIPSTIGNISTLT---ILDLSQN-KLSGEIPASFSNLKSLS-SFNVSYNNLS  155 (580)
Q Consensus       101 l~~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~~~~l~~l~~L~-~l~l~~n~l~  155 (580)
                      +++|++++ +|. +..+++|+   +|++++| .+++..+..|..+++|+ .|++++|+++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~  169 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT  169 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence            55555553 333 44444444   5555555 55443334455555555 5555555554

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.78  E-value=4.5e-19  Score=194.00  Aligned_cols=157  Identities=24%  Similarity=0.338  Sum_probs=131.1

Q ss_pred             EecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCC
Q 008031            4 ALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLD   83 (580)
Q Consensus         4 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~   83 (580)
                      +-++.+++ .+|..+.  +++++|||++|.|+++.+..|..+++|++|+|++|+|++..+..|.+|++|++|+|++|+|+
T Consensus        37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~  113 (635)
T 4g8a_A           37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ  113 (635)
T ss_dssp             ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence            44555677 6776553  47899999999999777788999999999999999998777778899999999999999998


Q ss_pred             cccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCC-cccccccCcCCCCeeecccccCcCccChhh
Q 008031           84 DQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSG-EIPASFSNLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus        84 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                      +..+..|..+++|++|+|++|++++..+..|+.+++|++|+|++|.+++ ..|..+..+++|+.|++++|++++..|..+
T Consensus       114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  193 (635)
T 4g8a_A          114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  193 (635)
T ss_dssp             EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred             CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence            8877888899999999999999987777778899999999999999876 357778889999999999999988777765


Q ss_pred             h
Q 008031          163 A  163 (580)
Q Consensus       163 ~  163 (580)
                      .
T Consensus       194 ~  194 (635)
T 4g8a_A          194 R  194 (635)
T ss_dssp             H
T ss_pred             c
Confidence            4

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.78  E-value=5.4e-19  Score=192.41  Aligned_cols=155  Identities=25%  Similarity=0.341  Sum_probs=85.4

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      ++.+++.++ .+|..+.  ++|++|+|++|.+++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|.+
T Consensus        16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l   92 (606)
T 3vq2_A           16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI   92 (606)
T ss_dssp             EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence            455555555 4444333  4555555555555555455555555555555555555544455555555555555555555


Q ss_pred             CcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCC-cccccccCcCCCCeeecccccCcCccCh
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSG-EIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ++..|..|..+++|++|+|++|.+++..+..++.+++|++|++++|.+++ .+|..|.++++|++|++++|++++..|.
T Consensus        93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~  171 (606)
T 3vq2_A           93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN  171 (606)
T ss_dssp             CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred             cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence            55555555555555555555555554444555555555555555555553 3455555555555555555555554444

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=1.2e-18  Score=159.99  Aligned_cols=132  Identities=27%  Similarity=0.389  Sum_probs=121.0

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCc-cccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPS-DLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      .+|++++|+|+ .+|..+..  +|++|+|++|.|+++.+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            46899999998 78876654  999999999999977664 589999999999999999988899999999999999999


Q ss_pred             CCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccc
Q 008031           80 NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP  135 (580)
Q Consensus        80 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  135 (580)
                      |+|++..+..|..+++|+.|+|++|+|++..|..+..+++|++|+|++|.+++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            99999988889999999999999999999999999999999999999999997543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.78  E-value=7e-19  Score=185.69  Aligned_cols=162  Identities=23%  Similarity=0.245  Sum_probs=147.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..|..|.++++|++|+|++|.|+.+.+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus        59 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n  138 (477)
T 2id5_A           59 EELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN  138 (477)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCT
T ss_pred             CEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCC
Confidence            47999999999888999999999999999999999777778899999999999999999888889999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      .++...+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|++++|++.+.+|.
T Consensus       139 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~  218 (477)
T 2id5_A          139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP  218 (477)
T ss_dssp             TCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred             ccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence            99998888999999999999999999977777789999999999999999987778899999999999999888766665


Q ss_pred             hh
Q 008031          161 SL  162 (580)
Q Consensus       161 ~~  162 (580)
                      ..
T Consensus       219 ~~  220 (477)
T 2id5_A          219 NC  220 (477)
T ss_dssp             TT
T ss_pred             cc
Confidence            43

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.77  E-value=5.8e-19  Score=175.21  Aligned_cols=161  Identities=19%  Similarity=0.183  Sum_probs=133.1

Q ss_pred             CEEEecCCcccccccccc--cCCCCCcEEEccCCccCCCCC----ccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCE
Q 008031            1 MFLALQYNNLSGRIPASL--GKLSELQEISLSHNKISGVMP----SDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVS   74 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~--~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~   74 (580)
                      ++|+|++|.+++..|..+  .++++|++|+|++|.+++..+    ..+..+++|++|+|++|+|++..+..|..+++|++
T Consensus        94 ~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  173 (310)
T 4glp_A           94 KELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTS  173 (310)
T ss_dssp             CEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCE
T ss_pred             eEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCE
Confidence            479999999998888888  899999999999999997555    34457899999999999999888889999999999


Q ss_pred             EECcCCCCCcc--c-c-hhhhccCCCCeeeeccccccccCCc----cccCCCCCcEEEccccccCCcccccccCc---CC
Q 008031           75 LTLESNNLDDQ--I-L-DSLDKLHNLSVLNLKRNQISGHIPS----TIGNISTLTILDLSQNKLSGEIPASFSNL---KS  143 (580)
Q Consensus        75 L~l~~N~l~~~--~-~-~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~~~~~l~~l---~~  143 (580)
                      |+|++|++.+.  . + ..+..+++|++|+|++|+++. ++.    .+..+++|++|+|++|.+++..|..+..+   ++
T Consensus       174 L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~  252 (310)
T 4glp_A          174 LDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSA  252 (310)
T ss_dssp             EECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTT
T ss_pred             EECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCc
Confidence            99999998653  2 1 224678899999999999973 333    25678999999999999998778777776   69


Q ss_pred             CCeeecccccCcCccChhhh
Q 008031          144 LSSFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus       144 L~~l~l~~n~l~~~~p~~~~  163 (580)
                      |+.|++++|+++ .+|..+.
T Consensus       253 L~~L~Ls~N~l~-~lp~~~~  271 (310)
T 4glp_A          253 LNSLNLSFAGLE-QVPKGLP  271 (310)
T ss_dssp             CCCEECCSSCCC-SCCSCCC
T ss_pred             CCEEECCCCCCC-chhhhhc
Confidence            999999999999 4565443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.77  E-value=2.2e-18  Score=180.53  Aligned_cols=178  Identities=24%  Similarity=0.241  Sum_probs=140.4

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCc----------------
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA----------------   64 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~----------------   64 (580)
                      ++|+|++|+|++..+..|.++++|++|+|++|.|+.+.+..|..+++|++|+|++|+|++..+.                
T Consensus       102 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~  181 (452)
T 3zyi_A          102 EVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL  181 (452)
T ss_dssp             CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC
T ss_pred             CEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC
Confidence            3678888888877777788888888888888888866666677788888888888777643332                


Q ss_pred             ---------cCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccc
Q 008031           65 ---------SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP  135 (580)
Q Consensus        65 ---------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  135 (580)
                               .|..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..+
T Consensus       182 ~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  259 (452)
T 3zyi_A          182 KKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER  259 (452)
T ss_dssp             TTCCEECTTTTTTCTTCCEEECTTSCCSSC--CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred             CCccccChhhccCCCCCCEEECCCCccccc--ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECH
Confidence                     356677888888888888764  357789999999999999999889999999999999999999998888


Q ss_pred             ccccCcCCCCeeecccccCcCccChhhhh--hcCCCcccccccccCC
Q 008031          136 ASFSNLKSLSSFNVSYNNLSGPVPTSLAL--KFNASSFVGNIQLCGY  180 (580)
Q Consensus       136 ~~l~~l~~L~~l~l~~n~l~~~~p~~~~~--~~~~~~~~~~~~~~~~  180 (580)
                      ..|..+++|+.|+|++|+|++.++..+..  .+......+|+..|..
T Consensus       260 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC  306 (452)
T 3zyi_A          260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC  306 (452)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred             HHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence            99999999999999999999776655431  2333444566666653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.77  E-value=1.2e-18  Score=163.55  Aligned_cols=133  Identities=26%  Similarity=0.314  Sum_probs=124.0

Q ss_pred             CEEEecCCccccccc-ccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIP-ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++|+|++..+ ..|.++++|+.|+|++|.|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  114 (220)
T 2v70_A           35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS  114 (220)
T ss_dssp             SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred             CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence            479999999997655 4589999999999999999988888999999999999999999988888899999999999999


Q ss_pred             CCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCc
Q 008031           80 NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGE  133 (580)
Q Consensus        80 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  133 (580)
                      |+|++..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|.++..
T Consensus       115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            999999899999999999999999999988899999999999999999999864

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.77  E-value=2.1e-18  Score=187.10  Aligned_cols=161  Identities=23%  Similarity=0.285  Sum_probs=110.4

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..+..|+++++|+.|+|++|.|++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N  157 (597)
T 3oja_B           78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN  157 (597)
T ss_dssp             SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence            36777777777666667777777777777777777766777777777777777777777555555677777777777777


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCC-------------------------------------CCCcEE
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNI-------------------------------------STLTIL  123 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-------------------------------------~~L~~L  123 (580)
                      .+++..+..|..+++|+.|+|++|.+++.....+..+                                     ++|+.|
T Consensus       158 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L  237 (597)
T 3oja_B          158 NLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL  237 (597)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEE
T ss_pred             cCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEE
Confidence            7777777777777777777777777765322221111                                     134444


Q ss_pred             EccccccCCcccccccCcCCCCeeecccccCcCccChhhh
Q 008031          124 DLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus       124 ~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~  163 (580)
                      +|++|.+++  +..+..+++|+.|++++|.+++.+|..+.
T Consensus       238 ~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  275 (597)
T 3oja_B          238 KLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFV  275 (597)
T ss_dssp             ECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             ECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhc
Confidence            444444443  24567778888888888888877776654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.77  E-value=2.2e-18  Score=179.89  Aligned_cols=177  Identities=26%  Similarity=0.273  Sum_probs=151.2

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCC-cCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN-AINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++|+|+...+..|.++++|++|+|++|.|+.+.+..|..+++|+.|+|++| .++...+..|.++++|+.|+|++
T Consensus       115 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~  194 (440)
T 3zyj_A          115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM  194 (440)
T ss_dssp             CEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTT
T ss_pred             CEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCC
Confidence            47999999999666678999999999999999999887889999999999999994 55545556799999999999999


Q ss_pred             CCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           80 NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        80 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |+++.. | .+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++.++
T Consensus       195 n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  272 (440)
T 3zyj_A          195 CNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH  272 (440)
T ss_dssp             SCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCT
T ss_pred             CcCccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccCh
Confidence            999764 3 47889999999999999998889999999999999999999998888999999999999999999997766


Q ss_pred             hhhhh--hcCCCcccccccccC
Q 008031          160 TSLAL--KFNASSFVGNIQLCG  179 (580)
Q Consensus       160 ~~~~~--~~~~~~~~~~~~~~~  179 (580)
                      ..+..  .+......+|+..|+
T Consensus       273 ~~~~~l~~L~~L~L~~Np~~Cd  294 (440)
T 3zyj_A          273 DLFTPLHHLERIHLHHNPWNCN  294 (440)
T ss_dssp             TTTSSCTTCCEEECCSSCEECS
T ss_pred             hHhccccCCCEEEcCCCCccCC
Confidence            55431  233334456666665

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.77  E-value=4.9e-19  Score=179.19  Aligned_cols=161  Identities=19%  Similarity=0.170  Sum_probs=142.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCC-ccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLP-ASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++|+|++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|++|++++..+ ..|..+++|+.|++++
T Consensus        79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~  158 (353)
T 2z80_A           79 QALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN  158 (353)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEE
T ss_pred             CEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCC
Confidence            479999999998788889999999999999999997666669999999999999999995444 4799999999999999


Q ss_pred             C-CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCcc
Q 008031           80 N-NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        80 N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      | .++...+..+..+++|+.|++++|++++..|..+..+++|++|++++|.++......+..+++|+.|++++|.+++..
T Consensus       159 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~  238 (353)
T 2z80_A          159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH  238 (353)
T ss_dssp             SSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCC
T ss_pred             CccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccc
Confidence            9 587777888999999999999999999888999999999999999999998544445567899999999999999765


Q ss_pred             Chh
Q 008031          159 PTS  161 (580)
Q Consensus       159 p~~  161 (580)
                      +..
T Consensus       239 ~~~  241 (353)
T 2z80_A          239 FSE  241 (353)
T ss_dssp             CC-
T ss_pred             ccc
Confidence            543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.77  E-value=2.3e-18  Score=188.39  Aligned_cols=162  Identities=28%  Similarity=0.317  Sum_probs=144.9

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|||++|+|+...+..|.++++|++|||++|.|+++.++.|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        55 ~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N  134 (635)
T 4g8a_A           55 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET  134 (635)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTS
T ss_pred             CEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCC
Confidence            47999999999777789999999999999999999888889999999999999999999777778999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeecccccccc-CCccccCCCCCcEEEccccccCCcccccccCcCCCC----eeecccccCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGH-IPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLS----SFNVSYNNLS  155 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~----~l~l~~n~l~  155 (580)
                      +|++..+..|..+++|++|+|++|.+++. .|..+..+++|++|+|++|++++..+..|..+.++.    .++++.|.+.
T Consensus       135 ~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~  214 (635)
T 4g8a_A          135 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN  214 (635)
T ss_dssp             CCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC
T ss_pred             cCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc
Confidence            99988888899999999999999999764 577889999999999999999988888887776554    6889999998


Q ss_pred             CccChhh
Q 008031          156 GPVPTSL  162 (580)
Q Consensus       156 ~~~p~~~  162 (580)
                      ...+..+
T Consensus       215 ~i~~~~~  221 (635)
T 4g8a_A          215 FIQPGAF  221 (635)
T ss_dssp             EECTTTT
T ss_pred             ccCcccc
Confidence            7665543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.77  E-value=3.5e-18  Score=171.34  Aligned_cols=153  Identities=25%  Similarity=0.400  Sum_probs=111.0

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|+++ .+|..+.  ++|++|++++|
T Consensus        57 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n  133 (332)
T 2ft3_A           57 TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDN  133 (332)
T ss_dssp             CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSS
T ss_pred             eEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCC
Confidence            46889999998766778899999999999999998777888888999999999999988 5555544  78888888888


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccc--cCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCcc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISG--HIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      .++...+..+..+++|+.|++++|.++.  ..+..+..+ +|++|++++|.+++ +|..+.  ++|+.|++++|.+++..
T Consensus       134 ~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~  209 (332)
T 2ft3_A          134 RIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIE  209 (332)
T ss_dssp             CCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCC
T ss_pred             ccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccC
Confidence            8887777778888888888888888853  555556555 55555555555553 332222  45555555555555444


Q ss_pred             Ch
Q 008031          159 PT  160 (580)
Q Consensus       159 p~  160 (580)
                      +.
T Consensus       210 ~~  211 (332)
T 2ft3_A          210 LE  211 (332)
T ss_dssp             TT
T ss_pred             HH
Confidence            33

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.76  E-value=3.6e-18  Score=175.33  Aligned_cols=160  Identities=23%  Similarity=0.290  Sum_probs=101.6

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|.|++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+|+...+..|..+++|++|+|++|.
T Consensus        73 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~  152 (390)
T 3o6n_A           73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN  152 (390)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCc
Confidence            56777777775555567777777777777777776666666777777777777777764433445667777777777777


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCC-------------------------------------CCCcEEE
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNI-------------------------------------STLTILD  124 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-------------------------------------~~L~~L~  124 (580)
                      +++..+..+..+++|+.|++++|++++.....+..+                                     ++|+.|+
T Consensus       153 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~  232 (390)
T 3o6n_A          153 LERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILK  232 (390)
T ss_dssp             CCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEE
T ss_pred             cCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEE
Confidence            766666666667777777777776654321111111                                     2344444


Q ss_pred             ccccccCCcccccccCcCCCCeeecccccCcCccChhhh
Q 008031          125 LSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus       125 l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~  163 (580)
                      +++|.+++.  ..+..+++|+.|++++|.+++..|..+.
T Consensus       233 l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~  269 (390)
T 3o6n_A          233 LQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV  269 (390)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             CCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence            444444432  3466778888888888888877666553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.76  E-value=2.2e-18  Score=190.25  Aligned_cols=163  Identities=25%  Similarity=0.294  Sum_probs=135.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        28 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n  107 (680)
T 1ziw_A           28 TVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN  107 (680)
T ss_dssp             SEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred             cEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCC
Confidence            46888889888766677888889999999999888888888888889999999999888555557888889999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccccccc--CcCCCCeeecccccCcCcc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFS--NLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~--~l~~L~~l~l~~n~l~~~~  158 (580)
                      ++++..+..|..+++|++|+|++|.+++..+..+..+++|++|++++|.+++..+..+.  .+++|+.|++++|++++..
T Consensus       108 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~  187 (680)
T 1ziw_A          108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS  187 (680)
T ss_dssp             CCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBC
T ss_pred             ccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccC
Confidence            88887778888888999999999988888888888888899999999988876666554  4578888999988888777


Q ss_pred             Chhhh
Q 008031          159 PTSLA  163 (580)
Q Consensus       159 p~~~~  163 (580)
                      |..+.
T Consensus       188 ~~~~~  192 (680)
T 1ziw_A          188 PGCFH  192 (680)
T ss_dssp             TTGGG
T ss_pred             hhhhh
Confidence            76543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.76  E-value=5.1e-18  Score=174.20  Aligned_cols=86  Identities=22%  Similarity=0.247  Sum_probs=74.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..|..|.++++|++|+|++|.++.+.+..|..+++|++|+|++|++++..+..|..+++|+.|++++|
T Consensus        96 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n  175 (390)
T 3o6n_A           96 QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN  175 (390)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSS
T ss_pred             CEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCC
Confidence            47899999999777788999999999999999999665566788999999999999999777888899999999999999


Q ss_pred             CCCccc
Q 008031           81 NLDDQI   86 (580)
Q Consensus        81 ~l~~~~   86 (580)
                      .++...
T Consensus       176 ~l~~~~  181 (390)
T 3o6n_A          176 RLTHVD  181 (390)
T ss_dssp             CCSBCC
T ss_pred             cCCccc
Confidence            887643

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.76  E-value=5e-18  Score=184.08  Aligned_cols=86  Identities=22%  Similarity=0.247  Sum_probs=76.7

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..|..|+++++|++|+|++|.|+++.+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus       102 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  181 (597)
T 3oja_B          102 QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN  181 (597)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCC
Confidence            47999999999877888899999999999999999776767899999999999999999888888999999999999999


Q ss_pred             CCCccc
Q 008031           81 NLDDQI   86 (580)
Q Consensus        81 ~l~~~~   86 (580)
                      .+++..
T Consensus       182 ~l~~~~  187 (597)
T 3oja_B          182 RLTHVD  187 (597)
T ss_dssp             CCSBCC
T ss_pred             CCCCcC
Confidence            987653

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.76  E-value=5.9e-18  Score=167.62  Aligned_cols=146  Identities=27%  Similarity=0.446  Sum_probs=94.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|++++|.|+ .++ .+..+++|++|+|++|.+++..+  +..+++|++|+|++|+|++ ++ .+..+++|+.|+|++|+
T Consensus        45 ~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~  118 (308)
T 1h6u_A           45 TLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQ  118 (308)
T ss_dssp             EEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSC
T ss_pred             EEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCC
Confidence            5677777776 333 46667777777777777764333  6677777777777777763 23 46667777777777777


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      +++..  .+..+++|+.|++++|++++..+  +..+++|++|+|++|.+++..+  +..+++|+.|++++|++++..+
T Consensus       119 l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~  190 (308)
T 1h6u_A          119 ITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP  190 (308)
T ss_dssp             CCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG
T ss_pred             CCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh
Confidence            76533  26666777777777777764332  6666777777777777664322  6666677777777776665443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.76  E-value=5.6e-18  Score=160.13  Aligned_cols=132  Identities=25%  Similarity=0.339  Sum_probs=121.7

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|++|+|++|.|+.+.+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        43 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N  122 (229)
T 3e6j_A           43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCN  122 (229)
T ss_dssp             SEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCC
Confidence            47999999999888999999999999999999999777778899999999999999999777777899999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGE  133 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  133 (580)
                      +|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|.+...
T Consensus       123 ~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          123 KLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             CCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             ccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            997 5678889999999999999999977777899999999999999999854

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.76  E-value=2.9e-18  Score=171.96  Aligned_cols=158  Identities=28%  Similarity=0.378  Sum_probs=99.4

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCC--CCCccCcCC---------
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING--SLPASFSNL---------   69 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l---------   69 (580)
                      ++|+|++|+|+ .+|..+.  ++|++|++++|.+++..+..|..+++|++|++++|.++.  ..+..+..+         
T Consensus       105 ~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~  181 (332)
T 2ft3_A          105 QKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE  181 (332)
T ss_dssp             CEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCS
T ss_pred             CEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcC
Confidence            35677777776 4554444  567777777777765555556667777777777776642  444444444         


Q ss_pred             -----------CCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccc
Q 008031           70 -----------SSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASF  138 (580)
Q Consensus        70 -----------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l  138 (580)
                                 ++|+.|+|++|.+++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|.++ .+|..+
T Consensus       182 n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  260 (332)
T 2ft3_A          182 AKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL  260 (332)
T ss_dssp             SBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred             CCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence                       35666666666666555566666666666666666666655556666666677777766666 556666


Q ss_pred             cCcCCCCeeecccccCcCccChhh
Q 008031          139 SNLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus       139 ~~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                      ..+++|+.|++++|++++..+..+
T Consensus       261 ~~l~~L~~L~l~~N~l~~~~~~~~  284 (332)
T 2ft3_A          261 PDLKLLQVVYLHTNNITKVGVNDF  284 (332)
T ss_dssp             GGCTTCCEEECCSSCCCBCCTTSS
T ss_pred             hcCccCCEEECCCCCCCccChhHc
Confidence            666666677777666665544433

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.76  E-value=1.7e-18  Score=186.95  Aligned_cols=160  Identities=29%  Similarity=0.315  Sum_probs=100.6

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|+|++..+..|.++++|++|+|++|.++++.+..|..+++|++|+|++|++++..|..|.++++|++|++++|+
T Consensus        32 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  111 (570)
T 2z63_A           32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN  111 (570)
T ss_dssp             EEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             EEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccc
Confidence            56666666665555566666666666666666665555566666666666666666665555666666666666666666


Q ss_pred             CCcccchhhhccCCCCeeeecccccccc-CCccccCCCCCcEEEccccccCCcccccccCcCCC----CeeecccccCcC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGH-IPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSL----SSFNVSYNNLSG  156 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L----~~l~l~~n~l~~  156 (580)
                      ++...+..+..+++|++|++++|.+++. +|..+..+++|++|++++|.+++..+..+..+++|    ..|++++|.+++
T Consensus       112 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~  191 (570)
T 2z63_A          112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF  191 (570)
T ss_dssp             CCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE
T ss_pred             cccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCcee
Confidence            6655544566666666666666666542 45666666666666666666665555556666665    566666666665


Q ss_pred             ccChh
Q 008031          157 PVPTS  161 (580)
Q Consensus       157 ~~p~~  161 (580)
                      ..|..
T Consensus       192 ~~~~~  196 (570)
T 2z63_A          192 IQPGA  196 (570)
T ss_dssp             ECTTT
T ss_pred             cCHHH
Confidence            55543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.76  E-value=8.6e-18  Score=168.37  Aligned_cols=156  Identities=22%  Similarity=0.368  Sum_probs=113.9

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+|+ .+|..+.  ++|++|++++|
T Consensus        55 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n  131 (330)
T 1xku_A           55 ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHEN  131 (330)
T ss_dssp             CEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSS
T ss_pred             eEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCC
Confidence            46888999988666668888999999999999988777888888899999999998888 5555443  67888888888


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccc--cCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCcc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISG--HIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      .+++..+..+..+++|+.|++++|.++.  ..+..+..+++|++|++++|.++. +|..+.  ++|+.|++++|++++..
T Consensus       132 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~  208 (330)
T 1xku_A          132 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVD  208 (330)
T ss_dssp             CCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEEC
T ss_pred             cccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccC
Confidence            8877777777777778888888777753  556667777777777777776663 333332  56666666666666554


Q ss_pred             Chhh
Q 008031          159 PTSL  162 (580)
Q Consensus       159 p~~~  162 (580)
                      |..+
T Consensus       209 ~~~~  212 (330)
T 1xku_A          209 AASL  212 (330)
T ss_dssp             TGGG
T ss_pred             HHHh
Confidence            4433

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.76  E-value=1.3e-18  Score=183.40  Aligned_cols=156  Identities=25%  Similarity=0.201  Sum_probs=126.9

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCc----------------
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA----------------   64 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~----------------   64 (580)
                      ++|+|++|.|++..|..|.++++|+.|+|++|.|++..|  |..+++|++|+|++|.|++..+.                
T Consensus        37 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~  114 (487)
T 3oja_A           37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV  114 (487)
T ss_dssp             CEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCE
T ss_pred             cEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCC
Confidence            478999999998778899999999999999999986554  88888888888888877632211                


Q ss_pred             cCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCcccc-CCCCCcEEEccccccCCcccccccCcCC
Q 008031           65 SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIG-NISTLTILDLSQNKLSGEIPASFSNLKS  143 (580)
Q Consensus        65 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~l~~l~~  143 (580)
                      ....+++|+.|+|++|.|++..+..+..+++|+.|+|++|.+++..|..+. .+++|++|+|++|.+++..  .+..+++
T Consensus       115 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~  192 (487)
T 3oja_A          115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAK  192 (487)
T ss_dssp             EECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTT
T ss_pred             CccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc--ccccCCC
Confidence            012357788999999999888888888999999999999999988887776 7899999999999998652  2446889


Q ss_pred             CCeeecccccCcCccCh
Q 008031          144 LSSFNVSYNNLSGPVPT  160 (580)
Q Consensus       144 L~~l~l~~n~l~~~~p~  160 (580)
                      |+.|+|++|.+++.+|.
T Consensus       193 L~~L~Ls~N~l~~~~~~  209 (487)
T 3oja_A          193 LKTLDLSSNKLAFMGPE  209 (487)
T ss_dssp             CCEEECCSSCCCEECGG
T ss_pred             CCEEECCCCCCCCCCHh
Confidence            99999999999976664

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.76  E-value=2.4e-18  Score=170.77  Aligned_cols=154  Identities=18%  Similarity=0.183  Sum_probs=130.5

Q ss_pred             CEEEecCCccccccc----ccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCC--C--CccCcCCCCC
Q 008031            1 MFLALQYNNLSGRIP----ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS--L--PASFSNLSSL   72 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~--~~~~~~l~~L   72 (580)
                      ++|+|++|.|++..+    ..+..+++|++|+|++|.+++..+..|..+++|++|+|++|++.+.  +  +..+..+++|
T Consensus       120 ~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L  199 (310)
T 4glp_A          120 SSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAI  199 (310)
T ss_dssp             SSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCC
T ss_pred             CEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCC
Confidence            468999999997554    4556899999999999999988889999999999999999998642  2  2345789999


Q ss_pred             CEEECcCCCCCcccch---hhhccCCCCeeeeccccccccCCccccCC---CCCcEEEccccccCCcccccccCcCCCCe
Q 008031           73 VSLTLESNNLDDQILD---SLDKLHNLSVLNLKRNQISGHIPSTIGNI---STLTILDLSQNKLSGEIPASFSNLKSLSS  146 (580)
Q Consensus        73 ~~L~l~~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~l~~l~~L~~  146 (580)
                      ++|+|++|+++.....   .+..+++|++|+|++|++++..|..+..+   ++|++|+|++|+++ .+|..+.  ++|+.
T Consensus       200 ~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~  276 (310)
T 4glp_A          200 QNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRV  276 (310)
T ss_dssp             CSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSC
T ss_pred             CEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCE
Confidence            9999999999753322   35788999999999999998878877777   69999999999999 6677664  89999


Q ss_pred             eecccccCcCc
Q 008031          147 FNVSYNNLSGP  157 (580)
Q Consensus       147 l~l~~n~l~~~  157 (580)
                      |++++|++++.
T Consensus       277 L~Ls~N~l~~~  287 (310)
T 4glp_A          277 LDLSSNRLNRA  287 (310)
T ss_dssp             EECCSCCCCSC
T ss_pred             EECCCCcCCCC
Confidence            99999999974

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.76  E-value=3.8e-18  Score=186.12  Aligned_cols=145  Identities=26%  Similarity=0.312  Sum_probs=64.7

Q ss_pred             EEEecCCcccccccccccCCC--CCcEEEccCCccCCCCCcccc-------CCCCCCEEEeeCCcCCCCCCccCcCCCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLS--ELQEISLSHNKISGVMPSDLG-------RLSRLRILDFSYNAINGSLPASFSNLSSL   72 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L   72 (580)
                      +|+|++|.|+ .+|..+..+.  +|+.|+|++|.+++..|..|.       .+++|++|+|++|+|++..+..+..+++|
T Consensus       381 ~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L  459 (636)
T 4eco_A          381 NLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL  459 (636)
T ss_dssp             EEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCC
T ss_pred             EEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCC
Confidence            4555555555 4444444433  455555555555544444444       44445555555555542222223334444


Q ss_pred             CEEECcCCCCCcccchhhhcc-------CCCCeeeeccccccccCCcccc--CCCCCcEEEccccccCCcccccccCcCC
Q 008031           73 VSLTLESNNLDDQILDSLDKL-------HNLSVLNLKRNQISGHIPSTIG--NISTLTILDLSQNKLSGEIPASFSNLKS  143 (580)
Q Consensus        73 ~~L~l~~N~l~~~~~~~~~~l-------~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~l~~l~~  143 (580)
                      +.|+|++|+++.+.+..+..+       ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++
T Consensus       460 ~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~  537 (636)
T 4eco_A          460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST  537 (636)
T ss_dssp             SEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSS
T ss_pred             CEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCC
Confidence            444444444442222222211       14444444444444 3333333  44444444444444443 4444444444


Q ss_pred             CCeeec
Q 008031          144 LSSFNV  149 (580)
Q Consensus       144 L~~l~l  149 (580)
                      |+.|++
T Consensus       538 L~~L~L  543 (636)
T 4eco_A          538 LKGFGI  543 (636)
T ss_dssp             CCEEEC
T ss_pred             CCEEEC
Confidence            444444

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.75  E-value=6.1e-19  Score=196.30  Aligned_cols=156  Identities=26%  Similarity=0.386  Sum_probs=117.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEc-cCCccCCC-------------------------------------------
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISL-SHNKISGV-------------------------------------------   37 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l-~~n~l~~~-------------------------------------------   37 (580)
                      .|+|++|.|.|.+|+.|++|++|+.|+| ++|.+.+.                                           
T Consensus       327 ~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~  406 (876)
T 4ecn_A          327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD  406 (876)
T ss_dssp             EEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHH
T ss_pred             EEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHH
Confidence            5788888888888888888888888888 66644322                                           


Q ss_pred             ---------------------------------CCccccCCCCCCEEEeeCCcCCC-----------------CCCccCc
Q 008031           38 ---------------------------------MPSDLGRLSRLRILDFSYNAING-----------------SLPASFS   67 (580)
Q Consensus        38 ---------------------------------~~~~~~~l~~L~~L~l~~n~l~~-----------------~~~~~~~   67 (580)
                                                       +|..|..+++|+.|+|++|+|++                 .+|..+.
T Consensus       407 ~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~  486 (876)
T 4ecn_A          407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS  486 (876)
T ss_dssp             HHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCC
T ss_pred             HhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhh
Confidence                                             56677778888888888888876                 2677766


Q ss_pred             --CCCCCCEEECcCCCCCcccchhhhccCCCCeeeecccc-ccc-cCCccccCCC-------CCcEEEccccccCCcccc
Q 008031           68 --NLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQ-ISG-HIPSTIGNIS-------TLTILDLSQNKLSGEIPA  136 (580)
Q Consensus        68 --~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~-~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~  136 (580)
                        ++++|+.|+|++|++.+.+|..|..+++|+.|+|++|+ +++ .+|..++.++       +|++|+|++|.++ .+|.
T Consensus       487 f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~  565 (876)
T 4ecn_A          487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA  565 (876)
T ss_dssp             GGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred             hccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence              78888888888888777777778888888888888887 776 5666555544       7888888888877 6776


Q ss_pred             --cccCcCCCCeeecccccCcCccC
Q 008031          137 --SFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       137 --~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                        .|..+++|+.|++++|+++ .+|
T Consensus       566 ~~~l~~L~~L~~L~Ls~N~l~-~lp  589 (876)
T 4ecn_A          566 SASLQKMVKLGLLDCVHNKVR-HLE  589 (876)
T ss_dssp             HHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred             hhhhhcCCCCCEEECCCCCcc-cch
Confidence              7777888888888888777 555

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.75  E-value=3.1e-18  Score=184.98  Aligned_cols=161  Identities=26%  Similarity=0.334  Sum_probs=128.6

Q ss_pred             CEEEecCCcccccc--cccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCC-ccCcCCCCCCEEEC
Q 008031            1 MFLALQYNNLSGRI--PASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLP-ASFSNLSSLVSLTL   77 (580)
Q Consensus         1 ~~L~L~~N~i~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l   77 (580)
                      ++|+|++|++++..  +..+.++++|+.|++++|.+++..+ .+..+++|+.|++++|++++..+ ..+..+++|++|++
T Consensus       350 ~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l  428 (570)
T 2z63_A          350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI  428 (570)
T ss_dssp             CEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEEC
T ss_pred             CEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeC
Confidence            46888888888543  6778888888888888888885443 48888888888888888876555 46788888888888


Q ss_pred             cCCCCCcccchhhhccCCCCeeeecccccc-ccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcC
Q 008031           78 ESNNLDDQILDSLDKLHNLSVLNLKRNQIS-GHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG  156 (580)
Q Consensus        78 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~  156 (580)
                      ++|.+++..+..+..+++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++..|..|..+++|+.|++++|++++
T Consensus       429 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  508 (570)
T 2z63_A          429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS  508 (570)
T ss_dssp             TTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             cCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCC
Confidence            888888777888888888888888888886 4677788888888888888888887778888888888888888888887


Q ss_pred             ccChhh
Q 008031          157 PVPTSL  162 (580)
Q Consensus       157 ~~p~~~  162 (580)
                      .+|..+
T Consensus       509 ~~~~~~  514 (570)
T 2z63_A          509 VPDGIF  514 (570)
T ss_dssp             CCTTTT
T ss_pred             CCHHHh
Confidence            766544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.75  E-value=1.1e-17  Score=164.10  Aligned_cols=145  Identities=26%  Similarity=0.428  Sum_probs=126.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|++++|.|+. ++ .+..+++|++|+|++|.+++..+  +..+++|++|+|++|++++ ++ .+..+++|+.|+|++|
T Consensus        49 ~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n  122 (291)
T 1h6t_A           49 DQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHN  122 (291)
T ss_dssp             CEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTS
T ss_pred             cEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCC
Confidence            478999999984 44 58999999999999999996544  8999999999999999984 44 4899999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      ++++.  ..+..+++|+.|++++|++++.  ..+..+++|++|+|++|.+++..+  +..+++|+.|++++|++++.
T Consensus       123 ~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l  193 (291)
T 1h6t_A          123 GISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL  193 (291)
T ss_dssp             CCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred             cCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC
Confidence            99874  5688899999999999999865  578899999999999999997555  89999999999999999864

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.75  E-value=6.7e-18  Score=181.91  Aligned_cols=156  Identities=26%  Similarity=0.385  Sum_probs=127.7

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCC--CccccCCCCCCEEEeeCCcCCCCCC-ccCcCCCCCCEEEC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVM--PSDLGRLSRLRILDFSYNAINGSLP-ASFSNLSSLVSLTL   77 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l   77 (580)
                      ++|+|++|+|++.+|..+.++++|++|+|++|.+++..  |..|..+++|+.|+|++|++++.+| ..+..+++|+.|+|
T Consensus       356 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l  435 (562)
T 3a79_B          356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL  435 (562)
T ss_dssp             CEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEEC
T ss_pred             eEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEEC
Confidence            46888999998878888889999999999999988533  4568888999999999999986455 45788889999999


Q ss_pred             cCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccccc-ccCcCCCCeeecccccCcC
Q 008031           78 ESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPAS-FSNLKSLSSFNVSYNNLSG  156 (580)
Q Consensus        78 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-l~~l~~L~~l~l~~n~l~~  156 (580)
                      ++|++++..+..+.  ++|+.|+|++|+++ .+|..+..+++|++|+|++|++++ +|.. +..+++|+.|++++|++.+
T Consensus       436 ~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c  511 (562)
T 3a79_B          436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDC  511 (562)
T ss_dssp             CSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCC
T ss_pred             CCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCC
Confidence            99998876665543  68999999999998 667767789999999999999984 5544 8889999999999999987


Q ss_pred             ccCh
Q 008031          157 PVPT  160 (580)
Q Consensus       157 ~~p~  160 (580)
                      ..+.
T Consensus       512 ~c~~  515 (562)
T 3a79_B          512 TCPG  515 (562)
T ss_dssp             CHHH
T ss_pred             Ccch
Confidence            6664

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.74  E-value=5.7e-18  Score=180.80  Aligned_cols=149  Identities=21%  Similarity=0.326  Sum_probs=73.8

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCC--CCCccCcCCCCCCEEECcC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING--SLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~   79 (580)
                      .|++++|.+.+..  .+..+++|++|+|++|.+++..|..+..+++|++|+|++|+|++  .+|..+..+++|+.|+|++
T Consensus       306 ~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~  383 (520)
T 2z7x_B          306 NFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ  383 (520)
T ss_dssp             EEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCS
T ss_pred             EEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCC
Confidence            3555555554211  11345555555555555554455555555555555555555553  2334455555555555555


Q ss_pred             CCCCcccc-hhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCc
Q 008031           80 NNLDDQIL-DSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus        80 N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      |.+++.+| ..+..+++|+.|++++|++++..|..+.  ++|++|+|++|+++ .+|..+..+++|+.|++++|+++
T Consensus       384 N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~  457 (520)
T 2z7x_B          384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK  457 (520)
T ss_dssp             SCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence            55544222 2344455555555555555444443332  45555555555555 44444445555555555555555

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.74  E-value=4.6e-18  Score=191.76  Aligned_cols=160  Identities=28%  Similarity=0.356  Sum_probs=120.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCC-CccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVM-PSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|||++|.|++..+..|.++++|++|+|++|.+.+.+ |..|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        27 ~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  106 (844)
T 3j0a_A           27 ERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF  106 (844)
T ss_dssp             CEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTT
T ss_pred             CEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcC
Confidence            36788888888777778888888888888888544333 67788888888888888888877778888888888888888


Q ss_pred             CCCCcccchh--hhccCCCCeeeeccccccccCC-ccccCCCCCcEEEccccccCCcccccccCc--CCCCeeecccccC
Q 008031           80 NNLDDQILDS--LDKLHNLSVLNLKRNQISGHIP-STIGNISTLTILDLSQNKLSGEIPASFSNL--KSLSSFNVSYNNL  154 (580)
Q Consensus        80 N~l~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l--~~L~~l~l~~n~l  154 (580)
                      |.+++..+..  +..+++|++|+|++|.+++..+ ..++++++|++|+|++|.+++..+..+..+  ++|+.|++++|.+
T Consensus       107 n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l  186 (844)
T 3j0a_A          107 CGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL  186 (844)
T ss_dssp             CCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBS
T ss_pred             CCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCcc
Confidence            8887655544  7778888888888888876544 467788888888888888877777777666  6777777777777


Q ss_pred             cCccCh
Q 008031          155 SGPVPT  160 (580)
Q Consensus       155 ~~~~p~  160 (580)
                      .+..|.
T Consensus       187 ~~~~~~  192 (844)
T 3j0a_A          187 YSRVSV  192 (844)
T ss_dssp             CCCCCC
T ss_pred             cccccc
Confidence            665554

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=1.8e-18  Score=192.44  Aligned_cols=157  Identities=24%  Similarity=0.386  Sum_probs=142.6

Q ss_pred             CEEEecCCcccc-----------------ccccccc--CCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCc-CCC
Q 008031            1 MFLALQYNNLSG-----------------RIPASLG--KLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNA-ING   60 (580)
Q Consensus         1 ~~L~L~~N~i~~-----------------~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~   60 (580)
                      ++|+|++|+|++                 .+|..++  ++++|+.|+|++|.+.+.+|..|..+++|+.|+|++|+ +++
T Consensus       451 ~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg  530 (876)
T 4ecn_A          451 QIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA  530 (876)
T ss_dssp             CEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCH
T ss_pred             CEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCccc
Confidence            479999999997                 3899988  99999999999999999999999999999999999998 887


Q ss_pred             -CCCccCcCC-------CCCCEEECcCCCCCcccch--hhhccCCCCeeeeccccccccCCccccCCCCCcEEEcccccc
Q 008031           61 -SLPASFSNL-------SSLVSLTLESNNLDDQILD--SLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKL  130 (580)
Q Consensus        61 -~~~~~~~~l-------~~L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  130 (580)
                       .+|..+..+       ++|+.|+|++|+++ .+|.  .+..+++|+.|+|++|+++ .+| .+..+++|+.|+|++|.+
T Consensus       531 ~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l  607 (876)
T 4ecn_A          531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQI  607 (876)
T ss_dssp             HHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCC
T ss_pred             ccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCcc
Confidence             678765554       59999999999998 6777  8999999999999999999 777 899999999999999999


Q ss_pred             CCcccccccCcCC-CCeeecccccCcCccChhh
Q 008031          131 SGEIPASFSNLKS-LSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus       131 ~~~~~~~l~~l~~-L~~l~l~~n~l~~~~p~~~  162 (580)
                      + .+|..+..+++ |+.|++++|+++ .+|..+
T Consensus       608 ~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~  638 (876)
T 4ecn_A          608 E-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIF  638 (876)
T ss_dssp             S-CCCTTSCEECTTCCEEECCSSCCC-SCCSCC
T ss_pred             c-cchHHHhhccccCCEEECcCCCCC-cCchhh
Confidence            9 88989999999 999999999999 566543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.74  E-value=2.1e-17  Score=163.59  Aligned_cols=147  Identities=29%  Similarity=0.454  Sum_probs=128.0

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++ +++ +.++++|++|+|++|.+++. + .+..+++|++|+|++|+|++ ++. +..+++|+.|+|++|
T Consensus        66 ~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n  139 (308)
T 1h6u_A           66 IGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLN  139 (308)
T ss_dssp             CEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred             CEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCC
Confidence            479999999995 444 99999999999999999854 3 68899999999999999995 443 899999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      .+++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|.+++..+  +..+++|+.|++++|++++..|
T Consensus       140 ~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~  212 (308)
T 1h6u_A          140 QITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP  212 (308)
T ss_dssp             CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG
T ss_pred             ccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc
Confidence            9987654  8899999999999999996444  8899999999999999986544  8899999999999999997664

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.74  E-value=7.4e-18  Score=181.59  Aligned_cols=138  Identities=23%  Similarity=0.335  Sum_probs=107.4

Q ss_pred             cCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCC--CCccCcCCCCCCEEECcCCCCCc-ccchhhhccCC
Q 008031           19 GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS--LPASFSNLSSLVSLTLESNNLDD-QILDSLDKLHN   95 (580)
Q Consensus        19 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~   95 (580)
                      ..+++|++|+|++|.+++..|..+..+++|++|+|++|+|++.  +|..|..+++|+.|+|++|.+++ ..+..+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            6677888888888888877788888888888888888888852  24567888888888888888877 44445777888


Q ss_pred             CCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           96 LSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        96 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |+.|++++|++++..+..+.  ++|++|+|++|+++ .+|..+..+++|+.|++++|++++.++
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~  490 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPD  490 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCT
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCH
Confidence            88888888888776665543  68888888888888 567666688888888888888885433

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.74  E-value=1.5e-17  Score=163.29  Aligned_cols=145  Identities=30%  Similarity=0.423  Sum_probs=128.8

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++..+  +.++++|+.|+|++|.+++ ++ .+..+++|++|+|++|+|++.  ..+..+++|+.|+|++|
T Consensus        71 ~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n  144 (291)
T 1h6t_A           71 TKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNN  144 (291)
T ss_dssp             CEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSS
T ss_pred             CEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCC
Confidence            479999999995444  9999999999999999985 33 599999999999999999954  46889999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      ++++.  ..+..+++|+.|++++|++++..+  +..+++|+.|+|++|.+++ ++ .+..+++|+.|++++|+++..
T Consensus       145 ~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          145 KITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             CCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred             cCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence            99875  678999999999999999996655  8999999999999999985 44 489999999999999999853

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.74  E-value=8.2e-18  Score=179.53  Aligned_cols=158  Identities=20%  Similarity=0.317  Sum_probs=120.5

Q ss_pred             CEEEecCCcccccccccc-----cCCCCCcEEEccCCccCCCCC-c-------------------------cccCCCCCC
Q 008031            1 MFLALQYNNLSGRIPASL-----GKLSELQEISLSHNKISGVMP-S-------------------------DLGRLSRLR   49 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~-~-------------------------~~~~l~~L~   49 (580)
                      ++|+|++|++++.+|..+     .++++|+.++++.|.+  .+| .                         .+..+++|+
T Consensus       250 ~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~  327 (520)
T 2z7x_B          250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL  327 (520)
T ss_dssp             SEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred             cEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCccc
Confidence            367888888887788777     6666666666655555  122 1                         126788899


Q ss_pred             EEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCc--ccchhhhccCCCCeeeeccccccccCCc-cccCCCCCcEEEcc
Q 008031           50 ILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDD--QILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLTILDLS  126 (580)
Q Consensus        50 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~  126 (580)
                      +|+|++|++++..|..+..+++|++|+|++|++++  ..|..+..+++|+.|++++|++++.+|. .+..+++|++|+++
T Consensus       328 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls  407 (520)
T 2z7x_B          328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS  407 (520)
T ss_dssp             EEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECC
T ss_pred             EEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECc
Confidence            99999999988788888889999999999999986  4456788889999999999999874554 47788899999999


Q ss_pred             ccccCCcccccccCcCCCCeeecccccCcCccChhhh
Q 008031          127 QNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus       127 ~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~  163 (580)
                      +|.+++..+..+.  ++|+.|++++|+++ .+|..+.
T Consensus       408 ~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~  441 (520)
T 2z7x_B          408 SNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV  441 (520)
T ss_dssp             SSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred             CCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence            9998876666554  68889999999988 5565443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=1.7e-17  Score=160.17  Aligned_cols=143  Identities=27%  Similarity=0.461  Sum_probs=78.9

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|+|+ .++ .+..+++|+.|+|++|.|++..+  +..+++|+.|+|++|+|++ +|. +.. ++|+.|+|++|+
T Consensus        45 ~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~  117 (263)
T 1xeu_A           45 NFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNE  117 (263)
T ss_dssp             EEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSC
T ss_pred             EEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCc
Confidence            4556666665 333 45556666666666666654322  5556666666666666653 232 222 556666666666


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      |++.  ..+..+++|+.|+|++|++++. + .+..+++|++|+|++|.+++.  ..+..+++|+.|++++|++++.
T Consensus       118 l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          118 LRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             cCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            6543  2355566666666666666543 2 455566666666666666543  4455566666666666665543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.73  E-value=3.6e-18  Score=183.58  Aligned_cols=154  Identities=20%  Similarity=0.255  Sum_probs=90.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|.++++|++|+|++|.
T Consensus        30 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~  109 (549)
T 2z81_A           30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP  109 (549)
T ss_dssp             EEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred             EEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCc
Confidence            45666666665555556666666666666666665555556666666666666666665444446666666666666666


Q ss_pred             CCcc-cchhhhccCCCCeeeecccc-ccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCc
Q 008031           82 LDDQ-ILDSLDKLHNLSVLNLKRNQ-ISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus        82 l~~~-~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      +++. .+..+..+++|++|++++|. +....+..+..+++|++|++++|.+++..|..+..+++|+.|+++.|.+.
T Consensus       110 l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~  185 (549)
T 2z81_A          110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA  185 (549)
T ss_dssp             CSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred             ccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence            6542 33455556666666666665 33222345556666666666666666555556666666666666666554

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.73  E-value=1.2e-17  Score=149.80  Aligned_cols=137  Identities=19%  Similarity=0.218  Sum_probs=121.7

Q ss_pred             cCCCCCcEEEccCCccC-CCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCC
Q 008031           19 GKLSELQEISLSHNKIS-GVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLS   97 (580)
Q Consensus        19 ~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~   97 (580)
                      ...++|++|+|++|.++ +.+|..+..+++|++|+|++|+|++.  ..|..+++|+.|+|++|.+++..|..+..+++|+
T Consensus        21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   98 (168)
T 2ell_A           21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT   98 (168)
T ss_dssp             SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred             CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence            34578999999999998 67788889999999999999999955  7899999999999999999888888888899999


Q ss_pred             eeeeccccccccCC-ccccCCCCCcEEEccccccCCccc---ccccCcCCCCeeecccccCcCc
Q 008031           98 VLNLKRNQISGHIP-STIGNISTLTILDLSQNKLSGEIP---ASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        98 ~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~---~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      .|+|++|++++... ..+..+++|++|++++|.+++..+   ..+..+++|+.|++++|.+...
T Consensus        99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A           99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            99999999996432 678999999999999999996555   4789999999999999998743

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.72  E-value=3.3e-17  Score=150.27  Aligned_cols=131  Identities=22%  Similarity=0.316  Sum_probs=107.5

Q ss_pred             cEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccc
Q 008031           25 QEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN  104 (580)
Q Consensus        25 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  104 (580)
                      +.+++++|.|+ .+|..+.  ++|+.|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            67888888888 4555443  58888888888888 67778888888888888888888877778888888888888888


Q ss_pred             cccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031          105 QISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       105 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      +|++..+..|..+++|++|+|++|.++...+..|..+++|+.|++++|++.+...
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            8887777788888999999999999986666678889999999999999875443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.72  E-value=5.7e-18  Score=168.56  Aligned_cols=155  Identities=25%  Similarity=0.206  Sum_probs=104.6

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCc----------------
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA----------------   64 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~----------------   64 (580)
                      ++|+|++|+|++..|..|.++++|+.|+|++|.+++..+  +..+++|++|+|++|+|++..+.                
T Consensus        37 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~  114 (317)
T 3o53_A           37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV  114 (317)
T ss_dssp             SEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEE
T ss_pred             CEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCc
Confidence            478999999997777889999999999999999886544  88888888888888887732110                


Q ss_pred             cCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCcccc-CCCCCcEEEccccccCCcccccccCcCC
Q 008031           65 SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIG-NISTLTILDLSQNKLSGEIPASFSNLKS  143 (580)
Q Consensus        65 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~l~~l~~  143 (580)
                      ....+++|+.|++++|++++..+..+..+++|+.|+|++|.+++..+..+. .+++|++|+|++|.+++. + ....+++
T Consensus       115 ~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~  192 (317)
T 3o53_A          115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAK  192 (317)
T ss_dssp             EECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTT
T ss_pred             CccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-ccccccc
Confidence            011234566666666666665555666666677777777766655555443 566677777777776643 2 2334667


Q ss_pred             CCeeecccccCcCccC
Q 008031          144 LSSFNVSYNNLSGPVP  159 (580)
Q Consensus       144 L~~l~l~~n~l~~~~p  159 (580)
                      |+.|++++|++++.++
T Consensus       193 L~~L~Ls~N~l~~l~~  208 (317)
T 3o53_A          193 LKTLDLSSNKLAFMGP  208 (317)
T ss_dssp             CCEEECCSSCCCEECG
T ss_pred             CCEEECCCCcCCcchh
Confidence            7777777777765444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.72  E-value=3.8e-17  Score=149.88  Aligned_cols=128  Identities=27%  Similarity=0.400  Sum_probs=117.4

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      .++++++|+|+ .+|..+.  ++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            36899999999 7777664  58999999999999 67789999999999999999999888888999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSG  132 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  132 (580)
                      +|+...+..|..+++|+.|+|++|+|+...+..+..+++|+.|+|++|.+..
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            9999988899999999999999999997777779999999999999999974

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=2.1e-17  Score=148.26  Aligned_cols=133  Identities=29%  Similarity=0.337  Sum_probs=118.7

Q ss_pred             CEEEecCCccc-ccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLS-GRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++|.|+ +.+|..+..+++|++|+|++|.|++.  ..+..+++|++|+|++|+|++.+|..+..+++|+.|+|++
T Consensus        27 ~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  104 (168)
T 2ell_A           27 RELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG  104 (168)
T ss_dssp             SEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBS
T ss_pred             CEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccC
Confidence            47999999998 77888899999999999999999965  7899999999999999999977888888899999999999


Q ss_pred             CCCCcccc-hhhhccCCCCeeeeccccccccCC---ccccCCCCCcEEEccccccCCcccc
Q 008031           80 NNLDDQIL-DSLDKLHNLSVLNLKRNQISGHIP---STIGNISTLTILDLSQNKLSGEIPA  136 (580)
Q Consensus        80 N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~~~  136 (580)
                      |.|++... ..+..+++|+.|++++|.+++..+   ..+..+++|++|++++|.+. ..|.
T Consensus       105 N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          105 NKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             SSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             CccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            99987543 788999999999999999996554   47889999999999999987 4443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.71  E-value=2.1e-17  Score=177.61  Aligned_cols=158  Identities=26%  Similarity=0.317  Sum_probs=142.6

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      .|+++|.++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|.+
T Consensus        10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   86 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL   86 (549)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence            578899999 7887665  7999999999999988889999999999999999999988888999999999999999999


Q ss_pred             CcccchhhhccCCCCeeeecccccccc-CCccccCCCCCcEEEccccccCCccc-ccccCcCCCCeeecccccCcCccCh
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGH-IPSTIGNISTLTILDLSQNKLSGEIP-ASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ++..+..|..+++|++|+|++|++++. .|..+..+++|++|++++|.+.+.++ ..|..+++|+.|++++|.+++..|.
T Consensus        87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  166 (549)
T 2z81_A           87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ  166 (549)
T ss_dssp             CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred             CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence            998888899999999999999999863 56789999999999999999555554 6899999999999999999988887


Q ss_pred             hhh
Q 008031          161 SLA  163 (580)
Q Consensus       161 ~~~  163 (580)
                      .+.
T Consensus       167 ~l~  169 (549)
T 2z81_A          167 SLK  169 (549)
T ss_dssp             TTT
T ss_pred             hhh
Confidence            654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.71  E-value=9.5e-18  Score=166.96  Aligned_cols=143  Identities=24%  Similarity=0.190  Sum_probs=74.9

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|+|++. +    ..++|++|++++|.+++..+.   .+++|++|+|++|++++..+..+..+++|+.|+|++|.
T Consensus        84 ~L~Ls~n~l~~l-~----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  155 (317)
T 3o53_A           84 TLDLNNNYVQEL-L----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE  155 (317)
T ss_dssp             EEECCSSEEEEE-E----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSC
T ss_pred             EEECcCCccccc-c----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCC
Confidence            566666666632 2    225556666666655543222   24455555555555554444455555555555555555


Q ss_pred             CCcccchhh-hccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCc
Q 008031           82 LDDQILDSL-DKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus        82 l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      +++..+..+ ..+++|++|+|++|.+++. +. ...+++|++|+|++|.+++ ++..+..+++|+.|++++|+++
T Consensus       156 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~  227 (317)
T 3o53_A          156 IDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV  227 (317)
T ss_dssp             CCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred             CCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc
Confidence            555444444 2455555555555555533 21 2235555555555555553 3333555555555555555555

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.71  E-value=8.4e-18  Score=177.23  Aligned_cols=167  Identities=23%  Similarity=0.201  Sum_probs=133.9

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..+     .++|+.|+|++|.|++..+.   .+++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        83 ~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  154 (487)
T 3oja_A           83 RTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN  154 (487)
T ss_dssp             CEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTS
T ss_pred             CEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCC
Confidence            479999999994332     38999999999999966543   4688999999999999888888999999999999999


Q ss_pred             CCCcccchhhh-ccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           81 NLDDQILDSLD-KLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        81 ~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      .|++..|..+. .+++|+.|+|++|.|++..+  +..+++|++|+|++|.+++ +|..+..+++|+.|++++|.+++. |
T Consensus       155 ~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~l-p  230 (487)
T 3oja_A          155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLI-E  230 (487)
T ss_dssp             CCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEE-C
T ss_pred             CCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCccc-c
Confidence            99998888776 78999999999999986633  4458999999999999996 455588999999999999999974 4


Q ss_pred             hhhhh--hcCCCcccccccccC
Q 008031          160 TSLAL--KFNASSFVGNIQLCG  179 (580)
Q Consensus       160 ~~~~~--~~~~~~~~~~~~~~~  179 (580)
                      ..+..  .+....+.+|+..|+
T Consensus       231 ~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          231 KALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             TTCCCCTTCCEEECTTCCBCHH
T ss_pred             hhhccCCCCCEEEcCCCCCcCc
Confidence            43321  233334456666554

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.71  E-value=4.7e-17  Score=175.00  Aligned_cols=145  Identities=27%  Similarity=0.425  Sum_probs=124.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|. .++ .+..+++|+.|+|++|.|++..+  +..+++|+.|+|++|+|++ ++ .|..+++|+.|+|++|
T Consensus        46 ~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N  119 (605)
T 1m9s_A           46 DQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHN  119 (605)
T ss_dssp             CCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTS
T ss_pred             CEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCC
Confidence            35789999998 344 58999999999999999996544  8899999999999999984 44 6889999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      .|+..  ..+..|++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+++..|  +..+++|+.|+|++|+|++.
T Consensus       120 ~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l  190 (605)
T 1m9s_A          120 GISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL  190 (605)
T ss_dssp             CCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred             CCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence            99774  4688899999999999999865  568889999999999999987656  88999999999999999875

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.71  E-value=7.3e-17  Score=146.02  Aligned_cols=134  Identities=22%  Similarity=0.324  Sum_probs=110.7

Q ss_pred             CCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeec
Q 008031           23 ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLK  102 (580)
Q Consensus        23 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  102 (580)
                      +.+.+++++|+++. +|..+  .++|+.|+|++|++++..+..|..+++|++|+|++|+|+...+..+..+++|+.|+|+
T Consensus         8 ~~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A            8 SGTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             ETTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence            35788888888884 45433  3688999999999886666677888899999999999987777778888999999999


Q ss_pred             cccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031          103 RNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       103 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      +|++++..+..+..+++|++|+|++|.+++..+..+..+++|+.|++++|++.+..|
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            999987777778888999999999999987666667889999999999999988766

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.71  E-value=2e-17  Score=145.09  Aligned_cols=129  Identities=21%  Similarity=0.259  Sum_probs=114.2

Q ss_pred             CCCCcEEEccCCccC-CCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCee
Q 008031           21 LSELQEISLSHNKIS-GVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVL   99 (580)
Q Consensus        21 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L   99 (580)
                      .++|+.|++++|.++ +.+|..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+++..|..+..+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            478999999999998 67888889999999999999999955  778999999999999999988788888889999999


Q ss_pred             eecccccccc-CCccccCCCCCcEEEccccccCCccc---ccccCcCCCCeeeccc
Q 008031          100 NLKRNQISGH-IPSTIGNISTLTILDLSQNKLSGEIP---ASFSNLKSLSSFNVSY  151 (580)
Q Consensus       100 ~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~---~~l~~l~~L~~l~l~~  151 (580)
                      ++++|++++. .+..+..+++|++|++++|.+++..+   ..+..+++|+.||+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            9999999864 34778999999999999999996655   4789999999999864

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.71  E-value=7.3e-17  Score=162.76  Aligned_cols=147  Identities=26%  Similarity=0.424  Sum_probs=71.6

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|++++|.+.+..+  +..+++|++|++++|.+++. +. +..+++|+.|++++|++++..+  +..+++|+.|++++|.
T Consensus       159 ~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~  232 (347)
T 4fmz_A          159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK  232 (347)
T ss_dssp             EEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred             EEEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence            45666666653222  55666666666666666532 21 4455555555555555543222  4445555555555555


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ++...+  +..+++|+.|++++|.+++.  +.+..+++|++|++++|.+++.  ..+..+++|+.|++++|++++..|.
T Consensus       233 l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~  305 (347)
T 4fmz_A          233 ITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME  305 (347)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred             cCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence            544332  44445555555555554432  2344445555555555554432  2344444555555555554444333

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.70  E-value=6.9e-17  Score=173.73  Aligned_cols=146  Identities=30%  Similarity=0.413  Sum_probs=130.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.|++..+  +.++++|+.|+|++|.|++ +| .+..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|
T Consensus        68 ~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N  141 (605)
T 1m9s_A           68 TKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNN  141 (605)
T ss_dssp             CEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred             CEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCC
Confidence            479999999996544  9999999999999999995 34 78999999999999999995 3 45899999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCcc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      .|++.  ..+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++++.+
T Consensus       142 ~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p  213 (605)
T 1m9s_A          142 KITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP  213 (605)
T ss_dssp             CCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred             ccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence            99875  678899999999999999997666  89999999999999999964  46999999999999999998653

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.70  E-value=1.2e-16  Score=144.59  Aligned_cols=131  Identities=24%  Similarity=0.320  Sum_probs=116.8

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .+++++|+++ .+|..+.  ++|++|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        11 ~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   87 (177)
T 2o6r_A           11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK   87 (177)
T ss_dssp             EEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence            6899999999 5665443  699999999999998777788999999999999999997777778999999999999999


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccc
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP  135 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  135 (580)
                      |++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|.+++..+
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            998888888999999999999999997777667889999999999999986543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.70  E-value=4e-17  Score=150.50  Aligned_cols=135  Identities=18%  Similarity=0.326  Sum_probs=121.3

Q ss_pred             ccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCC
Q 008031           18 LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLS   97 (580)
Q Consensus        18 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~   97 (580)
                      ...+++|+.|++++|.|+ .+| .+..+++|++|++++|.++ .+ ..+..+++|++|++++|.+++..+..+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            467789999999999999 556 6899999999999999887 33 4789999999999999999988888999999999


Q ss_pred             eeeeccccccccCCccccCCCCCcEEEccccc-cCCcccccccCcCCCCeeecccccCcCcc
Q 008031           98 VLNLKRNQISGHIPSTIGNISTLTILDLSQNK-LSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus        98 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      +|++++|++++..+..+..+++|++|+|++|. ++ .++ .+..+++|+.|++++|++++..
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~  175 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR  175 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH
Confidence            99999999998788889999999999999998 66 455 6999999999999999998743

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.69  E-value=3.7e-17  Score=143.42  Aligned_cols=125  Identities=24%  Similarity=0.362  Sum_probs=113.0

Q ss_pred             CEEEecCCccc-ccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLS-GRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|++++|.++ +.+|..+..+++|+.|+|++|.+++.  ..+..+++|++|+|++|+|++.+|..+..+++|+.|++++
T Consensus        20 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~   97 (149)
T 2je0_A           20 KELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG   97 (149)
T ss_dssp             SEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTT
T ss_pred             eEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCC
Confidence            47999999999 78898999999999999999999966  7899999999999999999977888888899999999999


Q ss_pred             CCCCcc-cchhhhccCCCCeeeeccccccccCC---ccccCCCCCcEEEccc
Q 008031           80 NNLDDQ-ILDSLDKLHNLSVLNLKRNQISGHIP---STIGNISTLTILDLSQ  127 (580)
Q Consensus        80 N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~~  127 (580)
                      |.+++. .+..+..+++|+.|++++|++++..+   ..+..+++|+.|++++
T Consensus        98 N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           98 NKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             SCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            999875 34789999999999999999997655   4788999999999874

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.69  E-value=1.1e-16  Score=161.48  Aligned_cols=149  Identities=30%  Similarity=0.463  Sum_probs=131.7

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|++++|.+++ ++. +..+++|+.|++++|.+++..+  +..+++|++|+|++|++++. +. +..+++|+.|++++|
T Consensus       180 ~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n  253 (347)
T 4fmz_A          180 YSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTN  253 (347)
T ss_dssp             SEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSS
T ss_pred             CEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCC
Confidence            479999999994 443 8999999999999999996543  88999999999999999954 43 889999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      .++..  ..+..+++|+.|++++|++++.  +.+..+++|+.|++++|.+++..+..+..+++|+.|++++|++++.+|
T Consensus       254 ~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~  328 (347)
T 4fmz_A          254 QISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP  328 (347)
T ss_dssp             CCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred             ccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence            99874  4688999999999999999864  458889999999999999998888889999999999999999998877

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.69  E-value=8.5e-18  Score=185.34  Aligned_cols=122  Identities=25%  Similarity=0.320  Sum_probs=67.4

Q ss_pred             CCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccC
Q 008031           37 VMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGN  116 (580)
Q Consensus        37 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  116 (580)
                      ..++.|..+++|+.|+|++|+|. .+|..+..+++|+.|+|++|.|+ .+|..|..|++|+.|+|++|+|+ .+|..++.
T Consensus       215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~  291 (727)
T 4b8c_D          215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS  291 (727)
T ss_dssp             -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred             cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence            34555555666666666666665 44544555666666666666665 44555556666666666666665 44555666


Q ss_pred             CCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChhh
Q 008031          117 ISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus       117 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                      +++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|++.+|..+
T Consensus       292 l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~  336 (727)
T 4b8c_D          292 CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL  336 (727)
T ss_dssp             GTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred             CCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence            666666666666655 445556666666666666666665555544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=3.2e-17  Score=163.78  Aligned_cols=137  Identities=14%  Similarity=0.182  Sum_probs=99.3

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccc--------------cHH--------HHHHHHHHHhcCCCCcce
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK--------------GQR--------EFESEVSLLGKIRHPNLL  346 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~e~~~l~~l~h~niv  346 (580)
                      |++.+.||+|+||.||+|...+|+.||||+++.....              ...        ...+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            5567899999999999999999999999987532110              001        124567777777544432


Q ss_pred             eeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-
Q 008031          347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-  425 (580)
Q Consensus       347 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-  425 (580)
                      -..-+..   ...++||||++|++|.++...         .....++.|++.+|.|||+. |||||||||.|||+++++ 
T Consensus       177 vp~p~~~---~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPIAQ---SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH-GLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEEEE---ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEEEEEC
T ss_pred             CCeeeec---cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeCCCC
Confidence            2211211   134799999999888765432         12456889999999999994 999999999999998766 


Q ss_pred             ---------CeEEeeccccccc
Q 008031          426 ---------NAKISDFGLSRLM  438 (580)
Q Consensus       426 ---------~~kl~Dfg~~~~~  438 (580)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999976543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.68  E-value=1.5e-16  Score=169.21  Aligned_cols=142  Identities=23%  Similarity=0.372  Sum_probs=86.7

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|+|++ +|. +.+  +|+.|+|++|.|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+
T Consensus       104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~  171 (571)
T 3cvr_A          104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ  171 (571)
T ss_dssp             EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred             EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence            44555555553 443 333  55555555555553 333   35566666666666653 443   35566777777777


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCC-------cEEEccccccCCcccccccCcCCCCeeecccccC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL-------TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL  154 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-------~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l  154 (580)
                      |++ +|. |.  ++|+.|+|++|+|+ .+|. +..  +|       +.|+|++|.|+ .+|..+..+++|+.|+|++|+|
T Consensus       172 L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l  242 (571)
T 3cvr_A          172 LTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL  242 (571)
T ss_dssp             CSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSC
T ss_pred             CCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcC
Confidence            665 333 43  67777777777777 4554 443  56       77888888887 5677677788888888888888


Q ss_pred             cCccChhhhh
Q 008031          155 SGPVPTSLAL  164 (580)
Q Consensus       155 ~~~~p~~~~~  164 (580)
                      ++.+|..+..
T Consensus       243 ~~~~p~~l~~  252 (571)
T 3cvr_A          243 SSRIRESLSQ  252 (571)
T ss_dssp             CHHHHHHHHH
T ss_pred             CCcCHHHHHH
Confidence            8777776653

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.67  E-value=8.8e-17  Score=155.19  Aligned_cols=142  Identities=22%  Similarity=0.313  Sum_probs=123.1

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      ++|++|.+++ ++ .+..+++|+.|++++|.|+. ++ .+..+++|+.|+|++|+|++..+  +..+++|+.|+|++|++
T Consensus        24 l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l   97 (263)
T 1xeu_A           24 QNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRL   97 (263)
T ss_dssp             HHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCC
T ss_pred             HHhcCCCccc-cc-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCcc
Confidence            5688899984 44 68899999999999999994 55 68899999999999999995544  99999999999999999


Q ss_pred             CcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      ++..+  +.. ++|+.|+|++|++++. + .+..+++|+.|+|++|++++. + .+..+++|+.|++++|++++.
T Consensus        98 ~~l~~--~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A           98 KNLNG--IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             SCCTT--CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CCcCc--ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            87433  333 8999999999999964 3 589999999999999999964 4 689999999999999999976

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.67  E-value=4.1e-16  Score=163.82  Aligned_cols=144  Identities=33%  Similarity=0.456  Sum_probs=87.5

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|++++|.+++..+  ++.+++|++|++++|.+++.  ..+..+++|+.|++++|++++..+  +..+++|+.|++++|.
T Consensus       203 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~  276 (466)
T 1o6v_A          203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ  276 (466)
T ss_dssp             EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred             EEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCc
Confidence            56777777774433  56666777777777766643  346666666666666666664433  5666666666666666


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      +++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|.+++..+  +..+++|+.|++++|++++.
T Consensus       277 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          277 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             CCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             cCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence            655433  5566666666666666664333  5556666666666666665443  55556666666666666543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.67  E-value=3.5e-16  Score=164.39  Aligned_cols=147  Identities=32%  Similarity=0.480  Sum_probs=129.6

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|++++ + +.+..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|
T Consensus       224 ~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n  297 (466)
T 1o6v_A          224 DELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN  297 (466)
T ss_dssp             CEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSS
T ss_pred             CEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCC
Confidence            478999999995 3 468999999999999999996544  8899999999999999995544  889999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      ++++..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++..|
T Consensus       298 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~  370 (466)
T 1o6v_A          298 QLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP  370 (466)
T ss_dssp             CCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred             cccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence            9987655  7899999999999999997665  78899999999999999965  468999999999999999998877

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.67  E-value=1.4e-16  Score=143.89  Aligned_cols=135  Identities=19%  Similarity=0.215  Sum_probs=117.3

Q ss_pred             ccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCC
Q 008031           16 ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHN   95 (580)
Q Consensus        16 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~   95 (580)
                      ..+.++.+|++|+|++|.++. +|......++|++|+|++|+|++.  ..|..+++|+.|+|++|.|++..+..+..+++
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            457889999999999999995 465444445999999999999954  67999999999999999999876667799999


Q ss_pred             CCeeeeccccccccCCc--cccCCCCCcEEEccccccCCccccc----ccCcCCCCeeecccccCc
Q 008031           96 LSVLNLKRNQISGHIPS--TIGNISTLTILDLSQNKLSGEIPAS----FSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus        96 L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~----l~~l~~L~~l~l~~n~l~  155 (580)
                      |+.|+|++|+++ .+|.  .+..+++|+.|++++|.++ .+|..    +..+++|+.||++.|.+.
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            999999999997 4555  7889999999999999998 55654    899999999999999876

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.66  E-value=5.8e-18  Score=181.04  Aligned_cols=153  Identities=20%  Similarity=0.216  Sum_probs=128.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCc-------------cCCCCCccccC------------------------
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNK-------------ISGVMPSDLGR------------------------   44 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~-------------l~~~~~~~~~~------------------------   44 (580)
                      .|+|++|+|+ .+|+.+++|++|++|++++|.             +.+..|..+..                        
T Consensus       353 ~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~l~  431 (567)
T 1dce_A          353 RCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL  431 (567)
T ss_dssp             SCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH
T ss_pred             eccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhhhhh
Confidence            4678888887 788888888888888887664             23233332221                        


Q ss_pred             --------CCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccC
Q 008031           45 --------LSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGN  116 (580)
Q Consensus        45 --------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  116 (580)
                              ...|+.|+|++|+|++ +|. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +| .++.
T Consensus       432 ~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~  506 (567)
T 1dce_A          432 ENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVAN  506 (567)
T ss_dssp             HHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTT
T ss_pred             cccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCC
Confidence                    1258899999999995 676 999999999999999998 668899999999999999999996 56 7999


Q ss_pred             CCCCcEEEccccccCCcc-cccccCcCCCCeeecccccCcCccCh
Q 008031          117 ISTLTILDLSQNKLSGEI-PASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus       117 l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +++|++|+|++|+|++.. |..|..+++|+.|+|++|++++.+|.
T Consensus       507 l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            999999999999999876 99999999999999999999987764

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.63  E-value=2.8e-16  Score=173.24  Aligned_cols=157  Identities=21%  Similarity=0.237  Sum_probs=125.7

Q ss_pred             EEecCCcccc---------cccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCC
Q 008031            3 LALQYNNLSG---------RIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLV   73 (580)
Q Consensus         3 L~L~~N~i~~---------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~   73 (580)
                      ++|+.|.|.+         ..+..+..+++|+.|+|++|.|. .+|..+..+++|++|+|++|+|+ .+|..|.+|++|+
T Consensus       196 l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~  273 (727)
T 4b8c_D          196 KKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLR  273 (727)
T ss_dssp             --------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCC
T ss_pred             CccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCC
Confidence            4556655553         44778999999999999999999 67777779999999999999999 8899999999999


Q ss_pred             EEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCC-CCeeecccc
Q 008031           74 SLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKS-LSSFNVSYN  152 (580)
Q Consensus        74 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~-L~~l~l~~n  152 (580)
                      .|+|++|.|+ .+|..|..|++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|
T Consensus       274 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N  351 (727)
T 4b8c_D          274 VLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDN  351 (727)
T ss_dssp             EEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHC
T ss_pred             EEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccC
Confidence            9999999998 56889999999999999999998 77888999999999999999999988888766532 235899999


Q ss_pred             cCcCccChhhh
Q 008031          153 NLSGPVPTSLA  163 (580)
Q Consensus       153 ~l~~~~p~~~~  163 (580)
                      .+++.+|..+.
T Consensus       352 ~l~~~~p~~l~  362 (727)
T 4b8c_D          352 RPEIPLPHERR  362 (727)
T ss_dssp             CCCCCCCCC--
T ss_pred             cccCcCccccc
Confidence            99999998654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.63  E-value=8.1e-17  Score=163.38  Aligned_cols=163  Identities=21%  Similarity=0.245  Sum_probs=130.9

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCC----ccccCCC-CCCEEEeeCCcCCCCCCccCcCC-----C
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMP----SDLGRLS-RLRILDFSYNAINGSLPASFSNL-----S   70 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l-----~   70 (580)
                      |+++|++|.+++.+|..+...++|++|||++|.|+...+    ..|..++ +|++|+|++|+|++..+..|..+     +
T Consensus         1 ~~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~   80 (362)
T 3goz_A            1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA   80 (362)
T ss_dssp             CEEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred             CccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence            578999999998888877777789999999999997666    7788888 89999999999987766666664     8


Q ss_pred             CCCEEECcCCCCCcccchhhhc----c-CCCCeeeeccccccccCCccccC-----CCCCcEEEccccccCCcc----cc
Q 008031           71 SLVSLTLESNNLDDQILDSLDK----L-HNLSVLNLKRNQISGHIPSTIGN-----ISTLTILDLSQNKLSGEI----PA  136 (580)
Q Consensus        71 ~L~~L~l~~N~l~~~~~~~~~~----l-~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~----~~  136 (580)
                      +|++|+|++|.+++..+..+..    + ++|+.|+|++|++++..+..+..     .++|++|+|++|.+++..    +.
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  160 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ  160 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence            9999999999998777665544    3 89999999999998766554433     368999999999998533    33


Q ss_pred             cccCcC-CCCeeecccccCcCccChhhh
Q 008031          137 SFSNLK-SLSSFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus       137 ~l~~l~-~L~~l~l~~n~l~~~~p~~~~  163 (580)
                      .+..++ +|+.|++++|++++..+..+.
T Consensus       161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~  188 (362)
T 3goz_A          161 ILAAIPANVNSLNLRGNNLASKNCAELA  188 (362)
T ss_dssp             HHHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             HHhcCCccccEeeecCCCCchhhHHHHH
Confidence            445555 899999999999877766554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.63  E-value=7.5e-17  Score=161.92  Aligned_cols=161  Identities=17%  Similarity=0.216  Sum_probs=128.7

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCC-CCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGV-MPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|++++|.+++..+. +.++++|++|+|++|.+++. ++..+..+++|++|+|++|++++..+..+..+++|++|+|++
T Consensus        73 ~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~  151 (336)
T 2ast_B           73 IAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  151 (336)
T ss_dssp             SEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             eEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCC
Confidence            3688999999865544 66789999999999998754 677788899999999999998877778888899999999999


Q ss_pred             C-CCCcc-cchhhhccCCCCeeeeccc-ccccc-CCccccCCC-CCcEEEcccc--ccC-CcccccccCcCCCCeeeccc
Q 008031           80 N-NLDDQ-ILDSLDKLHNLSVLNLKRN-QISGH-IPSTIGNIS-TLTILDLSQN--KLS-GEIPASFSNLKSLSSFNVSY  151 (580)
Q Consensus        80 N-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~-~L~~L~l~~N--~l~-~~~~~~l~~l~~L~~l~l~~  151 (580)
                      | .+++. .+..+..+++|++|++++| .+++. ++..+..++ +|++|+|++|  .++ +.++..+..+++|+.|++++
T Consensus       152 ~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~  231 (336)
T 2ast_B          152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD  231 (336)
T ss_dssp             CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred             CCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCC
Confidence            8 67763 5666788899999999999 88754 566677888 9999999998  455 35566777888999999999


Q ss_pred             cc-CcCccChhh
Q 008031          152 NN-LSGPVPTSL  162 (580)
Q Consensus       152 n~-l~~~~p~~~  162 (580)
                      |. +++..+..+
T Consensus       232 ~~~l~~~~~~~l  243 (336)
T 2ast_B          232 SVMLKNDCFQEF  243 (336)
T ss_dssp             CTTCCGGGGGGG
T ss_pred             CCcCCHHHHHHH
Confidence            98 665555544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.62  E-value=4.6e-18  Score=156.96  Aligned_cols=146  Identities=24%  Similarity=0.325  Sum_probs=95.2

Q ss_pred             EEecCCcccccccc------cccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEE
Q 008031            3 LALQYNNLSGRIPA------SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLT   76 (580)
Q Consensus         3 L~L~~N~i~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~   76 (580)
                      ++|+.|.+++.+|.      .+..+++|++|+|++|.|++ +| .+..+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus        23 l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~   99 (198)
T 1ds9_A           23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW   99 (198)
T ss_dssp             TTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEE
T ss_pred             cchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEE
Confidence            45556666655554      67777777777777777774 45 6667777777777777776 5566666667777777


Q ss_pred             CcCCCCCcccchhhhccCCCCeeeeccccccccCC-ccccCCCCCcEEEccccccCCcccc----------cccCcCCCC
Q 008031           77 LESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIP-STIGNISTLTILDLSQNKLSGEIPA----------SFSNLKSLS  145 (580)
Q Consensus        77 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----------~l~~l~~L~  145 (580)
                      |++|++++. + .+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+++..|.          .+..+++|+
T Consensus       100 L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~  177 (198)
T 1ds9_A          100 ISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK  177 (198)
T ss_dssp             EEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCS
T ss_pred             CcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcE
Confidence            777777653 2 46667777777777777764322 3566677777777777777654443          256667777


Q ss_pred             eeecccccCc
Q 008031          146 SFNVSYNNLS  155 (580)
Q Consensus       146 ~l~l~~n~l~  155 (580)
                      .||  +|+++
T Consensus       178 ~Ld--~~~i~  185 (198)
T 1ds9_A          178 KLD--GMPVD  185 (198)
T ss_dssp             EEC--CGGGT
T ss_pred             EEC--CcccC
Confidence            665  55554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.62  E-value=3.3e-17  Score=167.83  Aligned_cols=157  Identities=18%  Similarity=0.259  Sum_probs=95.4

Q ss_pred             CEEEecCC---cccccccccc-------cCCCCCcEEEccCCccCC----CCCccccCCCCCCEEEeeCCcCCCCCCcc-
Q 008031            1 MFLALQYN---NLSGRIPASL-------GKLSELQEISLSHNKISG----VMPSDLGRLSRLRILDFSYNAINGSLPAS-   65 (580)
Q Consensus         1 ~~L~L~~N---~i~~~~~~~~-------~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-   65 (580)
                      ++|+|++|   ++++.+|..+       .++++|++|+|++|.|+.    .+|..+..+++|++|+|++|.|+...+.. 
T Consensus        63 ~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l  142 (386)
T 2ca6_A           63 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI  142 (386)
T ss_dssp             CEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHH
T ss_pred             cEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHH
Confidence            35677775   3334444443       567777777777777775    24556666777777777777775322222 


Q ss_pred             ---CcCC---------CCCCEEECcCCCCCc-ccc---hhhhccCCCCeeeeccccccc-----cCCccccCCCCCcEEE
Q 008031           66 ---FSNL---------SSLVSLTLESNNLDD-QIL---DSLDKLHNLSVLNLKRNQISG-----HIPSTIGNISTLTILD  124 (580)
Q Consensus        66 ---~~~l---------~~L~~L~l~~N~l~~-~~~---~~~~~l~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~L~  124 (580)
                         +..+         ++|++|+|++|+++. ..+   ..+..+++|+.|+|++|+++.     ..+..+..+++|++|+
T Consensus       143 ~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~  222 (386)
T 2ca6_A          143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD  222 (386)
T ss_dssp             HHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEE
T ss_pred             HHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEE
Confidence               2233         677777777777752 223   345566677777777776652     2333566666777777


Q ss_pred             ccccccC----CcccccccCcCCCCeeecccccCcCc
Q 008031          125 LSQNKLS----GEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus       125 l~~N~l~----~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      |++|.++    ..++..+..+++|+.|+|++|.+++.
T Consensus       223 Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~  259 (386)
T 2ca6_A          223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR  259 (386)
T ss_dssp             CCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             CcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence            7777664    34555666666777777777766644

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.62  E-value=1.3e-15  Score=153.72  Aligned_cols=159  Identities=19%  Similarity=0.184  Sum_probs=114.4

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCC-CccccCCCCCCE-EEeeCCcCCCCCCccCcCCCCCCEEECc
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVM-PSDLGRLSRLRI-LDFSYNAINGSLPASFSNLSSLVSLTLE   78 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~   78 (580)
                      ++|+|++|+|+.+.+..|.++++|++|+|++|.+.+.+ +..|..+++|+. +.+++|+|+...|..|..+++|++|+++
T Consensus        33 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~  112 (350)
T 4ay9_X           33 IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS  112 (350)
T ss_dssp             SEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEE
T ss_pred             CEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccc
Confidence            47899999999544567899999999999999986544 456788888775 6667788887777888899999999999


Q ss_pred             CCCCCcccchhhh-------------------------cc-CCCCeeeeccccccccCCccccCCCCCcEEEccc-cccC
Q 008031           79 SNNLDDQILDSLD-------------------------KL-HNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ-NKLS  131 (580)
Q Consensus        79 ~N~l~~~~~~~~~-------------------------~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~  131 (580)
                      +|+|+...+..+.                         .+ ..++.|+|++|+|+. ++.......+|+.|++++ |.++
T Consensus       113 ~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~  191 (350)
T 4ay9_X          113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE  191 (350)
T ss_dssp             EECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCC
T ss_pred             ccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCccc
Confidence            8888664433221                         12 246667777777774 344444456777788764 5555


Q ss_pred             CcccccccCcCCCCeeecccccCcCccCh
Q 008031          132 GEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus       132 ~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ...+..|..+++|+.||+++|+|+..++.
T Consensus       192 ~i~~~~f~~l~~L~~LdLs~N~l~~lp~~  220 (350)
T 4ay9_X          192 ELPNDVFHGASGPVILDISRTRIHSLPSY  220 (350)
T ss_dssp             CCCTTTTTTEECCSEEECTTSCCCCCCSS
T ss_pred             CCCHHHhccCcccchhhcCCCCcCccChh
Confidence            44445678888888888888888865443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.62  E-value=1e-16  Score=160.99  Aligned_cols=152  Identities=21%  Similarity=0.277  Sum_probs=76.5

Q ss_pred             EEEecCCccccc-ccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCC-cCCC-CCCccCcCCCCCCEEECc
Q 008031            2 FLALQYNNLSGR-IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN-AING-SLPASFSNLSSLVSLTLE   78 (580)
Q Consensus         2 ~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~-~~~~~~~~l~~L~~L~l~   78 (580)
                      +|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+..+++|++|+|++| .+++ .++..+..+++|++|+++
T Consensus        97 ~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~  176 (336)
T 2ast_B           97 HMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS  176 (336)
T ss_dssp             EEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECC
T ss_pred             EEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCC
Confidence            455555555533 4444555555555555555555444445555555555555555 3442 133444455555555555


Q ss_pred             CC-CCCcc-cchhhhccC-CCCeeeeccc--ccc-ccCCccccCCCCCcEEEccccc-cCCcccccccCcCCCCeeeccc
Q 008031           79 SN-NLDDQ-ILDSLDKLH-NLSVLNLKRN--QIS-GHIPSTIGNISTLTILDLSQNK-LSGEIPASFSNLKSLSSFNVSY  151 (580)
Q Consensus        79 ~N-~l~~~-~~~~~~~l~-~L~~L~l~~N--~l~-~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~l~~l~~L~~l~l~~  151 (580)
                      +| .+++. .+..+..++ +|++|++++|  .++ +.++..+..+++|++|+|++|. +++..+..+..+++|+.|++++
T Consensus       177 ~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~  256 (336)
T 2ast_B          177 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR  256 (336)
T ss_dssp             CCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             CCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCC
Confidence            55 55432 344445555 5555555555  232 2233344455555555555555 4444444555555555555555


Q ss_pred             cc
Q 008031          152 NN  153 (580)
Q Consensus       152 n~  153 (580)
                      |.
T Consensus       257 ~~  258 (336)
T 2ast_B          257 CY  258 (336)
T ss_dssp             CT
T ss_pred             CC
Confidence            53

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.61  E-value=5.4e-15  Score=154.37  Aligned_cols=139  Identities=19%  Similarity=0.258  Sum_probs=110.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++. +  ++++++|++|+|++|.++++ |  +..+++|++|++++|+|++. +  +..+++|++|++++|
T Consensus        88 ~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n  158 (457)
T 3bz5_A           88 TYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLN  158 (457)
T ss_dssp             SEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTC
T ss_pred             CEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCC
Confidence            4789999999964 3  88999999999999999864 4  88899999999999999863 3  778888888888888


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG  156 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~  156 (580)
                      ...+..  .+..+++|+.|++++|++++ +|  +..+++|+.|++++|.+++.   .+..+++|+.|++++|++++
T Consensus       159 ~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~  226 (457)
T 3bz5_A          159 KKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE  226 (457)
T ss_dssp             SCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred             Cccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc
Confidence            544433  46677888888888888875 34  67778888888888888754   37777888888888888876

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.61  E-value=1.2e-16  Score=162.22  Aligned_cols=159  Identities=19%  Similarity=0.249  Sum_probs=128.2

Q ss_pred             CEEEecCCccccccc----ccccCCC-CCcEEEccCCccCCCCCccccCC-----CCCCEEEeeCCcCCCCCCcc----C
Q 008031            1 MFLALQYNNLSGRIP----ASLGKLS-ELQEISLSHNKISGVMPSDLGRL-----SRLRILDFSYNAINGSLPAS----F   66 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~----~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~----~   66 (580)
                      ++|||++|.|++..+    ..|.+++ +|++|+|++|.|++..+..+..+     ++|++|+|++|+|++..+..    +
T Consensus        25 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l  104 (362)
T 3goz_A           25 TSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTL  104 (362)
T ss_dssp             CEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHH
T ss_pred             eEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHH
Confidence            479999999997666    7888998 89999999999998777777775     99999999999999665553    4


Q ss_pred             cCC-CCCCEEECcCCCCCcccchhhhc-----cCCCCeeeeccccccccCCc----cccCCC-CCcEEEccccccCCccc
Q 008031           67 SNL-SSLVSLTLESNNLDDQILDSLDK-----LHNLSVLNLKRNQISGHIPS----TIGNIS-TLTILDLSQNKLSGEIP  135 (580)
Q Consensus        67 ~~l-~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~~~----~~~~l~-~L~~L~l~~N~l~~~~~  135 (580)
                      ..+ ++|+.|+|++|.|+...+..+..     ..+|++|+|++|++++....    .+..++ +|++|+|++|.+++..+
T Consensus       105 ~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~  184 (362)
T 3goz_A          105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC  184 (362)
T ss_dssp             HTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred             HhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence            445 89999999999998877665543     36999999999999864433    345555 99999999999987666


Q ss_pred             ccc----cCc-CCCCeeecccccCcCccC
Q 008031          136 ASF----SNL-KSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       136 ~~l----~~l-~~L~~l~l~~n~l~~~~p  159 (580)
                      ..+    ..+ ++|+.|||++|.+++...
T Consensus       185 ~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~  213 (362)
T 3goz_A          185 AELAKFLASIPASVTSLDLSANLLGLKSY  213 (362)
T ss_dssp             HHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred             HHHHHHHHhCCCCCCEEECCCCCCChhHH
Confidence            544    444 599999999999986433

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.60  E-value=8.3e-17  Score=164.89  Aligned_cols=164  Identities=21%  Similarity=0.308  Sum_probs=135.0

Q ss_pred             CEEEecCCcccc----cccccccCCCCCcEEEccCCccCCCCCcccc----CC---------CCCCEEEeeCCcCC-CCC
Q 008031            1 MFLALQYNNLSG----RIPASLGKLSELQEISLSHNKISGVMPSDLG----RL---------SRLRILDFSYNAIN-GSL   62 (580)
Q Consensus         1 ~~L~L~~N~i~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l---------~~L~~L~l~~n~l~-~~~   62 (580)
                      ++|+|++|.|++    .++..+.++++|++|+|++|.|+...+..+.    .+         ++|++|+|++|+|+ ..+
T Consensus        97 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~  176 (386)
T 2ca6_A           97 HTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM  176 (386)
T ss_dssp             CEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGH
T ss_pred             cEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHH
Confidence            479999999997    4788899999999999999999744333333    34         89999999999997 344


Q ss_pred             C---ccCcCCCCCCEEECcCCCCCc-----ccchhhhccCCCCeeeecccccc----ccCCccccCCCCCcEEEcccccc
Q 008031           63 P---ASFSNLSSLVSLTLESNNLDD-----QILDSLDKLHNLSVLNLKRNQIS----GHIPSTIGNISTLTILDLSQNKL  130 (580)
Q Consensus        63 ~---~~~~~l~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~~L~l~~N~l  130 (580)
                      +   ..|..+++|+.|+|++|+|+.     ..+..+..+++|+.|+|++|.++    ..+|..+..+++|++|+|++|.+
T Consensus       177 ~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i  256 (386)
T 2ca6_A          177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL  256 (386)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred             HHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence            4   467789999999999999973     34447888999999999999996    56778889999999999999999


Q ss_pred             CCc----cccccc--CcCCCCeeecccccCcC----ccChhhhh
Q 008031          131 SGE----IPASFS--NLKSLSSFNVSYNNLSG----PVPTSLAL  164 (580)
Q Consensus       131 ~~~----~~~~l~--~l~~L~~l~l~~n~l~~----~~p~~~~~  164 (580)
                      ++.    ++..+.  .+++|+.|+|++|++++    .+|..+..
T Consensus       257 ~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~  300 (386)
T 2ca6_A          257 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE  300 (386)
T ss_dssp             CHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHh
Confidence            865    456664  38999999999999997    46666533

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.60  E-value=5.9e-15  Score=156.98  Aligned_cols=136  Identities=27%  Similarity=0.425  Sum_probs=106.7

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++ +|..+.  ++|+.|+|++|.|+ .+|   ..+++|++|+|++|+|++ +|. |..  +|+.|+|++|
T Consensus        62 ~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N  130 (571)
T 3cvr_A           62 SELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNN  130 (571)
T ss_dssp             SEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSS
T ss_pred             cEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCC
Confidence            368999999985 776553  78999999999998 456   457889999999999985 666 655  8999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|.|++ +|. |.  ++|+.|+|++|+|+. +|.
T Consensus       131 ~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~-lp~  197 (571)
T 3cvr_A          131 QLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLES-LPA  197 (571)
T ss_dssp             CCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSS-CCC
T ss_pred             cCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCc-hhh
Confidence            9877 343   57888999999998885 554   46788888999888886 565 55  788888888888884 444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.59  E-value=9e-15  Score=152.67  Aligned_cols=144  Identities=23%  Similarity=0.287  Sum_probs=124.5

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++ ++  ++++++|++|++++|.++++ +  +..+++|++|++++|+..+.+  .+..+++|+.|++++|
T Consensus       109 ~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n  180 (457)
T 3bz5_A          109 TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN  180 (457)
T ss_dssp             CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence            479999999996 44  89999999999999999974 3  888999999999999655455  4888999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ++++. +  +..+++|+.|++++|++++.   .+..+++|++|++++|++++ +|  +..+++|+.|++++|++++.++.
T Consensus       181 ~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~  251 (457)
T 3bz5_A          181 KITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS  251 (457)
T ss_dssp             CCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred             cccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence            99874 3  78889999999999999965   38889999999999999997 55  88999999999999999987654


Q ss_pred             h
Q 008031          161 S  161 (580)
Q Consensus       161 ~  161 (580)
                      .
T Consensus       252 ~  252 (457)
T 3bz5_A          252 T  252 (457)
T ss_dssp             T
T ss_pred             H
Confidence            3

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.59  E-value=1.6e-15  Score=137.00  Aligned_cols=127  Identities=26%  Similarity=0.291  Sum_probs=108.2

Q ss_pred             CEEEecCCcccccccccccCCC-CCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcC
Q 008031            1 MFLALQYNNLSGRIPASLGKLS-ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLES   79 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   79 (580)
                      ++|+|++|+|+ .++. +..+. +|+.|+|++|.|++.  ..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus        22 ~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   97 (176)
T 1a9n_A           22 RELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN   97 (176)
T ss_dssp             EEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred             eEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCC
Confidence            36999999999 4554 55554 999999999999965  6899999999999999999965555569999999999999


Q ss_pred             CCCCcccc-hhhhccCCCCeeeeccccccccCCcc----ccCCCCCcEEEccccccCC
Q 008031           80 NNLDDQIL-DSLDKLHNLSVLNLKRNQISGHIPST----IGNISTLTILDLSQNKLSG  132 (580)
Q Consensus        80 N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~~  132 (580)
                      |.|+.... ..+..+++|+.|++++|.++ ..|..    +..+++|+.|++++|.+..
T Consensus        98 N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           98 NSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             CcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            99966443 37889999999999999998 55664    8899999999999998863

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.59  E-value=6.9e-15  Score=158.40  Aligned_cols=86  Identities=27%  Similarity=0.292  Sum_probs=61.4

Q ss_pred             CCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeec
Q 008031           70 SSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNV  149 (580)
Q Consensus        70 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l  149 (580)
                      ++|+.|+|++|+|+++ |   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|.|+ .+|..+..+++|+.|+|
T Consensus       221 ~~L~~L~Ls~N~L~~l-p---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTSL-P---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCcC-C---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            4566666666666542 2   34567777777777777 3444   4677888888888888 66777888888888888


Q ss_pred             ccccCcCccChhhhh
Q 008031          150 SYNNLSGPVPTSLAL  164 (580)
Q Consensus       150 ~~n~l~~~~p~~~~~  164 (580)
                      ++|++++.+|..+..
T Consensus       292 ~~N~l~~~~~~~l~~  306 (622)
T 3g06_A          292 EGNPLSERTLQALRE  306 (622)
T ss_dssp             CSCCCCHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHh
Confidence            888888877776653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.57  E-value=1.8e-15  Score=161.79  Aligned_cols=122  Identities=25%  Similarity=0.320  Sum_probs=108.7

Q ss_pred             CCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeec
Q 008031           23 ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLK  102 (580)
Q Consensus        23 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  102 (580)
                      .|+.|+|++|.|++ +|. |..+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            58999999999996 565 999999999999999999 889999999999999999999987 45 89999999999999


Q ss_pred             cccccccC-CccccCCCCCcEEEccccccCCcccc---cccCcCCCCeeec
Q 008031          103 RNQISGHI-PSTIGNISTLTILDLSQNKLSGEIPA---SFSNLKSLSSFNV  149 (580)
Q Consensus       103 ~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~---~l~~l~~L~~l~l  149 (580)
                      +|+|++.. |..+..+++|+.|+|++|.+++..+.   .+..+++|+.|++
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            99999876 99999999999999999999975442   2345889999874

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=1.4e-14  Score=129.79  Aligned_cols=108  Identities=24%  Similarity=0.320  Sum_probs=90.4

Q ss_pred             CCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeec
Q 008031           23 ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLK  102 (580)
Q Consensus        23 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  102 (580)
                      +.+.|++++|.|+. +|..+  .++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            35788999998884 56555  3788999999999987778888889999999999999988777778889999999999


Q ss_pred             cccccccCCccccCCCCCcEEEccccccCCc
Q 008031          103 RNQISGHIPSTIGNISTLTILDLSQNKLSGE  133 (580)
Q Consensus       103 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  133 (580)
                      +|+|++..+..+..+++|++|+|++|.++..
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            9999877776788899999999999988743

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.55  E-value=1.9e-14  Score=129.33  Aligned_cols=106  Identities=23%  Similarity=0.302  Sum_probs=88.8

Q ss_pred             CcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeecc
Q 008031           24 LQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKR  103 (580)
Q Consensus        24 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  103 (580)
                      -+.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            478899999887 5565553  7899999999999877788888999999999999999887777778889999999999


Q ss_pred             ccccccCCccccCCCCCcEEEccccccCC
Q 008031          104 NQISGHIPSTIGNISTLTILDLSQNKLSG  132 (580)
Q Consensus       104 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  132 (580)
                      |+|++..+..+..+++|++|+|++|.+..
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCccc
Confidence            99986666668889999999999999873

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.55  E-value=2.1e-14  Score=128.61  Aligned_cols=110  Identities=25%  Similarity=0.310  Sum_probs=100.0

Q ss_pred             CCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEcc
Q 008031           47 RLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLS  126 (580)
Q Consensus        47 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  126 (580)
                      ..+.|++++|+|+ .+|..+.  ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            3579999999999 5776663  799999999999999989999999999999999999998777778999999999999


Q ss_pred             ccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031          127 QNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       127 ~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      +|+|++..+..|..+++|+.|+|++|++.+..+
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            999998777789999999999999999997655

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.55  E-value=1.7e-14  Score=145.53  Aligned_cols=157  Identities=18%  Similarity=0.177  Sum_probs=126.8

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCC-ccCcCCCCCCE-EECcC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLP-ASFSNLSSLVS-LTLES   79 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~-L~l~~   79 (580)
                      .++.++|+|+ .+|..+.  +++++|+|++|+|+.+.++.|..+++|++|+|++|++.+.+| ..|.++++|++ +.+.+
T Consensus        13 ~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            5688899999 7887763  689999999999997767789999999999999999876555 56889998775 66778


Q ss_pred             CCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccc-cccCCcccccccCcC-CCCeeecccccCcCc
Q 008031           80 NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ-NKLSGEIPASFSNLK-SLSSFNVSYNNLSGP  157 (580)
Q Consensus        80 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~l~~l~-~L~~l~l~~n~l~~~  157 (580)
                      |+|+.+.+..|..+++|+.|++++|+++...+..+....++..|++.+ |.+....+..|..+. .++.|++++|+|+..
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i  169 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  169 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC
Confidence            999998899999999999999999999976666666777788888865 466644455666654 577888888888755


Q ss_pred             cChh
Q 008031          158 VPTS  161 (580)
Q Consensus       158 ~p~~  161 (580)
                      .+..
T Consensus       170 ~~~~  173 (350)
T 4ay9_X          170 HNSA  173 (350)
T ss_dssp             CTTS
T ss_pred             Chhh
Confidence            4433

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.53  E-value=4.2e-14  Score=127.13  Aligned_cols=109  Identities=24%  Similarity=0.315  Sum_probs=98.3

Q ss_pred             CCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccc
Q 008031           48 LRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ  127 (580)
Q Consensus        48 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  127 (580)
                      -+.+++++|+++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            478999999998 6777664  8999999999999999899999999999999999999977777789999999999999


Q ss_pred             cccCCcccccccCcCCCCeeecccccCcCccC
Q 008031          128 NKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       128 N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |+|++..+..|..+++|+.|+|++|++....+
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            99997666679999999999999999986544

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.52  E-value=1.2e-13  Score=143.97  Aligned_cols=138  Identities=25%  Similarity=0.365  Sum_probs=104.0

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|+|++|++++ ++..   .++|++|+|++|.+++ +| .|..+++|++|++++|++++ +|..+   .+|++|++++|+
T Consensus       115 ~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~  184 (454)
T 1jl5_A          115 SLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQ  184 (454)
T ss_dssp             EEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSC
T ss_pred             EEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCc
Confidence            45566666552 2211   1588999999999885 66 58888999999999998884 55543   588899999998


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      +++ +| .+..+++|+.|++++|++++ +|..   .++|++|++++|.++ .+| .+..+++|+.|++++|++++.
T Consensus       185 l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l  252 (454)
T 1jl5_A          185 LEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL  252 (454)
T ss_dssp             CSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC
T ss_pred             CCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcc
Confidence            877 34 57888889999999988885 4433   258888888888888 566 488888888888888888863

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.51  E-value=1.3e-13  Score=143.68  Aligned_cols=139  Identities=24%  Similarity=0.341  Sum_probs=111.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|.+++ +|..   +++|++|++++|.+++ ++..   .++|++|++++|++++ +| .|.++++|++|++++|
T Consensus        94 ~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N  163 (454)
T 1jl5_A           94 ESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNN  163 (454)
T ss_dssp             SEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred             CEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCC
Confidence            367888888885 5543   3789999999999885 3321   2699999999999995 67 5999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ++++ +|..   +.+|++|++++|++++ +| .+..+++|++|++++|.+++ +|...   ++|+.|++++|.++ .+|.
T Consensus       164 ~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~  232 (454)
T 1jl5_A          164 SLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE  232 (454)
T ss_dssp             CCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC
T ss_pred             cCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc
Confidence            9986 4433   3589999999999996 55 58999999999999999985 44432   58999999999998 4553

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.51  E-value=1.3e-13  Score=148.54  Aligned_cols=112  Identities=26%  Similarity=0.377  Sum_probs=71.7

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|++++|.|+ .+|..+.  ++|+.|+|++|.|+. +|.   .+++|++|+|++|+|+ .+|.   .+++|++|+|++|+
T Consensus        44 ~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~  112 (622)
T 3g06_A           44 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNP  112 (622)
T ss_dssp             EEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCC
T ss_pred             EEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCc
Confidence            5778888877 6666555  677788888887773 443   4577777777777777 4444   56677777777777


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSG  132 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  132 (580)
                      |++...    .+++|+.|++++|+++. +|..   +++|++|+|++|.+++
T Consensus       113 l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~  155 (622)
T 3g06_A          113 LTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS  155 (622)
T ss_dssp             CCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred             CCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC
Confidence            765332    34566666666666653 3332   2556666666666553

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.48  E-value=3.2e-16  Score=144.54  Aligned_cols=139  Identities=22%  Similarity=0.275  Sum_probs=120.8

Q ss_pred             cccCCCCCcEEEccCCccCCCCCc------cccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhh
Q 008031           17 SLGKLSELQEISLSHNKISGVMPS------DLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSL   90 (580)
Q Consensus        17 ~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~   90 (580)
                      .+.....++.++++.|.+++..|.      .+..+++|++|+|++|+|++ +| .+..+++|+.|+|++|.++. +|..+
T Consensus        13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~   89 (198)
T 1ds9_A           13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLD   89 (198)
T ss_dssp             HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHH
T ss_pred             HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchh
Confidence            356677888889999999887776      89999999999999999995 67 89999999999999999974 56777


Q ss_pred             hccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccc-ccccCcCCCCeeecccccCcCccCh
Q 008031           91 DKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP-ASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        91 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ..+++|+.|+|++|++++ +| .+..+++|++|++++|.+++..+ ..+..+++|+.|++++|++++.+|.
T Consensus        90 ~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A           90 AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            888999999999999996 44 68889999999999999996433 5789999999999999999877654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.46  E-value=3.8e-15  Score=156.29  Aligned_cols=156  Identities=23%  Similarity=0.213  Sum_probs=112.5

Q ss_pred             CEEEecCCccccc----ccccccCCCCCcEEEccCCccCCCC-----CccccCCCCCCEEEeeCCcCCCC----CCccCc
Q 008031            1 MFLALQYNNLSGR----IPASLGKLSELQEISLSHNKISGVM-----PSDLGRLSRLRILDFSYNAINGS----LPASFS   67 (580)
Q Consensus         1 ~~L~L~~N~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~   67 (580)
                      ++|+|++|.+++.    ++..+..+++|++|+|++|.++...     +..+..+++|++|+|++|+|++.    ++..+.
T Consensus       202 ~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~  281 (461)
T 1z7x_W          202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR  281 (461)
T ss_dssp             CEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred             eEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHh
Confidence            4688999998863    5777888899999999999887432     22333578899999999988843    566677


Q ss_pred             CCCCCCEEECcCCCCCcccchhhhcc-----CCCCeeeecccccccc----CCccccCCCCCcEEEccccccCCcccccc
Q 008031           68 NLSSLVSLTLESNNLDDQILDSLDKL-----HNLSVLNLKRNQISGH----IPSTIGNISTLTILDLSQNKLSGEIPASF  138 (580)
Q Consensus        68 ~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~l  138 (580)
                      .+++|+.|+|++|.++...+..+...     ++|+.|++++|.+++.    ++..+..+++|++|+|++|.+++..+..+
T Consensus       282 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l  361 (461)
T 1z7x_W          282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL  361 (461)
T ss_dssp             HCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHH
T ss_pred             hCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHH
Confidence            78888888888888866555444432     5788888888887754    34556667888888888887775444434


Q ss_pred             cC-----cCCCCeeecccccCcC
Q 008031          139 SN-----LKSLSSFNVSYNNLSG  156 (580)
Q Consensus       139 ~~-----l~~L~~l~l~~n~l~~  156 (580)
                      ..     .++|+.|++++|++++
T Consensus       362 ~~~l~~~~~~L~~L~L~~n~i~~  384 (461)
T 1z7x_W          362 CQGLGQPGSVLRVLWLADCDVSD  384 (461)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCCH
T ss_pred             HHHHcCCCCceEEEECCCCCCCh
Confidence            32     5678888888887774

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.45  E-value=4e-15  Score=156.15  Aligned_cols=163  Identities=15%  Similarity=0.149  Sum_probs=130.1

Q ss_pred             CEEEecCCccccccccccc-----CCCCCcEEEccCCccCCC----CCccccCCCCCCEEEeeCCcCCCCC-----CccC
Q 008031            1 MFLALQYNNLSGRIPASLG-----KLSELQEISLSHNKISGV----MPSDLGRLSRLRILDFSYNAINGSL-----PASF   66 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~-----~~~~   66 (580)
                      ++|+|++|.+++..+..+.     .+++|++|+|++|.++..    ++..+..+++|++|+|++|++++..     +..+
T Consensus       173 ~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~  252 (461)
T 1z7x_W          173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLL  252 (461)
T ss_dssp             CEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred             CEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHh
Confidence            4799999999865555554     367999999999999864    4677888999999999999987432     3334


Q ss_pred             cCCCCCCEEECcCCCCCcc----cchhhhccCCCCeeeeccccccccCCccccC-----CCCCcEEEccccccCCc----
Q 008031           67 SNLSSLVSLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQISGHIPSTIGN-----ISTLTILDLSQNKLSGE----  133 (580)
Q Consensus        67 ~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~----  133 (580)
                      ..+++|+.|+|++|.++..    ++..+..+++|++|++++|.+++..+..+..     .++|++|+|++|.+++.    
T Consensus       253 ~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  332 (461)
T 1z7x_W          253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH  332 (461)
T ss_dssp             STTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             cCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHH
Confidence            4689999999999999875    4666778999999999999997654444433     36999999999999865    


Q ss_pred             ccccccCcCCCCeeecccccCcCccChhhh
Q 008031          134 IPASFSNLKSLSSFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus       134 ~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~  163 (580)
                      ++..+..+++|+.|++++|.+++..+..+.
T Consensus       333 l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~  362 (461)
T 1z7x_W          333 FSSVLAQNRFLLELQISNNRLEDAGVRELC  362 (461)
T ss_dssp             HHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred             HHHHHhhCCCccEEEccCCccccccHHHHH
Confidence            456677889999999999999876555544

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.40  E-value=7.7e-15  Score=148.55  Aligned_cols=162  Identities=16%  Similarity=0.185  Sum_probs=122.0

Q ss_pred             CEEEecCCcccccccccccCC-----CCCcEEEccCCccCCCCCcc-ccCCCCCCEEEeeCCcCCCCCCccC-----cCC
Q 008031            1 MFLALQYNNLSGRIPASLGKL-----SELQEISLSHNKISGVMPSD-LGRLSRLRILDFSYNAINGSLPASF-----SNL   69 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~-----~~l   69 (580)
                      +.|+|++|.|+......+..+     ++|++|+|++|.|+...... ...+++|+.|+|++|+|+......+     ...
T Consensus        75 ~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~  154 (372)
T 3un9_A           75 RQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQ  154 (372)
T ss_dssp             CEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTT
T ss_pred             CEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcC
Confidence            479999999996544444333     79999999999987432222 2346789999999999984433333     356


Q ss_pred             CCCCEEECcCCCCCccc----chhhhccCCCCeeeeccccccccC----CccccCCCCCcEEEccccccCCc----cccc
Q 008031           70 SSLVSLTLESNNLDDQI----LDSLDKLHNLSVLNLKRNQISGHI----PSTIGNISTLTILDLSQNKLSGE----IPAS  137 (580)
Q Consensus        70 ~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~~~~  137 (580)
                      ++|+.|+|++|.|+...    ...+..+++|++|+|++|.|++..    ...+..+++|++|+|++|.+++.    +...
T Consensus       155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~  234 (372)
T 3un9_A          155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA  234 (372)
T ss_dssp             CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred             CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence            88999999999997643    334567899999999999997532    45567788999999999999853    3445


Q ss_pred             ccCcCCCCeeecccccCcCccChhh
Q 008031          138 FSNLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus       138 l~~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                      +...++|++|||++|+|+......+
T Consensus       235 L~~~~~L~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          235 AREHPSLELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             HHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred             HHhCCCCCEEeccCCCCCHHHHHHH
Confidence            5667999999999999985544443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.39  E-value=7.1e-13  Score=132.35  Aligned_cols=158  Identities=15%  Similarity=0.172  Sum_probs=109.7

Q ss_pred             CEEEecCCccc--------------------ccccccccC--------CCCCcEEEccCCccCCCCCccccCCCCCCEEE
Q 008031            1 MFLALQYNNLS--------------------GRIPASLGK--------LSELQEISLSHNKISGVMPSDLGRLSRLRILD   52 (580)
Q Consensus         1 ~~L~L~~N~i~--------------------~~~~~~~~~--------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~   52 (580)
                      ++|||++|+|.                    .+....|.+        +++|++|+|.+ .++.+.+..|..+++|+.|+
T Consensus        52 ~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~  130 (329)
T 3sb4_A           52 KVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQ  130 (329)
T ss_dssp             CEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEE
T ss_pred             eEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEE
Confidence            47899999988                    223346777        99999999999 88877788899999999999


Q ss_pred             eeCCcCCCCCCccCcC----------------------------------------------------------------
Q 008031           53 FSYNAINGSLPASFSN----------------------------------------------------------------   68 (580)
Q Consensus        53 l~~n~l~~~~~~~~~~----------------------------------------------------------------   68 (580)
                      |++|.+....+..|..                                                                
T Consensus       131 l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~  210 (329)
T 3sb4_A          131 IRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIE  210 (329)
T ss_dssp             BCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEE
T ss_pred             cCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEe
Confidence            9999875333333332                                                                


Q ss_pred             --------------CCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCc-EEEccccccCCc
Q 008031           69 --------------LSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLT-ILDLSQNKLSGE  133 (580)
Q Consensus        69 --------------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~  133 (580)
                                    +++|+.|+|++|+++.+....|..+.+|+.|+|.+| ++.+.+..|..+.+|+ .|+|.+ .++..
T Consensus       211 ~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I  288 (329)
T 3sb4_A          211 GKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAI  288 (329)
T ss_dssp             ECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEE
T ss_pred             eeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEE
Confidence                          456677777777776666666777777777777666 6555566667777776 777766 55545


Q ss_pred             ccccccCcCCCCeeecccccCcCccChh
Q 008031          134 IPASFSNLKSLSSFNVSYNNLSGPVPTS  161 (580)
Q Consensus       134 ~~~~l~~l~~L~~l~l~~n~l~~~~p~~  161 (580)
                      .+..|.++++|+.|+++.|+++...+..
T Consensus       289 ~~~aF~~c~~L~~l~l~~n~i~~I~~~a  316 (329)
T 3sb4_A          289 EFGAFMGCDNLRYVLATGDKITTLGDEL  316 (329)
T ss_dssp             CTTTTTTCTTEEEEEECSSCCCEECTTT
T ss_pred             chhhhhCCccCCEEEeCCCccCccchhh
Confidence            5566777777777777667666443333

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.37  E-value=1e-12  Score=132.29  Aligned_cols=104  Identities=22%  Similarity=0.186  Sum_probs=64.3

Q ss_pred             cEEEccCC-ccCCCCCccccCCCCCCEEEeeC-CcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeec
Q 008031           25 QEISLSHN-KISGVMPSDLGRLSRLRILDFSY-NAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLK  102 (580)
Q Consensus        25 ~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  102 (580)
                      ..++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|..|++|+.|+|++|+|++..+..|..|++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            34566666 666 3455 66666666666664 66665555566666666666666666666666666666666666666


Q ss_pred             cccccccCCccccCCCCCcEEEccccccC
Q 008031          103 RNQISGHIPSTIGNISTLTILDLSQNKLS  131 (580)
Q Consensus       103 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  131 (580)
                      +|+|++..+..+..++ |+.|+|++|.+.
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            6666644444444433 666666666665

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.36  E-value=3.5e-12  Score=128.30  Aligned_cols=108  Identities=23%  Similarity=0.240  Sum_probs=97.6

Q ss_pred             CEEEeeCC-cCCCCCCccCcCCCCCCEEECcC-CCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEcc
Q 008031           49 RILDFSYN-AINGSLPASFSNLSSLVSLTLES-NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLS  126 (580)
Q Consensus        49 ~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  126 (580)
                      ..++++++ +|+ .+|. |..+++|+.|+|++ |.|++..+..|..|++|+.|+|++|+|++..|..|..+++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            45799998 899 6788 99999999999996 99999888999999999999999999999999999999999999999


Q ss_pred             ccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031          127 QNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       127 ~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      +|+|++..+..|..++ |+.|+|.+|+|.....
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCA  120 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence            9999977666777776 9999999999986544

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.26  E-value=1.7e-11  Score=122.26  Aligned_cols=103  Identities=16%  Similarity=0.098  Sum_probs=94.4

Q ss_pred             CCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCC-eeeeccccccccCCccccCCCCCcEE
Q 008031           45 LSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLS-VLNLKRNQISGHIPSTIGNISTLTIL  123 (580)
Q Consensus        45 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L  123 (580)
                      +++|+.|+|++|+++...+..|.++.+|+.|+|++| ++.+....|..+.+|+ .|++.+ +++.+.+..|..|++|+.|
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            679999999999999777778999999999999998 8888888999999999 999999 7887888899999999999


Q ss_pred             EccccccCCcccccccCcCCCCeeec
Q 008031          124 DLSQNKLSGEIPASFSNLKSLSSFNV  149 (580)
Q Consensus       124 ~l~~N~l~~~~~~~l~~l~~L~~l~l  149 (580)
                      ++++|.++...+..|.++++|+.++.
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EeCCCccCccchhhhcCCcchhhhcc
Confidence            99999999777789999999999874

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=1.3e-11  Score=119.03  Aligned_cols=136  Identities=17%  Similarity=0.122  Sum_probs=105.3

Q ss_pred             hhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          291 TAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      ....++.|+.+.||++... ++.+++|............+.+|+++++.+. +..+.++++++.. .+..++||||++|.
T Consensus        18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~   95 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGV   95 (263)
T ss_dssp             EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSE
T ss_pred             eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEEEEecCCe
Confidence            4456777888999999765 6899999986543233456889999999884 6778888888875 56889999999999


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-------------------------------------------  406 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  406 (580)
                      +|.+.+..        ......++.+++++++.||+.                                           
T Consensus        96 ~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           96 LCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             EHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             ehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            98876321        122346788999999999971                                           


Q ss_pred             ---------------CCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          407 ---------------ENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       407 ---------------~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                                     ..++|+|+++.||+++++..+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                           248999999999999876556799999764

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.18  E-value=7.1e-13  Score=134.12  Aligned_cols=154  Identities=20%  Similarity=0.199  Sum_probs=112.1

Q ss_pred             EEEecCCcccccccccc-cCCCCCcEEEccCCccCCCCCccc-----cCCCCCCEEEeeCCcCCC----CCCccCcCCCC
Q 008031            2 FLALQYNNLSGRIPASL-GKLSELQEISLSHNKISGVMPSDL-----GRLSRLRILDFSYNAING----SLPASFSNLSS   71 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~   71 (580)
                      +|+|++|.|++.....+ ..+++|+.|+|++|.|+......+     ...++|++|+|++|.|+.    .++..+..+++
T Consensus       105 ~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~  184 (372)
T 3un9_A          105 EVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS  184 (372)
T ss_dssp             EEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSS
T ss_pred             EEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCC
Confidence            69999999986544443 346789999999999984433333     356899999999999974    34455678899


Q ss_pred             CCEEECcCCCCCccc----chhhhccCCCCeeeecccccccc----CCccccCCCCCcEEEccccccCCcccccccCcCC
Q 008031           72 LVSLTLESNNLDDQI----LDSLDKLHNLSVLNLKRNQISGH----IPSTIGNISTLTILDLSQNKLSGEIPASFSNLKS  143 (580)
Q Consensus        72 L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~  143 (580)
                      |++|+|++|.|+...    ...+..+++|+.|+|++|.|++.    +...+..+++|++|+|++|.|++.....+..+..
T Consensus       185 L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~  264 (372)
T 3un9_A          185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGG  264 (372)
T ss_dssp             CCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC-
T ss_pred             cCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhc
Confidence            999999999997643    45567788999999999999863    3344556799999999999998654544544321


Q ss_pred             -----CCeee--cccccCc
Q 008031          144 -----LSSFN--VSYNNLS  155 (580)
Q Consensus       144 -----L~~l~--l~~n~l~  155 (580)
                           |+.+.  +..|.+.
T Consensus       265 ~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          265 AAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             -----CEEECCCC----CH
T ss_pred             CCCccchhhHhhhcCCccC
Confidence                 55555  5556554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.12  E-value=9.2e-12  Score=134.81  Aligned_cols=139  Identities=17%  Similarity=0.116  Sum_probs=76.5

Q ss_pred             cCCCCCcEEEccCCccCCCCCccccC-CCCCCEEEee----CCcCCCC-----CCccCcCCCCCCEEECcCC--CCCccc
Q 008031           19 GKLSELQEISLSHNKISGVMPSDLGR-LSRLRILDFS----YNAINGS-----LPASFSNLSSLVSLTLESN--NLDDQI   86 (580)
Q Consensus        19 ~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~----~n~l~~~-----~~~~~~~l~~L~~L~l~~N--~l~~~~   86 (580)
                      ..+++|++|+++.|.+++..+..+.. +++|+.|+|+    .|++++.     ++..+..+++|+.|+|++|  .+++..
T Consensus       375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~  454 (592)
T 3ogk_B          375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG  454 (592)
T ss_dssp             HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred             hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence            34566666666666555443334433 5666666664    4555532     2222445666666666532  255444


Q ss_pred             chhhhc-cCCCCeeeecccccccc-CCccccCCCCCcEEEccccccCCc-ccccccCcCCCCeeecccccCcCc
Q 008031           87 LDSLDK-LHNLSVLNLKRNQISGH-IPSTIGNISTLTILDLSQNKLSGE-IPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        87 ~~~~~~-l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      ...+.. +++|+.|+|++|++++. ++..+..+++|++|+|++|.+++. ++..+..+++|+.|++++|+++..
T Consensus       455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            444433 66677777777666542 233345566677777777766543 233344566777777777766643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=1.2e-10  Score=111.80  Aligned_cols=126  Identities=15%  Similarity=0.201  Sum_probs=93.9

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCc--ceeeeeEEECCCCcEEEEEeeCCCCChhh
Q 008031          296 GKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPN--LLALRAYYLGPKGEKLLVFDYMPHGSLAT  373 (580)
Q Consensus       296 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~g~L~~  373 (580)
                      +.|..+.||++...+|+.+++|.....   ....+.+|+.+++.+.+.+  +.+++++... .+..++||||++|.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEEEecCCcccC-
Confidence            356669999998777888999987543   2245788999999885444  5568887765 45789999999998884 


Q ss_pred             hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------------
Q 008031          374 FLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE----------------------------------------------  407 (580)
Q Consensus       374 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------------  407 (580)
                       ...      .+   ...++.++++.++.||+..                                              
T Consensus       104 -~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 -SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             -TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             -cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence             211      11   2356777888888888631                                              


Q ss_pred             -----------CcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          408 -----------NIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       408 -----------~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                                 +++|+|++|.||++++++.+.|+|||.+.
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                       29999999999999876656799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=4e-10  Score=113.77  Aligned_cols=140  Identities=15%  Similarity=0.241  Sum_probs=104.7

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEcc--ccc-cccHHHHHHHHHHHhcCC--CCcceeeeeEEECCC--CcEEEEEe
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLR--EKI-TKGQREFESEVSLLGKIR--HPNLLALRAYYLGPK--GEKLLVFD  364 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~--~~~~lv~e  364 (580)
                      .+.++.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+..  +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            356899999999999876 4678888775  322 123346888999999986  456788888886532  45899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN--------------------------------------  406 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  406 (580)
                      |++|..+.+..     ...++..++..++.+++++|+.||+.                                      
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99998775422     12367788889999999999999961                                      


Q ss_pred             -------------------CCcccCCCCCCCeeeCCCCC--eEEeecccccc
Q 008031          407 -------------------ENIIHGNLTSSNVLLDDSTN--AKISDFGLSRL  437 (580)
Q Consensus       407 -------------------~~i~H~Dlk~~Nil~~~~~~--~kl~Dfg~~~~  437 (580)
                                         .+++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               36899999999999997653  68999998864

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.02  E-value=1.1e-10  Score=126.24  Aligned_cols=126  Identities=11%  Similarity=0.066  Sum_probs=77.2

Q ss_pred             CEEEecCCcccccccccccCC-C-CCcEEEccCCc-cCC-CCCccccCCCCCCEEEeeCCcCCCC----CCccCcCCCCC
Q 008031            1 MFLALQYNNLSGRIPASLGKL-S-ELQEISLSHNK-ISG-VMPSDLGRLSRLRILDFSYNAINGS----LPASFSNLSSL   72 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l-~-~L~~L~l~~n~-l~~-~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L   72 (580)
                      ++|+|++|.+++..+..+..+ + +|++|+|++|. ++. .++.....+++|++|+|++|.+++.    ++..+..+++|
T Consensus       115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L  194 (592)
T 3ogk_B          115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL  194 (592)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred             CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence            467888887776666556553 3 37777777775 220 1122233567777777777776644    23334566777


Q ss_pred             CEEECcCCCCCc----ccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccc
Q 008031           73 VSLTLESNNLDD----QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQ  127 (580)
Q Consensus        73 ~~L~l~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  127 (580)
                      +.|+|++|.+++    ..+..+..+++|+.|++++|.+.+ ++..+..+++|+.|+++.
T Consensus       195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~  252 (592)
T 3ogk_B          195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS  252 (592)
T ss_dssp             CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred             cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence            777777777762    333445567777777777777664 444555556666665553

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.94  E-value=2.3e-10  Score=123.76  Aligned_cols=124  Identities=15%  Similarity=0.175  Sum_probs=68.7

Q ss_pred             EEEecCCccccccccccc-CCCCCcEEEccCC-ccCCC-CCccccCCCCCCEEEeeCCcCCCCCCccC----cCCCCCCE
Q 008031            2 FLALQYNNLSGRIPASLG-KLSELQEISLSHN-KISGV-MPSDLGRLSRLRILDFSYNAINGSLPASF----SNLSSLVS   74 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~-~l~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~----~~l~~L~~   74 (580)
                      +|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+    ..+++|+.
T Consensus       109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~  188 (594)
T 2p1m_B          109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS  188 (594)
T ss_dssp             EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred             eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence            566777766655555554 5667777777766 34321 23334456777777777777654333222    25557777


Q ss_pred             EECcCCC--CCcc-cchhhhccCCCCeeeeccc-cccccCCccccCCCCCcEEEcc
Q 008031           75 LTLESNN--LDDQ-ILDSLDKLHNLSVLNLKRN-QISGHIPSTIGNISTLTILDLS  126 (580)
Q Consensus        75 L~l~~N~--l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~  126 (580)
                      |+|++|.  ++.. ....+..+++|+.|++++| .+++ ++..+..+++|+.|+++
T Consensus       189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~  243 (594)
T 2p1m_B          189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTG  243 (594)
T ss_dssp             EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECS
T ss_pred             EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccc
Confidence            7777765  3211 1112234567777777766 3332 44445555555555543

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.91  E-value=1.1e-10  Score=126.19  Aligned_cols=87  Identities=15%  Similarity=0.202  Sum_probs=39.8

Q ss_pred             cCCCCCCEEECcCCCCCcccchhhhc-cCCCCeeeeccccccccCCccc-cCCCCCcEEEccccccCCcccc-cccCcCC
Q 008031           67 SNLSSLVSLTLESNNLDDQILDSLDK-LHNLSVLNLKRNQISGHIPSTI-GNISTLTILDLSQNKLSGEIPA-SFSNLKS  143 (580)
Q Consensus        67 ~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~-~l~~l~~  143 (580)
                      ..+++|+.|+|++ .++......+.. +++|+.|+|++|.+++.....+ ..+++|++|+|++|.+++.... .+..+++
T Consensus       429 ~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~  507 (594)
T 2p1m_B          429 EHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLET  507 (594)
T ss_dssp             HHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGG
T ss_pred             hhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCC
Confidence            3444555555544 444433333333 4555555555555543322222 3345555555555555332221 2233455


Q ss_pred             CCeeecccccC
Q 008031          144 LSSFNVSYNNL  154 (580)
Q Consensus       144 L~~l~l~~n~l  154 (580)
                      |+.|++++|++
T Consensus       508 L~~L~l~~~~~  518 (594)
T 2p1m_B          508 MRSLWMSSCSV  518 (594)
T ss_dssp             SSEEEEESSCC
T ss_pred             CCEEeeeCCCC
Confidence            55555555554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.89  E-value=4.4e-10  Score=110.64  Aligned_cols=184  Identities=18%  Similarity=0.218  Sum_probs=117.1

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCc--ceeeeeEEECCC--CcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPN--LLALRAYYLGPK--GEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~~~~~~~~~~--~~~~lv~e~~~  367 (580)
                      +.++.|.+..||+..    ..+++|+....  .....+.+|+++++.+ .+..  +.+.+.......  ...|+|||+++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            568999999999863    56888885432  2345788999999887 3333  334444432211  13478999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-----------------------------------------  406 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------------  406 (580)
                      |.++.+....     .++..++..++.++++.++.||+.                                         
T Consensus       100 G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          100 GVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            9888754322     356667777788888877777741                                         


Q ss_pred             ----------------CCcccCCCCCCCeeeCC--CCCeEEeecccccccccccccceee-------------ecCcccc
Q 008031          407 ----------------ENIIHGNLTSSNVLLDD--STNAKISDFGLSRLMTAAANVNVIA-------------TAGALGY  455 (580)
Q Consensus       407 ----------------~~i~H~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~-------------~~g~~~y  455 (580)
                                      ..++|+|+++.||++++  ...+.|+||+.+..-..........             ....++.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                            24799999999999997  4557899999876432211100000             0000011


Q ss_pred             CC-ccccccCCCCCcccchhHHHHHHHHHcCCCCC
Q 008031          456 RA-PELSKLKKANTKTDVYSLGVTILELLTGKSPG  489 (580)
Q Consensus       456 ~a-PE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~  489 (580)
                      .. |+....  .....+.|+++.++|.+.+|+.+|
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11 221110  112258999999999999998775

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.88  E-value=8e-09  Score=105.34  Aligned_cols=145  Identities=10%  Similarity=0.151  Sum_probs=97.1

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .++|++|+++.+....|. +.+|+.+.|.++ ++.+....|..+++|+.|+|..| ++..-...|.+ .+|+.+.| .|+
T Consensus       184 ~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~  258 (401)
T 4fdw_A          184 KADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNG  258 (401)
T ss_dssp             EEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETT
T ss_pred             eeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCC
Confidence            578888888843334444 678888888754 66566778888888888888764 45344455655 56777777 455


Q ss_pred             CCcccchhhhccCCCCeeeecccccc-----ccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccc
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQIS-----GHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN  152 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n  152 (580)
                      ++.+....|..+.+|+.+++.+|.+.     .+.+..|..|++|+.++|. |.++......|.++++|+.+++..|
T Consensus       259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~  333 (401)
T 4fdw_A          259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN  333 (401)
T ss_dssp             CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred             ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence            66666667777777777777766654     3455567777777777777 3455455566777777777777444

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.83  E-value=2e-08  Score=102.45  Aligned_cols=144  Identities=15%  Similarity=0.145  Sum_probs=80.0

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      ++|..| |+.+-..+|.++ +|+.++|.+ .++.+.+..|..+++|+.++|++|+++......|. +.+|+.+.|.+| +
T Consensus       140 i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l  214 (401)
T 4fdw_A          140 VVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-L  214 (401)
T ss_dssp             EECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-C
T ss_pred             EEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-h
Confidence            444444 443444455553 566666664 45545556666667777777766666633333444 466666666633 5


Q ss_pred             CcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccC
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNL  154 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l  154 (580)
                      +.+....|..+.+|+.+++..| ++.+....|.. .+|+.+.| .|.++......|.++++|+.+++.+|.+
T Consensus       215 ~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~  283 (401)
T 4fdw_A          215 KEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTF  283 (401)
T ss_dssp             CEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred             heehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccc
Confidence            5555566666666666666653 44344444444 45666666 3334434445556666666666555544

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.76  E-value=3.4e-09  Score=106.18  Aligned_cols=137  Identities=16%  Similarity=0.184  Sum_probs=68.0

Q ss_pred             ccccCCCCCcEEEccCCccC---------CCCCccccCCCCCCEEEeeCCc-CCCCCCccCcCCCCCCEEECcCCCCCcc
Q 008031           16 ASLGKLSELQEISLSHNKIS---------GVMPSDLGRLSRLRILDFSYNA-INGSLPASFSNLSSLVSLTLESNNLDDQ   85 (580)
Q Consensus        16 ~~~~~l~~L~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~   85 (580)
                      .++..+++|+.|.+..+...         +.++..+..+|+|+.|+|++|. +.  ++. +. +++|+.|+|..|.++..
T Consensus       133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~  208 (362)
T 2ra8_A          133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDS  208 (362)
T ss_dssp             TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHH
T ss_pred             HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChH
Confidence            34445566666666544321         1133344556666666666653 22  222 22 56666666666666544


Q ss_pred             cchhhh--ccCCCCeeeecc--cccccc-----CCccc--cCCCCCcEEEccccccCCccccccc---CcCCCCeeeccc
Q 008031           86 ILDSLD--KLHNLSVLNLKR--NQISGH-----IPSTI--GNISTLTILDLSQNKLSGEIPASFS---NLKSLSSFNVSY  151 (580)
Q Consensus        86 ~~~~~~--~l~~L~~L~l~~--N~l~~~-----~~~~~--~~l~~L~~L~l~~N~l~~~~~~~l~---~l~~L~~l~l~~  151 (580)
                      ....+.  .+++|+.|+|+.  |...+.     +...+  ..+++|++|+|.+|.+++..+..+.   .+++|+.|+|+.
T Consensus       209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~  288 (362)
T 2ra8_A          209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA  288 (362)
T ss_dssp             HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCS
T ss_pred             HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCC
Confidence            333343  466666666642  111110     00111  2356666666666666533222222   355666666666


Q ss_pred             ccCcC
Q 008031          152 NNLSG  156 (580)
Q Consensus       152 n~l~~  156 (580)
                      |.+.+
T Consensus       289 n~L~d  293 (362)
T 2ra8_A          289 GVLTD  293 (362)
T ss_dssp             SCCBH
T ss_pred             CCCCh
Confidence            66654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.73  E-value=1.3e-09  Score=98.62  Aligned_cols=115  Identities=15%  Similarity=0.215  Sum_probs=72.3

Q ss_pred             cccCCCCCCEEEeeCC-cCCC----CCCccCcCCCCCCEEECcCCCCCccc----chhhhccCCCCeeeecccccccc--
Q 008031           41 DLGRLSRLRILDFSYN-AING----SLPASFSNLSSLVSLTLESNNLDDQI----LDSLDKLHNLSVLNLKRNQISGH--  109 (580)
Q Consensus        41 ~~~~l~~L~~L~l~~n-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~--  109 (580)
                      .+...++|++|+|++| .|..    .+...+...++|++|+|++|.|+...    ...+...++|++|+|++|.|+..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            4445566666666666 6652    22334455566777777777775432    22344456777777777777643  


Q ss_pred             --CCccccCCCCCcEEEc--cccccCCc----ccccccCcCCCCeeecccccCc
Q 008031          110 --IPSTIGNISTLTILDL--SQNKLSGE----IPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       110 --~~~~~~~l~~L~~L~l--~~N~l~~~----~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                        +...+...++|++|+|  ++|.++..    +...+...++|+.|++++|.+.
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              3445666677888888  77887753    3345556688888888888875

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.70  E-value=3.8e-09  Score=95.57  Aligned_cols=119  Identities=16%  Similarity=0.192  Sum_probs=93.5

Q ss_pred             cccccccCCCCCcEEEccCC-ccCCC----CCccccCCCCCCEEEeeCCcCCC----CCCccCcCCCCCCEEECcCCCCC
Q 008031           13 RIPASLGKLSELQEISLSHN-KISGV----MPSDLGRLSRLRILDFSYNAING----SLPASFSNLSSLVSLTLESNNLD   83 (580)
Q Consensus        13 ~~~~~~~~l~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~   83 (580)
                      .+...+...++|++|+|++| .|...    +...+...++|++|+|++|+|+.    .+...+...++|++|+|++|.|+
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            34556778899999999999 88732    34566678999999999999974    23445666789999999999998


Q ss_pred             ccc----chhhhccCCCCeeee--cccccccc----CCccccCCCCCcEEEccccccC
Q 008031           84 DQI----LDSLDKLHNLSVLNL--KRNQISGH----IPSTIGNISTLTILDLSQNKLS  131 (580)
Q Consensus        84 ~~~----~~~~~~l~~L~~L~l--~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~  131 (580)
                      ...    ...+...++|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            643    445667789999999  88999764    3344566689999999999986

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.66  E-value=2.6e-09  Score=101.58  Aligned_cols=80  Identities=28%  Similarity=0.363  Sum_probs=50.0

Q ss_pred             cCCCCCCEEECcCCCCCcc--cchhhhccCCCCeeeeccccccccCCccccCCC--CCcEEEccccccCCccc-------
Q 008031           67 SNLSSLVSLTLESNNLDDQ--ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS--TLTILDLSQNKLSGEIP-------  135 (580)
Q Consensus        67 ~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~-------  135 (580)
                      .++++|+.|+|++|+|++.  ++..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+..|       
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            3466677777777777662  334556677777777777777644  2233333  77777777777765443       


Q ss_pred             ccccCcCCCCeee
Q 008031          136 ASFSNLKSLSSFN  148 (580)
Q Consensus       136 ~~l~~l~~L~~l~  148 (580)
                      ..+..+|+|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence            2356677777765

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.64  E-value=3.5e-08  Score=98.84  Aligned_cols=140  Identities=19%  Similarity=0.270  Sum_probs=99.3

Q ss_pred             ccccccCCCCCcEEEccCCc-cCCCCCccccCCCCCCEEEeeCCcCCCCCCccCc--CCCCCCEEECcC--CCCCcc---
Q 008031           14 IPASLGKLSELQEISLSHNK-ISGVMPSDLGRLSRLRILDFSYNAINGSLPASFS--NLSSLVSLTLES--NNLDDQ---   85 (580)
Q Consensus        14 ~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~--N~l~~~---   85 (580)
                      +...+..+|+|++|+|++|. +.  ++. + .+++|+.|+|..|.++......+.  .+++|+.|+|+.  |...+.   
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~  239 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM  239 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCG
T ss_pred             HHHHHhcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhH
Confidence            44566788999999999884 33  333 4 389999999999998743323333  689999999863  222111   


Q ss_pred             --cchhh--hccCCCCeeeeccccccccCCcccc---CCCCCcEEEccccccCCc----ccccccCcCCCCeeecccccC
Q 008031           86 --ILDSL--DKLHNLSVLNLKRNQISGHIPSTIG---NISTLTILDLSQNKLSGE----IPASFSNLKSLSSFNVSYNNL  154 (580)
Q Consensus        86 --~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~~---~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~l~l~~n~l  154 (580)
                        +...+  ..+++|+.|+|.+|.+.+..+..+.   .+++|++|+|+.|.+++.    ++..+.++++|+.|++++|.+
T Consensus       240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i  319 (362)
T 2ra8_A          240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL  319 (362)
T ss_dssp             GGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred             HHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence              11122  2478999999999998753333332   478999999999999863    344456789999999999998


Q ss_pred             cCc
Q 008031          155 SGP  157 (580)
Q Consensus       155 ~~~  157 (580)
                      +..
T Consensus       320 ~d~  322 (362)
T 2ra8_A          320 SDE  322 (362)
T ss_dssp             CHH
T ss_pred             CHH
Confidence            744

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.59  E-value=1.5e-08  Score=96.33  Aligned_cols=105  Identities=23%  Similarity=0.274  Sum_probs=72.5

Q ss_pred             ccCCCCCcE--EEccCCccC---CCCCccccCCCCCCEEEeeCCcCCC--CCCccCcCCCCCCEEECcCCCCCcccchhh
Q 008031           18 LGKLSELQE--ISLSHNKIS---GVMPSDLGRLSRLRILDFSYNAING--SLPASFSNLSSLVSLTLESNNLDDQILDSL   90 (580)
Q Consensus        18 ~~~l~~L~~--L~l~~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~   90 (580)
                      |...+.|..  ++++.|...   ..++.....+++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            555555665  677777543   2222223457888888888888886  3445666788888888888888765  334


Q ss_pred             hccC--CCCeeeeccccccccCCc-------cccCCCCCcEEE
Q 008031           91 DKLH--NLSVLNLKRNQISGHIPS-------TIGNISTLTILD  124 (580)
Q Consensus        91 ~~l~--~L~~L~l~~N~l~~~~~~-------~~~~l~~L~~L~  124 (580)
                      ..+.  +|++|+|++|.+.+.+|+       .+..+++|+.||
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            4444  888899999988876653       366788888876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.50  E-value=7e-07  Score=87.59  Aligned_cols=134  Identities=16%  Similarity=0.182  Sum_probs=90.3

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCC---cceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHP---NLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      +.++.|....||+.    |..+++|+...  ......+.+|+++|+.+.+.   .+.+.+.++....+..++||||++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            56788999999988    56788887432  22345788999999999642   35666666654456789999999998


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS--------------------------------------------  405 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~--------------------------------------------  405 (580)
                      ++.+..-.     .++..+...++.++++.|+.||+                                            
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            87653211     12333333444444444444432                                            


Q ss_pred             ---------------CCCcccCCCCCCCeeeCC---CCCe-EEeecccccc
Q 008031          406 ---------------NENIIHGNLTSSNVLLDD---STNA-KISDFGLSRL  437 (580)
Q Consensus       406 ---------------~~~i~H~Dlk~~Nil~~~---~~~~-kl~Dfg~~~~  437 (580)
                                     ...++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           135699999999999987   4554 8999997753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.34  E-value=1.7e-06  Score=83.13  Aligned_cols=132  Identities=16%  Similarity=0.207  Sum_probs=91.0

Q ss_pred             cccccCce-EEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          294 IMGKSTYG-TVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       294 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|+..|+.+. +--+.++++++.+ .+..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEeeCCcc
Confidence            44556665 68988765 5667889875433   2346788999998884 4446777888776 568899999999988


Q ss_pred             hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 008031          371 LATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN--------------------------------------------  406 (580)
Q Consensus       371 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  406 (580)
                      +.+.....       ......++.+++..|+-||+.                                            
T Consensus       107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            77654321       112233445555555555510                                            


Q ss_pred             -------------CCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          407 -------------ENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       407 -------------~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                                   ..++|+|+.+.||++++++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                         137899999999999987666799999774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=1.7e-06  Score=86.92  Aligned_cols=81  Identities=6%  Similarity=0.008  Sum_probs=56.1

Q ss_pred             ccc-cccCceEEEEEEeC-------CCCEEEEEEccccc---cccHHHHHHHHHHHhcCC-C--CcceeeeeEEECCC--
Q 008031          293 EIM-GKSTYGTVYKATLE-------DGSQVAVKRLREKI---TKGQREFESEVSLLGKIR-H--PNLLALRAYYLGPK--  356 (580)
Q Consensus       293 ~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~--  356 (580)
                      +.| +.|....+|+....       ++..+++|......   ......+.+|+.+++.+. +  ..+.+++.++.+..  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88889999998764       26678898765432   111245778888888884 3  35677777775432  


Q ss_pred             CcEEEEEeeCCCCChhh
Q 008031          357 GEKLLVFDYMPHGSLAT  373 (580)
Q Consensus       357 ~~~~lv~e~~~~g~L~~  373 (580)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35789999999877654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.19  E-value=8.7e-07  Score=78.01  Aligned_cols=84  Identities=14%  Similarity=0.171  Sum_probs=55.0

Q ss_pred             CCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC-CCcccchhhhcc----CCCCeeeecccc-ccccCCccccCCCC
Q 008031           46 SRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN-LDDQILDSLDKL----HNLSVLNLKRNQ-ISGHIPSTIGNIST  119 (580)
Q Consensus        46 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~~~~~~~l~~  119 (580)
                      .+|+.|||+++.|+..--..+..+++|+.|+|++|. |+...-..+..+    ++|++|+|++|. |++..-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            467777777777765444456677777777777774 666555555553    367777777764 66544445666777


Q ss_pred             CcEEEccccc
Q 008031          120 LTILDLSQNK  129 (580)
Q Consensus       120 L~~L~l~~N~  129 (580)
                      |++|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777777764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.11  E-value=9.4e-07  Score=77.78  Aligned_cols=92  Identities=8%  Similarity=0.113  Sum_probs=74.2

Q ss_pred             CccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeecccc-ccccCCccccCC----CCCcEEEccccc-cCCcccc
Q 008031           63 PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQ-ISGHIPSTIGNI----STLTILDLSQNK-LSGEIPA  136 (580)
Q Consensus        63 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~~~  136 (580)
                      |.....-.+|+.|+|+++.|+......+..+++|+.|+|++|. |++..-..+..+    ++|++|+|++|. +|+.--.
T Consensus        54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~  133 (176)
T 3e4g_A           54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII  133 (176)
T ss_dssp             CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred             CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence            4333333579999999999998877888999999999999995 776554556654    479999999985 8876566


Q ss_pred             cccCcCCCCeeecccccC
Q 008031          137 SFSNLKSLSSFNVSYNNL  154 (580)
Q Consensus       137 ~l~~l~~L~~l~l~~n~l  154 (580)
                      .+..+++|+.|++++++-
T Consensus       134 ~L~~~~~L~~L~L~~c~~  151 (176)
T 3e4g_A          134 ALHHFRNLKYLFLSDLPG  151 (176)
T ss_dssp             HGGGCTTCCEEEEESCTT
T ss_pred             HHhcCCCCCEEECCCCCC
Confidence            788999999999999863

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.08  E-value=8.4e-06  Score=82.98  Aligned_cols=109  Identities=11%  Similarity=0.185  Sum_probs=48.7

Q ss_pred             ccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCC
Q 008031           40 SDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST  119 (580)
Q Consensus        40 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  119 (580)
                      ..|..+.+|+.+.+.++..+ .....|.++.+|+.+.+. +.++.+....|..+.+|+.+.|..+ ++.+....|..|.+
T Consensus       259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~  335 (394)
T 4gt6_A          259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ  335 (394)
T ss_dssp             TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred             ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence            34444445555554433322 333344445555555543 3333444444444555555554432 33333444445555


Q ss_pred             CcEEEccccccCCcccccccCcCCCCeeecccc
Q 008031          120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN  152 (580)
Q Consensus       120 L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n  152 (580)
                      |+.+.|..+ ++......|.++++|+.+++.+|
T Consensus       336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~  367 (394)
T 4gt6_A          336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGS  367 (394)
T ss_dssp             CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSC
T ss_pred             CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCc
Confidence            555555332 33233344555555555554444

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.04  E-value=1.7e-05  Score=80.80  Aligned_cols=75  Identities=13%  Similarity=0.084  Sum_probs=49.0

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEcccccc-------ccHHHHHHHHHHHhcCCC--Ccc-eeeeeEEECCCCcEE
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-------KGQREFESEVSLLGKIRH--PNL-LALRAYYLGPKGEKL  360 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~ni-v~~~~~~~~~~~~~~  360 (580)
                      .+.+|.|.++.||++... +++.++||.......       .....+..|+++++.+..  +.. .+++.+.   .+..+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d---~~~~~  111 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAV  111 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc---CCccE
Confidence            367899999999999765 478899998653221       123456778888887732  333 4455432   33568


Q ss_pred             EEEeeCCCC
Q 008031          361 LVFDYMPHG  369 (580)
Q Consensus       361 lv~e~~~~g  369 (580)
                      +||||+++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.96  E-value=1.3e-05  Score=79.78  Aligned_cols=139  Identities=17%  Similarity=0.276  Sum_probs=76.9

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCC-----CCcceeee-e-EEECCCCcEEEEEee
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-----HPNLLALR-A-YYLGPKGEKLLVFDY  365 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~-~~~~~~~~~~lv~e~  365 (580)
                      +.|+.|..+.||+....+| .+++|+....    ...+..|+.+++.+.     .|.++... | .+....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4466677899999987654 5889987642    233444555555542     24443310 0 011114567899999


Q ss_pred             CCCCChh--------------hhhhhcCC----C-------CCCCHHHH-------------------------------
Q 008031          366 MPHGSLA--------------TFLHARGP----E-------TPIDWPTR-------------------------------  389 (580)
Q Consensus       366 ~~~g~L~--------------~~l~~~~~----~-------~~~~~~~~-------------------------------  389 (580)
                      ++|.++.              ..+|....    .       ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11121110    0       00122211                               


Q ss_pred             HHHHHHHHHHHHHhhc------------CCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          390 MKIIKGMTRGLLHLHS------------NENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       390 ~~i~~~i~~~l~~LH~------------~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      ..+..++..++.+|+.            ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345555541            2589999999999999877889999999763

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.94  E-value=4.7e-05  Score=77.43  Aligned_cols=130  Identities=15%  Similarity=0.156  Sum_probs=90.4

Q ss_pred             ccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCC
Q 008031           16 ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHN   95 (580)
Q Consensus        16 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~   95 (580)
                      ..+.++..|+.+.+..+... +....|..+..|+.+.+..+.+.   ...|..+.+|+.+.+.++ ++.+....|..+.+
T Consensus       247 ~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~  321 (394)
T 4fs7_A          247 SVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTS  321 (394)
T ss_dssp             STTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTT
T ss_pred             ccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCC
Confidence            34556666677766666544 45556666677777766655433   245677788888888654 66666777888888


Q ss_pred             CCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccc
Q 008031           96 LSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN  152 (580)
Q Consensus        96 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n  152 (580)
                      |+.++|..+ ++.+....|.+|.+|+.++|..| ++......|.++++|+.+++..+
T Consensus       322 L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          322 LVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             CCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            888888644 66566677888888888888766 66455677888888888887644

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.92  E-value=4.9e-05  Score=77.27  Aligned_cols=136  Identities=15%  Similarity=0.137  Sum_probs=108.0

Q ss_pred             EEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031            3 LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus         3 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      +.+..+... .....|.++..++.+.+..+.+.   ...|..+.+|+.+.+..+ ++..-...|.++.+|+.++|.++ +
T Consensus       258 ~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v  331 (394)
T 4fs7_A          258 ISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V  331 (394)
T ss_dssp             EEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C
T ss_pred             EEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c
Confidence            344444333 55677889999999999887654   357888999999999865 66566678999999999999754 8


Q ss_pred             CcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCee
Q 008031           83 DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSF  147 (580)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l  147 (580)
                      +.+....|..+.+|+.+.+..| ++.+....|.+|.+|+.++|..+ ++ .+...|.++++|+.+
T Consensus       332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            7888889999999999999877 77677888999999999999866 33 345678888887754

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.91  E-value=4.9e-05  Score=76.78  Aligned_cols=134  Identities=14%  Similarity=0.150  Sum_probs=100.1

Q ss_pred             cccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccC
Q 008031           15 PASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLH   94 (580)
Q Consensus        15 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~   94 (580)
                      ...+..+.+|+.+.+..+ ++.+....|..+.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++.+....|..+.
T Consensus       210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~  286 (379)
T 4h09_A          210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS  286 (379)
T ss_dssp             TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred             ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence            345566777888887655 33355667788888888888766 55455667888888888888654 6666667788888


Q ss_pred             CCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccc
Q 008031           95 NLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN  152 (580)
Q Consensus        95 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n  152 (580)
                      +|+.+.+.++.++.+....|.++.+|+.++|..+ ++.....+|.++.+|+.+.+..+
T Consensus       287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            9999998888887677777888889999988755 65455677888888888877544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.84  E-value=4.9e-05  Score=76.79  Aligned_cols=127  Identities=13%  Similarity=0.148  Sum_probs=103.8

Q ss_pred             cccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhc
Q 008031           13 RIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDK   92 (580)
Q Consensus        13 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~   92 (580)
                      .....+.++.+|+.+.+..+ ++.+....|..+.+|+.+.+..+ ++......|.++.+|+.+.+.++.++.+....|..
T Consensus       231 i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~  308 (379)
T 4h09_A          231 LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMD  308 (379)
T ss_dssp             ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTT
T ss_pred             EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcC
Confidence            44567888999999999877 66566788999999999999754 66455678999999999999999998888889999


Q ss_pred             cCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCC
Q 008031           93 LHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKS  143 (580)
Q Consensus        93 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~  143 (580)
                      +.+|+.+.|..+ ++.+....|.+|.+|+.+.|..+ ++..-..+|.+++.
T Consensus       309 c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~  357 (379)
T 4h09_A          309 CVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSI  357 (379)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSC
T ss_pred             CCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCC
Confidence            999999999765 77677778999999999999765 65444566776643

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.80  E-value=0.00015  Score=73.55  Aligned_cols=83  Identities=12%  Similarity=0.229  Sum_probs=40.4

Q ss_pred             cCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCC
Q 008031           65 SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSL  144 (580)
Q Consensus        65 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L  144 (580)
                      .|.++..|+.+.+.++.. .+....|..+.+|+.+.+. +.++.+....|..+.+|+.++|..+ ++......|.++.+|
T Consensus       260 aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L  336 (394)
T 4gt6_A          260 AFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL  336 (394)
T ss_dssp             TTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred             eeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence            344555555555543332 3334445555555555553 3344344444555555555555443 332334455555555


Q ss_pred             Ceeecc
Q 008031          145 SSFNVS  150 (580)
Q Consensus       145 ~~l~l~  150 (580)
                      +.+.+.
T Consensus       337 ~~i~ip  342 (394)
T 4gt6_A          337 ERIAIP  342 (394)
T ss_dssp             CEEEEC
T ss_pred             CEEEEC
Confidence            555553

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.78  E-value=6.4e-06  Score=73.88  Aligned_cols=113  Identities=13%  Similarity=0.207  Sum_probs=65.2

Q ss_pred             cCCCCCCEEEeeCC-cCCC----CCCccCcCCCCCCEEECcCCCCCcccch----hhhccCCCCeeeecccccccc----
Q 008031           43 GRLSRLRILDFSYN-AING----SLPASFSNLSSLVSLTLESNNLDDQILD----SLDKLHNLSVLNLKRNQISGH----  109 (580)
Q Consensus        43 ~~l~~L~~L~l~~n-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~----  109 (580)
                      .+-+.|+.|+|++| +|..    .+...+..-..|+.|+|++|+|+.....    .+..-..|+.|+|++|.|+..    
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            34456666666654 5542    2233444455666667766666543322    233445677777777776542    


Q ss_pred             CCccccCCCCCcEEEcccc---ccCC----cccccccCcCCCCeeecccccCc
Q 008031          110 IPSTIGNISTLTILDLSQN---KLSG----EIPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       110 ~~~~~~~l~~L~~L~l~~N---~l~~----~~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      +...+..-+.|++|+|++|   .+..    .+...+..-+.|..|+++.|.+.
T Consensus       118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            2223444567888888765   3332    23455666788888888877654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.73  E-value=9.2e-06  Score=72.85  Aligned_cols=86  Identities=17%  Similarity=0.222  Sum_probs=38.9

Q ss_pred             cCCCCCcEEEccCC-ccCC----CCCccccCCCCCCEEEeeCCcCCC----CCCccCcCCCCCCEEECcCCCCCcccch-
Q 008031           19 GKLSELQEISLSHN-KISG----VMPSDLGRLSRLRILDFSYNAING----SLPASFSNLSSLVSLTLESNNLDDQILD-   88 (580)
Q Consensus        19 ~~l~~L~~L~l~~n-~l~~----~~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~-   88 (580)
                      .+-+.|++|+|++| .|..    .+.+.+...+.|+.|+|++|+|..    .+...+..-+.|+.|+|++|.|+..... 
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            33445555555553 4431    123334444555555555555542    1222233334555555555555432222 


Q ss_pred             ---hhhccCCCCeeeeccc
Q 008031           89 ---SLDKLHNLSVLNLKRN  104 (580)
Q Consensus        89 ---~~~~l~~L~~L~l~~N  104 (580)
                         .+..-..|++|+|++|
T Consensus       118 la~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHhhCCceeEEECCCC
Confidence               2223334555555543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.66  E-value=0.00019  Score=69.45  Aligned_cols=75  Identities=17%  Similarity=0.253  Sum_probs=55.6

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCC---CcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRH---PNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      .+.+|.|..+.||+....+|+.|++|+-..........|..|+..|+.|.-   -.+.+++++.     ..++||||+++
T Consensus        20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~~~lv~e~l~~   94 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----DRTLAMEWVDE   94 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----TTEEEEECCCC
T ss_pred             EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----CceEEEEeecc
Confidence            466899999999999999999999998765544444568899999988842   2344444432     34789999987


Q ss_pred             CCh
Q 008031          369 GSL  371 (580)
Q Consensus       369 g~L  371 (580)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.56  E-value=0.00053  Score=66.81  Aligned_cols=135  Identities=17%  Similarity=0.166  Sum_probs=89.1

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCC---CCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR---HPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      +.|+.|.+..+|+.... +..+++|+....   ....+..|++.|+.+.   ...+.+++.++.. .+..++||||+++.
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~G~  116 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALNKS  116 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCCCC
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEeccCC
Confidence            56889999999998864 678888876532   3456888999998883   3567888888765 56799999999988


Q ss_pred             Chhh-----------hhhhcCCCC-------------------CCCHHHHH---HHH----------------HHHHHH-
Q 008031          370 SLAT-----------FLHARGPET-------------------PIDWPTRM---KII----------------KGMTRG-  399 (580)
Q Consensus       370 ~L~~-----------~l~~~~~~~-------------------~~~~~~~~---~i~----------------~~i~~~-  399 (580)
                      .+..           .+|......                   .-+|.+..   ++.                .++... 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           123322100                   11344321   111                111111 


Q ss_pred             HHHhhc---CCCcccCCCCCCCeeeCCCCCeEEeecc
Q 008031          400 LLHLHS---NENIIHGNLTSSNVLLDDSTNAKISDFG  433 (580)
Q Consensus       400 l~~LH~---~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg  433 (580)
                      ...|..   .+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            233421   25799999999999999877 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.54  E-value=0.00037  Score=71.32  Aligned_cols=79  Identities=14%  Similarity=0.192  Sum_probs=46.4

Q ss_pred             CCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeeecCccccCCccccccC---CCCCcccchhHHHHHHHHH
Q 008031          407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK---KANTKTDVYSLGVTILELL  483 (580)
Q Consensus       407 ~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~  483 (580)
                      +.++|+|+++.||+++.++ ++++||+.+..-.........-..-...|++|+.....   .-....++.+....+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            5899999999999999776 99999998764322111100000001235666544311   1112345557777777777


Q ss_pred             cCC
Q 008031          484 TGK  486 (580)
Q Consensus       484 tg~  486 (580)
                      ++.
T Consensus       311 ~~~  313 (420)
T 2pyw_A          311 NKR  313 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.15  E-value=0.00084  Score=65.26  Aligned_cols=136  Identities=13%  Similarity=0.085  Sum_probs=73.4

Q ss_pred             hccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcc-eeeeeEEECCCCcEEEEEeeC-CCC
Q 008031          292 AEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNL-LALRAYYLGPKGEKLLVFDYM-PHG  369 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~-~~g  369 (580)
                      .+.|+.|....+|+.     ..+++|+....... .....+|+.+++.+....+ .+++++.   .+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~---~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD---PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC---TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE---CCCCEEEEeecCCCc
Confidence            366888999999998     55888877543211 1123567777777642222 3455443   33457899999 654


Q ss_pred             Chhhh------------------hhhcCCCC--CCCH-HHHHH---------------------HHHHHHHHHHHhhcCC
Q 008031          370 SLATF------------------LHARGPET--PIDW-PTRMK---------------------IIKGMTRGLLHLHSNE  407 (580)
Q Consensus       370 ~L~~~------------------l~~~~~~~--~~~~-~~~~~---------------------i~~~i~~~l~~LH~~~  407 (580)
                      ++...                  +|......  ..+. .....                     .+..+...+.-.....
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            44310                  11111100  0111 11111                     1111111111111124


Q ss_pred             CcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       408 ~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            5899999999999 5566789999997753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.08  E-value=0.0029  Score=62.14  Aligned_cols=139  Identities=18%  Similarity=0.195  Sum_probs=79.2

Q ss_pred             cccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCC--CcceeeeeE----EECCCCcEEEEEeeCC
Q 008031          294 IMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRH--PNLLALRAY----YLGPKGEKLLVFDYMP  367 (580)
Q Consensus       294 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~----~~~~~~~~~lv~e~~~  367 (580)
                      .++ |....||+....+|+.+++|...... .....+..|+.+++.+..  -.+.+++..    +....+..+++|||++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            455 77789999887777789999876332 234566778888877732  123444432    0001345678999998


Q ss_pred             CCChhh-----h---------hhhcC------CCCCCCHHHH----------------------HHHHHHHHHHHHHhh-
Q 008031          368 HGSLAT-----F---------LHARG------PETPIDWPTR----------------------MKIIKGMTRGLLHLH-  404 (580)
Q Consensus       368 ~g~L~~-----~---------l~~~~------~~~~~~~~~~----------------------~~i~~~i~~~l~~LH-  404 (580)
                      |..+..     +         +|...      .....++...                      ...+.+++..+.-+- 
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            754321     0         11110      0111222211                      111112222222211 


Q ss_pred             --cCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          405 --SNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       405 --~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                        ....++|+|+++.||+++ + .+.++||+.+.
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence              114689999999999999 4 89999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.06  E-value=0.0035  Score=61.78  Aligned_cols=139  Identities=12%  Similarity=0.141  Sum_probs=71.0

Q ss_pred             ccccccCceE-EEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCC-C-CcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          293 EIMGKSTYGT-VYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-H-PNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       293 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      +.|+.|+... +|+....+|..+++|.......   ..+..|+.+++.+. + -.+.+++.+... .+  +++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~-~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA-RG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT-TT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC-CC--EEEEeeCCCc
Confidence            4455555544 6677654467777776433211   23445666666663 2 234556665322 22  7899999776


Q ss_pred             Chhhhhhhc---------------------CC--CCCCCHHHHH-------HH-------------HHHHHHHHHHh---
Q 008031          370 SLATFLHAR---------------------GP--ETPIDWPTRM-------KI-------------IKGMTRGLLHL---  403 (580)
Q Consensus       370 ~L~~~l~~~---------------------~~--~~~~~~~~~~-------~i-------------~~~i~~~l~~L---  403 (580)
                      .+.+++...                     ..  ...++.....       .+             ...+...++.+   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            665443221                     00  0112211110       00             00111122222   


Q ss_pred             --hcCCCcccCCCCCCCeeeCCC----CCeEEeecccccc
Q 008031          404 --HSNENIIHGNLTSSNVLLDDS----TNAKISDFGLSRL  437 (580)
Q Consensus       404 --H~~~~i~H~Dlk~~Nil~~~~----~~~kl~Dfg~~~~  437 (580)
                        .....++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence              112479999999999999874    6789999998754

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.04  E-value=0.00098  Score=55.67  Aligned_cols=55  Identities=15%  Similarity=0.217  Sum_probs=29.8

Q ss_pred             EEEccCCccC-CCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCC
Q 008031           26 EISLSHNKIS-GVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL   82 (580)
Q Consensus        26 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l   82 (580)
                      .++.+++.|+ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            5666666665 12333221  2566666666666644444555566666666666655

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.04  E-value=0.0019  Score=66.15  Aligned_cols=72  Identities=10%  Similarity=0.150  Sum_probs=49.1

Q ss_pred             ccccccCceEEEEEEeCC--------CCEEEEEEccccccccHHHHHHHHHHHhcCCCCc-ceeeeeEEECCCCcEEEEE
Q 008031          293 EIMGKSTYGTVYKATLED--------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPN-LLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv~  363 (580)
                      +.|+.|....||++...+        +..+++|+....  .....+.+|+.+++.+...+ ..++++.+.  +   .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---CEEE
Confidence            567888899999998753        578999987432  11245567999988884333 356666552  2   3899


Q ss_pred             eeCCCCCh
Q 008031          364 DYMPHGSL  371 (580)
Q Consensus       364 e~~~~g~L  371 (580)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.02  E-value=0.0012  Score=55.18  Aligned_cols=55  Identities=29%  Similarity=0.382  Sum_probs=29.9

Q ss_pred             EEEeeCCcCC-CCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccc
Q 008031           50 ILDFSYNAIN-GSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQI  106 (580)
Q Consensus        50 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  106 (580)
                      .++.++++++ ..+|..+.  ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            5666666665 23443322  2466666666666555555555555555555555544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.00  E-value=0.0012  Score=66.09  Aligned_cols=138  Identities=16%  Similarity=0.206  Sum_probs=81.6

Q ss_pred             ccccccCceEEEEEEeC--------CCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEE
Q 008031          293 EIMGKSTYGTVYKATLE--------DGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +.+..|....+|+....        +++.+++|+... .......+.+|.++++.+. +.-..++++++.  +   .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~---g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E---GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T---EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C---ccEE
Confidence            45677888889998864        257899998633 2233456678999998884 333355666653  2   2899


Q ss_pred             eeCCCCChhhh-----------------hhhcCC--CCCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 008031          364 DYMPHGSLATF-----------------LHARGP--ETPID--WPTRMKIIKGMTR-------------------GLLH-  402 (580)
Q Consensus       364 e~~~~g~L~~~-----------------l~~~~~--~~~~~--~~~~~~i~~~i~~-------------------~l~~-  402 (580)
                      ||++|.+|..-                 +|....  .....  +.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998655421                 111110  11122  4555555544422                   1222 


Q ss_pred             ---hhc---CCCcccCCCCCCCeeeCCC----CCeEEeeccccc
Q 008031          403 ---LHS---NENIIHGNLTSSNVLLDDS----TNAKISDFGLSR  436 (580)
Q Consensus       403 ---LH~---~~~i~H~Dlk~~Nil~~~~----~~~kl~Dfg~~~  436 (580)
                         |..   ...++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               221   1368999999999999876    689999999775

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.91  E-value=0.0013  Score=64.51  Aligned_cols=141  Identities=9%  Similarity=0.137  Sum_probs=76.1

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCc--ceeeeeEE-----ECCCCcEEEEEee
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPN--LLALRAYY-----LGPKGEKLLVFDY  365 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~-----~~~~~~~~lv~e~  365 (580)
                      +.|+.|....+|+....+| .+++|......  ....+..|+.+++.+....  +.+++...     ....+..+++|+|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            5577788899999987755 57788876521  2234566777777663211  22332210     0013467899999


Q ss_pred             CCCCChhh--------------hhhhcCCC---C---CC---CHHHHHH------------HHHHHHHHHHHhhc-----
Q 008031          366 MPHGSLAT--------------FLHARGPE---T---PI---DWPTRMK------------IIKGMTRGLLHLHS-----  405 (580)
Q Consensus       366 ~~~g~L~~--------------~l~~~~~~---~---~~---~~~~~~~------------i~~~i~~~l~~LH~-----  405 (580)
                      ++|..+..              .+|.....   .   ..   .|.....            +...+...+++++.     
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            99865421              01211100   0   01   1222100            00113334444431     


Q ss_pred             -CCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          406 -NENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       406 -~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                       ..+++|+|+++.||+++.+..+.|+||+.+.
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             1479999999999999876555799998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.85  E-value=0.012  Score=53.05  Aligned_cols=102  Identities=16%  Similarity=0.100  Sum_probs=66.5

Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeee
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT  449 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  449 (580)
                      +|.+.|...  .+++++++++.++.|.+.+|.-+-..+.-..+=+.|..|++..+|.|.+.+ +.+.             
T Consensus        34 SL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            789999877  478999999999999999987661101111233456889999999888764 2111             


Q ss_pred             cCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCC
Q 008031          450 AGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP  488 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  488 (580)
                      .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            0112366888763 3445678899999999998875444

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.51  E-value=0.0054  Score=61.38  Aligned_cols=73  Identities=8%  Similarity=0.106  Sum_probs=43.6

Q ss_pred             ccccccCceEEEEEEeCC---------CCEEEEEEccccccccHHHHHHHHHHHhcCCCCc-ceeeeeEEECCCCcEEEE
Q 008031          293 EIMGKSTYGTVYKATLED---------GSQVAVKRLREKITKGQREFESEVSLLGKIRHPN-LLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv  362 (580)
                      +.++.|....+|+....+         +..+++|+....... ......|..+++.+...+ +.++++..   .  -++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---C--CcEE
Confidence            567788888999998753         268888886543221 112457888888774333 34565543   2  2689


Q ss_pred             EeeCCCCCh
Q 008031          363 FDYMPHGSL  371 (580)
Q Consensus       363 ~e~~~~g~L  371 (580)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.32  E-value=0.018  Score=59.24  Aligned_cols=73  Identities=11%  Similarity=0.108  Sum_probs=47.0

Q ss_pred             ccccccCceEEEEEEeCC-CCEEEEEEccccccccHHHHHHHHHHHhcCCCCcc-eeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          293 EIMGKSTYGTVYKATLED-GSQVAVKRLREKITKGQREFESEVSLLGKIRHPNL-LALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      +.|+.|-...+|+....+ +..+++|+...... ..-+..+|..+++.+...++ .++++++ . +   .+||||++|.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~-~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFF-T-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEE-T-T---EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEe-C-C---eEEEEeeCCcc
Confidence            567888899999998874 47888888643321 11122578888888864444 4566665 2 2   25999998754


Q ss_pred             h
Q 008031          371 L  371 (580)
Q Consensus       371 L  371 (580)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.96  E-value=0.032  Score=54.93  Aligned_cols=31  Identities=23%  Similarity=0.359  Sum_probs=27.2

Q ss_pred             CCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       407 ~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ..++|+|+.+.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999878899999987653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.44  E-value=0.048  Score=55.24  Aligned_cols=73  Identities=4%  Similarity=0.066  Sum_probs=47.4

Q ss_pred             ccccccCceEEEEEEeCC--------CCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEE
Q 008031          293 EIMGKSTYGTVYKATLED--------GSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +.+..|....+|+....+        +..+++|+..... ...-+..+|.++++.+. +.-..++++.+   .  -++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~---~--~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF---P--EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE---T--TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc---C--CCEEE
Confidence            556778888999998763        5789998864432 11123457888888774 33344555533   1  26899


Q ss_pred             eeCCCCCh
Q 008031          364 DYMPHGSL  371 (580)
Q Consensus       364 e~~~~g~L  371 (580)
                      ||++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.27  E-value=0.24  Score=49.85  Aligned_cols=30  Identities=23%  Similarity=0.398  Sum_probs=25.0

Q ss_pred             CcccCCCCCCCeee------CCCCCeEEeecccccc
Q 008031          408 NIIHGNLTSSNVLL------DDSTNAKISDFGLSRL  437 (580)
Q Consensus       408 ~i~H~Dlk~~Nil~------~~~~~~kl~Dfg~~~~  437 (580)
                      .++|+|+.+.||++      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567799999998753

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.04  E-value=0.21  Score=31.99  Aligned_cols=10  Identities=10%  Similarity=0.032  Sum_probs=4.0

Q ss_pred             HHhhhhhhcc
Q 008031          224 ILMCCLIRKR  233 (580)
Q Consensus       224 ~~~~~~~r~r  233 (580)
                      .++++++||+
T Consensus        30 ~~~~~~RRr~   39 (44)
T 2ks1_B           30 GIGLFMRRRH   39 (44)
T ss_dssp             HHHHHHHTTT
T ss_pred             HHHHHhhhhH
Confidence            3334444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.88  E-value=0.25  Score=31.55  Aligned_cols=10  Identities=20%  Similarity=0.245  Sum_probs=4.0

Q ss_pred             Hhhhhhhccc
Q 008031          225 LMCCLIRKRT  234 (580)
Q Consensus       225 ~~~~~~r~r~  234 (580)
                      ++++++||+.
T Consensus        30 ~~~~~RRRr~   39 (44)
T 2l2t_A           30 FAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHTTCS
T ss_pred             HHHHhhhhhh
Confidence            3344444433

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=89.82  E-value=0.24  Score=31.54  Aligned_cols=17  Identities=24%  Similarity=0.653  Sum_probs=6.6

Q ss_pred             HHHHHHHHhhhhhhccc
Q 008031          218 LLIIVCILMCCLIRKRT  234 (580)
Q Consensus       218 ~~~~~~~~~~~~~r~r~  234 (580)
                      +++++.+.+.++.|||+
T Consensus        23 l~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           23 LVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhheehhh
Confidence            33333333333444433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.12  E-value=4.8  Score=36.13  Aligned_cols=114  Identities=11%  Similarity=0.111  Sum_probs=76.7

Q ss_pred             CCCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCcccCCCCCCCe
Q 008031          341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL-HLHSNENIIHGNLTSSNV  419 (580)
Q Consensus       341 ~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~i~H~Dlk~~Ni  419 (580)
                      .||++ . ..+-.+ ++.+.+.++.-+++.-...++      .++...+++++.+|+.... +++   .-+|--++|+|+
T Consensus        48 ~~~~f-~-~~I~~~-eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~---~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI-V-RDIDVS-EDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA---RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS-E-EEEEEC-SSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS---SSEECCCCGGGE
T ss_pred             cCCCC-C-eEEEEe-CCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh---CceeEEEeCceE
Confidence            57777 2 223333 556777777654443333443      3778899999999998776 554   357788999999


Q ss_pred             eeCCCCCeEEeecccccccccccccceeeecCccccCCccccccCCCCCccc-chhHHHHHHHHHcCCCCCC
Q 008031          420 LLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTD-VYSLGVTILELLTGKSPGE  490 (580)
Q Consensus       420 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D-v~s~G~~l~el~tg~~p~~  490 (580)
                      +++.++.+++.-.|+-.                  -++|.-+.      ..| .-.+=+++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~------------------~lpP~e~~------ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKE------------------SLPPDEWD------DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETT------------------TBSSCSCC------HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCcc------------------cCCCCCCC------HHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999998777543                  23333221      122 3357788888999988774

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=81.39  E-value=0.83  Score=28.23  Aligned_cols=21  Identities=29%  Similarity=0.346  Sum_probs=9.4

Q ss_pred             CCCCcceeeehhHHHHHHHHH
Q 008031          200 KLSTKDIILIGAGALLIVLLI  220 (580)
Q Consensus       200 ~~~~~~~~~i~~~~~~~~~~~  220 (580)
                      ..+...+..+++++++.++++
T Consensus         7 ~ls~GaIAGiVvG~v~gv~li   27 (38)
T 2k1k_A            7 GLTGGEIVAVIFGLLLGAALL   27 (38)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCceeeeehHHHHHHHHH
Confidence            344444544444444444333

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.70  E-value=3.8  Score=36.69  Aligned_cols=116  Identities=7%  Similarity=0.031  Sum_probs=77.4

Q ss_pred             CCCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCee
Q 008031          341 RHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL  420 (580)
Q Consensus       341 ~h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil  420 (580)
                      .||+.+.. .+-.+ ++.+.+.++.-+  +..+|-.-+    ..+...+++++.+|+....+++.   =+|--++|+|++
T Consensus        43 ~~~~Fl~~-~I~e~-eD~v~~~y~~~~--~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTEL-RDSFQIHYDIND--NHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEEC-SSEEEEEECCCT--TSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEc-ccEEEEEEEcCc--ccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEE
Confidence            67888766 34443 446666665543  333333222    36788999999999988766653   467889999999


Q ss_pred             eCCCCCeEEeecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCC
Q 008031          421 LDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGE  490 (580)
Q Consensus       421 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~  490 (580)
                      ++.++.+++.--|+-..                  ++|.-     .+...=.-.+=+++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTT------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccC------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999987775432                  22221     1112223457888999999999875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	580
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-61
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-57
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-48
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.003
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-12
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-10
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-12
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-11
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-09
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	4e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	8e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.001

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-61
 Identities = 62/268 (23%), Positives = 114/268 (42%), Gaps = 19/268 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E +G   +G V+       ++VAVK L++  +     F +E +L+ +++H  L+ L A  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
              +    ++ +YM +GSL  FL        +     + +   +  G+  +    N IH 
Sbjct: 78  T--QEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER-NYIHR 133

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           +L ++N+L+ D+ + KI+DFGL+RL+              + + APE         K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S G+ + E++T      P  G   P+ + ++ +            M       +EL   
Sbjct: 194 WSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYR---------MVRPDNCPEELYQ- 241

Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
             L   C    P  RP    +   LE+ 
Sbjct: 242 --LMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-61
 Identities = 64/273 (23%), Positives = 123/273 (45%), Gaps = 19/273 (6%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +G  ++GTVYK        V +  +     +  + F++EV +L K RH N+L    Y 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
             P+    +V  +    SL   LH    ET  +    + I +   +G+ +LH+  +IIH 
Sbjct: 74  TAPQ--LAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK-SIIHR 128

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELSKLKKAN---T 468
           +L S+N+ L +    KI DFGL+ + +  +  +     +G++ + APE+ +++  N    
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           ++DVY+ G+ + EL+TG+    P +       +  +V   +       +L +        
Sbjct: 189 QSDVYAFGIVLYELMTGQL---PYSNINNRDQIIFMVGRGY----LSPDLSKVRSNCPKA 241

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
           +     L   C+      RP   Q++  +E + 
Sbjct: 242 MKR---LMAECLKKKRDERPLFPQILASIELLA 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-59
 Identities = 70/269 (26%), Positives = 127/269 (47%), Gaps = 23/269 (8%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +GK  +G V       G++VAVK ++       + F +E S++ ++RH NL+ L    
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           +  KG   +V +YM  GSL  +L +RG  + +     +K    +   + +L  N N +H 
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN-NFVHR 127

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           +L + NVL+ +   AK+SDFGL++  ++  +         + + APE  + KK +TK+DV
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKFSTKSDV 183

Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S G+ + E+ +      P     L   V  + K       + ++     P     +   
Sbjct: 184 WSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKG------YKMDAPDGCP---PAVYE- 231

Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEIR 561
             +  +C     + RP  LQ+ +QLE I+
Sbjct: 232 --VMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-58
 Identities = 62/270 (22%), Positives = 125/270 (46%), Gaps = 21/270 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +G   +G V+     +  +VA+K +RE     + +F  E  ++ K+ HP L+ L    
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
           L  +    LVF++M HG L+ +L  +         T + +   +  G+ +L     +IH 
Sbjct: 70  LE-QAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHR 125

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           +L + N L+ ++   K+SDFG++R +      +   T   + + +PE+    + ++K+DV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185

Query: 473 YSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLN 531
           +S GV + E+ + GK P E  + +E+ + +++  +            +         +  
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------LYKPRLASTHVYQ 233

Query: 532 TLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
              +  HC    P  RP   ++++QL EI 
Sbjct: 234 ---IMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-57
 Identities = 51/269 (18%), Positives = 111/269 (41%), Gaps = 21/269 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           + +G   +G V          VA+K ++E  +  + EF  E  ++  + H  L+ L    
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
                   ++ +YM +G L  +L              +++ K +   + +L S    +H 
Sbjct: 69  TKQ-RPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK-QFLHR 124

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           +L + N L++D    K+SDFGLSR +      + + +   + +  PE+    K ++K+D+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184

Query: 473 YSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLN 531
           ++ GV + E+ + GK P E    +E  + +A  ++            +       +++  
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------LYRPHLASEKVYT 232

Query: 532 TLKLALHCVDPSPSARPEVLQVVQQLEEI 560
              +   C       RP    ++  + ++
Sbjct: 233 ---IMYSCWHEKADERPTFKILLSNILDV 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 4e-56
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 25/277 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKITKGQ-REFESEVSLLGKIRHPNLLA 347
           E++G+  +G VY  TL D        AVK L      G+  +F +E  ++    HPN+L+
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L    L  +G  L+V  YM HG L  F+              +     + +G+  L S  
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK- 149

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT---AAANVNVIATAGALGYRAPELSKLK 464
             +H +L + N +LD+    K++DFGL+R M      +  N       + + A E  + +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
           K  TK+DV+S GV + EL+T  +P  P            +++            +     
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRR---------LLQPEY 258

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
             D L     + L C  P    RP   ++V ++  I 
Sbjct: 259 CPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIF 292

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-55
 Identities = 66/297 (22%), Positives = 116/297 (39%), Gaps = 33/297 (11%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
           E +GK  +G V++     G +VAVK    +  +     E+E+     +RH N+L   A  
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 353 L---GPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS---- 405
               G   +  LV DY  HGSL  +L+       +     +K+      GL HLH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 406 ---NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT---AGALGYRAPE 459
                 I H +L S N+L+  +    I+D GL+    +A +   IA     G   Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 460 L------SKLKKANTKTDVYSLGVTILELLTGKSPGE-------PLNGAELPQWVASIVK 506
           +       K  ++  + D+Y++G+   E+    S G        P             ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 507 EEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +    +     +     +  + L    K+   C   + +AR   L++ + L ++  +
Sbjct: 243 KVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-55
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 28/288 (9%)

Query: 280 LMFTADDLLCATAEIMGKSTYGTVYKATL---EDGSQVAVKRLREKITKGQRE-FESEVS 335
           L    D+LL A  E+ G   +G+V +      +    VA+K L++   K   E    E  
Sbjct: 3   LFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 336 LLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKG 395
           ++ ++ +P ++ L           +LV +    G L  FL   G    I      +++  
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQ 117

Query: 396 MTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA--GAL 453
           ++ G+ +L    N +H +L + NVLL +   AKISDFGLS+ + A  +     +A    L
Sbjct: 118 VSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 454 GYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNE 512
            + APE    +K ++++DV+S GVT+ E L+ G+ P + + G E+  ++    + E    
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-- 234

Query: 513 VFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                     P    EL     L   C       RP+ L V Q++   
Sbjct: 235 ----------PECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 9e-55
 Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 19/268 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYY 352
             +G+  +G V+  T    ++VA+K L+   T     F  E  ++ K+RH  L+ L A  
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 353 LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHG 412
              +    +V +YM  GSL  FL     +  +  P  + +   +  G+ ++    N +H 
Sbjct: 82  --SEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM-NYVHR 137

Query: 413 NLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDV 472
           +L ++N+L+ ++   K++DFGL+RL+              + + APE +   +   K+DV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197

Query: 473 YSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNT 532
           +S G+ + EL T    G       + + V   V+  +         M   P   + L + 
Sbjct: 198 WSFGILLTELTTK---GRVPYPGMVNREVLDQVERGYR--------MPCPPECPESLHD- 245

Query: 533 LKLALHCVDPSPSARPEVLQVVQQLEEI 560
             L   C    P  RP    +   LE+ 
Sbjct: 246 --LMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 9e-54
 Identities = 58/283 (20%), Positives = 110/283 (38%), Gaps = 19/283 (6%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
             +G    G V+K +    G  +A K +  +I    R     E+ +L +   P ++    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            +    GE  +  ++M  GSL   L   G    I      K+   + +GL +L     I+
Sbjct: 72  AFYS-DGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIM 127

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           H ++  SN+L++     K+ DFG+S  +    +    +  G   Y +PE  +    + ++
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYSVQS 184

Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE----------VFDLELMR 520
           D++S+G++++E+  G+ P  P +  EL       V+ +              +    +  
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244

Query: 521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
             P    ELL+ +        PS     E    V +     P 
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (461), Expect = 2e-53
 Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 45/297 (15%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNL 345
             +G+  +G V++A        E  + VAVK L+E+ +   Q +F+ E +L+ +  +PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPET---------------------PI 384
           + L            L+F+YM +G L  FL +  P T                     P+
Sbjct: 79  VKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137

Query: 385 DWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV 444
               ++ I + +  G+ +L      +H +L + N L+ ++   KI+DFGLSR + +A   
Sbjct: 138 SCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196

Query: 445 NVIAT-AGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS 503
                 A  + +  PE     +  T++DV++ GV + E+ +      P  G    + +  
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMAHEEVIYY 254

Query: 504 IVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           +             ++        EL N   L   C    P+ RP    + + L+ +
Sbjct: 255 VRDG---------NILACPENCPLELYN---LMRLCWSKLPADRPSFCSIHRILQRM 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (456), Expect = 7e-53
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 19/273 (6%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-VAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G   YG VY+   +  S  VAVK L+E  T    EF  E +++ +I+HPNL+ L   
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
                    ++ ++M +G+L  +L     +  +     + +   ++  + +L    N IH
Sbjct: 82  CTRE-PPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK-NFIH 138

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTD 471
            +L + N L+ ++   K++DFGLSRLMT             + + APE     K + K+D
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198

Query: 472 VYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLN 531
           V++ GV + E+ T      P  G +L Q    + K+      + +E     P   +++  
Sbjct: 199 VWAFGVLLWEIATYGMS--PYPGIDLSQVYELLEKD------YRMERPEGCP---EKVYE 247

Query: 532 TLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA 564
              L   C   +PS RP   ++ Q  E +  E+
Sbjct: 248 ---LMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (457), Expect = 9e-53
 Identities = 69/303 (22%), Positives = 137/303 (45%), Gaps = 43/303 (14%)

Query: 282 FTADDLLCATA--------------EIMGKSTYGTVYKATLEDGSQ----VAVKRLREKI 323
           FT +D   A                +++G   +G V    L+   +    VA+K L+   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 324 TKGQ-REFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPET 382
           T+ Q R+F SE S++G+  HPN++ L           +++ ++M +GSL +FL       
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQNDG-- 123

Query: 383 PIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA 442
                  + +++G+  G+ +L    N +H +L + N+L++ +   K+SDFGLSR +    
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 443 N----VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL 497
           +     + +     + + APE  + +K  + +DV+S G+ + E+++ G+ P   +   ++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

Query: 498 PQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQL 557
              +          + + L    D P     L    +L L C     + RP+  Q+V  L
Sbjct: 243 INAIE---------QDYRLPPPMDCP---SAL---HQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 558 EEI 560
           +++
Sbjct: 288 DKM 290

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 5e-52
 Identities = 63/272 (23%), Positives = 110/272 (40%), Gaps = 27/272 (9%)

Query: 296 GKSTYGTVYKATLED---GSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALRA 350
           G   +GTV K   +       VAVK L+ +        E  +E +++ ++ +P ++ +  
Sbjct: 16  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM-- 73

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
             +      +LV +    G L  +L        +     ++++  ++ G+ +L  + N +
Sbjct: 74  IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-NFV 129

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAPELSKLKKANT 468
           H +L + NVLL     AKISDFGLS+ + A  N     T     + + APE     K ++
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           K+DV+S GV + E  +      P  G +  +  A + K          E M        E
Sbjct: 190 KSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEKG---------ERMGCPAGCPRE 238

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           + +   L   C       RP    V  +L   
Sbjct: 239 MYD---LMNLCWTYDVENRPGFAAVELRLRNY 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 9e-52
 Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 25/272 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQRE-FESEVSLLGKIRHPNLLALR 349
             +G  +YG   K     DG  +  K L    +T+ +++   SEV+LL +++HPN++   
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 350 AYYLGPKGEKL-LVFDYMPHGSLATFLHARGPET-PIDWPTRMKIIKGMTRGLLHLHS-- 405
              +      L +V +Y   G LA+ +     E   +D    ++++  +T  L   H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 406 --NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
                ++H +L  +NV LD   N K+ DFGL+R++    +    A  G   Y +PE    
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPEQMNR 188

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
              N K+D++SLG  + EL     P    +  EL              ++ + +  R   
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------KIREGKFRRIPY 236

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
              DEL     +    ++     RP V ++++
Sbjct: 237 RYSDELNE---IITRMLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-51
 Identities = 70/272 (25%), Positives = 122/272 (44%), Gaps = 30/272 (11%)

Query: 293 EIMGKSTYGTVYKATL-EDGSQVAVKRLR-EKITKGQRE-FESEVSLLGKIRHPNLLALR 349
             +G+ ++ TVYK    E   +VA   L+  K+TK +R+ F+ E  +L  ++HPN++   
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 350 AYYLGP---KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS- 405
             +      K   +LV + M  G+L T+L        +         + + +GL  LH+ 
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR 131

Query: 406 NENIIHGNLTSSNVLLDDSTN-AKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK 464
              IIH +L   N+ +   T   KI D GL+ L  A+    VI T     + APE+ + +
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT---PEFMAPEMYE-E 187

Query: 465 KANTKTDVYSLGVTILELLTGKSP-GEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           K +   DVY+ G+ +LE+ T + P  E  N A++ + V S VK    ++V   E+     
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE--- 244

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
                      +   C+  +   R  +  ++ 
Sbjct: 245 -----------IIEGCIRQNKDERYSIKDLLN 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-51
 Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 36/292 (12%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ---VAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLA 347
           +++G+  +G V KA ++        A+KR++E  +K   R+F  E+ +L K+  HPN++ 
Sbjct: 16  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLH-------------ARGPETPIDWPTRMKIIK 394
           L       +G   L  +Y PHG+L  FL              A    + +     +    
Sbjct: 76  LLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134

Query: 395 GMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALG 454
            + RG+ +L      IH +L + N+L+ ++  AKI+DFGLSR       V        + 
Sbjct: 135 DVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKTMGRLPVR 191

Query: 455 YRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVF 514
           + A E        T +DV+S GV + E+++      P  G    +    + +       +
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQG------Y 243

Query: 515 DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAAT 566
            LE   +     DE+ +   L   C    P  RP   Q++  L  +  E  T
Sbjct: 244 RLEKPLNCD---DEVYD---LMRQCWREKPYERPSFAQILVSLNRMLEERKT 289

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (441), Expect = 3e-50
 Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 31/270 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ---REFESEVSLLGKIRHPNLLAL 348
             +G  ++G VY A  + +   VA+K++     +     ++   EV  L K+RHPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           R  YL       LV +Y    +       + P   +       +  G  +GL +LHS+ N
Sbjct: 81  RGCYLRE-HTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSH-N 135

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL---SKLKK 465
           +IH ++ + N+LL +    K+ DFG + +M  A +       G   + APE+       +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVILAMDEGQ 190

Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
            + K DV+SLG+T +EL   K P   +N       +  I + E             +   
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNESPAL--------QSGHW 239

Query: 526 GDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
            +   N       C+   P  RP    +++
Sbjct: 240 SEYFRN---FVDSCLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 4e-50
 Identities = 61/269 (22%), Positives = 109/269 (40%), Gaps = 24/269 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G   +G VYKA   E     A K +  K  +   ++  E+ +L    HPN++ L   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +        ++ ++   G++   +     E P+       + K     L +LH N  IIH
Sbjct: 78  FYYE-NNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN-KIIH 133

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL-----SKLKKA 466
            +L + N+L     + K++DFG+S   T        +  G   + APE+     SK +  
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPY 192

Query: 467 NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG 526
           + K DV+SLG+T++E+   + P   LN   +   +  I K E          +       
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIAKSEP-------PTLAQPSRWS 242

Query: 527 DELLNTLKLALHCVDPSPSARPEVLQVVQ 555
               +       C++ +  AR    Q++Q
Sbjct: 243 SNFKD---FLKKCLEKNVDARWTTSQLLQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 1e-49
 Identities = 65/278 (23%), Positives = 107/278 (38%), Gaps = 27/278 (9%)

Query: 293 EIMGKSTYGTVYKATLE----DGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNL 345
           E +G  ++G V +   +        VAVK L+  +    +   +F  EV+ +  + H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L    L       +V +  P GSL   L     +      T  +    +  G+ +L S
Sbjct: 74  IRLYGVVL--TPPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES 129

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAPELSKL 463
               IH +L + N+LL      KI DFGL R +    +  V+         + APE  K 
Sbjct: 130 K-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           +  +  +D +  GVT+ E+ T      P  G    Q +  I KE         E +    
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDKEG--------ERLPRPE 238

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
               ++ N   + + C    P  RP  + +   L E +
Sbjct: 239 DCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-49
 Identities = 59/276 (21%), Positives = 106/276 (38%), Gaps = 24/276 (8%)

Query: 293 EIMGKSTYGTVYKATL----EDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLA 347
             +G+  +G V++            VA+K  +   +   RE F  E   + +  HP+++ 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           L       +    ++ +    G L +FL  R     +D  + +     ++  L +L S  
Sbjct: 73  LIGVIT--ENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK- 127

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
             +H ++ + NVL+  +   K+ DFGLSR M  +           + + APE    ++  
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
           + +DV+  GV + E+L       P  G +    +  I            E +   P    
Sbjct: 188 SASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENG---------ERLPMPPNCPP 236

Query: 528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
            L +   L   C    PS RP   ++  QL  I  E
Sbjct: 237 TLYS---LMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  170 bits (432), Expect = 1e-48
 Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 21/266 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G   +G V++ T    G+  A K +       +     E+  +  +RHP L+ L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +     E ++++++M  G L   +        +     ++ ++ + +GL H+H N N +H
Sbjct: 92  FEDD-NEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN-NYVH 147

Query: 412 GNLTSSNVLL--DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
            +L   N++     S   K+ DFGL+  +      +V  T G   + APE+++ K     
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEGKPVGYY 205

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           TD++S+GV    LL+G SP    N  E    + ++   +W     D          G + 
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSCDWN---MDDSAFSGISEDGKDF 259

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQ 555
           +         +   P+ R  + Q ++
Sbjct: 260 IR------KLLLADPNTRMTIHQALE 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-48
 Identities = 63/276 (22%), Positives = 123/276 (44%), Gaps = 26/276 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-----VAVKRLREKITKGQR-EFESEVSLLGKIRHPNLL 346
           +++G   +G VYK  L+  S      VA+K L+   T+ QR +F  E  ++G+  H N++
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L           +++ +YM +G+       R  +        + +++G+  G+ +L + 
Sbjct: 73  RLEGVISKY-KPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 129

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM--TAAANVNVIATAGALGYRAPELSKLK 464
            N +H +L + N+L++ +   K+SDFGLSR++     A          + + APE    +
Sbjct: 130 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188

Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
           K  + +DV+S G+ + E++T    GE          V   + + +             PT
Sbjct: 189 KFTSASDVWSFGIVMWEVMTY---GERPYWELSNHEVMKAINDGF-----------RLPT 234

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             D      +L + C     + RP+   +V  L+++
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-48
 Identities = 61/295 (20%), Positives = 113/295 (38%), Gaps = 44/295 (14%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ------VAVKRLREKITKGQRE-FESEVSLLGKI-RHPN 344
           +++G   +G V  AT    S+      VAVK L+EK    +RE   SE+ ++ ++  H N
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGP--------------------ETPI 384
           ++ L        G   L+F+Y  +G L  +L ++                         +
Sbjct: 103 IVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161

Query: 385 DWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV 444
            +   +     + +G+  L    + +H +L + NVL+      KI DFGL+R + + +N 
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 445 NVIATA-GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVAS 503
            V   A   + + APE         K+DV+S G+ + E+ +      P  G  +      
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIPVDANFYK 278

Query: 504 IVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE 558
           +++  +         M       +E+     +   C       RP    +   L 
Sbjct: 279 LIQNGFK--------MDQPFYATEEIYI---IMQSCWAFDSRKRPSFPNLTSFLG 322

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 8e-48
 Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 39/295 (13%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQRE-FESEVSLLGKI-RHPN 344
           + +G   +G V +AT       +    VAVK L+      +RE   SE+ +L  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARG---------------PETPIDWPTR 389
           ++ L        G  L++ +Y  +G L  FL  +                 E  +D    
Sbjct: 89  IVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-VNVIA 448
           +     + +G+  L S  N IH +L + N+LL      KI DFGL+R +   +N V    
Sbjct: 148 LSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE 508
               + + APE         ++DV+S G+ + EL +  S   P  G  +      ++KE 
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKFYKMIKEG 264

Query: 509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +         M        E+ +   +   C D  P  RP   Q+VQ +E+   E
Sbjct: 265 FR--------MLSPEHAPAEMYD---IMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  168 bits (426), Expect = 1e-47
 Identities = 52/266 (19%), Positives = 114/266 (42%), Gaps = 21/266 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G   +G V++      G     K +       +   ++E+S++ ++ HP L+ L   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +   K E +L+ +++  G L   + A      +     +  ++    GL H+H + +I+H
Sbjct: 95  FED-KYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH-SIVH 150

Query: 412 GNLTSSNVLLD--DSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
            ++   N++ +   +++ KI DFGL+  +    +  V  T     + APE+   +     
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           TD++++GV    LL+G S   P  G +  + + ++ + +W    FD +          + 
Sbjct: 209 TDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRCDWE---FDEDAFSSVSPEAKDF 262

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQ 555
           +       + +   P  R  V   ++
Sbjct: 263 IK------NLLQKEPRKRLTVHDALE 282

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-47
 Identities = 58/267 (21%), Positives = 105/267 (39%), Gaps = 22/267 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQREFESEVSLLGKIRHPNLLALRA 350
           + +G+  YG V  A        VAVK +  ++        + E+ +   + H N++    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
           +       + L  +Y   G L   +        +  P   +    +  G+++LH    I 
Sbjct: 71  HRREG-NIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGI-GIT 125

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPE-LSKLKKANT 468
           H ++   N+LLD+  N KISDFGL+ +        ++    G L Y APE L + +    
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
             DV+S G+ +  +L G+          LP    S   +E+++       +     I   
Sbjct: 186 PVDVWSCGIVLTAMLAGE----------LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQ 555
            L    L    +  +PSAR  +  + +
Sbjct: 236 PLA---LLHKILVENPSARITIPDIKK 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-47
 Identities = 58/283 (20%), Positives = 118/283 (41%), Gaps = 31/283 (10%)

Query: 293 EIMGKSTYGTVYKATL------EDGSQVAVKRLREKITKGQR-EFESEVSLLGKIRHPNL 345
             +G+ ++G VY+         E  ++VA+K + E  +  +R EF +E S++ +    ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPE-------TPIDWPTRMKIIKGMTR 398
           + L           L++ + M  G L ++L +  P         P      +++   +  
Sbjct: 86  VRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 399 GLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA-GALGYRA 457
           G+ +L++N   +H +L + N ++ +    KI DFG++R +               + + +
Sbjct: 145 GMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203

Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           PE  K     T +DV+S GV + E+ T      P  G    Q +  +++           
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEG---------G 252

Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
           L+       D L    +L   C   +P  RP  L+++  ++E 
Sbjct: 253 LLDKPDNCPDML---FELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (415), Expect = 3e-47
 Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 28/267 (10%)

Query: 293 EIMGKSTYGTVYKATL-EDGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLAL 348
             +GK  +G VY A   +    +A+K L +        + +   EV +   +RHPN+L L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
             Y+        L+ +Y P G++   L         D       I  +   L + HS   
Sbjct: 72  YGYFHDA-TRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSK-R 126

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           +IH ++   N+LL  +   KI+DFG S    ++    +  T   L Y  PE+ + +  + 
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT---LDYLPPEMIEGRMHDE 183

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
           K D++SLGV   E L GK    P       +    I + E+T              + + 
Sbjct: 184 KVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISRVEFT----------FPDFVTEG 230

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQ 555
             +   L    +  +PS RP + +V++
Sbjct: 231 ARD---LISRLLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-46
 Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 31/288 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G+   GTVY A  +  G +VA++++  +    +    +E+ ++ + ++PN++     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           YL    E  +V +Y+  GSL   +     ET +D      + +   + L  LHSN  +IH
Sbjct: 86  YLVG-DELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN-QVIH 139

Query: 412 GNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTD 471
            ++ S N+LL    + K++DFG    +T           G   + APE+   K    K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 472 VYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDELLN 531
           ++SLG+  +E++ G+ P    N           +    TN   +L+       I  + LN
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 532 TLKLALHCVDPSPSARP---EVL-----QVVQQLEEIRP--EAATAAT 569
                  C+D     R    E+L     ++ + L  + P   AA  AT
Sbjct: 252 ------RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 6e-46
 Identities = 59/280 (21%), Positives = 122/280 (43%), Gaps = 28/280 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           E +G+  +G V++            K ++ K T  Q   + E+S+L   RH N+L L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           +     E +++F+++    +   ++       ++    +  +  +   L  LHS+ NI H
Sbjct: 70  FESM-EELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSH-NIGH 125

Query: 412 GNLTSSNVLLDDSTNA--KISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
            ++   N++     ++  KI +FG +R +    N  +     A  Y APE+ +    +T 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVSTA 183

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
           TD++SLG  +  LL+G +P       ++   + +I+  E+T   FD E  ++      + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQI---IENIMNAEYT---FDEEAFKEISIEAMDF 237

Query: 530 LNTLKLALHCVDPSPSARP---EVLQ---VVQQLEEIRPE 563
           ++        +     +R    E LQ   + Q++E +  +
Sbjct: 238 VD------RLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-45
 Identities = 59/275 (21%), Positives = 117/275 (42%), Gaps = 26/275 (9%)

Query: 293 EIMGKSTYGTVYKATLEDGSQ-----VAVKRLREKIT-KGQREFESEVSLLGKIRHPNLL 346
           +++G   +GTVYK       +     VA+K LRE  + K  +E   E  ++  + +P++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L    L       L+   MP G L  ++        I     +     + +G+ +L   
Sbjct: 75  RLLGICL--TSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA-ANVNVIATAGALGYRAPELSKLKK 465
             ++H +L + NVL+    + KI+DFGL++L+ A     +       + + A E    + 
Sbjct: 131 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI 525
              ++DV+S GVT+ EL+T  S   P +G    +  + + K          E +   P  
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKG---------ERLPQPPIC 238

Query: 526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
             ++     + + C      +RP+  +++ +  ++
Sbjct: 239 TIDVYM---IMVKCWMIDADSRPKFRELIIEFSKM 270

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 5e-45
 Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 36/290 (12%)

Query: 293 EIMGKSTYGTVYKAT------LEDGSQVAVKRLREKITKG-QREFESEVSLLGKIRH-PN 344
           + +G+  +G V +A             VAVK L+E  T    R   SE+ +L  I H  N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPET-------------PIDWPTRMK 391
           ++ L      P G  +++ ++   G+L+T+L ++  E               +     + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 392 IIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA- 450
               + +G+  L S    IH +L + N+LL +    KI DFGL+R +    +      A 
Sbjct: 139 YSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197

Query: 451 GALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT 510
             L + APE    +    ++DV+S GV + E+ +  +   P  G ++ +     +KE   
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCRRLKEG-- 253

Query: 511 NEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                   MR       E+    +  L C    PS RP   ++V+ L  +
Sbjct: 254 ------TRMRAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-44
 Identities = 67/292 (22%), Positives = 116/292 (39%), Gaps = 40/292 (13%)

Query: 293 EIMGKSTYGTVYKATL--------EDGSQVAVKRLR-EKITKGQREFESEVSLLGKI-RH 342
           + +G+  +G V  A             ++VAVK L+ +   K   +  SE+ ++  I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 343 PNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGP-------------ETPIDWPTR 389
            N++ L        G   ++ +Y   G+L  +L AR P             E  +     
Sbjct: 79  KNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137

Query: 390 MKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA-ANVNVIA 448
           +     + RG+ +L S    IH +L + NVL+ +    KI+DFGL+R +           
Sbjct: 138 VSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE 508
               + + APE    +    ++DV+S GV + E+ T    G         + +  ++KE 
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL---GGSPYPGVPVEELFKLLKEG 253

Query: 509 WTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                     M       +EL     +   C    PS RP   Q+V+ L+ I
Sbjct: 254 --------HRMDKPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (395), Expect = 8e-44
 Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 24/268 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           +++G   +  V  A        VA+K + +K  +G+    E+E+++L KI+HPN++AL  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
            Y    G   L+   +  G L   +  +G           ++I  +   + +LH    I+
Sbjct: 75  IYE-SGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDL-GIV 129

Query: 411 HGNLTSSNVLL---DDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
           H +L   N+L    D+ +   ISDFGLS++    + ++     G  GY APE+   K  +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQKPYS 187

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
              D +S+GV    LL G     P       +    I+K E+    FD     D      
Sbjct: 188 KAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYE---FDSPYWDDISDSAK 241

Query: 528 ELLNTLKLALHCVDPSPSARPEVLQVVQ 555
           + +       H ++  P  R    Q +Q
Sbjct: 242 DFIR------HLMEKDPEKRFTCEQALQ 263

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-42
 Identities = 50/272 (18%), Positives = 104/272 (38%), Gaps = 28/272 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLAL 348
           +I+G+ ++ TV  A  L    + A+K L ++             E  ++ ++ HP  + L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              +     +      Y  +G L  ++   G     D          +   L +LH    
Sbjct: 74  YFTFQ-DDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK-G 128

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT-AGALGYRAPELSKLKKAN 467
           IIH +L   N+LL++  + +I+DFG +++++  +      +  G   Y +PEL   K A 
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
             +D+++LG  I +L+ G  P    N   + Q                 ++++      +
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ-----------------KIIKLEYDFPE 231

Query: 528 ELLNTLK-LALHCVDPSPSARPEVLQVVQQLE 558
           +     + L    +    + R    ++     
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  151 bits (382), Expect = 3e-42
 Identities = 62/280 (22%), Positives = 106/280 (37%), Gaps = 36/280 (12%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR---------EKITKGQREFESEVSLLGKIR- 341
           EI+G+     V +        + AVK +          E++ + +     EV +L K+  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 342 HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
           HPN++ L+  Y        LVFD M  G L  +L  +     +      KI++ +   + 
Sbjct: 69  HPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVIC 124

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL- 460
            LH   NI+H +L   N+LLDD  N K++DFG S  +     +  +   G   Y APE+ 
Sbjct: 125 ALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--CGTPSYLAPEII 181

Query: 461 -----SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD 515
                        + D++S GV +  LL G     P    +    +  I+   +      
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSGNYQFG--- 235

Query: 516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
                +     D + +   L    +   P  R    + + 
Sbjct: 236 ---SPEWDDYSDTVKD---LVSRFLVVQPQKRYTAEEALA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (381), Expect = 3e-42
 Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 26/279 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ---REFESEVSLLGKIRHPNLLAL 348
           EI+G      V+ A  L     VAVK LR  + +       F  E      + HP ++A+
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 349 RAYYLGPKGEKL---LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
                          +V +Y+   +L   +H  G   P+     +++I    + L   H 
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ 129

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATA--GALGYRAPELSKL 463
           N  IIH ++  +N+++  +   K+ DFG++R +  + N      A  G   Y +PE ++ 
Sbjct: 130 N-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
              + ++DVYSLG  + E+LTG+    P  G          V+E+    +          
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVREDP---IPPSARHEGLS 242

Query: 524 TIGDELLNTLKLALHCVDPSPSARPE-VLQVVQQLEEIR 561
              D ++      L  +  +P  R +   ++   L  + 
Sbjct: 243 ADLDAVV------LKALAKNPENRYQTAAEMRADLVRVH 275

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 58/279 (20%), Positives = 115/279 (41%), Gaps = 16/279 (5%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
             +G+  YG V  A    +  +VA+K++     +   +    E+ +L + RH N++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 351 YYLGP---KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
               P   + + + +  ++    L   L  +     +        +  + RGL ++HS  
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA- 128

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT--AGALGYRAPELSKLKK 465
           N++H +L  SN+LL+ + + KI DFGL+R+     +     T       YRAPE+    K
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188

Query: 466 ANT-KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
             T   D++S+G  + E+L+ +       G      +  I+    +    DL  + +   
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRP---IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
               L    K  +      P+A  + L ++ ++    P 
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (362), Expect = 2e-39
 Identities = 44/278 (15%), Positives = 85/278 (30%), Gaps = 24/278 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G  ++G +Y  T +  G +VA+K    K      +   E  +   ++    +    +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
                   ++V + +       F             T + +   M   + ++HS  N IH
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSK-NFIH 126

Query: 412 GNLTSSNVL---LDDSTNAKISDFGLSRLMTAAANVNVIAT------AGALGYRAPELSK 462
            ++   N L           I DFGL++    A     I         G   Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
             + + + D+ SLG  ++    G  P + L  A   Q       E  + +     +    
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-----ERISEKKMSTPIEVLC 241

Query: 523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                E          C       +P+   + Q    +
Sbjct: 242 KGYPSEFAT---YLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 3e-39
 Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 30/274 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQR------EFESEVSLLGKIRHPNL 345
           E +G   +  V K      G Q A K ++++ TK  R      + E EVS+L +I+HPN+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + L   Y   K + +L+ + +  G L  FL  +     +      + +K +  G+ +LHS
Sbjct: 76  ITLHEVYEN-KTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHS 131

Query: 406 NENIIHGNLTSSNVLLDD----STNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
              I H +L   N++L D        KI DFGL+  +        I   G   + APE+ 
Sbjct: 132 L-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIV 188

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD 521
             +    + D++S+GV    LL+G SP       E    V+++  E      F+ E   +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE------FEDEYFSN 242

Query: 522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
              +  + +         +   P  R  +   +Q
Sbjct: 243 TSALAKDFIR------RLLVKDPKKRMTIQDSLQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-39
 Identities = 52/272 (19%), Positives = 113/272 (41%), Gaps = 23/272 (8%)

Query: 291 TAEIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALR 349
           T++++G    G V +        + A+K L+    K +RE E         + P+++ + 
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRAS---QCPHIVRIV 71

Query: 350 AYYLGPKGEK---LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
             Y      +   L+V + +  G L + +  RG +         +I+K +   + +LHS 
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSI 130

Query: 407 ENIIHGNLTSSNVLLDDSTN---AKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKL 463
            NI H ++   N+L          K++DFG ++  T  ++ ++        Y APE+   
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGP 187

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
           +K +   D++SLGV +  LL G  P    +G  +   + + ++              +  
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP-----EWS 242

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
            + +E+   ++   + +   P+ R  + + + 
Sbjct: 243 EVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  140 bits (352), Expect = 4e-38
 Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 20/278 (7%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLR-EKITKGQRE-FESEVSLLGKIRHPNLLALRA 350
           E +G+ TYG VYKA    G   A+K++R EK  +G       E+S+L +++H N++ L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 351 YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENII 410
                K   +LVF+++            G    ++  T    +  +  G+ + H    ++
Sbjct: 68  VIHTKK-RLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDR-RVL 122

Query: 411 HGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKT 470
           H +L   N+L++     KI+DFGL+R                       L   KK +T  
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 471 DVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV----KEEWTN----EVFDLELMRDA 522
           D++S+G    E++ G      ++ A+    +  I+     + W N      +D       
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 523 PTIGDELLNTL-----KLALHCVDPSPSARPEVLQVVQ 555
           P   +  L  L      L    +   P+ R    Q ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 8e-38
 Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 27/267 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFES----EVSLLGKIRHPNLLA 347
           +++GK ++G V+ A   +     A+K L++ +     + E     +  L     HP L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 348 LRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNE 407
           +   +   K     V +Y+  G L   + +       D          +  GL  LHS  
Sbjct: 68  MFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK- 122

Query: 408 NIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKAN 467
            I++ +L   N+LLD   + KI+DFG+ +      +       G   Y APE+   +K N
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLGQKYN 181

Query: 468 TKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD 527
              D +S GV + E+L G+SP    +  EL   +               +       +  
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------DNPFYPRWLEK 228

Query: 528 ELLNTLKLALHCVDPS--PSARPEVLQ 552
           E  + L       +P      R ++ Q
Sbjct: 229 EAKDLLVKLF-VREPEKRLGVRGDIRQ 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  139 bits (350), Expect = 9e-38
 Identities = 44/280 (15%), Positives = 98/280 (35%), Gaps = 26/280 (9%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
             +G+ ++G +++ T L +  QVA+K    +      +   E      +     +    Y
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIP-NVY 67

Query: 352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIH 411
           Y G +G   ++   +   SL   L   G        T     K M   +  +H   ++++
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK-SLVY 124

Query: 412 GNLTSSNVLLDDSTN-----AKISDFGLSRLMTAAANVNVI------ATAGALGYRAPEL 460
            ++   N L+    +       + DFG+ +          I        +G   Y +   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
              ++ + + D+ +LG   +  L G  P + L  A   Q    I +++ +  + +L    
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL---- 240

Query: 521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI 560
                 +E     K   +  + +  A P+   +     ++
Sbjct: 241 -CAGFPEEF---YKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 64/279 (22%), Positives = 116/279 (41%), Gaps = 20/279 (7%)

Query: 293 EIMGKSTYGTVYKATL-EDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAY 351
           +++G  ++G VY+A L + G  VA+K++     + +R    E+ ++ K+ H N++ LR +
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 352 YLGPKGEK-----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
           +     +K      LV DY+P        H    +  +        +  + R L ++HS 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141

Query: 407 ENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAP-ELSKLK 464
             I H ++   N+LLD D+   K+ DFG ++ +        ++   +  YRAP  +    
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGAT 198

Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
              +  DV+S G  + ELL G+       G      +  I+K   T     +  M   P 
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQIREMN--PN 253

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
             +     +K         P   PE + +  +L E  P 
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  139 bits (352), Expect = 3e-37
 Identities = 62/277 (22%), Positives = 109/277 (39%), Gaps = 31/277 (11%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ------REFESEVSLLGKIRHPNL 345
            I+G+  +G VY     + G   A+K L +K  K +            +SL+     P +
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 346 LALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHS 405
           + +   +  P  +   + D M  G L   L   G                +  GL H+H+
Sbjct: 70  VCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHN 125

Query: 406 NENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKLK 464
              +++ +L  +N+LLD+  + +ISD GL+   +        A+ G  GY APE L K  
Sbjct: 126 R-FVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQKGV 181

Query: 465 KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT 524
             ++  D +SLG  + +LL G SP       +  +    I +   T  V          +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAV------ELPDS 231

Query: 525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR 561
              EL + L+     +    + R   L   +  +E++
Sbjct: 232 FSPELRSLLE---GLLQRDVNRRLGCLG--RGAQEVK 263

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  137 bits (346), Expect = 7e-37
 Identities = 59/264 (22%), Positives = 104/264 (39%), Gaps = 29/264 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLAL 348
             +G  ++G V+      +G   A+K L+++I    K       E  +L  + HP ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              +     +  ++ DY+  G L + L           P        +   L +LHS  +
Sbjct: 70  WGTFQDA-QQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK-D 124

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           II+ +L   N+LLD + + KI+DFG ++ +            G   Y APE+   K  N 
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKPYNK 180

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
             D +S G+ I E+L G +   P   +   +    I+  E           R  P   ++
Sbjct: 181 SIDWWSFGILIYEMLAGYT---PFYDSNTMKTYEKILNAEL----------RFPPFFNED 227

Query: 529 LLNTLKLALHCVDPSPSARPEVLQ 552
           + + L      +    S R   LQ
Sbjct: 228 VKDLLS---RLITRDLSQRLGNLQ 248

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-36
 Identities = 70/275 (25%), Positives = 113/275 (41%), Gaps = 14/275 (5%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           E +G+ TYG VYKA     G  VA+K++R +  T+G       E+SLL ++ HPN++ L 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                    KL +     H  L  F+ A    T I  P     +  + +GL   HS+  +
Sbjct: 68  DVIH--TENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSH-RV 123

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKLKKANT 468
           +H +L   N+L++     K++DFGL+R                L YRAPE L   K  +T
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYST 182

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
             D++SLG    E++T ++      G      +  I +   T +      +   P     
Sbjct: 183 AVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
                +     V P      +   ++ Q+    P 
Sbjct: 240 FPKWARQDFSKVVPPLD--EDGRSLLSQMLHYDPN 272

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-35
 Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 31/285 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-----EKITKGQREFESEVSLLGKIRHPNLL 346
           + +G+  + TVYKA        VA+K+++     E      R    E+ LL ++ HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 347 ALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN 406
            L   + G K    LVFD+M                 +        +    +GL +LH +
Sbjct: 64  GLLDAF-GHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQH 119

Query: 407 ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKLKK 465
             I+H +L  +N+LLD++   K++DFGL++   +              YRAPE L   + 
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH-QVVTRWYRAPELLFGARM 177

Query: 466 ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV----KEEWTN---------- 511
                D++++G  + ELL         +  +    +   +    +E+W +          
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 512 -EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
                + L       GD+LL+ ++        +P AR    Q ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 4e-35
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 27/285 (9%)

Query: 293 EIMGKSTYGTVYKAT--LEDGSQVAVKRLREKITKG--QREFESEVSL---LGKIRHPNL 345
             +G+  YG V+KA      G  VA+KR+R +  +         EV++   L    HPN+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 346 LALRAYYLGPKGEK----LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLL 401
           + L       + ++     LVF+++           + PE  +   T   ++  + RGL 
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLT--TYLDKVPEPGVPTETIKDMMFQLLRGLD 130

Query: 402 HLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELS 461
            LHS+  ++H +L   N+L+  S   K++DFGL+R+ +    +   +    L YRAPE+ 
Sbjct: 131 FLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVTLWYRAPEVL 187

Query: 462 KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIV----KEEWTNEV---- 513
                 T  D++S+G    E+   K      +  +    +  ++    +E+W  +V    
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 514 --FDLELMRDAPTIGDELLNTLK-LALHCVDPSPSARPEVLQVVQ 555
             F  +  +       ++    K L L C+  +P+ R      + 
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 6e-35
 Identities = 60/286 (20%), Positives = 114/286 (39%), Gaps = 22/286 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR--EKITKGQREFESEVSLLGKIRHPNLLAL- 348
             +G+ T+G V+KA   + G +VA+K++    +          E+ +L  ++H N++ L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 349 ------RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
                  + Y   KG   LVFD+  H       +              ++++ +  GL +
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYY 132

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN---VNVIATAGALGYRAPE 459
           +H N  I+H ++ ++NVL+      K++DFGL+R  + A N            L YR PE
Sbjct: 133 IHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 460 -LSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL 518
            L   +      D++  G  + E+ T       + G      +A I +   +        
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 519 MRDAPTIGD-ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           + +       EL+   K  +     +    P  L ++ +L  + P 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-34
 Identities = 52/275 (18%), Positives = 99/275 (36%), Gaps = 42/275 (15%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE------FESEVSLLGKIR--HP 343
            ++G   +G+VY    + D   VA+K + +       E         EV LL K+     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 344 NLLALRAYYLGPKGEKLLVFDYM-PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
            ++ L  ++  P    +L+ +   P   L  F+  RG    +           +   + H
Sbjct: 70  GVIRLLDWFERP-DSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRH 125

Query: 403 LHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-L 460
            H+   ++H ++   N+L+D +    K+ DFG   L+      +   T     Y  PE +
Sbjct: 126 CHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR---VYSPPEWI 181

Query: 461 SKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR 520
              +       V+SLG+ + +++ G  P E             I++ +            
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFFR-------- 224

Query: 521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQ 555
               +  E  +   L   C+   PS RP   ++  
Sbjct: 225 --QRVSSECQH---LIRWCLALRPSDRPTFEEIQN 254

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 63/274 (22%), Positives = 107/274 (39%), Gaps = 12/274 (4%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLR-EKITKGQRE-FESEVSLLGKIRHPNLLALR 349
           E +G+ TYGTV+KA   E    VA+KR+R +   +G       E+ LL +++H N++ L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
                 K +  LVF++        F    G    +D       +  + +GL   HS  N+
Sbjct: 68  DVLHSDK-KLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR-NV 122

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTK 469
           +H +L   N+L++ +   K+++FGL+R                       L   K  +T 
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 470 TDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDEL 529
            D++S G    EL     P     G ++   +  I +   T        M   P      
Sbjct: 183 IDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 530 LNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
           +     +L  V P  +       ++Q L +  P 
Sbjct: 241 MYPATTSLVNVVPKLN--ATGRDLLQNLLKCNPV 272

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-32
 Identities = 59/280 (21%), Positives = 113/280 (40%), Gaps = 22/280 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALR 349
           + +G   YG V  A     G++VA+K+L          +    E+ LL  +RH N++ L 
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 350 AYY-----LGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
             +     L    +  LV  +M  G+    L        +       ++  M +GL ++H
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH 138

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKL 463
           +   IIH +L   N+ +++    KI DFGL+R   +     V        YRAPE +   
Sbjct: 139 AA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----VTRWYRAPEVILNW 193

Query: 464 KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP 523
            +     D++S+G  + E++TGK+  +  +  +  + +  +       E        +A 
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV-TGTPPAEFVQRLQSDEAK 252

Query: 524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
                L    K     +  + S  P  + +++++  +  E
Sbjct: 253 NYMKGLPELEKKDFASILTNAS--PLAVNLLEKMLVLDAE 290

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-32
 Identities = 58/260 (22%), Positives = 101/260 (38%), Gaps = 26/260 (10%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE---FESEVSLLGKIRHPNLLAL 348
           +++GK T+G V        G   A+K LR+++   + E     +E  +L   RHP L AL
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
           +  +         V +Y   G L   L                    +   L +LHS  +
Sbjct: 71  KYAFQTH-DRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR-D 125

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           +++ ++   N++LD   + KI+DFGL +    +    +    G   Y APE+ +      
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDNDYGR 184

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
             D + LGV + E++ G+    P    +  +    I+ EE          +R   T+  E
Sbjct: 185 AVDWWGLGVVMYEMMCGRL---PFYNQDHERLFELILMEE----------IRFPRTLSPE 231

Query: 529 LLNTLKLALHCVDPSPSARP 548
             + L      +   P  R 
Sbjct: 232 AKSLLA---GLLKKDPKQRL 248

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 7e-32
 Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 26/266 (9%)

Query: 293 EIMGKSTYGTVYKATL----EDGSQVAVKRLREKI----TKGQREFESEVSLLGKIRHPN 344
           +++G   YG V+        + G   A+K L++       K      +E  +L  IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 345 LLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
            L    Y    + +  L+ DY+  G L T L  R              +  +   L HLH
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLH 146

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE--LSK 462
               II+ ++   N+LLD + +  ++DFGLS+   A          G + Y AP+     
Sbjct: 147 KL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205

Query: 463 LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA 522
               +   D +SLGV + ELLTG SP            ++  + +       +    ++ 
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK------SEPPYPQEM 259

Query: 523 PTIGDELLNTLKLALHCVDPSPSARP 548
             +  +L+         +   P  R 
Sbjct: 260 SALAKDLIQ------RLLMKDPKKRL 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (309), Expect = 1e-31
 Identities = 44/213 (20%), Positives = 86/213 (40%), Gaps = 13/213 (6%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQRE---FESEVSLLGKIRHPNLLAL 348
           + +G  ++G V      E G+  A+K L ++     ++     +E  +L  +  P L+ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 349 RAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN 408
              +        +V +Y+  G + + L   G       P        +     +LHS  +
Sbjct: 107 EFSFKDNS-NLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSL-D 161

Query: 409 IIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANT 468
           +I+ +L   N+L+D     +++DFG ++ +            G     APE+   K  N 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNK 217

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWV 501
             D ++LGV I E+  G  P       ++ + +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (303), Expect = 6e-31
 Identities = 51/280 (18%), Positives = 109/280 (38%), Gaps = 21/280 (7%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRA 350
             +G+  Y  V++A  + +  +V VK L+      +++ + E+ +L  +R  PN++ L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 97

Query: 351 YYLGPKGEKL-LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
               P      LVF+++ +               +        +  + + L + HS   I
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM-GI 150

Query: 410 IHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPEL-SKLKKAN 467
           +H ++   NV++D +    ++ D+GL+         NV     +  ++ PEL    +  +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPELLVDYQMYD 208

Query: 468 TKTDVYSLGVTILELLTGKSP-GEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG 526
              D++SLG  +  ++  K P     +  +    +A ++  E   +  D   +   P   
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 527 DELLNTLKLALHCVDPSPSAR---PEVLQVVQQLEEIRPE 563
           D L    +        S +     PE L  + +L     +
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (287), Expect = 1e-28
 Identities = 48/287 (16%), Positives = 94/287 (32%), Gaps = 16/287 (5%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRA- 350
             +G   + TV+ A  + + + VA+K +R          E E+ LL ++   +     + 
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 351 -----------YYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRG 399
                      +         +V  +   G     L  +     I      +I K +  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 400 LLHLHSNENIIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAAANV-NVIATAGALGYRA 457
           L ++H    IIH ++   NVL++   +   +    ++ L  A     +   +     YR+
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 458 PELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE 517
           PE+          D++S    I EL+TG    EP  G    +    I +           
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA 564
           L+R+         +   L              + +  +  ++   E 
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-28
 Identities = 60/275 (21%), Positives = 113/275 (41%), Gaps = 12/275 (4%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALR 349
             +G   YG+V  A   + G +VAVK+L          +    E+ LL  ++H N++ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 350 AYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENI 409
             +   +  +     Y+    +   L+       +       +I  + RGL ++HS  +I
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DI 142

Query: 410 IHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPE-LSKLKKANT 468
           IH +L  SN+ +++    KI DFGL+R         V        YRAPE +      N 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNWMHYNQ 198

Query: 469 KTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE 528
             D++S+G  + ELLTG++      G +    +  I++   T     L+ +         
Sbjct: 199 TVDIWSVGCIMAELLTGRT---LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE 563
              T    ++  +    A P  + +++++  +  +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-26
 Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 17/204 (8%)

Query: 293 EIMGKSTYGTVYKAT-LEDGSQVAVKRLREKITKGQ--REFESEVSLLGKIRHPNLLALR 349
           + +G    G V  A        VA+K+L          +    E+ L+  + H N+++L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 350 AYYLGPK-----GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLH 404
             +   K      +  LV + M                 +D      ++  M  G+ HLH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLH 136

Query: 405 SNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSKLK 464
           S   IIH +L  SN+++      KI DFGL+R    +  +          YRAPE+    
Sbjct: 137 SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP--YVVTRYYRAPEVILGM 193

Query: 465 KANTKTDVYSLGVTILELLTGKSP 488
                 D++S+G  + E++  K  
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.8 bits (227), Expect = 5e-22
 Identities = 29/204 (14%), Positives = 63/204 (30%), Gaps = 33/204 (16%)

Query: 293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKIT----------KGQREFESEVSLLGKIRH 342
           ++MG+     V+    E   +  VK  +   T           G   F        +   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 343 PNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLH 402
             L  L+   +         + +  + ++   L        +      +++  +   +  
Sbjct: 66  RALQKLQGLAVPKV------YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 403 LHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIATAGALGYRAPELSK 462
            +    I+HG+L+  NVL+ +     I DF  S           +   G       ++  
Sbjct: 119 FYHR-GIVHGDLSQYNVLVSE-EGIWIIDFPQSV---------EVGEEGWREILERDVRN 167

Query: 463 L-----KKANTKTDVYSLGVTILE 481
           +     +   T+ D+ S    IL+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 94.3 bits (233), Expect = 2e-21
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 19/173 (10%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L+L  N L      +L  L+ L ++ L++N+IS + P  L  L++L  L    N I+   
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 279

Query: 63  PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
           P   + L++L +L L  N L+D        L NL+ L L  N IS   P  + +++ L  
Sbjct: 280 P--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQR 333

Query: 123 LDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP-------TSLALKFNA 168
           L  + NK+S    +S +NL +++  +  +N +S   P       T L L   A
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 57.7 bits (138), Expect = 2e-09
 Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 6/87 (6%)

Query: 67  SNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLS 126
           + L+  +   L   N+ D +  S   L  ++ L   R  I   I   +  ++ LT ++ S
Sbjct: 19  TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFS 74

Query: 127 QNKLSGEIPASFSNLKSLSSFNVSYNN 153
            N+L+   P    NL  L    ++ N 
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQ 99

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 4e-08
 Identities = 17/106 (16%), Positives = 47/106 (44%), Gaps = 9/106 (8%)

Query: 24  LQEISLSHNK-ISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNL 82
           L   +++ +  I+ +       L+           +  ++  S ++L  + +L  +   +
Sbjct: 1   LGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI 56

Query: 83  DDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQN 128
               +D ++ L+NL+ +N   NQ++   P  + N++ L  + ++ N
Sbjct: 57  KS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 12/54 (22%), Positives = 26/54 (48%), Gaps = 4/54 (7%)

Query: 3  LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN 56
          L      +   I   +  L+ L +I+ S+N+++ + P  L  L++L  +  + N
Sbjct: 49 LQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 81.6 bits (200), Expect = 1e-17
 Identities = 32/143 (22%), Positives = 58/143 (40%), Gaps = 3/143 (2%)

Query: 13  RIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSL 72
           ++P  L    +   + L +NKI+ +   D   L  L  L    N I+   P +F+ L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 73  VSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSG 132
             L L  N L +        L  L V   +  ++   + + +  +  +  L  +  K SG
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140

Query: 133 EIPASFSNLKSLSSFNVSYNNLS 155
               +F  +K LS   ++  N++
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT 163

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 70.8 bits (172), Expect = 5e-14
 Identities = 39/158 (24%), Positives = 68/158 (43%), Gaps = 8/158 (5%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS 61
            L L  N +S   P +   L +L+ + LS N++  +       L  LR      N I   
Sbjct: 59  TLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELR---VHENEITKV 115

Query: 62  LPASFSNLSSLVSLTLESNNLDD--QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIST 119
             + F+ L+ ++ + L +N L        +   +  LS + +    I+  IP   G   +
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPS 172

Query: 120 LTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP 157
           LT L L  NK++    AS   L +L+   +S+N++S  
Sbjct: 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 67.4 bits (163), Expect = 7e-13
 Identities = 38/150 (25%), Positives = 62/150 (41%), Gaps = 12/150 (8%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
           +   N++  IP  L     L E+ L  NKI+ V  + L  L+ L  L  S+N+I+     
Sbjct: 157 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISG------HIPSTIGNIS 118
           S +N   L  L L +N L       L     + V+ L  N IS         P      +
Sbjct: 214 SLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 272

Query: 119 TLTILDLSQNKLS-GEI-PASFSNLKSLSS 146
           + + + L  N +   EI P++F  +   ++
Sbjct: 273 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.5 bits (140), Expect = 5e-10
 Identities = 37/156 (23%), Positives = 66/156 (42%), Gaps = 6/156 (3%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSH--NKISGVMPSDLGRLSRLRILDFSYNAING 60
           L +  N ++    +    L+++  + L     K SG+       + +L  +  +   I  
Sbjct: 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163

Query: 61  SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
           ++P       SL  L L+ N +      SL  L+NL+ L L  N IS     ++ N   L
Sbjct: 164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221

Query: 121 TILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
             L L+ NKL  ++P   ++ K +    +  NN+S 
Sbjct: 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.4 bits (194), Expect = 7e-17
 Identities = 64/252 (25%), Positives = 90/252 (35%), Gaps = 75/252 (29%)

Query: 3   LALQYNNLSGR--IPASLGKLSELQEISLS-------------------------HNKIS 35
           L L   NL     IP+SL  L  L  + +                          H  +S
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 36  GVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHN 95
           G +P  L ++  L  LDFSYNA++G+LP S S+L +LV +T + N +   I DS      
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 96  LSVLNLKRN-----------------------------------------------QISG 108
           L                                                           
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 109 HIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLALK-FN 167
                +G    L  LDL  N++ G +P   + LK L S NVS+NNL G +P    L+ F+
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294

Query: 168 ASSFVGNIQLCG 179
            S++  N  LCG
Sbjct: 295 VSAYANNKCLCG 306

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 66.3 bits (160), Expect = 2e-12
 Identities = 16/59 (27%), Positives = 28/59 (47%), Gaps = 1/59 (1%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLP 63
           L+ N + G +P  L +L  L  +++S N + G +P   G L R  +  ++ N      P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.4 bits (142), Expect = 3e-10
 Identities = 16/59 (27%), Positives = 25/59 (42%), Gaps = 1/59 (1%)

Query: 77  LESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP 135
           L +N +   +   L +L  L  LN+  N + G IP   GN+    +   + NK     P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.1 bits (123), Expect = 6e-08
 Identities = 43/129 (33%), Positives = 61/129 (47%), Gaps = 3/129 (2%)

Query: 36  GVMPSDLGRLSRLRILDFSYNAING--SLPASFSNLSSLVSLTLESN-NLDDQILDSLDK 92
           GV+     +  R+  LD S   +     +P+S +NL  L  L +    NL   I  ++ K
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99

Query: 93  LHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYN 152
           L  L  L +    +SG IP  +  I TL  LD S N LSG +P S S+L +L       N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159

Query: 153 NLSGPVPTS 161
            +SG +P S
Sbjct: 160 RISGAIPDS 168

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 48.6 bits (114), Expect = 1e-06
 Identities = 33/138 (23%), Positives = 58/138 (42%), Gaps = 3/138 (2%)

Query: 19  GKLSELQEISLSHNKISGVM--PSDLGRLSRLRILDFSYNA-INGSLPASFSNLSSLVSL 75
            +   +  + LS   +      PS L  L  L  L       + G +P + + L+ L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 76  TLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP 135
            +   N+   I D L ++  L  L+   N +SG +P +I ++  L  +    N++SG IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 136 ASFSNLKSLSSFNVSYNN 153
            S+ +   L +      N
Sbjct: 167 DSYGSFSKLFTSMTISRN 184

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 41.7 bits (96), Expect = 1e-04
 Identities = 11/32 (34%), Positives = 16/32 (50%), Gaps = 1/32 (3%)

Query: 2   FLALQYNNLSGRIPASLGKLSELQEISLSHNK 33
            L + +NNL G IP   G L      + ++NK
Sbjct: 272 SLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.5 bits (176), Expect = 1e-14
 Identities = 36/152 (23%), Positives = 57/152 (37%), Gaps = 4/152 (2%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
           LQ N L      +   L  L  + L  N+IS V       L  L  L    N +    P 
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILD 124
           +F +L  L++L L +NNL     ++L  L  L  L L  N       +     + L    
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFR 254

Query: 125 LSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
            S +++   +P   +         ++ N+L G
Sbjct: 255 GSSSEVPCSLPQRLAGRDLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (174), Expect = 2e-14
 Identities = 39/182 (21%), Positives = 60/182 (32%), Gaps = 28/182 (15%)

Query: 6   QYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL--- 62
               L   +P  +   +  Q I L  N+IS V  +       L IL    N +       
Sbjct: 19  PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 63  ----------------------PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLN 100
                                 PA+F  L  L +L L+   L +        L  L  L 
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135

Query: 101 LKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT 160
           L+ N +      T  ++  LT L L  N++S     +F  L SL    +  N ++   P 
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 161 SL 162
           + 
Sbjct: 196 AF 197

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.8 bits (169), Expect = 9e-14
 Identities = 36/182 (19%), Positives = 59/182 (32%), Gaps = 25/182 (13%)

Query: 6   QYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS 65
               L    PA+   L  L  + L    +  + P     L+ L+ L    NA+      +
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148

Query: 66  FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTI----------- 114
           F +L +L  L L  N +      +   LH+L  L L +N+++   P              
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 115 -------------GNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTS 161
                          +  L  L L+ N    +  A       L  F  S + +   +P  
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR 267

Query: 162 LA 163
           LA
Sbjct: 268 LA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (153), Expect = 8e-12
 Identities = 42/176 (23%), Positives = 63/176 (35%), Gaps = 25/176 (14%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNK-------------------------ISGV 37
           + L  N +S    AS      L  + L  N                          +  V
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 38  MPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLS 97
            P+    L RL  L      +    P  F  L++L  L L+ N L     D+   L NL+
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156

Query: 98  VLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNN 153
            L L  N+IS         + +L  L L QN+++   P +F +L  L +  +  NN
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (112), Expect = 1e-06
 Identities = 32/143 (22%), Positives = 47/143 (32%), Gaps = 4/143 (2%)

Query: 26  EISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQ 85
             S     +  V P  +      + +    N I+    ASF    +L  L L SN L   
Sbjct: 15  TTSCPQQGLQAV-PVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 86  ILDSLDKLHNLSVLNLKRNQISGHI-PSTIGNISTLTILDLSQNKLSGEIPASFSNLKSL 144
              +   L  L  L+L  N     + P+T   +  L  L L +  L    P  F  L +L
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 145 SSFNVSYNNLSGPVPTSLALKFN 167
               +  N L      +     N
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGN 154

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 60.9 bits (147), Expect = 5e-12
 Identities = 28/126 (22%), Positives = 53/126 (42%), Gaps = 9/126 (7%)

Query: 25  QEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDD 84
           + + L+H  ++      L +L  +  LD S+N +    P + + L  L    L++++   
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNAL 55

Query: 85  QILDSLDKLHNLSVLNLKRNQI-SGHIPSTIGNISTLTILDLSQNKLSGE---IPASFSN 140
           + +D +  L  L  L L  N++        + +   L +L+L  N L  E          
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 141 LKSLSS 146
           L S+SS
Sbjct: 116 LPSVSS 121

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.5 bits (133), Expect = 4e-10
 Identities = 30/119 (25%), Positives = 52/119 (43%), Gaps = 7/119 (5%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L + +L+  +   L +L  +  + LSHN++  + P+ L  L  L +L  S NA+    
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN-- 57

Query: 63  PASFSNLSSLVSLTLESNNLDD-QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL 120
               +NL  L  L L +N L     +  L     L +LNL+ N +          ++ +
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.1 bits (119), Expect = 3e-08
 Identities = 19/105 (18%), Positives = 35/105 (33%), Gaps = 26/105 (24%)

Query: 75  LTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTL-------------- 120
           L L   +L   +L  L++L  ++ L+L  N++    P+ +  +  L              
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59

Query: 121 --------TILDLSQNKL-SGEIPASFSNLKSLSSFNVSYNNLSG 156
                     L L  N+L          +   L   N+  N+L  
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 64.5 bits (155), Expect = 9e-12
 Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 11/92 (11%)

Query: 80  NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFS 139
           N   ++I    D   +L  LN+  N++   +P+       L  L  S N L+ E+P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQ 324

Query: 140 NLKSLSSFNVSYNNLSG--PVPTSLA-LKFNA 168
           NLK L   +V YN L     +P S+  L+ N+
Sbjct: 325 NLKQL---HVEYNPLREFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 60.6 bits (145), Expect = 2e-10
 Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 9/92 (9%)

Query: 53  FSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS 112
           +  NA +  + +      SL  L + +N L +  L +L     L  L    N ++  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE--LPAL--PPRLERLIASFNHLA-EVPE 321

Query: 113 TIGNISTLTILDLSQNKLSGEIPASFSNLKSL 144
              N   L  L +  N L  E P    +++ L
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.4 bits (129), Expect = 1e-08
 Identities = 22/96 (22%), Positives = 40/96 (41%), Gaps = 9/96 (9%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
              N  S  I +       L+E+++S+NK+  +         RL  L  S+N +   +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL----PPRLERLIASFNHLA-EVPE 321

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLN 100
              NL     L +E N L  +  D  + + +L + +
Sbjct: 322 LPQNLK---QLHVEYNPL-REFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 1e-06
 Identities = 21/71 (29%), Positives = 29/71 (40%), Gaps = 10/71 (14%)

Query: 86  ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLS 145
           + D LD+      L L    +S  +P    +   L  L  S N L+ E+P    +LK   
Sbjct: 32  LRDCLDR--QAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLK--- 81

Query: 146 SFNVSYNNLSG 156
           S  V  NNL  
Sbjct: 82  SLLVDNNNLKA 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.2 bits (154), Expect = 1e-11
 Identities = 17/91 (18%), Positives = 30/91 (32%), Gaps = 5/91 (5%)

Query: 71  SLVSLTLESNNL-DDQILDSLDKLHNLSVLNLKRNQISG----HIPSTIGNISTLTILDL 125
            + SL ++   L D +  + L  L    V+ L    ++      I S +     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 126 SQNKLSGEIPASFSNLKSLSSFNVSYNNLSG 156
             N+L               S  +   +L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.1 bits (146), Expect = 2e-10
 Identities = 11/92 (11%), Positives = 35/92 (38%), Gaps = 5/92 (5%)

Query: 23  ELQEISLSHNKISGVMPSDL-GRLSRLRILDFSYNAING----SLPASFSNLSSLVSLTL 77
           ++Q + +   ++S    ++L   L + +++      +       + ++     +L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 78  ESNNLDDQILDSLDKLHNLSVLNLKRNQISGH 109
            SN L D  +  + +        +++  +   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.8 bits (145), Expect = 2e-10
 Identities = 17/89 (19%), Positives = 27/89 (30%), Gaps = 9/89 (10%)

Query: 63  PASFSNLSSLVSLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQISGHIPSTIG--- 115
                  S L  L L   ++ D     +  +L   H+L  L+L  N +       +    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 116 --NISTLTILDLSQNKLSGEIPASFSNLK 142
                 L  L L     S E+      L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.3 bits (136), Expect = 3e-09
 Identities = 9/74 (12%), Positives = 27/74 (36%), Gaps = 5/74 (6%)

Query: 95  NLSVLNLKRNQIS-GHIPSTIGNISTLTILDLSQNKLSGE----IPASFSNLKSLSSFNV 149
           ++  L+++  ++S       +  +    ++ L    L+      I ++     +L+  N+
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 150 SYNNLSGPVPTSLA 163
             N L       + 
Sbjct: 63  RSNELGDVGVHCVL 76

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.5 bits (134), Expect = 4e-09
 Identities = 15/88 (17%), Positives = 27/88 (30%), Gaps = 5/88 (5%)

Query: 3  LALQYNNLS-GRIPASLGKLSELQEISLSHNKISGVMPSDLGR----LSRLRILDFSYNA 57
          L +Q   LS  R    L  L + Q + L    ++     D+         L  L+   N 
Sbjct: 7  LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 58 INGSLPASFSNLSSLVSLTLESNNLDDQ 85
          +               S  ++  +L + 
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 8e-09
 Identities = 16/79 (20%), Positives = 23/79 (29%), Gaps = 9/79 (11%)

Query: 94  HNLSVLNLKRNQISG----HIPSTIGNISTLTILDLSQNKLSGEIPASFS-----NLKSL 144
             L VL L    +S      + +T+    +L  LDLS N L                  L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 145 SSFNVSYNNLSGPVPTSLA 163
               +     S  +   L 
Sbjct: 429 EQLVLYDIYWSEEMEDRLQ 447

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.6 bits (129), Expect = 2e-08
 Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 13/91 (14%)

Query: 46  SRLRILDFSYNAING----SLPASFSNLSSLVSLTLESNNLDDQ----ILDSLDKLH-NL 96
           S LR+L  +   ++     SL A+     SL  L L +N L D     +++S+ +    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 97  SVLNLKRNQISGHIPSTIGNIS----TLTIL 123
             L L     S  +   +  +     +L ++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 3e-08
 Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 13/91 (14%)

Query: 22  SELQEISLSHNKISGV----MPSDLGRLSRLRILDFSYNAINGSLPASFS-----NLSSL 72
           S L+ + L+   +S      + + L     LR LD S N +  +               L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 73  VSLTLESNNLDDQILDSLDKLH----NLSVL 99
             L L      +++ D L  L     +L V+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 1e-05
 Identities = 12/68 (17%), Positives = 22/68 (32%), Gaps = 6/68 (8%)

Query: 109 HIPSTIGNISTLTILDLSQNKLSGE----IPASFSNLKSLSSFNVSYNNLSGPVPTSL-- 162
                    S L +L L+   +S      + A+     SL   ++S N L       L  
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419

Query: 163 ALKFNASS 170
           +++     
Sbjct: 420 SVRQPGCL 427

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.9 bits (146), Expect = 6e-11
 Identities = 33/195 (16%), Positives = 51/195 (26%), Gaps = 49/195 (25%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN-------- 56
               NL+  +P  L K  +   + LS N +     + L   +RL  L+            
Sbjct: 17  CDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD 73

Query: 57  -------------------------------------AINGSLPASFSNLSSLVSLTLES 79
                                                 +      +   L  L  L L+ 
Sbjct: 74  GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133

Query: 80  NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFS 139
           N L       L     L  L+L  N ++      +  +  L  L L +N L   IP  F 
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192

Query: 140 NLKSLSSFNVSYNNL 154
               L    +  N  
Sbjct: 193 GSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (116), Expect = 4e-07
 Identities = 31/182 (17%), Positives = 56/182 (30%), Gaps = 48/182 (26%)

Query: 17  SLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLT 76
            + K++   E++     ++ + P DL +     IL  S N +     A+    + L  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 77  LESNN---------------------------------------------LDDQILDSLD 91
           L+                                                L    L +L 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 92  KLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSY 151
            L  L  L LK N++    P  +     L  L L+ N L+       + L++L +  +  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 152 NN 153
           N+
Sbjct: 182 NS 183

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.8 bits (131), Expect = 2e-09
 Identities = 27/142 (19%), Positives = 53/142 (37%), Gaps = 6/142 (4%)

Query: 5   LQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA 64
           L+   +  ++   + K  +  + +L    +      DL   +   +L+   +    +L  
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRI 59

Query: 65  SFSNLSSLVSLTLESNNLDDQ--ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTI 122
              N+  L+SL L +N L     +   + K  NL +LNL  N++             L  
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 123 LDLSQNKLSGEIPASFSNLKSL 144
           L L  N LS       + + ++
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (113), Expect = 4e-07
 Identities = 24/135 (17%), Positives = 46/135 (34%), Gaps = 10/135 (7%)

Query: 29  LSHNKISGVMPSDLGRL--SRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQI 86
           L   ++   +   + +      + LD      +  L       +  V L    +++   +
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDL----VAQNIDVVLNR-RSSMAATL 57

Query: 87  LDSLDKLHNLSVLNLKRNQISGH--IPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSL 144
               + +  L  LNL  N++     + S +     L IL+LS N+L  E          L
Sbjct: 58  RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117

Query: 145 SSFNVSYNNLSGPVP 159
               +  N+LS    
Sbjct: 118 EELWLDGNSLSDTFR 132

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (134), Expect = 2e-09
 Identities = 28/101 (27%), Positives = 43/101 (42%), Gaps = 7/101 (6%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISL--SHNKISGVMPSDLGRLSRLRILDFSYNAING 60
           L L   NL    P   G+L     I+     + +   +        R++ +D S + I  
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 60

Query: 61  -SLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLN 100
            +L    S  S L +L+LE   L D I+++L K  NL  LN
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 5e-07
 Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 66  FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDL 125
            +NLS L +L  + N + D  +  L  L NL  ++LK NQIS   P  + N S L I+ L
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 126 S 126
           +
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 2e-06
 Identities = 17/48 (35%), Positives = 23/48 (47%), Gaps = 4/48 (8%)

Query: 7   YNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFS 54
            N +S   P  L  L  L E+ L +N+IS V P  L   S L I+  +
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 3e-06
 Identities = 15/61 (24%), Positives = 27/61 (44%), Gaps = 4/61 (6%)

Query: 90  LDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNV 149
           L  L  L+ L    N+IS   P  + ++  L  + L  N++S   P   +N  +L    +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 150 S 150
           +
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 3e-06
 Identities = 20/76 (26%), Positives = 34/76 (44%), Gaps = 5/76 (6%)

Query: 30  SHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDS 89
           S         + L  LS+L  L    N I+   P   ++L +L+ + L++N + D  +  
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSP 212

Query: 90  LDKLHNLSVLNLKRNQ 105
           L    NL ++ L  NQ
Sbjct: 213 LANTSNLFIVTL-TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 4e-06
 Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 5/63 (7%)

Query: 18  LGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTL 77
           L  LS+L  +    NKIS + P  L  L  L  +    N I+   P   +N S+L  +TL
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 78  ESN 80
            +N
Sbjct: 225 -TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 9e-05
 Identities = 15/83 (18%), Positives = 37/83 (44%), Gaps = 7/83 (8%)

Query: 28  SLSHNK-ISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQI 86
           S++    I+ + P     L+    +    + +  ++  + ++L  + +L+     +    
Sbjct: 2   SITQPTAINVIFPDP--ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-- 55

Query: 87  LDSLDKLHNLSVLNLKRNQISGH 109
           ++ +  L+NL  L LK NQI+  
Sbjct: 56  IEGVQYLNNLIGLELKDNQITDL 78

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 9/57 (15%), Positives = 23/57 (40%), Gaps = 4/57 (7%)

Query: 3  LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAIN 59
          +A   +N++  +  +   L  +  +S     ++ +    +  L+ L  L+   N I 
Sbjct: 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT 76

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 14/51 (27%), Positives = 24/51 (47%), Gaps = 2/51 (3%)

Query: 109 HIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP 159
              + + N+S LT L    NK+S   P   ++L +L   ++  N +S   P
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 4e-06
 Identities = 37/181 (20%), Positives = 60/181 (33%), Gaps = 43/181 (23%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
             L   N++  +  S   L ++  +      I  +    +  L+ L  ++FS N +    
Sbjct: 23  TVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT 78

Query: 63  PAS------------------FSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN 104
           P                        +      L   N     +D L  L NL+ L L  N
Sbjct: 79  PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138

Query: 105 QISGHI--------------------PSTIGNISTLTILDLSQNKLSG-EIPASFSNLKS 143
            IS                          + N++TL  LD+S NK+S   + A  +NL+S
Sbjct: 139 TISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLES 198

Query: 144 L 144
           L
Sbjct: 199 L 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 12/83 (14%), Positives = 36/83 (43%), Gaps = 7/83 (8%)

Query: 28  SLSHNK-ISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQI 86
           +++ +  I+ +       L+           +  ++  S ++L  + +L  +   +    
Sbjct: 1   TITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-- 54

Query: 87  LDSLDKLHNLSVLNLKRNQISGH 109
           +D ++ L+NL+ +N   NQ++  
Sbjct: 55  IDGVEYLNNLTQINFSNNQLTDI 77

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 7e-06
 Identities = 12/62 (19%), Positives = 18/62 (29%), Gaps = 13/62 (20%)

Query: 14  IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLV 73
                   S    + +S  +I  +    L  L +LR               S  NL  L 
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR-------------STYNLKKLP 239

Query: 74  SL 75
           +L
Sbjct: 240 TL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 8e-06
 Identities = 12/49 (24%), Positives = 19/49 (38%), Gaps = 3/49 (6%)

Query: 108 GHIP-STIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
             +P       S   ILD+S+ ++         NLK L + +    NL 
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 2e-05
 Identities = 8/50 (16%), Positives = 16/50 (32%), Gaps = 3/50 (6%)

Query: 86  ILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP 135
             D         +L++ R +I       + N+  L        K   ++P
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 3e-05
 Identities = 14/68 (20%), Positives = 24/68 (35%), Gaps = 4/68 (5%)

Query: 24  LQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLD 83
            +     +N +  +        S   ILD S   I+        NL  L + +    NL 
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL- 235

Query: 84  DQILDSLD 91
            + L +L+
Sbjct: 236 -KKLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 12/42 (28%), Positives = 17/42 (40%), Gaps = 3/42 (7%)

Query: 65  SFSNLSSLVSLTLESNNL---DDQILDSLDKLHNLSVLNLKR 103
            F   S  V L +    +       L++L KL   S  NLK+
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK 237

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 12/59 (20%), Positives = 22/59 (37%), Gaps = 3/59 (5%)

Query: 95  NLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNN 153
           +  V   + ++++  IPS +        L     KL      +FS    L    +S N+
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.002
 Identities = 9/51 (17%), Positives = 18/51 (35%), Gaps = 3/51 (5%)

Query: 6  QYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN 56
          Q + ++  IP+ L       E+     K+  +          L  ++ S N
Sbjct: 16 QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 1e-05
 Identities = 18/79 (22%), Positives = 31/79 (39%), Gaps = 12/79 (15%)

Query: 77  LESNNLDD----QILDSLDKLHN--LSVLNLKRNQISGHIPSTI-----GNISTLTILDL 125
           L    L       ++D+  KL N  L  L L+ N+I      T+       +  L  L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 126 SQNKLSGEIPASFSNLKSL 144
           + N+ S E       ++ +
Sbjct: 310 NGNRFSEE-DDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 1e-05
 Identities = 14/94 (14%), Positives = 32/94 (34%), Gaps = 11/94 (11%)

Query: 71  SLVSLTLESNNLDDQ----ILDSLDKLHNLSVLNLKRNQISG----HIPSTIGNISTLTI 122
           S+   +L+ + +  +    +   L +  ++  + L  N I       +   I +   L I
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 123 LDLSQN---KLSGEIPASFSNLKSLSSFNVSYNN 153
            + S     ++  EIP +   L          + 
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.3 bits (105), Expect = 1e-05
 Identities = 20/104 (19%), Positives = 33/104 (31%), Gaps = 18/104 (17%)

Query: 1   MFLALQYNNLSGRIPASLG------KLSELQEISLSHNKISGVMPSDL-----GRLSRLR 49
             L L    LS R  A++       +   LQ + L +N+I       L      ++  L 
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305

Query: 50  ILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKL 93
            L+ + N            +  + S            LD LD +
Sbjct: 306 FLELNGNRF-SEEDDVVDEIREVFSTRGRGE------LDELDDM 342

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.3 bits (100), Expect = 6e-05
 Identities = 17/88 (19%), Positives = 32/88 (36%), Gaps = 8/88 (9%)

Query: 3  LALQYNNLSGR----IPASLGKLSELQEISLSHNKISG----VMPSDLGRLSRLRILDFS 54
           +L+ + ++      + A L +   ++EI LS N I       +  ++     L I +FS
Sbjct: 8  KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 55 YNAINGSLPASFSNLSSLVSLTLESNNL 82
                        L  L+   L+   L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 8e-05
 Identities = 9/67 (13%), Positives = 19/67 (28%), Gaps = 11/67 (16%)

Query: 100 NLKRNQISGHIPSTIGNI------STLTILDLSQNKLSGEIP-----ASFSNLKSLSSFN 148
            L    +S    + + +         L  L L  N++  +            +  L    
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 149 VSYNNLS 155
           ++ N  S
Sbjct: 309 LNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 9e-04
 Identities = 13/61 (21%), Positives = 25/61 (40%), Gaps = 6/61 (9%)

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSL-----DKLHNLSVLNLKRNQISGHIPSTIGNIST 119
           S      L +L L+ N ++   + +L     +K+ +L  L L  N+ S      +  I  
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIRE 326

Query: 120 L 120
           +
Sbjct: 327 V 327

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 1e-05
 Identities = 29/190 (15%), Positives = 66/190 (34%), Gaps = 48/190 (25%)

Query: 1   MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAING 60
           +   L+  +++  +  +  +L+ + +I  +++ I  V    +  L  +  L  + N +  
Sbjct: 27  IKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD 82

Query: 61  SLPASFSNLSSLVSLTLE--------------------SNNLDDQILDSLDKLHNLSVLN 100
                 +NL +L  L L+                      +     ++ L  L  L  L 
Sbjct: 83  --IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140

Query: 101 LKRNQISGHI--------------------PSTIGNISTLTILDLSQNKLSGEIPASFSN 140
           L  N+I+                          +  ++ L  L LS+N +S ++  + + 
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAG 198

Query: 141 LKSLSSFNVS 150
           LK+L    + 
Sbjct: 199 LKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 9e-05
 Identities = 10/73 (13%), Positives = 29/73 (39%), Gaps = 4/73 (5%)

Query: 89  SLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFN 148
           S D        NLK+  ++  +  T   ++++  +  + + +          L +++   
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLF 74

Query: 149 VSYNNLSGPVPTS 161
           ++ N L+   P +
Sbjct: 75  LNGNKLTDIKPLA 87

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 3e-04
 Identities = 9/76 (11%), Positives = 32/76 (42%), Gaps = 6/76 (7%)

Query: 34  ISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKL 93
           I  +   D    +     +    ++  ++  + + L+S+  +   ++++    +  +  L
Sbjct: 14  IKQIFSDD--AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYL 67

Query: 94  HNLSVLNLKRNQISGH 109
            N++ L L  N+++  
Sbjct: 68  PNVTKLFLNGNKLTDI 83

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 6e-04
 Identities = 15/41 (36%), Positives = 22/41 (53%), Gaps = 3/41 (7%)

Query: 65  SFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQ 105
             + L+ L +L L  N++ D  L +L  L NL VL L  +Q
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL-FSQ 210

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (99), Expect = 2e-05
 Identities = 29/129 (22%), Positives = 45/129 (34%), Gaps = 7/129 (5%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL 62
           L L+   +   I      L +   I  S N+I  +       L RL+ L  + N I    
Sbjct: 23  LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIG 79

Query: 63  PASFSNLSSLVSLTLESNNLDD----QILDSLDKLHNLSVLNLKRNQISGHIPSTIGNIS 118
                 L  L  L L +N+L +      L SL  L  L +L         +    I  + 
Sbjct: 80  EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVP 139

Query: 119 TLTILDLSQ 127
            + +LD  +
Sbjct: 140 QVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 8e-05
 Identities = 24/132 (18%), Positives = 46/132 (34%), Gaps = 7/132 (5%)

Query: 21  LSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN 80
               +E+ L   KI  V+ +    L +   +DFS N I       F  L  L +L + +N
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNN 73

Query: 81  NLDDQILDSLDKLHNLSVLNLKRNQISG----HIPSTIGNISTLTILDLSQNKLSGEIPA 136
            +          L +L+ L L  N +         +++ +++ L IL             
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 137 SFSNLKSLSSFN 148
               +  +   +
Sbjct: 134 VIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 4e-04
 Identities = 14/81 (17%), Positives = 28/81 (34%), Gaps = 4/81 (4%)

Query: 79  SNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASF 138
           +  L +Q             L+L+  +I   I +    +     +D S N++       F
Sbjct: 4   TAELIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGF 59

Query: 139 SNLKSLSSFNVSYNNLSGPVP 159
             L+ L +  V+ N +     
Sbjct: 60  PLLRRLKTLLVNNNRICRIGE 80

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.001
 Identities = 15/92 (16%), Positives = 31/92 (33%), Gaps = 3/92 (3%)

Query: 64  ASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTIL 123
           A ++N      L L    +   I +    L     ++   N+I          +  L  L
Sbjct: 12  AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68

Query: 124 DLSQNKLSGEIPASFSNLKSLSSFNVSYNNLS 155
            ++ N++          L  L+   ++ N+L 
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 41.7 bits (96), Expect = 8e-05
 Identities = 33/158 (20%), Positives = 53/158 (33%), Gaps = 5/158 (3%)

Query: 25  QEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASF-SNLSSLVSLTLESNNLD 83
             +  +   +  + P D+        L  + N +           L  LV L L+ N L 
Sbjct: 11  TTVDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 84  DQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKS 143
               ++ +   ++  L L  N+I          +  L  L+L  N++S  +P SF +L S
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 144 L-SSFNVSYNNLSGPVPTSLALKFNASSFVGNIQLCGY 180
           L S    S            A      S  G    CG 
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 4e-04
 Identities = 29/150 (19%), Positives = 40/150 (26%), Gaps = 4/150 (2%)

Query: 22  SELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPA-SFSNLSSLVSLTLESN 80
                +  + +         L     L  L          L       L  L +LT+  +
Sbjct: 8   HGSSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 81  NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS-GEIPASFS 139
            L     D+      LS LNL  N +   +        +L  L LS N L          
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125

Query: 140 NLKSLSSFNVSYNNLSGPVPTSLALKFNAS 169
             +      V    L       LA   NAS
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.001
 Identities = 24/145 (16%), Positives = 47/145 (32%), Gaps = 4/145 (2%)

Query: 3   LALQYNNLSGRIPASLGKLSELQEISLSHNK-ISGVMPSDLGRLSRLRILDFSYNAINGS 61
           L    +         L     L E+ + + + +  +   DL  L  LR L    + +   
Sbjct: 13  LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71

Query: 62  LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQIS-GHIPSTIGNISTL 120
            P +F     L  L L S N  + +     +  +L  L L  N +        +      
Sbjct: 72  APDAFHFTPRLSRLNL-SFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEE 130

Query: 121 TILDLSQNKLSGEIPASFSNLKSLS 145
            +  + + KL        +++ + S
Sbjct: 131 GLGGVPEQKLQCHGQGPLAHMPNAS 155

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 18/58 (31%), Positives = 25/58 (43%), Gaps = 8/58 (13%)

Query: 5  LQYNNLSGRIP------ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN 56
           +   L G IP      A+L  L   + ++LS N I  +  S L  +  LRIL    N
Sbjct: 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRN 80

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	580
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.85
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.85
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.78
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.73
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.73
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.72
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.67
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.65
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.65
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.62
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.61
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.6
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.6
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.59
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.58
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.52
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.52
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.51
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.51
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.5
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.42
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.41
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.33
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.32
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.22
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.0
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.98
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.97
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.94
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.8
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.75
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.69
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.68
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.56
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.25
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.12
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.07
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.97
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.79
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.62
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.99
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.52
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.58

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-54  Score=413.44  Aligned_cols=254  Identities=24%  Similarity=0.427  Sum_probs=198.4

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |.+.+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|++++++++||||++++|+|.. ++..++||||+++
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~~~~   84 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEH   84 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTT
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEEEEecCC
Confidence            3457899999999999999988889999999754 3345789999999999999999999999986 5689999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.+++...  ...+++..+..++.|||.||+|||+. +|+||||||+|||+++++.+||+|||+++............
T Consensus        85 g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          85 GCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             CBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             CcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence            9999998764  34689999999999999999999994 99999999999999999999999999998776554444445


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..||+.|+|||++.+..|+.++|||||||++|||+| |++||...+..++.+.+   ..+...   .      .+...  
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i---~~~~~~---~------~p~~~--  227 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---STGFRL---Y------KPRLA--  227 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH---HHTCCC---C------CCTTS--
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH---HhcCCC---C------Ccccc--
Confidence            678999999999999999999999999999999999 56666544433332222   221110   0      01111  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                       ..++.+++.+||+.||++|||++|++++|+++++
T Consensus       228 -~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         228 -STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence             2356788999999999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=409.31  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=201.2

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|+++  ..||||+++...  ....+.|.+|+.++++++|||||++++++.+  +..++||||+
T Consensus        10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~Ey~   85 (276)
T d1uwha_          10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWC   85 (276)
T ss_dssp             CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECC
T ss_pred             EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEEecC
Confidence            456789999999999999875  369999986543  2344679999999999999999999999853  4789999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-cc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-VN  445 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  445 (580)
                      ++|+|.+++...  ...+++..++.++.|||+||+|||+ ++|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus        86 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          86 EGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             CEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence            999999999764  2469999999999999999999999 4999999999999999999999999999987654332 23


Q ss_pred             eeeecCccccCCcccccc---CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          446 VIATAGALGYRAPELSKL---KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      .....||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+..+.   +.........    .+......
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~~~~----~p~~~~~~  235 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYL----SPDLSKVR  235 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHHTSC----CCCGGGSC
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCC----CCcchhcc
Confidence            345679999999999864   3578899999999999999999999987654322   2222222211    11111111


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ...+   .++.+++.+||+.||++|||+.|++++|+.+++.
T Consensus       236 ~~~~---~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         236 SNCP---KAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            2222   3566788899999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=402.06  Aligned_cols=251  Identities=20%  Similarity=0.376  Sum_probs=211.3

Q ss_pred             hhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCCC
Q 008031          290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  369 (580)
                      ++.+.||+|+||.||+|++++++.||||+++... ...++|.+|+.++++++||||++++|+|.+ ++..++||||+++|
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey~~~g   84 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANG   84 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEECCTTE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEccCCC
Confidence            4678999999999999999988899999997543 345789999999999999999999999976 66899999999999


Q ss_pred             ChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceeee
Q 008031          370 SLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIAT  449 (580)
Q Consensus       370 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  449 (580)
                      +|.+++...  ...+++..+.+++.||++||+|||+. ||+||||||+||++++++.+||+|||+++.............
T Consensus        85 ~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  161 (258)
T d1k2pa_          85 CLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  161 (258)
T ss_dssp             EHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred             cHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence            999997654  24688999999999999999999995 999999999999999999999999999987765555455556


Q ss_pred             cCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHHH
Q 008031          450 AGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGDE  528 (580)
Q Consensus       450 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (580)
                      .||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..++...+..   ....   .      .+...+  
T Consensus       162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~---~~~~---~------~p~~~~--  227 (258)
T d1k2pa_         162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRL---Y------RPHLAS--  227 (258)
T ss_dssp             CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---TCCC---C------CCTTCC--
T ss_pred             CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh---CCCC---C------Cccccc--
Confidence            78999999999999999999999999999999998 8999987765444433322   1110   0      111112  


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          529 LLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       529 ~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                       .++.+++.+||+.||++|||+.|++++|.++
T Consensus       228 -~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         228 -EKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             3567889999999999999999999999764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=403.16  Aligned_cols=248  Identities=23%  Similarity=0.337  Sum_probs=206.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |...+.||+|+||.||+|.+. +|+.||||+++.......+.+.+|++++++++||||+++++++.+ ++..|+||||++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy~~  100 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLA  100 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEEEecC
Confidence            567789999999999999975 799999999976655566789999999999999999999999987 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++.+.    .+++.++..++.||+.||+|||+ +||+||||||+|||++.++++||+|||+|+....... ...
T Consensus       101 gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~  174 (293)
T d1yhwa1         101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS  174 (293)
T ss_dssp             TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred             CCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccc
Confidence            99999988764    58999999999999999999999 5999999999999999999999999999987654332 233


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...||+.|||||++.+..++.++||||+||++|||++|+.||.+.+..   +.+..+........    .      ....
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~~~~~~~~----~------~~~~  241 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGTPEL----Q------NPEK  241 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHHCSCCC----S------SGGG
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCC----C------Cccc
Confidence            457999999999999999999999999999999999999999765432   22222222221111    0      0011


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...++.+++.+||+.||++|||+.|+++|
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12356788999999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-53  Score=408.14  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=206.2

Q ss_pred             HHhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      .|.+.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+  +..++||||++
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey~~   90 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYME   90 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCT
T ss_pred             HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEEeCC
Confidence            356678999999999999999988899999997543 345779999999999999999999998854  56899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++.... ...+++..+++++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+...........
T Consensus        91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred             CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence            999999876542 2358999999999999999999999 59999999999999999999999999999887655444444


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCC-CCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSP-GEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIG  526 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (580)
                      ...||+.|||||++.++.++.++|||||||++|||+||..| |...+..+..+   .+..+...      .   .+...+
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---~i~~~~~~------~---~p~~~~  236 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRM------V---RPDNCP  236 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTTCCC------C---CCTTCC
T ss_pred             ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH---HHHhcCCC------C---CcccCh
Confidence            56789999999999999999999999999999999996554 44433322222   22221110      0   111122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          527 DELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       527 ~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                         .++.+++.+||+.||++|||+.|+++.|+.+-
T Consensus       237 ---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         237 ---EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence               35678889999999999999999999998863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-52  Score=407.91  Aligned_cols=258  Identities=26%  Similarity=0.388  Sum_probs=210.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++... ...++|.+|+++|++++|||||+++++|.+ ++..++||||++
T Consensus        19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E~~~   96 (287)
T d1opja_          19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMT   96 (287)
T ss_dssp             EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCT
T ss_pred             eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee-CCeeEEEeeccc
Confidence            556789999999999999986 68899999987543 345679999999999999999999999986 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++.... ...+++..++.++.||++||+|||++ ||+||||||+|||+++++.+||+|||+|+...........
T Consensus        97 ~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          97 YGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             TCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred             CcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence            999999997653 35689999999999999999999994 9999999999999999999999999999877655544444


Q ss_pred             eecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          448 ATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       448 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ...|++.|+|||++.+..|+.++|||||||++|||++|..||.....  ..+ +...+......     ..   ....  
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~-~~~~i~~~~~~-----~~---~~~~--  241 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQ-VYELLEKDYRM-----ER---PEGC--  241 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH-HHHHHHTTCCC-----CC---CTTC--
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHH-HHHHHhcCCCC-----CC---Cccc--
Confidence            55688999999999999999999999999999999997766543322  112 22222222111     11   1112  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                       ..++.+++.+||+.||++|||+.|+++.|+.+.++.
T Consensus       242 -~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         242 -PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             -hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence             235678889999999999999999999999886554

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=400.10  Aligned_cols=244  Identities=27%  Similarity=0.418  Sum_probs=203.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||+|.+. +|+.||+|++....   ......+.+|++++++++||||+++++++.+ ++..++|||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~ivmE   86 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLILE   86 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEEEe
Confidence            567899999999999999986 78999999986432   2345678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...+   .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|......   
T Consensus        87 y~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---  159 (263)
T d2j4za1          87 YAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  159 (263)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred             ecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence            999999999998753   68999999999999999999999 59999999999999999999999999999765433   


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.+..+   ....+......       .   +..
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~~-------~---p~~  226 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRISRVEFT-------F---PDF  226 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTCCC-------C---CTT
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCC-------C---Ccc
Confidence            2234679999999999999999999999999999999999999997654332   22222222110       0   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .+   .++.+++.+||+.||++|||+.|+++|
T Consensus       227 ~s---~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         227 VT---EGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             SC---HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CC---HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            12   356678889999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-52  Score=408.15  Aligned_cols=256  Identities=24%  Similarity=0.455  Sum_probs=196.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCC---EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGS---QVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||.||+|.+. +++   .||||.+..... ...+.|.+|+++|++++|||||+++|+|.. ++..++||
T Consensus        28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~iv~  106 (299)
T d1jpaa_          28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STPVMIIT  106 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEEE
Confidence            445689999999999999975 332   589998865443 334679999999999999999999999976 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.+++...  ...+++.+++.++.|||+||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus       107 Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         107 EFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             ECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            999999999988764  3468999999999999999999999 5999999999999999999999999999987654332


Q ss_pred             c----ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          444 V----NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       444 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .    ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.+....++...+.   .+....       
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~---~~~~~~-------  253 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE---QDYRLP-------  253 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCCCC-------
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCC-------
Confidence            2    1223457899999999999999999999999999999998 899998765443333222   211110       


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                        ....   ...++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       254 --~~~~---~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         254 --PPMD---CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             --CCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --CCcc---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence              1111   223567888999999999999999999999998654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=400.12  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=200.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+ ++..++||||+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivmEy~   85 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEEecc
Confidence            566799999999999999986 799999999865432 234568999999999999999999999987 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-cc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-VN  445 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  445 (580)
                      ++|+|.+++...   ..+++.++..++.||++||+|||+ .||+||||||+|||+++++.+||+|||+|+....... ..
T Consensus        86 ~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          86 SGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             TTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            999999999764   369999999999999999999999 4999999999999999999999999999987654332 22


Q ss_pred             eeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      .....||+.|||||++.+..+ +.++||||+||++|||++|+.||..........  ..........     ..   .. 
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~~~~~~~~~-----~~---~~-  230 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEKKTYL-----NP---WK-  230 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HHHHTTCTTS-----TT---GG-
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HHHhcCCCCC-----Cc---cc-
Confidence            344679999999999988776 568999999999999999999997655433221  1111111000     00   01 


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ....++.+++.+||+.||++|||+.|+++|
T Consensus       231 --~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         231 --KIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             --GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              112356678899999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=404.26  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=205.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||+++.......+.+.+|++++++++|||||++++++.+ ++..++||||++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvmEy~~   92 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCA   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEEecCC
Confidence            566789999999999999986 799999999976655566789999999999999999999999987 668999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccccee
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVI  447 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  447 (580)
                      +|+|.+++.+.  ...+++.++..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+....... ...
T Consensus        93 ~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~~  168 (288)
T d2jfla1          93 GGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD  168 (288)
T ss_dssp             TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HHT
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-ccc
Confidence            99999998754  2469999999999999999999999 5999999999999999999999999999976543322 222


Q ss_pred             eecCccccCCcccc-----ccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          448 ATAGALGYRAPELS-----KLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       448 ~~~g~~~y~aPE~~-----~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                      ...||+.|||||++     .+..|+.++||||+||++|||+||+.||.+.+..+...   .+........          
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~---~i~~~~~~~~----------  235 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---KIAKSEPPTL----------  235 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHHSCCCCC----------
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---HHHcCCCCCC----------
Confidence            45799999999987     35668899999999999999999999998766544333   2222221110          


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ........++.+++.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0011112366788999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=400.11  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             hc-cccccCceEEEEEEeC---CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          292 AE-IMGKSTYGTVYKATLE---DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       292 ~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .+ .||+|+||.||+|.+.   ++..||||+++..... ..+.|.+|+++|++++|||||+++|++..  +..++||||+
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~lvmE~~   90 (285)
T d1u59a_          13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMA   90 (285)
T ss_dssp             EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECC
T ss_pred             CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEEEEEeC
Confidence            45 4999999999999874   3557999999755433 34679999999999999999999999964  4689999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc--
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--  444 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  444 (580)
                      ++|+|.+++...  ...+++..+.+++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+|+........  
T Consensus        91 ~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  167 (285)
T d1u59a_          91 GGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  167 (285)
T ss_dssp             TTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             CCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence            999999998654  3469999999999999999999999 49999999999999999999999999999877543322  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.+..++...+.   .+...         ..++
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~---~~~~~---------~~p~  235 (285)
T d1u59a_         168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---QGKRM---------ECPP  235 (285)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---TTCCC---------CCCT
T ss_pred             cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCC---------CCCC
Confidence            2223458899999999999999999999999999999998 999998776544433332   21111         0112


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ..+   .++.+++.+||+.||++||||.+|++.|+.+..
T Consensus       236 ~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         236 ECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            222   356688889999999999999999999987654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=400.92  Aligned_cols=251  Identities=23%  Similarity=0.358  Sum_probs=192.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-CCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-KGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||.++....  ...+.+.+|++++++++||||+++++++.+. ++..|+|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            567799999999999999986 799999999865432  2345688999999999999999999998753 456899999


Q ss_pred             eCCCCChhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----cccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          365 YMPHGSLATFLHARG-PETPIDWPTRMKIIKGMTRGLLHLHSNEN-----IIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-----i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      |+++|+|.+++.+.. ....+++..++.++.||+.||+|||+. +     |+||||||+|||++.++.+||+|||+|+..
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            999999999986531 234699999999999999999999983 4     999999999999999999999999999876


Q ss_pred             ccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          439 TAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       439 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ..... ......||+.|||||++.+..|+.++|||||||++|||+||+.||...+..++   ...+.......       
T Consensus       165 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~~~i~~~~~~~-------  233 (269)
T d2java1         165 NHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKIREGKFRR-------  233 (269)
T ss_dssp             ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHTCCCC-------
T ss_pred             ccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---HHHHHcCCCCC-------
Confidence            54322 23346799999999999999999999999999999999999999976554332   22222222110       


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        .....+   .++.+++.+||+.||++|||+.|+++|
T Consensus       234 --~~~~~s---~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         234 --IPYRYS---DELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CCcccC---HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              011122   356678889999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=398.60  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=199.1

Q ss_pred             ccccccCceEEEEEEeC---CCCEEEEEEccccccc--cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          293 EIMGKSTYGTVYKATLE---DGSQVAVKRLREKITK--GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      +.||+|+||.||+|.++   +++.||||+++.....  ..+.|.+|+++|++++|||||+++++|..  +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence            57999999999999864   3567999999654332  34579999999999999999999999964  46899999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc--c
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--N  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~  445 (580)
                      +|+|.++++..   ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++........  .
T Consensus        91 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          91 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999999874   3699999999999999999999995 9999999999999999999999999999876543322  2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+.   .+...         ..+..
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~---~~~~~---------~~p~~  234 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERM---------GCPAG  234 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCC---------CCCTT
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH---cCCCC---------CCCcc
Confidence            223468999999999999999999999999999999998 899998765443333222   21111         01112


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                      .+   .++.+++.+||+.||++|||+.+|++.|+.+-
T Consensus       235 ~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         235 CP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             cC---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            22   35668888999999999999999999988753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=389.62  Aligned_cols=245  Identities=23%  Similarity=0.369  Sum_probs=195.4

Q ss_pred             hhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC---CCcEEEEEe
Q 008031          291 TAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP---KGEKLLVFD  364 (580)
Q Consensus       291 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~~lv~e  364 (580)
                      ..+.||+|+||+||+|.+. +++.||+|.+.....  ...+.+.+|+++|++++|||||++++++...   +...++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            3467999999999999986 788999999865432  2345689999999999999999999998642   345799999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccCCCCCCCeeeC-CCCCeEEeecccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNEN--IIHGNLTSSNVLLD-DSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--i~H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~  441 (580)
                      |+++|+|.+++.+.   ..+++..+..++.||++||+|||++ +  |+||||||+|||++ +++.+||+|||+|+.....
T Consensus        93 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          93 LMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            99999999999875   3689999999999999999999994 7  99999999999997 5789999999999764332


Q ss_pred             cccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          442 ANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                         ......||+.|||||++.+ .++.++||||+||++|||++|+.||......  .+....+..+...     ......
T Consensus       169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~~~~~~-----~~~~~~  237 (270)
T d1t4ha_         169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVKP-----ASFDKV  237 (270)
T ss_dssp             ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCCC-----GGGGGC
T ss_pred             ---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHHHcCCCC-----cccCcc
Confidence               2235679999999999875 6999999999999999999999999754322  2222222221111     111111


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         .   ..++.+++.+||+.||++|||+.|+++|
T Consensus       238 ---~---~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         238 ---A---IPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             ---C---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---C---CHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence               1   1256788999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=395.11  Aligned_cols=256  Identities=23%  Similarity=0.420  Sum_probs=197.0

Q ss_pred             HhhhccccccCceEEEEEEeCCC-----CEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLEDG-----SQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      +...++||+|+||.||+|.++++     ..||||+++..... ....|.+|++++++++|||||+++|++.+ .+..++|
T Consensus         9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~~~~~~v   87 (283)
T d1mqba_           9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMMII   87 (283)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEE
T ss_pred             eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-CCceEEE
Confidence            34568999999999999987632     36999998754433 34568999999999999999999999986 5689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+.+|++.+++...  ...+++.++++++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus        88 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          88 TEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             EEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence            9999999999988764  3469999999999999999999999 499999999999999999999999999998765432


Q ss_pred             c--cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCC-CCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 N--VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPG-EPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .  .......||+.|||||++.++.++.++|||||||++|||++|..|+ ...+..++   ...+..+...         
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~~~~~---------  232 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAINDGFRL---------  232 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTCCC---------
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH---HHHHhccCCC---------
Confidence            2  2233456899999999999999999999999999999999965554 43333222   2222211111         


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      .....   ...++.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       233 ~~~~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         233 PTPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCchh---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            01111   223567889999999999999999999999988654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=405.81  Aligned_cols=267  Identities=21%  Similarity=0.354  Sum_probs=205.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |++.+.||+|+||.||+|.+. +|+.||+|+++..... ....+.+|+.+|++++|||||+++++|.+ ++..++||||+
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iVmEy~   86 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHM   86 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcC
Confidence            567789999999999999986 7899999998754332 34678999999999999999999999987 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      ++|+|.+++.+.+   .+++..+..++.|++.||.|||+..||+||||||+|||++.++++||+|||+|+......   .
T Consensus        87 ~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~  160 (322)
T d1s9ja_          87 DGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A  160 (322)
T ss_dssp             TTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C
T ss_pred             CCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---c
Confidence            9999999998753   689999999999999999999972289999999999999999999999999998664332   2


Q ss_pred             eeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcccc--------------
Q 008031          447 IATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNE--------------  512 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------  512 (580)
                      ....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+..........+.....              
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY  240 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence            346799999999999999999999999999999999999999987654332221111111000000              


Q ss_pred             ------------ccchhhhccCCCcH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcc
Q 008031          513 ------------VFDLELMRDAPTIG--DELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRP  562 (580)
Q Consensus       513 ------------~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~  562 (580)
                                  ..+.......+..+  ....++.+++.+||+.||++|||+.|+++|  +++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                        00000000000000  012467789999999999999999999996  554433

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=398.13  Aligned_cols=247  Identities=21%  Similarity=0.332  Sum_probs=201.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||+++...   ....+.+.+|++++++++||||+++++++.+ ++..|+|||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ivmE   88 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLS   88 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEEEE
Confidence            667899999999999999985 79999999986432   2344678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc-
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN-  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  443 (580)
                      |+++|+|.+++...+   .+++..+..++.|++.||+|||+ +||+||||||+|||+++++.+||+|||+|+....... 
T Consensus        89 y~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          89 YAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             ccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            999999999988753   69999999999999999999999 5999999999999999999999999999987654332 


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                      .......||+.|||||++.+..|+.++||||+||++|||++|+.||...+..++   ...+......       .   ..
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~~~~~~-------~---p~  231 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKLEYD-------F---PE  231 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHTTCCC-------C---CT
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HHHHHcCCCC-------C---Cc
Confidence            233345799999999999999999999999999999999999999986543332   2333222210       0   01


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..   ..++.+++.+||+.||++|||++|++++
T Consensus       232 ~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         232 KF---FPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             TC---CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             cC---CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            11   2356688999999999999999997554

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.8e-51  Score=399.56  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=188.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|++++++++||||+++++++.+ ++..|+||||+
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvmE~~   89 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIMQLV   89 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEecc
Confidence            667899999999999999986 789999999865432 334568899999999999999999999987 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC---CCCCeEEeecccccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD---DSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      +||+|.+++...   ..+++..+..++.||+.||+|||+ .||+||||||+||++.   +++.+||+|||+|+.......
T Consensus        90 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          90 SGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             CCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            999999999764   369999999999999999999999 4999999999999995   578899999999986643322


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                        .....||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+..   ..+......   .+...   .+
T Consensus       166 --~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~~~~~~---~~~~~---~~  234 (307)
T d1a06a_         166 --LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQILKAEYE---FDSPY---WD  234 (307)
T ss_dssp             ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHTTCCC---CCTTT---TT
T ss_pred             --eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHhccCCC---CCCcc---cc
Confidence              23457999999999999999999999999999999999999999765433322   222222211   01111   11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ..   ..++.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~---s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         235 DI---SDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TS---CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CC---CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            12   2356788889999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=391.35  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=200.2

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      +++.+.||+|+||.||+|.++ |+.||||+++..  ...+.+.+|++++++++||||++++|+|.+.++..++||||+++
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~   85 (262)
T d1byga_           9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   85 (262)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence            456789999999999999986 789999999654  34567999999999999999999999997656678999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.+++.+.. ...+++..+++++.||+.||.|||+. +|+||||||+||+++.++.+|++|||+++.......    .
T Consensus        86 g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~----~  159 (262)
T d1byga_          86 GSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----T  159 (262)
T ss_dssp             EEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred             CCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecCCCCc----c
Confidence            99999997642 23589999999999999999999994 999999999999999999999999999986543322    2


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..++..|+|||++.+..++.++|||||||++|||+| |+.||...+..++...+..   +..      +..   .+..+ 
T Consensus       160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~---~~~------~~~---~~~~~-  226 (262)
T d1byga_         160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYK------MDA---PDGCP-  226 (262)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT---TCC------CCC---CTTCC-
T ss_pred             ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCC------CCC---CccCC-
Confidence            457889999999999999999999999999999998 7888877665554444322   111      111   11112 


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                        .++.+++.+||+.||++|||+.+++++|++++..
T Consensus       227 --~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence              3566888999999999999999999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=391.99  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=200.5

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPH  368 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  368 (580)
                      |++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||+++++|.+  +..++||||+++
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey~~~   95 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSK   95 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTT
T ss_pred             EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEecCC
Confidence            6778999999999999999988889999999754 3345789999999999999999999999853  468999999999


Q ss_pred             CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccceee
Q 008031          369 GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNVIA  448 (580)
Q Consensus       369 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  448 (580)
                      |+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++............
T Consensus        96 g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  173 (285)
T d1fmka3          96 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  173 (285)
T ss_dssp             CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             Cchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence            99999887542 23599999999999999999999995 99999999999999999999999999998776555444455


Q ss_pred             ecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCC-CCCCCCChhHHHHHHhhhhccccccchhhhccCCCcHH
Q 008031          449 TAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPG-EPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTIGD  527 (580)
Q Consensus       449 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (580)
                      ..||+.|+|||.+.++.++.++|||||||++|||++|..|| ......+....+.   .+...      .   ..+..  
T Consensus       174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~~~~~------~---~~~~~--  239 (285)
T d1fmka3         174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYRM------P---CPPEC--  239 (285)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCC------C---CCTTS--
T ss_pred             ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCC------C---CCccc--
Confidence            67999999999999999999999999999999999966554 4333322222222   11110      0   11122  


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          528 ELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       528 ~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                       ..++.+++.+||+.||++|||+++|++.|+.+...
T Consensus       240 -~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         240 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence             23567888999999999999999999999986543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=393.18  Aligned_cols=256  Identities=21%  Similarity=0.369  Sum_probs=198.8

Q ss_pred             HHhhhccccccCceEEEEEEeCC----CCEEEEEEcccccccc-HHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLED----GSQVAVKRLREKITKG-QREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      .|.+.+.||+|+||.||+|.+..    +..||||.++...... .+.+.+|++++++++||||+++++++.  ++..++|
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~iv   85 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWII   85 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCeEEEE
Confidence            36678999999999999998752    3468999986544333 456999999999999999999999995  4578999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|.+++...  ...+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+|+......
T Consensus        86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999988764  3468999999999999999999999 599999999999999999999999999998776554


Q ss_pred             ccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhcc
Q 008031          443 NVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRD  521 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (580)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..++...+..   +...      .   .
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~---~~~~------~---~  230 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERL------P---M  230 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCCC------C---C
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCC------C---C
Confidence            444455678999999999999999999999999999999998 8999988766555443322   2111      0   1


Q ss_pred             CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          522 APTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       522 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      ++..+   .++.++|.+||+.||++|||+.||+++|+.+.++
T Consensus       231 ~~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         231 PPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            12222   3567888899999999999999999999998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.2e-50  Score=401.45  Aligned_cols=250  Identities=23%  Similarity=0.389  Sum_probs=206.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|++++++++|||||++++++.+ ++..++||||++
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~  106 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMS  106 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEECCCC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCC
Confidence            677899999999999999985 799999999976655556778999999999999999999999987 678999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC--CCCCeEEeecccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD--DSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +|+|.+++...  ...+++..+..++.||+.||+|||++ ||+||||||+|||++  .++.+||+|||+|+......  .
T Consensus       107 gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~  181 (350)
T d1koaa2         107 GGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S  181 (350)
T ss_dssp             SCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--C
T ss_pred             CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheeccccc--c
Confidence            99999998653  24699999999999999999999995 999999999999996  46789999999998765433  2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+.|||||++.+..++.++||||+||++|||++|+.||.+.+..+   .+..+.......   +.....     
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~~~---~~~~~~-----  250 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVKSCDWNM---DDSAFS-----  250 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCCS---CCGGGG-----
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCC---Cccccc-----
Confidence            345679999999999999999999999999999999999999997654333   333333222110   111111     


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ....++.+++.+||+.||++|||+.|+++|
T Consensus       251 -~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         251 -GISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             112356788999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=399.57  Aligned_cols=255  Identities=22%  Similarity=0.322  Sum_probs=202.7

Q ss_pred             HHhhhccccccCceEEEEEEeCC-C-----CEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATLED-G-----SQVAVKRLREKI-TKGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      .|.+.+.||+|+||.||+|++.. +     ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+ .+..
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~  116 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-SGPI  116 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSC
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-CCeE
Confidence            35678899999999999998752 2     269999986543 33446789999999998 89999999999987 6689


Q ss_pred             EEEEeeCCCCChhhhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCe
Q 008031          360 LLVFDYMPHGSLATFLHARGP--------------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNV  419 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Ni  419 (580)
                      ++||||+++|+|.++++.+..                    ...+++..++.++.||++||+|||+ ++|+||||||+||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDlKp~Ni  195 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNV  195 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTCSGGGE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCchhcc
Confidence            999999999999999976531                    1358999999999999999999999 4999999999999


Q ss_pred             eeCCCCCeEEeecccccccccccccc-eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCCh
Q 008031          420 LLDDSTNAKISDFGLSRLMTAAANVN-VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAEL  497 (580)
Q Consensus       420 l~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~  497 (580)
                      +++.++.+||+|||+|+......... .....||+.|||||++.++.++.++|||||||++|||+| |+.||.+.+..+.
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~  275 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  275 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998765543322 223468999999999999999999999999999999998 8999987654432


Q ss_pred             hHHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 008031          498 PQWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLE  558 (580)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~  558 (580)
                         +..++......     .   .+...   ..++.++|.+||+.||++|||++||+++|.
T Consensus       276 ---~~~~~~~~~~~-----~---~p~~~---~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         276 ---FYKLIQNGFKM-----D---QPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ---HHHHHHTTCCC-----C---CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---HHHHHhcCCCC-----C---CCCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence               22223222111     0   11112   235678889999999999999999999995

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.9e-50  Score=401.31  Aligned_cols=250  Identities=21%  Similarity=0.392  Sum_probs=206.6

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||+++.........+.+|++++++++||||+++++++.+ ++..++||||++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~  109 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLS  109 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCC
Confidence            667899999999999999985 799999999976655556678899999999999999999999986 678999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC--CCCCeEEeecccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD--DSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +|+|.+++...  ...+++.+++.++.||+.||+|||+. ||+||||||+|||++  .++.+||+|||+|+......  .
T Consensus       110 gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~  184 (352)
T d1koba_         110 GGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I  184 (352)
T ss_dssp             CCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred             CChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence            99999987654  34689999999999999999999995 999999999999998  67899999999998775433  2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....||+.|||||++.+..++.++||||+||++|||+||+.||.+.+..+...   .+......   .....   .+..
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i~~~~~~---~~~~~---~~~~  255 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ---NVKRCDWE---FDEDA---FSSV  255 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHHHCCCC---CCSST---TTTS
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCCCC---CCccc---ccCC
Confidence            344679999999999999999999999999999999999999998655433332   22222111   00001   1111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ..++.+++.+||+.||.+|||+.|+++|
T Consensus       256 ---s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         256 ---SPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               2356788999999999999999999886

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-50  Score=394.63  Aligned_cols=246  Identities=26%  Similarity=0.386  Sum_probs=200.1

Q ss_pred             HHHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          287 LLCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       287 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      ..|+..+.||+|+||.||+|.+. +|+.||||+++.....   ..+.+.+|++++++++|||||++++++.+ ++..++|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEE
Confidence            34777899999999999999975 7889999998754322   23568899999999999999999999987 6689999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      |||+++|+|..++...   ..+++.++..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        94 ~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             EECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            9999999998776553   3699999999999999999999994 9999999999999999999999999999865432 


Q ss_pred             ccceeeecCccccCCcccccc---CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          443 NVNVIATAGALGYRAPELSKL---KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       443 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                          ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.+.+..   +.+..+........       
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~~i~~~~~~~~-------  234 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPAL-------  234 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCCC-------
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCC-------
Confidence                23569999999998753   46899999999999999999999999765432   22333332221110       


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       .....   ..++.+++.+||+.||++|||+.|+++|
T Consensus       235 -~~~~~---s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         235 -QSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -SCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -CCCCC---CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence             01111   2356788889999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=388.30  Aligned_cols=249  Identities=26%  Similarity=0.391  Sum_probs=203.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT------KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++....      ...+.+.+|+++|++++|||||++++++.+ ++..++
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~i   90 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDVIL   90 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEE
Confidence            677899999999999999985 799999999864322      234679999999999999999999999987 678999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC----CeEEeecccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST----NAKISDFGLSRL  437 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~----~~kl~Dfg~~~~  437 (580)
                      ||||+++|+|.+++...+   .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++    .+|++|||+|..
T Consensus        91 v~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            999999999999998753   69999999999999999999999 4999999999999998766    499999999987


Q ss_pred             cccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ......  .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+..   ..+......   ....
T Consensus       167 ~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~~~~~~---~~~~  238 (293)
T d1jksa_         167 IDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVNYE---FEDE  238 (293)
T ss_dssp             CTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHTTCCC---CCHH
T ss_pred             cCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH---HHHHhcCCC---CCch
Confidence            654332  23457899999999999999999999999999999999999999875533322   222222111   0111


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ...   ..   ...+.+++.+||+.||++|||+.|+++|
T Consensus       239 ~~~---~~---s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         239 YFS---NT---SALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHT---TS---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hcC---CC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111   11   1356688999999999999999999885

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=392.98  Aligned_cols=255  Identities=23%  Similarity=0.426  Sum_probs=204.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCC----EEEEEEccccc-cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGS----QVAVKRLREKI-TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  362 (580)
                      |...+.||+|+||.||+|.+. +|+    .||+|.++... ....++|.+|++++++++|||||+++|+|.+  +..+++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~v   88 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLI   88 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeeEE
Confidence            567899999999999999875 444    58999886543 3456789999999999999999999999985  467889


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAA  442 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~  442 (580)
                      +||+.+|+|.+++...  ...+++..+++++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus        89 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          89 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            9999999999988765  35689999999999999999999994 99999999999999999999999999998765433


Q ss_pred             cc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          443 NV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       443 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .. ......||+.|||||++.++.++.++|||||||++|||+| |+.||...+..++...+..   +...         .
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~---~~~~---------~  233 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERL---------P  233 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH---TCCC---------C
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCC---------C
Confidence            32 2334468999999999999999999999999999999999 8999987765554443332   1111         0


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      .++..   ..++.+++.+||+.||++|||+.|++++|+.+...
T Consensus       234 ~p~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         234 QPPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             CCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCccc---CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            11122   23567888899999999999999999999987543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=391.34  Aligned_cols=246  Identities=23%  Similarity=0.320  Sum_probs=204.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |.+.+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|+.+|++++||||+++++++.+ ++..|+|||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv~e   85 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVME   85 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-cccccccee
Confidence            566799999999999999985 89999999997542   2345678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+++|+|.+++...+   .+++..+..++.||+.||+|||+ +||+||||||+|||+++++.+||+|||+|+....... 
T Consensus        86 y~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-  160 (337)
T d1o6la_          86 YANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             CCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred             ccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence            999999999998753   68999999999999999999999 4999999999999999999999999999986543322 


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                      ......||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..++.+   .+.....       ..   +..
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---~i~~~~~-------~~---p~~  227 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEI-------RF---PRT  227 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHCCC-------CC---CTT
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH---HHhcCCC-------CC---Ccc
Confidence            2334679999999999999999999999999999999999999998765433322   2222111       01   111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~  556 (580)
                      .+   .++.+++.+||+.||.+||+     +.|+++|
T Consensus       228 ~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         228 LS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             SC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC---HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            22   35668889999999999995     7888876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-49  Score=391.08  Aligned_cols=257  Identities=24%  Similarity=0.373  Sum_probs=207.6

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEccccccc-cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKITK-GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |++.+.||+|+||.||+|++.      +++.||||+++..... ..++|.+|++++++++||||++++++|.. .+..++
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~~   93 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCL   93 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc-CCceEE
Confidence            566789999999999999864      4578999999755433 34679999999999999999999999986 668999


Q ss_pred             EEeeCCCCChhhhhhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCee
Q 008031          362 VFDYMPHGSLATFLHARG---------------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVL  420 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil  420 (580)
                      +|||+++|+|.+++....                     ....+++..++.++.|++.||+|||+ ++++||||||+|||
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrDlKp~NIL  172 (301)
T d1lufa_          94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCL  172 (301)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeEEcccceE
Confidence            999999999999997542                     12348899999999999999999999 59999999999999


Q ss_pred             eCCCCCeEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCC-CCCCCCCCCChh
Q 008031          421 LDDSTNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGK-SPGEPLNGAELP  498 (580)
Q Consensus       421 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~-~p~~~~~~~~~~  498 (580)
                      ++.++.+||+|||+|+........ ......|++.|+|||.+.+..|+.++|||||||++|||++|. +||...+..++.
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~  252 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI  252 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH
Confidence            999999999999999866444332 233456889999999999999999999999999999999985 678776554444


Q ss_pred             HHHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          499 QWVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ..+.   .+...         ......+   .++.+++.+||+.||++||||.||++.|+++.+
T Consensus       253 ~~v~---~~~~~---------~~p~~~~---~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         253 YYVR---DGNIL---------ACPENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHH---TTCCC---------CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHH---cCCCC---------CCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            3332   22111         1111222   356788999999999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=388.24  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=202.5

Q ss_pred             hccccccCceEEEEEEeCCC----CEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          292 AEIMGKSTYGTVYKATLEDG----SQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      .++||+|+||+||+|.+.++    ..||||+++.... ...++|.+|+++|++++||||++++|++...++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999997532    2589999875333 344679999999999999999999999887667899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc--
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV--  444 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  444 (580)
                      ++|+|.+++...  ...+++..+++++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999998765  3457888999999999999999999 59999999999999999999999999999876543222  


Q ss_pred             -ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCC-CCCChhHHHHHHhhhhccccccchhhhccC
Q 008031          445 -NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPL-NGAELPQWVASIVKEEWTNEVFDLELMRDA  522 (580)
Q Consensus       445 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (580)
                       ......||+.|+|||.+.+..++.++||||||+++|||+||+.||... +..+....+   ..+....         .+
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i---~~g~~~~---------~p  256 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRLL---------QP  256 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH---HTTCCCC---------CC
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCCC---------Cc
Confidence             222346899999999999999999999999999999999977777543 222222222   2221110         11


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          523 PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       523 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      +..+   .++.++|.+||+.||++|||+.||+++|+.+...
T Consensus       257 ~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         257 EYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1222   3567888999999999999999999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-48  Score=385.44  Aligned_cols=243  Identities=24%  Similarity=0.353  Sum_probs=202.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|+.++++++||||+++++++.+ ++..++|||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE   84 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMD   84 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeEee
Confidence            567899999999999999985 79999999986432   2345678999999999999999999999987 678999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |++||+|.+++...   ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+......  
T Consensus        85 ~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--  158 (316)
T d1fota_          85 YIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  158 (316)
T ss_dssp             CCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             ecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence            99999999998875   367889999999999999999999 599999999999999999999999999998765432  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                        ....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+   ....+......          .++.
T Consensus       159 --~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~~~~----------~p~~  223 (316)
T d1fota_         159 --YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEKILNAELR----------FPPF  223 (316)
T ss_dssp             --CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHCCCC----------CCTT
T ss_pred             --ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HHHHHHcCCCC----------CCCC
Confidence              24679999999999999999999999999999999999999998654333   33333322111          0111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      .+   .++.+++.+||+.||.+||     |++++++|
T Consensus       224 ~s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         224 FN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             SC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC---HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            22   2566788899999999996     89999886

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-49  Score=386.67  Aligned_cols=259  Identities=25%  Similarity=0.344  Sum_probs=197.8

Q ss_pred             HhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  360 (580)
                      |.+.+.||+|+||.||+|.+.      +++.||||+++.... ...+.+.+|...+.++ +|+||+.+++++...+...+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~   94 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   94 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence            567899999999999999864      346899999975433 3345678888888887 78999999999987666789


Q ss_pred             EEEeeCCCCChhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCe
Q 008031          361 LVFDYMPHGSLATFLHARGP-------------ETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNA  427 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~  427 (580)
                      +||||+++|+|.++++....             ...+++.+++.++.||++||+|||+ ++|+||||||+|||+++++.+
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl~~~~~~  173 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVV  173 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGGCE
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeECCCCcE
Confidence            99999999999999976421             2358899999999999999999999 599999999999999999999


Q ss_pred             EEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcC-CCCCCCCCCCChhHHHHHHh
Q 008031          428 KISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTG-KSPGEPLNGAELPQWVASIV  505 (580)
Q Consensus       428 kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg-~~p~~~~~~~~~~~~~~~~~  505 (580)
                      ||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+|| ..||......+   .+...+
T Consensus       174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---~~~~~~  250 (299)
T d1ywna1         174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRL  250 (299)
T ss_dssp             EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HHHHHH
T ss_pred             EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence            99999999866443322 22345799999999999999999999999999999999996 56786654332   222222


Q ss_pred             hhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          506 KEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                      ..+....        .....   ..++.+++.+||+.||++|||+.|++++|+++.+
T Consensus       251 ~~~~~~~--------~~~~~---~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         251 KEGTRMR--------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHTCCCC--------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCCCC--------CCccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2221111        01111   2356788999999999999999999999998754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=381.01  Aligned_cols=253  Identities=26%  Similarity=0.364  Sum_probs=194.8

Q ss_pred             HhhhccccccCceEEEEEEeC--CC--CEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE--DG--SQVAVKRLREKIT---KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |++.+.||+|+||.||+|.+.  ++  ..||||+++....   ...+.|.+|+.++++++||||++++|++.+  +..++
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~~l   87 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPMKM   87 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cchhe
Confidence            566789999999999999864  23  3689999865432   234579999999999999999999999964  46789


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++|++.+++...  ...+++..++.++.|||.||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            99999999999988764  2459999999999999999999999 49999999999999999999999999999876544


Q ss_pred             ccc--ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          442 ANV--NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       442 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ...  ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+...   .+.......     . 
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~---~i~~~~~~~-----~-  235 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGERL-----P-  235 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHHTSCCCC-----C-
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH---HHHhCCCCC-----C-
Confidence            332  2223457889999999999999999999999999999998 899998765444333   332222111     0 


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEI  560 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~  560 (580)
                        ..+..+   .++.+++.+||+.||++|||+.||++.|++.
T Consensus       236 --~~~~~~---~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 --RPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --Cccccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              111222   3566888999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=383.66  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=203.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCC--EEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGS--QVAVKRLREKIT-KGQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +.+.+.||+|+||.||+|.+. +|.  .||||.++.... ...+.|.+|+++|.++ +||||++++++|.+ ++..++||
T Consensus        12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~iV~   90 (309)
T d1fvra_          12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAI   90 (309)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CCeeEEEE
Confidence            345789999999999999986 444  478888764433 3456799999999999 79999999999987 67899999


Q ss_pred             eeCCCCChhhhhhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEe
Q 008031          364 DYMPHGSLATFLHAR-------------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKIS  430 (580)
Q Consensus       364 e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~  430 (580)
                      ||+++|+|.++++..             .....+++..+.+++.|||.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus        91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEEC
T ss_pred             EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCCCceEEc
Confidence            999999999999754             223569999999999999999999999 599999999999999999999999


Q ss_pred             ecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCC-CCCCCCCCCChhHHHHHHhhhhc
Q 008031          431 DFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGK-SPGEPLNGAELPQWVASIVKEEW  509 (580)
Q Consensus       431 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~  509 (580)
                      |||+++........  ....||..|+|||.+.+..++.++|||||||++|||++|. .||...+..++...+   ..+..
T Consensus       170 DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i---~~~~~  244 (309)
T d1fvra_         170 DFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQGYR  244 (309)
T ss_dssp             CTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG---GGTCC
T ss_pred             cccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH---HhcCC
Confidence            99999765433222  2346899999999999999999999999999999999965 567665543333322   22111


Q ss_pred             cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          510 TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                      .      .   .....+   .++.++|.+||+.||++|||+.||+++|+++.++..
T Consensus       245 ~------~---~~~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         245 L------E---KPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             C------C---CCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             C------C---CCccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            1      1   111222   356688889999999999999999999999875543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=381.55  Aligned_cols=259  Identities=23%  Similarity=0.263  Sum_probs=196.1

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccccc-----cHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK-----GQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      .++||+|+||+||+|.+. +|+.||||+++.....     ..+.+.+|+.++++++|||||++++++.. ++..++||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE~   81 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDF   81 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEEC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehhhh
Confidence            478999999999999986 7999999998654322     12468899999999999999999999987 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +.++++..+...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+........ 
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence            988877666543   3468889999999999999999999 49999999999999999999999999999876543322 


Q ss_pred             eeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh------h
Q 008031          446 VIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE------L  518 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  518 (580)
                      .....||+.|+|||++.. ..|+.++||||+||++|||++|+.||...++.+....+.+.........+.+..      .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            234578999999998764 467999999999999999999999998765544433333322111000000000      0


Q ss_pred             hccCCCc-H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          519 MRDAPTI-G-----DELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       519 ~~~~~~~-~-----~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      ....+.. .     ....++.+++.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0000000 0     112467789999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=382.47  Aligned_cols=265  Identities=25%  Similarity=0.339  Sum_probs=199.3

Q ss_pred             hhhccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCC---cEEEEEeeC
Q 008031          290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKG---EKLLVFDYM  366 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~e~~  366 (580)
                      ...+.||+|+||.||+|++. |+.||||+++.... .....+.|+..+.+++||||++++++|.....   ..++||||+
T Consensus         6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~   83 (303)
T d1vjya_           6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence            34688999999999999975 89999999864321 11223445555667899999999999986432   578999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSN-------ENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      ++|+|.+++++.    .+++..+.+++.|+|.||+|||+.       +||+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          84 EHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             TTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             cCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            999999999874    589999999999999999999962       499999999999999999999999999998765


Q ss_pred             ccccc---ceeeecCccccCCccccccCC------CCCcccchhHHHHHHHHHcCCCCCCCCCCCCh-----------hH
Q 008031          440 AAANV---NVIATAGALGYRAPELSKLKK------ANTKTDVYSLGVTILELLTGKSPGEPLNGAEL-----------PQ  499 (580)
Q Consensus       440 ~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-----------~~  499 (580)
                      .....   ......||+.|||||++.+..      ++.++|||||||++|||+||..||......+.           ..
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            43322   223457999999999987543      56789999999999999999988754332211           11


Q ss_pred             HHHHHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccccc
Q 008031          500 WVASIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEAA  565 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~~  565 (580)
                      .+......    ...++.... .....+....+.+++.+||+.||++|||+.||++.|+++.++..
T Consensus       240 ~~~~~~~~----~~~~p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         240 EMRKVVCE----QKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHHHTT----SCCCCCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhc----cccCCCCCc-ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            11111111    111111111 11122345678899999999999999999999999999976643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.8e-48  Score=376.84  Aligned_cols=257  Identities=22%  Similarity=0.344  Sum_probs=200.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccccc---HHHHHHHHHHHhcCCCCcceeeeeEEECCCC---cEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKG---QREFESEVSLLGKIRHPNLLALRAYYLGPKG---EKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~l  361 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++.....+   .+.+.+|++++++++||||+++++++...+.   ..|+
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            567899999999999999975 79999999997544322   3468999999999999999999999976332   3789


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||++||+|.+++...+   .+++.+++.++.||+.||+|||+ .||+||||||+|||++.++.++++|||.+......
T Consensus        89 vmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            999999999999987753   68999999999999999999999 59999999999999999999999999998755332


Q ss_pred             cc--cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          442 AN--VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       442 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..  .......||+.|||||++.+..++.++||||+||++|||+||+.||...+..   +............    +.. 
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~~~~~~~~~----~~~-  236 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVREDPIP----PSA-  236 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCCCC----GGG-
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---HHHHHHHhcCCCC----Cch-
Confidence            22  2334457999999999999999999999999999999999999999765432   2233333322111    000 


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhc
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARP-EVLQVVQQLEEIR  561 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ev~~~L~~~~  561 (580)
                       ..+..+   .++.+++.+||+.||++|| |++++++.|.+++
T Consensus       237 -~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         237 -RHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -TSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -hccCCC---HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence             111122   3566788899999999999 8999999998875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-48  Score=386.30  Aligned_cols=243  Identities=21%  Similarity=0.269  Sum_probs=202.7

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEe
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFD  364 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  364 (580)
                      |++.+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|+++|+.++||||+++++++.. ....++|||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v~e  121 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVME  121 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccccc
Confidence            667899999999999999986 79999999986432   2334678999999999999999999999987 668999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      |+.+|+|.+++.+.+   .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+......  
T Consensus       122 ~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--  195 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--  195 (350)
T ss_dssp             CCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred             cccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence            999999999998753   689999999999999999999995 99999999999999999999999999998765332  


Q ss_pred             ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCC
Q 008031          445 NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPT  524 (580)
Q Consensus       445 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (580)
                        ....||+.|||||++.+..++.++||||+||++|||+||+.||.+.+.   ......+......          ....
T Consensus       196 --~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~~~~~----------~p~~  260 (350)
T d1rdqe_         196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVR----------FPSH  260 (350)
T ss_dssp             --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCC----------CCTT
T ss_pred             --ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHhcCCCC----------CCcc
Confidence              235699999999999999999999999999999999999999976543   3333333322111          0111


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008031          525 IGDELLNTLKLALHCVDPSPSARP-----EVLQVVQQ  556 (580)
Q Consensus       525 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ev~~~  556 (580)
                      .+   .++.+++.+||+.||.+|+     |+.|+++|
T Consensus       261 ~s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         261 FS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC---HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            22   3566888899999999994     89999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.8e-48  Score=374.87  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=201.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc---------cHHHHHHHHHHHhcCC-CCcceeeeeEEECCCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK---------GQREFESEVSLLGKIR-HPNLLALRAYYLGPKG  357 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  357 (580)
                      |++.+.||+|+||+||+|++. +|+.||||+++.....         ..+.+.+|+.++++++ ||||+++++++.+ ++
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~   83 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NT   83 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-Cc
Confidence            567899999999999999985 7899999998643211         1235889999999996 9999999999987 67


Q ss_pred             cEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccc
Q 008031          358 EKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRL  437 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~  437 (580)
                      ..|+||||+++|+|.++++..+   .+++.++..++.||++||+|||+ .||+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCCCeEEccchheeE
Confidence            8999999999999999998753   68999999999999999999999 4999999999999999999999999999987


Q ss_pred             cccccccceeeecCccccCCccccc------cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          438 MTAAANVNVIATAGALGYRAPELSK------LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      ......  .....||..|+|||.+.      ...++.++||||+||++|||++|+.||.+.+..+..+   .+..+... 
T Consensus       160 ~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~---~i~~~~~~-  233 (277)
T d1phka_         160 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR---MIMSGNYQ-  233 (277)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCCC-
T ss_pred             ccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH---HHHhCCCC-
Confidence            654332  23457999999999875      3457889999999999999999999998765433222   22222211 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        ..      .+.......++.+++.+||+.||++|||+.|+++|
T Consensus       234 --~~------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         234 --FG------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             --CC------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             --CC------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              00      11111222367788999999999999999999876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-48  Score=380.90  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=203.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||+||+|.+. +|+.||||+++... .....+.+|+++|++++||||+++++++.+ ++..|+||||++
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE~~~   84 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFEFIS   84 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEecCC
Confidence            567899999999999999986 78899999997543 234568899999999999999999999987 678999999999


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC--CCCeEEeecccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD--STNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      ||+|.+++...  ...+++.++..++.||+.||+|||+. ||+||||||+|||++.  ...+|++|||+++......  .
T Consensus        85 gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~  159 (321)
T d1tkia_          85 GLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N  159 (321)
T ss_dssp             CCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccCC--c
Confidence            99999999764  24689999999999999999999995 9999999999999984  4579999999998764432  2


Q ss_pred             eeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCCCc
Q 008031          446 VIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAPTI  525 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (580)
                      .....+|+.|+|||.+.+..++.++||||+||++|+|++|+.||...+..+   ....+......   .+.....   ..
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i~~~~~~---~~~~~~~---~~  230 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEYT---FDEEAFK---EI  230 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC---CCHHHHT---TS
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC---CChhhcc---CC
Confidence            334568999999999999999999999999999999999999998765433   23333322211   1111111   11


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          526 GDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       526 ~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                         ..++.+++.+||..||++|||+.|+++|
T Consensus       231 ---s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         231 ---SIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               1256788999999999999999999985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=380.25  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=203.2

Q ss_pred             HHhhhccccccCceEEEEEEeCC--------CCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCC
Q 008031          288 LCATAEIMGKSTYGTVYKATLED--------GSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRAYYLGPKG  357 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  357 (580)
                      .|++.+.||+|+||.||+|+...        +..||||+++..... ...++.+|+..+.++ +|||||+++++|.+ ++
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-~~   92 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DG   92 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-CC
Confidence            45678999999999999998632        347999999765443 346788899999888 89999999999986 66


Q ss_pred             cEEEEEeeCCCCChhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          358 EKLLVFDYMPHGSLATFLHARG-------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       358 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      ..++||||+++|+|.+++..+.             ....+++.++++++.||+.||+|||+. +|+||||||+|||++.+
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTED  171 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTT
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeecccceeecCC
Confidence            8999999999999999997653             234689999999999999999999994 99999999999999999


Q ss_pred             CCeEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHH
Q 008031          425 TNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~  502 (580)
                      +.+||+|||+++........ ......+++.|+|||.+.++.|+.++|||||||++|||++ |+.||...+..++...+ 
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i-  250 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-  250 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH-
Confidence            99999999999876544332 2334568899999999999999999999999999999998 78888765543322222 


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRP  562 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~  562 (580)
                         ..+...     ..   ....   ..++.+++.+||+.||++|||+.||++.|+++..
T Consensus       251 ---~~~~~~-----~~---p~~~---~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         251 ---KEGHRM-----DK---PSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ---HTTCCC-----CC---CSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HcCCCC-----CC---Cccc---hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence               111110     11   1111   2357789999999999999999999999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-47  Score=385.49  Aligned_cols=247  Identities=22%  Similarity=0.302  Sum_probs=198.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHH---HHHHHhcCCCCcceeeeeEEECCCCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFES---EVSLLGKIRHPNLLALRAYYLGPKGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~~l  361 (580)
                      |.+.+.||+|+||.||+|++. +|+.||||++....   ......+.+   |+++++.++|||||++++++.+ ++..|+
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~~~i   84 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSF   84 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CCEEEE
Confidence            556789999999999999986 79999999986432   122233434   4777888899999999999987 668999


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 vmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999999875   368899999999999999999999 59999999999999999999999999999876543


Q ss_pred             cccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhc
Q 008031          442 ANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMR  520 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .   .....||+.|||||++.+ ..|+.++||||+||++|||+||+.||......+.............       ..  
T Consensus       161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-------~~--  228 (364)
T d1omwa3         161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------EL--  228 (364)
T ss_dssp             C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC-------CC--
T ss_pred             c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-------CC--
Confidence            2   234579999999999864 5689999999999999999999999987665554433322111110       00  


Q ss_pred             cCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 008031          521 DAPTIGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQ  556 (580)
Q Consensus       521 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~  556 (580)
                       ....+   .++.++|.+||+.||++|||     ++|+++|
T Consensus       229 -~~~~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         229 -PDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             -CSSSC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             -CCCCC---HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence             11122   35678888999999999999     6888875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=383.73  Aligned_cols=251  Identities=21%  Similarity=0.318  Sum_probs=196.1

Q ss_pred             Hhhh-ccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcC-CCCcceeeeeEEEC---CCCcEEEE
Q 008031          289 CATA-EIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKI-RHPNLLALRAYYLG---PKGEKLLV  362 (580)
Q Consensus       289 ~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---~~~~~~lv  362 (580)
                      |.+. +.||+|+||.||+|.+. +|+.||||+++.     ...+.+|+.++.++ +||||+++++++.+   .+...|+|
T Consensus        13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            4444 57999999999999975 799999999853     34577899987654 89999999999864   23468999


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC---CCCeEEeecccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD---STNAKISDFGLSRLMT  439 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~  439 (580)
                      ||||+||+|.+++..++ ...+++.++..++.||+.||+|||+ .||+||||||+|||++.   ++.+||+|||+|+...
T Consensus        88 mEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeecc
Confidence            99999999999998653 3469999999999999999999999 59999999999999985   5679999999998765


Q ss_pred             cccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhh
Q 008031          440 AAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELM  519 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ....  .....||+.|||||++.+..|+.++||||+||++|+|+||+.||.+.+..+....+..........  +     
T Consensus       166 ~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~--~-----  236 (335)
T d2ozaa1         166 SHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--F-----  236 (335)
T ss_dssp             CCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS--C-----
T ss_pred             CCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC--C-----
Confidence            4332  234579999999999999999999999999999999999999998766554433332211111000  0     


Q ss_pred             ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          520 RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       520 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                       ..+.......++.+++.+||+.||++|||+.|+++|
T Consensus       237 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         237 -PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             001111223467789999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=381.40  Aligned_cols=246  Identities=24%  Similarity=0.335  Sum_probs=199.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc---cccHHHHHHHHHHHh-cCCCCcceeeeeEEECCCCcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI---TKGQREFESEVSLLG-KIRHPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      |.+.+.||+|+||+||+|.+. +|+.||||+++...   ....+.+..|..++. .++||||+++++++.+ ++..|+||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yivm   82 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFFVM   82 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeEEE
Confidence            556799999999999999986 79999999996432   233455677777765 6899999999999987 66899999


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      ||+++|+|.++++...   .+++.++..++.||+.||+|||+. +|+||||||+|||+++++++|++|||+++.......
T Consensus        83 Ey~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             eecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            9999999999998753   688999999999999999999994 999999999999999999999999999986543322


Q ss_pred             cceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhhhccCC
Q 008031          444 VNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLELMRDAP  523 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (580)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+   ....+..+..       ..   +.
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~~-------~~---p~  224 (320)
T d1xjda_         159 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMDNP-------FY---PR  224 (320)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC-------CC---CT
T ss_pred             -cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCC-------CC---Cc
Confidence             2334579999999999999999999999999999999999999998655333   2222222111       01   11


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 008031          524 TIGDELLNTLKLALHCVDPSPSARPEVL-QVVQQ  556 (580)
Q Consensus       524 ~~~~~~~~l~~li~~cl~~~P~~Rps~~-ev~~~  556 (580)
                      ..+   .++.+++.+||+.||++|||+. |+++|
T Consensus       225 ~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         225 WLE---KEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             TSC---HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             cCC---HHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence            122   3566888899999999999996 77653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-48  Score=379.59  Aligned_cols=260  Identities=20%  Similarity=0.331  Sum_probs=208.1

Q ss_pred             HHhhhccccccCceEEEEEEeC------CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEE
Q 008031          288 LCATAEIMGKSTYGTVYKATLE------DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  360 (580)
                      .+...+.||+|+||.||+|.+.      +++.||||+++.... .....|.+|+.++++++||||++++++|.. ++..+
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~   99 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTL   99 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-CCcee
Confidence            3457789999999999999864      357899999975433 233568999999999999999999999976 66899


Q ss_pred             EEEeeCCCCChhhhhhhc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecc
Q 008031          361 LVFDYMPHGSLATFLHAR-------GPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFG  433 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg  433 (580)
                      +||||+++|+|.+++...       .....+++..+.+++.|+|+||.|||+. +|+||||||+|||+++++++||+|||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~~Kl~DFG  178 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFG  178 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCceEEEeecc
Confidence            999999999999998643       2234578999999999999999999994 99999999999999999999999999


Q ss_pred             ccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcC-CCCCCCCCCCChhHHHHHHhhhhccc
Q 008031          434 LSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTG-KSPGEPLNGAELPQWVASIVKEEWTN  511 (580)
Q Consensus       434 ~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~  511 (580)
                      +|+........ ......||+.|+|||.+.+..++.++|||||||++|||+|| +.||...+..+   ....+..+... 
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~~i~~~~~~-  254 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFVMEGGLL-  254 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHHHHHTTCCC-
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhCCCC-
Confidence            99876544332 12233588999999999999999999999999999999997 57776654333   33333222211 


Q ss_pred             cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          512 EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                              ...+..+   ..+.++|.+||+.||++|||+.+|+++|++..+..
T Consensus       255 --------~~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         255 --------DKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             --------CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             --------CCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                    1111222   35778899999999999999999999999876543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=377.84  Aligned_cols=260  Identities=26%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             HHhhhccccccCceEEEEEEe------CCCCEEEEEEccccccc-cHHHHHHHHHHHhcC-CCCcceeeeeEEECCCCcE
Q 008031          288 LCATAEIMGKSTYGTVYKATL------EDGSQVAVKRLREKITK-GQREFESEVSLLGKI-RHPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  359 (580)
                      .+++.+.||+|+||.||+|++      .+++.||||+++..... ....+.+|+.+++++ +|||||+++++|.+ ....
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-~~~~  102 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GGPT  102 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSC
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-CCEE
Confidence            456789999999999999985      24668999999754433 345689999999999 79999999999986 5679


Q ss_pred             EEEEeeCCCCChhhhhhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCC
Q 008031          360 LLVFDYMPHGSLATFLHARG---------------PETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDS  424 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~  424 (580)
                      ++||||+++|+|.+++++..               ....+++..+.+++.||++||+|||+ ++++||||||+||+++.+
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHG  181 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEETT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccccccccc
Confidence            99999999999999997643               12358999999999999999999999 599999999999999999


Q ss_pred             CCeEEeeccccccccccccc-ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCCChhHHHH
Q 008031          425 TNAKISDFGLSRLMTAAANV-NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLT-GKSPGEPLNGAELPQWVA  502 (580)
Q Consensus       425 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~  502 (580)
                      +.+|++|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |.+||...+..+.   +.
T Consensus       182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---~~  258 (311)
T d1t46a_         182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FY  258 (311)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---HH
T ss_pred             CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---HH
Confidence            99999999999876544332 2234578999999999999999999999999999999999 6666655544332   22


Q ss_pred             HHhhhhccccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhccc
Q 008031          503 SIVKEEWTNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPE  563 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~  563 (580)
                      .++..+....        ....   ....+.++|.+||+.||++|||+.|+++.|+++..+
T Consensus       259 ~~i~~~~~~~--------~~~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         259 KMIKEGFRML--------SPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHTCCCC--------CCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCC--------Cccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            2222222110        0111   123577889999999999999999999999876543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=369.86  Aligned_cols=265  Identities=24%  Similarity=0.328  Sum_probs=198.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++....  ...+.+.+|++++++++||||+++++++.+ ++..++||||
T Consensus         4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~e~   82 (298)
T d1gz8a_           4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEF   82 (298)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEEee
Confidence            556789999999999999985 799999999965432  234678999999999999999999999987 6689999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +.+ ++.+++.... ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+....... .
T Consensus        83 ~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~  158 (298)
T d1gz8a_          83 LHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-T  158 (298)
T ss_dssp             CSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-C
T ss_pred             cCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccCcceeccCCcceeccCCcc-c
Confidence            965 5555554432 3469999999999999999999999 5999999999999999999999999999986644322 2


Q ss_pred             eeeecCccccCCccccccCC-CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh------h
Q 008031          446 VIATAGALGYRAPELSKLKK-ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE------L  518 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  518 (580)
                      .....||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+.+..+....+......  ..+.....      .
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDY  236 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC--CCTTTSTTGGGSTTC
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC--Cchhhcccccccccc
Confidence            23457999999999876655 578999999999999999999999865533322222211110  00000000      0


Q ss_pred             hccC----CCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhh
Q 008031          519 MRDA----PTI-----GDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEI  560 (580)
Q Consensus       519 ~~~~----~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~  560 (580)
                      ....    ...     .....++.+++.+||+.||++|||+.|+++|  ++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            0000    000     0112467788999999999999999999987  4444

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-46  Score=367.09  Aligned_cols=262  Identities=22%  Similarity=0.297  Sum_probs=197.5

Q ss_pred             HhhhccccccCceEEEEEEeCCCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||+||+|++.+|+.||||+++....  ...+.+.+|+.+|++++||||+++++++.. ++..+++|||+
T Consensus         4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~e~~   82 (286)
T d1ob3a_           4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFEHL   82 (286)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEECC
T ss_pred             ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEEEee
Confidence            556789999999999999999999999999865432  235679999999999999999999999987 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccce
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVNV  446 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  446 (580)
                      .++.+..+....   ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.|........ ..
T Consensus        83 ~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  157 (286)
T d1ob3a_          83 DQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY  157 (286)
T ss_dssp             SEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             hhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence            876666665543   4699999999999999999999995 999999999999999999999999999987644322 23


Q ss_pred             eeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc--------hh
Q 008031          447 IATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD--------LE  517 (580)
Q Consensus       447 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~  517 (580)
                      ....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+....+...........+.+        ..
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            34568899999998765 4568999999999999999999999987654333333222111110000000        00


Q ss_pred             hhccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          518 LMRDAP-----TIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      .....+     ........+.+++.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000     001112466788999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-47  Score=365.72  Aligned_cols=238  Identities=20%  Similarity=0.364  Sum_probs=191.9

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccc------cHHHHHHHHHHHhcCC--CCcceeeeeEEECCCCcE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITK------GQREFESEVSLLGKIR--HPNLLALRAYYLGPKGEK  359 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~  359 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++.....      ....+.+|+.++++++  ||||+++++++.+ ++..
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~~~~   84 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-PDSF   84 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-SSEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-CCeE
Confidence            667899999999999999985 7999999998643211      1234678999999986  8999999999987 6689


Q ss_pred             EEEEeeCCC-CChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-CCCeEEeecccccc
Q 008031          360 LLVFDYMPH-GSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-STNAKISDFGLSRL  437 (580)
Q Consensus       360 ~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-~~~~kl~Dfg~~~~  437 (580)
                      ++||||+.+ +++.+++...   ..+++.++..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEECcccccee
Confidence            999999976 5788888764   368999999999999999999999 59999999999999984 57899999999986


Q ss_pred             cccccccceeeecCccccCCccccccCCC-CCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccch
Q 008031          438 MTAAANVNVIATAGALGYRAPELSKLKKA-NTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDL  516 (580)
Q Consensus       438 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      .....   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+         .+......   +  
T Consensus       161 ~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~~~~~---~--  223 (273)
T d1xwsa_         161 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVF---F--  223 (273)
T ss_dssp             CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCCCC---C--
T ss_pred             ccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhhcccC---C--
Confidence            54332   234579999999999887665 567899999999999999999996521         11111110   0  


Q ss_pred             hhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          517 ELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       517 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                           .+..+   .++.+++.+||+.||++|||+.|+++|
T Consensus       224 -----~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         224 -----RQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -----SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 11122   256678889999999999999999886

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=362.03  Aligned_cols=265  Identities=23%  Similarity=0.337  Sum_probs=198.4

Q ss_pred             HHhhhccccccCceEEEEEEeC-C-CCEEEEEEccccccc--cHHHHHHHHHHHhcC---CCCcceeeeeEEEC----CC
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-D-GSQVAVKRLREKITK--GQREFESEVSLLGKI---RHPNLLALRAYYLG----PK  356 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----~~  356 (580)
                      .|++.+.||+|+||+||+|.+. + ++.||||+++.....  ....+.+|+.+++.+   +||||+++++++..    ..
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            4677899999999999999974 4 567999998654322  233566788877765   79999999999863    23


Q ss_pred             CcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          357 GEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       357 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                      ...+++|||++++++.......  ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            4678999999887665444332  34689999999999999999999995 99999999999999999999999999988


Q ss_pred             ccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh----cccc
Q 008031          437 LMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE----WTNE  512 (580)
Q Consensus       437 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~  512 (580)
                      .......  .....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+.......    +...
T Consensus       165 ~~~~~~~--~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGGGG--GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhccccc--CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            6543332  234679999999999999999999999999999999999999998765444333332221110    0000


Q ss_pred             cc----------chhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhh
Q 008031          513 VF----------DLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEI  560 (580)
Q Consensus       513 ~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~  560 (580)
                      ..          ...........   ...+.+|+.+||+.||++|||+.|+++|  ++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDI---DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSC---CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccchhhhhccccccchhhccccC---CHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            00          00000001111   2356678889999999999999999986  4444

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=370.79  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=196.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----CCcEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGP-----KGEKLLV  362 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~lv  362 (580)
                      |...++||+|+||+||+|++. +|+.||||+++....    .+.+|+++|++++||||+++++++...     ..+.++|
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            556789999999999999986 799999999865422    234799999999999999999998642     2347899


Q ss_pred             EeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeecccccccccc
Q 008031          363 FDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAA  441 (580)
Q Consensus       363 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~  441 (580)
                      |||++++.+..+.+.......+++.++..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.....
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            9999776444444333334579999999999999999999999 4999999999999999764 8999999999876543


Q ss_pred             cccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhh-------ccccc
Q 008031          442 ANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEE-------WTNEV  513 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~  513 (580)
                      ..  .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+.......       .....
T Consensus       177 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         177 EP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             SC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             cc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            32  223578999999998764 578999999999999999999999997655433222222111000       00000


Q ss_pred             cchhhhccC------CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhccc
Q 008031          514 FDLELMRDA------PTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPE  563 (580)
Q Consensus       514 ~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~  563 (580)
                      .+.......      ........++.+|+.+||+.||++|||+.|+++|  +++++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            000000000      0001112356788899999999999999999986  5666543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-44  Score=356.83  Aligned_cols=259  Identities=17%  Similarity=0.198  Sum_probs=198.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEeeCC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDYMP  367 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  367 (580)
                      |.+.+.||+|+||.||+|.+. +|+.||||++....  ...++..|+++++.++|++++..++.+....+..++||||+ 
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            567899999999999999975 78999999876543  23457889999999988887777666665577889999999 


Q ss_pred             CCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeC---CCCCeEEeeccccccccccccc
Q 008031          368 HGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLD---DSTNAKISDFGLSRLMTAAANV  444 (580)
Q Consensus       368 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~  444 (580)
                      ++++.+.+...  ...+++..+..++.|++.||+|||+ +||+||||||+|||++   .+..+|++|||+|+........
T Consensus        86 ~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            56777766554  3468999999999999999999999 5999999999999986   3557999999999877543321


Q ss_pred             ------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchhh
Q 008031          445 ------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLEL  518 (580)
Q Consensus       445 ------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                            ......||+.|||||.+.+..++.++|||||||++|||++|+.||......+....+...........  .+..
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  240 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--IEVL  240 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--HHHH
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--hhHh
Confidence                  22345799999999999999999999999999999999999999987765554444333222111100  0011


Q ss_pred             hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 008031          519 MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIR  561 (580)
Q Consensus       519 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~  561 (580)
                         .+..+   .++.+++.+||+.+|++||++.++.+.|+.+.
T Consensus       241 ---~~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         241 ---CKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             ---TTTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             ---ccCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence               11112   25667888999999999999999999888764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=359.83  Aligned_cols=265  Identities=22%  Similarity=0.293  Sum_probs=197.0

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccc--cccHHHHHHHHHHHhcCCCCcceeeeeEEECC-------CCc
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI--TKGQREFESEVSLLGKIRHPNLLALRAYYLGP-------KGE  358 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------~~~  358 (580)
                      |.+.+.||+|+||+||+|.+. +|+.||||++....  ......+.+|+++|++++||||+++++++...       ++.
T Consensus        12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~   91 (318)
T d3blha1          12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   91 (318)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred             EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence            567899999999999999985 89999999986432  23446788999999999999999999998652       245


Q ss_pred             EEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccc
Q 008031          359 KLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLM  438 (580)
Q Consensus       359 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~  438 (580)
                      .++||||++++.+..+...   ...++...+..++.|++.||.|||+. ||+||||||+|||++.++.+|++|||+++..
T Consensus        92 ~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          92 IYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             EEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeecceeeec
Confidence            7999999988766655443   34688999999999999999999994 9999999999999999999999999999766


Q ss_pred             ccccc---cceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccc---
Q 008031          439 TAAAN---VNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTN---  511 (580)
Q Consensus       439 ~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---  511 (580)
                      .....   .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.++.+....+..........   
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            53222   122234699999999988654 68999999999999999999999998765544444443332211100   


Q ss_pred             cccchhh------h-ccCCCcHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008031          512 EVFDLEL------M-RDAPTIGDE------LLNTLKLALHCVDPSPSARPEVLQVVQQL  557 (580)
Q Consensus       512 ~~~~~~~------~-~~~~~~~~~------~~~l~~li~~cl~~~P~~Rps~~ev~~~L  557 (580)
                      .......      . .......+.      ...+++|+.+||+.||++|||++|+++|=
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp  306 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  306 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence            0000000      0 000111111      23566899999999999999999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.4e-44  Score=348.01  Aligned_cols=261  Identities=16%  Similarity=0.196  Sum_probs=207.2

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCCC-CcceeeeeEEECCCCcEEEEEeeC
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIRH-PNLLALRAYYLGPKGEKLLVFDYM  366 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~  366 (580)
                      |.+.+.||+|+||.||+|++. +|+.||||++....  ....+.+|++.++.+.| +|++.+++++.. +...++||||+
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~~   83 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL   83 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEEec
Confidence            567899999999999999976 78999999875432  23457789999999965 899999999876 66899999999


Q ss_pred             CCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCC-----CCCeEEeecccccccccc
Q 008031          367 PHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDD-----STNAKISDFGLSRLMTAA  441 (580)
Q Consensus       367 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~-----~~~~kl~Dfg~~~~~~~~  441 (580)
                       +++|.+++...+  ..++..++..++.|++.||+|||+ +||+||||||+|||++.     ++.+||+|||+|+.....
T Consensus        84 -~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          84 -GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence             789999987653  468999999999999999999999 59999999999999974     567999999999876543


Q ss_pred             ccc------ceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccc
Q 008031          442 ANV------NVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFD  515 (580)
Q Consensus       442 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ...      ......||+.|||||++.+..++.++|||||||++|||+||+.||.+............+........  .
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~--~  237 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP--L  237 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC--H
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC--h
Confidence            221      22345799999999999999999999999999999999999999988766655554443332221110  0


Q ss_pred             hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcccc
Q 008031          516 LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQLEEIRPEA  564 (580)
Q Consensus       516 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~L~~~~~~~  564 (580)
                      ..+.   +..+   .++.+++..||+.+|++||++..+.+.|+++..+.
T Consensus       238 ~~l~---~~~p---~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         238 RELC---AGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHT---TTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhc---CCCC---HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            1111   1122   25667888999999999999999999998875444

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=356.25  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=203.4

Q ss_pred             HhhhccccccCceEEEEEEeC----CCCEEEEEEccccc----cccHHHHHHHHHHHhcCCC-CcceeeeeEEECCCCcE
Q 008031          289 CATAEIMGKSTYGTVYKATLE----DGSQVAVKRLREKI----TKGQREFESEVSLLGKIRH-PNLLALRAYYLGPKGEK  359 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~  359 (580)
                      |.+.+.||+|+||.||+|...    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+ ....
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~~~  104 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETKL  104 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TTEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-CCce
Confidence            667899999999999999852    58899999986532    2234568899999999966 899999999987 6689


Q ss_pred             EEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccc
Q 008031          360 LLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMT  439 (580)
Q Consensus       360 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~  439 (580)
                      +++|||+.+|+|.+++...+   .+....+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus       105 ~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999998753   577889999999999999999994 99999999999999999999999999998776


Q ss_pred             cccccceeeecCccccCCccccccC--CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhccccccchh
Q 008031          440 AAANVNVIATAGALGYRAPELSKLK--KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWTNEVFDLE  517 (580)
Q Consensus       440 ~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ...........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......+....+.........       
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-------  253 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-------  253 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-------
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC-------
Confidence            5555445556799999999988654  4678999999999999999999999887766665555443221111       


Q ss_pred             hhccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 008031          518 LMRDAPTIGDELLNTLKLALHCVDPSPSARPE-----VLQVVQQ  556 (580)
Q Consensus       518 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ev~~~  556 (580)
                           +.......++.+++.+||++||++|||     ++|+++|
T Consensus       254 -----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         254 -----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                 001112236677888999999999994     7888875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-44  Score=356.62  Aligned_cols=266  Identities=22%  Similarity=0.300  Sum_probs=196.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC---CcEEEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT-KGQREFESEVSLLGKIRHPNLLALRAYYLGPK---GEKLLVF  363 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~  363 (580)
                      |...+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+.+|++++||||+++++++....   ...++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            567899999999999999875 899999999965432 23457889999999999999999999997532   1234555


Q ss_pred             eeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccc
Q 008031          364 DYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       364 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~  443 (580)
                      +|+.+|+|.+++...    .+++..++.++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++.......
T Consensus        90 ~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          90 THLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            667799999999764    599999999999999999999995 999999999999999999999999999986644322


Q ss_pred             c--ceeeecCccccCCccccc-cCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---ccc----
Q 008031          444 V--NVIATAGALGYRAPELSK-LKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEV----  513 (580)
Q Consensus       444 ~--~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----  513 (580)
                      .  ......||+.|+|||++. ...++.++||||+||++|||++|+.||...+..+..............   ...    
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence            1  223456899999999874 456788999999999999999999999765433222222111100000   000    


Q ss_pred             -----------cchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcc
Q 008031          514 -----------FDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRP  562 (580)
Q Consensus       514 -----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~  562 (580)
                                 .........+..   ..++.+++.+||+.||++|||+.|+++|  +++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~---s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNA---DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhcccccCCccCCCCHHHhCCCC---CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                       000000001111   1357789999999999999999999987  554443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-44  Score=357.49  Aligned_cols=263  Identities=20%  Similarity=0.282  Sum_probs=194.4

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCC-----CcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPK-----GEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  360 (580)
                      |.+.+.||+|+||+||+|.+. +|+.||||+++....  ...+.+.+|+++|++++|||||+++++|...+     ...+
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            667899999999999999985 799999999975432  22456889999999999999999999997632     2579


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+ +.+|.++.+..    .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+|+....
T Consensus       100 lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             EEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceeccCC
Confidence            999999 66787777653    599999999999999999999995 999999999999999999999999999986543


Q ss_pred             ccccceeeecCccccCCcccccc-CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhc----------
Q 008031          441 AANVNVIATAGALGYRAPELSKL-KKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEW----------  509 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  509 (580)
                      .    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+.............          
T Consensus       174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            3    234579999999998865 4568999999999999999999999977654332222221110000          


Q ss_pred             --------cccccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhcccc
Q 008031          510 --------TNEVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIRPEA  564 (580)
Q Consensus       510 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~~~~  564 (580)
                              .............+..   ...+.+|+.+||..||++|||+.|+++|  ++.+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNA---SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTC---CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             hhhhhhccCCcccccchHHhccCC---CHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence                    0000000000011111   2356688999999999999999999997  66665433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.5e-43  Score=349.75  Aligned_cols=257  Identities=17%  Similarity=0.230  Sum_probs=194.7

Q ss_pred             HHhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECC-CCcEEEEEe
Q 008031          288 LCATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGP-KGEKLLVFD  364 (580)
Q Consensus       288 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv~e  364 (580)
                      .|++.+.||+|+||+||+|++. +|+.||||+++..   ..+.+.+|+++|++++ ||||+++++++... ....++|||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            4777899999999999999985 7999999998643   3467889999999995 99999999999753 446899999


Q ss_pred             eCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCC-CeEEeecccccccccccc
Q 008031          365 YMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDST-NAKISDFGLSRLMTAAAN  443 (580)
Q Consensus       365 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  443 (580)
                      |+++++|.++.+      .+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||+|+.......
T Consensus       113 ~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~  185 (328)
T d3bqca1         113 HVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE  185 (328)
T ss_dssp             CCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred             ecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence            999999987643      489999999999999999999995 999999999999998654 599999999987654332


Q ss_pred             cceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCC-hhHHHHHHhhhhcc-------cccc
Q 008031          444 VNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAE-LPQWVASIVKEEWT-------NEVF  514 (580)
Q Consensus       444 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~-------~~~~  514 (580)
                        .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....... ....+.........       ....
T Consensus       186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             --ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence              2345689999999987754 57999999999999999999999997654321 11111111110000       0000


Q ss_pred             chhhh--------------ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          515 DLELM--------------RDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       515 ~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                      +....              ...........++.+|+.+||..||++|||++|+++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000              0000111122467789999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=345.24  Aligned_cols=260  Identities=23%  Similarity=0.284  Sum_probs=198.8

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECCCCcEEEEEee
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGPKGEKLLVFDY  365 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  365 (580)
                      |.+.+.||+|+||+||+|++. +|+.||||+++....  .....+.+|+.+++.++||||+++++++.. ....++++|+
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~~~   82 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEF   82 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEeee
Confidence            567799999999999999985 789999999864432  234678999999999999999999999987 6688999999


Q ss_pred             CCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccccccc
Q 008031          366 MPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAAANVN  445 (580)
Q Consensus       366 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  445 (580)
                      +.++++..++...   ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+|++|||.++........ 
T Consensus        83 ~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-  157 (292)
T d1unla_          83 CDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-  157 (292)
T ss_dssp             CSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred             ccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence            9999888887654   4688999999999999999999995 9999999999999999999999999999876544332 


Q ss_pred             eeeecCccccCCccccccCC-CCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---ccc------cc
Q 008031          446 VIATAGALGYRAPELSKLKK-ANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---NEV------FD  515 (580)
Q Consensus       446 ~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~------~~  515 (580)
                      .....++..|+|||.+.+.. ++.++||||+||++|||++|+.||.....  ..+....+......   ..+      .+
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            22345778899999887655 68999999999999999999999754322  22222222111000   000      00


Q ss_pred             -------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          516 -------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       516 -------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                             ................+.+++.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   00000000111122456788999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=354.25  Aligned_cols=259  Identities=22%  Similarity=0.240  Sum_probs=188.1

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC-----CCcEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP-----KGEKL  360 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~  360 (580)
                      |.+.++||+|+||+||+|.+. +|+.||||+++....  .....+.+|+.++++++||||+++++++...     ....|
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            667899999999999999986 799999999975432  2335688999999999999999999999642     35789


Q ss_pred             EEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeeccccccccc
Q 008031          361 LVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTA  440 (580)
Q Consensus       361 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~  440 (580)
                      +||||+.++ +.+.+..     .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+|++|||+++....
T Consensus        99 iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          99 LVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhcccc
Confidence            999999665 4444432     489999999999999999999994 999999999999999999999999999876544


Q ss_pred             ccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhh--------------
Q 008031          441 AANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVK--------------  506 (580)
Q Consensus       441 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------------  506 (580)
                      ..  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+.....              
T Consensus       172 ~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             cc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            32  22345689999999999999999999999999999999999999976543222222111110              


Q ss_pred             -----hhcc-cc-----ccchhh-hccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          507 -----EEWT-NE-----VFDLEL-MRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       507 -----~~~~-~~-----~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                           .... ..     ...... ............++.+|+.+||..||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                 0000 00     000000 00000111234567889999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=346.37  Aligned_cols=261  Identities=21%  Similarity=0.282  Sum_probs=195.5

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCcceeeeeEEECC----CCcEEE
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKIT--KGQREFESEVSLLGKIRHPNLLALRAYYLGP----KGEKLL  361 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~~l  361 (580)
                      |+..+.||+|+||+||+|.+. +|+.||||+++....  ...+.+.+|++++++++||||+++++++...    +...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            677899999999999999975 799999999975432  2345688999999999999999999998642    234566


Q ss_pred             EEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEeecccccccccc
Q 008031          362 VFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISDFGLSRLMTAA  441 (580)
Q Consensus       362 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~  441 (580)
                      +++|+.+|+|.+++...    .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++......
T Consensus       100 i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             EEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             EEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhcccCcc
Confidence            77888899999999653    599999999999999999999995 9999999999999999999999999998765432


Q ss_pred             cccceeeecCccccCCccccccC-CCCCcccchhHHHHHHHHHcCCCCCCCCCCCChhHHHHHHhhhhcc---c------
Q 008031          442 ANVNVIATAGALGYRAPELSKLK-KANTKTDVYSLGVTILELLTGKSPGEPLNGAELPQWVASIVKEEWT---N------  511 (580)
Q Consensus       442 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~------  511 (580)
                          .....|++.|+|||...+. .++.++||||+||++|+|++|+.||.+.+.......+.........   .      
T Consensus       175 ----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         175 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             ----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             ----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence                2235688999999986654 5688999999999999999999999876543333333221110000   0      


Q ss_pred             ---------cccchhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhhc
Q 008031          512 ---------EVFDLELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ--LEEIR  561 (580)
Q Consensus       512 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~--L~~~~  561 (580)
                               ......+......   ....+.+|+.+||+.||++|||+.|+++|  +.++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~---~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIG---ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhcccCCCcchhhhcCC---CCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                     0000000000011   12356788999999999999999999986  44443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-38  Score=322.04  Aligned_cols=263  Identities=22%  Similarity=0.245  Sum_probs=191.3

Q ss_pred             HhhhccccccCceEEEEEEeC-CCCEEEEEEccccccccHHHHHHHHHHHhcCC-----------CCcceeeeeEEEC-C
Q 008031          289 CATAEIMGKSTYGTVYKATLE-DGSQVAVKRLREKITKGQREFESEVSLLGKIR-----------HPNLLALRAYYLG-P  355 (580)
Q Consensus       289 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~-~  355 (580)
                      |.+.+.||+|+||+||+|++. +|+.||||+++.... ..+.+.+|+++++.++           |+||+++++++.. .
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            667899999999999999985 799999999975432 2356788998888775           5789999988864 2


Q ss_pred             CCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCC------eEE
Q 008031          356 KGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTN------AKI  429 (580)
Q Consensus       356 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~------~kl  429 (580)
                      ....+++++++..+..............+++..+..++.||+.||+|||+..||+||||||+|||++.++.      +++
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence            34566777777666544444444445678999999999999999999997459999999999999986543      999


Q ss_pred             eecccccccccccccceeeecCccccCCccccccCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCCh---hHHHHHHhh
Q 008031          430 SDFGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGVTILELLTGKSPGEPLNGAEL---PQWVASIVK  506 (580)
Q Consensus       430 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~  506 (580)
                      +|||.+.......    ....||+.|+|||++....++.++||||+||++++|++|+.||.+......   .........
T Consensus       174 ~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         174 ADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             CCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             eeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            9999987554322    245699999999999999999999999999999999999999976543211   111111100


Q ss_pred             --h----------hccccccc-----------------hhhhccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008031          507 --E----------EWTNEVFD-----------------LELMRDAPTIGDELLNTLKLALHCVDPSPSARPEVLQVVQQ  556 (580)
Q Consensus       507 --~----------~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev~~~  556 (580)
                        +          .......+                 ...............++.+|+.+||..||++|||++|+++|
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0          00000000                 00001122334566788999999999999999999999987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=2.4e-24  Score=195.66  Aligned_cols=167  Identities=17%  Similarity=0.182  Sum_probs=120.1

Q ss_pred             hhhccccccCceEEEEEEeCCCCEEEEEEccccccc------------------cHHHHHHHHHHHhcCCCCcceeeeeE
Q 008031          290 ATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITK------------------GQREFESEVSLLGKIRHPNLLALRAY  351 (580)
Q Consensus       290 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~~  351 (580)
                      ++++.||+|+||.||+|.+.+|+.||||+++.....                  ....+.+|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            457899999999999999989999999987532110                  11234578899999999999988765


Q ss_pred             EECCCCcEEEEEeeCCCCChhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccCCCCCCCeeeCCCCCeEEee
Q 008031          352 YLGPKGEKLLVFDYMPHGSLATFLHARGPETPIDWPTRMKIIKGMTRGLLHLHSNENIIHGNLTSSNVLLDDSTNAKISD  431 (580)
Q Consensus       352 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i~H~Dlk~~Nil~~~~~~~kl~D  431 (580)
                      .     ..+++|||++++.+.+          ++.....+++.|++.+++|||+. ||+||||||+|||+++++ ++++|
T Consensus        83 ~-----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~~-~~liD  145 (191)
T d1zara2          83 E-----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEEG-IWIID  145 (191)
T ss_dssp             E-----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETTE-EEECC
T ss_pred             c-----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCCC-EEEEE
Confidence            3     2379999998865543          23344568999999999999994 999999999999999754 99999


Q ss_pred             cccccccccccccceeeecCccccCCccccccCCCCCcccchhHHH
Q 008031          432 FGLSRLMTAAANVNVIATAGALGYRAPELSKLKKANTKTDVYSLGV  477 (580)
Q Consensus       432 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~  477 (580)
                      ||.|.............  ..... -.+ +..+.|+.++|+||..-
T Consensus       146 FG~a~~~~~~~~~~~l~--rd~~~-~~~-~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         146 FPQSVEVGEEGWREILE--RDVRN-IIT-YFSRTYRTEKDINSAID  187 (191)
T ss_dssp             CTTCEETTSTTHHHHHH--HHHHH-HHH-HHHHHHCCCCCHHHHHH
T ss_pred             CCCcccCCCCCcHHHHH--HHHHH-HHH-HHcCCCCCcccHHHHHH
Confidence            99987654332211100  00000 001 12367788999999754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.85  E-value=1e-21  Score=193.11  Aligned_cols=180  Identities=32%  Similarity=0.550  Sum_probs=117.2

Q ss_pred             EEEecCCcccc--cccccccCCCCCcEEEccC-CccCCCCCccccCCCCCCEEEeeCCcCCCC-----------------
Q 008031            2 FLALQYNNLSG--RIPASLGKLSELQEISLSH-NKISGVMPSDLGRLSRLRILDFSYNAINGS-----------------   61 (580)
Q Consensus         2 ~L~L~~N~i~~--~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------   61 (580)
                      .|||++|.+++  .+|+.+++|++|++|+|++ |.+++.+|..|+++++|++|+|++|+|.+.                 
T Consensus        54 ~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~  133 (313)
T d1ogqa_          54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS  133 (313)
T ss_dssp             EEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECC
T ss_pred             EEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccc
Confidence            46666666665  3566666666666666664 566666666666666666666666666544                 


Q ss_pred             -------CCccCcCCCCCCEEECcCCCCCcccchhhhccCCC-Ceeeecc------------------------------
Q 008031           62 -------LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNL-SVLNLKR------------------------------  103 (580)
Q Consensus        62 -------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~------------------------------  103 (580)
                             +|..|.++++|+.+++++|.+++.+|..+..+.++ +.++++.                              
T Consensus       134 ~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~  213 (313)
T d1ogqa_         134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA  213 (313)
T ss_dssp             SSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECC
T ss_pred             cccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence                   44445555555555555555554444433333222 2233333                              


Q ss_pred             -----------------ccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChhhh-hh
Q 008031          104 -----------------NQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTSLA-LK  165 (580)
Q Consensus       104 -----------------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~-~~  165 (580)
                                       |.+++.+ ..+..+++|+.|+|++|+++|.+|..|.++++|++|||++|+|+|.+|.... ..
T Consensus       214 ~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~  292 (313)
T d1ogqa_         214 SVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR  292 (313)
T ss_dssp             GGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGG
T ss_pred             cccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCC
Confidence                             3332222 2345567899999999999999999999999999999999999999886422 35


Q ss_pred             cCCCcccccccccCCCC
Q 008031          166 FNASSFVGNIQLCGYSG  182 (580)
Q Consensus       166 ~~~~~~~~~~~~~~~~~  182 (580)
                      +....+.+|..+||.|.
T Consensus       293 L~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         293 FDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             SCGGGTCSSSEEESTTS
T ss_pred             CCHHHhCCCccccCCCC
Confidence            56667789999999753

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=5.4e-21  Score=183.02  Aligned_cols=159  Identities=26%  Similarity=0.315  Sum_probs=142.8

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|||++|+|++..+..|.++++|++|+|++|+|+. ++ .+..+++|++|+|++|+++ ..+..+..+++|+.|++++|
T Consensus        34 ~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~  110 (266)
T d1p9ag_          34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN  110 (266)
T ss_dssp             CEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSS
T ss_pred             CEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-cccccccccccccccccccc
Confidence            479999999997666789999999999999999984 33 4678999999999999998 56778999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      .+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|.
T Consensus       111 ~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~  189 (266)
T d1p9ag_         111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK  189 (266)
T ss_dssp             CCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred             ccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccCh
Confidence            999888888999999999999999999887888889999999999999999888888999999999999999999 5665


Q ss_pred             hhh
Q 008031          161 SLA  163 (580)
Q Consensus       161 ~~~  163 (580)
                      .+.
T Consensus       190 ~~~  192 (266)
T d1p9ag_         190 GFF  192 (266)
T ss_dssp             TTT
T ss_pred             hHC
Confidence            544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=1.2e-19  Score=175.41  Aligned_cols=179  Identities=26%  Similarity=0.294  Sum_probs=142.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCC-------------------------CCccccCCCCCCEEEeeC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGV-------------------------MPSDLGRLSRLRILDFSY   55 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------------------~~~~~~~l~~L~~L~l~~   55 (580)
                      ++|+|++|+|+...+..|.++++|+.|++++|.|..+                         .+..|..+++|++|++++
T Consensus        35 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~  114 (284)
T d1ozna_          35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR  114 (284)
T ss_dssp             SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCC
Confidence            4799999999966667899999999999999987522                         244566678888888888


Q ss_pred             CcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCccc
Q 008031           56 NAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP  135 (580)
Q Consensus        56 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  135 (580)
                      |.+....+..+..+.+|+.+++++|+|+.+.+..|..+++|+.|++++|+++...+..+..+++|+.+++++|++++..|
T Consensus       115 n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~  194 (284)
T d1ozna_         115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP  194 (284)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccCh
Confidence            88876667777888888899999998888777788888889999999999887778888888999999999999888778


Q ss_pred             ccccCcCCCCeeecccccCcCccChhhhh--hcCCCcccccccccC
Q 008031          136 ASFSNLKSLSSFNVSYNNLSGPVPTSLAL--KFNASSFVGNIQLCG  179 (580)
Q Consensus       136 ~~l~~l~~L~~l~l~~n~l~~~~p~~~~~--~~~~~~~~~~~~~~~  179 (580)
                      ..|..+++|++||+++|.+.+.+|..+..  .+....+.+|+..|.
T Consensus       195 ~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             hHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            88888899999999999998777766542  122233335554443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=1.5e-19  Score=163.67  Aligned_cols=156  Identities=24%  Similarity=0.300  Sum_probs=100.7

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCC-CCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISG-VMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      .++.++|+++ .+|..+.  +++++|+|++|.|+. ..+..|..+++|+.|+|++|++....+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            4566777777 5665553  467777777777764 33556667777777777777777666667777777777777777


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +|+.+.+..|..+++|++|+|++|+|+.+.++.|..+++|++|+|++|.+..... ...-...++.+.+..|.+....|.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCCh
Confidence            7776666667777777777777777776666667777777777777777663221 111112344455566666555554


Q ss_pred             h
Q 008031          161 S  161 (580)
Q Consensus       161 ~  161 (580)
                      .
T Consensus       168 ~  168 (192)
T d1w8aa_         168 K  168 (192)
T ss_dssp             T
T ss_pred             h
Confidence            3

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1e-18  Score=166.92  Aligned_cols=152  Identities=25%  Similarity=0.293  Sum_probs=140.0

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|+ .++ .++.+++|++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+|+.|++++|
T Consensus        58 ~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n  134 (266)
T d1p9ag_          58 TQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN  134 (266)
T ss_dssp             CEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred             ccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceeecccccccccccccccccc
Confidence            47999999999 444 4688999999999999999 45778999999999999999999888888999999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG  156 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~  156 (580)
                      .++...+..+..+++|+.|++++|++++..+..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus       135 ~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             ccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            999888888999999999999999999888888999999999999999999 788888899999999999999874

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=5.6e-18  Score=163.50  Aligned_cols=154  Identities=22%  Similarity=0.290  Sum_probs=140.6

Q ss_pred             CCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCccc
Q 008031            7 YNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQI   86 (580)
Q Consensus         7 ~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~   86 (580)
                      .|.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|+|++..+..|..+++|+.|+|++|+|+...
T Consensus        90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~  169 (284)
T d1ozna_          90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (284)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence            44455445678899999999999999998777888999999999999999999777788999999999999999999988


Q ss_pred             chhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccCh
Q 008031           87 LDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus        87 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      +..|..+++|+.|++++|++++..|..|..+++|++|++++|.+++..+..|..+++|++|++++|++.+..+.
T Consensus       170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~  243 (284)
T d1ozna_         170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA  243 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred             hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence            99999999999999999999999999999999999999999999988888999999999999999999976553

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=7.4e-18  Score=152.40  Aligned_cols=135  Identities=22%  Similarity=0.298  Sum_probs=121.6

Q ss_pred             CcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCC-CCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeec
Q 008031           24 LQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGS-LPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLK  102 (580)
Q Consensus        24 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  102 (580)
                      .+++++++|+++ .+|..+.  +++++|+|++|+|++. .+..|..+++|+.|+|++|.+....+..+..+++|+.|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            568999999999 5666553  6899999999999854 46678999999999999999999999999999999999999


Q ss_pred             cccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccChh
Q 008031          103 RNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVPTS  161 (580)
Q Consensus       103 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~  161 (580)
                      +|+|+...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++.+..+..
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~  145 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA  145 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH
Confidence            99999888889999999999999999999888889999999999999999998665543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.73  E-value=2.9e-18  Score=168.04  Aligned_cols=143  Identities=28%  Similarity=0.519  Sum_probs=132.9

Q ss_pred             CCCCcEEEccCCccCCC--CCccccCCCCCCEEEeeC-CcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCC
Q 008031           21 LSELQEISLSHNKISGV--MPSDLGRLSRLRILDFSY-NAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLS   97 (580)
Q Consensus        21 l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~   97 (580)
                      ...++.|||++|.+++.  +|..++++++|++|+|++ |++++.+|..|.+|++|++|+|++|++.+..+..+..+.+|+
T Consensus        49 ~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~  128 (313)
T d1ogqa_          49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence            34699999999999874  789999999999999987 899989999999999999999999999999999999999999


Q ss_pred             eeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCC-CeeecccccCcCccChhhh
Q 008031           98 VLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSL-SSFNVSYNNLSGPVPTSLA  163 (580)
Q Consensus        98 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L-~~l~l~~n~l~~~~p~~~~  163 (580)
                      .++++.|.+.+.+|..+..++.++.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+.
T Consensus       129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~  195 (313)
T d1ogqa_         129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA  195 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG
T ss_pred             ccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999988876 7899999999998887665

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.72  E-value=4.4e-17  Score=158.90  Aligned_cols=157  Identities=29%  Similarity=0.407  Sum_probs=112.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCcc---------------
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPAS---------------   65 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------------   65 (580)
                      ++|||++|+|+...+..|.++++|++|++++|.+..+.|..|..+++|++|++++|+|+. +|..               
T Consensus        34 ~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~~~~l~~L~~~~n~l  112 (305)
T d1xkua_          34 ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEI  112 (305)
T ss_dssp             CEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCCTTCCEEECCSSCC
T ss_pred             CEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccchhhhhhhhhccccch
Confidence            479999999995555679999999999999999998888899999999999999998763 1111               


Q ss_pred             ---------------------------------CcCCCCCC---------------------EEECcCCCCCcccchhhh
Q 008031           66 ---------------------------------FSNLSSLV---------------------SLTLESNNLDDQILDSLD   91 (580)
Q Consensus        66 ---------------------------------~~~l~~L~---------------------~L~l~~N~l~~~~~~~~~   91 (580)
                                                       |..+++|+                     .|++++|.++...+..+.
T Consensus       113 ~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~~  192 (305)
T d1xkua_         113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLK  192 (305)
T ss_dssp             CBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGT
T ss_pred             hhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHhh
Confidence                                             22233444                     444444444444445566


Q ss_pred             ccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCccC
Q 008031           92 KLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        92 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      .+++++.|++++|.+++..+..+..+++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|+....
T Consensus       193 ~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~  259 (305)
T d1xkua_         193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS  259 (305)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred             ccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccCh
Confidence            6667777777777777666666777777777777777776 456667777777777777777775433

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=2.8e-16  Score=142.70  Aligned_cols=145  Identities=28%  Similarity=0.446  Sum_probs=122.6

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|++++|.|+. + +.+..+++|++|+|++|+|++. + .+..+++|++|++++|.+. .++ .+.++++|+.|++++|
T Consensus        43 ~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~  116 (199)
T d2omxa2          43 TTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNN  116 (199)
T ss_dssp             CEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSS
T ss_pred             CEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-c-cccCCcccccccccccccc-ccc-cccccccccccccccc
Confidence            478999999984 3 3588899999999999999864 3 3899999999999999988 444 4889999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      .+...  ..+..+++|+.|++++|++.. ++ .+..+++|+.|++.+|.+++..  .+.++++|+.|++++|+++..
T Consensus       117 ~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i  187 (199)
T d2omxa2         117 QITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDI  187 (199)
T ss_dssp             CCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred             ccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCCC
Confidence            98764  357789999999999999974 33 5888999999999999998643  488999999999999999863

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=8.1e-17  Score=140.60  Aligned_cols=129  Identities=20%  Similarity=0.213  Sum_probs=110.7

Q ss_pred             ccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCC
Q 008031           16 ASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHN   95 (580)
Q Consensus        16 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~   95 (580)
                      +.+.++.+|++|||++|+|+. +++.+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~   88 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD   88 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence            457788899999999999994 5777788999999999999999 444 5899999999999999998877777888999


Q ss_pred             CCeeeeccccccccCC-ccccCCCCCcEEEccccccCCccc----ccccCcCCCCeee
Q 008031           96 LSVLNLKRNQISGHIP-STIGNISTLTILDLSQNKLSGEIP----ASFSNLKSLSSFN  148 (580)
Q Consensus        96 L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~----~~l~~l~~L~~l~  148 (580)
                      |+.|++++|+|+.... ..+..+++|++|++++|.++. .+    ..+..+|+|++||
T Consensus        89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             cccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            9999999999985422 468889999999999999974 34    3578899999987

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.65  E-value=3e-16  Score=130.20  Aligned_cols=103  Identities=29%  Similarity=0.406  Sum_probs=76.5

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|||++|+|+ .++ .+.++++|++||+++|+|+ .+|..|..+++|++|++++|+|++ +| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57888888888 444 4788888888888888887 456677888888888888888873 44 4777888888888888


Q ss_pred             CCCcccc-hhhhccCCCCeeeeccccccc
Q 008031           81 NLDDQIL-DSLDKLHNLSVLNLKRNQISG  108 (580)
Q Consensus        81 ~l~~~~~-~~~~~l~~L~~L~l~~N~l~~  108 (580)
                      +|+.... ..+..+++|+.|++++|+++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            8865432 456677777777777777763

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.65  E-value=1e-15  Score=140.07  Aligned_cols=145  Identities=25%  Similarity=0.394  Sum_probs=122.5

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|++++|.|+. ++ .+.++++|++|+|++|+|+++ + .+..+++|++|++++|+|++ ++ .+..+++|+.|++++|
T Consensus        49 ~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~  122 (210)
T d1h6ta2          49 DQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHN  122 (210)
T ss_dssp             CEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTS
T ss_pred             cEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccccccc
Confidence            468999999984 33 488999999999999999964 3 47889999999999999984 55 5888999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcCc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      .+..  ...+..+++|+.+++++|.+++.  ..+..+++|+++++++|++++. + .+.++++|+.|++++|+++..
T Consensus       123 ~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l  193 (210)
T d1h6ta2         123 GISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL  193 (210)
T ss_dssp             CCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC
T ss_pred             cccc--ccccccccccccccccccccccc--cccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCCC
Confidence            9865  34688899999999999999843  3577899999999999999864 3 388999999999999999853

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.62  E-value=1.6e-15  Score=138.80  Aligned_cols=139  Identities=30%  Similarity=0.442  Sum_probs=120.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++ ++ .++++++|+.|++++|+|+. +| .+..+++|+.|++++|.+. .+ ..+..+++|+.+++++|
T Consensus        71 ~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n  144 (210)
T d1h6ta2          71 TKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN  144 (210)
T ss_dssp             CEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSS
T ss_pred             CEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccccc
Confidence            479999999995 44 47899999999999999995 44 5889999999999999987 33 35889999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeeccc
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSY  151 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~  151 (580)
                      .++.  +..+..+++|+.+++++|++++. + .+.++++|+.|+|++|+++. ++ .|..+++|++|+|++
T Consensus       145 ~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         145 KITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             cccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            9976  44677899999999999999854 3 38899999999999999984 44 599999999999874

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.61  E-value=1.5e-15  Score=125.91  Aligned_cols=118  Identities=27%  Similarity=0.370  Sum_probs=85.0

Q ss_pred             cEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccc
Q 008031           25 QEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRN  104 (580)
Q Consensus        25 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  104 (580)
                      +.|||++|.|+ .++ .+..+++|++|++++|+|+ .+|..|..+++|+.|++++|.|+..  ..+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc--CccccccccCeEECCCC
Confidence            57888888888 444 4788888888888888888 5677788888888888888888764  24778888888888888


Q ss_pred             cccccCC-ccccCCCCCcEEEccccccCCcc---cccccCcCCCCee
Q 008031          105 QISGHIP-STIGNISTLTILDLSQNKLSGEI---PASFSNLKSLSSF  147 (580)
Q Consensus       105 ~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~---~~~l~~l~~L~~l  147 (580)
                      +|+.... ..+..+++|+.|++++|+++...   ......+|+|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            8874432 45677788888888888876321   1223345666554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.60  E-value=4.6e-15  Score=144.27  Aligned_cols=109  Identities=22%  Similarity=0.251  Sum_probs=91.5

Q ss_pred             CCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEc
Q 008031           46 SRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDL  125 (580)
Q Consensus        46 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  125 (580)
                      ++|+.|++++|.++...+..|..++.++.|++++|.+++..+..+..+++|++|+|++|+|+ .+|..+..+++|++|+|
T Consensus       171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L  249 (305)
T d1xkua_         171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  249 (305)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence            34555666666666556677888999999999999999998999999999999999999999 66888999999999999


Q ss_pred             cccccCCccccc------ccCcCCCCeeecccccCc
Q 008031          126 SQNKLSGEIPAS------FSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       126 ~~N~l~~~~~~~------l~~l~~L~~l~l~~n~l~  155 (580)
                      ++|+|+......      +..+++|+.|++++|++.
T Consensus       250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             CCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            999999643333      345788999999999986

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=7.6e-16  Score=134.31  Aligned_cols=121  Identities=25%  Similarity=0.266  Sum_probs=103.3

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|||++|+|+ .++..+..+++|+.|||++|.|+.+ + .|..+++|++|++++|+|++..+..+..+++|+.|+|++|
T Consensus        21 r~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N   97 (162)
T d1a9na_          21 RELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN   97 (162)
T ss_dssp             EEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSC
T ss_pred             cEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCccccccccccccceeccc
Confidence            36999999999 5677778899999999999999954 3 5889999999999999999655556678999999999999


Q ss_pred             CCCcccc-hhhhccCCCCeeeeccccccccCCc----cccCCCCCcEEEc
Q 008031           81 NLDDQIL-DSLDKLHNLSVLNLKRNQISGHIPS----TIGNISTLTILDL  125 (580)
Q Consensus        81 ~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~l  125 (580)
                      +|+.... ..+..+++|++|++++|.++. .+.    .+..+++|++||.
T Consensus        98 ~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          98 SLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             CCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred             cccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence            9977543 568899999999999999984 443    4778999999873

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.59  E-value=8.4e-15  Score=135.82  Aligned_cols=149  Identities=26%  Similarity=0.378  Sum_probs=112.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|++++|+|+. + +.+.++++|++|+|++|.+++..  .+..+++|+.|++++|.++. ++ .+..+++|+.|.+++|
T Consensus        44 ~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~  117 (227)
T d1h6ua2          44 TTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTST  117 (227)
T ss_dssp             CEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTS
T ss_pred             CEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccc--cccccccccccccccccccc-cc-cccccccccccccccc
Confidence            478999999994 4 35899999999999999998553  38899999999999999883 33 4788899999999988


Q ss_pred             CCCcccc--------------------hhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccC
Q 008031           81 NLDDQIL--------------------DSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSN  140 (580)
Q Consensus        81 ~l~~~~~--------------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~  140 (580)
                      .+.+..+                    ..+..+++|+.|++++|.+++..  .+..+++|+.|+|++|++++. + .+..
T Consensus       118 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~  193 (227)
T d1h6ua2         118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLAS  193 (227)
T ss_dssp             CCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGG
T ss_pred             cccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcC
Confidence            8765322                    12445567777777777776432  267777888888888877743 2 3777


Q ss_pred             cCCCCeeecccccCcCccC
Q 008031          141 LKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       141 l~~L~~l~l~~n~l~~~~p  159 (580)
                      +++|++|++++|++++..|
T Consensus       194 l~~L~~L~Ls~N~lt~i~~  212 (227)
T d1h6ua2         194 LPNLIEVHLKNNQISDVSP  212 (227)
T ss_dssp             CTTCCEEECTTSCCCBCGG
T ss_pred             CCCCCEEECcCCcCCCCcc
Confidence            7888888888888775443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.58  E-value=9.3e-15  Score=132.46  Aligned_cols=135  Identities=31%  Similarity=0.465  Sum_probs=115.2

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|++. + .+.++++|++|++++|.+.. ++ .+..+++|+.|++++|.+...  ..+..+++|+.|++++|
T Consensus        65 ~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n  138 (199)
T d2omxa2          65 TQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSN  138 (199)
T ss_dssp             CEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSS
T ss_pred             CcCccccccccCc-c-cccCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhh
Confidence            4799999999954 3 39999999999999999984 44 488999999999999998843  34888999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCee
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSF  147 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l  147 (580)
                      ++...  ..+..+++|+.|++.+|++++. + .+..+++|++|++++|++++ ++ .+..+++|+.|
T Consensus       139 ~l~~~--~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         139 TISDI--SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CCCCC--GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             hhccc--ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            99753  3588899999999999999854 3 48899999999999999985 33 58888988875

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.52  E-value=5e-14  Score=141.35  Aligned_cols=148  Identities=30%  Similarity=0.468  Sum_probs=89.4

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      .|++++|.+++..|  +..+++|++|++++|.++. + +.+..+++|+.|++++|++++..+  +..+++|+.|++++|.
T Consensus       201 ~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~  274 (384)
T d2omza2         201 SLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ  274 (384)
T ss_dssp             EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred             eeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcc
Confidence            34555555553322  3334455555555555542 1 234445555555555555543221  4444455555555444


Q ss_pred             CCccc--------------------chhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCc
Q 008031           82 LDDQI--------------------LDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNL  141 (580)
Q Consensus        82 l~~~~--------------------~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l  141 (580)
                      +++..                    ...+..+++++.|++++|++++..  .+..+++|++|++++|++++ ++ .|.++
T Consensus       275 l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l  350 (384)
T d2omza2         275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANL  350 (384)
T ss_dssp             CCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGC
T ss_pred             cCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCC
Confidence            43321                    234667778888888888888653  37788889999999988874 33 58888


Q ss_pred             CCCCeeecccccCcCccC
Q 008031          142 KSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus       142 ~~L~~l~l~~n~l~~~~p  159 (580)
                      ++|++|++++|++++.+|
T Consensus       351 ~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         351 TNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             TTCCEEECCSSCCCBCGG
T ss_pred             CCCCEEECCCCcCCCChh
Confidence            889999999988887655

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.52  E-value=4.4e-14  Score=141.81  Aligned_cols=141  Identities=28%  Similarity=0.445  Sum_probs=110.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCC-------------------
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL-------------------   62 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-------------------   62 (580)
                      .|++++|.++. + +.+..+++|+.|++++|.+++..  .+..+++|+.|++++|++++..                   
T Consensus       223 ~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~  298 (384)
T d2omza2         223 ELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE  298 (384)
T ss_dssp             EEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCS
T ss_pred             EEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCccccccccccccccccccc
Confidence            57777777773 2 35677777777777777777442  3666777777777777766322                   


Q ss_pred             -CccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCc
Q 008031           63 -PASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNL  141 (580)
Q Consensus        63 -~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l  141 (580)
                       ...+..+++++.|++++|++++..  .+..+++|+.|++++|+|++ ++ .+..+++|++|++++|++++..|  +.++
T Consensus       299 ~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l  372 (384)
T d2omza2         299 DISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANL  372 (384)
T ss_dssp             CCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred             cccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccC
Confidence             123566789999999999998754  38899999999999999984 44 58999999999999999997654  8999


Q ss_pred             CCCCeeecccc
Q 008031          142 KSLSSFNVSYN  152 (580)
Q Consensus       142 ~~L~~l~l~~n  152 (580)
                      ++|+.|+|++|
T Consensus       373 ~~L~~L~L~~N  383 (384)
T d2omza2         373 TRITQLGLNDQ  383 (384)
T ss_dssp             TTCSEEECCCE
T ss_pred             CCCCEeeCCCC
Confidence            99999999998

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.51  E-value=2e-16  Score=143.07  Aligned_cols=131  Identities=24%  Similarity=0.361  Sum_probs=84.2

Q ss_pred             cccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhc
Q 008031           13 RIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDK   92 (580)
Q Consensus        13 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~   92 (580)
                      .++..+..+++|+.|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .++..+..+++|+.|++++|+|+..  ..+..
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~  113 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK  113 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred             hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence            345567777777777777777774 33 4667777777777777776 4454444556677777777777653  34666


Q ss_pred             cCCCCeeeeccccccccCC-ccccCCCCCcEEEccccccCCccccc----------ccCcCCCCeee
Q 008031           93 LHNLSVLNLKRNQISGHIP-STIGNISTLTILDLSQNKLSGEIPAS----------FSNLKSLSSFN  148 (580)
Q Consensus        93 l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~----------l~~l~~L~~l~  148 (580)
                      +++|+.|++++|+|+.... ..+..+++|+.|+|++|.+....+..          +..+|+|+.||
T Consensus       114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            7777777777777763321 34666777777777777765322221          45567777665

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=4.3e-14  Score=132.34  Aligned_cols=159  Identities=18%  Similarity=0.174  Sum_probs=109.1

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCC-CccccCCCCCCEEEeeC-CcCCCCCCccCcCCCCCCEEECc
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVM-PSDLGRLSRLRILDFSY-NAINGSLPASFSNLSSLVSLTLE   78 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~   78 (580)
                      ++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|..+++++.|.+.. |++....+..|.++++|+.|+++
T Consensus        32 ~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~  111 (242)
T d1xwdc1          32 IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS  111 (242)
T ss_dssp             SEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEE
T ss_pred             CEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccc
Confidence            47899999998555557888999999999999876543 55678888888888764 66776677778888888888888


Q ss_pred             CCCCCcccch-hh------------------------hcc-CCCCeeeeccccccccCCccccCCCCCcEE-EccccccC
Q 008031           79 SNNLDDQILD-SL------------------------DKL-HNLSVLNLKRNQISGHIPSTIGNISTLTIL-DLSQNKLS  131 (580)
Q Consensus        79 ~N~l~~~~~~-~~------------------------~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L-~l~~N~l~  131 (580)
                      +|+++...+. .+                        ..+ ..++.|++++|+++...+. ....+++..+ ++.+|+++
T Consensus       112 ~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~-~~~~~~l~~~~~l~~n~l~  190 (242)
T d1xwdc1         112 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNC-AFNGTQLDELNLSDNNNLE  190 (242)
T ss_dssp             SCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTT-TTTTCCEEEEECTTCTTCC
T ss_pred             hhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccc-cccchhhhccccccccccc
Confidence            8887653221 11                        111 2455566666666643333 3334444444 45677777


Q ss_pred             CcccccccCcCCCCeeecccccCcCccCh
Q 008031          132 GEIPASFSNLKSLSSFNVSYNNLSGPVPT  160 (580)
Q Consensus       132 ~~~~~~l~~l~~L~~l~l~~n~l~~~~p~  160 (580)
                      ...+..|.++++|+.|++++|+|+..++.
T Consensus       191 ~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~  219 (242)
T d1xwdc1         191 ELPNDVFHGASGPVILDISRTRIHSLPSY  219 (242)
T ss_dssp             CCCTTTTTTSCCCSEEECTTSCCCCCCSS
T ss_pred             cccHHHhcCCCCCCEEECCCCcCCccCHH
Confidence            54455678888888888888888855443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.50  E-value=8.3e-14  Score=128.97  Aligned_cols=141  Identities=23%  Similarity=0.402  Sum_probs=113.8

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCC-----------------
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLP-----------------   63 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-----------------   63 (580)
                      ++|+|++|+|++..+  +..+++|+.|++++|.++. ++ .+..+++|+.|++++|.+.+..+                 
T Consensus        66 ~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~  141 (227)
T d1h6ua2          66 IGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI  141 (227)
T ss_dssp             CEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred             cEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccccccccccccccchhccccchhhhhchhhhh
Confidence            478999999985433  8999999999999999884 33 57788888888888887663211                 


Q ss_pred             ---ccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccC
Q 008031           64 ---ASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSN  140 (580)
Q Consensus        64 ---~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~  140 (580)
                         ..+..+++|+.|++++|.++...  .+..+++|+.|+|++|++++. + .+..+++|++|+|++|++++. + .+.+
T Consensus       142 ~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~  215 (227)
T d1h6ua2         142 TNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLAN  215 (227)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTT
T ss_pred             chhhhhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-cccc
Confidence               12456778999999999997643  488999999999999999854 3 388999999999999999954 3 3899


Q ss_pred             cCCCCeeeccc
Q 008031          141 LKSLSSFNVSY  151 (580)
Q Consensus       141 l~~L~~l~l~~  151 (580)
                      +++|+.|++++
T Consensus       216 l~~L~~L~lsn  226 (227)
T d1h6ua2         216 TSNLFIVTLTN  226 (227)
T ss_dssp             CTTCCEEEEEE
T ss_pred             CCCCCEEEeeC
Confidence            99999999873

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=3.1e-13  Score=116.61  Aligned_cols=104  Identities=22%  Similarity=0.197  Sum_probs=47.6

Q ss_pred             EEEeeCCcCCCCCCccCcCCCCCCEEECcCC-CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEcccc
Q 008031           50 ILDFSYNAINGSLPASFSNLSSLVSLTLESN-NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQN  128 (580)
Q Consensus        50 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  128 (580)
                      .++++++.+. ..|..+..+++|++|++++| .|+.+.+..|..+++|+.|+|++|+|+.+.+..|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            3444444443 23333444444444444333 244444444444444555555555544444444555555555555555


Q ss_pred             ccCCcccccccCcCCCCeeecccccCc
Q 008031          129 KLSGEIPASFSNLKSLSSFNVSYNNLS  155 (580)
Q Consensus       129 ~l~~~~~~~l~~l~~L~~l~l~~n~l~  155 (580)
                      +|+...+..|..+ +|+.|+|++|+|.
T Consensus        91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          91 ALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             CCcccChhhhccc-cccccccCCCccc
Confidence            5553222233222 4555555555554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=1.7e-13  Score=118.29  Aligned_cols=111  Identities=19%  Similarity=0.076  Sum_probs=90.8

Q ss_pred             cCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCc-CCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCC
Q 008031           19 GKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNA-INGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLS   97 (580)
Q Consensus        19 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~   97 (580)
                      ..+...+.++++++.+. ..|..+..+++|+.|++++|+ |+...+..|.++++|+.|+|++|+|+.+.+..|..+++|+
T Consensus         5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~   83 (156)
T d2ifga3           5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS   83 (156)
T ss_dssp             SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred             CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence            34456678899999888 567778889999999997664 8866667799999999999999999988888899999999


Q ss_pred             eeeeccccccccCCccccCCCCCcEEEccccccC
Q 008031           98 VLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS  131 (580)
Q Consensus        98 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  131 (580)
                      +|+|++|+|+. +|.......+|+.|+|++|.+.
T Consensus        84 ~L~Ls~N~l~~-l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          84 RLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             EEECCSSCCSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred             ceeccCCCCcc-cChhhhccccccccccCCCccc
Confidence            99999999984 4444444457999999999885

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=3.4e-12  Score=119.12  Aligned_cols=156  Identities=18%  Similarity=0.195  Sum_probs=124.2

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCC-CccCcCCCCCCEEECcC-
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSL-PASFSNLSSLVSLTLES-   79 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~-   79 (580)
                      +++.++++++ .+|+.+.  +++++|||++|+|+.+.+..|..+++|++|+|++|.+...+ +..|..++++++|.+.. 
T Consensus        12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            5778888888 7877664  58999999999999766778999999999999999987544 45788999999999864 


Q ss_pred             CCCCcccchhhhccCCCCeeeeccccccccCCc-cccCCCCCcEEEccccccCCcccccccCcC-CCCeeecccccCcCc
Q 008031           80 NNLDDQILDSLDKLHNLSVLNLKRNQISGHIPS-TIGNISTLTILDLSQNKLSGEIPASFSNLK-SLSSFNVSYNNLSGP  157 (580)
Q Consensus        80 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~-~L~~l~l~~n~l~~~  157 (580)
                      |++....+..|..+++|++|++++|.++...+. .+..+..+..+...++.+....+..|..++ .+..|++++|+++..
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i  168 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  168 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence            788888888899999999999999999754332 244556666677778788765566677664 788899999999855


Q ss_pred             cCh
Q 008031          158 VPT  160 (580)
Q Consensus       158 ~p~  160 (580)
                      .+.
T Consensus       169 ~~~  171 (242)
T d1xwdc1         169 HNC  171 (242)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.32  E-value=2.4e-14  Score=129.11  Aligned_cols=133  Identities=24%  Similarity=0.261  Sum_probs=107.9

Q ss_pred             CCCCcEEEccCC--ccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCe
Q 008031           21 LSELQEISLSHN--KISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSV   98 (580)
Q Consensus        21 l~~L~~L~l~~n--~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~   98 (580)
                      ...++.++++.+  .++ .++..+..+++|++|+|++|+|+ .++ .|..+++|+.|+|++|.|+.+ +.....+++|+.
T Consensus        22 ~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~   97 (198)
T d1m9la_          22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKI-ENLDAVADTLEE   97 (198)
T ss_dssp             CTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCE
T ss_pred             ccccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccccc-cccccccccccc
Confidence            345677777765  344 56678999999999999999999 454 588999999999999999754 445556678999


Q ss_pred             eeeccccccccCCccccCCCCCcEEEccccccCCccc-ccccCcCCCCeeecccccCcCccC
Q 008031           99 LNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP-ASFSNLKSLSSFNVSYNNLSGPVP  159 (580)
Q Consensus        99 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~l~l~~n~l~~~~p  159 (580)
                      |++++|+++..  +.+..+++|+.|+|++|+++.... ..|..+++|+.|++++|++....+
T Consensus        98 L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  157 (198)
T d1m9la_          98 LWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             EECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred             ccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence            99999999853  347889999999999999985422 568999999999999999875443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.22  E-value=3.7e-12  Score=121.74  Aligned_cols=155  Identities=21%  Similarity=0.249  Sum_probs=95.1

Q ss_pred             CEEEecCCccccc-ccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCC-cCCCC-CCccCcCCCCCCEEEC
Q 008031            1 MFLALQYNNLSGR-IPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYN-AINGS-LPASFSNLSSLVSLTL   77 (580)
Q Consensus         1 ~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~l   77 (580)
                      ++|||+++.+++. +...+.++++|++|+|++|.++...+..+..+++|+.|+|+++ .++.. +...+.++++|++|++
T Consensus        49 ~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~l  128 (284)
T d2astb2          49 QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL  128 (284)
T ss_dssp             CEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC
T ss_pred             CEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccc
Confidence            4688888887743 3455778888888888888887666667778888888888884 46521 2222356778888888


Q ss_pred             cCC-CCCccc-chhhhc-cCCCCeeeeccc--ccccc-CCccccCCCCCcEEEcccc-ccCCcccccccCcCCCCeeecc
Q 008031           78 ESN-NLDDQI-LDSLDK-LHNLSVLNLKRN--QISGH-IPSTIGNISTLTILDLSQN-KLSGEIPASFSNLKSLSSFNVS  150 (580)
Q Consensus        78 ~~N-~l~~~~-~~~~~~-l~~L~~L~l~~N--~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~~~~l~~l~~L~~l~l~  150 (580)
                      +++ .++... ...+.. .++|+.|+++++  .++.. +......+++|++|+|++| .+++.....+..+++|++|+++
T Consensus       129 s~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~  208 (284)
T d2astb2         129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS  208 (284)
T ss_dssp             CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred             ccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECC
Confidence            875 454321 122222 346666666653  23221 1122344566777777664 3555555566666677777776


Q ss_pred             cc-cCc
Q 008031          151 YN-NLS  155 (580)
Q Consensus       151 ~n-~l~  155 (580)
                      ++ .++
T Consensus       209 ~C~~i~  214 (284)
T d2astb2         209 RCYDII  214 (284)
T ss_dssp             TCTTCC
T ss_pred             CCCCCC
Confidence            63 444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=1.2e-10  Score=110.95  Aligned_cols=144  Identities=19%  Similarity=0.216  Sum_probs=104.8

Q ss_pred             cCCCCCcEEEccCCccCCC-CCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC-CCCcccc-hhhhccCC
Q 008031           19 GKLSELQEISLSHNKISGV-MPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN-NLDDQIL-DSLDKLHN   95 (580)
Q Consensus        19 ~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~-~~~~~l~~   95 (580)
                      ....+|++|||++|.++.. +...+..+++|++|+|++|.+++..+..+..+++|+.|+|+++ .++.... ..+..+++
T Consensus        43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~  122 (284)
T d2astb2          43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR  122 (284)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred             ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence            3456899999999998733 3556788999999999999998777778889999999999994 6765332 33467899


Q ss_pred             CCeeeeccc-ccccc-CCcccc-CCCCCcEEEcccc--ccCCc-ccccccCcCCCCeeeccccc-CcCccChhh
Q 008031           96 LSVLNLKRN-QISGH-IPSTIG-NISTLTILDLSQN--KLSGE-IPASFSNLKSLSSFNVSYNN-LSGPVPTSL  162 (580)
Q Consensus        96 L~~L~l~~N-~l~~~-~~~~~~-~l~~L~~L~l~~N--~l~~~-~~~~l~~l~~L~~l~l~~n~-l~~~~p~~~  162 (580)
                      |++|+++++ .++.. +...+. ..++|+.|+++++  .++.. +...+..+++|+.|++++|. +++.....+
T Consensus       123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l  196 (284)
T d2astb2         123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF  196 (284)
T ss_dssp             CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred             ccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhh
Confidence            999999986 45432 112233 3478999999975  45432 23344678999999999864 664444443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.98  E-value=3.2e-09  Score=104.01  Aligned_cols=135  Identities=21%  Similarity=0.276  Sum_probs=87.3

Q ss_pred             EEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCC
Q 008031            2 FLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNN   81 (580)
Q Consensus         2 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   81 (580)
                      +|||++|.|+ .+|+.   +++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++ .++..   .+.|++|++++|.
T Consensus        42 ~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~  109 (353)
T d1jl5a_          42 ELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQ  109 (353)
T ss_dssp             EEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSC
T ss_pred             EEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---ccccccccccccc
Confidence            5777777777 56643   456777788877777 45543   346777777777777 33321   1357778888777


Q ss_pred             CCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccCCcccccccCcCCCCeeecccccCcC
Q 008031           82 LDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIPASFSNLKSLSSFNVSYNNLSG  156 (580)
Q Consensus        82 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~  156 (580)
                      +... | .+..+++|+.|++++|.++.. +.   ....+..+.+.++...  ....+..++.++.+++++|.+..
T Consensus       110 l~~l-p-~~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~  176 (353)
T d1jl5a_         110 LEKL-P-ELQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK  176 (353)
T ss_dssp             CSSC-C-CCTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS
T ss_pred             cccc-c-chhhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccccccccceecccccccccc
Confidence            7653 3 245677777788777777632 22   2355666666666554  23456677778888888887764

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.97  E-value=5.4e-11  Score=117.02  Aligned_cols=141  Identities=18%  Similarity=0.244  Sum_probs=75.2

Q ss_pred             ccccCCCCCcEEEccCCccCCC----CCccccCCCCCCEEEeeCCcCCCCCC----c---------cCcCCCCCCEEECc
Q 008031           16 ASLGKLSELQEISLSHNKISGV----MPSDLGRLSRLRILDFSYNAINGSLP----A---------SFSNLSSLVSLTLE   78 (580)
Q Consensus        16 ~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~----~---------~~~~l~~L~~L~l~   78 (580)
                      ..+..+++|++|+|++|.++..    +...+...++|+.|++++|.++..-.    .         .....+.|+.|+++
T Consensus        87 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~  166 (344)
T d2ca6a1          87 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG  166 (344)
T ss_dssp             HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC
T ss_pred             HHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecc
Confidence            3455566777777777776643    12233456677777777776541100    0         01234556666666


Q ss_pred             CCCCCcccc----hhhhccCCCCeeeecccccccc-----CCccccCCCCCcEEEccccccCCc----ccccccCcCCCC
Q 008031           79 SNNLDDQIL----DSLDKLHNLSVLNLKRNQISGH-----IPSTIGNISTLTILDLSQNKLSGE----IPASFSNLKSLS  145 (580)
Q Consensus        79 ~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~  145 (580)
                      +|.++....    ..+..+.+|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|+
T Consensus       167 ~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~  246 (344)
T d2ca6a1         167 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR  246 (344)
T ss_dssp             SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred             cccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccch
Confidence            666643222    2234455666666666665431     223345556666666666665421    233455556666


Q ss_pred             eeecccccCcC
Q 008031          146 SFNVSYNNLSG  156 (580)
Q Consensus       146 ~l~l~~n~l~~  156 (580)
                      .|++++|.+++
T Consensus       247 ~L~Ls~n~i~~  257 (344)
T d2ca6a1         247 ELGLNDCLLSA  257 (344)
T ss_dssp             EEECTTCCCCH
T ss_pred             hhhhhcCccCc
Confidence            66666666653

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.94  E-value=8.2e-11  Score=115.71  Aligned_cols=156  Identities=19%  Similarity=0.263  Sum_probs=111.7

Q ss_pred             CEEEecCCccccc----ccccccCCCCCcEEEccCCccCCCCCc-------------cccCCCCCCEEEeeCCcCCCC--
Q 008031            1 MFLALQYNNLSGR----IPASLGKLSELQEISLSHNKISGVMPS-------------DLGRLSRLRILDFSYNAINGS--   61 (580)
Q Consensus         1 ~~L~L~~N~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~-------------~~~~l~~L~~L~l~~n~l~~~--   61 (580)
                      ++|+|++|.++..    +...+...++|++|++++|.+......             .....+.|+.|++++|+++..  
T Consensus        96 ~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~  175 (344)
T d2ca6a1          96 HTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM  175 (344)
T ss_dssp             CEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGH
T ss_pred             ccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccc
Confidence            4689999998853    556678889999999999987521110             123467899999999988732  


Q ss_pred             --CCccCcCCCCCCEEECcCCCCCcc-----cchhhhccCCCCeeeecccccccc----CCccccCCCCCcEEEcccccc
Q 008031           62 --LPASFSNLSSLVSLTLESNNLDDQ-----ILDSLDKLHNLSVLNLKRNQISGH----IPSTIGNISTLTILDLSQNKL  130 (580)
Q Consensus        62 --~~~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l  130 (580)
                        +...+..+++|+.|+|++|+|+..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.+
T Consensus       176 ~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i  255 (344)
T d2ca6a1         176 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL  255 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred             ccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCcc
Confidence              233455678899999999998753     223466788899999999988643    334567788899999999998


Q ss_pred             CCccc----ccccC--cCCCCeeecccccCcC
Q 008031          131 SGEIP----ASFSN--LKSLSSFNVSYNNLSG  156 (580)
Q Consensus       131 ~~~~~----~~l~~--l~~L~~l~l~~n~l~~  156 (580)
                      ++...    ..+..  .+.|+.|++++|+++.
T Consensus       256 ~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~  287 (344)
T d2ca6a1         256 SARGAAAVVDAFSKLENIGLQTLRLQYNEIEL  287 (344)
T ss_dssp             CHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             CchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence            75422    23332  3578899999998874

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.80  E-value=1.5e-10  Score=100.16  Aligned_cols=125  Identities=23%  Similarity=0.169  Sum_probs=83.2

Q ss_pred             CCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCccc--chhhhccCCCCeee
Q 008031           23 ELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQI--LDSLDKLHNLSVLN  100 (580)
Q Consensus        23 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~  100 (580)
                      +.+.||++++...    ..+..+..+..|+..+|.+. .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            4566777765532    23444555555555555544 44445567888899999999887653  34567788899999


Q ss_pred             eccccccccCCccccCCCCCcEEEccccccCCccc-------ccccCcCCCCeeecccccC
Q 008031          101 LKRNQISGHIPSTIGNISTLTILDLSQNKLSGEIP-------ASFSNLKSLSSFNVSYNNL  154 (580)
Q Consensus       101 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-------~~l~~l~~L~~l~l~~n~l  154 (580)
                      |++|+|+...+-......+|+.|++++|.+.....       ..+..+|+|+.||  ++.+
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence            99999885433334445678889999998875443       2356788998876  5554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.75  E-value=6.4e-08  Score=94.41  Aligned_cols=115  Identities=23%  Similarity=0.299  Sum_probs=82.9

Q ss_pred             CEEEecCCcccccccccccCCCCCcEEEccCCccCCCCCccccCCCCCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCC
Q 008031            1 MFLALQYNNLSGRIPASLGKLSELQEISLSHNKISGVMPSDLGRLSRLRILDFSYNAINGSLPASFSNLSSLVSLTLESN   80 (580)
Q Consensus         1 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   80 (580)
                      ++|+|++|+|+ .+|..+   .+|+.|++++|+++. +++ +  .+.|++|++++|.|+ .+|. +..+++|+.|++++|
T Consensus        61 ~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~  130 (353)
T d1jl5a_          61 ESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNN  130 (353)
T ss_dssp             SEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSS
T ss_pred             CEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhh-h--ccccccccccccccc-cccc-hhhhccceeeccccc
Confidence            47999999999 777654   579999999999984 442 1  247999999999999 5664 688999999999999


Q ss_pred             CCCcccchhhhccCCCCeeeeccccccccCCccccCCCCCcEEEccccccC
Q 008031           81 NLDDQILDSLDKLHNLSVLNLKRNQISGHIPSTIGNISTLTILDLSQNKLS  131 (580)
Q Consensus        81 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  131 (580)
                      .+.....    ....+..+.+..+...  ....+..++.++.|++.+|...
T Consensus       131 ~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         131 SLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             CCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             ccccccc----ccccccchhhcccccc--ccccccccccceeccccccccc
Confidence            9865332    2345555666555543  2234555666677777666655

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.69  E-value=3.4e-10  Score=97.83  Aligned_cols=107  Identities=21%  Similarity=0.153  Sum_probs=53.9

Q ss_pred             CCCEEEeeCCcCCCCCCccCcCCCCCCEEECcCCCCCcccchhhhccCCCCeeeeccccccccC--CccccCCCCCcEEE
Q 008031           47 RLRILDFSYNAINGSLPASFSNLSSLVSLTLESNNLDDQILDSLDKLHNLSVLNLKRNQISGHI--PSTIGNISTLTILD  124 (580)
Q Consensus        47 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~  124 (580)
                      ..+.|+++++...    ..+..+..+..|+..+|.+ ......+..+++|++|+|++|+|+...  +..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            3445555544322    1233333344444433333 223333445666677777777666432  23345566666777


Q ss_pred             ccccccCCcccccccCcCCCCeeecccccCcCcc
Q 008031          125 LSQNKLSGEIPASFSNLKSLSSFNVSYNNLSGPV  158 (580)
Q Consensus       125 l~~N~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~  158 (580)
                      |++|.++...+-.+....+|+.|++++|+++...
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~  131 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTF  131 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred             cccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence            7777666433323333445666666777666443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.68  E-value=7.9e-10  Score=112.60  Aligned_cols=156  Identities=21%  Similarity=0.205  Sum_probs=92.7

Q ss_pred             EEEecCCcccc-----cccccccCCCCCcEEEccCCccCCC----CCccccCCCCCCEEEeeCCcCCCCCCc----c-Cc
Q 008031            2 FLALQYNNLSG-----RIPASLGKLSELQEISLSHNKISGV----MPSDLGRLSRLRILDFSYNAINGSLPA----S-FS   67 (580)
Q Consensus         2 ~L~L~~N~i~~-----~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~----~-~~   67 (580)
                      .|++++|.+..     ...........++.|++++|.+...    ....+...+.++.+++++|.++.....    . ..
T Consensus       230 ~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~  309 (460)
T d1z7xw1         230 ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE  309 (460)
T ss_dssp             EEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTS
T ss_pred             ccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccc
Confidence            46666776542     2233444566788888888776522    122344567777888877777521111    1 12


Q ss_pred             CCCCCCEEECcCCCCCcccchhh----hccCCCCeeeecccccccc----CCcccc-CCCCCcEEEccccccCCc----c
Q 008031           68 NLSSLVSLTLESNNLDDQILDSL----DKLHNLSVLNLKRNQISGH----IPSTIG-NISTLTILDLSQNKLSGE----I  134 (580)
Q Consensus        68 ~l~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~----~~~~~~-~l~~L~~L~l~~N~l~~~----~  134 (580)
                      ....|+.+++++|.++......+    ....+|++|+|++|++++.    ++..+. ..+.|++|+|++|.++..    +
T Consensus       310 ~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l  389 (460)
T d1z7xw1         310 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL  389 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred             cccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHH
Confidence            33567777787777765443333    3445777788877777542    222222 345677788887777642    3


Q ss_pred             cccccCcCCCCeeecccccCcCc
Q 008031          135 PASFSNLKSLSSFNVSYNNLSGP  157 (580)
Q Consensus       135 ~~~l~~l~~L~~l~l~~n~l~~~  157 (580)
                      ...+..+++|++||+++|+|+..
T Consensus       390 ~~~l~~~~~L~~L~Ls~N~i~~~  412 (460)
T d1z7xw1         390 AATLLANHSLRELDLSNNCLGDA  412 (460)
T ss_dssp             HHHHHHCCCCCEEECCSSSCCHH
T ss_pred             HHHHhcCCCCCEEECCCCcCCHH
Confidence            34455667777788887777643

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.56  E-value=4.6e-09  Score=106.77  Aligned_cols=161  Identities=20%  Similarity=0.135  Sum_probs=103.1

Q ss_pred             EEEecCCccccc----ccccccCCCCCcEEEccCCccCCCCCc----cc-cCCCCCCEEEeeCCcCCCCCC----ccCcC
Q 008031            2 FLALQYNNLSGR----IPASLGKLSELQEISLSHNKISGVMPS----DL-GRLSRLRILDFSYNAINGSLP----ASFSN   68 (580)
Q Consensus         2 ~L~L~~N~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~----~~-~~l~~L~~L~l~~n~l~~~~~----~~~~~   68 (580)
                      +|++++|.+...    ....+...+.++.+++++|.++.....    .+ ...+.|+.+++++|.++....    ..+..
T Consensus       259 ~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~  338 (460)
T d1z7xw1         259 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ  338 (460)
T ss_dssp             EEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccccccc
Confidence            578888887742    234456678888888888887622111    11 234578888888888874322    23345


Q ss_pred             CCCCCEEECcCCCCCcccchh----hh-ccCCCCeeeecccccccc----CCccccCCCCCcEEEccccccCCccccc--
Q 008031           69 LSSLVSLTLESNNLDDQILDS----LD-KLHNLSVLNLKRNQISGH----IPSTIGNISTLTILDLSQNKLSGEIPAS--  137 (580)
Q Consensus        69 l~~L~~L~l~~N~l~~~~~~~----~~-~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~--  137 (580)
                      .++|++|+|++|+|+......    +. ....|+.|+|++|+|+..    +...+..+++|++|+|++|+++......  
T Consensus       339 ~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~  418 (460)
T d1z7xw1         339 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV  418 (460)
T ss_dssp             CSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHH
T ss_pred             ccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHH
Confidence            567888888888886532222    22 345688888888888643    3344566788888888888887532222  


Q ss_pred             --cc-CcCCCCeeecccccCcCccChhh
Q 008031          138 --FS-NLKSLSSFNVSYNNLSGPVPTSL  162 (580)
Q Consensus       138 --l~-~l~~L~~l~l~~n~l~~~~p~~~  162 (580)
                        +. +...|+.|++.+|.+.......+
T Consensus       419 ~~l~~~~~~L~~l~l~~~~~~~~~~~~l  446 (460)
T d1z7xw1         419 ESVRQPGCLLEQLVLYDIYWSEEMEDRL  446 (460)
T ss_dssp             HHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred             HHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence              22 23468888888888875444433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.25  E-value=9.6e-07  Score=82.15  Aligned_cols=129  Identities=18%  Similarity=0.160  Sum_probs=84.4

Q ss_pred             cCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEEeeCCCCChhhhhh
Q 008031          298 STYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVFDYMPHGSLATFLH  376 (580)
Q Consensus       298 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  376 (580)
                      ++.+.||+.... ++.+++|+...........+.+|+..++.+. +--+.+++.+... ++..++||++++|.++.+...
T Consensus        25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~~lv~~~l~G~~~~~~~~  102 (263)
T d1j7la_          25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLCSEEYE  102 (263)
T ss_dssp             CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEHHHHTT
T ss_pred             CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCceEEEEEeccccccccccc
Confidence            334689988654 6677888876554444456788888887763 4345666776654 567899999999987765432


Q ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHhhc---------------------------------------------------
Q 008031          377 ARGPETPIDWPTRMKIIKGMTRGLLHLHS---------------------------------------------------  405 (580)
Q Consensus       377 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~---------------------------------------------------  405 (580)
                      ..     .   ....++.++++.++.||+                                                   
T Consensus       103 ~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         103 DE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             TC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             cc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence            21     0   112233334444444441                                                   


Q ss_pred             -------CCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          406 -------NENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       406 -------~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                             ...++|+|+.+.||++++++.+-|+||+.+.
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                   0237899999999999976656799999764

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.12  E-value=4.4e-07  Score=78.16  Aligned_cols=40  Identities=10%  Similarity=0.091  Sum_probs=21.9

Q ss_pred             ccCCCCCcEEEccccccCCc-------ccccccCcCCCCeeeccccc
Q 008031          114 IGNISTLTILDLSQNKLSGE-------IPASFSNLKSLSSFNVSYNN  153 (580)
Q Consensus       114 ~~~l~~L~~L~l~~N~l~~~-------~~~~l~~l~~L~~l~l~~n~  153 (580)
                      +...++|++|+|++|.+...       +...+...+.|+.|+++.+.
T Consensus        96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            34445566666666654421       23344455677777776654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.07  E-value=8.4e-07  Score=76.29  Aligned_cols=113  Identities=17%  Similarity=0.178  Sum_probs=78.9

Q ss_pred             ccCCCCCcEEEccCC-ccCCC----CCccccCCCCCCEEEeeCCcCCC----CCCccCcCCCCCCEEECcCCCCCcccc-
Q 008031           18 LGKLSELQEISLSHN-KISGV----MPSDLGRLSRLRILDFSYNAING----SLPASFSNLSSLVSLTLESNNLDDQIL-   87 (580)
Q Consensus        18 ~~~l~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~-   87 (580)
                      ..+.++|++|+|+++ .++..    +...+...+.|++|+|++|.|+.    .+...+...+.|+.|+|++|.|+.... 
T Consensus        11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~   90 (167)
T d1pgva_          11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA   90 (167)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence            456788999999874 46521    23356677889999999999873    333445567889999999999876433 


Q ss_pred             ---hhhhccCCCCeeeecccccccc-------CCccccCCCCCcEEEcccccc
Q 008031           88 ---DSLDKLHNLSVLNLKRNQISGH-------IPSTIGNISTLTILDLSQNKL  130 (580)
Q Consensus        88 ---~~~~~l~~L~~L~l~~N~l~~~-------~~~~~~~l~~L~~L~l~~N~l  130 (580)
                         ..+...++|++|+|++|.+...       +...+...++|+.|+++.+..
T Consensus        91 ~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          91 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence               2455667899999998876532       233455568889998876654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.97  E-value=8.9e-06  Score=74.93  Aligned_cols=75  Identities=15%  Similarity=0.116  Sum_probs=51.9

Q ss_pred             cccccCc-eEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCC--CCcceeeeeEEECCCCcEEEEEeeCCCCC
Q 008031          294 IMGKSTY-GTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIR--HPNLLALRAYYLGPKGEKLLVFDYMPHGS  370 (580)
Q Consensus       294 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~e~~~~g~  370 (580)
                      .+..|.. +.||+....++..+++|......   ...+..|+..++.+.  .-.+.+++.+..+ ++..++||++++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeeccc
Confidence            3445554 67999998888888999765432   234677888887763  2335667777665 567899999998866


Q ss_pred             hh
Q 008031          371 LA  372 (580)
Q Consensus       371 L~  372 (580)
                      +.
T Consensus        93 ~~   94 (255)
T d1nd4a_          93 LL   94 (255)
T ss_dssp             TT
T ss_pred             cc
Confidence            54

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.79  E-value=1.3e-06  Score=75.09  Aligned_cols=62  Identities=23%  Similarity=0.345  Sum_probs=29.2

Q ss_pred             cCCCCeeeecccccccc----CCccccCCCCCcEEEc--cccccCC----cccccccCcCCCCeeecccccC
Q 008031           93 LHNLSVLNLKRNQISGH----IPSTIGNISTLTILDL--SQNKLSG----EIPASFSNLKSLSSFNVSYNNL  154 (580)
Q Consensus        93 l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l--~~N~l~~----~~~~~l~~l~~L~~l~l~~n~l  154 (580)
                      ..+++.|++++|.++..    +...+...++|+.++|  ++|.+..    .+...+...++|+.|+++.+..
T Consensus        73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            34444444444444321    1223444455555443  3444432    2333445566677777666543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.62  E-value=7.9e-06  Score=69.92  Aligned_cols=118  Identities=16%  Similarity=0.193  Sum_probs=85.1

Q ss_pred             cccccccCCCCCcEEEccC-CccCCC----CCccccCCCCCCEEEeeCCcCCCC----CCccCcCCCCCCEEECcCCCCC
Q 008031           13 RIPASLGKLSELQEISLSH-NKISGV----MPSDLGRLSRLRILDFSYNAINGS----LPASFSNLSSLVSLTLESNNLD   83 (580)
Q Consensus        13 ~~~~~~~~l~~L~~L~l~~-n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~   83 (580)
                      .+.....+.++|++|+|++ +.|+..    +...+...++|++|+|++|.++..    +...+...++|+.|++++|.++
T Consensus         8 ~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_           8 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            3445556789999999997 456521    234556789999999999999742    3344566789999999999997


Q ss_pred             cccc----hhhhccCCCCeeee--ccccccc----cCCccccCCCCCcEEEcccccc
Q 008031           84 DQIL----DSLDKLHNLSVLNL--KRNQISG----HIPSTIGNISTLTILDLSQNKL  130 (580)
Q Consensus        84 ~~~~----~~~~~l~~L~~L~l--~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l  130 (580)
                      ....    ..+...++|+.++|  +.|.+..    .+...+...++|+.|+++.+..
T Consensus        88 ~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          88 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             chhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            6433    45667788987655  5677754    2444566789999999987754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=0.00022  Score=69.84  Aligned_cols=76  Identities=12%  Similarity=0.048  Sum_probs=48.1

Q ss_pred             hccccccCceEEEEEEeC-CCCEEEEEEccccc-------cccHHHHHHHHHHHhcC-CC--CcceeeeeEEECCCCcEE
Q 008031          292 AEIMGKSTYGTVYKATLE-DGSQVAVKRLREKI-------TKGQREFESEVSLLGKI-RH--PNLLALRAYYLGPKGEKL  360 (580)
Q Consensus       292 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l-~h--~niv~~~~~~~~~~~~~~  360 (580)
                      .+.||.|....||+.... +++.++||.-....       .-...+...|++.++.+ .+  ..+.+++.+.   .+..+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d---~~~~~  107 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAV  107 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc---CCCCE
Confidence            356899999999999876 46789999643211       11223455688888766 22  3455555543   34568


Q ss_pred             EEEeeCCCCC
Q 008031          361 LVFDYMPHGS  370 (580)
Q Consensus       361 lv~e~~~~g~  370 (580)
                      +|||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            9999997754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.99  E-value=0.001  Score=62.99  Aligned_cols=68  Identities=21%  Similarity=0.181  Sum_probs=44.3

Q ss_pred             eEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCCCcc--eeeeeE----EECCCCcEEEEEeeCCCC
Q 008031          301 GTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRHPNL--LALRAY----YLGPKGEKLLVFDYMPHG  369 (580)
Q Consensus       301 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~----~~~~~~~~~lv~e~~~~g  369 (580)
                      -.||++..++|+.+++|+.+... ...+++..|+..+..|....+  +..+..    .....+..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            47999999999999999976543 245667888888877742211  111110    011244678899999764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.52  E-value=0.0051  Score=59.77  Aligned_cols=72  Identities=10%  Similarity=0.134  Sum_probs=48.6

Q ss_pred             ccccccCceEEEEEEeCC--------CCEEEEEEccccccccHHHHHHHHHHHhcCC-CCcceeeeeEEECCCCcEEEEE
Q 008031          293 EIMGKSTYGTVYKATLED--------GSQVAVKRLREKITKGQREFESEVSLLGKIR-HPNLLALRAYYLGPKGEKLLVF  363 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  363 (580)
                      +.|+.|-.-.+|++...+        .+.|.+++.. . ........+|..+++.+. +.-..++++++.  +   .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~---g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C---ceEE
Confidence            567888889999998753        3457776654 2 223345678999988884 433456777663  2   5889


Q ss_pred             eeCCCCCh
Q 008031          364 DYMPHGSL  371 (580)
Q Consensus       364 e~~~~g~L  371 (580)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.58  E-value=0.028  Score=52.34  Aligned_cols=141  Identities=11%  Similarity=0.103  Sum_probs=71.5

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEccccccccHHHHHHHHHHHhcCCC-----Ccceeee-e-EEECCCCcEEEEEee
Q 008031          293 EIMGKSTYGTVYKATLEDGSQVAVKRLREKITKGQREFESEVSLLGKIRH-----PNLLALR-A-YYLGPKGEKLLVFDY  365 (580)
Q Consensus       293 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv~~~-~-~~~~~~~~~~lv~e~  365 (580)
                      +.|..|.--+.|+....+|+ +++|+.....  ...++..|++++..+..     |..+... | ......+....++.+
T Consensus        24 ~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~  100 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  100 (316)
T ss_dssp             EEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             ecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeee
Confidence            34566777888999887665 7888875432  22345556777766632     2211110 0 000013355677777


Q ss_pred             CCCCChhhhh--------------hhcCC------CCCC------------------CHHHHHHHHHHHHHHHHHhhc--
Q 008031          366 MPHGSLATFL--------------HARGP------ETPI------------------DWPTRMKIIKGMTRGLLHLHS--  405 (580)
Q Consensus       366 ~~~g~L~~~l--------------~~~~~------~~~~------------------~~~~~~~i~~~i~~~l~~LH~--  405 (580)
                      ..+......-              +....      ....                  ........+..+...+...+.  
T Consensus       101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (316)
T d2ppqa1         101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  180 (316)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             cccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc
Confidence            7664332110              00000      0000                  000122222233333333222  


Q ss_pred             -CCCcccCCCCCCCeeeCCCCCeEEeeccccc
Q 008031          406 -NENIIHGNLTSSNVLLDDSTNAKISDFGLSR  436 (580)
Q Consensus       406 -~~~i~H~Dlk~~Nil~~~~~~~kl~Dfg~~~  436 (580)
                       ..|++|+|+.+.||+++.+...-|+||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence             1589999999999999988767899999774